SAMPLE_ID	SAMPLE_NAME	PUBCHEM_SID	PRIMARY_MOA	ASSAY_NAME	LIBRARY	CAS	ALIAS	AC50	LOG_AC50	AUC	CURVE_CLASS2	DATA_POINTS	DRUG_NAME	EFFICACY	MAX_RESPONSE	P_HILL	R2	GENE_ID	GENE_SYMBOL	SMILES	SUPPLIER	SUPPLIER_ID	DATA0	DATA1	DATA2	DATA3	DATA4	DATA5	DATA6	DATA7	DATA8	DATA9	DATA10	DATA11	DATA12	DATA13	DATA14	CONC0	CONC1	CONC2	CONC3	CONC4	CONC5	CONC6	CONC7	CONC8	CONC9	CONC10	CONC11	CONC12	CONC13	CONC14
NCGC00181116-02	Carbomycin A	124893648	Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			11.0676527398	-4.9559444758	-20.1539792541	4	7		-10.27378634	-12.59572849	0.0077810221	0.9621220274			CO[C@H]1[C@@H](CC(=O)O[C@H](C)C[C@@H]2OC2\C=C/C(=O)[C@H](C)C[C@H](CC=O)[C@@H]1OC3OC(C)C(OC4CC(C)(O)C(OC(=O)CC(C)C)C(C)O4)C(C3O)N(C)C)OC(C)=O	NCI	NSC-51001	-4.19662882	-3.0331031	-2.28545979	-2.69625611	-1.95090654	-5.30345735	-12.59572849									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090820-03	4-Acetamidobenzoic acid	170466207	immune response Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	556-08-1				-13.1415500321	4	7		0	-2.34214595					O=C(C)Nc1ccc(cc1)C(=O)O	Specs	AE-562/J256200	-3.02810253	-0.01710362	-2.69796008	-3.84528557	-5.35197686	-2.19015194	-2.34214595									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179392-03	Beclomethasone	170464981		DPI_SARS-CoV-2_General	2019_NPC_01	4419-39-0		11.0676527398	-4.9559444758	-36.1703058093	-2.2	7		-63.8134394568	-48.34351474	0.0001711598	0.9946133566			OCC(=O)[C@@]4(O)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(Cl)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-855	3.27983928	4.02423828	0	0	-1.76876618	-20.71751613	-48.34351474									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159422-04	Tiopronin	170465217	Copper Chelator	DPI_SARS-CoV-2_General	2019_NPC_01	1953-02-2	 Dextiopronin; Meprin (detoxicant); ; Tiopronino;Tiopronin; Tiopronin; Thiopronine			4.9410357348	4	7		0	1.6222656				MPO	OC(=O)CNC(=O)C(C)S	Labotest	LT00451995	-0.21542856	-0.38849659	1.06504838	0.28845913	3.68218038	1.40759185	1.6222656									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159406-12	Noradrenaline bitartrate monohydrate	170465227	alpha/beta-adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	69815-49-2	; Norepinephrine bitartrate; Noreinefrina; L-(-)-NOREPINEPHRINE; L-Arterenol; NET protein, human; SLC6A2 protein, human; ;Norepinephrine bitartrate;L(-)-Norepinephrine bitartrate; Arterenol hydrochloride; Slc6a2 protein, mouse; (-)-Norepinephrine; Receptors, Adrenergic; (-)Arterenol; (-)-Arterenol bitartrate; Receptor, Adrenergi; Arterenol; Epinephrine Receptors; L(-)-Norepinephrine bitartrate; Norepinephrine Receptors;NOREPINEPHRINE; Noradrenaline bitartrate; Slc6a2 protein, rat; D-Norepinephrine Tartrate;(+/-)-NOREPINEPHRINE; Net protein, rat; Adrenergic Receptor; Norepinephrine; L-Arterenol hydrochloride; Noradrenaline Bitartrate	15.6334750258	-4.8059444758	-58.2085896655	-2.2	7		-49.496242208	-48.66796786	0.0016417601	0.9829987262	148	ADRA1A	Oc1ccc(cc1O)[C@@H](O)CN.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O	Microsource	01500436	-7.20112313	-4.08776602	-4.67695157	-7.2014448	-10.59990864	-13.02911733	-48.66796786									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00271789-02	Actinomycin D	170464668	DNA-Directed RNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	50-76-0		11.0676527398	-4.9559444758	-35.70567187	4	7		-15.509614336	-19.0210641	0.0385136217	0.9077517232		PRKDC	CC(C)[C@H]6NC(=O)[C@@H](NC(=O)c1ccc(C)c2OC3=C(C)C(=O)C(N)=C(C3=Nc12)C(=O)N[C@@H]5C(=O)N[C@@H](C(=O)N4CCC[C@H]4C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]5C)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]7CCCN7C6=O	SIGMA	A1410	-5.06620192	-4.42495174	-8.20599059	-6.2783756	-3.17971882	-9.73626709	-19.0210641									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00092386-13	Sertraline hydrochloride	170465121	Selective Seratonin Reuptake Inhibitor (SSRI)	DPI_SARS-CoV-2_General	2019_NPC_01	79559-97-0		5.5469662594	-5.2559444758	-34.9096258093	-2.2	7		-39.0650553888	-35.58338192	0.0005565144	0.9902194607		SLC6A4	Cl.Clc1ccc(cc1Cl)[C@@H]3CC[C@H](NC)c2ccccc23	Microsource	01505262	0.07019582	1.02377404	2.94655261	-2.28008127	-3.44871339	-21.42385284	-35.58338192									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249912-01	Floctafenine	170465681	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	23779-99-9		9.8640558873	-5.0059444758	-28.4794609965	-2.2	7		-42.426820612	-30.77235051	0.0000163625	0.9983459243	5743	PTGS2	OCC(O)COC(=O)c3ccccc3Nc1ccnc2c(cccc12)C(F)(F)F	GVK	FFS-11-286-NCI-159	1.39181371	1.64927798	0.57273769	-0.68477688	-4.96624879	-15.45810255	-30.77235051									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160408-06	Benziodarone			DPI_SARS-CoV-2_General	2019_NPC_02			6.2237985085	-5.2059444758	-65.0049253966	-2.2	7		-75.0828854066	-65.42358369	0.0000202881	0.9981559416			CCC1=C(C(=O)C2=CC(=C(O)C(=C2)I)I)C3=CC=CC=C3O1	Bionet	KS-1133_CM2	0	2.77899697	0	1.04997311	-8.97987311	-38.51465614	-65.42358369									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389765-01	DIBEKACIN			DPI_SARS-CoV-2_General	2019_NPC_02	34493-98-6				1.0756959266	4	7		0	-0.82290824					NC[C@@H]1CC[C@@H](N)[C@H](O1)O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O	Microsource	01503114	1.50061273	-2.03515905	0.59773564	0.979819	3.41468051	-1.24483277	-0.82290824									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00263905-04	TOLTRAZURIL			DPI_SARS-CoV-2_General	2019_NPC_02	69004-03-1		13.9333492831	-4.8559444758	-6.0900386518	4	7		-20.538481664	-14.19873472	0.0088738363	0.9590722402			CN1C(=O)NC(=O)N(C1=O)C2=CC=C(OC3=CC=C(SC(F)(F)F)C=C3)C(=C2)C	Microsource	01505681	0.36301417	2.45096907	3.14807435	1.11077333	-1.3473374	-3.72040586	-14.19873472									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160431-02	2-[(4-Chloro-3-methylphenyl)amino]benzoic acid			DPI_SARS-CoV-2_General	2019_NPC_02			1.9681378985	-5.7059444758	-100.7206299221	-2.2	7		-86.2847119836	-75.72658517	0.0013921097	0.9843720396			CC1=CC(=CC=C1Cl)NC2=CC=CC=C2C(O)=O	Scientific Exchange	F-137102	4.60357465	0	4.16539697	-6.22734607	-36.68702326	-52.72453965	-75.72658517									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182031-05	Etizolam		GABA-A receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	40054-69-1				8.2115500415	4	7		0	1.87889454					CCC1=CC\2=C(S1)[N]3C(=NN=C3C\N=C2C4=CC=CC=C4Cl)C	MedChem Express	HY-B0677	0	1.40913396	0	3.97773776	0	4.9464487	1.87889454									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00387803-01	Atosiban		Oxytocin receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	90779-69-4		22.0828704269	-4.6559444758	-34.0407470292	4	7		-20.4912225159	-23.03191742	0.0160641487	0.9434959337			CCOC1=CC=C(CC2NC(=O)CCSSCC(NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(NC2=O)C(C)CC)C(C)O)C(=O)N3CCCC3C(=O)NC(CCCN)C(=O)NCC(N)=O)C=C1	ChemieTek	CT-ATOS	-4.09489237	-7.82877867	-6.91263683	-4.98327994	-3.03923199	-4.59413754	-23.03191742									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015610-17	Leflunomide	170464823	DHODH Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	75706-12-6	; Arava;Leflunomide; Leflunomida; Leflunomide;HWA-486/RS-34821			13.8987946619	4	7		0	3.62981927			3716	DHODH	Cc2oncc2C(=O)Nc1ccc(cc1)C(F)(F)F	Selleck	S1247	1.37244935	3.7896743	4.03353562	1.53259588	4.43841039	2.02246049	3.62981927									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159441-03	Deslanoside	170465236	Sodium/potassium-transporting ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	17598-65-1	Deslanoside; Cedilanid; Cedilanid-D; Cedilanid-d; C, Desacetyllanatosid; Lanatoside, Desacety; Deslanatoside C; C, Deslanatosid; C, Desacetyldigilanid; Desacetyl Lanatoside; Deslanosido; 			-16.7319711777	4	7	Cedilanid-d;Cedilanid-D;C, Desacetyllanatosid;deslanoside;Cedilanid;LS-87553;C, Deslanatosid;Lanatoside, Desacety;CIPLUS_171064;Deslanatoside C;deslanosidum;Deslanosido;C, Desacetyldigilanid;CARD-20(22)-ENOLIDE, 3-((O-.BETA.-D-GLUCOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL-(1->4)-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL)OXY)-12,14-DIHYDROXY-, (3B,5B,12B)-;Card-20(22)-enolide, 3-((O-beta-D-glucopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-;DEACETYLANATOSIDE C;Desacetyl Lanatoside;deacetyllanatoside c;DESLANOSIDE;Deslanosidum;Deslanoside;	0	-8.03528428					O=C1C=C(CO1)[C@H]2CC[C@@]9(O)[C@]2(C)[C@H](O)C[C@H]4[C@H]9CC[C@@H]3C[C@H](CC[C@@]34C)O[C@@H]8O[C@H](C)[C@@H](O[C@@H]7O[C@H](C)[C@@H](O[C@@H]6O[C@H](C)[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)C6)[C@@H](O)C7)[C@@H](O)C8	ChemDiv	N045-0007	-3.29436255	-2.70970264	-2.38112647	-4.39210374	-2.10374055	-3.099751	-8.03528428									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017324-07	Simvastatin	170464984	HMG-CoA Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	79902-63-9	; Zocor;Simvastatin;SIMVASTATIN	4.4061119169	-5.3559444758	-63.4829783374	-2.2	7		-70.5360827322	-64.50533573	0.0000031298	0.9992770527	3156	HMGCR	CC(C)(CC)C(=O)O[C@H]2C[C@@H](C)C=C3C=C[C@H](C)[C@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@@H]23	Vitas	STK801938	3.21690509	2.75857014	0.89444566	1.96904708	-7.58513932	-43.33553534	-64.50533573									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015095-15	Amitriptyline hydrochloride	170464758	Sodium-dependent serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	549-18-8		19.6813789847	-4.7059444758	-15.9954175785	4	7		-25.1393120559	-20.11609338	0.008765668	0.9592755744	6532	SLC6A4	Cl.CN(C)CC\C=C1\c3ccccc3CCc2ccccc12	Microsource	01500117	-1.61450391	1.71769248	-1.0358022	-0.19815888	-3.25077399	-3.37923675	-20.11609338									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159392-05	1,1,1-Trichloro-2-methyl-2-propanol	170465458		DPI_SARS-CoV-2_General	2019_NPC_01	57-15-8				7.5781930173	4	7		0	-2.20526729					ClC(Cl)(Cl)C(C)(C)O	Labotest	LT03378907	0.37518457	0.74034256	4.55021813	2.90214965	-0.43394407	4.38030388	-2.20526729									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179259-06	Meropenem			DPI_SARS-CoV-2_General	2019_NPC_02	96036-03-2				-4.0091504423	4	7		0	-2.68277601					C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)=C([N@@]2C1=O)C(O)=O	Prestwick	Prestw-1106	-1.60697357	-3.75846058	1.25876093	1.07335781	1.46139771	-2.19372416	-2.68277601									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183879-01	Bisbentiamine	144206468		DPI_SARS-CoV-2_General	2019_NPC_02	2667-89-2		11.0676527398	-4.9559444758	-26.1929094662	-2.2	7	BISBENTIAMINE;Bisbentiamina;Beston;CIPLUS_213921;bisbentiaminum;Bisbentiamine;bisbentiamine;Bisbentiaminum;	-42.9029872045	-38.41506921	0.0000798612	0.9963322241			Nc4nc(C)ncc4CN(C=O)C(/C)=C(/CCOC(=O)c1ccccc1)SSC(/CCOC(=O)c2ccccc2)=C(/C)N(C=O)Cc3cnc(C)nc3N	ACC	Bisbentiamine	0	0	0	0	1.936649	-10.43310785	-38.41506921									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274080-01	Estriol	170465807	Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	50-27-1		24.777388143	-4.6059444758	-21.6918402015	4	7		-13.1163906121	-11.82514389	0.236501679	0.6969214993		ESR1	Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)[C@H](O)C[C@@H]12)c4cc3	SIGMA	E3625	-0.89481838	-3.14860588	-6.34537399	-4.37060075	-2.14575957	-5.23299511	-11.82514389									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017360-04	Aconitine			DPI_SARS-CoV-2_General	2019_NPC_02	302-27-2				-5.719869629	4	7		0	-8.05308472					CCN1C[C@]2(COC)[C@H](O)C[C@H](OC)[C@@]34C5C[C@]6(O)[C@@H](OC)[C@H](O)[C@](OC(C)=O)(C([C@H](OC)C23)[C@@H]14)C5[C@H]6OC(=O)C7=CC=CC=C7	Prestwick	Prestw-NAT-0127	0.93181345	-1.07417589	-1.84477626	-1.54105184	0.27326949	1.17906802	-8.05308472									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165774-05	Cloprostenol (sodium salt)			DPI_SARS-CoV-2_General	2019_NPC_02	55028-72-3				-11.6304027386	4	7		0	-2.6922894					O[C@@H](COC1=CC(=CC=C1)Cl)\C=C\[C@H]2[C@H](O)C[C@H](O)[C@@H]2C\C=C/CCCC([O-])=O	Cayman	16764	-0.15491688	-2.83905842	-1.15093411	-3.17330402	-2.86338902	-4.43442315	-2.6922894									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274074-01	2-(Dodecyloxy)ethanol	170466587		DPI_SARS-CoV-2_General	2019_NPC_02	4536-30-5				0.0628121385	4	7		0	-0.49469629					OCCOCCCCCCCCCCCC	SIGMA	03819	0	-0.42274019	-0.38677012	-0.29230877	1.565953	0	-0.49469629									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253588-01	Gimatecan	170465615		DPI_SARS-CoV-2_General	2019_NPC_02	292618-32-7		6.9832167823	-5.1559444758	-67.1390032682	-2.2	7		-51.0755292944	-52.66137088	0.0006422681	0.9894767467			CC(C)(C)O\N=C\c1c3CN4C(=O)C=5COC(=O)[C@](O)(CC)C=5C=C4c3nc2ccccc12	GVK	FFS-11-286-NCI-141	-4.05327291	-6.85393518	-7.07672113	-1.49895938	-7.78699237	-29.19485156	-52.66137088									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016642-04	Piperacetazine	170465363		DPI_SARS-CoV-2_General	2019_NPC_01	3819-00-9		6.2237985085	-5.2059444758	-74.1711191257	-2.2	7		-76.5024587428	-71.29857291	0.0005520747	0.9902535697			CC(=O)c2cc3N(CCCN1CCC(CCO)CC1)c4ccccc4Sc3cc2	Prestwick	Prestw-1048	-4.6934379	4.30766975	-0.89932003	-1.55767928	-9.90965843	-39.74287311	-71.29857291									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162385-04	Olprinone	170465898	Phosphodiesterase III (PDE3) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	119615-63-3	;Olprinone; Olprinone;Loprinone; Coretec;Olprinone hydrochloride			-2.1984199139	4	7		0	-4.31421257			5139	PDE3A	Cl.N#CC3=CC(c1ccc2nccn2c1)=C(C)NC3=O	SIGMA	O7389	1.41117808	-1.14105603	1.29901782	-1.68811298	0.3628889	-0.09146806	-4.31421257									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167962-06	Quinapril hydrochloride	170465312	Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	82586-55-8				-4.8215224844	4	7		0	-5.35347646					Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)O	Microsource	01503076	-1.14007697	1.05798128	-0.58736078	-3.35866757	1.18002335	-0.04573403	-5.35347646									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164533-02	Buformin	170465982	"AMP-activated protein kinase, AMPK Activator"	DPI_SARS-CoV-2_General	2019_NPC_01	692-13-7				9.4939718144	4	7		0	4.89721427					NC(=N)NC(=N)NCCCC	Labotest	LT02684528	3.47348292	2.39695067	0	0	2.82444298	1.30596067	4.89721427									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015466-11	Gabapentin	170464715	Calcium Channels (Voltage-Gated) alpha2/delta-1 Subunit Ligands	DPI_SARS-CoV-2_General	2019_NPC_01	60142-96-3	 Go 3450;; Gabapentin hydrochloride;Gabapentin hydrochloride; ; Neurontin;Gabapentin; Gabapentino; Gabapentin; gabapentin ISTD			-24.2311686768	4	7		0	-3.77683709				CACNA2D1	NCC1(CC(=O)O)CCCCC1	Vitas	STK598009	-4.06893714	-4.82077846	-3.95067144	-6.01750821	-9.29553875	-3.79592459	-3.77683709									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163125-06	Pregnenolone	170465558	Steroid	DPI_SARS-CoV-2_General	2019_NPC_01	145-13-1	; ; 5-Pregnen-3beta-ol-20-one; Allopregnandione; Allopregnane-3,20-dione; Pregnenolona; Pregnenolone acetate; PREGNENOLONE; 5 Pregnen 3 beta ol 20 on;Pregnenolone; Pregnenolone	12.4181106199	-4.9059444758	-26.117541317	4	7		-11.694103096	-11.10238017	0.2768658013	0.6559813558			CC(=O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CC=C1C[C@@H](O)CC[C@@]12C	Prestwick Chemical, Inc.	Prestw-546	-3.71069639	-6.51648056	-5.03765446	-0.94062759	-4.7175557	-8.18639158	-11.10238017									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015996-10	Tiapride hydrochloride	170465877	Dopamine D3 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	51012-33-0				9.9640037536	4	7		0	3.83767205					Cl.O=S(C)(=O)c1cc(c(OC)cc1)C(=O)NCCN(CC)CC	Microsource	01503086	2.42296614	3.93627679	1.58173089	0	1.59112825	1.90558463	3.83767205									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095133-06	Famciclovir	170464774	antiviral	DPI_SARS-CoV-2_General	2019_NPC_01	104227-87-4	; ; Famciclovir; FAMCICLOVIR;FAMCICLOVIR;Famciclovir	22.0828704269	-4.6559444758	-19.4641828763	4	7		-16.997287776	-14.16440648	0.1569915286	0.776027511			CC(=O)OCC(COC(C)=O)CCn2cnc1cnc(N)nc12	Microsource	01505201	-2.65533851	0.27610135	-2.70770881	-3.93558582	-5.26569558	-2.95746735	-14.16440648									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167537-02	Donepezil hydrochloride	170464858	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	120011-70-3		11.0676527398	-4.9559444758	-29.1828403608	4	7		-11.85755616	-15.34509823	0.0458917441	0.8981375209			Cl.COc1cc2C(=O)C(Cc2cc1OC)CC4CCN(Cc3ccccc3)CC4	Sequoia	SRP04573d	-4.95965225	-2.96380143	-7.25486979	-4.16949232	-3.72834636	-7.25291244	-15.34509823									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094047-10	Ivermectin		Glutamate-gated Chloride Channel Activator	DPI_SARS-CoV-2_General	2019_NPC_02	70288-86-7		3.9269513795	-5.4059444758	-85.5032368893	-2.2	7		-73.2102934927	-72.99148552	0.0000863783	0.9961822496			[H][C@@](C)(CC)[C@@]1([H])O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@]([H])(C\C=C(C)\[C@@H](O[C@@]4([H])C[C@H](OC)[C@@H](O[C@@]5([H])C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C6/CO[C@]7([H])[C@H](O)C(C)=C[C@@]([H])(C(=O)O3)[C@]67O)O2	APExBIO	A2813	1.11678883	-1.79029315	1.375964	-4.58574001	-8.37155146	-55.00281849	-72.99148552									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00345792-04	AN-2728		Phosphodiesterase IIII (PDE4) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	906673-24-3				5.0337949531	4	7		0	-3.77205917				PDE4A	OB1OCC2=CC(=CC=C12)OC3=CC=C(C=C3)C#N	MedChem Express	HY-10978	-0.02080973	2.51565063	0	3.07976522	2.89665661	1.578354	-3.77205917									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164526-02	Camylofin	170465936	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	54-30-8				7.9652719138	4	7		0	-0.38528808					CC(C)CCOC(=O)C(NCCN(CC)CC)c1ccccc1	Labotest	LT03328450	4.10766587	3.62108144	0	0	0	4.09065501	-0.38528808									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095116-05	Metaxalone	170465241		DPI_SARS-CoV-2_General	2019_NPC_01	1665-48-1				-20.8421574582	4	7		0	-5.01381461					Cc1cc(cc(C)c1)OCC2CNC(=O)O2	Microsource	01504229	-6.87192893	-4.56666748	-3.63871219	-4.75832142	-2.2103233	-4.20753087	-5.01381461									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021139-11	5,5-Diphenylhydantoin	170464785		DPI_SARS-CoV-2_General	2019_NPC_01	57-41-0				4.605761314	4	7		0	2.08359737					O=C1NC(=O)C(N1)(c2ccccc2)c3ccccc3	Vitas	STK182871	0	1.82275759	1.23321391	0	0	1.96148178	2.08359737									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00273481-01	Metixene hydrochloride	170465287	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	1553-34-0		13.9333492831	-4.8559444758	-29.7350771349	-2.4	7		-33.191237236	-25.57603103	0.0039230362	0.973337498			Cl.CN1CCCC(C1)CC2c4ccccc4Sc3ccccc23	Prestwick Chemical, Inc.	Prestw-491	-1.71616682	1.31697901	-2.8149448	-3.61451827	-5.02207786	-11.45383404	-25.57603103									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093976-08	Idarubicin hydrochloride	170464627	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	57852-57-0	 ; Idarubicina; Idamycin; Idarubicin hydrochloride;Idarubicin HCl; Idarubicin Hcl; 4 Desmethoxydaunorubici; IDARUBICIN HCl; 4 Demethoxydaunorubici; 4-Desmethoxydaunorubicin;Idarubicin; Idarubicin; Hydrochloride, Idarubici;Idarubicin?HCl	5.5469662594	-5.2559444758	-101.6828476549	-2.1	7		-113.282033409	-86.33494715	0.0001529105	0.9949095453	7153	TOP2A	Cl.CC(=O)[C@@]4(O)C[C@H](O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1)c5c(O)c3C(=O)c2ccccc2C(=O)c3c(O)c5C4	Sequoia	57852-57-0	2.9361218	2.73902314	2.64921645	-6.8954273	-29.28234279	-52.43660755	-86.33494715									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178815-03	Tolmetin sodium dihydrate	170465216	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	64490-92-2				-2.0491321347	4	7		0	-7.51311754					[Na+].O.O.O=C([O-])Cc2ccc(C(=O)c1ccc(C)cc1)n2C	Microsource	01500582	1.11103043	2.09397219	1.6597207	0.57942659	-0.2309293	-2.44422989	-7.51311754									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018158-09	Doxazosin mesylate	170465395	alpha1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	77883-43-3	; Doxazosin Mesilate; Doxazosin mesylate salt;Doxazosin mesylate; Doxazosin mesilate; Doxazosin hydrochloride;DOXAZOSIN MESYLATE	15.6334750258	-4.8059444758	-69.4424075054	-2.2	7		-73.5235830867	-63.95275151	0.0000289672	0.9977954708	148	ADRA1A	CS(=O)(=O)O.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4COc5ccccc5O4	Microsource	01505976	-5.6277685	-6.49693356	-5.04740318	-5.41048988	-9.0722225	-19.63514406	-63.95275151									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182046-04	Efonidipine hydrochloride monoethanolate			DPI_SARS-CoV-2_General	2019_NPC_02	[111011-76-8]		2.4777388143	-5.6059444758	-105.5690418384	-1.1	7		-84.3139418742	-81.20154117	0.0000084157	0.9988135001			CC1=C(C(c2cccc(c2)[N+]([O-])=O)C(=C(C)N1)P3(=O)OCC(C)(C)CO3)C(=O)OCCN(Cc4ccccc4)c5ccccc5	Tocris	3733	2.00467063	-1.19891889	0.1758046	-1.63926759	-24.05009149	-65.04603533	-81.20154117									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386242-02	Cilengitide		Integrin alpha-V/beta-5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	188968-51-6				6.7433178617	4	7		0	-2.3022404					CC(C)[C@@H]1N(C)C(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O	MedChem Express	HY-16141	2.78619159	1.48998591	2.33702914	1.2697893	3.04873702	0.54021045	-2.3022404									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091056-05	Styrene	225144204		DPI_SARS-CoV-2_General	2019_NPC_02	100-42-5				0.6005184661	4	7		0	-2.12148599					C=CC1=CC=CC=C1	SIGMA	S4972	0.50174571	-1.22663956	0.62586437	1.07803475	3.24359005	-1.74746336	-2.12148599									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182063-03	Cadralazine	170466021		DPI_SARS-CoV-2_General	2019_NPC_02	64241-34-5				10.7454382306	4	7		0	1.21771393					O=C(OCC)NNc1ccc(nn1)N(CC(C)O)CC	Kemprotec	64241-34-5	2.77231844	4.04952759	0	1.48025162	3.16279733	3.08154829	1.21771393									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253600-01	Iothalamate sodium	170465058		DPI_SARS-CoV-2_General	2019_NPC_01	1225-20-3				10.4711376938	4	7		0	4.92763175					[Na+].O=C(C)Nc1c(I)c(c(I)c(c1I)C([O-])=O)C(=O)NC	GVK	FFS-11-286-NCI-047	0.62692131	0.93092579	1.16253564	4.37203702	2.64172969	1.5498755	4.92763175									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00096081-04	beta-Carotene	225144219	Vitamin/Supplement	DPI_SARS-CoV-2_General	2019_NPC_01	7235-40-7	; ;BETA-CAROTENE; Solatene; Provitamin A; beta,beta-Carotene; Ro 8-8427; Ro-8-8427;beta-CAROTENE; Betacaroteno; beta-Carotene	0.015633475	-7.8059444758	-34.3241871704	4	7		-9.079882104	-8.82613875	0.1184148935	0.8156046744		CAT	CC\1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)/CCCC2(C)C)C(C)(C)CCC1	Microsource	01500143	0.44780093	-4.47381924	1.82057469	-0.68979356	-4.01715475	-10.06656842	-8.82613875									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00167438-02	Trospium chloride	174006890	Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	10405-02-4	Trospium chloride; Cloruro de trospio; Trospium chloride; Spasmoplex; 			6.9133425866	4	7		0	-3.01640009					[Cl-].OC(c1ccccc1)(c2ccccc2)C(=O)O[C@@H]3C[C@@H]5CC[C@H](C3)[N+]45CCCC4	Selleck	S2549	2.72311379	0.38360984	2.31775974	1.59279605	1.13434502	4.10081813	-3.01640009									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016602-04	Benperidol	170466409	Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	2062-84-2		15.6334750258	-4.8059444758	-71.7171059592	-2.4	7		-37.7676982316	-40.56170946	0.0043100094	0.9719730456			Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)N3c4ccccc4NC3=O	Prestwick Chemical, Inc.	Prestw-484	-13.63493331	-9.43875681	-11.37432673	-7.78337974	-12.57930264	-17.62792825	-40.56170946									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024427-05	Naltrexone hydrochloride	170465207	mu-Opioid Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	16590-41-3	;Naltrexone hydrochloride; ReVia;Naltrexone hydrochloride dihydrate; Naltrexona			5.5822310678	4	7		0	-0.1013916			4988	OPRM1	O=C1CC[C@@]6(O)[C@H]3Cc5ccc(O)c4O[C@@H]1[C@]6(CCN3CC2CC2)c45	Prestwick	Prestw-116	4.28678624	2.70481589	0	1.3218953	-0.11419581	0	-0.1013916									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185770-01	Sucrose octasulfate, sodium salt	144207173		DPI_SARS-CoV-2_General	2019_NPC_01	74135-10-7				-2.7506641651	4	7		0	0.3295227					[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]S(=O)O[C@H]1[C@H](O[C@H](COS([O-])=O)[C@@H](OS([O-])=O)[C@@H]1OS([O-])=O)O[C@]2(COS([O-])=O)O[C@H](COS([O-])=O)[C@@H](OS([O-])=O)[C@@H]2OS([O-])=O	Toronto Research	S699020	0.64144458	-1.12639578	-0.77258658	-4.75832142	2.96147795	-1.10777987	0.3295227									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094561-06	Phenothrin	170465585		DPI_SARS-CoV-2_General	2019_NPC_01	26002-80-2		4.4061119169	-5.3559444758	-68.3110451591	-2.2	7		-66.0742693448	-61.46865732	0.0002526998	0.9934409405			C/C(C)=C/C3C(C(=O)OCc2cccc(Oc1ccccc1)c2)C3(C)C	Microsource	01504098	-1.2368988	0.40315684	-0.97730984	2.97238317	-12.33060955	-40.25102902	-61.46865732									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015060-18	Azathioprine	170464989	Purine Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	446-86-6	 Azathiopurine;Azathioprine; Imurel; Imuran; ; Azatioprina; Immuran; Azathioprine Sulfate; Azathioprine Sodium Salt; Azathioprine;AZATHIOPRINE; Azothioprine			-35.0142750802	4	7		0	-11.33558085				HPRT1	O=[N+]([O-])c3ncn(C)c3Sc2ncnc1ncnc12	Specs	AG-670/36150031	-7.34635587	-8.04603318	-7.48458483	-6.59442647	-5.95087043	-6.35194878	-11.33558085									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016637-10	Diloxanide furoate	170466783		DPI_SARS-CoV-2_General	2019_NPC_01	3736-81-0				5.0055844781	4	7		0	0.36500976					ClC(Cl)C(=O)N(C)c1ccc(cc1)OC(=O)c2ccco2	Microsource	01505532	0	2.35785667	1.06992274	2.48576517	0.63188347	0.34046445	0.36500976									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178213-05	Nafronyl oxalate	170465616	Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	3200-06-4				3.1759003799	4	7		0	-5.926339					O=C(O)C(=O)O.CCN(CC)CCOC(=O)C(Cc1cccc2ccccc12)CC3CCCO3	Microsource	01503419	0.89318132	0	0	2.29011463	3.5299193	2.33243559	-5.926339									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160471-02	Crocin?		Tyrosinase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	42553-65-1		12.4181106199	-4.9059444758	3.0697087287	4	7		-10.444489368	-7.45374114	0.0760074944	0.8619660891			CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)\C=C\C=C(/C)C(=O)O[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O	DC Chemicals	DCZ-122	3.97465837	-0.38115919	1.25407281	3.46327433	1.99367916	-0.16441188	-7.45374114									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249917-01	Cloxazolam	170465787	GABA-A receptor; benzodiazepine site Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	24166-13-0		13.9333492831	-4.8559444758	-10.2031766056	4	7		-20.1584693	-16.38205775	0.0032147135	0.976020291			Clc1ccccc1C34OCCN4CC(=O)Nc2ccc(Cl)cc23	GVK	FFS-11-286-NCI-177	2.06478763	-0.08085195	-0.60711188	0.61501766	-0.9766414	-3.18959038	-16.38205775									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181104-04	Dithiazanine chloride	124893646		DPI_SARS-CoV-2_General	2019_NPC_02			0.4943738883	-6.3059444758	-205.8742934458	-1.1	7		-108.6140132189	-99.44822337	0.0001523472	0.9949187409			CCN1C(/SC2=C1C=CC=C2)=C/C=C/C=C/C3=[N+](CC)C4=C(S3)C=CC=C4	NCI	NSC-221154	4.09951675	-2.71893553	-16.81863998	-34.32172673	-72.6065157	-97.0781661	-99.44822337									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162383-04	Vancomycin hydrochloride		glycopeptide antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	1404-93-9				0.8754931954	4	7		0	-0.28064501					CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=CC4=CC(=C3O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O[C@H]6C[C@](C)(N)[C@H](O)[C@H](C)O6)OC7=C(Cl)C=C(C=C7)[C@@H](O)[C@@H]8NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)C9=CC=C(O)C(=C9)C%10=C(C=C(O)C=C%10O)[C@H](NC8=O)C(O)=O)C(=C2)Cl	Selleck	S2575	1.03354991	-2.67735452	0.86495863	1.30720483	1.29030725	0.24896655	-0.28064501									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00241108-04	Axitinib	170466656	VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	319460-85-0	AG-013736;Inlyta;Axitinib; Axitinib;AG-13736	5.5469662594	-5.2559444758	-61.5658051311	-2.2	7		-55.1511915495	-51.44841364	0.0004751368	0.9909707202	2321	FLT1	CNC(=O)c4ccccc4Sc1ccc3c(c1)nnc3/C=C/c2ccccn2	Sequoia	319460-85-0	1.74108072	-2.89911987	-4.23103068	-1.58782125	-10.47691467	-31.77376926	-51.44841364									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00085849-02	MEBHYDROLIN		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	524-81-2		12.4181106199	-4.9059444758	-22.863170188	-2.2	7		-44.9776197435	-34.45274223	0.0005866601	0.9899548733			CN1CCC2=C(C1)C3=CC=CC=C3[N]2CC4=CC=CC=C4	Microsource	01501116	1.38500312	0.00693017	0.22737395	3.91693754	-0.85782858	-11.35851184	-34.45274223									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160478-02	Menadione sodium bisulfite	225144239	NQO1 protein Substrate	DPI_SARS-CoV-2_General	2019_NPC_02	130-37-0				-1.7825120803	4	7		0	-5.27517481					CC1(CC(=O)C2=CC=CC=C2C1=O)[S]([O-])(=O)=O	SIGMA	M5750	2.52722606	-2.7096953	-1.50723143	0.27827795	2.35487014	0.56839534	-5.27517481									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344134-02	Limaprost			DPI_SARS-CoV-2_General	2019_NPC_02	74397-12-9				9.6325953891	4	7		0	-1.83132759					CCCC[C@H](C)C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O	MedChem Express	HY-B0683	4.89953525	2.29388528	0.69149809	1.98536118	4.74063161	0.7093198	-1.83132759									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015061-13	Aciclovir	170464640	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	59277-89-3	; ; Acyclovir Sod; Zovirax; Acycloguanosine;ACYCLOVIR; ACVbetaglc; Acyclovir;Acyclovir; Acyclovir-side chain-2-3H; Zovirax sodium			0.8527672667	4	7		0	0.49174926					NC2=Nc1c(ncn1COCCO)C(=O)N2	Microsource	01503603	-2.18091158	1.00422704	-0.8359533	1.18644493	0.07359285	1.53463082	0.49174926									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00319019-01	Nemorubicin	170465590	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	108852-90-0		0.9864055887	-6.0059444758	-151.9650514817	-1.1	7		-98.595016601	-89.07252034	0.0000026347	0.9993366871		TOP2A	COC1CN(CCO1)C6CC(OC5C[C@@](O)(Cc4c5c(O)c3C(=O)c2c(OC)cccc2C(=O)c3c4O)C(=O)CO)OC(C)C6O	GVK	FFS-11-286-NCI-135	3.50252947	0.33474235	-3.13177841	-21.79998495	-52.54275999	-76.52319732	-89.07252034									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016260-13	Ethacrynic acid	170465426	Sodium/potassium-transporting ATPase subunit alpha-1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	58-54-8				5.7320498443	4	7		0	3.67037591			476	ATP1A1	Clc1c(ccc(OCC(=O)O)c1Cl)C(=O)C(=C)CC	Specs	AN-153/J108037	-0.17185874	0	0	0.78009381	3.81921535	1.00106713	3.67037591									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090749-12	Diethylstilbestrol	170464803	Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	6898-97-1	; ;DIETHYLSTILBESTROL;Diethylstilbestrol; Diethylstilbesterol; pseudo-DES; (Z,E)-Diethylstilbestrol; 5   Diethylstilbestrol; Dietilestilbestrol; (E)-Diethylstilbestrol; Stilbestrol; Diethylstilbestrol [DES]	5.5469662594	-5.2559444758	-46.6272531889	-2.2	7		-42.0302268807	-38.14858939	0.0000088968	0.9987807848	2099	ESR1	Oc1ccc(cc1)C(CC)=C(CC)c2ccc(O)cc2	Microsource	01500244	-1.45958899	-1.38050676	-0.38263752	-2.85198284	-8.25508806	-23.65973881	-38.14858939									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344584-01	Verapamil	170464904	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	52-53-9		15.6334750258	-4.8059444758	-45.4901082446	4	7		-29.274986228	-26.40744214	0.0004336445	0.9913999875		DRD2	COc1cc(ccc1OC)C(C#N)(CCCN(C)CCc2ccc(OC)c(OC)c2)C(C)C	SIGMA	V106	-5.39539612	-4.92828695	-6.82654578	-5.75162415	-8.60021317	-13.83200366	-26.40744214									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167563-01	Mofezolac	144206111	Cyclooxygenase-1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	78967-07-4	Mofezolac; Mofezolaco; 			2.651817089	4	7	mofezolac;n-22;(3,4-di-(4-methoxyphenyl)-5-isoxazolyl)acetic acid;mofezolacum;(3,4-bis(4-methoxyphenyl)-5-isoxazolyl)acetic acid;Mofezolac;CIPLUS_213447;Mofezolaco;LS-86501;N-22;3,4-BIS(P-METHOXYPHENYL)-5-ISOXAZOLEACETIC ACID;3,4-DMPIAA;N 22;MOFEZOLAC;Mofezolacum;	0	-4.78999191					O=C(O)Cc2onc(c1ccc(OC)cc1)c2c3ccc(OC)cc3	SigmaAldrich	R678899	3.63245393	0.74614798	1.69944446	0.60098683	0.7200057	0.12213454	-4.78999191									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178575-05	Morantel tartrate	170465696	Neuronal acetylcholine receptor; alpha3/beta2 Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	26155-31-7				9.1553645656	4	7		0	1.51262903					Cc2ccsc2\C=C\C1=NCCCN1C.O=C(O)[C@H](O)[C@H](O)C(=O)O	Microsource	01503931	0	0	4.31541689	3.62696724	0	4.01164976	1.51262903									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178852-05	Tobramycin	225144300	30S Ribosomal Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	32986-56-4	 Nebcin; Tobrex; Obracin;TOBRAMYCIN; Tobramycin Sulphate;; Sulfate, Tobramyci; Brulamycin;Tobramycin; Tobramycin Base; Tobramicina; Tobracin; Nebicin			-15.0322943586	4	7		0	-5.87927508					NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O	Microsource	01500579	-1.7457051	-2.03977916	-1.07123602	-3.58487477	-1.13347432	-2.48966554	-5.87927508									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00095606-02	(2S,5R)-5-Methyl-2-(propan-2-yl)cyclohexanone	170465578	TNF-alpha Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	14073-97-3				1.5770506361	4	7		0	-0.00506958					CC(C)[C@@H]1CC[C@@H](C)CC1=O	SIGMA	63680	-0.80120059	3.07132211	-0.04630645	2.22991447	-3.34213064	1.12302454	-0.00506958									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090680-06	Carbaryl	170465695	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	63-25-2		13.9333492831	-4.8559444758	-30.1500404698	-3	7		-66.477300956	-58.73108413	0.0001539955	0.9948923217			CNC(=O)Oc2cccc1ccccc12	Bosche	C1592	0	4.39563125	0.99924447	0	2.91579962	-7.13959043	-58.73108413									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016497-09	Ethionamide	170465169	Cell Wall Biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	536-33-4	 ; Ethionamide; Trecator S; Trecator;Ethionamide; Etionamida;ETHIONAMIDE; 9   Ethionamide; Trecator-SC			-53.905360941	4	7		0	-13.51043066					CCc1cc(ccn1)C(N)=S	Microsource	01500292	-8.57599303	-3.33031984	-35.12709902	-4.89878847	-5.95087043	-9.28400833	-13.51043066									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00264001-02	CALCIUM GLUCEPTATE			DPI_SARS-CoV-2_General	2019_NPC_02	299-28-5				-14.7307927051	4	7		0	-5.46068592					OC[C@@H](O)[C@@H](O)[C@@H](O)[C@@H](O)C(O)C([O-])=O	Microsource	01300012	-1.43124697	-1.60086858	-1.59161764	-4.1320768	-2.91566666	-5.33164224	-5.46068592									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179499-05	Dipivefrin hydrochloride		Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	64019-93-8		5.5469662594	-5.2559444758	-9.8690775927	4	7		-10.9344051759	-10.77867098	0.0639064437	0.875461387			CNCC(O)C1=CC(=C(OC(=O)C(C)(C)C)C=C1)OC(=O)C(C)(C)C	Prestwick	Prestw-632	1.66246618	0.50590219	-2.42610347	-1.33058953	2.57348573	-6.91939121	-10.77867098									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00484844-01	Cilastatin		Renal dipeptidase  Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	81129-83-1				8.1147738971	4	7		0	3.46763069					CC1(C)C[C@H]1C(=O)N\C(=C/CCCCSC[C@@H](N)C(O)=O)C(O)=O	Enzo	PI153	0.54336516	2.37242718	1.53536016	1.31655871	1.20476202	2.03870725	3.46763069									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160481-02	Tioxidazole	124892286	microtubule polymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			8.7913490634	-5.0559444758	0.5466380903	4	7		-8.382795032	-6.56899586	0.127143033	0.8077210601			CCCOC1=CC=C2N=C(NC(=O)OC)SC2=C1	Chembridge	5175278	3.62320516	-0.00693017	-0.7149387	2.87865678	1.67526079	-1.60184141	-6.56899586									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179493-03	Solanine alpha		Cholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	20562-02-1		12.4181106199	-4.9059444758	-54.8238921421	-2.2	7		-45.7087060241	-46.45388384	0.0000413584	0.9973648887			C[C@H]1CC[C@@H]2[C@@H](C)[C@H]3[C@H](C[C@H]4[C@@H]5C\C=C6\C[C@H](CC[C@]6(C)[C@H]5CC[C@]34C)O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O[C@@H]9O[C@@H](C)[C@H](O)[C@@H](O)[C@H]9O)N2C1	Prestwick	Prestw-NAT-0174	-4.19662882	-6.15167826	-6.33599775	-6.44248533	-5.73865932	-14.66084179	-46.45388384									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532506-01	SODIUM LAURYL SULFOACETATE			DPI_SARS-CoV-2_General	2019_NPC_02					2.2761427061	4	7		0	-4.7043714					CCCCCCCCCCCCOC(=O)C[S]([O-])(=O)=O	SIGMA	MFCD00214054	2.32837753	-0.57982397	1.80727128	0.83483385	2.84913148	-0.36170613	-4.7043714									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159459-04	Mycophenolate mofetil	170464859	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	128794-94-5	 Mycophenolate mofetil; ;MYCOPHENOLATE MOFETIL; Cellcept;	22.0828704269	-4.6559444758	0.3616685312	4	7		-18.988897624	-14.99074802	0.0209638278	0.9345636397	727833	IMPDH1	Oc3c1C(=O)OCc1c(C)c(OC)c3C\C=C(/C)CCC(=O)OCCN2CCOCC2	Sequoia	115007-34-6	1.29257135	4.361424	0	0	3.70248186	2.51537172	-14.99074802									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016542-06	Levonordefrin	170464794	Adrenergic receptor alpha-2 Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	829-74-3		6.9832167823	-5.1559444758	-80.6045030168	-2.2	7		-86.3343007791	-76.17043928	0.0005501006	0.9902710766			Oc1ccc(cc1O)[C@@H](O)[C@H](C)N	Enzo	AC1038	1.39665481	3.86297554	-1.96193122	-6.64960995	-13.76186368	-40.71853245	-76.17043928									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179363-03	Ursodiol	225144303	Steroid	DPI_SARS-CoV-2_General	2019_NPC_02	128-13-2	; Urosiol; Ursodexycholic Acid; Antigall; Chenique Acid; Acido chenodeoxicholico;Urosiol; Sodium chenodeoxycholate; Litursol; Acido ursodeoxicolico; Urso;Ursodiol (Actigal Urso); UDCA-menthol; Ursodeoxy cholic acid; Chenodesoxycholic acid;URSODIOL; Ursometh; Acide chenodeoxycholique			-3.0071388393	4	7		0	-2.16905294				NR14H	C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	Prestwick	Prestw-958	1.37575435	0.29337707	-2.28545979	-2.90204148	2.81111138	-1.91187523	-2.16905294									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344378-02	Norgestrel		Progestogen hormone	DPI_SARS-CoV-2_General	2019_NPC_02	6533-00-2				11.5390928517	4	7		0	-3.66265519				CYP19A1	CC[C@]12CC[C@H]3[C@@H](CCC/4=C/C(=O)CCC34)[C@@H]1CC[C@@]2(O)C#C	Cayman	10006319	3.90066822	3.26410867	4.17008509	4.4220471	2.26457239	1.37166479	-3.66265519									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181296-02	Seratrodast	170465940	Prostanoid TP Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	112665-43-7	 Bronica; (+-)-7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid;Seratrodast;AA 2414; 	9.8640558873	-5.0059444758	-65.6274893021	-2.2	7		-68.4451824216	-65.43785378	0.0000264149	0.9978950589	6915	TBXA2R	O=C2C(C)=C(C)C(=O)C(C)=C2C(CCCCCC(=O)O)c1ccccc1	Tocris	3025	-2.44398714	-4.14192982	-4.5451349	-3.85146037	-3.18655989	-26.44212702	-65.43785378									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167476-02	Calcium hopantenate	50112729		DPI_SARS-CoV-2_General	2019_NPC_02		Calcium hopantenate; Hopate; Acido hopantenico; 			4.4218071601	4	7	Calcium hopantenate;Hopate;acide hopantenique;CIPLUS_171572;CIPLUS_170762;Acide hopantenique;Acidum hopantenicum;Calcium Hopantenate;Hopantenic acid;CALCIUM HOPANTENATE;HOPANTENIC ACID;Calcium Hopantenate Anhydride;pantogab;CIPLUS_159419;Acido hopantenico;CIPLUS_685059;acidum hopantenicum;	0	-4.91366598					CC(C)(CO)C(O)C(=O)NCCCC([O-])=O	InterBioScreen	STOCK1N-30476	3.23013249	-1.01873455	-0.35395326	4.67460188	1.60872561	1.99642991	-4.91366598									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168776-03	Delavirdine	170464664	Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	136817-59-9		11.0676527398	-4.9559444758	-6.5145997166	4	7		-15.0841459359	-14.23678828	0.0388127474	0.9072612442			O=C(c1cc2cc(NS(C)(=O)=O)ccc2n1)N3CCN(CC3)c4ncccc4NC(C)C	Sequoia	147221-93-0	3.45210294	-1.57776802	-1.67131572	1.36332811	0.80079842	-0.83615182	-14.23678828									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522453-01	MLN9708		Proteasome subunit beta type-5 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1239908-20-3				8.1842074512	4	7		0	0			5693	PSMB5	CC(C)C[C@H](NC(=O)CNC(=O)C1=CC(=CC=C1Cl)Cl)B2OC(=O)C(CC(O)=O)(CC(O)=O)O2	MedChem Express	HY-10452	3.3457421	2.55723163	0.7454115	1.63926759	3.52874082	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249052-02	Calcium levulinate	170465651		DPI_SARS-CoV-2_General	2019_NPC_01	5743-49-7				17.5969339939	4	7		0	2.87445185					[Ca+2].O.O.O=C([O-])CCC(C)=O.CC(=O)CCC([O-])=O	SIGMA	L2009	4.79025972	4.51291324	3.76057128	2.54094865	3.64157742	3.91280045	2.87445185									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159511-04	Butenafine	170465093	Trichophyton mentagrophytes Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	101828-21-1		22.0828704269	-4.6559444758	-26.7003936939	-3	7		-41.2582190566	-37.94580619	0.0065092748	0.9651616882			CN(Cc1ccc(cc1)C(C)(C)C)Cc3cccc2ccccc23	Bionet	KS-1035	-5.5164234	-3.53556332	-2.90268334	2.20984774	0	0	-37.94580619									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183869-01	Gusperimus trihydrochloride	144206777	Heat shock protein HSP90 Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_02	85468-01-5				-19.8288552643	4	7	CIPLUS_667980;15-DEOXYSPERGUALIN TRIHYDROCHLORIDE;LS-171915;Gusperimus;Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride, (-)-;gusperimus trihydrochloride;gusperimus;Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-;Gusperimus Hydrochloride;deoxyspergualin;LS-74249;CIPLUS_667979;LS-74248;NKT-01;CIPLUS_756341;NSC-356894;1-amino-19-guanidino-11-hydroxy-4,9,12-triazanonadecane-10,13-dione;(-)-15-Deoxyspergualin;BMY-42215-1;gusperimusum;Gusperimus trihydrochloride;Gusperimus hydrochloride;GUSPERIMUS TRIHYDROCHLORIDE;15-deoxyspergualin;3HCl of gusperimus;GUSPERIMUS;gusperimus, (+-)-isomer;Spanidin;DEOXYSPERGUALIN;CIPLUS_192812;	0	-9.08528754			3303		Cl.Cl.Cl.O=C(NCCCCNCCCN)C(O)NC(=O)CCCCCCNC(=N)N	NCI	NSC_356894	-1.76882702	-3.01462265	-3.19495558	-4.88974113	-5.40598341	-3.29763247	-9.08528754									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090991-02	N,N-Dimethylbenzylamine	144207006		DPI_SARS-CoV-2_General	2019_NPC_02	103-83-3				-18.1782926942	4	7	Zephiran chloride;CIPLUS_150764;Drapolene;Cloruro de benzalconio;N,N-Dimethylbenzylamine;N-benzyl-N,N-dimethylamine hydrochloride;CIPLUS_167204;N-benzyl-N,N-dimethylamine nitrate;Benzalkonium chloride;Compounds, Benzalkoniu;CIPLUS_776792;Germex;Osvan;ALKYL DIMETHYL ETHYLBENZYL AMMONIUM CHLORIDE;N,N-dimethylbenzylamine;NCGC00095057-01;Alkyl* dimethyl benzyl ammonium chloride *(50%C12, 30%C14, 17%C16, 3%C18);chlorure de benzalkonium;BENZALKONIUM CHLORIDE;Alkyldimethylbenzylammonium Chloride;AB07944111-01;ALKYLBENZYL TRIMETHYL AMMONIUM CHLORIDE;N-Benzyldimethylamine;Chloride, Alkyldimethylbenzylammoniu;BTC212;Zephiran;NCGC00095057-02;N-benzyl-N,N-dimethylamine;DMBA;BTC-2125;NCGC00164245-01;benzalkonii chloridum;Chloride, Benzalkoniu;Asepsol;CIPLUS_718497;CIPLUS_159160;benzyldimethylamine;N-benzyl-N,N-dimethylamine hydrobromide;Benzalkonium Chloride;Benzalkonii chloridum;Chlorure de benzalkonium;BTC 212;ALKYL DIMETHYL BENZYL AMMONIUM CHLORIDE;BDMA;Benzalkonium Compounds;ALKYL ETHYLBENZYL DIMETHYL AMMONIUM CHLORIDE;	0	-5.81268135					CN(C)Cc1ccccc1	SigmaAldrich	136921	-3.83592684	-1.70713114	-4.1513326	-4.51090896	-1.23802961	-6.29932356	-5.81268135									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00370833-02	NS-304		platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	475086-01-2		12.4181106199	-4.9059444758	-61.4860895155	-2.2	7		-78.8946711912	-70.96989012	0.00000556	0.9990360653			CC(C)N(CCCCOCC(=O)N[S+](C)([O-])=O)C1=NC(=C(N=C1)C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-14870	-3.95153645	-2.31236573	-1.2728253	-2.62142506	-3.42418554	-20.97895528	-70.96989012									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00347676-02	Schisandrol B		MAPK signaling pathway Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	58546-54-6		22.0828704269	-4.6559444758	0.8401795039	4	7		-15.4013699319	-12.00114161	0.0424669077	0.9023204277			COC1=CC2=C(C(=C1OC)OC)C3=C(OC)C4=C(OCO4)C=C3C[C@H](C)[C@@](C)(O)C2	MedChem Express	HY-N0692	0	3.51359468	3.9450552	0	0.2019818	2.59301015	-12.00114161									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00476141-01	11?-Prostaglandin E1		Prostanoid EP1 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	24570-01-2		13.9333492831	-4.8559444758	4.1960770508	4	7		-18.0886410159	-12.99053418	0.0063945831	0.9656128545		PTGER2	CCCCCC(O)\C=C\[C@H]1[C@@H](O)CC(=O)C1CCCCCCC(O)=O	Cayman	13450	3.8498	4.24357227	3.9450552	0.94708042	2.40239527	0.53551297	-12.99053418									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016624-05	Diphenidol	170465280	Muscarinic acetylcholine receptor M5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	972-02-1				10.5781162153	4	7		0	0.30924438					OC(CCCN1CCCCC1)(c2ccccc2)c3ccccc3	Prestwick	Prestw-252	4.87739937	1.24612114	1.20153055	0.54430983	4.11866213	3.06926165	0.30924438									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016384-15	Sulfisoxazole	170464636	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	127-69-5	; ;SULFISOXAZOLE; Sulfisoxazole; Sulfafurazole(SIZ);Sulfisoxazole			14.0929234378	4	7		0	3.76669793					Cc2c(NS(=O)(=O)c1ccc(N)cc1)onc2C	Microsource	01500555	0.53494058	2.95404012	3.11715532	3.58441819	3.78368776	3.36399207	3.76669793									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178737-05	Trimeprazine tartrate	170465278	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	4330-99-8		13.9333492831	-4.8559444758	-32.5202146269	-2.2	7		-61.6940128216	-47.11667638	0.0019302711	0.9815177322			O=C(O)[C@H](O)[C@H](O)C(=O)O.CN(C)C[C@H](C)CN1c3ccccc3Sc2ccccc12.CN(C)C[C@H](C)CN1c3ccccc3Sc2ccccc12	Microsource	01500593	-0.87381696	3.70659956	3.0001706	1.79346327	-5.32152464	-13.32384776	-47.11667638									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025158-02	(S)-(+)-Dimethindene maleate	170465880	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	1217457-81-2		22.0828704269	-4.6559444758	-4.6281375426	4	7		-9.7020227679	-8.50168564	0.404006649	0.5083435557			C[C@@H](C=1c2ccccc2CC=1CCN(C)C)c3ccccn3.O=C(O)/C=C\C(=O)O	Tocris	1425	-2.44717159	4.59110123	2.12765957	-0.16304211	-5.26569558	0.86894659	-8.50168564									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016267-06	Isocarboxazid		Monoamine oxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	59-63-2				-21.2313137145	4	7		0	-6.535699					CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2	Prestwick	Prestw-795	-6.13887026	-3.03772321	-5.70778932	-2.35016252	-1.72753844	-5.69804585	-6.535699									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00015741-13	4,4 -(2,3-Dimethyltetramethylene)dipyrocatechol		5-Lipoxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	500-38-9		5.5469662594	-5.2559444758	-118.3729399715	-2.1	7		-106.390826188	-90.34390905	0.0000085026	0.9988073775		ALOX5	CC(CC1=CC(=C(O)C=C1)O)C(C)CC2=CC(=C(O)C=C2)O	Prestwick	Prestw-NAT-0055	-1.36650558	-1.26822056	-4.99050655	-9.8940673	-23.53206758	-60.22172116	-90.34390905									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00248247-02	Dimethyl maleate	170466784	NFkappaB-inducing kinase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	624-48-6				-33.391017482	4	7		0	-10.41716216				NFE2L2	COC(=O)/C=C\C(=O)OC	GVK	FFS-12-73-NCI-3423	-7.10999098	-7.66707478	-6.56102764	-6.77922503	-5.06380249	-6.95697106	-10.41716216									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346438-03	Retaspimycin (Hydrochloride)		Heat shock protein HSP90 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	857402-63-2		6.2237985085	-5.2059444758	-99.4063509695	-2.1	7		-89.0004138764	-87.26632736	0.0000038377	0.999199294		HSP90AB1	CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=CC(=C2O)NC(=O)C(=C\C=C/[C@H](OC)[C@@H](OC(N)=O)C(=C\[C@H](C)[C@H]1O)/C)/C)O	MedChem Express	HY-10210	-4.41397489	-3.59213657	-3.06368815	-4.30980053	-12.24009695	-48.92897407	-87.26632736									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015242-13	Chlorothiazide	170465303	Hypertension treatment	DPI_SARS-CoV-2_General	2019_NPC_01	58-94-6	; ; Clorotiazida;CHLOROTHIAZIDE; Chlorothiazide;Chlorothiazide; Fluitoran; SK-Chlorothiazide			-49.2554133424	4	7		0	-11.71579935				SLC12A3	NS(=O)(=O)c2cc1c(N=CNS1(=O)=O)cc2Cl	Microsource	01500180	-9.77658364	-8.29525741	-15.68813824	-7.18639476	-10.34106481	-10.64586615	-11.71579935									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094856-05	Adenine	170465950	Xanthine dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	73-24-5				-33.5038160407	4	7		0	-9.12524397					Nc1ncnc2ncnc12	Microsource	01500807	-8.96812141	-6.59955531	-5.11564427	-8.02919708	-6.66649749	-5.95558717	-9.12524397									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00096077-06	Olanzapine	170465009	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	132539-06-1	; ;OLANZAPINE; Zyprexa; OLANZAPINE;Olanzapine; Olanzapine; Lilly brand of olanzapine	15.6334750258	-4.8059444758	-17.6791909495	-3	7		-45.5238270276	-34.93954526	0.0001408123	0.9951204383	1813	DRD2	CN1CCN(CC1)C2=Nc4ccccc4Nc3sc(C)cc23	SIGMA	O1141	0.12344783	2.03044445	3.10253223	1.95399704	0.32228595	-6.46882464	-34.93954526									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379034-03	Caspofungin Acetate			DPI_SARS-CoV-2_General	2019_NPC_02	179463-17-3		2.6938104809	-5.5696329617	-121.4079724793	-2.1	7		-103.6332112493	-88.27474671	0.0003971078	0.9917537015			CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@@H](O)[C@H](O)C4=CC=C(O)C=C4)[C@H](O)CCN	Selleck	S3073	2.93417189	2.65425397	0.18049272	-2.99090335	-22.37720695	-48.13979707	-88.27474671									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00091399-01	Benzothiazole	17389158		DPI_SARS-CoV-2_General	2019_NPC_02					-2.8924528972	4	7	CIPLUS_150270;Benzothiazole;benzothiazole;AB07993090-01;	0	0.39480569					S1C=NC2=CC=CC=C12	NIEHS	AB07993090	-0.90406715	-1.29132112	-2.2667073	0.6898487	1.42813012	-2.11856445	0.39480569									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00351599-02	Abemaciclib		CDK4/6 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1231930-82-7		8.7913490634	-5.0559444758	-39.2825214038	-2.2	7		-48.7619749804	-45.27422347	0.0002242667	0.9938267202		CDK4	CCN1CCN(CC1)CC2=CN=C(NC3=NC=C(F)C(=N3)C4=CC(=C5N=C(C)[N](C(C)C)C5=C4)F)C=C2	Selleck	S7158	0.77920877	-2.03515905	-2.22920232	1.13415803	-0.89109617	-18.78523112	-45.27422347									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181786-02	Naratriptan hydrochloride	170465423	5-HT1B Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	143388-64-1	Naratriptan hydrochloride; Naratriptan hydrochloride; Amerge; 			-21.3292037024	4	7		0	-8.72853541			3351	HTR1B	Cl.CN1CCC(CC1)c2cnc3ccc(CCS(=O)(=O)NC)cc23	SIGMA	N1415	-5.06601309	-4.46995773	-4.12789199	-5.64740547	-0.66772806	-4.11029688	-8.72853541									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253597-01	Isosulfan blue	170464639		DPI_SARS-CoV-2_General	2019_NPC_01	68238-36-8		11.0676527398	-4.9559444758	-111.2259080758	-2.1	7		-99.3524175977	-84.92053433	3.223E-7	0.9997681909			[Na+].CC/[N+](CC)=C1\C=C/C(C=C1)=C(/c2ccc(cc2)N(CC)CC)c3cc(ccc3S([O-])(=O)=O)S([O-])(=O)=O	GVK	FFS-11-286-NCI-038	-8.53242321	-7.76748845	-7.63081572	-9.9756691	-17.01009998	-44.43823365	-84.92053433									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015848-09	Tranylcypromine hydrochloride			DPI_SARS-CoV-2_General	2019_NPC_01					10.6962910523	4	7		0	0.253479					N[C@@H]1C[C@H]1C2=CC=CC=C2	Tocris	3852	2.25352795	2.48979891	2.00092613	2.73158251	4.87996752	0.82829412	0.253479									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249915-01	Bupranolol	170465802	Beta-3 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	14556-46-8				-5.934322522	4	7		0	-4.45109123					Clc1ccc(C)cc1OCC(O)CNC(C)(C)C	GVK	FFS-11-286-NCI-172	-1.22721661	0.70124856	0.91881748	-3.10281687	-3.35228138	0.88927283	-4.45109123									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016386-06	Sulfamerazine	170464738	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	127-79-7				4.5167775449	4	7		0	3.89343743					O=S(=O)(Nc1nc(C)ccn1)c2ccc(N)cc2	Vitas	STK520614	0	3.52578982	0	0	0	0	3.89343743									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249921-01	Omoconazole	170465847		DPI_SARS-CoV-2_General	2019_NPC_01	74512-12-2		12.4181106199	-4.9059444758	-94.7611239049	-2.1	7		-109.2665874605	-85.79757167	0.0000021667	0.9993985674			C\C(=C(\OCCOc1ccc(Cl)cc1)c2ccc(Cl)cc2Cl)n3ccnc3	GVK	FFS-11-286-NCI-199	-4.79025972	-2.90517262	-4.95479028	-4.69310457	-12.817845	-40.85573454	-85.79757167									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090770-09	5-Bromo-2'-deoxyuridine	170465870	base conversion or substitution editing Activator	DPI_SARS-CoV-2_General	2019_NPC_01	59-14-3				11.8647596515	4	7		0	0					BrC1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2	Bosche	B0691	3.63808002	1.32919589	4.22851015	3.32355081	2.31183069	2.25621221	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164543-02	Lomerizine dihydrochloride	170466010	Ca channel blocker - benzhydryl class	DPI_SARS-CoV-2_General	2019_NPC_01	101477-54-7	 ; Terranas; Lomerizine HCl; LOMERIZINE DiHCl;Lomerizine; Lomerizine	8.7913490634	-5.0559444758	-39.1500801337	-2.2	7		-64.2758738732	-52.86051051	0.0000737805	0.996473997			Cl.Cl.Fc1ccc(cc1)C(c2ccc(F)cc2)N3CCN(CC3)Cc4ccc(OC)c(OC)c4OC	Sequoia	SRP01568l	4.00600295	0	3.28288367	1.75332982	-1.43886718	-23.62416789	-52.86051051									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017048-03	Levopropoxyphene napsylate		Kappa Opioid Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	5714-90-9				-4.1436005336	4	7		0	-6.59277934					O[S+]([O-])(=O)C1=CC=C2C=CC=CC2=C1.CCC(=O)O[C@](CC3=CC=CC=C3)([C@@H](C)CN(C)C)C4=CC=CC=C4	Prestwick	Prestw-1054	0.04393165	0.37191896	0.14298774	0.07249258	-0.7912934	-0.79387448	-6.59277934									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167550-08	Narasin		Nf-kappa B Signaling Pathway Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	55134-13-9		9.8640558873	-5.0059444758	-17.6548359767	-2.4	7		-33.333824864	-28.61152072	0.0011819244	0.9856457257			CC[C@H]([C@@H]1O[C@@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@@]3(O[C@@]4(CC[C@](C)(O4)[C@H]5CC[C@](O)(CC)[C@H](C)O5)[C@H](O)C=C3)[C@H](C)C[C@@H]2C)[C@@H](C)C[C@@H]1C)C(O)=O	Enzo	NP198	3.13302042	-0.21945529	1.18843909	-0.22683161	2.29308747	-9.74727546	-28.61152072									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160603-02	4-Styrylpyridine	144205483		DPI_SARS-CoV-2_General	2019_NPC_02	103-31-1	4-styrylpyridine; 4-stilbazole, (E)-isomer; 4-stilbazole, (Z)-isomer; 	25.355181056	-4.5959332839	-13.2092936889	-3	7	CIPLUS_714835;4-stilbazole, (E)-isomer;STYRYLPYRIDINIUM CHLORIDE;CIPLUS_679001;4-STYRYLPYRIDINIUM CHLORIDE;4-stilbazole;4-styrylpyridine;4-stilbazole, (Z)-isomer;4-stilbazole monohydrochloride, (E)-isomer;4-stilbazole monohydrochloride;	-37.930124152	-35.77510346	0.0002612871	0.993333408			C(=Cc1ccncc1)c2ccccc2	Maybridge	JFD 00085	0	0	0	0	2.99645938	-4.0257422	-35.77510346									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00532507-01	INOSITOL NIACINATE			DPI_SARS-CoV-2_General	2019_NPC_02			2.0945655622	-5.6789060412	-19.1891568578	4	7		-14.184583556	-13.90381963	0.0095974533	0.9573575543			O=C(O[C@@H]1[C@H](OC(=O)C2=CC=CN=C2)[C@H](OC(=O)C3=CC=CN=C3)[C@@H](OC(=O)C4=CN=CC=C4)[C@H](OC(=O)C5=CC=CN=C5)[C@H]1OC(=O)C6=CC=CN=C6)C7=CC=CN=C7	SIGMA	MFCD00006387	0.22428264	0.23793573	1.3150184	-2.21453125	0.73901575	-5.18132281	-13.90381963									5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7	0.0000016599999999	0.00000831								
NCGC00179556-03	Cefadroxil	170464658	Solute carrier family 15 member 2 Substrate	DPI_SARS-CoV-2_General	2019_NPC_02	50370-12-2				8.0822685909	4	7		0	-0.55177663					CC=3CS[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](N)c1ccc(O)cc1)C=3C(=O)O	Vitas	STK801939	2.25901177	2.27540484	1.12280537	2.71964081	1.96991659	1.70518602	-0.55177663									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179297-04	Azapropazone		interleukin-1 alpha production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	13539-59-8		25.355181056	-4.5959332839	-15.4736165543	-3	7		-46.574656324	-45.2409266	0.0000969536	0.995955323			CCCC1C(=O)N2N(C1=O)\C(=N/C3=C2C=C(C)C=C3)N(C)C	Prestwick	Prestw-1003	0.79308192	0.32571785	2.32765289	-1.39138975	0.83406601	-2.74332958	-45.2409266									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00182065-02	Dimemorfan phosphate	144206689		DPI_SARS-CoV-2_General	2019_NPC_02	36304-84-4	dimemorfan; Astomin; Dimemorfano; Dimemorfane; Dastosin; 			-3.7298035523	4	7	LS-174594;Dimemorfano;DIMEMORFAN;CIPLUS_789081;Dimemorfane;3,17-dimethylmorphinan;Astomin;CIPLUS_775315;Dastosin;LS-174593;dimemorfanum;CIPLUS_739426;CIPLUS_207834;dimemorfan, (9alpha,13alpha,14alpha)-isomer;Yamanouchi brand of dimemorfan phosphate;Dimemorfan Phosphate;at-17;dinemorphan;Dimemorfan;(+)-3,17-DIMETHYLMORPHINAN;dimemorfan phosphate;dimemorfan phosphate (1:1) salt;dimemorfan;d-3-methyl-N-methylmorphinan;LS-174853;DIMEMORFAN PHOSPHATE;Dimemorfan phosphate;AT 17;LS-91711;Dimemorfanum;	0	-4.91366598					O=P(O)(O)O.Cc3ccc4C[C@@H]1N(C)CC[C@]2(CCCC[C@H]12)c4c3	Kemprotec	36304-84-4	0.65435039	-0.94019266	0.23675019	-0.82547997	0.84357104	-1.578354	-4.91366598									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168251-01	Ethylmorphine	144206163	Opioid receptors; mu/kappa/delta Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	76-58-4	Ethylmorphine hydrochloride; Veralgin; Dionin; Morphine 3-ethyl ether; 			-12.1103582964	4	7	Dionin;LS-91899;CIPLUS_781610;Veralgin;Morphine 3-ethyl ether;Ethylmorphine;LS-91901;LS-91902;LS-91903;CIPLUS_173377;CIPLUS_165781;O-Ethylmorphine hydrochloride;CIPLUS_730767;CIPLUS_149399;ETHYLMORPHINE HYDROCHLORIDE;Ethylmorphine hydrochloride;Morphinan-6-alpha-ol, 7,8-didehydro-4,5-alpha-epoxy-3-ethoxy-17-methyl-, hydrochloride,dihydrate;ethyl-alpha-isomorphine;CIPLUS_3884309;Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-ethoxy-17-methyl-, (5alpha,6alpha)-;Ethylmorphine Hydrochloride;ETHYLMORPHINE;	0	-2.61618228					CCOc1ccc2C[C@H]4N(C)CC[C@@]35[C@@H](Oc1c23)[C@@H](O)C=C[C@@H]45	SigmaAldrich	E8512	-1.9538024	-2.74665619	-1.38534024	-3.59422866	-2.66853599	-3.06745584	-2.61618228									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015730-11	Neostigmine bromide	170465765	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	114-80-7				-14.9078768588	4	7		0	-4.10635979					[Br-].O=C(Oc1cccc(c1)[N+](C)(C)C)N(C)C	Enzo	AC743	-1.1788057	-0.2321206	-3.89217908	-3.98575263	-6.67157286	-2.3070278	-4.10635979									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249933-01	Nitrogen mustard N-oxide	170465894		DPI_SARS-CoV-2_General	2019_NPC_01	126-85-2				-17.9567133125	4	7		0	-4.32435173					[O-][N+](C)(CCCl)CCCl	GVK	FFS-11-286-NCI-237	-3.10555999	-4.07799252	-4.10665107	0.23829232	-4.72263107	-6.75339194	-4.32435173									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015264-13	Clomipramine hydrochloride	170464702	Serotonin Transporter (SERT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	303-49-1	 7   Clomipramine; ; Chlomipramine;; Hydiphen;CLOMIPRAMINE HYDROCHLORIDE; Anafranil;Clomipramine; Anafranil hydrochloride; Chloripramine;Clomipramine?HCl; Clomipramina; 8   Clomipramine Hcl;Clomipramine hydrochloride; Clomipramine hydrochloride	13.9333492831	-4.8559444758	-22.0568275486	-3	7		-41.36713898	-30.30594915	0.0006825922	0.9891536043	6532	SLC6A4	CN(C)CCCN2c3ccccc3CCc1ccc(Cl)cc12	Microsource	02300061	1.67743809	-0.01710362	1.97655431	0.93561091	-3.35228138	-9.86838762	-30.30594915									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094754-05	Phenacemide	170465322	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	63-98-9				6.7264158527	4	7		0	0.22306152					O=C(Cc1ccccc1)NC(N)=O	Microsource	01500472	1.31435626	3.85320204	1.87906705	1.82356335	1.5505253	-0.92484374	0.22306152									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016759-04	Naproxen sodium	170465301	Cyclooxygenase-1/2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	26159-34-2	NAPROXEN(+); ; Naprosin; Synflex; Anaprox; 2   Dl-Naproxen;(S)-Naproxen; (S)-Naproxen; Proxen; Naproxeno; (R) -Naproxen sodium salt; (-)-Naproxen sodium; DL-Naproxen;Naproxen; Naprosyn; Aleve; Naproxen	13.9333492831	-4.8559444758	-3.4316292389	4	7		-27.16427974	-24.30356645	0.0007482821	0.9886386381	5743	PTGS2	[Na+].[O-]C(=O)[C@@H](C)c1ccc2cc(ccc2c1)OC	Microsource	01500425	3.39118437	3.86786229	1.00655602	2.33024807	1.07344059	1.86493216	-24.30356645									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182047-03	Fludarabine phosphate	170464764	Purine Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	21679-14-1	 ; Fludarabine phosphate; F-ara-AMP;Fludarabine phosphate; Fludara;FLUDARABINE PHOSPHATE			7.4996264945	4	7		0	-0.29403564				HPRT1	Nc3nc(F)nc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	Microsource	01505705	3.80751821	-0.63283407	2.81981916	1.33192866	3.21017104	0.5335637	-0.29403564									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179009-06	Phenethicillin potassium salt		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	132-93-4				9.5685275484	4	7		0	0.84193502					CC(OC1=CC=CC=C1)C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C([O-])=O	Prestwick	Prestw-723	3.3734884	0	2.94648508	4.06659963	0.6819856	2.09037956	0.84193502									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379052-01	Ticagrelor		Purinergic receptor P2Y12 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	274693-27-5		12.4181106199	-4.9059444758	-34.4583471766	-2.2	7		-71.3702611416	-51.79565238	0.0000034678	0.9992390883			CCCSC1=NC(=C2N=N[N]([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)C2=N1)N[C@@H]4C[C@H]4C5=CC=C(F)C(=C5)F	MedChem Express	HY-10064	3.11452288	2.40476795	2.33234101	3.29022753	-1.3093173	-19.96899662	-51.79565238									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160614-01	Glucuronamide	144205490		DPI_SARS-CoV-2_General	2019_NPC_02	61914-43-0	Glucuronamide; D-Glucuronic acid amide; Guronamin; 			-7.5221260279	4	7	Glucuronamide;CIPLUS_791650;GLUCURONAMIDE;glucuronamide;D-Glucuronic acid amide;glucuronamidum;Guronamin;	0	-5.96489559					O[C@H]1[C@H](O)[C@H](O[C@@H](O)[C@@H]1O)C(N)=O	SigmaAldrich	MFCD00006619	-0.79308192	-2.09522049	-1.58692951	-2.55127096	1.30456479	-1.53607666	-5.96489559									6.38E-9	3.1899999999E-8	1.59E-7	7.97E-7	0.00000399	0.0000199	0.0000997								
NCGC00037856-01	Medronic acid	144204525		DPI_SARS-CoV-2_General	2019_NPC_02	1984-15-2				0.2858556462	4	7	Medronate disodium;Acido medronico;Acide medronique;PHOSPHONIC ACID, METHYLENEBIS-;Methylene Diphosphonic Acid;CIPLUS_159401;acidum medronicum;METHYLENE DIPHOSPHONIC ACID;METHYLENEDIPHOSPHONIC ACID;Methylenediphosphonic acid trisodium salt tetrahydrate;CIPLUS_738322;MEDRONIC ACID;Medronic acid;MEDRONATE DISODIUM;Acidum medronicum;MEDRONATE SODIUM;Methylenediphosphonic acid;methylene diphosphonate;METHYLENE DIPHOSPHONIC ACID, SODIUM SALT;acide medronique;CIPLUS_175020;	0	0.64215383					O=P(O)(O)CP(=O)(O)O	DPISMR	3714055	0.15029249	-1.85035459	2.59487588	0.69920258	0.07366395	-1.74276588	0.64215383									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016527-06	Clopamine			DPI_SARS-CoV-2_General	2019_NPC_02	636-54-4				10.2559930696	4	7		0	3.98611045					C[C@H]1CCC[C@@H](C)N1NC(=O)C2=CC(=C(Cl)C=C2)[S+](N)([O-])=O	Enzo	CM112	0	4.81646608	2.91835634	1.57846737	1.26179217	1.08981586	3.98611045									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179359-04	Penbutolol sulfate			DPI_SARS-CoV-2_General	2019_NPC_02	38363-32-5		3.9269513795	-5.4059444758	-48.9663098197	4	7		-10.7237677799	-18.52257052	0.0023439787	0.9797244988			CC(C)(C)NCC(O)COC1=C(C=CC=C1)C2CCCC2	Prestwick	Prestw-1043	-7.41520035	-7.82877867	-7.08609737	-9.19252625	-9.20324121	-15.59564074	-18.52257052									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016747-07	Dilazep	170465831	Equilibrative nucleoside transporter 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	35898-87-4		11.0676527398	-4.9559444758	-23.7426042503	-2.4	7		-35.222288404	-29.76857367	3.634E-7	0.9997541339			COc1cc(cc(OC)c1OC)C(=O)OCCCN3CCCN(CCCOC(=O)c2cc(OC)c(OC)c(OC)c2)CC3	Enzo	AC640	0.30498874	0	0	0	-1.0226869	-10.7881498	-29.76857367									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00073457-04	Metomidate hydrochloride	170466159	Cytochrome P450 2A5 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	35944-74-2				3.2417677244	4	7		0	0					Cl.CC(c1ccccc1)n2cncc2C(=O)OC	Vitas	STK331722	0	0	0	4.63792109	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167513-04	Vandetanib	170465617	EGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	443913-73-3	 ;AZD-6474;Caprelsa;ZD-6474;Zactima;Vandetanib; Vandetanib;CH-331			8.7736821209	4	7		0	-1.2927429			1956	EGFR	CN4CCC(COc2cc3ncnc(Nc1ccc(Br)cc1F)c3cc2OC)CC4	Sequoia	443913-73-3	2.05504321	4.30766975	0	0	3.38273359	3.85182174	-1.2927429									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095122-05	Irbesartan	170464670		DPI_SARS-CoV-2_General	2019_NPC_01	138402-11-6				1.2727186973	4	7		0	-1.77942257					CCCCC5=NC1(CCCC1)C(=O)N5Cc2ccc(cc2)c3ccccc3c4nnnn4	Microsource	01504259	0	1.94981308	0	1.21403667	0	0	-1.77942257									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093704-12	Cyclosporine A	170466812	immunosuppressant	DPI_SARS-CoV-2_General	2019_NPC_01	59865-13-3	 Antibiotic S 7481F1; ; 11-me-Leu-CsA;Cyclosporin A; cyclosporin A synthetase;; Cyclophilins; F-7-62 cyclosporin; CYCLOSPORIN A;CYCLOSPORINE; Cyclosporine; cyclosporin O; CYCLOSPORINE; Cyclosporin A; cyclosporin metabolite M1; H-7-94 cyclosporin; cyclosporin A-SPTP; 3-MeAla-7-Phe-8-Ser-CsA; Cs29 (cyclosporin); M1 cyclosporin metabolite; Cyclosporin SG	4.9437388825	-5.3059444758	-80.7213015597	-2.2	7		-48.3671287349	-53.74261742	0.0001685402	0.994655154		PPP3CC	C[C@H](C\C=C\C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C)C(C)C	Microsource	01502202	-8.22259337	-4.08287927	-6.54870708	-8.44056488	-11.33583718	-36.58722496	-53.74261742									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159429-03	Coenzyme Q10	225144226	mitochondrial electron transport	DPI_SARS-CoV-2_General	2019_NPC_01					5.3814406116	4	7		0	-2.91500849				NDUFV3	COC\1=C(/OC)C(=O)\C(=C(C)/C1=O)C\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CC\C=C(C)\CCC=C(C)C	Tocris	3003	2.92159853	0.21257361	4.5940874	4.39712043	0	3.40464454	-2.91500849									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00159391-03	Sulfobromophthalein	170465816	Solute carrier organic anion transporter family member 1B1 Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	71-67-0		6.2237985085	-5.2059444758	-46.3574113505	-2.2	7		-43.1694417249	-41.06866746	0.0001773446	0.9945173911			[Na+].[Na+].[O-]S(=O)(=O)c1cc(ccc1O)C3(OC(=O)c2c(Br)c(Br)c(Br)c(Br)c23)c4ccc(O)c(c4)S([O-])(=O)=O	Labotest	LT03378988	-3.03294363	-0.15393261	-0.47037606	-2.42054832	-6.68679896	-22.68407948	-41.06866746									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263571-01	Bendazac sodium	170465952	Xanthine dehydrogenase/oxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	23255-99-4				11.0759063715	4	7		0	2.49423335					[Na+].[O-]C(=O)COc3nn(Cc1ccccc1)c2ccccc23	Sequoia	20187-55-7	0	4.03889853	2.00092613	3.67471844	4.25062173	0	2.49423335									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159467-03	(-)-Cocaine hydrochloride	144206436	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	53-21-4				-3.5395197797	4	7		0	0.25210484					Cl.CN3[C@H]1CC[C@@H]3[C@H]([C@H](C1)OC(=O)c2ccccc2)C(=O)OC	RTI	9041-001	0.6219797	-1.19891889	-0.69618621	-0.72726422	-0.20673431	-3.22717024	0.25210484									4.22E-9	2.11E-8	1.06E-7	5.28E-7	0.00000264	0.000013199999999	0.000065999999999								
NCGC00179265-03	Netilmicin sulfate	170465142	Lysosomal phospholipase A1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	56391-57-2				7.7043713734	4	7		0	1.1913513					O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.NC3CC=C(CN)OC3O[C@@H]2[C@@H](N)C[C@@H](NCC)[C@H](O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O)[C@H]2O.NC3CC=C(CN)OC3O[C@H]2[C@H](O)[C@@H](O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O)[C@H](NCC)C[C@@H]2N	Bosche	N2413	0.98516206	2.69504239	-0.66535059	2.95733313	2.99700553	-1.75821942	1.1913513									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00015623-10	Proglumide	170465774	Cholecystokinin B receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	6620-60-6				-25.9393965495	4	7		0	-9.06947859				CCKBR	O=C(NC(CCC(=O)O)C(=O)N(CCC)CCC)c1ccccc1	Microsource	01501119	-6.70249074	-2.0353312	-6.2269991	-4.20648657	-4.86474141	-6.44341684	-9.06947859									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016034-05	Tulobuterol hydrochloride	170465781	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	56776-01-3				-12.6906263455	4	7		0	-4.08608147					Cl.OC(CNC(C)(C)C)c1ccccc1Cl	Microsource	01503954	-2.95064508	-1.47824175	-2.57122663	-5.81182432	-1.43379181	-0.91976218	-4.08608147									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095795-06	5,7-Dichloro-8-hydroxy-2-methylquinoline	170465701	Botulinum neurotoxin type A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	72-80-0				12.4394676414	4	7		0	4.24323845					Oc1c(Cl)cc(Cl)c2ccc(C)nc12	Microsource	00212151	2.09861303	4.62530848	1.43062562	3.16301703	0.34766279	2.99811982	4.24323845									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093366-05	(4-Aminophenyl)arsonic acid	170465635	Apoptosis Activator	DPI_SARS-CoV-2_General	2019_NPC_01	98-50-0				4.3808548955	4	7		0	2.96063471					O=[As](O)(O)c1ccc(N)cc1	Labotest	LTBB003365	1.44506572	-2.25523493	2.30313665	2.05433065	1.35766127	-0.82829412	2.96063471									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344532-01	Mucic acid	170464883		DPI_SARS-CoV-2_General	2019_NPC_01	526-99-8				-24.5819070541	4	7		0	-5.27236318					O[C@@H]([C@H](O)[C@H](O)[C@@H](O)C(=O)O)C(=O)O	SIGMA	M89617	-5.55999322	-4.59598798	-2.468865	-7.86364663	-4.09836066	-6.78388129	-5.27236318									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016572-12	Sulfamonomethoxine	170465768		DPI_SARS-CoV-2_General	2019_NPC_01	1220-83-3				-48.1855150266	4	7		0	-11.74114725					O=S(=O)(Nc1cc(OC)ncn1)c2ccc(N)cc2	Microsource	01501147	-10.62861569	-10.78261294	-10.64317224	-10.53753731	-8.23478658	-9.58890187	-11.74114725									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015513-11	Histamine dihydrochloride	170465001	Histamine Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	51-45-6	Histamine dihydrochloride;Histamine;HISTAMINE DIHYDROCHLORIDE;HISTAMINE; Histamine dihydrochloride			-2.923586696	4	7		0	-1.31302122			9704	HRH1	NCCc1cncn1	Vitas	STK346752	-0.05083146	-3.02245461	-0.93831493	0.12290867	-1.52007309	2.21555973	-1.31302122									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181019-01	Testosterone isocaproate	144206222		DPI_SARS-CoV-2_General	2019_NPC_02	15262-86-9	Testosterone isocaproate; Ambosex; Mixogen; 	12.4181106199	-4.9059444758	-13.6452848756	-2.4	7	Testosterone 4-methylvalerate;TESTOSTERONE ISOCAPROATE;estrandron;Testosterone Isocaproate;Androst-4-en-3-one, 17-((4-methyl-1-oxopentyl)oxy)-, (17beta)-;4-Androsten-17beta-ol-3-one 17-(4-methylpentanoate);Ambosex;testosterone isocaproate;CIPLUS_662693;Testosterone isocaproate;CIPLUS_750718;	-40.978832712	-29.14902726	0.0012969596	0.9849440222			CC(C)CCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	InterBioScreen	BB_NC-1398	3.45210294	4.18813093	0	4.08530739	0	-9.15069523	-29.14902726									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166257-03	NCGC00166257-03	50111747		DPI_SARS-CoV-2_General	2019_NPC_02					-11.857131283	4	7	Mn3O4;Manganese(II,III) oxide;hausmannite;manganese oxide;manganous-manganic oxide;CIPLUS_158079;manganese oxide, hydrate;	0	-6.13613661					O=[Mn]O[Mn]O[Mn]=O	SigmaAldrich	377473	-1.48673958	2.14604172	-1.11811725	-5.98414517	0.04514887	-5.98459226	-6.13613661									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160444-02	Clofenamide	170466058	Carbonic anhydrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	671-95-4				-19.396012953	4	7		0	-7.08220324					O=S(N)(=O)c1cc(ccc1Cl)S(N)(=O)=O	Enamine	Z401602360	-5.22111684	-4.09265277	-3.70695328	-3.0175333	-3.29645232	-3.2369531	-7.08220324									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016410-13	Thiabendazole	170464939	Methionine Aminopeptidase-1 (MetAP1) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	148-79-8	;THIABENDAZOLE; ; Omnizole;Thiabendazole; Thibendole; Mintezol; Tiabendazole;Tiabendazole; Mintesol			-8.900918457	4	7		0	-7.06192492				METAP1	n1c3ccccc3nc1c2cscn2	Labotest	LT00134862	0.93675114	-1.38539351	-1.18690746	-1.94396368	-0.13449728	-3.66380405	-7.06192492									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091469-04	Saquinavir	225144210	protease inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	149845-06-7	Saquinavir mesylate;Saquinavir mesylate; Fortovase; Ro 31-8959; Ro 31 895; Saquinivir; Ro 31895; ; Saquinavir mesylate;Saquinavir mesylate; Fortovase; Ro 31-8959; Ro 31 895; Saquinivir; Ro 31895; ;saquinavir	12.4181106199	-4.9059444758	-51.4517950481	-2.2	7		-75.4639426068	-57.16965349	0.0004075722	0.9916460651			CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=C(C=CC=C5)C=C4	Prestwick	Prestw-1114	1.52252318	2.14283969	0.09505008	-4.77838814	-5.66664975	-23.76136999	-57.16965349									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016064-12	Terfenadine	170465598		DPI_SARS-CoV-2_General	2019_NPC_01	50679-08-8		3.9269513795	-5.4059444758	-25.8916041731	-2.4	7		-31.2280550559	-27.69004588	0.001789575	0.982235013			CC(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4	Microsource	01503708	0	4.78168446	0	2.09948077	-3.50961782	-19.53351288	-27.69004588									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016421-07	Cyclizine hydrochloride	170465270	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	303-25-3				-6.2350299418	4	7		0	-7.85784898					Cl.Cl.CN1CCN(CC1)C(c2ccccc2)c3ccccc3	Microsource	01500211	-0.95611551	0.03176387	2.11791085	-2.88709961	-1.55560067	0.2235886	-7.85784898									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249920-01	Nandrolone cyclohexylpropionate	170465905	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	912-57-2		8.7913490634	-5.0559444758	-30.3889580864	-2.2	7		-40.2112210376	-36.90244018	0.0019093909	0.9816269064			O=C5CC[C@H]4C(CC[C@@H]3[C@@H]4CC[C@@]2(C)[C@H]3CC[C@@H]2OC(=O)CCC1CCCCC1)=C5	GVK	FFS-11-286-NCI-188	-2.10640708	0.39963963	-2.47767282	1.96197647	1.6039731	-15.08831266	-36.90244018									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164551-05	Biapenem			DPI_SARS-CoV-2_General	2019_NPC_02	120410-24-4				12.8777653386	4	7		0	3.51995434					C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(=C(\N2C1=O)C([O-])=O)/SC3C[N]4C=NC=[N+]4C3	MedChem Express	HY-13573	0	3.81852203	3.12463374	4.30044665	1.00515648	0	3.51995434									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00249916-01	Dimorpholamine	170465773	skeletal muscle contraction Activator	DPI_SARS-CoV-2_General	2019_NPC_01	119-48-2				-17.8715482424	4	7		0	-9.36858381					O=C(N(CCCC)CCN(CCCC)C(=O)N1CCOCC1)N2CCOCC2	GVK	FFS-11-286-NCI-176	-4.53368189	-4.54712048	-1.96193122	-0.78009381	-2.95132721	-3.87214797	-9.36858381									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025125-18	Colchicine	170465011	Tubulin polymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	64-86-8	; ; Colchicine;COLCHICINE; Colchicine derivatives; Colchicine, (+-)-Isomer; Colchicine, (R)-Isomer;Colchicine			7.5058472498	4	7		0	1.88588375			203068	TUBB	CC(=O)N[C@H]2CCc3cc(OC)c(OC)c(OC)c3C1=CC=C(OC)C(=O)C=C12	Prestwick Chemical, Inc.	Prestw-363	3.6526033	0	0	0	3.22539715	2.55602419	1.88588375									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024584-17	BROMOCRIPTINE			DPI_SARS-CoV-2_General	2019_NPC_01	22260-51-1		4.4061119169	-5.3559444758	-99.1054014033	-2.1	7		-88.7682796388	-86.48196497	0.0000023116	0.9993787464			[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N3C(=O)[C@](NC(=O)[C@H]4CN(C)[C@]5([H])CC6=C(Br)NC7=CC=CC(=C67)C5=C4)(O[C@@]23O)C(C)C	SIGMA	B2134	-1.42570135	0.52532558	-1.99605177	-2.24998119	-13.28985434	-58.18385081	-86.48196497									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015998-06	THIOTHIXENE		dopamine secretion Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	5591-45-7, 3313-26-6 [//Z//]		15.6334750258	-4.8059444758	-54.3411682864	-2.2	7		-77.8542548584	-60.49564762	0.0015670967	0.9833953045			CN(C)[S+]([O-])(=O)C1=CC2=C(SC3=C(C=CC=C3)\C2=C/CCN4CCN(C)CC4)C=C1	Microsource	01500576	2.08328516	0.57982397	-1.87759312	-5.97946823	-7.53035668	-19.32544156	-60.49564762									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025297-04	Gabexate mesilate	170465830	NF-kappaB Activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	56974-61-9	; ;Gabexate mesylate; Gabexate mesylate;Benzoic acid, 4-((6-((aminoiminomethyl)amino)-1-oxohexyl)oxy)-, ethyl ester;Gabexate mesilate; Gabexate Methanesulfonate; Arodate; Gabexato			4.8833339186	4	7		0	-4.38518669			4790	NFKB1	O=C(Oc1ccc(cc1)C(=O)OCC)CCCCCNC(=N)N.CS(=O)(=O)O	Prestwick	Prestw-1008	2.3309854	4.27834926	-1.33313836	3.0677001	1.38303812	0.645358	-4.38518669									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015786-16	Pindolol	170464892	Serotonin 1a (5-HT1a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	13523-86-9				10.1762761956	4	7		0	-3.73628045					CC(C)NCC(O)COc2cccc1nccc12	Enzo	AC181	1.43054244	2.71458939	3.54122493	3.13291695	4.21001878	2.3934143	-3.73628045									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263872-02	SPIRAMYCIN		Bacterial 70S ribosome Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_02	8025-81-8				4.5401374641	4	7		0	-3.12990534					CO[C@H]1[C@H](O)CC(=O)O[C@@H](C)C\C=C\C=C\[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]3O[C@H](C)[C@@H](O[C@H]4C[C@@](C)(O)[C@H](O)[C@H](C)O4)[C@@H]([C@H]3O)N(C)C	Microsource	01503423	2.43011399	3.05158354	0.64930499	2.54659402	0.02613882	0.23017663	-3.12990534									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167420-01	Perflenapent	144205977		DPI_SARS-CoV-2_General	2019_NPC_02	678-26-2	QW-7437; 2H,3H-perfluoropentane; 			12.4867194276	4	7	CIPLUS_156010;QW7437;perfluoropentane;DODECAFLUOROPENTANE;dodecafluoropentane;QW-7437;2H,3H-perfluoropentane;perflenapentum;QW 7437;PERFLUOROPENTANE;PERFLENAPENT;Perflenapent;	0	1.45079199					FC(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F	Alfa Aesar	L16969	4.13651183	4.7425443	3.21370807	3.55681313	0	1.24953025	1.45079199									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166309-02	Altrenogest	170465646		DPI_SARS-CoV-2_General	2019_NPC_02	850-52-2		12.4181106199	-4.9059444758	-55.0212387181	-2.2	7		-85.2758407444	-66.11806117	0.0000433304	0.9973012923			O=C3C=C4CC[C@@H]2C(C=C[C@@]1(C)[C@H]2CC[C@@]1(O)CC=C)=C4CC3	SIGMA	33994	0.68672108	1.58238814	0.78994867	-2.97219559	-3.69983129	-25.21608418	-66.11806117									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181132-01	Halofuginone hydrochloride	144206292		DPI_SARS-CoV-2_General	2019_NPC_02	1217623-74-9	halofuginone; Halofuginona; Stenorol; 	3.1192883571	-5.5059444758	-129.9371311146	-2.1	7	halofunginone;LS-176413;Halofuginone hydrobromide;halofuginone;LS-140372;HALOFUGINONE;RU-19110;Halofuginonum;4(3H)-Quinazolinone, 7-bromo-6-chloro-3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-, trans-;7-bromo-6-chlorofebrifugine;Halofuginone Hydrobromide;HALOFUGINONE HYDROBROMIDE;CIPLUS_205078;7-bromo-6-chloro- 3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-4(3H)- quinazolinone;CIPLUS_205079;Halofuginona;halofuginone lactate;LS-173665;Stenorol;halofuginonum;7-bromo-6-chloro-3,3-(3-hydroxy-2-piperidyl)acetonyl-4(3H)-quinazolinone-hydrolactate;Halofuginone;CIPLUS_205081;CIPLUS_205080;	-115.0511439863	-93.00765828	0.0001454902	0.995035516			Cl.O[C@@H]3CCCN[C@H]3CC(=O)CN2C=Nc1cc(Br)c(Cl)cc1C2=O	Toronto Research	H102500	-1.43587135	4.43299684	-0.44302759	-12.33543016	-39.32942043	-66.71364149	-93.00765828									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253567-01	Talbutal	170465408	GABA-A receptor; anion channel Positive Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	115-44-6				-7.2084660995	4	7		0	-7.74865623					O=C1NC(=O)NC(=O)C1(CC=C)C(C)CC	GVK	FFS-11-286-NCI-35	2.19427039	-1.74409203	-0.66336935	-2.64948671	-0.56317278	-0.9723788	-7.74865623									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024778-02	Bifemelane	170465900	Monoamine oxidase B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	90293-01-9		0.3926951379	-6.4059444758	-32.790316866	4	7		-16.12345836	-12.72971534	0.2485207331	0.6810071778			CNCCCCOc2ccccc2Cc1ccccc1	Tocris	0767	-2.48105923	1.71769248	1.17715873	-2.01419721	-27.1862153	-8.6183241	-12.72971534									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015273-19	Chlorpromazine	170465371	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	50-53-3		11.0676527398	-4.9559444758	-54.567391744	-2.2	7		-92.0350054439	-67.4507617	0.0000256419	0.9979260545			CN(C)CCCN1c3ccccc3Sc2ccc(Cl)cc12	Vitas	STK182870	3.14428872	4.9624942	2.06185567	0.45400958	-7.64096838	-30.08282941	-67.4507617									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016507-05	Thonzonium bromide	170465335	osteoclast development Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	553-08-2		7.8352981002	-5.1059444758	-105.9213371381	-2.2	7		-73.3723556319	-76.1907176	0.000179139	0.9944869767			[Br-].COc1ccc(cc1)CN(CC[N+](C)(C)CCCCCCCCCCCCCCCC)c2ncccn2	Prestwick Chemical, Inc.	Prestw-925	-12.15355941	-7.249493	-10.10699227	-11.38033963	-11.01101355	-42.55805681	-76.1907176									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344182-03	5-trans Prostaglandin F2?		Prostanoid FP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	36150-01-3				-36.4291200255	4	7		0	-14.72672787					CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C\CCCC(O)=O	Cayman	16210	-7.15623483	-5.99459447	-5.58589813	-7.91572153	-4.94974218	-9.63453589	-14.72672787									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390646-02	Isavuconazole			DPI_SARS-CoV-2_General	2019_NPC_02	241479-67-4		12.4181106199	-4.9059444758	-18.8923968004	4	7		-19.0645197761	-18.00884745	0.00171544	0.9826726556			C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](O)(C[N]3C=NC=N3)C4=CC(=CC=C4F)F	MedChem Express	HY-14273	-1.43587135	-0.45508097	-0.8180774	-3.05638052	-1.66575577	-6.05975197	-18.00884745									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00188865-03	Pazopanib	170465625	VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	444731-52-6	Pazopanib; Pazopanib;GSK-786034/Votrient/Armala	6.2237985085	-5.2059444758	-27.5164718685	-2.2	7		-34.366003896	-32.38833658	0.0003836448	0.9919033064	10715	FLT1	NS(=O)(=O)c1cc(ccc1C)Nc2nccc(n2)N(C)c3ccc4c(C)n(C)nc4c3	Sequoia	SRP010772p	0.79770631	2.56185174	-0.64461686	-0.64775624	0.22574436	-17.20687711	-32.38833658									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390731-01	Tafamidis		Transthyretin Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	594839-88-0		11.0676527398	-4.9559444758	-52.7628500698	4	7		-18.977260808	-25.46734529	0.0002107522	0.9940385585			OC(=O)C1=CC=C2N=C(OC2=C1)C3=CC(=CC(=C3)Cl)Cl	MedChem Express	HY-14852	-8.6452866	-9.15013052	-8.43158857	-7.56962795	-9.07492337	-13.67906802	-25.46734529									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091208-09	4-Hexylresorcinol	170465471	Tyrosinase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	136-77-6		11.0676527398	-4.9559444758	-51.8765791586	-2.2	7		-74.8445159848	-55.94281514	0.0001445645	0.9950526802			Oc1cc(O)ccc1CCCCCC	Microsource	01500330	-0.81572386	2.0060107	-0.82133021	1.36704543	-7.94041517	-25.84989075	-55.94281514									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023212-14	Stavudine	170464820	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	3056-17-5	 2',3'-didehydro-3'-deoxythymidine; ; Zerit; Dideoxydidehydrothymidine;; Stavudine;Stavudine; 2',3'-Anhydrothymidine; stavudine (d4T);2',3'-didehydro-3'-deoxythymidine; D4T (2',3'-Didehydro-3'-deoxythymidine); Sanilvudine; Estavudina; 2',3'-Didehydro-3'-deoxythymidine; Estavudina (INN-Spanish);2',3'-Didehydro-3'-deoxythymidine			-7.0609619563	4	7		0	-2.05317989			7015	TERT	CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@@H](CO)O2	Prestwick	Prestw-1279	0.27836274	-5.33877391	-1.94730813	0.09280859	0.55067756	-2.17998882	-2.05317989									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179676-03	Lynestrenol	170465984		DPI_SARS-CoV-2_General	2019_NPC_01	52-76-6		11.0676527398	-4.9559444758	-61.1619501015	-2.2	7		-36.364357668	-41.98626144	0.0000576011	0.9968886726			C[C@]32CC[C@@H]1[C@H]4CCCC=C4CC[C@H]1[C@@H]3CC[C@]2(O)C#C	Prestwick Chemical, Inc.	Prestw-95	-8.24679883	-6.68263005	-8.87865273	-7.40211202	-8.40734913	-16.47441435	-41.98626144									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094572-12	Amitraz	170465703		DPI_SARS-CoV-2_General	2019_NPC_01	33089-61-1		11.0676527398	-4.9559444758	-27.0165933999	-2.2	7		-40.0551697072	-35.26906796	0.0008542018	0.9878367992			Cc2ccc(/N=C/N(C)/C=N/c1ccc(C)cc1C)c(C)c2	Microsource	01505299	1.09166606	-3.06154861	0.16329117	1.24162841	-0.04821601	-11.40301845	-35.26906796									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249906-01	Nicoboxil	170465989	positive regulation of vasodilation Activator	DPI_SARS-CoV-2_General	2019_NPC_01	13912-80-6				7.6976738155	4	7		0	2.53478999					O=C(OCCOCCCC)c1cccnc1	GVK	FFS-11-286-NCI-130	4.36908479	0	1.02605347	-0.0125417	0	3.8569033	2.53478999									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015643-11	Metoclopramide	170464848	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	364-62-5				12.591797233	4	7		0	0.04562622					Nc1cc(OC)c(cc1Cl)C(=O)NCCN(CC)CC	Enzo	AC840	3.25079273	4.61553498	3.46323511	2.24998119	1.36781201	3.13532192	0.04562622									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181320-01	Mersalyl acid	144206341		DPI_SARS-CoV-2_General	2019_NPC_02	486-67-9	2-(3-Hydroxymercurio-2-methoxypropylcarbamoyl)phenoxyacetic acid; Salyrganic acid; Mersalyl acid; 			-29.6618274816	4	7	Mersalyl acid;2-(3-Hydroxymercurio-2-methoxypropylcarbamoyl)phenoxyacetic acid;2-[N-(3-Hydroxymercuri-2-methoxypropyl)carbamoyl]phenoxyacetic acid;Salyrganic acid;	0	-6.94001808					O[Hg]CC(OC)CNC(=O)c1ccccc1OCC(=O)O	SIGMA	M9784	-4.12726306	-5.0705722	-6.78605752	-4.4688165	-5.96677993	-6.87241638	-6.94001808									5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7	0.0000016599999999	0.00000831								
NCGC00379079-03	Cefoselis (sulfate)		Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	122841-12-7		6.9832167823	-5.1559444758	-19.1580539585	4	7		-11.0638342841	-11.26861057	0.0326090057	0.9166534635			CO\N=C(/C(=O)N[C@H]1[C@H]2SC/C(=C(N2C1=O)/C(O)=O)CN3\C=C/C(=N)N3CCO)C4=CSC(=N4)N	MedChem Express	HY-B0186B	-2.52260168	-1.39296357	-0.382082	-4.18352314	-2.89665661	-7.61461856	-11.26861057									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263831-02	NYSTATIN		Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC_02	114-90-9		6.9832167823	-5.1559444758	-18.0519674496	-2.2	7		-38.4368073079	-32.86400609	0.0011560926	0.9858010018			C[C@@H]1OC(=O)CC(O)CC(O)CC(O)CCC(O)C(O)C[C@]2(O)CC(O)C(C(CC(OC3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H]1C)O2)C(O)=O	Microsource	01500446	0	4.36369517	4.35760999	2.13502327	3.02022194	-14.91920331	-32.86400609									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166266-03	1,3-Bis(4-carboxyphenoxy)propane	170466646		DPI_SARS-CoV-2_General	2019_NPC_02	3753-81-9				-14.9905421296	4	7		0	-3.12990534					O=C(O)c1ccc(cc1)OCCCOc2ccc(cc2)C(=O)O	SIGMA	655538	3.05440588	-28.85028529	2.47298469	2.8225335	1.23802961	0.263059	-3.12990534									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378911-02	(S)-Tedizolid		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1431699-67-0		6.9832167823	-5.1559444758	-57.3318631566	4	7		-15.015320104	-22.12814536	0.003333889	0.9756154719			C[N]1N=NC(=N1)C2=CC=C(C=N2)C3=CC=C(C=C3F)N4C[C@@H](CO)OC4=O	MedChem Express	HY-14855A	-9.75051446	-9.96789023	-7.94871194	-10.37579216	-10.69077775	-16.91093574	-22.12814536									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344540-01	17-BETA-ESTRADIOL 3,17-DIPROPIONATE	225144386		DPI_SARS-CoV-2_General	2019_NPC_02	113-38-2				6.2584441544	4	7		0	4.59496742					CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=C(C=CC(=C4)OC(=O)CC)[C@H]3CC[C@]12C	SIGMA	E9125	3.37811279	1.21277923	-1.84008814	2.8459182	0	0	4.59496742									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183366-07	NORETHINDRONE ACETATE		Progesterone Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	51-98-9		22.0828704269	-4.6559444758	-2.1816809976	4	7		-19.650454268	-15.95871189	0.0194767944	0.9371713937			CC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C	Microsource	01500438	0	0	0	2.99090335	4.42696576	1.50319429	-15.95871189									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015703-06	Mecamylamine	170465225	Neuronal acetylcholine receptor; alpha4/beta2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	60-40-2				4.8400098848	4	7		0	2.61590327					CNC2(C)C1CCC(C1)C2(C)C	Enzo	AC741	1.53704645	0	0	0	3.22539715	0.23883327	2.61590327									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015692-08	Methoxamine hydrochloride	225144174		DPI_SARS-CoV-2_General	2019_NPC_01	61-16-5				-4.9081640727	4	7		0	-3.73121087					COC1=CC(=C(OC)C=C1)C(O)C(C)N	Prestwick	Prestw-535	-0.07503691	-0.44713759	0.46062733	-2.00918053	-1.20032482	-0.94008842	-3.73121087									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090793-05	NAPHTHALENE, ZONE REFINED	225144198	Metabolism of xenobiotics by cytochrome P450 Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	91-20-3				13.9133963518	4	7		0	3.23946161					C1=CC=C2C=CC=CC2=C1	SIGMA	147141	0.48895021	2.08908544	3.13177841	4.37203702	4.59574684	2.79993902	3.23946161									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181042-02	Menthyl salicylate	225144318		DPI_SARS-CoV-2_General	2019_NPC_01	89-46-3		12.4181106199	-4.9059444758	-18.9367453551	-3	7		-51.5049555099	-46.9341715	0.000592062	0.9899036353			CC(C)C1CCC(C)CC1OC(=O)C2=CC=CC=C2O	SIGMA	84320	4.11734805	2.78789063	0	4.88373843	0	-3.34366584	-46.9341715									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091398-01	Nitrobenzene	17389793	Glutathione reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02		Nitrobenzene; Nitrobenzene-d5; Pentadeuteronitrobenzene; 			-16.3021653762	4	7	Nitrobenzene;CIPLUS_150482;NCGC00091398-02;CIPLUS_699787;Nitrobenzene-13C6;1,2-dinitrobenzene;ortho-dinitrobenzene;AB07993089-01;o-dinitrobenzene;nitrobenzene;Nitrobenzene-d5;CIPLUS_763567;Pentadeuteronitrobenzene;CIPLUS_174736;Nitrobenzene-15N;	0	-2.34980735					[O-][N+](=O)C1=CC=CC=C1	NIEHS	AB07993089	-3.76193669	-1.46688535	-2.24795481	-4.98327994	-2.61625835	-6.59526494	-2.34980735									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182033-01	Felypressin	144206485	Vasopressin V1a receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	56-59-7	Felypressin; Octopressin; Felipresina; 	12.4181106199	-4.9059444758	-8.0525861948	4	7	LS-175689;Felypressine;Felypressin;Felypressinum;felypressine;H-CYS-PHE-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2  (1-6);PLV-2;Phenylalanyl-Lysyl Vasopressi;Vasopressin, 2-L-phenylalanine-8-L-lysine-;Lysine Vasopressin, Phenylalanin;Vasopressin, Phenylalanine Lysin;Vasopressin, Phenylalanyl Lysy;felypressinum;FELYPRESSIN;CIPLUS_148784;Octopressin;Felipresina;	-27.662227084	-22.21852257	0.0009145225	0.9874192356			NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]4CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N4	ACC	FELYPRESSIN	0.92256468	3.77232091	0.71025058	2.47176297	1.81783618	-4.42502818	-22.21852257									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178032-03	CITICOLINE			DPI_SARS-CoV-2_General	2019_NPC_02	987-78-0				14.3842619588	4	7		0	1.65532988					C[N+](C)(C)CCO[P]([O-])(=O)O[P](O)(=O)OC[C@H]1OC([C@H](O)[C@@H]1O)N2\C=C/C(=N\C2=O)N	Microsource	01505244	0	3.96174548	0	3.69712134	3.1532923	3.78617061	1.65532988									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00179351-03	Quinethazone	170465167	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	73-49-4				-35.2042758561	4	7		0	-9.95100604					NS(=O)(=O)c1cc2C(=O)NC(Nc2cc1Cl)CC	Prestwick	Prestw-1050	-4.65444288	-8.38781215	-6.44851269	-7.6912284	-8.36204643	-7.46429914	-9.95100604									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344326-02	9(E),12(E)-Octadecadienoic acid		Streptococcus mutans Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	n/a		5.5469662594	-5.2559444758	-80.0571346209	-2.2	7		-54.541710552	-53.33206488	0.0004670647	0.9910492363			CCCCC/C=C/C/C=C/CCCCCCCC(O)=O	Enzo	BL118	-5.79204143	-2.88063942	-9.16762382	-6.57343966	-14.37397524	-35.7102593	-53.33206488									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167455-02	Zofenopril	170465605		DPI_SARS-CoV-2_General	2019_NPC_02	81872-10-8				4.2808171631	4	7		0	-3.59130476					O=C([C@@H](C)CSC(=O)c1ccccc1)N3C[C@@H](Sc2ccccc2)C[C@H]3C(=O)O	Bosche	Z6238	0	2.94994109	2.05574178	1.55508266	3.83290165	-0.01409245	-3.59130476									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00390779-02	Brivaracetam		Synaptic vesicle glycoprotein 2A Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	357336-20-0				5.4721613809	4	7		0	-0.03805356					CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1	MedChem Express	HY-14449	3.85904876	2.29850539	0.29769579	2.312747	1.90338141	-2.69165727	-0.03805356									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183654-01	Etidocaine	144206521	Sodium channel protein type II alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	36637-18-0				-14.9424425449	4	7	LS-45490;etidocaine;2',6'-Butyroxylidide, 2-(N-ethylpropylamino)-, hydrochloride, (+-)-;W-19053;etidocainum;DURANEST;CIPLUS_178862;CIPLUS_178863;BUTANAMIDE, N-(2,6-DIMETHYLPHENYL)-2-(ETHYLPROPYLAMINO)-, (+/-)-, MONOHYDROCHLORIDE;CIPLUS_183648;ETIDOCAINE HYDROCHLORIDE;Etidocaina;Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, (+-)-;Etidocaine;LS-178540;w-19053;2-(Ethylpropylamino)-2',6'-butyroxylidide;LS-48494;W1905;Duranest;W 1905;ETIDOCAINE;BUTANAMIDE, N-(2,6-DIMETHYLPHENYL)-2-(ETHYLPROPYLAMINO)-, (+/-);(+-)-n-(2,6-dimethylphenyl)-2-(ethylpropylamino)butanamide;Etidocainum;	0	-6.5309423					O=C(Nc1c(C)cccc1C)C(CC)N(CC)CCC	ACC		0.27052649	-1.28670101	-4.46074869	-3.83275261	-2.65427845	-4.47670049	-6.5309423									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178238-05	Midodrine hydrochloride	170464672	Alpha-1b adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	3092-17-9				-1.2393192361	4	7		0	-4.58796989					Cl.COc1ccc(cc1C(O)CNC(=O)CN)OC	Microsource	01503257	1.0723017	0.22723386	0.99680729	-1.50751248	-0.14464802	1.07729051	-4.58796989									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018187-09	Cinnarizine	170465920	Voltage-gated calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	298-57-7		6.2237985085	-5.2059444758	-77.2815202866	-2.1	7		-84.286545338	-80.35791235	0.0000466852	0.9971980036			c1ccccc1C(c2ccccc2)N3CCN(CC3)C/C=C/c4ccccc4	Prestwick	Prestw-278	2.38423741	0.2321206	0.28027589	-3.61451827	-4.63634979	-44.53478327	-80.35791235									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021623-05	Nadolol	170464945	Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	42200-33-9				5.5805633396	4	7		0	0.47654052					CC(C)(C)NCC(O)COc2cccc1C[C@@H](O)[C@@H](O)Cc12	Microsource	01503260	1.20301116	3.38407408	-2.67846263	0.72992701	2.30167995	2.72879719	0.47654052									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249898-01	Sodium 3, 4-dimethylphenyl-glyoxylate	170465549		DPI_SARS-CoV-2_General	2019_NPC_01	81632-85-1				10.5986220465	4	7		0	-3.21411371					[Na+].Cc1ccc(cc1C)C(=O)C([O-])=O	GVK	FFS-11-286-NCI-75	2.85382325	2.84164488	2.51760864	1.98409712	4.21001878	3.27252401	-3.21411371									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016285-05	Sulfanilamide	170464653	Carbonic Anhydrase Type I/II/IX Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	63-74-1	 ; p-Aminobenzenesulfonamide; Sulfonamide CS61; Trikolpon; Sulfanilamida;SULFANILAMIDE; Sulfanilamide;Sulfanilamide			-22.3941107803	4	7		0	-6.84393298			759	CA1	Nc1ccc(cc1)S(=O)(N)=O	Labotest	LT00847607	-5.97632706	-4.84032546	-6.91428432	-3.8653523	-4.91041973	-0.55388993	-6.84393298									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024494-02	D-Alanine	170465038	Alanine aminotransferase 1 Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	338-69-2				-29.2045231384	4	7		0	-12.41540138					C[C@@H](N)C(=O)O	Tocris	0205	-7.39960787	-2.63151465	-5.44710097	-5.15965586	-6.7629295	-5.24925047	-12.41540138									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183005-01	Zanapezil fumerate	144206802	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	263248-42-6	CIPLUS_775863; Zanapezil Fumarate; 	13.9333492831	-4.8559444758	-72.0105272484	-2.2	7	CIPLUS_775863;ZANAPEZIL;Zanapezil Fumarate;CIPLUS_3882440;CIPLUS_3882439;zanapezilum;	-88.4451402741	-72.04887075	0.0000131801	0.9985145869			O=C(O)/C=C/C(=O)O.O=C(CCC2CCN(Cc1ccccc1)CC2)c3ccc4CCCCNc4c3	Pharmaron	PH-NIH-100582	-4.3109917	-2.21614093	-4.02866126	-3.33358417	-8.39212303	-26.53590121	-72.04887075									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163886-05	Fenchlorphos	170466415	Cholinesterases; ACHE & BCHE Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	299-84-3				14.546747827	4	7		0	2.35228511					Clc1cc(OP(=S)(OC)OC)c(Cl)cc1Cl	Microsource	01505668	4.56272844	1.54665624	3.83856109	1.10617804	4.81906309	3.30809492	2.35228511									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00242511-03	Seocalcitol		Vitamin D Analog	DPI_SARS-CoV-2_General	2019_NPC_02	134404-52-7		5.5469662594	-5.2559444758	-76.3217969743	-2.2	7		-86.9345240943	-76.69695096	0.0000133319	0.9985059144		VDR	CCC(O)(CC)/C=C/C=C/[C@@H](C)[C@H]1CC[C@H]2\C(CCCC12C)=C\C=C3/C[C@@H](O)C[C@H](O)C3=C	MedChem Express	HY-32341	1.18615459	3.19942711	-0.51803755	1.14818885	-10.41988451	-45.91319053	-76.69695096									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390187-02	Delafloxacin (meglumine)		Staphylococcus Aureus Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	352458-37-8		9.8640558873	-5.0059444758	0.1953542277	4	7		-10.089497216	-7.99124768	0.1265322124	0.8076156197			NC1=C(F)C=C(F)C(=N1)N2\C=C(C(O)=O)/C(=O)C3=CC(=C(N4CC(O)C4)C(=C23)Cl)F	MedChem Express	HY-14814A	0	0.18480445	0	3.29958141	4.43647078	-1.61123638	-7.99124768									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091687-01	Benzene sulfonic acid	17389167		DPI_SARS-CoV-2_General	2019_NPC_02					2.0447159463	4	7	CIPLUS_668287;CIPLUS_746452;CIPLUS_158198;Benzene sulfonic acid;Sodium benzenesulfonate;SODIUM BENZENESULFONATE;CIPLUS_188702;AB08082695-01;CIPLUS_750422;Benzenesulfonic acid monohydrate;CIPLUS_3730420;Benzenesulfonic Acid Sodium Salt;CIPLUS_750425;CIPLUS_740728;CIPLUS_153872;CIPLUS_213852;4-Formyl-1-methylpyridinium benzenesulfonate;CIPLUS_213853;CIPLUS_750569;Benzenesulfonic acid;Benzene Sulfonic Acid;p-Toluenesulfonic acid, polymer-bound;benzenesulfonic acid;CIPLUS_664858;ALUMINUM PHENOLSULFONATE;SODIUM DECYLBENZENESULFONATE;CIPLUS_198271;CIPLUS_3741824;CIPLUS_753058;CIPLUS_203733;CIPLUS_752981;CIPLUS_198836;CIPLUS_763507;CIPLUS_210324;CIPLUS_750514;CIPLUS_750536;CIPLUS_198267;CIPLUS_198368;Benzenesulfonic acid sodium salt;CIPLUS_3729342;CIPLUS_198511;CIPLUS_150435;CIPLUS_204905;CIPLUS_198364;CIPLUS_670392;CIPLUS_3825062;CIPLUS_3745729;	0	-1.75997717					O[S+]([O-])(=O)C1=CC=CC=C1	NIEHS	AB08082695	1.85669033	0.57058375	-0.15236399	1.06868087	3.16279733	-2.19372416	-1.75997717									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016549-05	Dosulepin hydrochloride		Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	897-15-4		13.9333492831	-4.8559444758	-41.4817719683	-2.4	7		-35.1974117761	-29.05865005	0.0051205191	0.9693362785			CN(C)CC\C=C1/C2=C(CSC3=C1C=CC=C3)C=CC=C2	Prestwick	Prestw-488	-5.36659807	-3.63371757	-0.97747357	-5.85786778	-7.97709289	-13.79180759	-29.05865005									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164626-02	Tiagabine hydrochloride	170465153	GAT-1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	145821-59-6		12.4181106199	-4.9059444758	-25.9690962403	-3	7		-51.9821386037	-44.82709413	0.0001229847	0.99544067		SLC6A1	Cl.Cc3ccsc3C(=C\CCN1CCC[C@H](C1)C(=O)O)\c2sccc2C	Sequoia	SRP023505t	3.64632708	-0.27027651	1.08998851	1.31655871	0.7912934	-9.79894776	-44.82709413									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181765-03	Pranlukast hydrate	384568399	Leukotriene CysLT1/2 (LTD4) Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	103177-37-3		2.4777388143	-5.6059444758	-47.8680322556	-1.2	7		-53.5045426404	-45.07919897	0.0001077363	0.9957338488		CYSLTR1	O=C(NC1=CC=C2C(=O)\C=C(/OC2=C1)C3=NN=N[NH]3)C4=CC=C(OCCCCC5=CC=CC=C5)C=C4	Selleck	S1829	3.2856251	4.40989628	3.81378777	3.4024741	-9.0891809	-40.21984216	-45.07919897									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015608-11	Loperamide hydrochloride	170464852	mu-Opioid Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	53179-11-6	 ;LOPERAMIDE; Hydrochloride, Loperamid;Loperamide; Loperamide Hcl;Loperamide hydrochloride; Loperamide hydrochloride; Loperamida	13.9333492831	-4.8559444758	-24.5879139	-2.4	7		-31.441497044	-23.28458087	0.0051573712	0.9692325259	4988	OPRM1	CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4	Enzo	ALX-550-253	0.32193256	1.30720551	-3.00504497	-0.87039406	-5.16926356	-10.18852584	-23.28458087									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164591-04	Artemether	225144260	antimalarial agents	DPI_SARS-CoV-2_General	2019_NPC_01	71963-77-4	duplicate RN; ; Artemetero; Arthemeter; Artemether;artemether;Artemether	22.0828704269	-4.6559444758	-1.4647094851	4	7		-14.37645434	-11.56371195	0.1249251992	0.8084289249		PfATP6	CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3	SIGMA	A9361	-1.26110425	-1.4635815	-0.56298896	1.85868011	4.01715475	4.00426851	-11.56371195									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015970-11	Sulindac	170464648	ABCC1 Expression Enhancer	DPI_SARS-CoV-2_General	2019_NPC_01	38194-50-2	 ; Sulindac;Sulindac; Sulindaco; Clinoril; Sulindac sulfide; Sulindac sulfone;SULINDAC; Suldinac	9.8640558873	-5.0059444758	-42.4109103291	-2.2	7		-42.6177693945	-41.45902512	0.0001269363	0.9953684316		ABCC1	CS(=O)c1ccc(cc1)/C=C3\c2ccc(F)cc2C(CC(=O)O)=C3C	Microsource	01500556	-4.62566262	-1.75678647	-2.2300212	-1.77339654	-3.25584936	-15.9103613	-41.45902512									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166006-02	L-Cystine	170465457	Cystine/glutamate transporter Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	56-89-3				17.9638565372	4	7		0	3.38140985					N[C@@H](CSSC[C@H](N)C(=O)O)C(=O)O	Bosche	C0896	0	2.44093141	3.78981746	0	4.81398772	2.42898521	3.38140985									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00015841-11	Pargyline hydrochloride	170465066	Monoamine oxidase B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	306-07-0				-25.9293907571	4	7		0	-10.05804669					Cl.CN(Cc1ccccc1)CC#C	Microsource	01500462	-4.37392588	-4.400518	-7.75267481	-5.21985602	-2.71278486	-5.1831902	-10.05804669									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016892-04	Iopamidol	170464646		DPI_SARS-CoV-2_General	2019_NPC_01	60166-93-0				11.6328116594	4	7		0	1.81490963					O=C(Nc1c(I)c(c(I)c(c1I)C(=O)NC(CO)CO)C(=O)NC(CO)CO)[C@H](C)O	Prestwick	Prestw-871	2.72795488	-0.13438561	4.17001779	1.49747912	3.44363802	3.65364094	1.81490963									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379065-05	Riociguat		Soluble Guanylate Cyclase (sGC) Activator	DPI_SARS-CoV-2_General	2019_NPC_02	625115-55-1				-20.0471078189	4	7		0	-10.41240546				GUCY1A2	COC(=O)N(C)C1=C(N)N=C(N=C1N)C2=N[N](CC3=CC=CC=C3F)C4=NC=CC=C24	MedChem Express	HY-14779	-0.90869153	-4.89500797	-6.61259699	-1.45218998	-4.46498586	-2.51785043	-10.41240546									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166061-02	L-Cysteine ethyl ester hydrochloride	225144266		DPI_SARS-CoV-2_General	2019_NPC_02	868-59-7				-8.0703962368	4	7		0	-8.17675879					CCOC(=O)[C@@H](N)CS	SIGMA	C121908	0.60348216	-1.14347756	0.0304728	-0.82080303	-1.80833116	-2.22190906	-8.17675879									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00271513-02	Lofexidine	170466275	Adrenergic receptor alpha-2 Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	31036-80-3		15.6334750258	-4.8059444758	-6.5773879374	4	7		-19.456262184	-13.71355182	0.0452807854	0.8985044529			Clc2cccc(Cl)c2OC(C)C1=NCCN1	Prestwick	Prestw-1430	2.28675808	0	4.14664448	-0.45600168	-1.98892664	-2.98759865	-13.71355182									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159379-04	BETA-HYDROXYETHYL SALICYLATE	225144223		DPI_SARS-CoV-2_General	2019_NPC_01	87-28-5				-7.6355390117	4	7		0	0.65397582					OCCOC(=O)C1=CC=CC=C1O	SIGMA	172049	-5.56483431	-1.30720551	-3.70695328	0.98076103	-1.83982135	-0.15244677	0.65397582									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179274-03	Tribenoside	170465999		DPI_SARS-CoV-2_General	2019_NPC_02	10310-32-4				8.994650156	4	7		0	-1.76473386					O[C@@H]2[C@@H](OCc1ccccc1)[C@H](O[C@H]2OCC)C(COCc3ccccc3)OCc4ccccc4	Prestwick	Prestw-1019	4.02090222	0	0	1.88246849	3.88517929	4.54246524	-1.76473386									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00347131-03	D(-)-Tartaric acid			DPI_SARS-CoV-2_General	2019_NPC_02	526-83-0				9.3210231017	4	7		0	1.27479427					OC(C(O)C(O)=O)C(O)=O	DC Chemicals	DCJ-065	4.35848228	0.23331562	1.18375097	2.20517737	3.32913528	1.20255543	1.27479427									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263855-02	CEFAMANDOLE SODIUM			DPI_SARS-CoV-2_General	2019_NPC_02	34444-01-4		12.4181106199	-4.9059444758	-32.2687765726	-3	7		-39.111990837	-37.32102935	0.0007742776	0.9884310542			C[N]1N=NN=C1SCC/2=C(/N3C(SC2)[C@@H](NC(=O)C(O)C4=CC=CC=C4)C3=O)C([O-])=O	Microsource	01502038	-2.1017827	-0.61678486	-4.47481306	-0.34375512	-0.89109617	-9.64862834	-37.32102935									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016490-12	Flufenamic acid	170465857	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	530-78-9		13.9333492831	-4.8559444758	3.4192462057	4	7		-11.968543252	-9.14045271	0.0739927462	0.8638103443			FC(F)(F)c1cc(ccc1)Nc2ccccc2C(=O)O	Vitas	STK985630	3.31372691	0	4.28212815	3.48910126	0	0.80288633	-9.14045271									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015818-14	Praziquantel	170464906	antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC_01	55268-74-1	; ; Praziquantel, (R)-Isomer; Praziquantel, (+-)-Isomer;PRAZIQUANTEL;Praziquantel; Praziquantel, (S)-Isomer; Biltricide; Praziquantel			-16.8192376513	4	7		0	-4.78568351					O=C2CN(CC1c3ccccc3CCN12)C(=O)C4CCCCC4	Vitas	STK030186	-2.78604798	-3.37918733	-3.42911457	-3.38375097	-0.67248642	-6.89059403	-4.78568351									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249923-01	Cholesolvin	170466018	Triglyceride Biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	14929-11-4		4.4061119169	-5.3559444758	-41.3169001362	-1.2	7		-48.7600821232	-47.00007604	0.000466776	0.9910510153			Clc2ccc(OC(C)(C)C(=O)OCCCOC(=O)C(C)(C)Oc1ccc(Cl)cc1)cc2	GVK	FFS-11-286-NCI-201	4.24321642	0	4.84755429	0	3.7278587	-36.3585548	-47.00007604									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016268-08	Niacin	170465044	Nicotinic acid	DPI_SARS-CoV-2_General	2019_NPC_01	59-67-6	NIACIN;Niacin; ; Niacin; Niacin-d4 (ring-d4);Nicotinic acid			14.4013627446	4	7		0	3.34085321				HCAR3	O=C(O)c1cccnc1	Vitas	STK301803	3.91402222	2.91005937	0.28027589	4.10615296	3.65172816	3.3487474	3.34085321									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510884-01	Tylvalosin		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	63409-12-1				10.2210658257	4	7		0	0					CC[C@H]1OC(=O)C[C@@H](OC(C)=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/C(=C/[C@@H]1CO[C@@H]4O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]4OC)C	SantaCruz Bio	sc-473950	3.91454138	2.7882372	2.60894025	1.87779155	2.30734501	1.24953025	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00188864-02	Iloperidone	170465198	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	133454-47-4	Iloperidone	13.9333492831	-4.8559444758	-37.548678715	-2.2	7		-59.5140798116	-49.21752366	0.0005967612	0.9898630523	1813	DRD2	CC(=O)c4ccc(OCCCN1CCC(CC1)c3noc2cc(F)ccc23)c(OC)c4	Bosche	I2337	0.49249694	1.54542724	0.84620614	-4.18820008	-1.51842787	-13.75892522	-49.21752366									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386518-01	Cannabidiol	377020361	Cannabinoid Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	13956-29-1		6.2237985085	-5.2059444758	-115.1971627435	-2.1	7		-93.888260844	-81.9388289	0.0006034612	0.989802253		CNR1	CCCCCC1=CC(=C([C@@H]2\C=C(C)/CC[C@H]2C(C)=C)C(=C1)O)O	Axon Medchem	1234	-2.44861153	-6.39654416	-9.07386137	-8.62193953	-27.98992467	-48.56726794	-81.9388289									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178214-04	BENZALKONIUM CHLORIDE			DPI_SARS-CoV-2_General	2019_NPC_02	8001-54-5				-3.6114264609	4	7		0	-5.5700899					CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1	Microsource	01503610	2.43011399	3.84162258	-0.30238391	-2.02745364	-3.15804482	-1.67230365	-5.5700899									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094817-05	Flopropione	170465817	Catechol O-methyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	2295-58-1		12.4181106199	-4.9059444758	-12.4684009702	4	7		-13.60909736	-13.4242478	0.0802165215	0.8565376858	1312	COMT	O=C(CC)c1c(O)cc(O)cc1O	Microsource	01500629	-0.70437877	-2.73902314	0.83107894	-3.63960168	1.8804243	-3.36399207	-13.4242478									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015150-04	Betaine	174007375	Nitric Oxide (NO) Donors	DPI_SARS-CoV-2_General	2019_NPC_01	590-46-5	Betaine-trimethyl-d9  hydrochloride; ;Betaine hydrochloride; Betaine hydrochloride;Betaine	19.6813789847	-4.7059444758	-28.1098754911	4	7		-28.527551564	-22.92971027	0.0035743934	0.9746255749			[Cl-].C[N+](C)(C)CC(=O)O	Selleck	S2580	-2.43264832	-0.8234173	-4.72082084	-3.40883437	-4.06790844	-7.54103359	-22.92971027									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179382-03	Hexylcaine hydrochloride	170465088	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	532-76-3				-50.8968278368	4	7		0	-14.61052952					Cl.CC(CNC1CCCCC1)OC(=O)c2ccccc2	Prestwick Chemical, Inc.	Prestw-788	-11.25795754	-8.95985535	-10.05337428	-10.85860486	-10.99578744	-10.02591595	-14.61052952									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090974-06	Diethyl phthalate	225144200	Androgen receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	84-66-2				-21.099829257	4	7		0	-4.08101189			367	AR	CCOC(=O)C1=CC=CC=C1C(=O)OCC	SIGMA	524972	-3.47348292	-3.8189948	-6.14413492	-4.06100283	-3.70248186	-6.01656588	-4.08101189									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015705-07	Memantine hydrochloride	170464999	NMDA Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	19982-08-2	 Namenda; ;Memantine;MEMANTINE HYDROCHLORIDE; Axura;Memantine hydrochloride; Ebixa; Memantine hydrochloride; Memantine HCL; Memantina;Memantine Hydrochloride; Memantin			-6.2198283772	4	7		0	-3.88329827			2903	GRIN2A	CC13CC2(C)CC(N)(C1)CC(C2)C3	Vitas	STK520682	-0.32677365	-0.37383634	-1.61585143	-0.90551082	0.04821601	-2.80502058	-3.88329827									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015073-05	Amifostine	170465179	Alkaline phosphatase placental-like Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	20537-88-6				10.2356402205	4	7		0	0					OP(=O)(O)SCCNCCCN	Prestwick	Prestw-1489	3.36213783	1.86429496	3.36087349	1.48242908	2.17479572	4.08049189	0									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00091099-01	Dibromomannitol	17389938	DNA Crosslinking Agent	DPI_SARS-CoV-2_General	2019_NPC_02		Mitobronitol; Dibromomannitol; 			10.5260447533	4	7	NSC 9410;MITOBRONITOL;mitobronitol;CIPLUS_725146;R 54;mitobronitolum;Mitolactolum;Mitolactol;elobromol;NCGC00091099-02;Mitobronitolum;Mitobronitol (1,6-Dibromo-1,6-dideoxy-D-mannitol);Galactitol, 1,6-dibromo-1,6-dideoxy-;CIPLUS_167927;NSC-94,100;Dibromodulcitol;NSC-94100;DIBROMODULCITOL;NSC9410;CIPLUS_153526;NCGC_SIGMA_D4393;1,6-Dibromo-1,6-dideoxy-D-mannitol;NSC94,10;NSC-104800;D-Mannitol, 1,6-dibromo-1,6-dideoxy-;AB07944772-01;mitolactol;NSC 10480;LS-369;Myelobromol;NSC10480;LS-1295;Dibromomannitol;MITOLACTOL;mitolactolum;Mitobronitol;NSC 94,10;MYELOBROMOL;1,6-DIBROMO-1,6-DIDEOXY-D-GALACTITOL;	0	2.65423584					O[C@H](CBr)[C@@H](O)[C@H](O)[C@H](O)CBr	NIEHS	AB07944772	0	1.45995519	0	4.85232561	4.08478483	2.66347238	2.65423584									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167527-03	Grepafloxacin hydrochloride	170466148	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	161967-81-3		0.0024777388	-8.6059444758	-35.9386504621	4	7		-10.3302848599	-9.21371831	0.5213000388	0.3468169019			Cl.CC1CN(CCN1)c4cc2c(C(=O)C(=CN2C3CC3)C(=O)O)c(C)c4F	Sequoia	SRP02578g	-2.87405489	-7.717896	-7.30175101	-6.24605383	-14.81595894	-5.6040962	-9.21371831									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183655-01	Tazanolast	144206520	histamine secretion by mast cell Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	82989-25-1				-14.9157553605	4	7	CIPLUS_710388;tazanolast;tazanolastum;butyl 3'-(1h-tetrazol-5-yl)oxanilate;Tazanolastum;TAZANOLAST;LS-12662;butyl-3'-(1H-tetrazol-5-yl)oxanilate;Acetic acid, oxo((3-(1H-tetrazol-5-yl)phenyl)amino)-, butyl ester;Tazanolast;Tazanol;	0	-9.38020264					O=C(OCCCC)C(=O)Nc1cccc(c1)c2nnnn2	ACC		-1.31101297	-0.3441983	-0.91652798	-1.97133036	-2.95368676	-6.81134912	-9.38020264									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095136-09	Olmesartan medoxomil			DPI_SARS-CoV-2_General	2019_NPC_02	144689-63-4				-7.4062009692	4	7		0	-6.94953147					CCCC1=NC(=C([N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)C(=O)OCC/5=C(C)/OC(=O)O5)C(C)(C)O	APExBIO	A4082	0.47862378	-1.04645522	-2.42141534	-2.54659402	1.29981228	-1.09921082	-6.94953147									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164631-05	Sunitinib malate	170465289	VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	341031-54-7	 Sunitinib malate;Sunitinib malate; Sunitinib base; ;Sutent	11.0676527398	-4.9559444758	-83.5268401381	-2.2	7		-94.947342282	-73.79787585	0.0000045167	0.9991313099	2321	FLT1	O=C(O)C(O)CC(=O)O.CCN(CC)CCNC(=O)C1C(C)=C(N=C1C)/C=C2/c3cc(F)ccc3NC2=O	Sequoia	SRP01785s	-4.06893714	-2.0548782	-2.10328776	-4.70815461	-13.20864843	-37.83220692	-73.79787585									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023282-21	AMPICILLIN SODIUM			DPI_SARS-CoV-2_General	2019_NPC_02	69-52-3, 69-53-4 [ampicillin]		13.9333492831	-4.8559444758	-14.9126942198	4	7		-10.224229324	-10.86429149	0.0189242701	0.9388195668			CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C(=O)N2[C@H]1C(O)=O	Microsource	01500123	-1.70871003	-2.88987965	-0.67743372	-3.14524238	-1.54694295	-3.22717024	-10.86429149									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182546-02	Gefarnate	170465908	positive regulation of mucus secretion Interacts	DPI_SARS-CoV-2_General	2019_NPC_02	51-77-4				-9.2594568564	4	7		0	1.57922276					C\C(C)=C\CCC(\C)=C\COC(=O)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)C	Sequoia	51-77-4	-2.83705982	-7.12652175	-5.90937859	1.34929729	0	0	1.57922276									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166271-02	Pregnenolone acetate			DPI_SARS-CoV-2_General	2019_NPC_02	1778-02-5				5.0024889008	4	7		0	1.69814013					CC(=O)O[C@H]1CC[C@]\2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@H]4C(C)=O)[C@@H]3C\C=C2C1	SIGMA	P49902	2.00467063	2.56647185	-0.55085441	-0.60566377	0	2.5272454	1.69814013									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182076-03	Polythiazide	170465068	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	346-18-9		11.0676527398	-4.9559444758	-5.5731317705	4	7		-14.2164058399	-11.4303382	0.0061994175	0.9662793657			NS(=O)(=O)c2cc1c(NC(CSCC(F)(F)F)N(C)S1(=O)=O)cc2Cl	Kemprotec	346-18-9	-0.62660408	2.21534339	0.8602705	0.46067862	0.77703586	-3.05806088	-11.4303382									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00013364-03	Vitamin B6			DPI_SARS-CoV-2_General	2019_NPC_02	8059-24-3				-27.3582665876	4	7		0	-6.64034629					CC1=C(O)C(=C(CO[P](O)(O)=O)C=N1)C	DC Chemicals	DCZ-121	-7.91000948	-4.82108619	-4.63420923	-6.85873302	-2.43566286	-7.72266065	-6.64034629									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160383-02	Lenperone Hydrochloride		Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	24677-86-9		9.8640558873	-5.0059444758	3.772926231	4	7		-8.8005755639	-6.08381297	0.0590107999	0.8823150632			FC1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)C(=O)C3=CC=C(F)C=C3	Glixx	GLXC-06484	2.05553886	1.19429878	0.69618621	4.26303113	2.45467291	-0.61067268	-6.08381297									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159319-04	Zonisamide	174006630	Na channel blocker, T-type Ca channel blocker	DPI_SARS-CoV-2_General	2019_NPC_01	68291-97-4	 ; Zonisamide sodium salt; Elan brand of zonisamide; Excegran; Zonegran; Zonisamide;Zonisamide; Zonisamide sodium			-1.0423857443	4	7		0	0.57286254					NS(=O)(=O)Cc2noc1ccccc12	Vitas	STK711131	-0.7963595	0.2809881	1.7133387	-0.6295934	1.86012282	-4.38030388	0.57286254									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164578-02	Etoricoxib	170465621	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	202409-33-4				-29.657666794	4	7		0	-13.63717016			5743	PTGS2	CS(=O)(=O)c1ccc(cc1)c3cc(Cl)cnc3c2cnc(C)cc2	Sequoia	SRP02700e	-4.81446518	-5.07000269	-6.38785309	-4.75330474	-4.10343602	-7.16499822	-13.63717016									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167441-02	Pramipexole hydrochloride	170465264	Dopamine D3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	104632-26-0	 ; PRAMIPEXOLE HCl; pramipexol, (R)-isomer;Pramipexole; Pramipexole; Pramipexole Hcl; Mirapex;Pramipexole (Mirapex)			10.0678526058	4	7		0	2.25089351			1814	DRD3	CCCN[C@@H]1Cc2sc(N)nc2CC1	Prestwick Chemical, Inc.	Prestw-1316	4.70312008	0.97734992	0	0	4.10343602	3.07434321	2.25089351									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015836-12	Pirenzepine	170465793	Muscarinic acetylcholine receptor M1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	28797-61-7				4.4179136004	4	7		0	-0.16222656			1128	CHRM1	O=C(CN1CCN(C)CC1)N4c2ccccc2C(=O)Nc3cccnc34	Enzo	AC220	2.36971413	-0.02687712	2.3372572	1.82858003	1.32213369	0.03048935	-0.16222656									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00185766-04	Esmolol hydrochloride	170465277	sodium ion transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	81161-17-3				2.9924306295	4	7		0	-2.56861533					Cl.CC(C)NCC(O)COc1ccc(cc1)CCC(=O)OC	Prestwick	Prestw-1137	-0.94568661	0.7923491	4.46543682	2.0695461	0.57743032	-0.77508455	-2.56861533									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179264-03	Tiletamine Hydrochloride		Glutamate [NMDA] receptor subunit epsilon 2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	14176-50-2				7.3605789103	4	7		0	3.61033154					CCNC1(CCCCC1=O)C2=CC=CS2	USP	1667359	0	0	0	0	2.92517168	4.88538144	3.61033154									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185745-01	Cefroxadine	144206693		DPI_SARS-CoV-2_General	2019_NPC_02	51762-05-1				-42.1610235485	4	7		0	-13.59463445					N[C@H](C1=CCC=CC1)C(=O)N[C@@H]3C(=O)N2C(=C(OC)CS[C@@H]23)C(=O)O	Kemprotec	51762-05-1	-7.15161044	-7.30208598	-10.0114859	-10.77800903	-5.65311408	-9.39026682	-13.59463445									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095123-10	Candesartan cilexetil (Atacand)			DPI_SARS-CoV-2_General	2019_NPC_02	145040-37-5		4.4061119169	-5.3559444758	-78.9748676009	-2.2	7		-80.8999191363	-75.35080626	0.0000071839	0.9989039634			CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=N[NH]5)C(=O)OC(C)OC(=O)OC6CCCCC6	Adooq	A10176	-0.14566811	1.3652429	2.85272263	1.31655871	-10.05394102	-51.51258925	-75.35080626									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378574-01	Brexpiprazole		Dopamine D3 receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	913611-97-9		6.2237985085	-5.2059444758	-77.2481637397	-2.1	7		-86.6857203987	-83.51329496	0.0000034831	0.9992372255			O=C\1NC2=C(\C=C1)C=CC(=C2)OCCCCN3CCN(CC3)C4=C5C=CSC5=CC=C4	MedChem Express	HY-15780	1.8959976	0	0	0	-1.96041157	-47.41168734	-83.51329496									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094932-04	NCGC00094932-04			DPI_SARS-CoV-2_General	2019_NPC_02					7.9192307337	4	7		0	3.86243638					CC1O[C@@H](CC(O)[C@H]1O[C@H]2CC(O)[C@@H](O[C@H]3CC(OC(C)=O)[C@H](O[C@H]4OC(CO)C(O)C(O)C4O)[C@@H](C)O3)C(C)O2)OC5CC[C@]6(C)C(CCC7C6CC(O)[C@@]8(C)C(CC[C@@]78O)\C9=C\C(=O)OC9)C5	SIGMA	L2261	0.03699508	4.16041027	0	4.22093866	0	0	3.86243638									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181048-02	Dolasetron mesylate hydrate	225144319	Serotonin 3a (5-HT3a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	115956-13-3		9.8640558873	-5.0059444758	-7.41878842	4	7		-6.651072636	-6.79256053	0.4952020915	0.3863287749			O=C1CN2[C@H]3CC(C[C@@H]2CC1C3)OC(=O)C4=C[NH]C5=CC=CC=C45	SIGMA	D9571	3.32262018	-3.73998013	-4.50762992	-0.76935669	3.01546943	-2.70105224	-6.79256053									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090708-11	OXYQUINOLINE HEMISULFATE		Trichophyton interdigitale Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	134-31-6		15.6334750258	-4.8059444758	-38.3037445907	-2.2	7		-65.3378918386	-52.25229511	0.0008495838	0.9878643746			OC1=CC=CC2=CC=CN=C12	Microsource	01500456	3.60933201	0.85241054	-1.41346898	-2.54659402	-3.34814533	-12.42484029	-52.25229511									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183009-01	Pranazepide	144206813	Cholecystokinin A receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	150408-73-4	Panazepide; 	4.4061119169	-5.3559444758	-55.0067919051	-2.2	7	PANAZEPIDE;PRANAZEPIDE;FK480;FR120480;CIPLUS_709224;1H-Indole-2-carboxamide, N-(1-(2-fluorophenyl)-3,4,6,7-tetrahydro-4-oxopyrrolo(3,2,1-jk)(1,4)benzodiazepin-3-yl)-, (S)-;Panazepide;LS-173385;FR 120480;FK 480;Pranazepide;N-(1-(2-fluorophenyl)-3,4,6,7-tetrahydro-4-oxo-pyrrolo(3,2,1-jk)(1,4)benzodiazepin-3-yl)-1H-indole-2-carboxamide;FR-120480;pranazepide;pranazepidum;	-56.478657068	-51.64888089	0.0000803167	0.9963201492			Fc6ccccc6C3=N[C@H](NC(=O)c1cc2ccccc2n1)C(=O)N5CCc4cccc3c45	Pharmaron	PH-NIH-126867	0.02420546	3.86786229	0	0	-8.67126833	-34.97128919	-51.64888089									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016261-08	Pyridoxine	170464634	Oxidative Stress Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	65-23-6				-6.4674083141	4	7		0	-1.80984005					Oc1c(CO)c(cnc1C)CO	Vitas	STK177324	-1.28046862	1.00911379	-2.80519607	-3.39378433	-0.96178247	-0.49291123	-1.80984005									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167419-03	ENZACAMENE			DPI_SARS-CoV-2_General	2019_NPC_01	36861-47-9		12.4181106199	-4.9059444758	-96.705460402	-2.1	7		-110.3046352415	-89.95969684	0.0000899143	0.9961043294			CC1=CC=C(C=C1)\C=C/2C3CCC(C)(C2=O)C3(C)C	SIGMA	78551	-5.77300123	-5.28990642	-4.82805683	-2.2198811	-14.30492818	-38.27430256	-89.95969684									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094985-05	Zoalene	170465727		DPI_SARS-CoV-2_General	2019_NPC_01	148-01-6				10.1052929021	4	7		0	-2.79333857					Cc1c(cc(cc1[N+](=O)[O-])[N+]([O-])=O)C(N)=O	Vitas	STK395739	4.66439135	4.31744325	1.59147961	2.01419721	2.0783637	2.04786829	-2.79333857									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263574-01	Diflucortolone valerate	170465700	Annexin A1 Activator	DPI_SARS-CoV-2_General	2019_NPC_01	59198-70-8		9.8640558873	-5.0059444758	-27.038148103	-2.2	7		-51.1152315532	-37.96608451	0.000145166	0.995043926	301	ANXA1	CCCCC(=O)OCC(=O)[C@H]4[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Sequoia	59198-70-8	1.37244935	3.84342854	3.79469182	0.34615095	-1.83982135	-17.52629707	-37.96608451									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015760-12	Octopamine	170465959	Dopamine transporter Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	104-14-3				-13.001779754	4	7		0	-6.05814808					OC(CN)c1ccc(O)cc1	Vitas	STK801377	-3.212064	-0.98468004	-2.03992104	-1.14631149	-4.27599858	-2.47471924	-6.05814808									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164574-06	Erlotinib	170465434	EGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	183321-74-6	 ;CP-358774; Erlotinib hydrochlorid;Erlotinib hydrochlorid;OSI-774; erlotinib HCl; Erlotinib HCL;RG-1415;Tarceva;Ro-50-8231;NSC-718781	9.8640558873	-5.0059444758	-35.5056202452	4	7		-10.0106343799	-14.92484348	0.0403546643	0.9058989345	1956	EGFR	C#Cc1cc(ccc1)Nc3ncnc2cc(OCCOC)c(cc23)OCCOC	Sequoia	SRP01330e	-7.37056132	-5.01136169	-7.01177159	-6.26332556	-4.49931483	-9.61430967	-14.92484348									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025323-08	Ubenimex		Leukotriene A4 Hydrolase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	[58970-76-6]				-22.3795422687	4	7		0	-7.98649099				LTA4H	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(O)=O	Tocris	1956	-4.1457606	-4.03566726	-3.71533719	-4.72137128	-2.17902716	-7.32807215	-7.98649099									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181152-02	Nedaplatin			DPI_SARS-CoV-2_General	2019_NPC_02	95734-82-0		10.7242526854	-4.9696329617	-1.8761003075	4	7		-28.6485040239	-21.79042002	0.0000256298	0.9979296344			O=C1C[O-][Pt++][O-]1	MedChem Express	HY-13700	4.18738006	4.40527617	4.7936054	3.51939761	3.90418934	4.26531379	-21.79042002									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00482546-01	Ganirelix			DPI_SARS-CoV-2_General	2019_NPC_02	123246-29-7		6.2237985085	-5.2059444758	-70.5188511678	-2.2	7		-83.040360556	-67.11696713	0.0001433451	0.9950731348			CCNC(NCC)=NCCCC[C@@H](NC(=O)[C@@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](CO)NC(=O)[C@H](CC2=CN=CC=C2)NC(=O)[C@H](CC3=CC=C(Cl)C=C3)NC(=O)C(CC4=CC5=CC=CC=C5C=C4)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N6CCCC6C(=O)N[C@H](C)C(N)=O	DC Chemicals	DC8877	4.66369165	2.72355564	-0.51803755	-4.43607792	-14.32645011	-38.2375047	-67.11696713									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015754-16	Nilutamide	170465021	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	63612-50-0	 ;Nilutamide; Nilutamide;NILUTAMIDE; Nilandron	7.8352981002	-5.1059444758	4.9313305751	4	7		-8.343932976	-5.70327748	0.1870641068	0.7468900454	374	AR	FC(F)(F)c1cc(ccc1[N+]([O-])=O)N2C(=O)C(C)(C)NC2=O	Microsource	01504152	-0.92222787	3.87274904	1.47449489	3.19311711	4.54499315	-0.83337568	-5.70327748									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161831-04	Mefloquine hydrochloride	170465100	antimalarial agents; Inhibtion of heme crystallization	DPI_SARS-CoV-2_General	2019_NPC_01	51773-92-3		12.4181106199	-4.9059444758	-27.7698310788	4	7		-23.712314008	-20.17692834	0.0167329605	0.9422145159		GJD2	Cl.O[C@@H](c2cc(nc1c2cccc1C(F)(F)F)C(F)(F)F)[C@H]3CCCCN3	SIGMA	M2319	-3.60419238	0.57419308	-1.83519778	-5.18473926	-4.18464193	-10.3917882	-20.17692834									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164620-02	Nadifloxacin	170465882	DNA gyrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	124858-35-1				-51.450769758	4	7		0	-14.7676865					O=C(O)C3=CN2C(C)CCc1c(c(F)cc(c12)C3=O)N4CCC(O)CC4	Sequoia	SRP00810n	-9.79594801	-6.86343978	-9.92176647	-11.11947225	-12.54885043	-12.53112455	-14.7676865									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016322-13	Dapsone	170464895	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	80-08-0				-33.5218824427	4	7		0	-9.84005475					Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2	Vitas	STK387118	-6.1748118	-5.12375693	-15.41517389	-2.12456418	-5.48393646	-6.39768281	-9.84005475									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159513-03	Cefprozil	225144231	Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	92665-29-7	 ;Cefprozil hydrate; Cefprozilo; Cefprozil monohydrate;CEFPROZIL; cis-Cefprozil	0.2693810481	-6.5696329617	-7.8131028208	4	7		-5.5078922039	-3.16341791	0.4691064249	0.4227503163			C/C=C/C1=C(/N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)C2=O)C(O)=O	Selleck	S2544 	0.98516206	-0.04153737	-1.78157978	4.00080267	-9.58991017	-0.54880837	-3.16341791									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00023902-09	4-Androstene-3,17-dione	170465907	Cytochrome P450 19A1 Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	63-05-8				-19.3203695138	4	7		0	-8.5625206					O=C2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	Vitas	STK801871	-2.58272215	-2.22591443	-3.35112476	-2.60114882	-5.94579506	-4.55815844	-8.5625206									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00013895-08	Benzbromarone	170465792	Xanthine dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	3562-84-3		6.9832167823	-5.1559444758	-78.146294352	-2.2	7		-59.7652929995	-56.44977314	0.001417402	0.9842312262			Brc1cc(cc(Br)c1O)C(=O)c2c3ccccc3oc2CC	Labotest	LT00134669	-3.40086656	-2.57287365	-6.35373254	-8.87701608	-17.35522509	-30.779003	-56.44977314									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094571-08	Crotamiton	170464851	antipruritic	DPI_SARS-CoV-2_General	2019_NPC_01	483-63-6	; Eurax;CROTAMITON;Crotamiton; ; CROTAMITON; 7   Crotamiton; Veteusan			6.9146603554	4	7		0	3.24960077					CCN(C(=O)C=CC)c1ccccc1C	Microsource	01505271	0.93675114	3.36452708	0.80183276	1.00082775	1.64188195	-0.27440419	3.24960077									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249884-01	Sulfisoxazole acetal	170465159	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	80-74-0				5.9963724618	4	7		0	2.77812983					Cc1c(onc1C)N(C(C)=O)S(=O)(=O)c2ccc(N)cc2	GVK	FFS-11-286-NCI-17	1.53704645	0.36406284	1.00655602	3.55933479	-0.07359285	0.13720209	2.77812983									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015646-05	Fomepizole	170465026	Alcohol Dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	56010-88-9	FOMEPIZOLE HYDROCHLORIDE;4-Methylpyrazole hydrochloride; 4-Methylpyrazole hydrochloride			14.1595198655	4	7		0	3.65009759			124	ADH1	Cl.Cc1cnnc1	Microsource	01505432	3.57030475	0	2.87831152	4.36702034	4.56021926	2.24096753	3.65009759									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00177980-03	Oxiconazole nitrate	170465226	Steroid biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	64211-46-7		6.2237985085	-5.2059444758	-73.8683920937	-2.1	7		-91.2835275618	-85.52062027	0.0000076916	0.9988657943			[O-][N+](=O)O.Clc3ccc(C(=N\OCc1ccc(Cl)cc1Cl)\Cn2ccnc2)c(Cl)c3	Microsource	01505330	1.4219982	1.53156691	4.21696632	0.3764937	-2.91091415	-45.78166103	-85.52062027									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167547-02	Agaric acid	170465652		DPI_SARS-CoV-2_General	2019_NPC_02	666-99-9		3.9269513795	-5.4059444758	-11.8861259048	4	7		-18.858250484	-16.54854207	0.008315767	0.960392767			O=C(O)C(CCCCCCCCCCCCCCCC)C(O)(CC(=O)O)C(=O)O	SIGMA	A7384	0	0.08085195	3.76221842	3.60825948	-0.90060119	-11.08136039	-16.54854207									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179636-04	Clindamycin hydrochloride		Antibacterial	DPI_SARS-CoV-2_General	2019_NPC_02	21462-39-5				-13.662346514	4	7		0	-7.13504257					CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)C2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O	Prestwick	Prestw-137	-1.16765706	-2.61729308	-4.31541689	-3.0891191	0.45386498	-3.46204434	-7.13504257									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015482-07	Gallamine triethiodide	170465398	Muscarinic M2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	65-29-2	 Triethiodide, Gallamin; ;Gallamine triethiodide; Gallamine triethiodide; Gallamine Triethyl Iodide; Triethyl Iodide, Gallamin;GALLAMINE TRIETHIODIDE; Triethioduro de galamina; Iodide, Gallamoniu; Triethochloride, Gallamin; Iodide, Gallamine Triethy; Gallamine Triethochloride; Flaxedil			12.5859925463	4	7		0	0				ACHE	[I-].[I-].[I-].CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC	Enzo	C112	4.32551497	3.66750556	4.20413833	3.48408458	0	2.45947457	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022019-03	Clobetasone butyrate	170465575	corticosteroid	DPI_SARS-CoV-2_General	2019_NPC_01	25122-57-0		6.9832167823	-5.1559444758	-19.7986708496	-2.4	7		-35.492268896	-29.16022408	0.0071001805	0.9635283333			ClCC(=O)[C@@]3(OC(=O)CCC)[C@@H](C)C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@@]4(F)C(=O)C[C@@]23C	SIGMA	C5548	0	4.87941945	2.48348809	3.96066923	-5.15403746	-12.50571675	-29.16022408									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164559-03	Duloxetine hydrochloride	170465319	Serotonin Transporter (SERT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	136434-34-9	 ; Duloxetine hydrochloride;Duloxetine hydrochloride; Cymbalta;DULOXETINE HYDROCHLORIDE;Duloxetine HCl; DULOXETINE HCl; 0   Duloxetine Hcl	15.6334750258	-4.8059444758	-50.1805512192	-2.2	7		-48.3895030073	-40.56170946	0.0035782326	0.9745599549	6532	SLC6A4	Cl.CNCC[C@H](Oc1cccc2ccccc12)c3cccs3	Sequoia	SRP05005d	-6.10219543	-2.6266279	-5.14976481	-2.91218301	-10.09237172	-14.50785101	-40.56170946									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178851-03	Moxalactam disodium	170465353	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	64953-12-4				-3.5638889411	4	7		0	-7.1176903					[Na+].[Na+].O=C3N1C(=C(CO[C@@H]1[C@]3(OC)NC(=O)C(c2ccc(O)cc2)C([O-])=O)CSc4nnnn4C)C([O-])=O	Microsource	01500418	1.66291482	-2.83187138	-0.53861714	2.4004816	1.03791301	-1.40759185	-7.1176903									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091345-04	Hexanedioic acid	170465352		DPI_SARS-CoV-2_General	2019_NPC_01	124-04-9				-13.5108703744	4	7		0	-4.84651847					OC(=O)CCCCC(=O)O	Specs	AE-562/J262759	-4.49495316	-0.51066533	-2.27876484	-4.5576542	-2.74323707	-1.22973728	-4.84651847									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183600-04	PARAMETHADIONE		Voltage-gated T-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	115-67-3				-24.7871075352	4	7		0	-8.48594397					CCC1(C)OC(=O)N(C)C1=O	Microsource	01505456	-4.89028648	-3.65219802	-5.74998242	-3.94967612	-4.18934011	-6.78316422	-8.48594397									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00485328-01	(6R)-5,6,7,8-Tetrahydrobiopterin dihydrochloride	363681287	Phenylalanine-4-hydroxylase Substrate	DPI_SARS-CoV-2_General	2019_NPC_02	69056-38-8				-8.4043590409	4	7		0	-5.88403177					C[C@H](O)[C@H](O)[C@H]1CNC\2=C(N1)\C(=O)N\C(=N2)N	SIGMA	T4425	0.77458438	-1.20815912	-3.03087129	-1.48492856	-0.36831975	-2.24069899	-5.88403177									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181118-01	Sulfabromomethazine	144206282		DPI_SARS-CoV-2_General	2019_NPC_02	116-45-0	CIPLUS_654340; 			9.4007210983	4	7	CIPLUS_654340;CIPLUS_151449;SULFABROMOMETHAZINE;SULFABROMOMETHAZINE SODIUM;	0	-2.68277601					O=S(=O)(Nc1nc(C)c(Br)c(C)n1)c2ccc(N)cc2	NCI	NSC-5874	-0.45550186	4.04952759	3.76221842	4.16949232	0	3.93179256	-2.68277601									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016528-05	Proguanil hydrochloride	170464800	DHFR inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	637-32-1	Proguanil hydrochloride; Chlorguanide; ; Proguanil hydrochloride;Proguanil hydrochloride; Chlorguanide; ;Proguanil hydrochloride;CHLOROGUANIDE HYDROCHLORIDE			3.4592749147	4	7		0	-5.08985831					Cl.Clc1ccc(NC(=N)NC(=N)NC(C)C)cc1	Prestwick Chemical, Inc.	Prestw-999	1.40633699	1.52222249	1.35751018	3.15298367	0.75369233	0.64027644	-5.08985831									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015238-13	Chlorzoxazone	170464957	Intermediate conductance calcium-activated potassium channel protein 4 Activator	DPI_SARS-CoV-2_General	2019_NPC_01	95-25-0		8.7913490634	-5.0559444758	-89.0685367213	-2.2	7		-78.2779748252	-70.69022331	0.00003848	0.9974574788			Clc1cc2NC(=O)Oc2cc1	Vitas	STK071582	-6.63471546	-2.94426662	-6.82654578	-7.09107783	-12.56407654	-38.26413944	-70.69022331									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389552-01	CEFONICID SODIUM		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	71420-79-6		11.0676527398	-4.9559444758	8.1392533453	4	7		-10.0745611959	-6.31213433	0.0980829296	0.8376053828			O[C@@H](C(=O)N[C@@H]1[C@H]2SC\C(=C(/N2C1=O)C([O-])=O)CSC3=NN=N[N]3C[S]([O-])(=O)=O)C4=CC=CC=C4	Microsource	01505474	4.91803279	2.61036291	0.17346054	4.58574001	3.67131621	0.6059752	-6.31213433									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166300-02	Pyridoxal phosphate hydrate	170466028	P2X purinoceptor 2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	41468-25-1				5.8424865202	4	7		0	1.2510108					O.Oc1c(C=O)c(cnc1C)COP(=O)(O)O	SIGMA	P3657	0	0.6306452	4.26384754	2.25194678	0.67248057	-0.40868095	1.2510108									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094476-03	Terguride	144204835	Serotonin 1a (5-HT1a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	37686-84-3	R(+)-Terguride; S(+)-Terguride; Teluron; 			6.6487003389	4	7	Teluron;R(+)-TERGURIDE;transdihydrolisuride;CIPLUS_3867987;S(+)-N,N-Diethyl-N'([8alpha]-6-methylergolin-8-yl)urea;TERGURIDE;NCGC00016838-01;NCGC00015990-01;Terguride;N-(D-6-methyl-8-isoergolin-1-yl)-N',N'-diethylurea;NCGC00016838-02;CIPLUS_739798;S(+)-Terguride;S(-)-terguride hydrogen maleate;terguride;VUFB 6638;dironyl maleate (1:1);NCGC00094476-01;trans-9,10-dihydrolisuride hydrogen maleate;LS-159804;NCGC00094476-03;LS-159803;NCGC00094476-02;R(+)-Terguride;R(+)-N,N-Diethyl-N'[(8alpha)-6-methylergolin-8-yl]urea;S(+)-Terguride (5R, 8S, 10R);CIPLUS_179126;1,1-DIETHYL-3-(6-METHYL-ERGOLIN-8A-YL)UREA;terguridum;dironyl;urea, N,N-diethyl-N'-((8 alpha)-6-methylergolin-8-yl)-, (Z)-2-butenedioate (1:1);	0	4.78999191					CCN(CC)C(=O)N[C@H]1C[C@@H]2c3cccc4ncc(C[C@H]2N(C)C1)c34	BIOMOL	AC-839	0	-0.59830442	0.54147817	1.57379043	0	4.38275085	4.78999191									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00483046-01	SCE 2174			DPI_SARS-CoV-2_General	2019_NPC_02	95789-30-3		4.9437388825	-5.3059444758	-97.9401888858	-2.1	7		-110.9365219053	-83.67977929	0.0000736756	0.9964757192			CC(OC(=O)OC1CCCCC1)OC(=O)\C2=C(CS[C@@H]3[C@H](NC(=O)CC4=CSC(=N4)N)C(=O)N23)/CSC5=NN=N[N]5CCN(C)C	DC Chemicals	DC9200	3.8174293	2.75589642	3.16682684	-4.80087926	-28.34161063	-53.50901917	-83.67977929									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016348-15	Ethoxyquin		Heat shock protein HSP 90-beta Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	91-53-2		2.5355181056	-5.5959332839	-135.3510076949	-1.1	7		-100.5690957547	-98.28283309	5.085E-7	0.9997087741	3326	HSP90AB1	CCOC1=CC\2=C(NC(C)(C)\C=C2C)C=C1	Prestwick	Prestw-765	1.92143171	1.11113678	-1.12280537	-10.00631387	-49.47128294	-87.77715145	-98.28283309									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00016018-11	Tetrahydrozoline HCl		Adrenergic receptor alpha Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	522-48-5				18.6312531763	4	7		0	2.32126718					C1CC(\C2=N\CCN2)C3=C(C1)C=CC=C3	Selleck	S4043	4.80242318	3.39809189	4.7514123	2.91139537	4.6265713	4.56595265	2.32126718									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024596-08	Carbidopa	225144194	decarboxylase inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	28860-95-9		22.0828704269	-4.6559444758	-4.0370850845	4	7		-16.8391168799	-14.0325974	0.0226811325	0.931704592		DDC	C[C@@](CC1=CC(=C(O)C=C1)O)(NN)C(O)=O	Prestwick	Prestw-1177	-1.28530971	0.24678085	-0.71409422	2.91218301	2.02761001	1.58544641	-14.0325974									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017258-08	Methergine	170465383	Serotonin 2b (5-HT2b) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	113-42-8		15.6334750258	-4.8059444758	-64.8617401991	-2.2	7		-57.5048370361	-53.73247826	0.0005702545	0.9900950518			CC[C@@H](CO)NC(=O)[C@@H]2C=C1c3cccc4ncc(C[C@H]1N(C)C2)c34	Enzo	AC576	-6.78478929	-4.56178073	-6.86554069	-7.39709534	-10.84860174	-16.0221556	-53.73247826									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179685-03	Isoflupredone acetate	170465628		DPI_SARS-CoV-2_General	2019_NPC_02	338-98-7		17.5410474839	-4.7559444758	-7.8558423746	4	7		-11.667221616	-9.72268468	0.1042453485	0.8310997933			CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-6	0.28902402	2.40476795	-2.10731113	-2.2893623	-0.28752703	-1.90248027	-9.72268468									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166241-02	2,6-DIIODO-4-NITROPHENOL	225144276		DPI_SARS-CoV-2_General	2019_NPC_02	305-85-1		12.4181106199	-4.9059444758	-46.574615919	-2.2	7		-33.8630198279	-34.2006374	0.001283201	0.985030278			OC1=C(I)C=C(C=C1I)[N+]([O-])=O	SIGMA	145416	-3.15151795	-5.25537665	-7.60179086	-5.99349905	-5.45826106	-13.4723788	-34.2006374									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091110-01	Glutaraldehyde	144204634		DPI_SARS-CoV-2_General	2019_NPC_02	111-30-8	Glutaraldehyde (Glutaric dialdehyde)			7.5760247816	4	7	glutaral;polyglutaraldehyde;glutaralum;poly(glutaraldehyde);CIPLUS_151232;Glutaral;Sterihyde L;Glutaraldehyde (Glutaric dialdehyde);GLUTARALDEHYDE;pentanedial, homopolymer;Sonacide;Glutaraldehyde solution;CIPLUS_690280;Glutaralum;Glutaric dialdehyde solution;Pentanedial;AB07944785-01;Pentane-1,5-dial;Glutaraldehyde;CIPLUS_765795;GLUTARAL;	0	0					O=CCCCC=O	NIEHS	AB07944785	3.23475687	0	2.47767282	-0.14732362	3.20081743	2.17493424	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181154-03	Nitarsone	170465716		DPI_SARS-CoV-2_General	2019_NPC_01	98-72-6				5.6209890561	4	7		0	-4.57783073					O=[N+]([O-])c1ccc(cc1)[As](O)(O)=O	Vitas	STK368450	1.38697262	3.90695629	1.95705686	-0.70986029	2.78891539	2.21047817	-4.57783073									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016089-06	Nonivamide	170466476	Vanilloid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	2444-46-4		15.6334750258	-4.8059444758	-43.9663227319	-2.2	7		-42.510402704	-39.51230641	0.0001649807	0.9947151344			Oc1ccc(cc1OC)CNC(=O)CCCCCCCC	Specs	AN-153/I105041	-3.96727422	-4.47381924	-3.25363749	-4.607821	-6.60051769	-10.32064637	-39.51230641									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274269-01	NCGC00274269-01	225144370		DPI_SARS-CoV-2_General	2019_NPC_01			7.5921894793	-5.1196329617	-57.5686290317	-2.2	7		-37.3771678359	-32.63795595	0.0102252887	0.9557035307			CCCCCCCCCCCCNCCNCCNCC(O)=O	GVK	FFS-11-286-NCI-158	-9.47643599	-2.32364942	-6.64131998	-5.56600697	-8.5443841	-15.51908125	-32.63795595									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00091493-09	Anethole	170465678	TNF signaling pathway Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	104-46-1		4.9437388825	-5.3059444758	-4.879739003	4	7		-11.843413348	-10.28617779	0.0370346198	0.9098016129	4313		COc1ccc(C=CC)cc1	Microsource	01503705	0	0.71346544	0	4.19143653	3.41826118	-7.54611515	-10.28617779									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164493-02	Dipyrithione	170465699		DPI_SARS-CoV-2_General	2019_NPC_01	3696-28-4				5.433931346	4	7		0	2.96063471					[O-][n+]2ccccc2SSc1cccc[n+]1[O-]	Labotest	LT00452770	3.91886331	0	0	0	0	2.15966258	2.96063471									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00018157-13	Flurbiprofen		non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC_01	5104-49-4	 R-(-)-Flurbiprofen;;FLURBIPROFEN;(?)-Flurbiprofen;Flurbiprofen; Anside; Flurbiprofeno; (R)-2-Flurbiprofen; Ansaid; (S)-(+)-Flurbiprofen; S-(+)-Flurbiprofen; Ocufen			8.8157453715	4	7		0	0				PTGS2	CC(C(O)=O)C1=CC=C(C(=C1)F)C2=CC=CC=C2	SIGMA	F8514	4.05925496	4.62042173	4.05790744	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249885-01	Estradiol acetate	170465258		DPI_SARS-CoV-2_General	2019_NPC_01	4245-41-4		12.4181106199	-4.9059444758	-18.8072040004	4	7		-22.1418258961	-21.36827964	0.0009401079	0.987251799			CC(=O)Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)CC[C@@H]12)c4cc3	GVK	FFS-11-286-NCI-18	-1.1788057	-2.85141838	-0.41675806	-0.54932651	-0.52530072	-5.30514762	-21.36827964									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183010-01	Pelubiprofen	144206823	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	69956-77-0	PELUBIPROFEN; 			0.5646466648	4	7	2-OCMPP;BENZENEACETIC ACID, .ALPHA.-METHYL-4-((E)-(2-OXOCYCLOHEXYLIDENE)METHYL)-;2-(4-((2-oxocyclohexylidene)methyl)phenyl)propionic acid;PELUBIPROFEN;CIPLUS_706216;Pelubiprofen;pelubiprofene;LS-176792;2-(4-((E)-(2-OXOCYCLOHEXYLIDENE)METHYL)PHENYL)PROPANOIC ACID;(+/-)-P-(((E)-2-OXOCYCLOHEXYLIDENE)METHYL)HYDRATROPIC ACID;CS-670;pelubiprofenum;CS 670;	0	-0.63876708			5743	PTGS2	O=C(O)C(C)c1ccc(cc1)\C=C2/CCCCC2=O	Pharmaron	PH-NIH-149772	0	1.29010189	0	0	0	0	-0.63876708									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015959-09	Sanguinarine	170466353	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	2447-54-3		7.5921894793	-5.1196329617	-99.5731145495	-2.2	7		-78.2315650857	-67.94251096	0.0011746407	0.9856774184	100009298	PPP1CA	C[n+]2cc1c6OCOc6ccc1c3ccc4cc5OCOc5cc4c23	Tocris	2302	-4.93065137	-4.06333227	-7.73317735	-8.77668247	-14.36075725	-24.36099395	-67.94251096									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00263960-01	OXANTEL PAMOATE		antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC_02			2.4777388143	-5.6059444758	-92.1271403712	-1.2	7		-76.1490748261	-73.13418637	0.0000298931	0.9977599402			CN1CCC/N=C1/C=C/C2=CC=CC(=C2)O.OC(=O)C3=CC4=CC=CC=C4C(=C3O)CC5=C(O)C(=CC6=CC=CC=C56)C(O)=O	Microsource	MS-01505982	2.30063123	2.37242718	1.62912262	-3.78130627	-17.77677447	-61.33972191	-73.13418637									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178803-03	HOMATROPINE METHYLBROMIDE			DPI_SARS-CoV-2_General	2019_NPC_02	80-49-9, 87-00-3 [homatropine]				8.3427804048	4	7		0	3.90524663					C[N+]1(C)C2CC[C@H]1CC(C2)OC(=O)C(O)C3=CC=CC=C3	Microsource	01500333	1.94686582	2.157592	0	0	4.94974218	0	3.90524663									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346540-03	FESOTERODINE FUMARATE		Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC_02	286930-03-8		11.0676527398	-4.9559444758	-51.012685006	-2.2	7		-38.9591965281	-40.3462874	0.0011859554	0.9856158543		CHRM1	CC(C)N(CC[C@H](C1=CC=CC=C1)C2=C(OC(=O)C(C)C)C=CC(=C2)CO)C(C)C	Microsource	01504374	-3.5815857	-4.34521472	-4.59201613	-8.55646236	-5.39647839	-16.19222097	-40.3462874									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185778-04	Nitisinone		4-Hydroxyphenylpyruvate Dioxygenase (4HPPD) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	104206-65-7		13.9333492831	-4.8559444758	-16.8351860276	-2.4	7		-36.0336060479	-28.77800504	0.0011523928	0.9858313155		HPD	[O-][N+](=O)C1=CC(=CC=C1C(=O)C2C(=O)CCCC2=O)C(F)(F)F	MedChem Express	HY-B0607	2.19889477	2.35394673	1.4181571	-1.63459065	-0.11168405	-6.53419767	-28.77800504									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159411-02	Triethanolamine	144206717		DPI_SARS-CoV-2_General	2019_NPC_02	102-71-6	trolamine salicylate; Tris(2-hydroxyethyl)amine; Solupront; Thiofaco T-35; Myoflex; texapon TH; 			1.9441383057	4	7	CIPLUS_734310;CIPLUS_3747852;CIPLUS_740704;CIPLUS_752482;CIPLUS_750425;CIPLUS_737530;CIPLUS_737531;Triethanolamine aluminate barium salt;CIPLUS_749510;CIPLUS_686266;triethanolamine salicylate;TRIETHANOL AMMONIUM CHLORIDE;CIPLUS_740747;CIPLUS_3755473;CIPLUS_732537;CIPLUS_739845;CIPLUS_749773;CIPLUS_749544;CIPLUS_749685;CIPLUS_740695;CIPLUS_3889761;CIPLUS_745468;CIPLUS_691861;CIPLUS_753415;CIPLUS_740654;CIPLUS_3730238;CIPLUS_175532;CIPLUS_3749955;NCGC_FLUKA_90290;CIPLUS_739743;LS-173901;2,2',2''-Nitrilotriethanol hydrochloride;CIPLUS_749503;CIPLUS_738415;trolamine salicylate;CIPLUS_752427;CIPLUS_752428;CIPLUS_3756040;NCGC00159411-04;CIPLUS_666794;CIPLUS_3885762;Tris(2-hydroxyethyl)amine hydrochloride;CIPLUS_193084;CIPLUS_748749;CIPLUS_3755605;CIPLUS_3733577;CIPLUS_740728;Myoflex;CIPLUS_739153;CIPLUS_3745711;CIPLUS_3755043;Trolamine (Triethanolamine hydrochloride);CIPLUS_736952;CIPLUS_687637;Triethanolamine;CIPLUS_732449;CIPLUS_3749677;CIPLUS_746627;CIPLUS_3753376;CIPLUS_668732;CIPLUS_193079;CIPLUS_667351;Triethanolamine Hydrochloride;CIPLUS_193078;Tris(2-hydroxyethyl)amine;CIPLUS_3887736;CIPLUS_749757;CIPLUS_737348;CIPLUS_738912;CIPLUS_767549;Trolamine salicylate;2,2',2''-Nitrilotriethanol;CIPLUS_753583;Triethanolamine hydrochloride;CIPLUS_750558;CIPLUS_3752239;CIPLUS_3745729;	0	-2.19759311					OCCN(CCO)CCO	Labotest	LT03329084	3.85442438	-0.35805863	-1.81664752	-0.04443093	3.29586769	-0.36640361	-2.19759311									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182974-01	Improsulfan tosylate	144206762		DPI_SARS-CoV-2_General	2019_NPC_02	32784-82-0	NSC-140117; Improsulfano; 			8.9911314406	4	7	Improsulfano;improsan hydrochloride;LS-1222;NSC-102627;3,3'-IMINO BIS(DIMETHANESULFONATE)1-PROPANOL HYDROCHLORIDE;IMPROSULFAN TOSILATE;improsan tosylate;Improsulfan;iminodipropyl dimethanesulfonate 4-toluenesulphonate;alkylating agent 864;yoshi 864;dimesyloxydipropylamine tosylate;improsulfan;CIPLUS_161918;Improsulfanum;bis(3-mesyloxypropyl)amine;3,3'-iminobis-1-propanol dimethanesulfonate;864 T;improsan;LS-122362;LS-122363;CIPLUS_168735;improsulfanum;IMPROSULFAN;3,3'-iminodi-1- propanol dimethanesulfonate;NSC-140117;Improsulfan Tosilate;Improsulfan tosilate;CIPLUS_731133;	0	-2.7826666					Cc1ccc(cc1)S(O)(=O)=O.CS(=O)(=O)OCCCNCCCOS(C)(=O)=O	NCI	NSC_140117	4.01627783	0.76000832	1.09467664	3.23878119	3.21032246	2.77151447	-2.7826666									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164633-02	Nisoldipine	170465320	Ca2+ channel blocker (dihydropyridine)	DPI_SARS-CoV-2_General	2019_NPC_02	63675-72-9	Nisoldipine;Nisoldipine; Sular; Bay K 5552; Nisoldipino; ; Nisoldipine;NISOLDIPINE	1.7541047484	-5.7559444758	-145.6326820286	-1.1	7		-105.7213718287	-98.22099605	0.0000110633	0.9986391429			CC=1NC(C)=C(C(C=1C(=O)OCC(C)C)c2ccccc2[N+]([O-])=O)C(=O)OC	Sequoia	SRP03410n	3.50759555	1.98433782	-1.375964	-10.03437551	-41.42527862	-86.85644495	-98.22099605									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274064-01	Betamethasone valerate	174007479	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC_01	33755-46-3	Betamethasone valerate	9.8640558873	-5.0059444758	-15.9570596896	-3	7		-35.7808167079	-30.65068059	0.0017928015	0.9822182784		NRC31	OCC(=O)[C@@]4(OC(=O)CCCC)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Selleck	S1690	3.06683126	0	0	4.63290441	1.76369081	-9.07566441	-30.65068059									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016876-12	Albendazole	170464897	Tubulin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	54965-21-8		2.7800686746	-5.5559444758	-13.4274530792	4	7		-19.8785582119	-17.39879851	0.0035128661	0.974829786			O=C(OC)Nc1nc2cc(ccc2n1)SCCC	Vitas	STK387550	1.72584901	3.95093703	0	4.35698698	-0.48469776	-15.58514152	-17.39879851									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090764-04	2-Ethylhexyl 4-(dimethylamino)benzoate	170465499		DPI_SARS-CoV-2_General	2019_NPC_01	21245-02-3		7.8352981002	-5.1059444758	-75.7230119515	-2.1	7		-96.5831005513	-88.4743099	0.0000202998	0.998155224			CN(C)c1ccc(cc1)C(=O)OCC(CC)CCCC	Bosche	E2279	0	0	0	0	0	-41.60780527	-88.4743099									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182082-03	Tesaglitazar	170466025		DPI_SARS-CoV-2_General	2019_NPC_01	251565-85-2				8.5816403994	4	7		0	1.70844846					O=S(C)(=O)Oc1ccc(cc1)CCOc2ccc(C[C@@H](OCC)C(=O)O)cc2	Tocris	3965	2.94096289	2.45070491	-0.57273769	3.88541902	0.65218495	1.72773007	1.70844846									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016055-16	Trimethoprim	170464633	Bacterial dihydrofolate reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	738-70-5				0.0648791946	4	7		0	0					Nc2nc(N)ncc2Cc1cc(OC)c(OC)c(OC)c1	Vitas	STK177322	0	0.09284824	0	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094516-08	Coumaphos	170466302		DPI_SARS-CoV-2_General	2019_NPC_01	56-72-4		7.8352981002	-5.1059444758	-74.0802694017	-2.2	7		-65.9988453867	-60.98704722	0.0017147277	0.9826083064			CCOP(=S)(OCC)Oc1ccc2c(c1)OC(=O)C(Cl)=C2C	Microsource	00330012	-1.57577518	-0.02199037	-4.25288197	-10.37198686	-10.79277267	-33.02505209	-60.98704722									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016819-05	Gliquidone	170465581	Cytochrome P450 3A4 Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	33342-05-1		13.9333492831	-4.8559444758	-75.8689147631	-2.2	7		-43.8313173922	-44.71369547	0.0005103194	0.9906425964			O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)CCN4C(=O)c3cc(ccc3C(C)(C)C4=O)OC	Prestwick Chemical, Inc.	Prestw-991	-12.01800886	-8.9745156	-11.54005508	-8.75661575	-12.0920672	-21.81513288	-44.71369547									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181103-02	Propiverine hydrochloride	170466036	Muscarinic acetylcholine receptor Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	54556-98-8		15.6334750258	-4.8059444758	-6.5375693384	4	7		-19.32201972	-13.6016831	0.0138218934	0.9480516502			Cl.CN3CCC(OC(=O)C(OCCC)(c1ccccc1)c2ccccc2)CC3	Sequoia	54556-98-8	1.69196137	2.46536516	1.84007214	-1.27674518	-0.6927879	-3.06926165	-13.6016831									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015479-19	Genistein	170466848	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	446-72-0	; ; Genistein;GENISTEIN;Genistein (4',5,7-Trihydroxyisoflavone); Genestein;Genistein	13.9333492831	-4.8559444758	-45.600725784	-2.2	7		-46.93697307	-37.47433525	0.0419582552	0.9025558341	7153	TOP2A	Oc1ccc(cc1)C3=COc2cc(O)cc(O)c2C3=O	Vitas	STK801619	-3.93338659	-0.85762455	-2.11303648	-1.26169514	-15.31492666	-13.62365974	-37.47433525									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016239-04	Methantheline bromide	170465350	Histamine H2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	53-46-3				2.3279834556	4	7		0	0.2281311			3274	HRH2	[Br-].CC[N+](C)(CC)CCOC(=O)C1c3ccccc3Oc2ccccc12	Prestwick	Prestw-1066	0	0	0	0	2.71278486	0.44717719	0.2281311									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159373-04	Thymol	170465504	Aldose reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	89-83-8				-27.1963231825	4	7		0	-8.11132798			231	AKR1B1	CC(C)c1ccc(C)cc1O	Labotest	LTBB001943	-4.42233679	-6.03269235	-6.31473764	-5.41550656	-5.02207786	-5.72183546	-8.11132798									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164034-05	Triclocarban	170465481		DPI_SARS-CoV-2_General	2019_NPC_01	101-20-2		0.4943738883	-6.3059444758	-8.9727299177	4	7		-9.6244480479	-1.3180908	0.3165066329	0.6861525807			Clc2ccc(NC(=O)Nc1ccc(Cl)cc1)cc2Cl	Specs	AN-153/I101902	0.26383947	3.30099934	0.30464771	2.57104874	-13.43704004	-3.32842116	-1.3180908									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018130-09	Phenazopyridine hydrochloride	170465267		DPI_SARS-CoV-2_General	2019_NPC_01	136-40-3		9.8640558873	-5.0059444758	-79.4618627218	-2.1	7		-114.1381714079	-84.1955844	0.0000578504	0.9968792037			Cl.Nc2nc(N)ccc2/N=N/c1ccccc1	Microsource	01500473	2.77636579	1.73235273	3.57047111	-1.87874683	-15.24894686	-41.0589969	-84.1955844									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016360-06	Monobenzone	170464724	topical medical depigmentation treatment	DPI_SARS-CoV-2_General	2019_NPC_01	103-16-2	; ; 4-(Benzyloxy)phenol;4-(Benzyloxyl)phenol; 4-(Benzyloxyl)phenol; Benoquin;MONOBENZONE;Monobenzone; Monobenzona; Novo-depigman; ICN brand of monobenzone	19.6813789847	-4.7059444758	-23.6456153518	-3	7		-63.0462599121	-57.05812273	0.0000558826	0.9969335786		TYR	Oc2ccc(OCc1ccccc1)cc2	Microsource	01503031	2.24384576	2.65106165	-0.62635568	2.9924499	0.85012435	1.17892169	-57.05812273									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016686-13	Pimaricin		Anti-fungal	DPI_SARS-CoV-2_General	2019_NPC_02	7681-93-8				-7.1436045634	4	7		0	-5.5748466					C[C@@H]1O[C@@H](O[C@H]2C[C@@H]3O[C@@](O)(C[C@@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]4O[C@@H]4C=CC(=O)O[C@@H](C)CC=CC=CC=CC=C2)[C@H](O)[C@H](N)[C@@H]1O	Enzo	NP232	1.75957826	0.79696921	-2.9089801	1.91053013	0.41109237	-1.53607666	-5.5748466									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00181756-01	gamma-Oryzanol	144206489	lipid oxidation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	11042-64-1	ORYZANOL; Hi-Z; 	0.5546966259	-6.2559444758	-57.8767188698	4	7	gamma-oryzanol;cycloartenol ferulic acid ester;ferulic acid cycloartenol ester;CIPLUS_3885867;LS-7631;triacontane 3-(4-hydroxy-3-methoxyphenyl)-2-propenate;ORYZANOL;R-ORIZANOL;oryzanol;CYCLOARTENOL FERULATE;Gamma Oryzanol;Hi-Z;CIPLUS_666235;GAMMA ORYZANOL;FRACYE;9,19-CYCLO-9.BETA.-LANOST-24-EN-3.BETA.-OL 4-HYDROXY-3-METHOXYCINAMATE;gamma Oryzanol;Gamma oryzanol;	-13.466278404	-5.59387338	0.0055370227	0.9859185965			Oc1ccc(cc1OC)/C=C/C(=O)O[C@H]4CC[C@]63C[C@@]56CC[C@]2(C)[C@H](CC[C@@]2(C)[C@@H]5CC[C@H]3C4(C)C)[C@H](C)CC\C=C(/C)C	ACC	GAMMA ORYZANOL	-7.98862401	-6.06389614	-7.02515178	-10.49739261	-16.77874676	-19.78579481	-5.59387338									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095029-08	NCGC00095029-08		Staphylococcus aureus Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			4.9437388825	-5.3059444758	-85.7883189454	-2.2	7		-76.1792798328	-62.84069828	0.0000250297	0.9979511443			CC[C@H]([C@H]1O[C@@](CC)(C[C@@H]1C)[C@H]2CC[C@](O)(CC)[C@H](C)O2)C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCC3=C(C([O-])=O)C(=C(C)C=C3)O	Analyticon	NP-009923	-1.40812504	0.4689413	-3.95443145	-6.55473189	-21.4362094	-42.51221345	-62.84069828									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346517-07	Daptomycin		Lipopeptide Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	103060-53-3		5.3748585361	-5.2696329617	-14.1884727996	4	7		-21.183727344	-18.90310612	0.0115962368	0.9526503698			CCCCCCCCCC(=O)N[C@@H](CC1=C[NH]C2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]3[C@@H](C)OC(=O)[C@H](CC(=O)C4=CC=CC=C4N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC3=O)[C@@H](C)CC(O)=O	Enzo	A201	0	1.24512001	-1.1696866	2.12566939	4.01349714	-4.11029688	-18.90310612									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00161419-07	Trimetrexate	404904680	Dihydrofolate Reductase (DHFR) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	[82952-64-5]		6.9832167823	-5.1559444758	-87.2581918598	-2.1	7		-105.7403795858	-91.00033297	0.0000588918	0.9968510113	1719	DHFR	COC1=C(OC)C(=CC(=C1)NCC2=C(C)C3=C(C=C2)N=C(N)N=C3N)OC	NCGCChem	NCGC00161419-05pur	1.91218294	3.93864492	2.70739083	-1.95729953	-14.73516622	-48.02236001	-91.00033297									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091532-06	Clorophene	170465725		DPI_SARS-CoV-2_General	2019_NPC_01	120-32-1		15.6334750258	-4.8059444758	1.7617924775	4	7		-26.7675850999	-15.63965425	0.0012591539	0.9852000273			Oc2ccc(Cl)cc2Cc1ccccc1	Bosche	B0598	4.9161281	2.85141838	4.56971558	3.53425139	1.36273664	-2.76436811	-15.63965425									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263541-01	Reboxetine mesylate	170465620		DPI_SARS-CoV-2_General	2019_NPC_01	98769-84-7				6.4587281847	4	7		0	-3.99989861					CS(=O)(=O)O.CCOc3ccccc3O[C@H](c1ccccc1)[C@H]2CNCCO2	Prestwick Chemical, Inc.	Prestw-1328	3.56062256	0	0	3.82521885	4.48408872	0.50307434	-3.99989861									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015523-13	Hydroquinone	170464661		DPI_SARS-CoV-2_General	2019_NPC_01	123-31-9		11.0676527398	-4.9559444758	-11.4522500874	4	7		-15.72699044	-12.6891587	0.015709214	0.9443714586			Oc1ccc(O)cc1	Vitas	STK397446	-0.71890204	1.85452146	0.09505008	-2.09446409	-0.43901944	-5.53381778	-12.6891587									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024667-14	Methyldopa	170464643	DOPA decarboxylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	41372-08-1	; L-alpha-Methyl DOPA;METHYLDOPA; L-alpha-Methyl-DOPA;Methyldopa; ; DL-alpha-Methyl-DOPA; Methoplain; Metildopa;L-alpha-Methyl DOPA; alpha-Methyl-L-DOPA; L(-)-alpha-Methyldopa;Methyldopa sesquihydrate; Methyldopa (L,-);Methyldopa (L,-); L-Methyldopa; Methyldopa sesquihydrate; Aldomet; L-Alphamethyl Dopa	6.2237985085	-5.2059444758	-96.5129780932	-2.1	7		-110.5240931744	-95.19657296	0.0000081155	0.9988348697	1644	DDC	O.O.O.Oc1ccc(C[C@](C)(N)C(=O)O)cc1O.O=C(O)[C@@](C)(N)Cc1cc(O)c(O)cc1	Microsource	01500403	0.47684748	3.7603538	1.91806195	-2.46068177	-13.81261737	-56.16139031	-95.19657296									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091326-06	Acetanilide	170465493		DPI_SARS-CoV-2_General	2019_NPC_01	103-84-4				-20.6058470737	4	7		0	-6.77802844					O=C(C)Nc1ccccc1	Vitas	STK046402	-6.84288239	-3.50624282	-1.91318759	-6.46900946	-2.33720753	-3.51643884	-6.77802844									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015563-13	Imipramine	170464777	Serum paraoxonase/arylesterase 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	50-49-7		13.9333492831	-4.8559444758	3.0925027459	4	7		-13.532838208	-7.94403184	0.0353792556	0.9125466515	5444	PON1	CN(C)CCCN2c3ccccc3CCc1ccccc12	Enzo	AC813	0	3.93139004	2.95630133	2.88208293	1.78399229	-1.13826922	-7.94403184									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094616-07	Chlorthalidone	170464745	renal sodium excretion Activator	DPI_SARS-CoV-2_General	2019_NPC_01	77-36-1				-21.3401953629	4	7		0	-7.13796862					NS(=O)(=O)c1cc(ccc1Cl)C3(O)NC(=O)c2ccccc23	Microsource	01500187	-6.68796747	-2.46536516	-4.16514343	-7.16632804	-3.95625032	-0.91468062	-7.13796862									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015748-17	Nifedipine	170465006	Voltage-gated L-type calcium channel alpha-1C subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	21829-25-4		11.0676527398	-4.9559444758	-76.8669155234	-2.1	7		-101.4994249	-81.255228	1.003E-7	0.9998706813			CC=1NC(C)=C(C(C=1C(=O)OC)c2ccccc2[N+]([O-])=O)C(=O)OC	Specs	AN-153/I100964	-0.69469658	-0.89671855	-0.63123005	-2.41051496	-8.24493732	-35.83515423	-81.255228									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182979-02	Perlapine		Histamine H1 receptor Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	[1977-11-3]		12.4181106199	-4.9059444758	-34.078112008	4	7		-13.776675956	-17.10983209	0.095891997	0.839383677			CN1CCN(CC1)C/2=N/C3=C(CC4=C2C=CC=C4)C=CC=C3	Tocris	5549	-4.98277417	-3.54593546	-4.56388739	-9.50588125	-4.78340422	-8.62457723	-17.10983209									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179506-05	Kanamycin (sulfate)		30S Ribosomal Protein Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_02	25389-94-0				-1.4801704286	4	7		0	0.58507349					NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	MedChem Express	HY-16566A	-0.02543411	-0.39963963	1.89634561	-3.6690597	-0.78178837	-0.43216836	0.58507349									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00248225-03	9(Z)-Hexadecenoic acid		Gap junction Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	373-49-9		19.6813789847	-4.7059444758	-37.4499378571	4	7		-23.8128651879	-25.49112876	0.1137909219	0.819439154			CCCCCC\C=C/CCCCCCCC(O)=O	Enzo	BL103	-2.49947976	-11.53410797	-8.68005907	-4.09466127	-1.48040777	-6.13491169	-25.49112876									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178417-03	Ribostamycin sulfate	170465814	Protein disulfide-isomerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	53797-35-6				14.2183748378	4	7		0	3.15368882			5034	P4HB	O=S(=O)(O)O.N[C@@H]3[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]3O[C@@H]2[C@@H](N)C[C@@H](N)C(O)[C@H]2O[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	Microsource	01503939	0	0	2.38859849	3.6222903	4.24161776	4.55655768	3.15368882									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00344583-01	Vinblastine sulfate	170464976	Tubulin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	18556-44-0		6.2237985085	-5.2059444758	-101.6239887257	-2.1	7		-81.9430374899	-80.56069555	0.0000123285	0.9985634001		TUBB	O=S(=O)(O)O.O=C(OC)[C@@]2(C[C@@H]4C[C@@](O)(CC)C[N@](CCc1c3ccccc3nc12)C4)c5cc9c(cc5OC)N(C)[C@@H]6[C@]98CCN7CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]6(O)C(=O)OC)[C@H]78	SIGMA	V1377	-4.99358555	-4.65462897	-4.21876142	-7.71816289	-15.57884586	-47.63453428	-80.56069555									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021146-09	Ketanserin	170466645	5-HT2A Antagonists?	DPI_SARS-CoV-2_General	2019_NPC_01	74050-98-9	Ketanserin tartrate;Ketanserin;KETANSERIN TARTRATE	15.6334750258	-4.8059444758	-29.3490466271	-2.4	7		-33.948510792	-29.74322577	0.0054728451	0.9682335726	3356	HTR2A	Fc1ccc(cc1)C(=O)C4CCN(CCN2C(=O)c3ccccc3NC2=O)CC4	Enzo	NS515	-3.02810253	-0.20280011	-0.25590407	-5.67637394	-2.80921687	-7.67823568	-29.74322577									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015989-17	Thalidomide	170465323	TNF-alpha Production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	50-35-1	(?)-Thalidomide; ; (+)-Thalidomide; Sedoval; Thalidomide;Thalidomide; Thalomid;thalidomide;THALIDOMIDE; Talidomida; (-)-Thalidomide; (+/-)-Thalidomide; (R)-(+)-Thalidomide; (S)-(-)-Thalidomide; (?)-Thalidomide			-4.7394074199	4	7		0	-4.84651847			7124	TNF	O=C1NC(=O)CCC1N3C(=O)c2ccccc2C3=O	Microsource	01503607	0.83992932	0.96024629	-1.53298725	-2.3503148	-0.68771253	-0.32521978	-4.84651847									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179578-03	Mometasone furoate	170464666	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC_01	83919-23-7	; 2-Furoate;Mometasone furoate; Nasonex; Mometasone Fuorate; Elocon; Sch 32088	6.2237985085	-5.2059444758	-70.4754707629	-2.2	7		-67.7621859999	-61.1949	0.0003738945	0.9920029062		CYP3A4	ClCC(=O)[C@@]5(OC(=O)c1ccco1)[C@H](C)C[C@@H]3[C@]5(C)C[C@H](O)[C@]2(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]23	Prestwick Chemical, Inc.	Prestw-572	-1.33856171	2.38717717	-5.02303137	-3.31853413	-10.59483327	-36.83113979	-61.1949									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094918-07	Saccharin	170465766	Taste receptor type 1 member 3 Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	81-07-2				-11.3662603948	4	7		0	-4.56262199			83756	TAS1R3	O=C2NS(=O)(=O)c1ccccc12	Vitas	STK803263	-1.97274466	-0.48623158	-1.66946943	-5.21985602	-0.7587677	-2.77453123	-4.56262199									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00506887-01	Sodium aurothiomalate(I)		Prostaglandin E synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	12244-57-4		1.3933349283	-5.8559444758	-22.3844076511	4	7		-15.077106032	-10.89758836	0.0500987879	0.8927206277			OC(=O)CC(S[Au])C([O-])=O	Alfa Aesar	39740	1.81507087	-1.27284068	0.80401303	-1.38671281	-3.41468051	-3.85193536	-10.89758836									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00167439-03	Trenbolone (acetate)		Progesterone receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_02	10161-34-9		4.9437388825	-5.3059444758	-96.7349307813	-2.1	7		-103.4760024741	-95.01498359	0.0000038453	0.999198462			CC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC/4=C/C(=O)CCC4=C3/C=C\[C@]12C	MedChem Express	HY-12360	3.53071747	0	2.40266285	0	-12.55851531	-60.01503194	-95.01498359									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249890-01	Mebutamate	170465233		DPI_SARS-CoV-2_General	2019_NPC_02	64-55-1				14.0228577692	4	7		0	1.50787233					O=C(N)OCC(C)(COC(=O)N)C(C)CC	GVK	FFS-11-286-NCI-34	4.70993549	2.30312551	3.57000539	4.47817038	2.97269681	1.03814355	1.50787233									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181120-02	Acetophenazine Maleate		Sigma opioid receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	5714-00-1		12.4181106199	-4.9059444758	-35.4061016392	-2.2	7		-57.2583836715	-42.61998763	0.0010740744	0.9863228107			[CH3][C](=[O])C1=CC=C2[S]C3=C(C=CC=C3)[N]([CH2][CH2][CH2][N]4[CH2][CH2][N]([CH2][CH2][OH])[CH2][CH2]4)C2=C1	USP	1007000	0	2.71431542	-1.7697663	2.20985431	-5.32043818	-16.3425404	-42.61998763									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344520-01	L-Valine	225144376	tryptophan transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	72-18-4				-1.5612773197	4	7		0	-4.86134234					CC(C)[C@H](N)C(O)=O	SIGMA	94620	0.83470138	-0.60292453	0.68680997	1.27914318	0.90060119	-1.63942127	-4.86134234									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179669-04	Norethindrone	170464683		DPI_SARS-CoV-2_General	2019_NPC_01	68-22-4		0.3119288357	-6.5059444758	-26.3243373458	4	7		-10.715728568	-7.75645738	0.4085702962	0.4998715117			O=C4CC[C@H]3C(CC[C@@H]2[C@@H]3CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)=C4	Prestwick Chemical, Inc.	Prestw-253	-1.39181371	-0.40315684	0.85545076	-4.45230391	-22.26310714	-4.21261243	-7.75645738									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164528-04	GLYCERYL LAURATE	225144258	Toxic shock syndrome toxin-1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	142-18-7		13.9333492831	-4.8559444758	-33.2027673523	-2.2	7		-58.6837089004	-43.69977947	0.0006061262	0.9897834206	3552	tst	CCCCCCCCCCCC(=O)OCC(O)CO	SIGMA	M1765	1.43538354	2.70481589	-0.30952207	1.95901372	-5.07283155	-15.21418771	-43.69977947									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015496-08	N,N,N,N',N',N'-Hexamethylhexane-1,6-diaminium	170465837		DPI_SARS-CoV-2_General	2019_NPC_01	60-26-4				0.8021714964	4	7		0	-1.61719602					C[N+](C)(C)CCCCCC[N+](C)(C)C	Enzo	AC740	-0.45748312	0.11972536	-0.87982257	1.86369679	0.80952139	0.89943595	-1.61719602									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016925-11	Omeprazole	170465443	ABCC3 Expression Enhancer	DPI_SARS-CoV-2_General	2019_NPC_01	73590-58-6	 ; Omeprazole ER; Zegerid; Prilosec;AGI-010/DM-3458;Omepral; ESOMEPRAZOLE Mg; Losec sodium; Esomeprazole;Omeprazole; Omeprazole; Omeprazol; Nexium; Losec	8.7913490634	-5.0559444758	-6.5014296431	4	7		-15.425439152	-13.68786596	0.0092154915	0.9582523628	8714	ABCC3	Cc3c(OC)c(C)cnc3CS(=O)c1nc2cc(ccc2n1)OC	Microsource	01505693	-0.38002566	1.35118626	1.73283615	-0.17307548	2.86504593	-4.38538544	-13.68786596									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016344-07	5-Aminosalicylic acid	170464840	reactive oxygen species biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	89-57-6		6.2237985085	-5.2059444758	-121.6045789854	-2.1	7		-101.5093797359	-88.42868368	0.0000185918	0.9982348058	16534		OC(=O)c1cc(N)ccc1O	Vitas	STK301678	-6.25711035	-2.5875339	-7.34810265	-10.25158653	-25.05963559	-55.98861731	-88.42868368									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023193-06	Triamcinolone acetonide	170464660	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC_01	76-25-5	; ; Cinonide; Kenalog; Pevisone; Kenacort A; Acetonide, Triamcinolon; A, Kenacor; Azmacort; Tricort 4;Triamcinolone acetonide; Kenalog 40; 40, Kenalo; Tricort4;TRIAMCINOLONE ACETONIDE; Triamcinolone acetonide; Monacort; Tricort-40	13.9333492831	-4.8559444758	8.0267593816	4	7		-10.8283059999	-6.940255	0.1023126121	0.832915295		NRC31	OCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Sequoia	76-25-5	4.90160482	4.79145796	3.36574785	2.12958086	-0.04314064	1.72773007	-6.940255									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164552-06	Bromfenac Na			DPI_SARS-CoV-2_General	2019_NPC_01			6.2237985085	-5.2059444758	-34.3545925187	-2.2	7		-45.1259663856	-40.39441332	0.000141717	0.9951032341			NC1=C(CC([O-])=O)C=CC=C1C(=O)C2=CC=C(Br)C=C2	Sequoia	SRP034005b	0	2.24546143	2.45911628	2.69646575	-4.03745622	-22.05396616	-40.39441332									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159368-05	1-Hexadecanol	170465348	Fatty aldehyde dehydrogenase Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	36653-82-4				-5.9028210356	4	7		0	0			224	ALDH3A2	CCCCCCCCCCCCCCCCO	Labotest	LTBB001504	-3.63808002	-2.98824737	-2.68821135	-2.32523139	3.08328681	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249911-01	Normethadone	170465674	Mu-type opioid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	467-85-6		4.9437388825	-5.3059444758	-3.8279589423	4	7		-17.6471251359	0	0.0498084066	0.9339838373	25601	Oprm1	CCC(=O)C(CCN(C)C)(c1ccccc1)c2ccccc2	GVK	FFS-11-286-NCI-156	3.9654096	4.62704151	2.1635686	0.26892407	3.57151344	-11.37260428	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179611-05	DIHYDROSTREPTOMYCIN [5mM]		Large-conductance mechanosensitive channel Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	128-46-1				-16.2694468091	4	7		0	-7.65827903			947787	mscL	CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H](O[C@@H](C)[C@]2(O)CO)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]3NC(N)=N	Microsource	01500249	-2.80468913	-5.68966712	-2.52924216	-2.82721044	-0.43485493	-3.30232995	-7.65827903									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181771-02	Ibutilide fumarate		K(ATP) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	[122647-32-9]				9.2748787189	4	7		0	3.88621985					CCCCCCCN(CC)CCCC(O)C1=CC=C(N[S+](C)([O-])=O)C=C1	Tocris	3908	0	0	0.52975786	2.82721044	4.08953734	2.893649	3.88621985									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344578-01	Flavin adenine dinucleotide disodium salt hydrate	225144395	oxidative phosphorylation Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	84366-81-4				4.6344370586	4	7		0	0.44712933					O.[Na+].[Na+].CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO[P]([O-])(=O)O[P]([O-])(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)[N]4C=NC5=C4N=CN=C5N)C\6=N\C(=O)NC(=O)C6=N/C2=C1	SIGMA	F8384	1.41274943	1.17119823	0.90715173	1.40542057	0.75327329	1.10390831	0.44712933									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00390569-01	Netupitant	363680908		DPI_SARS-CoV-2_General	2019_NPC_02	290297-26-6		9.8640558873	-5.0059444758	-71.6951115121	-2.1	7		-102.3601769448	-82.09104314	0.0000026055	0.9993404022			CN1CCN(CC1)C2=CC(=C(C=N2)N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C4=C(C)C=CC=C4	MedChem Express	HY-16346	1.88443663	2.21072328	-0.18049272	-0.67581788	-6.57510158	-37.26512589	-82.09104314									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00189076-01	Dibromopropamidine dihydrochloride	144207153		DPI_SARS-CoV-2_General	2019_NPC_02	50357-61-4		7.8352981002	-5.1059444758	-35.3383530578	-2.2	7	Dibromopropamidine dihydrochloride	-33.311111644	-30.67592637	0.0010448814	0.9865234897			Cl.Cl.Brc2cc(ccc2OCCCOc1ccc(cc1Br)C(=N)N)C(=N)N	Toronto Research	D425800	0.78383315	-1.63782947	-1.48379082	-4.01983023	-5.18736782	-15.85400225	-30.67592637									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185754-01	Terlipressin	144206925	Vasopressin V1a Receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	14636-12-5		19.6813789847	-4.7059444758	-19.1970792015	4	7		-20.999976212	-19.58331351	0.2964156834	0.6304414995		AVPR1A	NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C(=O)[C@@H]3CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N3	Sequoia	TERLIPRESSIN	0.17341441	1.28670101	0.879023	-13.06035592	0.83406601	-2.79969936	-19.58331351									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183839-01	Rapacuronium bromide	144206855	Muscarinic acetylcholine receptor M5 Negative Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	156137-99-4		19.6813789847	-4.7059444758	-48.300466495	4	7	rapacuronium bromide;rapacuronium;RAPACURONIUM BROMIDE;Rapacuronium Bromide;RAPACURONIUM;Org-9487;rapacuronii bromidum;ORG-9487;Raplon;LS-173498;bromure de rapacuronium;CIPLUS_755198;Org 9487;1-(3A-(ACETYLOXY)-17B-(1-OXYPROPOXY)-2B-(1-PIPERIDINYL)-5A-ANDROSTAN-16B-YL)-1-(2-PROPENYL)PIPERIDINIUM BROMIDE;1-ALLYL-1-(3.ALPHA.,17.BETA.-DIHYDROXY-2.BETA.-PIPERIDINO-5.ALPHA.-ANDROSTAN-16.BETA.-YL)PIPERIDINIUM BROMIDE, 3-ACETATE 17-PROPIONATE;Organon brand of rapacuronium bromide;	-25.963794008	-28.13616892	0.001594957	0.9832853835			[Br-].C=CC[N+]1(CCCCC1)[C@H]6C[C@@H]5[C@](C)(CC[C@H]2[C@H]5CC[C@H]3C[C@H](OC(C)=O)[C@H](C[C@]23C)N4CCCCC4)[C@H]6OC(=O)CC	Pharmaron	PH-NIH-169871	-8.22743446	-7.71373421	-7.87940825	-5.66634058	-8.91996143	-9.73118553	-28.13616892									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024595-08	Carbetapentane	170465562	Sigma-1 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	77-23-6				-25.6182132298	4	7		0	-9.33816633					CCN(CC)CCOCCOC(=O)C1(CCCC1)c2ccccc2	Enzo	NO103	-5.38571394	-4.89896645	-5.35936243	-4.23156997	-4.3876567	-5.51349154	-9.33816633									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160682-02	Isocaine	170466550		DPI_SARS-CoV-2_General	2019_NPC_01	94-14-4		22.0828704269	-4.6559444758	-0.7709034864	4	7		-22.0428126039	-17.53567717	0.004013848	0.9730420818			Nc1ccc(cc1)C(=O)OCC(C)C	Vitas	STK267625	2.05504321	2.42138442	0	3.53926807	0.99223469	3.18613751	-17.53567717									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091125-07	Gallic acid	170465633	intrinsic apoptotic signaling pathway in response to oxidative stress Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	149-91-7		6.9832167823	-5.1559444758	-39.5235937928	4	7		-12.982312356	-15.36082736	0.0176271547	0.9410565169			Oc1cc(cc(O)c1O)C(=O)O	Vitas	STK298718	-6.00053252	-4.54223373	-7.43584119	-6.60947651	-9.52393037	-11.0371462	-15.36082736									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094437-05	d-Tryptophan	170465485	Tryptophan metabolism Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	153-94-6		12.4181106199	-4.9059444758	-17.9437626532	-3	7		-42.3850092468	-39.81141162	0.0016506478	0.9829518015			O=C(O)[C@H](N)Cc2cnc1ccccc12	SIGMA	93660	2.35519086	3.11530286	3.57047111	-2.48074849	0.39841648	-2.52553483	-39.81141162									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021148-08	Metoprolol tartrate	170464652		DPI_SARS-CoV-2_General	2019_NPC_01	56392-17-7				0.5839270582	4	7		0	-1.45496946					O=C(O)[C@H](O)[C@@H](O)C(=O)O.CC(C)NCC(O)COc1ccc(CCOC)cc1.CC(C)NCC(O)COc1ccc(cc1)CCOC	Microsource	01500411	-1.14975916	2.21125418	-0.44600424	1.59279605	-1.57590215	1.2653082	-1.45496946									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181795-02	Lumiracoxib	170465597	Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	220991-20-8		15.6334750258	-4.8059444758	3.4629146915	4	7		-16.7562545919	-13.13021216	0.0437807499	0.9004289875			Clc2cccc(F)c2Nc1ccc(C)cc1CC(=O)O	Sequoia	220991-20-8	0	3.86297554	4.16026906	4.97403868	0	1.8598506	-13.13021216									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015163-09	Benserazide	170465804	DOPA decarboxylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	14919-77-8	; ; Benserazida; Benserazide Hcl; Ro 8-0576-12; Ro 8-0576-7;Benserazide hydrochloride; Benserazide hydrochloride; Ro 8-0576;BENSERAZIDE HYDROCHLORIDE; Benseraszide; Ro 4460; Ro 4 460	15.6334750258	-4.8059444758	-42.395789322	-2.2	7		-40.7410981738	-37.22592583	0.0004776809	0.9909523361	1644	DDC	Cl.Oc1ccc(CNNC(=O)C(N)CO)c(O)c1O	Microsource	01500137	-2.21964031	-3.78478755	-6.00277839	-4.67805453	-5.32152464	-10.63570303	-37.22592583									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00013289-09	Pridinol	170465865	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	511-45-5				-6.2086773005	4	7		0	-6.18995716					OC(CCN1CCCCC1)(c2ccccc2)c3ccccc3	Specs	AG-680/20240026	-2.25352795	1.15571628	-0.45575297	2.94729977	-3.34720601	-2.33243559	-6.18995716									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159522-05	Cephalexin	170464982	Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	15686-71-2				3.6090425692	4	7		0	-0.9378723					CC=3CS[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](N)c1ccccc1)C=3C(=O)O	SIGMA	33989	0.04114927	1.91316246	-0.56298896	-0.1931422	0.10404507	4.57340312	-0.9378723									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160546-02	Haloxon	170466328	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	321-55-1				7.4982322563	4	7		0	3.99989861					O=P(OCCCl)(OCCCl)Oc1ccc2c(c1)OC(=O)C(Cl)=C2C	SIGMA	290963	4.36908479	1.58086349	0	0	2.77876466	-0.87910971	3.99989861									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016599-04	Flucytosine	170465407	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	2022-85-7	 Flucytosine;Flucytosine;Flucytosine (Ancobon)			3.9942591526	4	7		0	1.1660034				TYMS	FC1=CNC(=O)N=C1N	Vitas	STK292386	-0.46232421	1.51244899	-1.15766128	1.94396368	2.89549815	0.09146806	1.1660034									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095121-16	NATEGLINIDE			DPI_SARS-CoV-2_General	2019_NPC_02	105816-04-4				-27.5796892372	4	7		0	-11.28288065					CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(O)=O	Microsource	01504258	-5.01052047	-3.82776225	-7.30175101	-5.0487571	-3.52874082	-6.38387824	-11.28288065									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262957-01	Tobicillin	170466044		DPI_SARS-CoV-2_General	2019_NPC_02	151287-22-8	Tobicillinum;Tobicilline;Tobicillin	5.5469662594	-5.2559444758	-40.0472915373	4	7		-29.4640155959	-29.55334633	0.0103442476	0.9554148171			CC(C)C(=O)OCc4cc(OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)Cc1ccccc1)[C@H]3SC2(C)C)ccc4	GVK	FFS-11-286-NCI-195	-0.94568661	0.9170921	-5.89531422	-5.15164979	-4.28914288	-19.66835776	-29.55334633									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094048-01	Iofetamine hydrochloride	144204790		DPI_SARS-CoV-2_General	2019_NPC_02	82691-32-5	Iofetamine hydrochloride; Iofetamine; Spectamine; iofetaminum (123I); 			-28.3840697901	4	7	(123I)(+/-)-N-ISOPROPYL-P-IODOAMPHETAMINE;Spectamine;NCGC00162226-01;BENZENEETHANAMINE, 4-(IODO-(SUP 123) I)-.ALPHA.-METHYL-N-(1-METHYLETHYL)-, HYDROCHLORIDE;IOFETAMINE HYDROCHLORIDE I-123;IOFETAMINE (123 I);CIPLUS_733786;NCGC00015533-01;N-Isopropyl-p-Iodoamphetamine(123I) Hydrochloride;Benzeneethanamine, 4-iodo-alpha-methyl-N-(1-methylethyl)-;CIPLUS_192774;Iofetamine hydrochloride;M123 I-123;(+/-)-2-(N-Isopropyl)amino-4'-iodophenylpropane;NCGC_SIGMA_I120;N-ISOPROPYL-1-(4-IODOPHENYL)-2-PROPYLAMINE HYDROCHLORIDE, I-123, DL-;N-Isopropyl-p-iodoamphetamine(123I) hydrochloride;IOFETAMINE HYDROCHLORIDE I 123;IPRIOFENAMINE HYDROCHLORIDE, I-123;iofetaminum (123I);WHO NO. 5526;Iofetamine hydrochloride I 123;CIPLUS_210740;(+/-)-P-IODO-123I-N-ISOPROPYL-.ALPHA.-METHYLPHENETHYLAMINE;Iofetamine;iofetamine (123 I);N-Isopropyl-p-iodoamphetamine hydrochloride;RO-22-6303/001, I-123;NCGC00094048-01;IOFETAMINE I-123;BENZENEETHANAMINE, 4-(IODO-123I)-.ALPHA.-METHYL-N-(1-METHYLETHYL)-, (+/-)-;	0	-9.30885221					Cl.Ic1ccc(CC(C)NC(C)C)cc1	SigmaAldrich	Lopac-I-120	-3.46597609	-4.59008062	-7.00171116	-5.37146599	-5.45826106	-7.80721533	-9.30885221									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00013556-15	Liothyronine Sodium		Thyroid hormone receptor beta-1 Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	1955-6-1		5.5469662594	-5.2559444758	-84.1477993603	-2.2	7		-82.299291255	-72.19236075	0.0002287456	0.9937625346			N[C@@H](CC1=CC(=C(OC2=CC(=C(O)C=C2)I)C(=C1)I)I)C(O)=O	APExBIO	B1779	3.86829753	-2.6265333	-1.49785518	-5.31066576	-16.74072666	-43.52217212	-72.19236075									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016551-04	Meprylcaine hydrochloride	170466009	"Sodium channel alpha subunits; brain (Types I, II, III) Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC_01	956-03-6				-38.6441657475	4	7		0	-7.46749132					Cl.CC(C)(COC(=O)c1ccccc1)NCCC	Prestwick Chemical, Inc.	Prestw-1064	-8.01442645	-6.24282259	-8.20599059	-9.11781674	-7.94041517	-10.38670664	-7.46749132									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510033-02	Distigmine Bromide		Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	15876-67-2				-12.2811897294	4	7		0	-3.43909052					CN(CCCCCCN(C)C(=O)OC1=C[N+](=CC=C1)C)C(=O)OC2=C[N+](=CC=C2)C	SantaCruz Bio	sc-482341	-0.3861361	-4.46995773	-3.16682684	-1.54572878	-0.4966376	-4.92296129	-3.43909052									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181354-02	Tocoretinate	225144326	Retinoic acid receptor gamma Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	40516-48-1		0.9864055887	-6.0059444758	-26.9538928613	4	7		-20.1894353839	-18.90786282	0.0156504036	0.9442642317	1282		CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(=C(C)C(=C2C)OC(=O)\C=C(C)\C=C\C=C(C)\C=C\C3=C(/C)CCCC3(C)C)C	Bosche	T3082	0	0	0	4.93651053	0	-2.1843292	-18.90786282									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00532504-01	CARNIDAZOLE		Trichomonas Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02					-46.6681992835	4	7		0	-11.1449365					COC(=S)NCC[N]1C(=NC=C1[N+]([O-])=O)C	SIGMA	32671	-6.80478161	-8.36009148	-10.78502614	-11.36730351	-8.80878264	-12.4483277	-11.1449365									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183281-03	Valeric acid			DPI_SARS-CoV-2_General	2019_NPC_02	109-52-4				9.3430640802	4	7		0	0.27588831					CCCCC(O)=O	SIGMA	110140	4.81167195	4.8257063	0	0	3.7426039	-0.06576475	0.27588831									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182606-01	Physalien	144206657		DPI_SARS-CoV-2_General	2019_NPC_02	144-67-2	Helenien; Palmitato de xantofila; 	3.1192883571	-5.5059444758	-69.9926483834	-2.2	7	xanthophyll dipalmitate;Xantofyl palmitate;Helenien;Palmitate de xantofyle;heleniene;CIPLUS_214390;palmitate de xantofyle;xantofyle palmitate;Xantofyli palmitas;helenien;Palmitato de xantofila;xantofyli palmitas;XANTOFYL PALMITATE;HELENIEN;	-47.9757804219	-46.06383485	0.0000366567	0.9975193267			O=C(O[C@@H]2CC(C)=C(/C=CC(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](OC(=O)CCCCCCCCCCCCCCC)CC1(C)C)C(C)(C)C2)CCCCCCCCCCCCCCC	INDOFINE	020309S	-1.52373465	-1.71637136	-4.83111038	-5.38549681	-16.80250933	-35.19353626	-46.06383485									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164520-02	L-Threonine	170465476		DPI_SARS-CoV-2_General	2019_NPC_01	72-19-5				8.1130425433	4	7		0	1.5715698					O=C(O)[C@@H](N)[C@@H](C)O	Labotest	LTBB004859	2.39391959	0	2.39087519	2.46569845	0	3.60282535	1.5715698									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00159340-05	Tazobactam sodium	170465148	Bacterial beta-lactamase TEM Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	89785-84-2				8.1974229598	4	7		0	4.41560417					[Na+].O=S3(=O)[C@@](C)(Cn1ccnn1)[C@@H](N2C(=O)C[C@H]23)C([O-])=O	Prestwick	Prestw-1349	3.49768838	2.04999145	-1.09429456	0	4.0577577	0	4.41560417									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091238-03	2,2'-Dithiobisbenzothiazole	170465723		DPI_SARS-CoV-2_General	2019_NPC_01	120-78-5				9.0010710075	4	7		0	1.71351804					c1cccc2sc(nc12)SSc3nc4ccccc4s3	Bosche	D1170	3.99632077	2.58264715	0	0	4.14403898	1.9716449	1.71351804									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00024452-04	Miglustat	170464950	Maltase-glucoamylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	72599-27-0				6.830360447	4	7		0	1.84532711					OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)CN1CCCC	Tocris	3117	1.47411226	0.08551812	3.25363749	-0.23327564	-0.30705984	4.15163372	1.84532711									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164597-02	Ropivacaine hydrochloride	170465120	Voltage-gated potassium channel subunit Kv1.5 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	98717-15-8		0.0027800687	-8.5559444758	-11.8669880389	4	7		26.6580132159	-1.07982054	0.0197164182	0.9366814405			Cl.CCCN2CCCC[C@H]2C(=O)Nc1c(C)cccc1C	Sequoia	SRP01307r	-20.13167768	1.29254526	3.79956618	-2.66134899	0.0989697	0.79780477	-1.07982054									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159456-11	Imatinib	170465393	Bcr-Abl Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	220127-57-1	GGP-57148B; ; Imatinib base; Imatinib base(IMA-3);STI-571; Imatinib;Imatinib;Gleevec; Glivec	11.0676527398	-4.9559444758	-23.1058290858	-3	7		-35.0146130679	-32.09551089	0.0065000491	0.9651967441	25	ABL1	CS(=O)(=O)O.Cc3ccc(cc3Nc1nc(ccn1)c2cccnc2)NC(=O)c4ccc(cc4)CN5CCN(C)CC5	Prestwick	Prestw-1290	-0.00242055	3.7212598	-0.90906875	-3.81518549	1.10389281	-8.94354388	-32.09551089									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253576-01	Amelometasone	170465753		DPI_SARS-CoV-2_General	2019_NPC_01	123013-22-9		12.4181106199	-4.9059444758	-10.6755615952	4	7		-18.4443233399	-17.87026945	0.709021118	0.94471072			COCC(=O)[C@]3(OC(=O)CC)[C@@]4(C)C[C@H](O)C2(F)[C@@H](CCC1=CC(=O)C=C[C@@]12C)[C@@H]4C[C@@H]3C	GVK	FFS-11-286-NCI-162	-2.63597415	2.82209788	0.18766299	-32.03401309	-0.45424555	-1.6616698	-17.87026945									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181343-03	Ivabradine hydrochloride		HCN [I(f)] Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	148849-67-6		8.7913490634	-5.0559444758	-24.5298900529	4	7		-10.824186448	-12.9715074	0.0083459066	0.9606845241		HCN	COC1=C(OC)C=C2CC(=O)N(CCCN(C)C[C@H]3CC4=CC(=C(OC)C=C34)OC)CCC2=C1	MedChem Express	HY-B0162A	-4.42784804	-3.31492989	-4.14195635	-2.28468536	-3.60953354	-7.67098835	-12.9715074									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182074-03	Nicomolol	170465790	Cholesterol biosynthesis Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	27959-26-8		6.2237985085	-5.2059444758	-62.9280902202	-2.2	7		-57.0633116158	-51.80992247	0.0002578837	0.9933743576	311849		O=C(OCC4(COC(=O)c1cccnc1)CCCC(COC(=O)c2cccnc2)(COC(=O)c3cccnc3)C4O)c5cccnc5	Kemprotec	27959-26-8	1.41274943	-2.56185174	-3.20433183	-5.03940322	-10.03493097	-31.48722285	-51.80992247									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263180-14	Trametinib		Mek 1/2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1204531-25-8		11.0676527398	-4.9559444758	-14.4249624054	-3	7		-43.7198068736	-37.28773248	0.0005690706	0.9901072209		MAP2K1	CN1C(=O)C(=C/2N(C(=O)N(C3CC3)C(=O)C2=C1/NC4=CC=C(I)C=C4F)C5=CC=CC(=C5)NC(C)=O)\C	ActiveBioChem	A-1258	4.58507711	4.12344938	0	3.00025723	3.58101846	-7.65219842	-37.28773248									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182997-01	Melinamide	144206837	Acyl coenzyme A:cholesterol acyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	14417-88-0	Melinamide; Artes; Melinamida; 	0.2208287043	-6.6559444758	-27.6376865014	4	7	MELINAMIDE;LS-173854;N-(2-methylbenzyl)linoleamide;(z,z)-n-(1-phenylethyl)-9,12-octadecadienamide;melinamide;melinamidum;CIPLUS_214142;Artes;Melinamidum;LS-88004;Melinamida;N-(2-methylbenzyl)linoleamide, (S-(Z,Z))-isomer;Melinamide;	-14.8649210359	-15.72076753	0.0109405846	0.9541366063			CCCCC\C=C/C\C=C/CCCCCCCC(=O)NC(C)c1ccccc1	Pharmaron	PH-NIH-152054	-0.05083146	2.74879664	0.10479881	-7.53756239	-11.31046034	-11.64693328	-15.72076753									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021575-05	Fluorometholone	170464629	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	426-13-1				-22.432635354	4	7		0	-11.23925883					CC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](C)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-718	-4.45622443	-1.57597674	-6.92403305	-4.14126972	-4.61097295	-2.04278673	-11.23925883									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015833-15	Pyrazinamide	170464703	Fatty Acid Synthase (FAS) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	98-96-4	Pyrazinecarboxamide;PYRAZINAMIDE; Pyrazinamide;Pyrazinamide; Pyrazinecarboxamide			10.9561431426	4	7		0	1.0899597			2194	FAS	NC(=O)c1cnccn1	Vitas	STK801661	4.32551497	3.1397366	4.8719261	0	1.15972187	1.48889679	1.0899597									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162179-08	cis-Flupentixol	170465964		DPI_SARS-CoV-2_General	2019_NPC_01	53772-82-0		4.9437388825	-5.3059444758	-89.0765580461	-2.2	7		-87.52011356	-76.2667613	0.000033671	0.9976221085			FC(F)(F)c2cc3C(=C\CCN1CCN(CCO)CC1)/c4ccccc4Sc3cc2	Tocris	4057	-1.35308499	0.55464608	0.42650679	-1.82858003	-19.49703091	-48.27989227	-76.2667613									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015471-08	Ganciclovir	170464961	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	82410-32-0	 ; Gancyclovir; UL97 protein, HCMV; Biolf 62;Ganciclovir; Cytovene; Vitrasert; Ganciclovir			6.9458686874	4	7		0	1.11023802				UL54	OCC(CO)OCn2cnc1c2N=C(N)NC1=O	Prestwick	Prestw-839	2.81509452	0.38849659	2.24951866	1.4774124	1.57082678	0.68601047	1.11023802									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025060-15	Methotrexate	170464688	Dihydrofolate Reductase (DHFR) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	59-05-2	 Methylaminopterin; Antifolan; Amethopterin (R,S); Mtx-1 protein, rat; Dl-Amethopterin; Methotrexate Hydrate;Abitrexate (Methotrexate); (+/-)Amethopterin; ; D-Methotrexate; (-)Amethopterin; Mexate; methotrexate; Methotrexate hydrate; Metotrexato; Slc19a1 protein, rat; L-Amethopterin hydrate; (+)-Amethopterin hydrate; Methotrexate; 8   D-(-)-Amethopterin;Methotrexate hydrate; DL-Amethopterin; MTXGlu3; Methotrexate Pres-Fre; (+)-Amethopterin;Methotrexate			13.610785959	4	7		0	2.14950191			1719	DHFR	O=C(O)[C@H](CCC(=O)O)NC(=O)c1ccc(cc1)N(C)Cc2nc3c(nc2)nc(N)nc3N	Prestwick	Prestw-135	0	3.37430058	3.95554581	3.00248326	3.85474293	3.66380405	2.14950191									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253575-01	Arimoclomol	170465602	Heat shock 70 kDa protein 1 Activator	DPI_SARS-CoV-2_General	2019_NPC_01	289893-25-0				5.843045214	4	7		0	-0.84661986					O[C@H](CN1CCCCC1)CO\N=C(/Cl)c2ccc[n+]([O-])c2	GVK	FFS-11-286-NCI-145	3.34761455	3.15439685	1.86444396	-0.79012717	-0.25123078	1.77854566	-0.84661986									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00246113-02	NCGC00246113-02			DPI_SARS-CoV-2_General	2019_NPC_02					-24.1907581292	4	7		0	-6.57850925					C(CC1=CC=CC=C1)NCC2=CC=CC=C2	Specs	AN-465/J120002	-4.00240468	-4.60394095	-4.38573873	-5.61466688	-4.40320319	-6.7643743	-6.57850925									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263120-06	Enzalutamide	384568604	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	915087-33-1		11.0676527398	-4.9559444758	3.5877213514	4	7		-12.6524045119	-10.12700376	0.063932957	0.8753899667		AR	CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C2(C)C)C3=CC(=C(C=C3)C#N)C(F)(F)F	MedChem Express	HY-70002	4.06714606	4.30825383	3.10119313	0	0	1.42333709	-10.12700376									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510931-01	Mavacoxib		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	170569-88-7		15.6334750258	-4.8059444758	-9.4299617087	-2.4	7		-35.525353184	-24.18779432	0.0076604539	0.9620462467			N[S+]([O-])(=O)C1=CC=C(C=C1)[N]2N=C(C=C2C3=CC=C(F)C=C3)C(F)(F)F	SantaCruz Bio	sc-488033	4.53883327	0	4.08101076	2.74302551	-1.59446807	-4.87598647	-24.18779432									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00065890-14	Nevirapine		Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	129618-40-2				0.2271838384	4	7		0	-1.07976978				TERT	CC1=CC=NC2=C1NC(=O)C3=CC=CN=C3N2C4CC4	MedChem Express	HY-10570	0.12717057	0.7138072	1.62912262	-0.47470945	1.10971176	-1.96354754	-1.07976978									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167459-02	Doxapram hydrochloride	170465313	Potassium channel subfamily K member 9 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	113-07-5				7.6817134425	4	7		0	-4.133568					Cl.O=C4N(CC)CC(CCN1CCOCC1)C4(c2ccccc2)c3ccccc3	Sequoia	113-07-5	4.34923351	-1.28670101	2.21982607	1.37268199	3.90418934	3.68752349	-4.133568									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015162-10	Buspirone	170464909	Serotonin 1a (5-HT1a) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	36505-84-7				-40.0936617681	4	7		0	-13.4495957					O=C4CC1(CCCC1)CC(=O)N4CCCCN2CCN(CC2)c3ncccn3	Enzo	AC526	-9.37961416	-7.95318494	-7.04589213	-7.7683297	-7.10805461	-8.25753341	-13.4495957									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018171-06	Clidinium bromide	170464768		DPI_SARS-CoV-2_General	2019_NPC_01	3485-62-9				5.7607437612	4	7		0	-1.15586424					[Br-].OC(c1ccccc1)(c2ccccc2)C(=O)OC4C[N+]3(C)CCC4CC3	Microsource	01500192	0.9609566	1.01400054	3.823938	1.85366343	2.69755875	-1.20941105	-1.15586424									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016010-09	Terbutaline hemisulfate	170464990	cAMP biosynthetic process Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	23031-32-5		22.0828704269	-4.6559444758	-1.6532734869	4	7		-11.5902131719	-9.24184431	0.080584216	0.8566180102			Oc1cc(cc(O)c1)C(O)CNC(C)(C)C.O=S(=O)(O)O.CC(C)(C)NCC(O)c1cc(O)cc(O)c1	Microsource	01500558	0.34613802	-0.80387031	0.33389389	-0.8854441	3.05790996	2.57126887	-9.24184431									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015649-08	Moxonidine hydrochloride hydrate	170466534	Imidazoline I1 Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	75438-57-2	 Zint; ; Moxon; MOXONIDINE HCl; Cynt;Moxonidine; Moxonidine; Lilly brand of moxonidine; Physiotens; Normatens;Moxonidine hydrochloride; Moxonidine hydrochloride			10.1390736958	4	7		0	0			11188	NISCH	COc2nc(C)nc(Cl)c2NC1=NCCN1	Prestwick	Prestw-1016	0	4.51291324	1.40137944	0	4.42825966	4.1668784	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095264-04	Chloroxine	170465084	Antibacterial	DPI_SARS-CoV-2_General	2019_NPC_01	773-76-2	; ; Capitrol; CHLOROXINE;CHLOROXINE; Chloroxine;Chloroxine	1.106765274	-5.9559444758	-92.1472514306	-1.2	7		-61.2301842759	-57.69182023	0.0000457559	0.9972263311			Oc1c(Cl)cc(Cl)c2cccnc12	Vitas	STK075368	0	3.49158257	2.21052375	-6.92552738	-31.64238948	-55.48554296	-57.69182023									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164568-04	Montelukast sodium	170465230	Cysteinyl leukotriene receptor 1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	151767-02-1		3.499899101	-5.4559444758	-125.3970866983	-2.1	7		-94.0186616211	-92.07878127	0.0001103323	0.9956814131			[Na+].CC(C)(O)c5ccccc5CC[C@@H](SCC1(CC([O-])=O)CC1)c2cccc(c2)/C=C/c3ccc4ccc(Cl)cc4n3	Sequoia	SRP06641m	-3.69133203	-1.73235273	-0.5971095	-10.76830461	-22.75034259	-70.55744702	-92.07878127									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018113-07	Sodium 4-phenylbutyrate	170465108	Glutamine Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	1716-12-7				8.8620405197	4	7		0	0					[Na+].[O-]C(=O)CCCc1ccccc1	Microsource	00306001	1.67017646	0	3.35599912	0.14046705	3.63142669	3.93312668	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166210-02	PAROMOMYCIN SULFATE		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	1263-89-4				10.2798283249	4	7		0	0.29910522					NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@@H](O[C@@H]2CO)O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4N)[C@H](N)[C@@H](O)[C@@H]1O	SIGMA	P9297	1.7839421	2.66083515	4.72569521	2.88709961	2.45901639	0	0.29910522									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00015036-11	Amantadine hydrochloride	170464860	Dopamine Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	768-94-5	 Adamantamine fumarate;Adamantamine fumarate;AMANTADINE HYDROCHLORIDE; 1-Adamantylamine;AMANTIDINE; ; Symmetrel; Ambroxol Hydrochloride;Amantadine hydrochloride; Amantadine hydrochloride; 1-Aminoadamantane; Midantan; Amantadina;Amantadine; Adamantine hydrochloride			-10.4122541967	4	7		0	-3.57912347			1812	DRD1	NC13CC2CC(CC(C1)C2)C3	Vitas	STK298781	-1.55156972	-2.57287365	-1.47936926	-2.56603206	-1.10389281	-2.97271203	-3.57912347									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166134-02	Estradiol cypionate	170464789	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	313-06-4		5.5469662594	-5.2559444758	-75.3790952885	-2.2	7		-82.0032821182	-71.05551063	0.0000094793	0.9987406836			Oc4cc5CC[C@@H]1[C@H](CC[C@]2(C)[C@H](CC[C@@H]12)OC(=O)CCC3CCCC3)c5cc4	SIGMA	E8004	0.71446739	0.44584074	1.92916247	-0.51212497	-14.00327923	-42.81754979	-71.05551063									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167798-05	Oxaliplatin		DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC_02	61825-94-3				6.3309345745	4	7		0	3.19174238				H2AFX	O=C1O[Pt]2(NC3CCCCC3N2)OC1=O	Cayman	13106	1.46361766	-0.91247199	1.28220154	1.1762505	1.31406981	2.37222849	3.19174238									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00014602-05	L-Penicillamine		Copper Chelator	DPI_SARS-CoV-2_General	2019_NPC_02	1113-41-3				11.2386471464	4	7		0	0				CAT	CC(C)(S)[C@H](N)C(O)=O	Enzo	NP226	4.77930126	3.6429578	4.22634256	2.77108715	0	3.0533634	0									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00262537-04	Thiethylperazine dimalate 		Dopamine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	52239-63-1		3.1192883571	-5.5059444758	-132.0676995072	-2.1	7		-101.3814916978	-94.73433858	0.0000473043	0.9971792483			CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN4CCN(C)CC4)C=C1	Prestwick	Prestw-1068	1.81044648	-2.56647185	-4.65764984	-9.22994177	-28.65527648	-74.16384818	-94.73433858									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00174736-02	Uridine triacetate	174006168	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	4105-38-8	Uridine triacetate			0.0914622804	4	7		0	-4.59496742				TYMS	CC(=O)OC[C@@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N2\C=C/C(=O)NC2=O	SIGMA	T6001	2.85555735	-2.5064104	1.108741	1.38671281	1.48040777	-0.63885757	-4.59496742									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015606-06	LOBELINE HYDROCHLORIDE		Synaptic vesicular amine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	90-69-7				-9.9106833283	4	7		0	-6.32640441					CN1C(CCCC1CC(=O)C2=CC=CC=C2)CC(O)C3=CC=CC=C3	Microsource	01500758	0.44625309	-2.15990205	-3.29340616	-2.01342282	2.87289404	-5.24239008	-6.32640441									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024928-23	Tamoxifen	170465425	Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC_01	54965-24-1	Soltamox; "Tamoxifen; ; Novaldex; Tamoxifen; Tomaxithen; Tamoxifen citrate salt; Tamoxifen, citrate salt; Nolvadex; Tamoxifeno;ICI-46474;ICI-46474?;Tamoxifen citrate;Tamoxifen; Zitazonium; Citrate, Tamoxife	3.9269513795	-5.4059444758	-151.8538880131	-2.1	7		-96.1725956559	-97.6198322	0.0000410048	0.9973746785	2099	ESR1	O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCOc1ccc(cc1)/C(c2ccccc2)=C(/CC)c3ccccc3	Microsource	01500557	-11.31120955	-6.0473526	-10.38483098	-15.38866732	-30.19083388	-70.67940444	-97.6198322									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015898-15	Rolipram	170465962	Phosphodiesterase IIII (PDE4) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	61413-54-5	; ;Rolipram; Rolipram; (R)-(+)-Rolipram; (S)-(-)-Rolipram			-2.3255152234	4	7		0	2.52972041			5141	PDE4A	COc2ccc(cc2OC1CCCC1)C3CC(=O)NC3	Prestwick Chemical, Inc.	Prestw-924	-0.73826641	-0.18813986	0.24615535	-1.07106128	-3.54514541	0.03557091	2.52972041									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024674-14	NCGC00024674-14			DPI_SARS-CoV-2_General	2019_NPC_01					17.6303297415	4	7		0	1.79463131					OC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5CC=C	Microsource	01500422	3.95275095	4.86475921	3.69720455	3.34863421	4.95609806	3.17597439	1.79463131									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090757-06	Melphalan	170464727	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC_01	148-82-3	; Mustard, Phenylalanin; Melfalano;Melphalan; ; Sarcolisina; L-Phenylalanine mustard;MELPHALAN; Melphalan	6.2237985085	-5.2059444758	-67.4843358916	-2.2	7		-80.679006868	-65.14917239	0.000202356	0.9941371614		H2AFX	O=C(O)[C@@H](N)Cc1ccc(cc1)N(CCCl)CCCl	Microsource	01500382	4.50947644	0	3.9165509	-2.28509795	-15.69557935	-37.73057574	-65.14917239									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00538147-01	NCGC00538147-01			DPI_SARS-CoV-2_General	2019_NPC_02			11.0676527398	-4.9559444758	-43.8950350655	-2.2	7		-59.0057080292	-54.54977881	0.0003584897	0.992172442			CCCCCCCCNC(=N)NC(=N)NCC1=CC(=C(Cl)C=C1)Cl	Pharmaron	PH-NIH-2017-009-L1-5-0	-0.69134546	2.13218139	-3.46217857	-2.57465566	-1.0146615	-16.06069147	-54.54977881									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346712-07	Verteporfin			DPI_SARS-CoV-2_General	2019_NPC_02	129497-78-5		0.0175410475	-7.7559444758	-26.6201383738	4	7		-10.311811608	0	0.692973347	0.391952244			COC(=O)CCC1=C(C)C2=CC3=NC(=CC4=C(C)C(C=C)=C(N4)C=C5N=C(C=C1N2)\C(CCC(O)=O)=C5\C)\C6=C\C=C(/[C@@H](C(=O)OC)[C@@]36C)C(=O)OC	Prestwick	Prestw-1105	0.36763856	-0.3441983	-10.20369893	-18.59317634	-51.46258584	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344538-01	1,3-Propanedisulfonic acid disodium salt	225144385		DPI_SARS-CoV-2_General	2019_NPC_02	36589-58-9				-8.7794099056	4	7		0	-3.743519					[O-][S](=O)(=O)CCC[S]([O-])(=O)=O	SIGMA	P8579	-0.87169646	-1.47150546	-4.62014486	-3.29022753	0.34455718	0.15031943	-3.743519									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263445-02	Brucine-N-oxide		Vascular endothelial growth factor receptor 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	357-57-3				1.2438635117	4	7		0	-2.63520906					COC1=CC2=C(C=C1OC)[C@@]34CCN5CC/6=C/CO[C@H]7CC(=O)N2[C@H]3[C@H]7[C@H]6C[C@@H]45	Enzo	NP038	0.82545261	0.33957818	0.05391341	0.80209527	1.64674572	0.12683202	-2.63520906									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166104-04	alpha-Lipoic acid amide	170465868	apoptotic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	940-69-2		11.0676527398	-4.9559444758	-40.798108668	4	7		-26.746001396	-29.89024359	0.0000367689	0.9975189539			NC(=O)CCCCC1CCSS1	Microsource	01505740	-5.45833031	-4.26857576	-5.32036753	-4.54762084	-5.02207786	-11.37761065	-29.89024359									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181023-03	NOLATREXED HCL			DPI_SARS-CoV-2_General	2019_NPC_01	152946-68-4				-1.6187890307	4	7		0	-3.95427239					CC1=C(SC2=CC=NC=C2)C3=C(C=C1)N=C(N)N=C3O	Sequoia	152946-68-4	0	0	0	0.6672185	0	0	-3.95427239									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091151-04	Phenoxyacetic acid	170465537	cell proliferation Activator	DPI_SARS-CoV-2_General	2019_NPC_01	122-59-8				-5.8351695345	4	7		0	-4.38518669					O=C(O)COc1ccccc1	Vitas	STK300005	-0.68017331	-2.25034818	-3.17077332	-2.71151579	1.38811349	2.3680065	-4.38518669									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023234-05	Flurandrenolide	170465298		DPI_SARS-CoV-2_General	2019_NPC_01	1524-88-5				-10.8091310429	4	7		0	-5.85536488					OCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)CC[C@@]12C	Prestwick Chemical, Inc.	Prestw-645	-1.08198388	-0.80875706	-2.17640321	-0.33360925	-2.88027204	-3.80100615	-5.85536488									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00096056-02	Ethacridine lactate hydrate	170465798		DPI_SARS-CoV-2_General	2019_NPC_01	6402-23-9		1.9681378985	-5.7059444758	-122.0575691061	-2.1	7		-102.612671416	-89.9191402	0.0011120473	0.9860704231			O.O=C(O)C(C)O.CCOc1ccc2nc3cc(N)ccc3c(N)c2c1	Labotest	LT00244813	2.63113306	3.86297554	2.79544734	-8.81179923	-44.80789727	-62.42695259	-89.9191402									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179630-03	Homatropine hydrobromide	170465642	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	51-56-9				9.2075997267	4	7		0	4.87085573					Br.CN3[C@@H]1CC[C@H]3C[C@H](C1)OC(=O)C(O)c2ccccc2	Labotest	LT00112435	4.96427663	0	2.23389044	0.81144915	0	1.64411875	4.87085573									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094558-09	CACODYLIC ACID			DPI_SARS-CoV-2_General	2019_NPC_02	75-60-5				9.3534872797	4	7		0	-1.18441707					C[As](C)(O)=O	Microsource	01503947	1.05667183	0.91247199	1.05248353	4.48284732	4.05151724	1.99173243	-1.18441707									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00389309-01	Lubiprostone		ClC-2 Channel Activators	DPI_SARS-CoV-2_General	2019_NPC_02	136790-76-6				11.9007845284	4	7		0	-0.51372307				CLCN2	CCCCC(F)(F)C1(O)CCC2C(CC(=O)C2CCCCCCC(O)=O)O1	APExBIO	B2108	2.31912877	4.00332648	1.13218162	1.89182237	4.16557755	3.97876738	-0.51372307									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346457-02	Copanlisib		PI3K alpha/delta Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1032568-63-0				7.7353764418	4	7		0	-0.98939257				PIK3CA	COC1=C(OCCCN2CCOCC2)C=CC\3=C1/N=C(/NC(=O)C4=CN=C(N)N=C4)N5CC/N=C35	Selleck	S2802	2.60121621	3.93864492	2.0182368	1.90585319	2.86814153	0.77038707	-0.98939257									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00091325-09	Dichlorophen	170465475	"Indoleamine 2,3-dioxygenase Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC_01	97-23-4		6.9832167823	-5.1559444758	-90.3421399365	-2.2	7		-74.154604006	-69.1744189	0.0006220934	0.989644171			Oc2ccc(Cl)cc2Cc1cc(Cl)ccc1O	Microsource	01500626	-2.25352795	-3.85808879	-5.73956277	-9.10778338	-18.81693143	-37.37994817	-69.1744189									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025018-10	Yohimbine	170465467	alpha2-Adrenoceptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	146-48-5	; ; Yohimbine HCL; YOHIMBINE;Yohimbine hydrochloride;YOHIMBINE HYDROCHLORIDE; Yohimbine hydrochloride	0.3926951379	-6.4059444758	-11.4111158516	4	7		-8.3521203559	-11.54343363	0.2733523835	0.6563206557	150	ADRA2A	O=C(OC)[C@H]2[C@@H](O)CC[C@H]3CN4CCc1c5ccccc5nc1[C@@H]4C[C@H]23	Microsource	01500663	-2.10829521	3.13484985	2.25439302	-0.36872601	-8.34136933	-2.26129376	-11.54343363									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182060-03	l-Oxyfedrine hydrochloride	170465929	Adrenergic receptor beta Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	16777-42-7		9.8640558873	-5.0059444758	-1.2937128724	4	7		-18.575219896	-14.64601658	0.0013092378	0.9849127361			Cl.COc1cc(ccc1)C(=O)CCN[C@@H](C)[C@H](O)c2ccccc2	APAC	555781	3.02810253	2.16727344	1.28926909	2.50583189	3.62635132	-3.3233396	-14.64601658									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015938-05	Salmeterol xinafoate	170465397	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	94749-08-3		6.2237985085	-5.2059444758	-116.4678240353	-2.1	7		-81.7462919935	-83.58216522	0.000111601	0.9956567962			OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc2ccccc2.O=C(O)c2ccc1ccccc1c2O	Prestwick Chemical, Inc.	Prestw-945	-8.15965919	-10.24507049	-7.51870537	-7.63287932	-20.8673806	-49.43340617	-83.58216522									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182978-01	Tiaramide hydrochloride	144206772		DPI_SARS-CoV-2_General	2019_NPC_02	35941-71-0				-3.4926533329	4	7		0	-3.29163297					Cl.OCCN1CCN(CC1)C(=O)CN2c3cc(Cl)ccc3SC2=O	NCI	NSC_289337	1.21852528	3.38423156	-1.75101381	-2.46708603	-0.77228334	-2.08568207	-3.29163297									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164564-06	Emtricitabine		Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	143491-57-0				0.058723965	4	7		0	0.22832136				TERT	NC\1=N\C(=O)N(\C=C1F)[C@@H]2CS[C@H](CO)O2	Adooq	A10349	0.40000925	-0.22869551	0.879023	-0.19409302	1.95090654	-2.88425404	0.22832136									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183833-01	Bimosiamose	144206811	Selectin E Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	187269-40-5				-17.0321175482	4	7		0	-2.37834752					O=C(O)Cc1cccc(c1)c3cc(ccc3O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)CCCCCCc5ccc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)c(c5)c6cccc(CC(=O)O)c6	Pharmaron	PH-NIH-124707	1.7457051	-1.23125967	-2.05105366	-4.29576971	-3.9279519	-5.13434799	-2.37834752									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00091021-01	Trichloroacetic acid	17388684		DPI_SARS-CoV-2_General	2019_NPC_02		Trichloroacetic acid			7.7781756053	4	7	TCA sodium salt;Rubidium Trichloroacetate;CIPLUS_695902;Sodium trichloroacetate;Trichloroacetic acid-1-13C;Acid, Trichloroaceti;Acetic acid, trichloro-;TRICHLOROACETIC ACID;AB07944365-01;CIPLUS_665666;TRICHLOROACETIC-ACID;Sodium Trichloroacetate;CIPLUS_3745296;CIPLUS_166806;Trichloroacetic acid;Trichloroacetate, Rubidiu;CIPLUS_155922;CIPLUS_664828;CIPLUS_149367;Trichloroacetic acid solution;Trichloroacetic Acid;Trichloroacetate, Sodiu;AB07944376-01;CIPLUS_3859089;	0	1.70765352					OC(=O)C(Cl)(Cl)Cl	NIEHS	AB07944365	0.96418414	0	4.00131267	1.05465005	1.82734121	2.01991732	1.70765352									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183097-01	Beraprost sodium	144206467	Thyroid hormone receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	88475-69-8	Beraprost sodium; Procylin; 	15.6334750258	-4.8059444758	-40.5465838386	-3	7	TRK-100;1H-Cyclopenta(b)benzofuran-5-butanoic acid, 2,3,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-ynyl)-, monosodium salt;beraprost;4-(1,2,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyloct-6-yne-1-enyl)-5-cyclopenta(b)benzofuranyl)butyrate;BERAPROST;CIPLUS_685106;beraprost sodium;Procylin;Beraprost sodium;TRK 100;Beraprost Sodium;CIPLUS_193198;Beraprostum;1H-Cyclopenta(b)benzofuran-5-butanoic acid, 2,3,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-ynyl)-;Beraprost;trk-100;BERAPROST SODIUM;ML-1129;2,3,3A,8B-TETRAHYDRO-2-HYDROXY-1((E)-(3S)-3-HYDROXY-4-METHYL-1-OCTEN-6-YNYL)-1H-CYCLOPENTA(B)BENZOFURAN-5-BUTYRIC ACID SODIUM SALT;LS-57735;beraprostum;LS-57736;	-45.8495696441	-42.14431813	0.0003435535	0.9923422804	19222		[Na+].CC(CC#CC)[C@H](O)/C=C/[C@H]2[C@H](O)C[C@@H]3Oc1c(cccc1CCCC([O-])=O)[C@H]23	ACC	BERAPROST SODIUM	-1.01967676	-4.87190741	-3.37779236	-3.05638052	-4.8119193	-9.11311537	-42.14431813									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015860-06	Prilocaine hydrochloride	170464697	reactive oxygen species biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	1786-81-8				-5.3620161552	4	7		0	-4.43081291					Cl.O=C(Nc1ccccc1C)C(C)NCCC	Microsource	01503270	0.38002566	-0.64260757	-0.36801443	-1.30182858	-0.62173273	-1.76330098	-4.43081291									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095152-09	Alfuzosin hydrochloride	170465022	alpha1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	81403-68-1	; Uroxatral ER; ; ALFLUZOCIN;ALFUZOSIN HYDROCHLORIDE; Uroxatral; Alfuzosin Hcl (Uroxatral);Alfuzosin hydrochloride; Afluzosin;ALFLUZOSIN			9.3099511964	4	7		0	3.31550531			148	ADRA1A	Cl.O=C(NCCCN(C)c2nc1cc(OC)c(OC)cc1c(N)n2)C3CCCO3	Microsource	01505263	0	0	0	4.5074874	4.27092321	2.04278673	3.31550531									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166413-02	Argatroban	170464871	Thrombin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	74863-84-6	; 2   Argatroban; Argatroban Anhydride; Argipidine monohydrate; Acova; Novastan;Argatroban	13.9333492831	-4.8559444758	1.5720729643	4	7		-11.649894804	-9.70824567	0.0833983686	0.8531487464		F2	C[C@H]1C[C@H](C(=O)O)N(CC1)C(=O)[C@H](CCCNC(=N)N)NS(=O)(=O)c3cccc2C[C@@H](C)CNc23	Sequoia	SRP07170a	3.91402222	1.89361546	-1.12354074	0.31354253	3.69740649	1.00614869	-9.70824567									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159491-04	Rimantadine	170465164	M2 Channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	1501-84-4	; Flumadine; Riamantadine;Rimantadine hydrochloride; Rimantadina; ; Hydrochloride, Rimantadin; Flumadine Oral; Roflual;RIMANTADINE HYDROCHLORIDE; Rimantadine hydrochloride; Rimantadine Hcl			-32.9823626035	4	7		0	-11.43697245					Cl.CC(N)C12CC3CC(C1)CC(C2)C3	Vitas	STK177253	-3.78815385	-6.92208078	-9.0151349	-6.0476083	-5.28092169	-7.62233853	-11.43697245									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166245-04	Proflavin hemisulfate	170466523	RNA Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	1811-28-5		8.7913490634	-5.0559444758	-50.9874317842	-2.2	7		-70.5641555396	-59.89708753	0.0000307413	0.9977285978			O=S(=O)(O)O.Nc1cc2nc3cc(N)ccc3cc2cc1.Nc1cc2nc3cc(N)ccc3cc2cc1	Vitas	STK380650	-0.77699513	2.71458939	0.08530136	0.84029398	-3.50454246	-27.15585142	-59.89708753									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018123-07	Acetylcholine chloride	170464783	Acetylcholinesterase Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	60-31-1				14.026383106	4	7		0	4.45616081					[Cl-].C[N+](C)(C)CCOC(=O)C	Microsource	01500104	3.93338659	4.65462897	3.88243036	-0.47909298	0	4.83764419	4.45616081									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179585-04	Rescinnamin	363676949	Serotonergic synapse Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			2.3206226918	-5.6343954654	-124.3815504927	-2.1	7		-95.1896589398	-87.65161965	6.094E-7	0.9996811756			CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([NH]C5=C4C=CC(=C5)OC)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)\C=C\C6=CC(=C(OC)C(=C6)OC)OC	Analyticon	NP-011016	0	-0.28413685	-0.83214177	-0.25021631	-4.77865171	-45.36358512	-87.65161965									7.02E-10	3.51E-9	1.75E-8	8.77E-8	4.39E-7	0.0000021899999999	0.000011								
NCGC00179370-05	Methotrimeprazine maleat salt		Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	7104-38-3		6.9832167823	-5.1559444758	-81.164944269	-2.2	7		-66.6644971196	-66.12281787	0.0002570553	0.9933842065			COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1	Prestwick	Prestw-797	-3.4937224	-1.87345515	-4.84986287	-6.95227182	-13.49000784	-35.70556182	-66.12281787									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263874-02	BLEOMYCIN (bleomycin B2 shown)			DPI_SARS-CoV-2_General	2019_NPC_02	9041-93-4, 11056-06-7 [bleomycin]				9.4502546412	4	7		0	0					CC[C@@H]1OC(OC(C(NC(=O)C2=NC(=NC(=C2C)N)C(CC(N)=O)NCC(N)C(N)=O)C(=O)NC(C)C(O)C(C)C(=O)NC(C(C)O)C(=O)NCCC3=NC(=CS3)C4=NC(=CS4)C(=O)NCCCCNC(N)=N)C5=C[NH]C=N5)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]6O)[C@@H](C)[C@@H]1C	Microsource	01503692	0.78383315	3.11164499	3.17620309	2.34080864	1.52793289	2.94062383	0									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00015713-13	Nitrendipine	170465897	Intermediate conductance calcium-activated potassium channel protein 4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	39562-70-4		11.0676527398	-4.9559444758	-36.5483085335	-2.2	7		-64.1499201567	-48.97721224	0.0007184329	0.9888585327			CC=1NC(C)=C(C(C=1C(=O)OCC)c2cccc(c2)[N+]([O-])=O)C(=O)OC	SigmaAldrich	N144	4.04957277	3.1983776	2.03992104	-2.8620162	-1.0886667	-20.5599878	-48.97721224									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024025-05	Dehydrocholic acid	170465502	bile acid secretion Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	81-23-2		8.7913490634	-5.0559444758	-39.619227986	-2.2	7		-54.8927150184	-49.53993562	0.0000359083	0.9975447242	1045		O=C(O)CC[C@@H](C)[C@H]4CC[C@@H]3[C@]4(C)C(=O)C[C@H]2[C@H]3C(=O)C[C@@H]1CC(=O)CC[C@@]12C	Prestwick	Prestw-123	0	2.67060864	0	0	-1.60127899	-20.3872148	-49.53993562									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164605-02	Ampiroxicam	170466020	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	99464-64-9				-45.8395617697	4	7		0	-16.28349091					O=C(OCC)OC(C)OC=2c1ccccc1S(=O)(=O)N(C)C=2C(=O)Nc3ccccn3	Sequoia	SRP05637a	-10.75448406	-6.47738657	-9.94126392	-9.88536885	-9.67111607	-6.90583871	-16.28349091									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164555-03	Entacapone	170464850	NCI-H1299 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	130929-57-6		13.9333492831	-4.8559444758	-33.6101707262	-2.2	7		-39.25302274	-31.87751895	0.003898307	0.9734063451			Oc1cc(\C=C(/C#N)C(=O)N(CC)CC)cc([N+]([O-])=O)c1O	Sequoia	SRP10885e	0.99000315	-1.35118626	-1.88394141	-5.3803898	-4.36735522	-12.01788709	-31.87751895									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095056-04	Retinyl palmitate	225144218		DPI_SARS-CoV-2_General	2019_NPC_01	79-81-2		6.2237985085	-5.2059444758	-42.246748921	-2.2	7		-45.433854652	-37.02821221	0.0008194904	0.9880899173			CCCCCCCCCCCCCCCC(=O)OC\C=C(C)\C=C\C=C(C)\C=C\C1=C(C)\CCCC1(C)C	SIGMA	R1512	0.27836274	0.18325311	1.61585143	-2.72154915	-11.30538497	-20.56506936	-37.02821221									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016258-06	Menadione	170464997	CDC25 Phosphatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	58-27-5	 ; Menadione (K3);Menadione / vitamin K3;MENADIONE; Kappaxin; Kipca, oil soluble;Menadione; Menadione; Vitamin- K3	15.6334750258	-4.8059444758	-50.9923494581	-2.2	7		-60.2218803767	-49.02790804	0.0001301769	0.9953083078	5923	CDC25	O=C2C=C(C)C(=O)c1ccccc12	Specs	AE-562/J257372	-3.18785854	-2.6559484	-3.8629329	-2.49579853	-7.43287824	-16.43884344	-49.02790804									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091330-07	Anthralin	170466655		DPI_SARS-CoV-2_General	2019_NPC_01	1143-38-0		6.2237985085	-5.2059444758	-130.6391940041	-2.1	7		-100.517814672	-88.98633748	0.0003403286	0.9923739918			Oc2cccc1Cc3cccc(O)c3C(=O)c12	Microsource	01500127	-7.48674751	-5.22149192	-6.16850674	-14.99736624	-32.19052936	-53.97631993	-88.98633748									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249929-01	Neticonazole	170466035	ergosterol biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	130726-68-0		11.0676527398	-4.9559444758	-86.910010888	-2.1	7		-121.0261951136	-92.57004233	0.0000214069	0.9981054162			CS\C=C(/c1ccccc1OCCCCC)n2ccnc2	GVK	FFS-11-286-NCI-232	3.57696132	0.27027651	-1.63849886	-1.92456095	-10.79058052	-43.90736565	-92.57004233									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522021-01	Dexamethasone 21-Palmitate		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	14899-36-6		0.2477738814	-6.6059444758	-104.6953142776	-1.2	7		-30.1796296561	-37.22589545	0.0000512232	0.997066769			CCCCCCCCCCCCCCCC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC\4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C	Toronto Research	D298830	-8.32620407	-8.98380651	-12.17739856	-23.82667259	-31.73015232	-36.94099962	-37.22589545									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532499-01	ROMIFIDINE		Alpha-2B adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02					2.2133448814	4	7		0	-4.00989393				ADRA2B	FC1=CC=CC(=C1N\C2=N\CCN2)Br	Enamine	EN300-177066	1.79194895	1.32828201	1.49316706	0.18941608	2.06971936	-0.62476513	-4.00989393									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165719-15	ALENDRONATE SODIUM			DPI_SARS-CoV-2_General	2019_NPC_02					5.8615117479	4	7		0	2.93012415					NCCCC(O)(P(O)(O)=O)P(O)([O-])=O	Microsource	01505166	0	0	0	1.81699132	4.36043058	0	2.93012415									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168748-02	Rotigotine	170465204	Dopamine D4 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	99755-59-6		17.5410474839	-4.7559444758	-43.2688589485	-2.2	7		-40.8246206539	-33.95804595	0.00939516	0.9576611145			Oc2cccc1C[C@H](CCc12)N(CCC)CCc3cccs3	Tocris	3896	0.02543411	-5.83289057	-6.09690349	-5.39017375	-7.21193831	-11.78128523	-33.95804595									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167454-02	Pilsicainide	170465988	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	88069-67-4				11.300645083	4	7		0	4.62826428					Cc3cccc(C)c3NC(=O)CC12CCCN2CCC1	SIGMA	P0026	0	0.10857262	4.62952111	2.87397984	2.77784378	2.28297632	4.62826428									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016806-13	Mebendazole	170464914	Tubulin depolymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	31431-39-7	; ; Vermox;Mebendazole; Mebendazol; Mebendazole;MEBENDAZOLE	11.0676527398	-4.9559444758	-17.3867135916	-3	7		-33.572824516	-30.89402043	0.0030917987	0.9764291381	203068	TUBB	O=C(OC)Nc1nc2cc(ccc2n1)C(=O)c3ccccc3	Microsource	01501110	-2.67470288	3.46226208	0.68484804	1.13627812	1.60127899	-5.86411911	-30.89402043									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024501-04	D-Glutamic acid	225144193	Metabotropic glutamate receptor 1 Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	6893-26-1				3.0725427432	4	7		0	0					N[C@H](CCC(O)=O)C(O)=O	SIGMA	49460	1.26110425	0	0	3.71986856	0	0	0									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00095054-05	Resorcinol monoacetate	170465513		DPI_SARS-CoV-2_General	2019_NPC_01	102-29-4		0.4943738883	-6.3059444758	-23.5238166217	4	7		-11.94975384	-2.29651973	0.536512053	0.3990008033			O=C(C)Oc1cccc(O)c1	Microsource	01503500	0.52525839	-2.45559166	-3.55584802	-0.08277523	-24.9581282	-1.77854566	-2.29651973									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159462-04	Ritonavir	170464891	HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_01	155213-67-5		13.9333492831	-4.8559444758	-54.9856531754	-2.2	7		-50.757396108	-42.9342729	0.002204893	0.9802103492			CC(C)c4nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc3cncs3)C(C)C)cs4	Bosche	R1692	-5.53094668	-3.00290762	-2.4298701	-8.77166579	-8.3464447	-18.37999898	-42.9342729									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015826-13	Perphenazine	170464834	Muscarinic acetylcholine receptor M1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	58-39-9		6.2237985085	-5.2059444758	-80.302268912	-2.1	7		-97.9815644672	-84.64677701	0.0000158047	0.998372836	1128	CHRM1	OCCN1CCN(CC1)CCCN2c4ccccc4Sc3ccc(Cl)cc23	Microsource	01503934	4.39813134	3.11041611	0	-0.57440991	-10.47302441	-47.37537476	-84.64677701									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164560-05	ABACAVIR SULFATE			DPI_SARS-CoV-2_General	2019_NPC_01	188062-50-2		22.0828704269	-4.6559444758	-19.2073725977	4	7		-12.866594004	-10.72216167	0.3547456084	0.5692061977			NC1=NC2=C(N=C[N]2[C@@H]\3C[C@H](CO)\C=C3)C(=N1)NC4CC4	SIGMA	SML0089	-2.69406724	-2.78789063	-5.86629622	-2.53091529	0.77906918	-6.37227501	-10.72216167									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00373041-03	Favipiravir		RNA-dependant RNA polymeriase	DPI_SARS-CoV-2_General	2019_NPC_02	259793-96-9				15.7134384183	4	7		0	2.13575608					NC(=O)C1=NC(=CN=C1O)F	Bio Vision	2778	2.88792804	4.56698006	3.78565903	2.86462596	4.86419694	1.99173243	2.13575608									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390365-01	Delamanid			DPI_SARS-CoV-2_General	2019_NPC_02	681492-22-8		1.7541047484	-5.7559444758	-76.4325549029	-2.2	7		-55.656685536	-50.1450792	0.0001833985	0.9944220224			CC1(COC2=CC=C(C=C2)N3CCC(CC3)OC4=CC=C(OC(F)(F)F)C=C4)C[N]5C=C(N=C5O1)[N+]([O-])=O	Bio Vision	2280	1.16303267	0.00231006	-2.18232109	-7.19547272	-25.67545089	-37.62213454	-50.1450792									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346433-07	Peramivir		Influenza Infection Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	330600-85-6				2.6921149766	4	7		0	0.670694				NEU1	CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O	Adooq	A11124	1.17690582	-2.03053894	1.19312721	-1.07803475	3.60002851	-0.84554679	0.670694									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00509862-02	Fluralaner			DPI_SARS-CoV-2_General	2019_NPC_02	864731-61-3		5.5469662594	-5.2559444758	-57.7031003502	-2.2	7		-59.2494410924	-55.78651953	0.0000542976	0.9969776147			CC1=C(C=CC(=C1)\C2=N\OC(C2)(C3=CC(=CC(=C3)Cl)Cl)C(F)(F)F)C(=O)NCC(=O)NCC(F)(F)F	MedChem Express	HY-16973	2.11565585	-0.9586731	-1.59630576	-0.71791034	-6.60836918	-32.65219842	-55.78651953									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183007-01	Risarestat	144206824	Aldose reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	79714-31-1	CT-112; Risrestat; 	6.9832167823	-5.1559444758	-6.097223427	4	7	LS-151322;CT-112;Risarestat;risarestatum;5-(3-ethoxy-4-pentyloxyphenyl)-2,4-thiazolidinedione;RISARESTAT;5-(3-ETHOXY-4-PENTYLOXYPHENYL)-2,4-THIAZOLIDINEDIONE;Risrestat;CIPLUS_709552;2,4-Thiazolidinedione, 5-(3-ethoxy-4-(pentyloxy)phenyl)-;CT 112;	-9.6488845599	-8.4574038	0.0632060579	0.8768649764			CCCCCOc1ccc(cc1OCC)C2SC(=O)NC2=O	Pharmaron	PH-NIH-149775	1.7179588	0.84317032	1.47910269	-2.34080864	0.35406221	-4.34517099	-8.4574038									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183001-01	Tolvaptan	124894207	Vasopressin (AVP) V2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	150683-30-0	 ; Tolvaptan;Tolvaptan	15.6334750258	-4.8059444758	-70.0456737256	-2.2	7	OPC 41061;OPC-41061;7-chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine;tolvaptan;TOLVAPTAN;Tolvaptan;7-CHLORO-5-HYDROXY-1-(2-METHYL-4-(2-METHYLBENZOYLAMINO)BENZOYL)-2,3,4,5-TETRAHYDRO-1H-BENZAPINE, DL-;CIPLUS_789421;tolvaptanum;	-52.8223650616	-46.32545308	0.0001794269	0.9944855989	554	AVPR2	Cc1ccccc1C(=O)Nc2ccc(c(C)c2)C(=O)N4CCCC(O)c3cc(Cl)ccc34	Pharmaron	PH-NIH-116369	-6.52269417	-9.1408903	-7.07672113	-9.40298856	-11.47494238	-21.86208192	-46.32545308									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274067-01	Eltrombopag olamine	174006931	Thrombopoietin Receptor (TpoR) Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	496775-61-2	Eltrombopag	0.6983216782	-6.1559444758	-195.3721177221	-1.1	7		-102.3492000894	-91.93683303	0.0002589195	0.9933588968	4352	MPL	O=C(O)c1cccc(c1)c4cccc(N\N=C2\C(=O)N(N=C2C)c3ccc(C)c(C)c3)c4O	Selleck	S2229	-0.62692131	-11.31526865	-20.52350662	-32.38016405	-61.85606253	-83.52050409	-91.93683303									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249931-01	Docarpamine	170465850	Dopamine D1 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	74639-40-0		22.0828704269	-4.6559444758	-21.2942198807	4	7		-14.6306298439	-15.84750703	0.0275564204	0.9239258516			CC(=O)N[C@@H](CCSC)C(=O)NCCc1cc(OC(=O)OCC)c(cc1)OC(=O)OCC	GVK	FFS-11-286-NCI-235	-3.09103672	-4.3321035	-1.57198216	-5.38540648	-1.80936913	-2.41882209	-15.84750703									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015288-09	Cyclothiazide	170465274	renal sodium ion absorption Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	2259-96-3		13.9333492831	-4.8559444758	-31.9058801747	4	7		-17.843918952	-21.39869712	0.0033068494	0.9756629932			NS(=O)(=O)c4cc1c(NC(NS1(=O)=O)C3CC2C=CC3C2)cc4Cl	Microsource	01503263	-5.2985743	-5.44139566	-5.59333187	-4.21150325	-2.77876466	-6.34686722	-21.39869712									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015578-12	Ketoprofen	170465449	non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC_01	22071-15-4	 Alrheumat; Orudis; Alrheumum; ; Ketoprofen;Ketoprofen; Ketoprofeno; (S)-(+)-Ketoprofen; (S)-Ketoprofen; Profenid;KETOPROFEN			2.595005246	4	7		0	-1.83518795				PTGS1	CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2	Microsource	01501215	0.21542856	2.52400616	2.60534718	-2.50081521	0.0329899	2.22572285	-1.83518795									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159412-04	Tromethamine	170464686	calcium ion transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	77-86-1				-28.6832860215	4	7		0	-5.36361562					OCC(N)(CO)CO	Labotest	LT03329109	-5.44380703	-6.83900604	-6.47559163	-5.67637394	-7.31106938	-5.41694192	-5.36361562									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016361-20	Acetaminophen		Cyclooxygenase-3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	103-90-2				7.2315336895	4	7		0	3.32017314				PTGS1	CC(=O)NC1=CC=C(O)C=C1	Adooq	A10030	0	0	4.68577858	3.14991932	0	0	3.32017314									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183860-01	Mefruside	144206878	Carbonic anhydrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	7195-27-9		13.9333492831	-4.8559444758	-21.0738124293	-3	7	LS-30042;Mefrusida;Mefrusidum;1,3-Benzenedisulfonamide, 4-chloro-N1-methyl-N1-((tetrahydro-2-methyl-2-furanyl)methyl)-;CIPLUS_166167;fda 1902;Mefruside;MEFRUSIDE;mefruside;Baycaron;mefrusidum;	-68.4637539885	-63.12609999	0.0000046355	0.9991199802			CC2(CN(C)S(=O)(=O)c1ccc(Cl)c(c1)S(N)(=O)=O)CCCO2	Pharmaron	PH-NIH-183408	3.48909801	2.40014784	4.85923912	3.29022753	3.06774707	0.4744457	-63.12609999									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00538141-01	NCGC00538141-01		Microsomal triglyceride transfer protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			4.9437388825	-5.3059444758	-70.469938194	-2.2	7		-62.5921609686	-52.05727061	0.0001371447	0.9951825531			CN(CC1=CC=CC=C1)C(=O)[C@H](NC(=O)C2=CC3=C(C=CC(=C3)NC(=O)C4=CC=CC=C4C5=CC=C(C=C5)C(F)(F)F)[N]2C)C6=CC=CC=C6	Pharmaron	PH-NIH-2017-009-L1-1-0	1.52835904	-3.24562822	-0.83214177	-6.56876272	-16.78825179	-35.61630966	-52.05727061									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094762-08	Piperazine			DPI_SARS-CoV-2_General	2019_NPC_02	110-85-0				-0.234999585	4	7		0	-2.95390762					C1CNCCN1	Microsource	01500490	-0.52024324	-0.64912564	-0.49928506	-0.0865234	2.79210132	0.31003382	-2.95390762									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00249888-01	Vitamin B12	170464872		DPI_SARS-CoV-2_General	2019_NPC_02	68-19-9				2.6240286287	4	7		0	-4.62826428					NC(=O)CC[C@@H]8C=2N=C(C(C)=C1[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@](C)(N1[Co+]C#N)[C@@H]7N=C(C(C)=C3N=C(C=2)C(C)(C)[C@@H]3CCC(N)=O)[C@](C)(CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@@H]6[C@@H](CO)O[C@H](n5cnc4cc(C)c(C)cc45)[C@@H]6O)[C@H]7CC(N)=O)[C@@]8(C)CC(N)=O	GVK	FFS-11-286-NCI-25	3.64632708	0.63988542	0.83214177	0.31569347	2.34536511	-0.41807591	-4.62826428									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00508704-02	HALOPERIDOL DECANOATE		Dopamine D4 receptor Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC_02			4.9437388825	-5.3059444758	-45.3898888209	-2.2	7		-36.5720623872	-37.48751368	0.0002942294	0.9929198525			CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3	Key Organics	KS-1419	-0.13641934	-3.44429301	-3.14338623	-0.51212497	-3.9992396	-25.43686584	-37.48751368									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016505-06	PROPOXYCAINE HYDROCHLORIDE			DPI_SARS-CoV-2_General	2019_NPC_02	550-83-4				4.9118216828	4	7		0	0.56129002					CCCOC1=C(C=CC(=C1)N)C(=O)OCCN(CC)CC	Microsource	01505572	0	0	0	2.42967051	0	4.17606163	0.56129002									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167586-03	Piroctone Olamine	225144295		DPI_SARS-CoV-2_General	2019_NPC_02	68890-66-4		0.5546966259	-6.2559444758	-148.0811339395	-1.2	7		-63.1724836525	-64.11073586	0.0001337791	0.9952421427			CC(CC/1=C/C(=C\C(=O)N1O)C)CC(C)(C)C	Bosche	P6136	-8.26146269	-8.43863337	-16.54204074	-31.7681173	-44.1104484	-54.65990229	-64.11073586									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185769-02	Stiripentol		"Gaba Synthesis, Release, Reuptake And Degradation Modulator"	DPI_SARS-CoV-2_General	2019_NPC_02			13.9333492831	-4.8559444758	-9.2785068259	4	7		-13.593255012	-13.82771251	0.0154775158	0.9447844809			CC(C)(C)C(O)C=CC1=CC=C2OCOC2=C1	APExBIO	A8704	0.96880853	0	0.9212161	-2.39693193	-1.48516028	-0.82205938	-13.82771251									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00261967-01	Prednisolone farnesylate	170466045	Glucocorticoid and meneralocorticoid receptor agonists/antagonists Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	118244-44-3	No2-cbl;Nitritocobalamin;Nitrocobalamin	2.7800686746	-5.5559444758	-50.1077711611	-1.2	7		-40.2780288294	-39.10954669	0.0094253468	0.9575535405			C/C(C)=C\CCC(\C)=C\CCC(/C)=C/C(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	GVK	FFS-11-286-NCI-185	0	3.9709857	2.73551956	-7.88298295	-7.09312549	-33.93461105	-39.10954669									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159507-02	Alclofenac	144205279	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	22131-79-9	Alclofenac; Mervan; Prinalgin; Alclofenaco; 	28.448981057	-4.5459332839	-47.5791203574	4	7	NCGC_ALDRICH_L129054;mervan ethanolamine salt;NCGC00159507-03;Acetic acid, 4-allyloxy-3-chlorophenyl-, compd. with 2-aminoethanol;CIPLUS_758519;Alclofenaco;Benzeneacetic acid, 3-chloro-4-(2-propenyloxy)-;Alclofenacum;Prinalgin;alclofenacum;CIPLUS_173003;epinal;Mervan;CIPLUS_785326;Acetic acid, 4-allyloxy-3-chlorophenyl-;alclofenac;LS-10937;LS-10936;4-allyloxy-3-chlorophenylacetic acid;Alclofenac;ALCLOFENAC;CIPLUS_174183;	-14.151257656	-19.7878514	0.0544908699	0.8871076957			Clc1cc(ccc1OCC=C)CC(=O)O	SigmaAldrich	T100277	-6.32847002	-8.85444339	-9.32233187	-11.2269953	-8.18145094	-11.74370537	-19.7878514									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00163128-08	Pioglitazone hydrochloride	170465116	PPARgamma Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	112529-15-4	Pioglitazona; Pioglitazone HCl;AA-10090;Pioglitazone HCl;PIOGLITAZONE HYDROCHLORIDE; ;Zactos;Actos;U-72107A;Glustin			-26.5247208959	4	7		0	-7.94403184			5468	PPARG	Cl.CCc1ccc(nc1)CCOc3ccc(CC2SC(=O)NC2=O)cc3	Microsource	01504401	-3.93822768	-5.98382486	-6.81679706	-2.70649911	-5.09820839	-7.53595203	-7.94403184									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015442-15	Fluorouracil	170464762	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	51-21-8	 5-Fluorouracil;FLUOROURACIL;5-Fluorouracil			-16.9513051962	4	7		0	-9.96679425				TYMS	FC1=CNC(=O)NC1=O	Vitas	STK297802	-3.20238182	-5.05045569	-1.43062562	-2.85198284	-0.91102878	-3.38939987	-9.96679425									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025262-02	Cisapride	170465200		DPI_SARS-CoV-2_General	2019_NPC_01	81098-60-4		5.5469662594	-5.2559444758	-6.7675664658	4	7		-20.823806748	-17.35317229	0.0010573719	0.986457697			Clc1cc(c(OC)cc1N)C(=O)NC3CCN(CCCOc2ccc(F)cc2)CC3OC	Tocris	1695	2.20027594	4.32233	1.28926909	3.13793363	1.70786175	-9.18237715	-17.35317229									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182983-01	Fezatione	144206829		DPI_SARS-CoV-2_General	2019_NPC_01	15387-18-5	Fezatione; 	1.9681378985	-5.7059444758	-137.3587865851	-1.1	7	Fezatione;FEZATIONE;fezationum;fezatione;3-((P-METHYLBENZYLIDENE)AMINO)-4-PHENYL-4-THIAZOLINE-2-THIONE;CIPLUS_789398;	-84.1115562107	-85.69111049	0.0000595679	0.9968328726			S=C2SC=C(N2/N=C/c1ccc(C)cc1)c3ccccc3	Pharmaron	PH-NIH-150803	-4.68859681	-1.92293596	-2.29338793	-10.53753731	-33.10409582	-79.52131714	-85.69111049									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253592-01	Menadiol	170465455	regulation of blood coagulation Activator	DPI_SARS-CoV-2_General	2019_NPC_01	481-85-6		13.9333492831	-4.8559444758	-24.7892877908	-3	7		-41.1696408179	-33.8647943	0.0014277894	0.984181519			Oc1cc(C)c(O)c2ccccc12	GVK	FFS-11-286-NCI-27	1.28530971	-1.38539351	2.65896517	-1.86369679	-1.8144445	-8.76568931	-33.8647943									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016715-04	Trapidil	170465770	C-C motif chemokine 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	15421-84-8				-7.2575305988	4	7		0	-4.12156853			100009130	CCL2	CCN(CC)c1cc(C)nc2ncnn12	Prestwick Chemical, Inc.	Prestw-1012	0.25899838	-2.85141838	-0.5971095	-3.92053578	0.60650662	-0.76223385	-4.12156853									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015500-19	Haloperidol	170464841	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	52-86-8	; ;Haloperidol; Haloperidol hydrochloride; Haloperidol Lact;Haloperidol..HCl; Vesadol;HALOPERIDOL;Haloperidol?HCl;Haloperidol hydrochloride; Haloperidol metabolite II; Haloperidol Dec; Haldol	13.9333492831	-4.8559444758	-3.5238893071	4	7		-13.908025148	-11.17335429	0.0132780316	0.9492937915	1813	DRD2	Fc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(Cl)cc3	Enzo	AC250	1.04809624	-0.8722848	2.75157808	0.93059423	0.88057656	-1.32120535	-11.17335429									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182622-03	EFLOXATE			DPI_SARS-CoV-2_General	2019_NPC_02	119-41-5		22.0828704269	-4.6559444758	-35.615836895	4	7		-14.6879986999	-18.07544118	0.1389261538	0.7941474065			CCOC(=O)COC1=CC=C2C(=O)\C=C(/OC2=C1)C3=CC=CC=C3	Microsource	01504518	-5.34810053	-10.24509691	-8.04247439	-4.12272291	-3.75210893	-5.97519729	-18.07544118									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016936-04	Aztreonam	170465110	beta-lactam antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	78110-38-0	; ;Aztreonam; Aztreonam; Aztreonam lysinate;AZTREONAM; Azactam			-0.865930746	4	7		0	1.13558592					Nc1nc(cs1)/C(=N\OC(C)(C)C(=O)O)C(=O)N[C@@H]2C(=O)N([C@H]2C)S(=O)(=O)O	Microsource	01505122	1.28046862	-0.61817382	-1.7523336	-2.43058168	2.43871492	-0.97057777	1.13558592									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181915-01	Mepranoprofen arbamel	144206887		DPI_SARS-CoV-2_General	2019_NPC_01	118635-52-2	Y-23023; 			10.901176496	4	7	N,N-DCDBPA;CIPLUS_747910;N,N-dimethylcarbamoylmethyl alpha,2-dimethyl-5H-1-benzopyrano(2,3-b)pyridine-7-acetate;LS-172989;Tilnoprofen Arbamel;TILMICOSIN PHOSPHATE;Mepranoprofen Arbamel;Mepranoprofen arbamel;CIPLUS_741518;TILNOPROFEN ARBAMEL;Y-23023;CIPLUS_3889595;Tilnoprofen arbamel;Tilmicosin Phosphate;Tilmicosin phosphate;tilnoprofenum arbamelum;THYMOSTIMULIN TILNOPROFEN ARBAMEL;Y 23023;MEPRANOPROFEN ARBAMEL;	0	3.62981927					CN(C)C(=O)COC(=O)C(C)c1cc2Cc3ccc(C)nc3Oc2cc1	Pharmaron	PH-NIH-7	4.88224046	4.32721675	3.79956618	0	0	0	3.62981927									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249887-01	Indecainide	170465192	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	74517-78-5		7.8352981002	-5.1059444758	-50.1439533224	-2.2	7		-52.2521862607	-49.43347444	0.0000413124	0.9973657626			NC(=O)C3(CCCNC(C)C)c1ccccc1c2ccccc23	GVK	FFS-11-286-NCI-023	-2.60208651	0.06597112	-2.41037264	-2.22991447	-3.79891387	-23.56318919	-49.43347444									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094906-06	Nefopam hydrochloride	170465579	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	23327-57-3				9.4128393036	4	7		0	-2.78826899					Cl.CN1Cc3ccccc3C(OCC1)c2ccccc2	Microsource	01501137	3.33309128	0	2.95630133	3.95063586	4.08820992	1.34661314	-2.78826899									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179244-03	Dorzolamide hydrochloride	170465119	Carbonic Anhydrase Type II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	130693-82-2	; Trusopt; 1   Dorzolamide;Dorzolamide HCL;Dorzolamide hydrochloride			6.7583322186	4	7		0	0			760	CA2	Cl.NS(=O)(=O)c1cc2[C@H](C[C@H](C)S(=O)(=O)c2s1)NCC	Prestwick Chemical, Inc.	Prestw-1116	0	0	4.70619775	0	0	4.95960161	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183866-01	Oxypertine hydrochloride	144206763	Adenylate cyclase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	17506-66-0		12.4181106199	-4.9059444758	-72.3306999438	-2.1	7	OXYPERTINE;LS-82918;oxypertine;CIPLUS_152240;Indole, 5,6-dimethoxy-2-methyl-3-(2-(4-phenyl-1-piperazinyl)ethyl)-;Oxipertina;Equipertine;Forit;CIPLUS_179718;Oxypertinum;Oxypertin;oxypertinum;1H-Indole, 5,6-dimethoxy-2-methyl-3-(2-(4-phenyl-1-piperazinyl)ethyl)-;Oxypertine;	-102.8572277944	-80.57365742	0.0000656009	0.9966756956			Cl.COc3cc4nc(C)c(CCN1CCN(CC1)c2ccccc2)c4cc3OC	NCI	NSC_169107	1.55148096	-1.41144402	0.37270575	-4.55767837	-6.89351995	-31.72679444	-80.57365742									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167503-02	Aclarubicin	174007366	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	57576-44-0	; Aclacin;Aclarubicin; Aclaplastin; Aclacinon; Aclarubicino;Aclacinomycin A	3.9269513795	-5.4059444758	-131.644473906	-2.1	7		-111.1326261662	-94.02083432	0.0000253422	0.9979380164	7153	TOP2A	CC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)N(C)C)C5=C(O)C6=C(C=C5[C@H]1C(=O)OC)C(=O)C7=CC=CC(=C7C6=O)O	Carbosynth	OA08264	0.31214595	0.7553882	-6.21410656	-13.04632509	-31.19787087	-68.04772642	-94.02083432									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166140-02	Pyrithioxin dihydrochloride	170465839	acetylcholine biosynthetic process Activator	DPI_SARS-CoV-2_General	2019_NPC_02	10049-83-9				7.9443005459	4	7		0	2.57337202					Cl.Cl.Oc1c(CO)c(cnc1C)CSSCc2cnc(C)c(O)c2CO	Vitas	STK801801	0.07399015	0.80389937	2.58549964	0	2.01268921	3.95058249	2.57337202									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091058-11	Linolenic acid	225144205	Fatty acid desaturase 2 Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	463-40-1		12.4181106199	-4.9059444758	-29.4287511345	-3	7		-53.2644926667	-49.79341462	0.0000204313	0.9981498603	9415	FADS2	CC\C=C/C/C=C\C\C=C/CCCCCCCC(O)=O	SIGMA	62160	0	0	0	2.21235608	0	-6.75339194	-49.79341462									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018204-13	Vinpocetine	170465859	Na channel blocker, also PDE1, IKK inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	42971-09-5	;Vinpocetine; Cavinton	12.4181106199	-4.9059444758	-53.3480780494	-2.2	7		-55.4710221117	-44.44500773	0.0000487534	0.9971377802			O=C(OCC)C1=C[C@@]5(CCCN4CCc3c(n1c2ccccc23)[C@@H]45)CC	Prestwick Chemical, Inc.	Prestw-268	-2.65533851	-4.21482151	-1.83032341	-4.69812125	-7.39227529	-22.09970019	-44.44500773									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018250-06	Sulconazole nitrate	170465344	Lanosterol 14-alpha demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	61318-91-0		7.8352981002	-5.1059444758	-89.0633920927	-2.1	7		-90.9292799161	-86.14230311	1.05E-7	0.9998677128			[O-][N+](=O)O.Clc3ccc(C(SCc1ccc(Cl)cc1)Cn2ccnc2)c(Cl)c3	Microsource	01501148	-3.06199017	-3.61863806	-2.6150959	-3.50916798	-7.6714206	-42.0753087	-86.14230311									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164602-03	RACTOPAMINE HYDROCHLORIDE		Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	90274-24-1		15.6334750258	-4.8059444758	-27.508780065	-2.2	7		-57.6598565368	-42.92413374	0.0005040674	0.9906974054			CC(CCC1=CC=C(O)C=C1)NCC(O)C2=CC=C(O)C=C2	FLUKA	34198	0	4.46404574	0	-0.17809216	-0.01268842	-11.25057168	-42.92413374									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178318-04	Sodium 2-mercaptoethanesulfonate	170464862	Antineoplastic Enhancing Agents	DPI_SARS-CoV-2_General	2019_NPC_01	19767-45-4				10.2215540096	4	7		0	3.88329827				CAT	[Na+].[O-]S(=O)(=O)CCS	Microsource	01502014	0	2.69015564	2.75157808	0	4.16941582	2.0834392	3.88329827									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016372-07	4-Hydroxy-3-nitrophenylarsonic acid	170465666		DPI_SARS-CoV-2_General	2019_NPC_01	121-19-7				6.8451045765	4	7		0	-0.69960204					O=[N+]([O-])c1cc(ccc1O)[As](O)(O)=O	Microsource	01500530	2.74247815	1.17037652	0.57273769	0.10785863	3.47916561	2.33751715	-0.69960204									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016049-07	Tetracaine hydrochloride	170465190	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	136-47-0				6.9946249672	4	7		0	-3.56391473					Cl.CN(C)CCOC(=O)c1ccc(NCCCC)cc1	Microsource	01500564	2.24868685	4.41517824	1.47936926	2.2198811	1.33735979	1.06712739	-3.56391473									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091886-04	Denatonium benzoate	170464678	Glycolysis / Gluconeogenesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	3734-33-6				-18.727182584	4	7		0	-6.11898304					O=C(Nc1c(C)cccc1C)C[N+](Cc2ccccc2)(CC)CC.[O-]C(=O)c1ccccc1	Vitas	STK301730	-5.49221795	-2.25034818	-1.20153055	-7.64792937	-4.08820992	-1.67183292	-6.11898304									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160454-01	Felbinac ethyl	144205377		DPI_SARS-CoV-2_General	2019_NPC_02	14062-23-8	ethyl 4-biphenyl acetate; BPAA-Et; 	28.448981057	-4.5459332839	-6.1450880954	-3	7	BPAA-Et;Felbinac Ethyl;FELBINAC ETHYL;ethyl 4-biphenyl acetate;Felbinac ethyl;LS-44075;4-biphenylylacetic acid ethyl ester;CIPLUS_169170;LM-001;ethyl 4-biphenylacetate;felbinac ethyl ester;LM 001;	-43.4743376319	-30.39528136	0.0012828825	0.9850265623			O=C(OCC)Cc1ccc(cc1)c2ccccc2	Enamine	T5544767	4.60357465	4.88576775	2.98399006	0	0.88159114	-8.80308155	-30.39528136									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00408859-01	Cetilistat		Pancreatic lipase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	282526-98-1		17.5410474839	-4.7559444758	-7.1647370159	4	7		-12.245921132	-8.53826761	0.1371879733	0.7972617388			CCCCCCCCCCCCCCCCOC/1=N/C2=C(C=C(C)C=C2)C(=O)O1	Glixx	GLXC-06700	1.33413489	-0.13167317	-2.12606362	2.23323902	-2.49269301	-2.58361518	-8.53826761									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164625-04	Cerivastatin sodium	170465109	HMG-CoA reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	143201-11-0		15.6334750258	-4.8059444758	-12.836636043	-2.4	7		-33.106904764	-23.00575397	0.002683808	0.9781170772			[Na+].CC(C)c1nc(c(/C=C/[C@@H](O)C[C@@H](O)CC([O-])=O)c(c1COC)c2ccc(F)cc2)C(C)C	Sequoia	143201-11-0	3.18785854	0.55953283	2.44936755	-1.07106128	-0.04314064	-5.99623965	-23.00575397									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249902-01	Epsiprantel	170465737	calcium ion homeostasis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	98123-83-2				0.255247741	4	7		0	-6.14940052					O=C2CN(CC1c3ccccc3CCCN12)C(=O)C4CCCCC4	GVK	FFS-11-286-NCI-105	0.81572386	3.53067657	0.25590407	-1.30182858	-0.83997361	2.57126887	-6.14940052									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018243-09	Sulfamethazine	170464893	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	57-68-1				11.7614194498	4	7		0	2.25089351					O=S(=O)(Nc1nc(C)cc(C)n1)c2ccc(N)cc2	Vitas	STK097514	3.57030475	1.98157695	0	4.69310457	2.60112673	2.39849586	2.25089351									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015817-14	Promethazine	170465107		DPI_SARS-CoV-2_General	2019_NPC_01	60-87-7		11.0676527398	-4.9559444758	-68.3138975256	-2.2	7		-93.6906415615	-70.59897088	0.0001386754	0.9951546968			CN(C)C(C)CN1c3ccccc3Sc2ccccc12	Enzo	AC765	1.24658098	1.62973098	-2.1374083	-0.76002709	-12.158047	-32.27298135	-70.59897088									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263570-01	Sivelestat sodium hydrate	170465996	Neutrophil Elastase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	201677-61-4				-20.8671893609	4	7		0	-8.49661606				ELANE	O.O.O.O.[Na+].CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=C1C(=O)NCC([O-])=O	Bosche	S3046	-4.86287609	-3.58443082	-3.68258146	-4.92888855	-2.75846318	-3.78067991	-8.49661606									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00092321-03	Tetrabenazine Mesylate		Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	804-53-5		9.8640558873	-5.0059444758	-42.2896352441	4	7		-29.20703154	-29.36783523	0.0109316538	0.9540862131		SLC18A2	COC1=C(OC)C=C2[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CCC2=C1	Glixx	GLXC-06104	-1.27864228	-6.37806371	-6.44851269	-5.27325024	-3.18180738	-15.83051484	-29.36783523									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249613-11	Carfilzomib		Proteasome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	868540-17-4		15.6334750258	-4.8059444758	-34.8766774942	-3	7		-45.042634913	-37.80145555	0.0005213812	0.9905396262		PSMD1	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4	Selleck	S2853_CM1	-2.00004624	-2.22920372	-0.0726659	-2.78044104	-4.87370197	-9.49361142	-37.80145555									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182548-02	Flutropium bromide	170465904	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	63516-07-4		19.6813789847	-4.7059444758	-26.6899350622	4	7		-12.481697976	-11.42558151	0.4669587382	0.4285063394			[Br-].[Br-].C[N+]2(CCF)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(O)(c3ccccc3)c4ccccc4	APAC	871826	-2.41161645	-5.56954423	-7.3205035	-5.92334495	-1.02416653	-7.38913942	-11.42558151									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159503-02	Methylprednisolone acetate	144205275		DPI_SARS-CoV-2_General	2019_NPC_02	53-36-1	Methylprednisolone acetate; Depo-Medrol; Depo-medrol; Depo-Medrone; 			2.1736319917	4	7	methylprednisolone acetate, (11beta,16alpha)-isomer;6alpha-METHYLPREDNISOLONE ACETATE;methylprednisolone acetate;NCGC00095841-01;Methylprednisolone Acetate;Methylprednisolone acetate;methylprednisolone acetate, (11beta,16beta)-isomer;6-Methyl Prednisolone Acetate;LS-118505;METHYLPREDNISOLONE ACETATE;11.BETA.,17,21-TRIHYDROXY-6.ALPHA.-METHYLPREGNA-1,4-DIENE-3,20-DIONE 21-ACETATE;PREGNA-1,4-DIENE-3,20-DIONE, 21-(ACETYLOXY)-11,17-DIHYDROXY-6-METHYL-,   (6.ALPHA.,11.BETA.)-;Depo-medrol;acetyl-methylprednisolone;(6.ALPHA.,11.BETA.)-11,17-DIHYDROXY-6-METHYL-3,20-DIOXOPREGNA-1,4-DIEN-21-YL ACETATE;Depo-Medrone;methylprednisolone-21-acetate;Depo-Medrol;CIPLUS_148680;	0	3.6531418					CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](C)C1=CC(=O)C=C[C@@]12C	SigmaAldrich	R201170	0.36532637	0	0	0	0	0	3.6531418									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00479249-03	Enasidenib	363681106	IDH1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1446502-11-9		11.0676527398	-4.9559444758	-12.4153152511	4	7		-26.10976074	-23.00813395	0.0103189717	0.9555013823		IDH1	CC(C)(O)CNC1=NC(=NC(=N1)NC2=CC(=NC=C2)C(F)(F)F)C3=CC=CC(=N3)C(F)(F)F	ChemieTek	CT-AG221	4.33536036	-1.4437848	-0.28363142	0	2.48318799	-5.35982713	-23.00813395									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016069-13	Brimonidine	170464941	Alpha-2C adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	59803-98-4		22.0828704269	-4.6559444758	-15.0158899077	4	7		-23.4107627199	-21.1756356	0.0004065683	0.9916770048	152	ADRA2C	Brc2c3nccnc3ccc2NC1=NCCN1	Enzo	AC155	-1.37729044	-0.79898356	0.56298896	-1.29179522	-1.49469624	-1.1535139	-21.1756356									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091544-18	Estradiol		Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	50-28-2		17.5410474839	-4.7559444758	-5.7833217967	4	7		-25.673189532	-18.89432461	0.0061217176	0.9663397346	2099	ESR1	C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@H]2O	Prestwick	Prestw-441	3.23142836	2.09397219	-1.16741001	2.6563323	0.81459676	-1.54479394	-18.89432461									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016743-08	Piromidic acid	170466042		DPI_SARS-CoV-2_General	2019_NPC_01	19562-30-2				3.4292496216	4	7		0	-0.66918456					O=C(O)C2=CN(CC)c1nc(ncc1C2=O)N3CCCC3	Microsource	01502045	3.05230799	2.95892687	1.17228437	-1.84864675	-0.87042582	3.14548503	-0.66918456									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00013109-03	Phenol red	170465805	amyloid fibril formation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	143-74-8		11.0676527398	-4.9559444758	-22.8543914702	-2.2	7		-45.274809262	-39.22334035	0.0001115474	0.9956600623			Oc1ccc(cc1)C3(OS(=O)(=O)c2ccccc23)c4ccc(O)cc4	Labotest	LT00455865	0	1.54421287	1.90587605	1.65048787	2.71278486	-10.9253519	-39.22334035									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181008-02	Olsalazine sodium	225144315	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	6054-98-4		8.7913490634	-5.0559444758	-23.9230218867	4	7		-27.1944876	-25.5482091	0.0000143173	0.9984541699			OC1=CC=C(C=C1C([O-])=O)/N=N/C2=CC=C(O)C(=C2)C([O-])=O	Bosche	O2307	-0.3861361	-1.20353901	-0.74775556	-0.9330496	-1.18575197	-10.51296505	-25.5482091									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344533-01	Nalpha-Acetyl-L-glutamine	170465810		DPI_SARS-CoV-2_General	2019_NPC_02	2490-97-3				1.6453776674	4	7		0	-2.72558626					O=C(C)NC(CCC(N)=O)C(=O)O	SIGMA	A9125	2.13415339	-1.00487422	-0.66336935	1.71409864	0.80555093	1.49379932	-2.72558626									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016009-19	Tolazamide	170465136	ATP-sensitive inward rectifier potassium channel 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	1156-19-0				-10.3110234116	4	7		0	-7.5486046					Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2	Enzo	KC135	-0.44780093	0.70613531	-0.0658039	-2.96736649	-3.89534589	-2.40357742	-7.5486046									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159369-04	1-Octadecanol	170465526		DPI_SARS-CoV-2_General	2019_NPC_01	112-92-5				7.0603772112	4	7		0	4.76033561					CCCCCCCCCCCCCCCCCCO	Labotest	LTBB001505	2.61176869	0	0	3.98073595	0	0	4.76033561									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159352-14	ETIDRONATE DISODIUM			DPI_SARS-CoV-2_General	2019_NPC_01	7414-83-7				-12.1405883569	4	7		0	-2.16471065					CC(O)(P(O)(O)=O)P(O)(O)=O	Microsource	01505537	-5.86982306	-1.37073326	-3.71670201	-2.44563173	-1.31198295	-1.20432949	-2.16471065									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181337-03	2,4-Dichlorobenzyl alcohol	170465574		DPI_SARS-CoV-2_General	2019_NPC_01	1777-82-8				10.4547616975	4	7		0	-0.4562622					OCc1ccc(Cl)cc1Cl	Bosche	D0540	2.83445889	1.84474797	3.09278351	1.20651165	2.23570015	4.17704152	-0.4562622									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00487176-01	EAA-090			DPI_SARS-CoV-2_General	2019_NPC_02	144912-63-0				5.0466783448	4	7		0	2.45921134					O[P](O)(=O)CCN1CCCN/C2=C1/C(=O)C2=O	SIGMA	SML0206	0	0	0	0	2.9679443	3.0251785	2.45921134									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00242497-12	Vismodegib		Hedgehog Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	879085-55-9		9.8640558873	-5.0059444758	-69.439514717	-2.2	7		-36.328016486	-40.77914665	0.0000034807	0.9992382656		SHH	C[S+]([O-])(=O)C1=CC=C(C(=C1)Cl)C(=O)NC2=CC(=C(Cl)C=C2)C3=NC=CC=C3	ActiveBioChem	A-1113	-9.23258341	-9.50125898	-8.75038091	-9.41701939	-10.25354656	-21.72585494	-40.77914665									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00483038-01	TAK-599			DPI_SARS-CoV-2_General	2019_NPC_02	400827-46-5		8.7913490634	-5.0559444758	-1.1169365086	4	7		-21.11839414	-14.26532845	0.0015715249	0.9834252349			CCO\N=C(/C(=O)N[C@H]1[C@H]2SC\C(=C(/N2C1=O)C(O)=O)SC3=NC(=CS3)C4=CC=[N+](C)C=C4)C5=NSC(=N5)N[P](O)(O)=O	DC Chemicals	DC7923	4.19662882	2.68197464	2.1635686	4.42672404	1.04792909	-5.22360015	-14.26532845									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00186054-01	Tannic acid	124896727	Beta-secretase 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			0.0440611192	-7.3559444758	-271.8669006539	-1.1	7		-96.0255302025	-92.43209818	0.0008818109	0.9876284772			OC1=CC(=CC(=C1O)O)C(=O)OC2=CC(=CC(=C2O)O)C(=O)OC[C@H]3O[C@@H](OC(=O)C4=CC(=C(O)C(=C4)OC(=O)C5=CC(=C(O)C(=C5)O)O)O)[C@H](OC(=O)C6=CC(=C(O)C(=C6)OC(=O)C7=CC(=C(O)C(=C7)O)O)O)[C@@H](OC(=O)C8=CC(=C(O)C(=C8)OC(=O)C9=CC(=C(O)C(=C9)O)O)O)[C@@H]3OC(=O)C%10=CC(=C(O)C(=C%10)OC(=O)C%11=CC(=C(O)C(=C%11)O)O)O	SIGMA	16201	-9.75051446	-33.08230728	-50.62000422	-63.83322031	-76.07109759	-86.19879744	-92.43209818									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181334-04	DIBUNATE SODIUM	225144323		DPI_SARS-CoV-2_General	2019_NPC_02			7.8352981002	-5.1059444758	-4.7758076441	4	7		-13.802026356	-11.50168863	0.0235910254	0.9302830474			CC(C)(C)C1=CC=C2C(=C1)C=CC(=C2[S]([O-])(=O)=O)C(C)(C)C	Bosche	D6477	0.58960901	3.11164499	-0.85089426	1.04061923	2.44041537	-4.46730552	-11.50168863									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093985-11	Metolazone	170464665	Carbonic Anhydrase Type VII Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	17560-51-9	; Metolazona; Microx;Metolazone; Metolazone; ; Diulo; Zaroxolyn;METOLAZONE; METOLAZONE			-2.287388816	4	7		0	-3.07216547			766	CA7	NS(=O)(=O)c1cc2C(=O)N(C(C)Nc2cc1Cl)c3ccccc3C	Microsource	02300325	-0.05083146	-0.07085787	1.56223343	-0.14799207	-1.47439476	-0.77747853	-3.07216547									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00250402-09	Dapagliflozin		SGLT-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	461432-26-8		22.0828704269	-4.6559444758	-31.7417477769	-3	7		-79.8710697788	-69.62374542	0.0001260599	0.9953820779		SCL5A2	CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C=C1	DC Chemicals	DC6904	4.44634558	0	0	0	0	2.80909433	-69.62374542									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159519-14	Tolterodine Tartrate 			DPI_SARS-CoV-2_General	2019_NPC_02	124937-52-6		12.4181106199	-4.9059444758	-28.0391421958	4	7		-19.395459092	-20.52038244	0.0629903708	0.8761355202			[H][C@@](CCN(C(C)C)C(C)C)(C1=CC=CC=C1)C2=CC(C)=CC=C2O	Bosche	T0008	-2.35612384	-7.22354409	-5.97032418	-1.17157356	-1.02416653	-6.96166855	-20.52038244									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179590-04	Syrosingopine			DPI_SARS-CoV-2_General	2019_NPC_02	84-36-6		2.4777388143	-5.6059444758	-136.1785583333	-1.1	7		-99.376349714	-92.94106455	0.0000283155	0.9978199569			CCOC(=O)OC1=C(OC)C=C(C=C1OC)C(=O)O[C@@H]2C[C@@H]3CN4CCC5=C([NH]C6=C5C=CC(=C6)OC)[C@H]4C[C@@H]3[C@@H]([C@H]2OC)C(=O)OC	Glixx	GLXC-06136	0.25202895	-0.15015362	-5.44056633	-8.33664617	-33.97809092	-77.09507704	-92.94106455									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017041-05	Dobesilate Calcium			DPI_SARS-CoV-2_General	2019_NPC_02	20123-80-2 (anhydrous)				-45.4805593668	4	7		0	-12.12005898					OC1=CC(=C(O)C=C1)[S+](O)([O-])=O	SIGMA	SML0488	-9.64877801	-9.08544896	-10.69126368	-9.83326708	-6.85074733	-10.11837655	-12.12005898									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160445-02	Bromisovalum	170465828		DPI_SARS-CoV-2_General	2019_NPC_01	496-67-3				7.5278819273	4	7		0	2.61083369					CC(C)C(Br)C(=O)NC(N)=O	Labotest	LT00134620	1.30951516	2.61196765	0.02193463	-0.02759174	2.20017256	2.72879719	2.61083369									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091023-06	Cetylpyridinium bromide	170465500		DPI_SARS-CoV-2_General	2019_NPC_01	140-72-7		0.78352981	-6.1059444758	-16.7259929396	4	7		-10.1836221399	-7.89333604	0.1129085197	0.82135531			[Br-].CCCCCCCCCCCCCCCC[n+]1ccccc1	Vitas	STK177346	-0.33645584	1.49778875	-0.5581146	-3.95565254	-3.23554789	-11.40301845	-7.89333604									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00189077-01	Methsuximide	144207162	Voltage-gated T-type calcium channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	77-41-8				11.1174535262	4	7	Methsuximide	0	3.12793085					CC1(CC(=O)N(C)C1=O)c2ccccc2	Toronto Research	M271900	1.27562753	3.37430058	2.90268334	1.60784609	2.69755875	1.72773007	3.12793085									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165912-03	Tofisopam			DPI_SARS-CoV-2_General	2019_NPC_02	22345-47-7		11.0676527398	-4.9559444758	-13.183099828	4	7		-16.377562668	-14.89796889	0.02444832	0.928792325			CCC1\C(=N/N=C(C2=CC(=C(OC)C=C2)OC)\C3=C1C=C(OC)C(=C3)OC)C	SIGMA	T8200	0.76071123	0.94943288	-1.79320691	-2.98622641	0.65822304	-5.18602029	-14.89796889									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00538148-01	NCGC00538148-01			DPI_SARS-CoV-2_General	2019_NPC_02					-24.1506381155	4	7		0	-6.15992009					OCCN(CCO)CCOC(=O)C1=CC=CC=C1O	Pharmaron	PH-NIH-2017-009-L1-9-0	-2.34687507	-6.45198549	-4.53575866	-3.89355284	-6.25193071	-6.5013153	-6.15992009									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522023-01	Paliperidone Palmitate			DPI_SARS-CoV-2_General	2019_NPC_02	199739-10-1		9.8640558873	-5.0059444758	5.8824783269	4	7		-9.3747799999	-6.14565	0.0724784199	0.8661999034			CCCCCCCCCCCCCCCC(=O)OC1CCCN\2C(=O)/C(=C(C)\N=C12)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Toronto Research	P141020	0	2.94994109	4.01537704	3.74389075	2.72556614	-0.38519354	-6.14565									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016872-12	Ticlopidine hydrochloride	170464698	P2Y12 (P2T) Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	55142-85-3	 Ticlid; Ticlopidina;Ticlopidine; ;; Ticlodone; Ticlopidine Hcl;TICLOPIDINE HYDROCHLORIDE; Ticlopidine hydrochloride; Hydrochloride, Ticlopidin;Ticlopidine hydrochloride	22.0828704269	-4.6559444758	-73.1716867862	-3	7		-79.6407762908	-76.33773542	0.0032500712	0.9757868507	64805	P2RY12	Clc3ccccc3CN1CCc2sccc2C1	Vitas	STK589340	-12.77321908	-9.45830381	-9.37583778	-8.34524795	-5.9711719	-1.57020174	-76.33773542									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015997-10	Taurine	170465726	Antioxidant	DPI_SARS-CoV-2_General	2019_NPC_01	107-35-7	L-Taurine;Taurine;l-Taurine; Taurine;TAURINE			12.2750234668	4	7		0	3.27494867				CAT	NCCS(=O)(=O)O	Microsource	01505463	2.74247815	0	4.43323341	3.65465172	2.51992082	1.82427969	3.27494867									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159510-05	Aripiprazole	170465392	5-HT1A/2A Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	129722-12-9	 Abilify;;Aripiprazole; ;ARIPIPRAZOLE; Aripiprazole	6.9832167823	-5.1559444758	-69.8413525057	-2.2	7		-76.1830118418	-66.82720337	0.0001452369	0.995040529	3356	HTR2A	Clc4cccc(N3CCN(CCCCOc1ccc2CCC(=O)Nc2c1)CC3)c4Cl	Microsource	01505851	-2.39876068	2.20148069	0.6507275	-1.32691198	-12.19357458	-36.53640937	-66.82720337									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181911-01	Bucolome	144206890	Cytochrome P450 2C9 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	841-73-6	Bucolome; Bucolom; Paramidine; Paramidin; Bucolomo; 			5.8774645441	4	7	Paramidine;2,4,6(1H,3H,5H)-Pyrimidnetrione, 5-butyl-1-cyclohexyl-;Barbituric acid, 5-butyl-1-cyclohexyl-;bucolome;CIPLUS_156649;LS-23912;Bucolomo;Paramidin;Bucolomum;Bucolome;bucolomum;1-cyclohexyl-5-butylbarbituric acid;Bucolom;BUCOLOME;CIPLUS_165895;	0	-0.71481078					O=C2C(CCCC)C(=O)NC(=O)N2C1CCCCC1	Pharmaron	PH-NIH-95	0.20574638	4.52268673	0	-0.73494369	0	4.96468316	-0.71481078									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182049-02	Nitroscanate	225144331	ATP biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			6.2237985085	-5.2059444758	-57.7859472318	-2.2	7		-66.0770108877	-57.08509727	0.0002472069	0.9935137952			[O-][N+](=O)C1=CC=C(OC2=CC=C(C=C2)N=C=S)C=C1	Oakwood	8991	-1.14453513	3.46739356	2.05105366	-2.83656432	-9.48839199	-31.71270199	-57.08509727									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00507682-01	Emodepside		synaptic transmission Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	155030-63-0		3.1192883571	-5.5059444758	-84.6969101917	-2.2	7		-84.9687009476	-77.75293726	5.727E-7	0.9996909253	174419		CC(C)C[C@@H]1N(C)C(=O)[C@@H](C)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](CC2=CC=C(C=C2)N3CCOCC3)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)OC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](CC4=CC=C(C=C4)N5CCOCC5)OC1=O	AdvChemBlocks	M15352	3.47060048	4.47919795	3.28402991	1.30720483	-17.50588123	-57.47839158	-77.75293726									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274057-01	Phenylpropanolamine hydrochloride	170465627	Adrenergic receptor alpha-1 Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	154-41-6		3.9269513795	-5.4059444758	-46.3715972787	4	7		-18.54015196	-10.69305047	0.0125139038	0.9753507765			Cl.O[C@H]([C@@H](C)N)c1ccccc1	Microsource	02300253	-6.43020648	-5.41246044	-4.99519467	-7.55559713	-7.75372478	-19.61198797	-10.69305047									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016345-08	4-Methylumbelliferone	170465819	MAO-A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	90-33-5	 Hymecromon; Cholestil; ; Mendiaxon; Himecromona; beta-Methylumbelliferone;4-Methylumbelliferone (4-MU); Cantabiline; 4-Methylumbelliferone;4-Methylumbelliferone;Hymecromone			-10.4576401912	4	7		0	-1.3434387				MAOA	Oc1ccc2c(c1)OC(=O)C=C2C	Vitas	STK364326	0.47684748	-4.3125565	-1.52323853	-4.33692026	-1.70786175	-2.53061639	-1.3434387									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183836-01	Emiglitate	144206827	Maltase-glucoamylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	80879-63-6		15.6334750258	-4.8059444758	-16.2537126258	4	7	N-(beta-(4-ethoxycarbonyl)phenoxy)ethyl-1-desoxy-nojirimycin;Emiglitate;BAY-o-1248;EMIGLITATE;BAY-o 1248;BAY o 1248;LS-177593;N-(beta-(4-ethoxycarbonyl)phenoxy)ethyl-1-desoxynojirimycin;CIPLUS_214267;emiglitate;emiglitatum;	-18.7544431481	-15.00595676	0.0024887313	0.9790424104			O=C(OCC)c2ccc(OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO)cc2	Pharmaron	PH-NIH-150421	-0.21058747	-1.77144672	-2.09353903	-0.22324228	-2.21539867	-5.42710504	-15.00595676									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022043-06	Deoxycorticosterone acetate	170465334	Mineralocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	56-47-3		17.5410474839	-4.7559444758	-20.0354856747	4	7		-16.918202328	-14.09850194	0.0445749825	0.8997601541			CC(=O)OCC(=O)[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	SIGMA	D7000	-2.81993561	0.01710362	-2.20077502	-3.47405122	-4.66680201	-4.97484628	-14.09850194									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016522-10	Bisacodyl	170464843		DPI_SARS-CoV-2_General	2019_NPC_01	603-50-9		11.0676527398	-4.9559444758	-2.362900395	4	7		-7.816139008	-6.93011584	0.2225616042	0.7116331923			CC(=O)Oc1ccc(cc1)C(c2ccc(OC(C)=O)cc2)c3ccccn3	Labotest	LT00134695	-0.53978167	-1.85452146	2.29338793	-0.19815888	3.51469319	-1.38726561	-6.93011584									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00271596-03	Exemestane	170464628	Aromatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	107868-30-4	Exemestane	17.5410474839	-4.7559444758	-13.8379435759	4	7		-14.1763073039	-11.99162822	0.0115584804	0.953086773	1588	CYP19A1	O=C3C=C4C(=C)C[C@@H]1[C@H](CC[C@]2(C)C(=O)CC[C@@H]12)[C@@]4(C)C=C3	Tocris	3759	-0.1780388	-2.9545612	-1.05717166	-1.87779155	-1.24753463	-3.44325442	-11.99162822									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532508-01	DROMETRIZOLE TRISILOXANE			DPI_SARS-CoV-2_General	2019_NPC_02					-1.6634239031	4	7		0	0.9608524					CC(CC1=CC(=CC(=C1O)[N]2N=C3C=CC=CC3=N2)C)C[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C	SIGMA	68790	0.33064348	-3.13474555	0.18518084	-1.14818885	0	0	0.9608524									5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7	0.0000016599999999	0.00000831								
NCGC00090714-01	Sodium xylenesulfonate	144204551		DPI_SARS-CoV-2_General	2019_NPC_02	1300-72-7	PENTOSAN POLYSULFATE SODIUM; Sodium xylenesulfonate; 			0.5227068207	4	7	XYLANPOLYSULFATE SODIUM;ELMIRON;Sodium xylenesulfonate;AB02509377-01;PENTOSAN POLYSULFATE SODIUM;CIPLUS_158001;	0	0					[Na+].Cc1ccc(cc1C)S(=O)([O-])=O	NIEHS	AB02509377	0.77227219	0	0	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091149-21	VALPROATE SODIUM			DPI_SARS-CoV-2_General	2019_NPC_01	1069-66-5, 99-66-1 [valproic acid]				4.2363957055	4	7		0	1.48031736					CCCC(CCC)C(O)=O	Microsource	01500606	1.90496938	0.8625113	0.03655772	0.09782527	0	2.10376544	1.48031736									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016271-05	Tolazoline hydrochloride	170465219	Adrenergic receptor alpha-1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	59-97-2				-45.8042549465	4	7		0	-14.1086411					Cl.c2cc(CC1=NCCN1)ccc2	Specs	AT-139/J221336	-7.88855808	-7.41075574	-8.64955765	-10.181353	-9.23970969	-11.7688907	-14.1086411									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023230-10	Noscapine	170465539	Tubulin polymerization inhibitors	DPI_SARS-CoV-2_General	2019_NPC_01	128-62-1		17.5410474839	-4.7559444758	-5.3584901634	4	7		-24.815416596	-18.17951383	0.0068535382	0.9642734722		TUBB	COc3c5OCOc5cc4CCN(C)[C@@H]([C@H]2OC(=O)c1c(OC)c(ccc12)OC)c34	Vitas	STK054401	2.80541234	3.55022357	1.35263581	0.21320892	-0.68771253	-1.09761675	-18.17951383									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018302-07	Trichlormethiazide	170464812	Diuretic	DPI_SARS-CoV-2_General	2019_NPC_01	133-67-5	;Trichlormethiazide; Esmalorid; Naqua; Triclormetiazida; Esmaloride; Triazide;TRICHLORMETHIAZIDE			17.4830553947	4	7		0	3.35606195				SLC12A3	NS(=O)(=O)c2cc1c(NC(NS1(=O)=O)C(Cl)Cl)cc2Cl	Prestwick Chemical, Inc.	Prestw-825	2.56819887	4.72793022	3.91167654	4.55263752	4.2556971	2.54586107	3.35606195									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015316-05	Eflornithine Hydrochloride	170465007	Ornithine Decarboxylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	96020-91-6	 ; 1   Eflornithine; DFMO hydrochloride; Ornidyl; DL-alpha-Difluoromethylornithine hydrochloride;DFMO;Eflornithine Hydrochloride;DL-alpha-Difluoromethylornithine hydrochloride			-12.8172708759	4	7		0	-2.91500849			89874	ODC1	Cl.FC(F)C(N)(CCCN)C(=O)O	Bosche	E2777	-2.80541234	-0.11483862	-1.75720796	-4.93892192	-5.74278029	-0.86894659	-2.91500849									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015675-11	Milrinone	170465221	Phosphodiesterase III (PDE3) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	78415-72-2	 ; Milrinone Lact; Milrinone;Milrinone			4.6609512478	4	7		0	2.04304073			5139	PDE3A	N#CC1=CC(=C(C)NC1=O)c2ccncc2	Prestwick	Prestw-1065	0	0	0	2.48074849	0	2.64749225	2.04304073									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183029-02	Troxipide	170465889	reactive oxygen species biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	30751-05-4				7.1325091376	4	7		0	1.6983093					O=C(NC1CCCNC1)c2cc(OC)c(OC)c(OC)c2	Sequoia	30751-05-4	0.16217655	3.36452708	-0.19741171	1.19647829	0	4.40571167	1.6983093									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00483924-02	Brigatinib	384569265	IGF-1R Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1197953-54-0		15.6334750258	-4.8059444758	-50.3872650393	-2.2	7		-36.35976332	-33.30637873	0.0002831723	0.9930617646		IGFR1	COC1=C(NC2=NC=C(Cl)C(=N2)NC3=CC=CC=C3[P](C)(C)=O)C=CC(=C1)N4CCC(CC4)N5CCN(C)CC5	MedChem Express	HY-12857	-6.47645032	-4.67324263	-6.86575561	-7.41061198	-7.3925338	-14.35080797	-33.30637873									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181335-02	Fosfestrol tetrasodium	225144324	estrogen-related receptor gamma Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	4719-75-9				10.5590510306	4	7		0	1.79803073			2104	ESRRG	CC\C(=C(\CC)C1=CC=C(O[P](O)(O)=O)C=C1)C2=CC=C(O[P](O)(O)=O)C=C2	Bosche	F12397	4.19662882	1.75333226	0	1.83102215	1.37109997	1.55956407	1.79803073									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00017147-02	CEFEPIME HYDROCHLORIDE		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	123171-59-5		13.9333492831	-4.8559444758	-3.0010220437	4	7		-14.461851308	-11.63487609	0.0022182989	0.9802746635			CO\N=C(/C(=O)N[C@H]1[C@H]2SC\C(=C(/N2C1=O)C(O)=O)C[N+]3(C)CCCC3)C4=CSC(=N4)N	Microsource	01502420	2.02779255	2.02129871	0.47584445	0.53083273	0.57743032	-1.08511838	-11.63487609									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181009-02	Timepidium bromide	170465823	Muscarinic acetylcholine receptor M5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	35035-05-3				0.7689772651	4	7		0	-2.24516006					[Br-].COC1C\C(C[N+](C)(C)C1)=C(/c2sccc2)c3cccs3	Bosche	T3573	2.01854378	0.68146642	1.48379082	-0.43261698	1.18099945	-2.07628711	-2.24516006									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164561-02	Zanamivir	170464662	Neuraminidase (Sialidase) Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_01	139110-80-8	 ; Zanamivir Anhydride;Zanamivir; Zanamivir; Relenza;Zanamivir (Relenza);Zanamavir			-16.2981125034	4	7		0	-3.39661859				NEU2	O[C@@H]([C@@H]1OC(=C[C@H](NC(=N)N)[C@H]1NC(C)=O)C(=O)O)[C@H](O)CO	Sequoia	SRP00400z	-5.10977174	-1.99135045	-3.37062221	-4.34695362	-2.46916713	-3.62823314	-3.39661859									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00186028-02	Levetiracetam	170464988	N-Type Calcium Channel (Ca(v) 2.2) Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	33996-58-6	Levetiracetam			14.626632553	4	7		0	-0.6754507				CACNA1B	O=C1CCCN1C(CC)C(N)=O	Prestwick	Prestw-1427	4.28449213	2.29388528	3.11994562	2.51853238	4.52201602	4.83370913	-0.6754507									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094740-05	NORETHYNODREL		Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	68-23-5		15.6334750258	-4.8059444758	-18.6020855534	-3	7		-41.679826856	-30.56652238	0.0000508896	0.9970769422			C[C@]12CCC\3C(CCC\4=C3CCC(=O)C4)C1CC[C@@]2(O)C#C	Microsource	01500439	1.17228144	1.93813671	1.49785518	0.96111124	-1.15723689	-7.93404735	-30.56652238									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165972-02	1-Phenyl-1-propanol		Glycolysis / Gluconeogenesis Activator	DPI_SARS-CoV-2_General	2019_NPC_02	93-54-9				-4.5685845539	4	7		0	1.04647291					CCC(O)C1=CC=CC=C1	SIGMA	111309	-1.4219982	-1.70251103	-4.1513326	0.76935669	0.55842026	-1.41863961	1.04647291									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00345881-04	Conivaptan hydrochloride		Vasopressin (AVP) V1a/V2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	168626-94-6		8.7913490634	-5.0559444758	-75.0114600785	-2.1	7		-103.814203496	-84.84516958	0.0000463807	0.9972071597		AVPR1A	CC1=NC2=C([NH]1)C3=CC=CC=C3N(CC2)C(=O)C4=CC=C(NC(=O)C5=CC=CC=C5C6=CC=CC=C6)C=C4	APExBIO	A8402	2.47173345	-0.5105223	4.28728816	-1.74216028	-6.67965687	-41.08417888	-84.84516958									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00142615-08	Epinephrine	170464973	alpha/beta-adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	51-43-4	 TEC solution;;(-)-Epinephrine bitartrate; L-Epinephrine; DL-Adrenaline; 4-(1-Hydroxy-2-; ; (+/-)-Adrenalin; TAC combination; L-(-)-EPINEPHRINE; Epinephrin; Asmatane mist; (+/-)-Epinephrine; Epinephrine; Epinefrina; (-)-Epinephrine bitartrate; dl-Adrenaline; (-)-Adrenalin; Adrenaline-L Bitartrate; Adrenalin chloride; Piladren; Sphygmogenin; Racepinephrine Hcl;Epinephrine; Levorenone; Racepinefrina; (-)-Epinephrine	5.3748585361	-5.2696329617	-21.0042841948	4	7		-27.9577577199	-26.2147981	0.0015330409	0.9836020753	148	ADRA1A	Oc1ccc(cc1O)[C@@H](O)CNC	Labotest	LT03210011	0	0	0	1.79847995	3.54007004	-4.31932517	-26.2147981									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00013565-03	D-Leucine	170465492	Mammalian target of Rapamycin (mTORC1) Activator	DPI_SARS-CoV-2_General	2019_NPC_01	328-38-1				2.7533849613	4	7		0	-1.42455198					CC(C)C[C@@H](N)C(=O)O	Bosche	L0932	-0.97547987	2.34808317	-1.10404328	1.37707879	0.43394407	3.09466944	-1.42455198									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00025179-12	Mifepristone	170465151	Progesterone Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	84371-65-3	RU-486; ;VX-410;RU-38486;VGX-410C;VGX-410;Mifepristone (Mifeprex); Corlux; Mifepristone;C-1073;CI-1073;Mifepristone; Mifeprex	2.7800686746	-5.5559444758	-128.0946398189	-2.1	7		-103.8451496752	-95.22699044	0.0000763215	0.9964124798	5241	PGR	CN(C)c1ccc(cc1)[C@H]5C[C@@]2(C)[C@@H](CC[C@@]2(O)C#CC)[C@@H]4CCC3=CC(=O)CCC3=C45	Prestwick	Prestw-299	1.36760826	0.22234711	0.61660696	-10.04088595	-27.35877785	-76.23354845	-95.22699044									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018277-06	Mebeverine hydrochloride	170466168		DPI_SARS-CoV-2_General	2019_NPC_01	2753-45-9		7.8352981002	-5.1059444758	-5.1701296618	4	7		-13.602380164	-9.25198347	0.041585663	0.9038321068			Cl.COc1cc(ccc1OC)C(=O)OCCCCN(CC)C(C)Cc2ccc(OC)cc2	Microsource	01501117	1.69196137	2.07931195	-0.91881748	2.94228309	-1.73323859	-4.42603791	-9.25198347									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274280-01	Pixantronemaleate	225144373	DNA Modulator	DPI_SARS-CoV-2_General	2019_NPC_01			4.9437388825	-5.3059444758	-92.6061876202	-2.2	7		-90.836772196	-78.61397683	0.0000376265	0.9974857075			NCCNC1=C2C(=O)C3=C(C=NC=C3)C(=O)C2=C(NCCN)C=C1	GVK	FFS-12-73-NCI-2833	3.82204149	-1.16548977	-1.63047452	-3.88541902	-18.54286149	-51.68961837	-78.61397683									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015829-12	Promazine hydrochloride	170464766	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	53-60-1		9.8640558873	-5.0059444758	-39.7566104177	-2.2	7		-72.8561760204	-52.92134547	0.0000761117	0.996418372			Cl.CN(C)CCCN1c3ccccc3Sc2ccccc12	Microsource	01500509	2.59966596	4.54712048	4.7403183	0.96069431	-6.02700096	-23.7105544	-52.92134547									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023016-07	Cefmetazole sodium	170465052	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	56796-39-5		17.5410474839	-4.7559444758	-54.1942813129	4	7		-9.6733470759	-19.63955286	0.1542680454	0.7794369102			[Na+].N#CCSCC(=O)N[C@]3(OC)C(=O)N2C(=C(CSc1nnnn1C)CS[C@@H]23)C([O-])=O	Prestwick	Prestw-700	-10.92876334	-8.66176363	-8.82990909	-9.96061906	-14.20849617	-10.4781747	-19.63955286									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522025-01	Mepitiostane (Contains ~15% 3a,4a-Epithio isomer)		Estrogen receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	21362-69-6		1.3933349283	-5.8559444758	-4.8010627562	4	7		-14.9588500519	-10.00808638	0.0014150592	0.9842899247			COC1(CCCC1)O[C@H]2CC[C@H]3[C@@H]4CC[C@H]5C[C@@H]6S[C@@H]6C[C@]5(C)[C@H]4CC[C@]23C	Toronto Research	M224920	2.71220144	3.65219802	4.74203605	4.28641583	-2.58774327	-12.04904171	-10.00808638									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510142-01	Methylprednisolone aceponate			DPI_SARS-CoV-2_General	2019_NPC_02	86401-95-8		12.4181106199	-4.9059444758	-37.4272234312	4	7		-20.2122886279	-22.48965419	0.0112880755	0.9533811912			CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3C[C@H](C)\C4=C\C(=O)\C=C/[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O	Glixx	GLXC-08106	-6.46257717	-6.11471736	-6.32193338	-2.312747	-5.22063541	-10.35325066	-22.48965419									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160575-01	Uracil mustard	144205464	DNA Interacts	DPI_SARS-CoV-2_General	2019_NPC_02	66-75-1	Uracil Mustard; Uramustina; Uracil Mustard Capsules; Mustard, Uraci; 			7.9270247786	4	7	5-(Bis(2-chloroethyl)amino)-2,4-(1H,3H)pyrimidinedione;URACIL MUSTARD;LS-285;Uramustina;Mustard, Uraci;uramustinum;uramustine;URAMUSTINE;Uramustine;Uracil Mustard;CIPLUS_149101;2,4(1H,3H)-PYRIMIDINEDIONE, 5-(BIS(2-CHLOROETHYL)AMINO)-;2,4(1H,3H)-Pyrimidinedione, 5-(bis(2-chloroethyl)amino)-;Uracil Mustard Capsules;5-(BIS(2-CHLOROETHYL)AMINO)URACIL;Uracil mustard;Uramustinum;	0	-3.85767968					O=C1NC(=O)NC=C1N(CCCl)CCCl	SigmaAldrich	S375063	1.77345141	0.87089099	3.33091114	2.56997872	2.75883373	1.25422773	-3.85767968									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00166270-02	1,3,5-Trihydroxybenzene dihydrate	225144277	Voltage-gated calcium channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	6099-90-7				-10.0546683008	4	7		0	-4.23821529					OC1=CC(=CC(=C1)O)O	SIGMA	P38005	-0.45550186	-0.24717596	-2.58081151	-2.40628581	-1.1619894	-4.34986847	-4.23821529									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00188437-01	Sultamicillin tosylate	144206543	Staphylococcus Aureus Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	83105-70-8		8.7913490634	-5.0559444758	2.7683862634	4	7	Sultamicillin tosilate	-10.10431432	-7.5869286	0.1821291599	0.7509015832			O=S(=O)(O)c1ccc(C)cc1.O=C1C[C@@H]5N1[C@@H](C(=O)OCOC(=O)[C@@H]3N4C(=O)[C@@H](NC(=O)[C@H](N)c2ccccc2)[C@H]4SC3(C)C)C(C)(C)S5(=O)=O	APAC	812244	4.77005249	-1.27746079	0.44771571	2.87865678	4.36043058	-1.34347989	-7.5869286									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166142-04	Diperodon hydrochloride	170465536	sodium ion transmembrane transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	537-12-2		15.6334750258	-4.8059444758	-39.116496295	-2.4	7		-30.0128019999	-27.76958569	0.0016188928	0.9831468814			Cl.O=C(Nc1ccccc1)OCC(OC(=O)Nc2ccccc2)CN3CCCCC3	Prestwick	Prestw-300	-2.34225069	-5.29233755	-5.22491268	-5.91866801	-5.28717059	-11.0249906	-27.76958569									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091533-10	Ethinylestradiol	170464983	Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	57-63-6	;ETHINYL ESTRADIOL; Minulet; Ovulen 50; Conova 30; Oviol; Ovoresta M; Ovostat; Serial C; Varnoline;Ethinyl Estradiol; ; Trikvilar; Desogen (contraceptive); Practil 21; Yermonil (CIBA); Ministat; Oraconal; Mircette; Modicon; Valdys;17alpha-Ethinylestradiol; 17alpha-Ethinylestradiol; Cilest; Novacyclin 22;Ethinylestradiol; Ethinyl estradiol;Ethinyl estradiol; Ortho-Cept; Fisioquens; Femovan; Diane-35; Etinilestradiol; Ethynyl estradiol; Femodene; Gynatrol; Diane; Lestrin; Tri-Ervonum; Bisecurin II; Ovulen-50; Ovidol;17alpha-Ethynylestradiol; Estinyl; Oracon; Demulen; Triregol	12.4181106199	-4.9059444758	-37.3338690544	-2.2	7		-51.30826849	-39.24868825	0.0001519163	0.9949295433	2099	ESR1	Oc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)c4cc3	Prestwick	Prestw-1405	1.13523588	-1.65416473	-0.19253735	-1.87874683	-4.86474141	-16.32196758	-39.24868825									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095911-06	Quetiapine	170465146	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	111974-69-7		15.6334750258	-4.8059444758	0.2610842712	4	7		-26.912435676	-16.17702973	0.0012122981	0.9854841386			OCCOCCN1CCN(CC1)C3=Nc4ccccc4Sc2ccccc23	Microsource	01505187	1.60482173	4.32721675	3.28288367	3.99578599	2.55544841	-3.14040348	-16.17702973									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249922-01	Estriol benzoate diacetate	170465998		DPI_SARS-CoV-2_General	2019_NPC_01	2508-47-6		2.7800686746	-5.5559444758	-30.8162393404	4	7		-25.714822912	-0.37007934	7.775E-7	0.9999626546			CC(=O)O[C@@H]4C5(C)CCC2C(CCc3cc(OC(=O)c1ccccc1)ccc23)C5C[C@H]4OC(C)=O	GVK	FFS-11-286-NCI-200	0	0	0	0.03010008	-3.61112521	-23.09568576	-0.37007934									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090782-06	Nelfinavir mesylate	170465351	HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_01	159989-65-8	 Mesylate, Nelfinavi;; ; Viracept; Nelfinavir mesylate;Nelfinavir mesylate;Nelfinavir; Viracept 250mg; Nelfinavir mesilate; Nelfinavir Mesilate	5.5469662594	-5.2559444758	-68.0123227	-2.2	7		-68.6309599296	-63.54718512	0.0000801212	0.9963243123			CS(=O)(=O)O.Oc1cccc(c1C)C(=O)N[C@@H](CSc2ccccc2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C	Tocris	3766	-2.8828698	1.80565397	0.7433404	-1.57774601	-9.43257372	-38.1320189	-63.54718512									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015207-12	Cilostazol	170465347	Phosphodiesterase III (PDE3) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	73963-72-1	Cilostazol;CILOSTAZOL;; ; Pletal; Pletaal; Cilostazole; Cilostazol	15.6334750258	-4.8059444758	-48.4097595314	4	7		-13.4458522439	-21.40883628	0.073538428	0.8641174306	5139	PDE3A	O=C1CCc2cc(ccc2N1)OCCCCc4nnnn4C3CCCCC3	Microsource	01505230	-12.57957544	-8.68131063	-8.69342692	-6.45395941	-7.62574227	-9.47202602	-21.40883628									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183017-01	Ethyl 4-nitrophenyl ethylphosphonate	144206877		DPI_SARS-CoV-2_General	2019_NPC_01	546-71-4	Ethyl-p-Nitrophenyl Ethylphosphonate; Armin; Armine; 			9.2321234627	4	7	ETHYL 4-NITROPHENYL-ETHYL PHOSPHONATE;Armine;p-Nitrophenyl-O-ethyl ethylphosphonate;ETHYL 4-NITROPHENYL ETHYLPHOSPHONATE;Ethyl 4-nitrophenyl ethylphosphonate;LS-106606;CIPLUS_208139;Ethyl-p-Nitrophenyl Ethylphosphonate;Ethyl 4-Nitrophenyl Ethylphosphonate;Armin;	0	0.93280272					[O-][N+](=O)c1ccc(OP(=O)(OCC)CC)cc1	Pharmaron	PH-NIH-183377	2.73763706	1.86429496	1.74258487	1.98409712	2.42856418	1.83444281	0.93280272									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015725-15	Nimesulide	170465612	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	51803-78-2	; ;NIMESULIDE; Nimesulide;Nimesulide; Nimesulida	11.0676527398	-4.9559444758	0.8539455661	4	7		-14.6125573439	-12.17713112	0.0312060823	0.9182471659	5743	PTGS2	[O-][N+](=O)c2cc(Oc1ccccc1)c(cc2)NS(C)(=O)=O	Vitas	STL018679	3.85592913	0	0	3.29345072	3.44363802	-0.06097871	-12.17713112									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015399-16	Etodolac	170464915	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	41340-25-4	; ; Etodolac;Etodolac; Etodolaco; 6-OH etodolac glucuronide;ETODOLAC; Etodolac, (+-)-Isomer; Lodine; Etodolac, Monosodium Salt			-14.9233427375	4	7		0	-10.66132671			5743	PTGS2	O=C(O)CC3(CC)OCCc2c3nc1c(cccc12)CC	Microsource	01501005	-4.33519715	-1.87895521	-1.82544905	-2.41553164	-1.00238542	-1.98688958	-10.66132671									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159324-04	2-Ethylhexyl salicylate	170465498		DPI_SARS-CoV-2_General	2019_NPC_01	118-60-5		22.0828704269	-4.6559444758	-4.8490149736	-2.4	7		-33.527299688	-27.52274974	0.0037995677	0.9737596971			Oc1ccccc1C(=O)OCC(CC)CCCC	Bosche	E1869	3.57998693	1.88384196	0	4.34193694	0	4.13638904	-27.52274974									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00319020-01	NCGC00319020-01	225144374	Prostanoid IP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02					5.5295074586	4	7		0	-4.30005232					CCCCC[C@@H](O)CC[C@@H]1[C@@H](O)C[C@H]2CC3=C(C[C@@H]12)C=CC=C3OCC(O)=O	GVK	FFS-11-286-NCI-96	3.26250318	1.55004736	3.36841612	1.03594229	2.24080983	-0.20199173	-4.30005232									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346455-05	Cobimetinib		Mek Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1453848-26-4		13.9333492831	-4.8559444758	-33.2515937799	-2.2	7		-64.9522665643	-48.82747467	0.0002143568	0.9939654604		MAP2K1	OC1(CN(C1)C(=O)C2=C(NC3=C(F)C=C(I)C=C3)C(=C(F)C=C2)F)[C@@H]4CCCCN4	ActiveBioChem	A-1318	2.19427039	4.14192982	-0.21330958	0.40455534	-2.07922439	-15.12119504	-48.82747467									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181094-01	Sodium tyropanoate	144206263		DPI_SARS-CoV-2_General	2019_NPC_02	7246-21-1	TYROPANOATE SODIUM; Bilopaque; Tyropanoate; Tyropanoic acid; Sodium, Tyropanoat; Tiropanoato sodico; Tyropanoate, Sodiu; 	9.8640558873	-5.0059444758	-3.0252971796	4	7	Benzenepropanoic acid, alpha-ethyl-2,4,6-triiodo-3-((1-oxobutyl)amino)-;Bilopaque;BENZENEPROPANOIC ACID, .ALPHA.-ETHYL-2,4,6-TRIIODO-3-((1-OXOBUTYL)AMINO)-;natrii tyropanoas;Tyropanoate de sodium;Sodium, Tyropanoat;Sodium tyropanoate;Natrii tyropanoas;WIN 8851;BENZENEPROPANOIC ACID, .ALPHA.-ETHYL-2,4,6-TRIIODO-3-((1-OXOBUTYL)AMINO)-, MONOSODIUM SALT;Tyropanoate sodium;TYROPANOATE SODIUM;Tyropanoic acid;WIN8851;Tyropanoate;WIN-88512;Tiropanoato sodico;CIPLUS_166239;SODIUM TYROPANOATE;2-(3-(BUTYRYLAMINO)-2,4,6-TRIIODOBENZYL)BUTANOIC ACID;Tyropanoate Sodium;CIPLUS_175604;Tyropanoate, Sodiu;TYROPANIC ACID;Sodium Tyropanoate;tyropanoate de sodium;	-16.5418826999	-13.78490225	0.0178608156	0.9401677357			[Na+].O=C(Nc1c(I)c(CC(CC)C([O-])=O)c(I)cc1I)CCC	NCI	NSC-107434	3.86829753	-0.80620943	2.32296477	1.01255758	2.62576337	-2.83258174	-13.78490225									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160628-03	Rutin trihydrate	170465691	Aldose reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	153-18-4		13.9333492831	-4.8559444758	-6.9489412034	4	7		-25.503688116	-16.25307343	0.0071244646	0.963544622			Oc1ccc(cc1O)C=4Oc5cc(O)cc(O)c5C(=O)C=4O[C@@H]3O[C@H](CO[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]3O	Enzo	NP266	3.91886331	3.49646932	0	0.63962676	-0.02791453	-5.58463337	-16.25307343									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018200-12	Phenolphthalein	170465559	store-operated calcium entry Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	77-09-8		13.9333492831	-4.8559444758	-50.3919245124	-2.2	7		-55.8532616227	-44.65793009	0.0007938523	0.988279958			Oc1ccc(cc1)C3(OC(=O)c2ccccc23)c4ccc(O)cc4	Vitas	STK029876	-5.98116816	-0.49600508	-2.8539397	-3.14295031	-7.36689844	-18.76111591	-44.65793009									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179542-03	Brinzolamide	170464926	Carbonic anhydrase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	138890-62-7				7.1778698481	4	7		0	3.66530633					NS(=O)(=O)c1cc2[C@H](CN(CCCOC)S(=O)(=O)c2s1)NCC	Prestwick Chemical, Inc.	Prestw-365	1.04325515	0.18813986	2.69796008	0	3.41318581	0.19309924	3.66530633									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253608-01	Chlorexolone	170466039		DPI_SARS-CoV-2_General	2019_NPC_01	2127-01-7				11.1186324976	4	7		0	2.25089351					NS(=O)(=O)c1cc2C(=O)N(Cc2cc1Cl)C3CCCCC3	GVK	FFS-11-286-NCI-259	0	2.44581816	4.07253053	0	4.73785718	2.95238579	2.25089351									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00013841-09	Cyclobenzaprine hydrochloride	170464953	5-HT2A Receptor Ligands	DPI_SARS-CoV-2_General	2019_NPC_01	6202-23-9	 Lisseril; ; Flexeril; Ciclobenzaprina;CYCLOBENZAPRINE HYDROCHLORIDE; Cyclobenzaprine hydrochloride;Cyclobenzaprine hydrochloride	13.9333492831	-4.8559444758	-15.1054248718	-3	7		-41.2576360519	-30.21469671	0.0008663001	0.987751525	3356	HTR2A	Cl.CN(C)CC\C=C2/c3ccccc3C=Cc1ccccc12	Microsource	01503207	2.73279597	2.32364942	0	4.21651993	-0.05836675	-7.94755831	-30.21469671									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168290-05	Avermectin B1a			DPI_SARS-CoV-2_General	2019_NPC_02	65195-55-3		4.9437388825	-5.3059444758	-105.5851058344	-2.2	7		-72.426651045	-76.13090425	0.0000457503	0.9972264612			CC[C@H](C)[C@H]1O[C@@]2(C[C@@H]3C[C@@H](C/C=C(C)/[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)/C=C/C=C/6CO[C@@H]7[C@H](O)\C(=C/[C@@H](C(=O)O3)[C@]67O)C)O2)\C=C/[C@@H]1C	MedChem Express	HY-15308	-7.99787278	-6.53976761	-8.03778627	-4.4688165	-15.75695649	-51.09921082	-76.13090425									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181096-01	Chlophedianol	144206265		DPI_SARS-CoV-2_General	2019_NPC_02	791-35-5	CHLOPHEDIANOL HYDROCHLORIDE; Coldrin; Baltix; 	3.499899101	-5.4559444758	-38.9212181006	4	7	sl 501;BENZENEMETHANOL, 2-CHLORO-.ALPHA.-(2-(DIMETHYLAMINO)ETHYL)- .ALPHA.-PHENYL;CHLOPHEDIANOL;Clofedanol hydrochloride;2-chloro-alpha-(2-dimethylaminoethyl)benzhydrol;clofedanol;Clofedanolum;clofedanol hydrochloride;Baltix;1-(2-CHLOROPHENYL)-3-(DIMETHYLAMINO)-1-PHENYLPROPAN-1-OL;2-CHLORO-.ALPHA.-(2-(DIMETHYLAMINO)ETHYL)BENZHYDROL HYDROCHLORIDE;CIPLUS_660723;chlophedianol;CLOFEDANOL;CHLOPHEDIANOL HYDROCHLORIDE;BENZENEMETHANOL, 2-CHLORO-.ALPHA.-(2-(DIMETHYLAMINO)ETHYL)-.ALPHA.-PHENYL-, HYDROCHLORIDE;Coldrin;1-Phenyl-1-(o-chlorophenyl)-3-dimethylaminopropanol;Benzhydrol, 2-chloro-alpha-(2-(dimethylamino)ethyl)-, hydrochloride;Chlophedianol;Clofedanol Hydrochloride;chlophendianol hydrochloride;clofedanolum;Clofedanol;Benzhydrol, 2-chloro-alpha-(2-(dimethylamino)ethyl)-;CIPLUS_156451;Chlophedianol hydrochloride;1-(2-CHLOROPHENYL)-3-(DIMETHYLAMINO)-1-PHENYLPROPAN-1-OL HYDROCHLORIDE;LS-32307;LS-32306;	-19.3156728681	-20.2682776	0.0324886358	0.9161765361			OC(CCN(C)C)(c1ccccc1Cl)c2ccccc2	NCI	NSC-113595	-6.59668432	-0.83855021	-5.31867514	-4.62783247	-6.73668702	-16.48816234	-20.2682776									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179767-02	NCGC00179767-02	363676967	lipid metabolic process Modulator	DPI_SARS-CoV-2_General	2019_NPC_02			4.6302510042	-5.3343954654	-31.8326672886	4	7		-21.943753108	-18.36559958	0.0040546661	0.9729353366			CC(=O)OC(C)(C)\C=C\C(=O)[C@](C)(O)[C@H]1C(O)C[C@@]2(C)[C@@H]3C\C=C4/[C@@H](/C=C(/O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C	Analyticon	NP-005666	-1.00117922	-0.91247199	-2.31827665	-4.15078456	-3.00121189	-8.16422398	-18.36559958									7.02E-10	3.51E-9	1.75E-8	8.77E-8	4.39E-7	0.0000021899999999	0.000011								
NCGC00167520-06	Cilomilast		Phosphodiesterase IIII (PDE4) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	153259-65-5		11.0676527398	-4.9559444758	-32.1569826421	4	7		-12.2869724401	-16.25362698	0.0237420862	0.9301937284		PDE4A	COC1=CC=C(C=C1OC2CCCC2)C3(CCC(CC3)C(O)=O)C#N	APExBIO	A4329	-4.52496011	-4.26205272	-6.20004219	-6.64359376	-3.51448328	-8.74201428	-16.25362698									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253602-01	Thenyldiamine	170465520		DPI_SARS-CoV-2_General	2019_NPC_02	91-79-2				3.0718854731	4	7		0	-3.11563526					CN(C)CCN(Cc1ccsc1)c2ccccn2	GVK	FFS-11-286-NCI-087	0	0.49897203	0.71728276	4.01047635	-0.89584868	2.41450582	-3.11563526									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510317-02	Elbasvir		Nonstructural protein 5A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1370468-36-2		2.4777388143	-5.6059444758	-136.9339508553	-1.1	7		-93.5833593958	-88.92165723	0.0002364082	0.9936572066			COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C2=NC=C([NH]2)C3=CC=C4C(=C3)O[C@H]([N]5C6=C(C=C(C=C6)C7=CN=C([NH]7)[C@@H]8CCCN8C(=O)[C@@H](NC(=O)OC)C(C)C)C=C45)C9=CC=CC=C9	MedChem Express	HY-15789	-0.40463363	-2.19686294	-5.46400694	-9.3375114	-30.5800442	-80.90003758	-88.92165723									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166138-04	Ethynodiol diacetate	170464933	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	297-76-7		7.8352981002	-5.1059444758	-30.623415716	-2.2	7		-49.5957760576	-43.63316368	0.0010163396	0.9867024593	5241	PGR	CC(=O)O[C@@]4(C#C)CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CCC1=C[C@H](CC[C@@H]12)OC(C)=O	Prestwick Chemical, Inc.	Prestw-908	3.9376633	3.98946615	2.51048967	-2.23791596	0.40633985	-19.38650883	-43.63316368									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181016-04	Bexarotene	170465308	Retinoid RXR Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	153559-49-0	 ; LG69 compound; Bexarotene;Bexarotene;Targretin; Elan brand of bexarotene; Bexarotene (Targretin); 3-methyl-TTNEB	3.499899101	-5.4559444758	-71.1057958828	-2.2	7		-60.344598776	-57.37049898	0.0000615893	0.9967798434	6256	RXRA	O=C(O)c1ccc(cc1)C(=C)c2cc3c(cc2C)C(C)(C)CCC3(C)C	CiVentiChem	CV-1209	1.99542186	-0.82930999	-0.55085441	-3.8888759	-11.75058812	-43.38594513	-57.37049898									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181140-02	Carboquone	124893654	cell growth Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			11.0676527398	-4.9559444758	-13.2432611316	-2.4	7		-31.4604956439	-27.88374637	0.0022612824	0.9799612219			CO[C@@H](COC(N)=O)\C1=C(/N2CC2)C(=O)\C(=C(\N3CC3)C1=O)C	NCI	NSC-134679	2.27750931	1.62396914	-1.73694944	2.64013283	2.86338902	-5.50544908	-27.88374637									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159365-04	m-Cresyl acetate	170466849		DPI_SARS-CoV-2_General	2019_NPC_01	122-46-3				6.9770155166	4	7		0	2.09880611					O=C(C)Oc1cc(C)ccc1	Labotest	LTBB001299	-0.33161475	1.90827571	2.14228266	0.6295934	2.46409176	1.5752833	2.09880611									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167499-02	Roxatidine acetate hydrochloride	170465941		DPI_SARS-CoV-2_General	2019_NPC_01	93793-83-0				-3.9604256183	4	7		0	-0.31938354					Cl.CC(=O)OCC(=O)NCCCOc2cc(CN1CCCCC1)ccc2	Prestwick Chemical, Inc.	Prestw-428	-2.84414107	2.34319642	-2.32750847	-2.92221637	-2.23062478	2.46963768	-0.31938354									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095135-05	Almotriptan	170465288	5-HT1B Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	154323-57-6	; ; ALMOTRIPTAN; Almogran; Almotriptan;ALMOTRIPTAN; Axert			-48.3308741081	4	7		0	-13.65744848			3351	HTR1B	O=S(=O)(Cc1ccc2ncc(CCN(C)C)c2c1)N3CCCC3	Microsource	01505204	-9.66523854	-8.07046693	-8.91764763	-9.19808363	-9.76247272	-13.53727324	-13.65744848									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021145-11	Loxapine succinate	170465094	Muscarinic acetylcholine receptor M1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	27833-64-3		13.9333492831	-4.8559444758	-18.4874860875	-3	7		-51.7500443547	-40.27781298	0.0005622297	0.9901670996	1128	CHRM1	O=C(O)CCC(=O)O.CN1CCN(CC1)C3=Nc4ccccc4Oc2ccc(Cl)cc23	Microsource	02300242	2.6069276	4.13663352	1.86931832	4.42220383	-1.0886667	-7.93231363	-40.27781298									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091585-05	Octocrylene	170464719	photosensitizer	DPI_SARS-CoV-2_General	2019_NPC_01	6197-30-4	2-Ethylhexyl-2-cyano-3,3-diphenylacrylate; ; 2-Ethylhexyl-2-cyano-3,3-diphenylacrylate; "2-Ethylhexyl-2-cyano-3; Octocrileno;OCTOCRYLENE	1.5633475026	-5.8059444758	-124.4071452904	-1.1	7		-92.103353525	-88.92550252	0.000022486	0.9980580434		CAT	CCC(CCCC)COC(=O)C(\C#N)=C(\c1ccccc1)c2ccccc2	Labotest	LT00159303	4.61113935	1.36584651	0.07555263	-1.60282941	-38.2048419	-77.05167946	-88.92550252									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015611-18	Lidocaine	170464729	Sodium channel protein type IX alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	137-58-6		22.0828704269	-4.6559444758	-68.1815851514	-3	7		-50.0302721778	-53.40295557	0.001954621	0.9813995418			O=C(Nc1c(C)cccc1C)CN(CC)CC	Vitas	STK552033	-9.83467674	-6.54091431	-7.8062928	-13.18132792	-11.62513323	-8.58275319	-53.40295557									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00388389-01	N-acetyl-D-Glucosamine			DPI_SARS-CoV-2_General	2019_NPC_02	7512-17-6				4.3615616606	4	7		0	0.52799315					CC(=O)NC(C=O)C(O)C(O)[C@H](O)CO	Cayman	13136	2.66595759	3.89706392	0.2179977	0.08184646	0.47287503	-1.40924464	0.52799315									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00013037-01	Thanite	144203555		DPI_SARS-CoV-2_General	2019_NPC_02	115-31-1	isobornyl thiocyanoacetate; 			6.6114646479	4	7	CIPLUS_151404;isobornyl thiocyanoacetate;CIPLUS_745354;ISOBORNYL THIOCYANOACETATE;thanite;isobornyl thiocyanoacetate, (exo)-isomer;	0	-1.75522047					N#CSCC(=O)O[C@@H]1C[C@H]2CC[C@]1(C)C2(C)C	NCI		0	3.83700247	0	3.46795127	0	3.48083427	-1.75522047									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389499-01	TELITHROMYCIN		Ketolide antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	191114-48-4		7.8352981002	-5.1059444758	-21.8269970943	4	7		-29.655662844	-27.21305237	0.0008639113	0.9877726153			CCC1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](OC2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@@H](C)[C@@H]3N(CCCC[N]4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC	Microsource	01505265	1.81507087	1.98895793	-0.54147817	-1.40074363	-0.33980467	-12.16647877	-27.21305237									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017256-17	Galanthamine		Acetylcholinesterase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_02	357-70-0				-10.8205865954	4	7		0	-2.31175379				ACHE	COC1=CC=C2CN(C)CC[C@@]34\C=C/[C@H](O)C[C@@H]3OC1=C24	MedChem Express	HY-76299	-1.2139009	-2.02129871	-3.2605893	-0.85821855	-2.99645938	-3.42446449	-2.31175379									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181159-03	Trabectedin	384568393	DNA-Damaging Drug	DPI_SARS-CoV-2_General	2019_NPC_02	114899-77-3		1.5998037708	-5.7959332839	-117.8664376335	-2.2	7		-67.6497219555	-65.58055463	0.0001387328	0.9951539585		H2AFX	COC1=CC2=C(CCN[C@]23CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=C6C(=C(OC)C(=C7)C)O)[C@H](O)N5[C@@H](COC3=O)C8=C4C(=C(C)C9=C8OCO9)OC(C)=O)C=C1O	MedChem Express	HY-50936	-2.77694282	-5.08905265	-6.15784909	-1.59717513	-5.87648219	-33.51183766	-65.58055463									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00025167-02	Formoterol hemifumarate		Voltage-Gated K(V) 7 (KCNQ) Channel Activator	DPI_SARS-CoV-2_General	2019_NPC_02	1448		17.5410474839	-4.7559444758	-34.4643366406	4	7		-11.875856404	-17.33815345	0.0306259065	0.9193632381			COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC(=C(O)C=C2)NC=O)C=C1	Tocris	1448	-5.42671507	-7.02025919	-8.28625677	-4.52493978	-5.11608013	-6.02217212	-17.33815345									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160395-04	Dibenzepin hydrochloride	170466001	Monoamine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	315-80-0				3.0691979329	4	7		0	-3.54870599					Cl.CN(C)CCN3c1ccccc1N(C)c2ccccc2C3=O	Enzo	NS107	0.97547987	0	0	0	3.60097447	2.52553483	-3.54870599									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015562-25	Indomethacin	170464705	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	53-86-1	 Indocin;; Cu salt; Indocid; Al salt; Indocin I.V.; ; Li salt; Cu(2+) salt; Metindol; Mg salt; Indomethacin; Ca salt; Osmosin; Cu-IMCC; Zn salt; Combiflex;Indomethacin; Indomet 140; Amuno; NH4 salt;INDOMETHACIN; Indometacina	11.0676527398	-4.9559444758	-18.8907450833	4	7		-21.922929712	-21.18577476	0.0041876446	0.9724334567		PTGS2	Clc1ccc(cc1)C(=O)n3c2ccc(cc2c(CC(=O)O)c3C)OC	Microsource	01500350	-0.86413478	-0.35917609	-2.83931661	-1.67306293	1.16479724	-6.49931399	-21.18577476									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016855-10	Fenbendazole	170465647	antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC_01	43210-67-9	; ; Phenbendasol; Fenbendazole; Panacur;FENBENDAZOLE; Fenbendazol;Fenbendazole	4.9437388825	-5.3059444758	-8.0042917081	4	7		-14.7440875999	-13.120073	0.0068010691	0.9644703484		CYP3A4	O=C(OC)Nc1nc2cc(ccc2n1)Sc3ccccc3	Vitas	STK378581	2.39876068	0	3.20489386	0.07023353	0.96685784	-8.12541288	-13.120073									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095304-05	Furazolidone	170464641	DNA Crosslinking Agent	DPI_SARS-CoV-2_General	2019_NPC_01	67-45-8				4.3756046001	4	7		0	-0.81620238					[O-][N+](=O)c2oc(/C=N/N1CCOC1=O)cc2	Vitas	STK388219	2.07924866	0.22234711	0.64585314	2.12958086	2.18494645	-0.32013822	-0.81620238									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183003-01	Depolipon	144206803		DPI_SARS-CoV-2_General	2019_NPC_01	16488-48-5	p-Butylaminobenzoyldiethylaminoethyl hydrochloride; Calvital liquid; T cain; 	15.6334750258	-4.8059444758	-26.796564774	4	7	P-BUTYLAMINOBENZOYLDIETHYLAMINOETHYL HYDROCHLORIDE;Calvital liquid;T cain;CIPLUS_170427;p-Butylaminobenzoyldiethylaminoethyl Hydrochloride;p-Butylaminobenzoyldiethylaminoethyl hydrochloride;CIPLUS_162500;	-17.476732836	-15.44701022	0.0218735993	0.9332662257			[Cl-].CC[NH+](CC)CCOC(=O)c1ccc(NCCCC)cc1	Pharmaron	PH-NIH-101688	-3.95759204	-2.13306619	-2.67358826	-3.72990192	-6.92534132	-7.39366838	-15.44701022									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015701-06	Metyrosine	170465112	Tyrosine 3-hydroxylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	672-87-7				19.5185657918	4	7		0	4.05566399					Oc1ccc(C[C@](C)(N)C(=O)O)cc1	Vitas	STK272180	2.56335778	2.6266279	4.05303307	4.71317129	3.40811044	2.98287515	4.05566399									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00015854-10	Propantheline bromide	170464881	Muscarinic acetylcholine receptor M4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	50-34-0				-10.7012542263	4	7		0	-7.51818712					[Br-].CC(C)[N+](C)(CCOC(=O)C1c3ccccc3Oc2ccccc12)C(C)C	Microsource	01500511	-0.98516206	-0.53021233	-1.87419268	-0.52424311	-3.07821144	-2.6779816	-7.51818712									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185741-02	Nepafenac	170465203	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	78281-72-8	Nepafenac	13.9333492831	-4.8559444758	-52.4212088787	4	7		-14.1257262079	-22.94491901	0.0113423571	0.9533748425	5743	PTGS2	Nc1c(cccc1CC(N)=O)C(=O)c2ccccc2	Selleck	S1255	-7.84014717	-8.39787915	-11.15010602	-9.91546893	-10.24970817	-10.38162508	-22.94491901									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016960-07	Glimepiride	170464966	K(ATP) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	93479-97-1	 Glimepride; Glimepiride; Amaryl;Glimepiride; 	8.7913490634	-5.0559444758	-2.264861965	4	7		-14.4543864599	-12.04532205	0.0173799466	0.9411316801		KCNJ8	CC=3CN(C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C(=O)C=3CC	Sequoia	SRP01525g	0.64628567	2.43604466	-0.20716044	2.38041488	3.56544689	-2.95238579	-12.04532205									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378665-02	Ixabepilone		Microtubule-Stabilizing Agents	DPI_SARS-CoV-2_General	2019_NPC_02	219989-84-1				-8.7847253319	4	7		0	-3.96232698				TUBB	C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(C)=C\C3=CSC(=N3)C	Adooq	A11449	0.46012625	-5.02437109	-0.06797778	-1.65797535	-0.44911247	-2.82788425	-3.96232698									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166055-04	SODIUM NITROPRUSSIDE			DPI_SARS-CoV-2_General	2019_NPC_02	13755-38-9		5.5469662594	-5.2559444758	-49.6630672801	-2.2	7		-62.0242353556	-52.21424154	0.0002148022	0.9939584496			[O]=[N][Fe--]([C]#[N])([C]#[N])([C]#[N])([C]#[N])[C]#[N]	Microsource	01300037	0.63354066	4.68710296	0	2.50450156	-7.92481525	-31.55768508	-52.21424154									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181109-03	Decoquinate	170466244	Antiprotozoal agent	DPI_SARS-CoV-2_General	2019_NPC_02	18507-89-6		1.106765274	-5.9559444758	-30.2132369818	4	7		-19.5820767759	-17.98506398	0.0090529954	0.9585881975			O=C(OCC)c1cnc2cc(OCC)c(cc2c1O)OCCCCCCCCCC	Microsource	01505356	1.77345141	-0.17325418	-0.62117625	-2.29871618	0.77228334	-2.48966554	-17.98506398									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00253613-01	Anileridine	170465266		DPI_SARS-CoV-2_General	2019_NPC_02	144-14-9		11.0676527398	-4.9559444758	-54.7837431997	-2.2	7		-68.5875945371	-58.77848071	0.0002531555	0.9934355274			O=C(OCC)C2(CCN(CCc1ccc(N)cc1)CC2)c3ccccc3	GVK	FFS-11-286-NCI-043	2.02779255	-3.277969	-1.50254331	-3.36973552	-4.17033006	-23.68940248	-58.77848071									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346691-02	Canagliflozin		SGLT-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	842133-18-0		9.8640558873	-5.0059444758	-22.6713021915	-2.2	7		-39.272725108	-34.6763069	0.0009118584	0.9874240068		SCL5A2	CC1=C(CC2=CC=C(S2)C3=CC=C(F)C=C3)C=C(C=C1)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O	Selleck	S2760	0.83701357	0	0	4.39398545	-0.14495164	-11.33972191	-34.6763069									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00521081-01	Cycrimine Hydrochloride			DPI_SARS-CoV-2_General	2019_NPC_02	126-02-3				6.9233873603	4	7		0	0.37577891					OC(CCN1CCCCC1)(C2CCCC2)C3=CC=CC=C3	Toronto Research	C991450	0	4.27129294	0	3.25748895	0	2.09507704	0.37577891									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00387269-01	Rifaximin		Pregnane X Receptor (PXR) Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	[80621-81-4]		12.4181106199	-4.9059444758	-39.0492525462	-2.2	7		-66.2599296036	-49.06055273	0.000205481	0.99409293		rpoB	CO[C@H]1\C=C/O[C@@]2(C)OC3=C(C)C(=C4C(=C(NC(=O)\C(=C/C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C)C5=C(N=C6C=C(C)C=C[N]56)C4=C3C2=O)O)O	Tocris	5359	3.17463988	2.86215898	0.22737395	-1.23237378	-4.57904617	-19.21739947	-49.06055273									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095129-06	Valdecoxib	170465163	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	181695-72-7		24.777388143	-4.6059444758	-21.6634743878	4	7		-13.615022544	-11.95913919	0.311479129	0.6179829798		COX2	NS(=O)(=O)c1ccc(cc1)c3c(C)onc3c2ccccc2	SIGMA	PZ0179	-3.90434004	-0.61328707	-6.32448636	-4.62287105	-2.61635284	-4.00935007	-11.95913919									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016801-05	Levobunolol hydrochloride	170464743	Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	27912-14-7				15.1656065188	4	7		0	3.69572381					Cl.CC(C)(C)NC[C@H](O)COc2cccc1c2CCCC1=O	Prestwick Chemical, Inc.	Prestw-847	3.28468037	4.82077846	2.87343716	0	4.69725423	3.33858428	3.69572381									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167523-03	Ormetoprim	170465718	Folate biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	6981-18-6				-53.7147935854	4	7		0	-16.76003143					Nc2nc(N)ncc2Cc1cc(OC)c(OC)cc1C	Sequoia	SRP01245o	-9.23438143	-7.2983605	-13.46542858	-11.34522287	-11.28000812	-11.87052188	-16.76003143									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263540-04	Asenapine		Dopamine D1/D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	65576-45-6				5.121846395	4	7		0	-0.37102221				HTR2A	CN1C[C@@H]2[C@@H](C1)C3=C(OC4=C2C=CC=C4)C=CC(=C3)Cl	MedChem Express	HY-10121	-1.09366691	3.50897457	1.81664752	-0.15200056	2.92517168	0.56839534	-0.37102221									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181041-01	5-Chloro-2-methyl-3(2H)-isothiazolone	144206242	aerobic respiration Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	26172-55-4				16.2323435516	4	7	MBC-215;5-chloro-N-methylisothiazolone;5-Chloro-2-methyl-4-isothiazolin-3-one solution;5-chloro-2-methyl-4-isothiazolin-3-one hydrochloride;5-Chloro-2-methyl-3(2H)-isothiazolone;5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE;5243-K-Cg;CIPLUS_182875;Kathon 886 biocide;MBC 215;5-Chloro-2-methyl-isothiazol-3-one;Kathon CG;5-chloro-2-methylisothiazolin-3-one;CIPLUS_182376;CIPLUS_180763;methylchloro-isothiazolinone;CIPLUS_175198;METHYLCHLOROISOTHIAZOLINONE;LS-86318;LS-174152;CIPLUS_694515;5-chloro-2-methyl-4-isothiazolin-3-one;Kathon 886;Kathon WT;Kathon biocide;kathon cg 5243;	0	3.59606146					ClC1=CC(=O)N(C)S1	SigmaAldrich	344	0.71446739	4.04028737	2.70739083	4.66524799	4.17033006	4.2371289	3.59606146									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182973-01	Chromonar hydrochloride	144206761	Platelet Aggregation (Plug Formation) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	655-35-6	Carbocromene; Intercordin; Carbocromeno; Cardiocap; Carbocromen Hydrochloride; Carbochromene; Carbocromen hydrochloride; Intensain; Hydrochloride, Chromona; 			15.6408227605	4	7	Carbocromenum;Carbocromen hydrochloride;NSC-110430;Chromonar;Intensain;Carbocromen;Carbocromen Hydrochloride;carbocromene;Intercordin;((3-(2-(DIETHYLAMINO)ETHYL)-4-METHYL-2-OXO-2H-1-BENZOPYRAN-7-YL)-OXY)ACETIC ACID ETHYL ESTER HYROCHLORIDE;Chromonar Hydrochloride;Hydrochloride, Chromona;chromonar;Carbocromeno;Carbochromene;carbocromenum;Acetic acid, ((3-(2-(diethylamino)ethyl)-4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy)-, ethyl ester;Cardiocap;Chromonar hydrochloride;Carbocromene;CHROMONAR HYDROCHLORIDE;CIPLUS_155933;LS-11691;LS-11690;CIPLUS_156471;CARBOCROMEN;	0	2.34980735					Cl.O=C(OCC)COc1ccc2c(c1)OC(=O)C(CCN(CC)CC)=C2C	NCI	NSC_110430	4.60357465	4.34983483	4.91549659	3.51004373	0	3.3680947	2.34980735									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390805-02	Icatibant		Bradykinin B2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	130308-48-4				-3.5120508288	4	7		0	-5.27041811					N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC(=O)N[C@@H](CC3=CC=CS3)C(=O)N[C@@H](CO)C(=O)N4CC5=C(C[C@@H]4C(=O)N6[C@H]7CCCC[C@H]7C[C@H]6C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C=CC=C5	MedChem Express	HY-17446	0	0	0	0	0	1.22134536	-5.27041811									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00522306-02	Valbenazine			DPI_SARS-CoV-2_General	2019_NPC_02	1025504-45-3		13.9333492831	-4.8559444758	-12.1226851168	-2.4	7		-35.041383248	-25.03448604	0.0000896234	0.9961163627			COC1=C(OC)C=C2[C@H]3C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN3CCC2=C1	MedChem Express	HY-16771	1.67171495	2.08598027	3.1996437	1.31655871	0.21623934	-6.90060128	-25.03448604									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181319-01	Plicamycin	144206340	DNA Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	18378-89-7	Plicamycin; Mithracin; Mithramycine; Mitramycin; Plicamicina; Mithramycinum; Mitramicina; Acid, Aureoli; 	11.0676527398	-4.9559444758	-43.9708919817	-2.2	7	Mithramycine;Plicamycinum;CIPLUS_741126;plicamycinum;Mithramycinum;Acid, Aureoli;Mithracin;mithramycin A;PA-144;Mithramycin A;NCGC00162423-01;NSC-24559;Mithramycin A Streptomyces plicatus;MITHRAMYCIN A;mithramycin;Plicamycin;MITHRAMYCIN;WHO NO. 2029;Mitramycin;Plicamicina;CIPLUS_171437;Aureolic acid;Plicamycine;PLICAMYCIN;Mitramicina;Mithramycin;plicamycin;AUREOLIC ACID;plicamycine;A-2371;LS-91528;	-76.6599914355	-57.31817533	0.0001542117	0.9948887019			C[C@@H](O)[C@H](O)C(=O)[C@@H](OC)C6Cc7cc8cc(O[C@H]2C[C@@H](O[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1)[C@@H](O)[C@@H](C)O2)c(C)c(O)c8c(O)c7C(=O)[C@H]6O[C@H]5C[C@@H](O[C@H]4C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@H](O)[C@@H](C)O4)[C@H](O)[C@@H](C)O5	SIGMA	M6891	1.66477838	3.81852203	2.39328661	2.73834857	-6.85074733	-23.3934611	-57.31817533									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00188399-06	Fingolimod hydrochloride		Sphingosine Kinase 1 (SphK1) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			4.4061119169	-5.3559444758	-33.0948990867	-2.2	7		-39.237026112	-32.69752176	0.0002128586	0.9939891617		SPHK1	CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1	Selleck	S5002	3.09140096	0.82468988	2.89960385	-1.59717513	-6.18064301	-21.63660278	-32.69752176									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346688-03	Alectinib (CH5424802)		ALK Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1256580-46-7		2.6938104809	-5.5696329617	-24.0659393309	4	7		-26.742258476	-24.36854873	0.003129894	0.9762810059		ALK	CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C)(C)C5=C(C2=O)C6=CC=C(C=C6[NH]5)C#N	Axon Medchem	1884	0	0	3.5090598	4.16013844	3.59052349	-16.80759113	-24.36854873									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00094851-05	Iodamide	170465213		DPI_SARS-CoV-2_General	2019_NPC_01	440-58-4				-17.1365218217	4	7		0	-4.86679679					O=C(C)Nc1c(I)c(c(I)c(CNC(C)=O)c1I)C(=O)O	Microsource	01500772	-3.18301745	-2.05976495	-2.97092442	-4.10113628	-3.12896513	-5.50332842	-4.86679679									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015678-10	Moxisylyte hydrochloride	170465759	Adrenergic receptor alpha-1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	964-52-3				-33.8046579983	4	7		0	-9.60178449					Cl.CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C	Prestwick Chemical, Inc.	Prestw-42	-8.53242321	-4.05355878	-6.58770198	-8.92718288	-5.91534284	-7.37334214	-9.60178449									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182995-01	Etomidoline	144206828		DPI_SARS-CoV-2_General	2019_NPC_01	21590-92-1	Etomidoline; Smedolin; Etomidolina; 			-12.3521379483	4	7	Etomidolina;2-ethyl-3-(p-(beta-piperidinoethoxy)phenylamino)-isoindoline-1-one;Etomidolinum;K-2680;2-ETHYL-3-(.BETA.-PIPERIDINO-P-PHENETIDINO)PHTHALIMIDINE;K 2680;Phthalimidine, 2-ethyl-3-(beta-piperidino-p-phenetidino)-;etomidolinum;Etomidoline;LS-109527;CIPLUS_213965;Smedolin;ETOMIDOLINE;amidoline;1h-isoindol-1-one, 2-ethyl-2,3-dihydro-3-((4-(2-(1-piperidinyl)ethoxy)phenyl)amino)- (9ci);etomidoline;	0	-7.85784898					O=C4c1ccccc1C(Nc3ccc(OCCN2CCCCC2)cc3)N4CC	Pharmaron	PH-NIH-150630	-0.53009948	-0.07574462	-5.72493968	1.46236235	-3.63650206	-3.25219777	-7.85784898									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253587-01	Sitaxentan	170465720	Endothelin ETA Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	184036-34-8	Sitaxentan	11.0676527398	-4.9559444758	-45.8076728913	-2.2	7		-81.3297761792	-62.37104256	0.0000917319	0.996065327		EDNRA	O=C(Cc1cc2OCOc2cc1C)c3sccc3S(=O)(=O)Nc4onc(C)c4Cl	GVK	FFS-11-286-NCI-102	3.27499818	0	3.52172747	4.15631976	-3.61620058	-25.73301489	-62.37104256									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022653-09	Cefazolin	170465254	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	25953-19-9				5.3248638575	4	7		0	2.93528681					O=C(O)C=3N4C(=O)[C@@H](NC(=O)Cn1cnnn1)[C@H]4SCC=3CSc2nnc(C)s2	Microsource	01500164	0	0	0	0	0.43648175	4.96976472	2.93528681									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179034-07	Pentamidine isethionate	170464786	PRL Phosphatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	140-64-7	 cis-Pt(II) pentamidine; Pentamidin; Pt-pentamidine complex; platinum(II) pentamidine;4,4 -(Pentane-1,5-diylbis(oxy))dibenzimidamide; Pentam 300; Pt-pent; cis-Pt pentamidine iodide;Pentamidine isethionate;	7.8352981002	-5.1059444758	-40.4794699961	4	7		-10.880638408	-16.29869965	0.072937104	0.8653994267		PTP4A1	OCCS(=O)(=O)O.OCCS(=O)(=O)O.N=C(N)c1ccc(cc1)OCCCCCOc2ccc(cc2)C(=N)N	Prestwick Chemical, Inc.	Prestw-553	-5.56483431	-9.15043859	-8.19624187	-5.70145735	-5.82398619	-11.35728441	-16.29869965									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263544-01	Dexrazoxane hydrochloride	170464709	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	24584-09-6	Dexrazoxane hydrochloride;Dexrazoxane Hydrochloride			0.763203288	4	7		0	-1.10516844			7153	TOP2A	O=C2CN(C[C@H](C)N1CC(=O)NC(=O)C1)CC(=O)N2	Tocris	3857	-2.60208651	3.45737533	1.09429456	-2.40549828	-0.48977313	2.7897759	-1.10516844									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015661-12	Molsidomine	170465872		DPI_SARS-CoV-2_General	2019_NPC_01	25717-80-0				-0.9557699949	4	7		0	-2.21033687					O=C(OCC)[N-]c1c[n+](no1)N2CCOCC2	Microsource	01500673	-0.30740929	3.98514428	-0.52886842	-1.91888028	0.57605441	-1.51430459	-2.21033687									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162149-07	Demeclocycline hydrochloride	170465205	Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	64-73-3		4.4061119169	-5.3559444758	-100.361582287	-2.2	7		-92.3985450289	-78.88773415	3.861E-7	0.9997462734			Cl.NC(=O)C=2C(=O)[C@@]3(O)C(O)=C4C(=O)c1c(c(Cl)ccc1O)[C@@H](O)[C@H]4C[C@H]3[C@@H](C=2O)N(C)C	Microsource	01500226	1.29983298	0.20280011	-1.67921815	-6.37369253	-23.59792925	-53.91534123	-78.88773415									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163338-03	D-Phenylalanine			DPI_SARS-CoV-2_General	2019_NPC_02	673-06-3				-3.5924245931	4	7		0	-3.73400561					N[C@H](CC1=CC=CC=C1)C(O)=O	Selleck	S4153	-0.08555111	0.43660052	-0.57429502	-0.82080303	0.44435996	-0.15501691	-3.73400561									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00163160-04	Talipexole	170466015	Dopamine D4 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	101626-70-4		19.6813789847	-4.7059444758	-10.8831872809	4	7		-11.9677067799	-11.63975565	0.0822199115	0.8546503143			C=CCN1CCc2sc(N)nc2CC1	Tocris	2759	-0.48652966	-1.10196203	-3.43398894	-2.57104874	1.74338933	-0.95025154	-11.63975565									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253670-01	Meropenem	170466350	Carbapenem Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	96036-03-2				1.20971761	4	7		0	0					O[C@H](C)[C@H]3C(=O)N2C(=C(S[C@H]1C[C@H](NC1)C(=O)N(C)C)[C@H](C)[C@@H]23)C(=O)O	GVK	FFS-12-73-NCI-194	0	0	0	0	1.0556768	0.67584735	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090766-07	Prednisone	170464847	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC_01	53-03-2	 Prednisona; ; Dehydrocortisone; Prednisone;Prednisone;; Deltasone;Prednisone (Adasone); 1-Cortisone; Meticorten; Kortancyl; Deltamid			3.9326746029	4	7		0	1.71351804				NRC31	OCC(=O)[C@@]3(O)CC[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@H]4C(=O)C[C@@]23C	Prestwick Chemical, Inc.	Prestw-77	1.46200954	0	0	1.22657837	0	1.69215915	1.71351804									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016418-15	Methoxsalen	170465041	Cytochrome P450 CYP1A2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	298-81-7	 ;METHOXSALEN; Methoxsalen, 8-;Methoxy-8-psoralen; Ammoidin;Methoxsalen;8-Methoxypsoralen; Methoxy-8-psoralen			10.9032064295	4	7		0	2.88966059			1544	CYP1A2	COc1c3occc3cc2C=CC(=O)Oc12	Microsource	01500400	4.67891463	3.75546705	4.36011796	0	0.76891844	0	2.88966059									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090965-07	Propyl-4-hydroxybenzoate			DPI_SARS-CoV-2_General	2019_NPC_01	94-13-3		17.5410474839	-4.7559444758	-11.9452551941	4	7		-14.707586624	-13.08965552	0.0356871941	0.9118820674			CCCOC(=O)C1=CC=C(O)C=C1	SigmaAldrich	P53357	-3.23626946	0.10017837	0.01706027	0.46905962	-2.57574989	-2.09360232	-13.08965552									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00186632-01	Strychnine	124897819	Glycine receptor subunit alpha-1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	1421-86-9				-4.3672826692	4	7	STRYCHNINE HCl	0	-4.66631784					O=C1C[C@@H]2OC\C=C/3C[N@]4CC[C@@]56[C@@H]4C[C@@H]3[C@@H]2[C@@H]5N1C7=C6C=CC=C7	BIOMOL	AC745	0.3537654	1.38372335	-0.10079464	-1.49895938	-1.74654849	-1.10860579	-4.66631784									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162106-17	Cefsulodin Sodium Salt		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	52152-93-9				-11.0937702787	4	7		0	-5.15625743					NC(=O)C1=CC=[N+](CC/2=C(/N3[C@H](SC2)[C@H](NC(=O)[C@@H](C4=CC=CC=C4)[S]([O-])(=O)=O)C3=O)C([O-])=O)C=C1	Glixx	GLXC-08405	-0.53874078	-4.2158516	-3.95443145	-1.39606669	-2.86814153	0.97707629	-5.15625743									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253603-01	Mibolerone	170466095	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	3704-09-4				-32.920704881	4	7		0	-10.57413309					C[C@@H]3CC1=CC(=O)CC[C@@H]1[C@H]4CC[C@@]2(C)[C@@H](CC[C@]2(C)O)[C@H]34	GVK	FFS-11-286-NCI-098	-3.09140096	-4.6640024	-7.1329786	-8.98206393	-6.90777749	-8.44137542	-10.57413309									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390707-01	Oclacitinib		Tyrosine-protein kinase JAK3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1208319-26-9		15.6334750258	-4.8059444758	-4.7420516901	4	7		-25.829829236	-18.60819103	0.0204834309	0.9353285085			CN[S+]([O-])(=O)C[C@H]1CC[C@@H](CC1)N(C)C2=C3C=C[NH]C3=NC=N2	MedChem Express	HY-13577	4.85791579	0	0	4.51090896	0.34455718	-2.30646374	-18.60819103									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167502-01	NCGC00167502-01	50112755		DPI_SARS-CoV-2_General	2019_NPC_02		CIPLUS_205233; Santeson; 	9.8640558873	-5.0059444758	0.6705129713	4	7	Santeson;CIPLUS_684703;Dexamethasone Metasulfobenzoate Sodium;Dexamethasone metasulfobenzoate sodium;CIPLUS_205233;DEXAMETHASONE METASULFOBENZOATE SODIUM;	-21.616206064	-15.93017172	0.0007113228	0.9889437222			CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)C5=CC=CC(=C5)S([O-])(=O)=O	Pharmeks	PHAR046594	2.8416842	3.89706392	2.18232109	4.22093866	3.76636647	-3.8425404	-15.93017172									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015999-19	Tolbutamide	170465238	"Sulfonylurea receptor 1, Kir6.2 Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC_01	64-77-7				9.3116105943	4	7		0	4.68936149					Cc1ccc(cc1)S(=O)(=O)NC(=O)NCCCC	Enzo	AC117	3.03778472	2.41161092	3.1074066	0	0	1.32120535	4.68936149									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015156-15	Baclofen	170465099	GABA-B receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	1134-47-0				-23.5776124218	4	7		0	-4.90735343					Clc1ccc(cc1)C(CN)CC(=O)O	Vitas	STK535284	-0.86897587	-2.25523493	-3.47298384	-4.27672009	-2.05806222	-3.49103105	-4.90735343									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00022398-05	Fluocinonide	170464717	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC_01	356-12-7	;Fluocinonide; Lidex; Fluocinonido;Fluocinonide (Vanos)			-26.0337117077	4	7		0	-12.26838356				NRC31	CC(=O)OCC(=O)[C@]45OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-774	-3.45411856	-2.84164488	-2.53223173	-3.17806707	-5.75293103	-10.34605417	-12.26838356									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015400-05	Enoximone	170466419	Phosphodiesterase 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	77671-31-9		12.4181106199	-4.9059444758	-32.1643788692	4	7		-26.0944457281	-26.28070264	0.0007792837	0.9884079033			O=C(C=1NC(=O)NC=1C)c2ccc(SC)cc2	Tocris	1693	-5.02747319	-2.0353312	-3.04891424	-3.23325056	-3.2000203	-9.80740891	-26.28070264									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017366-08	Pergolide methanesulfonate	170465250	Dopamine D3 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	66104-23-2		13.9333492831	-4.8559444758	-66.2670185005	-2.2	7		-68.5588404937	-56.38893818	0.0002205148	0.9938783605			CS(=O)(=O)O.CSC[C@@H]1C[C@@H]2c3cccc4ncc(C[C@H]2N(C1)CCC)c34	Enzo	AC755	-5.66165614	-4.361424	-6.46096854	-2.39546492	-9.6000609	-23.97479547	-56.38893818									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015755-10	Nimustine	170466029	DNA Crosslinking Agent	DPI_SARS-CoV-2_General	2019_NPC_01	42471-28-3				-0.426047946	4	7		0	-2.70715571					Nc1nc(C)ncc1CNC(=O)N(CCCl)N=O	Microsource	01504151	0.94159223	3.77501405	-5.90041676	-0.35869265	1.13434502	1.88017684	-2.70715571									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178500-07	Streptozotocin	170464827	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC_01	18883-66-4				3.8908933232	4	7		0	-0.84155028				H2AFX	O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(=O)N(C)N=O	Microsource	01500543	0.83992932	-1.42937425	-0.80183276	2.22991447	1.30183221	4.09065501	-0.84155028									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182990-01	Tandospirone	144206869	Serotonin 1a (5-HT1a) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	87760-53-0	Tandospirone citrate; Sediel; 			-20.2340713495	4	7	LS-178008;TANDOSPIRONE;Sediel;CIPLUS_196843;CIPLUS_667992;TANDOSPIRONE CITRATE;tandospirone;Tandospirone;tandospironum;SM-3997;sm 3997;(3A-A,4B,7B,7A-A)-HEXAHYDRO-2-(4-(4-(2-PYRIMIDINYL)-1-PIPERAZINYL)-BUTYL)-4,7-METHANO-1H-ISOINDOLE-1,3(2H)-DIONE DIHYDROGEN CITRATE;SM 3997;Tandospirone citrate;LS-90979;4,7-Methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, (3aalpha,4beta,7beta,7aalpha)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1);3a,4,7,7a-hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-4,7-methano-1H-isoindole-1,3(2H)-dione;	0	-4.31421257					O=C4N(CCCCN1CCN(CC1)c2ncccn2)C(=O)[C@@H]5[C@H]3CC[C@H](C3)[C@H]45	Pharmaron	PH-NIH-172250	-4.97906228	-0.63772082	-4.36499232	-9.18805027	-4.1897173	-2.48996392	-4.31421257									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249110-03	Sucralose	170466823		DPI_SARS-CoV-2_General	2019_NPC_01	56038-13-2				-29.5884151533	4	7		0	-10.20506451					O[C@H]1[C@H](O[C@H](CO)[C@H](Cl)[C@@H]1O)O[C@]2(CCl)O[C@H](CCl)[C@@H](O)[C@@H]2O	Microsource	01505953	-6.9445453	-5.90075012	-5.54458824	-5.67637394	-3.50961782	-7.27679252	-10.20506451									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091455-09	Celecoxib	170464693	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	169590-42-5	; 5   Celecoxib (Celebrex);Celecoxib; Celecoxib; Celebrex;CELECOXIB	12.4181106199	-4.9059444758	-24.694006475	-2.2	7		-56.9563509144	-40.87602342	0.0003417165	0.9923615589	5743	PTGS2	NS(=O)(=O)c1ccc(cc1)n3nc(cc3c2ccc(C)cc2)C(F)(F)F	Microsource	01503678	4.15123569	3.57954407	4.93529283	0	-1.80936913	-15.22943239	-40.87602342									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183838-01	Perisoxal citrate	144206844		DPI_SARS-CoV-2_General	2019_NPC_02	14838-45-0		11.0676527398	-4.9559444758	-4.8529465042	4	7	Perisoxal Citrate;perisoxal, (S)-isomer;1-Piperidineethanol, alpha-(5-phenyl-3-isoxazolyl)-, citrate (2:1);LS-115490;perisoxal citrate (2:1);Perisoxalum;CIPLUS_213305;CIPLUS_744614;LS-115487;perisoxal citrate;3-(1-hydroxy-2-piperidinoaethyl)-5-phenyl-isoxazol (german);Isoxal;CIPLUS_791151;1-Piperidineethanol, alpha-(5-phenyl-3-isoxazolyl)-;3-(1-hydroxy-2-piperidinoethyl)-5-phenylisoxazole;PERISOXAL;perisoxal citrate (1:1);perisoxal;perisoxalum;31252-S;isoxal;alpha-(5-phenyl-3-isoxazolyl)-1-piperidineethanol;Perisoxal citrate;perisoxal, (R)-isomer;PERISOXAL CITRATE;CIPLUS_742412;perisoxal, (+-)-isomer;Perisoxal;	-17.4426580399	-15.3688817	0.0049989678	0.9697927815			OC(CN1CCCCC1)c2cc(on2)c3ccccc3.O=C(O)C(O)(CC(=O)O)CC(=O)O	Pharmaron	PH-NIH-153178-6	1.39656408	0	0	1.73514487	3.09150964	-1.5266817	-15.3688817									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389841-01	LINACLOTIDE (1 mg/ml)		Heat-stable enterotoxin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	851199-59-2		4.2694018929	-5.3696329617	-19.0022091807	4	7		-17.444965044	-15.78747087	0.0172700312	0.9412490034			C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CC4=CC=C(O)C=C4)C(O)=O)NC(=O)[C@H](CC5=CC=C(O)C=C5)NC(=O)[C@H](CCC(O)=O)NC3=O)C(=O)N[C@@H](CC(N)=O)C(=O)N6CCC[C@H]6C(=O)N[C@@H](C)C(=O)N2	Microsource	01504425	2.67058198	-1.42992446	0.63992874	-2.0461614	-0.22574436	-6.84892897	-15.78747087									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00091635-09	Fenthion	170466807	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	55-38-9		12.4181106199	-4.9059444758	-10.5645823279	-3	7		-32.761412892	-31.05117741	0.0031096542	0.976356538			Cc1cc(ccc1SC)OP(=S)(OC)OC	Bosche	F1401	0	4.8843062	3.42424021	0	0	0	-31.05117741									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185751-06	Cefuroxime Axetil			DPI_SARS-CoV-2_General	2019_NPC_02	64544-07-6		11.0676527398	-4.9559444758	-37.4348244806	-2.2	7		-34.5557933254	-35.16624649	0.0005613152	0.9901802458			[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N\OC)\C3=CC=CO3)C(=O)OC(C)OC(C)=O	Enzo	AC3055	-3.75268792	-2.50179029	-3.25590117	-5.11423427	-1.46139771	-11.06257046	-35.16624649									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159483-04	Hydroxychloroquine sulfate	170464696	Autophagy Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	747-36-4	; Hidroxicloroquina;Plaquenil???;Hydroxychloroquine sulfate; Oxychlorochin;Plaquenil; Plaquenil;HYDROXYCHLOROQUINE SULFATE; Hydroxychloroquine sulfate; Hydroxychloroguine			-1.8892231351	4	7		0	-1.96699703			84557	MAP1LC3A	O=S(=O)(O)O.CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12	Microsource	01503978	1.35308499	-1.09218853	1.48911798	0.23829232	2.96147795	-2.6779816	-1.96699703									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00167529-02	Itopride hydrochloride	170465974	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	122892-31-3				8.4471122176	4	7		0	3.12990534			43	ACHE	Cl.COc1cc(ccc1OC)C(=O)NCc2ccc(OCCN(C)C)cc2	Sequoia	SRP02400i	0	0	0	4.84764867	4.87845448	0	3.12990534									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181297-01	Mebrofenin	144206328		DPI_SARS-CoV-2_General	2019_NPC_02	78266-06-5	Mebrofenin; Mebrofenino; 			12.8015970813	4	7	Technetium (99mTc) mebrofenin;TECHNETIUM TC-99M MEBROFENIN KIT;mebrofeninum;Mebrofenin;Mebrofenine;CIPLUS_191790;technetium Tc 99m mebrofenin;MEBROFENIN;Technetium Tc 99m Mebrofenin;2,2'-((2-((3-BROMO-2,4,6-TRIMETHYLPHENYL)-AMINO)-2-OXOETHYL)IMINO)DIACETIC ACID;Mebrofenin ((3-Bromo-2,4,6-trimethylphenylcarbamoyl) methyliminodiacetic acid);Mebrofeninum;mebrofenine;Mebrofenino;SQ-26962;	0	0.44712933					Cc1cc(C)c(Br)c(C)c1NC(=O)CN(CC(=O)O)CC(=O)O	ACC	mebrofenin	4.47409189	2.93608076	2.27608354	4.65589411	3.06774707	0.7093198	0.44712933									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253598-01	Sulfacytine	170465286	Dihydropteroate synthetase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	17784-12-2		11.0676527398	-4.9559444758	-17.8627942929	4	7		-24.82591062	-23.18825885	0.0044711979	0.9714537817			O=C1N=C(C=CN1CC)NS(=O)(=O)c2ccc(N)cc2	GVK	FFS-11-286-NCI-041	-0.4090722	-0.69636181	-2.86368843	1.89881356	0.52022535	-6.52472178	-23.18825885									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160485-01	Diamthazole	144205400		DPI_SARS-CoV-2_General	2019_NPC_02	95-27-2	Diamthazole; Asterol; 			-12.221109844	4	7	DIAMTHAZOLE HYDROCHLORIDE;diamthazole dihydrochloride;CIPLUS_151863;Benzothiazole, 6-(2-diethylaminoethoxy)-2-dimethylamino-, dihydrochloride;amikazol;DIMAZOLE DIHYDROCHLORIDE;DIAMTHAZOLE;Dimazole Dihydrochloride;diamthazole;dimazole;dimazol;Dimazole dihydrochloride;Dimazol;6-(2-diethylaminoethylaminoethoxy)-2- dimethylaminobenzothiazole;Dimazole;Asterol;Diamthazole;CIPLUS_207319;LS-40729;dimazolum;DIMAZOLE-DIHYDROCHLORIDE;CIPLUS_166123;dimazole hydrochloride;Dimazolum;DIMAZOLE;	0	-9.17090805					CCN(CC)CCOc1ccc2nc(sc2c1)N(C)C	InterBioScreen	STOCK1S-45555	-1.57922727	-0.1409134	-4.42324371	-1.20431214	-2.44516788	-2.48027057	-9.17090805									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00025155-07	Omacetaxine mepesuccinate		Alkaloid	DPI_SARS-CoV-2_General	2019_NPC_02	26833-87-4		0.5546966259	-6.2559444758	-29.6134272281	4	7		-6.4937999439	-12.86210341	0.4021443676	0.5099647639		RPL3	COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]\1[C@H]2C3=CC4=C(OCO4)C=C3CCN5CCC[C@]25\C=C1OC	MedChem Express	HY-14944	-3.56308816	-1.39758368	-7.54084527	-2.19114655	-13.4757503	-4.60822999	-12.86210341									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167984-01	Tiquizium bromide	144206157		DPI_SARS-CoV-2_General	2019_NPC_02	71731-58-3	Tiquizium bromide; Bromuro de tiquizio; 	12.4181106199	-4.9059444758	-40.8601879075	4	7	CIPLUS_214419;tiquizium bromide;thiaton;Bromuro de tiquizio;Tiquizium Bromide;bromide (cis)-isomer;Tiquizii bromidum;LS-176911;tiquizii bromidum;TIQUIZIUM BROMIDE;bromure de tiquizium;Tiquizium bromide;3-(di-2-thienylmethylene)-5-methyl-trans-quinolizidinium bromide;3-(Di-2-thienylmethylene)-5-methyl-trans-quinolizidinium bromide;LS-142883;Thiaton;Bromure de tiquizium;HSR 902;HSR-902;	-11.7378724561	-18.34181611	0.0091661598	0.958542015			[Br-].C[N@@+]14CCCC[C@@H]4CC\C(C1)=C(/c2sccc2)c3cccs3	Bosche	T6489	-6.06025573	-8.09212502	-8.45971731	-6.63423988	-6.52757646	-9.03795566	-18.34181611									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166088-02	Decitabine	170465126	DNA Methyltransferase (DNMT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	2353-33-5	 ;5-Aza-2 -deoxycytidine; Dacogen; 5-Aza-2??-deoxycytidine;Decitabine; Decitabine	17.5410474839	-4.7559444758	-40.4909981505	4	7		-14.8538195841	-16.05029023	0.0163142111	0.9435468133	1786	DNMT1	NC1=NC(=O)N(C=N1)[C@H]2C[C@H](O)[C@@H](CO)O2	Tocris	2624	-5.99569143	-5.33877391	-7.82091589	-7.7934131	-8.55961021	-10.5035825	-16.05029023									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159474-03	Fluprednisolone	170465086	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	53-34-9				-22.0300893574	4	7		0	-2.46381587					OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	SIGMA	34206	-3.47348292	-4.28812276	-7.87453389	-4.969022	-7.6866467	-1.47365212	-2.46381587									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163169-05	Pizotifen	170466311	Antimigraine drugs	DPI_SARS-CoV-2_General	2019_NPC_01	15574-96-6	 Pizotyline;Pizotyline;PIZOTIFEN MALATE; Pizotifen malate;PIZOTYLINE MALATE; ; Pizotifeno;Pizotifen malate; Polomigran; Pizotifen hydrogen malate; Sandomigran	8.7913490634	-5.0559444758	-15.8890126063	4	7		-29.081734308	-25.48477859	0.0003639117	0.9921218854		CHRM1	CN1CC/C(CC1)=C3\c4ccccc4CCc2sccc23	BIOMOL	NS740	2.27289231	0.78921006	1.17228437	0	1.93625336	-9.60922811	-25.48477859									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262543-01	Midecamycin		Ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	35457-80-8				5.5081273893	4	7		0	1.67911335					CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@@H](O)[C@H](C)C[C@H](CC=O)[C@H](OC2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC	Prestwick Chemical, Inc.	Prestw-153	2.62433813	2.03053894	-0.18986897	-0.45600168	0.84832355	1.841413	1.67911335									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016279-05	Aminohippuric acid	170465155		DPI_SARS-CoV-2_General	2019_NPC_01	61-78-9				11.5461329549	4	7		0	3.64502801					O=C(NCC(=O)O)c1ccc(N)cc1	Vitas	STK801822	2.72311379	3.32543309	0.5044966	1.87874683	2.79906613	2.62716601	3.64502801									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021122-08	Alverine citrate	170466248		DPI_SARS-CoV-2_General	2019_NPC_01	5560-59-8		0.4943738883	-6.3059444758	-8.4923433897	4	7		-11.083489828	0.05576538	0.5582496618	0.3618321009			O=C(O)C(O)(CC(=O)O)CC(=O)O.CCN(CCCc1ccccc1)CCCc2ccccc2	Microsource	01500109	1.03357297	0	0.51911969	3.96066923	-20.90290819	1.8598506	0.05576538									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263897-02	PREDNISOLONE HEMISUCCINATE			DPI_SARS-CoV-2_General	2019_NPC_02	2920-86-7		15.6334750258	-4.8059444758	-38.5528392439	4	7		-18.0384074079	-22.64186843	0.040423422	0.9049423394			C[C@]12C[C@H](O)C3C(CCC/4=C/C(=O)/C=C\[C@]34C)C1CC[C@]2(O)C(=O)COC(=O)CCC(O)=O	Microsource	01505450	-7.77127795	-3.77694102	-8.85351961	-7.16273414	-3.44319559	-7.30928222	-22.64186843									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378907-01	Edoxaban tosylate monohydrate		Coagulation Factor X Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1229194-11-9				6.9099133882	4	7		0	-2.36883413					CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(Cl)C=C4)C(=O)N(C)C	MedChem Express	HY-10264B	4.13188744	0	4.77954103	2.5559479	2.0079367	-1.67700113	-2.36883413									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016878-04	Piretanide	170465869	Cystic fibrosis transmembrane conductance regulator Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	55837-27-9				-10.1347466002	4	7		0	-8.17216294					O=C(O)c2cc(c(Oc1ccccc1)c(c2)N3CCCC3)S(N)(=O)=O	Prestwick Chemical, Inc.	Prestw-1047	0.65596786	-2.00112395	-1.39163072	1.08611132	-3.78368776	-2.88124397	-8.17216294									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183049-01	Zelandopam	144206852		DPI_SARS-CoV-2_General	2019_NPC_01	139233-53-7	ZELANDOPAM; 	12.4181106199	-4.9059444758	-103.6264468796	-2.1	7	ZELANDOPAM;CIPLUS_3879393;zelandopamum;	-111.6457645407	-88.31208334	0.0001797824	0.9944765436			Cl.Oc1ccc(cc1O)[C@H]3CNCc2c3ccc(O)c2O	Pharmaron	PH-NIH-155132	-1.18848789	-8.11444768	-4.40398723	-7.67802945	-17.38060194	-42.92901062	-88.31208334									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165846-04	Nefazodone hydrochloride	170465078	Serotonin transporter Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	82752-99-6		13.9333492831	-4.8559444758	-41.3391672172	-2.2	7		-63.0441421268	-48.51828949	0.0000249297	0.9979557338			Cl.Clc1cccc(c1)N4CCN(CCCN3N=C(CC)N(CCOc2ccccc2)C3=O)CC4	Prestwick	Prestw-1152	-1.08904252	0.3441983	0.16174023	-0.92837266	-4.24637027	-16.82638106	-48.51828949									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00092361-06	Prostaglandin E2	174006772	prostaglandin	DPI_SARS-CoV-2_General	2019_NPC_01	363-24-6	; alpha, Prostaglandin E; 15-ketoprostaglandin E; E2alpha, Prostaglandi; Prostenon; E2, Prostaglandi; ; PROSTAGLANDIN E2; Prostaglandin,PGE2; 8-iso-PGE2; Dinoprostone Betadex; Prepidil; alpha, PGE; 15-ketoprostaglandin E1; Dinoprostone; Dinoprostona;Prostaglandin E2; Gel, Prepidi; 8-isoprostaglandin E2; 8,12-epi-PGE2; 8,12-epi-prostaglandin E2; 15-keto-PGE;Dinoprostone; E2 alpha, Prostaglandi; 15-keto PGE1; Prepidil Gel; PGE2 alpha; Prostaglandin E2 alpha			7.3667129934	4	7		0	2.48916377				PTGER2	O[C@@H]1CC(=O)[C@H](C/C=C\CCCC(=O)O)[C@H]1/C=C/[C@@H](O)CCCCC	Tocris	2296	0	0.91382217	0.27783871	0	3.46901487	4.00426851	2.48916377									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160654-06	Ethylparaben	170465715		DPI_SARS-CoV-2_General	2019_NPC_01	120-47-8				-23.1422994971	4	7		0	-7.46242174					Oc1ccc(cc1)C(=O)OCC	Vitas	STK070911	-3.11524218	-4.17084077	-4.73544393	-3.37371761	-7.46840583	-4.71568677	-7.46242174									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182026-02	Tiludronate disodium salt hydrate	225144329	Osteoclasts Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	89987-06-4				16.4448859156	4	7		0	3.57227798					O[P]([O-])(=O)C(SC1=CC=C(Cl)C=C1)[P](O)([O-])=O	SIGMA	T4580	0	3.94326503	1.78617473	4.88038725	0	0	3.57227798									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00166296-02	L-(+)-Lysine monohydrochloride	225144279	Serotonin 4 (5-HT4) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	657-27-2				-2.3264453863	4	7		0	-1.71351804					NCCCC[C@H](N)C(O)=O	Bosche	L1919	-1.58545736	0.8429643	-1.26489727	2.04429729	1.81951987	0.21850704	-1.71351804									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00164553-02	Clofarabine	170465145	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	123318-82-1	 Clofarabine; ; Clolar;Clofarabine			6.9919589747	4	7		0	0				POLA1	Nc3nc(Cl)nc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F	Sequoia	SRP03671c	0	0	2.52735736	2.67639903	4.79876161	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090868-06	HALOTHANE		GABA-A receptor; anion channel Positive Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	151-67-7				-0.5023181489	4	7		0	0.30442848					FC(F)(F)C(Cl)Br	Microsource	01505434	3.21163495	-0.74152787	-0.22268583	-0.78338751	0.15445667	-2.46617813	0.30442848									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00388506-02	Pinaverium bromide			DPI_SARS-CoV-2_General	2019_NPC_02	53251-94-8		6.2237985085	-5.2059444758	-26.0760459311	-2.4	7		-34.912643296	-29.51053608	0.0027391729	0.9778659636			COC1=C(OC)C=C(C[N+]2(CCOCCC3CC[C@H]4C[C@@H]3C4(C)C)CCOCC2)C(=C1)Br	Prestwick	Prestw-1601	3.77118546	0.15015362	2.04167741	-0.14264668	-6.51331892	-14.24276588	-29.51053608									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181776-02	Dicyclopentamethylenethiuram disulfide	170465709		DPI_SARS-CoV-2_General	2019_NPC_01	94-37-1		6.9832167823	-5.1559444758	-71.5844008128	-2.2	7		-60.5184502948	-49.70216218	0.000223254	0.9938405875			S=C(SSC(=S)N1CCCCC1)N2CCCCC2	Labotest	LT00159442	-1.33856171	-2.82209788	-5.2570008	-8.87701608	-16.44165863	-30.24035774	-49.70216218									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249894-01	Fosphenytoin	170465016	Sodium channel protein type VIII alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	93390-81-9				3.774664015	4	7		0	4.49671745					OP(=O)(O)OCN1C(=O)C(NC1=O)(c2ccccc2)c3ccccc3	GVK	FFS-11-286-NCI-63	0.27352165	3.34986684	-2.44936755	-2.94228309	2.4082627	1.38218405	4.49671745									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179342-03	Oxprenolol hydrochloride	170464995	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	6452-73-9				-16.555842201	4	7		0	-6.15516339					Cl.CC(C)NCC(O)COc1ccccc1OCC=C	Tocris	3288	1.03817429	-3.59675668	-7.0298399	-1.96665342	-3.90894185	-3.54190154	-6.15516339									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095158-08	Secnidazole		antiprotozoal agent	DPI_SARS-CoV-2_General	2019_NPC_02	3366-95-8				10.0389194572	4	7		0	2.91109737					CC(O)C[N]1C(=NC=C1[N+]([O-])=O)C	Prestwick	Prestw-1340	3.14689357	2.88987965	0	1.39138975	4.2226077	0	2.91109737									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00023339-16	Pilocarpine	170464845	Muscarinic acetylcholine receptor M3 Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	92-13-7				3.0216892536	4	7		0	-0.12166992			1131	CHRM3	Cn2cncc2C[C@H]1COC(=O)[C@H]1CC	Enzo	AC214	-3.02810253	2.78789063	1.06992274	0.86537738	-0.05329138	2.6779816	-0.12166992									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015260-22	CEFACLOR			DPI_SARS-CoV-2_General	2019_NPC_01	70356-03-5, 53994-73-3 [anhydrous]				-0.6418332805	4	7		0	-4.57783073					N[C@@H](C(=O)N[C@H]1[C@H]2SCC(Cl)=C(N2C1=O)C(O)=O)C3=CC=CC=C3	Microsource	01500771	3.59935129	3.58443082	1.03092783	2.17974766	0.44409481	-1.93099243	-4.57783073									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00270540-02	Miglitol	170465326	alpha-Glucosidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	72432-03-2	Miglitol;Miglitol (Glyset)			0.0596137663	4	7		0	-0.83717833			2548	GAA	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	Prestwick	Prestw-1169	-0.55723832	2.56185174	-1.5212958	-2.75237939	0.4966376	2.47557309	-0.83717833									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179246-05	VIOMYCIN SULFATE		70s Ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	37883-00-4		11.0676527398	-4.9559444758	4.1437300092	4	7		-14.0496599	-10.04138325	0.0023877449	0.9795081295			NCCC[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@@H](NC(=O)\C(NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O)=C\NC(N)=O)[C@H]2C[C@H](O)N=C(N)N2	Microsource	01503848	3.45672732	2.01205849	2.39797473	2.20050043	3.74735641	-0.20199173	-10.04138325									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386215-04	ALOGLIPTIN BENZOATE			DPI_SARS-CoV-2_General	2019_NPC_02	850649-62-6		13.9333492831	-4.8559444758	-7.0854340484	4	7		-29.4477477	-24.53978975	0.0040187836	0.9729893967			CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC3=CC=CC=C3C#N)C1=O	Microsource	01506318	4.12726306	0	0	3.94499918	2.06496685	-1.63002631	-24.53978975									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532516-01	IOBITRIDOL			DPI_SARS-CoV-2_General	2019_NPC_02					14.42048621	4	7		0	4.26675546					CN(CC(O)CO)C(=O)C1=C(I)C(=C(I)C(=C1I)NC(=O)C(CO)CO)C(=O)N(C)CC(O)CO	Carbosynth	FI24594	0	4.38217561	0	4.62315553	4.96875223	3.44325442	4.26675546									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00385183-01	NCGC00385183-01		Potassium-transporting ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			1.0724252685	-5.9696329617	-203.8427215419	-1.1	7		-96.9956602184	-98.76801598	0.001156648	0.9857870124			OC[C@H]1O[C@@H](OC2=CC=CC3=C2C(=O)C4=C(C=C(C=C4O)C(O)=O)[C@@H]3[C@@H]5C6=C(C(=O)C7=C5C=C(C=C7O)C(O)=O)C(=CC=C6)O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H](O)[C@@H](O)[C@@H]1O	Analyticon	NP-010759	-8.16897501	-7.2281642	-10.83190736	-20.31896733	-36.10246418	-95.72998873	-98.76801598									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00181168-01	Trifluomeprazine 2-butenedioate	144206322		DPI_SARS-CoV-2_General	2019_NPC_02	71609-19-3	Trifluomeprazine; Trifluomeprazina; 	13.9333492831	-4.8559444758	-44.5394467407	-2.2	7	Trifluomeprazinum;Trifluomeprazine;CIPLUS_214394;trifluomeprazine;TRIFLUOMEPRAZINE;trifluomeprazinum;Trifluomeprazina;TRIFLUOMEPRAZINE MALEATE;	-73.9647053244	-56.03386767	0.0000214788	0.9981026932			O=C(O)C=CC(=O)O.FC(F)(F)c1cc2N(CC(C)CN(C)C)c3ccccc3Sc2cc1	NCI	NSC-170991	0	0	0	1.26043542	-4.07052729	-18.64900413	-56.03386767									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00485958-01	Eluxadoline	363681443		DPI_SARS-CoV-2_General	2019_NPC_02	864821-90-9		15.6334750258	-4.8059444758	10.9557252998	4	7		-14.973029544	-7.47752462	0.0031122725	0.9765260251			COC1=CC=C(CN([C@@H](C)C2=NC=C([NH]2)C3=CC=CC=C3)C(=O)[C@@H](N)CC4=C(C)C=C(C=C4C)C(N)=O)C=C1C(O)=O	MedChem Express	HY-12247	4.60819903	4.30825383	4.84517475	2.76173327	3.73785139	1.19785795	-7.47752462									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016375-09	Sulfadimethoxine	170465690	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	122-11-2	; ; Sulfadimetoxina; Sulfadimethoxine Sodium; Rofenaid; Sulfadimethoxine;Sulfadimethoxine;SULFADIMETHOXINE; Deposul; Abcid; Agribon; Sulphadimethoxine; Sulfadimethoxine Base			3.4265224032	4	7		0	2.21540645					COc2nc(NS(=O)(=O)c1ccc(N)cc1)cc(OC)n2	Vitas	STK018258	1.43054244	0.2809881	-1.33313836	0.06772519	-0.05329138	2.88632552	2.21540645									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164632-02	Tibolone	170465874	Steryl-sulfatase  Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	5630-53-5		17.5410474839	-4.7559444758	-39.3787148648	-2.4	7		-30.1472358719	-27.7356721	0.0001366493	0.9952005953		AR	O=C1CC=2C[C@@H](C)[C@H]3[C@@H]4CC[C@@](O)(C#C)[C@@]4(C)CC[C@@H]3C=2CC1	Sequoia	SRP02352t	-5.25500448	-3.86297554	-5.14976481	-5.49577345	-6.00162412	-9.81757203	-27.7356721									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522534-01	Quinagolide (hydrochloride)			DPI_SARS-CoV-2_General	2019_NPC_02	94424-50-7		15.6334750258	-4.8059444758	-5.3549743506	4	7		-25.7018265679	-16.00152214	0.0113426444	0.9532456507			CCCN1C[C@H](C[C@@H]2CC3=C(O)C=CC=C3C[C@@H]12)N[S+]([O-])(=O)N(CC)CC	MedChem Express	HY-13736A	2.68445513	2.44172885	4.24978317	0.4700325	-1.59446807	-3.7626832	-16.00152214									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182975-01	Amoebicon	144206766		DPI_SARS-CoV-2_General	2019_NPC_02	116-49-4	Glycobiarsol; Glicobiarsol; 	4.9437388825	-5.3059444758	-32.8620178899	-2.4	7	GLYCOBIARSOL;LS-172304;Glicobiarsol;Glycobiarsol;glycobiarsolum;Glycobiarsolum;CIPLUS_151450;glycobiarsol;	-34.6211950399	0	0.0000685069	0.999259165			O=C(Nc1ccc(cc1)[As](O)(=O)O[Bi]=O)CO	NCI	NSC_221709	0	0.66529603	0	0	0	-27.1843292	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179358-04	Methacycline hydrochloride	170465224	Tetracycline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	3963-95-9		1.9681378985	-5.7059444758	-148.5599117887	-1.1	7		-92.4166346316	-88.78846977	1.835E-7	0.9998250912			Cl.NC(=O)C=3C(=O)[C@@]4(O)C(O)=C2C(=O)c1c(O)cccc1C(=C)[C@H]2[C@H](O)[C@H]4[C@@H](C=3O)N(C)C	Prestwick Chemical, Inc.	Prestw-964	-4.1457606	-4.28515327	-6.6782307	-15.73088885	-41.99082765	-72.90492296	-88.78846977									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094819-07	Hexetidine	170465729		DPI_SARS-CoV-2_General	2019_NPC_01	141-94-6		11.0676527398	-4.9559444758	-1.9769498226	4	7		-25.148019064	-21.37334922	0.0044039287	0.9716731526			CCC(CCCC)CN1CC(C)(N)CN(CC(CCCC)CC)C1	Microsource	01500633	4.38360807	0	3.9701689	2.04680563	4.23539562	-1.20432949	-21.37334922									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091414-07	Salicylamide	170465496		DPI_SARS-CoV-2_General	2019_NPC_01	65-45-2				6.7414090459	4	7		0	2.32186763					O=C(N)c1ccccc1O	Vitas	STK301812	3.41054874	1.28277176	1.9521825	0	-0.05329138	1.40759185	2.32186763									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183014-01	Sulfamethomidine	144206847	Bacterial dihydrofolate reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	3772-76-7	Sulfametomidine; Sulfametomidina; Sulfametomidine Anhydride; 			13.0783954867	4	7	LS-147802;sulfamethomidine;Sulfametomidina;sulfamidine;Sulfanilamide, N(sup 1)-(6-methoxy-2-methyl-4-pyrimidinyl)-;Sulfametomidine Anhydride;SULFAMETOMIDINE;CIPLUS_162501;Sulfamethomidine;Sulfametomidine;Sulfametomidinum;sulfametomidine;4-sulfanilamido-2-methyl-6-methoxypyrimidine;sulfametomidinum;	0	2.93528681					Cc2nc(NS(=O)(=O)c1ccc(N)cc1)cc(OC)n2	Pharmaron	PH-NIH-154290	2.94580398	0	3.67283274	4.70313793	4.88504289	0.38111693	2.93528681									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160631-02	Famphur	170466840	Trichostrongylus axei Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	52-85-7				6.6307353958	4	7		0	-1.1913513					O=S(=O)(N(C)C)c1ccc(OP(=S)(OC)OC)cc1	SIGMA	34341	3.79299494	1.38539351	1.23077673	0.89547746	2.30675532	0.89435439	-1.1913513									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159397-03	Iodoantipyrine	170465556		DPI_SARS-CoV-2_General	2019_NPC_01	129-81-7				-29.8975623491	4	7		0	-7.52832628					O=C2C(I)=C(C)N(C)N2c1ccccc1	Labotest	LT00454726	-6.71701401	-7.51337748	-5.86629622	-7.51247899	-4.65665127	-5.04090655	-7.52832628									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161344-07	Eicosapentaenoic Acid		lipoprotein oxidation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	10417-94-4		8.7913490634	-5.0559444758	-5.6499738067	4	7		-25.68384626	-20.98653855	0.0026223742	0.9783769222			CC\C=C/C/C=C\C\C=C/C/C=C\C\C=C/CCCC(O)=O	MedChem Express	HY-B0660	4.46484312	0.19635473	3.4059211	3.56616701	3.07249958	-6.82074408	-20.98653855									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018166-02	Estradiol valerate			DPI_SARS-CoV-2_General	2019_NPC_02	979-32-8		7.8352981002	-5.1059444758	-58.7976898151	-2.2	7		-79.406673648	-68.1111164	0.000078395	0.9963642362			CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=C(C=CC(=C4)O)[C@H]3CC[C@]12C	APExBIO	B1506	0	0.76693848	4.93424908	0	-4.883207	-33.57760241	-68.1111164									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015948-10	Spironolactone			DPI_SARS-CoV-2_General	2019_NPC_01	52-01-7		22.0828704269	-4.6559444758	-0.8265941684	4	7		-19.779752092	-15.64979341	0.0259779695	0.9261935023			[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]4([H])[C@@]2([H])[C@@]([H])(CC5=CC(=O)CC[C@]45C)SC(C)=O	Prestwick	Prestw-128	4.30130952	0	0	0	3.67202964	2.7897759	-15.64979341									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263839-02	Pentisomicin	170465779	Staphylococcus aureus Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	55870-64-9				4.6386971594	4	7		0	0					N[C@@H]3CC=C(CN)O[C@@H]3O[C@H]2[C@@H](O)[C@@H](O[C@H]1OC[C@@](C)(O)[C@H](NC)[C@H]1O)[C@H](N)C[C@@H]2N	Microsource	01500536	0	3.40850783	0	0	3.23047252	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346667-02	Lornoxicam		non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC_02	70374-39-9		13.9333492831	-4.8559444758	-13.4675464325	-2.4	7		-33.18056414	-23.48380345	0.0007057477	0.9889746937		PTGS1	CN1\C(=C(O)/C2=C(C=C(Cl)S2)[S+]1([O-])=O)C(=O)NC3=NC=CC=C3	Selleck	S2047	1.73645633	2.88063942	-0.28363142	2.22856207	-0.18772426	-7.87298008	-23.48380345									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178711-03	Gemifloxacin mesylate	170465333	Topoisomerase IV subunit A  Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	204519-65-3		11.0676527398	-4.9559444758	-5.8511816653	4	7		-9.04844694	-8.79037245	0.1373615406	0.7968686531			CS(=O)(=O)O.CO\N=C1/CN(CC1CN)c2nc3c(cc2F)C(=O)C(=CN3C4CC4)C(=O)O	Microsource	01505802	2.85093297	0.11319273	-2.36515787	-1.39138975	1.05743412	-1.91187523	-8.79037245									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015810-12	Papaverine hydrochloride	170465687	Phosphodiesterase X (PDE10) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	61-25-6	; ;Papaverine?HCl;PAPAVERINE HYDROCHLORIDE; Pavatym; Cerespan;Papaverine hydrochloride; Albatran; Omnopon-Scopolamine; Hydrochloride, Papaverin; Cepaverin; Papaverine hydrochloride; Papaverine Hcl; Pavabid	17.5410474839	-4.7559444758	-28.5838818354	4	7		-15.7993667239	-17.31768523	0.0223208432	0.9324289024	10846	PDE10A	Cl.COc1ccc(cc1OC)Cc3nccc2cc(OC)c(cc23)OC	Vitas	STK039035	-5.46801249	-5.91052362	-4.86217738	-3.49913462	-2.06821296	-6.19442045	-17.31768523									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159380-05	Benzoyl peroxide	170464986		DPI_SARS-CoV-2_General	2019_NPC_01	94-36-0				-57.1855547188	4	7		0	-16.88170135					O=C(OOC(=O)c1ccccc1)c2ccccc2	Labotest	LTBB002750	-12.36172633	-10.15222225	-8.41071385	-12.40374244	-13.11221641	-13.03419889	-16.88170135									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346545-03	Telaprevir (VX-950)		HCV NS3 NS4A Protease Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	402957-28-2		7.8352981002	-5.1059444758	1.8045166387	4	7		-13.422870192	-8.68572516	0.0679673512	0.870752499			CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C3=NC=CN=C3)C4CCCCC4)C(C)(C)C)C(=O)C(=O)NC5CC5	Selleck	S1538	4.54808204	2.86677909	0	4.35656993	-0.12118908	-2.37222849	-8.68572516									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093350-05	Amikacin	174006656	30S ribosomal protein S12 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	37517-28-5				-19.9054190597	4	7		0	-3.05379822					NCC[C@H](O)C(=O)N[C@@H]3C[C@H](N)[C@@H](O[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H]3O[C@H]2O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O	Vitas	STK039706	-1.85669033	-3.29182933	-6.16253721	-0.43729392	-2.39289024	-4.22303645	-3.05379822									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00183363-01	Sincalide	144207030	Cholecystokinin A receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	25126-32-3		12.4181106199	-4.9059444758	-1.9187741085	4	7	Sincalide;ASP-TYR(SO3-H)-MET-GLY-TRP-MET-ASP-PHE-NH2;Sincalida;(Tyr[SO3H]27)Cholecystokinin fragment 26-33 Amide;sincalidum;SINCALIDE;Pancreozymin C-terminal octapeptide;NTOC00000205-01;CCK Octapeptide, sulfated;sincalide;Caerulein, 1-de(5-oxo-L-proline)-2-de-L-glutamine-5-L-methionine-;Cholecystokinin octapeptide;SQ-19844;Sincalidum;CCK-8;CIPLUS_174725;	-15.014436568	-12.92869714	0.0191994431	0.9377824063			NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](Cc2ccc(OS(=O)(=O)O)cc2)NC(=O)[C@@H](N)CC(=O)O)Cc4cnc3ccccc34	SigmaAldrich	C2175	0.86938426	1.21277923	-0.3633295	4.24432336	1.28555474	-0.2113867	-12.92869714									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249611-04	Ixazomib		Proteasome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1072833-77-2				-12.0481228524	4	7		0	-5.68900728				PSMD1	CC(C)C[C@H](NC(=O)CNC(=O)C1=C(Cl)C=CC(=C1)Cl)B(O)O	Selleck	S2180	-0.37226294	0.17325418	-1.16031035	-3.23410425	-0.17821923	-8.18771139	-5.68900728									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159414-01	p-Menthane-1,8-diol monohydrate	225144225		DPI_SARS-CoV-2_General	2019_NPC_01	2451-01-6				12.4660120272	4	7		0	2.60576411					CC(C)(O)C1CCC(C)(O)CC1	SIGMA	M4031	1.19332898	2.83675813	3.89705345	3.33860085	0	4.63946339	2.60576411									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016889-06	Tenoxicam	170465677	non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC_01	59804-37-4	 Tilcotil; Tenoxicam; ;TENOXICAM;Tenoxicam; Mobiflex			1.4274323783	4	7		0	-3.44731439				PTGS2	OC=2c1sccc1S(=O)(=O)N(C)C=2C(=O)Nc3ccccn3	Microsource	01503142	0	1.13861265	0	0	0	3.50627573	-3.44731439									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00345789-05	Venetoclax (ABT-199)		Bcl-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	8444499-71-4		3.499899101	-5.4559444758	-118.5555248828	-2.1	7		-105.9410169866	-91.17633069	0.000001601	0.9994830549		BCL2	CC1(C)CCC(=C(\C1)C2=CC=C(Cl)C=C2)/CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)N[S+]([O-])(=O)C5=CC=C(NCC6CCOCC6)C(=C5)[N+]([O-])=O)OC7=CN=C8[NH]C=CC8=C7	ChemieTek	CT-A769	1.80119772	2.43248862	-2.02292492	-7.14870332	-29.45845116	-66.41770011	-91.17633069									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181091-01	Bunamidine hydrochloride	144206260		DPI_SARS-CoV-2_General	2019_NPC_02	1055-55-6	Bunamidine hydrochloride; Bunamidina; Scolaban; 	4.9437388825	-5.3059444758	-47.4973057216	-2.2	7	bunamidinum;bunamidine monohydrochloride;N,N-DIBUTYL-4-(HEXYLOXY)-1-NAPHTHAMIDINE MONOHYDROCHLORIDE;bunamidine;LS-174664;Scolaban;CIPLUS_738221;CIPLUS_157296;Bunamidinum;N,N-dibutyl-4-(hexyloxy)-1-naphthamidine monohydrochloride;LS-95153;NSC-106571;1-Naphthamidine, N,N-dibutyl-4-hexyloxy-, monohydrochloride;CIPLUS_3885993;1-naphthalenecarboximidamide, n,n-dibutyl-4-(hexyloxy)-, hydrochloride;BUNAMIDINE HYDROCHLORIDE;Bunamidine hydrochloride;Bunamidina;BUNAMIDINE;Bunamidine;	-45.1426770704	-44.11358988	0.0000442061	0.9972747704			Cl.CCCCN(CCCC)C(=N)c1ccc(OCCCCCC)c2ccccc12	NCI	NSC-106571	0.34914102	-1.93813671	-0.99153794	0.39520146	-4.56478863	-27.92653138	-44.11358988									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016682-06	ESTROPIPATE			DPI_SARS-CoV-2_General	2019_NPC_02	7280-37-7				0.533550253	4	7		0	-4.20016173					C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O[S+](O)([O-])=O)=C4)[C@H]1CCC2=O	Microsource	01505116	-1.10754006	2.27540484	1.67600384	-0.94708042	0.90060119	1.09921082	-4.20016173									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160511-01	Desoxycorticosterone Pivalate	29216193		DPI_SARS-CoV-2_General	2019_NPC_02		DESOXYCORTICOSTERONE PIVALATE; Percorten; 			4.6226367215	4	7	CIPLUS_156479;percoten pivalate;DESOXYCORTICOSTERONE PIVALATE;Percorten;Pregn-4-ene-3,20-dione, 21-(2,2-dimethyl-1-oxopropoxy)-;dtma;11-DEOXYCORTICOSTERONE PIVALATE;LS-118664;deoxycortone pivalate;desoxycoticosterone trimethylacetate;desoxycorticosterone pivalate;Desoxycorticosterone pivalate;PREGN-4-ENE-3,20-DIONE, 21-(2,2-DIMETHYL-1-OXOPROPOXY)-;	0	-1.20820054					[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)COC(=O)C(C)(C)C	InterBioScreen	STOCK1N-55228	-0.43700432	2.66349419	1.25876093	1.22769684	2.1552646	0.64355505	-1.20820054									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166290-03	Polyoxyethylene (9) lauryl ether	170466791		DPI_SARS-CoV-2_General	2019_NPC_02	3055-99-0				7.7480713602	4	7		0	0					CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO	SIGMA	P9641	-0.65435039	4.06338793	1.44628583	3.94967612	2.25981988	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165825-02	Milnacipran hydrochloride	225144261	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	101152-94-7				-7.5117630876	4	7		0	-4.88036912					CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2	SIGMA	M1318	-0.98730606	-1.161958	-1.73226132	-0.6898487	0.04039636	-2.56482525	-4.88036912									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249897-01	Nitromersol	170465514		DPI_SARS-CoV-2_General	2019_NPC_01	133-58-4		11.0676527398	-4.9559444758	-24.7682653265	-3	7		-47.8079769778	-43.10156903	0.0004960306	0.9907728824			Cc1ccc(c2[Hg]Oc12)[N+]([O-])=O	GVK	FFS-11-286-NCI-74	0	1.87651184	0	0.58695161	4.34197838	-9.72610397	-43.10156903									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162143-03	Clodronate	225144247	ADP/ATP translocase 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	22560-50-5		0.0440611192	-7.3559444758	-3.0247445539	4	7		-7.03108664	2.24582393	0.4643916813	0.5111459696	293	SLC25A6	O[P]([O-])(=O)C(Cl)(Cl)[P](O)([O-])=O	Prestwick	Prestw-1381	3.27983928	-0.19791336	2.49323682	1.78844658	-10.4425722	0.12195742	2.24582393									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00159341-18	Lamivudine		Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	134678-17-4				4.1247467142	4	7		0	-2.3069971				TERT	NC\1=N\C(=O)N(\C=C1)[C@@H]2CS[C@H](CO)O2	SIGMA	L1295	2.51797729	3.16246622	-0.23206207	-1.91520707	2.28358244	0.23487411	-2.3069971									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00319018-01	Exametazime	170465570		DPI_SARS-CoV-2_General	2019_NPC_01	105613-48-7				2.3987214011	4	7		0	0.85168944					C/C(=N\O)[C@@H](C)NCC(C)(C)CN[C@H](C)C(\C)=N\O	GVK	FFS-11-286-NCI-100	2.88044925	0	0	0	0	0	0.85168944									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179308-04	Fluticasone propionate	170464975	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC_01	80474-14-2	 Flovent;;Fluticasone propionate (Flonase, Veramyst); Cutivate;Fluticasone propionate			-27.7404160621	4	7		0	-6.49920154				NR3C1	O=C(SCF)[C@@]4(OC(=O)CC)[C@H](C)C[C@H]3C2C[C@H](F)C1=CC(=O)C=C[C@]1(C)[C@@]2(F)[C@@H](O)C[C@@]34C	Prestwick Chemical, Inc.	Prestw-997	-2.51494687	-2.66572189	-4.03840998	-5.21483934	-8.12820383	-12.30753595	-6.49920154									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00042523-03	N-Oxydiethylenebenzothiazole-2-sulfenamide	170465568		DPI_SARS-CoV-2_General	2019_NPC_01	102-77-2		6.2237985085	-5.2059444758	-65.2181324015	-2.2	7		-58.648994956	-51.79082913	0.0007164428	0.988874287			c1cccc2sc(nc12)SN3CCOCC3	Labotest	LT00078541	-4.29646842	-2.16727344	1.34288709	-4.45230391	-14.02578288	-30.79424768	-51.79082913									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181300-01	Riboflavin tetrabutyrate	144206329	platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	752-56-7	CIPLUS_668986; Hibon; vitamin B2 tetrabutyrate; 	6.2237985085	-5.2059444758	-59.7449835372	-2.2	7	Hibon;Riboflavin butyrate;Riboflavin Butyrate;riboflavin tetrabutyrate, riboflavin-2-14C-labeled;vitamin B2 tetrabutyrate;RIBOFLAVIN BUTYRATE;riboflavin tetrabutyrate;CIPLUS_668986;	-71.8475479227	-65.59958141	0.0000907025	0.9960874666			CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN2C3=NC(=O)NC(=O)C3=Nc1cc(C)c(C)cc12	ACC	riboflavin butyrate	4.6775648	1.19891889	-0.15705211	-0.66178706	-3.78537652	-37.12889891	-65.59958141									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249416-01	Oberadilol	144206753	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	114856-44-9		15.6334750258	-4.8059444758	-27.9378983711	-3	7		-46.6203919521	-37.39713647	0.0004151255	0.9915722163			Clc3cc(OCC(O)CNC(C)(C)CNc1ccc(cc1)C2=NNC(=O)CC2C)c(C#N)cc3	NCGCChem	DJM10-028	1.64396865	-0.81544965	-0.73369119	0.51680191	-3.05824205	-9.2634348	-37.39713647									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00345812-02	Ingenol mebutate		PKC Activator	DPI_SARS-CoV-2_General	2019_NPC_02	75567-37-2		15.6334750258	-4.8059444758	-51.7948496886	-2.2	7		-41.9178199144	-36.96427722	0.0003408456	0.992376276		PRKCA	C\C=C(C)/C(=O)O[C@H]1C(=C/C23[C@H](C)C[C@@H]4[C@H](C(\C=C(CO)/[C@@H](O)[C@]12O)C3=O)C4(C)C)\C	MedChem Express	HY-B0719	-4.06252168	-6.43812516	-6.37819085	-7.45738138	-6.67490436	-15.33727922	-36.96427722									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160594-03	IPROHEPTINE		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	13946-02-6				10.9949110263	4	7		0	4.83755886					CC(C)CCCC(C)NC(C)C	Microsource	01506195	4.66369165	0	3.06368815	1.999392	0	2.4990605	4.83755886									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090797-12	Digoxin		Steroid	DPI_SARS-CoV-2_General	2019_NPC_01	20830-75-5	; ; 12beta-Hydroxydigitoxin; Card-Cosaldon; Lanoxin;Digoxin; Digoxin			0.4650111593	4	7		0	-1.87067501				RORC	C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C/8=C/C(=O)OC8)C4	Prestwick	Prestw-437	0.67533222	3.08598236	-1.95705686	1.69814634	1.61142973	-3.0133645	-1.87067501									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023509-13	Lovastatin	170464913	HMG-CoA Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	75330-75-5	; ; Lovastatin (Mevinolin); Monacolin K; Mevacor;LOVASTATIN; Mevinolin (lovastatin); 6-Methylcompactin; 6 Methylcompacti; Lovastatin;Lovastatin; 6-alpha-Methylcompactin; 6alpha-Methylcompactin	11.0676527398	-4.9559444758	-71.23276761	-2.2	7		-76.9533547367	-62.09728524	0.000023566	0.9980122555	3156	HMGCR	C[C@@H](CC)C(=O)O[C@H]2C[C@@H](C)C=C3C=C[C@H](C)[C@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@@H]23	Vitas	STK801953	-3.52673493	-3.60886456	-1.67921815	-5.87704116	-9.26508654	-31.23634331	-62.09728524									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179596-03	Butoconazole nitrate	170464901	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC_01	64872-77-1	 Butoconazol;;Butoconazole nitrate; Femstat	6.2237985085	-5.2059444758	-74.6921642855	-2.1	7		-89.5854325668	-84.3730197	0.0000200648	0.9981659764			[O-][N+](=O)O.Clc1ccc(cc1)CCC(Sc2c(Cl)cccc2Cl)Cn3ccnc3	Prestwick Chemical, Inc.	Prestw-408	0	3.27412222	0	2.98743322	-4.55006852	-44.94130799	-84.3730197									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165883-04	Rufinamide	170465202	Sodium channel protein type IX alpha subunit Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	106308-44-5				-39.868879384	4	7		0	-9.73359357					NC(=O)c2cn(Cc1c(F)cccc1F)nn2	Tocris	3828	-8.47917121	-8.42719965	-6.88503814	-7.67802945	-9.2549358	-9.24335586	-9.73359357									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095164-04	Protionamide	170465795	tuberculosis treatment	DPI_SARS-CoV-2_General	2019_NPC_01	14222-60-7	; ; Trevintix; Peteha; PROTHIONAMIDE; Prothionamide; Protionamida;PROTHIONAMIDE;PROTIONAMIDE;Prothionamide			10.8178508409	4	7		0	1.29781248					CCCc1cc(ccn1)C(N)=S	Vitas	STK366469	2.87802871	2.30898918	3.42424021	2.52088193	2.45901639	0.99598557	1.29781248									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163355-05	Indigo	170465746		DPI_SARS-CoV-2_General	2019_NPC_01	482-89-3		12.4181106199	-4.9059444758	-35.6062418087	4	7		-28.7414550481	-27.39601024	0.000543463	0.9903492099			O=C3c4ccccc4N/C3=C2/Nc1ccccc1C2=O	Enzo	AC1057	-5.07104301	-3.98025753	-3.36087349	-2.1947977	-4.56529463	-11.26581635	-27.39601024									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164512-02	Guaiacol carbonate	170465684		DPI_SARS-CoV-2_General	2019_NPC_01	553-17-3				5.3318918685	4	7		0	0					COc2ccccc2OC(=O)Oc1ccccc1OC	Labotest	LT02084807	3.52673493	0	0	0	4.21509415	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016391-13	Clioquinol	170465019		DPI_SARS-CoV-2_General	2019_NPC_01	130-26-7		0.4943738883	-6.3059444758	-142.7011375693	-1.2	7		-75.8781442118	-70.69022331	0.0001652645	0.9947060166			Oc1c(I)cc(Cl)c2cccnc12	Microsource	01505114	3.49768838	2.36763017	-0.43625551	-14.87696591	-63.02339745	-78.31190609	-70.69022331									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015096-17	Amiodarone hydrochloride	170464920	Muscarinic M3 Receptor Ligands	DPI_SARS-CoV-2_General	2019_NPC_01	1951-25-3	; Ancaron; Kordaron; Amiodarone;Amiodarone; Amiodarona;Amiodarone hydrochloride;Amiodarone?HCl	4.4061119169	-5.3559444758	-117.2822264787	-2.1	7		-80.1166529395	-83.72411346	0.0000260103	0.9979110113		CHRM3	CCN(CC)CCOc1c(I)cc(cc1I)C(=O)c2c3ccccc3oc2CCCC	Microsource	02300165	-4.82414736	-5.02602194	-8.88840145	-8.60611533	-17.25879308	-60.2063113	-83.72411346									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090827-07	Guaiacol	225144199	intestine smooth muscle contraction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	90-05-1				9.0886003333	4	7		0	2.89979975					COC1=C(O)C=CC=C1	Prestwick	Prestw-1268	4.42233679	0	0.32658234	0	2.80921687	3.39956299	2.89979975									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016777-08	Probucol	170464772	Serine Protease Hepsin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	23288-49-5	 Bisbid; Aventis Brand of Probucol; Panavir; Lorelco; Biphenabid;PROBUCOL; Probucol; Superlipid;Probucol; Lurselle; Hoechst Brand of Probucol; 	1.106765274	-5.9559444758	-17.5518279039	4	7		-10.7171301159	-11.84760843	0.0285554982	0.9223232854		ABCA1	CC(C)(C)c2cc(SC(C)(C)Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)cc(c2O)C(C)(C)C	Microsource	01501109	-0.34613802	-1.9962372	2.40062392	-0.38377606	-6.70202507	-9.16713248	-11.84760843									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164582-02	Feprazone	170465969		DPI_SARS-CoV-2_General	2019_NPC_01	30748-29-9		1.241811062	-5.9059444758	-81.8630352915	-1.2	7		-40.9615572768	-43.08129072	0.0003836755	0.9918986601			C/C(C)=C\CC2C(=O)N(c1ccccc1)N(C2=O)c3ccccc3	Sequoia	SRP00472f	-3.28468037	-1.08241503	-5.71031659	-4.15130308	-24.44551591	-46.07449566	-43.08129072									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095125-05	Losartan	170465135	Angiotensin II receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	114798-26-4		12.4181106199	-4.9059444758	-34.9145626871	-2.2	7		-46.7833895276	-39.60862843	0.0007686251	0.9884724898			OCc4c(Cl)nc(CCCC)n4Cc1ccc(cc1)c2ccccc2c3nnnn3	Microsource	01504268	1.0723017	0.56441958	-3.52660184	-2.33024807	-2.04791149	-13.77102495	-39.60862843									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182037-01	Alacepril	124893756	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	74258-86-9	Alacepril; ; Alacepril			-12.9337103344	4	7	N-(1-(3-(acetylthio)-2-methyl-1-oxopropyl)-L-prolyl)-L-phenylalanine;CIPLUS_214255;aracepril;alacepril;ALACEPRIL;DU-1219;Alacepril;DU 1219;cetapril;alaceprilum;LS-105750;Cetapril;	0	-4.31432241			1636	ACE	O=C(N[C@@H](Cc1ccccc1)C(=O)O)[C@@H]2CCCN2C(=O)[C@H](C)CSC(C)=O	ACC	ALACEPRIL	0.12254619	-5.68966712	-2.81521765	-1.92923789	-0.78178837	-4.15257422	-4.31432241									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017331-08	(-)-Epicatechin	170465932	superoxide anion generation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	490-46-0		12.4181106199	-4.9059444758	-40.5490865723	-2.2	7		-62.9750703368	-47.32959874	0.0001076651	0.995735949			Oc1ccc(cc1O)[C@H]2Oc3cc(O)cc(O)c3C[C@H]2O	Microsource	00210205	2.70374943	-1.22413077	0.71896858	0.0125417	-4.52976704	-19.91462981	-47.32959874									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163469-03	Monensin sodium salt			DPI_SARS-CoV-2_General	2019_NPC_01	22373-78-0		1.6996795075	-5.7696329617	-32.1876891013	4	7		-10.1690280441	-13.05416846	0.189610659	0.7432790935			[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]2(CC)CC[C@@]([H])(O2)[C@]3(C)CCC4(C[C@H](O)[C@@H](C)[C@]([H])(O4)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O3)[C@@]5([H])O[C@@](O)(CO)[C@H](C)C[C@@H]5C	SIGMA	M5273	-7.17207659	-2.69015564	-6.49508908	-1.24664509	-4.69725423	-11.59611769	-13.05416846									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00094792-18	Tioguanine		Purine Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	154-42-7				1.8663439528	4	7		0	-4.2239452				HPRT1	NC/1=N/C2=C([NH]C=N2)C(=S)N1	Cayman	15774	0.70059423	0.16863406	0.68680997	1.98536118	1.69902336	0.63885757	-4.2239452									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181085-01	Miripirium chloride	144206257		DPI_SARS-CoV-2_General	2019_NPC_02	2748-88-1	CIPLUS_160809; Cloruro de miripirio; 	22.0828704269	-4.6559444758	1.1340084609	4	7	Miripirii chloridum;Miripirium chloride;1-TETRADECYL-4-PICOLINIUM CHLORIDE;MIRIPIRIUM CHLORIDE;Cloruro de miripirio;Chlorure de miripirium;CIPLUS_160809;MYRISTYL-GAMMA-PICOLINIUM CHLORIDE;miripirii chloridum;chlorure de miripirium;myristyl-gamma-picolinium chloride;1-myristylpicolinium;	-10.989059596	-8.32421633	0.0673391771	0.8718969631			[Cl-].Cc1cc[n+](CCCCCCCCCCCCCC)cc1	NCI	NSC-36338	0	1.31904179	0.25081456	3.33699694	0	2.99699361	-8.32421633									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164253-04	LITHIUM CITRATE			DPI_SARS-CoV-2_General	2019_NPC_02	6080-58-6, 919-16-4 [anhydrous]				-46.229646062	4	7		0	-11.31617752					OC(CC([O-])=O)(CC([O-])=O)C([O-])=O	Microsource	01504269	-7.11923975	-9.98637067	-10.70532805	-8.68741669	-9.82106789	-11.50883127	-11.31617752									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167433-05	Rocuronium bromide		Steroid non-depolarizing neuromuscular Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	119302-91-9				1.3840555109	4	7		0	-3.23930933					CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N5CCOCC5)[N+]6(CCCC6)CC=C	MedChem Express	HY-17440	1.75957826	0.78310887	1.81664752	1.06400393	0.44911247	-1.3951522	-3.23930933									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015453-08	Fexofenadine hydrochloride	170464669	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	153439-40-8				-1.5768617892	4	7		0	-7.69562242					Cl.O=C(O)C(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4	Microsource	01504179	1.65323264	-1.76655997	1.46474617	2.10951413	0.61665736	-0.47766655	-7.69562242									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095312-04	Deracoxib	170465679	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	169590-41-4		12.4181106199	-4.9059444758	-50.6093531281	-2.2	7		-41.8147162729	-34.91926694	0.0002744746	0.993167807	791253	PTGS2	NS(=O)(=O)c1ccc(cc1)n3nc(cc3c2ccc(OC)c(F)c2)C(F)F	Microsource	01505222	-5.09524847	-3.8092213	-3.56559674	-7.04592771	-8.11805309	-18.59850602	-34.91926694									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274070-01	Perindopril	170464836	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	82834-16-0				5.3679034268	4	7		0	-1.90109249				ACE	O=C(OCC)[C@H](CCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCCC[C@H]12)C(=O)O	Selleck	S1506	4.49979425	2.49957241	0.15354244	1.46737904	0.63188347	0.00508156	-1.90109249									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025212-08	Cantharidin	170465704	PP-1 Inhibitors;PP-2A Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_01	56-25-7				4.8919327749	4	7		0	-0.4816101				PPP1CA	O=C2OC(=O)[C@]3(C)C1CCC(O1)[C@]23C	Enzo	PR105	1.91465156	1.81054072	2.9611757	1.84363007	-3.82936609	2.71863408	-0.4816101									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024357-07	Scopolamine hydrobromide	170464830	Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	114-49-8				8.4460107664	4	7		0	2.75278193				CHRM1	Br.OC[C@H](c1ccccc1)C(=O)O[C@H]2C[C@@H]3N(C)[C@H](C2)[C@H]4O[C@@H]34	Prestwick Chemical, Inc.	Prestw-877	3.23626946	0	4.07740489	1.19146161	-1.55560067	3.15564815	2.75278193									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178319-06	Thiamphenicol	170465845	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	15318-45-3	;THIAMPHENICOL; Thiomycetin; Thiamcol;Thiamphenicol (Thiophenicol);Thiamphenicol; Vicemycetin; Tiamfenicol; Raceophenidol; Urfamycin; Armai; Thiocymetin			-24.8626777056	4	7		0	-5.96965229					O=S(C)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl	Microsource	01503136	-4.50183819	-4.84880686	-4.99050655	-6.62020906	-2.50219804	-7.74614806	-5.96965229									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166299-03	BISMUTH SUBSALICYLATE	225144280		DPI_SARS-CoV-2_General	2019_NPC_02	14882-18-9				-19.8419005104	4	7		0	-3.44860391					O[Bi]1OC(=O)C2=CC=CC=C2O1	Microsource	01505412	-2.31912877	-2.08136016	-4.01068892	-2.78979492	-4.03250719	-1.84611048	-3.44860391									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00095143-07	Rosuvastatin calcium (Crestor)			DPI_SARS-CoV-2_General	2019_NPC_02	147098-20-2		10.7242526854	-4.9696329617	-8.3088097139	4	7		-14.700494692	-12.66707891	0.0016120768	0.9832566231			CC(C)C1=C(\C=C\C(O)CC(O)CC(O)=O)C(=NC(=N1)N(C)[S+](C)([O-])=O)C2=CC=C(F)C=C2	Adooq	A10810	0	-0.2240754	0.31644828	0.70855646	1.80357864	0.52142052	-12.66707891									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00180998-01	Amylmetacresol	144206204		DPI_SARS-CoV-2_General	2019_NPC_02	1300-94-3	Amylmetacresol; 	11.0676527398	-4.9559444758	-8.0989701829	-3	7	amylmetacresolum;amylmetacresol;AMYLMETACRESOL;CIPLUS_158004;6-N-AMYL-M-CRESOL;Amylmetacresol;	-34.509798796	-31.67483233	0.0015734342	0.983371633			Oc1cc(C)ccc1CCCCC	SigmaAldrich	MFCD00127710	0	3.45353323	3.99193643	1.37268199	4.9592472	-1.47031191	-31.67483233									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160580-02	2-Hydroxy-N-(4-hydroxyphenyl)-benzamide		Ribonucleoside-diphosphate reductase M2 chain Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	526-18-1		13.9333492831	-4.8559444758	-20.8608979037	-2.4	7		-30.2638776519	-23.13656471	0.0004347517	0.9913844108			OC1=CC=C(NC(=O)C2=CC=CC=C2O)C=C1	DC Chemicals	DC8981	0.94568661	-0.83855021	-1.54473641	0.03507705	-2.03169926	-8.92991357	-23.13656471									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522018-01	Echothiophate Iodide		Cholinesterases; ACHE & BCHE Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	513-10-0				1.5807186624	4	7		0	-0.11416068					CCO[P](=O)(OCC)SCC[N+](C)(C)C	Toronto Research	E325800	2.85555735	0.54748319	-1.50254331	0.10055422	0.80079842	-0.36170613	-0.11416068									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166308-02	Difloxacin hydrochloride	170465623	Bacterial DNA gyrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	91296-86-5				-52.1599726752	4	7		0	-16.36778766					Cl.CN1CCN(CC1)c2cc3N(C=C(C(=O)O)C(=O)c3cc2F)c4ccc(F)cc4	Vitas	STK618168	-7.8730144	-9.92168911	-10.7990905	-12.52718472	-7.73471473	-13.66967306	-16.36778766									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015009-23	4-Aminopyridine		Voltage-gated potassium channel subunit Kv1.3 Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	504-24-5				-4.2773170191	4	7		0	-1.7266803					NC1=CC=NC=C1	MedChem Express	HY-B0604	-1.52835904	-0.0207905	1.09467664	-3.1125038	2.54972317	-3.62645622	-1.7266803									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00182996-01	Pamicogrel	144206832	platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	101001-34-7	KBT-3022; 	2.7800686746	-5.5559444758	-99.0020492034	-2.2	7	KB-3022;KB 3022;pamicogrel;1H-Pyrrole-1-acetic acid, 2-(4,5-bis(4-methoxyphenyl)-2-thiazolyl)-, ethyl ester;LS-136537;CIPLUS_207912;PAMICOGREL;Pamicogrel;ETHYL 2-(4,5-BIS(P-METHOXYPHENYL)-2-THIAZOLYL)PYRROLE-1-ACETATE;pamicogrelum;ethyl 2-(4,5-bis(4-methoxyphenyl)thiazol-2-yl)pyrrol-1-ylacetate;KBT-3022;	-90.8039086436	-78.63932473	0.0000032905	0.9992586461			O=C(OCC)Cn1cccc1c2nc(c(s2)c3ccc(OC)cc3)c4ccc(OC)cc4	Pharmaron	PH-NIH-151650	4.44170116	3.97537078	-0.29977334	-5.97235809	-26.08993554	-58.26515575	-78.63932473									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091231-04	Quinidine hydrochloride monohydrate	170465031	Antimalarial Agents; Cytochrome P450 Cyp2d6 Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_01	6151-40-2				7.9868991797	4	7		0	-3.15327875				CYP2D6	[H][C@@]1(CC2CCN1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12	Prestwick	Prestw-280	0	0	4.96453901	3.0426167	4.33690301	1.45840744	-3.15327875									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094937-04	Carprofen	170464799	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	53716-49-7		15.6334750258	-4.8059444758	-18.8054128305	4	7		-18.9816608	-15.401384	0.0072014667	0.9634373249			O=C(O)C(C)c1ccc2c3cc(Cl)ccc3nc2c1	Microsource	01502006	-1.99210902	0.3005351	-2.54198045	-1.82356335	-3.38780896	-5.90477158	-15.401384									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182055-03	Bazedoxifene	170466793	Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC_01	198481-33-3	TSE-424/WAY-140424;Bazedoxifene; Bazedoxifene	1.106765274	-5.9559444758	-167.0860916204	-1.1	7		-100.1724771204	-98.27380802	0.0000026705	0.9993321744	2099	ESR1	CC(=O)O.Oc1ccc(cc1)c5c(C)c2cc(O)ccc2n5Cc3ccc(cc3)OCCN4CCCCCC4	APAC	872287	-0.05567255	-2.48491216	-1.7133387	-17.9622244	-55.20732883	-87.5501804	-98.27380802									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094874-05	Esculin hydrate	225144214	tumor necrosis factor production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	66778-17-4				-29.5659222468	4	7		0	-12.54214088					OC[C@H]1O[C@@H](OC2=C(O)C=C3OC(=O)\C=C/C3=C2)[C@H](O)[C@@H](O)[C@@H]1O	SIGMA	E8250	-6.60082783	-4.07310577	-6.55358144	-3.91050242	-5.29107243	-6.61618985	-12.54214088									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024683-23	Parthenolide			DPI_SARS-CoV-2_General	2019_NPC_01	20554-84-1				1.485652892	4	7		0	0.62862792					C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]3OC(=O)C(=C)[C@@H]3CC1	SIGMA	P0667	0	1.65172136	0	0	0	0	0.62862792									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015455-10	Felodipine	170464849	Voltage-gated calcium channel alpha2/delta subunit 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	72509-76-3		12.4181106199	-4.9059444758	-68.5059592773	-2.2	7		-60.0652021836	-50.14321563	0.0001204743	0.9954879184			CC=1NC(C)=C(C(C=1C(=O)OCC)c2cccc(Cl)c2Cl)C(=O)OC	Specs	AE-641/11429675	-5.55999322	-3.85320204	-7.39684629	-7.5626458	-9.78784957	-26.20559988	-50.14321563									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181782-03	Sertindole	170465613	Serotonin 2c (5-HT2c) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	106516-24-9		6.2237985085	-5.2059444758	-80.0435461041	-2.2	7		-82.0604338096	-76.44484612	0.0000824562	0.9962705295			Fc1ccc(cc1)n5cc(C3CCN(CCN2CCNC2=O)CC3)c4cc(Cl)ccc45	Prestwick	Prestw-1341	2.06941201	-0.88937143	-1.33845901	-2.23323902	-12.45396003	-41.95791056	-76.44484612									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017253-03	Ergobasine	124882896	Serotonin (5-HT) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	129-51-1		15.6334750258	-4.8059444758	-37.1684863126	4	7	ERGONOVINE MALEATE	-28.752614908	-31.06597536	0.0013339517	0.9847336552			C[C@@H](CO)NC(=O)[C@H]\1CN(C)[C@@H]\2CC3=C[NH]C4=CC=CC(=C34)C2=C1	BIOMOL	AC824	-2.93879627	-5.33391855	-6.79074565	-4.90377195	-3.73309888	-6.13021421	-31.06597536									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017063-07	Amodiaquin dihydrochloride dihydrate		Antimalarial; Histamine N-methyl Transferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	6398-98-7		8.7913490634	-5.0559444758	-17.7582897123	-2.4	7		-30.306378732	-27.75531561	0.000926265	0.9873290583			CCN(CC)CC1=C(O)C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl	Prestwick	Prestw-309	0.00462438	0	0	3.18265791	1.73704346	-9.3949643	-27.75531561									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378936-02	Letermovir		Tripartite terminase subunit UL28 homolog Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	917389-32-3		8.7913490634	-5.0559444758	-27.9178267731	-2.2	7		-35.440208344	-32.45017362	0.0010730896	0.9863354017	3077457	TRM1	COC1=CC(=CC=C1)N2CCN(CC2)/C3=N/C4=C(F)C=CC=C4[C@H](CC(O)=O)N3C5=CC(=CC=C5OC)C(F)(F)F	MedChem Express	HY-15233	-0.43700432	-2.91760031	1.69006821	0.19876996	-0.24475441	-13.77301766	-32.45017362									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346501-07	Bleomycin sulfate		glycopeptide antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	9041-93-4		12.4181106199	-4.9059444758	5.2238417997	4	7		-8.3919041079	-6.15992009	0.1099616898	0.8255324335			C[C@@H](O)[C@@H](NC(=O)[C@H](C)[C@@H](O)[C@H](C)NC(=O)[C@@H](NC(=O)C1=C(C)C(=NC(=N1)[C@H](CC(N)=O)NC[C@@H](N)C(N)=O)N)C(O[C@H]2O[C@H](CO)[C@H](O)[C@@H](O)[C@H]2O[C@H]3O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]3O)C4=C[NH]C=N4)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C	Selleck	S1214	3.31799579	2.90836009	0.27425517	4.04789187	0.34455718	1.33408493	-6.15992009									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016367-08	Succinylsulfathiazole	170465721		DPI_SARS-CoV-2_General	2019_NPC_01	116-43-8				5.0179593591	4	7		0	0					O=S(=O)(Nc1nccs1)c2ccc(NC(=O)CCC(=O)O)cc2	Vitas	STK079059	2.59966596	0	1.01874193	0	0	3.64347782	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159423-03	Phytonadione	170464798	Vitamin K epoxide reductase complex subunit 1 Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	84-80-0		2.2082870427	-5.6559444758	-132.6988346878	-1.2	7		-69.1266259005	-71.25801627	0.0000018621	0.9994425254	79001	VKORC1	CC(C)CCC[C@@H](C)CCC[C@@H](C)CCCC(\C)=C\CC2=C(C)C(=O)c1ccccc1C2=O	Labotest	LT00452032	-8.55178757	-7.44496298	-10.97462894	-17.089322	-34.40339035	-57.92977285	-71.25801627									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017030-10	Fusidic Acid (sodium salt)			DPI_SARS-CoV-2_General	2019_NPC_02	751-94-0		17.5410474839	-4.7559444758	-16.3760261549	4	7		-16.1773898721	-13.23312562	0.004696671	0.9708928073			C[C@@H]1[C@H](O)CC[C@@]2(C)[C@H]1CC[C@@]3(C)[C@H]2[C@H](O)C[C@H]4\C([C@H](CC34C)OC(C)=O)=C(CCC=C(C)C)/C([O-])=O	Cayman	14825	-1.22777405	-0.16863406	-2.08387051	-2.48579379	-2.5259606	-4.99342352	-13.23312562									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090997-11	Dichlorvos	170466226	Butyrylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	62-73-7				7.7004719565	4	7		0	2.88966059					COP(=O)(OC)O\C=C(\Cl)Cl	Microsource	00330018	1.42086026	4.400518	1.19665619	1.86369679	0	0	2.88966059									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015508-16	Hydrochlorothiazide	170465005	Hypertension treatment	DPI_SARS-CoV-2_General	2019_NPC_01	58-93-5	; Moduretic; Dyazide;HYDROCHLOROTHIAZIDE; ; Tenesor; Capozide; Slimin; Hydrochlorothiazide; Esidrix; HydroDIURIL; Tolerzide; Oretic; Sectrazide; Triampur compositum; Spiridazide; Esidrex; Triampur (combination); Hypothiazide; Dihydrochlorothiazide; Hydrochlorothiazid;Hydrochlorothiazide; Dichlothiazide; Maxzide; Triampur; Hidroclorotiazida; Moducren			-45.6328742092	4	7		0	-14.32156346				SLC12A3	NS(=O)(=O)c2cc1c(NCNS1(=O)=O)cc2Cl	Specs	AN-153/I107325	-6.81867693	-9.18953258	-10.91126222	-8.8719994	-9.47317667	-9.43137355	-14.32156346									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018248-26	MELOXICAM SODIUM			DPI_SARS-CoV-2_General	2019_NPC_02	71125-38-7		12.4181106199	-4.9059444758	-40.0763105887	4	7		-19.701310676	-24.02606669	0.0454643925	0.898088803			CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3[S+]1([O-])=O	Microsource	01504150	-3.3457421	-8.4894546	-8.82070275	-5.76900592	-3.02497446	-9.86471251	-24.02606669									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249904-01	Butamisole	170466389	Nicotinic acetylcholine receptor alpha subunit Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	54400-59-8		22.0828704269	-4.6559444758	4.2765387051	4	7		-11.726356752	-8.52196396	0.0786394822	0.8586474638			CC(C)C(=O)Nc1cccc(c1)C2N=C3SCCN3C2	GVK	FFS-11-286-NCI-117	0	2.99313412	-0.13404499	4.3519703	2.71278486	2.62716601	-8.52196396									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00080392-05	Phosmet	170466810	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	732-11-6		9.8640558873	-5.0059444758	-33.4771850082	4	7		-25.2982288119	-26.34660718	0.0005012573	0.9907379804			COP(=S)(OC)SCN2C(=O)c1ccccc1C2=O	Vitas	STK097158	-4.36908479	-2.34808317	-3.59971729	-3.55431811	-2.46409176	-11.82478784	-26.34660718									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344523-01	L-(-)-Sorbose	170465548		DPI_SARS-CoV-2_General	2019_NPC_02	87-79-6				4.5095587591	4	7		0	0.21880797					O[C@H](C(=O)CO)[C@H](O)[C@@H](O)CO	SIGMA	140929	0	4.66862251	0	0.72258728	0	0.89721909	0.21880797									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262588-02	Merbromin	225144359		DPI_SARS-CoV-2_General	2019_NPC_02	129-16-8		15.6334750258	-4.8059444758	-48.3076934382	-2.2	7		-68.7905627107	-55.14436569	0.0002148332	0.9939584048			O.O.O.[Na+].[Na+].O[Hg]C1=C([O-])C(=CC2=C1OC3=CC(=C(Br)C=C3C24OC(=O)C5=CC=CC=C45)[O-])Br	Prestwick	Prestw-787	0.5618627	-3.13474555	-3.6121985	-0.62904848	-4.4412233	-16.24389327	-55.14436569									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167574-03	Xaliproden hydrochloride	170465603	Serotonin 1a (5-HT1a) receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	90494-79-4		5.5469662594	-5.2559444758	-1.9512528634	4	7		-16.675355564	-12.22946297	0.0054155374	0.9685024426			Cl.FC(F)(F)c1cccc(c1)C4=CCN(CCc2cc3ccccc3cc2)CC4	Tocris	2491	1.69483687	3.61985724	4.85923912	1.60185207	0.55366775	-5.84836528	-12.22946297									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016026-10	Terazosin hydrochloride	170465073	Alpha1-adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	63074-08-8	; ; Terazosin hydrochloride;TERAZOSIN HYDROCHLORIDE; Hytrin; Terazosina;Terazosin hydrochloride			5.5710365748	4	7		0	-1.82504879			148	ADRA1A	Cl.COC1=CC2=NC(=NC(N)=C2C=C1OC)N1CCN(CC1)C(=O)C1CCCO1	Vitas	STK567029	2.94096289	0	0	0	3.73293407	2.76944967	-1.82504879									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182053-03	Acrivastine		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	87848-99-5		13.9333492831	-4.8559444758	-41.9200581716	-2.2	7		-67.9083384912	-56.27645912	0.0001725545	0.99459089			CC1=CC=C(C=C1)\C(=C/CN2CCCC2)C3=CC=CC(=N3)\C=C\C(O)=O	Enzo	AC3005	1.02892552	1.79029315	-1.31033028	-2.88333372	-1.77031105	-14.34611048	-56.27645912									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253601-01	Calcium undecylenate	170465553		DPI_SARS-CoV-2_General	2019_NPC_01	1322-14-1				12.8145022105	4	7		0	3.13300043					[Ca+2].[O-]C(=O)\C=C\CCCCCCCC.[O-]C(=O)\C=C\CCCCCCCC	GVK	FFS-11-286-NCI-082	4.04231114	2.69015564	0	4.44728723	4.47901335	0.44209563	3.13300043									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022304-21	ACETYLCYSTEINE			DPI_SARS-CoV-2_General	2019_NPC_01	616-91-1				-13.5097134618	4	7		0	-3.25467035					CC(=O)N[C@@H](CS)C(O)=O	Microsource	01500105	-3.0474669	-1.39028025	-9.89252029	-0.63962676	-0.36796427	-1.62101733	-3.25467035									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091643-10	2-Mercaptobenzothiazole		Thyroid peroxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			12.4181106199	-4.9059444758	4.0366770368	4	7		-15.8671217279	-11.97260144	0.0173539644	0.9411416055		Tpo	SC1=NC2=C(S1)C=CC=C2	Specs	AE-562/J262422	4.41397489	0.25179607	2.54799466	4.33318523	2.87289404	0.526118	-11.97260144									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015819-15	Propafenone hydrochloride	170464755	Potassium Channel Subfamily K Member 3 (TASK-1; KCNK3) Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	54063-53-5	Propafenona; ;Propafenone; Propafenone Hcl; Propafenone;Propafenone hydrochloride; Rythmol;Propafenone?HCl; Propafenone, (S)-Isomer; Rhythmol; Propafenone, (R)-Isomer	11.0676527398	-4.9559444758	-3.5090456567	4	7		-9.6168538239	-8.43071152	0.1860191938	0.7474014752		KCNK3	CCCNCC(O)COc2ccccc2C(=O)CCc1ccccc1	SigmaAldrich	P-4670	-1.99210902	3.77501405	-1.53786162	2.05934733	0.91102878	-1.93607399	-8.43071152									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263955-02	TYLOSIN TARTRATE			DPI_SARS-CoV-2_General	2019_NPC_01	74610-55-2				-22.3740813278	4	7		0	-5.6982079					CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/C(=C/[C@@H]1CO[C@@H]4O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]4OC)C	FLUKA	33847	-3.77847167	-4.39563125	-6.36835563	-5.52587353	-1.72816322	-6.03181056	-5.6982079									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346560-06	Telbivudine		DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	3424-98-4				-13.5239123887	4	7		0	-5.02782667				P	CC/1=C/N([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O	Enzo	AC3257	-1.66246618	-3.73073991	-5.07020464	0.0865234	-1.85110377	-3.37748967	-5.02782667									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389454-01	IMEXON		Ribonucleoside-Diphosphate Reductase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_02	59643-91-3				-10.4032820446	4	7		0	-1.56019598				RRM1	N=C1NC(=O)N2CC12	Microsource	01506181	-1.15840829	-2.4648294	-3.14807435	-1.73748334	0.48238006	-5.61818865	-1.56019598									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00160502-01	NCGC00160502-01	29216184		DPI_SARS-CoV-2_General	2019_NPC_02		Kliostom; 			4.3707904682	4	7	CIPLUS_3884272;Kliostom;	0	-5.01355658					CC1=NC=C(N1CCOC(=O)C2=CC=CC=C2)[N+]([O-])=O	InterBioScreen	STOCK1S-09026	0.81851604	0.11550278	2.92773259	0	3.40517549	1.16497557	-5.01355658									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00351603-13	Ceritinib		ALK Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1032900-25-6		2.7800686746	-5.5559444758	-115.4650232138	-2.1	7		-94.8058317064	-86.85725158	0.0000031718	0.999272134		ALK	CC(C)OC1=CC(=C(C)C=C1NC2=NC=C(Cl)C(=N2)NC3=C(C=CC=C3)[S+]([O-])(=O)C(C)C)C4CCNCC4	MedChem Express	HY-15656	2.57809429	0.19635473	-0.8602705	-6.5781166	-27.76655657	-67.19748215	-86.85725158									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00371130-03	Vilazodone Hydrochloride		Sodium-dependent serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	163521-08-2		6.2237985085	-5.2059444758	-91.5662024798	-2.1	7		-100.9120011364	-87.64210626	0.0000620076	0.9967683861	6532	SLC6A4	NC(=O)C1=CC2=CC(=CC=C2O1)N3CCN(CCCCC4=C[NH]C5=C4C=C(C=C5)C#N)CC3	APExBIO	A3919	2.33300192	1.67941047	-0.95403296	-4.19755396	-15.6143811	-48.08342728	-87.64210626									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091320-05	Decanoic acid	225144209	Peroxisome proliferator-activated receptor gamma Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	334-48-5				7.5237901351	4	7		0	2.00248409			5468	PPARG	CCCCCCCCCC(O)=O	SIGMA	D1653	0.5785104	1.4049405	1.5671078	3.10783355	1.10389281	1.50922303	2.00248409									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167564-03	8-Bromotheophylline	170465479		DPI_SARS-CoV-2_General	2019_NPC_01	10381-75-6				-21.2444035218	4	7		0	-7.42693468					O=C2c1nc(Br)nc1N(C)C(=O)N2C	Vitas	STK803299	-5.97632706	-3.64795856	-5.50071897	-3.36870093	-2.14941887	-4.33456985	-7.42693468									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183025-01	Biliscopin	144206809		DPI_SARS-CoV-2_General	2019_NPC_01	51022-74-3	Iotroxic acid; Acido iotroxico; 			0.0988786277	4	7	Acido iotroxico;3,3'-(oxybis(2,1-ethanediyloxy(1-oxo-2,1-ethanediyl)imino)bis(2,4,6-tri iodobenzoic acid));iotroxic acid, calcium salt;iotroxic acid;BENZOIC ACID, 3,3'-(OXYBIS(2,1-ETHANEDIYLOXY(1-OXO-2,1-ETHANEDIYL)IMINO))BIS(2,4,6, TRIIODO-;SH 213 AB;acidum iotroxicum;3,3'-(3,6,9-TRIOXAUNDECANEDIOYLDIAMINO)BIS(2,4,6-TRIIODOBENZOIC ACID);IOTROXIC ACID;Iotroxic acid;3,3'-(OXYBIS(ETHYLENEOXYMETHYLENECARBONYLIMINO))BIS(2,4,6-TRIIODOBENZOIC ACID);Iotroxic Acid;iotroxinate;iotroxic acid, magnesium salt;CIPLUS_180821;Acide iotroxique;Acidum iotroxicum;acide iotroxique;	0	-5.58160756					O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)COCCOCCOCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I	Pharmaron	PH-NIH-120888-3	1.25142207	2.42627117	-0.00243718	-1.0660446	1.54037456	0.24391483	-5.58160756									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016798-11	(S)-Timolol	170465062	Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	26839-75-8		22.0828704269	-4.6559444758	-5.2468237733	4	7		-11.24723074	-9.78935895	0.0159639833	0.944138982			O[C@H](COc1nsnc1N2CCOCC2)CNC(C)(C)C	Enzo	AC172	-0.7963595	-0.59374007	1.19178182	-1.22657837	0.42379333	0.85370192	-9.78935895									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179445-03	Dydrogesterone	170465104	signaling/transport	DPI_SARS-CoV-2_General	2019_NPC_01	152-62-5		12.4181106199	-4.9059444758	-21.6974215691	4	7		-23.87080176	-22.3923348	0.2168747967	0.7137628644			CC(=O)[C@H]2CC[C@H]3[C@@H]4C=CC1=CC(=O)CC[C@@]1(C)[C@@H]4CC[C@]23C	Prestwick Chemical, Inc.	Prestw-671	-11.70817902	4.14640702	0.95293802	0.75501041	-1.7484647	-6.92108339	-22.3923348									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015823-17	Piroxicam	170464817	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	36322-90-4	; ;Piroxicam; Piroxicam cyclodextrin;PIROXICAM; Piroxicam;piroxicam; Feldene	19.6813789847	-4.7059444758	-32.3149319409	4	7		-27.6305794961	-22.89929279	0.0025873849	0.9785564806	5742	PTGS1	OC=2c1ccccc1S(=O)(=O)N(C)C=2C(=O)Nc3ccccn3	Vitas	STK177288	-4.59177499	-1.95714321	-3.823938	-4.90882183	-5.48393646	-8.33883836	-22.89929279									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178802-06	Deferoxamine mesylate	170464752	Iron Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC_02	138-14-7				5.004956652	4	7		0	-0.68972078				APP	ON(CCCCCNC(=O)CCC(=O)N(O)CCCCCN)C(=O)CCC(=O)NCCCCCN(O)C(C)=O.CS(=O)(=O)O	Microsource	01500224	1.04742306	1.39296357	1.1274935	0.47470945	1.71803341	1.95415257	-0.68972078									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016000-18	Disulfiram	170464767	Aldehyde Dehydrogenase (ALDH2) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	97-77-8	 ;Tetraethylthiuram disulfide; Disulfiram; Tetraethylthiuram disulfide; Disulfiramo; Teturam; Antabuse;Disulfiram;DISULFIRAM	13.9333492831	-4.8559444758	-63.8928775872	-2.2	7		-79.414881752	-62.0567286	0.0018692928	0.9818178761	217	ALDH2	CCN(CC)C(=S)SSC(=S)N(CC)CC	Microsource	01500262	-0.65596786	0.2418941	-1.5134898	-7.06097775	-11.8941278	-23.74612531	-62.0567286									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178054-06	Clarithromycin		Macrolide Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	81103-11-9	;CLARITHROMYCIN;Clarithromycin (Biaxin, Klacid); 6-O-Methylerythromycin; 14-OH-clarithromycin; Claritromicina;Clarithromycin; Erythromycin, 6-O-methyl-; Biaxin	13.9333492831	-4.8559444758	-3.9568975952	4	7		-19.701503128	-13.08458594	0.0091439479	0.9584309494			CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC	SIGMA	C9742	0.05567255	1.434261	3.39499403	2.72656583	0	-3.40464454	-13.08458594									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167437-02	Ramosetron hydrochloride	170465928	Serotonin 3a (5-HT3a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	132907-72-3		11.0676527398	-4.9559444758	-47.1806459821	-2.2	7		-31.3110421949	-34.89035818	0.0006205603	0.9896686251			Cl.O=C(c2cn(C)c1ccccc12)[C@H]3Cc4ncnc4CC3	Bosche	R2999	-5.07063747	-6.77077318	-5.77342303	-7.00839511	-3.87567426	-12.8429162	-34.89035818									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183104-02	Nizofenone	170466022		DPI_SARS-CoV-2_General	2019_NPC_02	54533-86-7		15.6334750258	-4.8059444758	-27.8091833358	-2.2	7		-59.9434191132	-44.27531751	0.0000747332	0.9964518959			Clc1ccccc1C(=O)c2cc(ccc2n3ccnc3CN(CC)CC)[N+]([O-])=O	APAC	556416	1.21852528	2.38628751	0.24612644	2.626102	-1.33307987	-11.49473882	-44.27531751									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016916-11	Norfloxacin	170464769	DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	70458-96-7	; ; Norfloxacin-d5;NORFLOXACIN; Norfloxacino; Noroxin; Norfloxacin;Norfloxacin; Norfloxacin Glutamate			-0.5178575409	4	7		0	-4.94284049			7155	TOP2B	O=C(O)C2=CN(CC)c1cc(c(F)cc1C2=O)N3CCNCC3	Vitas	STK177250	-1.64839155	2.49468566	0.49474787	-0.04765846	0.3628889	1.28055287	-4.94284049									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181000-02	Suplatast tosylate	170465881	Mediator Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	94055-76-2	 ;IPD-1151T; Tosilato de suplatast; Suplatast;Suplatast tosylate; Suplatast tosylate			-5.8745846472	4	7		0	-2.78826899					Cc1ccc(cc1)S(=O)([O-])=O.C[S+](C)CCC(=O)Nc1ccc(OCC(O)COCC)cc1	Tocris	3543	-1.27562753	-2.6168544	-0.6507275	-1.95901372	-0.60650662	0.76731541	-2.78826899									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00188943-03	Orotic acid	170465761	metabolite	DPI_SARS-CoV-2_General	2019_NPC_01	65-86-1	Orotic acid;Orotic acid (6-Carboxyuracil)			5.4538360163	4	7		0	2.13936275				DHODH	OC(=O)c1cc(O)nc(O)n1	Vitas	STK301771	3.44927747	-2.04021795	1.04067656	0.34865929	3.62127595	-0.12195742	2.13936275									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090887-04	Phenyl salicylate	170465501	Estrogen receptor alpha Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	118-55-8		24.777388143	-4.6059444758	-31.817968941	4	7		-26.143722596	-25.11976883	0.0612688616	0.8780565733			Oc2ccccc2C(=O)Oc1ccccc1	Specs	AT-084/J165064	-3.98663859	-6.47249982	-8.54232166	-4.75832142	-3.7278587	0.79780477	-25.11976883									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091902-11	Malathion	170465311	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	121-75-5		22.0828704269	-4.6559444758	-2.5109444866	4	7		-18.574066568	-15.06172214	0.0186450152	0.9387017208			CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC	Microsource	00330021	1.67017646	0	0	0	4.34705375	1.80903501	-15.06172214									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249903-01	Dexamethasone isonicotinate	170466851		DPI_SARS-CoV-2_General	2019_NPC_01	2265-64-7		12.4181106199	-4.9059444758	-43.1615899024	-2.2	7		-43.8474931263	-41.76319992	0.0009104889	0.9874324606			O=C1C=C2CC[C@@H]5[C@@](F)([C@@]2(C)C=C1)[C@@H](O)C[C@@]4(C)[C@H]5C[C@@H](C)[C@]4(O)C(=O)COC(=O)c3ccncc3	GVK	FFS-11-286-NCI-109	-5.2985743	-4.59110123	-3.79469182	-0.23327564	-3.58574836	-12.91224148	-41.76319992									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249883-01	Hydrocortamate	170465314	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	76-47-1		22.0828704269	-4.6559444758	-3.0154967932	4	7		-22.297166108	-18.16430509	0.0070931732	0.9636120399			CCN(CC)CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	GVK	FFS-11-286-NCI-02	0	1.94492633	0	0.74246871	3.75323555	2.95238579	-18.16430509									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160611-03	1-Ethyl-2-pyrrolidinone	170465488		DPI_SARS-CoV-2_General	2019_NPC_01	2687-91-4				-46.5018827991	4	7		0	-12.24810524					O=C1CCCN1CC	SIGMA	146358	-11.5581052	-9.63911354	-8.86402964	-11.19472245	-9.77769883	-6.62127141	-12.24810524									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346555-05	Apixaban		Coagulation Factor Xa Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	503612-47-3		22.0828704269	-4.6559444758	-4.6967936037	4	7		-18.27141702	-15.22618085	0.0021996631	0.980306467		F10	COC1=CC=C(C=C1)[N]2N=C(C(N)=O)C3=C2C(=O)N(CC3)C4=CC=C(C=C4)N5CCCCC5=O	APExBIO	A4341	0	1.23818984	0.97981763	0.25255478	0	2.29706877	-15.22618085									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532496-01	P-T-BUTYL-M-CRESOL			DPI_SARS-CoV-2_General	2019_NPC_02			6.2237985085	-5.2059444758	-90.8667354192	-2.2	7		-71.412851733	-67.00280645	0.0000058211	0.9990136832			CC1=CC(=CC=C1C(C)(C)C)O	SIGMA	A000011660	-6.00476312	-4.76564485	-4.14195635	-7.68655146	-15.79497659	-41.27207817	-67.00280645									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094818-09	Hexestrol	170466031	17-betahydroxysteroid dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	84-16-2	; ; Hexoestrolum; Hexestrol, (R*,S*)-Isomer;Hexestrol; Dihydrodiethylstilbestrol;meso-Hexestrol;HEXESTROL; HEXESTROL	12.4181106199	-4.9059444758	-79.3739844112	-2.2	7		-65.2810683912	-56.01378926	0.0000810886	0.9963028904	1645	AKR1C1	Oc1ccc(cc1)[C@@H](CC)[C@@H](CC)c2ccc(O)cc2	Microsource	01500632	-7.94665118	-5.96427786	-8.65443201	-6.83522713	-13.6096026	-28.55328015	-56.01378926									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00371080-02	Dexmedetomidine		Adrenergic receptor alpha-2 Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	113775-47-6		12.4181106199	-4.9059444758	-36.3603861262	4	7		-15.2746163801	-19.19326452	0.0412205885	0.9040337432			C[C@H](C1=CN=C[NH]1)C2=C(C)C(=CC=C2)C	Selleck	S3075	-4.52033573	-5.75896879	-8.77382152	-5.66611323	-3.54775087	-9.41375423	-19.19326452									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00319175-03	Rilpivirine			DPI_SARS-CoV-2_General	2019_NPC_02	500287-72-9		3.1192883571	-5.5059444758	-82.2519631127	-2.2	7		-73.1118774706	-66.75545831	0.0000063673	0.998968282			CC1=C(NC2=CC=NC(=N2)NC3=CC=C(C=C3)C#N)C(=CC(=C1)\C=C\C#N)C	APExBIO	A3765	1.38037874	2.41400818	1.26344905	-3.45392045	-17.25399805	-51.65351372	-66.75545831									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181030-02	Uracil	170465915	Dihydropyrimidine dehydrogenase Substrate	DPI_SARS-CoV-2_General	2019_NPC_02	66-22-8				14.2401545054	4	7		0	-0.56604671					O=C1C=CNC(=O)N1	Specs	AC-907/30002021	4.72843303	3.62447735	0	4.7354021	4.08003232	3.78617061	-0.56604671									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159326-03	Lincomycin hydrochloride	170465252	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	859-18-7	 ; Lincocin; Lincomycin HCL; Lincomycin hydrochloride; Lincomicina;Lincomycin hydrochloride; Lincolcina			2.4507148192	4	7		0	-3.15327875					Cl.O[C@@H]1[C@@H](O)[C@@H](O)[C@H](O[C@@H]1SC)[C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@@H](C)O	Prestwick	Prestw-302	3.8704524	0	0	1.7081797	0.18017561	0.24899639	-3.15327875									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016794-13	Gemfibrozil	170464998	PPARalpha Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	25812-30-0	 Gemfibrozilo; ;; Lopid;GEMFIBROZIL; Gemfibrozil;Gemfibrozil			10.429815079	4	7		0	1.0646118			5465	PPARA	O=C(O)C(C)(C)CCCOc1cc(C)ccc1C	Vitas	STK618740	0	0	4.87680047	4.85363835	2.86504593	1.51938615	1.0646118									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183273-04	Chloroprocaine HCl		"Sodium Channel Alpha Subunits; Brain (types I, Ii, Iii) Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC_02	3858-89-7				5.1423409735	4	7		0	-1.75522047					CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1	APExBIO	B4870	1.46361766	2.32160595	2.99336631	0.72726422	0.84832355	0.37110109	-1.75522047									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166059-02	Aluminum acetate, basic			DPI_SARS-CoV-2_General	2019_NPC_02	142-03-0				9.5003202159	4	7		0	-0.22356467					CC(=O)O[Al](O)OC(C)=O	SIGMA	289825	1.90293417	-0.13629328	2.56674715	3.51004373	3.48121569	3.60766629	-0.22356467									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00159492-03	Perazine	29215457	Cytochrome P450 1A2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02		Perazine; Perazine Maleate (1:1); Perazine Maleate (1:2); Maleate, Perazin; Taxilan; Dihydrochloride, Perazin; Perazine Dihydrochloride; Perazine Fendizoate; 	12.7076930516	-4.8959332839	-58.5464457311	-2.2	7	CIPLUS_744600;Perazine Fendizoate;LS-172810;CIPLUS_776815;PERAZINE DIMALONATE;Maleate, Perazin;10H-Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-;Perazine Dihydrochloride;Dihydrochloride, Perazin;CIPLUS_666528;10-(3-(4-Methyl-1-piperazinyl)propyl)phenothiazine dihydrochloride;Perazine Dimalonate;CIPLUS_660985;Perazine Maleate (1:1);Perazine Maleate;10h-phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-, (z)-2-butenedioate;CIPLUS_777988;PERAZINE MALEATE;LS-105591;LS-105593;pernazine;LS-173237;Perazine maleate;Pernazine;Perazine Maleate (1:2);Perazine;LS-105589;Perazine dimalonate;CIPLUS_149789;Cinchonan-9-ol, 6'-methoxy-, (9S)-, sulfate (2:1) (salt), mixt. with 5,5-diphenyl-2,4-imidazolidinedione and 10-(3-(4-methyl-1-piperazinyl)propyl)-10H-phenothiazine (Z)-2-butenedioate (1:2);Taxilan;CIPLUS_769544;phenrytmat;	-84.3262379295	-74.40898064	0.0000325066	0.9976637686			CN1CCN(CCCN2C3=CC=CC=C3SC4=CC=CC=C24)CC1	AKos	AKJ-93711	2.79544036	0	0	1.06868087	-10.8190956	-40.77414506	-74.40898064									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00247988-03	Cochineal	170466801	Solute carrier organic anion transporter family member 1B1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1343-78-8		11.0676527398	-4.9559444758	-28.0267587759	4	7		-25.915548048	-25.61955953	0.0032007235	0.9760239372			O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@@H]1CO)c4c(O)c3C(=O)c2c(C)c(C(=O)O)c(O)cc2C(=O)c3c(O)c4O	SIGMA	229253	-3.59083447	-2.0582596	-1.5634889	-4.08998433	-0.27326949	-9.31040962	-25.61955953									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00074022-02	Pyricarbate	144204540	Bradykinin B2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	1882-26-4	Angioxine; Anginin; Movecil; Lisator; Sospitan; Duaxol; Prodectin; Pyricarbato; Duvaline; Gasparol; Parmidine; Colesterinex; 			7.4069902057	4	7	CIPLUS_159179;Pyricarbate;Parmidine;Pyricarbato;Duaxol;2,6-Pyridinedimethanol, bis(methylcarbamate) (ester);Angioxine;Colesterinex;Gasparol;Movecil;Pyridinolcarbamate;Prodectin;LS-50369;Pyridinol carbamate;ravenil;Pyricarbatum;Duvaline;2,6-Pyridinedimethanol-bis-(N-methylcarbamate);Pyridinol Carbamate;PYRIDINOL CARBAMATE;pyricarbatum;Anginin;Sospitan;PYRICARBATE;Lisator;P-23;pyricarbate;PYRIDINOLCARBAMATE;	0	3.70070875					CNC(=O)OCc1cccc(COC(=O)NC)n1	InterBioScreen	STOCK4S-68399	-0.88556961	1.68403059	0	1.70006782	1.14773186	4.13378429	3.70070875									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386194-01	Clindamycin palmitate HCl		Antibacterial	DPI_SARS-CoV-2_General	2019_NPC_02	25507-04-4		1.5633475026	-5.8059444758	-64.4479007015	-1.2	7		-55.6655567691	-47.95224278	0.0000392998	0.9974306443			CCCCCCCCCCCCCCCC(=O)OC1C(O)C(O)C(OC1SC)C(NC(=O)C2CC(CCC)CN2C)C(C)Cl	Selleck	S2596	4.42784804	2.21072328	3.81378777	-5.83448308	-21.00848324	-39.52931229	-47.95224278									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00096122-05	Thioinosine	170465903	Serine/threonine-protein kinase N1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	574-25-4				11.1937672462	4	7		0	2.80854731			29355	Pkn1	Sc3ncnc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	SIGMA	852686	1.28046862	4.20504801	1.59147961	0	4.73785718	2.12409167	2.80854731									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016740-18	Prazosin	170465415	alpha1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	19216-56-9	Prazosin hydrochloride;PRAZOSIN HYDROCHLORIDE;PRAZOSIN; Polypress;; ; Pratsiol;Terazosin hydrochloride; Prazosina; Justac; Minipress;Prazosin; Prazosin hydrochloride; Furazosin hydrochloride			-9.4406953613	4	7		0	-7.08220324			148	ADRA1A	O=C(N1CCN(CC1)c3nc2cc(OC)c(OC)cc2c(N)n3)c4ccco4	Vitas	STK301545	-2.50526469	2.26989518	-0.09992445	-2.99746658	-0.58112978	-2.36292495	-7.08220324									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00018271-07	Homochlorcyclizine	170465786		DPI_SARS-CoV-2_General	2019_NPC_01	848-53-3		15.6334750258	-4.8059444758	-35.6751558907	4	7		-27.656101604	-23.01082355	0.0023857319	0.9794371898			Clc1ccc(cc1)C(c2ccccc2)N3CCCN(C)CC3	Enzo	AC927	-3.14912981	-2.88073888	-3.80444054	-5.52587353	-7.42780287	-10.99649372	-23.01082355									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181026-02	Robenidine	170465629	Eimeria tenella Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	25875-51-8		2.7800686746	-5.5559444758	-112.5777226417	-2.1	7		-96.2753175081	-86.80968463	0.0000220775	0.998075849			Clc2ccc(/C=N/NC(=N)N\N=C/c1ccc(Cl)cc1)cc2	SIGMA	33979	3.61395639	0.17325418	1.54004829	-5.291958	-25.87030392	-69.66835776	-86.80968463									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182705-02	Azatadine	170464865	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	3964-81-6				7.4028850092	4	7		0	-2.2071065					CN1CC\C(CC1)=C2\c4ncccc4CCc3ccccc23	APAC	555789	4.75617933	0	0	-0.20812385	3.75210893	4.11029688	-2.2071065									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344529-02	Cefamandole (nafate)		Bacterial Penicillin-binding Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	42540-40-9		15.6334750258	-4.8059444758	-40.8552049827	-3	7		-40.0707553403	-39.32835466	0.0003509529	0.9922604714			C[N]1N=NN=C1SCC/2=C(/N3[C@H](SC2)[C@H](NC(=O)[C@H](OC=O)C4=CC=CC=C4)C3=O)C([O-])=O	MedChem Express	HY-B1166	-2.89717681	-3.9709857	-5.18271958	-2.71964081	-6.01430506	-8.08906426	-39.32835466									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017013-05	Thiamine hydrochloride			DPI_SARS-CoV-2_General	2019_NPC_02	67-03-8				12.6460410016	4	7		0	1.86938115					CC1=C(CCO)SC=[N+]1CC2=CN=C(C)N=C2N	Prestwick	Prestw-631	4.32611159	0	4.65296172	2.18646961	3.01071692	2.63998497	1.86938115									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181325-03	Menaquinone		bone resorption Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	11032-49-8		4.4061119169	-5.3559444758	-101.2237733183	-2.1	7		-92.9128668609	-84.16020549	0.0000973707	0.995944882			CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/1=C(C)/C(=O)C2=C(C=CC=C2)C1=O	Prestwick	Prestw-NAT-0236	-2.06016324	0.21945529	-0.82276552	-0.26424713	-22.5055248	-55.99398722	-84.16020549									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164248-05	Sucrose		Starch and sucrose metabolism Substrate	DPI_SARS-CoV-2_General	2019_NPC_02	57-50-1				-30.3992447798	4	7		0	-6.22175712					OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	DC Chemicals	DCZ-038	-6.95276191	-3.98946615	-6.11096786	-7.4947969	-6.89351995	-7.57703871	-6.22175712									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181021-02	Bufogenin	124893634	Sodium/potassium-transporting ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			13.9333492831	-4.8559444758	-4.1497307718	4	7	CIPLUS_153297;resibufogenin;Bufogeninum;Bufogenine;Bufogenina;BUFOGENIN;14,15 beta-epoxy-3 beta-hydroxy-5 beta-bufa-20,22-dienolide;Bufogenin;bufogenine;bufogeninum;RESIBUFOGENIN;bufogenin;Resibufogenin;LS-45295;	-29.9121676199	-21.17680635	0.0013610302	0.984581241			C[C@]12CC[C@H](O)C[C@H]1CCC3C2CC[C@]4(C)[C@H](C[C@H]5O[C@@]345)C/6=C/OC(=O)/C=C6	Sequoia	RESIBUFOGENIN	3.10527411	4.21123149	0.88839924	3.70179828	1.52318038	-3.29293499	-21.17680635									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183598-02	Ximelagatran		Thrombin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	192939-46-1				2.9329454576	4	7		0	0.82290824					CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)\C(N)=N\O	DC Chemicals	DC7647	3.59545885	-0.76924854	0.33520077	0.01636929	2.94893425	-2.43799324	0.82290824									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167491-04	Lenalidomide	170465201	TNF-alpha Production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	191732-72-6	; IMiD3 cpd; Lenalidomide;Lenalidomide;ENMD-0997; Revimid;CC-5013; Lenalidomide(Revlimid);Revlimid; Revlimid			11.2072918734	4	7		0	0			7124	TNF	O=C1NC(=O)CCC1N3Cc2c(cccc2N)C3=O	Selleck	S1029	2.72311379	1.78610697	3.81418927	3.25331728	3.10358829	1.4380812	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015256-12	Chloroquine	170464753	antimalarial agents	DPI_SARS-CoV-2_General	2019_NPC_01	50-63-5	 ;Chloroquine (CQ); Chloroquine (CQ); Aralen hydrochloride;Chloroquine Diphosphate; Aralen; Chloroquine Sulphate; Cloquiante; Contramibial;Arequin; Cloroquina; Khingamin; Chlorochin; Arechine; Aralen phosphate; Cloquinato; Chingamin;Chloroquine diphosphate; ChloroquineSulphate; Sulfate, Chloroquin; Sulphate, Chloroquin			12.5249321278	4	7		0	2.31172847					O=P(O)(O)O.O=P(O)(O)O.CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12	Specs	AN-153/J116554	4.08346041	4.59598798	3.51197875	0	2.33720753	2.53569795	2.31172847									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00168786-02	Deserpidine	144206653	Synaptic vesicular amine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	131-01-1	Deserpidine	4.4061119169	-5.3559444758	-97.4872972161	-2.1	7	deserpidinum;CIPLUS_151707;LS-178544;CIPLUS_743119;deserpidine;reserpidine;ORETICYL FORTE;Deserpidine;METHYCLOTHIAZIDE;LS-7299;3-beta,20-alpha-Yohimban-16-beta-carboxylic acid, 18-beta-hydroxy-17-alpha-methoxy-,methyl ester, 3,4,5-trimethoxybenzoate (ester);Deserpidina;Deserpidinum;LS-178610;DESERPIDINE;	-95.0986538559	-87.1283832	0.0000019776	0.9994254239			COc1cc(cc(OC)c1OC)C(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccccc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC	GVK	GVK-NIH-19	0	1.93813671	-0.18049272	-0.33907817	-16.17517763	-59.01916573	-87.1283832									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263951-01	CEPHRADINE		Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02			15.6334750258	-4.8059444758	-5.2484358235	4	7		-14.5359368279	-9.61328069	0.0202911386	0.9361826772			CC/1=C(/N2[C@@H](SC1)[C@H](NC(=O)[C@H](N)/C3=C/C/C=C\C3)C2=O)C(O)=O	Microsource	MS-01500168	2.23588985	0.42274019	1.2728253	-0.60566377	-1.07169166	-2.44269072	-9.61328069									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183109-10	Maraviroc			DPI_SARS-CoV-2_General	2019_NPC_02	[376348-65-1]				-0.5155639448	4	7		0	-2.51153499					CC(C)C1=NN=C(C)N1C2CC3CCC(C2)N3CC[C@H](NC(=O)C4CCC(F)(F)CC4)C5=CC=CC=C5	Tocris	3756	2.22664108	1.26822056	-2.14481611	1.22769684	0.23049688	-1.578354	-2.51153499									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390811-01	Oxytocin		Oxytocin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	50-56-6				-18.2302669435	4	7		0	-6.56899586					CC[C@H](C)C1NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O	MedChem Express	HY-17571	-4.43709681	-2.29388528	-3.5512529	-6.65762458	-0.48713257	-3.83784292	-6.56899586									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378889-01	PF-04971729		Sodium/glucose cotransporter 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1210344-57-2		13.9333492831	-4.8559444758	-11.2080521492	4	7		-17.653736388	-13.46144699	0.0000602479	0.9968353304			CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@@]34OC[C@@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)C=C1	MedChem Express	HY-15461	0.03930727	-0.10857262	0.35395326	-0.60566377	-0.88634365	-4.67399474	-13.46144699									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386317-11	Ribociclib (LEE011)		CDK4/6 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			5.3748585361	-5.2696329617	-37.7600970236	-2.4	7		-30.71857014	-29.34880845	0.0081613296	0.9607363466		CDK4	CN(C)C(=O)C1=CC2=CN=C(NC3=NC=C(C=C3)N4CCNCC4)N=C2[N]1C5CCCC5	Bio Vision	9481-5	2.35612384	-4.61780129	-1.55880078	-2.88333372	-1.51367536	-9.93047726	-29.34880845									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00016288-06	Bemegride		GABA-A receptor; anion channel Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	64-65-3				12.3602212276	4	7		0	2.66850592					CCC1(C)CC(=O)NC(=O)C1	APExBIO	B1672	3.729566	0	1.9572912	1.99003812	4.63607633	2.54603533	2.66850592									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00508820-02	Dalfopristin		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	112362-50-2		11.0676527398	-4.9559444758	-64.4649994573	-2.2	7		-76.8304238256	-62.75032108	0.0003255809	0.9925442005			CCN(CC)CC[S+]([O-])(=O)[C@@H]1CCN2[C@H]1C(=O)O[C@H](C(C)C)[C@H](C)\C=C\C(=O)NC\C=C\C(=C\[C@@H](O)CC(=O)CC3=NC(=CO3)C2=O)C	MedChem Express	HY-A0241_cm1	1.01505237	-1.17581834	-5.81561614	-2.93478007	-6.77945964	-29.17606163	-62.75032108									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178778-07	DIETHYLCARBAMAZINE CITRATE			DPI_SARS-CoV-2_General	2019_NPC_02	1642-54-2				-32.9057864727	4	7		0	-10.68353708					CCN(CC)C(=O)N1CCN(C)CC1	Microsource	01500242	-5.79204143	-7.22354409	-6.10627974	-6.05429928	-5.04479243	-8.98158587	-10.68353708									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164076-03	SODIUM GLUCONATE			DPI_SARS-CoV-2_General	2019_NPC_02	527-07-1				2.3066856698	4	7		0	-0.10940399					OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O	Microsource	01300035	-0.53874078	-1.14809767	-1.82133565	0.80677221	3.25784759	2.81379181	-0.10940399									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178526-03	APRAMYCIN SULFATE			DPI_SARS-CoV-2_General	2019_NPC_02	65710-07-8				-3.8356242684	4	7		0	-1.89316463					CN[C@H]1[C@@H](O)[C@H]2O[C@@H](O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O)[C@H]3O)[C@H](N)C[C@@H]2O[C@@H]1O[C@H]4O[C@H](CO)[C@@H](N)[C@H](O)[C@H]4O	Microsource	01505249	0.25202895	2.04901938	-1.91978622	-1.30720483	-2.24556234	-0.87842916	-1.89316463									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015033-03	p-Aminoclonidine hydrochloride	90341674	Alpha-2A adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02					2.63869312	4	7		0	3.19649907			150	ADRA2A	NC1=CC(=C(N=C2NCCN2)C(=C1)Cl)Cl	SigmaAldrich	Lopac-A-0779	3.86367315	-2.69583497	-0.85089426	-0.85821855	2.55447568	-0.526118	3.19649907									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00068236-07	Gatifloxacin	170465592	DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	112811-59-3	; Tequin;GATIFLOXACIN;Gatifloxacin; Gatifloxacin Anhydride; Gatifloxacin hydrate; Gatifloxacin Hydrate; Gatiflo; Zymar			-29.983553975	4	7		0	-12.72971534			7155	TOP2B	CC1CN(CCN1)c2c(F)cc3c(c2OC)N(C=C(C3=O)C(=O)O)C4CC4	Vitas	STK801620	-5.06620192	-4.9624942	-3.22439131	-4.26668673	-7.80845557	-8.13049444	-12.72971534									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015834-19	Primidone	170464846	Anticonvulsant agent	DPI_SARS-CoV-2_General	2019_NPC_01	125-33-7	; ;Primaclone; Primidona;Primidone; Primidone; 2-Desoxyphenobarbital; Primaclone; Mysoline;Primidone (primaclone); Primidone (primaclone);PRIMIDONE			7.4790107007	4	7		0	-1.34850828				GABRA1	CCC1(C(=O)NCNC1=O)c2ccccc2	Specs	AN-153/I262077	2.09861303	2.21125418	1.83519778	2.27004791	2.32198142	1.04680116	-1.34850828									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025355-12	Paroxetine	170465075	5-HT Reuptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	61869-08-7	;Paroxetine;Paroxetine hydrochloride hemihydrate (MW = 374.83); Paroxetine hydrochloride hemihydrate (MW = 374.83); Paroxetina; ; Paroxetine Base;PAROXETINE HYDROCHLORIDE; Paxil; Paroxetine maleate;Paroxetine?HCl;Paroxetine Hydrochloride	12.4181106199	-4.9059444758	-98.2699213659	-2.2	7		-70.8435901913	-61.17969126	0.0008048726	0.9881944242	3350	HTR1A	Fc1ccc(cc1)[C@@H]4CCNC[C@H]4COc2ccc3OCOc3c2	Microsource	01504085	-12.82647109	-6.59466856	-9.63417904	-11.65124037	-19.91828656	-34.23446313	-61.17969126									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167467-03	Vecuronium bromide	170465295	Steroid non-depolarizing neuromuscular Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	50700-72-6	 ; Vecuronium bromide;Vecuronium bromide;Vecuronium Bromide; Bromuro de vecuronio; Norcuron	12.4181106199	-4.9059444758	-0.4954585395	4	7		-12.466236596	-9.97186383	0.0892977062	0.8465999366			[Br-].C[N+]1(CCCCC1)[C@H]6C[C@@H]5[C@](C)(CC[C@H]2[C@H]5CC[C@H]3C[C@H](OC(C)=O)[C@H](C[C@]23C)N4CCCCC4)[C@H]6OC(C)=O	Prestwick	Prestw-1359	0.06293419	0	4.80855938	0	3.10358829	-1.16367702	-9.97186383									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00261970-01	BEMOTRIZINOL	225144355		DPI_SARS-CoV-2_General	2019_NPC_02		Tinosorb s;Bemotrizinol;Bis-ethylhexyloxyphenol methoxyphenyl			-27.081972957	4	7		0	-6.61180612					CCCCC(CC)COC1=CC(=C(C=C1)C2=NC(=NC(=N2)C3=C(O)C=C(OCC(CC)CCCC)C=C3)C4=CC=C(OC)C=C4)O	GVK	FFS-11-286-NCI-081	-5.14462762	-7.34828709	-7.22205293	-3.12653462	-1.55644797	-2.47557309	-6.61180612									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00165856-03	Orlistat	170464663	Fatty acid synthase inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	96829-58-2				6.9044876303	4	7		0	0				FASN	O=C(O[C@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)CCCCCCCCCCC)C(CC(C)C)NC=O	Sequoia	96829-58-2	2.87318762	2.58264715	2.33238283	0	2.17987109	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160527-03	Mosapride citrate	170466008	5-HT4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	112885-42-4	; Gasmotin; ;Mosapride citrate; Mosapride citrate;AS-4370	15.6334750258	-4.8059444758	-15.0686496375	-2.4	7		-37.164596584	-26.38716382	0.0013555313	0.9846052967	3360	HTR4	O=C(O)C(O)(CC(=O)O)CC(=O)O.Clc1cc(c(OCC)cc1N)C(=O)NCC3CN(Cc2ccc(F)cc2)CCO3	Vitas	STK711184	2.4955825	0	0	3.26836732	-0.46947165	-6.8702678	-26.38716382									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163468-05	Mitomycin C	170464814	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC_01	50-07-7	; ; Ametycine; Mitomycin-C;Mitomycin C;Mitomycin; Mutamycin; MITOMYCIN C; Mitocin;MITOMYCIN C; Mitocin-C; Muamycin			6.2569745844	4	7		0	-4.19254265				H2AFX	NC(=O)OC[C@@H]3C=1C(=O)C(N)=C(C)C(=O)C=1N2C[C@@H]4N[C@@H]4[C@@]23OC	Sequoia	50-07-7	1.28530971	3.25213184	3.90192781	3.65465172	0.58620515	-0.52848214	-4.19254265									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015798-11	Dexpropranolol	170464682	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	5051-22-9				12.4693215637	4	7		0	1.76928341					CC(C)NC[C@@H](O)COc2cccc1ccccc12	Specs	AN-153/I110481	3.60419238	2.71458939	1.57198216	3.77505205	2.23570015	2.71863408	1.76928341									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181770-02	Garenoxacin mesylate hydrate	170465937	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	223652-90-2		4.2694018929	-5.3696329617	-64.4161438216	-2.2	7		-65.6325948611	-50.85802641	0.0000640929	0.9967150803			O.CS(=O)(=O)O.C[C@H]1NCc2cc(ccc12)c3ccc4c(c3OC(F)F)N(C=C(C4=O)C(=O)O)C5CC5	APAC	816272	3.80751821	0	0.66047623	-0.74497705	-7.14865756	-26.70359266	-50.85802641									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00167557-01	DL-Methionine methylsulfonium chloride	144206105	ERK1 and ERK2 cascade Activator	DPI_SARS-CoV-2_General	2019_NPC_02	3493-12-7	Sulfonium, (3-amino-3-carboxypropyl)dimethyl-, chloride, (S)-; Vitamin U; S-Methylmethionine; Vitamin U Chloride; S Methylmethionin; 			4.3823285182	4	7	Methylsulfonium Chloride, Methionin;Vitamin U Chloride;CIPLUS_203938;LS-148013;Sulfonium, (3-amino-3-carboxypropyl)dimethyl-, chloride, (S)-;Vitamin U;S Methylmethionin;S-Methylmethionine;CIPLUS_723454;methionylmethylsulfonium chloride;Sulfonium, (3-amino-3-carboxypropyl)dimethyl-, chloride, L-;DL-Met-S-methylsulfonium chloride;CIPLUS_3886671;Methylmethionine sulfonium chloride;CIPLUS_8144825;DL-methionine-S-methylsulfonium chloride;CIPLUS_742496;Methylmethionine Sulfonium Chloride;Chloride, Methionine Methylsulfoniu;DL-Methionine Methylsulfonium Chloride;(3-Amino-3-carboxypropyl)dimethyl sulfonium chloride;CIPLUS_157505;CIPLUS_777498;Methyl-methionine sulphonium chloride;MMSC;Chloride, Methylmethioninesulfoniu;DL-Methionine methylsulfonium chloride;CIPLUS_775683;METHYLMETHIONINE SULFONIUM CHLORIDE;	0	-0.15221424					[Cl-].C[S+](C)CCC(N)C(=O)O	SigmaAldrich	64382	3.78043423	2.66349419	-1.50254331	-0.4466478	2.44041537	-0.42747088	-0.15221424									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389655-01	Angiotensin II			DPI_SARS-CoV-2_General	2019_NPC_02	68521-88-0		12.4181106199	-4.9059444758	-2.4738741466	4	7		-7.630547492	-7.19212291	0.2765437145	0.6556043992			CCC(C)C(NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(NC(=O)C(CCCN=C(N)N)NC(=O)C(N)CC(O)=O)C(C)C)C(=O)NC(CC2=CN=C[NH]2)C(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(O)=O	APExBIO	A1042	0	0.70918709	-3.49030731	0.91901878	3.57151344	0.1832018	-7.19212291									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182709-03	Landiolol hydrochloride	170465910	Beta-1 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	144481-98-1				2.5985384007	4	7		0	-2.5020216					Cl.CC3(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N1CCOCC1)cc2)O3	APAC	877817	0	0	0.19690115	1.71877558	3.34814533	0.3429162	-2.5020216									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181148-01	Metharbital	144206305	GABA-A receptor; anion channel Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_02	50-11-3	Metharbital; Metarbital; 			-13.2152521586	4	7	metharbitone;Metharbital;metharbital;endiemal;metharbitalum;CIPLUS_148525;Metarbital;2,4,6(1H,3H,5H)-Pyrimidinetrione, 5,5-diethyl-1-methyl-;LS-24178;Metharbitalum;METHARBITAL;Barbituric acid, 5,5-diethyl-1-methyl-;methobarbitone;5,5-DIETHYL-1-METHYLBARBITURIC ACID;2,4,6(1H,3H,5H)-PYRIMIDINETRIONE, 5,5-DIETHYL-1-METHYL-;CIPLUS_178471;	0	-4.50459021					O=C1NC(=O)N(C)C(=O)C1(CC)CC	NCI	NSC-27156	-1.12141321	-1.5685278	-2.03230116	-3.57084395	-3.79963406	-3.45264938	-4.50459021									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090548-04	Deferiprone		Iron Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC_02	30652-11-0				-11.778489776	4	7		0	-2.5020216					CN/1\C=C/C(=O)/C(=C1C)O	Selleck	S4067	1.17228144	-1.47612557	-5.8906261	-0.76467975	-4.80716679	-4.30759113	-2.5020216									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00179401-03	Ethotoin	225144304	Sodium channel protein type V alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	86-35-1				-39.4426354465	4	7		0	-9.93197926					CCN1C(=O)NC(C1=O)C2=CC=CC=C2	Prestwick	Prestw-696	-5.60706606	-7.11728153	-7.84557324	-10.39917686	-7.52085165	-10.62570462	-9.93197926									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159506-06	Cyclandelate		Voltage-gated calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	456-59-7				8.2819825823	4	7		0	-0.98463587					CC1CC(CC(C)(C)C1)OC(=O)C(O)C2=CC=CC=C2	APExBIO	B1718	3.40585909	4.46995773	2.17294484	2.64948671	0	0	-0.98463587									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182994-01	Anacolin	144206808		DPI_SARS-CoV-2_General	2019_NPC_01	21216-78-4	Diphenylpiperidinomethyldioxolan iodide; Gastrophyllin-A; 			9.2440934992	4	7	Gastrophyllin-A;N-(2,2-diphenyl-1,3-dioxolan-4-ylmethyl)-N-methylpiperidinium;anacoline;Diphenylpiperidinomethyldioxolan Iodide;Diphenylpiperidinomethyldioxolan iodide;anacoline iodide;DIPHENYLPIPERIDINOMETHYLDIOXOLAN IODIDE;CIPLUS_770363;CIPLUS_784768;	0	3.47773187					[I-].C[N+]1(CCCCC1)CC2COC(O2)(c3ccccc3)c4ccccc4	Pharmaron	PH-NIH-117094	4.68375572	4.75725071	4.3942385	0	-5.19464041	2.62208446	3.47773187									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00091010-03	Domiphen bromide	170465494	HERG Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	538-71-6		22.0828704269	-4.6559444758	-18.4991548249	4	7		-14.570708148	-12.44074928	0.0843981212	0.8524734232			[Br-].CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1	Labotest	LT00847867	-2.61176869	-5.34366066	-1.96680559	-0.29849249	-3.12896513	-3.81625083	-12.44074928									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183004-01	Alilusem potassium	144206835	renal sodium ion transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	114417-20-8	M-17055; Alilusem Potassium; 	19.6813789847	-4.7059444758	-4.9394774403	4	7	Alilusem Potassium;M-17055;7-chloro-2,3-dihydro-1-(2-methylbenzoyl)-4(1H)-quinolinone 4-oxime-O-sulfonic acid;LS-77484;M17055;CIPLUS_774461;M 17055;	-22.868697876	-16.55724823	0.0158959091	0.9438262955			[K+].Cc1ccccc1C(=O)N3CC/C(=N\OS([O-])(=O)=O)c2ccc(Cl)cc23	Pharmaron	PH-NIH-151932	0	4.47381924	-0.27540153	1.73827978	0.23600467	-0.74698918	-16.55724823									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00420878-02	Dalbavancin			DPI_SARS-CoV-2_General	2019_NPC_02	171500-79-1		2.6938104809	-5.5696329617	-107.1197850671	-2.1	7		-90.8484041288	-82.26704086	0.0000686448	0.996598899			CN[C@H]1C(=O)N[C@@H]2CC3=CC=C(OC4=CC5=CC(=C4O[C@@H]6O[C@@H]([C@@H](O)[C@H](O)[C@H]6NC(=O)CCCCCCCCC(C)C)C(O)=O)OC7=CC=C(C=C7Cl)[C@@H](O)[C@@H]8NC(=O)[C@H](NC(=O)[C@@H]5NC(=O)[C@@H](NC2=O)C9=C(Cl)C(=CC(=C9)OC%10=C(O)C=CC1=C%10)O)C%11=CC=C(O)C(=C%11)C%12=C(O[C@H]%13O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%13O)C=C(O)C=C%12[C@H](NC8=O)C(=O)NCCCN(C)C)C=C3	MedChem Express	HY-17586	3.26712756	4.12806949	0	-2.78979492	-10.78107549	-48.08342728	-82.26704086									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00181136-01	Pyrrolnitrin	144206296	respiratory electron transport chain Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1018-71-9	Pyrrolnitrin; Pyrrolnitrin Microbial; Pirrolnitrina; 	4.9437388825	-5.3059444758	-96.7316557656	-2.1	7	3-Chloro-4-(3-chloro-2-nitrophenyl)pyrrole;Pirrolnitrina;pyrrolnitrine;LS-136879;Pyrrolnitrine;Pyrrolnitrinum;Pyrrolnitrin Microbial;PYRROLNITRIN;CIPLUS_157237;Pyrrolnitrin;pyrrolnitrinum;1H-Pyrrole, 3-chloro-4-(3-chloro-2-nitrophenyl)-;	-103.9981448907	-93.92094373	0.0000067526	0.9989373759			Clc2cncc2c1cccc(Cl)c1[N+]([O-])=O	NCI	NSC-107654	0	3.64757791	1.64787511	-0.01636929	-14.51655063	-58.33333333	-93.92094373									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159409-08	myo-Inositol			DPI_SARS-CoV-2_General	2019_NPC_02	87-89-8				10.1321793766	4	7		0	0.71350426					O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O	SIGMA	57569	3.94691207	3.21790755	0	1.79828356	2.85388399	2.26888388	0.71350426									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167447-02	Prosultiamine	170465884	Apoptosis Activator	DPI_SARS-CoV-2_General	2019_NPC_02	59-58-5				3.8189885125	4	7		0	-1.36992817					Nc1nc(C)ncc1CN(C=O)C(C)=C(CCO)SSCCC	Bosche	P5775	1.29713982	1.62396914	1.90572185	0.6430793	2.70655609	-1.63942127	-1.36992817									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386236-02	TAK 438		Potassium-transporting ATPase Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	881681-01-2		12.4181106199	-4.9059444758	-9.2280928189	4	7		-19.547590728	-13.78965894	0.0085437015	0.9599147259			CNCC1=C[N](C(=C1)C2=CC=CC=C2F)[S+]([O-])(=O)C3=CC=CN=C3	Axon Medchem	1971	2.03241693	2.09060038	-0.74775556	-0.71791034	0.15445667	-5.54772642	-13.78965894									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015277-17	Cinoxacin	170465414	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	28657-80-9		0.4406111917	-6.3559444758	-15.7929907959	4	7		-7.2152210319	-10.17464703	0.4800397752	0.4044892091			O=C(O)C2=NN(CC)c1cc3OCOc3cc1C2=O	Microsource	01500190	-1.90496938	0.45202434	-0.22178353	-0.55434319	-13.92935086	1.17384013	-10.17464703									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016564-06	Metformin	170464804	AMPK Activator	DPI_SARS-CoV-2_General	2019_NPC_01	1115-70-4	La-6023;SMP-862;Metformin hydrochloride;Metformin?HCl;Metformin HCl; Metformin HCl;ADX-155			-25.2635560927	4	7		0	-5.73369496			5562	PRKAA1	Cl.N=C(N)NC(=N)N(C)C	Vitas	STK011633	-4.32067388	-5.09443644	-1.59147961	-14.79669902	-1.60127899	-4.55307688	-5.73369496									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024504-09	Kainic acid	170465818	Glutamate receptor ionotropic kainate 5 Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	487-79-6				10.0642881679	4	7		0	0					CC(=C)[C@H]1CN[C@@H]([C@H]1CC(=O)O)C(=O)O	Enzo	EA123	4.84835282	0	3.16589895	4.49243735	0	2.04278673	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161414-03	Tropisetron	170466432	5-HT3 Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	89565-68-4	 ;Tropisetron hydrochloride; Tropisetron hydrochloride;Navoban			-44.9432026951	4	7		0	-11.74114725			3359	HTR3A	CN4[C@H]1CC[C@@H]4CC(C1)OC(=O)c3cnc2ccccc23	Bosche	T0234	-9.22469925	-6.49693356	-8.69342692	-8.59608197	-14.63990255	-8.0847604	-11.74114725									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016961-06	Atovaquone	170464681	Synergistic with proguanil, mitochondrial sensitizer (cytochrome bc1 complex)	DPI_SARS-CoV-2_General	2019_NPC_01	95233-18-4	 ; Atovaquone;Atovaquone; Mepron	0.9864055887	-6.0059444758	-117.5700960129	-1.2	7		-67.32749226	-65.25563357	0.0000093324	0.998750526		PFF0160c	Clc1ccc(cc1)[C@H]2CC[C@@H](CC2)C=4C(=O)c3ccccc3C(=O)C=4O	Bosche	A2953	-0.39939002	-1.09218853	-5.94428603	-15.18298342	-39.97614576	-56.43071294	-65.25563357									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168774-02	Rasagiline mesylate	170465410	MAO-B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	161735-79-1	 ; Azilect; N-2-propynyl-1-indanamine;Rasagiline mesylate; Rasagiline mesylate			2.9655230436	4	7		0	-1.74900509			4129	MAOB	CS(=O)(=O)O.C#CCN[C@@H]2CCc1ccccc12	Tocris	4308	-1.99210902	4.9429472	-1.30876654	1.03092783	-2.0783637	4.90878602	-1.74900509									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181110-02	Cambendazole	124893647	glucose transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			0.0098640559	-8.0059444758	-11.118924641	4	7		-9.045045904	-9.20420492	0.4487371214	0.4494880818			CC(C)OC(=O)NC1=CC2=C([NH]C(=N2)C3=CSC=N3)C=C1	SigmaAldrich	32593	4.18275567	-0.48742175	-5.05614027	-7.08790309	2.53071311	-2.90774145	-9.20420492									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167553-02	Norphenylephrine hydrochloride	225144293	Adrenergic receptor alpha-1 Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	4779-94-6				-0.0625512285	4	7		0	-2.00732531					NCC(O)C1=CC=CC(=C1)O	SIGMA	113727	2.9295475	2.13218139	-1.01966667	-2.06019222	-0.40158734	-0.06106727	-2.00732531									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163742-05	d-LIMONENE		response to oxidative stress Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	138-86-7				-1.7089245816	4	7		0	-2.88731389					CC(=C)C1CC\C(=C/C1)C	Microsource	00307080	-0.0578048	-2.18300261	-0.91652798	1.21834296	1.22852458	-0.27245396	-2.88731389									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00179240-04	Levocabastine hydrochloride	170465061	Neurotensin receptor type 2 Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	79547-78-7				8.0524297415	4	7		0	-2.18807972			23620	NTSR2	Cl.Fc1ccc(cc1)[C@@]2(CC[C@H](CC2)N3CC[C@@]([C@H](C)C3)(c4ccccc4)C(=O)O)C#N	Prestwick Chemical, Inc.	Prestw-1039	0	0	0	4.35656993	4.79766176	4.02104472	-2.18807972									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183137-01	Sulfadiazine silver	144207020		DPI_SARS-CoV-2_General	2019_NPC_02	22199-08-2		19.6813789847	-4.7059444758	-22.9864810746	4	7	Silver Sulfadiazine;Silver(I) sulfadiazine;Sulfadiazine silver;	-15.7455085079	-13.92284641	0.1821412081	0.7507683734			[Ag+].O=S(=O)([N-]c1ncccn1)c2ccc(N)cc2	SigmaAldrich	481181	-3.09140096	-0.80158932	-3.26527742	-7.35916563	-2.30734501	-5.65576851	-13.92284641									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167543-05	CEFTIOFUR HYDROCHLORIDE		Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	80370-57-6		12.4181106199	-4.9059444758	-57.1822580059	-2.2	7		-53.1017347472	-47.20068496	0.0000070026	0.9989184393			CO\N=C(\C(=O)N[C@H]1[C@H]2SC\C(=C(/N2C1=O)C(O)=O)CSC(=O)C3=CC=CO3)C4=CSC(=N4)N	Microsource	01504832	-4.35848228	-4.3359745	-5.31398701	-5.85786778	-6.6558943	-19.82337467	-47.20068496									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378682-03	Pasireotide (ditrifluoroacetate)		Somatostatin receptor 5 Agonist	DPI_SARS-CoV-2_General	2019_NPC_02			2.6938104809	-5.5696329617	-93.6139918609	-2.2	7		-74.758645297	-64.70056605	0.0004726395	0.9909933707			NCCCC[C@@H]1NC(=O)[C@@H](CC2=C[NH]C3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]4C[C@H](CN4C(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H](CC6=CC=C(OCC7=CC=CC=C7)C=C6)NC1=O)OC(=O)NCCN)C8=CC=CC=C8	MedChem Express	HY-79135	2.37462138	0	1.46503833	-7.48544302	-14.66863104	-37.85231116	-64.70056605									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00346570-04	Tebipenem pivoxil		Carbapenem Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	161715-24-8		11.0676527398	-4.9559444758	-17.7492926795	4	7		-15.1713412361	-14.91699567	0.0021018892	0.9808016433			C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)\C(=C(/N2C1=O)C(=O)OCOC(=O)C(C)(C)C)SC3CN(C3)/C4=N/CCS4	MedChem Express	HY-B0396	-1.85206594	-0.60754464	-1.58692951	-2.73367163	-1.24753463	-6.17249154	-14.91699567									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164583-02	Amdinocillin	170465354		DPI_SARS-CoV-2_General	2019_NPC_01	32887-01-7				-4.2600894527	4	7		0	2.12922359					OC(=O)[C@@H]2N3C(=O)[C@@H](/N=C/N1CCCCCC1)[C@H]3SC2(C)C	Sequoia	SRP01690m	-1.06261951	2.15749994	3.87755599	-17.81674066	1.23077704	3.87722953	2.12922359									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015452-20	Flutamide	170464921	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	13311-84-7	Flutamide; ; Eulexin; 2-Methyl-N-(4-nitro-3-;FLUTAMIDE; Flutamide; Flutamida	24.777388143	-4.6059444758	-32.9878512071	4	7		-22.173199744	-23.21867633	0.0248854193	0.9279371929	374	AR	O=C(Nc1cc(c(cc1)[N+]([O-])=O)C(F)(F)F)C(C)C	Microsource	01500995	-8.51789993	-4.302783	-3.18539641	-6.31349236	-4.55514389	-3.07434321	-23.21867633									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025176-02	Etomidate	170465117	GABAA Receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	33125-97-2	 Etomidato; ; Radenarkon; Ethomidate;ETOMIDATE; Etomidate;Etomidate; Amidate			-0.0032509381	4	7		0	-5.23687612			2554	GABRA1	CC(c1ccccc1)n2cncc2C(=O)OCC	Microsource	01505599	-1.97274466	0.17347961	-0.41675806	2.23994783	1.97178095	1.89033996	-5.23687612									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263529-01	Lacidipine	170465580	Ca channel blocker - DHP class	DPI_SARS-CoV-2_General	2019_NPC_01	103890-78-4		4.4061119169	-5.3559444758	-72.510956272	-2.2	7		-68.1483359146	-66.79678589	2.22E-8	0.9999391427			CC=1NC(C)=C(C(C=1C(=O)OCC)c2ccccc2/C=C/C(=O)OC(C)(C)C)C(=O)OCC	Sequoia	SRP00900l	0	0	0	0	-6.05745318	-47.31439606	-66.79678589									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262939-01	Cycotiamine	170465848		DPI_SARS-CoV-2_General	2019_NPC_01	6092-18-8	Cycotiamine;Cicotiamina;Cycotiaminum;Cycothiamine			0.4501839041	4	7		0	0					O=C1OCC\C(S1)=C(/C)N(C=O)Cc2cnc(C)nc2N	GVK	FFS-11-286-NCI-198	0	0	0.52155687	0	0	0.12195742	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181011-02	Gimeracil	170466048	Dihydropyrimidine Dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	103766-25-2	Gimeracil			6.9390582727	4	7		0	3.01640009			1806	DPYD	ClC1=CNC(=O)C=C1O	Bosche	G3084	3.80267712	0	0	0	3.97147642	0	3.01640009									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018218-10	Edaravone	170465935	Free Radical Scavenger	DPI_SARS-CoV-2_General	2019_NPC_01	89-25-8	;MCI-186; Developer Z; N-demethylantipyrine; Radicut;1-Phenyl-3-methyl-5-pyrazolone	13.9333492831	-4.8559444758	-56.3677785996	4	7		-24.4270952041	-25.57603103	0.0036226282	0.9744733148		NT5E	O=C2CC(C)=NN2c1ccccc1	Vitas	STK201315	-6.47011836	-8.65199013	-9.37583778	-9.44891765	-11.87382632	-15.73758829	-25.57603103									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017043-03	Denatonium benzoate		Taste receptor type 2 member 8 Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	3734-33-6				1.4548607962	4	7		0	-2.94439423			50836	TAS2R8	CC[N+](CC)(CC(=O)NC1=C(C)C=CC=C1C)CC2=CC=CC=C2	Prestwick	Prestw-961	3.42898102	2.16452216	-1.97135557	-0.67581788	1.2712972	0.19729425	-2.94439423									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274077-01	Hydrocortisone 17-butyrate	170465456		DPI_SARS-CoV-2_General	2019_NPC_02	13609-67-1		13.9333492831	-4.8559444758	-47.6639574494	4	7		-12.337914712	-19.52623317	0.0670122573	0.8720081001			OCC(=O)[C@@]4(OC(=O)CCC)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	SIGMA	H5270	-9.74126569	-6.83545473	-9.81458475	-10.42256156	-6.32797091	-10.62570462	-19.52623317									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183046-03	Mequitazine	170465794	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	29216-28-2		6.9832167823	-5.1559444758	-38.6480298754	-2.2	7		-55.7622240195	-46.72124914	0.0004013473	0.9917118458			c3ccc4Sc5ccccc5N(CC2CN1CCC2CC1)c4c3	Vitas	STK324459	2.75216034	4.02912503	1.85956959	2.34529812	-7.93026443	-23.02962549	-46.72124914									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163157-05	Mesoridazine	170465272	D(2) dopamine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	5588-33-0		15.6334750258	-4.8059444758	-6.6392890676	4	7		-27.3469874039	-17.78915617	0.0021882047	0.9803311018	1813	DRD2	CS(=O)c2cc3N(CCC1CCCCN1C)c4ccccc4Sc3cc2	Prestwick Chemical, Inc.	Prestw-529	1.14007697	2.99313412	2.96605006	2.12958086	-0.98715932	-4.28883581	-17.78915617									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094736-05	Nitromide	170466818	Eimeria tenella Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	121-81-3				4.4943362999	4	7		0	-1.33329954					O=[N+]([O-])c1cc(cc(c1)[N+]([O-])=O)C(N)=O	Microsource	01500435	-0.87381696	3.64795856	2.83444225	-2.05433065	0.75369233	3.099751	-1.33329954									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249886-01	Prednisolone tebutate	170465430		DPI_SARS-CoV-2_General	2019_NPC_01	7681-14-3		13.9333492831	-4.8559444758	-9.8112609449	-2.4	7		-32.9855517	-24.98795975	0.0019344229	0.9815176171			CC(C)(C)CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	GVK	FFS-11-286-NCI-19	3.83172367	2.67060864	0	3.15298367	0	-4.72076833	-24.98795975									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015897-08	Ranolazine	170465435	Sodium channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	95635-55-5	 ;RANOLAZINE;Ranolazine dihydrochloride; Ranolazine dihydrochloride; Ranexa;Ranolazine			-15.2990009462	4	7		0	-1.87067501			6335	SCN9A	OC(CN1CCN(CC1)CC(=O)Nc2c(C)cccc2C)COc3ccccc3OC	Microsource	01505366	-4.57725171	-3.66750556	0.69459677	-5.29510623	-4.66172664	-3.12007724	-1.87067501									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015870-27	Quercetin	170466817	Flavone	DPI_SARS-CoV-2_General	2019_NPC_01	6151-25-3	 Quercetine; quercetin-ATS; quercetin 3-O-glucuronide; quercetin RGRGal; ;quercetin 3-3AcAra-Gal;Quercetin dihydrate;Quercetine; quercetin HMGGlc; QME-Ara-Glc; amurenoside B; amurenoside A; Q-RR cpd; quercetin 3-O-fGalp; Q3MG cpd; Q-3-AP cpd; Q-tC-L-A-D-G;Sophoretin; Quercetin hydrate; Q-M-beta-D-G; flavonol 3-OMT; quercetin digal-Gal; quercetin 3-XR; Quercetine dihydrate;Meletin;Quercetin (Sophoretin); quercetin 3-RhaGlcGal	6.2237985085	-5.2059444758	-79.6817188617	-2.2	7		-80.589224612	-66.74102051	0.0015363145	0.9835622134		CYP75A12	O.O.Oc1ccc(cc1O)C=3Oc2cc(O)cc(O)c2C(=O)C=3O	Vitas	STK365650	1.72100792	4.42983849	-6.55358144	-6.23824216	-18.04039994	-38.92982367	-66.74102051									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024868-09	Bisoprolol fumarate	170464815	beta1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	104344-23-2	;Bisoprolol fumarate; Zebeta; ; Bisoprolol hemifumarate; Bisoprolol Hydrochloride; Bisoprolol fumarate; Bisoprolol hemifumarate salt; Bisoprolol, (+-)-Isomer; Bisoprolol, (-)-Isomer;Bisoprolol hemifumarate salt; 3   Bisoprolol Fumarate; Prestwick-05A11;BISOPROLOL FUMARATE			3.2768439876	4	7		0	-3.83260247			153	ADRB1	O=C(O)/C=C/C(=O)O.CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.CC(C)NCC(O)COc1ccc(cc1)COCCOC(C)C	Microsource	01505704	1.91949265	-0.02687712	1.75720796	3.90548574	0.75369233	-0.67076579	-3.83260247									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167356-07	Raltegravir			DPI_SARS-CoV-2_General	2019_NPC_01	871038-72-1		12.4181106199	-4.9059444758	-10.9657921403	4	7		-15.2741882359	-11.06182353	0.0031342675	0.9764543738			CN1C(=O)C([O-])=C(N=C1C(C)(C)NC(=O)C2=NN=C(C)O2)C(=O)NCC3=CC=C(F)C=C3	Selleck	S2005	0.20574638	0.45202434	0.12429626	-1.75332982	-1.04806375	-5.3203923	-11.06182353									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164595-02	Voglibose	170465993		DPI_SARS-CoV-2_General	2019_NPC_01	83480-29-9				17.6005447988	4	7		0	3.88329827					O[C@H]1[C@@H](NC(CO)CO)C[C@](O)(CO)[C@@H](O)[C@@H]1O	Sequoia	SRP01065v	4.79025972	4.78168446	4.1163998	3.28843404	3.78368776	1.64134356	3.88329827									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017343-11	RETINOL		Retinol dehydrogenase 12 Substrate	DPI_SARS-CoV-2_General	2019_NPC_02	68-26-8		4.9437388825	-5.3059444758	-68.1647591171	-2.2	7		-68.2816201358	-62.08914047	0.0002738854	0.9931684201	145226	RDH12	CC(=C\CO)/C=C/C=C(C)/C=C/C1=C(\C)CCCC1(C)C	Microsource	01501203	2.43473838	2.9129802	-2.84334638	-3.34635082	-9.2365088	-40.54396843	-62.08914047									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159322-14	ANCITABINE HYDROCHLORIDE			DPI_SARS-CoV-2_General	2019_NPC_02	10212-25-6				-8.5288193642	4	7		0	-2.60666889					[H][C@]1(CO)O[C@@]2([H])N3C=CC(=N)N=C3O[C@@]2([H])[C@]1([H])O	Microsource	01504137	-2.06478763	0.69994687	-1.44159771	-3.85613731	-1.20476202	-2.43329575	-2.60666889									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181130-02	Eletriptan	170465317	5-hydroxytryptamine receptor 1F Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	143322-58-1		11.0676527398	-4.9559444758	-53.5624459909	-2.2	7		-64.3422586752	-57.77481806	0.0000059878	0.9989997263	3355	HTR1F	CN4CCC[C@@H]4Cc2cnc3ccc(CCS(=O)(=O)c1ccccc1)cc23	Sequoia	143322-58-1	-2.11103147	-3.00076232	-1.18375097	-1.40542057	-4.13230996	-21.2889891	-57.77481806									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181785-03	Aprepitant			DPI_SARS-CoV-2_General	2019_NPC_02	170729-80-3		8.7913490634	-5.0559444758	-39.5662033982	-2.2	7		-47.2544118327	-42.99576654	0.000080623	0.9963141127			C[C@@H](O[C@H]1OCCN(CC2=NC(=O)NN2)[C@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F	Prestwick	Prestw-1600	1.08441814	-1.46226524	-1.78851879	-0.06313869	-3.09150964	-18.82281097	-42.99576654									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344330-02	Elaidic Acid		SiHa Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	112-79-8		9.8640558873	-5.0059444758	-15.8232853755	-3	7		-35.46182752	-31.2181896	0.0049095651	0.9699829574			CCCCCCCC/C=C/CCCCCCCC(O)=O	Cayman	90250	3.45210294	2.53875118	1.08530039	-2.22856207	4.38419314	-8.2111988	-31.2181896									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024499-06	D-Aspartic acid	225144192	Isoaspartyl peptidase/L-asparaginase Interacts	DPI_SARS-CoV-2_General	2019_NPC_01	56-84-8		0.0494373888	-7.3059444758	-4.1870921809	4	7		-4.8031518	-2.31679805	0.409494627	0.5035113397	80150	ASRGL1	N[C@@H](CC(O)=O)C(O)=O	Enzo	AC367	0.98516206	0.40804359	3.0001706	2.42054832	-7.7526265	0.49799278	-2.31679805									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00165740-05	Benazepril	170465003	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	86541-74-4	; Briem; Benazepril Free base; BENAZEPRIL HCl; Lotensin HCT 20/12.5mg;Benzapril; Labopal; Benazepril Hcl; Cibacen; Lotensin; Benzapril;Benazepril hydrochloride; Cibac???ne	7.8352981002	-5.1059444758	-28.632512519	-2.2	7		-41.7252160883	-37.29183037	0.0015895837	0.9832798519	1636	ACE	Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@H]3CCc2ccccc2N(CC(=O)O)C3=O	Microsource	01505200	-1.0723017	4.06333227	-1.28439473	2.50583189	0.17510024	-17.25697444	-37.29183037									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015323-11	Decamethonium bromide	170465349	Muscle-type nicotinic acetylcholine receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	541-22-0				5.4996477744	4	7		0	2.79840815					[Br-].[Br-].C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C	Enzo	AC737	1.63386827	0	4.17001779	0	0	0	2.79840815									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016610-07	Tolnaftate	170465508	Fungal Squalene Monooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	2398-96-1	; ; Separin;TOLNAFTATE; Tolnafrate;Tolnaftate; Tolnaftate; Tolnaftato; Tinactin			4.6156696984	4	7		0	0					Cc1cc(ccc1)N(C)C(=S)Oc2ccc3ccccc3c2	Prestwick Chemical, Inc.	Prestw-70	-0.36550238	3.1299631	3.823938	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160540-03	Ethiazide	170465925		DPI_SARS-CoV-2_General	2019_NPC_01	1824-58-4				7.6281378584	4	7		0	-3.55377557					NS(=O)(=O)c2cc1c(NC(NS1(=O)=O)CC)cc2Cl	Menai	H2748	1.7839421	0	4.54534376	3.72488524	1.72308785	1.87001372	-3.55377557									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181101-01	Isothipendyl hydrochloride	144206270	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	1225-60-1	Isothipendyl hydrochloride; Andantol; Isotipendilo; Adanton hydrochloride; 	11.0676527398	-4.9559444758	-53.5827849327	-2.2	7	ISOTHIPENDYL HYDROCHLORIDE;isothipendylum;isothipendyl;Isotipendilo;LS-133223;N,N,alpha-trimethyl-10H-pyrido(3,2-b)(1,4)benzothiazine-10-ethanamine;LS-133221;Isothipendyl;CIPLUS_157919;CIPLUS_213648;Andantol;10H-Pyrido(3,2-b)(1,4)benzothiazine-10-ethanamine, N,N,alpha-trimethyl-;Isothipendylum;Isothipendyl hydrochloride;Adanton hydrochloride;ISOTHIPENDYL;CIPLUS_694884;10H-Pyrido(3,2-b)(1,4)benzothiazine, 10-(2-dimethylamino-2-methylethyl)-, hydrochloride;10H-Pyrido(3,2-b)(1,4)benzothiazine, 10-(2-(dimethylamino)propyl)-;Isothipendyl Hydrochloride;	-52.0130094728	-49.24130714	0.00014678	0.9950156222			Cl.CN(C)C(C)CN1c3ccccc3Sc2cccnc12	NCI	NSC-169186	-3.20238618	-2.48792996	-3.78565903	-6.32556182	-4.43647078	-19.38181135	-49.24130714									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181773-05	Parecoxib		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	198470-84-7				9.6629611441	4	7		0	1.92646149					CCC(=O)N[S+]([O-])(=O)C1=CC=C(C=C1)C2=C(C)ON=C2C3=CC=CC=C3	MedChem Express	HY-17474	4.65906726	0	3.1996437	2.57465566	1.55644797	0.526118	1.92646149									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00387409-02	Ertapenem		Peptidoglycan synthase FtsI Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	153832-46-3				4.3460035142	4	7		0	-2.40688769			944799	ftsI	C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)\C(=C(/N2C1=O)C(O)=O)S[C@@H]3CN[C@@H](C3)C(=O)NC4=CC=CC(=C4)C(O)=O	Glixx	GLXC-05077	0	0	0	1.77022192	3.02497446	3.24126268	-2.40688769									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159498-03	Metipranolol	29215466	Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02		Metipranolol; Disorat; 	22.5978289027	-4.6459332839	1.8472052656	4	7	Trimepranol;(+/-)-1-(4-HYDROXY-2,3,5-TRIMETHYLPHENOXY)-3-(ISOPROPYLAMINO)-2-PROPANOL 4-ACETATE HYDROCHLORIDE;LS-122351;Phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-2,3,6-trimethyl-, 1-acetate;CIPLUS_173566;TRIMEPRANOL;METIPRANOLOL HYDROCHLORIDE;1-(4-HYDROXY-2,3,5-TRIMETHYLPHENOXY)-3-(ISOPROPYLAMINO)-2-PROPANOL 4-ACETATE -DL;(+/-)-1-(4-HYDROXY-2,3,5-TRIMETHYLPHENOXY)-3-(ISOPROPYLAMINO)-2-PROPANOL 4-ACETATE;Disorat;Metipranololum;Methypranol;metipranololum;PHENOL, 4-(2-HYDROXY-3-((1-METHYLETHYL)AMINO)PROPOXY)-2,3,6-TRIMETHYL-, (+/-)-, 1-ACETATE;PHENOL, 4-(2-HYDROXY-3-((1-METHYLETHYL)AMINO)PROPOXY)-2,3,6-TRIMETHYL-, (+/-)-, 1-ACETATE, HYDROCHLORIDE;1-(4-Acetoxy-2,3,5-Trimethylphenoxy)-3-Isopropylamino-2-Propanol;metipranolol;Metipranolol;METIPRANOLOL;Metipranolol (4-(2-Hydroxy-3-(isopropylamino)propoxy)-2,3,6-trimethylphenyl acetate);METHYPRANOL;	-15.155924464	-11.79660372	0.0318829074	0.9172731407			CC(C)NCC(O)COC1=CC(C)=C(OC(C)=O)C(C)=C1C	SigmaAldrich	R736139	1.89830979	2.5849523	1.13218162	-0.53083273	4.46973837	-1.77564825	-11.79660372									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00164554-06	Mupirocin			DPI_SARS-CoV-2_General	2019_NPC_02	12650-69-0				-0.0774186828	4	7		0	-0.68972078					C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]2CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]2O	Prestwick	Prestw-1795	2.42548961	-0.84317032	1.89634561	-0.9564343	0.55842026	-2.59770763	-0.68972078									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185748-01	Paramethasone acetate	144206683	Glucocorticoid receptor Interacts	DPI_SARS-CoV-2_General	2019_NPC_02	1597-82-6		11.0676527398	-4.9559444758	-5.5618553057	4	7		-12.704989772	-11.42082481	0.0134384159	0.9489616462			CC(=O)OCC(=O)[C@@]4(O)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Kemprotec	1597-82-6	0.81620384	-0.08547206	-0.93996859	2.40160887	1.06693914	-2.57422022	-11.42082481									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183015-01	Temoporfin	144206848	cell proliferation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	122341-38-2	Temoporfin; 	0.0986405589	-7.0059444758	-266.1254096228	-1.1	7	M-THPC;CIPLUS_197002;5,10,15,20-TETRA(3-HYDROXYPHENYL)-CHLORIN;TEMOPORFIN;Temoporfin;LS-172529;temoporfinum;	-98.9349261948	-97.5437885	0.0000086279	0.9987985728			Oc1cccc(c1)c9c2CCc(n2)c(c3cccc(O)c3)c4ccc(n4)c(c5cccc(O)c5)c6C=Cc(n6)c(c7cccc(O)c7)c8ccc9n8	Pharmaron	PH-NIH-154455	-5.39539612	-12.60537054	-38.80236894	-66.55379136	-89.37978988	-94.62879211	-97.5437885									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253590-01	Variotin	170465957		DPI_SARS-CoV-2_General	2019_NPC_01	19504-77-9		12.4181106199	-4.9059444758	-30.4676480229	-2.2	7		-43.0857139296	-36.04978328	0.0007093199	0.9889361346			O=C1CCCN1C(=O)/C=C/C=CC(\C)=C\C(O)CCCC	GVK	FFS-11-286-NCI-227	-1.43054244	-0.78921006	-1.91318759	2.35533148	-2.23062478	-12.43457493	-36.04978328									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015821-10	Piracetam	170465901	"Glutamate receptor ionotropic, AMPA 3 Positive Allosteric Modulator"	DPI_SARS-CoV-2_General	2019_NPC_01	7491-74-9				-26.1193165841	4	7		0	-8.54731186					O=C1CCCN1CC(=O)N	Specs	AE-641/30117005	-6.80415366	-5.28013292	-5.10589554	-4.28675346	-3.28630158	-6.37227501	-8.54731186									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090774-05	Nitazoxanide	170465090	antiprotozoal agent	DPI_SARS-CoV-2_General	2019_NPC_01	55981-09-4	Nitazoxanide; ; Alinia; Nitazoxanida; Nitazoxanide	3.9269513795	-5.4059444758	-76.3795749669	-2.2	7		-87.7589161187	-64.21130009	0.0119661594	0.9517156333			O=C(Nc1ncc(s1)[N+]([O-])=O)c2ccccc2OC(C)=O	Vitas	STK395664	4.98874446	4.84521221	-0.07067827	-0.99079439	-33.24620616	-36.23151583	-64.21130009									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159478-04	Benzoxiquine	170465534		DPI_SARS-CoV-2_General	2019_NPC_01	86-75-9				5.7504007739	4	7		0	0					O=C(Oc1cccc2cccnc12)c3ccccc3	Specs	AE-848/01460057	1.13523588	-1.54665624	0.49474787	-0.9105275	4.27092321	4.82239951	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091616-03	2-Ethoxybenzamide	170465775		DPI_SARS-CoV-2_General	2019_NPC_01	938-73-8				-26.6810575851	4	7		0	-5.60188588					CCOc1ccccc1C(N)=O	Specs	AN-153/I166787	-5.71974923	-5.71016688	-5.27162389	-2.03426393	-9.01639344	-6.37735657	-5.60188588									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015620-17	NCGC00015620-17			DPI_SARS-CoV-2_General	2019_NPC_01					4.6845539678	4	7		0	1.03419432					C1CN2CC(N=C2S1)C3=CC=CC=C3	Vitas	STL019093	2.02115557	-0.70613531	-0.21690917	1.3218953	1.83474598	1.73281163	1.03419432									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262940-01	Iodoxamic Acid	170465432		DPI_SARS-CoV-2_General	2019_NPC_01	31127-82-9	Acide iodoxamique;Iodoxamate meglumine;Iodoxamic acid			-1.6681237978	4	7		0	-3.16341791					O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)CCOCCOCCOCCOCCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I	GVK	FFS-11-286-NCI-61	0	0	0	0	0	0	-3.16341791									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015856-10	Prochlorperazine dimaleate	170464761	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	84-02-6	; ;Prochloperazine dimaleate; Proclorperazina; Prochlorperazine dimaleate; Compazine syrup;Prochlorperazine; Compro; Compazine;Prochlorperazine dimaleate; Maleate, Prochlorperazin	12.4181106199	-4.9059444758	-75.3260471442	-2.2	7		-92.2211857707	-71.37968619	0.0005372127	0.9903880688	1813	DRD2	O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O.CN1CCN(CC1)CCCN2c4ccccc4Sc3ccc(Cl)cc23	Prestwick Chemical, Inc.	Prestw-399	-0.72374313	-2.13795294	0.2120348	-6.24827552	-14.09176268	-30.97210224	-71.37968619									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344562-01	Celiprolol hydrochloride	170465958	Beta-2 adrenergic receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	57470-78-7				-1.6623571892	4	7		0	-2.62093897					Cl.CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(c1)C(C)=O	Prestwick	Prestw-1132	1.60697357	0.27951674	2.03230116	-1.0032037	-0.21148682	-3.05806088	-2.62093897									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179665-04	Danazol	170464884	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	17230-88-5		11.0676527398	-4.9559444758	-35.1352566862	-2.2	7		-67.6069305007	-48.56585644	0.00009722	0.9959492177			C#C[C@]3(O)CC[C@H]2[C@@H]4CCC1=Cc5oncc5C[C@]1(C)[C@H]4CC[C@@]23C	Prestwick	Prestw-105	2.24513862	3.45353323	4.20290195	2.19582349	-5.35845828	-20.31191281	-48.56585644									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00496851-01	NCGC00496851-01			DPI_SARS-CoV-2_General	2019_NPC_02	207300-70-7		21.7694880842	-4.6621517834	-33.2770713094	-3	7		-96.483028109	-87.46135185	0.0000289218	0.9977967404			OC1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O	SIGMA	G8645	0	3.24100811	0	1.0032037	4.17508257	0	-87.46135185									2.55E-9	1.28E-8	6.3799999999E-8	3.19E-7	0.00000159	0.00000797	0.000039899999999								
NCGC00016347-07	Benzthiazide	170465246	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	91-33-8		13.9333492831	-4.8559444758	1.7068202125	4	7		-12.241983728	-7.28498644	0.0130322861	0.9500818647			NS(=O)(=O)c3cc1c(N=C(NS1(=O)=O)CSCc2ccccc2)cc3Cl	Microsource	01500141	1.87592283	3.2179246	0.5044966	2.15968094	1.39826422	-1.15859546	-7.28498644									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091120-13	Griseofulvin	170465739	Tubulin beta chain Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	126-07-8				-0.886721402	4	7		0	-4.95297965				TUB2	O=C2c3c(O[C@]12C(=CC(=O)C[C@H]1C)OC)c(Cl)c(OC)cc3OC	Prestwick	Prestw-226	2.8828698	-0.2712146	-1.73283615	1.45734567	-3.37765822	3.60282535	-4.95297965									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023699-09	Cephalothin	170465101	Solute carrier family 22 member 7 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	153-61-7		6.2237985085	-5.2059444758	-33.4616377221	4	7		-28.80374458	-24.12106157	0.2354063472	0.6947245779	10864	SLC22A7	O=C(O)C=2N3C(=O)[C@@H](NC(=O)Cc1cccs1)[C@H]3SCC=2COC(C)=O	Microsource	01500166	-0.95127442	-2.39695067	-1.08942019	-1.73827978	-16.93904482	-6.60094517	-24.12106157									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160451-02	Ibufenac	170465922		DPI_SARS-CoV-2_General	2019_NPC_01	1553-60-2				7.6837031175	4	7		0	-0.34980102					CC(C)Cc1ccc(cc1)CC(=O)O	Enamine	Z104507406	2.6650207	0	0	4.40213711	4.27599858	0	-0.34980102									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015883-11	Risperidone	170464925	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	106266-06-2	 ; Risperdal;Risperidone; Risperidone; Risperidal; Risperdal Consta; Consta, Risperda	12.4181106199	-4.9059444758	-46.1796511277	4	7		-12.0445957961	-20.02484094	0.0153174808	0.9452108314	1813	DRD2	CC=5N=C1CCCCN1C(=O)C=5CCN2CCC(CC2)c4noc3cc(F)ccc34	Tocris	2865	-7.6561857	-7.77726195	-10.34096171	-7.07101111	-8.68141907	-9.67528838	-20.02484094									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378845-01	Trelagliptin succinate			DPI_SARS-CoV-2_General	2019_NPC_02	1029877-94-8				-5.2289616145	4	7		0	-3.23455263					CN1C(=O)\C=C(\N2CCC[C@@H](N)C2)N(CC3=C(C=CC(=C3)F)C#N)C1=O	MedChem Express	HY-15408A	-0.6820967	-1.28670101	-0.16642835	-2.21453125	0.28277452	-0.99586622	-3.23455263									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181342-02	Imidapril hydrochloride	170466024		DPI_SARS-CoV-2_General	2019_NPC_02	89396-94-1				-5.4636735321	4	7		0	-3.57703468					Cl.OC(=O)[C@@H]2CN(C)C(=O)N2C(=O)[C@H](C)N[C@@H](CCc1ccccc1)C(=O)OCC	SIGMA	SML0148	0.93181345	-1.6886507	-1.18375097	-2.13502327	1.59446807	-2.60710259	-3.57703468									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166146-02	Quinestrol	170465054	Estrogen receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	152-43-2		7.8352981002	-5.1059444758	-87.6798172061	-2.2	7		-79.041910746	-73.05807925	0.0000439222	0.9972827633			C#C[C@]5(O)CC[C@@H]2[C@]5(C)CC[C@@H]3c4ccc(OC1CCCC1)cc4CC[C@@H]23	SIGMA	E7887	-3.4937224	-3.24562822	-5.45931882	-8.03264504	-10.47691467	-39.74539647	-73.05807925									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179625-03	Thioproperazine dimethanesulfonate	170465871	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	2347-80-0		6.9832167823	-5.1559444758	-79.9712589049	-2.2	7		-70.0188496143	-68.12538648	0.0006378763	0.989511249			CS(=O)(=O)O.CS(=O)(=O)O.CN(C)S(=O)(=O)c2cc3N(CCCN1CCN(C)CC1)c4ccccc4Sc3cc2	Prestwick	Prestw-149	-1.29713982	-2.34932662	-2.15419235	-8.30390758	-13.13832189	-35.83709132	-68.12538648									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532497-01	CEFPODOXIME			DPI_SARS-CoV-2_General	2019_NPC_02					2.8324078382	4	7		0	-3.20601246					COC\C1=C(\N2[C@H](SC1)[C@H](NC(=O)\C(=N/OC)C3=CSC(=N3)N)C2=O)C(O)=O	Alfa Aesar	J66225	2.189646	0.87089099	3.06368815	1.27914318	1.60872561	-2.47557309	-3.20601246									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181149-01	3-Anilinopropan-1-ol	144206306		DPI_SARS-CoV-2_General	2019_NPC_02	31121-11-6	PHENYLPROPANOLAMINE MALEATE; 			7.470669346	4	7	PHENYLPROPANOLAMINE MALEATE;	0	0.41858916					OCCCNc1ccccc1	NCI	NSC-29092	3.99315591	2.97304165	1.08530039	0.1099081	0.08792149	2.25009395	0.41858916									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021394-04	Anisotropine methylbromide	144207024	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	80-50-2	Anisotropine methylbromide; Valpin; Lytispasm; Valpin 50; 			11.1649355439	4	7	LS-157873;Octatropini methylbromidum;ANISOTROPINE;(3-ENDO)-8,8-DIMETHYL-3-((2-PROPYLPENTANOYL)OXY)-8-AZONIABICYCLO(3.2.1)OCTANE BROMIDE;METHYLOCTATROPINE BROMIDE;OCTATROPINE METHYLBROMIDE;8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide;ANISOTROPINE METHYLBROMIDE;methylbromure d'octatropine;8-AZONIABICYCLO(3.2.1)OCTANE, 8,8-DIMETHYL-3-((1-OXO-2-PROPYLPENTYL)OXY)-, BROMIDE, (3-ENDO);3.ALPHA.-HYDROXY-8-METHYL-1.ALPHA.H,5.ALPHA.H-TROPANIUM BROMIDE 2-PROPYLVALERATE;Octatropine methylbromide;Valpin;CIPLUS_750008;Lytispasm;octatropine;Anisotropine methyl bromide;Metilbromuro de octatropina;CIPLUS_149624;anisotropine methylbromide;anisotropine methylbromide, (endo)-isomer;Methyloctatropine bromide;8-Azoniabicyclo(3.2.1)octane, 8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-, bromide, endo-, mixt. with 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one;octotropine methylbromide;Valpin 50;valpinax;Methylbromure d'octatropine;CIPLUS_709435;octatropini methylbromidum;Methyloctatropine Bromide;Anisotropine methylbromide;	0	4.32859249					[Br-].C[N+]2(C)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(CCC)CCC	SigmaAldrich	A5181	2.85093297	2.43248862	3.24183681	-0.19409302	3.32913528	1.13679068	4.32859249									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181349-02	Ranelic acid distrontium salt	225144325	Calcium-Sensing Receptor (CaSR) Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	135459-87-9	Strontium Ranelate;3-(3-cyano-4-carboxymethyl-5-carboxy-2-thienyl)-3-azapentanedioic distrontium salt; Strontium ranelate heptahydrate; 			-57.3646195303	4	7		0	-8.97822615			846	CASR	O.O.O.O.O.O.O.[Sr++].[Sr++].[O-]C(=O)CN(CC([O-])=O)C1=C(C#N)C(=C(S1)C([O-])=O)CC([O-])=O	APAC	825889	-11.07399608	-8.69597087	-8.69342692	-8.78671583	-7.63589301	-10.27491234	-8.97822615									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00167522-02	Hexoprenaline sulfate	170465755	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	32266-10-7		3.499899101	-5.4559444758	-110.6102483398	-2.2	7		-78.4656542041	-77.74707865	1.092E-7	0.9998650864			Oc1ccc(cc1O)C(O)CNCCCCCCNCC(O)c2ccc(O)c(O)c2.O=S(=O)(O)O	Sequoia	SRP01560h	-3.60903348	-3.99980453	-4.78906193	-7.66799609	-22.14129828	-57.53341125	-77.74707865									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183000-01	Lanperisone hydrochloride	144206892	Sodium channel alpha subunit Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	116287-13-9	Lanperisone; 			2.8986669478	4	7	Lanperisone hydrochloride;lanperisone;LANPERISONE HYDROCHLORIDE;Lanperisone Hydrochloride;CIPLUS_775823;CIPLUS_3846316;LANPERISONE;Lanperisone;lanperisonum;	0	-2.46381587					C[C@H](CN1CCCC1)C(=O)c2ccc(cc2)C(F)(F)F	Pharmaron	PH-NIH-98442	2.36971413	0.41781709	-0.45575297	1.46737904	0.63188347	1.65150668	-2.46381587									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159388-05	Pentaerythritol tetranitrate	225144224	Soluble guanylate cyclase Activator	DPI_SARS-CoV-2_General	2019_NPC_01					7.0529122268	4	7		0	0.35994018					[O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O	Labotest	LTBB004589	2.1131363	1.85940821	1.58660525	1.69312966	1.11911892	1.51430459	0.35994018									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159469-04	Methoxyphenamine	170465530	Adrenergic receptor beta Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	93-30-1				-16.9252054201	4	7		0	-4.47136955					COc1ccccc1CC(C)NC	ASDI	500012445	-0.62692131	-1.49778875	-5.34961371	-5.06433893	-4.65665127	-3.66380405	-4.47136955									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015237-07	Carbachol	170464972	Acetylcholinesterase Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	51-83-2				5.1623876604	4	7		0	2.40805049					[Cl-].C[N+](C)(C)CCOC(=O)N	Enzo	AC911	0.71890204	2.46047841	2.44449319	-0.79012717	-1.34243516	2.09868388	2.40805049									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015360-08	Pentetic acid	170465150	Radioactive metals Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC_01	67-43-6				-23.3290201691	4	7		0	4.36997795					O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O	Vitas	STK373226	0.06535473	1.10196203	-3.08303478	-2.1697143	-35.25605238	0.79780477	4.36997795									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00167561-03	D-alpha-Tocopherol succinate	225144294		DPI_SARS-CoV-2_General	2019_NPC_02	4345-03-3		4.4061119169	-5.3559444758	-105.637963915	-2.2	7		-90.2810815431	-73.47191172	0.0000296185	0.9977703968			CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(=C(C)C(=C2O1)C)OC(=O)CCC(O)=O	SIGMA	T3126	-2.05553886	-1.49460602	-1.8119594	-11.4468115	-28.50794858	-50.48853814	-73.47191172									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344521-01	1-(cis-3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride	225144377		DPI_SARS-CoV-2_General	2019_NPC_02	51229-78-8				-7.4216163023	4	7		0	-3.96708367					Cl\C=C/C[N]12CN3CN(CN(C3)C1)C2	SIGMA	C3892	1.63471988	-1.62858925	-3.47155482	0.3764937	0.47762755	-4.96054115	-3.96708367									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094719-08	Methenamine	170465468		DPI_SARS-CoV-2_General	2019_NPC_01	100-97-0				-43.9845605262	4	7		0	-10.12902081					C1N3CN2CN(CN1C2)C3	Microsource	01500394	-11.95507467	-7.26904	-9.98513319	-10.27165325	-8.75754961	-7.42415773	-10.12902081									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178831-03	Acriflavine hydrochloride	170465670	Hypoxia-inducible factor 1 alpha Interacts	DPI_SARS-CoV-2_General	2019_NPC_01	69235-50-3		15.6334750258	-4.8059444758	-64.5882070273	-2.2	7		-53.099073632	-52.66279689	0.001139951	0.9858992626			[Cl-].C[n+]1c3cc(N)ccc3cc2ccc(N)cc12.Nc1cc2nc3cc(N)ccc3cc2cc1	Microsource	01500618	-7.20596422	-9.98607276	-8.37659331	-3.83023553	-9.56960869	-13.9387164	-52.66279689									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015876-11	Ranitidine	170465134	Histamine H2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	66357-35-5				5.7185000459	4	7		0	0.1520874			3274	HRH2	[O-][N+](=O)\C=C(/NC)NCCSCc1ccc(CN(C)C)o1	Microsource	01501151	0	0	1.20396773	2.70148243	2.18494645	1.97672646	0.1520874									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164581-02	Estramustine	170466403	Estrogen receptor beta Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	2998-57-4		6.9832167823	-5.1559444758	-94.4055181555	-2.2	7		-69.399130698	-60.6118983	0.0006133578	0.9897194128	4130		ClCCN(CCCl)C(=O)Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)CC[C@@H]12)c4cc3	Sequoia	SRP01725e	-2.0598843	-7.93852469	-7.2749872	-13.2615948	-20.1416028	-38.74688754	-60.6118983									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016374-05	Carbarsone	170466507		DPI_SARS-CoV-2_General	2019_NPC_01	121-59-5				7.4043567601	4	7		0	0					O=C(N)Nc1ccc(cc1)[As](O)(O)=O	Prestwick Chemical, Inc.	Prestw-413	4.58693389	4.71326997	1.43793717	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091268-12	Oxytetracycline	225144208	Tetracycline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	79-57-2	; ; Oxytetracycline hydrochloride; Terramycin hydrochloride; Oxitetraciclina;Oxytetracycline hydrochloride;OXYTETRACYCLINE; Oxytetracycline Base;Oxytetracycline; Riomitsin;Oxytetracycline dihydrate; Oxytetracycline HCl; Oxytetracycline base; Oxytetracycline dihydrate; oxycort A; Terramycin	1.106765274	-5.9559444758	-149.1091312722	-1.1	7		-97.7068920916	-92.30691237	0.0000015662	0.9994886957			CN(C)[C@H]\1[C@@H]2[C@@H](O)[C@H]3\C(=C(O)/[C@]2(O)C(=O)\C(=C1O)C(N)=O)C(=O)C4=C(C=CC=C4O)[C@@]3(C)O	Prestwick	Prestw-307	2.48590032	1.60529724	-0.69947113	-16.7030376	-51.11658123	-79.24183139	-92.30691237									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161345-07	DOCONEXENT		Voltage-gated L-type calcium channel Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	6217-54-5		12.4181106199	-4.9059444758	-36.7796964745	-2.2	7		-40.8871816932	-34.37663511	0.0001997063	0.9941812002			CC\C=C/C/C=C\C\C=C/C/C=C\C\C=C/C\C=C/CCC(O)=O	Microsource	01503885	-1.24164721	-3.87858347	-2.09324676	-1.24172766	-4.16082504	-14.11593386	-34.37663511									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166215-05	2-Phenylethanol	170466787		DPI_SARS-CoV-2_General	2019_NPC_02	60-12-8				-6.6795949597	4	7		0	-4.44275317					OCCc1ccccc1	Microsource	01505398	0.88556961	-2.5064104	-2.8480345	-2.39225499	1.96516408	-1.27771514	-4.44275317									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386699-01	Fluphenazine decanoate dihydrochloride			DPI_SARS-CoV-2_General	2019_NPC_02	2376-65-0		1.5633475026	-5.8059444758	-109.3487378676	-1.2	7		-83.3276411576	-78.08114922	0.000003321	0.9992551937			CCCCCCCCCC(=O)OCCN1CCN(CCCN2C3=C(SC4=CC=C(C=C24)C(F)(F)F)C=CC=C3)CC1	Axon Medchem	2127	4.31686282	2.10446072	4.1935257	-2.43902439	-33.23194639	-72.39759489	-78.08114922									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025325-03	Vapiprost hydrochloride	174006925	Prostanoid TP Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	87248-13-3	GR 32191 hydrochloride; Vapiprost hydrochloride;GR-32191B; 	9.8640558873	-5.0059444758	-12.7987952013	4	7		-21.2225895439	-19.76882462	0.0023504829	0.9795873687	6915	TBXA2R	O[C@H]1C[C@H](OCC2=CC=C(C=C2)C3=CC=CC=C3)[C@H](CC\C=C/CCC(O)=O)[C@H]1N4CCCCC4	SIGMA	G5044	-0.52949201	1.03259489	-0.9634092	0.05378481	2.16476962	-5.17192785	-19.76882462									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164140-07	Dioctyl sulfosuccinate sodium salt	225144252		DPI_SARS-CoV-2_General	2019_NPC_01	577-11-7		17.5410474839	-4.7559444758	-15.5936888173	4	7		-17.88925502	-15.74104585	0.0167125201	0.9423714257			CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)[S]([O-])(=O)=O	SIGMA	323586	-3.5412582	-1.75678647	-0.09017572	0.46404294	-2.2103233	-3.41480766	-15.74104585									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016242-05	Metyrapone	170465268	Cytochrome P450 11B1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	54-36-4				-20.1678759678	4	7		0	-7.87305772					CC(C)(c1cccnc1)C(=O)c2cccnc2	Prestwick Chemical, Inc.	Prestw-904	-3.85592913	-2.26989518	0.07555263	-2.8118494	-7.2247881	-6.9566543	-7.87305772									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00188429-02	Acitazanolast	170466060	Mediator Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	114607-46-4	Acitazanolast			5.3217668077	4	7		0	-2.06838863					O=C(O)C(=O)Nc1cccc(c1)c2nnnn2	Life Chemicals	F2119-0003	1.75005446	0.87717155	-0.18766299	1.36704543	3.01730701	2.40865898	-2.06838863									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159447-07	8-Quinolinol Salicylic acid (1:1)	170465482	Trichophyton Interdigitale Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	2439-07-8				12.3692713874	4	7		0	3.12286127					O=C(O)c1ccccc1O.Oc1cccc2cccnc12	Specs	AE-562/J262360	4.14155351	4.58621448	2.76620116	3.97571927	0	0	3.12286127									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00180889-03	Flunixin meglumine	170466598	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	42461-84-7		12.4181106199	-4.9059444758	3.79093608	4	7		-10.5134343919	-8.34452866	0.0279699708	0.9235412066	791253	PTGS2	CNC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO.FC(F)(F)c2cccc(Nc1ncccc1C(=O)O)c2C	Microsource	01505113	3.19269963	1.26811152	2.0447954	3.67973512	0.30198447	1.33136846	-8.34452866									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183016-01	Cefteram	144206853		DPI_SARS-CoV-2_General	2019_NPC_01	82547-58-8	Cefteram; Ro 19-5247; Cefteram Pivoxil; Ro-19-5247; 			9.1169694406	4	7	7-(2-(2-amino-4-thiazoyl)-2-(methoxyimino)acetamido)-3-((5-methyl-2H-tetrazol-2-yl)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene carboxylic acid;ceftetrame;CIPLUS_213480;cefteram;Ro 19-5247;CEFTERAM;Cefteram Pivoxil;Ro-19-5247;cefteramum;Cefteram;LS-177691;	0	-0.54244506					Nc1scc(n1)/C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(=C(Cn2nc(C)nn2)CS[C@@H]34)C(=O)O	Pharmaron	PH-NIH-169126	2.1131363	3.92650329	0	0	2.55037304	4.93419381	-0.54244506									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183013-01	Doranidazole	144206845	Apoptosis Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	149838-23-3	DORANIDAZOLE; 			-17.2353458727	4	7	Doranidazole;RP 343;1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole;doranidazolum;(2RS,3SR)-3-((2-NITROIMIDAZOL-1-YL)METHOXY)BUTANE-1,2,4-TRIOL;RP-343;1,2,4-Butanetriol, 3-((2-nitro-1H-imidazol-1-yl)methoxy)-, (R*,S*)-;CIPLUS_741927;DORANIDAZOLE;	0	-6.69691516			81656		OC[C@@H](O)[C@H](CO)OCn1ccnc1[N+]([O-])=O	Pharmaron	PH-NIH-153447	-3.57030475	-4.52757348	-2.90268334	-2.73659919	-5.01192712	-0.97057777	-6.69691516									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249926-01	Pirmenol	170466004		DPI_SARS-CoV-2_General	2019_NPC_01	68252-19-7		11.0676527398	-4.9559444758	-8.851917147	4	7		-14.370687688	-13.64223974	0.0032593072	0.975894562			C[C@H]3CCC[C@@H](C)N3CCCC(O)(c1ccccc1)c2ccccn2	GVK	FFS-11-286-NCI-216	-0.33161475	1.61995749	0.22178353	-1.06102792	-0.00761305	-2.82534682	-13.64223974									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164634-02	Balsalazide disodium	170465305	agents for IBS and constipation	DPI_SARS-CoV-2_General	2019_NPC_01	80573-04-2	Balsalazide; Balsalazide; ;Balsalazide disodium; balsalzide Disodium; Colazide; Balsalazide sodium	22.0828704269	-4.6559444758	-17.754353534	4	7		-12.15575122	-11.24939799	0.0467095191	0.8975909638		ADORA1	OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)C(=O)NCCC(=O)O	Sequoia	SRP00900b	-2.8828698	-2.50445916	-4.30649996	-2.52589861	-0.70293864	-4.08049189	-11.24939799									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167781-12	CETIRIZINE HYDROCHLORIDE		Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_02	83881-52-1				13.4846724412	4	7		0	0.59458688				HRH1	OC(=O)COCCN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(Cl)C=C3	Microsource	01505371	4.6174478	4.23433205	2.16122454	2.92074925	3.67606872	1.38105975	0.59458688									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183277-01	Micronomicin sulfate	144206497		DPI_SARS-CoV-2_General	2019_NPC_02	66803-19-8		11.0676527398	-4.9559444758	-17.9052125789	-3	7	D-Streptamine, O-2-amino-6-(methylamino)-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6))-2-deoxy-;micronomicine;Santemycin;micronomicin;XK-62-2;KW-1062;Micronomicin Sulfate;gentamicin C2b;D-Streptamine, O-2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-alpha-D-erythro-hexopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6))-2-deoxy;LS-146966;CIPLUS_684924;Micronomicine;MICRONOMICIN;Micronomicina;MICRONOMICIN SULFATE;Micronomicin sulfate;6'-N-methylgentamicin C;Micronomicin;DE 020;Micronomicinum;sagamicin;DE-020;micronomicinum;KW 1062;CIPLUS_749329;Sagamicin;	-40.3983018559	-34.7714408	0.000928416	0.9873075671			O=S(=O)(O)O.N[C@@H]3CC[C@@H](CNC)O[C@@H]3O[C@H]2[C@H](O)[C@@H](O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O)[C@H](N)C[C@@H]2N	ACC	Micronomycin sulfate	4.2336239	1.30056134	-0.88371112	2.38290111	2.23605732	-8.52123262	-34.7714408									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390656-02	Pimavanserin			DPI_SARS-CoV-2_General	2019_NPC_02	706779-91-1		4.9437388825	-5.3059444758	-22.2934134876	4	7		-20.9645150599	-18.30376255	0.000379978	0.9919602512			CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C3CCN(C)CC3)C=C1	MedChem Express	HY-14557	-0.59423339	1.14347756	-1.06185978	-1.18560438	-4.22736022	-12.1852687	-18.30376255									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166072-02	D-Galactitol	170465564	osmotic diuretic agent	DPI_SARS-CoV-2_General	2019_NPC_02	608-66-2				12.1994452135	4	7		0	0.85620511				AVPR2	O[C@H]([C@@H](O)CO)[C@@H](O)[C@H](O)CO	SIGMA	D0256	4.54345765	2.07211994	3.4059211	4.45010874	0.77703586	1.70048854	0.85620511									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181352-01	Aspoxicillin	144206363		DPI_SARS-CoV-2_General	2019_NPC_02	63358-49-6	Aspoxicillin; Aspoxicillin Anhydride; Doyle; 			-36.2455964024	4	7	TA 058;TA-058;Doyle;Glycinamide, N-methyl-D-asparaginyl-N-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-D-2-(4-hydroxyphenyl)-, (2S-(2-alpha,5-alpha,6-beta))-;LS-72203;n(sup 4)-methyl-d-asparagininylamoxicillin;N(4)-methyl-D-asparaginylamoxicillin;CIPLUS_214228;aspoxicillinum;ASPOXICILLIN;Aspoxicillin;aspoxicilline;aspoxicillin;Aspoxicillin Anhydride;	0	-8.15773201					OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)NC)c1ccc(O)cc1)[C@H]3SC2(C)C	APAC	550484	-8.18747254	-6.51666705	-6.91263683	-10.94637888	-5.90499727	-7.49248403	-8.15773201									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00186037-02	Ibandronate sodium hydrate	225144338	Treatment of Osteoporosis	DPI_SARS-CoV-2_General	2019_NPC_02	138926-19-9	Ibandronate sodium			-23.7249957573	4	7		0	-6.12186653				FDPS	CCCCCN(C)CCC(O)([P](O)(O)=O)[P](O)([O-])=O	Prestwick	Prestw-1285	-1.65321742	-4.67324263	-6.12972035	-4.58574001	-2.70655609	-4.28410372	-6.12186653									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00167479-01	Bicisate dihydrochloride	144206036		DPI_SARS-CoV-2_General	2019_NPC_02	14344-58-2	Technetium tc 99m bicisate; 99mTc-ECD; Tc-ethyl cysteinate dimer; Tc-99m-L,L-ECD; Tc-99m ECD; Tc-99m-ECD; Tc-99m-bicisate; 	11.0676527398	-4.9559444758	-17.7366518708	-2.4	7	BICISATE DIHYDROCHLORIDE;N,N'-1,2-ETHYLENEDIYLBIS-CYSTEINE, DIETHYL ESTER DIHYDROCHLORIDE;	-30.5987014199	-29.24891785	0.0007186043	0.9888673547			Cl.Cl.O=C(OCC)C(CS)NCCNC(CS)C(=O)OCC	Epsilon	INVP_51441657	0	-1.83187415	0.6118	1.09674251	1.88912387	-5.0779782	-29.24891785									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182044-02	Toltrazuril (sulfone)			DPI_SARS-CoV-2_General	2019_NPC_02	69004-04-2		11.0676527398	-4.9559444758	-6.0481012141	4	7		-15.9996194639	-13.33301622	0.0384873087	0.9077383187			CN1C(=O)NC(=O)N(C1=O)C2=CC=C(OC3=CC=C(C=C3)[S+]([O-])(=O)C(F)(F)F)C(=C2)C	MedChem Express	HY-17008	3.52609309	-1.88269537	-0.25550268	2.0227767	1.3093173	-3.20368283	-13.33301622									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00264046-02	Glutathione	170465600	"Glutathione reductase, mitochondrial Substrate"	DPI_SARS-CoV-2_General	2019_NPC_02	70-18-8				5.8800240498	4	7		0	4.68058793			2936	GSR	O=C(NCC(=O)O)[C@@H](NC(=O)CC[C@H](N)C(=O)O)CS	Microsource	01502248	0	0	0	0	0	2.86546411	4.68058793									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00163953-03	Allethrin	144214035	Testis-specific androgen-binding protein Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_02	584-79-2		45.0885964097	-4.3459332839	-15.1036728788	-3	7	Allethrin	-48.1367074116	-42.22518194	0.0014482036	0.984059633			O=C2CC(OC(=O)C1C(/C=C(\C)C)C1(C)C)C(C)=C2CC=C	LightBiologicals	MOP-20453	-0.89019399	-0.77848876	-1.82133565	-0.92369572	0	4.25591883	-42.22518194									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00016065-11	Tropicamide	170464754	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	1508-75-4				7.468844416	4	7		0	0.52216674					OCC(c1ccccc1)C(=O)N(CC)Cc2ccncc2	Enzo	AC222	1.05293733	3.51112957	-0.96268675	2.57606542	2.15449424	1.9970527	0.52216674									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181002-04	Cinacalcet hydrochloride	170465336	Calcium-Sensing Receptor (CaSR) Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	364782-34-3	 Cinacalcet;Cinacalcet;Cinacalcet hydrochloride; Sensipar; 	22.0828704269	-4.6559444758	-22.3922151584	-3	7		-53.533852116	-46.9595194	0.0018992536	0.9816714245	846	CASR	Cl.FC(F)(F)c3cccc(CCCN[C@H](C)c2cccc1ccccc12)c3	Selleck	S1260	-0.72858422	1.32186576	-2.05454413	1.65299621	-1.75861544	4.93927537	-46.9595194									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018256-06	Oxyphenonium bromide	170465282	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	50-10-2				10.0990276104	4	7		0	3.40168817					[Br-].OC(C(=O)OCC[N+](C)(CC)CC)(c1ccccc1)C2CCCCC2	SIGMA	O5501	4.38844916	0	3.3462504	0	1.50992235	2.77453123	3.40168817									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016411-10	Butacaine	170465459		DPI_SARS-CoV-2_General	2019_NPC_01	149-16-6				-5.728266745	4	7		0	-2.70715571					Nc1ccc(cc1)C(=O)OCCCN(CCCC)CCCC	Microsource	01503914	-2.07440757	-1.25345127	-0.10967317	-2.35533148	1.55560067	-1.98180802	-2.70715571									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166218-02	4,4'-Dinitrodiphenylurea	170465744		DPI_SARS-CoV-2_General	2019_NPC_01	587-90-6		5.5469662594	-5.2559444758	-11.183666075	4	7		-19.507984584	-12.50665382	0.0038448998	0.9737129058			O=C(Nc1ccc(cc1)[N+]([O-])=O)Nc2ccc(cc2)[N+]([O-])=O	Specs	AN-153/I108774	2.72311379	2.39695067	-0.11454754	-1.31687862	-3.71263259	-6.45866152	-12.50665382									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179623-04	Lisinopril dihydrate	170464907	Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	83915-83-7				5.4920148511	4	7		0	0.26637492					O.O.OC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)N[C@@H](CCc1ccccc1)C(=O)O	Microsource	01501217	-0.77920877	2.1368015	3.10119313	-0.49809415	1.90813393	1.76155581	0.26637492									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532513-01	ADRENOCHROME MONOAMINOGUANIDINE MESILATE ANHYDROUS			DPI_SARS-CoV-2_General	2019_NPC_02			22.0828704269	-4.6559444758	-0.0222611121	4	7		-12.1329734119	-9.69414451	0.0409843998	0.9046418189			CN1CC(O)C/2=C/C(=N/NC(N)=N)C(=O)/C=C12	Carbosynth	FA17227	0	1.40220379	2.88553949	0	0	2.99229613	-9.69414451									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510940-01	Kebuzone		Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	853-34-9		13.9333492831	-4.8559444758	-34.3981313921	-2.2	7		-66.7496789208	-49.43157494	0.0002081876	0.9940537454			CC(=O)CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3	SantaCruz Bio	sc-488996	3.39661033	2.36780706	1.4603502	-0.05378481	-3.60953354	-15.38425404	-49.43157494									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185747-02	Niceritrol	170465789	Hydroxycarboxylic acid receptor 2 Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	5868-05-3		3.9269513795	-5.4059444758	-4.4674253484	4	7		-20.69611854	-15.99676545	0.0011168715	0.9860707916			O=C(OCC(COC(=O)c1cccnc1)(COC(=O)c2cccnc2)COC(=O)c3cccnc3)c4cccnc4	Kemprotec	5868-05-3	4.98277417	4.07262815	4.77485291	1.66265229	1.02891904	-10.69616685	-15.99676545									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015267-11	Citalopram hydrobromide		5-HT Reuptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	[59729-32-7]				6.4480722126	4	7		0	-4.0336774				HTR1A	CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3	Tocris	1427	2.87405489	2.67273441	2.34640538	1.98068424	1.78456859	0.69992484	-4.0336774									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00063561-03	4,5-Diphenylimidazole	170465946		DPI_SARS-CoV-2_General	2019_NPC_01	668-94-0		13.9333492831	-4.8559444758	-45.8563310392	-2.2	7		-50.7560910793	-40.53636156	0.0002303815	0.9937438981			c1ccc(cc1)c2ncnc2c3ccccc3	Labotest	LT03333454	-1.04325515	-2.48491216	-2.75157808	-4.48742067	-7.19433589	-17.10452767	-40.53636156									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167521-02	Tenatoprazole	170465931	Potassium-transporting ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	113712-98-4		9.8640558873	-5.0059444758	-6.286962942	4	7		-24.6746597039	-20.56221642	0.0087917499	0.9591720105		IDO1	Cc3c(OC)c(C)cnc3CS(=O)c1nc2nc(ccc2n1)OC	Sequoia	SRP011927t	4.08346041	0.00488675	4.02378689	0	3.51976856	-4.99009096	-20.56221642									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163470-27	FK-506		mTOR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	109581-93-3		4.9437388825	-5.3059444758	-81.3051041551	-2.2	7		-56.6930528343	-59.86300718	0.00002883	0.9978006815		MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O)/C=C(C)/[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)C\C(=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC)[C@H](C[C@H]4C)OC	Microsource	01503968	-5.48220768	-6.31338215	-4.91549659	-3.7158291	-11.61276525	-39.31322811	-59.86300718									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344556-01	Epitiostanol	225144391		DPI_SARS-CoV-2_General	2019_NPC_02	2363-58-8		5.5469662594	-5.2559444758	-23.1581009719	4	7		-19.11061694	-18.00884745	0.0014623043	0.984026179			C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H]5S[C@@H]5C[C@]34C)[C@@H]1CC[C@@H]2O	Prestwick	Prestw-1006	0.18266318	-2.28926517	-1.01966667	-0.39052452	-4.4412233	-11.58868846	-18.00884745									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166022-02	D-(-)-Mandelic acid	170465573		DPI_SARS-CoV-2_General	2019_NPC_02	611-71-2				8.8308283685	4	7		0	-0.61361366					O[C@@H](C(=O)O)c1ccccc1	SIGMA	154210	0	4.35907505	0.09141839	3.39779716	3.89943683	1.35287486	-0.61361366									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015094-22	Allopurinol			DPI_SARS-CoV-2_General	2019_NPC_02	315-30-0				7.2846347617	4	7		0	4.30956571					OC1=C2C=NNC2=NC=N1	APExBIO	A8360	0	0	0	4.39866239	2.24080983	1.62532882	4.30956571									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00183868-02	Fentiazac	170466003		DPI_SARS-CoV-2_General	2019_NPC_02	18046-21-4		12.4181106199	-4.9059444758	3.0377004433	4	7		-21.2589069079	-16.04908909	0.0106544183	0.9547757206			O=C(O)Cc1sc(nc1c2ccc(Cl)cc2)c3ccccc3	Prestwick	Prestw-1254	2.85786955	4.48843817	0.31879234	4.58574001	4.90696956	-0.61067268	-16.04908909									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00496843-01	Ripasudil		ROCK1/ROCK2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	887375-67-9				11.0180953183	4	7		0	4.21443181				ROCK1	C[C@H]1CNCCCN1[S+]([O-])(=O)C2=CC=CC3=CN=CC(=C23)F	Selleck	S7995	0	0	4.25915942	0.25489325	4.52201602	3.54659902	4.21443181									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379027-01	(24S)-24,25-Dihydroxyvitamin D3		Vitamin D3 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	55700-58-8		8.7913490634	-5.0559444758	-78.5844938601	-2.2	7		-52.800385928	-55.6200352	0.00068779	0.9891037549	7421	VDR	C[C@H](CC[C@H](O)C(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)CCC3=C	MedChem Express	HY-15439	-5.09838378	-8.42477304	-8.35189049	-11.43278067	-8.80403013	-28.52780909	-55.6200352									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183865-01	Flugestone	144206781		DPI_SARS-CoV-2_General	2019_NPC_02	337-03-1				-12.9382614316	4	7	CIPLUS_160491;Flugestonum;CIPLUS_679087;FLUROGESTONE ACETATE;Pregn-4-ene-3,20-dione, 17-(acetyloxy)-9-fluoro-11-hydroxy-, (11beta)-;Fluorogestone acetate;Flurogestone acetate;FLUGESTONE;Flugestona;flugestonum;flugestone;Flugestone;Flurogestone Acetate;Flugestone acetate;LS-118677;	0	-2.18332303					CC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)C1(F)[C@@]3(C)CCC(=O)C=C3CC[C@H]12	NCI	NSC_79327	-1.20465213	-1.06493566	-3.53718853	-1.02191147	-3.64280113	-6.43085306	-2.18332303									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263575-01	Ezetimibe	170465013	NPC1L1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	163222-33-1		13.9333492831	-4.8559444758	-36.8922642912	-2.2	7		-61.1214291187	-45.92532509	0.0003123755	0.9927006172		NPC1L1	Fc1ccc(cc1)[C@@H](O)CC[C@H]3C(=O)N(c2ccc(F)cc2)[C@@H]3c4ccc(O)cc4	Sequoia	163222-33-1	-0.69953768	2.67549539	-1.33801272	1.091128	-3.90042126	-15.99166624	-45.92532509									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166217-02	1-Bromoheptadecafluorooctane	170465144		DPI_SARS-CoV-2_General	2019_NPC_01	423-55-2				-4.3945092235	4	7		0	1.59184812					FC(F)(C(F)(F)C(Br)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F	SIGMA	343862	-2.28741558	-0.51066533	-0.5044966	-0.71487697	-0.13957265	-3.40464454	1.59184812									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00261971-01	Mazaticol	170466055		DPI_SARS-CoV-2_General	2019_NPC_01	42024-98-6	Mazaticol;Mazaticolum;Pentona;Mazaticol	17.5410474839	-4.7559444758	-36.9627899939	4	7		-28.466410264	-24.59760209	0.0037355152	0.9740349697			OC(C(=O)OC1CC2CCC(C)(C)C(C1)N2C)(c3cccs3)c4cccs4	GVK	FFS-11-286-NCI-243	-4.48527098	-2.95892687	-3.92142526	-6.9706775	-5.89504136	-10.23934143	-24.59760209									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091338-06	4-Chloro-3-methylphenol	170466134		DPI_SARS-CoV-2_General	2019_NPC_01	59-50-7				7.9810428626	4	7		0	1.57663938					Oc1ccc(Cl)c(C)c1	Microsource	01500178	0	3.71637305	0	0	4.57544536	1.94115555	1.57663938									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015054-12	Tacrine hydrochloride	170465420	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	321-64-2	 THA hydrochloride hydrate; THA hydrochloride; 9-Amino-1,2,3,4-tetrahydroacridine hydrochloride;9-Amino-1,2,3,4-tetrahydroacridine hydrochloride;Tacrine hydrochloride hydrate; ;TACRINE HYDROCHLORIDE;Tetrahydroaminoacridine Monohydrate;Tacrine hydrochloride;Tacrine (hydrochloride);Tacrine; Tetrahydroaminacrin;1,2,3,4-Tetrahydro-9-acridinamine hydrochloride; Tacrina; Cognex;Tacrin?HCl			9.4579551548	4	7		0	4.18240349			43	ACHE	Nc1c3ccccc3nc2CCCCc12	Vitas	STK101308	3.34761455	0	0	0	3.64665279	3.49103105	4.18240349									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181355-02	Carpronium chloride	225144327	Muscarinic acetylcholine receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02					9.2910558172	4	7		0	-1.45554868					COC(=O)CCC[N+](C)(C)C	APAC	877481	4.37235543	2.46020929	1.38065212	1.52234408	2.52120809	2.27358136	-1.45554868									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390584-01	Exatecan	384569198	DNA Topoisomerase I Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	169869-90-3		11.0676527398	-4.9559444758	-32.9872523847	-2.2	7		-56.527874232	-50.8157732	0.0003453766	0.9923190205		TOP1	CC[C@@]1(O)C(=O)OC/C2=C1/C=C3\N(CC4=C5[C@@H](N)CCC6=C5C(=CC(=C6C)F)N=C34)C2=O	MedChem Express	HY-13631A	2.47635783	2.03515905	1.31033028	-2.67287141	1.14773186	-13.08248779	-50.8157732									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166291-03	Lycopene		response to oxidative stress Modulator	DPI_SARS-CoV-2_General	2019_NPC_02					-6.0097982976	4	7		0	3.64362841					CC(C)=CCC\C(C)=C\C=C\C(C)=C\C=C\C(C)=C\C=C\C=C(C)\C=C\C=C(C)\C=C\C=C(C)\CCC=C(C)C	SigmaAldrich	75051	0.09942426	-1.90579593	-1.16031035	-3.36038164	-1.12872181	-3.88951522	3.64362841									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263444-01	Metocurine iodide	170465111		DPI_SARS-CoV-2_General	2019_NPC_01	7601-55-0		8.7913490634	-5.0559444758	-7.9882948151	4	7		-19.733707636	-16.86142303	0.0027179091	0.9780026891			[I-].[I-].COc7ccc1cc7Oc6cc5c(CC[N+](C)(C)[C@H]5Cc4ccc(Oc3c2c(CC[N+](C)(C)[C@@H]2C1)cc(OC)c3OC)cc4)cc6OC	Specs	AE-562/J259582	0	2.44581816	2.6150959	0.2307673	1.83982135	-5.84379288	-16.86142303									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091666-04	1,8-Cineol	170465483	tumor necrosis factor production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	470-82-6				9.8729356743	4	7		0	2.81868647					CC2(C)OC1(C)CCC2CC1	Labotest	LT00440774	2.29225667	0	2.6687139	2.95231645	2.17479572	1.98180802	2.81868647									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016781-08	Ambroxol hydrochloride	225144182	surfactant homeostasis Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	23828-92-4				6.9644071441	4	7		0	-2.10387569					NC1=C(CNC2CCC(O)CC2)C=C(Br)C=C1Br	Prestwick	Prestw-366	2.57303996	3.31565959	-0.18766299	1.75332982	2.79906613	1.38218405	-2.10387569									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015340-14	Desipramine hydrochloride	170465424	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	58-28-6		12.4181106199	-4.9059444758	-21.8736550618	4	7		-16.6069622601	-17.18080657	0.0058234935	0.9672965876			Cl.CNCCCN2c3ccccc3CCc1ccccc12	Microsource	01500227	-3.5412582	-1.25833802	-1.91318759	-3.76000201	-1.43379181	-6.53996646	-17.18080657									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015209-11	Cyclophosphamide	170464624	Bcl-2 Expression Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	6055-19-2	Cytophosphane;Endoxan;Neosar; Neosar; ; Sendoxan;Clafen;Revimmune; Cyclophosphane; Ciclophosphamide; Endoxon; Ciclofosfamida; (+-)-Cyclophosphamide; Cyclophosphamide; Cytoxan; Cytophosphan; Procytox;Cyclophosphamide;Cyclophosphamide monohydrate; Endoxan; (-)-Cyclophosphamide; Cytoxan Tablet; Cytoxan Injection;Procytox;Cytoxan			2.9135964336	4	7		0	3.62981927			596	BCL2	O.O=P1(NCCCO1)N(CCCl)CCCl	Vitas	STK177249	0.2178491	0	0	1.21905335	0	0	3.62981927									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159476-09	Tribromsalan	170465542		DPI_SARS-CoV-2_General	2019_NPC_01	87-10-5		4.9437388825	-5.3059444758	-83.2133299215	-2.2	7		-80.5410382524	-62.73098274	0.0006845195	0.9891277085			Oc1c(cc(Br)cc1Br)C(=O)Nc2ccc(Br)cc2	SIGMA	R416568	1.87108174	-1.82520097	-2.62971899	-3.42388442	-24.7601888	-40.92687637	-62.73098274									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178692-04	N-METHYL (-)EPHEDRINE [1R,2S]		Beta-1 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	552-79-4				-11.1113119961	4	7		0	0.83717833					C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C	Microsource	02300220	-3.09140096	-1.62858925	-4.77954103	-3.12653462	-1.35684243	-2.63998497	0.83717833									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181750-01	Cefozopran hydrochloride	144206474	Bacterial penicillin-binding protein Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_02	113981-44-5	Cefozopran; Firstcin; 			-1.7960378061	4	7	Cefozopran Hydrochloride;CEFOZOPRAN;LS-172220;Cefozopran;CEFOZOPRAN HYDROCHLORIDE;CIPLUS_766339;SCE-2787;CZOP;Firstcin;cefozopranum;SCE 2787;cefozopran;CIPLUS_214061;Cefozopran hydrochloride;	0	-4.17162156					Cl.CO\N=C(/c1nc(N)sn1)C(=O)N[C@@H]5C(=O)N4C(C([O-])=O)=C(C[n+]3ccn2ncccc23)CS[C@@H]45	ACC	CEFOZOPRAN HYDROCHLORIDE	2.12490462	-1.18505856	-1.05248353	-0.07716952	0.59168785	0.24426907	-4.17162156									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344534-01	Indigo carmine	225144381		DPI_SARS-CoV-2_General	2019_NPC_02	860-22-0		12.4181106199	-4.9059444758	-12.5368163006	4	7		-9.48687152	-9.9890596	0.0544397382	0.8878109539			[O-][S](=O)(=O)C1=CC2=C(NC(\C2=O)=C/3NC4=CC=C(C=C4C3=O)[S]([O-])(=O)=O)C=C1	SIGMA	131164	-1.81969525	-2.6681143	-1.83540001	-1.67200617	0.9386213	-3.40097708	-9.9890596									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522022-01	Befunolol		Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	39552-01-7				2.278422481	4	7		0	-0.37102221					CC(C)NCC(O)COC1=C2OC(=CC2=CC=C1)C(C)=O	Toronto Research	B131100	-0.19191195	1.42068424	-0.15236399	0.84418773	1.27604971	0.33821871	-0.37102221									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00384190-03	(S)-Crizotinib		HGFR (MET; c-Met) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1374356-45-2		2.7800686746	-5.5559444758	-148.3826638378	-2.1	7		-96.4315527237	-92.37026114	8.733E-7	0.9996183002		MET	C[C@H](OC1=CC(=CN=C1N)C2=C[N](N=C2)C3CCNCC3)C4=C(Cl)C=CC(=C4Cl)F	Axon Medchem	2296	-4.57582834	-6.75691284	-7.15173109	-15.84781236	-36.97692655	-71.48158587	-92.37026114									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167301-02	Triptorelin		Gonadotropin-releasing hormone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	57773-63-4		4.7903477126	-5.3196329617	-43.8148407372	-2.2	7		-54.67483233	-39.14760025	0.0002513685	0.993461026			CC(C)C[C@H](NC(=O)[C@@H](CC1=C[NH]C2=C1C=CC=C2)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CO)NC(=O)[C@H](CC4=C[NH]C5=C4C=CC=C5)NC(=O)[C@H](CC6=CN=C[NH]6)NC(=O)[C@@H]7CCC(=O)N7)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N8CCC[C@H]8C(=O)NCC(N)=O	Enzo	DL310	4.54345765	3.09778466	0.99622606	0.17538526	-5.04954495	-17.95847426	-39.14760025									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00181794-01	Dimethyl(2-phenoxyethyl)-2-thenylammonium iodide	144207154	acetylcholine metabolic process Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	109732-56-1	Thenium closylate; Thenatol; Closilato de tenio; Canopar; 			10.5518524685	4	7	Closilato de tenio;thenium closylate;thenii closilas;Closilate de thenium;THENIUM CLOSYLATE;CIPLUS_163117;closilate de thenium;Thenii closilas;Canopar;CIPLUS_3795079;Thenatol;THENIUM CLOSILATE;CIPLUS_3750771;Thenium closylate;Thenium closilate;	0	-0.46615611					[I-].C[N+](C)(Cc1cccs1)CCOc2ccccc2	Toronto Research	D476690	1.43587135	2.24306406	3.94974333	2.73367163	3.02972697	2.09977452	-0.46615611									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167515-03	Enocitabine		cell growth Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	55726-47-1 				11.4971136744	4	7		0	2.48299482					CCCCCCCCCCCCCCCCCCCCCC(=O)NC\1=N\C(=O)N(\C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O	Glixx	GLXC-05978	2.58734306	4.31287394	3.6965847	0	3.19606492	0.90661405	2.48299482									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00178896-05	Mepenzolate bromide	170465214	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	76-90-4				-15.0651640096	4	7		0	-5.65571041					[Br-].O=C(OC1CCC[N+](C)(C)C1)C(O)(c2ccccc2)c3ccccc3	Microsource	01500383	-1.40812504	-0.26103629	-3.98724831	-3.89822978	-2.74457619	-5.03100338	-5.65571041									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183107-01	NCGC00183107-01	124894307		DPI_SARS-CoV-2_General	2019_NPC_02		Carbetocin; Depotocin; Carbetocino; 			-18.7750990273	4	7	carbetocin;1-BUTYRIC ACID-2-(3-(4-METHOXYPHENYL)-ALANINE)OXYTOCIN;oxytocin, 1-desamino-1-monocarba-(Tyr(OMe))(2)-;1-Carbaoxytocin, 1-butanoic acid-2-(O-methyl-L-tyrosine)-;Carbetocino;Depotocin;dcomot;oxytocin, 1-desamino-1-monocarba-(tyrosine(O-methyl))(2)-;LS-174644;carbetocinum;Carbetocinum;1-deamino-1-monocarba-2-(Tyr(OMe))-oxytocin;CIPLUS_213985;carbetocine;Carbetocin;CARBETOCIN;	0	-7.16833944					CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2=CC=C(O)C=C2)N(C)C(=O)CCCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O	APAC	877872	-3.15614234	-3.94788514	-3.72002532	-1.43815916	-3.48121569	-5.81078542	-7.16833944									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181039-02	Ethyl linoleate	170466006	regulation of prostaglandin secretion Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	6114-21-2		12.4181106199	-4.9059444758	-31.754700398	-3	7		-56.6250297295	-53.17985064	0.0000089758	0.9987749167			O=C(CCCCCCC/C=C\C/C=C\CCCCC)OCC	SIGMA	L6253	0	0	0	1.89649931	0	-7.2106351	-53.17985064									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022185-14	Progesterone		Progestogen hormone	DPI_SARS-CoV-2_General	2019_NPC_02	[57-83-0]				1.6308444684	4	7		0	-5.20858108				PGR	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC/4=C/C(=O)CC[C@]4(C)[C@H]3CC[C@]12C	Tocris	2835	0	1.27977084	4.18883758	0.41390922	0	0.37579857	-5.20858108									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179599-03	Cefoperazone sodium	170465235	Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	62893-20-3				4.2179902798	4	7		0	0.06083496					[Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](c2ccc(O)cc2)C(=O)N[C@@H]5C(=O)N4C(=C(CSc3nnnn3C)CS[C@@H]45)C([O-])=O	Prestwick Chemical, Inc.	Prestw-327	0	0.71102206	-0.22665789	3.15800035	1.91087652	0.43701408	0.06083496									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015971-05	Succinylcholine chloride	170464625	Muscle-type nicotinic acetylcholine receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	71-27-2				7.4417628529	4	7		0	1.73886593					[Cl-].[Cl-].C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Vitas	STK177290	2.89739307	2.88073888	4.22851015	0	0	-0.58437929	1.73886593									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016590-06	Azaperone	170465697		DPI_SARS-CoV-2_General	2019_NPC_01	1649-18-9		7.8352981002	-5.1059444758	-7.798451977	4	7		-12.301982204	-9.83498517	0.0343443991	0.9139855848			Fc1ccc(cc1)C(=O)CCCN2CCN(CC2)c3ccccn3	Vitas	STK802185	-0.5204173	-1.02866079	2.37137774	1.58777937	-1.38303812	-4.7868286	-9.83498517									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021761-05	Flumethasone	170465750	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	2135-17-3		13.9333492831	-4.8559444758	-36.7889324025	4	7		-12.806273196	-16.52176117	0.2073206581	0.7252890567			OCC(=O)[C@@]4(O)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-734	-8.80352431	-3.34986684	-9.61468158	-5.8920912	-3.93087347	-8.85207582	-16.52176117									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015436-11	Fluphenazine hydrochloride	170465375	Nicotinic alpha7 Receptor Ligands	DPI_SARS-CoV-2_General	2019_NPC_01	69-23-8	 Motipress; Liogen;Fluphenazine; Flumezin;; ; Fluphenazine dihydrochloride;Fluphenazine di?HCl; Flufenazine; Prolixin; Lyogen; Motival;Fluphenazine dihydrochloride; Fluphenazine Hcl; prolixin S	6.2237985085	-5.2059444758	-72.8824002532	-2.2	7		-84.4131200726	-72.29221059	0.0000942182	0.9960117244	1813	DRD2	FC(F)(F)c2cc3N(CCCN1CCN(CCO)CC1)c4ccccc4Sc3cc2	Vitas	STK050763	0.94159223	3.49158257	3.04891424	-2.6563323	-13.89382328	-40.6626353	-72.29221059									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167737-02	Lazabemide hydrochloride	170466038	Monoamine oxidase B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	103878-83-7				-38.8624379493	4	7		0	-6.91997668					Cl.Clc1cnc(cc1)C(=O)NCCN	Tocris	2460	-7.56904606	-9.05270359	-10.23860008	-7.24659493	-6.18941278	-10.32064637	-6.91997668									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379045-01	Alfacalcidol-D6		Increase blood calcium level via a variety of mechanisms	DPI_SARS-CoV-2_General	2019_NPC_02			7.8352981002	-5.1059444758	-72.7039807645	-2.2	7		-87.8014793375	-74.47081768	0.0000149421	0.9984180701			C(C(C([2H])([2H])[2H])CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)C[C@H](O)C3=C)([2H])([2H])[2H]	MedChem Express	HY-15332	2.30988	-0.40887985	-1.22594407	-1.85440685	-8.13392581	-38.46768132	-74.47081768									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00507799-01	Flumethasone acetate			DPI_SARS-CoV-2_General	2019_NPC_02	2823-42-9				-41.4996455927	4	7		0	-16.93859107					C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O	Carbosynth	FF23330	-7.53080996	-7.717896	-7.82682075	-9.14575685	-7.24045339	-7.37034949	-16.93859107									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390559-05	Azilsartan Medoxomil		Type-1 angiotensin II receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	863031-21-4		9.8640558873	-5.0059444758	-37.0279981989	-2.2	7		-56.2599296036	-49.06055273	0.0000147928	0.9984264362	185	AGTR1	CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4\C5=N\C(=O)O[N-]5)C(=O)OC\C6=C(/C)OC(=O)O6	APExBIO	B2218	1.11678883	0.8755111	1.74632568	-0.75532587	-1.00990899	-17.91149944	-49.06055273									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263218-07	Teriflunomide		DHODH Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	108605-62-5				-3.425994305	4	7		0	-3.63411502				DHODH	C\C(O)=C(C#N)\C(=O)NC1=CC=C(C=C1)C(F)(F)F	Bio Vision	1973	-1.03354991	-0.96329322	0.19455709	-0.09120034	2.71606112	-3.01578354	-3.63411502									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510144-01	Gestonorone			DPI_SARS-CoV-2_General	2019_NPC_02	2137-18-0				14.9356822378	4	7		0	4.00038054					CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CC\C4=C\C(=O)CC[C@@H]4[C@H]3CC[C@]12C	Glixx	GLXC-08149	4.36310666	4.85342697	0	4.43607792	4.34142053	0.49793311	4.00038054									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00484900-01	Estramustine Phosphate·Na		Dna Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC_02	52205-73-9		8.7913490634	-5.0559444758	-31.4913730854	-2.2	7		-43.0634780904	-38.30566522	0.0011452003	0.9858683513		H2AFX	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=CC=C34)OC(=O)N(CCCl)CCCl)[C@@H]1CC[C@@H]2O[P](O)(O)=O	Enzo	AC1524	3.12377165	-1.96585738	1.44628583	-1.69071393	-0.50614262	-16.4740699	-38.30566522									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00371122-04	Betrixaban		Coagulation factor X Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	330942-05-7		7.8352981002	-5.1059444758	-5.2279866112	4	7		-16.968772296	-12.89064358	0.0101009042	0.9561381298			COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC3=NC=C(Cl)C=C3	MedChem Express	HY-10268	3.46135171	1.77643281	-0.45240383	2.73834857	0.35881472	-5.52893649	-12.89064358									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160543-01	Pregnandiol	144205439	G-protein coupled bile acid receptor 1 Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	80-92-2	Pregnandiol; Diol; Pregnantriol; 			-10.8324917768	4	7	ALLOPREGNANDIOL;CIPLUS_3727430;CIPLUS_149642;CIPLUS_679210;5BETA-PREGNANE-3ALPHA,20ALPHA-DIOL;CIPLUS_742702;CIPLUS_678965;allopregnane-3,20-diol;PREGNANDIOL;CIPLUS_696772;(3 alpha,5 alpha,20S)-pregnane-3,20-diol;Pregnantriol;Diol;Pregnanediol;Pregnandiol;PREGNANEDIOL;CIPLUS_742124;	0	-4.38091614					CC(O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]1[C@H]3CC[C@@H]2C[C@@H](O)CC[C@]12C	SigmaAldrich	R195952	-0.57573586	-1.88269537	-0.58835939	-1.7094217	-3.91369437	-4.41093574	-4.38091614									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00167584-01	Nicametate citrate	144206129	cell growth Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1641-74-3	Buffer solution from sodium citrate; Citric acid ammonium salt; Advil PM; Citric acid disodium salt; Euclidan; Alka-Seltzer; Sodium citrate buffer; Ammonium citrate dibasic; Sodium citrate monobasic; Citrate, Calciu; Tectlol; Pectamol; Citric acid-2,2,4,4-d4; Tc-99m-citrate; Citrate standard for IC; Bryrel; Astomatop; Pax??ladine; Caffeine, citrated; Antepar; Etoheptazina; Bismuth(III) citrate; Citric acid-13C6; DACH-Pt(II)citrate; Isoaminilo; Chemosol; Peracon; Aciletten; Tussimol; (239)Pu citrate; Tripelenamina; Anhydrous Citric Acid; Alverine citrate salt; Tritec; Tripelennamine Maleate; Toness; Citrato de galio (67 Ga); Cafcit; Oseltamivir citrate; Ferriseltz; Ammonium bismuth citrate; Citric acid solution; Ga-67 citrate; Sodium dihydrogencitrate; Pentoxyverine citrate; Tricalcium dicitrate; Silver citrate hydrate; Uralyt U; Zinc citrate dihydrate; Ascarex Syrup; Sinutab; Sodium dihydrogen citrate; DN 1417, (S)-isomer; Pyribenzamine; Tipepidina; AD 1308, citrate; Naldecon; U, Uraly; Oxeladin citrate salt; Citrate, Potassiu; 0.5 citrate CPD; Ammonium hydrogencitrate; Raniberl; technetium Tc 99m citrate; Citric acid lead salt; Citric acid calcium salt; Azanplus; Pentoxyverine Citrate; Citracal; Citric acid-2,4-13C2; Neoscan; Azaron; Citrates, Calciu; copper(II) citrate; Toclase; Citra ph; Citrate Solution; Banminth D; Oxeladina; Anhydrous citric acid; ethoheptazine HCl; Citric acid-1,5-14C; Clinitest; Oxeladin Tannate; Lithium citrate hydrate; Citric acid-1,5-13C2; Pylorid; Asverin; Tripotassium citrate; Alka Seltzer; DN 1417 citrate (1:1); Hetrazan; Butethamate citrate salt; DADP-PrD; ACD-A solution; Tri-lithium citrate; Gallii (67 Ga) citras; Citric acid zinc salt; Citric acid barium salt; Carricide citrate; gallii (67Ga) citras; Potassium hydroxycitrate; 67Ga-labeled; Negram-Citrat; Provasan; Banmint D; ACD solution; Iron(III) citrate; Mictral; Platinex; Acid, Citri; Trisodium citrate hydrate; Perogan; Norgesic forte; Orfenadrina; Citric Acid (Renacidin); Ammonium citrate tribasic; Magurlit; Sinecod; Cerebyx; Tetrodotoxin citrate; Dietilcarbamazina; 			-18.8599085831	4	7	Nicametate Citrate;2-(diethylamino)ethyl nicotinate;nicametatum;NICAMETATE CITRATE;Nicametate citrate;Nicotinic acid, 2-(diethylamino)ethyl ester;3-(diethylaminoethoxycarbonyl)pyridine citrate;LS-96550;Nicametate;Provasan;Euclidan;NICAMETATE;nicametate;Nicametatum;2-(diethylaminoethyl)nicotinate citrate;LS-96549;CIPLUS_213922;CIPLUS_669827;	0	-5.93159873					O=C(O)C(O)(CC(=O)O)CC(=O)O.CCN(CC)CCOC(=O)c1cccnc1	SigmaAldrich	R288020	-2.86018174	-4.95044931	-2.97461382	-3.6690597	-2.64477342	-5.5007516	-5.93159873									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016353-08	Butyl 4-aminobenzoate	170465735		DPI_SARS-CoV-2_General	2019_NPC_01	94-25-7				6.0908300148	4	7		0	-1.37892576					Nc1ccc(cc1)C(=O)OCCCC	Specs	AE-562/J257667	2.28741558	2.76834364	1.99605177	-0.41889282	0.00253768	3.19121907	-1.37892576									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095105-05	Acetrizoic acid	170465154	Solute carrier organic anion transporter family member 1B1 Activator	DPI_SARS-CoV-2_General	2019_NPC_01	85-36-9				-47.3070919787	4	7		0	-13.88557958					O=C(C)Nc1c(I)c(c(I)cc1I)C(=O)O	Microsource	01504142	-11.99864449	-9.76616903	-9.90226902	-9.5392179	-10.26493427	-6.1131155	-13.88557958									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018251-05	Methyl delta-aminolevulinate hydrochloride	225144187	Porphyrin and chlorophyll metabolism Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	79416-27-6				1.2446332571	4	7		0	-3.46759271					COC(=O)CCC(=O)CN	SIGMA	A5575	-0.67533222	1.01400054	-0.68484804	2.13459754	-0.11927118	2.70847096	-3.46759271									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249935-01	Phenylacetylglycine dimethylamide	170465887		DPI_SARS-CoV-2_General	2019_NPC_01	3738-06-5				-0.2962455391	4	7		0	2.70715571					CN(C)C(=O)CN(C(C)=O)c1ccccc1	GVK	FFS-11-286-NCI-239	3.39602546	2.02067095	0	0	-11.62005786	3.84165862	2.70715571									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166238-02	Benznidazole	170466539	Pyruvate:ferredoxin oxidoreductase Substrate	DPI_SARS-CoV-2_General	2019_NPC_02	22994-85-0				9.8374013297	4	7		0	4.39994292					O=C(Cn1ccnc1[N+]([O-])=O)NCc2ccccc2	SIGMA	419656	4.70531111	0.06930167	0.40786667	2.5091785	0	3.21307779	4.39994292									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386509-01	Fluticasone furoate	384569143	Glucocorticoid Receptor (GR) Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	397864-44-7		1.7541047484	-5.7559444758	-63.6810514148	-1.2	7		-47.5022594268	-41.66864862	0.0004551873	0.9911660986		NRC31	C[C@@H]1CC2C3C[C@H](F)C\4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C5=CC=CO5)C(=O)SCF	Axon Medchem	1172	0.77458438	1.86421493	-0.60711188	-9.78649767	-17.10667015	-34.80834273	-41.66864862									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344531-01	Droxidopa	170465890	Adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	23651-95-8		11.0676527398	-4.9559444758	-60.3857665737	-2.2	7		-74.5846453867	-57.26109499	0.0004777337	0.9909451537			Oc1ccc(cc1O)[C@H](O)[C@H](N)C(=O)O	SIGMA	D2384	0.16879003	1.87807526	-1.59161764	-6.27879241	-9.69750255	-27.68226231	-57.26109499									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183365-02	ORNITHINE HYDROCHLORIDE		G-protein coupled receptor family C group 6 member A Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	70-26-8				8.2180001166	4	7		0	0.51847976			222545	GPRC6A	NCCCC(N)C(O)=O	Microsource	01504524	2.99428889	1.94737693	-1.75101381	3.28087365	3.66181118	2.3957159	0.51847976									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00179295-03	Meptazinol hydrochloride	170466363	Mu opioid receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	59263-76-2				11.998054828	4	7		0	2.58548579					Cl.CN1CCCCC(CC)(C1)c2cccc(O)c2	Prestwick Chemical, Inc.	Prestw-1004	3.22658727	3.57465732	1.63047452	4.16133644	1.61142973	1.11286143	2.58548579									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023037-08	Pancuronium bromide	225144191	Steroid non-depolarizing Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	15500-66-0	; ;Pancuronium bromide; Pancuronium bromide; Bromide, Pancuroniu; Pancuronium Organon; Pancuronium dibromide; Pancuronium Curamed; Bromuro de pancuronio; Pavulon			12.5104370799	4	7		0	2.73757319					CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(C)=O)[N+]5(C)CCCCC5)[C@@]2(C)C[C@@H]1[N+]6(C)CCCCC6	Prestwick	Prestw-1034	4.56756953	0	4.58433867	0.74246871	1.49215855	4.5886478	2.73757319									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017074-02	Hydergine	144206902	Adrenergic receptor alpha Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	8067-24-1		5.5469662594	-5.2559444758	-83.6162252444	-2.1	7		-87.4322170988	-80.49279361	0.0000181422	0.9982563517			CS(=O)(=O)O.CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@@]7(O[C@]6(O)N([C@H](C(=O)N5CCC[C@H]56)C(C)C)C7=O)C(C)C	Prestwick Chemical, Inc.	CAS-8067-24-1	0.93181345	0.93557255	0.30238391	-0.94708042	-13.65159328	-46.47219091	-80.49279361									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249930-01	Tolycaine	170465945		DPI_SARS-CoV-2_General	2019_NPC_02	3686-58-6				9.509547822	4	7		0	1.55068259					O=C(Nc1c(C)cccc1C(=O)OC)CN(CC)CC	GVK	FFS-11-286-NCI-233	0	0.55210331	1.872905	2.96284171	4.87370197	2.17493424	1.55068259									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091534-02	o-Cresol	26753043		DPI_SARS-CoV-2_General	2019_NPC_02	95-48-7	2-Methylphenol-d8; o-Cresol-d8; 			14.275838099	4	7	2-methylphenol;CIPLUS_732542;CIPLUS_723417;methylphenol, polymer with formaldehyde;phenoaldehyde resinifying agent;CIPLUS_3741557;CIPLUS_3751665;CIPLUS_3881950;2-cresol, sodium salt;2-METHYLPHENOL;CIPLUS_749387;2-cresol, potassium salt;phenoaldehyde;CRESOL;CIPLUS_150287;CIPLUS_749458;O-CRESOL;ortho-cresol;Methylphenol tricresol;o-Cresol-d8;CIPLUS_3882512;o-cresol;NCGC00091534-02;Cresol mixture of isomers;CIPLUS_743211;CIPLUS_749586;AB08007336-01;2-cresol;CIPLUS_3752378;CIPLUS_671502;2-cresol, ammonium salt;CIPLUS_745732;tricresolformalin;2-Methylphenol-d8;CIPLUS_653786;CIPLUS_163487;2-Methylphenol;CIPLUS_3750176;CIPLUS_714209;CIPLUS_682977;o-Cresol;	0	0.1902678					CC1=C(O)C=CC=C1	SigmaAldrich	MFCD00002226	4.84866702	4.87652752	0	3.8654912	3.36240287	1.43742954	0.1902678									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00016498-08	Dyclonine hydrochloride	170464776	Sodium channel protein type II alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	536-43-6				6.1781711116	4	7		0	2.91500849					Cl.CCCCOc1ccc(cc1)C(=O)CCN2CCCCC2	Microsource	01500268	2.3358265	3.1299631	0.34851697	2.1195475	-1.61142973	0.39128004	2.91500849									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018254-08	Bifonazole	170465826	Cytochrome P450 51 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	60628-96-8		6.2237985085	-5.2059444758	-102.4024087934	-2.1	7		-94.2303523455	-85.22977871	0.0000238171	0.9980013209			c1cc(ccc1c2ccccc2)C(c3ccccc3)n4ccnc4	Microsource	01505309	-1.60966282	-2.14283969	-5.85167313	-5.34025635	-17.33492362	-50.00254078	-85.22977871									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094574-15	Fipronil	170465992		DPI_SARS-CoV-2_General	2019_NPC_01	120068-37-3				1.2725030859	4	7		0	-3.16341791					FC(F)(F)S(=O)c1c(N)n(nc1C#N)c2c(Cl)cc(cc2Cl)C(F)(F)F	Microsource	01505354	0.28078329	0	0	0	3.04775922	0.88927283	-3.16341791									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164071-03	Isopropyl tetradecanoic acid	170465683		DPI_SARS-CoV-2_General	2019_NPC_01	110-27-0				-6.3420785564	4	7		0	0					CC(C)OC(=O)CCCCCCCCCCCCC	SIGMA	172472	-0.84477041	-1.70303223	0.09505008	-3.83525221	-2.95132721	0.13720209	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094969-05	Anisindione	170465379	Vitamin K-dependent gamma-carboxylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	117-37-3		15.6334750258	-4.8059444758	-36.9025785212	-2.2	7		-53.7583753473	-42.81767256	0.0001521631	0.9949249526			COc1ccc(cc1)C3C(=O)c2ccccc2C3=O	Microsource	01502198	-0.47684748	-0.21746036	-2.10816212	-1.41219555	-4.41810892	-11.88068499	-42.81767256									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024842-05	Clomethiazole	170466516		DPI_SARS-CoV-2_General	2019_NPC_01	533-45-9				11.7344357046	4	7		0	1.35864744					ClCCc1scnc1C	Tocris	0881	1.63386827	0.92603905	4.81343375	3.4539845	2.45394102	2.53061639	1.35864744									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183597-01	Betamethasone butyrate propionate	144206581		DPI_SARS-CoV-2_General	2019_NPC_02	5534-02-1		11.0676527398	-4.9559444758	-44.9571856971	-2.2	7	Betamethasone butyrate propionate;BETAMETHASONE BUTYRATE PROPIONATE;Antebate;Betamethasone Butyrate Propionate;CIPLUS_213705;	-61.8819150427	-46.50145079	0.0001280974	0.9953460225			CCC(=O)OCC(=O)[C@@]4(OC(=O)CCC)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	APAC	877861	-0.14104372	0.28875696	-0.74775556	0.82547997	-7.81550745	-21.66478767	-46.50145079									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263173-09	Rucaparib		PARP Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	283173-50-2		6.9832167823	-5.1559444758	-80.2555207691	-2.2	7		-87.627431864	-72.60619322	0.0009136145	0.987403063		PARP1	CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=CC(=CC(=C34)[NH]2)F	APExBIO	A8893	2.47173345	0.65836587	-2.58549964	-2.89736454	-19.97243543	-37.66441188	-72.60619322									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00420892-01	NKH477		Adenylate cyclase Activator	DPI_SARS-CoV-2_General	2019_NPC_02					8.5102584001	4	7		0	-3.44860391					CN(C)CCC(=O)OC1C(OC(C)=O)C2(C)OC(C)(CC(=O)C2(O)C3(C)C(O)CCC(C)(C)C13)C=C	Bio Vision	9427-5	2.61046498	4.53463928	1.92447434	2.18646961	3.17230235	0.43216836	-3.44860391									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522027-01	Predocol			DPI_SARS-CoV-2_General	2019_NPC_02	630-67-1				1.0979280227	4	7		0	-6.17419017					C[C@]12C[C@H](O)[C@H]3[C@@H](CCC\4=C\C(=O)\C=C/[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C5=CC(=CC=C5)[S]([O-])(=O)=O	Toronto Research	P703795	2.79544036	-0.27489663	3.36841612	1.37735893	-0.2019818	-0.75159714	-6.17419017									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018241-07	Betamipron	170466040	Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	3440-28-6				6.7383994085	4	7		0	2.85924311			9376	SLC22A8	O=C(NCCC(=O)O)c1ccccc1	Vitas	STK288042	2.91675744	0	0	0	0.96178247	3.69937497	2.85924311									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167473-02	Capreomycin IB	174006669		DPI_SARS-CoV-2_General	2019_NPC_01	33490-33-4				-1.49160807	4	7		0	-0.80099364					NCCC[C@H](N)CC(=O)NC[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC(=O)[C@@H](NC(=O)C(\NC1=O)=C\NC(N)=O)[C@@H]2CCNC(N)=N2	Bosche	C2304	-0.36066129	-0.07574462	-0.03655772	0.07775855	0.96178247	0.01524468	-0.80099364									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00167832-06	Carvedilol tartrate	170465440	beta1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	NOCAS_45916	; carvedilol, 14C-labeled; 8   Carvedilol;Carvedilol; Coreg; carvedilol, (S)-isomer; Carvedilol; carvedilol, (R)-isomer	11.0676527398	-4.9559444758	-45.247610405	-2.2	7		-81.4064662508	-59.02005019	0.0000473839	0.997177389	153	ADRB1	O=C(O)C(O)C(O)C(=O)O.COc4ccccc4OCCNCC(O)COc2cccc3nc1ccccc1c23	Microsource	01504257	4.64986808	4.63508198	2.45911628	1.19647829	-6.96594427	-26.05315311	-59.02005019									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263572-01	Deferasirox	170464723	Iron Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC_01	201530-41-8		13.9333492831	-4.8559444758	-2.3126202087	4	7		-22.554662752	-15.46221896	0.0065937165	0.965019802		CAT	O=C(O)c1ccc(cc1)n3nc(nc3c2ccccc2O)c4ccccc4O	Sequoia	201530-41-8	2.10829521	0	3.49248129	3.95565254	1.78906765	-2.926978	-15.46221896									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091396-05	Benzoin	170465507		DPI_SARS-CoV-2_General	2019_NPC_01	119-53-9				7.2573215252	4	7		0	0.25854858					OC(C(=O)c1ccccc1)c2ccccc2	Vitas	STK358785	2.14218285	3.38896083	0	0.6672185	0	4.06016566	0.25854858									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159486-06	Hippuric acid	170464791	Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	495-69-2				1.9785549839	4	7		0	-0.1520874					O=C(NCC(=O)O)c1ccccc1	Vitas	STK011394	2.50526469	1.26811152	-1.47449489	4.10615296	-1.62158047	-1.75821942	-0.1520874									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018121-07	Proxyphylline	170465953	"3',5'-cyclic phosphodiesterase Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC_01	603-00-9				-44.7305723882	4	7		0	-10.93001445					CC(O)Cn2cnc1c2C(=O)N(C)C(=O)N1C	Microsource	01505915	-9.49095926	-10.37701273	-11.40357291	-10.25660321	-6.31122164	-8.20671782	-10.93001445									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016666-06	Hydrocotarnine hydrobromide	170465806	Cytochrome P450 3A4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	5985-00-2				9.078728873	4	7		0	1.96192745					Br.CN1Cc2c(OC)c3OCOc3cc2CC1	Vitas	STK802005	-0.93675114	2.29921568	2.68333699	2.62121554	2.50977009	2.30194624	1.96192745									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168778-06	Solifenacin (hydrochloride)		Muscarinic acetylcholine receptor M5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	180468-39-7		15.6334750258	-4.8059444758	-17.2796101367	4	7		-14.283808204	-12.31984017	0.0389735236	0.9074809468			O=C(O[C@H]1CN2CCC1CC2)N3CCC4=C(C=CC=C4)[C@@H]3C5=CC=CC=C5	MedChem Express	HY-I0230	-2.17577285	-2.99614221	0.47115633	-3.36038164	-1.74179597	-5.69804585	-12.31984017									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179649-06	Prednisolone	170464732	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC_02	50-24-8	; Prednisolona; Predonine; Delta-cortef;Prednisolone; Prednisolone Pivalate; P21EC cpd; 1-Dehydrohydrocortisone; 1-Dehydrocortisol;Benzo(a)pyrene; Di-Adreson-F;Prednisolone (Hydroretrocortine); Di Adreson; Socketol; Vasocidin; 21-NO-prednisolone; Predate; Prednisolone hexanoate; DiAdreson; Pal-PLS			-19.8021845556	4	7		0	-9.3136089				NRC31	OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick	Prestw-274	-0.99193045	-3.6845388	-3.17151497	-3.94032224	-4.99251479	-4.55655768	-9.3136089									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183872-01	Brotizolam	144207150		DPI_SARS-CoV-2_General	2019_NPC_02	57801-81-7		22.0828704269	-4.6559444758	-10.838259943	4	7	We 941;CIPLUS_183076;2-bromo-4-(2-chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine;brotizolamum;Lendormin;Europharma brand of brotizolam;Sintonal;Boehringer Ingelheim brand of brotizolam;Lindormin;Brotizolam;brotizolam;LS-152570;Lendorm;WE-941;2-BROMO-4-(2-CHLOROPHENYL)-9-METHYL-6H-THIENO(3,2-F)-S-TRIAZOLO(4,3-A)(1,4)DIAZEPINE;Brotizolamum;BROTIZOLAM;Promeco brand of brotizolam;WHO NO. 4549;WE 941;	-28.036769252	-24.19730771	0.0006718427	0.9892481664			Clc4ccccc4C2=NCc1nnc(C)n1c3sc(Br)cc23	Toronto Research	B689280	0	0	0	0	0.185348	2.56482525	-24.19730771									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095838-04	Sumatriptan	170465377	5-HT1B Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	103628-46-2	; ;SUMATRIPTAN; Sumatriptan; Imigran;Sumatriptan succinate;SUMATRIPTAN SUCCINATE; Succinate, Sumatripta; Imitrex			-21.3242746474	4	7		0	-9.90088971			3351	HTR1B	CNS(=O)(=O)Cc1cc2c(cc1)ncc2CCN(C)C	Microsource	01505372	-3.47832401	-2.85630513	-2.14715703	-5.57604033	-4.06790844	-5.02566187	-9.90088971									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253611-01	Isoaminile	170465846		DPI_SARS-CoV-2_General	2019_NPC_01	77-51-0		24.777388143	-4.6059444758	2.6187466018	4	7		-10.425641936	-7.02136828	0.2405046686	0.6922552142			CC(C)C(C#N)(CC(C)N(C)C)c1ccccc1	GVK	FFS-11-286-NCI-202	-2.65533851	3.11530286	0.06092954	2.26503123	3.55529615	2.62208446	-7.02136828									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178024-05	Metaraminol bitartrate	170465256	Adrenergic receptor alpha-1 Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	33402-03-8				14.6861259969	4	7		0	1.6983093					O[C@H](c1cc(O)ccc1)[C@H](C)N.O=C(O)[C@H](O)[C@H](O)C(=O)O	Microsource	01503251	2.6069276	1.91316246	3.20976822	3.15298367	4.42825966	4.50226129	1.6983093									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159450-04	Parethoxycaine	170465538		DPI_SARS-CoV-2_General	2019_NPC_01	94-23-5				-30.6018657148	4	7		0	-11.46232035					CCOc1ccc(cc1)C(=O)OCCN(CC)CC	Specs	AO-365/40892107	-7.33183259	-6.12065385	-6.62669689	-3.30850076	-5.60574532	-6.37227501	-11.46232035									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164584-03	Cetraxate hydrochloride	170465783	Prostaglandin Synthesis and Regulation Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	27724-96-5				-10.0637628091	4	7		0	-7.93389268					Cl.NC[C@H]1CC[C@@H](CC1)C(=O)Oc2ccc(CCC(=O)O)cc2	Sequoia	SRP02040c	1.58545736	0.52532558	-3.77519437	-1.97908044	-1.45409329	-3.26236089	-7.93389268									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015116-13	Aniracetam	170465854	AMPA receptor modulator	DPI_SARS-CoV-2_General	2019_NPC_01	72432-10-1	; ; Aniracetamun; Aniracetam;Aniracetam; Ro 13-5057; 3   Aniracetam			11.8689062176	4	7		0	2.35735469				GRIA1	O=C2CCCN2C(=O)c1ccc(OC)cc1	Enzo	AC439	3.9817975	0	3.59484292	4.969022	0	2.77961279	2.35735469									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179573-03	Tiaprofenic acid	170465577	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	33005-95-7				3.9434609386	4	7		0	0					O=C(c1ccc(s1)C(C)C(=O)O)c2ccccc2	Prestwick Chemical, Inc.	Prestw-496	0	0	4.09690234	1.5401209	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263579-01	rac Nebivolol hydrochloride	170465208	beta1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_02	169293-50-9		6.9832167823	-5.1559444758	-61.126200441	-2.2	7		-33.7757569316	-35.69899634	0.0014336232	0.9841529246		ADRB1	Cl.Fc1cc2CC[C@@H](Oc2cc1)[C@@H](O)CNC[C@H](O)[C@@H]3CCc4cc(F)ccc4O3	Sequoia	99200-09-6	-5.16312516	-8.5726166	-4.93424908	-8.36938475	-11.86940095	-21.78692221	-35.69899634									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178782-04	Dicloxacillin sodium salt monohydrate	170465296	peptidoglycan biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	13412-64-1		11.0676527398	-4.9559444758	-15.7824344264	4	7		-22.687247296	-20.57270608	0.0064860433	0.9652936996			[Na+].O.O=C([O-])[C@@H]3N4C(=O)[C@@H](NC(=O)c2c(C)onc2c1c(Cl)cccc1Cl)[C@H]4SC3(C)C	Microsource	01500238	2.77231844	-1.7302317	-1.30095403	-0.49341721	-0.33029965	-5.89064262	-20.57270608									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091066-01	3-Methylbutyl nitrite	144204625	vasodilation Activator	DPI_SARS-CoV-2_General	2019_NPC_02	110-46-3	Isoamyl nitrite			12.6240333628	4	7	Vaporole;CIPLUS_151172;Isopentyl nitrite-15N;Amyl nitrite;Nitrite, Amy;Amyl Nitrite;Amyl nitrite II;AMYL NITRITE;Isoamyl nitrite;LS-505;Isoamyl nitrite-15N;Isopentyl alcohol, nitrite;Amyl nitrite I;CIPLUS_167285;Isopentyl nitrite;isoamyl nitrite;Aspiral;isopentyl nitrite;AB07944735-01;	0	3.21552585					CC(C)CCON=O	NIEHS	AB07944735	0	3.86472314	4.23571881	3.5989056	3.61428605	0.31942879	3.21552585									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183852-01	Diponium bromide	144206825	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	2001-81-2				-41.7037502386	4	7	Diponium Bromide;diponium iodide;SA-267;triethyl(2-hydroxyethyl)ammonium bromide dicyclopentyl acetate;Diponii bromidum;diponium bromide;DIPONIUM BROMIDE;Dipenine bromide;TRIETHYL(2-HYDROXYETHYL)AMMONIUM BROMIDE DICYCLOPENTYLACETATE;CIPLUS_771421;Ammonium, (2-hydroxyethyl)triethyl-, bromide, dicyclopentylacetate;Unospaston;DIPENINE BROMIDE;Bromuro de diponio;LS-18253;HL 267;2-((dicyclopentylacetyl)oxy)-N,N,N-triethylethanaminium;diponii bromidum;diponium;Dipenine Bromide;Bromure de diponium;Diponium bromide;bromure de diponium;CIPLUS_769588;spaslar;Ethanaminium, 2-((dicyclopentylacetyl)oxy)-N,N,N-triethyl-, bromide, mixt. with (T-4)-bis(((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino)methanesulfonato)magnesium;CIPLUS_214084;	0	-13.38533987					[Br-].CC[N+](CC)(CC)CCOC(=O)C(C1CCCC1)C2CCCC2	Pharmaron	PH-NIH-150206	-7.58630257	-8.1244658	-11.13663533	-6.12445338	-7.5778818	-9.25403983	-13.38533987									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167558-02	Fleroxacin	170466056	Quinoline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	79660-72-3	 Ro 23-6240; ; Ro 23624; Quinodis; Megalocin; Fleroxacin;Fleroxacin; fleroxacin N-oxide; Megalone; Ro 23 624			-0.6938243938	4	7		0	-2.80854731					CN1CCN(CC1)c2c(F)c3c(cc2F)C(=O)C(=CN3CCF)C(=O)O	Prestwick	Prestw-1414	0.20090528	-0.62794732	-0.70921986	-1.24162841	0.96178247	2.55094263	-2.80854731									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018172-09	Indapamide	170465366	Carbonic Anhydrase Type VII Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	26807-65-8	; Veroxil;Indapamide; Indapamida; Lozol;INDAPAMIDE; Natrix; Indapamide Anhydride			12.4002499257	4	7		0	1.61719602			766	CA7	NS(=O)(=O)c1cc(ccc1Cl)C(=O)NN2c3ccccc3CC2C	Microsource	01500349	0.89318132	4.13663352	4.64283103	2.73659919	1.2206263	2.91681488	1.61719602									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00014711-14	Oxaprozin	170464987	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	21256-18-8		17.5410474839	-4.7559444758	4.5111566621	4	7		-14.099756664	-7.99979722	0.0513407471	0.8911468675			OC(=O)CCc1nc(c(o1)c2ccccc2)c3ccccc3	Microsource	01505267	3.58966911	0	4.37474105	3.00248326	1.73831396	-0.10671274	-7.99979722									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167456-02	Bisibutiamine	170466019		DPI_SARS-CoV-2_General	2019_NPC_01	3286-46-2				1.0685228535	4	7		0	-4.51192619					Nc2nc(C)ncc2CN(C=O)C(/C)=C(/CCOC(=O)C(C)C)SSC(/CCOC(=O)C(C)C)=C(/C)N(C=O)Cc1cnc(C)nc1N	Bosche	B6282	3.53157602	0	1.51105262	0	0	0	-4.51192619									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095933-04	Phenyl 4-aminosalicylate	170465273		DPI_SARS-CoV-2_General	2019_NPC_01	133-11-9		12.4181106199	-4.9059444758	-12.1525029497	4	7		-12.9581632879	-12.88180274	0.0462990664	0.8974144803			Oc2cc(N)ccc2C(=O)Oc1ccccc1	Microsource	00305025	-1.1255537	0.63283407	-0.42650679	-3.88541902	0.52530072	-3.42497078	-12.88180274									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167444-04	Cefpiramide (sodium)		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	74849-93-7		11.0676527398	-4.9559444758	-6.9342618576	4	7		-18.932454932	-16.61037911	0.0101226336	0.9560301386			C[N]1N=NN=C1SCC/2=C(/N3[C@H](SC2)[C@H](NC(=O)[C@H](NC(=O)C4=C(O)C=C(C)N=C4)C5=CC=C(O)C=C5)C3=O)C(O)=O	MedChem Express	HY-B0798	0	3.63371757	0	0	2.35487014	-3.37748967	-16.61037911									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522019-01	Polaprezinc			DPI_SARS-CoV-2_General	2019_NPC_02	107667-60-7				-18.0499614769	4	7		0	-6.16943348					O=C1CCN[Zn++]2[O-]C(=O)[C@H](CC3=CN=C[NH]3)[N-]12	Toronto Research	P688000	-1.31563736	-2.39090762	-1.11811725	-4.30512359	-2.38813773	-4.99812101	-6.16943348									5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7	0.0000016599999999	0.00000831								
NCGC00164571-14	Dutasteride			DPI_SARS-CoV-2_General	2019_NPC_02	164656-23-9		3.9269513795	-5.4059444758	-24.7640989528	4	7		-20.763758736	-21.05313228	0.0000265071	0.9978951842			[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)C3CC[C@]12C)C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F	APExBIO	A1659	-0.21040949	-0.47356141	0.4242751	-0.80209527	-2.40239527	-16.09827133	-21.05313228									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262549-02	Ajmaline		Voltage-gated potassium channel subunit Kv4.3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	12/7/4360				-6.0384041143	4	7		0	-7.34433715					CC[C@@H]1[C@@H](O)N2[C@H]3CC1C4[C@@H](O)[C@]5(C[C@@H]24)[C@H]3N(C)C6=CC=CC=C56	Prestwick	Prestw-NAT-0151	2.12952901	0.38115919	0.54616629	-3.31361223	-0.99089894	-1.78504322	-7.34433715									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160624-04	Ethopabate	170466827	folic acid biosynthetic process Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	59-06-3				1.4841084839	4	7		0	-0.87703734					CCOc1cc(ccc1C(=O)OC)NC(C)=O	SIGMA	00275	2.01147339	1.35607301	-1.37213326	-1.46236235	0.8907273	1.42791809	-0.87703734									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263909-02	Tadalafil	170464819	Phosphodiesterase V (PDE5) inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	171596-29-5		15.6334750258	-4.8059444758	-6.2173219316	4	7		-25.238954648	-19.36579554	0.0124780503	0.9507239088		PDE5A	O=C6N(C)CC(=O)N4[C@@H]6Cc1c5ccccc5nc1[C@H]4c2ccc3OCOc3c2	Microsource	01505639	2.81993561	-1.43914775	1.19665619	4.40715379	1.04298838	-2.22572285	-19.36579554									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095748-04	3-(Octadecyloxy)-1,2-propanediol	170465730		DPI_SARS-CoV-2_General	2019_NPC_01	544-62-7				-4.0792663702	4	7		0	-1.30288206					OC(CO)COCCCCCCCCCCCCCCCCCC	Microsource	01503983	-3.77363058	-0.33474235	-2.22027248	-1.00584443	4.18464193	-1.81919813	-1.30288206									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017358-15	Rotenone	170466816	NADH-Ubiquinone Oxidoreductase (Complex I) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	83-79-4	;ROTENONE;Rotenone	4.4061119169	-5.3559444758	-92.2154919856	-2.2	7		-82.8228181759	-74.85234848	0.0000035901	0.9992256173	51103	NDUFAF1	C=C(C)[C@@H]2Oc3ccc1C(=O)[C@H]4c5cc(OC)c(OC)cc5OC[C@H]4Oc1c3C2	Microsource	00200013	-1.1788057	-0.13438561	0.34364261	-4.96400532	-18.62914277	-50.96803699	-74.85234848									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159372-04	Butanedioic acid	170465738		DPI_SARS-CoV-2_General	2019_NPC_01	110-15-6				11.2143037227	4	7		0	-1.11023802					O=C(O)CCC(=O)O	Labotest	LTBB001662	3.27499818	3.98025753	1.11379201	4.11116964	2.32198142	2.18507038	-1.11023802									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274268-01	NCGC00274268-01	225144369		DPI_SARS-CoV-2_General	2019_NPC_01			15.6334750258	-4.8059444758	-5.998982742	4	7		-25.2207041599	-19.3505868	0.0012759866	0.9850923915			CCCCCCCC\C=C\CCCCCCCC(=O)NCCOC(=O)CC(C([O-])=O)[S]([O-])(=O)=O	GVK	FFS-11-286-NCI-103	0.10408346	1.34629951	3.30238113	2.05433065	1.30690758	-2.09868388	-19.3505868									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532495-01	Sizofilan			DPI_SARS-CoV-2_General	2019_NPC_02					11.0366884126	4	7		0	0.01902678					OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O[C@@H]3[C@@H](O)[C@H](O)O[C@H](CO)[C@H]3O)[C@H](O)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O	Kemprotec	TC838	0	4.18813093	4.91549659	1.55508266	3.37666041	1.7380684	0.01902678									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00484056-01	Testosterone (undecanoate)			DPI_SARS-CoV-2_General	2019_NPC_02	5949-44-0				6.6740640772	4	7		0	-3.75778909					CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC/4=C/C(=O)CC[C@]4(C)[C@H]3CC[C@]12C	MedChem Express	HY-B0626	2.62433813	2.23844395	3.04493566	4.36124687	1.59922059	-1.40454716	-3.75778909									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389304-01	Clindamycin Phosphate		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	24729-96-2				-0.0754370151	4	7		0	-0.44712933					CCCC1CC(N(C)C1)C(=O)NC(C(C)Cl)C2OC(SC)C(O[P](O)(O)=O)C(O)C2O	APExBIO	B1708	-0.06705357	0.21021507	-0.19924521	0.43261698	1.92714398	-1.91187523	-0.44712933									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00166236-02	Oteracil potassium		Orotate Phosphoribosyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	2207-75-2				-59.0940332598	4	7		0	-10.27096905				UMPS	OC1=NC(=NC(O)=N1)C([O-])=O	Bosche	O3085	-6.74121947	-6.79991204	-8.56181911	-11.73150726	-9.7827742	-7.17007978	-10.27096905									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00263559-01	Carbocysteine	170465800	regulation of mucus secretion Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	2387-59-9				5.105491358	4	7		0	0					OC(=O)C(N)CSCC(O)=O	Bosche	S0868	2.3309854	0	1.12597792	0	1.07597828	2.84567305	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016697-04	Trimetazidine dihydrochloride	170465797	"Trifunctional enzyme subunit beta, mitochondrial Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC_01	13171-25-0				0	4	7		0	0			3032	HADHB	Cl.Cl.COc2ccc(CN1CCNCC1)c(OC)c2OC	Vitas	STK315643	0	0	0	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016737-04	Epirizole	170465827		DPI_SARS-CoV-2_General	2019_NPC_01	18694-40-1				6.939928995	4	7		0	2.43339839					Cc1cc(nc(n1)n2nc(C)cc2OC)OC	Prestwick	Prestw-32	1.27078644	-2.56310015	1.48424362	2.48074849	3.77861239	1.68199604	2.43339839									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016383-05	Trimethadione	225144178	Voltage-gated T-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	127-48-0				12.6063852422	4	7		0	0.4562622					CN1C(=O)OC(C)(C)C1=O	Prestwick	Prestw-515	4.3642437	2.82209788	4.69644903	3.09780019	0	2.84567305	0.4562622									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091034-10	Captan	225144202		DPI_SARS-CoV-2_General	2019_NPC_02	133-06-2				-5.8682912609	4	7		0	-6.18846026					ClC(Cl)(Cl)SN1C(=O)C2C\C=C/CC2C1=O	SIGMA	32054	1.38500312	-0.40425974	-0.90715173	1.22769684	-0.75802581	-4.22773393	-6.18846026									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015219-07	Choline Chloride			DPI_SARS-CoV-2_General	2019_NPC_02	67-48-1				3.2846537762	4	7		0	2.70655948					C[N+](C)(C)CCO	Selleck	S4171	0.08555111	0.81082954	2.66519772	-0.57292519	1.96041157	-1.63472379	2.70655948									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00481544-01	Cetrorelix		Gonadotropin-releasing hormone receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02			6.0306904668	-5.2196329617	-63.7375611164	-2.2	7		-65.5470912772	-50.03567521	0.0004427574	0.9912887471			CC(C)C[C@H](\N=C(/O)[C@@H](CCCNC(O)=N)\N=C(/O)[C@H](CC1=CC=C(O)C=C1)\N=C(/O)[C@H](CO)\N=C(/O)[C@@H](CC2=CN=CC=C2)\N=C(/O)[C@@H](CC3=CC=C(Cl)C=C3)\N=C(/O)[C@@H](CC4=CC5=CC=CC=C5C=C4)\N=C(\C)O)/C(O)=N/[C@@H](CCCNC(N)=N)C(=O)N6CCC[C@H]6\C(O)=N\[C@H](C)C(O)=N	APExBIO	B4975	2.66133321	-2.05363949	-2.49173718	0.09587728	-6.38975358	-22.48214957	-50.03567521									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00386257-02	Aclidinium (Bromide)		Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	320345-99-1		15.6334750258	-4.8059444758	-51.8418998326	-2.2	7		-34.273417128	-32.23136565	0.0037790791	0.9738473281			OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C4=CC=CS4)C5=CC=CS5	MedChem Express	HY-14144	-7.73428287	-5.41708055	-4.92018471	-9.71634357	-7.37352375	-14.94269072	-32.23136565									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182034-01	Teprenone	144206513	Heat shock 70 kDa protein 1 Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	6809-52-5	Teprenone; Selbex; Teprenona; 	3.1192883571	-5.5059444758	-84.1923950511	-2.2	7	CIPLUS_165824;tetraprenylacetone;geranyl-geranyl-acetone;Teprenone;teprenonum;Selbex;LS-174701;teprenon;TEPRENONE;LS-174702;Teprenona;geranylgeranylacetone, (Z,E,E)-isomer;6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one;CIPLUS_3885398;LS-96803;tetraprenyl acetone;geranylgeranylacetone;Teprenonum;geranylgeranylacetone, (E,E,E)-isomer;teprenone;	-78.5702563876	-72.27798126	0.0000111194	0.9986358			C/C(C)=C\CCC(\C)=C\CCC(\C)=C\CCC(C)=CCCC(C)=O	ACC	TEPRENONE	1.06129621	1.70713114	4.1935257	0	-17.25399805	-55.63697858	-72.27798126									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185003-01	NCGC00185003-01	124896579		DPI_SARS-CoV-2_General	2019_NPC_02			13.9333492831	-4.8559444758	-53.137304811	-2.2	7	PPIX;NCGC00094273-03;3,7,12,17-Tetramethyl-8,13-divinyl-2,18-porphinedipropionic acid;protoporphyrin IX;NCGC00094273-02;NCGC00094273-01;CIPLUS_213719;Ooporphyrin disodium salt;Cobalt Protoporphyrin;Protoporphyrin disodium;CIPLUS_732479;Ooporphyrin;Prolmon;Protoporphyrin IX disodium salt;PROTOPORPHYRIN IX;Protoporphyrin;Protoporphyrin IX;NCGC00015844-01;NCGC00162303-01;Zinc ionophore II;3,7,12,17-Tetramethyl-8,13-divinyl-2,18-porphinedipropionic acid disodium salt;PROTOPORPHYRIN DISODIUM;NCGC00166283-01;Kammerer's porphyrin;NCGC_FLUKA_30157;MgProto;CIPLUS_154404;CIPLUS_744647;Mg protoporphyrin;Protoporphyrin IX disodium;divinyl-Mg-protoporphyrin;protoporphyrin IX, disodium salt;protoporphyrin IX dihydride;magnesium protoporphyrin;CIPLUS_736051;Depocolin-S;Protoporphyrin Disodium;	-92.7149788323	-69.48104457	0.0007632914	0.9885070733			CC1=C2[NH]C(=C1C=C)C=C\3N=C(C=C\4N=C(C=C5[NH]C(=C2)C(=C5C)C=C)\C(=C4CCC([O-])=O)C)\C(=C3C)CCC([O-])=O	FLUKA	30157	4.37697981	0	1.31970652	0.92837266	-8.34778889	-21.75873732	-69.48104457									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159354-06	BORNYL ACETATE			DPI_SARS-CoV-2_General	2019_NPC_02	76-49-3				12.3002868155	4	7		0	4.31432241					CC(=O)OC1CC2CCC1(C)C2(C)C	Microsource	01502510	3.73419039	-0.43198041	4.68577858	2.27065454	4.19884514	0	4.31432241									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016914-06	CEFOTETAN		Bacterial Penicillin-binding Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	6971256-7				13.8893311309	4	7		0	-2.37359083					CO[C@]2(NC(=O)C1SC(S1)=C(C(N)=O)C(O)=O)[C@H]3SCC(CSC4=NN=NN4C)=C(N3C2=O)C(O)=O	Microsource	01502424	2.43011399	4.71482363	4.2966644	2.21920819	3.31012523	4.76794438	-2.37359083									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015043-10	GABA	225144171	GABA-A receptor; anion channel Activator	DPI_SARS-CoV-2_General	2019_NPC_01					12.9837488549	4	7		0	2.33200679					NCCCC(O)=O	Vitas	STK301748	2.63113306	2.42627117	2.64921645	3.09278351	2.49454398	3.73494588	2.33200679									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00178395-04	Piperidolate hydrochloride	170465927		DPI_SARS-CoV-2_General	2019_NPC_01	129-77-1				5.2260314043	4	7		0	-0.5323059					Cl.CCN3CCCC(OC(=O)C(c1ccccc1)c2ccccc2)C3	Prestwick Chemical, Inc.	Prestw-1055	0	0	0	2.91719969	3.08328681	1.88017684	-0.5323059									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162129-06	Tocainide hydrochloride	170465114	Sodium channel alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	35891-93-1				6.0715267645	4	7		0	0					Cl.O=C(Nc1c(C)cccc1C)C(C)N	Prestwick	Prestw-1027	4.60145717	-0.08063137	1.8449465	1.18142825	-0.14972339	1.43299964	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167464-02	Hydrocortisone Sodium Phosphate	225144288		DPI_SARS-CoV-2_General	2019_NPC_02	6000-74-4				-1.9778578416	4	7		0	1.99781192					C[C@]\12CCC(=O)\C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO[P]([O-])([O-])=O)[C@@]4(C)C[C@H](O)[C@H]23	Bosche	H6475	0	0	2.40266285	-16.18455207	4.38894565	4.19015408	1.99781192									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00178520-03	Bromhexine hydrochloride	170465803	Mucolytic Agent	DPI_SARS-CoV-2_General	2019_NPC_02	611-75-6	; Amiorel;abiadin;Bromhexine hydrochloride;Bromhexine HCl;BROMHEXINE HYDROCHLORIDE; Amyorel	13.9333492831	-4.8559444758	-21.2983947773	-3	7		-53.1685772692	-51.02506778	0.0000489386	0.9971315983			Cl.CN(Cc1cc(Br)cc(Br)c1N)C2CCCCC2	Vitas	STK177356	2.12028024	3.13936566	0.57898315	2.25194678	0	0	-51.02506778									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179384-10	Chlorcyclizine		Hepatitis C virus Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	GRT00368		13.9333492831	-4.8559444758	-13.7438001257	4	7		-21.492936308	-16.24411359	0.0699424908	0.8679509521			CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(Cl)C=C3	SIGMA	SMl1473	2.11565585	3.1162651	-3.98724831	-1.98068424	-0.83406601	-5.76850808	-16.24411359									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249908-01	Mefenorex	170465601		DPI_SARS-CoV-2_General	2019_NPC_02	17243-57-1		11.0676527398	-4.9559444758	-16.5996858804	-3	7		-39.351186792	-32.79265566	0.0011360543	0.9859291862			CC(NCCCCl)Cc1ccccc1	GVK	FFS-11-286-NCI-140	4.18738006	3.49973434	-0.66336935	1.30252789	1.53268541	-8.7373168	-32.79265566									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167465-02	Calcipotriene	170464710	Vitamin D receptor Activator	DPI_SARS-CoV-2_General	2019_NPC_02	112965-21-6		3.1192883571	-5.5059444758	-32.4215615532	4	7		-29.457722664	0	0.0005960449	0.9968540242			C=C1C(/C[C@@H](O)C[C@@H]1O)=C\C=C2/CCC[C@]3(C)[C@H](CC[C@@H]23)[C@H](C)/C=C/[C@@H](O)C4CC4	Prestwick Chemical, Inc.	Prestw-1257	0.24971676	0	0	1.67668311	-0.86258109	-27.04810222	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00261973-01	Butoctamide semisuccinate	170466034		DPI_SARS-CoV-2_General	2019_NPC_02	32838-28-1	Butoctamide hydrogen succinate, monosodium salt;Butoctamide			-1.5927856387	4	7		0	-1.19393046					CC(CC(=O)NCC(CC)CCCC)OC(=O)CCC(=O)O	GVK	FFS-11-286-NCI-226	-0.54798955	-0.60292453	-1.53067204	0.81144915	-2.0459568	2.52254791	-1.19393046									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178220-05	Dipyrone	170465672	Prostaglandin G/H synthase 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	68-89-3				-33.7400850953	4	7		0	-11.98687152			5742	PTGS1	[Na+].[O-]S(=O)(=O)CN(C)C=2C(=O)N(c1ccccc1)N(C)C=2C	Vitas	STK177347	-8.90887651	-3.98484603	-5.08895713	-8.23375348	-6.79371718	-6.5013153	-11.98687152									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166322-02	PROTIRELIN		Thyrotropin-releasing hormone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	24305-27-9				-0.419622827	4	7		0	-3.65789849					NC(=O)C1CCCN1C(=O)C(CC2=CN=C[NH]2)NC(=O)C3CCC(=O)N3	Microsource	01506101	2.04629009	0.2656564	-0.69149809	-0.54954049	-0.29227954	1.4468245	-3.65789849									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181029-01	1,2-Ditetradecanoyl-rac-glycerol-3-phosphocholine	144206232	Apolipoprotein A-I Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_02	18656-38-7	1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE; 	7.8352981002	-5.1059444758	2.9913872765	4	7	L-beta,gamma-Dimyristoyl-alpha-lecithin;L-LECITHIN, BETA,GAMMA-DIMYRISTOYL;DL-beta,gamma-Dimyristoyl-alpha-lecithin;9   Dimyristoyl-L-3-Lecithin;3-sn-Phosphatidylcholine, 1,2-dimyristoyl;1,2-Dimyristoyl-sn-glycero-3-phosphocholine;1,2-Ditetradecanoyl-rac-glycerol-3-phosphocholine;Dimyristoylphosphatidylcholine;1,2-Dimyristoyl-rac-glycero-3-phosphocholine;DMPC;CIPLUS_670039;DL-alpha-Dimyristoyl-phosphatidylcholine;CIPLUS_168945;rac-Phosphatidylcholine, 1,2-dimyristoyl;1,2-Ditetradecanoyl-sn-glycero-3-phosphocholine;DIMYRISTOYL LECITHIN;DIMYRISTOYL PHOSPHATIDYLCHOLINE;1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE;CIPLUS_664335;3,5,9-Trioxa-4-phosphatricosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-((1-oxotetradecyl)oxy)-, inner salt, 4-oxide;	-11.118037392	-8.01503116	0.1146636528	0.8195998196			C[N+](C)(C)CCOP([O-])(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC	SigmaAldrich	P7930	0	0	4.49825367	4.52493978	3.21982748	-1.9212702	-8.01503116									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185765-02	Encainide hydrochloride		Sodium channel protein type V alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	66794-74-9				-11.0345064687	4	7		0	-4.25248537					COC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2CCC3CCCCN3C	SIGMA	E9156	-0.52024324	-4.0911086	-1.29157779	-1.88246849	-2.35487014	-2.45678316	-4.25248537									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160673-01	Propicillin	144205529		DPI_SARS-CoV-2_General	2019_NPC_02	551-27-9	Propicillin; Levopropylcillin; Propicilina; 	22.5978289027	-4.6459332839	-2.5788715866	4	7	Propicillinum;CIPLUS_782900;Propicillin;levopropicillinum;levopropicilline;LS-175596;CIPLUS_750386;Propicilina;CIPLUS_206990;PROPICILLIN POTASSIUM;Propicillin potassium;LS-175076;CIPLUS_669806;Levopropylcillin Potassium;propicilline;Propicilline;brocillin;propicillin;propicillinum;Propicillin Potassium;alpha-phenoxy propylpenicillin;LS-174659;Levopropylcillin potassium;Levopropylcillin;PROPICILLIN;	-24.22720354	-20.60600295	0.0025095956	0.9788719954			OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)C(CC)Oc1ccccc1)[C@H]3SC2(C)C	Vitas	STK177353	2.52722606	-0.05313128	1.20250346	3.9356453	1.42337761	-3.4479519	-20.60600295									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00263910-02	Aminopentamide sulfate	170466283	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	20701-77-3				-22.2104733154	4	7		0	-7.36103014					O=S(=O)(O)O.NC(=O)C(CC(C)N(C)C)(c1ccccc1)c2ccccc2	Microsource	01505650	-4.25773969	-4.03889853	-5.49097024	-5.55597361	-2.59097599	-4.42095635	-7.36103014									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183856-01	Phenyl 11-iodo-10-undecynoate	144206805		DPI_SARS-CoV-2_General	2019_NPC_01	2020-25-9		1.5633475026	-5.8059444758	-33.4768952002	4	7	Phenyliodoundecynoate;PHENYLIODOUNDECYNOATE;CIPLUS_3885239;CIPLUS_3845000;10-UNDECYNOIC ACID, 11-IODO-, PHENYL ESTER;11-IODOUNDECYNOIC ACID PHENYL ESTER;002020259;	-22.0261192079	-16.15168183	0.0539709155	0.8869300688			O=C(Oc1ccccc1)CCCCCCCCC#CI	Pharmaron	PH-NIH-102558	1.71616682	-0.42270384	-0.28515025	-1.20651165	-7.11820535	-28.35509934	-16.15168183									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159351-05	Cholesterol	225144221	Transient receptor potential cation channel subfamily V member 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	57-88-5		5.3748585361	-5.2696329617	-18.4365522082	-2.4	7		-32.3082938319	-27.34024486	0.0014427751	0.9841012002	7442	TRPV1	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C\C=C/4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	SIGMA	362794	0	3.94116353	1.44037435	4.07605288	2.1443435	-5.57955181	-27.34024486									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00091596-05	Octadecanoic acid	170465630		DPI_SARS-CoV-2_General	2019_NPC_01	57-11-4				3.2521124554	4	7		0	-2.17484981					O=C(O)CCCCCCCCCCCCCCCCC	Specs	AE-562/J263018	1.66775591	-1.80565397	2.68333699	1.25166178	1.40333959	1.14335078	-2.17484981									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016611-10	Bufexamac	170465813	non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC_01	2438-72-4	; ; 7   Bufexamac; Anderm; Droxarol; Bufexamaco;BUFEXAMAC; Bufexamac;Bufexamac	0.0027800687	-8.5559444758	-31.0369959415	4	7		-7.6732281559	-12.47116676	0.4876137131	0.397858366		PTGS1	ONC(=O)Cc1ccc(OCCCC)cc1	Microsource	01502003	-1.49347663	-10.39167298	-4.15052034	-5.47570672	-7.44810435	-6.08770771	-12.47116676									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182980-01	Fominoben hydrochloride	144206774		DPI_SARS-CoV-2_General	2019_NPC_02	24600-36-0	Fominoben; Noleptan; 			5.239070309	4	7	Fominoben;fominoben;Noleptan;VNC-3;LS-173706;fominobene;CIPLUS_3734982;fominobenum;Fominobenum;3'-CHLORO-1-(METHYL((MORPHOLINOCARBONYL)METHYL)-AMINO)-O-BENZOTOLUIDIDE;Fominobene;FOMINOBEN;CIPLUS_171289;PB-89;	0	-4.98501641					Cl.O=C(CN(C)Cc2c(NC(=O)c1ccccc1)cccc2Cl)N3CCOCC3	NCI	NSC_293901	3.54921501	0.76924854	-0.58367127	1.21366602	4.0752798	2.34874107	-4.98501641									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021305-19	Sirolimus		mTOR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	(53123-88-9)		2.4777388143	-5.6059444758	-85.3932965378	-2.2	7		-81.0272558688	-70.47519384	0.0002379146	0.9936371984		MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	SynKinase	SYN-1185	0.22659483	4.64090185	4.60608049	0.16135444	-25.13366442	-53.53720406	-70.47519384									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386239-01	Mirabegron		Beta-3 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	223673-61-8		8.7913490634	-5.0559444758	-50.3085558521	-2.2	7		-82.5919707047	-73.93331114	0.0000905771	0.996090045			NC1=NC(=CS1)CC(=O)NC2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2	Selleck	S4009	0.41157021	0	3.85598087	3.41182798	2.76358625	-26.64411875	-73.93331114									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182042-04	Propylhexedrine (hydrochloride)		Trace amine-associated receptor 1 Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	1007-33-6				-37.0338061735	4	7		0	-9.94624935					CNC(C)CC1CCCCC1	Cayman	12058	-8.70540359	-5.98073414	-6.92201308	-8.14489161	-6.04282014	-10.27339346	-9.94624935									3.19E-9	1.59E-8	7.9699999999E-8	3.99E-7	0.00000199	0.00000997	0.0000498								
NCGC00181306-04	Docetaxel	170464919	Tubulin depolymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	114977-28-5	 Docetaxolum; Docetaxel Hydrate; ; AE-docetaxel;DOCETAXEL; 5   Docetaxel; Docetaxel hydrate; Docetaxel Anhydrous; Docetaxel Trihydrate; Docetaxel;Docetaxel; Taxoltere metro	12.4181106199	-4.9059444758	-46.9886689194	-2.2	7		-57.6363982324	-45.17908957	0.0007323624	0.9887510265	203068	TUBB	CC(C)(C)OC(=O)N[C@@H](c1ccccc1)[C@@H](O)C(=O)O[C@H]5C[C@@]6(O)[C@@H](OC(=O)c2ccccc2)[C@H]4[C@@](C)([C@@H](O)C[C@H]3OC[C@]34OC(C)=O)C(=O)[C@H](O)C(=C5C)C6(C)C	Alfa Aesar	J60174	-1.78270018	1.037215	-1.54473641	-5.41355845	-6.00480004	-19.4992484	-45.17908957									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165767-04	Cyclofenil	170465970	Estrogen receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	2624-43-3		11.0676527398	-4.9559444758	-31.3810423777	-2.2	7		-45.5003091863	-41.28811302	0.0019330364	0.9815074841	2100	ESR2	CC(=O)Oc1ccc(cc1)C(/c2ccc(OC(C)=O)cc2)=C3/CCCCC3	Tocris	3999	4.0856436	-2.30774562	-1.78851879	-1.21366602	-0.34455718	-12.0537392	-41.28811302									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182977-01	Trimethoquinol	144206771	Beta-3 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	18559-59-6	Tretoquinol; Tetroquinol; Trimetoquinol; Inolin; Tretoquinol-(S) HCl; Tretoquinol-(R); 			-4.8192104118	4	7	CIPLUS_207808;AQ11;1,2,3,4-TETRAHYDRO-1-(3,4,5-TRIMETHOXYBENZYL)-6,7-ISOQUINOLINEDIOL MONOHYDRATE HYDROCHLORIDE;TRETOQUINOL;Tretoquinol Hydrochloride, (S)-Isomer;CIPLUS_169251;Inolin;6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((3,4,5-trimethoxyphenyl)methyl)-, (S)-;TETRAHYDROISOQUINOLINE;tretoquinol;Trimetoquinol hydrochloride;6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((3,4,5-trimethoxyphenyl)methyl)-, hydrochloride, (S)-;AQ-110;Tetroquinol;Trimetoquinol Hydrochloride Anhydride;Tretoquinolum;AQL 20;Tretoquinol;Tretoquinol-(S) HCl;LS-173897;AQ 11;Trimetoquinol;LS-85640;CV 70;Tretoquinol-(R);CIPLUS_171514;CIPLUS_171515;Trimetoquinol Hydrochloride;tretoquinolum;AQL-208;CV-705;CIPLUS_171513;TRIMETOQUINOL HYDROCHLORIDE;l-trimetoquinol;AQL20;CV70;	0	-7.12552918					Cl.COc1cc(cc(OC)c1OC)C[C@@H]2NCCc3cc(O)c(O)cc23	NCI	NSC_288748	1.40812504	-2.48792996	-1.1696866	1.77022192	-0.53941021	-0.45565577	-7.12552918									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024257-08	Phenylephrine hydrochloride	170465356	alpha1-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	61-76-7	; Naldecon; Neosynephrine; Metaoxedrin;Phenylephrine hydrochloride; Glauko-Biciron; ; Neo Synephrin; Neooxedrine chloride;PHENYLEPHRINE HYDROCHLORIDE; Neo-synephrine; dimotapp L.A.; Metasympatol; Fenilefrina; (-)-m-Oxedrine; Tannate, Phenylephrin; Neo-Synephrine; Phenylephrine Hcl; Mezaton; Dimetapp; Ru-Tuss; Phenylephrine hydrochloride			5.3492888754	4	7		0	0			148	ADRA1A	Cl.O[C@@H](CNC)c1cc(O)ccc1	Microsource	01500483	4.93549246	0	0	0	2.87519667	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015769-32	Ouabain octahydrate			DPI_SARS-CoV-2_General	2019_NPC_01	11018-89-6				2.7575408263	4	7		0	2.36749385					C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O	Enzo	CM109	0.39454893	3.04688836	-0.67509932	-1.02591115	1.20032482	-0.76731541	2.36749385									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016850-15	Bezafibrate	170465743	Peroxisome proliferator-activated receptor gamma Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	41859-67-0				10.8495656097	4	7		0	1.20149046					O=C(NCCc1ccc(OC(C)(C)C(=O)O)cc1)c2ccc(Cl)cc2	Microsource	01502046	0.38486675	1.88384196	3.15615023	4.11618632	2.4742425	2.61192134	1.20149046									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015469-09	Guanfacine hydrochloride	170465381	Alpha-2a adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	29520-14-7				-25.3315764015	4	7		0	-10.86410991					Cl.Clc1cccc(Cl)c1CC(=O)NC(=N)N	Enzo	AR102	-4.55304626	-1.61995749	-3.54609929	-6.51917626	-5.32152464	-6.63143452	-10.86410991									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00387301-01	Timiperone		serotonin receptor signaling pathway Modulator	DPI_SARS-CoV-2_General	2019_NPC_02			9.8640558873	-5.0059444758	-40.6063875089	-2.2	7		-74.2408552551	-63.44004186	0.0000573356	0.9968935302			FC1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)N3C(=S)NC4=C3C=CC=C4	Toronto Research	T443110	3.4937224	0	4.31541689	3.06105746	1.29030725	-22.29894776	-63.44004186									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168777-04	Etonogestrel		contraceptive	DPI_SARS-CoV-2_General	2019_NPC_02	54048-10-1				-31.1898414976	4	7		0	-13.78014555					CC[C@]12CC(=C)[C@H]3[C@@H](CCC/4=C/C(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	MedChem Express	HY-B0652	-3.9376633	-4.53001917	-5.3936851	-6.71842481	-7.49233657	-6.28053363	-13.78014555									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00507775-01	Midecamycin Acetate		Ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	55881-07-7		11.0676527398	-4.9559444758	-34.1598922846	-2.2	7		-65.4681539327	-47.32435904	0.0000244302	0.9979762612			CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@H](OC(C)=O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@](C)(OC(C)=O)[C@H](OC(=O)CC)[C@@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC	AvaChem	2845	4.71918426	2.81133775	2.40735098	1.04997311	-3.28161015	-20.73938369	-47.32435904									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00264110-02	AN-2690			DPI_SARS-CoV-2_General	2019_NPC_02	174671-46-6				4.4606823156	4	7		0	-4.0336774					OB1OCC2=CC(=CC=C12)F	MedChem Express	HY-10980	3.48909801	2.7882372	0	2.47643991	1.67526079	-0.89252161	-4.0336774									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181135-02	Pentamycin	144206785		DPI_SARS-CoV-2_General	2019_NPC_02	6834-98-6	Pentamycin; 	5.5469662594	-5.2559444758	-53.7673778284	-2.2	7	lagosin;NSC-277813;CIPLUS_3864474;PENTAMYCIN;fungichromin;pentamycin;LS-69889;Pentamycin;cogomycin;CIPLUS_215789;	-51.5290396202	-46.07810493	0.0004932637	0.9907983245			CCCCC[C@@H](O)C1C(=O)OC(C)[C@H](O)C=CC=CC=CC=CC=C(C)C(O)C(O)C(O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O	NCI	NSC-276732	-1.08904252	-1.36986301	-2.34640538	1.31188177	-10.48641969	-28.23186772	-46.07810493									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386200-02	Vildagliptin		Dipeptidyl peptidase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	274901-16-5				6.9788925007	4	7		0	2.3069971					OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N4CCC[C@H]4C#N	Axon Medchem	1631	0	0	2.9089801	1.16221968	1.83209372	2.33934611	2.3069971									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183128-07	Ammonium Glycyrrhizinate			DPI_SARS-CoV-2_General	2019_NPC_02	1407-03-0				5.791677238	4	7		0	1.02268944					[H][C@@]7(O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@]1([H])O[C@H]2CC[C@@]3(C)[C@@]([H])(CC[C@]4(C)[C@]3([H])C(=O)C=C5[C@]6([H])C[C@](C)(CC[C@]6(C)CC[C@@]45C)C(O)=O)C2(C)C)C(O)=O)O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)C(O)=O	Selleck	S2376	0	0	4.56388739	3.85613731	0	-0.91131154	1.02268944									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016323-09	Sulfachloropyridazine	170466574	Salmonella Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	80-32-0				2.9573139082	4	7		0	0					O=S(=O)(Nc1ccc(Cl)nn1)c2ccc(N)cc2	Microsource	01501142	0	0	0	0	0	4.23293867	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262929-01	BIBR-1048	170466107	Thrombin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	211915-06-9	Bibr 1048;BIBR-1048 (Dabigatran);3-((2-((4-Amino((e)-hexyloxycarbonylimino)methyl)-phenylamino)methyl-1-1h-benzoimidazole-5-carbonyl)pyridin-2-yl-amino)propionic acid ethyl ester;Dabigatranum etexilatum;Dabigatran etexilate; Dabigatran etexilate	6.2237985085	-5.2059444758	-59.587850751	-2.2	7		-68.2621733296	-62.27979012	0.0003051667	0.9927843045		F2	O=C(OCCCCCC)\N=C(\N)c1ccc(cc1)NCc3nc2cc(ccc2n3C)C(=O)N(CCC(=O)OCC)c4ccccn4	GVK	FFS-12-73-NCI-1548	3.24111055	3.91672979	-0.89444566	-2.34529812	-7.81353093	-34.28527872	-62.27979012									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015245-10	Bethanechol chloride	170464912	Muscarinic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	590-63-6	; ;Carbamyl-b-Methylcholine Cl; Urecholine; Bethanechol chloride;BETHANECHOL CHLORIDE;Bethanechol chloride			7.1756549856	4	7		0	3.02653925				CHRM2	[Cl-].C[N+](C)(C)CC(C)OC(=O)N	Enzo	AC912	2.86834653	0	4.09202798	0	1.14957113	-0.04065247	3.02653925									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166409-02	Sodium 2,3-dimercaptopropanesulfonate monohydrate	225144282	reactive oxygen species metabolic process Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	207233-91-8				-14.653871253	4	7		0	-5.81268135					O.[Na+].[O-][S](=O)(=O)CC(S)CS	SIGMA	38530	-2.51797729	-6.11009725	-3.96380769	0.19409302	-0.62495545	-3.63585118	-5.81268135									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015321-11	Dobutamine	170465050	beta1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	34368-04-2	 ; Dobutamine, (-)-Isomer;Dobutamine hydrochloride; Dobutamine hydrochloride;Dobutamine; Dobutamina; Dobutaminum; Dobutamine HCl; Dobutamine (+)-Isomer	11.0676527398	-4.9559444758	-62.2261905112	-2.2	7		-91.2738587144	-69.90443842	0.000038812	0.9974463986	153	ADRB1	Oc2ccc(CCNC(C)CCc1ccc(O)cc1)cc2O	Tocris	0515	0	3.39873433	0	0	-8.50378115	-31.2007724	-69.90443842									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160398-05	Nafamostat mesilate	170465855	Tryptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	82956-11-4	 Nafamostat mesylate; Ronastat; ;;Nafamostat mesylate	15.6334750258	-4.8059444758	-3.4002236421	4	7		-25.559592908	-15.88299409	0.0133310746	0.9489608603	7177	TPSAB1	CS(=O)(=O)O.N=C(N)Nc1ccc(cc1)C(=O)Oc2ccc3cc(ccc3c2)C(=N)N	Enzo	PI143	1.93401593	2.08908544	3.12690405	4.97905536	-1.38303812	-3.57233599	-15.88299409									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168085-05	Vorinostat (SAHA)	170465180	HDAC Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	149647-78-9	 ;MK-0683;SAHA; SAHA cpd; Vorinostat;Vorinostat; M344 compound;Zolinza			8.2990985895	4	7		0	-0.97335936			3065	HDAC1	O=C(Nc1ccccc1)CCCCCCC(=O)NO	Prestwick Chemical, Inc.	Prestw-1362	1.47411226	1.04332103	0	4.15631976	4.06283307	1.92082931	-0.97335936									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091297-05	Anilinium nitrate	170465650		DPI_SARS-CoV-2_General	2019_NPC_01	542-15-4		12.4181106199	-4.9059444758	4.4554652767	4	7		-18.093470384	-14.66122532	0.0115413878	0.9528078485			O[N+]([O-])=O.[NH3+]c1ccccc1	Vitas	STK301792	3.8172004	4.06821902	3.57534547	0	4.4536365	1.64134356	-14.66122532									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00184994-02	Cidofovir	225144336	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	113852-37-2	Cidofovir;CIDOFOVIR;Cidofovir (Vistide)			-53.9607724051	4	7		0	-9.64234113					NC/1=N/C(=O)N(C[C@@H](CO)OC[P](O)(O)=O)/C=C1	Sequoia	113852-37-2	-7.18659986	-7.43518948	-8.85428091	-9.7198184	-4.5196163	-8.2219625	-9.64234113									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00185000-22	Afatinib (BIBW2992)			DPI_SARS-CoV-2_General	2019_NPC_02	439081-18-2		12.4181106199	-4.9059444758	-33.0854402932	-2.2	7		-54.4329068152	-40.47947486	0.0005904144	0.989919871			CN(C)C\C=C\C(=O)NC1=CC2=C(NC3=CC(Cl)=C(F)C=C3)N=CN=C2C=C1O[C@H]4CCOC4	APExBIO	A8247	1.3618812	-1.14809767	3.69189658	-1.04529617	-3.13428225	-16.49285983	-40.47947486									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181037-03	Isoflurane		Glycine receptor Positive Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	26675-46-7				10.0260230043	4	7		0	-1.39371165					FC(F)OC(Cl)C(F)(F)F	SigmaAldrich	CPX6609	0	4.2574326	3.04024753	1.91520707	3.96121949	2.22190906	-1.39371165									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015014-11	Acetohexamide	170465411	"Sulfonylurea receptor 1, Kir6.2 Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC_01	968-81-0				3.1157983572	4	7		0	-0.14194824					O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)C(C)=O	Microsource	01505425	0	0	3.76544564	-1.22657837	0	2.02246049	-0.14194824									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015830-08	Phenelzine	170465229	MAO Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	156-51-4	 ;PHENELZINE SULFATE;Phenelzine sulfate; Phenelzine sulfate; 2-Phenelzine; Nardil;Phenylethylhydrazine sulfate; Phenylethylhydrazine sulfate; Fenelzina; Felazine	17.5410474839	-4.7559444758	-38.1529686526	4	7		-29.545513248	-29.10952828	0.0077731929	0.9617626737	4128	MAOA	O=S(=O)(O)O.NNCCc1ccccc1	Microsource	01500476	-7.90792245	-4.14152027	-3.31212985	-3.23826724	-7.00654723	-7.27171096	-29.10952828									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00013683-06	Chlorprothixene	170465069	Serotonin (5-HT) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	113-59-7		11.0676527398	-4.9559444758	-62.0772036495	-2.2	7		-97.3636029483	-71.86636587	0.0000158469	0.9983707637	3269		CN(C)CC\C=C1/c3ccccc3Sc2ccc(Cl)cc12	Microsource	01503203	2.51978796	3.52578982	0	1.00082775	-8.19418363	-33.38584278	-71.86636587									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018194-08	Bendroflumethiazide	170465156	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	73-48-3		15.6334750258	-4.8059444758	0.828378933	4	7		-18.0722795399	-11.31023295	0.0320253913	0.9170647137			FC(F)(F)c1cc2NC(NS(=O)(=O)c2cc1S(N)(=O)=O)Cc3ccccc3	Microsource	01503104	4.26258079	3.94605028	2.73695499	0	0.26645688	-1.36185782	-11.31023295									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179333-03	Phensuximide	170465315		DPI_SARS-CoV-2_General	2019_NPC_01	86-34-0				2.7736904859	4	7		0	0					O=C1C(CC(=O)N1C)c2ccccc2	Specs	AE-562/J258174	4.09798369	0	0	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183285-15	Nilotinib		Bcr-Abl Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	641571-10-0		6.2237985085	-5.2059444758	-74.7859615421	-2.1	7		-88.0880226431	-80.17409504	0.0000485786	0.9971414668		ABL1	CC1=C[N](C=N1)C2=CC(=CC(=C2)NC(=O)C3=CC(=C(C)C=C3)NC4=NC(=CC=N4)C5=CC=CN=C5)C(F)(F)F	Glixx	GLXC-90226	4.83016948	0	1.91978622	0.74129504	-9.12244849	-44.75291244	-80.17409504									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179658-04	Acenocoumarol	170465636	Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	152-72-7		11.0676527398	-4.9559444758	0.8229846043	4	7		-12.298506392	-9.83208866	0.0893700165	0.846523166			[O-][N+](=O)c1ccc(cc1)C(CC(C)=O)C2=C(O)c3ccccc3OC2=O	Prestwick	Prestw-110	1.11678883	1.80877359	4.01537704	-1.64862147	3.46220564	-0.12683202	-9.83208866									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262575-02	Cyproterone acetate	170465682	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	427-51-0		13.9333492831	-4.8559444758	-35.0688837584	-2.2	7		-69.6419160032	-51.24387576	0.000142883	0.9950820754		AR	CC(=O)[C@@]4(OC(C)=O)CC[C@H]3[C@@H]5C=C(Cl)C2=CC(=O)[C@@H]1C[C@@H]1[C@]2(C)[C@H]5CC[C@@]34C	Prestwick	Prestw-1074	0	3.09316455	3.60282225	0.18473914	-1.88912387	-16.51634724	-51.24387576									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022848-17	Hydrocortisone	170464635	immunosuppressant	DPI_SARS-CoV-2_General	2019_NPC_01	50-23-7	 Hydrodexan; Proctosedyl ointment; Hydrocortisone Valerate; Hydrocortisone Buteprate; Acticort; Hydrocortisone Probutate; 11 Epicortiso;Calmurid-HC; ; Hidrocortisona; Reichstein's substance M; Hydrocortisone Caproate; Cortril; Hydrocortisone solution; Daktacort; Hydrocortisone Tebutate; 17-Hydroxycorticosterone; Hydrocortisone base; Hydrocortisone; Epicortisol; Kendall's compound F; Alphaderm; Hydrocortisone Base; Proctosedyl suppository; Canesten HC; oxycort A;Hydrocortisone; 11-Epicortisol; Cortifair			-17.8041120796	4	7		0	-9.23170515			5743	PTGS2	OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	Prestwick Chemical, Inc.	Prestw-447	-3.13944763	-2.97847387	-2.25439302	-3.85030225	-3.88011978	-2.5052086	-9.23170515									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183829-01	Minodronic acid	144206806	Geranylgeranyl pyrophosphate synthetase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	180064-38-4				-80.3717371957	4	7	Minodronic Acid;MINODRONIC ACID;acidum minodronicum;CIPLUS_707422;acide minodronique;YM 529;Minodronic Acid Hydrate;	0	-15.92862031					O=P(O)(O)C(O)(Cc1cnc2ccccn12)P(=O)(O)O	Pharmaron	PH-NIH-115451	-10.60441023	-9.49739781	-13.30944895	-9.13286678	-7.6714206	-12.49047208	-15.92862031									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00164576-04	Lopinavir	170464773	HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_01	192725-17-0	;ABT-738; Lopinavir/Ritonavir;Lopinavir;LOPINAVIR; Lopinavir	8.7913490634	-5.0559444758	-41.5658044969	-2.2	7		-52.4091784795	-46.14331703	0.0006361358	0.9895285682			CC(C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)COc3c(C)cccc3C)N4CCCNC4=O	Bosche	L2844	0.92706896	2.53866641	-3.40474276	-1.14631149	-2.53007156	-21.01732812	-46.14331703									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015045-09	Methacholine chloride	170464971	Muscarinic acetylcholine receptor M2 Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	62-51-1				1.2228611382	4	7		0	-1.46510862					[Cl-].C[N+](C)(C)CC(C)OC(=O)C	Microsource	01500391	2.12281848	-0.57907982	-1.58660525	1.93393032	0.78921992	0.24391483	-1.46510862									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090726-12	Ribavirin	170464657	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	36791-04-5	; ;Ribavirin; Levovirin; Ribavirin; Virazole;RIBAVIRIN; Ribavirina; Drug:  Ribavirin			-2.3083596992	4	7		0	-1.46003904			727833	IMPDH1	NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Microsource	01503938	-2.30677995	-1.26811152	0.19741171	-0.45902626	0.00253768	1.56003862	-1.46003904									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164619-02	Anastrozole	170464923	Aromatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	120511-73-1	Anastrozole; Anastrozole; ; Arimidex; Zeneca ZD 1033; 4   Anastrazole			5.9639551277	4	7		0	-2.03290157			1588	CYP19A1	N#CC(C)(C)c1cc(cc(c1)C(C)(C)C#N)Cn2cncn2	Sequoia	SRP05647a	1.03841406	0.2614411	3.13177841	4.06100283	3.90549662	-2.30194624	-2.03290157									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091861-07	Dacarbazine	170464655	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC_01	4342-03-4	; ; Dacarbazino;Dacarbazine; Dacarbazine; DTIC-Dome; DACARBAZINE; Dacarbizine;DACARBAZINE; 6   Dacarbazine			2.1802733478	4	7		0	-2.48916377				H2AFX	CN(C)/N=N/c1ncnc1C(N)=O	Microsource	01500218	-1.28530971	0.67192807	1.05529965	1.96904708	2.26615236	0.27948575	-2.48916377									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346533-09	Daclatasvir dihydrochloride		HCV NS5A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1009119-65-6		4.4061119169	-5.3559444758	-89.8028629223	-2.1	7		-92.2268087361	-84.95933026	0.0000241953	0.9979853977			COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C2=NC=C([NH]2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C([NH]5)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C	Glixx	GLXC-90137	4.53420888	0	0	1.15754274	-12.00722382	-57.95753476	-84.95933026									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016265-08	Folic acid	170464833	folic acid-containing compound metabolic process Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	59-30-3				0.8201130607	4	7		0	1.79463131					O=C(O)[C@H](CCC(=O)O)NC(=O)c1ccc(cc1)NCc2cnc3NC(N)=NC(=O)c3n2	Microsource	01502020	-4.38360807	0.56930633	1.3672589	-0.46905962	2.2103233	0.38619849	1.79463131									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016397-04	Benzydamine hydrochloride	170465576	prostaglandin production involved in inflammatory response Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	132-69-4		7.8352981002	-5.1059444758	2.9420950382	4	7		-12.7579275599	-8.1316063	0.0294931313	0.9210671044			Cl.CN(C)CCCOc3nn(Cc1ccccc1)c2ccccc23	Vitas	STK711092	3.88497567	2.04021795	4.73544393	0.66972684	2.04283612	-2.91173332	-8.1316063									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249910-01	Ibafloxacine	170466478	Bacterial DNA gyrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	91618-36-9		15.6334750258	-4.8059444758	-54.16663579	4	7		-22.8088862	-25.44929153	0.005291742	0.9688718491			O=C(O)C3=CN1c2c(cc(F)c(C)c2CCC1C)C3=O	GVK	FFS-11-286-NCI-148	-8.01926754	-6.85855303	-9.88277156	-10.28670329	-9.37674466	-14.12673408	-25.44929153									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181914-01	Alloclamide	144206889		DPI_SARS-CoV-2_General	2019_NPC_01	5486-77-1	Alloclamide; Aloclamida; Hexacol; 	11.0676527398	-4.9559444758	-7.9575404877	4	7	ALLOCLAMIDE HYDROCHLORIDE;Hexacol;Alloclamide;Alloclamidum;alloclamidum;alloclamide hydrochloride;alloclamide;ALLOCLAMIDE;2-allyloxy-4-chloro-N-(2-diethylaminoethyl)benzamide;264 CE;Aloclamida;LS-25294;CIPLUS_774246;CIPLUS_214111;Alloclamide hydrochloride;Benzamide, 2-(allyloxy)-4-chloro-N-(2-(diethylamino)ethyl)-;	-18.547425916	-15.87285493	0.0015828209	0.9833735764			O=C(NCCN(CC)CC)c1ccc(Cl)cc1OCC=C	Pharmaron	PH-NIH-93	-0.52525839	1.91804921	1.4598718	0.27842577	1.11911892	-3.67904873	-15.87285493									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482960-01	Xanthophyll			DPI_SARS-CoV-2_General	2019_NPC_02	127-40-2		5.5469662594	-5.2559444758	-60.5299065062	-2.2	7		-57.4480331079	-55.0444751	0.0000122549	0.9985679476			CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(\C)CC(O)CC1(C)C)\C=C\C=C(C)\C=C\C2\C(=C/C(O)CC2(C)C)C	DC Chemicals	DCY-149	-2.27288492	0.36729885	-1.0243548	-1.47557468	-7.58263432	-33.17361894	-55.0444751									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522040-01	Carpipramine Dihydrochloride			DPI_SARS-CoV-2_General	2019_NPC_02	7075-03-8		15.6334750258	-4.8059444758	-42.4483325855	-2.2	7		-89.7153593624	-66.45102982	0.000025296	0.9979401822			NC(=O)C1(CCN(CCCN2C3=CC=CC=C3CCC4=C2C=CC=C4)CC1)N5CCCCC5	Toronto Research	C184320	3.90991699	1.35600268	0.12892337	2.00874588	-0.41584488	-17.46993611	-66.45102982									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262598-02	Atracurium besylate	225144360		DPI_SARS-CoV-2_General	2019_NPC_02	64228-81-5	Atracurium besylate			3.1679319237	4	7		0	-4.74242496					COC1=CC2=C(C=C1OC)C(CC3=CC(OC)=C(OC)C=C3)[N+](C)(CCC(=O)OCCCCCOC(=O)CC[N+]4(C)CCC5=C(C=C(OC)C(OC)=C5)C4CC6=CC(OC)=C(OC)C=C6)CC2	Prestwick	Prestw-5	4.61282342	0	1.42518928	3.22475037	-0.91485873	-0.09394964	-4.74242496									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015430-06	Fenoterol hydrobromide	170465657		DPI_SARS-CoV-2_General	2019_NPC_01	1944-12-3				-22.5966416376	4	7		0	-7.3965172					Br.Oc1cc(cc(O)c1)C(O)CNC(C)Cc2ccc(O)cc2	Microsource	01501007	-5.40023721	-4.20504801	-4.50634886	-4.31183686	-2.53514693	-5.96066873	-7.3965172									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094748-07	Oxyphenbutazone	170465310		DPI_SARS-CoV-2_General	2019_NPC_01	129-20-4		13.9333492831	-4.8559444758	-46.6239488375	-2.2	7		-74.9853108928	-62.28992928	0.0010002183	0.9868078436			Oc1ccc(cc1)N3C(=O)C(CCCC)C(=O)N3c2ccccc2	Microsource	01500455	-1.29499189	3.07132211	1.18690746	-0.43394286	-6.71725118	-15.5749784	-62.28992928									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164590-02	Drospirenone	170464870	Synthetic progesterone	DPI_SARS-CoV-2_General	2019_NPC_01	67392-87-4	 ; Drospirenone and estrogen;Drospirenone; Drospirenone; Yasmin; Drospirenona;DROSPIRENONE	17.5410474839	-4.7559444758	-37.6219225515	-2.4	7		-30.042781584	-26.27056348	0.0046220566	0.9709618749	5241	PGR	O=C1CC[C@]6(O1)[C@H]2C[C@H]2[C@H]5[C@@H]7[C@H]3C[C@H]3C4=CC(=O)CC[C@]4(C)[C@H]7CC[C@@]56C	Sequoia	SRP04800d	-3.9237044	-2.48491216	-6.27574273	-4.62788773	-7.05730092	-9.76167488	-26.27056348									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021318-08	Budesonide		Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC_01	51333-22-3		11.0676527398	-4.9559444758	-13.306964409	4	7		-22.7016171999	-21.834681	0.0075074667	0.9624782503		NR3C1	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC/5=C/C(=O)/C=C\[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO	SIGMA	B7777	1.62418609	-0.82830405	-0.93344057	-1.62791281	2.95640258	-3.70445653	-21.834681									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386356-02	Bepotastine (Beslilate)		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	190786-44-8				9.4965583733	4	7		0	-1.56970937					OC(=O)CCCN1CCC(CC1)O[C@@H](C2=CC=C(Cl)C=C2)C3=NC=CC=C3	MedChem Express	HY-A0015	0	0	3.39654485	4.64186329	3.4479481	3.28354002	-1.56970937									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181784-01	Iloprost	144207135	Prostanoid IP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	78919-13-8	Iloprost; 	17.5410474839	-4.7559444758	-40.3266763003	-2.2	7	LS-101845;ZK 3637;i1oprost;iloprostum;ZK 36 374;ZK-36374;ZK-00036374;Ventavis;ZK3637;CIPLUS_190653;Iloprost;(5E)-5-((3AS,4R,5R,6AS)-5-HYDROXY-4-((1E,3S)-3-HYDROXY-4-METHYLOCT-1-EN-6-YN-1-YL)HEXAHYDROPENTALEN-2(1H)-YLIDENE)PENTANOIC ACID;CIPLUS_191919;Pentanoic acid, 5-(hexahydro-5-hydroxy-4-(3-hydroxy-4-methyl-1-octen-6-ynyl)-2(1H)-pentalenylidene)-;ILOPROST;VENTAVIS;5-((E)-(1S,5S,6R 7R)-7-HYDROXY-6((E)-(3S,4RS)-3-HYDROXY-4-METHYL-1-OCTEN-6-INYL)-BICYLO (3,3,0)-OCTAN-3-YLIDENE)-PENTANOIC ACID;CoTherix Brand of Iloprost;PENTANOIC ACID, 5-((3AS,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-((1E,3S)-3-HYDROXY-4-METHYL-1-OCTEN-6-YNYL)-2(1H)-PENTALENYLIDENE)-, (5E)-;	-45.4749322216	-37.10222138	0.0036975787	0.974123877			O[C@@H]2C[C@@H]1C/C(C[C@@H]1C2/C=C/[C@@H](O)C(C)CC#CC)=C\CCCC(=O)O	Tocris	Tocris-2038	-2.99891327	0.39963963	-5.65153184	-4.96924912	-5.67212414	-10.90755355	-37.10222138									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164462-01	Pyriproxyfen	26757881	juvenile hormone metabolic process Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	95737-68-1				3.595227343	4	7	pyriproxyfen;pyriproxyfen, (S)-isomer;2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine;CIPLUS_668570;Pyriproxifen;pyriproxyfen, (R)-isomer;NCGC00164462-01;S 31183;juvinal;2-[1-Methyl-2-(4-phenoxyphenoxy)ethoxy]pyridine;NCGC00163945-01;CIPLUS_760107;Pyriproxyfen;S-31183;	0	3.9337868					CC(COC1=CC=C(OC2=CC=CC=C2)C=C1)OC3=NC=CC=C3	EPA	EPA-CAS-95737-68-1	0	-0.23793573	-1.88228124	1.03126535	2.55447568	0.71401729	3.9337868									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165810-02	Indoramin hydrochloride	170466233	Alpha-1d adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	38821-52-2		11.0676527398	-4.9559444758	-12.8256287777	-2.4	7		-30.332310972	-25.27692581	0.0001366979	0.9951962841			Cl.O=C(NC3CCN(CCc1cnc2ccccc12)CC3)c4ccccc4	SigmaAldrich	I2909	2.56335778	0.50577858	1.30876654	2.07941405	1.46931939	-7.12942731	-25.27692581									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015004-13	Amoxapine	170465376	5-HT2A Antagonists?	DPI_SARS-CoV-2_General	2019_NPC_01	14028-44-5	 Amoxapina; ; Asendin; Amoxapine; 2   Amoxapine;Amoxapine;AMOXAPINE;	15.6334750258	-4.8059444758	-51.6916392683	-2.2	7		-37.7850602841	-32.80525208	0.0439128478	0.8999796366	3356	HTR2A	Clc1ccc2Oc4ccccc4N=C(c2c1)N3CCNCC3	Enzo	AC814	-6.1748118	-4.23436851	-4.5404694	-5.4305566	-15.48748921	-13.54235479	-32.80525208									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023064-05	Medroxyprogesterone	170466063		DPI_SARS-CoV-2_General	2019_NPC_01	520-85-4		22.0828704269	-4.6559444758	2.3754601078	4	7		-10.776178048	-8.14681504	0.053627335	0.8884242514			CC(=O)[C@@]3(O)CC[C@H]2[C@@H]4C[C@H](C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	SIGMA	M6013	3.73974294	0	0	1.77339654	1.92610262	2.22572285	-8.14681504									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015673-13	Minoxidil	170464704	K(ATP) Channel Activator	DPI_SARS-CoV-2_General	2019_NPC_01	38304-91-5	Minoxidil; Loniten; Minoxidil; ;MINOXIDIL; Minoxidil Pfizer Bran; Riup; Pfizer Brand of Minoxidil; Regaine			-9.4856285424	4	7		0	-4.26858635					Nc1cc(nc(N)[n+]1[O-])N2CCCCC2	Microsource	01500415	-2.75700143	-2.99802087	-1.09916892	-0.13294203	-0.82982287	-2.62208446	-4.26858635									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015893-06	Ropinirole	170465139	Dopamine D3 receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	91374-21-9				-10.9444366002	4	7		0	-5.35347646					CCCN(CCC)CCc1cccc2NC(=O)Cc12	Microsource	01505178	-2.89739307	-1.76167322	-1.05529965	-0.77507713	-2.62650358	-2.59667666	-5.35347646									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016256-17	Pyrimethamine	170464930	Dihydrofolate Reductase (DHFR) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	58-14-0	Pirimetamina; ; Daraprim; Tindurine; Fansimef; Chloridin;Pyrimethamine; Suldox; Maloprim; Pyrimethamine; A.E.S. mixture; Folaprim; Malocide			-5.9043571852	4	7		0	-6.04293934			1719	DHFR	CCc1nc(N)nc(N)c1c2ccc(Cl)cc2	Microsource	01500520	-2.97000944	-0.77943656	-1.64509761	1.51754584	-0.39841648	0.29473042	-6.04293934									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00480885-01	INT-747 (Obeticholic acid)		Bile acid receptor FXR Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	459789-99-2		12.4181106199	-4.9059444758	-11.0145950441	4	7		-26.27529372	-23.1460781	0.0004585111	0.9911466528			CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCC(O)=O)[C@@]3(C)CC[C@@H]2[C@@]4(C)CC[C@@H](O)C[C@@H]14	Glixx	GLXC-05527	1.96305117	0.33033796	0.05860153	0.67581788	2.31209752	-3.57478392	-23.1460781									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181170-02	Bendamustine	170465340	DNA Alkylating Drugs	DPI_SARS-CoV-2_General	2019_NPC_02	16506-27-7	Bendamustine HCL;Bendamustine;Inno-P08001; Bendamustine;SyB L-0501;SDX-105			-16.1021310525	4	7		0	-8.62388812			7515	XRCC1	ClCCN(CCCl)c1cc2nc(CCCC(=O)O)n(C)c2cc1	Sequoia	3543-75-7	-3.08215219	-2.82057798	-2.5151778	-0.91434184	-2.02694675	-5.27057497	-8.62388812									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346435-13	MK-4827			DPI_SARS-CoV-2_General	2019_NPC_02					1.1261160159	4	7		0	-3.72449222					NC(=O)C1=CC=CC2=CN(N=C12)C3=CC=C(C=C3)[C@@H]4CCCNC4	Bio Vision	9462-5	0	3.1162651	0	1.77022192	-0.59168785	0.12683202	-3.72449222									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378902-03	Toceranib		VEGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	[356068-94-5]		4.7903477126	-5.3196329617	-68.7960883807	-2.2	7		-72.1329020599	-68.44408505	0.0000426512	0.9973225692		FLT1	CC1=C(C(=C([NH]1)\C=C2/C(=O)NC3=C2C=C(F)C=C3)C)C(=O)NCCN4CCCC4	Tocris	3909	0	0	0	0	3.00121189	-20.31191281	-68.44408505									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00164615-02	Prulifloxacin	170465849	Antibacterial	DPI_SARS-CoV-2_General	2019_NPC_01	123447-62-1	 ;Prulifloxacin; Prulifloxacin; Sword	11.0676527398	-4.9559444758	-20.9385692048	4	7		-15.891561688	-14.90963474	0.1205567343	0.8129422923			CC=5OC(=O)OC=5CN1CCN(CC1)c2cc3c(cc2F)C(=O)C(=C4SC(C)N34)C(=O)O	Bosche	P2859	-2.4955825	-2.20148069	2.3372572	-5.82185768	-3.31675379	-7.29711876	-14.90963474									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093936-08	D-Glutamine	170465304	Protein-glutamine gamma-glutamyltransferase Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	5959-95-5				3.541729569	4	7		0	2.27117183			1503		O=C(N)CC[C@@H](N)C(=O)O	Microsource	01300018	0.38970784	1.26322477	-0.41675806	-0.2182256	0.18525098	2.16474414	2.27117183									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016504-09	Droperidol	170464722	HERG Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	548-73-2		13.9333492831	-4.8559444758	-1.4674642245	4	7		-22.5827735639	-16.31897797	0.0154597634	0.9446543287			Fc1ccc(cc1)C(=O)CCCN2CC=C(CC2)N3c4ccccc4NC3=O	Microsource	01501002	4.84351173	0	2.40549828	4.41718715	0.79937065	-2.10376544	-16.31897797									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015389-14	Propofol	170464994	TRPV1 (Vanilloid VR1 Receptor) Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	2078-54-8	 ; Dipravan; Propofol;Propofol; propofol HP-beta-CD; 2,6-Bis(Isopropyl)-phenol;2,6-Diisopropylphenol;PROPOFOL	9.8640558873	-5.0059444758	-60.031883145	-2.2	7		-68.1827283204	-59.20255507	0.0000149104	0.998419989	7442	TRPV1	CC(C)c1cccc(C(C)C)c1O	SigmaAldrich	Lopac-D126608	-2.34550868	-0.80387031	-1.45499744	-4.00080267	-5.75800639	-26.9475075	-59.20255507									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015462-14	Glipizide	170465089	K(ATP) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	29094-61-9	; ; Glucotrol;Glipizide; Glipizide; Glypidizine; Glipizida; Samarium(III) ionophore I;GLIPIZIDE			-16.8670695916	4	7		0	-5.53091176				KCNJ8	Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3	Enzo	AC120	-5.09040738	-3.54533682	-2.82469352	-1.05601124	-4.06790844	-3.53676508	-5.53091176									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167542-01	Tiamulin	144206092	Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	55297-95-5	Tiamulin; Tiamulina; 	7.8352981002	-5.1059444758	-5.6275574445	4	7	TIAMULIN FUMARATE;THIAMUTILIN FUMARATE;tiamulin hydrochloride;(3AS,4R,5S,6S,8R,9S,9AR,10R)-5-HYDROXY-4,6,9,10-TETRAMETHYL-1-OXO-6-VINYLDECAHYDRO-3A,9-PROPANOCYCLOPENTA(8)ANNULEN-8-YL ((2-(DIETHYLAMINO)ETHYL)THIO)ACETATE (2E)-BUT-2-ENEDIOATE (SALT);Tiamulina;sandoz 81723hfu;Tiamuline;Tiamulinum;ACETIC ACID, ((2-(DIETHYLAMINO)ETHYL)THIO)-, (3AS,4R,5S,6S,8R,9S,9AR,10R)-6-ETHENYLDECAHYDRO-5-HYDROXY-4,6,9,10-TETRAMETHYL-1-OXO-3A,9-PROPANO-3AH-CYCLOPENTACYCLOOCTEN-8-YL ESTER, (2E)-2-BUTENEDIOATE (1:1) (SALT);tiamulinum;Tiamulin Hydrogen Fumarate;tiamuline;(1S,2R,3S,4S,6R,7S,14R)-6-[(2-Diethylaminoethylthio)acetoxy]-3-hydroxy-2,4,7,14-tetramethyl-4-vinyltricyclo[5,4,3,01.8]tetradecan-9-one;LS-174933;Thiamutilin fumarate;2-(diethylaminoethyl)thioacetoxymutilin;14-DEOXY-14-((2-DIETHYLAMINOETHYL)THIOACETOXY)MUTILIN HYDROGEN FUMARATE;CIPLUS_182128;Tiamulin;TIAMULIN HYDROGEN FUMARATE;Tiamulin Fumarate;TIAMULIN;LS-11694;LS-11693;(3AS,4R,5S,6S,8R,9S,9AR,10R)-6-ETHENYL-5-HYDROXY-4,6,9,10-TETRAMETHYL-1-OXODECAHYDRO-3A,9-PROPANO-3AH-CYCLOPENTACYCLOOCTEN-8-YL((2-(DIETHYL-AMINO)ETHYL)SULPHANYL)ACETATE HYDROGEN (E)-BUT-2-ENEDIOATE;CIPLUS_207320;Tiamulin fumarate;	-15.834086472	-13.19507206	0.0126906646	0.9503825361			CCN(CC)CCSCC(=O)O[C@@H]3C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@@]21CCC(=O)[C@H]1[C@@]3(C)C(C)CC2	SigmaAldrich	34044	3.69257093	0	0	1.90585319	1.79882613	-5.37861706	-13.19507206									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166222-04	N,N'-Dibenzylethane-1,2-diamine dihydrochloride	170465030	F-box only protein 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	3412-76-8		22.0828704269	-4.6559444758	8.0208559413	4	7		-10.2549112919	-6.04575941	0.0735771419	0.8649834992	26273	FBXO3	Cl.Cl.C(NCc1ccccc1)CNCc2ccccc2	SIGMA	D35201	4.24287267	3.61523713	1.6244345	3.71115216	0.54416273	2.43329575	-6.04575941									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346741-02	Travoprost		Prostanoid TP Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	157283-68-6		15.6334750258	-4.8059444758	-2.581328413	-2.4	7		-32.135874996	-20.52989583	0.0002278246	0.9937868737		TBXA2R	CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC2=CC(=CC=C2)C(F)(F)F	MedChem Express	HY-B0584	4.46021873	3.60137679	3.27465366	3.14991932	1.15248438	-3.70631342	-20.52989583									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00261966-01	NCGC00261966-01			DPI_SARS-CoV-2_General	2019_NPC_02		Selamectin	2.7800686746	-5.5559444758	-96.5518339569	-1.1	7		-85.4218237167	-81.28716168	0.0000018827	0.9994393802			CO[C@H]1C[C@H](O[C@@H](C)[C@H]1O)O[C@H]\2[C@@H](C)\C=C\C=C\3CO[C@@H]4C\C(=C/[C@@H](C(=O)O[C@H]5C[C@@H](C/C=C2C)O[C@@]6(CC[C@H](C)[C@H](O6)C7CCCCC7)C5)[C@]34O)C	GVK	FFS-11-286-NCI-104	3.32724456	2.22458361	1.79789503	-1.65797535	-18.46588884	-63.97031191	-81.28716168									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181290-01	Furazabol	144206325		DPI_SARS-CoV-2_General	2019_NPC_02	1239-29-8	Furazabol; Miotolan; 	11.0676527398	-4.9559444758	7.6238998234	4	7	androfurazanol;Miotolan;CIPLUS_157956;17 alpha-methyl-5 alpha-androstano(2,3-c)furazan-17 beta-ol;furazabol;FURAZABOL;LS-19413;Furazabol;17-METHYL-5.ALPHA.-ANDROSTANO(2,3-C)FURAZAN-17.BETA.-OL;Furazabolum;furazabolum;17-methyl-5 alpha-androstano(2,3-c)(1,2,5)oxadiazol-17 beta-ol;5-alpha-Androstano(2,3-c)(1,2,5)oxadiazol-17-beta-ol, 17-methyl-;	-15.492460644	-7.91038387	0.0009851937	0.9870116373			C[C@]5(O)CC[C@@H]4[C@]5(C)CC[C@H]1[C@H]4CC[C@H]2Cc3nonc3C[C@]12C	ACC	furazabol	4.48334066	3.35189078	4.44668433	3.90758366	1.96516408	-1.14148816	-7.91038387									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00142483-09	CYTIDINE		Dna Polymerase Inhibitors; Nucleoside	DPI_SARS-CoV-2_General	2019_NPC_02	65-46-3				10.7075969843	4	7		0	-0.89901536				POLB	NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Microsource	01503431	4.80242318	0	4.78891728	2.25194678	1.38535751	2.91713641	-0.89901536									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390564-03	GS-7340			DPI_SARS-CoV-2_General	2019_NPC_02	379270-37-8				11.4598744111	4	7		0	2.15002616					CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)C[N]1C=NC2=C1N=CN=C2N)OC3=CC=CC=C3	MedChem Express	HY-15232	1.41737381	4.2158516	4.51700616	4.27238501	0.76753083	-0.37579857	2.15002616									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183599-01	NCGC00183599-01	124894454		DPI_SARS-CoV-2_General	2019_NPC_02					9.2318473665	4	7	CIPLUS_736638;Uvinul-T-150;Uvinul T150;octyl triazone;CIPLUS_741452;Uvinul T 150;	0	-0.21405128					CCCCC(CC)COC(=O)C1=CC=C(NC2=NC(=NC(=N2)NC3=CC=C(C=C3)C(=O)OCC(CC)CCCC)NC4=CC=C(C=C4)C(=O)OCC(CC)CCCC)C=C1	USP	1265537	2.98041573	1.50384624	3.6543916	2.81317962	-0.14495164	2.65407741	-0.21405128									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016834-07	Fenbufen	170465799	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	36330-85-5				-23.0021320003	4	7		0	-3.42703607			5743	PTGS2	O=C(CCC(=O)O)c1ccc(cc1)c2ccccc2	Microsource	01501008	-8.73090795	-1.06775478	-2.48836246	-4.98407204	-7.8033802	-5.52873622	-3.42703607									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017291-17	Riboflavin			DPI_SARS-CoV-2_General	2019_NPC_01	 83-88-5				-29.6620293804	4	7		0	-7.8020836					CC1=CC2=C(C=C1C)N(C[C@@H](O)[C@@H](O)[C@@H](O)CO)C3=NC(=O)NC(=O)C3=N2	Selleck	S2540 	-4.53368189	-4.42983849	-4.50634886	-4.65297113	-6.53961326	-10.62553992	-7.8020836									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00164613-08	Epalrestat		Aldose Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	82159-09-9		8.7913490634	-5.0559444758	-53.4872306974	-2.2	7		-60.7235408827	-51.30571279	0.0001836807	0.9944179521		AKR1B1	CC(=C/C1=CC=CC=C1)\C=C2/SC(=S)N(CC(O)=O)C2=O	MedChem Express	HY-66009	1.93530486	-2.84829864	-1.78383066	-1.70006782	-6.87926241	-26.49379932	-51.30571279									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00521952-01	ROMURTIDE		TNF-alpha Activator	DPI_SARS-CoV-2_General	2019_NPC_02	78113-36-7		6.9832167823	-5.1559444758	-16.4078286544	4	7		-22.478357036	-20.81529753	0.0080988696	0.9609281682	3557		CCCCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)C(O)=O	Carbosynth	FA110464	2.66595759	-0.62602509	0.79932491	-1.96665342	1.77031105	-10.33446073	-20.81529753									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00506875-01	Vilanterol (GW642444; GW 642444X)		"adrenoceptor beta 2, surface Agonist"	DPI_SARS-CoV-2_General	2019_NPC_02	503068-34-6		13.9333492831	-4.8559444758	-39.5030630144	-2.2	7		-50.9157351431	-39.70889026	0.0003047509	0.9927932239	154	ADRB2	OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCOCC2=C(Cl)C=CC=C2Cl	TargetMol	T2645	-2.79081597	-0.80620943	0.23675019	-2.51385544	-5.62459901	-15.1587749	-39.70889026									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00014648-04	Spiclomazine hydrochloride		Adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02			3.9269513795	-5.4059444758	-129.3760148768	-2.1	7		-94.4923315399	-93.183656	0.0000071349	0.9989076736			ClC1=CC2=C(SC3=C(C=CC=C3)N2CCCN4CCC5(CC4)NC(=O)CS5)C=C1	NCI	NSC-290956	-6.24060672	-3.35651089	-5.06551651	-9.95019059	-23.77919825	-66.63848177	-93.183656									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00485883-01	Forodesine (hydrochloride)	363681392	Purine nucleoside phosphorylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	284490-13-7		11.0676527398	-4.9559444758	-13.0912150851	4	7		-29.8051657719	-26.50430481	0.0035384575	0.9747222223			OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)C2=C[NH]C3=C2\N=C/NC3=O	MedChem Express	HY-16209	0	0	0	4.53897061	2.20754224	-5.48196167	-26.50430481									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166397-04	Lofepramine hydrochloride	170465926	norepinephrine uptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	26786-32-3		9.8640558873	-5.0059444758	-66.891973265	-2.2	7		-103.034511164	-75.4049327	0.0003850161	0.9918823247			Cl.Clc1ccc(cc1)C(=O)CN(C)CCCN3c4ccccc4CCc2ccccc23	Sequoia	23047-25-8	0.18880256	4.54712048	3.81418927	2.41051496	-14.04100898	-35.75384928	-75.4049327									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015368-11	Dicyclomine	170464896	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	77-19-0		13.9333492831	-4.8559444758	-38.4657934552	4	7		-18.839681336	-21.37334922	0.1160294504	0.8174663665			CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2	Microsource	01500240	-7.79173626	-9.12600484	-7.34322829	-2.34028144	-4.99670101	-7.55627827	-21.37334922									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166113-04	Diphenylcyclopropenone	170465593	immune system process Activator	DPI_SARS-CoV-2_General	2019_NPC_01	886-38-4		22.0828704269	-4.6559444758	-24.8400042432	-3	7		-36.1146232	-33.43388	0.0026760553	0.9781311262			O=C2C(=C2c1ccccc1)c3ccccc3	Vitas	STK289679	-2.54399342	-2.5875339	-3.0537886	-3.41385105	-0.26138152	1.46857056	-33.43388									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183830-01	Lemildipine	144206840	Voltage-gated calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	94739-29-4		6.2237985085	-5.2059444758	-65.5587878382	-2.2	7	CIPLUS_208006;NPK 1886;isopropyl methyl 2-carbamoyloxymethyl-6-methyl-4-(2,3-dichlorophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;lemildipine;Lemidipine;Lemildipine;LS-131203;LEMILDIPINE;NB-818;NPK-1886;CIPLUS_701996;NB 818;lemildipinum;	-82.0538769639	-66.29489747	0.0001922847	0.9942862541			O=C(OC)C1=C(C)NC(COC(N)=O)=C(C1c2cccc(Cl)c2Cl)C(=O)OC(C)C	Pharmaron	PH-NIH-152804	0	3.52578982	3.12690405	2.46068177	-14.07653657	-38.84343717	-66.29489747									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178510-09	Roxithromycin		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	80214-83-1		12.4181106199	-4.9059444758	-9.6277772294	4	7		-15.0624078439	-13.38533987	0.0041889764	0.9725321455			CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)\C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O	Prestwick	Prestw-854	0.89019399	0.01155028	-0.03516092	-1.76086804	0.4253499	-3.18019542	-13.38533987									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389632-02	Tipiracil		Thymidine Phosphorylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	183204-72-0				-0.2165720777	4	7		0	-1.42700851				TYMP	ClC\1=C(/CN2CCCC2=N)NC(=O)NC1=O	Adooq	A13098	0.38151171	0.31185752	1.6666276	0.36713982	-1.15723689	-0.79387448	-1.42700851									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263884-02	Zolmitriptan	170464875	5-HT1B Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	139264-17-8	ZOLMITRIPTAN;Zolmitriptan (Zomig)	17.5410474839	-4.7559444758	-16.4110205647	4	7		-13.862507732	-11.13542311	0.0798801194	0.8578092595	3351	HTR1B	CN(C)CCc2cnc1ccc(cc12)C[C@@H]3NC(=O)OC3	Microsource	01505281	0.15029249	-1.60548869	-2.40266285	-4.18352314	-2.70180358	-4.33107854	-11.13542311									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181111-02	Tamibarotene	170465883	Retinoid RAR Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	94497-51-5	 ; Am80; Am 80;AM 80; Tamibarotene;tamibarotene; Amnoid	11.0676527398	-4.9559444758	-49.4691199056	-2.2	7		-35.4419075777	-36.52666128	0.0005628489	0.9901671886	5915	RARB	O=C(O)c1ccc(cc1)C(=O)Nc2ccc3c(c2)C(C)(C)CCC3(C)C	Tocris	3507	-4.72380864	-5.95763358	-7.60179086	-3.97773776	-5.76717439	-15.3419767	-36.52666128									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025346-08	Mirtazapine		5-HT2A/3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	85650-52-8 				6.4176928527	4	7		0	-1.65532988				HTR2A	CN1CCN2C(C1)C3=C(CC4=C2N=CC=C4)C=CC=C3	APExBIO	B2113	1.42431039	0	0	1.01021911	4.89746453	3.14731304	-1.65532988									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181100-01	Ormeloxifene	144206269	Estrogen receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	31477-60-8	Levormeloxifene; Compound 672; Compound 67-20; Compound 67 2; Centchroman; 	4.4061119169	-5.3559444758	-94.4439065045	-2.2	7	ORMELOXIFENE;levormeloxifenum;Centchroman;(-)-3,4-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)chromane;CIPLUS_3865012;LEVORMELOXIFENE;LEVORMELOXIFENE FUMARATE;CIPLUS_676257;CIPLUS_709447;1-(2-(p-(trans-7-methoxy-2,2-dimethyl-3-phenyl-4-chromanyl)phenoxy)ethyl)pyrrolidine;CIPLUS_3853907;ormeloxifenum;Compound 67-20;CIPLUS_3847290;Compound 672;NNC-46-0020 FUMARATE;CIPLUS_177424;CIPLUS_731807;Compound 67 2;Ormeloxifene;LS-137582;Pyrrolidine, 1-(2-(4-(3,4-dihydro-7-methoxy-2,2-dimethyl-3-phenyl-2H-1-benzopyran-4-yl)phenoxy)ethyl)-, trans-;ormeloxifene;levormeloxifene;trans-2,2-Dimethyl-3-phenyl-4-(p-(beta-pyrrolidinoethoxy)phenyl)-7-methoxychroman;LS-137965;Levormeloxifene Fumarate;7-METHOXY-2,2-DIMETHYL-3-PHENYL-4-(4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)CHROMANE FUMARATE, TRANS-3R,4R, L-;Levormeloxifene;	-95.606549975	-77.86234125	0.0000784453	0.9963628421			COc1ccc2c(c1)OC(C)(C)[C@H]([C@@H]2c4ccc(OCCN3CCCC3)cc4)c5ccccc5	NCI	NSC-147956	0.24509237	3.7677008	1.50254331	-5.56789748	-25.84178885	-50.51202555	-77.86234125									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00509859-03	ABT-450			DPI_SARS-CoV-2_General	2019_NPC_02	1221573-85-8		8.7913490634	-5.0559444758	-26.5615166834	-2.2	7		-49.8029776852	-43.79013461	0.000688505	0.9890984717			CC1=CN=C(C=N1)C(=O)N[C@H]2CCCCCC=C[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)OC5=NC6=C(C=CC=C6)C7=C5C=CC=C7)C(=O)N[S+]([O-])(=O)C8CC8	Glixx	GLXC-90367	0	0	3.25590117	3.08210369	3.82339662	-15.13528749	-43.79013461									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00348363-01	ARABITOL(D)		sugar alcohol	DPI_SARS-CoV-2_General	2019_NPC_01	488-82-4				5.2626192452	4	7		0	0					OC[C@@H](O)C(O)[C@H](O)CO	SIGMA	A3381	4.1996466	0	3.45836075	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091070-02	Diisopropylamine	170466002	Pyruvate dehydrogenase kinase isoform 4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	108-18-9				-41.1055754117	4	7		0	-9.76908063					CC(C)NC(C)C	Labotest	LTBB000412	-10.31878585	-6.14997434	-9.80478175	-7.73822961	-8.43272598	-9.31957925	-9.76908063									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274083-01	Loxiglumide	170465971	Cholecystokinin A receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	107097-80-3				13.702248647	4	7		0	2.28321362					Clc1ccc(cc1Cl)C(=O)NC(CCC(=O)O)C(=O)N(CCCCC)CCCOC	SIGMA	SML0130	4.40472612	3.13012544	0	4.1788462	2.39289024	3.91770011	2.28321362									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166076-07	Arbutin	170465722	Free Radical Scavenger	DPI_SARS-CoV-2_General	2019_NPC_02	497-76-7	Arbutin;ARBUTIN; 0   Arbutin; p-Arbutin;			-10.0665775971	4	7		0	-4.46177996					Oc1ccc(cc1)O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O	SIGMA	A4256	-0.73758931	-1.92427638	-2.92304447	-0.90498796	-1.65625074	-2.91243893	-4.46177996									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167457-02	Gestrinone	170466364	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	16320-04-0		4.4061119169	-5.3559444758	-133.0773945805	-2.1	7		-82.6485532166	-87.28059744	0.0000142034	0.9984577145	5241	PGR	O=C3C=C4CC[C@@H]2C(C=C[C@@]1(CC)[C@H]2CC[C@@]1(O)C#C)=C4CC3	Bosche	G6427	-7.9331314	-11.06747673	-10.68188744	-9.35154222	-22.71463536	-63.0777903	-87.28059744									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263117-05	Panobinostat		HDAC Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	404950-80-7		6.2237985085	-5.2059444758	-80.4529229201	-2.2	7		-89.432264664	-73.27688722	0.0003237128	0.9925650698		HDAC1	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C3=CC=CC=C3[NH]1	Selleck	S1030	4.53420888	0	2.37453412	-7.02710287	-17.39182093	-42.19748215	-73.27688722									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178756-05	LEUCOVORIN CALCIUM	225144299	Antineoplastic Enhancing Agents	DPI_SARS-CoV-2_General	2019_NPC_02	1492-18-8				-2.3100885514	4	7		0	-2.80169338				TYMS	N\C1=N\C(=O)\C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)N2C=O)/N1	Microsource	01500364	3.76656108	0.60292453	-2.07449427	1.13883497	1.07169166	4.21364149	-2.80169338									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00183861-01	(2R)-2-Propyloctanoic acid	144206875	S100 beta biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	185517-21-9				6.9745054125	4	7	Arundic Acid;Acido ar?ndico;(R)-2-Propyloctanoic acid;acidum arundicum;arundic acid;(R)-(-)-2-propyloctanoic acid;CIPLUS_783758;Acide arundique;ONO-2506;Arundic acid;ONO2506;Acidum arundicum;	0	2.76292109					O=C(O)[C@@H](CCCCCC)CCC	Pharmaron	PH-NIH-183336	2.12281848	0	2.576101	1.15634485	0	2.10376544	2.76292109									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167493-04	Manidipine	174006297	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	89226-75-5	; Manidipine 6300;Manidipine; Manidipine; Mandipine 6300; Calslot;manidipine dihydrochloride	2.4777388143	-5.6059444758	-113.2617849283	-1.1	7		-95.0518744756	-85.69618007	0.0000456478	0.9972293246			Cl.Cl.[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCN3CCN(CC3)C(c4ccccc4)c5ccccc5	Selleck	S2481	0.51799676	3.83365504	0	-1.37206211	-29.01842359	-71.38065959	-85.69618007									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018238-09	Oxibendazole	170465661	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	20559-55-1	OXIBENDAZOLE;Oxibendazole; Loditac; Oxibendazolo;			-4.3021746103	4	7		0	-4.15198601				POLB	O=C(OC)Nc1nc2cc(ccc2n1)OCCC	Microsource	01503373	0.36550238	1.76167322	-0.15354244	-1.61787945	0.99223469	-4.35997764	-4.15198601									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182993-01	Betiatide	144206816		DPI_SARS-CoV-2_General	2019_NPC_01	103725-47-9	Betiatide; 	22.0828704269	-4.6559444758	4.8067158364	4	7	CIPLUS_762860;MP-600;BETIATIDE;THIOBENZOIC ACID, S-ESTER WITH N-(N-(N-(MERCAPTOACETYL)GLYCYL)GLYCYL)GLYCINE;Betiatide;betiatidum;N-(N-(N-(MERCAPTOACETYL)GLYCYL)GLYCYL)GLYCINE BENZOATE (ESTER);GLYCINE, N-(N-(N-((BENZOYLTHIO)ACETYL)GLYCYL)GLYCYL)-;betiatide;BENZOYLMERCAPTOACETYLGLYCYLGLYCYLGLYCINE;	-11.884527636	-8.65377303	0.1208925255	0.8130179986			O=C(O)CNC(=O)CNC(=O)CNC(=O)CSC(=O)c1ccccc1	Pharmaron	PH-NIH-137963	1.05535788	0	4.07253053	0	4.83428919	3.47578637	-8.65377303									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164155-02	Benzylparaben	170465711	Estrogen receptor alpha Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	94-18-8		15.6334750258	-4.8059444758	-5.126969058	4	7		-19.0002281319	-17.50019011	0.0272728517	0.9241070023			Oc1ccc(cc1)C(=O)OCc2ccccc2	SIGMA	380709	-1.27078644	1.35118626	-1.70846433	3.20315048	3.57559762	0.68092891	-17.50019011									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015254-20	Clozapine	170464853	Dopamine D4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	5786-21-0	;Clozapine; ; clozapine N-glucuronide;CLOZAPINE; Leponex; Clozaril; Clozapine; Clozapina; Clo-Glu	13.9333492831	-4.8559444758	-24.9781883327	-2.2	7		-44.104927632	-34.5491876	0.0000616844	0.9967795449	1815	DRD4	CN1CCN(CC1)C2=Nc4cc(Cl)ccc4Nc3ccccc23	Enzo	D107	-0.44295984	1.82031422	-0.06092954	0.48410966	-1.23585241	-10.25458611	-34.5491876									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167469-02	NCGC00167469-02			DPI_SARS-CoV-2_General	2019_NPC_02			11.0676527398	-4.9559444758	3.4955695231	4	7		-20.46986634	-12.05822195	0.0032702662	0.9758092457			[H][C@@]2(CC1=CC(OC)=C(OC)C(OC)=C1)C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]4(C)CCC5=CC(OC)=C(OC)C=C5[C@@]4([H])CC6=CC(OC)=C(OC)C(OC)=C6	ACC	API-03789	2.84630859	4.50691862	4.80766977	4.52026284	0.65347052	-3.15201052	-12.05822195									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00483012-01	Phytic acid		lipid oxidation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	83-86-3		11.0676527398	-4.9559444758	4.3600996732	4	7		-11.816724544	-9.01393712	0.0560308436	0.885132514			O[P](O)(=O)OC1C(O[P](O)(O)=O)C(O[P](O)(O)=O)C(O[P](O)(O)=O)C(O[P](O)(O)=O)C1O[P](O)(O)=O	DC Chemicals	DCZ-023	3.40123471	4.15579015	3.66376784	0	0.74852078	1.17437054	-9.01393712									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182849-01	Epristeride	144206545	3-oxo-5-alpha-steroid 4-dehydrogenase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	119169-78-7	Epristeride; 	6.9832167823	-5.1559444758	-4.0849407506	4	7	SK&F 105657;EPRISTERIDE;CIPLUS_210870;17-N-t-butylcarboxamide androst-3,5-diene-3-carboxylic acid;SKF 105657;LS-19325;ONO 9302;Epristeride;ANDROSTA-3,5-DIENE-3-CARBOXYLIC ACID, 17-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)-, (17B)-;epristeride;ONO-9302;epristeridum;17B-(TERT-BUTYLCARBAMOYL)ANDROSTA-3,5-DIENE-3-CARBOXYLIC ACID;SK&F-105657;	-13.8555867439	-9.87965562	0.037283373	0.9097259399	6716	SRD5A2	CC(C)(C)NC(=O)[C@H]2CC[C@H]3[C@@H]4CC=C1C=C(CC[C@]1(C)[C@H]4CC[C@]23C)C(=O)O	APAC	816099	1.17690582	2.37704729	2.44485596	0.94708042	-2.69229855	-2.61180008	-9.87965562									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00261972-01	NCGC00261972-01	225144356		DPI_SARS-CoV-2_General	2019_NPC_02		Cymelarsan;Rm-110;Melarsominum;Merial brand of melarsomine			-3.7394037811	4	7		0	-0.53750654					NCCS[As](SCCN)C1=CC=C(NC2=NC(=NC(=N2)N)N)C=C1	GVK	FFS-11-286-NCI-125	0.71909177	-1.10651667	-1.55880078	-2.05551528	1.58496305	-2.50375799	-0.53750654									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00188863-02	Dronedarone hydrochloride	170465064	alpha,beta-Adrenoceptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	141626-36-0	Dronedarone; Dronedarone	4.9437388825	-5.3059444758	-81.887857825	-2.1	7		-91.3316225048	-85.08776102	0.0000172405	0.9983003096	148	ADRA1A	CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c2c3cc(ccc3oc2CCCC)NS(C)(=O)=O	SIGMA	D9696	0	3.62447735	3.64970348	0.06313869	-7.6871896	-52.64468245	-85.08776102									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159461-07	Amprenavir		HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_02	161814-49-9				4.8936920706	4	7		0	-5.76987109					CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)[S+]([O-])(=O)C3=CC=C(N)C=C3	SIGMA	SML0685	3.60470762	1.72561159	4.14195635	0.02104623	2.11249198	-0.14092446	-5.76987109									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00013369-07	Pamoic acid disodium salt			DPI_SARS-CoV-2_General	2019_NPC_02	[6640-22-8]		7.8352981002	-5.1059444758	-85.183431569	-2.2	7		-58.9627977423	-60.40527042	0.0000501893	0.9970949332			OC(=O)C1=C(O)C(CC2=C3C=CC=CC3=CC(C(O)=O)=C2O)=C4C=CC=CC4=C1	Tocris	4298	-8.07186293	-5.64346601	-7.53615715	-9.77714379	-11.78860823	-33.75140924	-60.40527042									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015146-17	Brompheniramine (maleate)		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	980-71-2				-2.2038096277	4	7		0	-3.12990534					CN(C)CCC(C1=CC=C(Br)C=C1)C2=CC=CC=N2	MedChem Express	HY-B0480	1.15840829	-0.57982397	-0.20862146	-0.45600168	1.2332771	-1.90248027	-3.12990534									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163699-07	Fumagillin		Methionine Aminopeptidase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	23110-15-8		8.7913490634	-5.0559444758	-48.13946657	-2.2	7		-38.8668154872	-38.84317176	0.0009937193	0.986859577			[H][C@@]1([C@H](OC)[C@@H](CC[C@]12CO2)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O)[C@@]3(C)O[C@@H]3CC=C(C)C	MedChem Express	HY-B0751	-1.58847603	-6.24408048	-4.7936054	-2.42031663	-5.26340803	-19.3160466	-38.84317176									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159497-02	Allylestrenol	144205271	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	432-60-0	Allylestrenol; Allyloestrenol; Turinal; Gestanon; Alilestrenol; Gestanin; Perselin; 	40.1852538492	-4.3959332839	-8.0469829345	-3	7	Estr-4-en-17-ol, 17-(2-propenyl)-, (17beta)-;Organon Brand of Allylestrenol;allylestrenolum;CIPLUS_153117;allylestrenol;Perselin;Allylestrenolum;Turinal;Gestanon;LS-64837;Alilestrenol;Gestanin;Allylestrenol Organon Bran;ALLYLESTRENOL;Allyloestrenol;Allylestrenol;ALLYL ESTRENOL;	-33.7540313039	-30.62835942	0.0186445724	0.9385205588			C[C@]32CC[C@@H]1[C@H]4CCCC=C4CC[C@H]1[C@@H]3CC[C@@]2(O)CC=C	SigmaAldrich	R187755	0	-3.96636559	-1.6666276	3.645675	4.96399971	0.80326945	-30.62835942									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00167981-03	Isosorbide mononitrate			DPI_SARS-CoV-2_General	2019_NPC_02	16051-77-7				4.2375268176	4	7		0	-2.69704609					O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+]([O-])=O	Prestwick	Prestw-1294	1.50061273	2.13218139	-0.24143832	0.44197086	2.59724829	0.38049605	-2.69704609									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00346551-03	Pomalidomide		TNF-alpha Production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	19171-19-8				-0.8920211653	4	7		0	-0.91804214				TNF	NC1=C2C(=O)N(C3CCC(=O)NC3=O)C(=O)C2=CC=C1	APExBIO	A4212	1.90293417	-3.29644944	-0.08673027	0.00233847	0.24950693	0.70462232	-0.91804214									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015594-09	LOXOPROFEN SODIUM			DPI_SARS-CoV-2_General	2019_NPC_01	80382-23-6				-2.1891866873	4	7		0	-0.55258422					CC(C(O)=O)C1=CC=C(CC2CCCC2=O)C=C1	Sequoia	80382-23-6	-2.05504321	1.38050676	-0.43625551	-1.30182858	-1.29675684	0.9299253	-0.55258422									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167440-02	Bosentan	170465245	"Endothelin receptor, ET-A/ET-B Antagonist"	DPI_SARS-CoV-2_General	2019_NPC_01	147536-97-8		12.4181106199	-4.9059444758	-5.5134464745	4	7		-15.834186712	-13.61182226	0.0355755831	0.9118451804			CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc3nc(nc(OCCO)c3Oc2ccccc2OC)c4ncccn4	Prestwick	Prestw-1244	3.08135454	-0.49111833	-1.8449465	2.49579853	0.91610415	-1.67691448	-13.61182226									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167533-02	Vardenafil	170465607	Phosphodiesterase V (PDE5) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	1193386-64-9	 ;Levitra;Vardenafil citrate; Vardenafil citrate; Vardenafil Hcl; Vardenafil HCLTrihydrate;Vardenafil Hydrochloride Trihydrate (Vivanza	13.9333492831	-4.8559444758	-18.1659798262	4	7		-28.357164584	-20.71430382	0.0008064759	0.9882096323	8654	PDE5A	O=C(O)C(O)(CC(=O)O)CC(=O)O.CCN1CCN(CC1)S(=O)(=O)c4cc(C2=NC(=O)c3c(C)nc(CCC)n3N2)c(OCC)cc4	Sequoia	SRP01005v	0.76247186	-0.74034256	1.06992274	-0.64464344	-2.97670406	-7.81543778	-20.71430382									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179460-03	Medrysone	170465194	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	2668-66-8		11.0676527398	-4.9559444758	-17.4381470467	4	7		-21.833983928	-20.27831994	0.0012891293	0.9850188318			CC(=O)[C@H]4CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3[C@@H](C)C[C@H]12	Prestwick Chemical, Inc.	Prestw-743	0.03146709	-1.24367777	-2.17152884	0.01755838	0.17510024	-6.45866152	-20.27831994									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183008-01	Israpafant	144206851	Interleukin-5 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	117279-73-9	ISRAPAFANT; 	4.9437388825	-5.3059444758	-75.5870973028	-2.2	7	6H-Thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 4-(2-chlorophenyl)-6,9-dimethyl-2-(2-(4-(2-methylpropyl)phenyl)ethyl)-;4-(2-chlorophenyl)-2-(2-(4-isobutylphenyl)ethyl)-6,9-dimethyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine;Y 24180;CIPLUS_695838;(+/-)-4-(O-CHLOROPHENYL)-2-(P-ISOBUTYLPHENETHYL)-6,9-DIMETHYL-6H-THIENO(3,2-F)-S-TRIAZOLO(4,3-A)(1,4)DIAZEPINE;israpafant;ISRAPAFANT;Israpafant;Y-24180;israpafantum;	-72.8897874784	-68.39877316	9.073E-7	0.9996109693			CC(C)Cc1ccc(cc1)CCc2cc5c(s2)n3c(C)nnc3C(C)N=C5c4ccccc4Cl	Pharmaron	PH-NIH-155125	-1.24173989	-0.53509908	-0.07067827	-0.82022726	-10.02639192	-43.90975151	-68.39877316									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160515-02	Acarbose	170464784	alpha-Glucosidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	56180-94-0	; Lasa Brand of Acarbose; Glucobay; Glumida; Bayer Brand of Acarbose; Precose;ACARBOSE; Prandase;Acarbose; Glucor; Acarbosa			11.6886002024	4	7		0	0.30924438			2548	GAA	OCC4=C[C@H](N[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]1C)O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]3O)[C@H](O)[C@@H](O)[C@@H]4O	Vitas	STK801930	1.64355046	4.45915899	1.47449489	2.98743322	3.6618789	2.31719091	0.30924438									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022858-08	Sodium cromoglycate	170464887	Mediator Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	15826-37-6	;CROMOLYN SODIUM; Nasalcrom; Cromolyn sodium salt; Cromoglycate; Cromoglycic Acid; Cromolyn disodium salt; Cromoglycate, Disodiu; Aarane; Intal;Cromolyn disodium salt; Cromoglycate, Sodiu; Sodium Cromoglicate; Opticrom; Gastrocrom; Cromoglycic acid; Sodium cromoglicate; 6   Cromolyn Sodium; Acido cromoglicico; Lomudal; Vicrom; Disodium chromoglycate; Nalcrom; Bicromat Spray			15.1972696748	4	7		0	1.69323972				KCNMA1	[Na+].[Na+].[O-]C(=O)C=4Oc3cccc(OCC(O)COc1cccc2OC(=CC(=O)c12)C([O-])=O)c3C(=O)C=4	Microsource	01500210	3.29920364	0	4.65745412	4.07605288	3.54514541	4.99009096	1.69323972									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015092-10	Aminocaproic acid	170465057	PAI Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	60-32-2	 6-Aminohexanoic acid;6-Aminohexanoic acid;AMINOCAPROIC ACID;6-AMINOCAPROIC ACID;Aminocaproic acid; 6-Aminocaproic acid			8.2090687778	4	7		0	-2.16471065			5054	SERPINE1	NCCCCCC(=O)O	Microsource	01500114	0	2.40183742	2.84906534	2.56603206	0.91102878	4.64962651	-2.16471065									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016959-06	Ciprofloxacin	170464757	DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	93107-08-5	 ;CIPROFLOXACIN; Bay0986; Ciprofloxacin hydrochloride; Bay 0986; Cipro IV;Ciprofloxacin; Ciprobay; Cipro; Ciprofloxacino; Ciprofloxacin Lactate; Ciprofloxacin Hcl; Ciprinol; Ciloxan;Ciprofloxacin hydrochloride; Bay-09867; Ciprofloxacin Base			-32.8754155745	4	7		0	-9.53081037			7155	TOP2B	Cl.O=C(O)C2=CN(c1cc(c(F)cc1C2=O)N3CCNCC3)C4CC4	Vitas	STK021082	-7.01232058	-6.41385882	-8.44970876	-3.02254998	-7.86936	-7.29711876	-9.53081037									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159437-03	Clobutinol hydrochloride	170466051	HERG Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	1215-83-4				7.5675305963	4	7		0	1.51073484					Cl.Clc1ccc(CC(C)(O)C(C)CN(C)C)cc1	Prestwick	Prestw-1380	4.34487934	0	2.41524701	0	3.06298533	0	1.51073484									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160484-02	Etafenone	170466000	vascular smooth muscle contraction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	90-54-0				4.9445536309	4	7		0	-5.50049428					CCN(CCOc2ccccc2C(=O)CCc1ccccc1)CC	Vitas	STK321191	0.71406095	3.49158257	0.35339134	-0.64464344	3.54514541	3.79084303	-5.50049428									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023673-10	Adenosine		Adenosine Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	[58-61-7]		3.499899101	-5.4559444758	-9.9845112443	4	7		-9.0738444199	-2.18332303	0.3088982276	0.6976875552		ADORA1	NC1=NC=NC2=C1N=C[N]2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O	Tocris	3624	2.90642558	0.4273603	-2.91835634	-0.80677221	-1.26654469	-7.14487035	-2.18332303									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179584-05	Ceftazidime		Penicillin-binding protein 4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	72558-82-8				-19.2769881516	4	7		0	-6.4358084					CC(C)(O\N=C(/C(=O)N[C@H]1[C@H]2SC\C(=C(/N2C1=O)C([O-])=O)C[N+]3=CC=CC=C3)C4=CSC(=N4)N)C(O)=O	Enzo	DL348	-3.73419039	-1.84573448	-4.16539697	-3.04234969	-5.18261531	-3.7110109	-6.4358084									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00017244-16	ENOXOLONE			DPI_SARS-CoV-2_General	2019_NPC_02	471-53-4		11.0676527398	-4.9559444758	-21.1563529697	-2.2	7		-46.4596870115	-39.74218713	0.0000502376	0.9970943264			[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]3(C)C2=CC(=O)[C@]4([H])[C@@]5(C)CC[C@H](O)C(C)(C)[C@]5([H])CC[C@@]34C)C(O)=O	Microsource	01500990	0.9179403	1.87345515	1.605682	2.85527208	2.83012143	-10.34385569	-39.74218713									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161336-01	Potassium ricinoleate	26754911	Prostanoid EP3 receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_02		Ricinoleic acid; 12-Hydroxyoleic acid; 	15.6334750258	-4.8059444758	-10.507293873	4	7	ricinelaidic acid;ricinoleic acid, (R-(E))-isomer;LS-195;12-oxooctadecanoic acid;Ricinoleic acid;RICINOLEIC ACID, SODIUM SALT;CIPLUS_658255;CIPLUS_680366;12-hydroxy-9-octadecenic acid;CIPLUS_750550;RICINOLEIC ACID;CIPLUS_671898;CIPLUS_166631;12-hydroxy-9-octadecenoic acid;CIPLUS_151987;CIPLUS_663822;CIPLUS_3886623;Ricinelaidic acid sodium salt;(R)-12-Hydroxy-9(E)-octadecenoic acid;kyselina 12-hydroxy-9-oktadecenova (czech);12-Hydroxyoleic acid;CIPLUS_661801;CIPLUS_164143;12-ketostearate;CIPLUS_689393;(R)-12-Hydroxy-cis-9-octadecenoic acid;Potassium ricinoleate;CIPLUS_686506;ricinoleic acid;CIPLUS_689370;CIPLUS_664600;LS-143811;HSDB 4280;CIPLUS_684810;POTASSIUM RICINOLEATE;CIPLUS_666567;12-HYDROXY-9-OCTADECENOIC ACID;	-11.788303284	-11.07358607	0.0220885319	0.9330913053			CCCCCC[C@@H](O)C\C=C/CCCCCCCC(O)=O	BIOMOL	BIOMOL_AL-112	-0.64510162	0.28413685	-2.90429198	-0.85354161	-0.10217903	-2.47557309	-11.07358607									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016634-04	Acetopromazine maleate	170465731		DPI_SARS-CoV-2_General	2019_NPC_01	3598-37-6		13.9333492831	-4.8559444758	-28.293806676	-2.2	7		-48.9370484855	-40.02940356	0.0032879144	0.9756521569			O=C(O)/C=C\C(=O)O.CC(=O)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1	Prestwick Chemical, Inc.	Prestw-576	3.44927747	1.09463191	0.5313056	-4.5325708	-0.39334112	-10.32572793	-40.02940356									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016506-07	Naphazoline hydrochloride	170464797	Alpha-1b adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	550-99-2				5.2615864388	4	7		0	-2.64125117					Cl.c2cc(CC1=NCCN1)cc3ccccc23	Vitas	STK300042	1.53704645	1.4049405	2.44936755	0	0	4.17704152	-2.64125117									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090970-03	Maleic acid	170465983	"NADP-dependent malic enzyme, mitochondrial Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC_01	110-16-7				-36.5355699118	4	7		0	-9.48518415					O=C(O)/C=C\C(=O)O	SIGMA	M0375	-5.79720669	-5.91052362	-9.96563574	-9.7198184	-7.45825509	-6.44341684	-9.48518415									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179546-05	Bambuterol hydrochloride	170466370	Butyrylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	81732-46-9				4.4392830044	4	7		0	1.31302122					Cl.O=C(Oc1cc(cc(c1)OC(=O)N(C)C)C(O)CNC(C)(C)C)N(C)C	Microsource	01505173	0	1.50511887	0	0.34113427	0	3.51643884	1.31302122									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091695-03	Triethylenetetramine	170465257	Copper Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC_01	112-24-3				11.3991294399	4	7		0	1.58677854					NCCNCCNCCN	Labotest	LTBB000434	3.00389708	3.7896743	3.17077332	2.45566509	1.70786175	1.07729051	1.58677854									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022248-04	Hydrocortisone 21-hemisuccinate sodium salt	170465053		DPI_SARS-CoV-2_General	2019_NPC_01	125-04-2				-27.3360969083	4	7		0	-10.28110821					[Na+].[O-]C(=O)CCC(=O)OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	Sequoia	125-04-2	-5.17754702	-4.52757348	-6.20262728	-5.95229137	-5.98639801	-3.66888561	-10.28110821									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159559-03	Eplerenone	170465283	Mineralocorticoid Receptor (MR) Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	107724-20-9	;Eplerenone; ; 9   Eplerenone; Inspra; Eplerenone			-13.0003160823	4	7		0	-7.50297838			4306	NR3C2	O=C(OC)[C@@H]4CC1=CC(=O)CC[C@]1(C)[C@@]65O[C@@H]6C[C@@]3(C)[C@@H](CC[C@]23CCC(=O)O2)[C@H]45	Tocris	2397	-4.37392588	0.21257361	-1.61585143	-2.28008127	-2.2103233	-2.81010214	-7.50297838									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182991-01	Glybuzole	144206873	insulin secretion Activator	DPI_SARS-CoV-2_General	2019_NPC_01	1492-02-0	Glybuzole; Gludiase; Glibuzol; 			1.2603198495	4	7	CIPLUS_216125;Glibuzol;desaglybuzole;LS-31372;glybuzole;Gludiase;N-(5-tert-butyl-1,3,4- thiadiazol-2-yl)benzenesulfonamide;GLYBUZOLE;Benzenesulfonamide, N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-;TH-1395;glybuzolum;Glybuzolum;Glybuzole;	0	0					O=S(=O)(Nc1nnc(s1)C(C)(C)C)c2ccccc2	Pharmaron	PH-NIH-183235	0	0	0	0	0	1.80395345	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095165-07	Carmofur	170465833	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	61422-45-5	 Mifurol;CARMOFUR; CARMOFUR; Carmofur; 			-25.1664603837	4	7		0	-4.49671745				TYMS	O=C1NC(=O)C(F)=CN1C(=O)NCCCCCC	Microsource	01505317	-4.27226297	-5.5635644	-4.85730301	-5.99744149	-5.95087043	-6.10803394	-4.49671745									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167576-02	Aprindine hydrochloride	170465842	Calmodulin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	33237-74-0		11.0676527398	-4.9559444758	-26.6143848887	-2.2	7		-50.8766589004	-44.60352947	0.0001075676	0.9957380928			Cl.CCN(CC)CCCN(c1ccccc1)C2Cc3ccccc3C2	Key Organics	KS-1222	0.84163796	1.15964795	3.43873796	0.11224657	2.05070931	-12.01146186	-44.60352947									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181122-01	2-Dodecylisoquinolinium tosylate	144206285		DPI_SARS-CoV-2_General	2019_NPC_02	5412-37-3	CIPLUS_189611; 	12.4181106199	-4.9059444758	-15.89284368	4	7	CIPLUS_160386;CIPLUS_150169;Lauryl isoquinolinium bromide;CIPLUS_164262;CIPLUS_189611;LAURYL ISOQUINOLINIUM BROMIDE;LAURYL ISOQUINOLINIUM SACCHARINATE;	-22.756718832	-17.71393236	0.0010579676	0.9864709888			[O-]S(=O)(=O)c1ccc(C)cc1.CCCCCCCCCCCC[n+]1cc2ccccc2cc1	NCI	NSC-4486	-0.13179495	0.2240754	-1.13218162	0.84886467	-2.36437516	-6.82544156	-17.71393236									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179245-04	Alcuronium chloride			DPI_SARS-CoV-2_General	2019_NPC_02	15180-03-7		11.0676527398	-4.9559444758	-32.3394380285	4	7		-21.6914482	-20.71540694	0.0345819041	0.9131504246			OC\C=C1/C[N@@+]2(CC[C@@]34[C@@H]2C[C@@H]1\C5=C\N6C7\C(=C/N(C35)C8=C4C=CC=C8)[C@H]\9C[C@H]%10[C@@]7(CC[N@@+]%10(CC=C)CC9=C\CO)C%11=C6C=CC=C%11)CC=C	Prestwick	Prestw-1036	-4.27986774	-0.97253344	-6.71573568	-5.03472628	-3.24359005	-10.5270575	-20.71540694									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181092-01	Ipodate sodium	144206261		DPI_SARS-CoV-2_General	2019_NPC_02	1221-56-3	IPODATE SODIUM; Ipodate; Biloptin; Oragrafin sodium; SoluBilopti; Calcium Ipodate; Calcium Iopodate; Iodopato sodico; Bilimin; Sodium, Ipodat; Solu Bilopti; Iopodate, Sodiu; Ipodate, Sodiu; Ipodate, Calciu; Solu-Biloptin; Iopodate, Calciu; 	13.9333492831	-4.8559444758	-12.1250116345	4	7	CIPLUS_157668;Ipodate sodium;BENZENEPROPANOIC ACID, 3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODO-, SODIUM SALT;Benzenepropanoic acid, 3-(((dimethylamino)methylene)amino)-2,4,6-triiodo-;BENZENEPROPANOIC ACID, 3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODO-, CALCIUM SALT;natrii iopodas;SODIUM 3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODOHYDROCINNAMATE;Ipodate Sodium;NSC-106962;CIPLUS_157904;Natrii iopodas;IPODATE CALCIUM;Ipodate;Iopodate, Sodiu;Bilimin;iopodate de sodium;SoluBilopti;Sodium, Ipodat;Ipodate, Sodiu;Sodium iopodate;Ipodate, Calciu;Calcium Ipodate;Iopodate de sodium;Biloptin;Ipodate Calcium;Oragrafin sodium;Solu-Biloptin;CALCIUM 3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODOHYDROCINNAMATE;Ipodic acid;CIPLUS_164488;Iodopato sodico;Sodium Iopodate;Solu Bilopti;BENZENEPROPANOIC ACID, 3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODO-;SODIUM IOPODATE;Iopodate, Calciu;IPODATE SODIUM;IPODIC ACID;3-(3-(((DIMETHYLAMINO)METHYLENE)AMINO)-2,4,6-TRIIODOPHENYL)PROPANOIC ACID;Calcium Iopodate;	-27.88022642	-21.56685535	0.0003271181	0.9925415629			[Na+].[O-]C(=O)CCc1c(I)c(/N=C/N(C)C)c(I)cc1I	NCI	NSC-106962	1.37575435	0.31185752	-0.02578467	2.18646961	0.37307226	-5.25648253	-21.56685535									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024995-43	Paclitaxel		Tubulin Depolymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	33069-62-4		9.8640558873	-5.0059444758	-36.7473273712	-2.2	7		-63.3289968083	-49.11287637	0.000454717	0.9911697827		TUBB	CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C3=CC=CC=C3)C4[C@@]5(CO[C@@H]5C[C@H](O)[C@@]4(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7	Aobious	AOB5558	1.04973525	0	4.40449122	4.45010874	-3.5572559	-21.85268696	-49.11287637									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179276-04	Etilefrine hydrochloride	225144301		DPI_SARS-CoV-2_General	2019_NPC_02	534-87-2				12.4177551624	4	7		0	3.81011273					CCNCC(O)C1=CC(=CC=C1)O	Prestwick	Prestw-1017	3.2255081	0.93095244	2.5151778	0.22683161	4.86894946	3.22717024	3.81011273									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164601-02	Liranaftate	170466057	Fungal Squalene Monooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	88678-31-3	 ;LIRANAFTATE; Liranaftate;Liranaftate; Zefnart; Liranaftato	12.4181106199	-4.9059444758	-18.6908220763	-3	7		-36.0797698404	-34.28049986	0.0001306705	0.9953012665			COc1cccc(n1)N(C)C(=S)Oc2cc3CCCCc3cc2	Sequoia	SRP01523l	2.41812505	0	0	0	0	-3.22170842	-34.28049986									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164548-02	Danofloxacin	170466637	Bacterial DNA gyrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	112398-08-0				8.163232037	4	7		0	-3.32564447					CN5C[C@@H]4C[C@H]5CN4c1cc2N(C=C(C(=O)O)C(=O)c2cc1F)C3CC3	Sequoia	SRP00900d	4.01568514	3.61863806	1.26977164	2.98241653	2.19002182	3.39956299	-3.32564447									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00183012-01	Penflutizide	144206843	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	1766-91-2	Penflutizide; Penflutizida; 	13.9333492831	-4.8559444758	-23.5380713214	4	7	LS-40450;Penflutizida;Penflutizidum;FT-124;Penflutizide;PENFLUTIZIDE;2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE, 3,4-DIHYDRO-3-PENTYL-6-(TRIFLUOROMETHYL)-, 1,1-DIOXIDE;3-n-pentyl-6-trifluoromethyl-7-sulfamyl-3,4- dihydro-1,2,4-benzothiadiazine-1,1-dioxide;penflutizidum;penfluzide;3-PENTYL-6-(TRIFLUOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE;penflutizide;CIPLUS_214081;	-22.781855976	-21.48487998	0.0186313493	0.9386621724			FC(F)(F)c1cc2NC(NS(=O)(=O)c2cc1S(N)(=O)=O)CCCCC	Pharmaron	PH-NIH-153110	-2.4423305	0.27610135	-1.65484634	-5.79175759	-1.58605289	-6.34686722	-21.48487998									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160482-02	Sulfalene	170465930	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	152-47-6				7.9012404577	4	7		0	0.61848876					COc2nccnc2NS(=O)(=O)c1ccc(N)cc1	Vitas	STK386859	0	0	1.42575126	4.21150325	4.1237375	1.07729051	0.61848876									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016561-05	Meticrane	170465801	Translocator protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	1084-65-7				-11.2168500088	4	7		0	-2.92514765					NS(=O)(=O)c2cc1c(CCCS1(=O)=O)cc2C	Microsource	01506077	-2.77636579	-1.4244875	1.0747971	-3.99578599	-4.1897173	-2.62208446	-2.92514765									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183283-01	Iomeprol	144207160		DPI_SARS-CoV-2_General	2019_NPC_02	78649-41-9				10.6183734601	4	7	Iomeprol;Iomeron 300;IOMEPROL;iomeprol 350;Iomeprolum;iomeprol 400;iomeprol;iomeprolum;Altana Pharma brand of iomeprol;Rovi brand of iomeprol;Imeron;CIPLUS_191882;Iomeron;N,N'-BIS(2,3-DIHYDROXYPROPYL)-5-((HYDROXYACETYL)METHYLAMINO)-2,4,6-TRIIODO-1,3-BENZENEDICARBOXAMIDE;	0	0.29491509					Ic1c(c(I)c(c(I)c1N(C)C(=O)CO)C(=O)NCC(O)CO)C(=O)NCC(O)CO	Toronto Research	I730500	3.88679507	3.57365613	3.32153489	0.9096649	2.06971936	1.32938745	0.29491509									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263532-01	Olopatadine hydrochloride	170465181	Mediator Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	140462-76-6	Olopatadine HCl;Olopatadine hydrochloride (Opatanol)			11.7920219334	4	7		0	-0.9560957				HRH1	Cl.O=C(O)Cc1ccc2OCc3ccccc3C(=C\CCN(C)C)\c2c1	Sequoia	SRP01210o	4.55270642	2.75589642	4.77016479	1.60652901	4.13706247	-0.08925216	-0.9560957									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00241103-06	Masitinib		FGFR 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1048007-93-7		9.8640558873	-5.0059444758	-77.1317440003	-2.2	7		-94.1514293851	-75.49350711	0.0000303826	0.9977417039		FGFR3	CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC(=CS4)C5=CC=CN=C5	Axon Medchem	1419	1.44512012	-0.31185752	-3.31684677	-3.23410425	-9.94463322	-38.00732807	-75.49350711									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510891-01	Cefacetrile			DPI_SARS-CoV-2_General	2019_NPC_02	10206-21-0				17.2670347327	4	7		0	2.54007516					CC(=O)OC\C1=C(\N2[C@H](SC1)[C@H](NC(=O)CC#N)C2=O)C(O)=O	SantaCruz Bio	sc-396239	4.69606234	4.46533761	3.62626286	3.14056544	4.61231376	2.3957159	2.54007516									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179430-04	Iocetamic acid			DPI_SARS-CoV-2_General	2019_NPC_02	16034-77-8				-18.5746335628	4	7		0	-10.91185844					CC(CN(C(C)=O)C1=C(I)C(=C(I)C=C1I)N)C(O)=O	Prestwick	Prestw-838	-1.12141321	-3.84624269	-3.7997234	-2.48111685	-2.09348193	-5.03570086	-10.91185844									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344542-01	Transfluthrin	225144388	Cytochrome P450 3A2 Activator	DPI_SARS-CoV-2_General	2019_NPC_01	118712-89-3		12.4181106199	-4.9059444758	-3.0673869774	4	7		-18.1794758	-12.2328965	0.0247643421	0.9282944367			CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC2=C(F)C(=CC(=C2F)F)F	SIGMA	46114	2.38423741	0.57907982	0.62635568	4.69812125	0	-3.37415519	-12.2328965									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090874-06	Piperonyl butoxide	170464741		DPI_SARS-CoV-2_General	2019_NPC_01	51-03-6		17.5410474839	-4.7559444758	-20.2029809168	-3	7		-48.574839673	-44.36389445	0.0001833812	0.9944232608			CCCc1cc2OCOc2cc1COCCOCCOCCCC	SIGMA	45626	1.16428243	3.48669582	0.46062733	-0.50919307	0	0	-44.36389445									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021123-03	Diatrizoic acid dihydrate	170464638		DPI_SARS-CoV-2_General	2019_NPC_01	50978-11-5				10.9268740199	4	7		0	-0.253479					O.O.O=C(C)Nc1c(I)c(c(I)c(NC(C)=O)c1I)C(=O)O	Bosche	D0803	2.34066759	3.7310333	2.69796008	3.43893446	0	3.68921185	-0.253479									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091502-11	Coumarin	170465665	Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	91-64-5				10.0234638358	4	7		0	0.53737548					O=C1C=Cc2ccccc2O1	Vitas	STK066167	0	0	3.67283274	4.89377179	1.7484647	3.61807002	0.53737548									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091454-07	Phenol	170465486		DPI_SARS-CoV-2_General	2019_NPC_01	108-95-2				11.8798715992	4	7		0	0.74522826					Oc1ccccc1	Specs	AE-562/J262148	3.61387457	3.60886456	0.8359533	3.2984674	1.72816322	3.46562325	0.74522826									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167434-02	Pemirolast potassium	170465431		DPI_SARS-CoV-2_General	2019_NPC_01	100299-08-9				4.4894494917	4	7		0	2.50944209					[K+].CC3=CC=CN1C3=NC=C(C1=O)c2[n-]nnn2	Bosche	P2486	0.54220221	0	0.78964685	0	0	2.3680065	2.50944209									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00167436-02	Azelnidipine	174006618	Ca channel blocker - DHP class	DPI_SARS-CoV-2_General	2019_NPC_01	123524-52-7	 ; Calblock;Azelnidipine; Azelnidipine	1.7541047484	-5.7559444758	-125.4975831016	-1.1	7		-89.6077311129	-87.38435021	0.0000577513	0.9968817467			[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC(C)C)=C(C)NC(N)=C2C(=O)OC3CN(C3)C(c4ccccc4)c5ccccc5	Bosche	A2998	4.08346041	0.68170157	0.83107894	-7.57769584	-32.45444856	-79.10971086	-87.38435021									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091195-08	Hexachlorophene	170464690	Glucose-6-phosphate dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	70-30-4		4.9437388825	-5.3059444758	-87.2514059633	-2.1	7		-91.3323718069	-87.53136803	0.0000816522	0.9962886402			Clc2c(Cc1c(O)c(Cl)cc(Cl)c1Cl)c(O)c(Cl)cc2Cl	Vitas	STK377478	1.25142207	3.38896083	2.05454413	-3.91050242	-6.27569406	-55.29244372	-87.53136803									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262941-01	Ipenoxazone hydrochloride	170465754	Glutamate [NMDA] receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	118635-68-0	2-Oxazolidinone,	19.6813789847	-4.7059444758	-25.7629082763	4	7		-11.5294601039	-13.1707688	0.0521868345	0.8905405699			Cl.CC(C)C[C@H]3N(CCCN1CCCCCC1)C(=O)O[C@H]3c2ccccc2	GVK	FFS-11-286-NCI-165	-5.48737685	-5.25569917	-2.31288538	-5.37537312	-3.54514541	-5.12221149	-13.1707688									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091106-05	Methyl salicylate	225144206		DPI_SARS-CoV-2_General	2019_NPC_01	90045-28-6				10.5000046919	4	7		0	2.84910395					COC(=O)C1=C(O)C=CC=C1	SIGMA	84330	3.73006076	2.81232438	0	0	3.19494493	3.25727933	2.84910395									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183050-01	Bethanidine sulfate (2:1)	144206760	adrenergic receptor signaling pathway involved in heart process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	114-85-2	Betanidine sulfate; Betanidin; Batel; Sulfate, Bethanidin; Benzaidin; Tenathan; Betanidina; 			7.6643517124	4	7	BETHANIDINE SULFATE;LS-73259;Bethanidine;Bethanidine, Sulfate (2:1);BETHANIDINE;Tenathan;Betanidine Sulfate;Betanidine sulfate;BETANIDINE SULFATE;Betanidinum;Batel;GUANIDINE, N,N'-DIMETHYL-N''-(PHENYLMETHYL)-, SULFATE (2:1);betanidine;Betanidina;CIPLUS_151384;Wellcome Brand of Betanidine Sulfate;1-BENZYL-2,3-DIMETHYLGUANIDINE SULFATE (2:1);Bethanidine sulfate;Betanidine;GUANIDINE, N,N'-DIMETHYL-N''-(PHENYLMETHYL)-;betanidinum;Betanidin;Sulfate, Bethanidin;Bethanidine Sulfate;Benzaidin;BETANIDINE;1-BENZYL-2,3-DIMETHYLGUANIDINE;CIPLUS_3728831;Guanidine, N,N'-dimethyl-N''-(phenylmethyl)-;CIPLUS_148752;LS-73261;	0	-1.79803073					O=S(=O)(O)O.C\N=C(/NC)NCc1ccccc1.C\N=C(\NCc1ccccc1)NC	NCI	NSC_106563	4.87641333	3.17170644	4.28728816	1.02191147	-1.24278212	0.35700864	-1.79803073									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00388420-02	Pentostatin	363680730	Adenosine Deaminase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	53910-25-1				7.7036395778	4	7		0	0.34248204				ADA	OC[C@H]1O[C@H](C[C@@H]1O)[N]2C=NC3=C2N\C=N/C[C@H]3O	MedChem Express	HY-A0006	4.29836528	1.41144402	2.59018776	0	1.0146615	1.58305148	0.34248204									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179239-05	Clocortolone pivalate			DPI_SARS-CoV-2_General	2019_NPC_02	34097-16-0		1.241811062	-5.9059444758	-18.2031172596	4	7		-11.232243512	-9.9890596	0.0319893247	0.9172821527			C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C	Prestwick	Prestw-1119	-0.23353141	1.73947192	-2.81521765	-2.06019222	-4.95449469	-10.19353626	-9.9890596									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263156-14	Nintedanib		VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	928326-83-4		1.7541047484	-5.7559444758	-75.8296008331	-1.2	7		-47.2846674216	-46.54901774	0.001112145	0.9860730092	2324	FLT1	COC(=O)C1=CC=C\2C(=C1)NC(=O)C2=C(\NC3=CC=C(C=C3)N(C)C(=O)CN4CCN(C)CC4)C5=CC=CC=C5	APExBIO	A8252	-2.3977433	2.37704729	-1.55880078	-5.46500479	-17.09241261	-49.33765502	-46.54901774									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021301-06	Fluocinolone acetonide	170464630	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC_01	67-73-2	; ; Fluocet; Synalar-C; Acetonida de fluocinolona; Sinalar; Synandone; Fluocinolone acetonide;Fluocinolone acetonide	13.9333492831	-4.8559444758	0.4528755559	4	7		-7.6530379439	-6.37753162	0.2645786257	0.6684527155		NRC31	OCC(=O)[C@]45OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick	Prestw-1419	3.62839784	-2.18193369	-0.74821476	2.70148243	1.47947013	0.69617359	-6.37753162									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263655-01	Huperzine A	170466837	Acetylcholinesterase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_01	102518-79-6				-6.1080421684	4	7		0	-4.42067375				ACHE	CC2=C[C@H]\3CC=1NC(=O)C=CC=1[C@@](N)(C2)C/3=C\C	Enzo	C117	-0.55430494	0.63283407	0.07067827	-1.59781273	-1.66725879	-2.3070278	-4.42067375									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018153-10	Dienestrol	170465362	Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	84-17-3	 (E,E)-Dienestrol; Ortho Dienestrol; Dienestrol, (Z,E)-Isomer; Dienoestrol; Ortho Brand of Dienestrol; Dienestrol, (E,E)-Isomer; Dienestrol, (Z,Z)-Isomer; Oestrasid;DIENESTROL; Synestrol;Dienestrol;	6.2237985085	-5.2059444758	-59.2167621217	-2.2	7		-67.5996806151	-61.66637094	0.0000635228	0.9967293505	2099	ESR1	Oc1ccc(cc1)C(=C\C)/C(=C/C)c2ccc(O)cc2	Microsource	01500241	3.69133203	0.46668458	0.68972241	-1.37707879	-6.76800487	-34.80359774	-61.66637094									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249914-01	Bencyclane	170465760		DPI_SARS-CoV-2_General	2019_NPC_01	2179-37-5		17.5410474839	-4.7559444758	3.6078673314	4	7		-11.288028184	-6.07335682	0.1080899698	0.8276482069			CN(C)CCCOC1(CCCCCC1)Cc2ccccc2	GVK	FFS-11-286-NCI-166	3.42023092	4.11708652	0.96268675	0	1.39826422	-0.04573403	-6.07335682									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159508-04	Rose Bengal disodium	225144230	Free Radical Stimulator	DPI_SARS-CoV-2_General	2019_NPC_01	632-69-9	; Bengal Rose B sodium salt; Rose Bengal Sodium I 125; ; Rose Bengal sodium salt; Rose bengal sodium;Rose bengal; Rose bengal;Rose Bengal; Bengal, Ros;Rose Bengal disodium; Acid Red- 94	1.241811062	-5.9059444758	-145.5491130336	-1.1	7		-97.4357532143	-93.62500317	0.000001455	0.9995071927			[O-]C(=O)C1=C(C(=C(Cl)C(=C1Cl)Cl)Cl)C/2=C/3\C=C(I)/C(=O)/C(=C3OC4=C2C=C(I)C(=C4I)[O-])I	SIGMA	R3877	1.41601917	2.06953845	0.76771222	-8.6663155	-49.68532711	-83.52050409	-93.62500317									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018210-05	Oxyphencyclimine hydrochloride	170465276	Muscarinic acetylcholine receptor M4 Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	125-52-0				0.9854580042	4	7		0	-3.41182733					Cl.CN3CCCN=C3COC(=O)C(O)(c1ccccc1)C2CCCCC2	Microsource	01503932	-1.37729044	3.1788306	2.76620116	-2.23493115	2.01745927	-0.41160628	-3.41182733									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021191-09	Cortisone acetate	170464685	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC_01	50-04-4	Cortisone acetate; ;; Cortisone 21-acetate;Cortisone 21-acetate; 6   Cortisone Acetate; Cortone acetate			11.4922007884	4	7		0	1.85546627				NRC31	CC(=O)OCC(=O)[C@@]3(O)CC[C@H]2[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4C(=O)C[C@@]23C	Selleck	S2559	2.85866434	1.51733574	0	3.30850076	4.46378724	2.98795671	1.85546627									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378896-03	Teneligliptin		Dipeptidyl peptidase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	760937-92-6		17.5410474839	-4.7559444758	-25.198832022	4	7		-16.501138484	-17.57123151	0.0366586931	0.9103331384			CC1=N[N](C2=CC=CC=C2)C(=C1)N3CCN(CC3)[C@@H]4CN[C@@H](C4)C(=O)N5CCSC5	MedChem Express	HY-14806	-2.37462138	-2.42786851	-1.73694944	-5.99349905	-5.63885655	-4.70217963	-17.57123151									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166079-02	C.I. Solvent Red 24	170465710		DPI_SARS-CoV-2_General	2019_NPC_02	85-83-6		1.3933349283	-5.8559444758	-131.1866643555	-1.1	7		-97.3906673662	-86.02482995	0.0000269554	0.997873172			Cc4ccccc4/N=N/c3ccc(/N=N/c1c2ccccc2ccc1O)c(C)c3	SIGMA	198102	1.5977248	4.16041027	0.20393333	-14.84227019	-44.34332153	-69.56501315	-86.02482995									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386387-01	Buclizine HCl		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	129-74-8		5.5469662594	-5.2559444758	-37.2504379276	-2.2	7		-40.8393664108	-39.66608001	0.0000908803	0.9960850218			CC(C)(C)C1=CC=C(CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(Cl)C=C4)C=C1	Selleck	S4140	0	0	0	0.6196946	1.83209372	-25.83145434	-39.66608001									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166301-04	SODIUM TETRADECYL SULFATE		Vitamin K-dependent protein S Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	139-88-8				-11.3129810624	4	7		0	-9.14236788			5627	PROS1	CCCCC(CC)CCC(CC(C)C)O[S]([O-])(=O)=O	Microsource	01300042	-2.21276793	-1.42992446	-1.39471649	-2.85994902	-0.14019913	-1.31999248	-9.14236788									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167490-03	Lumefantrine	170465388	antimalarial agents	DPI_SARS-CoV-2_General	2019_NPC_02	82186-77-4	;benflumetol, (+-)-isomer;Lumefantrine; Lumefantrine	1.5633475026	-5.8059444758	-139.7281883898	-2.1	7		-94.7351645722	-82.97103173	0.0000293089	0.9977819866			CCCCN(CCCC)CC(O)c4cc(Cl)cc3c4c1ccc(Cl)cc1\C3=C\c2ccc(Cl)cc2	SIGMA	L5420	-0.709843	-1.60548869	-3.42936171	-20.87084629	-43.9631205	-66.80289365	-82.97103173									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00506889-01	Sugammadex			DPI_SARS-CoV-2_General	2019_NPC_02	343306-71-8				13.311087949	4	7		0	4.28102554					O[C@@H]1[C@@H](O)[C@@H]2O[C@H]3O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]4O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]5O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]6O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]7O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]8O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]9O[C@H](CSCCC([O-])=O)[C@@H](O[C@H]1O[C@@H]2CSCCC([O-])=O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O	Proactive Molecular	P283-1548	3.18388864	2.52027074	2.45892033	0.10055422	3.09150964	4.56125517	4.28102554									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166105-04	BENZYL NICOTINATE	225144269		DPI_SARS-CoV-2_General	2019_NPC_01	94-44-0				-13.3541843229	4	7		0	-5.45486806					O=C(OCC1=CC=CC=C1)C2=CN=CC=C2	SIGMA	72351	-7.1091424	-3.12018961	-2.2300212	-1.49246244	-0.31213521	-0.95025154	-5.45486806									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00238452-03	Enzastaurin	170465609	PKCa, PKCb, PKCg inhbitor	DPI_SARS-CoV-2_General	2019_NPC_01	170364-57-5	 Enzastaurin;LY-317615;Enzastaurin	1.7541047484	-5.7559444758	-134.3078304532	-1.1	7		-101.4258852735	-95.93166206	0.0000068917	0.9989264425	5578	PRKCA	Cn2cc(c1ccccc12)C=3C(=O)NC(=O)C=3c7cn(C5CCN(Cc4ncccc4)CC5)c6ccccc67	Selleck	S1055	0	4.11708652	2.93680388	-5.44058996	-38.4687611	-82.98185883	-95.93166206									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249907-01	Sulthiame	170465788	Carbonic anhydrase XII Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	61-56-3				7.566343929	4	7		0	3.40675775					O=S2(=O)CCCCN2c1ccc(cc1)S(N)(=O)=O	GVK	FFS-11-286-NCI-132	3.14912981	1.74701297	0	0	0	3.46054169	3.40675775									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166147-02	Dihydrotachysterol	144205894	Vitamin D receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	67-96-9	Dihydrotachysterol; Dihydrotachysterin; Dihidrotaquisterol; Calcamine; Tachysterol, dihydro-; Tachystin; Hytakerol; 	4.9437388825	-5.3059444758	-67.3088642721	-2.2	7	parterol;LS-148512;Tachystin;CIPLUS_149136;Dihydrotachysterin;AT 10;Calcamine;dihydrotachysterol;dihydrotachysterolum;Hytakerol;NCGC00166147-01;Tachysterol, dihydro-;DIHYDROTACHYSTEROL;Dihydrotachysterol;AT-10;Dihydrotachysterolum;Dihidrotaquisterol;9,10-Secoergosta-5,7,22-trien-3-ol, (3beta,5E,7E,10alpha,22E)-;VITAMIN D1;9,10-Secoergosta-5,7,22-trien-3beta-ol;NCGC_SIGMA_D9257;	-75.536721688	-63.36393474	0.000050211	0.9970938472			C[C@H]3CC[C@H](O)C/C3=C\C=C1/CCC[C@]2(C)[C@H](CC[C@@H]12)[C@H](C)/C=C/[C@H](C)C(C)C	SIGMA	D9257	4.59895026	0	1.66193948	-0.01169235	-13.84644631	-40.77884254	-63.36393474									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166414-11	Pemetrexed Disodium heptahydrate		Thymidylate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	150399-23-8				5.5999444818	4	7		0	2.5020216					NC/1=N/C(=O)C2=C([NH]C=C2CCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1	Aobious	AOB2160	0	0	0	0	3.57626595	2.55073281	2.5020216									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168783-01	Diisopropyl fluorophosphate	144206196	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	55-91-4	Isoflurophate; Floropryl; Fluorostigmine; Dyflos; 			-21.1007934014	4	7	Diisopropylphosphofluoridate;DIFP;PHOSPHOROFLUORIDIC ACID, BIS(1-METHYLETHYL) ESTER;Bis(1-methylethyl) Phosphorofluoridate;Isoflurophate;CIPLUS_148756;DIISOPROPYLFLUOROPHOSPHATE;Phosphorofluoridic acid, bis(1-methylethyl) ester;Dyflos;Di isopropylphosphorofluoridat;diisopropyl phosphofluoridate;Fluorostigmine;Phosphoric acid diisopropyl ester fluoride;LS-108313;Floropryl;Di-isopropylphosphorofluoridate;6   Diisopropyl Fluorophosphate;ISOFLUROPHATE;Diisopropylfluorophosphate;Merck Brand of Isoflurophate;Diisopropyl phosphorofluoridate;	0	-4.86134234					FP(=O)(OC(C)C)OC(C)C	Toronto Research	D455300	-3.45672732	-4.6224214	-4.87330349	-4.66057105	-2.06021434	-6.95697106	-4.86134234									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016927-11	Enoxacin	170465263	Quinoline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	74011-58-8	; ; Enoxiacin Gluconate;Enoxacin; Penetrex; Enoxacin;ENOXACIN; 2   Enoxacin	24.777388143	-4.6059444758	5.7238391338	4	7		-10.603216648	-6.75268054	0.2364861567	0.6960792417			O=C(O)C2=CN(CC)c1nc(c(F)cc1C2=O)N3CCNCC3	Microsource	01503215	0	4.9527207	0	0	4.45871187	3.87722953	-6.75268054									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093351-06	Cefoxitin	170465105	Penicillin-binding protein 2B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	35607-66-0		9.8640558873	-5.0059444758	-8.4886265793	4	7		-14.6820993119	-13.48508276	0.0110856424	0.9539266537	933948	penA	O=C(O)C=2N3C(=O)[C@](NC(=O)Cc1cccs1)(OC)[C@H]3SCC=2COC(N)=O	Microsource	01502031	-1.19332898	0.69636181	0.24615535	-0.18310884	2.45901639	-4.03475786	-13.48508276									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179582-03	Bacampicillin hydrochloride	170465170		DPI_SARS-CoV-2_General	2019_NPC_01	37661-08-8				3.8981829531	4	7		0	-5.13041495					Cl.N[C@H](c1ccccc1)C(=O)N[C@@H]3C(=O)N2[C@@H](C(=O)OC(C)OC(=O)OCC)C(C)(C)S[C@@H]23	Prestwick Chemical, Inc.	Prestw-416	-0.74794859	2.42627117	3.55584802	1.86871347	0.93133025	1.38726561	-5.13041495									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164385-05	Clomifene citrate	170464951	Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC_01	911-45-5	; Zuclomifeno; Clomifeno; Clomiphene citrate (Z,E);CLOMIPHENE CITRATE; Clomifene Citrate; ; Clomiphene Hydrochloride; Clomid; Clomiphene citrate salt; (E)-isomer, HCl; Clomifen; cis-Clomiphene citrate; Clomifene citrate; Enclomifeno; (Z)-isomer, citrate; Clomiphene citrate	3.499899101	-5.4559444758	-143.2979053872	-2.1	7		-98.2238541552	-96.26625434	0.0000286303	0.9978078581	2099	ESR1	CCN(CCOc1ccc(cc1)C(c2ccccc2)=C(Cl)c3ccccc3)CC	Microsource	01500196	-3.53641711	-7.15175801	-9.5464405	-9.47901773	-31.46982693	-71.35525179	-96.26625434									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015252-12	Cyproheptadine hydrochloride	170465127	Histamine H1 Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	129-03-3	; ; Cyproheptadine hydrochloride;Cyproheptadine hydrochloride; Dihexazin; 1   Cyprohetadine;Cyproheptadine;CYPROHEPTADINE HYDROCHLORIDE; Viternum; 9   Cyproheptadine; Ciproheptadina; Periactin; Peritol; Antergan	13.9333492831	-4.8559444758	-39.8127568218	-2.2	7		-37.339727584	-30.26032293	0.0021177906	0.9806336603	9704	HRH1	CN1CC\C(CC1)=C2\c4ccccc4C=Cc3ccccc23	Vitas	STK802098	-1.22721661	-2.30410243	-4.60871049	-4.65798781	-7.74755113	-13.6287413	-30.26032293									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018181-12	Nalidixic acid	170465215	Quinoline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	389-08-2	; Negram-Citrat;NALIDIXIC ACID; Sodium, Nalidixat; Nevigramon; Acid, Nalidixi; Acido nalidixico; Nalidixic acid sodium; Mictral;Nalidixic acid; NegGram; Prestwick-03C08			10.3574018394	4	7		0	-1.56650022					O=C(O)C2=CN(CC)c1nc(C)ccc1C2=O	Vitas	STK735579	4.88224046	3.72614655	0.07067827	1.26671182	3.8598183	2.35276183	-1.56650022									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00180461-02	Hydroquinidine HCl		Sodium channel alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1476-98-8		9.8640558873	-5.0059444758	-27.1665321308	4	7		-16.381711436	-17.17166912	0.0122739219	0.9513090489			CC[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)C3=C4C=C(OC)C=CC4=NC=C3	Prestwick	Prestw-NAT-0284	-5.22786654	-2.23382384	-1.43690959	-4.01047635	-3.9992396	-9.17418264	-17.17166912									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166020-03	Ethyl 3-aminobenzoate methanesulfonic acid salt	170465717	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	886-86-2		19.6813789847	-4.7059444758	-22.6978186821	4	7		-11.003738528	-13.56112646	0.0439067421	0.9009074907			Nc1cc(ccc1)C(=O)OCC.CS(=O)(=O)O	Vitas	STK344228	-3.00873817	-6.28191658	-2.30801102	-3.67471844	-3.47409024	-3.59266223	-13.56112646									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178127-02	Ramipril	170464731	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	87333-19-5	;RAMIPRIL;Ramipril (Altace);Ramipril; Tritace; Altace; Ramipril and diuretics			-9.9608687652	4	7		0	-3.79108595			1636	ACE	O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2[C@@H](C[C@@H]3CCC[C@H]23)C(=O)O	Vitas	STK801937	-1.81969525	-3.80004158	-2.93710883	-0.40923228	0.53941021	-3.02048102	-3.79108595									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274271-01	Dimethisteron	170465914		DPI_SARS-CoV-2_General	2019_NPC_02	79-64-1		13.9333492831	-4.8559444758	-27.4950319242	-2.2	7		-40.6844408519	-31.40370071	0.001332504	0.9847352569			C[C@H]3C[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#CC)[C@@]4(C)CCC(=O)C=C34	GVK	FFS-11-286-NCI-184	2.30063123	-0.3441983	-0.93059234	-2.21920819	-3.51448328	-10.86997369	-31.40370071									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015889-11	Raloxifene hydrochloride	170465341	Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC_01	82640-04-8	 ; Keoxifene;Evista; Raloxifene Lilly Bran; Evista;RALOXIFENE HYDROCHLORIDE; Lilly Brand of Raloxifene; Raloxifene hydrochloride;Raloxifene hydrochloride	2.7800686746	-5.5559444758	-143.7633562035	-2.1	7		-103.5568495187	-97.38663152	5.985E-7	0.9996840312	2099	ESR1	Cl.Oc1ccc(cc1)c3sc2cc(O)ccc2c3C(=O)c5ccc(OCCN4CCCCC4)cc5	Microsource	01505622	-1.42086026	-2.56310015	-4.75006702	-12.49404269	-35.61640359	-75.45606992	-97.38663152									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179456-04	Glycopyrrolate bromide	170465427		DPI_SARS-CoV-2_General	2019_NPC_01	596-51-0				12.6470822811	4	7		0	1.30288206					[Br-].C[N+]3(C)CCC(OC(=O)C(O)(c1ccccc1)C2CCCC2)C3	Prestwick Chemical, Inc.	Prestw-746	4.00600295	4.41517824	2.77594989	4.16635312	-0.54052682	2.41374054	1.30288206									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094854-07	Allantoin	170465460	Allantoinase Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	97-59-6				2.2912346174	4	7		0	2.30665889			854845	DAL1	O=C1NC(=O)NC1NC(=O)N	Specs	AE-562/J258555	1.81782974	-1.46846825	-1.1820331	0.37374269	-0.59635588	2.65257381	2.30665889									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178286-05	Pralidoxime chloride	170465059	Butyrylcholinesterase Activator	DPI_SARS-CoV-2_General	2019_NPC_01	51-15-0				11.6387627805	4	7		0	0					[Cl-].O\N=C\c1cccc[n+]1C	Prestwick Chemical, Inc.	Prestw-943	4.71280227	4.48847949	4.58433867	0	3.01223164	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179290-03	Pivampicillin	170466065		DPI_SARS-CoV-2_General	2019_NPC_02	33817-20-8		6.9832167823	-5.1559444758	-57.7028145084	-2.2	7		-67.6880559398	-52.13337773	0.0100369196	0.956091304			CC(C)(C)C(=O)OCOC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)[C@H](N)c1ccccc1)[C@H]3SC2(C)C	Prestwick	Prestw-1009	3.84055123	3.53207512	0.40552261	-11.66662769	-13.41396764	-25.81736189	-52.13337773									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182998-01	Bisoxatin acetate	144206872		DPI_SARS-CoV-2_General	2019_NPC_02	14008-48-1	Bisoxatin acetate; 	13.9333492831	-4.8559444758	-27.2264525198	-2.2	7	LS-41817;2H-1,4-Benzoxazin-3-(4H)-one, 2,2-bis(p-hydroxyphenyl)-, diacetate;BISOXATIN ACETATE;bisoxatin diacetate;Bisoxatin Acetate;bisoxatin acetate;CIPLUS_169129;laxonalin;Bisoxatin acetate;	-56.1281929264	-41.76378252	0.0000112023	0.9986313423			CC(=O)Oc1ccc(cc1)C2(Oc3ccccc3NC2=O)c4ccc(OC(C)=O)cc4	Pharmaron	PH-NIH-183223	1.63009549	1.55004736	2.61362837	0.42794004	-0.30653708	-13.31736189	-41.76378252									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378669-02	Boldenone Undecylenate			DPI_SARS-CoV-2_General	2019_NPC_02	13103-34-9		5.5469662594	-5.2559444758	-45.3813440224	-2.2	7		-40.9085575599	-36.7930362	0.0004558564	0.9911623271			C[C@]12CC[C@H]3[C@@H](CCC\4=C\C(=O)\C=C/[C@]34C)[C@@H]1CC[C@@H]2OC(=O)CCCCCCCCC=C	MedChem Express	HY-17434	-0.44625309	-2.05363949	-1.10405288	-0.99384982	-10.66226267	-21.93724164	-36.7930362									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182985-01	Trolnitrate	144206882	Soluble guanylate cyclase Activator	DPI_SARS-CoV-2_General	2019_NPC_01	7077-34-1	TROLNITRATE PHOSPHATE; Trolnitrato; Angitrit; 			-15.552492149	4	7	trolnitratum;Trolnitratum;Trolnitrate;TROLNITRATE PHOSPHATE;2,2',2''- nitrilotrisethanol, trinitrate (ester);Trolnitrate Phosphate;Trolnitrate phosphate;LS-66974;trolnitrate;Trolnitrato;Ethanol, 2,2',2''-nitrilotris-, trinitrate (ester), phosphate (1:2) (salt) (9CI);Angitrit;CIPLUS_154803;Ethanol, 2,2',2''-nitrilotri-, trinitrate (ester), phosphate (1:2);trolnitrate phosphate (1:2);CIPLUS_658463;triethanolamine trinitrate;TROLNITRATE;	0	-9.16580061					O=[N+]([O-])OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O	Pharmaron	PH-NIH-183589	-1.13523588	-2.76345689	-1.40137944	-1.79847995	-3.48931635	-4.7868286	-9.16580061									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091390-04	4-Methoxyphenol	170464687	Tyrosinase Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	150-76-5				3.3102248346	4	7		0	-3.46252313					Oc1ccc(OC)cc1	Bosche	M0306	0.32435311	3.77501405	0	2.52589861	-0.18017561	0.91468062	-3.46252313									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015251-13	Clotrimazole	170464807	Lanosterol 14alpha-demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	23593-75-1	 ; Bay b 5097; Clotrimazole;Clotrimazole; b 5097, F; Clotrimazol; Kanesten; Baycuten; Canesten; Canesten HC; FB b 5097; b 5097, Ba; Baycuten SD; Lotrimin; Mycelex; Klotrimazole;CLOTRIMAZOLE; 5097, Bay	13.9333492831	-4.8559444758	-69.6551454735	-2.2	7		-102.6366125035	-78.51258523	0.0000190547	0.9982129671	1595	CYP51A1	Clc1ccccc1C(c2ccccc2)(c3ccccc3)n4ccnc4	Vitas	STK700023	-1.04809624	-0.8429643	1.16253564	-3.53425139	-6.02700096	-30.18446059	-78.51258523									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091641-12	MERCAPTOPURINE			DPI_SARS-CoV-2_General	2019_NPC_01	6112-76-1, 50-44-2 [anhydrous]				2.131589392	4	7		0	1.77942257					S=C1NC=NC2=C1NC=N2	Microsource	01500387	-1.99695011	1.40005375	1.62072579	-0.82524394	0.93133025	0.51323746	1.77942257									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253593-01	Bitolterol	170465239	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	30392-40-6		3.1192883571	-5.5059444758	-105.3213004162	-2.1	7		-91.6133051063	-81.04230564	0.0000244121	0.9979764038			O=C(Oc2cc(ccc2OC(=O)c1ccc(C)cc1)C(O)CNC(C)(C)C)c3ccc(C)cc3	GVK	FFS-11-286-NCI-028	1.57093409	-0.04642412	0.96268675	-6.0977751	-28.9676699	-56.95411352	-81.04230564									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167477-01	Fidarestat	144206034	Aldose reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	136087-85-9	SNK-860; Aldos; 			-29.3105481431	4	7	LS-145864;fidarestatum;fidarestat;Aldos;SNK-860;Fidarestat;FIDARESTAT;(2S,4S)-6-fluoro-2',5'-dioxospiro(chroman-4,4'-imidazolidine)-2-carboxamide;6-FLUORO-2',5'-DIOXOSPIRO(CHROMAN-4,4'-IMIDAZOLIDINE)-2-CARBOXAMIDE, 2S,4S, D-;CIPLUS_737489;Spiro(4H-1-benzopyran-4,4'-imidazolidine)-2-carboxamide, 6-fluoro-2,3-dihydro-2',5'-dioxo-, (2S-cis)-;SNK 860;fedarestat;	0	-9.26128526					NC(=O)[C@@H]2C[C@]1(NC(=O)NC1=O)c3cc(F)ccc3O2	Chemical Block	A4376/0186841	-3.97465837	-4.01718681	-7.36738473	-5.20777307	-5.42024095	-9.08493048	-9.26128526									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386281-05	Fidaxomicin			DPI_SARS-CoV-2_General	2019_NPC_02	873857-62-6		4.9437388825	-5.3059444758	-53.7061037123	-2.2	7		-62.5492317963	-58.37891833	0.0000214624	0.9981032326			CC[C@H]1\C=C(C)/[C@@H](O)C\C=C\C=C(CO[C@@H]2O[C@H](C)[C@@H](OC(=O)C3=C(CC)C(=C(O)C(=C3O)Cl)Cl)[C@H](O)[C@@H]2OC)\C(=O)O[C@@H](C\C=C(C)\C=C(C)\[C@@H]1O[C@@H]4OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]4O)[C@@H](C)O	Glixx	GLXC-90140	1.9538024	0	3.44342608	1.98536118	-3.62854359	-36.50883127	-58.37891833									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00348371-01	Chloramphenicol palmitate		Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	530-43-8		0.4943738883	-6.3059444758	-64.584762753	-1.2	7		-34.1527516635	-30.48338445	0.0027150353	0.9779565296			CCCCCCCCCCCCCCCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O	FLUKA	46109	0	0	1.46474617	-11.58602353	-23.86692382	-35.44387418	-30.48338445									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00261968-01	Bufetolol	170465825	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	53684-49-4	1-Tert-butylamino-3-(o-(tetrahydrofurfuryloxy)phenoxy)-2-propanol;B	9.8640558873	-5.0059444758	-24.980596114	-2.2	7		-36.006222904	-32.92185242	0.0005318496	0.9904446768			CC(C)(C)NCC(O)COc2ccccc2OCC1CCCO1	GVK	FFS-11-286-NCI-171	0.07019582	-1.16548977	-1.09429456	2.31018135	0.32228595	-11.3471213	-32.92185242									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168785-03	Diclazuril		antiprotozoal agent	DPI_SARS-CoV-2_General	2019_NPC_01	101831-37-2	 ; Diclazuril;Diclazuril;DICLAZURIL	7.8352981002	-5.1059444758	-27.8787869983	-2.2	7		-45.8340092736	-40.40455248	0.0000162569	0.9983504403			ClC1=CC=C(C=C1)C(C#N)C2=C(Cl)C=C(C=C2Cl)N3\N=C/C(=O)NC3=O	FLUKA	34057	2.75216034	1.74212622	2.2836392	0.77006045	0.92117952	-17.7956197	-40.40455248									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159418-05	Tegafur	170465809	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	37076-68-9	; S-1 compound; S-1 (combination); ; Tegafur (Ftorafur); UFT protocol; Tegafur; 1-UFT protocol; Franroze; Tegafur-Uracil; TS-1 cpd; S 1 (combination);Tegafur; S-1 cpd; Atillon			-19.3720776939	4	7		0	-4.92256217				TYMS	FC1=CN(C(=O)NC1=O)C2CCCO2	Labotest	LT00138127	-4.53852298	-6.1059936	-3.14152714	-3.31853413	-2.94117647	-4.10081813	-4.92256217									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00177979-05	Azelastine hydrochloride	170465172	Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	79307-93-0	; Astelin; Azelastina;AZELASTINE HYDROCHLORIDE; Azelastine Hydrchloride	15.6334750258	-4.8059444758	-17.3473589027	4	7		-28.2609819759	-20.21748498	0.0003313814	0.9924968349	9704	HRH1	Cl.Clc1ccc(cc1)CC3=NN(C(=O)c2ccccc23)C4CCCN(C)CC4	Microsource	01505340	-0.05567255	0.8820583	-1.32338963	-0.04264178	-1.60127899	-7.42923929	-20.21748498									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167488-08	Sorafenib	170465175	VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	475207-59-1	;Sorafenib;BAY-54-9085; Sorafenib Tosilate;BAY-43-0006; Sorafenib base;sorafenib; Sorafenib; Nexavar;Nexavar	6.9832167823	-5.1559444758	-62.6708944759	-2.4	7		-65.9759321712	-48.84540316	0.0740322264	0.8627312007	2321	FLT1	O=C(NC)c3cc(Oc2ccc(NC(=O)Nc1cc(c(Cl)cc1)C(F)(F)F)cc2)ccn3.O=S(=O)(O)c1ccc(C)cc1	Sequoia	284461-73-0	0.42359548	3.70171281	0.89444566	-20.78159882	-6.95579353	-30.09807409	-48.84540316									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015595-14	Labetalol HCl		Adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	32780-64-6		13.9333492831	-4.8559444758	-48.5499149913	4	7		-10.47703036	-17.91371355	0.1587419815	0.7751090127			CC(CCC1=CC=CC=C1)NCC(O)C2=CC(=C(O)C=C2)C(N)=O	APExBIO	B4795	-9.74589008	-7.21430386	-11.07100162	-10.80607067	-6.26618825	-11.14712514	-17.91371355									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183106-01	NCGC00183106-01	124894306	Aeromonas salmonicida Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02		Nifurpirinol; Furanace; 	11.0676527398	-4.9559444758	-33.0415715018	-2.2	7	P 7138;LS-131753;nifurpirinol;Nifurpirinolum;NIFURPIRINOL;Furanace;nifurpirinolum;6-(2-(5-nitro-2-furanyl)ethenyl)-2-pyridinemethanol;CIPLUS_208451;Nifurpirinol;6-hydroxymethyl-2-(2-(5-nitro-2-furyl)vinyl)pyridine;	-70.8171288602	-62.95010227	0.0000846399	0.9962214794			OCC1=CC=CC(\C=C\C2=CC=C(O2)[N+]([O-])=O)=N1	APAC	877864	1.81275868	0	4.13726823	4.18820008	3.28636266	-13.1576475	-62.95010227									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390702-02	Efinaconazole		Lanosterol 14-alpha demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	164650-44-6				12.1719131268	4	7		0	0.53274985					C[C@@H](N1CCC(=C)CC1)[C@](O)(C[N]2C=NC=N2)C3=CC=C(F)C=C3F	MedChem Express	HY-15660	1.83819279	0.98177366	4.56857551	3.58955172	4.4412233	1.64881623	0.53274985									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378606-02	Ipragliflozin		Sodium/glucose cotransporter 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	761423-87-4		11.0676527398	-4.9559444758	-56.6289705436	4	7		-27.116454976	-32.35979641	0.0056764441	0.9676285435			OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C2=CC=C(F)C(=C2)CC3=CC4=C(S3)C=CC=C4	MedChem Express	HY-14894	-7.29959074	-8.23996858	-9.10667823	-10.53480813	-5.59608393	-16.06069147	-32.35979641									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00241107-02	Bosutinib	170466788	Bcr-Abl Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	918639-10-8	 Bosutinib;Bosutinib;PF-5208763/SKI-606	6.2237985085	-5.2059444758	-83.4761316352	-2.2	7		-84.7220900932	-74.75621938	0.0000400082	0.9974071	25	ABL1	CO.COc4cc(Nc3c(C#N)cnc2cc(OCCCN1CCN(C)CC1)c(OC)cc23)c(Cl)cc4Cl	Sequoia	380843-75-4	1.6578418	-0.53362286	-2.93710883	-4.47817038	-13.30941235	-43.40003758	-74.75621938									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167462-03	Acamprosate Calcium	225144287		DPI_SARS-CoV-2_General	2019_NPC_02	77337-73-6				10.1485953227	4	7		0	3.14417543					CC(=O)NCCC[S]([O-])(=O)=O	Bosche	A0044	1.06129621	1.42530435	4.62014486	3.43053574	0	1.63942127	3.14417543									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161326-08	Calcifediol (monohydrate)			DPI_SARS-CoV-2_General	2019_NPC_02	63283-36-3		6.9832167823	-5.1559444758	-54.6288681651	-2.2	7		-66.9130713935	-60.91899348	0.0000884586	0.9961366738			C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(/CCC[C@]12C)=C/C=C3/C[C@@H](O)CCC3=C	MedChem Express	HY-32351A	0	2.60805285	-0.6727456	-0.9564343	-1.26179217	-31.92878617	-60.91899348									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249900-01	Glyceryl 1-(2-aminobenzoate)	170465551		DPI_SARS-CoV-2_General	2019_NPC_01	71574-35-1				7.5314721555	4	7		0	2.56520747					Nc1ccccc1C(=O)OCC(O)CO	GVK	FFS-11-286-NCI-90	4.9693801	0	0	0	0	4.0296763	2.56520747									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016385-08	Sulfabenzamide	170465133		DPI_SARS-CoV-2_General	2019_NPC_01	127-71-9				12.0174113291	4	7		0	2.67166865					Nc1ccc(cc1)S(=O)(=O)NC(=O)c2ccccc2	Vitas	STK985629	4.55788735	1.61507074	2.8149448	3.72488524	1.65203269	0.9553331	2.67166865									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178754-06	Primaquine diphosphate	174006623	antimalarial	DPI_SARS-CoV-2_General	2019_NPC_01	63-45-6		15.6334750258	-4.8059444758	-82.9592564594	-2.2	7		-96.8022270845	-79.64310157	0.000712299	0.9889046348			O=P(O)(O)O.O=P(O)(O)O.CC(CCCN)Nc1cc(cc2cccnc12)OC	Microsource	01500500	-3.85592913	-1.52222249	-10.84789549	-7.27167833	-9.07729787	-26.15478429	-79.64310157									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015603-08	Lomefloxacin hydrochloride	170465262	Quinoline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	98079-52-8	 ; Maxaquin;LOMEFLOXACIN HYDROCHLORIDE; Lomefloxacin hydrochloride;Lomefloxacin hydrochloride; Lemofloxacin			-3.456418794	4	7		0	-3.70586297					Cl.O=C(O)C2=CN(CC)c1c(F)c(c(F)cc1C2=O)N3CC(C)NCC3	Microsource	01502037	1.14975916	-3.16417035	4.69157466	-1.43727895	-4.77338476	1.41267341	-3.70586297									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164547-06	Zafirlukast	174007053	Leukotriene CysLT1 (LTD4) Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	107753-78-6	 ; Zafirlukast;Zafirlukast	5.5469662594	-5.2559444758	-115.9398154012	-2.1	7		-93.9313659	-81.36675876	0.0013779532	0.9844541879	10800	CYSLTR1	Cc1ccccc1S(=O)(=O)NC(=O)c5ccc(Cc3cn(C)c2ccc(cc23)NC(=O)OC4CCCC4)c(OC)c5	Sequoia	SRP00200z	-6.37329654	-6.72172405	-4.34062051	-5.8920912	-31.06887276	-50.32776056	-81.36675876									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183853-01	Mosapramine	144206880	Dopamine D4 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	89419-40-9		11.0676527398	-4.9559444758	-63.043829083	-2.2	7	MOSAPRAMINE HYDROCHLORIDE;LS-178090;Cremin;3-chloro-5-(3-(2-oxo-1,2,3,5,6,7,8,8a-octahydroimidazo(1,2-a)pyridine-3-spiro-4'-piperidino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine;Spiro(imidazo(1,2-a)pyridine-3(2H),4'-piperidin)-2-one, 1'-(3-(3-chloro-10,11-dihydro-5H-dibenz(b,f)azepin-5-yl)propyl)hexahydro-, dihydrochloride;CIPLUS_3853867;mosapraminum;CIPLUS_703731;Mosapramine hydrochloride;Y 516;(+/-)-1'-(3-(3-CHLORO-10,11-DIHYDRO-5H-DIBENZ(B,F]AZEPIN-5-YL)PROPYL)HEXAHYDROSPIRO(IMIDAZO(1,2-A)PYRIDINE-3(2H),4'-PIPERIDIN)-2-ONE;Mosapramine Hydrochloride;Mosapramine;mosapramine;Y-516;MOSAPRAMINE;	-93.3522724416	-69.58505488	0.0001871745	0.9943634242			Clc5ccc6CCc1ccccc1N(CCCN2CCC4(CC2)C(=O)NC3CCCCN34)c6c5	Pharmaron	PH-NIH-183543	0.13313001	3.96559728	2.87831152	-1.96904708	-11.08206872	-31.64286803	-69.58505488									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179663-03	(-)-(5S,8R)-Lisuride	170465966	Dopamine D5 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	159701-44-7		6.2237985085	-5.2059444758	-68.1554591804	-2.2	7		-78.0425464451	-70.87272819	0.0001779642	0.9945050356			CCN(CC)C(=O)N[C@@H]2C=C1c3cccc4ncc(C[C@@H]1N(C)C2)c34	Tocris	4052	0.39939002	1.22901752	4.57946431	-1.66302957	-10.00101507	-38.59952233	-70.87272819									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091071-08	p,p'-DDT	170465529		DPI_SARS-CoV-2_General	2019_NPC_01	50-29-3		8.7913490634	-5.0559444758	-31.9166560034	-2.2	7		-55.6900712303	-49.00762972	0.0001913005	0.9943022043			Clc1ccc(cc1)C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl	Specs	AE-562/J256064	0.58335149	3.11530286	0.39238624	3.2483006	2.83459372	-18.85258397	-49.00762972									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179366-03	Florfenicol	170465648		DPI_SARS-CoV-2_General	2019_NPC_01	73231-34-2				7.1625264664	4	7		0	0					O=S(C)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl	Prestwick Chemical, Inc.	Prestw-955	0.09924237	3.92650329	2.74182935	2.60114882	1.33228442	-0.45225875	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181755-01	Delapril hydrochloride	144206480		DPI_SARS-CoV-2_General	2019_NPC_02	83435-67-0	Delapril hydrochloride; Adecut; 	13.9333492831	-4.8559444758	-15.2497833765	4	7	Delapril Hydrochloride;Delapril hydrochloride;RHC-6000-A;RO-16-3037;N-(2,3-DIHYDRO-1H-INDEN-2-YL)-N-(N-((1S)-1-(ETHOXYCARBONYL)-3-PHENYLPROPYL)-L-ALANYL)GLYCINE HYDROCHLORIDE;CIPLUS_192483;derapril;USV 6000-A(SS);delapril;N-(2,3-dihydro-1H-inden-2-yl)-N-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)alanyl)glycine;CV 3317;N-(1-(S)-ETHOXYCARBONYL-3-PHENYLPROPYL)-(S)-ALANYL-N-(2-INDANYL)GLYCINE HYDROCHLORIDE;N-(N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl)-N-(indan-2-yl)glycine hydrochloride;DELAPRIL;LS-72517;DELAPRIL HYDROCHLORIDE;delaprilum;CV-3317;CIPLUS_667977;Delapril;LS-177754;Adecut;	-14.039575708	-13.36631309	0.0158773696	0.9441095585			Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(=O)O)C2Cc3ccccc3C2	ACC	DELAPRIL HYDROCHLORIDE	-0.74221369	-1.96585738	-1.51191955	-3.29958141	0.092674	-4.33107854	-13.36631309									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178483-14	Limonin			DPI_SARS-CoV-2_General	2019_NPC_01	1180-71-8				-1.220021086	4	7		0	-4.47643913					CC1(C)O[C@H]2CC(=O)OC[C@@]23[C@H]1CC(=O)[C@]4(C)[C@@H]3CC[C@@]5(C)[C@@H](OC(=O)[C@H]6O[C@@]456)c7ccoc7	Enzo	NP440	0.45264203	0.44713759	-2.93192952	-1.07607796	3.24569862	1.51430459	-4.47643913									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016786-15	Mycophenolic acid	170465182	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	24280-93-1	; ; Acido micofenolico; Acid, Mycophenoli; Mycophenolic acid;Mycophenolic acid;MYCOPHENOLIC ACID			-5.4330806886	4	7		0	-1.66789182			727833	IMPDH1	O=C(O)CCC(\C)=C\Cc1c(O)c2C(=O)OCc2c(C)c1OC	Microsource	01500674	-2.07440757	-1.07752828	-0.05605518	0.72992701	-3.26092473	-0.8435388	-1.66789182									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159515-03	Eszopiclone	170465445	GABAA Receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	138729-47-2	Eszopiclone; ; Estorra; Eszopiclone; Zopiclona;Zopiclone; Amoban			13.3351152487	4	7		0	0			2554	GABRA1	CN1CCN(CC1)C(=O)O[C@H]4c2nccnc2C(=O)N4c3ccc(Cl)cn3	Bionet	KS-1055	3.50252947	4.85009896	2.81981916	0.67725186	3.63142669	3.70953809	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016098-11	Xylazine	170466147	Sigma opioid receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	7361-61-7				5.8060462471	4	7		0	2.44860713					Cc2cccc(C)c2NC1=NCCCS1	Enzo	AC809	1.08198388	1.16548977	0.20228608	0.58945995	1.60127899	1.85476904	2.44860713									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263565-01	Gestodene	170466131	Progestogen hormone	DPI_SARS-CoV-2_General	2019_NPC_01	60282-87-3	Gestodene	22.0828704269	-4.6559444758	-2.5675964084	4	7		-10.981863572	-8.73488631	0.0813351183	0.85602773	5241	PGR	O=C4CC[C@H]3C(CC[C@@H]2[C@@H]3CC[C@@]1(CC)[C@H]2C=C[C@@]1(O)C#C)=C4	Bosche	G2883	-2.52462905	1.78610697	0.4118837	1.16637821	1.56575141	0.43193252	-8.73488631									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095049-04	Exalamide	170465990		DPI_SARS-CoV-2_General	2019_NPC_01	53370-90-4				-38.5085695765	4	7		0	-13.17583838					NC(=O)c1ccccc1OCCCCCC	Microsource	01503403	-7.01716167	-5.85676937	-10.22397699	-8.14458073	-4.23032026	-9.89887698	-13.17583838									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183870-01	Ethoheptazine hydrochloride	144206778	Opioid receptors; mu/kappa/delta Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	5982-61-6				6.3595644154	4	7	Equagesic;Azepine-4-carboxylic acid, hexahydro-1-methyl-4-phenyl-, ethyl ester;Ethoheptazinum;heptacyclazin;Azepine-4-carboxylic acid, hexahydro-1-methyl-4-phenyl-, ethyl ester, citrate;MEPROBAMATE;ERBULOZOLE ETHOHEPTAZINE;CIPLUS_213306;4-carbethoxy-1-methyl-4-phenylazacycloheptane;ethoheptazine citrate (1:1);ethylheptazine;CIPLUS_149424;LS-22816;ETHOHEPTAZINE CITRATE;ASPIRIN;ethoheptazine;LS-178547;LS-22817;1-methyl-1-carbethoxy-4-phenyl hexamethylenimine citrate;ethoheptazine HCl;ETHOHEPTAZINE;CIPLUS_165746;Etoheptazina;CIPLUS_675824;Ethoheptazine;ethoheptazinum;Ethoheptazine citrate;Ethoheptazine Citrate;	0	-3.32492984					Cl.CN1CCCC(CC1)(C(=O)OCC)c2ccccc2	NCI	NSC_400484	3.75731231	0	0	2.43434745	4.12280493	1.41394213	-3.32492984									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00186629-04	ATP (disodium salt)			DPI_SARS-CoV-2_General	2019_NPC_02	987-65-5				13.2881533543	4	7		0	3.32968653					NC1=NC=NC2=C1N=C[N]2[C@@H]3O[C@H](CO[P](O)(=O)O[P]([O-])(=O)O[P](O)([O-])=O)[C@@H](O)[C@H]3O	MedChem Express	HY-B0345A	0	0	0	2.34548558	3.56200841	1.06632845	3.32968653									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00160617-03	Thiamine pyrophosphate			DPI_SARS-CoV-2_General	2019_NPC_01	154-87-0				8.8752498541	4	7		0	2.02783199					CC1=NC=C(C[N+]2=CSC(=C2C)CCO[P](O)(=O)O[P](O)(O)=O)C(=N1)N	SIGMA	C8754	4.57725171	-1.11662228	2.50298555	-0.60952668	4.16941582	-1.86493216	2.02783199									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00015208-19	Caffeine	170464929	Chitinase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	69-22-7	; Annaca; Sig 8304;Caffeine; Vincents Powder; Spalt-tablette; Norgesic forte; Impletol; ; Fioricet; Syndol; Bex Powder; Dolomo; Caffeine solution; Sedalgin; Caffeine, Anhydrous; Synalgos; Caffeine-13C3 solution; Caffeine-sodium benzoate; Cerebyx; Midol; Theobromine, 1-methyl-; Caffeine benzoate sodium; Amidochin; impletol depot Bayer; Triaminicin; Caffeine, citrated; Caffeine-trimethyl-13C3; Sig-8304; Fiorinal; Elsinore pill; Doleron; Caffeine; 3   Caffeine; Migraine-Kranit;Caffeine, citrated;CAFFEINE; Rectoval; Propain; Cafcit			-7.1103206302	4	7		0	-1.54115232				ADORA2B	O=C(O)C(O)(CC(=O)O)CC(=O)O.O=C2c1n(C)cnc1N(C)C(=O)N2C	Enzo	AC1295	-1.10134824	-1.33163926	-1.95705686	-3.36870093	1.32720905	-2.61192134	-1.54115232									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159370-04	Docosanol	124892111	Anti-Herpes Simplex Virus Drug	DPI_SARS-CoV-2_General	2019_NPC_01	661-19-8	; ; Tadenan;DOCOSANOL; Docosanol (Abreva); Abreva; Doconsanol; 1-Docosanol			19.2141339519	4	7		0	2.86938227					CCCCCCCCCCCCCCCCCCCCCCO	Labotest	LTBB001507	0	2.47513866	4.31624869	4.47738731	2.07328833	3.77051679	2.86938227									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00016296-07	Dicumarol	170465275	Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	66-76-2		15.6334750258	-4.8059444758	-15.5013623567	-2.4	7		-33.288256316	-23.57354693	0.0027523231	0.977828203			OC=3c4ccccc4OC(=O)C=3CC1=C(O)c2ccccc2OC1=O	Vitas	STK801287	1.60482173	0.86739805	3.09765787	-0.49414303	-2.49454398	-6.93124651	-23.57354693									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016382-07	Oxethazaine	170465643		DPI_SARS-CoV-2_General	2019_NPC_01	126-27-2		11.0676527398	-4.9559444758	-49.1441686017	-2.2	7		-38.9037704424	-33.45415832	0.0005238167	0.9905210674			CC(C)(Cc1ccccc1)N(C)C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc2ccccc2	Microsource	01503279	-3.12976545	-4.3711975	-6.2269991	-3.91050242	-9.23970969	-18.29869404	-33.45415832									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344561-01	Norgestimate	170464733	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	35189-28-7		4.4061119169	-5.3559444758	-90.2111385317	-2.2	7		-75.800979876	-73.16748323	0.0000219951	0.9980796074			CC(=O)O[C@@]3(C#C)CC[C@H]2[C@@H]4CCC1=CC(\CC[C@@H]1[C@H]4CC[C@@]23CC)=N\O	Prestwick	Prestw-1452	0.33989225	-1.47612557	-3.29809428	-5.17035755	-13.95100159	-50.32412627	-73.16748323									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167512-04	Everolimus		mTOR inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	159351-69-6		4.7903477126	-5.3196329617	-59.953900277	-2.2	7		-57.4989773145	-54.36426771	0.0000736173	0.996478038		MTOR	CO[C@@H]1C[C@@H](CC[C@H]1OCCO)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)/[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C/C=C\C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	Adooq	A10374	0.2381558	-1.27746079	-2.46360845	1.30720483	-0.71050068	-18.32957535	-54.36426771									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00014670-17	Domperidone	170465594	Dopamine Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	57808-66-9	 ; Motilium; 5   Domperidone; Prestwick-06G02;Domperidone; Domperidona; Domperidone; TFMP domperidone;DOMPERIDONE; Domperidone Maleate (1:1)	9.8640558873	-5.0059444758	-6.578676377	-2.4	7		-32.0087323559	-25.42394363	0.0006345617	0.9895505873	1812	DRD1	Clc4cc5NC(=O)N(C3CCN(CCCN1c2ccccc2NC1=O)CC3)c5cc4	Microsource	02300212	3.88497567	4.3125565	1.9911774	2.31018135	4.52976704	-7.13959043	-25.42394363									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016278-10	Mefenamic acid	170464813	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	61-68-7		17.5410474839	-4.7559444758	-23.4666893583	4	7		-37.639426128	-28.86618844	0.6814728099	0.9762684813			O=C(O)c2ccccc2Nc1cccc(C)c1C	Vitas	STK666691	-39.52024786	1.66882498	-0.91394312	-2.95231645	-3.57559762	-7.64266477	-28.86618844									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274069-01	Nandrolone phenpropionate	170465193	Steroid hormone	DPI_SARS-CoV-2_General	2019_NPC_01	62-90-8		5.5469662594	-5.2559444758	-23.7931506083	4	7		-27.0185926799	-26.2654939	0.0264487195	0.9252745411		AR	O=C5CC[C@H]4C(CC[C@@H]2[C@@H]4CC[C@]3(C)[C@@H](OC(=O)CCc1ccccc1)CC[C@@H]23)=C5	Selleck	S1310	0.31709147	4.63019523	-5.65182423	1.74329646	0.55575293	-15.80873012	-26.2654939									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167466-02	Lomustine	170464967	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC_01	13010-47-4	 ;Lomustine (CeeNU); CeeBU; CeeNU; Lomustina; Lomustine;Lomustine			6.1298227374	4	7		0	0.08618286				H2AFX	O=C(NC1CCCCC1)N(CCCl)N=O	Bosche	L0449	0.94159223	0.70613531	3.51685311	0	1.66725879	1.90050307	0.08618286									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183658-01	Quadrisol	144207184	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	71109-09-6		13.9333492831	-4.8559444758	-19.1899441634	4	7	CIPLUS_214418;Vedaprofen;vedaprofen;VEDAPROFEN;vedaprofenum;2-(4-cyclohexyl-1-naphthalenyl)propanoic acid;	-11.482002572	-11.8156305	0.1185813661	0.8162133424	791253	PTGS2	O=C(O)C(C)c2ccc(c1ccccc12)C3CCCCC3	Toronto Research		-3.38736156	-4.06800804	-1.78383066	-4.47349344	-0.16396169	-4.77264186	-11.8156305									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021382-07	ERYTHROMYCIN ETHYLSUCCINATE		Bacterial 70S ribosome Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_02	1264-62-6, 114-07-8 [erythromycin]		13.9333492831	-4.8559444758	-1.2179410112	4	7		-12.518693816	-7.51557818	0.0529249825	0.8895262786			CCOC(=O)CCC(=O)O[C@@H]1[C@H](C[C@@H](C)O[C@H]1O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)N(C)C	Microsource	01500279	3.30412264	0	2.60894025	-0.00701541	0.29227954	-2.17023675	-7.51557818									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167552-01	Piperocaine hydrochloride	144206100	Nicotinic acetylcholine receptor  Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	533-28-8	piperocaine; Piperocainio; Neothesin; 			1.1833048558	4	7	Piperocaine;2-methylpiperidinepropanol benzoate;piperocaine hydrochloride;Neothesin;Piperocainio;CIPLUS_667885;piperocaine;Piperocainum;LS-172947;Methycaine hydrochoride;LS-116051;piperocaine, (+-)-isomer;(+/-)-2-methyl-1-piperidinepropanol benzoate (ester);PIPEROCAINE;piperocainum;CIPLUS_699088;piperocaine monohydrochloride, (+-)-isomer;CIPLUS_154086;CIPLUS_660991;PIPEROCAINE HYDROCHLORIDE;1-Piperidinepropanol, 2-methyl-, benzoate (ester), hydrochloride;METHYCAINE HYDROCHORIDE;metycaine hydrochloride;	0	-2.13099938					Cl.CC2CCCCN2CCCOC(=O)c1ccccc1	SigmaAldrich	S403253	-0.13179495	2.08136016	-1.43690959	1.19495826	2.17902716	-0.58718527	-2.13099938									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181093-01	Metrizoate sodium	144206262		DPI_SARS-CoV-2_General	2019_NPC_02	7225-61-8	Isopaque; Metrizoate; Isopaque cerebral; Isopaque coronar; Metrizoato sodico; Sodium, Metrizoat; 	11.0676527398	-4.9559444758	2.962544487	4	7	Isopaque;natrii metrizoas;BENZOIC ACID, 3-(ACETYLAMINO)-5-(ACETYLMETHYLAMINO)-2,4,6-TRIIODO-, MAGNESIUM SALT (2:1);CIPLUS_166229;MEGLUMINE METRIZOATE;Natrii metrizoas;Sodium, Metrizoat;methylglucamine metrizoate calcium;Isopaque cerebral;Sodium Metrizoate;Metrizoate Sodium;Metrizoate sodium;Triosil;CIPLUS_159326;METRIZOATE MEGLUMINE;SODIUM 3-ACETAMIDO-2,4,6-TRIIODO-5-(N-METHYLACETAMIDO)BENZOATE;methylglucamine metrizoate;CIPLUS_166216;Benzoic acid, 3-(acetylamino)-5-(acetylmethylamino)-2,4,6-triiodo-;METRIZOIC ACID;TRIOSIL;METRIZOATE MAGNESIUM;Isopaque coronar;CIPLUS_172535;Metrizoato sodico;metrizoate de sodium;METRIZOATE SODIUM;Metrizoate de sodium;Metrizoic acid;1-deoxy-1-(methylamino)-D-glucitol 3-(acetylamino)-5-(acetyl methylamino)-2,4,6-triiodobenzoate(salt) mixt. with 3-(acetylamino)-5-(acetylmethylamino)-2,4,6,- triiodobenzoic acid calcium salt (2:1);BENZOIC ACID, 3-(ACETYLAMINO)-5-(ACETYLMETHYLAMINO)-2,4,6-TRIIODO-, MONOSODIUM SALT;Metrizoate;SODIUM METRIZOATE;BENZOIC ACID, 3-(ACETYLAMINO)-5-(ACETYLMETHYLAMINO)-2,4,6-TRIIODO-, COMPD. WITH D-GLUCITOL, 1-DEOXY-1-(METHYLAMINO)- (1:1);sodium meglumine calcium metrizoate;meglumine metrizoate;meglumine calcium metrizoate;Sodium metrizoate;	-12.6329734119	-9.69414451	0.0214652605	0.9339588344			[Na+].Ic1c(NC(C)=O)c(I)c(c(I)c1N(C)C(C)=O)C([O-])=O	NCI	NSC-107431	3.32724456	2.07211994	0	2.52788626	3.6665637	0.06576475	-9.69414451									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016373-08	Benzethonium chloride	170465473		DPI_SARS-CoV-2_General	2019_NPC_01	121-54-0		7.8352981002	-5.1059444758	-41.8904038481	-2.2	7		-39.7065600419	-36.1461053	0.0003340751	0.992451212			[Cl-].CC(C)(C)CC(C)(C)c2ccc(OCCOCC[N+](C)(C)Cc1ccccc1)cc2	Microsource	01500138	-1.96790357	0.11972536	-1.76208233	-3.07773346	-7.4075014	-18.63915849	-36.1461053									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015838-06	Propionylpromazine hydrochloride	170466841	Trypanothione reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	7681-67-6		8.7913490634	-5.0559444758	-45.9566947705	-2.2	7		-62.7249245852	-57.36736711	0.0000041143	0.99917106			Cl.CCC(=O)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1	SIGMA	P7780	0.38728729	1.33408263	0	0	-0.53545145	-23.65465725	-57.36736711									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015882-15	Riluzole	170464928	Glutamate Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	1744-22-5	 ; Rilutek;PK-26124/RP-54274/Rilute;Riluzol; Prestwick-03A08;Riluzole; Riluzole; Riluzole hydrochloride			12.1753217496	4	7		0	1.60198728			2911	GRM1	FC(F)(F)Oc1ccc2nc(N)sc2c1	Vitas	STK503686	0	4.94783395	4.10665107	2.74663255	4.40795818	0	1.60198728									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016438-04	Procarbazine hydrochloride	170465402	DNA Alkylating Drugs	DPI_SARS-CoV-2_General	2019_NPC_01	366-70-1	; ; PROCARBAZINE HCl; Procarbazine Hcl; Procarbazina; Procarbazine HCl;Procarbazine hydrochloride (Matulane); Matulane;Procarbazine hydrochloride; Procarbazine hydrochloride			5.7496062825	4	7		0	-5.7995995				H2AFX	Cl.CC(C)NC(=O)c1ccc(CNNC)cc1	Prestwick	Prestw-1112	3.80751821	3.48180907	0.00487436	2.74161587	0	2.68814472	-5.7995995									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015766-13	Oxymetazoline hydrochloride	170464916	alpha2A(2D)-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	1491-59-4	; ; Oximetazolina;Oxymetazoline;OXYMETAZOLINE HYDROCHLORIDE; Afrazine; 3-[(4,5-Dihydro-; Afrin;OXYMETAZOLINE;Oxymetazoline..HCl;Oxymetazoline hydrochloride; Oxymetazoline hydrochloride	17.5410474839	-4.7559444758	-3.955792879	4	7		-13.639197996	-11.36599833	0.0069362235	0.9642225253	148	ADRA1A	CC(C)(C)c2cc(C)c(CC1=NCCN1)c(C)c2O	Enzo	AC138	0.44295984	1.77633347	0.70921986	-0.98076103	1.30183221	-0.32013822	-11.36599833									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163700-12	Vincristine sulfate	404904683		DPI_SARS-CoV-2_General	2019_NPC_01	[2068-78-2]		13.9333492831	-4.8559444758	-82.5137764112	-2.2	7		-50.7791560468	-46.07741249	0.0082946403	0.9603717887			CC[C@]1(O)C[C@H]2CN(CCC3=C([NH]C4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)\C=C/CN9CC[C@]67[C@H]89)C(=O)OC)C1	Tocris	1257	-9.61682763	-8.73995162	-7.9525237	-17.07928863	-13.56392428	-26.65277707	-46.07741249									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379053-02	Desmopressin (Acetate)		Vasopressin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	62288-83-9		7.5921894793	-5.1196329617	-6.4650727144	4	7		-16.027065596	-14.18922133	0.0334485264	0.91484183			NC(=N)NCCCC(NC(=O)C1CCCN1C(=O)C2CSSCCC(=O)NC(CC3=CC=C(O)C=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N2)C(=O)NCC(N)=O	MedChem Express	HY-17370	3.15614234	0	0	4.70266352	0	1.16967306	-14.18922133									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00386364-01	Lomitapide		Microsomal triglyceride transfer protein large subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	182431-12-5		5.5469662594	-5.2559444758	-58.4032067488	-2.2	7		-71.5310612216	-62.30794844	0.000168633	0.9946525747	4547	MTTP	FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C3=C(C=CC=C3)C4=CC=C(C=C4)C(F)(F)F)C5=C(C=CC=C5)C6=C1C=CC=C6	Selleck	S7635	4.05327291	0	0.67508966	3.89822978	-8.50937433	-36.56050357	-62.30794844									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159390-14	PERMETHRIN		Voltage-sensitive sodium channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	52341-33-0, 52645-53-1		4.4061119169	-5.3559444758	-72.9896369991	-2.2	7		-68.31848452	-59.8487371	0.0003120368	0.9927027038			CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC2=CC=CC(=C2)OC3=CC=CC=C3	Microsource	01504932	-2.33300192	1.2404999	-1.42284522	0	-17.0876601	-39.76888388	-59.8487371									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179626-05	NCGC00179626-05		Mineralocorticoid Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02					-15.1737402323	4	7		0	-6.1504067					C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)CCC([O-])=O	Prestwick	CAS-102731	1.07516937	-3.66143824	-3.38716861	-4.27706195	-2.74932871	-4.03513717	-6.1504067									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094363-07	D-SERINE		Serine palmitoyltransferase 1 Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	312-84-5				-1.0953326835	4	7		0	-3.83260247					N[C@H](CO)C(O)=O	SIGMA	S4250	-0.92706896	-0.10995187	-1.67921815	0	1.59620362	2.41882209	-3.83260247									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016957-05	Aceclofenac	170465979	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	89796-99-6		15.6334750258	-4.8059444758	-48.6111178595	4	7		-10.357446856	-18.76758511	0.0939185374	0.8420706642			Clc2cccc(Cl)c2Nc1ccccc1CC(=O)OCC(=O)O	Vitas	STK594349	-11.35477937	-7.66486671	-8.60081402	-11.03920536	-7.21971273	-9.86838762	-18.76758511									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00273564-01	Bropirimine	170465913	Toll-like receptor 7 Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	56741-95-8				10.7980875751	4	7		0	4.16212517					BrC1=C(NC(N)=NC1=O)c2ccccc2	Tocris	4316	0.32677365	2.5582134	2.74182935	0.18812552	1.9464041	4.55815844	4.16212517									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182989-01	Glyclopyramide	144206854		DPI_SARS-CoV-2_General	2019_NPC_01	631-27-6	Glyclopyramide; Deamelin-S; Gliclopiramida; 			-2.8122952899	4	7	glyclopyramidum;1-(p-chlorobenzenesulfonyl)-3-pyrrolidin-1- ylurea;Glyclopyramide;CIPLUS_214070;GLYCLOPYRAMIDE;Deamelin-S;glyclopyramide;Gliclopiramida;Glyclopyramidum;	0	-4.05566399					O=C(NS(=O)(=O)c1ccc(Cl)cc1)NN2CCCC2	Pharmaron	PH-NIH-169404	-1.66291482	0.2809881	-2.09841339	-2.17473098	3.08328681	1.56003862	-4.05566399									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018163-10	Bithionol	170465515	Adenylate cyclase type 10 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	97-18-7		5.5469662594	-5.2559444758	-74.9795656704	-2.2	7		-79.5411649839	-74.1121898	1.927E-7	0.9998207485			Oc2c(Sc1cc(Cl)cc(Cl)c1O)cc(Cl)cc2Cl	Specs	AN-153/J117612	0.88834023	0.04642412	0.94806366	-0.74999373	-8.18910826	-44.30103156	-74.1121898									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274276-01	NCGC00274276-01	225144372	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02			2.4777388143	-5.6059444758	-136.8404164103	-2.1	7		-101.0367407132	-89.09765495	0.0000194115	0.9981961403			CC(CC1=CC2=C(OCO2)C=C1)NCC(O)C3=CC(=C(O)C=C3)O	GVK	FFS-11-286-NCI-024	0.64972601	-0.82930999	-6.80949814	-14.66922339	-36.01691895	-70.90379557	-89.09765495									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182081-04	Zotepine	170465934	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	26615-21-4		6.9832167823	-5.1559444758	-70.1227536207	-2.2	7		-84.451790892	-77.6149931	0.0000080671	0.9988384289	3269	HRH1	CN(C)CCOC1=Cc3ccccc3Sc2ccc(Cl)cc12	Prestwick	Prestw-1368	0	0	0	2.39693193	-4.81667182	-39.3695979	-77.6149931									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178839-08	NAD+			DPI_SARS-CoV-2_General	2019_NPC_02	53-84-9				0.5543439521	4	7		0	-2.18807972					NC(=O)C1=C[N+](=CC=C1)[C@@H]2O[C@H](CO[P]([O-])(=O)O[P](O)(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)[N]4C=NC5=C(N)N=CN=C45)[C@@H](O)[C@H]2O	Adooq	A11679	-0.93181345	-1.01873455	-0.00234406	0.65711012	2.68279353	1.02874859	-2.18807972									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263517-03	BORNEOL			DPI_SARS-CoV-2_General	2019_NPC_02	507-70-0				-28.5481847973	4	7		0	-7.22066308					CC1(C)C2CCC1(C)C(O)C2	Microsource	01505747	-4.46021873	-5.75434868	-6.08283913	-6.16654585	-5.12558515	-7.9481398	-7.22066308									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179580-04	Biotin	170464763		DPI_SARS-CoV-2_General	2019_NPC_01	58-85-5		0.034998991	-7.4559444758	-324.8309796311	-1.1	7		-89.4034101819	-99.05959291	0.0003422091	0.9923521155			O=C1N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]2N1	Vitas	STK801941	-2.89739307	-14.42812813	-83.48565719	-93.28768154	-97.11465259	-98.8718939	-99.05959291									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090787-08	Benzophenone	170465649		DPI_SARS-CoV-2_General	2019_NPC_01	119-61-9				-4.003261423	4	7		0	4.54234367					O=C(c1ccccc1)c2ccccc2	Specs	AE-562/J256170	-1.74521337	-2.92471962	-3.6240891	-2.49579853	-1.30183221	2.88632552	4.54234367									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160508-03	Isosorbide	170465187		DPI_SARS-CoV-2_General	2019_NPC_01	652-67-5				-20.7795272667	4	7		0	-2.75278193					O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12	Vitas	STK801813	-4.30615061	-5.00647494	-5.08152373	-7.98404696	-5.08805766	-0.32013822	-2.75278193									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162116-04	Cephapirin sodium	170465306	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	24356-60-3		22.0828704269	-4.6559444758	6.4852291577	4	7		-11.9598362559	-7.88319688	0.0325041591	0.9166845703			[Na+].[O-]C(=O)C=2N3C(=O)[C@@H](NC(=O)CSc1ccncc1)[C@H]3SCC=2COC(C)=O	Microsource	01500167	3.8172004	3.81410805	0.89444566	1.50751248	1.81951987	3.49611261	-7.88319688									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182058-01	Doxercalciferol			DPI_SARS-CoV-2_General	2019_NPC_02	54573-75-0		6.2237985085	-5.2059444758	-84.3845605818	-2.2	7		-87.5538220049	-76.80159825	0.0003906721	0.9918221729			[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C3/CC(=C)[C@@H](O)C[C@@H]3O)[C@H](C)\C=C\C(C)C(C)C	Axon Medchem	1746	-0.22890703	0.65836587	0.85089426	-6.79793279	-16.34626809	-40.95734686	-76.80159825									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263538-01	Trovafloxacin mesylate	170465074	Streptococcus pneumoniae Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	147059-75-4		15.6334750258	-4.8059444758	-13.8457203191	4	7		-19.9643961319	-16.22033011	0.0018368396	0.982062871			CS(=O)(=O)O.O=C(O)C2=CN(c1nc(c(F)cc1C2=O)N3C[C@H]4[C@H](N)[C@H]4C3)c5ccc(F)cc5F	Tocris	3863	-0.6219797	-0.54748319	-0.44771571	0.39052452	-2.43566286	-3.93179256	-16.22033011									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346716-02	Dabrafenib		Raf kinase B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1195765-45-7		2.4777388143	-5.6059444758	-92.6034509357	-1.2	7		-66.5763233893	-62.24135471	0.0000319316	0.9976847394		BRAF	CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(F)C(=CC=C3)N[S+]([O-])(=O)C4=C(F)C=CC=C4F	Selleck	S2807	-1.97692432	-1.18505856	-0.48522069	-7.64913594	-22.68612029	-51.64411875	-62.24135471									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00247029-04	2-Deoxyglucose		sugar	DPI_SARS-CoV-2_General	2019_NPC_02	154-17-6				-29.4699754144	4	7		0	-8.31945964					OC[C@H]1OC(O)C[C@@H](O)[C@@H]1O	Cayman	14325	-6.55506486	-4.67786274	-4.86392724	-7.16741108	-5.22063541	-7.60992108	-8.31945964									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183867-06	ALOIN			DPI_SARS-CoV-2_General	2019_NPC_02	5133-19-7		3.1192883571	-5.5059444758	-130.2974499093	-2.1	7		-99.0063614182	-86.34352852	0.0000019808	0.999424955			[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@@]2([H])C3=C(C(O)=CC=C3)C(=O)C4=C2C=C(CO)C=C4O	Microsource	01503427	-0.81620384	-2.82519809	-4.41855559	-13.602881	-33.37452178	-66.30496054	-86.34352852									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00319021-01	NCGC00319021-01	225144375	DNA synthesis involved in DNA replication Activator	DPI_SARS-CoV-2_General	2019_NPC_02			12.4181106199	-4.9059444758	-55.0300160875	-2.2	7		-64.9751462679	-64.56262189	0.0007916735	0.9882920909			COCC1=C(F)C(=C(COC(=O)C2C(\C=C\C)C2(C)C)C(=C1F)F)F	GVK	FFS-11-286-NCI-255	-5.51457837	-7.19120331	-3.2605893	-1.13415803	0	-13.10127772	-64.56262189									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182965-05	Biperiden	170465324	Anticholinergic	DPI_SARS-CoV-2_General	2019_NPC_02	1235-82-1	 ; Biperideno;BIPERIDEN;Biperiden hydrochloride; Akineton lactate; Akineton hydrochloride; Hydrochloride, Biperide;Biperiden; Biperidine; Biperiden hydrochloride; Tasmolin; 2   Biperiden Hcl; Beperiden; Akineton			0.9239369047	4	7		0	-5.05161014				CHRNA2	Cl.OC(CCN1CCCCC1)(c2ccccc2)C4CC3C=CC4C3	Microsource	01505514	1.52835904	1.6101088	-1.04310729	2.70560999	0.75327329	-0.37110109	-5.05161014									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00507798-01	Drostanolone propionate		Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	521-12-0				3.5813144736	4	7		0	-1.62203301					CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)[C@H](C)C[C@]4(C)[C@H]3CC[C@]12C	Carbosynth	FD22623	1.68558811	2.65425397	-0.90246361	1.16221968	0	1.80383315	-1.62203301									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183871-04	N-Acetyl sulfamethoxazole	170466005		DPI_SARS-CoV-2_General	2019_NPC_01	21312-10-7				-25.9353106143	4	7		0	-4.97832755					Cc2cc(NS(=O)(=O)c1ccc(NC(C)=O)cc1)no2	Specs	AA-504/07985056	-5.27920993	-4.27834926	-4.94016719	-8.23989766	-5.17433893	-5.6049596	-4.97832755									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091517-06	L-Ascorbic acid	170464728		DPI_SARS-CoV-2_General	2019_NPC_01	50-81-7				-11.7130374637	4	7		0	-1.44989988					OC=1C(=O)O[C@H]([C@@H](O)CO)C=1O	Microsource	01502230	-3.5945102	-2.48002541	-3.95067144	-2.38543156	-1.6165051	-1.7480563	-1.44989988									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249924-01	Ibuprofen piconol	170465895		DPI_SARS-CoV-2_General	2019_NPC_01	64622-45-3				-43.8158548743	4	7		0	0					CC(C)Cc1ccc(cc1)C(C)C(=O)OCc2ccccn2	GVK	FFS-11-286-NCI-203	0.7431075	-2.18193369	-0.19253735	-0.12290867	-60.9374207	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015693-09	Mitoxantrone	170465183	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	70476-82-3	 ;Mitoxantrone; Mitoxantrone Hcl; Mitoxantrone; Mitozantrone;MITOXANTRONE HYDROCHLORIDE; Mitoxantrone dihydrochloride;Mitoxantrone dihydrochloride; Mitoxantrona;Mitoxantrone di?HCl;MITOXANTHRONE HYDROCHLORIDE	0.2477738814	-6.6059444758	-237.2940985961	-1.1	7		-104.7926254846	-98.63374819	0.0021608503	0.9804015443	7153	TOP2A	Cl.Cl.OCCNCCNc3ccc(NCCNCCO)c2C(=O)c1c(O)ccc(O)c1C(=O)c23	Microsource	01503278	-3.33793237	-2.38717717	-33.83539275	-45.60915043	-84.45160635	-95.609533	-98.63374819									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015704-09	Methapyrilene hydrochloride	170465531		DPI_SARS-CoV-2_General	2019_NPC_01	135-23-9				-7.5040276619	4	7		0	-6.84393298					Cl.CN(C)CCN(Cc1cccs1)c2ccccn2	Microsource	01503229	-1.16912352	-0.64749432	1.67921815	0.76504377	-0.27153225	-5.97083185	-6.84393298									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016270-09	Levodopa	225144176	Dopamine Precursors	DPI_SARS-CoV-2_General	2019_NPC_01	59-92-7	 beta Hydroxytyrosin; Dopaflex; 3-Hydroxy-DL-tyrosine; 3,4 Dihydroxyphenylalanin; DL-Tyrosine, 3-hydroxy-; Dihydroxyphenylalanine; DL-3-Hydroxytyrosine; ;L-3,4-Dihydroxyphenyl-alanine; Levopa; Sinemet CR4;LEVODOPA; L-3-Hydroxytyrosine; 3 Hydroxy DL tyrosin; Sinemet CR; Roberts Brand of Levodopa; 3 Hydroxy L tyrosin; Levodopa;L-3,4-Dihydroxyphenylalanine; beta-Hydroxytyrosine; Ro 8-0576-12;Levodopa; 3-Hydroxy-L-tyrosine;L-Dopa; Nakom; Larodopa; L-DOPA-ring-d3; Dopar; Maipedopa; Roche Brand of Levodopa; Ro 8-0576-7; L Dop; Ro 8-0576; D-3-Hydroxytyrosine	0.1393334928	-6.8559444758	-111.066009193	-2.2	7		-55.0690857039	-42.0977922	0.0000219592	0.9980819995		DRD1	N[C@@H](CC1=CC(=C(O)C=C1)O)C(O)=O	Enzo	AC1036	1.76457774	2.30410243	1.1820331	1.98409712	-1.31198295	-11.72823822	-42.0977922									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00371144-02	AWD 131-138			DPI_SARS-CoV-2_General	2019_NPC_02	188116-07-6				-26.6002995205	4	7		0	-6.48813205					ClC1=CC=C(C=C1)N2CC(=N/C2=O)\N3CCOCC3	MedChem Express	HY-14953	-8.07648732	-3.28258911	-7.86432573	-6.22266913	-0.59168785	-7.37504697	-6.48813205									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386213-04	Rupatadine (Fumarate)		Platelet activating factor receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	182349-12-8		12.4181106199	-4.9059444758	-74.6273009842	-2.2	7		-81.2101187595	-64.52456833	0.0000059721	0.9990009836			CC1=CN=CC(=C1)CN2CCC(CC2)=C3C4=CC=C(Cl)C=C4CCC5=CC=CN=C35	MedChem Express	HY-13511A	-5.02439363	-2.88525953	-3.97787206	-5.44629703	-9.55967968	-31.36978579	-64.52456833									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00180997-01	Ethylphenylacetylurea	144206203		DPI_SARS-CoV-2_General	2019_NPC_02	90-49-3	Pheneturide; Feneturida; Benuride; 			-35.5075995237	4	7	Ethylphenacemide;2-PHENYLBUTYRYLUREA;CIPLUS_778068;N-(AMINOCARBONYL)-2-PHENYLBUTANAMIDE;(2-phenylbutyryl)urea;2-Phenylbutyrylurea;PHENETURIDE;CIPLUS_778163;LS-7390;CIPLUS_778164;phenylethylacetylurea;ethylphenacemide, (+-)-isomer;BENZENEACETAMIDE, N-(AMINOCARBONYL)-.ALPHA.-ETHYL-;Benuride;ETHYLPHENACEMIDE;LS-28470;ethyl phenacemide;ethylphenacemide;pheneturide;Feneturida;CIPLUS_214323;ethylphenylacetylurea;Pheneturidum;Pheneturide;pheneturidum;	0	-8.3575132					CCC(C(=O)NC(N)=O)c1ccccc1	SigmaAldrich	MFCD00069050	-7.57242942	-7.71327589	-7.84088512	-7.39190422	-5.17311028	-9.04265314	-8.3575132									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263138-19	Regorafenib		VEGFR-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	835621-07-3		4.4061119169	-5.3559444758	-62.3490679197	-2.2	7		-45.3980946503	-48.16153736	0.0001163177	0.995566526		KDR	CNC(=O)C1=CC(=CC=N1)OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C(=C2)F	MedChem Express	HY-13308	-1.67171495	-1.70713114	-3.68252033	-5.35743517	-6.35648599	-34.16009019	-48.16153736									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179612-03	Neomycin sulfate	225144310	30S Ribosomal Protein Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_02	1405-10-3				0.5653787358	4	7		0	0.99890596					NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@@H](CN)[C@@H](O)[C@H](O)[C@H]4N)[C@H]3O)[C@H](N)[C@@H](O)[C@@H]1O	Prestwick	Prestw-158	-0.37226294	-0.68608653	-0.93059234	0.02572317	0.59168785	-0.18789929	0.99890596									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00390090-01	Alclometasone dipropionate		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	66734-13-2		6.2237985085	-5.2059444758	-14.1118365665	4	7		-27.459044852	-22.46587071	0.0000144758	0.9984454496			CCC(=O)OCC(=O)[C@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@@H]3[C@H](Cl)CC/4=C/C(=O)/C=C\[C@]4(C)[C@H]3[C@@H](O)C[C@]12C	Prestwick	Prestw-771	2.65208444	2.5849523	2.20107358	1.30252789	-0.32554713	-11.5792935	-22.46587071									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00480787-02	Cangrelor (AR-C69931)			DPI_SARS-CoV-2_General	2019_NPC_02	163706-36-3				9.5939184523	4	7		0	0.32821196					CSCCNC1=NC(=NC2=C1N=C[N]2[C@@H]3O[C@H](CO[P](O)(=O)O[P](O)(=O)C(Cl)(Cl)[P](O)(O)=O)[C@@H](O)[C@H]3O)SCCC(F)(F)F	DC Chemicals	DC7005	0	3.25948855	3.54656478	0	3.99448708	2.67756483	0.32821196									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179867-02	NCGC00179867-02			DPI_SARS-CoV-2_General	2019_NPC_02			2.4777388143	-5.6059444758	-123.6685558327	-2.2	7		-89.3797983199	-74.0664986	0.0001848905	0.9943980911			O[C@@H]1[C@@H](COC(=O)C2=CC(=C(O)C(=C2)O)O)O[C@@H](OC(=O)C3=CC(=C(O)C(=C3)O)O)[C@H](O)[C@H]1OC(=O)C4=CC(=C(O)C(=C4)O)O	Analyticon	NP-005114	3.25787879	-4.96892975	-9.57549049	-18.39206791	-34.57215503	-56.73149192	-74.0664986									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378990-02	Ledipasvir (GS 5885)		Nonstructural protein 5A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1256388-51-8		1.6996795075	-5.7696329617	-118.2502033922	-1.1	7		-84.7649716965	-81.37278219	0.0000015118	0.9994976824			COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1C3=NC=C([NH]3)C4=CC5=C(C=C4)C6=C(C=C(C=C6)C7=CC=C8N=C([NH]C8=C7)[C@@H]9[C@H]%10CC[C@H](C%10)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C5(F)F	Adooq	A13155	2.24513862	0.7923491	0.39614636	1.11545027	-10.33909179	-65.919767	-81.37278219									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00388518-02	Ticarcillin sodium			DPI_SARS-CoV-2_General	2019_NPC_02	74682-62-5				2.9843128997	4	7		0	-4.43323978					CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)C3=CSC=C3)C(=O)N2[C@H]1C([O-])=O	Prestwick	Prestw-1067	0	0	0	4.15078456	1.67050828	1.79443818	-4.43323978									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095082-06	Iopanoic acid	170465056		DPI_SARS-CoV-2_General	2019_NPC_01	96-83-3		15.6334750258	-4.8059444758	-3.2245726358	4	7		-27.382335052	-18.23527921	0.0001891148	0.9943480644			Ic1cc(I)c(N)c(I)c1CC(CC)C(=O)O	Microsource	01503923	1.72100792	3.62352481	2.80519607	2.67138235	1.90072578	-3.52660196	-18.23527921									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167744-02	Methylperone	170466288		DPI_SARS-CoV-2_General	2019_NPC_01	3575-80-2				6.6134335446	4	7		0	-1.97713619					Fc1ccc(cc1)C(=O)CCCN2CCC(C)CC2	Tocris	2495	1.51768209	0.77943656	3.16102459	0	3.4639395	2.07835764	-1.97713619									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274272-01	Iobenzamic acid	170465948		DPI_SARS-CoV-2_General	2019_NPC_01	3115-05-7		13.9333492831	-4.8559444758	-11.8977357971	-2.4	7		-34.5177562079	-28.76479684	0.0022531459	0.9799968218			Ic1cc(I)c(N)c(I)c1C(=O)N(CCC(=O)O)c2ccccc2	GVK	FFS-11-286-NCI-258	0.18154092	2.91005937	0.93344057	4.57270424	-0.15987413	-3.75527212	-28.76479684									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249899-01	Cinoxate	170465555		DPI_SARS-CoV-2_General	2019_NPC_01	104-28-9		13.9333492831	-4.8559444758	-9.9270071233	4	7		-16.736850776	-13.53070898	0.0225991488	0.9319200532			COc1ccc(C=CC(=O)OCCOCC)cc1	GVK	FFS-11-286-NCI-86	2.09377194	-0.18813986	0.89932003	-2.43559836	-0.69786327	-3.60282535	-13.53070898									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159425-09	ZINC UNDECYLENATE		Fatty Acid Biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	557-08-4				15.3983312375	4	7		0	4.04045525					OC(=O)CCCCCCCCC=C	Microsource	01505467	2.43748941	3.1983776	2.47373937	3.93056914	4.08820992	2.24096753	4.04045525									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00163736-04	Imidacloprid	170465741		DPI_SARS-CoV-2_General	2019_NPC_01	138261-41-3				-3.070454306	4	7		0	-2.43339839					[O-][N+](=O)/N=C2\NCCN2Cc1cnc(Cl)cc1	Vitas	STK786692	-2.27289231	0.29564835	0.93831493	-3.00248326	2.56559915	-1.1535139	-2.43339839									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016902-04	Etifenin	170466635		DPI_SARS-CoV-2_General	2019_NPC_01	63245-28-3				-27.517575699	4	7		0	-5.44979848					O=C(Nc1c(cccc1CC)CC)CN(CC(=O)O)CC(=O)O	Prestwick Chemical, Inc.	Prestw-504	-5.65197395	-6.91719403	-9.90714338	-4.54762084	-4.80383698	-3.60282535	-5.44979848									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379014-01	Cariprazine		Serotonin 1a (5-HT1a) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	839712-12-8				-0.3355132862	4	7		0	-4.26199876					CN(C)C(=O)N[C@H]1CC[C@@H](CC1)CCN2CCN(CC2)C3=CC=CC(=C3Cl)Cl	MedChem Express	HY-14763	3.81280492	0.03003072	-0.88839924	0.77871057	3.55250339	-0.94889139	-4.26199876									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00178501-04	CEFTIBUTEN		Peptidoglycan synthase FtsI Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	97519-39-6				-1.33991066	4	7		0	-6.68791324			944799	ftsI	NC1=NC(=CS1)\C(=C\CC(O)=O)C(=O)N[C@H]2[C@H]3SC\C=C(/N3C2=O)C(O)=O	Microsource	01505207	3.19313741	1.24974012	-1.49316706	-0.69920258	2.22179978	-1.24013529	-6.68791324									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253604-01	Rescimetol	170465875	smooth muscle contraction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	73573-42-9		1.9681378985	-5.7059444758	-134.1029013014	-1.1	7		-96.8741330926	-95.04352376	0.0000016679	0.9994723536			Oc1ccc(cc1OC)/C=C/C(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccc(OC)cc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC	GVK	FFS-11-286-NCI-194	1.03354991	-0.48742175	0.58367127	-4.14143068	-36.46365516	-80.70274333	-95.04352376									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532517-01	OZENOXACIN		Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02					-1.0261437775	4	7		0	-4.59972411					CNC1=C(C)C=C(C=N1)C2=CC=C3C(=O)\C(=C/N(C4CC4)C3=C2C)C(O)=O	NanjingKaimubo Pharm	KB-80783	3.63245393	2.46020929	1.94322683	0.03507705	2.7113086	-3.00169109	-4.59972411									5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7	0.0000016599999999	0.00000831								
NCGC00166323-02	Trifluridine	170464911	thymidylate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	70-00-8	 ; Viroptic; Trifluridina; Trifluridine;Trifluridine;Trifluridine (Viroptic)			-5.0547507334	4	7		0	2.38270259			7298	TYMS	FC(F)(F)C1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2	Prestwick Chemical, Inc.	Prestw-1056	-3.39118437	-0.31519535	-2.72720626	-3.72990192	-1.16987261	2.20031506	2.38270259									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023722-08	Floxuridine	170465247	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	50-91-9	; ; Floxiridina; 5-Fluorodeoxyuridine; Floxuridine; 5-Fluro-2??-Deoxyuridine; 5-FUdR;Floxuridine; 5 Fluorodeoxyuridin			13.2678793201	4	7		0	2.42325923				TYMS	FC1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2	Vitas	STK801909	3.61871566	3.11041611	3.5850942	4.0710362	0	2.88124397	2.42325923									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179247-04	Nomegestrol acetate		Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	58652-20-3		13.9333492831	-4.8559444758	-22.1081681192	-2.2	7		-50.0707796228	-36.41725729	0.0001268232	0.9953706965			CC(=O)O[C@@]1(CC[C@H]2[C@@H]3\C=C(C)/C4=C/C(=O)CC[C@@H]4[C@H]3CC[C@]12C)C(C)=O	SIGMA	SML0133	3.76193669	0.84779043	1.20250346	1.67200617	-0.59168785	-10.93573844	-36.41725729									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179310-03	Cefalonium	170466431	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	5575-21-3		13.9333492831	-4.8559444758	-24.1407552949	-3	7		-46.4122627588	-36.04147838	0.0006786923	0.9891814338			NC(=O)c4cc[n+](CC=2CS[C@@H]3[C@H](NC(=O)Cc1cccs1)C(=O)N3C=2C([O-])=O)cc4	SIGMA	32904	2.17577285	-0.5890642	-0.68680997	2.95348783	-1.29505976	-9.8412251	-36.04147838									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095899-09	Rizatriptan Benzoate		5-HT1B Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	145202-66-0				-12.6222893931	4	7		0	-6.36445797				HTR1B	CN(C)CCC1=C[NH]C2=CC=C(C[N]3C=NC=N3)C=C12	APExBIO	A8516	0.11329742	-1.15271778	-2.07449427	-6.00752987	-2.05546183	-2.07628711	-6.36445797									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015954-04	Sobuzoxane	90341303	DNA topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			11.0676527398	-4.9559444758	2.150690807	4	7		-10.5118917319	-8.34324311	0.034111292	0.9144027509			CC(C)COC(=O)OCN1C(=O)CN(CCN2CC(=O)N(COC(=O)OCC(C)C)C(=O)C2)CC1=O	SigmaAldrich	Lopac-S-4692	1.61159796	0.27027651	0.85089426	3.5989056	3.05824205	0.03288237	-8.34324311									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263152-12	Ponatinib		FGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1114544-31-8		5.5469662594	-5.2559444758	-85.0761780961	-2.1	7		-94.2635446874	-86.85725158	0.000032884	0.9976500665		FGFR1	CN1CCN(CC1)CC2=CC=C(NC(=O)C3=CC(=C(C)C=C3)C#CC4=CN=C5C=CC=N[N]45)C=C2C(F)(F)F	Glixx	GLXC-01988	2.16883627	0	0	2.51385544	-11.13276145	-49.69936114	-86.85725158									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378640-03	Alvimopan		mu-Opioid Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	1383577-62-5				0	4	7		0	0				OPRM1	C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(O)=O	MedChem Express	HY-76657	0	0	0	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179344-04	Pivmecillinam			DPI_SARS-CoV-2_General	2019_NPC_02	32886-97-8				-6.810157985	4	7		0	-5.39884888					CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](\N=C\N3CCCCCC3)C2=O	SIGMA	SML0817	0.86707207	-1.95661715	-0.15236399	-0.41858616	-0.28752703	-3.69691845	-5.39884888									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016023-18	Theobromine	170465487	Phosphodiesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	83-67-0	; ;Theobromine; Limptar; Theobromine;THEOBROMINE; 3,7-Dimethylxanthine			-21.7751101653	4	7		0	-7.45735216			5141	PDE4A	Cn1cnc2c1C(=O)NC(=O)N2C	Microsource	01500649	-5.75847796	-4.40540475	-4.90117228	-3.42388442	-3.27107547	-3.94837136	-7.45735216									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091011-08	Chloramphenicol	225144201	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	56-75-7	 Cloramfenicol;; Chlornitromycin;Chloramphenicol (Chloromycetin); Ophthochlor; ; Detreomycin; Corti-fluoral; Syntomycin;Chloramphenicol; Cloromisan; Chloramphenicol; Pantofenicol; Chloromycetin; Chlorocid			10.1390593397	4	7		0	0.89731566					OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O	Prestwick	Prestw-31	0	2.00112395	4.21388706	4.15130308	2.75846318	0.70125514	0.89731566									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263906-02	Rolitetracycline	170465919		DPI_SARS-CoV-2_General	2019_NPC_01	751-97-3		5.5469662594	-5.2559444758	-93.2574995001	-2.2	7		-78.698970197	-72.78395985	0.0000863496	0.9961830539			O=C(NCN1CCCC1)C4=C(O)[C@@H](N(C)C)[C@@H]5CC3C(C(=O)c2c(O)cccc2[C@@]3(C)O)=C(O)[C@]5(O)C4=O	Microsource	01505684	-1.47895336	-2.48979891	-3.15127586	-9.32851732	-15.64482566	-46.4911835	-72.78395985									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159320-04	Triamcinolone diacetate	170464837		DPI_SARS-CoV-2_General	2019_NPC_01	67-78-7				2.6668066833	4	7		0	-3.02653925					CC(=O)OCC(=O)[C@@]3(O)[C@@H](C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@@]4(F)[C@@H](O)C[C@@]23C)OC(C)=O	Sequoia	67-78-7	1.09166606	3.2374716	0.91881748	-1.02591115	1.07344059	0.83845724	-3.02653925									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164603-04	Ebastine	170465995	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	90729-43-4		5.5469662594	-5.2559444758	-69.399322912	-2.2	7		-62.2730879584	-62.26458138	0.0000025753	0.9993443196	3269	HRH1	CC(C)(C)c1ccc(cc1)C(=O)CCCN2CCC(CC2)OC(c3ccccc3)c4ccccc4	Sequoia	SRP00750e	-1.22721661	-1.60529724	-1.6061027	-3.35866757	-6.33152312	-38.2438132	-62.26458138									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164499-03	DL-alpha Tocopheryl nicotinate	170465780	platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	43119-47-7				1.3108086621	4	7		0	0.4309143					CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc3c(O1)c(C)c(C)c(OC(=O)c2cccnc2)c3C	Labotest	LT00772349	0.7963595	2.45070491	-0.89932003	-2.41553164	2.6062021	-0.96041466	0.4309143									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094852-04	L-Thyroxine		synthetic hormone	DPI_SARS-CoV-2_General	2019_NPC_02	51-48-9		6.0306904668	-5.2196329617	-67.5909913203	-2.2	7		-83.2042049192	-61.51833706	0.0001398129	0.9951349827		THRA	NC(CC1=CC(=C(OC2=CC(=C(O)C(=C2)I)I)C(=C1)I)I)C(O)=O	APExBIO	B2107	0	3.31261983	0	3.49601291	-5.08281254	-25.526118	-61.51833706									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00389455-01	Penicillin G Sodium		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	69-57-8				-14.3701081264	4	7		0	-7.28725681					CC1(C)SC2C(NC(=O)CC3=CC=CC=C3)C(=O)N2C1C([O-])=O	APExBIO	B1678	-4.4417212	-1.2820809	-2.7027027	-0.23618549	1.36634746	-7.90586246	-7.28725681									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093802-06	Dehydroepiandrosterone	170465614	Steroid hormone	DPI_SARS-CoV-2_General	2019_NPC_01	53-43-0	 DHEA phosphatide; ; Prasterona; DHEA sulfotransferase; Androstenolone; Dehydroepiandrosterone;Dehydroepiandrosterone; DHEA receptor;Dehydroepiandrosterone (DHEA); 5a-Androstanedione; Prasterone, 3 alpha Isome; trans-Dehydroandrosterone;trans-Dehydroandrosterone; DHEA sulphotransferase; 5-Androsten-3-ol-17-one;; 7   Androstanedione;DHEA; 5 Androsten 3 ol 17 on			0.9091997205	4	7		0	1.51073484				HSD11B1	O=C4CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CC=C1C[C@@H](O)CC[C@@]12C	Labotest	LT03329654	0	0	0.16085399	0	0	0	1.51073484									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00348372-01	LINDANE		GABA-A receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	58-89-9				0	4	7		0	0					[Cl][C@H]1[C@H]([Cl])[C@H]([Cl])[C@@H]([Cl])[C@H]([Cl])[C@@H]1[Cl]	SigmaAldrich	233390	0	0	0	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015680-18	Melatonin	170465589	NOS2 Expression Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	73-31-4	; ;Melatonin;MELATONIN; Melatonin			2.1678879592	4	7		0	-5.70834706				MTNR1B	CC(=O)NCCc2cnc1ccc(cc12)OC	Specs	AN-153/I149495	1.26110425	2.51423266	1.48424362	1.10116136	-1.4845455	2.57126887	-5.70834706									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018213-06	Cyclopentolate hydrochloride	170464720	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	5870-29-1				-3.4700913543	4	7		0	-1.96192745					Cl.OC1(CCCC1)C(C(=O)OCCN(C)C)c2ccccc2	Microsource	01500212	-1.77910101	-0.83807755	-0.73359167	-1.56771264	0.5608283	0.818131	-1.96192745									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015418-09	Ethosuximide	170464802	T-Type Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	77-67-8	 Etosuximida; ; Suxilep;ETHOSUXIMIDE;Ethosuximide; Ethosuximide; Zarontin			8.3589643558	4	7		0	1.48031736				CACNA1G	CC1(CC)CC(=O)NC1=O	Microsource	01502196	3.05714908	0.5912967	0	0	4.55006852	2.74404187	1.48031736									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159502-03	N-Cyclohexyl-2-benzothiazolesulfenamide	29215472	Aryl hydrocarbon receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02		N-cyclohexyl-2-benzothiazylsulfenamide; 	14.2582661155	-4.8459332839	-30.3696962177	-2.2	7	N-Cyclohexyl-2-benzothiazolesulfenamide;N-CYCLOHEXYLBENZOTHIAZYLSULFENAMIDE;N-cyclohexyl-2-benzothiazylsulfenamide;CIPLUS_150281;N-cyclohexyl-2-benzothiazyl sulfenamide;N-cyclohexyl-2-benzothiazolesulfenamide;thiohexam;	-51.9158778442	-39.21895067	0.0017631252	0.9823628992			C1CCC(CC1)NSC2=NC3=CC=CC=C3S2	SigmaAldrich	S365971	3.69257093	-0.52438264	4.2544713	-1.12480415	-10.53394482	-21.1057873	-39.21895067									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00387800-02	AHU-377			DPI_SARS-CoV-2_General	2019_NPC_02	149709-62-6				-14.2732448501	4	7		0	-5.04209675					CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(O)=O	Aobious	AOB2046	-3.08677657	-2.35856684	-3.78097091	-4.1320768	-0.58218283	-2.77151447	-5.04209675									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166122-01	Perflexane	144205881		DPI_SARS-CoV-2_General	2019_NPC_02	355-42-0	Perflexane; Imavist; Imagent; 			12.0287070186	4	7	perflexane;perfluorohexane;NCGC_FLUKA_77273;perflexanum;PERFLEXANE;PERFLUOROHEXANE;Perflexane;NCGC00166122-01;Tetradecafluorohexane;AF0150;AFO 150;CIPLUS_152856;Imavist;TETRADECAFLUOROHEXANE;Perfluorohexane;Imagent;perfluoro-n-hexane;	0	2.09770252					FC(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)F	FLUKA	FLUKA-77273	4.21050198	2.44634896	-0.19924521	1.74683722	3.19131241	4.3686584	2.09770252									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018234-07	Sulfaguanidine	170465708		DPI_SARS-CoV-2_General	2019_NPC_01	57-67-0				-3.4997183297	4	7		0	-0.38528808					Nc1ccc(cc1)S(=O)(=O)NC(=N)N	Specs	AT-084/J157969	2.5004236	-2.13306619	-1.74745924	-2.44563173	-0.11927118	-0.69109203	-0.38528808									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015656-12	Mianserin	170465596	5-HT2A Antagonists?	DPI_SARS-CoV-2_General	2019_NPC_01	24219-97-4	; ; Org GB 94;Mianserin; Mianserin Hcl;Mianserin hydrochloride; Mianserin hydrochloride; Mianserina;MIANSERIN HYDROCHLORIDE; Mianserine hydrochloride; Mianserine Hcl;Mianserin..HCl;Mianserine hydrochloride; Lerivon; Bolvidon; Tetramide; Hydrochloride, Mianseri; Tolvon	11.0676527398	-4.9559444758	-0.3546745108	4	7		-13.1605916239	-8.05049302	0.0070471565	0.9640328736	3356	HTR2A	CN1CC2N(CC1)c4ccccc4Cc3ccccc23	Enzo	AC554	2.86834653	2.26989518	0.41675806	1.90884692	0.97700858	-2.78469434	-8.05049302									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018102-12	Flunarizine	170466037	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	52468-60-7	Sibelium; ; Flu Narizine;Flunarizine dihydrochloride; Hydrochloride, Flunarizin;Flunarizine; Flunarizin; Flunarizina; Flunarizine	4.4061119169	-5.3559444758	-68.0895066505	-2.2	7		-77.4880738157	-73.23515247	0.0000046587	0.9991176803			Fc1ccc(cc1)C(c2ccc(F)cc2)N3CCN(CC3)C/C=C/c4ccccc4	Enzo	CA225	4.4755888	4.04867203	1.86444396	1.90383024	-2.84981982	-51.49143757	-73.23515247									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091449-10	Eugenol	170465464	reactive oxygen species biosynthetic process Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	97-53-0		6.9832167823	-5.1559444758	-37.2839158285	-2.2	7		-44.400813672	-35.75067806	0.0394388817	0.9060076377			Oc1ccc(cc1OC)CC=C	Microsource	01500296	0	2.83675813	1.64997197	-2.44061504	-15.08653505	-13.34417399	-35.75067806									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249925-01	Tilmacoxib	170466033	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	180200-68-4		12.4181106199	-4.9059444758	-24.9654040554	-2.2	7		-46.3355048049	-38.36151175	0.0007339166	0.9887405087			Cc2nc(C1CCCCC1)c(o2)c3ccc(c(F)c3)S(N)(=O)=O	GVK	FFS-11-286-NCI-214	3.3234091	-1.50756224	-0.40213497	1.92891364	0.41364259	-10.43244067	-38.36151175									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389674-01	Apremilast (CC-10004)		Phosphodiesterase 4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	608141-41-9		13.9333492831	-4.8559444758	-1.9659592451	4	7		-22.4255339439	-15.35461162	0.0030233583	0.9767609604			CCOC1=C(OC)C=CC(=C1)C(C[S+](C)([O-])=O)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(C)=O	APExBIO	A4317	4.36310666	1.02335466	2.23389044	2.55127096	1.28080222	-2.54603533	-15.35461162									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179566-03	Ritodrine hydrochloride	225144308	beta2-Adrenoceptor Agonists	DPI_SARS-CoV-2_General	2019_NPC_02	23239-51-2				8.4683699696	4	7		0	1.97402845				ADRB2	C[C@H](NCCC1=CC=C(O)C=C1)[C@H](O)C2=CC=C(O)C=C2	Prestwick	Prestw-349	0	3.90168403	1.77914254	0	3.07249958	1.87429538	1.97402845									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018185-23	Tranilast		TNF-alpha Production Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	53902-12-8		15.6334750258	-4.8059444758	1.3026287663	4	7		-11.655805548	-9.71317129	0.0617858333	0.8781181085		TNF	COC1=CC=C(\C=C\C(=O)NC2=CC=CC=C2C(O)=O)C=C1OC	Enzo	CT110	4.69606234	0	1.22125595	2.17711573	0	1.24483277	-9.71317129									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00248146-03	4-Methylbenzenesulfonic acid			DPI_SARS-CoV-2_General	2019_NPC_02					-20.5067459034	4	7		0	-5.98392237					CC1=CC=C(C=C1)[S+](O)([O-])=O	Specs	AE-562/J260927	-2.26363615	-3.59213657	-5.81092801	-4.94118748	-3.41943303	-4.86659151	-5.98392237									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095175-08	Cefditoren (Pivoxil)		Cephalosporin Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	117467-28-4		7.8352981002	-5.1059444758	-103.1815877063	-2.2	7		-75.7010031041	-78.0050421	0.000205157	0.9940962807			[H][C@]12SCC(\C=C/C3=C(C)N=CS3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C4=CSC(N)=N4)C(=O)OCOC(=O)C(C)(C)C	MedChem Express	HY-17452A	-7.2533469	-9.31645453	-6.05471039	-12.92472465	-12.41593993	-41.05599399	-78.0050421									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160621-05	DEXTROSE			DPI_SARS-CoV-2_General	2019_NPC_02	50-99-7				-27.1215870114	4	7		0	-7.22541978					[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O	Microsource	01300015	-2.53185045	-5.52796322	-8.78788589	-6.8680869	-3.60002851	-6.11142428	-7.22541978									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095227-06	Alizarin	170465641	Calcium Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	72-48-0		3.1192883571	-5.5059444758	-137.635325506	-2.1	7		-92.5031466338	-91.94697219	0.0000088187	0.9987853512			O=C3c1ccccc1C(=O)c2c3ccc(O)c2O	Vitas	STK801841	-6.76058384	-3.03711486	-6.44634545	-9.65961823	-30.49535604	-71.40098582	-91.94697219									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093358-08	Cefotaxime sodium salt		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	64485-93-4				-32.5468175878	4	7		0	-12.95784644					CO\N=C(/C(=O)N[C@H]1[C@H]2SC\C(=C(/N2C1=O)C([O-])=O)COC(C)=O)C3=CSC(=N3)N	SIGMA	C7039	-7.00747949	-6.16952134	-4.6867003	-5.03423884	-7.43795361	-6.67716856	-12.95784644									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159430-04	Hexobarbital	170465860	GABA-A receptor; benzodiazepine site Activator	DPI_SARS-CoV-2_General	2019_NPC_01	56-29-1				3.5110481537	4	7		0	3.65516717					CC1(C(=O)N=C(O)N(C)C1=O)C2=CCCCC2	Labotest	LT00244803	0.6317624	-0.07085787	-1.41112817	-0.83026062	1.33228442	2.63732913	3.65516717									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017134-08	Meclocycline sulfosalicylate			DPI_SARS-CoV-2_General	2019_NPC_01	73816-42-9		0.8791349063	-6.0559444758	-194.3841023953	-1.1	7		-88.5313363714	-92.23086867	0.0000043884	0.9991436761			CN(C)[C@H]\1[C@@H]2[C@@H](O)[C@@H]\3C(=C)C4=C(Cl)C=CC(=C4C(=O)C3=C(\O)[C@@]2(O)C(=O)\C(=C1O)C(N)=O)O.OC(=O)C5=C(O)C=CC(=C5)[S+](O)([O-])=O	SIGMA	M1388	-9.87340547	-8.9647421	-16.39492091	-32.68116487	-60.32837639	-80.63926013	-92.23086867									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023648-04	Desoximetasone	170464795	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	382-67-2		13.9333492831	-4.8559444758	-4.198326632	4	7		-19.6097310599	-17.59144255	0.0016684945	0.9829007767			OCC(=O)[C@H]4[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	SIGMA	D6038	2.48105923	2.0060107	1.35751018	-0.47909298	1.14957113	0.82829412	-17.59144255									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253579-01	Bolandiol dipropionate	170465909	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	1986-53-4		22.0828704269	-4.6559444758	2.3240876973	4	7		-11.068185856	-8.39015488	0.0317180666	0.917916032			CCC(=O)O[C@H]2CCC3C4CCC1(C)C(CC[C@@H]1OC(=O)CC)C4CCC3=C2	GVK	FFS-11-286-NCI-219	2.23900467	0.79898356	0.91881748	3.21820052	0	2.55094263	-8.39015488									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016032-11	alpha-Lipoic acid	170465713		DPI_SARS-CoV-2_General	2019_NPC_01	1077-28-7		15.6334750258	-4.8059444758	-21.8478963917	4	7		-21.23140098	-17.69283415	0.0220412733	0.9327654331			O=C(O)CCCCC1CCSS1	Vitas	STK801969	-2.0598843	0.2516676	-3.57534547	-1.08109464	-5.10835913	-6.40276437	-17.69283415									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00507698-01	Talaporfin sodium			DPI_SARS-CoV-2_General	2019_NPC_02	220201-34-3		6.9832167823	-5.1559444758	-101.7865567072	-2.1	7		-90.8182825387	-88.26999001	0.0002175005	0.9939190244			CCC1=C2[NH]C(=C1C)C=C3[NH]C(=CC4=NC(=C(CC(=O)N[C@@H](CC(O)=O)C(O)=O)C\5=NC(=C2)\C(=C5C(O)=O)C)[C@@H](CCC(O)=O)[C@@H]4C)C(=C3C=C)C	MedChem Express	HY-16477	-0.42775556	-2.97766176	-8.40814796	-5.91399107	-13.3284224	-48.00826757	-88.26999001									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181107-01	Arotinolol hydrochloride	144206274	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	68377-91-3	5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-2-thiophenecarboxamide; Almarl; 	8.7913490634	-5.0559444758	-3.5941621154	4	7	arotinolol, (+-)-isomer;LS-175382;AROTINOLOL HYDROCHLORIDE;CIPLUS_732431;CIPLUS_211026;arotinololum;s 596;Arotinolol Hydrochloride;S 596;5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-2-thiophenecarboxamide;2-(3'-tert-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)thiazole hydrochloride;S-596;arotinolol;LS-176661;LS-152938;AROTINOLOL;Arotinolol hydrochloride;Almarl;arotinolol hydrochloride;Arotinolol;CIPLUS_695770;	-13.365908768	-10.72159064	0.0627954504	0.8767493564			Cl.OC(CSc1nc(cs1)c2ccc(s2)C(N)=O)CNC(C)(C)C	NCI	NSC-317940	4.37697981	0.7553882	1.46503833	-1.52234408	1.76555854	-3.75798572	-10.72159064									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532512-01	HYDROCORTISONE ACEPONATE			DPI_SARS-CoV-2_General	2019_NPC_02			9.8640558873	-5.0059444758	-8.2905782279	4	7		-22.2921799959	-18.99348333	0.001082538	0.9862961335			CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CC\C4=C\C(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O	BOC Sciences	74050-20-7	1.16765706	1.13423734	3.10119313	0.49341721	2.21229475	-5.60879369	-18.99348333									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179341-04	Ondansetron	170464701	5-HT3 Antagonists	DPI_SARS-CoV-2_General	2019_NPC_02	99614-02-5	; ; Ondansetron, (R)-Isomer; Zofran;Ondansetron hydrochloride; Methoxamine HCl;Ondansetron Hydrochloride; Zofran ODT; Ondansetron, (S)-Isomer; Ondansetron; Ondansetron, (+,-)-Isomer	17.5410474839	-4.7559444758	-17.7315304828	4	7		-16.861587548	-13.88954954	0.0087767839	0.9594462397	3359	HTR3A	O=C1C(CCc3c1c2ccccc2n3C)Cn4ccnc4C	Prestwick	Prestw-1058	-1.68096372	-2.06749983	-2.25733105	-0.25489325	-3.71884134	-4.96523863	-13.88954954									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162068-06	Opipramol dihydrochloride	170465942	Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	909-39-7		15.6334750258	-4.8059444758	-30.3770897107	-3	7		-34.604760744	-31.73557071	0.0004724018	0.9910058482			Cl.Cl.OCCN1CCN(CC1)CCCN3c4ccccc4C=Cc2ccccc23	Prestwick Chemical, Inc.	Prestw-1456	-2.7715247	-0.39827009	-3.55097365	-3.42388442	-2.53514693	-6.92616495	-31.73557071									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016352-07	Benzocaine	170465463	Sodium channel protein type 10 subunit alpha Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	94-09-7				6.21847364	4	7		0	4.75019645			6336	SCN10A	Nc1ccc(cc1)C(=O)OCC	Vitas	STK043620	1.94369811	0	1.86931832	0	0	1.56003862	4.75019645									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159361-06	Menthyl Anthranilate			DPI_SARS-CoV-2_General	2019_NPC_01	134-09-8		13.9333492831	-4.8559444758	-21.3042493336	-3	7		-55.1976248966	-43.41081341	0.0003684098	0.9920647061			CC(C)C1CCC(C)CC1OC(=O)C2=CC=CC=C2N	SigmaAldrich	437387	2.78120688	4.15618052	3.823938	0	0	-8.40998018	-43.41081341									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095161-05	Rebamipide	170465891	Free Radical Scavenger	DPI_SARS-CoV-2_General	2019_NPC_01	90098-04-7	 ; Rebamipida;REBAMIPIDE; REBAMIPIDE; Rebamipide; Mucosta			8.5605720094	4	7		0	-2.73250361				CAT	Clc1ccc(cc1)C(=O)NC(CC3=CC(=O)Nc2ccccc23)C(=O)O	Microsource	01505310	3.20238182	3.61375131	1.10891765	0.54932651	3.67710501	2.26129376	-2.73250361									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095156-06	Carbadox	170466261		DPI_SARS-CoV-2_General	2019_NPC_01	6804-07-5		17.5410474839	-4.7559444758	-37.2336674328	4	7		-12.1125095801	-16.15168183	0.0071740951	0.963742564			O=C(OC)N\N=C\c2c[n+]([O-])c1ccccc1[n+]2[O-]	Microsource	01505294	-5.9569627	-6.69240355	-6.70956106	-5.64125718	-7.84398315	-8.43030642	-16.15168183									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00356590-01	Arsenic trioxide 			DPI_SARS-CoV-2_General	2019_NPC_02	1327-53-3				-47.5193933082	4	7		0	-10.07943681					[O]1[As]2[O][As]1[O]2	Enzo	AC2011	-8.229092	-10.49920303	-9.86146598	-10.75930127	-9.12720101	-12.16647877	-10.07943681									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168248-02	Benzoylecgonine	144206406		DPI_SARS-CoV-2_General	2019_NPC_02	519-09-5				-18.1615497295	4	7		0	-7.42044428					CN3[C@H]1CC[C@@H]3[C@H]([C@H](C1)OC(=O)c2ccccc2)C(=O)O	RTI	9180-001	-2.12490462	-3.26872878	-4.86861536	-2.68690223	-2.35487014	-5.83897031	-7.42044428									5.27E-9	2.63E-8	1.32E-7	6.59E-7	0.00000329	0.000016499999999	0.0000823								
NCGC00167565-06	Carbazochrome sodium sulfonate		Hemostatics	DPI_SARS-CoV-2_General	2019_NPC_02	51460-26-5		15.6334750258	-4.8059444758	-19.6736823028	4	7		-11.9871638919	-12.14384246	0.158467873	0.7751886997			CN1C(CC\2=C\C(=N\NC(N)=O)C(=O)\C=C12)[S]([O-])(=O)=O	MedChem Express	HY-B0491A	-0.48787255	-6.17477881	-4.05288202	-1.54572878	-2.11249198	-4.62701992	-12.14384246									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249414-01	Fonazine	144206752	Serotonin (5-HT) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	7456-24-8		8.0180122623	-5.0959332839	-82.5240336188	-2.1	7		-98.9725110574	-89.82542929	0.0000010752	0.9995764338	3269		CN(C)S(=O)(=O)c1cc2N(CC(C)N(C)C)c3ccccc3Sc2cc1	NCGCChem	DJM10-019	2.95729381	1.14347756	1.63381074	-0.46535556	-18.73678207	-60.93573844	-89.82542929									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00274275-01	Tripamide	170466047	Solute carrier family 12 member 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	73803-48-2				-19.7917833537	4	7		0	-10.76440089					NS(=O)(=O)c1cc(ccc1Cl)C(=O)NN3C[C@@H]4C2CC[C@@H](C2)[C@@H]4C3	GVK	FFS-11-286-NCI-189	-1.13991075	-3.00076232	-5.21553644	-4.79152538	-1.60872561	-4.47200301	-10.76440089									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178065-03	TENIPOSIDE		DNA Topoisomerase II Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_02	29767-20-2		13.9333492831	-4.8559444758	-35.8423049454	-2.2	7		-79.1371830912	-57.67968416	0.0001201694	0.9954924844		TOP2A	COC1=C(O)C(=CC(=C1)[C@H]2[C@@H]3C(COC3=O)C(O[C@@H]4O[C@@H]5CO[C@H](OC5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7)OC	Microsource	01504094	4.75617933	3.44891312	4.03881766	1.87779155	-3.42418554	-18.32487787	-57.67968416									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00014483-16	Pamelor		Norepinephrine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	894-71-3		8.7913490634	-5.0559444758	-9.6294628281	4	7		-19.27513878	-17.31261565	0.0057397763	0.9674857272			CNCCC=C1C2=C(CCC3=C1C=CC=C3)C=CC=C2	SIGMA	N7261	-0.38002566	-0.46179784	0.54836587	2.92723305	1.94132873	-5.30514762	-17.31261565									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00142384-03	Cholic Acid		Bile acid receptor FXR Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	81-25-4				-44.3971192676	4	7		0	-14.8437302					C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	SIGMA	C1129	-12.26490451	-9.27749407	-7.09463576	-6.98071086	-7.83383241	-9.25860054	-14.8437302									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166262-03	Ensulizole	170465490		DPI_SARS-CoV-2_General	2019_NPC_01	27503-81-7				13.6033322898	4	7		0	4.19761223					O=S(=O)(O)c1cc2nc(nc2cc1)c3ccccc3	Vitas	STK034479	0.91254569	0	4.46735395	4.62788773	4.00700401	2.3070278	4.19761223									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015121-17	Phenoxybenzamine hydrochloride	170465147	Adrenergenic Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	59-96-1	; ;Phenoxybenzamine; Fenoxibenzamina;PHENOXYBENZAMINE; Phenoxybenzamine HCl;Phenoxybenzamine HCl;Phenoxybenzamine hydrochloride;PHENOXYBENZAMINE HYDROCHLORIDE; Phenoxybenzamine hydrochloride	15.6334750258	-4.8059444758	-18.6553918582	-3	7		-48.3117918421	-44.57174723	0.0001093375	0.9957029314		ADORA1	CC(COc1ccccc1)N(Cc2ccccc2)CCCl	Microsource	02300176	1.44990681	2.66572189	0	2.86703288	0	0	-44.57174723									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090964-04	Tetraethylenepentamine	170464940	Oxidative Stress Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	112-57-2				18.415013965	4	7		0	3.83260247					NCCNCCNCCNCCN	Prestwick	Prestw-1387	3.88013458	4.97715445	3.53635056	0	4.72263107	4.4514457	3.83260247									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00013095-10	Geraniol	170465692	Trichomonas vaginalis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	106-24-1				6.0933452849	4	7		0	-4.08101189					C\C(C)=C\CCC(\C)=C\CO	Microsource	01501132	0	2.42138442	3.10253223	0.57691825	3.0020809	2.69322628	-4.08101189									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090698-06	1,3-Diphenylguanidine	170465656		DPI_SARS-CoV-2_General	2019_NPC_01	102-06-7				2.5029247131	4	7		0	-1.40427366					N=C(Nc1ccccc1)Nc2ccccc2	Vitas	STK802182	-0.68017331	2.72924964	0.10479881	-1.7583465	-0.45932092	4.68519742	-1.40427366									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253737-01	Istradefylline	174007485	Adenosine A2A Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	155270-99-8	Istradefylline	15.6334750258	-4.8059444758	-51.6133166469	-2.2	7		-52.2693383704	-42.95455122	0.0019163851	0.9815917767	135	ADORA2A	COc1ccc(cc1OC)/C=C/c3nc2c(C(=O)N(CC)C(=O)N2CC)n3C	GVK	FFS-12-73-NCI-1738	-4.36908479	-2.0255577	-8.14262387	-3.19813379	-7.36689844	-16.47441435	-42.95455122									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178255-02	QUININE ETHYL CARBONATE		Ferriprotoporphyrin IX Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	83-75-0		6.2237985085	-5.2059444758	-5.4212621008	4	7		-18.6709794	-15.5591495	0.0004683303	0.9910617071			CCOC(=O)O[C@H]([C@H]1C[C@@H]2CCN1C[C@@H]2C=C)C3=C4C=C(OC)C=CC4=NC=C3	Microsource	00310050	1.88443663	2.08598027	1.99010806	3.87016814	1.70377587	-7.49718151	-15.5591495									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346550-02	Lumacaftor		CFTR Channel Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	936727-05-8		6.9832167823	-5.1559444758	-30.6275014308	4	7		-17.971973752	-20.63929981	0.0041894249	0.9724447706		CFTR	CC1=C(N=C(NC(=O)C2(CC2)C3=CC4=C(OC(F)(F)O4)C=C3)C=C1)C5=CC=CC(=C5)C(O)=O	Selleck	S1565	-1.49598835	-3.8878237	-5.01863529	-2.8926876	-2.87764656	-12.12420143	-20.63929981									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181134-04	Haloprogin			DPI_SARS-CoV-2_General	2019_NPC_02	777-11-7		6.9832167823	-5.1559444758	-56.4462519673	-2.2	7		-61.1285972551	-57.29439186	0.0044497559	0.9714722813			[Cl]C1=CC(=C([O][CH2][C]#[C][I])C=C1[Cl])[Cl]	Prestwick	Prestw-1269	-4.22899951	-2.16452216	-2.44485596	-2.19114655	4.42696576	-31.07384442	-57.29439186									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167510-02	Doripenem	170465085	Carbapenem Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	148016-81-3		6.2237985085	-5.2059444758	-87.0408922232	-2.2	7		-69.575004302	-64.7433763	0.0001093142	0.9957023259		DPEP1	O[C@H](C)[C@H]3C(=O)N2C(=C(S[C@H]1C[C@@H](CNS(N)(=O)=O)NC1)[C@H](C)[C@@H]23)C(=O)O	Sequoia	148016-81-3	-2.6937039	-4.67324263	-4.41386747	-7.74735168	-18.18549058	-38.0777903	-64.7433763									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095978-06	Lufenuron	170465736		DPI_SARS-CoV-2_General	2019_NPC_01	103055-07-8		15.6334750258	-4.8059444758	-6.0258815889	4	7		-26.901738868	-17.83478239	0.0017120184	0.9826681188			Clc2cc(NC(=O)NC(=O)c1c(F)cccc1F)c(Cl)cc2OC(F)(F)C(F)C(F)(F)F	Microsource	01505355	0.58335149	2.35296992	3.81418927	1.30182858	1.14449576	-4.34981452	-17.83478239									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00348365-01	INDOCYANINE GREEN			DPI_SARS-CoV-2_General	2019_NPC_01	3599-32-4		0.1563347503	-6.8059444758	-243.8372849288	-1.1	7		-102.1082127178	-99.40939393	6.632E-7	0.9996673684			CC1(C)C(=C\C=C\C=C\C=C\C2=[N+](/CCCC[S]([O-])(=O)=O)C3=CC=C4C=CC=CC4=C3C2(C)C)/N(CCCC[S]([O-])(=O)=O)C5=CC=C6C=CC=CC6=C15	SIGMA	I2633	0.50589403	-2.0451047	-20.52350662	-62.03376226	-91.87179617	-97.93688704	-99.40939393									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021226-04	Dexamethasone 21-phosphate disodium salt	225144188	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	2392-39-4		5.059023725	-5.2959332839	-21.8732436933	-2.4	7		-31.667739724	-23.05644977	0.0061726822	0.9661593985			C[C@@H]1C[C@H]2[C@@H]3CC\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO[P]([O-])([O-])=O	SIGMA	D1159	4.02052623	0	0.5044966	0	2.71786022	3.91280045	-23.05644977									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00179248-03	Articaine hydrochloride	170464825	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	23964-57-0				-4.0119632936	4	7		0	-0.46640136					Cl.O=C(Nc1c(scc1C)C(=O)OC)C(C)NCCC	Prestwick Chemical, Inc.	Prestw-1032	0.079878	1.48801525	-2.03504667	-0.90049414	-0.10404507	-3.91280045	-0.46640136									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167453-02	Clinofibrate	174007296	treatment of lipoprotein diseases	DPI_SARS-CoV-2_General	2019_NPC_01	30299-08-2	 ; Lipoclin;Clinofibrate; Clinofibrate; Clinofibrato	12.4181106199	-4.9059444758	-6.3923316142	4	7		-12.1076271879	-11.75635599	0.0238336518	0.9299821512		HMGCR	O=C(O)C(C)(CC)Oc1ccc(cc1)C2(CCCCC2)c3ccc(OC(C)(CC)C(=O)O)cc3	Selleck	S2664	0.26383947	-1.88872871	-0.48499915	2.07941405	0.90595341	-1.14335078	-11.75635599									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018117-17	Theophyllamine	170466874	Adenosine Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	58-55-9	; Theocolin; 1,3-Dimethylxanthine; Choledyl-SA; Quadrinal; Theophylline solution; Novurite; Mercurofilina; Guaithylline; Choledyl; oxtripylline-SA;Theophylline; Guaifilina; Mercumatilina sodica; Aminofilina; Elixophyllin;Aminophylline ethylenediamine;THEOPHYLLINE; Teofilinato de colina; Mercumatiline sodique;Aminophylline; Brondecon; Theobret; Aminophylline, dihydrate; Brondaxin; Butaphyllamine; Tedral; Theodur G; Theophylline-[8-3H]; Mercumatilinum natricum; Euspirax; Novurit; Somophyllin;Theophylline monohydrate			7.2689780552	4	7		0	0			134	ADORA1	O=C2c1ncnc1N(C)C(=O)N2C	Labotest	LT00000171	-2.60208651	2.78789063	3.2390144	2.96234981	1.40333959	2.52553483	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182982-01	Dalcotidine	144206834	Histamine H2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	120958-90-9	Dalcotidine; 	8.7913490634	-5.0559444758	-6.8283200937	4	7	dalcotidine;KU-1257;CIPLUS_705874;DALCOTIDINE;dalcotidinum;N-ethyl-N'-(3-(3-(piperidinomethyl)phenoxy)propyl)urea;Dalcotidine;KU 1257;	-8.9465159359	-8.28876328	0.1910227521	0.7427143086	3274	HRH2	CCNC(=O)NCCCOc2cc(CN1CCCCC1)ccc2	Pharmaron	PH-NIH-151679	-1.85171738	-1.91316246	2.08866467	-0.95066095	2.77876466	-3.72986432	-8.28876328									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095836-05	Guaiazulene	170465862	lipid oxidation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	489-84-9		0.4406111917	-6.3559444758	-219.1552517832	-1.1	7		-87.9365576413	-96.63633368	0.0001033864	0.9958205288			CC(C)c1ccc(C)c2ccc(C)c2c1	Microsource	01502249	-9.84435892	-12.35125956	-15.84899223	-44.77638147	-71.50941481	-86.67615224	-96.63633368									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018097-06	Paroxypropione	170465896	Succinate semialdehyde dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	70-70-2				12.1335787729	4	7		0	2.08866695					O=C(CC)c1ccc(O)cc1	Labotest	LT00855519	2.7182727	3.39873433	2.54685482	2.30265633	2.38796122	2.51537172	2.08866695									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00014993-12	Nonanedioic acid	170465358	reactive oxygen species biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	123-99-9				8.4569801088	4	7		0	0			7299		O=C(O)CCCCCCCC(=O)O	Microsource	01500648	3.26047491	4.25391551	1.23565109	0	3.45378876	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159518-05	Rabeprazole	170464736	H+/K+-ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	117976-90-6	; ; Pariet;RABEPRAZOLE SODIUM;Rabeprazole sodium; Rabeprazole sodium; Sodium rabeprazole; Aciphex; Sodium Rabeprazole	15.6334750258	-4.8059444758	-7.956564057	-2.4	7		-35.732668368	-26.02722364	0.0012281627	0.9853634354		ATP4A	[Na+].Cc3c(OCCCOC)ccnc3CS(=O)c1[n-]c2ccccc2n1	Microsource	01505943	3.9237044	0	2.50785991	3.76501869	1.82967061	-3.65364094	-26.02722364									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159479-05	Methyl nicotinate	170465506		DPI_SARS-CoV-2_General	2019_NPC_01	93-60-7				12.6081064124	4	7		0	3.84274163					COC(=O)c1cccnc1	Vitas	STK803258	0	3.73592005	4.8329312	4.01083603	0	2.55602419	3.84274163									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166141-06	Carbinoxamine maleate	170465237	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	3505-38-2				-21.0348574036	4	7		0	-5.01355658					O=C(O)/C=C\C(=O)O.Clc1ccc(cc1)C(OCCN(C)C)c2ccccn2	Specs	AN-153/I210051	-3.63245393	-7.68555522	-5.22491268	-2.54191708	-2.98220184	-4.35926343	-5.01355658									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344522-01	Gluconolactone	170465327	Calcium Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC_02	90-80-2				7.8761647076	4	7		0	0.78961138					O[C@H]1[C@H](O)[C@@H](O)C(=O)O[C@@H]1CO	SIGMA	G2164	2.07866078	1.43454457	1.06185978	1.2230199	0	4.94175122	0.78961138									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389219-01	Oxeladin Citrate			DPI_SARS-CoV-2_General	2019_NPC_02	52432-72-1				6.9496841076	4	7		0	-1.47933216					CCN(CC)CCOCCOC(=O)C(CC)(CC)C1=CC=CC=C1	APExBIO	A8493	3.74806354	2.30312551	2.54330653	0.79274139	1.33307987	0.45565577	-1.47933216									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183845-01	Pibutidine	144206830	Histamine H2 receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_02	103922-33-4				-1.16291578	4	7	LS-55930;Pibutidine hydrochloride;IT-066;pibutidine hydrochloride;pibutidinum;PIBUTIDINE;PIBUTIDINE HYDROCHLORIDE;3-amino-4-(4-(4-(1-piperidinomethyl)-2-pyridyloxy)-2-butenylamino)-3-cyclobutene-1,2-dione;3-Cyclobutene-1,2-dione, 3-amino-4-((4-((4-(1-piperidinylmethyl)-2-pyridinyl)oxy)-2-butenyl)amino)-, monohydrochloride, (Z)-;IT 066;Pibutidine Hydrochloride;CIPLUS_3889336;pibutidine;CIPLUS_696295;	0	-5.15625743					NC=3C(=O)C(=O)C=3NC\C=C/COc2cc(CN1CCCCC1)ccn2	Pharmaron	PH-NIH-151621	1.26014474	4.22971194	-0.79463679	0.21280079	-0.67248057	0.789177	-5.15625743									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00532514-01	FLUPENTIXOL DECANOATE		Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02			2.4777388143	-5.6059444758	-98.3802473881	-2.2	7		-84.2746991411	-75.20810541	0.0000545967	0.9969687065			CCCCCCCCCC(=O)OCCN1CCN(CC\C=C2/C3=CC=CC=C3SC4=CC=C(C=C24)C(F)(F)F)CC1	SynInnova	SL-1062	2.81856228	1.52232669	1.20250346	-2.93478007	-29.64855167	-56.92408869	-75.20810541									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163732-03	Moxidectin			DPI_SARS-CoV-2_General	2019_NPC_02	113507-06-5		3.9269513795	-5.4059444758	-89.7154157238	-2.2	7		-80.5396232665	-78.10493269	0.0000082359	0.9988262869			CO\N=C/1C[C@]2(C[C@@H]3C[C@@H](C\C=C(C)\C[C@@H](C)\C=C\C=C\4CO[C@@H]5[C@H](O)\C(=C/[C@@H](C(=O)O3)[C@]45O)C)O2)O[C@@H]([C@H]1C)\C(C)=C\C(C)C	MedChem Express	HY-B0777	1.93992925	-0.26103629	-1.83540001	-1.24172766	-10.67652021	-57.32337467	-78.10493269									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346529-03	Safinamide		Sodium channel inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	133865-89-1				8.2854855962	4	7		0	-2.21661989					C[C@H](NCC1=CC=C(OCC2=CC(=CC=C2)F)C=C1)C(N)=O	MedChem Express	HY-70057	3.65557585	1.56390769	0	4.11804597	4.18934011	0.11743705	-2.21661989									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095169-05	Miltefosine	170465622		DPI_SARS-CoV-2_General	2019_NPC_01	58066-85-6		12.4181106199	-4.9059444758	1.4787260833	4	7		-7.038604848	-5.86550404	0.3386370607	0.5883058097			C[N+](C)(C)CCOP([O-])(=O)OCCCCCCCCCCCCCCCC	Microsource	01505329	-2.4423305	-0.19791336	1.00655602	3.27840068	4.36227986	0.45734031	-5.86550404									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179541-03	Carteolol hydrochloride	170465122	Adrenergic receptor beta Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	51781-21-6				8.9976161667	4	7		0	2.16471065					Cl.CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12	Prestwick Chemical, Inc.	Prestw-446	0.97547987	-1.05798128	1.98630304	3.07773346	3.50961782	2.77961279	2.16471065									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091888-09	3,3,5-Trimethylcyclohexyl salicylate	170465478		DPI_SARS-CoV-2_General	2019_NPC_01	118-56-9		22.0828704269	-4.6559444758	-15.2695165918	-3	7		-34.208968084	-30.17414007	0.0000019287	0.9994332132			O=C(OC1CC(C)CC(C)(C)C1)c2ccccc2O	Microsource	01505020	0	0.36650622	0	0.55183485	0	0	-30.17414007									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090753-06	Azithromycin		50S Ribosomal Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	83905-01-5	; Azithromycin hydrate; ADES azithromycin; N-desmethylazithromycin; Zitromax; Zithromax  (azithromycin); NDES azithromycin;Azithromycin (AZ);Azithromycin; Azithromycin (AZ); Azithromycin Hydrate			-2.8103791769	4	7		0	-1.83518795					CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O	FLUKA	57947	0.23479292	-1.76167322	-2.20564939	0.4740763	0.53037608	0.10163118	-1.83518795									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182999-01	Flomoxef	144206879	Streptococcus pneumoniae Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	99665-00-6	FLOMOXEF; 			-0.4522031691	4	7	CIPLUS_207906;LS-178431;FLOMOXEF;Flomoxef;flomoxefum;flomoxef;'(-)-(6R,7R)-7-(2-((DIFLUOROMETHYL)THIO)ACETAMIDO)-3-(((1-(2-HYDROXYETHYL)-1H-TETRAZOL-5-YL)THIO)METHYL)-7-METHOXY-8-OXO-5-OXA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID;flomoxef [5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[(difluoromethyl)thio]acetyl]amino]-3-[[[1-(2-hydroxyethyl)-1H-tetrazol-5-yl]thio]methyl]-7-methoxy-8-oxo-, (6R-cis)- ];Flomoxef [5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[(difluoromethyl)thio]acetyl]amino]-3-[[[1-(2-hydroxyethyl)-1H-tetrazol-5-yl]thio]methyl]-7-methoxy-8-oxo-, (6R-cis)- ];S 6315;	0	-3.98975945					O=C2N1C(=C(CO[C@H]1[C@@]2(OC)NC(=O)CSC(F)F)CSc3nnnn3CCO)C(=O)O	Pharmaron	PH-NIH-183450	-1.64839155	4.09753952	-1.06017401	0.4489929	-0.31213521	0.78764165	-3.98975945									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090955-06	Dicyclohexylamine	170466864	spermidine biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	101-83-7		12.4181106199	-4.9059444758	1.7569704742	4	7		-10.276178048	-8.14681504	0.0592261603	0.8815458807			C1CCCCC1NC2CCCCC2	Vitas	STK379549	3.09103672	2.04021795	0.01218591	0	3.40303507	0.21342548	-8.14681504									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018239-11	ISOETHARINE MESYLATE			DPI_SARS-CoV-2_General	2019_NPC_02	7279-75-6		12.4181106199	-4.9059444758	-21.1341145508	4	7		-28.0837653999	-27.5698045	0.0013158387	0.984839884			CCC(NC(C)C)C(O)C1=CC=C(O)C(=C1)O	Microsource	01505977	-0.61273093	0.15939384	-3.32153489	-0.87692631	0.43960744	-5.24239008	-27.5698045									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167432-05	Fosinopril·Na		Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	98048-97-6		4.0185253849	-5.3959332839	-39.5702855058	4	7		-14.423439264	-14.17019455	0.2469481055	0.6855977737			CCC(=O)O[C@@H](O[P](=O)(CCCCC1=CC=CC=C1)CC(=O)N2C[C@@H](C[C@H]2C([O-])=O)C3CCCCC3)C(C)C	Enzo	DL155	-5.98626558	-2.15066183	-8.11279623	-6.49860861	-3.60002851	-8.39909808	-14.17019455									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00142423-06	Phlorizin		SGLT-1/2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	60-81-1		11.0676527398	-4.9559444758	-52.7345816987	-2.2	7		-49.5982384744	-41.76378252	0.0012527312	0.9852041374		SCL5A2	OC[C@H]1O[C@@H](OC2=C(C(=O)CCC3=CC=C(O)C=C3)C(=CC(=C2)O)O)[C@H](O)[C@@H](O)[C@@H]1O	Prestwick	Prestw-NAT-0295	-0.44162871	-5.06133198	-6.12503223	-3.36973552	-7.74897227	-21.21382939	-41.76378252									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00506872-01	Acotiamide hydrochlorid		Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	773092-05-0		13.9333492831	-4.8559444758	-3.064041545	4	7		-20.070422876	-13.80868573	0.0020851006	0.9808482398			COC1=C(OC)C=C(C(=O)NC2=NC(=CS2)C(=O)NCCN(C(C)C)C(C)C)C(=C1)O	TargetMol	T2319	3.36886402	2.23844395	1.01029043	1.91520707	0.35881472	-2.75272454	-13.80868573									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167492-03	Lercanidipine hydrochloride	170465587	Voltage-gated L-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	132866-11-6		2.2082870427	-5.6559444758	-106.4230020465	-1.2	7		-86.2720116059	-77.85758455	0.0000183723	0.9982452663			Cl.CC=3NC(C)=C(C(C=3C(=O)OC(C)(C)CN(C)CCC(c1ccccc1)c2ccccc2)c4cccc(c4)[N+]([O-])=O)C(=O)OC	Sequoia	132866-11-6	0	3.03772321	1.04779541	-4.92715665	-28.83587197	-63.88575723	-77.85758455									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389762-01	D-(+)-MALTOSE			DPI_SARS-CoV-2_General	2019_NPC_02	69-79-4				-44.7470525199	4	7		0	-10.83575132					OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O	Microsource	01301024	-10.93898125	-8.53565571	-8.02841002	-9.57603536	-8.23372858	-10.87936866	-10.83575132									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00187912-17	Ibrutinib (PCI-32765)		BTK Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	936563-96-1		13.9333492831	-4.8559444758	-31.7381149487	-2.2	7		-68.2509632244	-51.70527517	0.0000120645	0.9985792194	695	BTK	NC1=C2C(=NC=N1)[N](N=C2C3=CC=C(OC4=CC=CC=C4)C=C3)[C@@H]5CCCN(C5)C(=O)C=C	APExBIO	A3001	2.31450438	2.45096907	3.11056937	0.86289549	-0.68673811	-14.38838782	-51.70527517									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522017-01	rac Alminoprofen		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	39718-89-3		13.9333492831	-4.8559444758	-22.8095145105	-3	7		-51.4669885325	-49.09384959	0.0011782358	0.9856569843			CC(C(O)=O)C1=CC=C(NCC(C)=C)C=C1	Toronto Research	A575150	2.47635783	-3.41657234	0.68680997	3.78130627	2.22179978	-1.26832018	-49.09384959									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091835-10	Chlormethine	170465017	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC_01	55-86-7	 Nitrogen mustard HCl;Nitrogen mustard HCl;Nitrogen mustard hydrochloride; Nitrogen mustard hydrochloride;MECHLORETHAMINE			-45.805939585	4	7		0	-11.71072977				H2AFX	Cl.ClCCN(C)CCCl	Microsource	01500375	-10.87551134	-9.04293009	-8.87377836	-8.51581509	-10.71664214	-9.01976726	-11.71072977									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179602-03	Testosterone propionate	170464835	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	57-85-2		15.6334750258	-4.8059444758	-8.2905914082	-2.4	7		-30.300740164	-25.66728347	0.0007207469	0.9888529533		AR	CCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	Vitas	STK801834	3.0474669	2.35785667	2.2836392	0.8603607	-0.22077856	-0.7317445	-25.66728347									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00186658-01	Dexpanthenol	170464647		DPI_SARS-CoV-2_General	2019_NPC_01	81-13-0				14.6175691129	4	7		0	3.30029657					CC(C)(CO)[C@@H](O)C(=O)NCCCO	Labotest	LT00244791	2.56819887	3.01756786	1.93755941	4.19143653	4.14403898	2.64749225	3.30029657									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182981-01	Proxazole citrate	144206776		DPI_SARS-CoV-2_General	2019_NPC_02	132-35-4	Proxazole; Proxazol; 			-4.8021663475	4	7	CIPLUS_151746;proxazole, (+)-isomer;Proxazole;LS-99108;PROXAZOLE;pirecin;Proxazole citrate;LS-175790;3 alpha-phenylpropyl-5 beta- diethylaminoethyl-1,2,4-oxadiazole;proxazole, (+-)-isomer;3-(alpha-ethylbenzyl)-5-(2-diethylaminoethyl)- 1,2,4-oxadiazole;toness;CIPLUS_210763;Proxazol;Proxazole Citrate;N,N-Diethyl-3-(1-phenylpropyl)-1,2,4-oxadiazole-5-ethanamine citrate;Proxazolum;CIPLUS_177396;CIPLUS_177395;CIPLUS_177394;proxazolum;propazoline;proxazole, (-)-isomer;Toness;PROXAZOLE CITRATE;1,2,4-Oxadiazole, 5-(2-(diethylamino)ethyl)-3-(alpha-ethylbenzyl)-, citrate;proxazole;	0	-3.05379822					CCC(c1nc(CCN(CC)CC)on1)c2ccccc2.O=C(O)C(O)(CC(=O)O)CC(=O)O	NCI	NSC_303872	-1.90755856	-1.078796	-1.3572115	-1.35397423	0.72951073	0.3429162	-3.05379822									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168746-02	Methyldigoxin	99455400		DPI_SARS-CoV-2_General	2019_NPC_02			15.9980377079	-4.7959332839	-0.2550647463	4	7		-12.763164156	-10.63597013	0.0187224364	0.9387359034			CO[C@H]1[C@@H](O)CC(O[C@@H]1C)OC2[C@@H](O)CC(O[C@@H]2C)OC3[C@@H](O)C[C@@H](O[C@@H]3C)OC4CC[C@@]5(C)C(CCC6C5CC(O)[C@]7(C)[C@@H](CCC67O)C/8=C/C(=O)OC8)C4	Chemdiv	N001-0009	1.32026174	1.99357805	3.33559926	-0.54486355	2.12199701	-3.80496054	-10.63597013									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00346587-16	Bergenin monohydrate			DPI_SARS-CoV-2_General	2019_NPC_02	477-90-7				-2.2467946844	4	7		0	-1.44603529					[H][C@]12OC(=O)C3=C(C(O)=C(OC)C(O)=C3)[C@]1([H])O[C@H](CO)[C@@H](O)[C@@H]2O	Prestwick	Prestw-NAT-0201	2.64283567	-0.09933239	-2.96054945	-1.10609639	-1.14297935	0.62946261	-1.44603529									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182064-02	Ceftezole sodium	144206691	Peptidoglycan biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	41136-22-5	Ceftezole; Celoslin; Falomesin; 	11.0676527398	-4.9559444758	3.0890550399	4	7	CEFTEZOLE SODIUM;LS-150087;LS-174169;Ceftezol;ceftezolum;Falomesin;Celoslin;ceftezol;Ceftezole sodium;Ceftezolum;Ceftezole;CIPLUS_748000;ceftezole;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 8-oxo-7-((1H-tetrazol-1-ylacetyl)amino)-3-((1,3,4-thiadiazol-2-ylthio)methyl)-, monosodium salt, (6R-trans)-;demethylcefazolin;Ceftezole Sodium;CIPLUS_207790;CEFTEZOLE;ceftezol, sodium salt;	-10.1751177319	-8.06259811	0.0241268874	0.9297122582			[Na+].[O-]C(=O)C=3N4C(=O)[C@@H](NC(=O)Cn1cnnn1)[C@H]4SCC=3CSc2nncs2	Kemprotec	41136-22-5	0	2.72817575	3.29340616	1.84505297	2.4879405	0.14562195	-8.06259811									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00370823-03	Pitolisant (hydrochloride)		Histamine H3 receptor Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	903576-44-3				1.4611495967	4	7		0	-0.69447748					ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1	MedChem Express	HY-12199B	1.19540336	1.66093003	-0.34457701	0	2.67804101	-2.53664036	-0.69447748									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00187598-03	Amaranth			DPI_SARS-CoV-2_General	2019_NPC_02	915-67-3		11.0676527398	-4.9559444758	-20.8282790257	4	7		-25.1223897679	-24.26865814	0.017915544	0.9399144605			OC1=C(N=NC2=CC=C(C3=CC=CC=C23)[S]([O-])(=O)=O)C4=CC=C(C=C4C=C1[S]([O-])(=O)=O)[S]([O-])(=O)=O	SIGMA	06409	1.81969525	-0.97715355	-2.38859849	-4.26303113	1.79882613	-7.4220218	-24.26865814									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379087-02	Tipranavir			DPI_SARS-CoV-2_General	2019_NPC_02	174484-41-4		9.8640558873	-5.0059444758	-56.394075321	-2.2	7		-81.5002140572	-67.04561671	0.000015356	0.9983963244			CCC[C@@]1(CCC2=CC=CC=C2)CC(=C([C@H](CC)C3=CC=CC(=C3)N[S+]([O-])(=O)C4=CC=C(C=N4)C(F)(F)F)/C(=O)O1)\O	MedChem Express	HY-15148	2.32375315	0.39039941	-0.3633295	1.7094217	-4.62181879	-29.48139797	-67.04561671									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159383-04	Propyl benzoate	170465563		DPI_SARS-CoV-2_General	2019_NPC_01	2315-68-6				-0.3265234449	4	7		0	-2.70208613					O=C(OCCC)c1ccccc1	Labotest	LTBB003527	0.87865805	3.28145234	0.57273769	-1.86871347	-2.11896665	0.85370192	-2.70208613									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532503-01	BUNITROLOL		Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02					4.1086936832	4	7		0	-1.00366266			154	ADRB2	CC(C)(C)NCC(O)COC1=CC=CC=C1C#N	UkrOrg	BBV-45651151	4.42784804	-0.71842731	-0.51334943	-0.40923228	3.28636266	0.70462232	-1.00366266									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344544-01	Cabergoline	170464667	Serotonin 2b (5-HT2b) receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	81409-90-7		13.9333492831	-4.8559444758	-62.5031076972	-2.2	7		-41.9666527276	-40.03234553	0.0000058173	0.9990148549			CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@@H]2c3cccc4ncc(C[C@H]2N(C1)CC=C)c34	SIGMA	C0246	-7.39670281	-7.78257756	-7.88307822	-7.7379978	-10.06344605	-18.59733183	-40.03234553									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379039-02	Tiotropium (Bromide)		Muscarinic M3 Antagonists	DPI_SARS-CoV-2_General	2019_NPC_02	136310-93-5				-26.6717216267	4	7		0	-7.22541978					C[N+]1(C)[C@H]2CC(C[C@@H]1[C@H]3O[C@H]23)OC(=O)C(O)(C4=CC=CS4)C5=CC=CS5	MedChem Express	HY-17360	-6.28685056	-6.69685139	-2.30421228	-6.47054697	-4.7358791	-6.41676062	-7.22541978									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018258-10	Econazole nitrate	170465422	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC_01	24169-02-6	; Pevisone; Spectazole;Econazole nitrate;ECONAZOLE NITRATE; Econazole nitrate salt	8.7913490634	-5.0559444758	-68.2781282987	-2.1	7		-95.4742592055	-85.57451015	0.0000173341	0.9982957188			[O-][N+](=O)O.Clc3ccc(C(OCc1ccc(Cl)cc1)Cn2ccnc2)c(Cl)c3	Microsource	01501185	1.55641081	0.37872309	3.44373766	-1.15634485	-1.71293712	-35.60648407	-85.57451015									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162150-04	Cilnidipine	170465867	Voltage-gated N-type calcium channel alpha-1B subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	132203-70-4		1.5633475026	-5.8059444758	-103.2377453368	-1.2	7		-71.1248637536	-68.53058224	0.0000066229	0.9989477165			CC=1NC(C)=C(C(C=1C(=O)OCCOC)c2cccc(c2)[N+]([O-])=O)C(=O)OC/C=C/c3ccccc3	Prestwick	Prestw-1376	1.27078644	2.54843991	-0.99680729	-5.57102365	-31.12977719	-62.12205905	-68.53058224									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016526-07	Berberine	170465752	Protein Tyrosine Phosphatase (PTP) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	633-65-8	 ; Natural Yellow- 18; Berberine bisulfate; Berberine chloride form; Erben; Umbellatine; Berberine sulphate;Berberine chloride; Berberine chloride; 0   Berberin Sulfate;BERBERINE CHLORIDE; Kyoberin; Natural Yellow 18; Berberine Tannate	9.8640558873	-5.0059444758	-23.6548826522	4	7		-22.164494092	-21.55078452	0.0039044471	0.9734253965	7803	PTP4A1	[Cl-].COc2ccc1cc3c4cc5OCOc5cc4CC[n+]3cc1c2OC	Labotest	LT00440956	-0.73342531	-0.16370611	-2.94167824	-3.51418466	-1.11404355	-9.14172468	-21.55078452									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091367-05	Danthron	170465532	DNA topoisomerase II alpha Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	117-10-2		1.7541047484	-5.7559444758	-138.7100786713	-1.2	7		-62.9768586039	-69.656029	0.0000094255	0.9987443276			Oc3cccc2C(=O)c1cccc(O)c1C(=O)c23	Labotest	LT00455159	-8.27584538	-10.77283945	-11.49618581	-17.3200893	-36.39801046	-61.93404136	-69.656029									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181131-04	Epothilone B		Tubulin depolymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	152044-54-7		7.8352981002	-5.1059444758	-7.7044396866	4	7		-10.4126670839	-9.92722257	0.1298721849	0.8039130871		TUBB	C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)\C(C)=C\C3=CSC(=N3)C	Adooq	A10360	0.3537654	-0.42274019	0.06797778	-2.81785656	3.52398831	-4.22773393	-9.92722257									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00507774-01	Cefbuperazone 		Peptidoglycan biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	76610-84-9				-0.5747704776	4	7		0	0.73728773					CCN1CCN(C(=O)N[C@H]([C@H](C)O)C(=O)N[C@@]2(OC)[C@H]3SC\C(=C(/N3C2=O)C(O)=O)CSC4=NN=N[N]4C)C(=O)C1=O	AvaChem	2487A	1.34800805	-0.30261729	-3.1574506	1.03126535	-0.83406601	0.58248779	0.73728773									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181160-01	Ecabet	144206316	Urease subunit alpha Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	33159-27-2	Ecabet; 	15.6334750258	-4.8059444758	-4.6942014996	4	7	LS-174407;CIPLUS_207819;ECABET;ecabet sodium;TA-2711;ecabetum;12-sulfodehydroabietic acid;Ecabet Sodium;Ecabetum;Ecabet;TA 2711;CIPLUS_3872531;ecabet;1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-1-phenanthrenecarboxylic acid 6-sodium salt;	-25.893830564	-19.91152547	0.0218321301	0.9329710065		ureC	CC(C)c2cc3CC[C@@H]1[C@](C)(CCC[C@@]1(C)C(=O)O)c3cc2S(=O)(=O)O	NCI	NSC-659804	4.70068672	4.96430964	-0.18518084	0	0	-1.02405111	-19.91152547									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344524-01	Benzylhexadecyldimethylammonium chloride	170465465		DPI_SARS-CoV-2_General	2019_NPC_02	122-18-9		6.9832167823	-5.1559444758	-14.075692524	4	7		-17.0305855479	-15.85882129	0.0147347795	0.9461315585			[Cl-].C[N+](C)(Cc1ccccc1)CCCCCCCCCCCCCCCC	SIGMA	13400	-0.44625309	0.81544965	1.3572115	-2.63077894	1.22377207	-8.51183766	-15.85882129									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090731-08	2-Phenoxyethanol	170465671	Vanilloid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	122-99-6				3.28780054	4	7		0	-0.24734814					OCCOc1ccccc1	Bosche	P2904	0.78383315	1.9335166	1.06185978	1.08738863	0	-0.35231116	-0.24734814									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00164607-01	Bentiromide sodium	144205782		DPI_SARS-CoV-2_General	2019_NPC_02	41748-47-4	Bentiromide; N-benzoyl-L-tyrosyl-PABA; Bentiromido; benzoyl-tyrosyl-PABA; PABA-peptide; 			5.0594378937	4	7	N-Benzoyl-L-tyrosyl-4-aminobenzoic acid sodium salt;benzoyl-tyrosyl-PABA;bentiromidum;bentiromide;CIPLUS_3741566;NCGC00164607-02;N-BENZOYL-L-TYROSYL-P-AMINOBENZOIC ACID;N-Benzoyl-L-tyrosine p-amidobenzoic acid sodium salt;Bentiromidum;BENTIROMIDE;PABA-peptide;NCGC00164607-01;N-benzoyl-L-tyrosyl-PABA;4-((2-(BENZOYLAMINO)-3-(4-HYDROXYPHENYL)-1-OXOPROPYL)AMINO)BENZOIC ACID;Bentiromide (N-Benzoyl-L-tyrosyl-p-aminobenzoic acid (bentiromide);Bentiromide;CIPLUS_178986;Bentiromido;NCGC_FLUKA_13135;N-benzoyl-L-tyrosyl-p-aminobenzoic acid;	0	3.7482757					[Na+].Oc3ccc(C[C@H](NC(=O)c1ccccc1)C(=O)Nc2ccc(cc2)C([O-])=O)cc3	Labotest	LT00645584	0	0	0	0	4.41270822	0	3.7482757									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181161-03	Ethyl salicylate	170466844		DPI_SARS-CoV-2_General	2019_NPC_01	118-61-6				9.2357585338	4	7		0	2.07345821					Oc1ccccc1C(=O)OCC	Labotest	LT02097419	1.7306901	2.93937987	2.29338793	0.27340909	1.57590215	2.89140708	2.07345821									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015822-15	Pyrilamine	170464656	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	91-84-9				-22.3290752345	4	7		0	-10.81848369					COc1ccc(cc1)CN(CCN(C)C)c2ccccn2	Enzo	AC277	-5.47285358	-4.50313974	-7.06051522	-1.4774124	-4.88504289	-0.55388993	-10.81848369									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016003-10	Trihexyphenidyl hydrochloride	170464756	Muscarinic acetylcholine receptor M5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	52-49-3				-3.0192595139	4	7		0	-3.11272211					Cl.OC(CCN1CCCCC1)(c2ccccc2)C3CCCCC3	Microsource	01500592	0.56398712	1.91804921	-0.56298896	-0.56437655	-1.80936913	-1.49905991	-3.11272211									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016066-14	Urapidil hydrochloride	170466013	Adrenergic receptor alpha-1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	64887-14-5				-24.815468811	4	7		0	-7.29005602			3350		Cl.COc3ccccc3N2CCN(CCCNC1=CC(=O)N(C)C(=O)N1C)CC2	Microsource	01503100	-5.75847796	-4.84521221	-3.79469182	-6.27335892	-4.24554636	-5.26957671	-7.29005602									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016395-06	Diphenylpyraline hydrochloride	170464816	Histamine H1 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	132-18-3				-28.4378054109	4	7		0	-11.03140605					Cl.CN3CCC(OC(c1ccccc1)c2ccccc2)CC3	Microsource	01500258	-3.95275095	-4.70349647	-6.36348127	-4.21150325	-6.88473836	-6.37227501	-11.03140605									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015861-09	Propentofylline	170465624	Adenosine receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	55242-55-2				10.2350946561	4	7		0	-2.84910395					CC(=O)CCCCN2C(=O)c1n(cnc1N(C)C2=O)CCC	SIGMA	P9689	1.76457774	3.80433455	3.64358656	1.85868011	2.88027204	2.89648864	-2.84910395									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164544-02	Lanoconazole	170465886	Lanosterol 14-alpha demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	101530-10-3		13.9333492831	-4.8559444758	-36.9754698358	-2.2	7		-60.2494360063	-47.53745152	0.0001749893	0.994553314	3641571	ERG11	N#C\C(=C1/SCC(S1)c2ccccc2Cl)n3ccnc3	Sequoia	SRP01160l	-0.59787476	2.15261319	0.51911969	-1.17139489	-3.63142669	-14.335078	-47.53745152									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161599-09	Troglitazone	170465091	CCL2 Expression Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	97322-87-7	; Rezulin;GR-92132X;Troglitazone; Troglitazone; Prelay;CS-045;CI-991	4.4061119169	-5.3559444758	-136.8497526508	-2.1	7		-96.4965663825	-95.77450508	0.0000100959	0.9987001891	6347	CCL2	Cc1c(O)c(C)c(C)c2OC(C)(CCc12)COc4ccc(CC3SC(=O)NC3=O)cc4	Prestwick Chemical, Inc.	Prestw-1467	-7.96117445	-7.62088597	-4.94991592	-11.30007274	-25.86154393	-66.13140912	-95.77450508									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249891-01	Bromodiphenhydramine	170465292	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	118-23-0		11.0676527398	-4.9559444758	-2.3578033293	4	7		-13.288303284	-11.07358607	0.0835675677	0.8527972905			Brc1ccc(cc1)C(OCCN(C)C)c2ccccc2	GVK	FFS-11-286-NCI-046	4.8255451	0.05775139	-1.48379082	1.31655871	1.95090654	-1.53137918	-11.07358607									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00247716-01	(+)-Pentazocine succinate	144206429		DPI_SARS-CoV-2_General	2019_NPC_02	124819-26-7				-35.0649820247	4	7		0	-5.08490701					O=C(O)CCC(=O)O.C/C(C)=C\CN2CC[C@]1(C)c3cc(O)ccc3C[C@H]2[C@H]1C	RTI	9709-002	-6.53656732	-7.18196309	-7.11422611	-8.45356967	-6.85074733	-8.87824126	-5.08490701									4.25E-9	2.13E-8	1.06E-7	5.31E-7	0.00000266	0.0000133	0.0000664								
NCGC00379044-01	Paricalcitol-D6 (ABT-358)		Vitamin D Receptor (VDR) Agonist	DPI_SARS-CoV-2_General	2019_NPC_02			7.8352981002	-5.1059444758	-42.5490673859	-2.2	7		-57.3976834832	-52.19521476	6.835E-7	0.9996624391		VDR	C[C@H](\C=C\[C@H](C)C(C([2H])([2H])[2H])(C([2H])([2H])[2H])O)[C@H]1CC[C@H]2C(/CCC[C@]12C)=C/[CH]=[C]3C[C@@H](O)[CH2][C@H](O)C3	MedChem Express	HY-76585	0.85319892	0.34881841	1.16499848	0.63840236	-1.4186251	-23.06933484	-52.19521476									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179520-04	Metrizamide			DPI_SARS-CoV-2_General	2019_NPC_02	31112-62-6				-4.359328827	4	7		0	-0.75155782					CN(C(C)=O)C1=C(I)C(=C(I)C(=C1I)NC(C)=O)C(=O)N[C@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O	Prestwick	Prestw-463	-1.46361766	0.07623184	1.7088207	-3.26216589	-0.41584488	-2.36283352	-0.75155782									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163798-06	Triethylene glycol			DPI_SARS-CoV-2_General	2019_NPC_01	112-27-6				9.6942652848	4	7		0	2.34721553					OCCOCCOCCO	SIGMA	T59455	3.27499818	3.54533682	-1.67921815	3.86033562	-1.12419429	4.32948829	2.34721553									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163778-09	Imazalil sulfate	170466809	O75469|||Q9UJ26 REC20 - 20% relative effective concentration; the concentration of the test compound showing 20% of the agonistic activity of 1 _ 10_5 M rifampicin via hPXR	DPI_SARS-CoV-2_General	2019_NPC_01	58594-72-2		15.6334750258	-4.8059444758	-22.1386917221	-3	7		-39.704354772	-31.83696231	0.0027013399	0.978024973			O=S(=O)(O)O.Clc2ccc(C(OCC=C)Cn1ccnc1)c(Cl)c2	Prestwick Chemical, Inc.	Prestw-963	-1.05777842	3.42805483	0.03655772	-0.80517721	-2.71786022	-6.57553737	-31.83696231									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182987-01	Esonarimod	144206833	cytokine production involved in inflammatory response Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	101973-77-7	Esonarimod; 	17.5410474839	-4.7559444758	-14.9773634223	4	7	LS-171798;Benzenebutanoic acid, alpha-((acetylthio)methyl)-4-methyl-gamma-oxo-;esonarimod;ESONARIMOD;CIPLUS_704625;KE-298;2-acetylthiomethyl-3-(4-methylbenzoyl)propionic acid;(?)-3-MERCAPTO-2-(P-METHYLPHENACYL)PROPIONIC ACID ACETATE;esonarimodum;KE 298;Esonarimod;	-13.000034264	-10.53458721	0.0399971527	0.9064648531			Cc1ccc(cc1)C(=O)CC(CSC(C)=O)C(=O)O	Pharmaron	PH-NIH-151652	-2.00663229	-1.39028025	-1.79132851	-0.11789199	-4.11358676	-4.12622593	-10.53458721									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018268-08	Itraconazole			DPI_SARS-CoV-2_General	2019_NPC_01	84625-61-6		2.4777388143	-5.6059444758	-127.3127963746	-1.2	7		-77.6502388768	-77.24519024	0.0001571199	0.9948394739			CCC(C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5COC(CN6C=NC=N6)(O5)C7=CC=C(Cl)C=C7Cl)C=C4	Selleck	S2476	-3.5945102	-6.97583502	-6.5584558	-8.12451401	-28.00842511	-70.76070939	-77.24519024									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166248-03	Green S			DPI_SARS-CoV-2_General	2019_NPC_01	3087-16-9		1.5633475026	-5.8059444758	-161.2082507711	-1.1	7		-100.7061228781	-98.75541811	0.0000107985	0.9986555768			CN(C)C1=CC=C(C=C1)C(=C/2\C=C/C(/C=C2)=[N+](C)C)C3=C4C=CC(=CC4=CC(=C3O)[S]([O-])(=O)=O)[S]([O-])(=O)=O	SIGMA	199583	-4.4174957	-0.2516676	-3.95554581	-15.23315022	-46.26960361	-86.20356725	-98.75541811									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183030-02	Terodiline hydrochloride		HERG Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	7082-21-5				4.2430007393	4	7		0	-4.23821529					CC(CC(C1=CC=CC=C1)C2=CC=CC=C2)NC(C)(C)C	SIGMA	T4577	1.67171495	3.42119245	3.55594102	0.68517176	2.02219424	-2.03870725	-4.23821529									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021569-09	Enalapril maleate	170464969	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	75847-73-3	 Enalaprila;;Enalapril; 7   Enalapril; Enalapril; ; Vasotec; Maleate, Enalapri; Renitec; 8   Enalapril maleate;Enalapril maleate; Enalapril maleate salt; Renitek;ENALAPRIL MALEATE; Renivace	0.4943738883	-6.3059444758	-48.7424158293	4	7		-16.7949029759	-22.78776203	0.1077868348	0.8256801105	1636	ACE	OC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N[C@@H](CCc1ccccc1)C(=O)OCC	Microsource	01501214	-2.68438506	-3.45248858	-5.58845751	-2.84194948	-25.43013754	-12.64291885	-22.78776203									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161643-05	Fluorescein sodium	170464991		DPI_SARS-CoV-2_General	2019_NPC_01	518-47-8		12.4181106199	-4.9059444758	-33.1831532381	4	7		-20.3015062	-21.18577476	0.0712750493	0.8663932291			[Na+].[Na+].[O-]c4cc5Oc1cc([O-])ccc1C3(OC(=O)c2ccccc23)c5cc4	Microsource	01505396	-6.7799482	-1.35118626	-5.06690064	-7.56766248	-2.65188042	-8.28802277	-21.18577476									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018269-05	Trimebutine maleate	170465734		DPI_SARS-CoV-2_General	2019_NPC_01	34140-59-5		13.9333492831	-4.8559444758	-26.2289041628	-2.2	7		-51.8894324584	-40.82532762	0.0000392103	0.9974344254			COc1c(cc(cc1OC)C(=O)OCC(CC)(c2ccccc2)N(C)C)OC.O=C(O)/C=C\C(=O)O	Microsource	01505011	2.26805122	1.02866079	1.45499744	-0.46404294	-0.15987413	-10.7881498	-40.82532762									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162218-05	Molindone hydrochloride	170465047	Serotonin 7 (5-HT7) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	15622-65-8		13.9333492831	-4.8559444758	-22.3245598446	-3	7		-58.8349598199	-50.69579985	0.0000935273	0.9960273631			Cl.O=C1C(CCc2nc(C)c(CC)c12)CN3CCOCC3	Prestwick	Prestw-1035	0	2.31876267	4.18464088	2.87204956	2.13926813	-5.21367956	-50.69579985									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094358-05	Isotretinoin	26753641	Retinoid RAR Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	4759-48-2	; Panretin; Retinoic acid, all-trans-; RETINOIC ACID, 9-cis-; Retinoic acid, trans; Roaccutane; "RETINOIC ACID, 13-cis-"; 9-cis-Tretinoin;13-cis-retinoic acid; Retinoic acid, 13-cis-; Tretinoin Potassium Salt; Retin A; 13 cis Retinoic Aci; ISOTRETINON; 9,13-di-cis-RA; Tretinoin Zinc Salt; Velac; 13-cis-retinoic acid; 13-cis-Retinoic acid; RETINOIC ACID, 13-cis-; Ro 4 378; ; Ro 4378; Ro 4-3780; Tretinoine;ISOTRETINON; Tretinoina;13-cis Retinoic acid; Isotretinoino; Tretinoino; Retinoic acid; Vesanoid; Tretinoin Tocoferil; Isotretinoin Anisatil; 9cRA compound;Isotretinoin	11.0676527398	-4.9559444758	-12.5867044386	-3	7	TRETINOIN;Tretinoinum;RETINOIC ACID, 9-cis-;9,13-di-cis-RA;Retinoic acid, trans;13-CIS-RETINOIC ACID;Tretinoina;ISOTRETINOIN;NCGC00161590-04;Panretin;9-cis-retinoic acid;ALL-TRANS-RETINOIC ACID;LG-100057;Isotrex;Tretinoin Tocoferil;CIPLUS_152537;9-cis-Retinoic acid;9-cis,13-cis-retinoic acid;9,13-di-cis-retinoic acid;Accutane;isotretinoine;Vitamin A acid;NCGC00161590-03;9-CIS-RETINOIC ACID;Velac;Retinoic acid, all-trans-;Tretinoin;SOLAGE;Tretinoin (Retinoic acid, all trans);NCGC00015890-01;RO-4-3780;CIPLUS_163676;NCGC00015890-02;TRETINOIN ZINC;NCGC00015890-03;NCGC00015890-04;Tretinoin Potassium Salt;LS-173936;Isotretinoin;Ro 4-3780;CIPLUS_711531;NCGC_Prestw-256;NCGC00021808-06;13 cis Retinoic Aci;NCGC00021808-05;NCGC_Prestw-257;Isotretinoinum;Isotretinoine;Isotretinoin Zinc Salt, 13-cis-Isomer;Isotretinoino;tretinoine retinoic acid;Tretinoine;Tretinoino;NCGC00021808-02;NCGC00021808-04;RETINOIC ACID, 13-cis-;Isotretinoin Anisatil;CIPLUS_660447;9cRA compound;CIPLUS_725243;13-cis-Retinoic acid;Vesanoid;alitretinoinum;tretinoin;CIPLUS_164122;alitretinoin;Isotretinoin (13-cis-retinoic acid);VITAMIN A ACID;CIPLUS_710508;9-cis-Tretinoin;CIPLUS_710507;ALITRETINOIN;LS-1328;LS-178647;NCGC00021808-14;9,13-retinoic acid;Retinoic acid, 13-cis-;Retin A;all-trans-Retinoic acid;ACCUTANE;ISOTREX;NSC-122758;Tretinoin,all-trans-retinoie acid;clindamycin phosphate - tretinoin formulation;Alitretinoin;isotretinoinum;13-cis-retinoic acid;Isotretinoin Zinc Salt, 13 cis Isome;VITAMIN A ACID, 13-CIS-;CIPLUS_3881593;Ro 4378;RETINOIC ACID, ALL-TRANS;NCGC00094358-02;NCGC00094358-01;NCGC00094358-04;Isotretinoin,13-cis-retinoic acid;NCGC00094358-03;NCGC00094358-06;NCGC00094358-08;NCGC00094358-07;Roaccutane;NCGC00094358-09;ISOTRETINON;Ro 4 378;Retinoic acid;CIPLUS_711632;LGD-1057;ATRA;LS-143465;LS-1154;tretinoinum;Ligand brand of alitretinoin;TRETINON;	-36.509798796	-31.67483233	0.0031275085	0.9762842898	5915	RARB	CC/1=C(\C=C\C(C)=C\C=C\C(C)=C/C(O)=O)C(C)(C)CCC1	BIOMOL	GR102	0.06474138	0	4.78891728	4.9552183	1.95090654	-5.87655017	-31.67483233									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182543-02	Xipamide	170466623	renal sodium excretion Activator	DPI_SARS-CoV-2_General	2019_NPC_02	14293-44-8				6.8184546867	4	7		0	-4.64253437					O=S(N)(=O)c1cc(c(O)cc1Cl)C(=O)Nc2c(C)cccc2C	APAC	555772	4.54345765	4.83032641	0	0	3.47646318	0.55430289	-4.64253437									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160513-01	Testosterone decanoate	144205416	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	5721-91-5	TESTOSTERONE UNDECANOATE; 	6.9832167823	-5.1559444758	-10.3702133175	4	7	CIPLUS_669074;Testosterone decanoate;ORG-538;testosterone decanoate;CIPLUS_732550;TESTOSTERONE UNDECANOATE;	-18.913998948	-13.26166579	0.0173980092	0.94106484			CCCCCCCCCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C	InterBioScreen	STOCK1N-56645	0.88325742	3.78618125	0	0	-3.58101846	-5.8953401	-13.26166579									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015787-09	PINACIDIL		"Sulfonylurea receptor 2, Kir6.2 Opener"	DPI_SARS-CoV-2_General	2019_NPC_02	85371-64-8, 60560-33-0 [anhydrous]				1.3507628439	4	7		0	-2.35932074					CC(N\C(NC1=CC=NC=C1)=N\C#N)C(C)(C)C	Microsource	02300270	2.29138246	0.61216475	1.9572912	0.38117064	-0.51564765	-0.94419391	-2.35932074									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378631-01	Boceprevir		"Hepatitis C virus serine protease, NS3/NS4A Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC_02	394730-60-0		3.9269513795	-5.4059444758	-17.3626461107	4	7		-11.081720016	-11.73476668	0.0246924766	0.9285691434			CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC3CCC3)C(=O)C(N)=O)C2(C)C)C(C)(C)C	MedChem Express	HY-10237	1.06129621	-2.41400818	-2.49642531	-0.35778594	-2.78734881	-8.96279594	-11.73476668									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015955-16	Salbutamol sulfate	170465034	beta2-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	18559-94-9	 Ventolin;Albuterol; Albuterol (Salbutamol); ;Salbutamol hemisulphate; Proventil; Albuterol hemisulfate;Albuterol hemisulfate; Sultanol; R-albuterol hydrochloride; Xopenex; Salbutamol hemisulfate;ALBUTEROL (+/-);Salbutamol; Salbutamol; Salbutamol hemisulphate;Salbutamol sulfate; Asmaven sulfate; Levalbuterol			11.4008656235	4	7		0	1.45496946			154	ADRB2	OCc1cc(ccc1O)C(O)CNC(C)(C)C	Enzo	AC176	3.49768838	3.78478755	0	3.87538566	4.33690301	-0.16769145	1.45496946									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164588-02	Malotilate	170465879	Liver Protein Metabolism	DPI_SARS-CoV-2_General	2019_NPC_01	59937-28-9	 Kantec; Malotilate; Malotilato;Malotilate; 	17.5410474839	-4.7559444758	-53.9474038426	-2.2	7		-43.5348399691	-38.27025931	0.0030006623	0.9767932291		MMP1	CC(C)OC(=O)C(/C(=O)OC(C)C)=C1/SC=CS1	Sequoia	SRP01140m	-5.18238811	-7.68930046	-7.85503644	-3.7349186	-9.85382937	-14.162305	-38.27025931									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164005-06	PENICILLIN V POTASSIUM			DPI_SARS-CoV-2_General	2019_NPC_02	132-98-9, 87-08-1 [penicillin, V]				-24.5487256416	4	7		0	-7.03515198					CC1(C)S[C@@H]2[C@H](NC(=O)COC3=CC=CC=C3)C(=O)N2[C@H]1C([O-])=O	Microsource	01500467	-6.27760179	-5.24151632	-5.54839315	-3.22475037	-3.11051969	-6.60935738	-7.03515198									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389572-01	FIROCOXIB		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	189954-96-9		9.8640558873	-5.0059444758	-29.1594166812	4	7		-12.68388656	-15.84455121	0.0072430895	0.963407117			CC\1(C)OC(=O)\C(=C1C2=CC=C(C=C2)[S+](C)([O-])=O)OCC3CC3	Microsource	01504526	-3.89604384	-4.55311973	-4.07163451	-5.7783598	-3.19131241	-8.39909808	-15.84455121									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182708-01	Pipecuronium bromide	144206565	Muscle-type nicotinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	52212-02-9	Pipecuronium bromide; Arduan; Pipecuronium; Bromuro de pipecuronio; 			-3.6066185628	4	7	CIPLUS_188694;Arduan;LS-113699;Bromuro de pipecuronio;pipecuronii bromidum;4,4'-(3A,17B-DIHYDROXY-5A-ANDROSTAN-2B,16B-YLENE)BIS-(1,1-DIMETHYLPIPERAZINIUM)DIBROMIDE,DIACETATE;bromure de pipecuronium;Pipecuronium Dibromide, (3 beta)-Isomer;pipecuronio bromuro (spanish);CIPLUS_207311;4,4'-(3.ALPHA.,17.BETA.-DIHYDROXY-5.ALPHA.-ANDROSTAN-2.BETA.,16.BETA.-YLENE)BIS(1,1-DIMETHYLPIPERAZINIUM)DIBROMIDE, DIACETATE (ESTER);Piperazinium, 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl);LS-177113;Pipecuronium;PIPECURONIUM BROMIDE;LS-172842;Pipecuronium Dibromide, (16 alpha)-Isomer;Bromure de pipecuronium;Pipecuronium Dibromide, (17 alpha)-Isomer;Pipecuronii bromidum;Pipecuronium bromide;LS-176664;LS-172841;CIPLUS_188695;PIPERAZINIUM, 4,4'-((2.BETA.,3.ALPHA.,5.ALPHA.,16.BETA.,17.BETA.)-3,17-BIS(ACETYLOXY)ANDROSTANE-2,16-DIYL)BIS(1,1-DIMETHYL-, DIBROMIDE;	0	-6.84964087					[Br-].[Br-].C[N+]1(C)CCN(CC1)[C@H]6C[C@@]5(C)[C@@H](CC[C@@H]3[C@@H]5CC[C@]2(C)[C@@H](OC(C)=O)[C@H](C[C@H]23)N4CC[N+](C)(C)CC4)C[C@@H]6OC(C)=O	APAC	872548	1.32951051	1.94275682	0.16642835	-1.15754274	-1.0859492	-1.14618564	-6.84964087									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182986-01	Acetylpheneturide	144206817		DPI_SARS-CoV-2_General	2019_NPC_01	13402-08-9	ACETYLPHENETURIDE; Crampol; 	0.0698321678	-7.1559444758	-33.9749211292	4	7	CIPLUS_669097;ACETYLPHENETURIDE;Crampol;Urea, 1-acetyl-3-(2-phenylbutyryl)-;Acetylpheneturide;LS-158754;acetylpheneturide;	-6.57131164	-12.70943702	0.3638561552	0.5571295052			CCC(C(=O)NC(=O)NC(C)=O)c1ccccc1	Pharmaron	PH-NIH-148128	-3.36213783	-3.50135607	-5.10102118	-14.25489753	-6.39750292	-6.50947711	-12.70943702									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094646-04	Dibenzothiophene	170465511	Cytochrome P450 2C9 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	132-65-0		12.4181106199	-4.9059444758	-19.9521603093	4	7		-29.5470203599	-29.2058503	0.0029380693	0.9770517493			c1cccc2sc3ccccc3c12	Vitas	STK367232	-2.73279597	0	-2.43961882	-0.15300875	2.12404202	-3.39448143	-29.2058503									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249893-01	Lodoxamide	170465346	type I hypersensitivity Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	53882-12-5				10.1920786399	4	7		0	1.05447264					Clc1c(cc(cc1NC(=O)C(=O)O)C#N)NC(=O)C(=O)O	GVK	FFS-11-286-NCI-60	3.57030475	3.65773206	1.27952036	3.2984674	0	2.09360232	1.05447264									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274059-01	Nelarabine	170464759	Antimetabolite	DPI_SARS-CoV-2_General	2019_NPC_01	121032-29-9				7.2294668053	4	7		0	2.56013789				HPRT1	Nc3nc2c(ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O)c(OC)n3	Selleck	S1213	2.9361218	1.52710924	0.15841681	0.8352773	1.76876618	1.28055287	2.56013789									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160570-01	Butonate	144205461		DPI_SARS-CoV-2_General	2019_NPC_02	126-22-7	Butonate; Butonato; Pedix PE 50; 			-13.5832811676	4	7	Pedix PE 50;Tribufon;butonatum;0,0,dimethyl-2,2,2-trichloro-1-n-butyryloxyethyl phosphonate;CIPLUS_173408;LS-47987;Butonate;BUTONATE;butonate;tribuphon;tribufon;Butonatum;Butonato;	0	-5.6652238					O=P(OC)(OC)C(OC(=O)CCC)C(Cl)(Cl)Cl	SigmaAldrich	S360910	-2.6058406	-4.17889071	-1.88228124	-3.77662933	-0.93386878	-2.1843292	-5.6652238									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00378598-01	PSI-7976		RNA-Directed RNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1190308-01-0				-7.8465759017	4	7		0	-5.48922609					CC(C)OC(=O)[C@H](C)N[P@@](=O)(OC[C@H]1O[C@@H](N2\C=C/C(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC3=CC=CC=C3	MedChem Express	HY-15005A	-0.64047724	1.07417589	-1.50254331	0.3998784	-3.57151344	-2.86546411	-5.48922609									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00387997-02	Valganciclovir·HCl		Viral Dna Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	175865-59-5		8.7913490634	-5.0559444758	-33.9629847923	4	7		-9.6674565599	-14.51743329	0.186647827	0.7466516785			CC(C)[C@H](N)C(=O)OCC(CO)OC[N]1C=NC2=C1N\C(=N/C2=O)N	Enzo	AC3286	-5.26023723	-4.24819238	-9.71613417	-4.56235531	-3.96121949	-10.0526118	-14.51743329									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015716-09	Nylidrin	170465637	Glutamate NMDA receptor; Grin1/Grin2c Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	447-41-6		22.0828704269	-4.6559444758	-39.0454547386	4	7		-12.974947256	-15.83229829	0.16440565	0.7695640197			OC(c1ccc(O)cc1)C(C)NC(C)CCc2ccccc2	Specs	AO-080/40212238	-6.71217292	-5.43650891	-5.5494626	-7.95896355	-10.59990864	-7.87641648	-15.83229829									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166124-03	Benzyl cinnamate	170465584		DPI_SARS-CoV-2_General	2019_NPC_02	103-41-3		8.7913490634	-5.0559444758	-83.0478017855	-2.1	7		-94.0349630305	-88.86457689	0.0000230225	0.9980350358			O=C(OCc1ccccc1)C=Cc2ccccc2	SIGMA	234214	-3.5815857	-1.22663956	-4.20759007	-3.23410425	-2.57823824	-37.07252912	-88.86457689									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346629-02	Dolutegravir (GSK1349572)		HIV Integrase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_02	1051375-16-6		15.6334750258	-4.8059444758	-43.3909021338	-3	7		-92.63799172	-77.6149931	0.000491718	0.9908099666			C[C@@H]1CCO[C@H]2CN\3/C=C(/C(=O)NCC4=C(F)C=C(F)C=C4)C(=O)\C(=C3C(=O)N12)O	Selleck	S2667	3.61858078	4.03566726	3.3027824	-1.77022192	-3.58101846	-9.02386321	-77.6149931									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162137-02	Dehydroepiandrosterone Sulfate (sodium salt)		Estrogen receptor alpha Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	1099-87-2				-40.7571072236	4	7		0	-12.69086239					C[C@]12CC[C@H]3[C@@H](C\C=C4\C[C@H](CC[C@]34C)O[S]([O-])(=O)=O)[C@@H]1CCC2=O	Cayman	15873	-9.03373488	-7.88422001	-8.17374183	-5.30131188	-7.11688805	-11.51352875	-12.69086239									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249901-01	Thiocyanoacetic acid sodium salt	170465517		DPI_SARS-CoV-2_General	2019_NPC_01	63906-52-5				-14.685793785	4	7		0	-4.60824821					[Na+].[O-]C(=O)CSC#N	GVK	FFS-11-286-NCI-92	-2.0017912	-1.99135045	-3.09278351	-6.72486016	-2.39303659	-1.39234717	-4.60824821									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024643-10	Ifenprodil	170465791	Kir3.1/Kir3.4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	23210-56-2		12.4181106199	-4.9059444758	-19.8908732364	4	7		-20.7763178601	-19.7054574	0.0008575528	0.9878445317			OC(C(C)N1CCC(CC1)Cc2ccccc2)c3ccc(O)cc3	SigmaAldrich	I-2892	-2.61660978	-2.15261319	-1.38188199	-0.30852585	-1.27137999	-5.94542406	-19.7054574									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094810-04	Warfarin sodium	170464790	Vitamin K Epoxide Reductase (VKER, VKOR) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	2610-86-8	 ; Coumafene;WARFARIN; (S)-(-)-Warfarin;Warfarin; Warfarin; WARFARIN;Potassium warfarin; (R)-(+)-Warfarin; Warfarina; Warfarin Sodium Clathrate; actosin P; Coumadin; Athrombin-K;(?)-Warfarin			-22.005848113	4	7		0	-6.33697498			79001	VKORC1	[K+].CC(=O)CC(C1=C([O-])c2ccccc2OC1=O)c3ccccc3	Labotest	LT00771738	-3.39602546	-4.68883622	-5.37885989	-2.73158251	-2.59605136	-8.01870014	-6.33697498									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024309-17	(+)-Diltiazem	170464699	Ca2+ channel blocker, similar pharmacology to verapamil	DPI_SARS-CoV-2_General	2019_NPC_01	42399-41-7				-8.2419850507	4	7		0	-7.26470812					CN(C)CCN1c3ccccc3S[C@H]([C@@H](OC(C)=O)C1=O)c2ccc(OC)cc2	Enzo	CA205	0.12344783	1.20458377	-0.47037606	-4.21651993	-0.9567071	-1.99197114	-7.26470812									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016251-13	Probenecid	170464839	Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	57-66-9				9.1086555444	4	7		0	-0.20785278					O=S(=O)(N(CCC)CCC)c1ccc(cc1)C(=O)O	Microsource	01500502	3.73006076	4.2930095	1.83032341	0.22825896	3.22539715	0	-0.20785278									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094960-06	Anthraquinone	170466833	Beta amyloid A4 protein Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	84-65-1				4.0876665607	4	7		0	-2.34214595					O=C2c1ccccc1C(=O)c3ccccc23	Vitas	STK398385	0.89802241	4.00469128	0	3.23826724	1.06836522	-0.17277301	-2.34214595									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00024016-03	Hydrocortisone valerate	170464775		DPI_SARS-CoV-2_General	2019_NPC_01	57524-89-7		15.6334750258	-4.8059444758	-7.1558842259	4	7		-28.313109928	-19.01092494	0.0022549132	0.9800176802			OCC(=O)[C@@]4(OC(=O)CCCC)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	SIGMA	H5395	2.5536756	0	2.87343716	2.71151579	0	-3.95853448	-19.01092494									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253606-01	Mexazolam	170465840		DPI_SARS-CoV-2_General	2019_NPC_01	31868-18-5		15.6334750258	-4.8059444758	-31.6294518259	-3	7		-50.756077156	-43.96339763	0.0000683006	0.9966091644			Clc1ccccc1C34OCC(C)N4CC(=O)Nc2ccc(Cl)cc23	GVK	FFS-11-286-NCI-217	-2.0017912	0.3005351	-0.56786332	-0.23327564	-2.48946861	-7.15991666	-43.96339763									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094772-04	PYRVINIUM PAMOATE		Cryptosporidium parvum Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			0.4406111917	-6.3559444758	-203.2179228535	-1.1	7		-97.327837973	-97.68348951	0.0000013577	0.9995239769			CN(C)C1=CC=C2C(=C1)C=CC(=[N+]2C)/C=C/C3=C(C)[N](C(=C3)C)C4=CC=CC=C4.OC(=O)C5=CC6=CC=CC=C6C(=C5O)CC7=C(O)C(=CC8=CC=CC=C78)C([O-])=O	Microsource	MS-01500521	-1.29251543	-3.13474555	-10.4052882	-38.46549587	-72.42116769	-91.43179256	-97.68348951									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179332-03	Naftifine hydrochloride	170464903	Squalene monooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	65473-14-5		9.8640558873	-5.0059444758	-100.8657120424	-2.1	7		-91.594946165	-91.34757171	0.0000294896	0.997775181	3646509		Cl.CN(C\C=C\c1ccccc1)Cc3cccc2ccccc23	Prestwick	Prestw-1063	-7.15161044	-9.2240523	-9.59893111	-5.50709726	-8.05313309	-36.09545284	-91.34757171									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346456-05	Macitentan		Endothelin ETA/ETB Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	441798-33-0		11.0676527398	-4.9559444758	-14.8608811382	4	7		-21.7386196079	-20.61551634	0.0033945123	0.9752959489		EDNRA	CCCN[S+]([O-])(=O)NC1=NC=NC(=C1C2=CC=C(Br)C=C2)OCCOC3=NC=C(Br)C=N3	Glixx	GLXC-90056	0	-2.7882372	0.37270575	0.76935669	0.43485493	-4.5001879	-20.61551634									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167979-01	Methenolone enanthate	144206153		DPI_SARS-CoV-2_General	2019_NPC_02	303-42-4	Methenolone enanthate; Metenolone enanthate; Metenolone Enanthate; Primobolan Depot; Primobolan depot; 	4.9437388825	-5.3059444758	-31.1120971662	4	7	Primobolan Depot;LS-174294;Primobolan depot;Methenolone Enanthate;CIPLUS_152547;methenolone oenanthate;Schering brand of methenolone enanthate;Metenolone Enanthate;Methenolone enanthate;methenolone enanthate, (17beta)-isomer;methenolone enanthate, (17alpha)-isomer;methenolone enanthate;methenolone heptanoate;METHENOLONE ENANTHATE;Metenolone enanthate;	-17.453790272	4.54264377	0.0507485326	0.9331798333			CCCCCCC(=O)O[C@H]2CC[C@H]3[C@@H]4CC[C@H]1CC(=O)C=C(C)[C@]1(C)[C@H]4CC[C@]23C	Bosche	M5729	-5.53770029	-1.71175125	-2.29952416	-3.96370694	-3.39091795	-15.83990981	4.54264377									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390666-01	Opicapone		Catechol O-methyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	923287-50-7		8.7913490634	-5.0559444758	-81.8521320322	-2.2	7		-52.929789116	-50.78723303	0.0038353909	0.9736134142			CC1=C(Cl)C(=[N+]([O-])C(=C1C2=NOC(=N2)C3=CC(=C(O)C(=C3)O)[N+]([O-])=O)Cl)C	MedChem Express	HY-14896	-3.3457421	-7.61625355	-12.43993343	-10.56754671	-15.44804315	-29.48609545	-50.78723303									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532500-01	GABAPENTIN ENACARBIL			DPI_SARS-CoV-2_General	2019_NPC_02					5.5788469736	4	7		0	-4.92793607					CC(C)C(=O)OC(C)OC(=O)NCC1(CCCCC1)CC(O)=O	AdvChemBlocks	G-5813	2.32837753	0.81082954	1.16031035	2.74302551	3.54775087	1.1837655	-4.92793607									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095042-09	ThioTEPA	225144216	Cytochrome P450 Oxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	52-24-4	;Thiotepa; THIOTEPA;Tris(aziridinyl)phosphine sulfide;Thio-TEPA; Thiofozil; Thio-Tep; ; Tiotepa; Tiofosyl; Tris(aziridinyl)phosphine sulfide; Tiofosfamid; Thio Tep; Tespamin; Thiopeta; Tespa; Girostan; Tiofozil;THIOTEPA; Thiotef; Thio-TEPA; Tio-tef			7.0406547195	4	7		0	2.32693721				CYP2B6	S=[P](N1CC1)(N2CC2)N3CC3	Microsource	01503324	0	0	1.65728352	0	0	0	2.32693721									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00263583-01	Temocapril hydrochloride	170465944	Angiotensin-I Converting Enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	110221-44-8				-14.4527664796	4	7		0	-8.80586043				ACE	Cl.O=C(OCC)[C@@H](N[C@H]1CS[C@@H](CN(CC(=O)O)C1=O)c2cccs2)CCc3ccccc3	Sequoia	110221-44-8	-2.3358265	-4.20504801	-1.41600253	-2.07941405	0.14464802	-4.21769399	-8.80586043									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168771-03	Fosamprenavir (Calcium Salt)			DPI_SARS-CoV-2_General	2019_NPC_02	226700-81-8				8.616284152	4	7		0	-2.26894354					CC(C)CN(C[C@@H](OP([O-])([O-])=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@@H]2CCOC2)[S+]([O-])(=O)C3=CC=C(N)C=C3	MedChem Express	HY-17431	4.71918426	4.42837672	1.88696936	0.04443093	2.64477342	0.46505073	-2.26894354									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00345882-03	Silodosin		alpha1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_02	160970-54-7		9.8640558873	-5.0059444758	-12.3189532746	4	7		-29.7400703999	-26.033392	0.0008684523	0.9877407208		ADRA1A	C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC3=CC=CC=C3OCC(F)(F)F	Prestwick	Prestw-1749	0	0.62602509	3.27934179	2.38290111	2.33110757	-6.60935738	-26.033392									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167559-01	Androstenone	144206107		DPI_SARS-CoV-2_General	2019_NPC_02	18339-16-7	5A-ANDROSTA-16-ENE-3-ONE; Androstenone; 			-5.7830333454	4	7	3-Keto-5alpha,16-androstene;5 alpha-androst-16-en-3-one;CIPLUS_663558;androsta-5,16-dien-3 beta-ol;5,16-androstadien-3 beta-ol;ANDROSTAENEONE;andien-beta;androstadienol;CIPLUS_728432;5A-ANDROSTA-16-ENE-3-ONE;androst-16-en-3-one;androst-16-en-3-one, (5beta)-isomer;16-(5alpha)Androsten-3-one;Androstenone;5alpha-Androst-16-en-3-one;	0	-2.84926033					O=C2C[C@@H]3CC[C@H]1[C@@H]4CC=C[C@@]4(C)CC[C@@H]1[C@@]3(C)CC2	SigmaAldrich	A8008	-1.84744156	-2.94994109	-3.83254026	-3.6924444	2.80635886	3.33990981	-2.84926033									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262959-01	Difethialone	170465892		DPI_SARS-CoV-2_General	2019_NPC_01	104653-34-1	2H-1-benzothiopyran-2-one,	2.4777388143	-5.6059444758	-103.5337549053	-2.2	7		-86.1376391023	-77.37699932	0.0000886741	0.9961314296			Brc1ccc(cc1)c2ccc(cc2)C4Cc3ccccc3C(C4)C5=C(O)c6ccccc6SC5=O	GVK	FFS-11-286-NCI-261	0.04841091	0	4.49660013	-5.65129054	-27.88154088	-60.80593526	-77.37699932									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164622-02	Voriconazole	170464890	Lanosterol 14alpha-demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	137234-62-9	 ; Vfend; Voriconazole;Voriconazole	24.777388143	-4.6059444758	5.1918367128	4	7		-11.492560392	-7.07713366	0.0103628754	0.9558915252	1595	CYP51A1	O[C@](Cn1cncn1)([C@@H](C)c2ncncc2F)c3ccc(F)cc3F	Sequoia	SRP01070v	2.1712294	1.15082953	3.15127586	1.35199538	2.94625184	2.06311296	-7.07713366									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179492-03	Flunisolide	170465331	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC_01	3385-03-3				-47.4573645462	4	7		0	-15.32027072				NR3C1	OCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-643	-10.82225934	-8.91587461	-11.4571909	-9.16798355	-8.34136933	-7.97296611	-15.32027072									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091612-09	Triacetin	170465543		DPI_SARS-CoV-2_General	2019_NPC_01	102-76-1				11.8962674646	4	7		0	3.77176751					O=C(C)OC(COC(C)=O)COC(=O)C	Microsource	01500585	4.18996442	3.46714883	4.48685141	0	0	2.15966258	3.77176751									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090987-05	1-Naphthaleneacetic acid	170466030	Fusarium oxysporum Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	86-87-3				-18.7582023635	4	7		0	-4.33449089					O=C(O)Cc2cccc1ccccc12	Specs	AE-562/J257199	-2.20511703	-2.25523493	-6.9971485	-7.14124464	-0.41364259	-4.61913715	-4.33449089									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090705-15	2',3'-Dideoxycytidine	170465128	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	7481-89-2	; ; 2',3' Dideoxycytidin; Cytidine, 2',3'-dideoxy-; 2',3'-dideoxycytidine;2',3'-Dideoxycytidine; 2',3'-Dideoxycytidine; Hivid; 2';Zalcitabine;2',3'-dideoxycytidine; Dideoxycytidine-3H; HIVID Roche; Zalcitibine	15.6334750258	-4.8059444758	-10.1666748819	4	7		-14.27764822	-9.81470685	0.2356771545	0.6971712045	7015	TERT	NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2	Prestwick Chemical, Inc.	Prestw-1037	0.12828892	0.47157133	1.04555092	-2.22991447	-5.27584632	-1.28055287	-9.81470685									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274056-01	Risedronate sodium	170464992	Farnesyl diphosphate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	115436-72-1		12.4181106199	-4.9059444758	-27.4978773405	4	7		-24.3567976879	-26.8231477	0.0028725383	0.9773328109		FDPS	[Na+].[Na+].[O-]P(=O)(O)C(O)(Cc1cccnc1)P([O-])(=O)O	Microsource	01505944	-2.14218285	-1.94248296	-2.76620116	-2.52589861	-5.95087043	-3.84674018	-26.8231477									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178768-03	POLYMYXIN B SULFATE		Peptide Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	1405-20-5, 1404-26-8 [polymyxin B]		1.3501034228	-5.8696329617	-25.60950272	4	7		-22.1380630719	-18.86505256	0.0048256318	0.9702877338			CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCN)NC1=O)C(C)O	Microsource	01500492	1.30407639	0	4.66702609	-0.28763183	-5.22063541	-14.14411875	-18.86505256									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00165722-03	Plerixafor hydrochloride		Chemokine CXCR4 (SDF-1 Receptor) Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	155148-31-5		2.4777388143	-5.6059444758	-62.8583026325	4	7		-13.611461112	-16.84821386	0.1734876483	0.7608438825		CXCR4	C1CNCCNCCCN(CCNC1)CC2=CC=C(CN3CCCNCCNCCCNCC3)C=C2	Selleck	S3013	-5.5053296	-10.86419183	-9.62237172	-9.59942006	-8.89432788	-11.39139421	-16.84821386									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00016710-05	Clemastine fumarate	170465318	Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	14976-57-9	 ;CLEMASTINE FUMARATE; Clemastine fumarate salt; Meclastine;Clemastine fumarate; Corto-Tavegil; Clemastine fumarate; Tavist; Tavegyl;CLEMASTINE; Clemastina	9.8640558873	-5.0059444758	-52.6158384585	-2.2	7		-53.1336635144	-49.36250032	0.000172381	0.994594451	9704	HRH1	CN3CCC[C@@H]3CCO[C@](C)(c1ccccc1)c2ccc(Cl)cc2.O=C(O)/C=C/C(=O)O	Microsource	01500191	-3.71069639	-0.43736409	-2.9075577	-4.83357163	-4.75815866	-21.5153209	-49.36250032									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167539-03	Indole	170465733	Tryptophan synthase beta chain Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	120-72-9		12.4181106199	-4.9059444758	-1.9597602944	4	7		-10.9917239079	-9.57643659	0.0496033342	0.8933697093	945768	trpB	c1cccc2nccc12	Specs	AE-562/J262413	-0.48168857	0.42270384	0.5581146	0.43394286	3.83951682	-0.36587225	-9.57643659									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016283-04	Diphemanil methylsulfate	170464876	antimitotic	DPI_SARS-CoV-2_General	2019_NPC_01	62-97-5	 Vagophemanil; ; Diphemanil; Prantal;Diphemanil methylsulfate; Diphemanil methylsulfate			6.8126972081	4	7		0	-1.95178829					[O-]S(=O)(=O)OC.C[N+]1(C)CC\C(CC1)=C(\c2ccccc2)c3ccccc3	Prestwick Chemical, Inc.	Prestw-79	4.37876697	1.90338896	2.91730643	-1.07607796	1.05821449	2.17490726	-1.95178829									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015708-15	Maprotiline hydrochloride	170464778	Noradrenaline Reuptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	10262-69-8	 ; Ciba 34276 Ba;MAPROTILINE HYDROCHLORIDE; Maprotilene Hydrochloride; Maprotiline hydrochloride;Maprotiline hydrochloride; Maprotilline HCl; Ludiomil; Maprotilina;Maprotiline	15.6334750258	-4.8059444758	-57.378047761	4	7		-27.04933316	-29.65197333	0.0015972279	0.983272291		SLC6A2	CNCCCC24CCC(c1ccccc12)c3ccccc34	Vitas	STK711156	-9.86372328	-7.8212427	-10.18010772	-7.52752903	-10.0466934	-14.59423751	-29.65197333									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015529-15	Ibuprofen lysine	170464979	Cyclooxygenase-1/2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	15687-27-1	; Ibuprofen, Aluminum Salt; Ibuprofen, (R)-Isomer;Ibuprofen Lysine (NeoProfen); Doctrin; Dexibuprofeno; (S)-(+)-Ibuprofen; Ibuprofen, Calcium Salt; Ibuprofen, (+-)-Isomer; Naproxen;IBUPROFEN; S-(+)-Ibuprofen; ; (?)-Ibuprofen; S(+)-Ibuprofen; Ibuprofen, Potassium Salt; ibuprofen-Lys; S-(+)-ibuprofen;(?)-Ibuprofen; Saren; Advil; Ibuprofen sodium salt; Ibuprofene; Arflamin;Ibuprofen; Ibufen; Ibuprofen, Magnesium Salt; Ibuprofeno			-9.9406510074	4	7		0	-1.51580442			5742	PTGS1	CC(C(=O)O)c1ccc(CC(C)C)cc1	Vitas	STK177358	-1.0142086	-4.29789625	-0.9431893	-1.61286277	-1.52007309	-3.72478276	-1.51580442									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253573-01	Tepoxalin	170466265	platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	103475-41-8		5.5469662594	-5.2559444758	-58.5036076906	-2.2	7		-68.6872829599	-55.5727358	0.0007257096	0.9887999058			CN(O)C(=O)CCc2cc(c1ccc(Cl)cc1)n(n2)c3ccc(OC)cc3	GVK	FFS-11-286-NCI-124	0	2.24301806	3.97504326	0.60952668	-15.92904634	-32.69983231	-55.5727358									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167449-02	Desogestrel	225144285	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	54024-22-5		11.0676527398	-4.9559444758	-71.2596726358	-2.2	7		-74.2522550618	-72.30652143	0.0000582197	0.996869531			CC[C@]12CC(=C)[C@H]3[C@@H](CCC/4=C/CCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C	SIGMA	32809	-3.21163495	-5.518723	-6.64072572	-5.10488039	-3.29586769	-23.7363773	-72.30652143									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522029-01	Zuclopenthixol Decanoate			DPI_SARS-CoV-2_General	2019_NPC_02	64053-00-5		6.9832167823	-5.1559444758	-76.9293730658	-2.2	7		-85.493721168	-69.99476764	0.0028568964	0.9773561091			CCCCCCCCCC(=O)OCCN1CCN(CC\C=C/2C3=CC=CC=C3SC4=C2C=C(Cl)C=C4)CC1	Toronto Research	Z701490	2.78619159	2.84829864	0.67743372	-8.8511096	-19.95342537	-34.70030064	-69.99476764									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091563-12	Thiram	170465664		DPI_SARS-CoV-2_General	2019_NPC_01	137-26-8		12.4181106199	-4.9059444758	-3.2782995169	4	7		-17.8703708439	-11.55864237	0.0375544467	0.9091119663			CN(C)C(=S)SSC(=S)N(C)C	Microsource	01503322	0	4.47381924	3.00504497	0	-0.09389433	-3.35891051	-11.55864237									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017325-06	Kojic acid	170466814	Tyrosinase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	501-30-4				-4.0301604886	4	7		0	-0.99870726					O=C1C=C(CO)OC=C1O	Labotest	LT00068503	-0.76731295	-1.76655997	-1.93268504	1.29179522	-1.0886667	-0.77239697	-0.99870726									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094087-05	Mizoribine	170466027	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	50924-49-7	; ;Mizoribine (Bredinin);MIZORIBINE; Mizoribine;Mizoribine; Mizoribina			-17.3998894166	4	7		0	-6.40287952			727833	IMPDH1	NC(=O)c2ncn([C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c2O	Sequoia	50524-49-7	-1.3434028	-1.82520097	-6.49021472	-1.52256252	-3.56544689	-5.35596321	-6.40287952									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160424-02	Clobenzorex hydrochloride	170465619		DPI_SARS-CoV-2_General	2019_NPC_01	5843-53-8		13.9333492831	-4.8559444758	-14.6638319132	4	7		8.601880764	4.09115105	0.1038003565	0.8320723758			Cl.Clc2ccccc2CNC(C)Cc1ccccc1	Specs	AN-153/I197377	-5.91823397	-5.12375693	-1.85469523	-5.12453909	-2.95132721	-3.28268713	4.09115105									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015409-11	Edrophonium chloride	170464801	Butyrylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	116-38-1				-17.2714542836	4	7		0	-9.35844465					[Cl-].C[N+](C)(CC)c1cccc(O)c1	Microsource	02300219	-2.25836904	-2.32364942	-5.13514172	-2.3503148	-1.83474598	-3.81625083	-9.35844465									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016618-04	Dimethisoquin hydrochloride	170465516	Neuronal acetylcholine receptor; alpha4/beta4 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	2773-92-4		11.0676527398	-4.9559444758	-64.831228335	4	7		-28.8262371864	-34.34133482	0.0037997609	0.973775122			Cl.CN(C)CCOc2nc(cc1ccccc12)CCCC	Prestwick Chemical, Inc.	Prestw-630	-10.50274732	-7.50360398	-12.35894811	-8.72149898	-10.07207024	-18.01920829	-34.34133482									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090814-07	4-Chlorophenol	170465673	macrophage activation involved in immune response Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	106-48-9				14.7504873938	4	7		0	1.31302122					Oc1ccc(Cl)cc1	Microsource	01500460	4.04957277	3.75546705	3.76544564	4.7633381	3.90549662	0	1.31302122									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090905-12	Busulfan	170465232	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC_01	55-98-1	Busulfan; 4   Busulfan; Busulfex;; ; Busulfan;BUSULFAN; Myleran; Busulfano	11.0676527398	-4.9559444758	-39.9452608068	4	7		-27.7344716721	-29.77364325	0.0005982973	0.9898634641		H2AFX	O=S(C)(=O)OCCCCOS(C)(=O)=O	Microsource	01500152	-3.32825019	-6.37476483	-3.78981746	-4.40715379	-5.07283155	-11.82478784	-29.77364325									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178060-03	Tolperisone hydrochloride	170465769	Voltage-gated calcium channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	3644-61-9				10.3021037595	4	7		0	2.29145015					Cl.CC(CN1CCCCC1)C(=O)c2ccc(C)cc2	Microsource	01501194	4.63050372	1.5026755	3.42911457	0	0	3.59266223	2.29145015									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182992-01	Fasoracetam	144206891	GABA-B receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	110958-19-5	FASORACETAM; Fasoracetam Anhydride; Fasoracetam Hydrate; 	2.4777388143	-5.6059444758	-14.6705827821	4	7	FASORACETAM;Fasoracetam Anhydride;CIPLUS_775811;CIPLUS_3849428;Fasoracetam;fasoracetam;(+)-1-(((R)-5-OXO-2-PYRROLIDINYL)CARBONYL)PIPERIDINE;Fasoracetam Hydrate;	-22.409649884	3.89850701	0.0152389876	0.9716218885			O=C([C@H]1CCC(=O)N1)N2CCCCC2	Pharmaron	PH-NIH-97984	3.73974294	1.395167	1.11866637	4.89878847	0	-18.25804157	3.89850701									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094908-06	Mephenesin	170466586	Glutamate NMDA receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	59-47-2				7.1453057704	4	7		0	0.89224608					OCC(O)COc1ccccc1C	Microsource	01501140	3.07167235	-1.23879102	0.30952207	1.82356335	0.83997361	4.84272575	0.89224608									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378604-01	ABT-333			DPI_SARS-CoV-2_General	2019_NPC_02	1132935-63-7		5.5469662594	-5.2559444758	-75.6112054718	-2.2	7		-81.5055415479	-74.5421681	0.0000157408	0.998376212			COC1=C(C=C(C=C1C2=CC3=CC=C(N[S+](C)([O-])=O)C=C3C=C2)N4\C=C/C(=O)NC4=O)C(C)(C)C	MedChem Express	HY-13998	1.26476913	1.48998591	0.31176016	-1.00788064	-11.50820997	-42.4746336	-74.5421681									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00174007-04	Pyrantel tartrate	170465676	Antiparasitic Agent	DPI_SARS-CoV-2_General	2019_NPC_02	33401-94-4				-5.1418522926	4	7		0	-2.26418684					O=C(O)[C@H](O)[C@@H](O)C(=O)O.CN2CCCN=C2/C=C/c1cccs1	Vitas	STK676402	-0.54336516	-1.82725404	0.85558238	-1.06868087	-0.06415892	-3.02048102	-2.26418684									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167969-02	Rubitecan	124893436		DPI_SARS-CoV-2_General	2019_NPC_02			25.355181056	-4.5959332839	-6.4969839258	-3	7		-40.4712933475	-35.29467726	0.0017753957	0.9823029176			CC[C@@]1(O)C(=O)OC/C2=C1/C=C/3N(CC4=CC5=C(C=CC=C5[N+]([O-])=O)N=C34)C2=O	SIGMA	R3655	0	4.71944374	0	3.22942731	4.2226077	-3.83784292	-35.29467726									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00167562-01	Buquinolate	144206110		DPI_SARS-CoV-2_General	2019_NPC_02	5486-03-3	Buquinolate; Buquinolato; Bonaid; 	17.5410474839	-4.7559444758	-5.9245324476	4	7	buquinolatum;BUQUINOLATE;Buquinolatum;CIPLUS_164381;buquinolate;Buquinolato;ethyl 4-hydroxy-6,7-diisobutoxy-3-quinolinecarboxylate;Buquinolate;Bonaid;	-24.5922798839	-16.74356657	0.0151669893	0.9452462673			CC(C)COc1cc2ncc(c(O)c2cc1OCC(C)C)C(=O)OCC	SigmaAldrich	R239542	3.1977618	-0.72304743	0.29769579	3.77195239	0.07366395	-2.36283352	-16.74356657									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167532-02	Balofloxacin	170465911	Antibacterial	DPI_SARS-CoV-2_General	2019_NPC_02	127294-70-6	 ;Balofloxacin; Balofloxacin; Balofloxacin Hydrate			-47.8102849466	4	7		0	-15.56866289					CNC1CCCN(C1)c2c(F)cc3c(c2OC)N(C=C(C3=O)C(=O)O)C4CC4	Sequoia	SRP00850b	-9.08460311	-7.75023678	-8.36126673	-11.69001239	-7.9818454	-12.07722661	-15.56866289									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091015-01	Phenolphthalin	17389504		DPI_SARS-CoV-2_General	2019_NPC_02		Phenolphthalin; 			15.1948426914	4	7	PHENOLATHALAIN, YELLOW;2-(Bis[4-hydroxyphenyl]methyl)benzoic acid;PHENOLPHTHALEIN;Phenolphthalin;NCGC00091015-02;CIPLUS_208575;AB07944344-01;phenolphthalin;	0	1.65532988					OC1=CC=C(C=C1)C(C2=CC=C(O)C=C2)C3=C(C=CC=C3)C(O)=O	NIEHS	AB07944344	2.68445513	4.84418674	4.38105061	3.12653462	3.39567046	2.14205186	1.65532988									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00188435-01	2-Hydroxyethyl octadecanoate	144206587		DPI_SARS-CoV-2_General	2019_NPC_02	111-60-4				8.1357211071	4	7	Polyoxyl 40 Stearate	0	0					O=C(CCCCCCCCCCCCCCCCC)OCCO	APAC	878043	0	3.28258911	4.02006516	4.33318523	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166115-02	Dibutyltin dilaurate	170466843		DPI_SARS-CoV-2_General	2019_NPC_02	77-58-7				-11.8283270417	4	7		0	-9.35641916					O=C(O[Sn](CCCC)(OC(=O)CCCCCCCCCCC)CCCC)CCCCCCCCCCC	SIGMA	291234	-1.12141321	-2.58957241	-1.49785518	-2.31742394	-0.69149063	-1.68169861	-9.35641916									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016991-05	Proparacaine	170465400	Sodium Channel Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	5875-06-9	; ;PROPARACAINE HYDROCHLORIDE; Alcaine; Proximetacaina; Proparacaine hydrochloride;Proparacaine hydrochloride			1.8741697802	4	7		0	-2.27624141				SCN10A	Cl.CCN(CC)CCOC(=O)c1ccc(OCCC)c(N)c1	Vitas	STK520616	0	0	0	0	0	4.40063011	-2.27624141									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164556-02	Fudosteine	170465764	Mucin-5AC Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	13189-98-5				7.5566091346	4	7		0	1.20149046			4586	MUC5AC	OCCCSC[C@H](N)C(=O)O	Sequoia	SRP02575f	2.8296178	3.2179246	-0.56298896	3.53926807	2.41333807	-0.74190762	1.20149046									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00181909-01	Sulcaine	144206885		DPI_SARS-CoV-2_General	2019_NPC_01	41653-21-8	Ethyl piperidinoacetylaminobenzoate; Sulcain; Nichicaine; 			4.2561925811	4	7	Ethyl Piperidinoacetylaminobenzoate;CIPLUS_3838938;P-(PIPERIDINOACETAMIDE)BENZOIC ACID ETHYL ESTER;Nichicaine;ETHYL PIPERIDINOACETYLAMINOBENZOATE;CIPLUS_196504;CIPLUS_180054;Sulcain;Ethyl piperidinoacetylaminobenzoate;	0	-4.23309929					O=C(CN1CCCCC1)Nc2ccc(cc2)C(=O)OCC	Pharmaron	PH-NIH-22	1.91949265	1.4440345	0.79208403	1.38209547	1.25107852	2.55602419	-4.23309929									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016408-09	Sulfapyridine	170464707	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	144-83-2	; ; Sulphapyridine; Sulfapiridina;Sulfapyridine; Sulfapyridine;SULFAPYRIDINE; Sulphapyridin			5.9217648609	4	7		0	-1.10009886					O=S(=O)(Nc1ccccn1)c2ccc(N)cc2	Vitas	STK292439	0.77699513	0	2.51760864	3.09278351	1.62158047	1.31612379	-1.10009886									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182704-02	Luliconazole	144206804	Lanosterol 14-alpha demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	187164-19-8	Luliconazole; Lulicon; 	9.8640558873	-5.0059444758	-74.6415052886	-2.2	7	Lulicon;Luliconazole;LULICONAZOLE;CIPLUS_787907;	-101.4969455804	-79.92192847	0.000018349	0.9982464323	3641571	ERG11	N#C/C(=C1/SC[C@H](S1)c2ccc(Cl)cc2Cl)n3ccnc3	Pharmaron	PH-NIH-102266	-0.55914603	0.06597112	2.93192952	-1.08611132	-9.85382937	-38.03546928	-79.92192847									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015659-14	Mexiletene hydrochloride	170464740		DPI_SARS-CoV-2_General	2019_NPC_01	5370-01-4				-2.4591293232	4	7		0	-0.96828978					Cl.CC(N)COc1c(C)cccc1C	Microsource	01503929	-2.34066759	0.19791336	-0.99193293	2.88709961	-0.18525098	-2.42898521	-0.96828978									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167468-02	Benorylate	170466237	prostaglandin biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	5003-48-5				-10.2202106709	4	7		0	-6.89462878					O=C(C)Oc2ccccc2C(=O)Oc1ccc(NC(C)=O)cc1	Bosche	B1551	-3.53157602	-0.8331908	-4.50634886	-2.17974766	2.10881592	-0.58437929	-6.89462878									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023654-13	Captopril	170464644	Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	62571-86-2				3.9976527501	4	7		0	0.94294188					OC(=O)[C@@H]1CCCN1C(=O)[C@H](C)CS	Vitas	STK802012	0	0	2.2836392	0	2.72293559	0	0.94294188									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016912-06	Terconazole			DPI_SARS-CoV-2_General	2019_NPC_02	67915-31-5		9.8640558873	-5.0059444758	-55.5170217511	-2.2	7		-84.370403842	-63.15939685	0.0002986335	0.9928628694			CC(C)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=NC=N4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2	Prestwick	Prestw-495	3.52609309	2.7882372	4.31541689	-4.03386105	-7.92006273	-30.36452461	-63.15939685									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161605-02	L-Ascorbyl 6-palmitate			DPI_SARS-CoV-2_General	2019_NPC_02	137-66-6		12.4181106199	-4.9059444758	-64.2102466865	-2.2	7		-57.9204310937	-47.66208438	0.0004605391	0.9911144741			CCCCCCCCCCCCCCCC(=O)OCC(O)C\1OC(=O)\C(=C1O)O	APExBIO	B2105	-4.55733081	-3.74460024	-4.14195635	-9.29541894	-9.90661312	-24.41751221	-47.66208438									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182551-01	Cythioate	144206631	Acetylcholinesterase and butyrylcholinesterase (AChE and BChE) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	115-93-5	Cythioate; Cyflee; 			-43.8206978487	4	7	Cyflee;CIPLUS_151430;CYTHIOATE;Cythioate;cythioate;O,O-dimethyl-O-(p-sulfamoylphenyl)-phosphorothioate;	0	-12.38167721					O=S(N)(=O)c1ccc(OP(=S)(OC)OC)cc1	Chemos	10702	-7.78052672	-8.19838758	-9.14418321	-9.64618946	-8.91809044	-9.91168734	-12.38167721									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167435-07	Nilvadipine		Voltage-gated L-type calcium channel alpha-1C subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	75530-68-6		11.0676527398	-4.9559444758	-60.5736224913	-2.2	7		-90.2011368539	-67.19783095	0.0000657351	0.996672482			COC(=O)C\1=C(\N\C(=C(/C1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C)C#N	MedChem Express	HY-14284	2.84630859	-0.12705306	-0.1758046	1.57379043	-8.98937813	-31.02217212	-67.19783095									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183020-01	Minopafant	144206826	Platelet activating factor receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	128420-61-1	Menopafant; Minopafant; 	3.1192883571	-5.5059444758	-76.2721051513	-2.2	7	E-5880;E 5880;1-ethyl-2-(N-(2-methoxy)benzoyl-N-(2-methoxy-3-(4-octadecylcarbamoyloxy)piperidinocarbonyloxypropyloxy)carbonyl)aminomethylpyridinium chloride;MENOPAFANT;CIPLUS_707454;Minopafant;Menopafant;minopafantum;	-65.8090035724	-58.18863907	0.0001824437	0.9944360389			[Cl-].COc1ccccc1C(=O)N(Cc2cccc[n+]2CC)C(=O)OC[C@@H](COC(=O)N3CCC(CC3)OC(=O)NCCCCCCCCCCCCCCCCCC)OC	Pharmaron	PH-NIH-150353	1.16428243	2.89051238	-0.68484804	-6.56934307	-16.39598031	-45.61715534	-58.18863907									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183854-01	Oxendolone	144206842		DPI_SARS-CoV-2_General	2019_NPC_01	33765-68-3		9.8640558873	-5.0059444758	-24.0896819514	4	7	16 ethyl-17-hydroxy-4-estren-3-one;oxendolone;16-beta-Ethyl-19-nortestosterone;NE-19595;Oxendolonum;oxendolonum;(16 beta,17 beta)-16-ethyl-17-hydroxyestr-4-en-3-one;16 beta-ethyl-19-nortestosterone;CIPLUS_178076;Oxendolona;16 beta-ethyl-17 beta-hydroxyestr-4-en-3-one;TSAA291;LS-64849;Oxendolone;OXENDOLONE;EHOO;Prostetin;TSAA-291;TSAA 291;PROSTETIN;16B-ETHYL-17B-HYDROXYESTR-4-EN-3-ONE;	-16.55876132	-17.43428557	0.0303125499	0.9195566706			CC[C@H]2C[C@H]3[C@@H]4CCC1=CC(=O)CC[C@@H]1[C@H]4CC[C@]3(C)[C@H]2O	Pharmaron	PH-NIH-152939	-5.0807252	-1.4635815	-3.57047111	-3.06268342	-0.30198447	-7.99329234	-17.43428557									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00013724-07	(-)-Scopolamine methyl bromide			DPI_SARS-CoV-2_General	2019_NPC_01	155-41-9				12.9195037623	4	7		0	4.75526603					[H][C@]12O[C@@]1([H])[C@]3([H])C[C@@H](C[C@@]2([H])[N+]3(C)C)OC(=O)[C@H](CO)C4=CC=CC=C4	SIGMA	S8502	4.18028224	0	4.80368502	1.85366343	0	4.18720463	4.75526603									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159448-05	4-Methoxycinnamic acid	225144227		DPI_SARS-CoV-2_General	2019_NPC_01	943-89-5				11.1559298575	4	7		0	4.52206535					COC1=CC=C(\C=C\C(O)=O)C=C1	SIGMA	M13807	4.72248445	0.9113788	2.468865	1.30182858	0	3.29285025	4.52206535									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022819-04	Ipratropium bromide		Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	66985-17-9	; Berodual; Atrovent; Bronchodual;Ipratropium bromide; fenoterol-ipratropium IK6; Duovent; Bromuro de ipratropio; Ipratroprium bromide; Iprafen			6.9366770642	4	7		0	0.3548706					CC(C)[N+]1(C)[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3	SIGMA	I1637	0	1.58330686	0	0	3.9917779	4.08557345	0.3548706									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167546-03	S-(5 -Adenosyl)-L-methionine p-toluenesulfonate salt	225144292	S-adenosylmethionine synthase isoform type-2 Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	17176-17-9				-0.5254505381	4	7		0	-4.51192619					C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)[N]2C=NC3=C2N=CN=C3N	SIGMA	A2408	1.37244935	-2.23568793	-0.20716044	0.95066095	1.22570167	1.59052797	-4.51192619									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178638-02	Valaciclovir	170465373	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	124832-27-5	Valaciclovir HCl; Valaciclovir Hcl;;Valacyclovir hydrochloride; valacyclovir, (DL)-isomer; valacyclovir, (D)-isomer; Valtrex;VALACYCLOVIR HYDROCHLORIDE			-22.4609933255	4	7		0	-5.91257194					Cl.CC(C)[C@H](N)C(=O)OCCOCn2cnc1c2N=C(N)NC1=O	Vitas	STK802272	-2.8416842	-4.67324263	-5.97970043	-4.70734046	-1.53268541	-8.02799699	-5.91257194									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167498-02	Thiamphenicol glycinate			DPI_SARS-CoV-2_General	2019_NPC_02	2393-92-2				-20.8313878917	4	7		0	-7.4965514					C[S+]([O-])(=O)C1=CC=C(C=C1)[C@@H](O)[C@@H](COC(=O)CN)NC(=O)C(Cl)Cl	Enzo	DL143	-2.05553886	-6.69223128	-8.39877171	-1.94326871	-2.37388019	-2.74332958	-7.4965514									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00142611-02	D-HISTIDINE	26754413	Histidine decarboxylase Substrate	DPI_SARS-CoV-2_General	2019_NPC_02		Histidine; L-Histidine hydrochloride; Cu-His; Zn(His)2; Histidine, L isome; DL-Histidine; L-Histidine-ul-13C,15N; Cu(His)2; poly(L-histidine); polyhistidine, (D)-isomer; Zn-His(2); L-Histidine-2,5-3H; D-His; Histidina; D-His-OH; L-isomer Histidin; L-Histidine-15N3; Fe(II)-histidinate; Levadial; L-Histidine-13C6,15N3; Poly-L-histidine; Pt(His)(adenine); PRu-Hi; Histidine, L-isomer; poly-(alpha-L-histidine); 			-25.0437193877	4	7	CIPLUS_688453;CIPLUS_670571;L-Histidine Monohydrochloride Monohydrate;L-Histidine monohydrochloride monohydrate;DL-Histidine monohydrochloride monohydrate;L-Histidine-15N3;Poly-L-histidine;L-HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE;CIPLUS_208166;polyhistidine;HISTIDINE, DL-;CIPLUS_163873;CIPLUS_213264;DL-Histidine;L-Histidine Monohydrochloride;poly-(alpha-L-histidine);CIPLUS_207332;(+/-)-2-Amino-3-(4-imidazolyl)propionic acid;S(+)-alpha-Amino-1H-imidazole-4-propanoic acid hydrochloride;HISTIDINE;L-alpha-Amino-beta-(4-imidazolyl)propionic acid monohydrochloride;NCGC00093950-01;Histidine, L isome;L-HISTIDINE;(R)-2-Amino-3-(4-imidazolyl)propionic acid;CIPLUS_3885719;NCGC00162189-01;L-Histidine hydrochloride;D-His;L-isomer Histidin;polyhistidine, (D)-isomer;D-HISTIDINE;L-Histidine;D-Histidine;D-alpha-Amino-beta-(4-imidazolyl)propionic acid;histidinum;CIPLUS_166016;CIPLUS_742841;Histidina;DL-alpha-Amino-beta-(4-imidazolyl)propionic acid monohydrochloride;D-alpha-Amino-beta-(4-imidazolyl)propionic acid monohydrochloride;L-Histidine dihydrochloride;(S)-2-Amino-3-(4-imidazolyl)propionic acid;L-Histidine Monohydrochloride Anhydride;L-Histidine-13C6,15N3;D-His-OH;CIPLUS_215801;CIPLUS_3886763;CIPLUS_149204;L-Histidine-2,5-3H;poly(L-histidine);L-Histidine hydrochloride solution;NCGC00015518-01;Histidinum;D-Histidine monohydrochloride monohydrate;Histidine, L-isomer;CIPLUS_214867;HISTIDINE, L-;L-HISTIDINE MONOHYDROCHLORIDE;L-Histidine monohydrochloride;CIPLUS_3887315;Histidine;CIPLUS_750166;histidine;L-Histidine-ul-13C,15N;NCGC00142611-02;Poly-L-histidine hydrochloride;CIPLUS_711628;	0	-7.40617419			3067	HDC	N[C@H](CC1=CNC=N1)C(O)=O	BIOMOL	BIOMOL_AC-1014	-2.91567435	-4.52077895	-7.25486979	-6.33959264	-3.82339662	-5.47726419	-7.40617419									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00521078-02	Cephaloglycin		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	3577-01-3		9.8640558873	-5.0059444758	-11.1726086209	4	7		-16.838819384	-16.11568282	0.0012912535	0.9850266298			CC(=O)OCC/1=C(/N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C2=O)C(O)=O	Toronto Research	C258000	0.24740456	0.7923491	0.4242751	-1.32591259	0.71050068	-4.66929726	-16.11568282									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00373220-03	CEFMENOXIME HYDROCHLORIDE			DPI_SARS-CoV-2_General	2019_NPC_02	75738-58-8		15.6334750258	-4.8059444758	-7.5268886589	4	7		-18.73498074	-16.86248395	0.0020732866	0.9808876068			CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC3=NN=NN3C)=C(N2C1=O)C(O)=O)C4=CSC(N)=N4	Microsource	01502422	0	0	0	2.4928092	0	-0.54021045	-16.86248395									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378657-01	Simeprevir			DPI_SARS-CoV-2_General	2019_NPC_02	923604-59-5		2.2082870427	-5.6559444758	-93.8596012506	-1.2	7		-79.0190267772	-74.61827522	0.0001240443	0.9954190206			COC1=C(C)C2=C(C=C1)C(=CC(=N2)C3=NC(=CS3)C(C)C)O[C@@H]4C[C@@H]5C(C4)C(=O)N(C)CCCC\C=C/[C@@H]6C[C@]6(NC5=O)C(=O)N[S+]([O-])(=O)C7CC7	MedChem Express	HY-10241	0	0	2.70739083	4.91780277	-19.59223439	-66.06538895	-74.61827522									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024846-08	Guanabenz	170465364	Adrenergic receptor alpha-2 Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	5051-62-7		7.8352981002	-5.1059444758	-6.6763398025	4	7		-9.850333328	-7.79194444	0.1954294848	0.7384548358			Clc1cccc(Cl)c1/C=N/NC(=N)N	Enzo	AC153	-2.03083775	-0.26632785	1.14303819	3.46401786	-2.43363955	-3.61807002	-7.79194444									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015747-09	Nicardipine	170465173	Ca channel blocker - DHP class	DPI_SARS-CoV-2_General	2019_NPC_01	55985-32-5	 ;Nicardipine hydrochloride; YC-93 hydrochloride; Dagan;Nicardipine?HCl;Nicardipine; Nicardipine; Cardene/SR; Nicardipino	3.9269513795	-5.4059444758	-92.1246221703	-2.1	7		-98.6150287749	-84.33246306	0.0000029773	0.9992948406			CC=2NC(C)=C(C(C=2C(=O)OCCN(C)Cc1ccccc1)c3cccc(c3)[N+]([O-])=O)C(=O)OC	Enzo	AC108	3.82688258	3.44760183	3.58996856	-0.76504377	-21.74541948	-56.45103918	-84.33246306									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164283-07	Hexadecyltrimethylammonium bromide	170465714	Cell membrane Interacts	DPI_SARS-CoV-2_General	2019_NPC_01	57-09-0				-8.7362557953	4	7		0	1.56650022					[Br-].C[N+](C)(C)CCCCCCCCCCCCCCCC	Microsource	01503200	-3.44927747	-2.26012168	-0.23640662	-3.66970176	-2.46409176	-1.71248539	1.56650022									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024714-11	Triprolidine	170464931	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	486-12-4		11.0676527398	-4.9559444758	-2.9022193904	4	7		-11.208106264	-8.50675522	0.0390191511	0.9075975535			Cc1ccc(cc1)C(=C\CN2CCCC2)/c3ccccn3	SigmaAldrich	T6764	0.69469658	0.03176387	0.20228608	3.44896782	0.27660762	-2.3680065	-8.50675522									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090686-11	Nitrofurazone	170464946	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	59-87-0	; ;Nitrofurazone; Furacilin; Nitrofurazone solution; Furacillin;NITROFURAZONE; Nitrofurazone;Nitrofural; Furacin			-55.0928149625	4	7		0	-16.23786469					O=[N+]([O-])c1ccc(/C=N/NC(N)=O)o1	Microsource	01500434	-11.54358192	-9.84435703	-11.6570398	-10.21145308	-11.17850074	-12.50063519	-16.23786469									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164100-01	Trisiloxane, octamethyl-	26757517		DPI_SARS-CoV-2_General	2019_NPC_02	107-51-7	Octamethyltrisiloxane; Poly(dimethylsiloxane); Trisiloxane, octamethyl-; 			12.9657878738	4	7	Trisiloxane, octamethyl-;Octamethyltrisiloxane;NCGC00164100-01;Poly(dimethylsiloxane);CIPLUS_208116;	0	0					C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C	SigmaAldrich	MFCD00008264	4.6775648	0.21945529	3.87942149	2.58868648	3.54299836	1.77095077	0									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00183103-01	Tocophersolan	144206517		DPI_SARS-CoV-2_General	2019_NPC_02	9002-96-4	TOCOFERSOLAN; Tocofersolano; vitamin E-TPGS; 	3.499899101	-5.4559444758	-46.930306796	-2.2	7	Tocofersolanum;tocofersolanum;dl-a-Tocopherol Polyethylene Glycol  Succinate;Tocophersolan;tocofersolan;tocopheryl poly(ethylene glycol) 1000 succinate;Tocofersolano;VITAMIN E POLYETHYLENE GLYCOL 1000 SUCCINATE;VITAMIN E POLYETHYLENE GLYCOL SUCCINATE;TOCOFERSOLAN;vitamine E PEG-1000-succinate;CIPLUS_698430;TPGS;CIPLUS_213643;ALPHA-TOCOPHERYL PEG-20 SUCCINATE, D-;A-TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATE;VITAMIN E TPGS;vitamin E-TPGS;.ALPHA.-(4-(((2R)-3,4-DIHYDRO-2,5,7,8-TETRAMETHYL-2-((4R,8R)-4,8,12-TRIMETHYLTRIDECYL)-2H-1-BENZOPYRAN-6-YL)OXY)-1,4-DIOXOBUTYL)-.OMEGA.-HYDROXY-POLY(OXY-1,2-ETHANEDIYL);alpha-tocopheryl polyethylene glycol succinate;TOCOPHERSOLAN;tocophersolan, (2R-(2R*(4R*,8R*)))-isomer;tocophersolan;	-32.978958312	-33.12086762	0.0005699283	0.9901021438			O=C(OCCO)CCC(=O)Oc2c(C)c(C)c1O[C@@](C)(CCc1c2C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C	ACC	V-00037	-0.81157946	-2.56185174	-3.86535712	-0.63840236	-9.18898368	-25.12683202	-33.12086762									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095055-13	SALINOMYCIN, SODIUM			DPI_SARS-CoV-2_General	2019_NPC_02	55721-31-8; 53003-10-4 (acid)		15.6334750258	-4.8059444758	-6.8347819591	-2.4	7		-31.723802504	-21.01983542	0.0034455837	0.9750850372			[H]C1(CC[C@@](O)(CC)C(C)O1)[C@@]2(C)CC[C@@]3(O2)OC4(OC(C(CC)C(=O)C(C)C(O)C(C)C5OC(CCC5C)C(CC)C([O-])=O)C(C)CC4C)\C=C/C3O	Microsource	01503602	3.63245393	0.59830442	4.73734793	2.2893623	0.01188128	-5.08267569	-21.01983542									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090762-11	Rifabutin		Cytochrome P450 3a4 Substrate	DPI_SARS-CoV-2_General	2019_NPC_02	72559-06-9		4.9437388825	-5.3059444758	-105.7844910839	-2.1	7		-97.2757360996	-87.58978262	0.0000214116	0.9981052202		PRKDC	[H][C@]1(C)\C=C\C=C(C)\C(=O)NC2=C3NC4(CCN(CC(C)C)CC4)N=C3C5=C(C2=O)C(O)=C(C)C6=C5C(=O)[C@](C)(O6)O\C=C\[C@]([H])(OC)[C@@]([H])(C)[C@@]([H])(OC(C)=O)[C@]([H])(C)[C@]([H])(O)[C@]([H])(C)[C@@]1([H])O	MedChem Express	HY-17025	-1.81044648	1.2820809	-1.98541994	-6.87744078	-18.03816268	-57.92465239	-87.58978262									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181788-01	Cefetamet pivoxil HCl	144206472		DPI_SARS-CoV-2_General	2019_NPC_02	111696-23-2	Cefetamet pivoxil hydrochloride; Ro 15-8075; Ro-15-8075; Cefyl; 	13.9333492831	-4.8559444758	-56.5206382813	-2.2	7	cefetamet pivaloyloxymethyl ester;7-(2 (2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-desacetoxyceph-3-em-4-carboxylic acid pivaloyloxymethyl ester;Cefyl;CIPLUS_685427;CEFETAMET PIVOXIL HYDROCHLORIDE;cefetamet pivoxil;CIPLUS_691806;Cefetamet pivoxil hydrochloride;Cefetamet Pivoxil Hydrochloride;Ro 15-8075;Ro-15-8075;CIPLUS_741318;cefetamet pivoxyl;	-74.7548161484	-58.52637587	0.0048109298	0.9702811906			Cl.CC=3CS[C@H]2N(C(=O)[C@H]2NC(=O)C(=N\OC)\c1csc(N)n1)C=3C(=O)OCOC(=O)C(C)(C)C	ACC	CEFETAMET PIVOXIL HCl	0	-1.16657811	-2.19169733	-0.41858616	-13.37119502	-19.57440812	-58.52637587									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183110-02	Imidafenacin		potassium ion transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	170105-16-5				-46.8516962427	4	7		0	-17.08129192					CC1=NC=C[N]1CCC(C(N)=O)(C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-B0662	-7.59555134	-7.59777311	-9.95522843	-8.65467811	-7.58263432	-12.99793311	-17.08129192									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167443-02	Afloqualone			DPI_SARS-CoV-2_General	2019_NPC_02	56287-74-2		7.8352981002	-5.1059444758	-66.5187683119	-2.2	7		-72.6201541196	-68.27284403	0.0005471022	0.9902985972			CC1=CC=CC=C1N2C(=O)C3=C(C=CC(N)=C3)N=C2CF	DC Chemicals	DC9026	2.70757705	-1.8919356	-3.26996554	-5.32937352	-3.06774707	-32.7367531	-68.27284403									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164600-10	ARTESUNATE		Antimalarial Agents	DPI_SARS-CoV-2_General	2019_NPC_02	182824-33-5				-4.5344793345	4	7		0	-5.37030871				PfATP6	C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	Microsource	01504829	0.30289718	2.52951096	-1.08061227	-3.21539649	1.17149443	-2.1326569	-5.37030871									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167452-03	Pirenoxine Sodium	225144286	maintenance of lens transparency Activator	DPI_SARS-CoV-2_General	2019_NPC_02	51410-30-1		15.6334750258	-4.8059444758	-33.9589980708	4	7		-28.434746896	-26.51857489	0.0007947694	0.9882921571			OC1=C2C(=NC(=C1)C([O-])=O)C(=O)/C=C\3OC4=CC=CC=C4\N=C23	Bosche	P6175	-3.81280492	-3.68915891	-3.95443145	-2.40628581	-5.90499727	-8.93461105	-26.51857489									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344541-01	Adrenochrome semicarbazone	225144387		DPI_SARS-CoV-2_General	2019_NPC_02	69-81-8				11.6135242607	4	7		0	0.12843077					CN1CC(O)C\2=C\C(=N/NC(N)=O)C(=O)\C=C12	SIGMA	A5877	2.80931351	4.26667283	2.56674715	2.56062484	2.45942542	1.94475761	0.12843077									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178826-03	Glucosamine hydrochloride	170466505	Solute carrier organic anion transporter family member 1B3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	66-84-2				8.7327674401	4	7		0	0.58507349					Cl.O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1N	Microsource	01500316	3.65095147	1.90579593	2.47298469	3.72518299	-0.01188128	0.42277339	0.58507349									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093362-05	Betahistine mesylate	170465694	Histamine H3 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	54856-23-4				2.8460088748	4	7		0	1.68817014					CS(=O)(=O)O.CNCCc1ccccn1	Prestwick Chemical, Inc.	Prestw-543	-1.44506572	1.93270946	2.67358826	0	0	-0.41160628	1.68817014									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00264003-02	(2R,3R)-2,3-Dimercaptosuccinic acid	170465255	Lead Chelating Agent	DPI_SARS-CoV-2_General	2019_NPC_01	27887-84-9		6.2237985085	-5.2059444758	-29.6229483295	-2.2	7		-34.514296212	-30.01191351	0.000600345	0.9898390317			O=C(O)[C@@H](S)[C@H](S)C(O)=O	Microsource	01505007	2.3309854	-0.53509908	-0.60198387	0.81521058	-5.29107243	-16.39310941	-30.01191351									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015806-06	Pirfenidone	170465606		DPI_SARS-CoV-2_General	2019_NPC_01	53179-13-8				2.1706222123	4	7		0	-3.95934197					CC2=CN(c1ccccc1)C(=O)C=C2	Sequoia	53179-13-8	2.56819887	-0.07574462	1.37213326	3.58441819	-0.44917018	-0.82829412	-3.95934197									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160456-03	2-Iodohippuric acid	170465302	renal filtration Interacts	DPI_SARS-CoV-2_General	2019_NPC_01	147-58-0				10.148798561	4	7		0	-2.02276241					O=C(NCC(=O)O)c1ccccc1I	SIGMA	106577	2.03567884	1.83008772	1.07967147	2.87204956	4.06790844	4.22785711	-2.02276241									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178069-05	Cloperastine hydrochloride	170465832		DPI_SARS-CoV-2_General	2019_NPC_01	14984-68-0		22.0828704269	-4.6559444758	-22.3072062593	4	7		-14.390165612	-14.08836278	0.0197419683	0.9370894616			Cl.Clc1ccc(cc1)C(OCCN2CCCCC2)c3ccccc3	Prestwick Chemical, Inc.	Prestw-793	-3.89465786	-1.26322477	-3.65333528	-3.82020217	-4.55006852	-4.22785711	-14.08836278									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165966-06	Vinorelbine tartrate 			DPI_SARS-CoV-2_General	2019_NPC_01	125317-39-7		8.7913490634	-5.0559444758	-30.8437752257	-2.2	7		-49.1159286232	-42.13327926	0.0003761716	0.9919806124			[H][C@@]12N3CC[C@@]14C5=CC(=C(OC)C=C5N(C)[C@@]4([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]6(C[C@@]7([H])CN(CC(CC)=C7)CC8=C6NC9=C8C=CC=C9)C(=O)OC	Bosche	V5183	0	4.11219977	0	2.6563323	-1.48962087	-17.62792825	-42.13327926									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095191-12	Oseltamivir Phosphate		Neuraminidase (sialidase) Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_02	204255-11-8				-5.9561920315	4	7		0	-5.62717024				NEU1	CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1	Enzo	DL194	0.46012625	-0.98177366	-3.72471344	-0.48874027	0.90060119	-0.42277339	-5.62717024									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390238-01	Isepamicin		30S Ribosomal Protein Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_02	58152-03-7				0	4	7		0	0					CN[C@@H]1[C@@H](O)[C@H](OC[C@]1(C)O)O[C@@H]2[C@@H](O)[C@H](OC3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CN	Adooq	A11662	0	0	0	0	0	0	0									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00091019-23	Dexamethasone		Antiinflammatory agent	DPI_SARS-CoV-2_General	2019_NPC_02	50-02-2				10.3717273369	4	7		0	-2.83023355				NR3C1	C[C@@H]1C[C@H]2[C@@H]3CCC\4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	Microsource	01500230	4.94115471	3.73073991	0.879023	4.51090896	1.62773567	1.44212702	-2.83023355									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510028-01	Amezinium methylsulfate		Amine oxidase [flavin-containing] B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	30578-37-1				-23.7182377705	4	7		0	-7.85806022			403451	MAOB	COC1=CC(=CN=[N+]1C2=CC=CC=C2)N	Ark Pharm	AK396807	-5.329603	-4.57622029	-4.46074869	-4.1320768	-4.15132001	-5.52423901	-7.85806022									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178697-04	Irinotecan	170464824	DNA Topoisomerase I Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	100286-90-6	;Irinotecan hydrochloride trihydrate;Irinotecan; Campto;Irinotecan hydrochloride	15.6334750258	-4.8059444758	3.4146459742	4	7		-14.460519432	-8.30043286	0.1018863018	0.8331518734	7150	TOP1	Cl.CC[C@]3(O)C=4C=C5c6nc7ccc(OC(=O)N1CCC(CC1)N2CCCCC2)cc7c(CC)c6CN5C(=O)C=4COC3=O	Prestwick	Prestw-1494	4.68681357	2.49255007	0	4.38463157	0	-0.26775648	-8.30043286									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263198-04	Lenvatinib		VEGFR-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	417716-92-8		7.8352981002	-5.1059444758	-14.9986091387	4	7		-15.0613138	-14.2177615	0.0092449709	0.9582046332		FLT1	COC1=C(C=C2C(=CC=NC2=C1)OC3=CC(=C(NC(=O)NC4CC4)C=C3)Cl)C(N)=O	APExBIO	A2174	0.89481838	-1.58700825	-0.98216169	-1.78892968	0.2400019	-7.48308906	-14.2177615									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167427-02	Epoprostenol sodium	124893308	Prostanoid IP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	61849-14-7				-4.8625449749	4	7	PROSTAGLANDIN I2 Na	0	-2.55434524			64805		CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2O\C(C[C@H]12)=C/CCCC([O-])=O	BIOMOL	PG011	1.03817429	-1.05569544	-1.62912262	-0.86757243	2.47368296	-4.95584367	-2.55434524									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183848-01	Troxacitabine	124894563	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	145918-75-8	Troxacitabine			-11.4152597932	4	7	2R(-)-cis-HMD-cytosine;Troxacitabine;LS-173247;LS-173246;LS-173400;TROXACITABINE;BCH-4556;BCH 4556, trans-(+-)-isomer;LS-173262;2'-DEOXY-3'-OXACYTIDINE,1'S,4'S,L-;BCH 4556, cis-(+-)-isomer;BCH 4556, (2S-trans)-isomer;BCH 4556, 2R(-)-cis-isomer;LS-173106;troxacitabine;CIPLUS_728716;troxacitabinum;CIPLUS_703293;	0	-2.94439423				POLB	OC[C@H]1OCC(O1)[N@@]2C=CC(N)=NC2=O	Pharmaron	PH-NIH-148677	-1.26476913	-2.0166786	-6.01251729	-2.8926876	0.26851698	-2.22660654	-2.94439423									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179619-06	Erythromycin propionate	170465433	NF-kappaB Activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	134-36-1				-18.9404059444	4	7		0	-9.6989012					CCC(=O)O[C@@H]3[C@H](C[C@@H](C)O[C@H]3O[C@@H]2[C@@H](C)[C@H](O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)N(C)C	Microsource	01500280	-1.93068048	-2.26616461	-4.71859544	-4.94586442	-2.09348193	-3.88481774	-9.6989012									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386267-03	(R)-Lansoprazole		H+/K+-ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	138530-94-6		22.0828704269	-4.6559444758	-23.7101059985	-3	7		-66.3438377046	-56.88055939	0.0000111695	0.9986329592		ATP4A	CC1=C(C[S@@+]([O-])C2=NC3=C([NH]2)C=CC=C3)N=CC=C1OCC(F)(F)F	MedChem Express	HY-13662B	2.85093297	0.53824297	1.92447434	0.61034072	1.35684243	1.79913566	-56.88055939									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091501-06	Resorcinol	170465462	leukotriene B4 biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	108-46-3				6.699996847	4	7		0	-2.73757319					Oc1cccc(O)c1	Specs	AE-562/J255633	0	2.65106165	3.17564768	2.76669928	0.55067756	2.5052086	-2.73757319									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263961-02	Ceftriaxone disodium trihydrate	170465387	Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	104376-79-6		17.5410474839	-4.7559444758	3.0182296435	4	7		-28.8177232519	-17.34810271	0.000131119	0.9953010499	9376	SLC22A8	[Na+].[Na+].O.O.O.Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(=C(CSC2=NC(=O)C([O-])=NN2C)CS[C@@H]34)C([O-])=O	Microsource	01503111	4.90644591	3.38407408	3.41936585	3.55933479	3.52484393	-1.23481884	-17.34810271									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015226-12	Mitotane	170464927	Antineoplastic Agent	DPI_SARS-CoV-2_General	2019_NPC_01	53-19-0	 ; ortho,para DD;Mitotane; Lysodren; Chlodithane; Mitotano; 2,4'-DDD solution; Khloditan;MITOTANE;1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; Mytotan;o,p'-DDD; Chloditan	3.499899101	-5.4559444758	-17.6681681906	4	7		-28.1110066519	-1.51073484	0.0108230163	0.977609621		CYP11B1	Clc2ccccc2C(C(Cl)Cl)c1ccc(Cl)cc1	Microsource	00330082	3.55094038	4.06333227	3.19027077	0	0	-20.50917221	-1.51073484									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160596-03	Aluminum monostearate	225144243		DPI_SARS-CoV-2_General	2019_NPC_01	7047-84-9				9.4951926448	4	7		0	1.55129148					CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O	SIGMA	06270	3.88013458	4.19527451	3.12690405	-0.66471016	1.60127899	0	1.55129148									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00016407-08	Sulfamethizole	170465369	Antibacterial	DPI_SARS-CoV-2_General	2019_NPC_01	144-82-1	; Sulfapral; ;Sulfamethizole; Sulfamethizole; Rufol; Sulfametizol; FNA, Sulfamethizo; Sulphamethizole; Thiosulfil; Sulfamethizol FNA;SULFAMETHIZOLE			6.6111712718	4	7		0	-0.9632202					Cc2nnc(NS(=O)(=O)c1ccc(N)cc1)s2	Labotest	LT00772293	2.40844286	2.81721113	2.10816212	-0.34364261	3.27107547	0	-0.9632202									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024567-03	Ambenonium chloride	170465386	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	115-79-7				-33.1202962026	4	7		0	-8.80079085					[Cl-].[Cl-].Clc2ccccc2C[N+](CC)(CC)CCNC(=O)C(=O)NCC[N+](Cc1ccccc1Cl)(CC)CC	Tocris	0388	-2.1663883	-9.35079532	-8.75679364	-7.43221211	-5.75800639	-7.34793435	-8.80079085									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018237-09	Trichlorfon	170465707	Butyrylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	52-68-6				5.3123484483	4	7		0	2.18498897					OC(C(Cl)(Cl)Cl)P(=O)(OC)OC	Prestwick	Prestw-51	-2.68922615	3.20326435	2.94655261	-0.7048436	0	3.10991412	2.18498897									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160623-04	Octinoxate	170464894		DPI_SARS-CoV-2_General	2019_NPC_01	5466-77-3		3.9269513795	-5.4059444758	-101.1140037161	-2.1	7		-101.1329370604	-92.87470533	0.0000111567	0.9986334224			COc1ccc(C=CC(=O)OCC(CC)CCCC)cc1	SIGMA	437174	3.08619563	0.35428934	4.69644903	0	-17.75110389	-64.92707963	-92.87470533									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253596-01	Ethchlorvynol	170464750	GABA-A receptor; anion channel Positive Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	113-18-8				-7.6402762792	4	7		0	-5.60338677					C#CC(O)(/C=C\Cl)CC	GVK	FFS-11-286-NCI-036	-2.02316817	-0.69070665	-1.89165749	-1.74216028	0.61545042	-1.03344607	-5.60338677									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263825-02	HETACILLIN POTASSIUM		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	5321-32-4, 3511-16-8 [hetacillin]				-50.8924160102	4	7		0	-16.60562241					CC1(C)N[C@@H](C(=O)N1[C@@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C([O-])=O)C4=CC=CC=C4	Microsource	01500327	-8.83951074	-9.61676176	-11.31009587	-8.57049318	-9.71651261	-12.50939496	-16.60562241									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386347-01	Ospemifene		Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC_02	128607-22-7		6.2237985085	-5.2059444758	-62.0645377449	-2.2	7		-82.3938781363	-69.20515626	0.0000210337	0.9981222007	2100	ESR2	OCCOC1=CC=C(C=C1)\C(=C(\CCCl)C2=CC=CC=C2)C3=CC=CC=C3	Selleck	S4285	4.39085297	4.53001917	2.81052952	0.1566775	-10.54344985	-37.8147313	-69.20515626									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522012-01	CEFTOBIPROLE MEDOCARIL SODIUM			DPI_SARS-CoV-2_General	2019_NPC_02	252188-71-9		11.0676527398	-4.9559444758	-27.8977663729	4	7		-18.6279455561	-20.39195167	0.0145641515	0.946467973			C\C1=C(COC(=O)N2CC[C@H](C2)N3CC\C(=C/C4=C(/N5[C@H](SC4)[C@H](NC(=O)\C(N=O)=C/6NS/C(=N6)N)C5=O)C(O)=O)C3=O)\OC(=O)O1	CheMall	HE073132	-2.16652408	-1.95199704	-6.5328989	-3.0891191	-2.93467671	-7.9199549	-20.39195167									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263521-01	Deflazacort	170466610	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC_02	14484-47-0	Deflazacort;Deflazacort (Calcort)			-23.4404188391	4	7		0	-8.21005565				NR3C1	CC(=O)OCC(=O)[C@@]54N=C(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Sequoia	14484-47-0	-2.56884552	-3.1578461	-5.07020464	-7.29368847	-2.06021434	-7.27170237	-8.21005565									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379007-02	Retapamulin		70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	224452-66-8		9.8640558873	-5.0059444758	-52.5677356286	4	7		-11.9253723921	-20.83432431	0.0265783241	0.9255838138			C[C@@H]1CCC23CCC(=O)[C@H]2C1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CSC4C[C@@H]5CC[C@H](C4)N5C	MedChem Express	HY-17010	-7.56318065	-10.8133706	-9.9083472	-10.37579216	-8.04362807	-13.026118	-20.83432431									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182544-01	Triamcinolone hexacetonide	144206532		DPI_SARS-CoV-2_General	2019_NPC_02	5611-51-8	Triamcinolone hexacetonide; Aristospan; 	3.1192883571	-5.5059444758	-29.1877956604	4	7	hexacetonide de triamcinolone;CL-34433;TATBA;Hexacetonide de triamcinolone;9-fluoro-11 beta,16 alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone, 21-(3,3-dimethylbutyrate);triamcinolone hexacetonide;Tiamcinoloni hexacetonidum;Aristospan;Hexacetonido de triancinolona;CIPLUS_164534;triamcinoloni hexacetonidum;TRIAMCINOLONE ACETONIDE 21-T-BUTYLACETATE;Triamcinolone hexacetonide;LS-1379;SQ-21360;Triamcinoloni hexacetonidum;TRIAMCINOLONE HEXACETONIDE;(11 beta, 16 alpha)-21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy)) pregna-1,4-diene-3,20-dione;Triamcinolone Hexacetonide;	-17.9696139119	-17.98982067	0.0007592909	0.9885721541			CC(C)(C)CC(=O)OCC(=O)[C@]45OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	APAC	555785	-2.10640708	-0.51514241	-2.07918239	-2.626102	-5.22538792	-15.70838031	-17.98982067									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022787-04	Oxacillin sodium		beta-lactam antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	1173-88-2				12.142764107	4	7		0	2.53531846					CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C([O-])=O)C(=NO1)C4=CC=CC=C4	Prestwick	Prestw-1475	4.86254017	4.89962808	0	0	4.4792434	1.37636227	2.53531846									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00013058-02	Malachite green oxalate	170465712		DPI_SARS-CoV-2_General	2019_NPC_01	2437-29-8		1.3933349283	-5.8559444758	-155.6558364382	-1.1	7		-103.2870497552	-99.11535829	0.000016037	0.9983607816			C/[N+](C)=C1\C=C/C(C=C1)=C(/c2ccccc2)c3ccc(cc3)N(C)C.[O-]C(=O)C(=O)O.[O-]C(=O)C(=O)O.O=C(O)C(=O)O.CN(C)c1ccc(cc1)C(\c2ccccc2)=C3/C=C/C(C=C3)=[N+](/C)C	SIGMA	38800	4.01084404	0	-0.35339134	-9.34858404	-48.14241486	-94.02408659	-99.11535829									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274075-01	1-Octacosanol		PI3K-Akt signaling pathway Activator	DPI_SARS-CoV-2_General	2019_NPC_01	557-61-9				-43.8002893679	4	7		0	-9.13031355					CCCCCCCCCCCCCCCCCCCCCCCCCCCCO	SIGMA	O3379	-4.98390337	-4.77679771	-5.38373425	-6.38372589	-4.95102269	-5.67101987	-9.13031355									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00025357-04	Nicorandil	170465582	K(ATP) Channel Activator	DPI_SARS-CoV-2_General	2019_NPC_01	65141-46-0	;Nicorandil; Nicorandil; ; Sigmart			9.5151324395	4	7		0	3.68051507				KCNJ8	O=C(NCCO[N+]([O-])=O)c1cccnc1	Prestwick	Prestw-106	0	2.26500843	0.35339134	1.5526626	4.83936456	1.82936125	3.68051507									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015686-11	Gallopamil hydrochloride	170465991	Voltage-gated L-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	16662-46-7		7.8352981002	-5.1059444758	-6.3869321504	4	7		-16.722377128	-14.35198094	0.0220704642	0.9326893553			Cl.COc1c(cc(cc1OC)C(C#N)(CCCN(C)CCc2ccc(OC)c(OC)c2)C(C)C)OC	Enzo	AC103	4.50463534	0	0	0.44648456	2.17479572	-5.2949845	-14.35198094									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183877-01	Unoprostone isopropyl ester	144207178	Prostanoid FP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	120373-24-2				12.5560123589	4	7	Ciba Vision brand of isopropyl unoprostone;Unoprostone;isopropyl 20-ethyl-9alpha,11alpha-dihydroxy-15-keto-cis-delta-5-prostanoate;ISOPROPYL UNOPROSTONE;UNOPROSTONE ISOPROPYL;unoprostone isopropyl;UF-021;Isopropyl unoprostone;Unoprostone isopropyl;Novartis brand of isopropyl unoprostone;CIPLUS_3762607;Eescula;LS-176760;ISOPROPYL Z-7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-(3-OXODECYL)CYCLOPENTYL)HEPT-5-ENOATE, D-;isopropyl unoprostone;UF 021;Rescula;CIPLUS_729221;	0	4.48556343					O[C@@H]1C[C@H](O)[C@H](C/C=C\CCCC(=O)OC(C)C)[C@H]1CCC(=O)CCCCCCC	Toronto Research	U800050	2.66595759	4.76564485	-0.22268583	0.86757243	3.18655989	3.40567456	4.48556343									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181916-01	Sulfaethoxypyridazine	144206640		DPI_SARS-CoV-2_General	2019_NPC_02	963-14-4	CIPLUS_157090; 			-7.2583814524	4	7	SULFAETHOXYPYRIDAZINE;sulfaethoxypyridazine;CIPLUS_157090;N-1-(6-ethoxy-3-pyridazinyl)sulfanilamide;	0	-9.0282072					O=S(=O)(Nc1ccc(OCC)nn1)c2ccc(N)cc2	FLUKA	02743	-0.27977525	-0.45046086	-0.16642835	-1.18560438	0.43010242	-1.93066516	-9.0282072									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167430-04	Tioconazole	170465343	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC_02	65899-73-2	 ; Vagistat-1;Tioconazole; Tioconazol;TIOCONAZOLE; Tioconazole	12.4181106199	-4.9059444758	-88.6093868333	-2.1	7		-111.4972424927	-88.98825096	0.0000134709	0.9984981012			Clc3sccc3COC(Cn1ccnc1)c2ccc(Cl)cc2Cl	Microsource	01505581	-2.43011399	-2.04439927	-1.46972645	-6.16186891	-10.03017846	-37.59864713	-88.98825096									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024715-05	L-Arginine	170465748		DPI_SARS-CoV-2_General	2019_NPC_01	74-79-3				-10.2102442478	4	7		0	-2.97584345					N[C@@H](CCCNC(=N)N)C(=O)O	Tocris	0663	0.31709147	-1.99135045	-2.33238283	-0.94062759	-2.15956961	-0.83845724	-2.97584345									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00166298-02	Melengestrol acetate	170465702		DPI_SARS-CoV-2_General	2019_NPC_01	2919-66-6		9.8640558873	-5.0059444758	-29.3704302169	-2.2	7		-50.6071835932	-44.39938151	0.0000635242	0.996730234			CC(=O)[C@@]3(OC(C)=O)C(=C)C[C@H]2[C@@H]4C=C(C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	Prestwick	Prestw-1435	3.16849418	0	0.9431893	2.10449745	0.0329899	-14.68062402	-44.39938151									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249918-01	Estriol tripropionate	170465876		DPI_SARS-CoV-2_General	2019_NPC_01	2236-31-9		15.6334750258	-4.8059444758	-13.416912051	4	7		-13.620111024	-13.85009252	0.0445625596	0.899636516			CCC(=O)Oc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2C[C@@H](OC(=O)CC)[C@@H]1OC(=O)CC)c4cc3	GVK	FFS-11-286-NCI-183	-0.93191005	-3.01268112	-2.93192952	-1.19647829	1.67233416	-2.37308806	-13.85009252									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253867-02	Prucalopride	170466188	5-HT4 Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	179474-81-8	Resolor;R093877;R 093877;Prucalopride; Prucalopride;Prucalopridum			11.506790357	4	7		0	-1.15586424			3360	HTR4	COCCCN1CCC(CC1)NC(=O)c2cc(Cl)c(N)c3CCOc23	GVK	FFS-12-73-NCI-2606	2.95548617	4.03889853	3.11715532	3.87036898	0	3.44529702	-1.15586424									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016087-11	Vigabatrin	225144175	Gamma-amino-N-butyrate transaminase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	[60643-86-9]				3.9801737499	4	7		0	-1.56143064					NC(CCC(O)=O)C=C	Tocris	0808	3.12008327	-2.24546143	1.8449465	1.9891138	4.91041973	-0.62503176	-1.56143064									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00018296-07	Meclizine hydrochloride	170464899	Constitutive Androstane Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	1104-22-9	; Meclozine dihydrochloride;Meclozine dihydrochloride; Meclizine Hcl;Meclizine dihydrochloride;MECLIZINE HYDROCHLORIDE;Meclizine hydrochloride; Meclozina	9.8640558873	-5.0059444758	-33.1259085345	-2.2	7		-56.2913107355	-50.59947783	0.0003136526	0.9926846537	9970	NR1I3	Cl.Cl.Cc1cccc(c1)CN2CCN(CC2)C(c3ccc(Cl)cc3)c4ccccc4	Microsource	01500376	0	0	0	2.10449745	3.89027052	-15.21926927	-50.59947783									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389663-01	Empagliflozin (BI 10773)		Sodium/glucose cotransporter 2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	864070-44-0				7.4645550643	4	7		0	-0.32345526					OCC1OC(C(O)C(O)C1O)C2=CC(=C(Cl)C=C2)CC3=CC=C(OC4CCOC4)C=C3	APExBIO	A4601	2.79081597	2.94070087	3.21370807	1.91520707	1.66575577	-1.51728673	-0.32345526									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00186637-01	Chromomycin A<SUB>3</SUB> from Streptomyces griseus	124897824		DPI_SARS-CoV-2_General	2019_NPC_02	7059-24-7		15.6334750258	-4.8059444758	-87.8185885052	-2.2	7	CHROMOMYCIN A3	-80.919015114	-71.1791847	0.0007512942	0.9886002665			CO[C@H]1[C@@H](O)CC(O[C@H]1C)O[C@H]2CC(O[C@@H](C)[C@H]2OC(C)=O)OC3=CC4=CC5=C(C(=C4C(=C3C)O)O)C(=O)[C@@H](OC6C[C@@H](OC7C[C@H](OC8C[C@](C)(O)[C@@H](OC(C)=O)[C@H](C)O8)[C@@H](O)[C@H](C)O7)[C@H](O)[C@@H](C)O6)[C@@H](C5)[C@@H](OC)C(=O)[C@@H](O)[C@H](C)O	BIOMOL	GR302	-6.05563134	-6.47970616	-8.9754108	-12.85924748	-13.12406435	-24.64768884	-71.1791847									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181760-01	Lobenzarit sodium	144206494	response to oxidative stress Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	64808-48-6	lobenzarit; Carfenil; CCA lobenzarit; 	4.7903477126	-5.3196329617	-13.9717931341	4	7	U-69951F;2-((2-carboxyphenyl)amino)-4-chlorobenzoic acid;LOBENZARIT;CIPLUS_685410;Benzoic acid, 2-((2-carboxyphenyl)amino)-4-chloro-, disodium salt;LS-36386;LOBENZARIT SODIUM;lobenzarit, disodium salt;Carfenil;4-chloro-2,2'-iminodibenzoic acid;CCA lobenzarit;CIPLUS_186740;lobenzarit disodium;lobenzarit;Lobenzarit Disodium;DISODIUM 4-CHLORO-2,2'-IMINODIBENZOATE;disodium 4-chloro-2,2'-iminodibenzoate;Lobenzaritum;N-(2-carboxyphenyl)-4-chloroanthranilic acid;Lobenzarit sodium;Lobenzarit;Lobenzarit disodium;lobenzaritum;lobenzart;LS-176311;	-19.2759121	-13.97992675	0.0325814716	0.9161428571	2936		[Na+].[Na+].O=C([O-])c2ccc(Cl)cc2Nc1ccccc1C([O-])=O	ACC	LOBENZARIT DISODIUM	-2.44398714	2.86677909	2.33702914	1.10609639	-1.75605351	-6.66572717	-13.97992675									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00185757-01	Diethylmethyl(2-3-methyl-2-phenylvaleryloxy)-ethyl)ammonium bromide	144207102	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	90-22-2				4.5879995945	4	7		0	-3.7482757					[Br-].CC[N+](C)(CC)CCOC(=O)C(C(C)CC)c1ccccc1	SigmaAldrich	S422649	2.72607459	0.40425974	3.41998547	0.41390922	2.86338902	-0.35231116	-3.7482757									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015619-13	Loratadine	170464867	Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	79794-75-5	 Sch2985; ; Claritin; Sch-434;LORATADINE; Wyeth Brand of Loratadine; Clarium; Sch 2985;Loratidine; Alavert; Loratadine Hydrochloride; Sch 434; Loratidine; Loratadine Wyeth Bran; Loratadine W/Pseudo; Loratadine;Loratadine;	15.6334750258	-4.8059444758	-32.1049913212	-2.2	7		-66.6785759591	-49.37770906	0.000215151	0.9939541665	9704	HRH1	Clc3cc4CCc1cccnc1C(=C2/CCN(CC2)C(=O)OCC)\c4cc3	Vitas	STK574925	2.07440757	1.99135045	2.99529624	-0.1931422	-2.84981982	-12.64291885	-49.37770906									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165862-02	Pamidronic acid	170464689	Farnesyl diphosphate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	40391-99-9				10.5332393551	4	7		0	3.28508783					OC(CCN)(P(O)(=O)O)P(=O)(O)O	Selleck	S1311	3.69133203	3.16417035	2.1374083	-1.12624476	2.51484546	2.32735403	3.28508783									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024822-03	EVANS BLUE		Serum albumin Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	314-13-6		1.106765274	-5.9559444758	-173.2121930495	-1.1	7		-101.2450127961	-98.50193911	0.0002547843	0.9934124476	6339		CC1=C(C=CC(=C1)C2=CC=C(\N=N\C3=C(O)C4=C(C=C3)C(=CC(=C4N)[S]([O-])(=O)=O)[S]([O-])(=O)=O)C(=C2)C)/N=N/C5=C(O)C6=C(N)C(=CC(=C6C=C5)[S]([O-])(=O)=O)[S]([O-])(=O)=O	SIGMA	206334	3.90918113	-0.2809881	-9.66342522	-15.6244513	-56.99893417	-94.77615732	-98.50193911									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018261-06	Perhexiline	170466435	mitochondrial carnitine palmitoyltransferase-1 inhbitior	DPI_SARS-CoV-2_General	2019_NPC_01	6724-53-4	Perhexiline;rac Perhexiline Maleate; Perhexiline	2.7800686746	-5.5559444758	-31.2334161583	4	7		-11.250959844	-1.2166992	0.193293124	0.8061870964		CPT1A	O=C(O)\C=C/C(=O)O.C(C(C1CCCCC1)C2CCCCC2)C3CCCCN3	Microsource	01503227	-7.30762714	-2.81232438	-2.3372572	-3.55431811	-6.1691113	-12.96305707	-1.2166992									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164549-02	Dofetilide	170465418	K(V)11.1 (erg1) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	115256-11-6	; 2   Dofetilide; Tikosyn; Dofetilide;Dofetilide; Dofetilida			-27.9327349935	4	7		0	-10.40784771				KCNH2	CS(=O)(=O)Nc1ccc(cc1)CCN(C)CCOc2ccc(cc2)NS(C)(=O)=O	Sequoia	SRP045723d	-4.73216663	-3.7310333	-7.06051522	-4.85865503	-5.40273055	-6.47390619	-10.40784771									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016329-07	Phenindione	170465130	Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	83-12-5		15.6334750258	-4.8059444758	-18.6244167075	4	7		-29.655572732	-23.04631061	0.0000735604	0.9964861393			O=C2c1ccccc1C(=O)C2c3ccccc3	Specs	AN-153/I102301	-1.04325515	0.18325311	0.02193463	-0.08277523	-1.60635436	-6.76863662	-23.04631061									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182039-02	Cilazapril	225144330	Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			9.8640558873	-5.0059444758	8.0416504122	4	7		-9.3610569399	-5.71754745	0.0175033257	0.9413913497			CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCCN3CCC[C@H](N3C2=O)C(O)=O	APAC	500074	2.37462138	1.84573448	3.47155482	4.36124687	3.52398831	0.3147313	-5.71754745									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179501-03	Aurantiamarin (Methyl Hesperidin)	225144305	Free Radical Scavenger	DPI_SARS-CoV-2_General	2019_NPC_02	11013-97-1	; Aurantiamarin; Hesperitin-7-rutinoside;Vitamin P; Hesperetin-7-Rutinoside;Methyl-Hesperidin;Hesperidin; Hesperetin 7 Rutinosid	15.6334750258	-4.8059444758	-11.1425598727	-2.4	7		-35.861033152	-25.30086096	0.0248009504	0.9279497832			COC1=C(O)C=C(C=C1)[C@@H]2CC(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)C=C3O	Prestwick	Prestw-400	4.73305741	3.43043267	3.77159466	-3.80936791	0.04990139	-4.88538144	-25.30086096									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094721-07	Methimazole	170464856	Thyroid peroxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	60-56-0				-2.1627150087	4	7		0	-0.47147094					S=C1NC=CN1C	Vitas	STK802184	-2.12281848	0.57419308	1.81570032	-3.15298367	0.35781353	-0.27948575	-0.47147094									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093588-04	cAMP	170466839	cAMP-dependent protein kinase type II-alpha regulatory subunit Activator	DPI_SARS-CoV-2_General	2019_NPC_01	60-92-4				17.9302903272	4	7		0	4.57783073			5576	PRKAR2A	Nc4ncnc3c4ncn3[C@@H]2O[C@@H]1COP(=O)(O)O[C@H]1[C@H]2O	SIGMA	A9501	4.80962409	0	4.75006702	3.72488524	4.77338476	0	4.57783073									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00159504-04	Thymol iodide	170465466		DPI_SARS-CoV-2_General	2019_NPC_01	552-22-7		6.9832167823	-5.1559444758	-52.683214144	-2.2	7		-41.5182424559	-36.90147271	0.0013168817	0.9848238042			IOc1cc(C)c(cc1C(C)C)c2cc(C(C)C)c(OI)cc2C	SIGMA	T2763	-1.05293733	-2.59242065	-5.06690064	-5.40045652	-12.56915191	-20.8953707	-36.90147271									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00261969-01	Alatrofloxacin mesylate	170465095		DPI_SARS-CoV-2_General	2019_NPC_02	146961-77-5	Alatrofloxacin mesylate;Cp-116,517;Cp 116517;Cp	15.6334750258	-4.8059444758	-41.2213548476	4	7		-17.417600024	-21.78566332	0.0784059313	0.8583049992			CS(=O)(=O)O.C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@]2(C)[C@@H]1CN(C[C@@H]12)c3nc4c(cc3F)C(=O)C(=CN4c5ccc(F)cc5F)C(=O)O	GVK	FFS-11-286-NCI-04	-3.9376633	-10.41604103	-8.67537095	-6.56876272	-4.34617304	-8.71852687	-21.78566332									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178864-03	Ethambutol dihydrochloride	174006619		DPI_SARS-CoV-2_General	2019_NPC_02	1070-11-7				2.1181598326	4	7		0	0.04756695					Cl.Cl.CC[C@@H](CO)NCCN[C@H](CO)CC	Microsource	01500288	-1.39887627	-0.0207905	-0.55085441	2.66351753	4.61706627	-2.35813604	0.04756695									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183837-01	Monatepil	124894552	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	103377-41-9	Monatepil; Monatepil	2.4777388143	-5.6059444758	-81.2453408644	-1.2	7	CIPLUS_696267;AJ 2615;MONATEPIL;monatepil, (S)-isomer;monatepil, (+-) monatepil;LS-172819;LS-172817;Monatepil Maleate;monatepil maleate;LS-173001;maleate;LS-171860;11-((4-(4-(4-fluorophenyl)-1-piperazinyl)butyryl)amino)-6,11-dihydrodibenzo(b,e)thiepin maleate;1-Piperazinebutanamide, N-(6,11-dihydrodibenzo(b,e)thiepin-11-yl)-4-(4-fluorophenyl)-, (Z)-2-butenedioate (1:1);CIPLUS_3853864;MONATEPIL MALEATE;monatepil;Monatepil maleate;CIPLUS_197056;monatepil x maleate;monatepil, (R)-isomer;monatepilum;LS-173055;AJ-2615;N-(6,11-DIHYDRODIBENZO(B.E)THIEPIN-11-YL)-4-(4-FLUOROPHENYL)-1-PIPERAZINEBUTYRAMIDE MALEATE, DL-;LS-173056;	-47.0937613326	-49.94529801	0.0001231184	0.9954374199			Fc1ccc(cc1)N2CCN(CC2)CCCC(=O)NC3c5ccccc5SCc4ccccc34	Pharmaron	PH-NIH-152406	-3.1977618	-3.31955	-5.61871499	-6.58279354	-13.78466364	-46.17624953	-49.94529801									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166415-03	Palonosetron hydrochloride	170465300	Serotonin 3a (5-HT3a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	135729-62-3				-3.1215089351	4	7		0	-4.68058793					Cl.O=C1N(C[C@H]3CCCc2cccc1c23)[C@@H]5CN4CCC5CC4	Bosche	P5846	-0.11329742	-0.4273603	-2.102623	1.92923789	-1.1239693	0.90191657	-4.68058793									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091250-12	Reserpine	170465405	Alkaloid anitpsychotic	DPI_SARS-CoV-2_General	2019_NPC_01	50-55-5		3.9269513795	-5.4059444758	-103.3479302318	-2.1	7		-96.2146814995	-91.72898025	0.000004711	0.9991126991		SLC18A2	COc1cc(cc(OC)c1OC)C(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccc(OC)cc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC	Vitas	STK801975	-0.4090722	0.38360984	0.73846604	0.37875937	-16.83246206	-62.96559785	-91.72898025									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016035-13	Trazodone hydrochloride	170465234	alpha2-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	25332-39-2	; ;Trazodone hydrochloride; Desyrel; Trazodone hydrochloride;TRAZODONE HYDROCHLORIDE; Trazodona;Trazodone?HCl	11.0676527398	-4.9559444758	-13.5300309237	4	7		-27.3795087559	-23.64959063	0.0002899172	0.9929806937	150	ADRA2A	Cl.Clc1cccc(c1)N2CCN(CC2)CCCN3N=C4C=CC=CN4C3=O	Microsource	01503121	0.97547987	0	2.60047281	0.71989365	0.60143125	-6.38751969	-23.64959063									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015428-15	(+/-) -Fluoxetine	170465374	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	54910-89-3		9.8640558873	-5.0059444758	-11.7480446421	4	7		-11.535461708	-9.19621809	0.0191835405	0.9383348495			FC(F)(F)c2ccc(OC(CCNC)c1ccccc1)cc2	Vitas	STK734483	-1.06261951	1.02377404	-1.72796178	-0.35869265	-2.55037304	-5.22892423	-9.19621809									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016272-05	Guanethidine sulfate	170464954		DPI_SARS-CoV-2_General	2019_NPC_01	60-02-6				-23.9371232946	4	7		0	-4.53220451					O=S(=O)(O)O.O=S(=O)(O)O.N=C(N)NCCN1CCCCCCC1	Vitas	STK895063	-3.53641711	-4.63019523	-3.2390144	-2.97739985	-2.10374055	-3.14548503	-4.53220451									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00015100-15	Altretamine	170464714	DNA Alkylating Drugs	DPI_SARS-CoV-2_General	2019_NPC_01	645-05-6	; ; Altretamine; Hexamethylmelamine;ALTRETAMINE; Melamine, hexamethyl-; Hexalen; Altretamina;Altretamine			3.437358175	4	7		0	0				H2AFX	CN(C)c1nc(nc(n1)N(C)C)N(C)C	Microsource	01503065	0	0.93825592	0	0	3.98162716	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510509-02	Vesnarinone		p97 ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	81840-15-5				1.3925352987	4	7		0	-5.70327736				VCP	COC1=CC=C(C=C1OC)C(=O)N2CCN(CC2)C3=CC4=C(NC(=O)CC4)C=C3	MedChem Express	HY-15297	2.4578603	0.57982397	3.5512529	2.33145476	-1.19525699	-1.35757234	-5.70327736									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178783-03	HYOSCYAMINE		M1 Muscarinic acetylcholine receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_02	101-31-5		19.6813789847	-4.7059444758	-22.0939845715	4	7		-12.289257944	-12.79075298	0.0263727564	0.926241362		CHRM1	CN1C2CC[C@@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3	Microsource	01500346	-3.26712756	-1.71637136	-4.94362533	-3.28555059	-4.19884514	-4.65050733	-12.79075298									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181006-02	1-(4-Hydroxyphenyl)-2-methyl-2-methylaminoethanol hydrochloride	225144314		DPI_SARS-CoV-2_General	2019_NPC_02					3.4624394243	4	7		0	-3.89097655					CNC(C)[C@@H](O)C1=CC=C(O)C=C1	SIGMA	CDS014222	1.44512012	1.21739934	1.96666745	0.81144915	1.74179597	0.75159714	-3.89097655									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164612-02	Propyphenazone	170465821	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	479-92-5				1.5633476761	4	7		0	-3.95427239					CC(C)C=2C(=O)N(c1ccccc1)N(C)C=2C	Specs	AE-562/J258456	0.22511074	0.89671855	-0.6507275	3.33860085	1.11404355	0.30489354	-3.95427239									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181912-01	Iomazenil	144206800	GABAergic synapse Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	127985-21-1				3.4645740615	4	7	IOMAZENIL (123I);iomazenilum (123I);iomazenil (123 I);Ro 16-0154;Iomazenil(123I);Ro-16-0154;IOMAZENIL (123 I);CIPLUS_208012;Iomazenil (123I);Benzodine;ethyl 7-iodo-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate;iomazenil;Iomazenil ((sup 123)I);(123I)iomazenil;	0	2.37763301					O=C(OCC)c3ncn2c3CN(C)C(=O)c1c(I)cccc12	Pharmaron	PH-NIH-10	0	0	1.02849065	0	0	2.13425479	2.37763301									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522037-01	Oxitropium Bromide		Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	30286-75-0				4.8010359811	4	7		0	-1.36517148					CC[N@@+]1(C)C2C[C@@H](CC1[C@H]3O[C@@H]23)OC(=O)[C@H](CO)C4=CC=CC=C4	Toronto Research	O847165	4.5897015	-1.62396914	-0.29300766	0	0.98614642	4.38744833	-1.36517148									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016446-17	Metronidazole		Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	443-48-1				-37.7521633248	4	7		0	-9.608524					CC1=NC=C([N]1CCO)[N+]([O-])=O	Enzo	DL447	-5.91689981	-7.57929266	-6.37350273	-7.53688937	-9.99691087	-9.54998121	-9.608524									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00480770-01	MK-3102		Dipeptidyl peptidase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1226781-44-7		12.4181106199	-4.9059444758	-76.9768691396	-2.2	7		-86.0233948567	-70.56557104	0.0000488154	0.9971347769			C[S+]([O-])(=O)[N]1C=C2CN(CC2=N1)[C@H]3CO[C@@H]([C@@H](N)C3)C4=C(F)C=CC(=C4)F	Adooq	A13310	-1.35263243	-4.90424819	-4.42324371	-5.21245002	-10.57196493	-30.48665915	-70.56557104									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166000-04	Iohexol	170464962		DPI_SARS-CoV-2_General	2019_NPC_02	66108-95-0				0.2408855131	4	7		0	-0.15697094					OCC(O)CNC(=O)c1c(I)c(N(CC(O)CO)C(C)=O)c(I)c(c1I)C(=O)NCC(O)CO	Prestwick	Prestw-512	0.25665333	-2.19686294	-1.56817702	1.79360662	4.99726731	-2.80909433	-0.15697094									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165791-04	Epinastine hydrochloride	170465284	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	108929-04-0				10.5602909436	4	7		0	-1.59824954					Cl.NC2=NCC3c4ccccc4Cc1ccccc1N23	SIGMA	E5156	2.71220144	4.96892975	0	3.09847298	1.96041157	3.66403608	-1.59824954									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00014810-01	Pirbuterol hydrochloride	144203612	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	38029-10-6	Pirbuterol hydrochloride; Maxair; 			-11.0833961463	4	7	6-(2-(tert-butylamino)-1-hydroxyethyl)-3-hydroxy-2-pyridinemethanol dihydrochloride;CIPLUS_3865153;CIPLUS_749202;pirbuterol sulfate;PIRBUTEROL HYDROCHLORIDE;Maxair;CIPLUS_210786;CP-24315-1;LS-176467;Pirbuterolum;pirbuterol acetate;Pirbuterol Hydrochloride;LS-66540;PIRBUTEROL;cp-24,314-14;CP 24315-1;pirbuterol acetate salt;LS-176523;CP-24,314-1;Pirbuterol Acetate;2-HYDROXYMETHYL-3-HYDROXY-6-(1-HYDROXY-2-TERT-BUTYLAMINOETHYL)-PYRIDINE, ACETATE;pirbuterolum;pyrbuterol;pirbuterol;PIRBUTEROL ACETATE;CIPLUS_179342;Pirbuterol acetate;LS-131417;Pirbuterol hydrochloride;pirbuterol dihydrochloride;Pirbuterol;2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-tert-butylamino ethyl)pyridine, dihydrochloride;	0	-2.29272701					Cl.Oc1ccc(nc1CO)C(O)CNC(C)(C)C	NCI		-3.05903027	-1.84573448	-0.90715173	-2.40628581	0.61545042	-6.62344983	-2.29272701									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00538143-01	NCGC00538143-01		surfactant homeostasis Activator	DPI_SARS-CoV-2_General	2019_NPC_02			8.7913490634	-5.0559444758	-56.8811683703	-2.2	7		-87.8734956927	-76.04052704	0.0000283789	0.9978176722			O[C@H]1CC[C@@H](CC1)NCC2=CC(=CC(=C2O)Br)Br	Pharmaron	PH-NIH-2017-009-L1-3-0	4.63132096	0.20559495	1.9572912	2.312747	-0.57743032	-32.41262683	-76.04052704									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00186014-02	Paliperidone	170464996	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	144598-75-4				1.2075665701	4	7		0	-4.85658564					CC=5N=C1[C@H](O)CCCN1C(=O)C=5CCN2CCC(CC2)c4noc3cc(F)ccc34	Tocris	4493	-1.32951051	2.91760031	2.02292492	4.25367724	1.28555474	-2.28297632	-4.85658564									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00182710-02	Flurbiprofen axetil	144206486		DPI_SARS-CoV-2_General	2019_NPC_02	91503-79-6				5.758399255	4	7	Flurbiprofen Axetil;CIPLUS_701423;Flurbiprofen axetil;FLURBIPROFEN AXETIL;Ropion;FP83;FP 83;FP-83;1-acetoxyethyl-2-(2-fluoro-4-biphenyl)propionate;	0	1.731437					Fc2cc(ccc2c1ccccc1)C(C)C(=O)OC(C)OC(C)=O	ACC	Flurbiprofen Axetil	1.61622234	1.30518145	4.05757015	0	0	0	1.731437									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181356-02	Oxapium iodide	170465824		DPI_SARS-CoV-2_General	2019_NPC_01	6577-41-9				-6.1797265286	4	7		0	-3.46759271					[I-].C[N+]1(CCCCC1)CC2COC(O2)(C3CCCCC3)c4ccccc4	APAC	877482	0.47684748	-2.0060107	-1.85469523	-2.18476434	-2.17479572	1.53463082	-3.46759271									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015735-11	Niclosamide	170465184	STAT-3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	50-65-7	 Yomesan;Niclosamide; Niclosamida;NICOLSAMIDE; ; Bayluscide;NICLOSAMIDE; Niclocide; Phenasal; Fenasal; Niclosamid; Radewerm; Bayer 73; Bayer 2353; Niclosamide; Clonitralide; Niclosamidel; Devermine; Niclosamide-olamine; Tr??d??mine	3.0225050719	-5.5196329617	-99.7397033498	-2.2	7		-67.3840655248	-61.97561532	0.0002045564	0.9941055709	6774	STAT3	Clc2cc(ccc2NC(=O)c1cc(Cl)ccc1O)[N+]([O-])=O	Vitas	STK396676	-2.30677995	-4.21970826	-5.19850844	-4.60280432	-17.58869208	-36.40428884	-61.97561532									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00013082-04	trans-Aconitic acid	170466847	Cytoplasmic aconitate hydratase Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	4023-65-8				-26.8735065314	4	7		0	-5.86550404			48	ACO1	OC(=O)C(\CC(=O)O)=C\C(=O)O	Specs	AE-562/J255898	-4.0883015	-4.72304347	-5.75418586	-6.87034389	-4.34705375	-8.36932771	-5.86550404									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091038-04	Sodium deoxycholate monohydrate	225144203		DPI_SARS-CoV-2_General	2019_NPC_01	145224-92-6		13.9333492831	-4.8559444758	-17.7037870406	4	7		-13.527571204	-13.34313452	0.0499211971	0.892852585			C[C@H](CCC([O-])=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C	SIGMA	D5670	-2.24384576	-0.43247734	-4.02378689	-3.71986856	-0.40349185	-4.50734285	-13.34313452									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021152-06	Hydroxyzine	170464958	antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC_01	68-88-2		4.4061119169	-5.3559444758	-103.7043521351	-2.1	7		-82.2546514727	-83.15125092	0.0000217891	0.9980885729			Clc1ccc(cc1)C(c2ccccc2)N3CCN(CC3)CCOCCO	Microsource	01500345	-5.8456176	-1.69814548	-4.28700251	-3.2984674	-13.98517992	-56.73560648	-83.15125092									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016951-05	Clebopride maleate	170465853	Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	84370-95-6				-0.7491608852	4	7		0	-2.37763301					O=C(O)/C=C\C(=O)O.Clc1cc(c(OC)cc1N)C(=O)NC3CCN(Cc2ccccc2)CC3	Prestwick	Prestw-380	0.74552804	0	0	0	0	0	-2.37763301									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179431-03	Carbenoxolone sodium	170465951	gap junction assembly Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	7421-40-1		13.9333492831	-4.8559444758	-40.7216190748	-3	7		-40.0008977161	-41.10415452	0.0003682053	0.9920692171			[Na+].[Na+].[O-]C(=O)CCC(=O)O[C@H]4CC[C@]3(C)[C@H]5C(=O)C=C1[C@@](C)(CC[C@@]2(C)CC[C@@](C)(C[C@@H]12)C([O-])=O)[C@]5(C)CC[C@H]3C4(C)C	Prestwick Chemical, Inc.	Prestw-837	-3.90434004	-4.11219977	-5.59333187	-4.45230391	-1.52007309	-7.79002998	-41.10415452									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015257-14	Clofibrate	170465329	PPARalpha Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	637-07-0	 ; Aluminium clofibrate; Miscleron; Athromidin; Atromid-S; Atromid S; Miskleron; Clofibrate;Clofibrate; Clofibrato; Atromid;CLOFIBRATE			2.4870590071	4	7		0	0			5465	PPARA	Clc1ccc(OC(C)(C)C(=O)OCC)cc1	Microsource	01503429	2.59724542	0.8918318	2.10816212	-0.46905962	-4.7835355	3.29285025	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379076-01	Maxacalcitol-D6		Vitamin D receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02			11.0676527398	-4.9559444758	-6.0910946983	4	7		-29.3267849479	-25.27232079	0.0018588969	0.9818911108			C[C@H](OCCC(C([2H])([2H])[2H])(C([2H])([2H])[2H])O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)C[C@H](O)C3=C	MedChem Express	HY-15329	2.84630859	0.19404468	4.72328356	2.27065454	3.69032626	-3.2882375	-25.27232079									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00014617-01	Benzylhydrochlorothiazide	144203604		DPI_SARS-CoV-2_General	2019_NPC_02	1824-50-6	Benzylhydrochlorothiazide; Behyd; BHCTh; 	11.0676527398	-4.9559444758	-43.1227820251	4	7	6-Chloro-3,4-dihydro-3-(phenylmethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide;Behyd;Benzylhydrochlorothiazide;LS-40438;BENZYLHYDROCHLOROTHIAZIDE;BHCTh;CIPLUS_208144;benzylhydrochlorothiazide;2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-(phenylmethyl)-, 1,1-dioxide;	-25.6821307319	-26.79446321	0.0028414042	0.9774701114			NS(=O)(=O)c3cc1c(NC(NS1(=O)=O)Cc2ccccc2)cc3Cl	NCI		-5.10763255	-6.46584583	-6.11096786	-2.8926876	-7.22144334	-13.84817738	-26.79446321									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178433-02	HYDROXYAMPHETAMINE HYDROBROMIDE		Adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	306-21-8, 1518-86-1 [hydroxyamphetamine]				7.701620595	4	7		0	1.56019598					CC(N)CC1=CC=C(O)C=C1	Microsource	00211425	1.95842678	0	2.25733105	2.03213058	1.82734121	1.82732056	1.56019598									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386567-02	FLIBANSERIN		Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	167933-07-5		11.0676527398	-4.9559444758	-22.6580231814	-3	7		-42.1404889859	-37.60643105	0.0005112831	0.9906316358			FC(F)(F)C1=CC(=CC=C1)N2CCN(CC2)CCN3C(=O)NC4=CC=CC=C34	SIGMA	SML0797	0	0	0	2.16776185	3.34814533	-9.56407366	-37.60643105									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167982-04	Pirarubicin			DPI_SARS-CoV-2_General	2019_NPC_01	72496-41-4		0.5546966259	-6.2559444758	-180.3506774329	-1.1	7		-105.455486553	-93.12311475	0.0000262948	0.9978994524			[H][C@]1(N)C[C@]([H])(O[C@@]2([H])C[C@@](O)(CC3=C(O)C4=C(C(=O)C5=C(OC)C=CC=C5C4=O)C(O)=C23)C(=O)CO)O[C@@]([H])(C)[C@@]1([H])O[C@@]6([H])CCCCO6	SIGMA	P8624	0.93675114	2.67060864	-11.13548293	-34.46208644	-61.34345024	-84.46059251	-93.12311475									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249928-01	Eicosapentaenoic acid ethyl ester	170466007		DPI_SARS-CoV-2_General	2019_NPC_01	73310-10-8		22.0828704269	-4.6559444758	-6.5114597971	4	7		-18.78468226	-16.07056855	0.0002637382	0.9933241253			O=C(/C=C\C=C/C=C\C=C/C=C\CCCCCCCCC)OCC	GVK	FFS-11-286-NCI-230	0	0	0.59954668	0	1.2536162	0.9553331	-16.07056855									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167422-01	Enflurane	144205979	Glycine receptor Positive Allosteric Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	13838-16-9	Enflurane; Ethrane; Enflurano; Pisa Brand of Enflurane; Enlirane; Zeneca Brand of Enflurane; Etran; Abbott Brand of Enflurane; Alyrane; Enfran; 			-3.2615167135	4	7	enfluranum;LS-7376;Enfran;ENFLURANE;Alyrane;Etran;Zeneca Brand of Enflurane;Ethane, 2-chloro-1-(difluoromethoxy)-1,1,2-trifluoro-;Enflurano;Baxter Anaesthesia Brand of Enflurane;CIPLUS_169039;HS_566;Pisa Brand of Enflurane;Enlirane;Enflurane;Ethrane;AstraZeneca Brand of Enflurane;nsc-115944;Enfluranum;Abbott Brand of Enflurane;enflurane;	0	-0.52799315					FC(Cl)C(F)(F)OC(F)F	Alfa Aesar	L16725	-0.20116072	-0.20559495	-1.69006821	-0.99852676	-0.47287503	-0.70462232	-0.52799315									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378920-01	Falecalcitriol			DPI_SARS-CoV-2_General	2019_NPC_02	83805-11-2		4.9437388825	-5.3059444758	-67.771301334	-2.2	7		-83.010607432	-65.84217286	0.00024179	0.993585315			C[C@H](CCCC(O)(C(F)(F)F)C(F)(F)F)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C3\C[C@@H](O)C[C@H](O)C3=C	MedChem Express	HY-32342	4.57582834	4.27591305	0.02109655	2.626102	-17.20647292	-41.45997745	-65.84217286									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178874-03	DL-Carnitine HCl		Mitochondrial carnitine/acylcarnitine carrier protein Substrate	DPI_SARS-CoV-2_General	2019_NPC_02	461-05-2				-31.1685571463	4	7		0	-5.62717024			788	SLC25A20	C[N+](C)(C)CC(O)CC(O)=O	Selleck	S2293	-7.84064371	-6.26256093	-7.76118703	-7.02242593	-3.88517929	-7.82130778	-5.62717024									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181082-01	Benzactyzine methobromide	144206254	Muscarinic acetylcholine receptor M4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	3166-62-9	Methylbenactyzium bromide; 	8.7913490634	-5.0559444758	7.556558203	4	7	diethyllachesine;diethyllachesine bromide;Methylbenactyzium Bromide;Methylbenactyzium bromide;CIPLUS_777361;diethyllachesine iodide;Ethanaminium, N,N-diethyl-2-((hydroxydiphenylacetyl)oxy)-N-methyl-;methylbenactyzium bromide;METHYLBENACTYZIUM BROMIDE;BENACTYZINE METHOBROMIDE;CIPLUS_161517;Bromure de methylbenactyzium;filcilin;methylbenactyzii bromidum;CIPLUS_3883265;bromure de methylbenactyzium;Methylbenactyzii bromidum;CIPLUS_157705;2-diethylaminoethyldiphenylglycolate methylbromide;Bromuro de metilbenacticio;(2-benziloyloxyethyl)diethylmethylammonium iodide;	-13.3258336079	-8.60486134	0.0005267144	0.990552685			OC(C(=O)OCCN(CC)CC)(c1ccccc1)c2ccccc2.BrC	NCI	NSC-11525	4.09489237	3.40733212	3.1996437	3.72985993	4.04676473	-1.04753852	-8.60486134									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178734-06	Sitagliptin		DPP-IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	654671-77-9				-36.8530471168	4	7		0	-9.34690577				DPP4	N[C@@H](CC(=O)N1CC[N]2C(=NN=C2C(F)(F)F)C1)CC3=C(F)C=C(F)C(=C3)F	Adooq	A10848	-4.59895026	-9.80618633	-10.12868897	-8.19633796	-5.76717439	-7.31867719	-9.34690577									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167528-02	Alosetron hydrochloride	170465416	Serotonin 3a (5-HT3a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	122852-69-1		13.9333492831	-4.8559444758	-58.2761580695	4	7		-18.4596669	-23.98801313	0.0069269901	0.9641731942			Cl.Cc4ncnc4CN1CCc3c(C1=O)c2ccccc2n3C	Sequoia	SRP04894a	-10.0048556	-8.60495738	-9.74426291	-12.0501368	-10.35334933	-14.83934611	-23.98801313									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159366-02	m-Cresol	29215286		DPI_SARS-CoV-2_General	2019_NPC_02		3-Methylphenol-d8; m-Cresol-d8; 			8.4693642541	4	7	3-Methylphenol-d8;3-cresol, sodium salt;CIPLUS_723418;CIPLUS_151039;CIPLUS_3741557;3-cresol;NCGC00159366-04;NCGC00159366-05;CIPLUS_3755532;m-Cresol;NCGC00159366-03;meta-cresol;Methylphenol tricresol;CRESOL, M-;CIPLUS_719811;3-Methylphenol;NCGC_FLUKA_61020;Cresol mixture of isomers;CIPLUS_161251;LS-460;Metacresol;3-cresol, calcium salt(1:2);m-Cresol-d8;m-Cresylic acid;CIPLUS_746155;3-methylphenol;	0	3.743519					CC1=CC(O)=CC=C1	Labotest	LTBB001401	3.31337141	4.20199127	0	0	1.88437136	0	3.743519									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263539-01	Ziprasidone	170465342	5-HT2A Antagonists?	DPI_SARS-CoV-2_General	2019_NPC_02	146939-27-7	Ziprasidone hydrochloride;Ziprasidone  Hydrochloride	6.2237985085	-5.2059444758	-77.0368387835	-2.2	7		-76.9080768634	-67.90182181	0.0004866949	0.9908583146	3356	HTR2A	O=C4Cc5cc(CCN1CCN(CC1)c3nsc2ccccc23)c(Cl)cc5N4	Prestwick Chemical, Inc.	Prestw-1188	1.82894402	-2.09984061	-2.55268278	-3.05638052	-16.49359599	-36.5792935	-67.90182181									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183881-09	Moxifloxacin hydrochloride		DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	186826-86-8				-43.4467157905	4	7		0	-14.01798031				TOP2B	COC1=C(N2C[C@@H]3CCCN[C@@H]3C2)C(=CC4=C1N(\C=C(\C(O)=O)C4=O)C5CC5)F	MedChem Express	HY-66011	-6.77703531	-7.23740442	-9.52860927	-9.8940673	-7.26896847	-11.09075536	-14.01798031									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015501-09	Apresoline	170464806	Smooth Muscle Relaxant	DPI_SARS-CoV-2_General	2019_NPC_01	304-20-1	 Hydrochloride, Hydralazin; ; Apressoline; Rolazine;Hydralazine?HCl; Apressin; Hydrazinophthalazine; Hipoftalin;HYDRALAZINE HYDROCHLORIDE; Hidralazina; Hydralazine hydrochloride;Hydralazine hydrochloride; Nepresol; Apresoline			12.3884410553	4	7		0	-0.31938354				SMO	Cl.NNc2nncc1ccccc12	Microsource	01500334	1.699223	3.83365504	3.35599912	3.46401786	2.8041415	3.72986432	-0.31938354									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00016394-10	2-Hydroxy-4-methoxybenzophenone	170465010		DPI_SARS-CoV-2_General	2019_NPC_01	131-57-7		15.6334750258	-4.8059444758	-23.6738051902	-3	7		-54.2641377906	-51.54748929	0.0000844988	0.996225205			O=C(c1ccc(cc1O)OC)c2ccccc2	Vitas	STK057962	0	1.36584651	0.4508786	-0.10785863	3.49946709	-0.18801768	-51.54748929									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023217-08	Meclofenamate sodium	170464886	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	6385-02-0		12.4181106199	-4.9059444758	-19.4435166003	4	7		-23.666586396	-23.47215533	0.0016422436	0.98302523			[Na+].O.Clc2ccc(C)c(Cl)c2Nc1ccccc1C([O-])=O	Microsource	01500377	-1.20785225	0.19302661	-1.39163072	-3.29345072	-0.54052682	-3.90771889	-23.47215533									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00247665-04	Anagrelide hydrochloride	170465269	Phosphodiesterase III (PDE3) inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	58579-51-4		4.7903477126	-5.3196329617	-7.3986788755	4	7		-20.1644825239	-17.63706877	0.0001603943	0.9947998151			Cl.Oc1cn2Cc3c(Nc2n1)ccc(Cl)c3Cl	Microsource	01505590	2.86834653	2.05976495	2.6687139	1.88376351	3.50961782	-1.34661314	-17.63706877									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00181040-02	dl-Coniine	170465693	Nicotinic acetylcholine receptor alpha1/beta1/gamma/delta Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	3238-60-6				8.8264750373	4	7		0	0.90745482					CCCC1CCCCN1	Specs	AE-562/J259451	2.36487304	1.46846825	3.50710438	0.23327564	0.86027509	3.58249911	0.90745482									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018284-06	MEPIVACAINE HYDROCHLORIDE		Sodium channel protein type X alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	1722-62-9				-13.7120460328	4	7		0	-3.99989861					CN1CCCCC1C(=O)NC2=C(C)C=CC=C2C	SIGMA	M3189	-4.79025972	-1.96691671	-3.42424021	-1.79346327	-3.0680607	-1.70740383	-3.99989861									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274084-01	DL-Isoleucine	170465505		DPI_SARS-CoV-2_General	2019_NPC_01	443-79-8				0.5613567548	4	7		0	-3.18369623					CC(CC)C(N)C(=O)O	SIGMA	I2752	0.0847191	-1.90827571	0.74821476	-0.28344245	3.05790996	1.50922303	-3.18369623									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165979-06	CINNAMIC ACID			DPI_SARS-CoV-2_General	2019_NPC_02	621-82-9				-13.139607532	4	7		0	-6.37872806					OC(=O)\C=C\C1=CC=CC=C1	Microsource	00270092	-3.38736156	-2.90836009	-0.86964675	-3.95435306	-0.16396169	-2.9735062	-6.37872806									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00183873-03	Granisetron·HCl			DPI_SARS-CoV-2_General	2019_NPC_02	107007-99-8				7.5352759483	4	7		0	1.24149741					CN1N=C(C(=O)NC2C[C@H]3CCC[C@H](C2)N3C)C4=C1C=CC=C4	Enzo	DL166	4.7654281	0	0.50866131	3.84678343	0	0.87373168	1.24149741									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179357-05	PREDNICARBATE		Glucocorticoid Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	73771-04-7		12.4181106199	-4.9059444758	-40.8049733486	-2.2	7		-57.3703800563	-44.59877277	0.0000455197	0.9972345568			CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(=O)CC	Microsource	01503876	1.20002775	-0.85241054	-1.72288507	-0.61034072	-3.91844688	-18.79932356	-44.59877277									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167423-01	Bevonium metilsulfate	144205980	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	5205-82-3	BEVONIUM METILSULFATE; Acabel; Metilsulfato de bevonio; 			-6.9590463486	4	7	Bevonii metilsulfas;Bevonium Methylsulfate;bevonii metilsulfas;bevonium;CIPLUS_213756;metilsulfate de bevonium;Metilsulfate de bevonium;LS-116671;Bevonium methylsulfate;Benzilsaeure-(N,N-dimethyl-2-hydroxymethyl-piperidinium)-ester-methylsulfat (German);piribenzil methyl sulfate;bevonium methyl sulfate;BEVONIUM METHYLSULFATE;2-(HYDROXYMETHYL)-1,1-DIMETHYLPIPERIDINIUM METHYLSULFATE, BENZILATE;BEVONIUM METILSULFATE;CG 201;2-(hydroxymethyl)-N,N-dimethylpiperidinium benzilate;Bevonium metilsulfate;Metilsulfato de bevonio;CIPLUS_3883657;CIPLUS_173844;Acabel;bevonium methylsulfate;bevonium sulfate (1:1);Piperidinium, 2-hydroxymethyl-1,1-dimethyl-, methanesulfonate, benzilate;	0	-3.89097655					[O-]S(=O)(=O)OC.OC(C(=O)OCC1CCCC[N+]1(C)C)(c2ccccc2)c3ccccc3	Apollo	OR3501T	-1.4497445	-2.65887408	-0.84620614	-1.1528658	-1.4946653	0.53551297	-3.89097655									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482904-01	Capromorelin		Ghrelin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	193273-66-4				-5.3947458781	4	7		0	-7.23017647					CN1\N=C2\CCN(C[C@]2(CC3=CC=CC=C3)C1=O)C(=O)[C@H](COCC4=CC=CC=C4)NC(=O)C(C)(C)N	DC Chemicals	DC7615	1.32488612	-2.54799141	1.51191955	0.32037041	0.02613882	-2.86076663	-7.23017647									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095157-05	Oxfendazole	170466223	antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC_01	53716-50-0	; OXFENDAZOLE;OXFENDAZOLE;Oxfendazole; ; Synanthic; Oxfendazol	5.5469662594	-5.2559444758	-56.6895396199	4	7		-26.3180097119	-25.59630935	0.003430675	0.9751709308		TUBB	O=C(OC)Nc1nc2cc(ccc2n1)S(=O)c3ccccc3	Vitas	STK378905	-6.38297872	-6.16463459	-7.36760011	-10.55760403	-14.48256611	-17.04863052	-25.59630935									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095045-05	Sulfanitran	170466141	Eimeria tenella Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	122-16-7		8.7913490634	-5.0559444758	-0.5992984343	4	7		-16.3437301919	-12.36977516	0.0061334747	0.9663782203			O=S(=O)(Nc1ccc(cc1)[N+]([O-])=O)c2ccc(NC(C)=O)cc2	Microsource	01503339	2.89739307	3.89718279	0.39482343	2.95733313	2.16972035	-3.75019056	-12.36977516									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016255-10	SULFINPYRAZONE	170464677	Canalicular Multispecific Organic Anion Transporter 1 Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	57-96-5		15.6334750258	-4.8059444758	-30.4319612325	-3	7		-51.781564468	-43.56797039	0.0011600834	0.9857731078			O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1	Microsource	01500554	0	0.10506512	-1.33313836	2.29513131	-4.36227986	-7.3784237	-43.56797039									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017245-10	Ellagic acid	170466649	Aldose Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	476-66-4	; Elagostasine; Acid, Ellagi; Acido elagico;ELLAGIC ACID; Acid, Benzoari;Ellagic Acid; EADME cpd;Ellagic acid; Ellagic acid hydrate	5.3748585361	-5.2696329617	-49.4888188341	-2.2	7		-51.105624702	-38.71638235	0.0024702977	0.9790109312	231	AKR1B1	Oc1c4OC(=O)c2cc(O)c(O)c3OC(=O)c(cc1O)c4c23	Vitas	STK801964	4.57241062	-0.2418941	-0.54836587	-3.5041513	-5.48901183	-17.59743889	-38.71638235									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00183276-01	Hydrocortisone buteprate	144206491		DPI_SARS-CoV-2_General	2019_NPC_02	72590-77-3				-13.6267533803	4	7	PANDEL;TS-408;HYDROCORTISONE PROBUTATE;Pandel;CIPLUS_189796;hydrocortisone 17-butyrate 21-propionate;LS-54998;Hydrocortisone Butyrate Propionate;Hydrocortisone butyrate propionate;HYDROCORTISONE BUTEPRATE;Hydrocortisone probutate;hydrocortisone buteprate;17-BUTYRYLOXY-21-PROPIONYLOXY-HYDROCORTISONE;Hydrocortisone buteprate;	0	-2.7826666					CCC(=O)OCC(=O)[C@@]4(OC(=O)CCC)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	ACC	HYDROCORTISONE PROBUTATE	-4.15500936	-1.36062279	-4.77954103	-3.95435306	-3.16754984	-0.70462232	-2.7826666									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00378691-02	Asunaprevir (BMS-650032)		Solute carrier organic anion transporter family member 2B1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	630420-16-5		8.7913490634	-5.0559444758	-55.3946864195	-2.2	7		-58.0762656511	-55.75322266	0.0002691586	0.9932292383			COC1=CN=C(O[C@@H]2C[C@H](N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)N[C@@]3(C[C@H]3C=C)C(=O)N[S+]([O-])(=O)C4CC4)C5=CC(=CC=C15)Cl	Adooq	A11295	-1.81507087	-4.69172307	-2.59018776	-3.41650492	-0.84832355	-23.89609169	-55.75322266									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179312-03	Cyclopenthiazide	170466046	Solute carrier family 12 member 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	742-20-1		7.8352981002	-5.1059444758	-11.7246809562	4	7		-18.5066593679	-16.67221614	0.0134491982	0.9487233405	6559	SLC12A3	NS(=O)(=O)c3cc1c(NC(NS1(=O)=O)CC2CCCC2)cc3Cl	Prestwick Chemical, Inc.	Prestw-994	1.2139009	0.95405299	0.50866131	-2.06019222	2.6732885	-7.45020669	-16.67221614									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166015-02	C.I. Basic Violet 14	124893209		DPI_SARS-CoV-2_General	2019_NPC_02			1.3933349283	-5.8559444758	-145.8542436319	-1.1	7		-103.9030347747	-96.72739381	0.0000010105	0.9995893672			CC1=CC(=CC=C1N)C(C2=CC=C(N)C=C2)=C/3\C=C/C(=N)/C=C3	SigmaAldrich	B0904	1.8058221	3.36575111	0.04922529	-12.44299979	-46.51997244	-81.95697106	-96.72739381									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249934-01	Tolciclate	170465866		DPI_SARS-CoV-2_General	2019_NPC_01	50838-36-3		12.4181106199	-4.9059444758	-9.9246255586	-3	7		-34.155686804	-31.79640567	0.0016431151	0.9829975285			Cc1cc(ccc1)N(C)C(=S)Oc2ccc4c(c2)C3CCC4C3	GVK	FFS-11-286-NCI-238	0	1.40982725	4.54534376	3.33107583	0	0.49799278	-31.79640567									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015714-16	Nimodipine	170466561	Voltage-gated L-type calcium channel Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	66085-59-4		11.0676527398	-4.9559444758	-56.53882386	-2.2	7		-73.6504524623	-55.79579732	0.0005480012	0.9902916747			CC=1NC(C)=C(C(C=1C(=O)OC(C)C)c2cccc(c2)[N+]([O-])=O)C(=O)OCCOC	SigmaAldrich	N149	-1.15460025	1.22413077	2.73208062	-5.00915544	-9.46302594	-27.18125921	-55.79579732									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018186-07	Procyclidine hydrochloride	170464805	Muscarinic acetylcholine receptor M4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	1508-76-5				-37.0876294707	4	7		0	-13.6523789					Cl.OC(CCN1CCCC1)(c2ccccc2)C3CCCCC3	Microsource	01500507	-8.62440394	-3.07620886	-11.86663742	-4.77337146	-5.14388672	-9.54316784	-13.6523789									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378622-03	Osimertinib mesylate		EGFR (Thr790Met Mutant) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1421373-65-0		1.9681378985	-5.7059444758	-135.5816470933	-1.1	7		-99.9922418271	-94.88655282	4.065E-7	0.9997396149		EGFR	COC1=C(NC2=NC=CC(=N2)C3=C[N](C)C4=C3C=CC=C4)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C	Axon Medchem	2342	1.69021249	1.71175125	-1.32908277	-9.02883334	-37.96544923	-77.46617813	-94.88655282									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379061-01	Umeclidinium bromide		Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	869113-09-7		9.8640558873	-5.0059444758	-44.5081744073	4	7		-18.95273406	-22.35646673	0.0203721833	0.9356286873	1131	CHRM3	OC(C1=CC=CC=C1)(C2=CC=CC=C2)C34CC[N+](CCOCC5=CC=CC=C5)(CC3)CC4	MedChem Express	HY-12100	-4.06252168	-8.57723671	-6.08752725	-8.37873863	-6.3232184	-13.51465614	-22.35646673									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00250399-08	Vemurafenib		Raf kinase B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1029872-54-5		3.499899101	-5.4559444758	-60.5264496244	-2.2	7		-54.776863434	-53.3130381	0.0000087203	0.9987923948		BRAF	CCC[S+]([O-])(=O)NC1=CC=C(F)C(=C1F)C(=O)C2=C[NH]C3=NC=C(C=C23)C4=CC=C(Cl)C=C4	Bio Vision	2235	0	0.84086026	0	1.5363749	-8.65194972	-40.12119504	-53.3130381									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179250-03	Halofantrine	170465140	antimalarial agents	DPI_SARS-CoV-2_General	2019_NPC_02	36167-63-2	; Halfan;HALOFANTRINE HYDROCHLORIDE; Halofantrina;Halofantrine hydrochloride;Halofantrine			1.950759042	4	7		0	-2.75412643					Cl.CCCCN(CCCC)CCC(O)c2cc1c(Cl)cc(Cl)cc1c3cc(ccc23)C(F)(F)F	Prestwick Chemical, Inc.	Prestw-1031	0.19191195	-0.2240754	-1.36658775	-3.29958141	4.74538412	4.83370913	-2.75412643									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090957-05	Octanoic acid		Solute carrier family 22 member 8 Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	124-07-2				9.1118131558	4	7		0	3.92385491					CCCCCCCC(O)=O	SIGMA	C2875	0	3.16417035	0.96268675	0	1.23077704	4.72076833	3.92385491									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015862-07	Pyridostigmine bromide	170464878	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	101-26-8				8.6238153571	4	7		0	0.3041748					[Br-].O=C(Oc1ccc[n+](C)c1)N(C)C	Specs	AQ-776/42801589	2.57788105	0	0	3.18308375	3.05790996	3.37415519	0.3041748									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091400-02	Allylthiourea	170465680		DPI_SARS-CoV-2_General	2019_NPC_01	109-57-9				-10.2199434071	4	7		0	-7.0669945					NC(=S)NCC=C	Labotest	LT00025093	-2.21479922	0.37383634	-0.94806366	-3.6847518	-2.00730853	-0.87910971	-7.0669945									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160615-03	Sucrose octaacetate	170465525		DPI_SARS-CoV-2_General	2019_NPC_01	126-14-7				8.4338464107	4	7		0	-1.90616207					CC(=O)O[C@H]1[C@H](O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)O[C@]2(COC(C)=O)O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]2OC(C)=O	SIGMA	252603	3.42507201	-0.30542185	3.32675294	0.29347581	4.88504289	1.98688958	-1.90616207									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178810-03	Novobiocin sodium	170465360	Heat Shock Protein 90 (hsp90) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	1476-53-5		8.7913490634	-5.0559444758	-84.5689209498	-2.2	7		-48.8908309044	-53.12412867	0.0026896027	0.9780618899		HSP90AB1	[Na+].C/C(C)=C\Cc1cc(ccc1O)C(=O)NC3=C([O-])c4ccc(O[C@@H]2OC(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@H]2O)c(C)c4OC3=O	Microsource	01500444	-8.57115194	-15.11227307	-7.69418245	-8.58103193	-11.79262041	-29.44763453	-53.12412867									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015279-08	Meclofenoxate hydrochloride	170465815		DPI_SARS-CoV-2_General	2019_NPC_01	3685-84-5		22.0828704269	-4.6559444758	-10.4892710456	4	7		-16.12997136	-14.6916428	0.0214655268	0.9338110574			Cl.Clc1ccc(OCC(=O)OCCN(C)C)cc1	Microsource	01503226	0.4139133	-2.48002541	-1.79132851	-1.72824642	1.30690758	0.37095381	-14.6916428									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00373228-02	Fluorometholone Acetate	363678077		DPI_SARS-CoV-2_General	2019_NPC_02	3801-06-7		15.6334750258	-4.8059444758	7.0768942178	4	7		-12.220663088	-6.01721924	0.0165901848	0.9430900186			C[C@H]\1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]4(C)\C=C/C(=O)/C=C14	Selleck	S4228	3.36423964	4.18351082	2.64644523	2.8693029	1.10020673	0.6059752	-6.01721924									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378916-02	MK-5172			DPI_SARS-CoV-2_General	2019_NPC_02	1350514-68-9		13.9333492831	-4.8559444758	-47.758286951	-2.2	7		-57.7173844103	-47.14360462	0.0000347219	0.9975861347			COC1=CC2=C(C=C1)N=C3CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N5C[C@@H](C[C@H]5C(=O)N[C@@]6(C[C@H]6C=C)C(=O)N[S+]([O-])(=O)C7CC7)OC3=N2)C(C)(C)C	MedChem Express	HY-15298	-1.26014474	-2.19686294	-2.64175711	-4.21626172	-4.83568187	-17.6578354	-47.14360462									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185755-03	Cefatrizine			DPI_SARS-CoV-2_General	2019_NPC_02	51627-14-6		15.6334750258	-4.8059444758	6.1297375665	4	7		-11.228797036	-8.52399753	0.0358672334	0.9117280199			[H][C@](N)(C(=O)N[C@]1([H])C(=O)N2\C(C(O)=O)=C(CSC3=CNN=N3)/CS[C@]12[H])C4=CC=C(O)C=C4	DC Chemicals	DC9221	4.25212144	4.19737116	1.35486744	2.45773215	0.76277832	2.31116122	-8.52399753									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00238451-11	Olaparib		PARP Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	763113-22-0				-8.610040832	4	7		0	-1.14636351				PARP1	FC1=C(C=C(C/C2=N/NC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5	Adooq	A10111	-1.26476913	-2.27540484	-3.67314409	-3.99176858	0.35406221	-0.63885757	-1.14636351									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185750-01	Astromicin	144206938	Bacterial 70S ribosome Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_02	55779-06-1		13.9333492831	-4.8559444758	-19.1783390027	-2.4	7		-32.876088088	-29.06340674	0.00004903	0.9971318032			NCC(=O)N(C)[C@H]2[C@@H](O)[C@H](O[C@H]1O[C@@H](CC[C@H]1N)[C@H](C)N)[C@@H](N)[C@H](O)[C@@H]2OC	Sequoia	ASTROMICIN SULPHATE	0	0	0	0.55889437	-1.40912007	-4.66459977	-29.06340674									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016281-11	Phenacetin	170465554	Prostaglandin G/H synthase 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	62-44-2				9.597225464	4	7		0	4.69950065			403544	PTGS1	CCOc1ccc(cc1)NC(C)=O	Vitas	STK011463	3.57514584	0	0.70190831	0.70735195	1.87534893	3.44021546	4.69950065									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253581-01	Indomethacin farnesil	170466014		DPI_SARS-CoV-2_General	2019_NPC_01	85801-02-1		15.6334750258	-4.8059444758	-9.6078154108	4	7		-12.4106486479	-12.42554054	0.0242302849	0.9293401625			Clc1ccc(cc1)C(=O)n3c2ccc(cc2c(CC(=O)OC\C=C(/C)CC\C=C(/C)CC\C=C(/C)C)c3C)OC	GVK	FFS-11-286-NCI-252	-3.12008327	-1.06286803	0	0	0.62173273	-0.90959906	-12.42554054									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253595-01	Clocapramine	170465785	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	47739-98-0		9.8640558873	-5.0059444758	-59.4305535238	-2.2	7		-89.8790398239	-69.6053332	0.0000173848	0.9982933382			Clc4ccc5CCc1ccccc1N(CCCN2CCC(CC2)(C(N)=O)N3CCCCC3)c5c4	GVK	FFS-11-286-NCI-179	3.98663859	1.93759621	0	1.01086111	-6.6309699	-32.70999543	-69.6053332									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159451-06	Tinoridine	170465864	lipid oxidation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	24237-54-5		15.6334750258	-4.8059444758	-32.9756074229	-3	7		-39.5717981907	-33.54034118	0.0005587089	0.9902042074			O=C(OCC)c1c2CCN(Cc2sc1N)Cc3ccccc3	Vitas	STK036143	-2.68438506	-0.57419308	-1.66946943	-3.78006873	-4.20494341	-9.05025662	-33.54034118									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018257-08	Methocarbamol	170464808	Muscle relaxant	DPI_SARS-CoV-2_General	2019_NPC_01	532-03-6	 Metocarbamol;;METHOCARBAMOL; Robaxin;Methocarbamol			4.5193521684	4	7		0	1.15079466					NC(=O)OCC(O)COc1ccccc1OC	Microsource	01500397	0.55914603	1.79588047	1.8449465	-0.82022726	2.88027204	-0.645358	1.15079466									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166139-03	3-Hydroxy-4-butyrophenetidide	170465885		DPI_SARS-CoV-2_General	2019_NPC_02	1083-57-4				-19.4183485333	4	7		0	-7.10174571					CCOc1ccc(cc1)NC(=O)CC(C)O	SIGMA	B4027	-2.36074823	-3.81390192	-4.75610042	-4.81958703	-2.73982368	-4.00695227	-7.10174571									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346565-04	Elvitegravir		HIV Integrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	697761-98-1		6.2237985085	-5.2059444758	-94.3856299437	-2.2	7		-67.5250094489	-65.20477572	0.0003929221	0.9917993157			COC1=CC2=C(C=C1CC3=C(F)C(=CC=C3)Cl)C(=O)\C(=C/N2[C@H](CO)C(C)C)C(O)=O	MedChem Express	HY-14740	-4.00702906	-8.25382892	-4.95768969	-11.93321329	-15.81398665	-41.02780909	-65.20477572									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00246969-06	Latanoprost		Prostanoid FP receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	130209-82-4				8.7431522677	4	7		0	-0.71350426					CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC2=CC=CC=C2	SIGMA	L1167	0	3.41195223	2.34171726	4.37527769	1.34258489	2.28767381	-0.71350426									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00538320-01	NCGC00538320-01		Prostamide/prostaglandin F synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			13.9333492831	-4.8559444758	-6.657843043	4	7		-12.572610952	-12.14384246	0.010383205	0.9556028862	127281	FAM213B	OC(=O)C1CCC2=C1C=C(Cl)C(=C2)C3CCCCC3	Pharmaron	PH-NIH-2017-009-L1-7-0	-0.58498462	-1.04645522	1.11342913	1.56911349	-0.85307606	-0.58248779	-12.14384246									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179594-03	Cefotiam hydrochloride	170465103	Escherichia coli Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	66309-69-1				-16.0821266071	4	7		0	-10.36008182					Cl.Nc1scc(n1)CC(=O)N[C@@H]4C(=O)N3C(=C(CSc2nnnn2CCN(C)C)CS[C@@H]34)C(=O)O	Prestwick	Prestw-482	-0.90406715	-6.44274527	-2.81052952	-2.04148446	-0.76277832	-2.25948891	-10.36008182									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274062-01	Zosuquidar trihydrochloride	174006281	P-Glycoprotein (MDR-1) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	167465-36-3	LY335979	5.5469662594	-5.2559444758	-90.6913668576	-2.1	7		-88.038338957	-80.73538505	0.000007859	0.9988535244		ABCBA	Cl.Cl.Cl.FC3(F)[C@@H]2c7ccccc7[C@H](c1ccccc1[C@@H]23)N4CCN(CC4)C[C@@H](O)COc6cccc5ncccc56	Selleck	S1481	-1.0058036	0.68146642	-1.86821687	-4.50623202	-12.95297388	-49.24840286	-80.73538505									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164598-03	CEFPODOXIME PROXETIL			DPI_SARS-CoV-2_General	2019_NPC_02	87239-81-4		12.4181106199	-4.9059444758	-48.7838083402	-2.2	7		-70.5899015423	-59.15901632	0.0006939913	0.9890521635			COCC/1=C(/N2[C@H](SC1)[C@H](NC(=O)C(=N/OC)/C3=CSC(=N3)N)C2=O)C(=O)OC(C)OC(=O)OC(C)C	Microsource	01505637	3.58621009	-3.4396729	-0.95403296	-3.08444216	-1.87486634	-19.29255919	-59.15901632									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016371-08	Diclofenamide		Carbonic Anhydrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	120-97-8				-0.0491753565	4	7		0	-0.99414927				CA1	N[S+]([O-])(=O)C1=CC(=C(Cl)C(=C1)[S+](N)([O-])=O)Cl	APExBIO	A8408	3.55846378	-0.47356141	-1.92447434	-0.04910787	0.00237626	-0.31942879	-0.99414927									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161327-01	Calcitriol	26754891	Vitamin D Analog	DPI_SARS-CoV-2_General	2019_NPC_02	32222-06-3	; ;Calcitriol (Rocaltrol); Receptors, Calcitriol; 1(alpha),25-DIHYDROXYVITAMIN D3;Calcitriol; Calcitriol	15.6334750258	-4.8059444758	-65.7675514892	-2.2	7	Receptors, Calcitriol;Calcitriolum;9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1alpha,3beta,5Z,7E)-;1alpha,25-Dihydroxyvitamin D3;RO-21-5535;CIPLUS_177636;Calcitriol;1,25-dihydroxyvitamin D3 monoglucuronide;1(alpha),25-DIHYDROXYVITAMIN D3;calcitriol glycoside;1,25-DIHYDROXY VITAMIN D3;CIPLUS_701127;1,25-DVDMG;calcitriolum;NCGC00161327-02;NCGC00161327-03;1 alpha,25-dihydroxy-previtamin D(3);1,25-dihydroxycholecalciferol glycoside;beta-D-Glucopyranosiduronic acid, (1alpha,3beta,5Z,7E)-dihydroxy-9,10-secocholesta-5,7,10(19)-trienyl;1,25-DIHYDROXYCHOLECALCIFEROL;HS_1248;LS-53093;CIPLUS_710322;1,25-dihydroxy-previtamin D(3);1,25-dihydroxytachysterol;1alpha,25-Dihydroxycholecalciferol;HS_234;9,10-secocholesta-5(10),6,8-triene-1,3,25-triol, (1 alpha,3 beta,6Z)-;Rocaltrol;CALCITRIOL;rocaltrol;1,25-dihydroxy-previtamin D(3), (1alpha,3alpha,6Z)-isomer;CIPLUS_682461;calcitriol;	-72.6622190108	-60.14365219	0.0000275146	0.9978517427	7421	VDR	[H][C@@]12CC[C@H]([C@H](C)CCCC(C)(C)O)[C@@]1(C)CCC\C2=C/C=C3/C[C@@H](O)C[C@H](O)C3=C	BIOMOL	BIOMOL_DM200	-4.93190594	-3.5228349	-6.17660158	-6.12913032	-7.67768458	-20.44344231	-60.14365219									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346704-03	Cabazitaxel		Tubulin depolymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	183133-96-2		11.0676527398	-4.9559444758	-78.9146577563	-2.2	7		-49.7908588193	-47.20544166	0.0000942533	0.9960133087		TUBB	CO[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]3[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)/C(=C(/[C@@H](OC)C(=O)[C@]13C)C5(C)C)C	APExBIO	B2157	-7.51693681	-8.63267805	-10.29277326	-10.86687089	-12.9577264	-27.26888388	-47.20544166									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181774-02	Chrysarobin	170465659		DPI_SARS-CoV-2_General	2019_NPC_01	491-59-8		0.8791349063	-6.0559444758	-144.8016700478	-1.2	7		-77.505523216	-81.06258396	0.0003434701	0.9923382856			Oc2c3c(cc1cccc(O)c12)cc(C)cc3O	Sequoia	491-59-8	-4.01568514	-1.05798128	-4.94016719	-17.32510598	-52.16718266	-66.68021749	-81.06258396									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00092377-04	Apafant	170466052	Platelet activating factor receptor Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	105219-56-5		15.6334750258	-4.8059444758	-29.9304600953	-2.4	7		-32.2630858479	-26.05257154	0.0022527905	0.9800147119			Clc1ccccc1C4=NCc2nnc(C)n2c3sc(cc34)CCC(=O)N5CCOCC5	Tocris	2339	-3.8172004	-1.91316246	0.01706027	-3.6847518	-3.70248186	-10.1936074	-26.05257154									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016760-08	Carbimazole	170465583		DPI_SARS-CoV-2_General	2019_NPC_01	22232-54-8				-15.0157927881	4	7		0	-5.80973866					S=C1N(C=CN1C)C(=O)OCC	Microsource	01505323	-3.25563382	-0.8820583	-2.22027248	-3.95063586	-2.55037304	-4.34473296	-5.80973866									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090903-11	Sulfasalazine	170464716	NFKB Activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	599-79-1	; Sulfasalazine; Azulfidine;Sulfasalazine; Sulfasalazina;Azulfidine; Salazosulfapyridinum; Salicylazosulfapyridine; Sulphasalazine, N-; Sulfasalazine DR; Salazosulfapiridina; Salazopyrine	12.4181106199	-4.9059444758	-44.995492623	-2.2	7		-53.155820936	-42.8835771	0.0000961362	0.9959730432	4790	NFKB1	O=S(=O)(Nc1ccccn1)c3ccc(/N=N/c2cc(C(=O)O)c(O)cc2)cc3	Microsource	01500552	-1.71132573	-1.46846825	-0.79208403	-4.38708706	-4.79368624	-18.93388892	-42.8835771									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00250406-02	Tipifarnib		Farnesyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	192185-72-1		6.2237985085	-5.2059444758	-90.4723124587	-2.1	7		-106.9290538935	-91.60443324	0.0000253364	0.9979382643		COX10	C[N]1C=NC=C1[C@@](N)(C2=CC=C(Cl)C=C2)C3=CC=C4N(C)C(=O)\C=C(\C5=CC=CC(=C5)Cl)C4=C3	Selleck	S1453	3.35961525	-0.13167317	3.04024753	-1.7561911	-13.91298149	-50.85494175	-91.60443324									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182066-02	Fluprednidene acetate	144206681		DPI_SARS-CoV-2_General	2019_NPC_02	1255-35-2	fluprednidene acetate; Decoderm; 			-4.1464866955	4	7	LS-172629;SQ-20918;9A-FLUORO-16-METHYLENEPREGNA-1,4-DIENE-11B,17A,21 TRIOL-3,20-DIONE,21 ACETATE;Decoderm;Fluprednidene acetate;fluprednylidene acetate;CIPLUS_157986;fluprednidene acetate;FLUPREDNIDENE ACETATE;Hermal brand of fluprednidene acetate;Boots brand of fluprednidene acetate;	0	-2.47348143					CC(=O)OCC(=O)[C@@]4(O)C(=C)CC3C2CCC1=CC(=O)C=C[C@]1(C)[C@@]2(F)[C@@H](O)C[C@@]34C	Kemprotec	1255-35-2	-1.60234919	-2.65425397	-1.71819695	0.25957019	0.87683863	0.72341225	-2.47348143									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167506-04	Pimecrolimus		Macrolide Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	137071-32-0		3.9269513795	-5.4059444758	-105.7186533819	-2.2	7		-61.854032036	-67.09318366	0.0001063822	0.9957606388			CC[C@@H]1/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)/C(C)=C/[C@@H]4CC[C@H](Cl)[C@@H](C4)OC	Selleck	S5004	-9.07072996	-4.71482363	-8.51128666	-10.68914716	-17.5296438	-50.42747088	-67.09318366									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378841-01	Levomefolate calcium			DPI_SARS-CoV-2_General	2019_NPC_02	151533-22-1				-8.5300383879	4	7		0	-0.92755553					CN\1[C@@H](CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC\3=C1C(=O)NC(=N3)\N	MedChem Express	HY-17383	-0.05318042	-1.05569544	-0.87433487	-2.89736454	-3.2626001	-2.06219466	-0.92755553									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00016797-11	Amoxicillin sodium		beta-lactam antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	26787-78-0				8.7470381661	4	7		0	-2.22613328					CC1(C)S[C@H]2[C@H](NC(=O)[C@@H](N)C3=CC=C(O)C=C3)C(=O)N2[C@H]1C(O)=O	Selleck	S3015	4.7376818	0	3.76690654	0	2.90140912	2.93592634	-2.22613328									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016508-04	Methazolamide		Carbonic anhydrase XII Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	554-57-4				8.6671188709	4	7		0	2.21661989					CN/1\N=C(/SC1=N\C(C)=O)[S+](N)([O-])=O	Selleck	S4039	3.54459063	0	0	2.59804036	1.17624694	3.52311161	2.21661989									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167470-05	Mezlocillin Sodium		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	42057-22-7				-15.8988479804	4	7		0	-7.08271893					CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCN(C3=O)[S+](C)([O-])=O)C4=CC=CC=C4)C(=O)N2[C@H]1C(O)=O	APExBIO	B4959	-2.24051423	-2.68197464	-4.90612034	-3.55213619	-0.06415892	-4.0257422	-7.08271893									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274270-01	NCGC00274270-01			DPI_SARS-CoV-2_General	2019_NPC_01			12.4181106199	-4.9059444758	-50.5987168459	4	7		-14.2866321359	-21.93100302	0.0101044673	0.9562101007			COC1[C@H](O)CC(=O)O[C@H](C)C/C=C/C=C/C(O)[C@H](C)C[C@H](CC=O)C1OC2OCC(OC3CC(C)(O)C(O)C(C)O3)C(C2O)N(C)C	GVK	FFS-11-286-NCI-160	-7.52547624	-9.66843404	-10.56030806	-7.83856322	-8.88950921	-11.60119925	-21.93100302									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274060-01	Posaconazole	170464963	Lanosterol 14alpha-demethylase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_01	171228-49-2		3.499899101	-5.4559444758	-106.5980994411	-2.1	7		-89.2670933526	-85.00671719	0.0000130796	0.9985200946		CYP51A1	C[C@H](O)[C@H](CC)N1N=CN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OCC6C[C@@](Cn5cncn5)(OC6)c7ccc(F)cc7F	Selleck	S1257	-0.32677365	0.94069929	-0.67509932	-5.33523967	-18.15205806	-64.87626404	-85.00671719									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022662-05	Dexamethasone acetate	170466872	Mineralocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	1177-87-3		13.9333492831	-4.8559444758	2.8044935577	4	7		-8.1773719279	-6.39780994	0.266796236	0.6654645612			CC(=O)OCC(=O)[C@@]4(O)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-130	-0.98516206	0	4.08227925	0	4.64650053	1.06204584	-6.39780994									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182988-01	Acreozast	144206850		DPI_SARS-CoV-2_General	2019_NPC_01	123548-56-1	Acreozast; Acreozst; Adeozast; 			3.0674189317	4	7	LS-172573;Acetamide, N,N'-(2-chloro-5-cyano-1,3-phenylene)bis(2-(acetyloxy))-;Acreozst;CIPLUS_706509;TYB-2285;TYB 2285;Acreozast;acreozast;Adeozast;ACREOZAST;acreozastum;3,5-bis(acetoxyacetylamino)-4-chlorobenzonitrile;	0	-1.69323972					Clc1c(cc(cc1NC(=O)COC(C)=O)C#N)NC(=O)COC(C)=O	Pharmaron	PH-NIH-154940	-0.91254569	1.90338896	-0.09505008	0.76504377	2.21539867	1.76330098	-1.69323972									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183024-01	Proglumetacin	144206876	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	57132-53-3	Proglumetacin; Miridacin; Proglumetacina; 	2.4777388143	-5.6059444758	-106.6340264383	-1.2	7	LS-82118;proglumetacine;Proglumetacinum;proxil;Proglumetacina;Proglumetacin Maleate;Proglumetacin;Proglumetacine;CIPLUS_182770;proglumetacin;Proglumetacin maleate;METACINE-P;LS-175816;Miridacin;PROGLUMETACIN MALEATE;PROTACINE;3'-(4-(2-(1-p-chlorobenzoyl-5-methoxy-2-methylindol-3-ylacetoxy)ethyl)piperazin-1-yl)propyl-4-benzamido-N,N-dipropylglutaramate (+-) dimaleate;PROGLUMETACIN;proglumetacinum;CIPLUS_685564;3-(4-(2-HYDROXYETHYL)-1-PIPERAZINYL)PROPYL DL-4-BENZAMIDO-N,N-DIPROPYLGLUTARAMATE 1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOLE-3-ACETATE;	-86.6203138068	-79.25781349	0.0000948239	0.9959985827			CCCN(CCC)C(=O)C(NC(=O)c1ccccc1)CCC(=O)OCCCN5CCN(CCOC(=O)Cc4c2cc(OC)ccc2n(C(=O)c3ccc(Cl)cc3)c4C)CC5	Pharmaron	PH-NIH-183347	0.2493162	3.25701859	0.99680729	-5.49577345	-23.56240166	-68.24533767	-79.25781349									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389554-01	DORAMECTIN		chloride transmembrane transport Activator	DPI_SARS-CoV-2_General	2019_NPC_02	117704-25-3		2.7800686746	-5.5559444758	-111.5516034166	-1.2	7		-82.1629531769	-77.48656234	0.0000434497	0.9972972685			CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1O)O[C@@H]2[C@H](C)O[C@@H](C[C@@H]2OC)O[C@H]\3[C@@H](C)\C=C\C=C\4CO[C@@H]5C(O)\C(=C/[C@@H](C(=O)O[C@H]6C[C@@H](C/C=C3C)O[C@@]\7(C6)O[C@@H]([C@@H](C)\C=C7)C8CCCCC8)[C@]45O)C	Microsource	01505902	-0.09942426	-2.64501374	-1.72757319	-6.92888712	-24.67742319	-65.10240511	-77.48656234									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00248803-03	DL-Cysteine	170464842		DPI_SARS-CoV-2_General	2019_NPC_02	3374-22-9				6.4228378172	4	7		0	-3.32492984					O=C(O)C(N)CS	Bosche	C2088	0	4.34059461	0	4.11804597	2.25506737	0.98647125	-3.32492984									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274079-01	Sodium urate	170465686		DPI_SARS-CoV-2_General	2019_NPC_02	1198-77-2				-0.6407699325	4	7		0	-2.51629168					[Na+].O=C1NC(=O)NC=2[N-]C(=O)NC1=2	SIGMA	U0881	2.98504012	-0.63988542	-0.76181993	1.52702102	2.99170686	-1.11800075	-2.51629168									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00247735-02	Varenicline tartrate	174007164	Nicotinic alpha3beta4 Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	230615-23-3	Varenicline dihydrochloride;Varenicline tartrate	13.9333492831	-4.8559444758	-12.3431022857	-2.4	7		-31.763402704	-28.13616892	0.0007052507	0.9889734645	1136	CHRNA3	Cl.c1c4c(cc2nccnc12)C3CC4CNC3	Selleck	S1440	-0.03146709	0.84785105	2.0447954	-0.07775855	3.11373902	-2.33243559	-28.13616892									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018167-05	Cladribine		Adenosine Deaminase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	4291-63-8				-16.3126679767	4	7		0	-7.21590639				ADA	NC1=NC(=NC2=C1N=C[N]2C3CC(O)C(CO)O3)Cl	APExBIO	A2187	0.66359916	-3.0331031	-2.14012799	-6.48925473	-2.94893425	-3.92709508	-7.21590639									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390266-01	Nalfurafine hydrochloride		Kappa opioid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	152658-17-8		13.9333492831	-4.8559444758	-14.439492477	4	7		-20.522808348	-19.60234029	0.0036047197	0.9745209949			CN([C@@H]1CC[C@@]2(O)[C@H]3CC4=C5C(=C(O)C=C4)O[C@@H]1[C@@]25CCN3CC6CC6)C(=O)\C=C\C7=COC=C7	Adooq	A12579	0.94106222	-1.89655571	-2.19638546	0.45600168	-0.69624314	-2.4473882	-19.60234029									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167426-03	Caramiphen edisylate	170465518		DPI_SARS-CoV-2_General	2019_NPC_02	125-86-0				-34.5567958795	4	7		0	-8.90453313					O=S(=O)(O)CCS(=O)(=O)O.CCN(CC)CCOC(=O)C1(CCCC1)c2ccccc2.CCN(CCOC(=O)C1(CCCC1)c2ccccc2)CC	ASDI	100028134	-5.81516336	-7.20506364	-7.70961768	-8.87917125	-5.27291305	-8.02329951	-8.90453313									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181088-01	Melitracen hydrochloride	144206258		DPI_SARS-CoV-2_General	2019_NPC_02	10563-70-9	Melitracen hydrochloride; Melitraceno; Trausabun; Deanxit; Metrisil; 	12.4181106199	-4.9059444758	-38.0553248355	-2.2	7	Melitracen Hydrochloride;LS-20367;n,n,10,10-tetramethyl-delta(sup 9(10h)),gamma-anthracenepropylamine hydrochloride;melitracenum;Melitracene;Melitracen hydrochloride;Metrisil;Trausabun;9-(3-Dimetilaminopropyliden)-10,10-dimetil-9,10-diidroanthracene (Italian);melitracene hydrochloride;N,N-dimethyl-3-(9,10-dihydro-10,10-dimethylanthracen-9-yliden)propylamine;CIPLUS_670601;melitracene;CIPLUS_168125;Melitracen;LS-20365;Melitracenum;MELITRACEN;MELITRACEN HYDROCHLORIDE;Melitraceno;	-57.1413927596	-42.91014603	0.00010988	0.9956924988			Cl.CN(C)CC\C=C2/c1ccccc1C(C)(C)c3ccccc23	NCI	NSC-78229	0.0578048	1.50384624	1.20719158	-2.42967051	-3.88042678	-18.54096204	-42.91014603									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167505-03	Eptifibatide		Integrin alpha-IIb/beta-3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	188627-80-7		9.8640558873	-5.0059444758	4.093257342	4	7		-10.4079341719	-7.00661181	0.0387580354	0.907985176			NC(=N)NCCCC[C@@H]1NC(=O)CCSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC3=C[NH]C4=CC=CC=C34)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O)C(N)=O	MedChem Express	HY-B0686	3.03590834	-0.01617039	3.4481142	2.80382574	2.62101086	-0.6576475	-7.00661181									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00184708-02	NCGC00184708-02	124896555	smooth muscle contraction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	26538-44-3		25.355181056	-4.5959332839	-12.9975567942	-2.4	7	Zearalanol`	-31.713599396	-22.26133283	0.0001537967	0.9949049816			CC1CCCC(O)CCCCCC2=CC(=CC(=C2C(=O)O1)O)O	SIGMA	NTP_SID_1403	2.23588985	0.55210331	0.78994867	-0.28763183	-2.12674952	-9.53588876	-22.26133283									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00389431-01	RIBOFLAVIN 5-PHOSPHATE SODIUM		NADH oxidation Oxidative Enzyme	DPI_SARS-CoV-2_General	2019_NPC_02	130-40-5				8.5497266654	4	7		0	1.46506207					CC1=C(C)C=C2N(C[C@@H](O)[C@@H](O)[C@@H](O)CO[P](O)([O-])=O)C\3=N\C(=O)NC(=O)C3=N/C2=C1	Microsource	01505763	2.4856066	1.71175125	0.8602705	2.32210088	0.65347052	2.87016159	1.46506207									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00389470-01	Dirithromycin		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	62013-04-1				0.0010938883	4	7		0	-5.78889787					CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC3OC(C)CC(C3O)N(C)C)C(C)(O)CC(C)C4NC(COCCOC)OC(C4C)C1(C)O	APExBIO	B1731	0.47862378	2.4232484	0.95872108	-1.34462035	1.72753844	0.14092446	-5.78889787									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183859-01	Prifinium bromide	144206846	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	4630-95-9		24.777388143	-4.6059444758	-8.8016722612	4	7	Pyrrolidinium, 1,1-diethyl-3-diphenylmethylene-2-methyl-, bromide;Prifinium Bromide;PRIFINIUM BROMIDE;Prifinium bromide;CIPLUS_213773;Bromuro de prifinio;Prifinii bromidum;pyrodifenium bromide;CIPLUS_163551;Pyrrolidinium, 3-(diphenylmethylene)-1,1-diethyl-2-methyl-, bromide;3-(Diphenylmethylene)-1,1-diethyl-2-methylpyrrolidinium bromide;prifinii bromidum;prifinium;Bromure de prifinium;prifinium bromide;bromure de prifinium;Padrin;LS-138326;	-10.6843457119	-9.73695476	0.158763452	0.7750292069			[Br-].CC[N+]3(CC)CC/C(=C(\c1ccccc1)c2ccccc2)C3C	Pharmaron	PH-NIH-153498	-0.46012625	-2.15528194	-2.27608354	-2.71028693	2.61150583	-0.26775648	-9.73695476									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182027-01	Amogastrin	144206458	Cholecystokinin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	16870-37-4	Amogastrin; Amogastrina; 	15.6334750258	-4.8059444758	-23.1393694536	-2.4	7	AMOGASTRIN;amogastrin;CIPLUS_214157;Amogastrina;tert-amyloxycarbonyltetragastrin;Amogastrinum;Amogastrin;Amogastrine;amogastrine;amogastrinum;	-39.9606145599	-29.9671788	0.0007269007	0.9888015117			NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)OC(C)(C)CC)Cc3cnc2ccccc23	ACC	AMOGASTRIN	1.88443663	-0.99101388	0.79463679	0.26424713	-3.05348953	-9.343292	-29.9671788									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378796-01	Tacalcitol		Vitamin D receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	57333-96-7		6.2237985085	-5.2059444758	-66.3072944875	-2.2	7		-73.32538172	-67.430909	0.0000660159	0.9966653163			CC(C)[C@H](O)CC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)C[C@H](O)C3=C	MedChem Express	HY-32337	1.76420264	1.32828201	0.16642835	-3.4024741	-7.14540313	-36.66854566	-67.430909									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021147-11	Doxylamine succinate	170465171	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	562-10-7				8.3610759193	4	7		0	4.11649895					O=C(O)CCC(=O)O.CN(C)CCOC(C)(c1ccccn1)c2ccccc2	Vitas	STL018676	0.41875439	2.6070809	1.19178182	-0.81521058	0.90087804	4.56832156	4.11649895									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249937-01	Amidoflumet	170465981		DPI_SARS-CoV-2_General	2019_NPC_01	84466-05-7				-40.0035777387	4	7		0	-7.63985704					Clc1cc(c(NS(=O)(=O)C(F)(F)F)cc1)C(=O)OC	GVK	FFS-11-286-NCI-248	-11.37414373	-9.75150878	-10.48231825	-7.05094439	-6.17418667	-6.99222521	-7.63985704									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021125-03	Diclofenac sodium	170464642	Cyclooxygenase-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	15307-79-6				-17.0606805425	4	7		0	-9.16073103				PTGS1	[Na+].Clc2cccc(Cl)c2Nc1ccccc1CC([O-])=O	Vitas	STK984493	-4.04957277	-2.16238669	-1.91318759	-3.20816716	-4.17956656	-2.11392855	-9.16073103									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095112-05	Avobenzone	170464749	UVA ray absorber	DPI_SARS-CoV-2_General	2019_NPC_01	70356-09-1	; ; Avobenzona; AVOBENZONE;AVOBENZONE; Shade uvaguard; Photoplex;Avobenzone; 1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione	17.5410474839	-4.7559444758	-9.9372632761	-2.4	7		-31.9094066079	-28.25783884	0.0005484347	0.9902970912		CAT	COc1ccc(cc1)C(=O)CC(=O)c2ccc(cc2)C(C)(C)C	Microsource	01504190	3.1007189	0.04642412	1.26489727	2.03928061	0	0.74698918	-28.25783884									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160529-06	Tizanidine hydrochloride	170465419	alpha2-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	51322-75-9	;Tizanidine hydrochloride; Tizanadine; ; Tizanidina; TIZANIDINE; Tizanidine;Tizanidine; Tizanidine Hcl; Zanaflex			-7.6974495391	4	7		0	-2.12415401			150	ADRA2A	Clc2ccc3nsnc3c2NC1=NCCN1	Vitas	STK711168	-2.40360177	0.3103086	-2.3372572	-1.64296285	-0.70801401	-2.7033894	-2.12415401									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181124-02	Sparteine	170465740	sodium ion transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	90-39-1				4.3019475622	4	7		0	0					C3CCCN4C[C@@H]2C[C@@H](CN1CCCC[C@H]12)[C@@H]34	Vitas	STK801664	1.15944134	0.16614949	0	0	0	4.86813354	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182711-02	Picosulfate sodium	225144334		DPI_SARS-CoV-2_General	2019_NPC_01					-18.3861687081	4	7		0	-5.73876454					[O-][S](=O)(=O)OC1=CC=C(C=C1)C(C2=CC=C(O[S]([O-])(=O)=O)C=C2)C3=CC=CC=N3	APAC	877841	-4.84835282	-4.01935153	-5.47147279	-3.99578599	-2.5402223	-1.25006352	-5.73876454									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274082-01	Sodium dodecyl sulfate	170465474		DPI_SARS-CoV-2_General	2019_NPC_02	151-21-3				-11.120907554	4	7		0	-2.28797032					[Na+].[O-]S(=O)(=O)OCCCCCCCCCCCC	SIGMA	61749	-2.05091447	-3.15322599	-2.02761304	-2.78511798	-1.46139771	-2.77151447	-2.28797032									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378610-02	Topiroxostat		Xanthine dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02					-1.1959181658	4	7		0	-2.62569567					[N]#[C]C1=NC=CC(=C1)C2=N[NH]C(=N2)C3=CC=NC=C3	APExBIO	B1192	2.11103147	-2.73279586	-1.79789503	1.39606669	0	1.36226982	-2.62569567									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167445-02	Eprazinone dihydrochloride	170465851	Neurokinin 1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	10402-53-6		3.8051084423	-5.4196329617	-19.6185817963	4	7		-11.161729552	-11.68719973	0.0073320442	0.9632486733			Cl.Cl.O=C(c1ccccc1)C(C)CN3CCN(CC(OCC)c2ccccc2)CC3	Bosche	E5680	-0.71909177	-2.88987965	-1.09467664	-2.0695461	-1.48991279	-6.28523112	-11.68719973									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00181167-01	Isoniazid sodium methanesulfonate	144206321		DPI_SARS-CoV-2_General	2019_NPC_02	3804-89-5	Methaniazide; Neoiscotin; Metaniazida; 			9.1259849599	4	7	CIPLUS_739573;Isoniazid Sodium Methanesulfonate Anhydride;Methaniazide;CIPLUS_207620;Isoniazid sodium methanesulfonate;Neoiscotin;Methaniazidum;LS-172896;METHANIAZIDE;methaniazide, sodium salt;isoniazid methanesulfonate;Isoniazid Sodium Methanesulfonate;Metaniazida;ISONICOTINIC ACID 2-(SULFOMETHYL)HYDRAZINE;CIPLUS_162545;methaniazidum;isoetam;methaniazide;ISONIAZID SODIUM METHANESULFONATE;	0	-2.85877372					[Na+].O=C(NNCS([O-])(=O)=O)c1ccncc1	NCI	NSC-81103	2.93879627	3.28720922	0	4.08063045	2.63051589	2.37222849	-2.85877372									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00248587-03	METHYLPHENIDATE HYDROCHLORIDE			DPI_SARS-CoV-2_General	2019_NPC_02	298-59-9, 113-45-1(base)				-19.240657942	4	7		0	-5.63668363					COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Microsource	01505907	-2.19427039	-6.08237659	-6.81887438	-3.1358885	-2.47368296	-2.63528749	-5.63668363									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179642-03	Isoconazole nitrate	170466012	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC_02	27523-40-6	;Isoconazole; Isoconazol; Travocort; Adestan-G;Isoconazole nitrate (Travogen)	7.8352981002	-5.1059444758	-75.4166336117	-2.1	7		-98.0648337565	-89.37829996	0.0000070418	0.9989148458			Clc3ccc(C(OCc1c(Cl)cccc1Cl)Cn2ccnc2)c(Cl)c3	Prestwick Chemical, Inc.	Prestw-127	1.8058221	0.1824944	1.15093411	-0.48874027	-1.20476202	-41.87805336	-89.37829996									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091595-07	Sodium 2-phenylphenate tetrahydrate	170465724		DPI_SARS-CoV-2_General	2019_NPC_01	6152-33-6				-29.2259778089	4	7		0	-10.21013409					[Na+].O.O.O.O.[O-]c2ccccc2c1ccccc1	Vitas	STK177354	-3.76394839	-4.73281697	-3.97504326	-8.2298643	-7.44810435	-6.08262615	-10.21013409									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015099-11	Alprenolol	170465812	Beta-adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	13655-52-2				4.4191384789	4	7		0	-1.74900509					CC(C)NCC(O)COc1ccccc1CC=C	Enzo	AC812	0.62692131	1.83986122	1.06017401	2.06938069	0.0329899	2.03262361	-1.74900509									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160620-02	L-Methionine	225144244	S-adenosylmethionine synthetase (MAT 1 and MAT 2) Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	63-68-3				-45.3453547861	4	7		0	-14.49899876					CSCC[C@H](N)C(O)=O	SIGMA	64320	-8.05315518	-10.20108975	-10.56030806	-10.31178669	-6.44318124	-5.84379288	-14.49899876									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00166307-05	ERGOCALCIFEROL		Vitamin D receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	50-14-6		4.4061119169	-5.3559444758	-115.3375807915	-2.2	7		-83.2014578112	-68.06925046	0.0000321262	0.9976777306			CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)CCC3=C	SIGMA	E5750	-4.29162733	-5.40230166	-7.8062928	-16.43213685	-32.07379587	-47.8174704	-68.06925046									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016879-06	Torsemide	170465279	Loop Diuretics	DPI_SARS-CoV-2_General	2019_NPC_01	56211-40-6	 ;Torsemide (Demadex); Torasemida;TORSEMIDE; Luprac; Demadex;Torsemide; Torsemide			7.289984838	4	7		0	-1.4194824					O=S(=O)(NC(=O)NC(C)C)c2cnccc2Nc1cc(C)ccc1	Prestwick	Prestw-1030	-0.25415729	3.55022357	0.99680729	2.08443073	1.85504745	3.26236089	-1.4194824									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016764-04	Benfotiamine	170465987		DPI_SARS-CoV-2_General	2019_NPC_01	22457-89-2				6.845293505	4	7		0	0					Nc2nc(C)ncc2CN(C=O)C(C)=C(CCOP(=O)(O)O)SC(=O)c1ccccc1	SIGMA	B9636	0.33645584	0	4.69644903	1.09614468	3.82936609	0	0									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00164431-01	Terpineol	144205671	Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	8000-41-7	(S)-p-Menth-1-en-8-ol; (-)-alpha-Terpineol; D-alpha-terpineol; (R)-p-Menth-1-en-8-ol; Terpineol mixed isomers; DL-alpha-terpineol; (+)-alpha-Terpineol; 			0.9123802451	4	7	ALPHA-TERPINEOL;CIPLUS_658650;alpha,alpha,4-trimethyl-3-cyclohexene-1-methanol;alpha-terpineol, sodium salt;DL-alpha-terpineol;CIPLUS_160295;CIPLUS_168066;NCGC00164431-01;1-alpha-terpineol;3-Cyclohexene-1-methanol, .alpha.,.alpha.,4-trimethyl-;(+)-alpha-Terpineol;CIPLUS_167185;CIPLUS_197210;(S)-2-(4-Methyl-3-cyclohexenyl)-2-propanol;TERPINEOL;alpha-terpineol;D-alpha-terpineol;(R)-2-(4-Methyl-3-cyclohexenyl)isopropanol;Terpineol mixed isomers;Terpineol;(R)-p-Menth-1-en-8-ol;CIPLUS_167234;CIPLUS_687752;CIPLUS_688650;alpha-Terpineol;(-)-alpha-Terpineol;(S)-p-Menth-1-en-8-ol;CIPLUS_167096;	0	1.9217048					CC1=CCC(CC1)C(O)(C)C	SigmaAldrich	MFCD00166983	0.77920877	0.16863406	0.2179977	-0.37181676	0.67723309	-1.43742954	1.9217048									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00181153-01	Treosulfan	144206310	cell growth Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	299-75-2	treosulfan; Dimesyl-meso-erythritol; Treosulfano; L-dihydroxybusulfan; 			7.8636812623	4	7	treosulfan, (R*,R*)-isomer;Treosulfano;LS-173863;CIPLUS_677281;treosulfan, ((R*,R*)-(+-))-isomer;CIPLUS_152492;(S-(R*,R*))- 1,2,3,4-butanetetrol, 1,4-dimethanesulfonate;LS-1145;(2R,3R)-4,5-Bis(mesyloxy)butane-2,3-diol;L-threitol-1,4-bismethanesulfonate;TREOSULFAN;CIPLUS_673029;Dimesyl-meso-erythritol;L-dihydroxybusulfan;treosulfan;Treosulfanum;LS-64629;NSC 39069;CIPLUS_168615;LS-174277;LS-173777;treosulfan, (R*,S*)-isomer;treosulfanum;treosulfan, (R-(R*,R*))-isomer;Treosulfan;	0	0.91328545					CS(=O)(=O)OCC(O)C(O)COS(C)(=O)=O	NCI	NSC-39068	1.93992925	-0.59830442	1.24938468	2.36419334	4.15132001	1.51728673	0.91328545									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00388369-01	Prednisolone Phosphate (sodium salt)		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	125-02-0				10.3359257867	4	7		0	0					C[C@]12C[C@H](O)[C@H]3[C@@H](CCC\4=C\C(=O)\C=C/[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO[P]([O-])([O-])=O	Cayman	15933	0	3.81390192	3.89348585	2.15373103	2.72556614	2.20311913	0									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00166144-03	2,3-Dihydroxypropyl octanoate	170465212		DPI_SARS-CoV-2_General	2019_NPC_02	502-54-5		15.6334750258	-4.8059444758	6.0607456751	4	7		-16.1261713399	-10.52180945	0.0029217935	0.9772274965			OCC(O)COC(=O)CCCCCCC	SIGMA	M2265	3.04515711	2.50179029	4.61545674	3.51472067	2.20278973	0.82205938	-10.52180945									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178877-03	Methicillin sodium hydrate	170465152	peptidoglycan biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	7246-14-2				-14.5113934708	4	7		0	-6.08856966					[Na+].O.O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)c1c(OC)cccc1OC)[C@H]3SC2(C)C	Microsource	01500395	-2.78619159	-2.52489085	-3.29809428	-3.8888759	-2.10773947	-1.64881623	-6.08856966									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00509984-01	Omapatrilat		Neprilysin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	167305-00-2		8.7913490634	-5.0559444758	-13.8672925346	4	7		-14.901488848	-14.08457404	0.007198152	0.9634383066	1636		OC(=O)[C@@H]1CCC[C@@H]2SCC[C@H](NC(=O)[C@@H](S)CC3=CC=CC=C3)C(=O)N12	MedChem Express	HY-18208	-0.33064348	-0.72766754	0.10548276	-2.38757805	0.51089514	-6.39797069	-14.08457404									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00014017-03	L-Proline	225144170		DPI_SARS-CoV-2_General	2019_NPC_01	147-85-3				9.6762731721	4	7		0	0					OC(=O)[C@@H]1CCCN1	SIGMA	81710	4.30130952	-0.55953283	4.65257976	0	3.89027052	1.69215915	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015802-18	Pimozide	170464864	HERG Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	2062-78-4		11.0676527398	-4.9559444758	-75.2102332201	-2.2	7		-93.8940960724	-73.31119617	0.0000136236	0.9984896866			Fc1ccc(cc1)C(CCCN2CCC(CC2)N3c4ccccc4NC3=O)c5ccc(F)cc5	NCGCChem	NCGC00015802-17pur	-1.72584901	-0.73056906	-3.08303478	-0.98076103	-9.82337715	-36.02317191	-73.31119617									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159417-05	Triclosan	170464936	Bacterial enoyl-[acyl-carrier-protein] reductase Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	3380-34-5		13.9333492831	-4.8559444758	-40.8333174022	-2.2	7		-72.7357481458	-59.31408583	0.0007644484	0.988499256			Clc2cc(Cl)ccc2Oc1ccc(Cl)cc1O	Labotest	LT02056532	1.64355046	0	3.35112476	1.18142825	-5.52961478	-14.27918085	-59.31408583									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015774-06	Oxatomide	170466059	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	60607-34-3		13.9333492831	-4.8559444758	-68.3981188809	-2.2	7		-83.098751614	-65.84370485	0.0001089983	0.9957085847	3269	HRH1	O=C5Nc1ccccc1N5CCCN2CCN(CC2)C(c3ccccc3)c4ccccc4	Enzo	EI114	-4.09798369	-1.51244899	-2.33238283	-6.33355908	-8.51393189	-25.53483409	-65.84370485									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164589-02	Phenprobamate	170465902		DPI_SARS-CoV-2_General	2019_NPC_01	673-31-4				-0.5486209705	4	7		0	-2.19512813					NC(=O)OCCCc1ccccc1	Sequoia	SRP014251p	0.97063878	-2.05976495	2.86856279	-0.72491033	1.38811349	-1.54479394	-2.19512813									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018249-05	Ethoxzolamide	170465083	Carbonic anhydrase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	452-35-7				7.9277927596	4	7		0	1.33836912					NS(=O)(=O)c1nc2ccc(cc2s1)OCC	Labotest	LT00453128	2.41328395	1.87406846	2.35675465	2.79178268	1.60127899	-0.63011332	1.33836912									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159339-10	Streptomycin sulfate		30s Ribosomal Protein Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_02	3810-74-0				16.188435816	4	7		0	2.70180279					CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H](O[C@@H](C)[C@]2(O)C=O)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]3NC(N)=N	Prestwick	Prestw-321	4.21050198	4.57622029	4.30604065	2.19582349	1.52793289	3.7110109	2.70180279									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00390804-01	Goserelin (acetate)		LNCaP Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	145781-92-6		7.5921894793	-5.1196329617	-16.1372393083	4	7		-28.678138232	-20.98178186	0.0015958982	0.9832722013			CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=C[NH]C3=C2C=CC=C3)NC(=O)[C@H](CC4=CN=C[NH]4)NC(=O)[C@@H]5CCC(=O)N5)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N6CCC[C@H]6C(=O)NNC(N)=O	MedChem Express	HY-13673A	2.35612384	1.29132112	3.3449755	0.75532587	-0.62970796	-4.25122135	-20.98178186									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00346580-04	Vinflunine (Tartrate)			DPI_SARS-CoV-2_General	2019_NPC_02	1201898-17-0		12.4181106199	-4.9059444758	-31.3610923766	-2.2	7		-67.3901203488	-49.91675784	0.00022361	0.9938349839			[H][C@@]12N3CC[C@@]14C5=CC(=C(OC)C=C5N(C)[C@@]4([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)\C=C/C3)C(=O)OC)[C@]6(C[C@H]7C[C@H](CN(C7)CC8=C6NC9=C8C=CC=C9)C(C)(F)F)C(=O)OC	MedChem Express	HY-B0628A	4.53420888	4.38217561	2.89491573	0	-2.18853219	-16.69954904	-49.91675784									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183011-01	Itasetron	144206831	Serotonin 3 (5-HT3) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	123258-84-4	Itasetron; DAU 6215 hydrochloride; 			3.8468232721	4	7	itasetronum;itasetron;DAU 6215 hydrochloride;ITASETRON HYDROCHLORIDE HYDRATE;(endo-N-8-methyl-8-azabicyclo(3.2.1.)-oct-3-yl)-2,3-dihydro-2-oxo-1H-benzimidazol-1-carboxamide;Itasetron Hydrochloride Hydrate;U-98079A;CIPLUS_197009;Itasetron;DAU 6215;CIPLUS_3881158;LS-32715;N-(8-methyl-8-azabicyclo (3.2.1.)oct-3-yl)2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxamide;ENDO-2,3-DIHYDRO-N-((8-METHYL)-8-AZABICYCLO(3.2.1)OCT-3-YL)-2-OXO-1H-BENZIDAZOLE-1-CARBOXAMIDE HYDROCHLORIDE HYDRATE;2-OXO-N-1.ALPHA.H,5.ALPHA.H-TROPAN-3.ALPHA.-YL-1-BENZIMIDAZOLINE-1-CARBOXAMIDE;ITASETRON;LS-172560;1H-BENZIMIDAZOLE-1-CARBOXAMIDE, 2,3-DIHYDRO-N-(8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL)-2-OXO, ENDO-;	0	-2.72236445					CN4[C@@H]1CC[C@H]4C[C@H](C1)NC(=O)N2c3ccccc3NC2=O	Pharmaron	PH-NIH-151623	-1.04809624	-0.12949886	1.75720796	1.55767928	1.37288738	4.01443163	-2.72236445									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182048-01	Pipothiazine palmitate	144206970	Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	37517-26-3	Pipotiazine palmitate; Pipotiazin Retard; Piportil depot; 	4.4061119169	-5.3559444758	-20.572356632	4	7	Hexadecanoic acid, 2-(1-(3-(2-((dimethylamino)sulfonyl)-10H-phenothiazin-10-yl)propyl)-4-piperidinyl)ethyl ester;Pipotiazine palmitate;pipotiazine palmitate;pipothiazin palmitate;Pipotiazin Retard;LS-74847;CIPLUS_179082;Piportil depot;pipothiazine palmitate;PIPOTIAZINE PALMITATE;19552 RP;	-23.763758736	-21.05313228	0.0000221782	0.9980752261			CN(C)S(=O)(=O)c2cc3N(CCCN1CCC(CCOC(=O)CCCCCCCCCCCCCCC)CC1)c4ccccc4Sc3cc2	Sigma - DiscoveryCPR	CSZ6713	0.44625309	1.65168981	0.72431495	0.3764937	-2.67804101	-14.06426156	-21.05313228									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386545-01	Ciclesonide		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	126544-47-6		4.9437388825	-5.3059444758	-58.4117334005	-2.2	7		-60.8743043341	-55.59149503	0.0000116533	0.9986035689		NR3C1	CC(C)C(=O)OCC(=O)[C@@]12OC(O[C@@H]1C[C@H]3[C@@H]4CCC\5=C\C(=O)\C=C/[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)C6CCCCC6	Axon Medchem	1426	2.01854378	1.04645522	0.59304751	-1.55040572	-7.29273103	-36.40078918	-55.59149503									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00408835-01	Frovatriptan succinate		Serotonin 1d (5-HT1d) receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	158930-09-7				14.0234746785	4	7		0	-4.00513723					CN[C@@H]1CCC2=C(C1)C3=C([NH]2)C=CC(=C3)C(N)=O	Glixx	GLXC-06564	4.89491086	4.0541477	4.62952111	0.66178706	4.15607252	4.8431041	-4.00513723									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183332-01	Dihydroergocriptine	144206629	D(1A) dopamine receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	25447-66-9		9.8640558873	-5.0059444758	-67.8360291135	-2.2	7	CIPLUS_752814;Vasobral;LS-174243;CIPLUS_746395;Dihydroergocryptine Mesylate;CIPLUS_691892;CIPLUS_737198;CIPLUS_3861508;Ergotaman-3',6',18-trione, 9,10alpha-dihydro-12'-hydroxy-5'alpha-isobutyl-2'-isopropyl;Dihydroergocryptine;DIHYDROERGOCRYPTINE MESYLATE;	-95.5337963148	-74.64681539	0.0000357323	0.9975501514	1812	DRD1	CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@@]7(O[C@]6(O)N([C@@H](CC(C)C)C(=O)N5CCC[C@H]56)C7=O)C(C)C	Chemical Block	A4425/0188924	3.65557585	0.25641618	0.47115633	-2.35483946	-6.87926241	-35.7901165	-74.64681539									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161602-06	Doxycycline	170465097	Matrix Metalloproteinase (MMP) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	10592-13-9	; ; Monodox;DOXYCYCLINE HYDROCHLORIDE; Doryx; 1   Doxycycline Mono; Doxycycline hydrochloride; Doxycycline SSa; Atridox;Doxycycline; Doxiciclina; Vibramycin; Vibra-Tabs;Doxycycline hydrochloride; 0   Doxycycline Hyclate; Periostat	13.9333492831	-4.8559444758	-27.2533649856	-2.2	7		-58.8112848792	-46.67562292	0.0000595999	0.9968332447	4312	MMP1	Cl.NC(=O)C=3C(=O)[C@@]4(O)C(O)=C2C(=O)c1c(O)cccc1[C@H](C)[C@H]2[C@H](O)[C@H]4[C@@H](C=3O)N(C)C	Prestwick	Prestw-1399	2.52462905	3.05666186	0.20716044	1.88878019	-0.3628889	-11.01681996	-46.67562292									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022003-06	Diflorasone diacetate	170465294		DPI_SARS-CoV-2_General	2019_NPC_01	33564-31-7		9.8640558873	-5.0059444758	-12.718965162	4	7		-28.017122508	-24.59760209	0.000895568	0.9875494527			CC(=O)OCC(=O)[C@@]4(OC(C)=O)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-619	0.76247186	0.86739805	2.29338793	0	3.03760849	-6.58061893	-24.59760209									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163329-03	Clopidogrel bisulfate	170465231	P2Y12 (P2T) Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	135046-48-9	; Clopidogrel hydrochloride;Plavix; Isocover;CLOPIDOGREL SULFATE; Iscover; 4   Clopidogrel;Clopidogrel hydrogen sulfate			10.4470296673	4	7		0	0.67932372			64805	P2RY12	O=S(=O)(O)O.Clc1ccccc1[C@H](N2CCc3sccc3C2)C(=O)OC	Vitas	STK580572	3.16849418	4.65462897	1.45012308	1.95399704	0	3.30809492	0.67932372									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095124-08	Rosiglitazone	170465417	PPARgamma Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	122320-73-4	; ;Rosiglitazone;ROSIGLITAZONE MALEATE; Avandia; ROSIGLTAZONE HCl; Rosiglitazone; rosiglitazone (Avandia); ROSIGLITAZONE;ROSIGLITAZONE	11.0676527398	-4.9559444758	3.8773228953	4	7		-16.447149624	-12.45595802	0.0192135577	0.9377078328	5468	PPARG	CN(CCOc2ccc(CC1SC(=O)NC1=O)cc2)c3ccccn3	Microsource	01504263	3.57998693	3.18371735	4.20413833	0	4.56529463	-0.47766655	-12.45595802									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162247-06	Levallorphan	170465778	Mu-type opioid receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	152-02-3				7.5012369635	4	7		0	-1.38399534			4988	OPRM1	Oc3ccc4C[C@H]1N(CC[C@@]2(CCCC[C@@H]12)c4c3)CC=C	SIGMA	L121	0	3.23258485	0	4.23156997	1.65710805	2.65765537	-1.38399534									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181743-02	Lypressin	144206977	Vasopressin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	50-57-7		12.4181106199	-4.9059444758	-12.1447496736	-2.4	7	8-L-LYSINEVASOPRESSIN;CYS-TYR-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2 (1,6-DISULFIDE);Lypressin;Lyspressin;VASOPRESSIN, 8-LYSINE;Lysyl Vasopressin;Lipresina;Lypressinum;CIPLUS_148560;LYPRESSIN;LS-161412;Lysipressin;lypressine;Lypressine;Vasopressin, 8-Lysin;lypressinum;Lysine Vasopressin;[Lys8]-Vasopressin;VASOPRESSIN PIG;Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2, cyclic 1-6 disulfide;Lys Vasopressi;L-CYSTEINYL-L-TYROSYL-L-PHENYLALANYL-L-GLUTAMINYL-L-ASPARAGINYL-L-CYSTEINYL-L-PROLYL-L-LYSYLGLYCINAMIDE CYCLIC (1->6)-DISULFIDE;Lysine vasopressin;8 Lysine Vasopressi;8-Lysine Vasopressin;Lys-Vasopressin;8-l-lysine vasopressin;VASOPRESSIN, 8-L-LYSINE;Vasopressin, Lysy;Postacton;Diapid;Vasopressin, 8-L-lysine-;	-30.548304236	-26.29025353	0.003798014	0.9737717103			NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]4CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N4	Sigma DiscoveryCPR	CPY6754	0	0	0	4.45010874	2.58299076	-4.57534761	-26.29025353									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249415-01	Fabesetron	144206751	5-hydroxytryptamine receptor 4 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	129300-27-2		6.9832167823	-5.1559444758	-107.6474237485	-2.1	7		-86.5565725614	-81.15873091	0.0000506175	0.9970819186	3360	HTR4	Cc4ncnc4C[C@H]3CCc2c(C)c1ccccc1n2C3=O	NCGCChem	DJM10-012	-3.72031723	-6.32262238	-6.66416633	-10.66576246	-18.20925314	-47.3412251	-81.15873091									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00142624-05	Lactulose	170464861	Synthetic sugar	DPI_SARS-CoV-2_General	2019_NPC_01	4618-18-2	; Cephulac; Lactulosa; Chronulac; Duphalac;LACTULOSE; Amivalex; Normase;Lactulose			0.8072634275	4	7		0	0.87196776					O[C@H]2[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@@H](CO)O[C@]2(O)CO	Microsource	01500363	0.10892455	3.03711486	-1.36238454	1.00584443	-1.39826422	-0.88927283	0.87196776									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095109-08	Venlafaxine	170465123	5-HT Reuptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	93413-69-5	; ;D,L-Venlafaxine?HCl;VENLAFAXINE HYDROCHLORIDE; Effexor XR; VENLAFAXINE; Effexor;VENLAFAXINE; Venlafaxina;Venlafaxine hydrochloride; Venlafaxine			-17.9866445429	4	7		0	-3.90864617			3350	HTR1A	OC1(CCCCC1)C(CN(C)C)c2ccc(OC)cc2	Microsource	01504171	-3.76394839	-1.86918171	-3.06841169	-5.62620714	-2.89549815	-5.68118299	-3.90864617									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015110-09	Aminoglutethimide	170465259	Aromatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	125-84-8	 (S)-(-)-Aminoglutethimide; (+-)-p-Aminoglutethimide;(?)-p-Aminoglutethimide; Glutethimide, para-amino; (?)-p-Aminoglutethimide;AMINOGLUTETHIMIDE; (R)-(+)-Aminoglutethimide;Glutethimide, para-amino;p-Aminoglutethimide; Orimeten; p-Aminoglutethimide; ;Aminoglutethimide (Cytadren); Cytadren;Aminoglutethimide; Aminoglutetimida			4.7061392447	4	7		0	3.05695673			1588	CYP19A1	CCC1(CCC(=O)NC1=O)c2ccc(N)cc2	Vitas	STK802074	0	0	0	0	1.89818809	2.53061639	3.05695673									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016305-11	Silver sulfadiazine		Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	68-35-9	; Diazin; Silver Sulphadiazine; Ditrim; Sulphadiazine; Sulfadiazine sodium salt; Perfringens Supplement I;Sulfadiazine; ;SULFADIAZINE; Tibirox; Diaziprim Forte; Silver(I) sulfadiazine; SPS Agar Supplement; Tribrissen; Zinc Sulfadiazine; Sulfadiazina sodica; Sulfazine; Triglobe; Silvadene; Sterinor; Sulfadiazine; Sulfadiazina; Sulfazin; Sulfadiazine, Zin			10.9427909683	4	7		0	2.58548579					NC1=CC=C(C=C1)[S+]([O-])(=O)NC2=NC=CC=N2	SIGMA	S8626	2.50526469	0	3.64358656	0	4.35212912	3.28268713	2.58548579									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016667-04	Benoxinate hydrochloride	170464771	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	5987-82-6		11.0676527398	-4.9559444758	2.450680883	4	7		-11.171605288	-8.47633774	0.0483416019	0.8949642345			Cl.CCN(CC)CCOC(=O)c1cc(OCCCC)c(N)cc1	Vitas	STK520615	2.26805122	2.05976495	-0.37776315	4.25665337	2.55037304	-0.78256009	-8.47633774									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015964-17	Spiperone	170465856	Dopamine D4 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	749-02-0		6.9832167823	-5.1559444758	-28.306994486	4	7		-17.238996908	-16.50148285	0.0299972393	0.9200868765			Fc1ccc(cc1)C(=O)CCCN2CCC4(CC2)C(=O)NCN4c3ccccc3	Enzo	AC807	-4.76605427	-1.30231876	-2.51760864	-2.02924725	-7.84398315	-9.7464302	-16.50148285									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00538142-01	NCGC00538142-01		vasoconstriction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			8.7913490634	-5.0559444758	-62.8485555217	-2.2	7		-74.1599988133	-65.50444751	0.0000035069	0.9992347213			CCCCCCC(COC(=O)C1=CN=CC=C1)(COC(=O)C2=CN=CC=C2)COC(=O)C3=CN=CC=C3	Pharmaron	PH-NIH-2017-009-L1-20-0	-1.87518787	-1.03259489	-1.0243548	-0.25489325	-5.46301357	-30.92352499	-65.50444751									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164566-09	Pitavastatin Calcium			DPI_SARS-CoV-2_General	2019_NPC_02	147526-32-7		12.4181106199	-4.9059444758	-21.195727433	-2.2	7		-39.5770822439	-30.48090187	0.0002346835	0.9936873302			O[C@H](C[C@H](O)\C=C\C1=C(C2=CC=C(F)C=C2)C3=C(C=CC=C3)N=C1C4CC4)CC([O-])=O	APExBIO	A8504	1.05204745	2.89449976	-0.30707203	0.62904848	-0.87208612	-10.69616685	-30.48090187									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183121-01	Zinc pyrithione	144206950		DPI_SARS-CoV-2_General	2019_NPC_02	13463-41-7		3.9269513795	-5.4059444758	-5.194485008	4	7	pyrithionum zincicum;LS-784;Pyrithione zincique;PYRITHIONE ZINC;pyrithione zinc;Zinc Pyrithione;Zinc pyrithione;NCGC00094659-02;ZINC OMADINE;NCGC00094659-01;CIPLUS_168786;ZINC DI(2-PYRIDINETHIOL-1-OXIDE);Piritionato cincico;zinc pyrithione;ZINC PYRION;AB07944716-01;Finecide ZPT;Pyrithione zinc;VANCIDE ZP;Pyrithionum zincicum;Sebulon shampoo;2-Mercaptopyridine N-oxide zinc salt Pyrithione zinc;(T-4)-bis(1-hydroxy-2(1H)- pyridinethionato-O,S)zinc;2-Mercaptopyridine N-oxide zinc salt;	-12.585002136	-9.23750178	0.0038576866	0.9737191989			[O-][n+]2ccccc2S[Zn]Sc1cccc[n+]1[O-]	SIGMA	H6377	2.49947976	2.9129802	0.92590422	0.32037041	-0.5726778	-6.4731304	-9.23750178									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181099-01	Siccanin	144206268		DPI_SARS-CoV-2_General	2019_NPC_02	22733-60-4	Siccanin; Ladar; Sicanina; Piadar; 	11.0676527398	-4.9559444758	-35.1498416027	-2.2	7	Siccaninum;LS-173961;siccanine;Siccanine;Siccanin;Ladar;SICCANIN;CIPLUS_214175;Sicanina;Benzoic acid, 2-hydroxy-, 2-hydroxyethyl ester, mixt. with (4aS-(4aalpha,6aalpha,11balpha,13aR*,13balpha))-1,2,3,4,4a,5,6,6a,11b,13b-decahydro-4,4,6a,9-tetramethyl-13H-benzo(a)furo(2,3,4-mn)xanthen-11-ol;CIPLUS_769555;siccaninum;Piadar;siccanin;	-71.9088379384	-64.61018884	0.000016378	0.9983437048			Cc1cc2O[C@@]4(C)CC[C@H]5C(C)(C)CCCC53CO[C@@H](c2c(O)c1)[C@H]34	NCI	NSC-135048	3.62782955	1.33752223	3.27465366	1.10609639	3.1152722	-13.89984968	-64.61018884									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160504-01	Testosterone 17-phenylpropionate	144206667		DPI_SARS-CoV-2_General	2019_NPC_02	1255-49-8	testosterone 17-phenylpropionate; Retandrol; Mixogen; 	6.9832167823	-5.1559444758	-12.9020012385	-2.2	7	TESTOSTERONE PHENYL PROPIONATE;CIPLUS_3882657;testosterone phenylpropionate;Retandrol;Testosterone Phenylpropionate;CIPLUS_157987;Testosterone 17-phenylpropionate;testosterone 17-phenylpropionate;estandron prolongatum;4-Androsten-17beta-ol-3-one 17-phenylpropionate;Testosterone phenylpropionate;Mixogen;Testosterone hydrocinnamate;	-36.411549252	-30.34295771	0.0007526606	0.9885968859			O=C5CC[C@@]4(C)C(CC[C@@H]2[C@@H]4CC[C@]3(C)[C@@H](OC(=O)CCc1ccccc1)CC[C@@H]23)=C5	InterBioScreen	STOCK1N-42343	0.9479988	4.59008062	4.60139237	3.64099806	3.71408882	-13.04021045	-30.34295771									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378997-07	Micafunginsodium			DPI_SARS-CoV-2_General	2019_NPC_02	208538-73-2		4.7903477126	-5.3196329617	-61.2363037391	-2.2	7		-67.5691385616	-55.73419588	0.0002188785	0.993900766			CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)C5[C@@H](O)[C@@H](C)CN5C(=O)C(NC(=O)C(NC(=O)C6C[C@@H](O)CN6C(=O)C(NC4=O)[C@@H](C)O)[C@H](O)[C@@H](O)C7=CC=C(O)C(=C7)O[S+](O)([O-])=O)[C@H](O)CC(N)=O	Bio Vision	2585	0.28902402	2.90836009	-1.24469656	3.60825948	-2.82536891	-24.16384818	-55.73419588									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00014925-06	Topotecan hydrochloride	170465137	DNA Topoisomerase I Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	119413-54-6	; Hycamtamine; Topotecane; Nogitecan hydrochloride;Nogitecan hydrochloride/NSC-609699;Topotecan hydrochloride; Topotecan hydrochloride;TOPOTECAN HYDROCHLORIDE; Nogitecan Hydrochloride; Hycamtin	12.4181106199	-4.9059444758	-29.8155184197	-2.2	7		-49.8237053524	-36.98765557	0.0004852705	0.9908769235	7150	TOP1	Cl.CN(C)Cc1c2cc3CN4C(=O)C=5COC(=O)[C@](O)(CC)C=5C=C4c3nc2ccc1O	Prestwick	Prestw-1196	-0.14281219	2.77811714	0	2.05934733	-4.35720449	-15.10239341	-36.98765557									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167472-03	Amlexanox	170465365	Mediator Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	68302-57-8	 3   Amlexanox; ; Solfa;Amlexanox; Aphthasol; Amlenanox	17.5410474839	-4.7559444758	-23.1676556041	-2.4	7		-30.703340096	-25.61658767	0.0002725125	0.9931981319		IL3	CC(C)c1cc2C(=O)c3cc(c(N)nc3Oc2cc1)C(=O)O	Bosche	A2169	-1.18848789	-0.44713759	-2.41524701	-1.68811298	-2.76861392	-5.35088165	-25.61658767									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015718-12	Naftopidil	170466026	alpha1-Adrenoceptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	57149-07-2	;Naftopidil;Naftopidil dihydrochloride; Flivas; KT-611 dihydrochloride; Naftopidil	13.9333492831	-4.8559444758	-68.695195069	-2.2	7		-63.6856970687	-53.94033104	0.0000070936	0.998911274	148	ADRA1A	OC(CN1CCN(CC1)c2ccccc2OC)COc4cccc3ccccc34	Tocris	0597	-5.01294992	-6.6288758	-6.56333016	-6.98071086	-9.15342841	-23.41582397	-53.94033104									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015344-16	NCGC00015344-16			DPI_SARS-CoV-2_General	2019_NPC_01			12.4181106199	-4.9059444758	-0.6830639772	4	7		-16.716293632	-14.34691136	0.0063969826	0.9656017576			CN(C)CC\C=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2	Microsource	01500264	1.49347663	2.6070809	3.78006873	-0.00250834	1.67740953	0.3353829	-14.34691136									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00348378-01	FOSFOMYCIN		UDP-N-acetylglucosamine 1-carboxyvinyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	26016-99-9				-9.934887421	4	7		0	-1.42962156					C[C@@H]1O[C@@H]1[P]([O-])([O-])=O	SIGMA	P5396	1.51284099	-3.98025753	-1.80107723	-2.20984774	-3.3979597	-1.94115555	-1.42962156									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00344537-01	L-Glutathione oxidized disodium salt	225144384	Glutathione reductase Substrate	DPI_SARS-CoV-2_General	2019_NPC_02	103239-24-3				-42.3678820967	4	7		0	-9.83684536					N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C([O-])=O)C(=O)NCC(O)=O)C(=O)NCC([O-])=O)C(O)=O	SIGMA	G4626	-5.44521261	-9.75074499	-7.22205293	-6.1384842	-5.97628496	-7.31867719	-9.83684536									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00091512-04	(2E)-3-Phenylprop-2-enal	144204695	Peroxisome proliferator-activated receptor gamma Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	14371-10-9	CINNAMALDEHYDE; trans-3-Phenyl-2-propenal; 	11.0676527398	-4.9559444758	-34.3995015498	-2.2	7	CIPLUS_757838;CINNAMALDEHYDE;cinnamaldehyde;trans-3-Phenyl-2-propenal;2-propenal, 3-phenyl- (9ci);trans-cinnamaldehyde;CIPLUS_150798;Cinnamic aldehyde;LS-378;cinnamic aldehyde, (E)-isomer;AB08006278-01;cinnamic aldehyde;trans-Cinnamaldehyde;Cinnamaldehyde (trans), neat;CIPLUS_169354;beta-phenylacrolein;AB08007164-01;Cinnamaldehyde;LS-850;	-46.2624744384	-35.04732912	0.0003108294	0.9927215816	5468	PPARG	O=C\C=C\c1ccccc1	Labotest	LT00939010	1.27864228	0.49666197	0.34457701	-3.26216589	-4.08953734	-17.51221345	-35.04732912									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00388284-07	Darunavir (Ethanolate)		Hiv Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_02	635728-49-3		7.8352981002	-5.1059444758	-13.5296666032	4	7		-10.303120388	-10.66926699	0.11205346	0.8226091878			CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@H]3OCC[C@@H]23)[S+]([O-])(=O)C4=CC=C(N)C=C4	MedChem Express	HY-17041	0.52486763	-4.03566726	-2.44954408	-0.05378481	0.41584488	-5.69334837	-10.66926699									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262603-04	Idelalisib		PI3Kdelta Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	870281-82-6		12.4181106199	-4.9059444758	-10.5424391463	-2.4	7		-34.047210204	-27.12267517	0.0000717517	0.9965265914		PIK3CD	CC[C@H](NC1=C2N=C[NH]C2=NC=N1)C/3=N/C4=C(C(=CC=C4)F)C(=O)N3C5=CC=CC=C5	Axon Medchem	2170	3.50759555	2.0582596	1.42284522	2.26130066	1.82258869	-5.58530628	-27.12267517									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183031-08	D-Pantothenic acid			DPI_SARS-CoV-2_General	2019_NPC_02	79-83-4				-10.2267447794	4	7		0	-5.59863007					[H][C@](O)(C(=O)NCCC(O)=O)C(C)(C)CO	Selleck	S2498	-0.57111147	1.12961722	-3.33559926	-2.64480977	0.29703206	-5.29875986	-5.59863007									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182040-01	Bevantolol hydrochloride	144206530	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	42864-78-8	Bevantolol hydrochloride; Calvan; Vantol; 	11.0676527398	-4.9559444758	-7.5990126523	4	7	bevantolol;1-((3,4-DIMETHOXYPHENETHYL)AMINO)-3-M-TOLYLOXY-2-PROPANOL HYDROCHLORIDE;1-((2-(3,4-dimethoxyphenyl)ethyl)amino)- 3-(3-methylphenoxy)-2-propanol;Bevantolol;CI 775;bevantololum;Bevantololum;Calvan;CIPLUS_180342;Bevantolol Hydrochloride;2-propanol, 1-((2-(3,4-dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-, hcl (10ci);Bevantolol hydrochloride;bevantolol hydrochloride;CI-775;LS-122160;BEVANTOLOL;BEVANTOLOL HYDROCHLORIDE;Vantol;LS-122167;CIPLUS_668470;	-15.392379772	-14.49364981	0.0011801481	0.9857138184			Cl.COc1cc(ccc1OC)CCNCC(O)COc2cc(C)ccc2	APAC	555783	0.15491688	0.79696921	0.64930499	-0.6898487	1.48516028	-2.32995115	-14.49364981									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510497-02	Eribulin mesylate		Tubulin Polymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	441045-17-6		17.5410474839	-4.7559444758	-7.4372072827	4	7		-25.029610432	-18.77467536	0.0069287923	0.9640630958		TUBB	CO[C@H]1[C@@H](C[C@H](O)CN)O[C@H]2C[C@H]3O[C@@H](CC[C@@H]4O[C@@H](CC[C@@]56C[C@H]7O[C@@H]8[C@@H](O[C@H]9CC[C@H](CC(=O)C[C@H]12)O[C@@H]9[C@@H]8O5)[C@H]7O6)CC4=C)C[C@@H](C)C3=C	MedChem Express	HY-13442A	-1.01042799	0.39039941	3.49499543	2.25194678	0.56792529	-2.20781661	-18.77467536									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181031-03	Hydroxycitronellal	225144317	Transient receptor potential cation channel subfamily M member 8 Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	107-75-5				4.4489662872	4	7		0	-2.01262325					CC(CCCC(C)(C)O)CC=O	SIGMA	82934	-0.5204173	1.04820778	0.48012478	2.44563173	2.65188042	1.76330098	-2.01262325									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016765-09	Diflunisal	170464956	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	22494-42-4				8.1906996142	4	7		0	-3.35099237					OC(=O)c1cc(ccc1O)c2ccc(F)cc2F	Microsource	01500245	4.98390337	1.22413077	3.61921474	2.3753982	-0.65726032	2.85583617	-3.35099237									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016509-06	Trimethobenzamide hydrochloride	170465132	Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	554-92-7				-9.2522748667	4	7		0	-2.35228511					Cl.COc1c(cc(cc1OC)C(=O)NCc2ccc(OCCN(C)C)cc2)OC	Microsource	01500594	-3.27015709	-1.23879102	-2.35188029	-0.94062759	0.77399381	-4.53783221	-2.35228511									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159384-04	6-Chlorothymol	170465546	Estrogen receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	89-68-9				8.4637499079	4	7		0	-1.520874					Oc1cc(C)c(Cl)cc1C(C)C	Labotest	LTBB003695	4.22385206	2.15505656	0.53617996	1.5652043	3.62635132	1.28563443	-1.520874									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025349-05	Apomorphine	170465297	D2-like dopamine receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	58-00-4		8.7913490634	-5.0559444758	-86.4682127286	-2.1	7		-108.0762845093	-87.46039391	0.0000031502	0.9992746342			Oc3ccc2C[C@@H]1c4c(CCN1C)cccc4c2c3O	Specs	AE-562/J258166	0.61239803	0	-0.64585314	-0.10785863	-12.66558392	-44.92606332	-87.46039391									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022735-06	Methylprednisolone	170465051	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC_01	83-43-2	; Medrone; Metipred;Methylprednisolone, 6-alpha; 6alpha-Methylprednisolone; Urbason;6alpha-Methylprednisolone; 6 Methylprednisolon; Medrol Veriderm; Medrol; Metilprednisolona;Methylprednisolone; 6-Methylprednisolone; Methylprednisolone Base; 6-alfa-Methylprednisolone			10.306909368	4	7		0	-0.07097412				NRC31	OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](C)C1=CC(=O)C=C[C@@]12C	Prestwick	Prestw-279	2.1663883	1.9864637	2.65409081	3.53425139	3.14419124	1.38218405	-0.07097412									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532494-01	PHENINDAMINE		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02			13.9333492831	-4.8559444758	-17.1309347468	-3	7		-48.6863197511	-37.44946012	0.0002898577	0.9929731308			CN1CC\C2=C(/C1)C(C3=CC=CC=C3)C4=CC=CC=C24	SIGMA	A001025678	1.55148096	1.73485181	3.18557933	4.77749456	0.29703206	-7.76024051	-37.44946012									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183844-01	Sitafloxacin hydrate	124894559	DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	127254-12-0	Sitafloxacin	15.6334750258	-4.8059444758	-18.1236516211	4	7	DU-6859A;Sitafloxacin Hydrate;sitafloxacin;sitafloxacinum;SITAFLOXACIN;CIPLUS_215256;Sitafloxacin;3-Quinolinecarboxylic acid, 7-(7-amino-5-azaspiro(2.4)hept-5-yl)-8-chloro-6-fluoro-1-(2-fluorocyclopropyl)-1,4-dihydro-4-oxo-, (1R-(1alpha(S*),2alpha))-;SITAFLOXACIN SESQUIHYDRATE;sitafloxacine;CIPLUS_3818295;	-19.7383817759	-16.44865148	0.0095432076	0.9574670739	7155	TOP2B	N[C@H]2CN(CC12CC1)c3c(F)cc4c(c3Cl)[N@@](C=C(C4=O)C(=O)O)C5C[C@H]5F	Pharmaron	PH-NIH-183573	-1.00117922	-2.49717018	0.71025058	-2.32677782	-3.1152722	-5.32694476	-16.44865148									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178241-04	Dichloro(ethylenediamine)platinum(II)	170466890	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC_01	14096-51-6		8.7913490634	-5.0559444758	-73.4894577232	-2.1	7		-107.6084535267	-90.2993587	0.0000022359	0.9993890088			[Cl-][Pt]1([Cl-])NCCN1	Microsource	01502107	0.83992932	3.57954407	2.14715703	1.51754584	-4.29122469	-40.80491895	-90.2993587									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016692-05	Bromperidol	170465873	Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	10457-90-6		0.5546966259	-6.2559444758	-3.8883296	4	7		-6.756457376	-6.46371448	0.1158987996	0.8188348417			Fc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(Br)cc3	Microsource	01505972	0.94643333	3.7994478	0.09505008	2.20483106	-5.14388672	-2.56110575	-6.46371448									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095107-09	Gliclazide	170465698	K(ATP) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	21187-98-4	; ; Gliclazida;Gliclazide; GLICLAZIDE; Glimicron;GLICLAZIDE			6.3637087912	4	7		0	-2.22554561				KCNJ8	Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2	Vitas	STK803142	0.10650401	4.76213746	3.09278351	0	2.82444298	0	-2.22554561									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532501-01	ARIPIPRAZOLE LAUROXIL		Serotonin 1a (5-HT1a) receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_02			1.8667835223	-5.7289060412	-66.4087841903	4	7		-27.0901928361	-30.51419873	0.7221474611	0.9776522318			CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C4=C(Cl)C(=CC=C4)Cl)C=C12	Astatech	42552	-8.03024347	-5.79592968	-4.69984295	-3.3557047	-59.89829622	-17.4464487	-30.51419873									5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7	0.0000016599999999	0.00000831								
NCGC00263546-01	Moexipril hydrochloride	170465131	Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	82586-52-5				-0.453764107	4	7		0	-5.53203634					Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3cc(OC)c(OC)cc3C[C@H]2C(=O)O	Tocris	2691	2.73532336	2.68659475	-0.48053257	-0.84886467	2.11249198	-2.59301015	-5.53203634									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164507-02	Nifuroxime	124893124		DPI_SARS-CoV-2_General	2019_NPC_02			15.6334750258	-4.8059444758	-3.4587540002	4	7		-14.53144176	-10.8595348	0.0718940942	0.8661434111			[O-][N+](=O)C1=CC=C(CN=O)O1	Enamine	T1302-8796 	3.92379015	0.54286308	2.12606362	-1.63926759	-0.22574436	-1.36226982	-10.8595348									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253658-01	Dapoxetine	170466555	Serotonin Transporter (SERT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	119356-77-3	Dapoxetine hydrochloride (Priligy);Dapoxetine	15.6334750258	-4.8059444758	-60.025073951	-2.2	7		-61.5447842852	-49.65513961	0.0086798657	0.959387924	6532	SLC6A4	CN(C)[C@@H](CCOc2cccc1ccccc12)c3ccccc3	GVK	FFS-12-73-NCI-1987	-5.74117321	0.52900275	-6.75792879	-9.34686528	-9.31254901	-17.9725667	-49.65513961									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167973-02	Eperisone hydrochloride	170465796	skeletal muscle contraction Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	56839-43-1				-16.778138011	4	7		0	-6.65461637					Cl.CC(CN1CCCCC1)C(=O)c2ccc(CC)cc2	Bosche	E3497	-1.65321742	-2.1783825	-5.01394716	-2.35016252	-3.33388779	-4.50488538	-6.65461637									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390625-02	Maropitant		Substance-P receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	147116-67-4		3.1192883571	-5.5059444758	-19.8304317387	4	7		-21.54904152	-19.2075346	0.0002967813	0.9928987428	403815	TACR1	COC1=CC=C(C=C1CN[C@H]2C3CCN(CC3)[C@H]2C(C4=CC=CC=C4)C5=CC=CC=C5)C(C)(C)C	MedChem Express	HY-10053	0.29827279	2.4232484	0.67743372	1.23237378	-3.29586769	-15.21514468	-19.2075346									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185743-02	Cloflucarban	170465550		DPI_SARS-CoV-2_General	2019_NPC_02	369-77-7		5.5469662594	-5.2559444758	-20.4166978422	4	7		-29.0402892039	-25.86690767	0.000269135	0.9932358974			FC(F)(F)c1cc(ccc1Cl)NC(=O)Nc2ccc(Cl)cc2	Enamine	Z124030490	0	1.9335166	2.2057617	2.70093305	-1.06693914	-15.47820368	-25.86690767									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159505-03	Octadecanoic acid, monoester with 1,2-propanediol	29215477		DPI_SARS-CoV-2_General	2019_NPC_02		PROPYLENE GLYCOL MONOSTEARATE; 			8.6972914373	4	7	CERASYNT PA;CIPLUS_158145;PROPYLENE GLYCOL STEARATE SE;PROPYLENE GLYCOL MONOSTEARATE;CIPLUS_679055;PROPYLENE GLYCOL STEARATE;	0	0					CCCCCCCCCCCCCCCCCC(=O)OCC(C)O	SigmaAldrich	S591173	0.95955976	4.48843817	3.39654485	3.21539649	0	0	0									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00159377-04	4-tert-Butylphenol	170465689	UDP-glucuronosyltransferase 1-6 Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	98-54-4				-3.5934168325	4	7		0	-6.24572254					CC(C)(C)c1ccc(O)cc1	Labotest	LTBB002519	2.69890833	1.34629951	0.72871731	0.60451	-3.44871339	-2.27653844	-6.24572254									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00065934-05	Oxcarbazepine	170464811	Sodium channel inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	28721-07-5	; Oxcarbazepina; Oxcarbazepine;Oxcarbazepine;OXCARBAZEPINE; Timox; Trileptal; Oxacarbazepine	17.5410474839	-4.7559444758	-44.3178612315	4	7		-15.56315076	-20.73965172	0.026080809	0.9262539487			NC(=O)N3c1ccccc1C(=O)Cc2ccccc23	Vitas	STK594696	-9.88308765	-5.27035942	-8.05975969	-7.53756239	-8.39212303	-8.9282992	-20.73965172									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167538-02	Clorprenaline hydrochloride	170466032	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	6933-90-0				1.3271439383	4	7		0	1.56143064					Cl.OC(CNC(C)C)c1ccccc1Cl	Sequoia	SRP036805c	0.01210273	-0.3200821	2.8539397	-2.36536484	3.14926661	-2.61192134	1.56143064									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018291-03	Procaterol	170465820	beta2-Adrenoceptor Agonists	DPI_SARS-CoV-2_General	2019_NPC_01	72332-33-3				1.4033729485	4	7		0	0				ADRB2	CC(C)N[C@@H](CC)[C@H](O)c2ccc(O)c1NC(=O)C=Cc12	Bosche	P2505	0.23721347	0	0.83351612	0	0.94401868	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090808-04	Amphotericin B		Macrolide Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	1397-89-3	 Amphotericin B trihydrate; L-AmB; Amphotericinum B; PAME amphotericin B ester; Abelcet; ; liposomal amphotericin B; Ambisome; amphotericinum B; Amphocil; D-AmB cpd; AmBisome;Amphotericin B;Amphotericin B (Abelcet); Amphotericin B solution; amphotericin??B; HAmB-DOC; Amphozone; Amfotericina B; Fungizone; Amphotericin B; Amphotericine B	15.6334750258	-4.8059444758	-28.6238788001	-3	7		-40.4123723083	-34.05743834	0.009323126	0.9578239818			C[C@H]1O[C@@H](O[C@@H]\2C[C@@H]3O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C2)C[C@H](O)[C@H]3C(O)=O)[C@@H](O)[C@@H](N)[C@@H]1O	SIGMA	A9528	-1.85655847	2.47513866	0.65560186	-5.63122382	-3.0680607	-7.89674272	-34.05743834									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159337-04	Efavirenz	170464810	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	154598-52-4	 Sustiva;0   Efavirenz;DMP-266;L-743726; ;Stocrin;Sustiva; efavirenz (EFV or EFZ); Efavirenz;Efavirenz; efavirenz, (R)-isomer	13.9333492831	-4.8559444758	-49.5433367157	-2.2	7		-58.381533972	-46.6553446	0.0000447025	0.9972596752	7015	TERT	FC(F)(F)[C@@]3(C#CC1CC1)OC(=O)Nc2ccc(Cl)cc23	Vitas	STK582240	-3.39118437	-1.41960075	-2.84419098	-3.55431811	-6.45840735	-18.13100259	-46.6553446									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522551-01	Monepantel			DPI_SARS-CoV-2_General	2019_NPC_02	887148-69-8		6.2237985085	-5.2059444758	-12.2725476986	4	7		-14.4447272	-11.620606	0.0431483351	0.9015487516			C[C@](COC1=CC(=CC=C1C(F)(F)F)C#N)(NC(=O)C2=CC=C(SC(F)(F)F)C=C2)C#N	MedChem Express	HY-14774	-0.66822354	2.53413107	-2.03698929	1.12012721	-3.17230235	-6.59056746	-11.620606									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167460-03	Ceftizoxim·Na		Bacterial Penicillin-binding Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	68401-82-1		13.9333492831	-4.8559444758	3.4868903272	4	7		-10.321219612	-7.76768301	0.0821499892	0.8549832399			[H][C@@]2(NC(=O)C(=N\OC)\C1=CSC(N)=N1)C(=O)N3C(=CCS[C@]23[H])C([O-])=O	Enzo	AC3053	1.93530486	4.5808404	2.63238086	0.06781563	0.33980467	1.35287486	-7.76768301									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00248275-02	S-Hydroprene	225144342		DPI_SARS-CoV-2_General	2019_NPC_02	65733-18-8		22.0828704269	-4.6559444758	-27.309115702	-3	7		-74.5146268378	-64.48651477	0.0001178117	0.9955370087			CCOC(=O)\C=C(C)\C=C\C[C@@H](C)CCCC(C)C	SIGMA	46426	2.93879627	3.79080136	0	0	0	2.94532131	-64.48651477									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346470-02	Zilpaterol·HCl		beta1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_02	119520-06-8		12.4181106199	-4.9059444758	-69.7320466229	-2.2	7		-72.1641246608	-57.59882034	0.0015089784	0.9837157476		ADRB1	CC(C)N[C@@H]1CCN2C(=O)NC3=CC=CC(=C23)[C@H]1O	Enzo	AR113	-2.99428889	-2.67735452	-2.38859849	-7.80347497	-14.83021648	-25.72810973	-57.59882034									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016569-09	TRANEXAMIC ACID	225144181	Tissue-type Plasminogen Activator Inhibitor (tpa) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	1197-18-8	; ;TRANEXAMIC ACID; cis-AMCHA; Cyklokapron; Tranexamic acid; Acido tranexamico; Transamin; Rikavarin;Tranexamic acid			7.7645001593	4	7		0	0.90238524			5054	SERPINE1	NC[C@H]1CC[C@@H](CC1)C(O)=O	Microsource	01502026	3.22174618	0	4.39911287	0	3.51469319	0	0.90238524									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00094881-07	Glafenine hydrochloride	170465943		DPI_SARS-CoV-2_General	2019_NPC_01	65513-72-6		9.8640558873	-5.0059444758	-30.3799544747	4	7		-26.7669658799	-25.94104078	0.0002709094	0.9932183627			Cl.OCC(O)COC(=O)c3ccccc3Nc1ccnc2cc(Cl)ccc12	Microsource	01500996	-1.13523588	-3.50624282	-2.8539397	-2.11453081	-2.98177942	-11.34203974	-25.94104078									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015202-08	Ciprofibrate	170466356	PPARalpha Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	52214-84-3				9.6520369054	4	7		0	0				PPARA	ClC2(Cl)CC2c1ccc(OC(C)(C)C(=O)O)cc1	Vitas	STK624758	4.59661608	0	0	0.8729024	4.03238086	4.45652726	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090730-03	D-Camphor	170465497		DPI_SARS-CoV-2_General	2019_NPC_01	464-49-3				-13.8325422335	4	7		0	-5.67792958					CC2(C)[C@H]1CC(=O)[C@]2(C)CC1	Vitas	STK803534	-1.78878319	0.24678085	-3.823938	-3.72990192	-4.7175557	-1.7480563	-5.67792958									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015519-11	Dopamine hydrochloride	170464942	Neurotransmitter	DPI_SARS-CoV-2_General	2019_NPC_01	51-61-6	 ; Tensophoril; Actopamin; Dopamine hydrobromide;DOPAMINE HYDROCHLORIDE; 8   Dopamine; Hydrochloride, Dopamin; Dopamina; Dopamine hydrochloride;Dopamine hydrochloride; Intropin;Dopamine;3-HYDROXYTYRAMINE	0.6223798508	-6.2059444758	-101.6951612294	-1.4	7		-44.0642450951	-47.68446934	0.3847885419	0.9985526325		DRD2	Oc1ccc(CCN)cc1O	Vitas	STK301601	-4.94033355	-2.44581816	-4.02378689	-4.01585271	-46.9649292	-13.4051527	-47.68446934									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00348215-03	Bedaquiline (TMC-207)		ATP synthase subunit c Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	843663-66-1		13.9333492831	-4.8559444758	-18.1730015576	-3	7		-42.9278171479	-35.35651429	0.0000093111	0.9987527887	886937	atpE	COC1=NC2=C(C=C(Br)C=C2)C=C1[C@@H](C3=CC=CC=C3)[C@@](O)(CCN(C)C)C4=CC=CC5=C4C=CC=C5	Adooq	A12327	2.189646	0.92171221	1.37127587	1.40074363	0.60119288	-5.74502067	-35.35651429									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024379-29	EMETINE DIHYDROCHLORIDE			DPI_SARS-CoV-2_General	2019_NPC_02	316-42-7, 483-18-1 [emetine]		17.5410474839	-4.7559444758	-40.0770485477	-2.4	7		-30.34599524	-26.52808828	0.0011510721	0.9858566933			CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(OC)=C(OC)C=C45	Microsource	01500272	-2.90642558	-5.435561	-5.5390169	-5.83916002	-6.20915809	-11.49004134	-26.52808828									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167518-09	Temsirolimus		mTOR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	162635-04-3		3.3913064689	-5.4696329617	-76.1254770444	-2.2	7		-73.6879370207	-66.05146744	0.000069792	0.9965707167		MTOR	CO[C@@H]1C[C@@H](CC[C@H]1OC(=O)C(C)(CO)CO)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	Adooq	A10906	0	4.24819238	0	2.00406894	-1.95090654	-34.93987223	-66.05146744									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00025341-06	Isradipine	170465070	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	75695-93-1	;Isradipine; Isradipine; DynaCirc; Lomir; Isradipine, (S)-Isomer; Dynacirc; Isaradipine; Isradipine, (R)-Isomer; Isradipine, (+-)-Isomer	8.7913490634	-5.0559444758	-39.5444126824	-2.2	7		-71.183049856	-54.3053408	0.0000207514	0.9981351216			O=C(OC)C3=C(C)NC(C)=C(C(=O)OC(C)C)C3c1cccc2nonc12	Tocris	2004	3.19754073	3.84342854	3.36574785	4.19143653	-4.89011826	-25.22994055	-54.3053408									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025195-06	Ozagrel hydrochloride	170466054	Thromboxane Synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	78712-43-3	; ; Ozagrel hydrochloride;Ozagrel hydrochloride; Ozagrel HCL; OZAGREL HCl; Ozapen;Ozagrel			-26.5651540145	4	7		0	-6.89969836			6915	TBXA2R	Cl.O=C(O)/C=C/c2ccc(Cn1ccnc1)cc2	Prestwick	Prestw-979	-6.04410234	-4.09265277	-5.70544223	-5.23992274	-7.06745166	-4.84272575	-6.89969836									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015339-07	Dequalinium dichloride	225144172	Protein kinase C beta Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	522-51-0		1.5998037708	-5.7959332839	-18.2633447858	4	7		-17.612557344	-12.17713112	0.0028394414	0.9775559901			CC1=CC(=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C)N	Prestwick	Prestw-388	2.96032726	0.55464608	0.4508786	0.52925979	-1.20540019	-6.58570049	-12.17713112									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00262945-01	Rivaroxaban	170466121	Coagulation Factor Xa Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	366789-02-8	Bay 59-7939;Rivaroxaban (Xarelto);5-Chloro-n-(((5s)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide;Rivaroxaban;Rivaroxabanum; Rivaroxaban			-14.5235444423	4	7		0	-7.8274315			83541	F10	O=C(NCC3CN(c1ccc(cc1)N2CCOCC2=O)C(=O)O3)c4ccc(Cl)s4	GVK	FFS-12-73-NCI-1931	-3.19754073	-2.32364942	-2.22514684	-3.57940151	-2.05806222	-1.59052797	-7.8274315									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015771-13	Orphenadrine dihydrogen citrate	170464910	Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	4682-36-4	; ; Mebedrol; Norgesic forte; Orphenadrine citrate salt; Orfenadrina; Orphenadrine Hcl;ORPHENADRINE CITRATE;Orphenadrine dihydrogen citrate; Orphenadrine hydrochloride;Orphenadrine hydrochloride			7.3248799447	4	7		0	-3.74641961				CHRM1	O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCOC(c1ccccc1)c2ccccc2C	Microsource	01500447	1.56125191	3.56977057	0.71896858	0	3.30660306	4.20244931	-3.74641961									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016306-08	D-Cycloserine	170465249	NMDA Glycine-Site Receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	68-41-7	D-cycloserine;CYCLOSERINE; Cycloserine;CYCLOSERINE (D);D-Cycloserine;(S)-(-)-Cycloserine; (S)-(-)-Cycloserine			-30.4128672754	4	7		0	-7.76659654			2903	GRIN2A	N[C@@H]1CONC1=O	Microsource	01500215	-5.75847796	-7.45473648	-5.26674953	-6.96566082	-5.15403746	-7.23614005	-7.76659654									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159336-03	Sulbactam	170465248	beta-Lactamase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	68373-14-8	; Sultamicillin (base); B??tamaze; Sodium Sulbactam; Penicillanic Acid Sulfone; Sodium, Sulbacta; Combactam; Sulfone, Penicillanic Aci;Sulbactam sodium;Sulbactam			-40.4769312731	4	7		0	-11.21391093				bla	O=S2(=O)C(C)(C)[C@@H](N1C(=O)C[C@H]12)C(=O)O	Vitas	STK801889	-10.46885968	-6.23793584	-6.84116887	-8.99239973	-9.9299599	-7.31236343	-11.21391093									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00241101-09	Neratinib		EGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	698387-09-6		2.0140336209	-5.6959332839	-66.3819188461	-2.2	7		-49.40776768	-44.0898064	0.0002959743	0.9928974091		EGFR	CCOC1=CC2=C(C=C1NC(=O)\C=C\CN(C)C)C(=C(C=N2)C#N)NC3=CC=C(OCC4=CC=CC=N4)C(=C3)Cl	Glixx	GLXC-90246	2.02316817	-2.59419252	0.31644828	0.92837266	-1.31406981	-15.9996242	-44.0898064									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00093644-07	Amsacrine	404904675	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	54301-15-4		13.9333492831	-4.8559444758	-42.2293778655	-2.2	7		-79.543642682	-58.74518385	0.000851919	0.9878459276		TOP2A	COC1=C(NC2=C3C=CC=CC3=NC4=C2C=CC=C4)C=CC(=C1)N[S+](C)([O-])=O	Glixx	GLXC-03289	3.89604384	4.4191365	0.65868123	0.9096649	-6.76044959	-19.10935738	-58.74518385									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182057-03	Detomidine hydrochloride	170465639	Alpha-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	90038-01-0				3.3134236391	4	7		0	-3.79711541					Cl.Cc2cccc(Cc1cncn1)c2C	Selleck	S1579	0	1.46113812	0	0	1.20286251	4.94435693	-3.79711541									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160662-02	Ambrisentan	170465143	Endothelin ETA Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	177036-94-1				-16.2198408347	4	7		0	-7.60943956				EDNRA	O=C(O)[C@@H](Oc1nc(C)cc(C)n1)C(OC)(c2ccccc2)c3ccccc3	Prestwick	Prestw-1497	-1.72100792	-4.22459501	-2.60047281	-3.72990192	-2.40318733	-2.84059149	-7.60943956									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017323-08	Tetracycline hydrochloride	170464838	30S Ribosomal Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	64-75-5	 Achromycin;; Tetraciclina; Tetracycline Hcl; Bristacycline; Tetrabid; Hostacyclin; Contramibial; Sustamycin;Tetracycline hydrochloride; Tetracycline hydrate; Ulcrux powder;Tetracycline;TETRACYCLINE HYDROCHLORIDE; Achromycin V; 4 Epitetracyclin; 4-Epitetracycline; Topicycline	13.9333492831	-4.8559444758	-59.9057095505	-2.2	7		-85.0799599564	-67.10603027	0.0002253227	0.9938102537		PADI1	Cl.NC(=O)C1=C(O)[C@@H](N(C)C)[C@@H]2C[C@H]4C(=C(O)[C@]2(O)C1=O)C(=O)c3c(O)cccc3[C@@]4(C)O	Microsource	01500566	0.77215404	-3.15439685	1.09429456	-4.06100283	-6.06252855	-23.65973881	-67.10603027									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025000-14	Ketoconazole		Aromatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	13463-41-7	; ; Ketoconazol; Nizoral;Ketoconazole; Ketoconazole; Ketocanazole	6.2237985085	-5.2059444758	-98.8219466554	-2.1	7		-100.8346176244	-88.89001546	0.0000074662	0.9988825658	1588	CYP19A1	CC(=O)N1CCN(CC1)C2=CC=C(OC[C@H]3CO[C@@](C[N]4C=CN=C4)(O3)C5=CC=C(Cl)C=C5Cl)C=C2	SIGMA	K1003	-1.2368988	-0.81853055	0.87007385	-4.37203702	-16.9085926	-51.92845165	-88.89001546									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018107-05	2-Thiosalicylic acid	170465571	prostaglandin biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	147-93-3				-11.1437549065	4	7		0	-5.28757192					OC(=O)c1ccccc1S	SIGMA	T33200	-2.07440757	-2.78789063	-0.93344057	-3.30348408	-2.33213216	-0.58946085	-5.28757192									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00348375-01	TILMICOSIN		Bacterial 70S ribosome Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	108050-54-0		22.0828704269	-4.6559444758	0.7938565998	4	7		-11.4088616199	-8.67405135	0.0448803152	0.8995955387			CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@@H]([C@H]2O)N(C)C)[C@@H](CCN3C[C@H](C)C[C@H](C)C3)C[C@@H](C)C(=O)/C=C/C(=C/[C@@H]1CO[C@@H]4O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]4OC)C	FLUKA	33864	1.85655847	0	2.45911628	-0.17809216	0.54052682	3.05909853	-8.67405135									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263585-01	Zaltoprofen	170465838	Cyclooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	74711-43-6				-0.2444377576	4	7		0	-4.50685661				PTGS2	O=C(O)C(C)c1cc2CC(=O)c3ccccc3Sc2cc1	Sequoia	74711-43-6	1.15460025	-1.18503677	0.80670712	2.29513131	-1.24092778	1.25514508	-4.50685661									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016229-14	Propylthiouracil	170464965	Antithyroid Drugs	DPI_SARS-CoV-2_General	2019_NPC_01	51-52-5	; ; 6 Propyl 2 Thiouraci;Propylthiouracil;6-Propyl-2-thiouracil; Propiltiouracilo;PROPYLTHIOURACIL; Propylthiouracil			3.5006342547	4	7		0	1.95685787			7173	TPO	S=C1NC(CCC)=CC(=O)N1	Microsource	01500515	1.96306247	2.12817944	-1.93268504	1.98409712	-0.30198447	-0.24391483	1.95685787									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185774-02	Erdosteine	170465586	Mucolytic Agent	DPI_SARS-CoV-2_General	2019_NPC_01	84611-23-4	Erdosteine			11.788571365	4	7		0	3.82753289				CAT	O=C1SCCC1NC(=O)CSCC(=O)O	Bosche	E2165	0.0847191	0.55464608	4.33574614	2.43058168	3.98670253	2.58651354	3.82753289									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160567-01	Acetomenaphthone	144205458		DPI_SARS-CoV-2_General	2019_NPC_02	573-20-6	Acetomenaphtone; Acetomenaphthone; Menadiol diacetate; Vitamin K4; 			6.3243711616	4	7	Menadiol diacetate;ACETOMENAPHTONE;Acetomenaphtone;Vitamin K4;Acetomenaphthone (2-Methyl-1,4-naphthalenediol diacetate);Acetomenaphthone;CIPLUS_154611;	0	0					CC(=O)Oc1cc(C)c(OC(C)=O)c2ccccc12	SigmaAldrich	S353078	0	0	4.45137245	0	4.59805622	0	0									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00165976-02	Squalane	170465658		DPI_SARS-CoV-2_General	2019_NPC_02	111-01-3				1.9518782394	4	7		0	-1.53165581					CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C	SIGMA	234311	3.77118546	-1.83649426	-1.41346898	0.13796974	2.27882993	1.1320932	-1.53165581									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00242480-03	Ivacaftor		CFTR Channel Activator	DPI_SARS-CoV-2_General	2019_NPC_02	873054-44-5		4.4061119169	-5.3559444758	-98.4769146892	-2.2	7		-78.6137558549	-77.37715835	0.0000431328	0.9973072544		CFTR	CC(C)(C)C1=CC(=C(NC(=O)C/2=C/NC3=C(C=CC=C3)C2=O)C=C1O)C(C)(C)C	APExBIO	A5047	-2.30988	-5.05671187	-4.79829352	-1.74683722	-15.42428059	-53.27884254	-77.37715835									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389662-01	Luteinizing hormone releasing hormone human acetate salt (LHRH)		Putative gonadotropin-releasing hormone II receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	71447-49-9		12.4181106199	-4.9059444758	-18.3038250732	4	7		-28.424677732	-20.35389811	0.0001575305	0.9948458279		GNRHR2	CC(C)CC(NC(=O)CNC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CO)NC(=O)C(CC2=C[NH]C3=CC=CC=C23)NC(=O)C(CC4=CN=C[NH]4)NC(=O)C5CCC(=O)N5)C(=O)NC(CCCN=C(N)N)C(=O)N6CCCC6C(=O)NCC(N)=O	APExBIO	A1147	0.81620384	1.13423734	-0.21330958	-0.45600168	-3.08675712	-9.00507328	-20.35389811									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183108-01	Propamidine	144206602		DPI_SARS-CoV-2_General	2019_NPC_01	104-32-5	Propamidine; DAPP-Br; Propamidina; 			6.5508189305	4	7	Propamidine;Propamidinum;propamidinum;Propamidina;LS-171900;1,3-di-(p-amidinophenoxymethyl)-propane;propamidine;4,4'-(trimethylenedioxy)dibenzamidine dihydrochloride;CIPLUS_209523;DAPP-H;4,4'-(TRIMETHYLEDEDIOXY)DIBENZAMIDINE;CIPLUS_657475;CIPLUS_206886;propamidine diisethionate;1,3-bis(p-amidinophenoxy)propane;1,3-di-(4-amidinophenoxy)propane;PROPAMIDINE;propamidine isethionate;LS-27580;propamidine dihydrochloride;DAPP-Br;4,4'-(trimethylenedioxy)dibenzamidine;	0	-3.73628045					N=C(N)c1ccc(cc1)OCCCOc2ccc(cc2)C(=N)N	Beta Pharma	86-41342	-1.95822138	1.55154299	4.17489215	3.19311711	4.09836066	1.06712739	-3.73628045									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016741-09	Tinidazole	170465196		DPI_SARS-CoV-2_General	2019_NPC_01	19387-91-8				8.5719578842	4	7		0	2.97584345					O=S(=O)(CCn1c(cnc1C)[N+]([O-])=O)CC	Vitas	STK801761	0	1.51733574	1.40625381	2.23994783	3.54007004	1.31612379	2.97584345									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160421-03	Tetrabenazine	170464675	Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	58-46-8	 ; Nitoman;Tetrabenazine; Tetrabenazine; Tetrabenazina; Xenazine	19.6813789847	-4.7059444758	-36.8001441307	4	7		-26.423540268	-23.26430255	0.0144075433	0.9467609263	6571	SLC18A2	CC(C)CC2CN3CCc1cc(OC)c(OC)cc1C3CC2=O	Chemical Block	A2708/0115225	-4.22869315	-2.49468566	-7.83553898	-5.79175759	-5.46871035	-9.41104731	-23.26430255									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263530-01	Lafutidine	170465978	Histamine H2 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	118288-08-7				5.8148359139	4	7		0	-1.12037718				HRH2	O=S(CC(=O)NC/C=C\COc2cc(CN1CCCCC1)ccn2)Cc3ccco3	Sequoia	SRP01115l	2.34550868	2.61196765	2.3762521	0.34865929	0	1.55495706	-1.12037718									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094981-07	Benzyl benzoate	170465382		DPI_SARS-CoV-2_General	2019_NPC_01	120-51-4		22.0828704269	-4.6559444758	-35.4351425741	4	7		-27.859585312	-28.63298776	0.098206949	0.8359678789			O=C(OCc1ccccc1)c2ccccc2	Microsource	01503002	-6.51852928	-6.34544433	-4.62333358	-5.50079013	-9.36151855	3.04893541	-28.63298776									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165864-04	Pipamperone dihydrochloride	170465949	Serotonin 2c (5-HT2c) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	2448-68-2				-3.3753106693	4	7		0	-3.25467035					Cl.Cl.Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(C(N)=O)N3CCCCC3	Microsource	01505690	-1.64839155	0.8625113	-0.53861714	-1.35199538	-0.14972339	0.40144316	-3.25467035									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164624-02	Adefovir dipivoxil	170464742	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	142340-99-6	 ;Hepsera;Adefovir Dipivoxil (Preveon, Hepsera);Adefovir dipivoxil; Preveon; Adefovir dipivoxil; Adefovir pivoxil; Adefovir Pivoxil			-17.412643331	4	7		0	-10.81341411					CC(C)(C)C(=O)OCOP(=O)(OCOC(=O)C(C)(C)C)COCCn2cnc1c(N)ncnc12	Sequoia	SRP02645a	-2.51494687	-2.89051238	-3.80444054	-4.68808789	-0.98715932	-1.94623711	-10.81341411									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166280-02	Bismuth(III) gallate basic hydrate	225144278		DPI_SARS-CoV-2_General	2019_NPC_02	99-26-3				-27.7608342297	4	7		0	-7.0113685					O[Bi]1OC2=CC(=CC(=C2O1)O)C(O)=O	SIGMA	15102	-4.14113621	-1.85959482	-0.93996859	-1.49895938	-3.12002471	-4.88538144	-7.0113685									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00016557-06	Ethaverine hydrochloride	170466346	Voltage-gated L-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	985-13-7		15.6334750258	-4.8059444758	-51.7680376562	-2.2	7		-47.5590738969	-41.97612228	0.0004175003	0.991547959			Cl.CCOc1ccc(cc1OCC)Cc3nccc2cc(OCC)c(cc23)OCC	Microsource	01501000	-3.60903348	-3.69193931	-6.74855597	-6.21315875	-7.32122012	-14.92962041	-41.97612228									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016530-07	Sulfameter	170465428	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	651-06-9	; Sulfametoxidine; Sulfamethoxydine; 5-Methoxysulfadiazine; ;Sulfameter; Sulfameter;SULFAMETER; Sulfametoxidiazina; Sulla; Sulfamethoxydiazine; Sulphamethoxydiazine			-15.9626431003	4	7		0	-3.32564447					O=S(=O)(Nc1ncc(cn1)OC)c2ccc(N)cc2	Microsource	01501155	-3.95275095	-3.29611259	-4.49172577	-4.02086939	-2.29660458	-2.3934143	-3.32564447									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095150-08	Telmisartan	170464873	Angiotensin AT1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	144701-48-4	; Telmisartan and diuretics;Telmisartan; Telmisartan; Micardis; Telmisartan Sodium;TELMISARTAN	15.6334750258	-4.8059444758	-41.7516811942	-2.2	7		-46.1446121475	-39.02562673	0.0003206084	0.9926067128	189	AGT	O=C(O)c1ccccc1c2ccc(cc2)Cn3c4cc(cc(C)c4nc3CCC)c6nc5ccccc5n6C	Microsource	01505261	-2.91675744	-4.22459501	-3.22926568	-1.55767928	-6.0371517	-12.42441181	-39.02562673									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183858-01	Blonanserin	144206818	Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	132810-10-7		1.6996795075	-5.7696329617	-40.084504457	-2.2	7	AD-5423;BLONANSERIN;blonanserin;AD 5423;2-(4-ETHYLPIPERAZIN-1-YL)-4-(4-FLUOROPHENYL)-5,6,7,8,9,10-HEXAHYDROCYCLOOCTA[B]PYRIDINE;blonanserinum;Blonanserin;blonanserine;Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-;2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine;CIPLUS_702318;	-41.400496816	-33.66708068	0.0000614601	0.9967845213			CCN1CCN(CC1)c3cc(c2ccc(F)cc2)c4CCCCCCc4n3	Pharmaron	PH-NIH-148160	4.58693389	2.99802087	3.79469182	3.64461836	-6.87458763	-23.48188424	-33.66708068									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00485920-01	Tofogliflozin (hydrate)	363681416	Sodium/glucose cotransporter 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1201913-82-7		11.0676527398	-4.9559444758	-11.6272788826	4	7		-17.588878848	-17.15739904	0.0486838025	0.8939220759			CCC1=CC=C(CC2=CC3=C(CO[C@]34O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C=C2)C=C1	MedChem Express	HY-13413	-0.16879003	0.78310887	-4.17008509	-0.14264668	3.25784759	-3.25065765	-17.15739904									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015408-05	RACEPHEDRINE HYDROCHLORIDE		Norepinephrine Transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	134-71-4, 90-81-3 [racephedrine]				-19.3675746758	4	7		0	-5.24663464					CNC(C)C(O)C1=CC=CC=C1	Microsource	01500525	-3.90529261	-2.28464506	-3.25121305	-4.89441807	-5.01627736	-4.52367531	-5.24663464									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262942-01	Etifelmine hydrochloride	170465899		DPI_SARS-CoV-2_General	2019_NPC_01	1146-95-8	Etifelmine;Etifelmine	17.5410474839	-4.7559444758	-44.2597825373	4	7		-29.030326756	-25.59630935	0.0032119444	0.976003356			Cl.CCC(\CN)=C(/c1ccccc1)c2ccccc2	GVK	FFS-11-286-NCI-209	-6.73637838	-4.73770372	-5.39348298	-5.98239145	-9.34121707	-12.03821332	-25.59630935									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178480-03	(+)-Tubocurarine chloride hydrochloride	170464882	Small conductance calcium-activated potassium channel protein 2 Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	57-94-3				-4.135556918	4	7		0	-7.84264024			1135		[Cl-].Cl.Oc7ccc1cc7Oc5cc6[C@H](Cc4ccc(Oc2c3[C@@H](C1)[N+](C)(C)CCc3cc(OC)c2O)cc4)N(C)CCc6cc5OC	Microsource	01500602	0	0	0	0	0	0	-7.84264024									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022408-04	Flumethasone pivalate			DPI_SARS-CoV-2_General	2019_NPC_01	2002-29-1		1.7541047484	-5.7559444758	-22.9605298362	4	7		-14.305239416	-15.25436618	0.0052183272	0.9690882533			C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C/4=C/C(=O)/C=C\[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C	SIGMA	F0891	-2.26321013	0.75988956	-1.41112817	0.79012717	-5.68695123	-13.60841506	-15.25436618									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181028-02	D-Pantethine	225144316	HMG-CoA reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	16816-67-4				-19.4572741525	4	7		0	-1.95178829					CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO	SIGMA	P2125	-4.44170116	-4.71326997	-3.85318418	-6.52920962	-5.30629853	-1.6616698	-1.95178829									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024196-05	Megestrol acetate	170465406	Progesterone Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	595-33-5	; Novacyclin 22; Serial C; Megeron; Megace;Megestrol acetate; Megestrol 17-acetate;Megestrol Acetate; Oraconal; Me-quingestanol	15.6334750258	-4.8059444758	-54.9426459263	-2.2	7		-45.70095238	-43.37532635	0.0002787476	0.9931115738	5241	PGR	CC(=O)[C@@]3(OC(C)=O)CC[C@H]2[C@@H]4C=C(C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	Prestwick Chemical, Inc.	Prestw-956	-8.22259337	-4.8745327	-6.04664766	-5.59109038	-7.84905852	-13.56268103	-43.37532635									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178830-05	Isosorbide dinitrate	170464980		DPI_SARS-CoV-2_General	2019_NPC_02	87-33-2				7.1670103667	4	7		0	0.37102221					[O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+]([O-])=O)CO[C@H]12	Microsource	01500358	4.86716456	2.94994109	2.3089004	0	0	0	0.37102221									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167534-02	Pazufloxacin	170465985	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	127045-41-4				12.4194487327	4	7		0	1.55068259					NC1(CC1)c4c(F)cc2c3N(C=C(C2=O)C(=O)O)[C@@H](C)COc34	Sequoia	SRP010775p	0	3.10702488	4.96237782	0	4.4412233	4.08680947	1.55068259									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166037-04	beta-Glycerol phosphate disodium salt pentahydrate			DPI_SARS-CoV-2_General	2019_NPC_02	13408-09-8				-22.90969092	4	7		0	-6.60229273					OCC(CO)OP([O-])([O-])=O	SIGMA	50020	-4.64056972	-6.8631754	-3.33559926	-4.42672404	-2.42140532	-6.25704622	-6.60229273									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182030-01	Sulbenicillin disodium	144206509		DPI_SARS-CoV-2_General	2019_NPC_02	28002-18-8	Sulbenicillin; Lilacillin; I.M., Kedacilli; Sulbenicilina; Kedacillin I.M.; 			6.7544904344	4	7	Hormona Brand of Sulbenicillin Sodium Salt;Disodium alpha-Sulfobenzylpenicillin;CIPLUS_711187;Sulbenicillin;alpha-Sulfobenzylpenicillin, Disodiu;Sulbenicillin sodium;Sulbenicillinum;SULBENICILLIN SODIUM;Sulbenicilina;4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylsulfoacetyl)amino)-, (2S-(2alpha,5alpha,6beta(S*)))-;sulbenicillinum;I.M., Kedacilli;CIPLUS_180114;Disodium alpha Sulfobenzylpenicilli;SULBENICILLIN;Sulbenicilline;LS-174908;Sulbenicillin Sodium;Kedacillin I.M.;Lilacillin;sulbenicilline;	0	3.68168197					[Na+].[Na+].O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)[C@@H](c1ccccc1)S([O-])(=O)=O)[C@H]3SC2(C)C	ACC	SULBENICILLIN DISODIUM	0.29133622	0	0	0	3.23883754	3.3680947	3.68168197									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167536-03	Tosufloxacin toluenesulfonic acid	170466053	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	115964-29-9		12.4181106199	-4.9059444758	-3.2509434161	4	7		-22.1118299	-19.25985825	0.0094818844	0.9575012662			O=S(=O)(O)c1ccc(C)cc1.O=C(O)C2=CN(c1nc(c(F)cc1C2=O)N3CCC(N)C3)c4ccc(F)cc4F	Sequoia	SRP02535t	0	4.24357227	2.38391036	0	3.92319939	-0.67173995	-19.25985825									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386547-01	Difluprednate		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	23674-86-4		13.9333492831	-4.8559444758	-9.8533415112	-2.4	7		-35.9821148319	-26.65176236	0.0019318103	0.9815265932			CCCC(=O)O[C@@]1(CC[C@H]2C3C[C@H](F)C\4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)COC(C)=O	Axon Medchem	1428	3.61858078	0	4.24509505	2.89736454	0.36356724	-5.00751597	-26.65176236									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00509864-02	ORNIPRESSIN			DPI_SARS-CoV-2_General	2019_NPC_02					-31.9657503626	4	7		0	-11.76330685					NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]2CSSC[C@H](N)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O	MedChem Express	HY-P0083_cm1	-4.70531111	-5.7635889	-5.17334333	-5.79706756	-5.35370577	-10.21702368	-11.76330685									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249895-01	Bornelone	170465560		DPI_SARS-CoV-2_General	2019_NPC_01	2226-11-1		15.6334750258	-4.8059444758	-62.6963695962	-2.2	7		-37.9468719879	-39.16250539	0.0000034452	0.9992422709			CC2(C)C(=C\C=C\C(C)=O)/C1CCC2C1	GVK	FFS-11-286-NCI-70	-8.74059013	-8.3734454	-9.13211962	-9.03253317	-9.54423184	-15.61054932	-39.16250539									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016809-07	Moricizine hydrochloride	174006664	class 1c antiarrhythmic, Na(v)1.5 channel blocker	DPI_SARS-CoV-2_General	2019_NPC_01	29560-58-5	 Moracizina;Moricizine hydrochloride; Ethmozine; Moracizine;Moracizine; ; Ethmozin; Hydrochloride, Moricizin; Etmozin	11.0676527398	-4.9559444758	-1.135072954	4	7		-29.2175610199	-22.68130085	0.0013716434	0.9845136409			Cl.O=C(OCC)Nc1cc2N(c3ccccc3Sc2cc1)C(=O)CCN4CCOCC4	Prestwick	Prestw-1051	4.88224046	3.98025753	3.99454071	1.3218953	4.86474141	-3.40464454	-22.68130085									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253577-01	Lenampicillin hydrochloride	170465777		DPI_SARS-CoV-2_General	2019_NPC_01	80734-02-7				0.5950220415	4	7		0	-4.53220451					Cl.N[C@H](c1ccccc1)C(=O)N[C@@H]4C(=O)N3[C@@H](C(=O)OCC=2OC(=O)OC=2C)C(C)(C)S[C@@H]34	GVK	FFS-11-286-NCI-173	0	2.07686857	0	0	0	2.1952335	-4.53220451									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016612-05	Sulfadoxine	170464751	Dihydropteroate Synthase (DHPS) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	2447-57-6	; Sulfadoxine Roche Bran; Ro 4439; Ro 4 439; Sulphorthodimethoxine; Ro 4-4393; Sulphormetoxin; Sulformetoxine; Suldox; Ro 6-2153; Borgal; Sulfadoxin;SULFADOXINE; Fanasil; Fansimef; Sulfadoxina; Sulfadoxine;Sulfadoxine			-12.6316895029	4	7		0	-3.51321893					O=S(=O)(Nc1ncnc(OC)c1OC)c2ccc(N)cc2	Microsource	01506086	-2.42780723	-1.56620324	-4.08715362	-4.64795445	-0.64203421	-2.12409167	-3.51321893									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094887-05	Fenoprofen calcium salt dihydrate	170465299	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	71720-56-4				13.1690497314	4	7		0	2.88966059					[Ca+2].O.O.[O-]C(=O)[C@@H](C)c2cc(Oc1ccccc1)ccc2.[O-]C(=O)[C@@H](C)c2cc(Oc1ccccc1)ccc2	Microsource	01501011	2.41328395	1.87895521	3.88243036	2.3753982	4.93579658	1.25006352	2.88966059									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159458-05	Atorvastatin calcium	170465113	HMG-CoA Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	134523-03-8		13.9333492831	-4.8559444758	-35.2602244996	-2.2	7		-60.6247243468	-49.70216218	0.000222407	0.9938520861			[Ca+2].O[C@H](CCn1c(c(c(c1C(C)C)C(=O)Nc2ccccc2)c3ccccc3)c4ccc(F)cc4)C[C@@H](O)CC([O-])=O.[O-]C(=O)C[C@H](O)C[C@H](O)CCn4c(c1ccc(F)cc1)c(c2ccccc2)c(C(=O)Nc3ccccc3)c4C(C)C	Prestwick	Prestw-1232	2.85382325	-1.59552374	0.90419439	0.13795871	-2.12911739	-13.03928045	-49.70216218									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179408-03	Iodixanol	170464924		DPI_SARS-CoV-2_General	2019_NPC_01	92339-11-2				13.8151407221	4	7		0	0					OCC(O)CNC(=O)c1c(I)c(c(I)c(C(=O)NCC(O)CO)c1I)N(CC(O)CN(C(C)=O)c2c(I)c(c(I)c(c2I)C(=O)NCC(O)CO)C(=O)NCC(O)CO)C(C)=O	SIGMA	D1556	3.36697892	4.74259047	3.24876313	0	3.62127595	4.89354134	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016640-06	Todralazine hydrochloride	170465782	histone acetylation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	3778-76-5				-0.6222057733	4	7		0	-3.67544549					Cl.O=C(OCC)NNc2nncc1ccccc12	Microsource	01501174	2.77636579	0	1.17228437	0.06772519	-1.84489672	-0.20326236	-3.67544549									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021193-03	AMCINONIDE			DPI_SARS-CoV-2_General	2019_NPC_01	51022-69-6		6.9832167823	-5.1559444758	-42.2476061079	-2.2	7		-37.3051633671	-34.47821348	0.0006511644	0.9894087044			CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]4[C@@H]5CCC/6=C/C(=O)/C=C\[C@]6(C)[C@@]5(F)[C@@H](O)C[C@]24C	FLUKA	A2428	-1.74037228	-2.0841987	0.23153226	-4.85363835	-6.30614627	-19.74693836	-34.47821348									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262960-01	Resocortol butyrate	170466824	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	76738-96-0	Resocortol	15.6334750258	-4.8059444758	-25.1080612015	-3	7		-45.6271323857	-36.21200983	0.0001849968	0.9944004356			CCC(=O)[C@@]4(OC(=O)CCC)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12	GVK	FFS-11-286-NCI-149	0.8496115	0.58885332	0.90906875	-2.06938069	-0.78414455	-8.07459729	-36.21200983									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00483049-02	Gamithromycin			DPI_SARS-CoV-2_General	2019_NPC_02	145435-72-9				-31.5923966532	4	7		0	-8.79512914					CCCN1C[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)C(C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@H]1C	Ark Pharm	AK105038	-5.76891951	-4.8257063	-7.35332036	-7.32642705	-7.3545137	-6.11612176	-8.79512914									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181307-01	Febantel	144206335		DPI_SARS-CoV-2_General	2019_NPC_02	58306-30-2	Febantel; Bayer brand of febantel; Rintal; Armadose; 	15.6334750258	-4.8059444758	-12.4788644976	4	7	N-{2-[2,3-Bis-(methoxycarbonyl)-guanido]-5-(phenylthio)-phenyl}-2-methoxyacetamide;Bayer brand of febantel;febantel;DIMETHYL ((2-(2-METHOXYACETAMIDO)-4-(PHENYLTHIO)PHENYL)IMIDOCARBONYL)DICARBAMATE;BAY H 5757;FEBANTEL / PRAZIQUANTEL / PYRANTEL AS PYRANTEL EMBONATE;FEBANTEL / IMIDACLOPRID / IVERMECTIN / PRAZIQUANTEL / PYRANTEL AS PYRANTEL EMBONATE;FEBANTEL / PYRANTEL EMBONATE;CARBAMIC ACID, ((2-((METHOXYACETYL)AMINO)-4-(PHENYLTHIO)PHENYL)CARBONIMIDOYL)BIS-, DIMETHYL ESTER;Febantel;febantelum;Bay Vh 5757;LS-50021;((2-((methoxyacetyl)amino)-4-(phenylthio)phenyl)carbonimidoyl)bis(carbamic acid), dimethyl ester;Febantelum;2'-(2,3-bis(methoxycarbonyl)guanidino)-5'-phenylthio-2-methoxyacetanilide;Rintal;BAY VH 5757;dimethyl 2-(methoxyacetyl)amino-4-(phenylthio)phenyl(carbonimidoyl)bis(carbamate);CIPLUS_183199;FEBANTEL;Armadose;	-19.854849448	-16.96237454	0.0081742698	0.9608093028			O=C(OC)N/C(NC(=O)OC)=N\c2ccc(Sc1ccccc1)cc2NC(=O)COC	FLUKA	33981	1.42662258	0.89399155	-2.22920232	-0.51212497	-1.4566452	-3.13322059	-16.96237454									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015383-07	NCGC00015383-07			DPI_SARS-CoV-2_General	2019_NPC_02			15.6334750258	-4.8059444758	9.5268977361	4	7		-9.386196068	-6.15516339	0.0923351814	0.8439022786			OC[C@H]1NC[C@@H](O)[C@@H](O)[C@@H]1O	BIOMOL	S-110	0	4.55311973	4.37167436	3.55681313	2.93942922	2.85137166	-6.15516339									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168463-06	Bretylium tosylate		norepinephrine secretion Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	61-75-6				-26.4042912135	4	7		0	-7.24444656					CC[N+](C)(C)CC1=C(Br)C=CC=C1	Prestwick	Prestw-942	-3.5815857	-5.97149391	-5.71716556	-5.0487571	-3.47646318	-8.62927471	-7.24444656									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178714-04	Topiramate	170464746	Na channel blocker	DPI_SARS-CoV-2_General	2019_NPC_02	97240-79-4	 Ortho brand of topiramate; ; Topamax;Topiramate; Topiramate; Epitomax; McN 4853; Cilag brand of topiramate; Topiramato			3.240442106	4	7		0	-0.66593731					NS(=O)(=O)OC[C@]23OC[C@H]1OC(C)(C)O[C@H]1[C@@H]3OC(C)(C)O2	Microsource	01505801	1.14453513	2.00281827	-0.06328966	-0.1332928	1.73704346	0.48853814	-0.66593731									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164789-04	Fulvestrant	170464917	Estrogen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	129453-61-8	; Faslodex;Fulvestrant;Fulvestrant (Faslodex)	2.2082870427	-5.6559444758	-36.1052107057	-1.2	7		-35.573800124	-32.97816677	0.000989874	0.986881808	2099	ESR1	FC(F)(F)C(F)(F)CCCS(=O)CCCCCCCCC[C@@H]2Cc1cc(O)ccc1[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@H]23	Prestwick	Prestw-1424	4.01627783	0	0	4.90377195	-4.39845068	-31.18658399	-32.97816677									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181308-01	Sorbitan monohexadecanoate	144206336		DPI_SARS-CoV-2_General	2019_NPC_02	26266-57-9	Sorbitan monopalmitate; Span 40; Palmitato de sorbitano; 	12.4181106199	-4.9059444758	-2.3337421774	4	7	sorbitan monopalmitate;SPAN-40;CIPLUS_158227;Palmitato de sorbitano;sorbitan monohexadecanoate;Span 40;SORBITAN PALMITATE;Palmitate de sorbitan;SORBITAN MONOPALMITATE;Sorbitani palmitas;sorbitan palmitate;CIPLUS_204868;palmitate de sorbitan;Sorbitan monopalmitate;sorbitani palmitas;	-14.8431955479	-12.78599629	0.0160456502	0.943654286			O[C@H](COC(=O)CCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1O	SigmaAldrich	388920	3.66020024	2.20148306	-0.18049272	0.38584758	0.61069791	-0.25366404	-12.78599629									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160584-01	Chlorphenesin	144207103		DPI_SARS-CoV-2_General	2019_NPC_02	104-29-0	1,2-Propanediol, 3-(4-chlorophenoxy)-; Mycil; Clorfenesina; Chlorphenesin carbamate; 			-31.9264297247	4	7	CIPLUS_150785;CHLORPHENESIN;Clorfenesina;1,2-Propanediol, 3-(4-chlorophenoxy)-;chlorphenesinum;Chlorphenesin carbamate;4-CHLOROPHENYL GLYCERYL ETHER;Mycil;Chlorphenesinum;1,2-PROPANEDIOL, 3-(4-CHLOROPHENOXY);LS-120277;3-(P-CHLOROPHENOXY)PROPANE-1,2-DIOL;Chlorphenesine;chlorphenesine;3-(4-CHLOROPHENOXY)PROPANE-1,2-DIOL;Chlorphenesin;	0	-6.68315654					Clc1ccc(OCC(O)CO)cc1	SigmaAldrich	S427640	-5.82441213	-4.73330407	-6.17191346	-7.13934944	-5.7339068	-8.93461105	-6.68315654									6.38E-9	3.1899999999E-8	1.59E-7	7.97E-7	0.00000399	0.0000199	0.0000997								
NCGC00182036-01	Peplomycin sulfate	144206501		DPI_SARS-CoV-2_General	2019_NPC_02	70384-29-1	Peplomycin sulfate; Peplomycin Sulfate (1:1); Peplomycina; Sulfate, Peplomyci; Pepleo; 			3.3705515539	4	7	nk 631;Peplomycin;Sulfate, Peplomyci;Pepleo;Peplomycine;bleomycin pep;Peplomycina;NK63;Peplomycin Sulfate;CIPLUS_188638;LS-177021;PEPLOMYCIN SULFATE;Peplomycinum;LS-44906;Bleomycinamide, N1-(3-((1-phenylethyl)amino)propyl)-, (S)-;NK-631;peplomycinum;LS-102345;CIPLUS_699356;Peplomycin Sulfate (1:1);Peplomycin sulfate;NK 63;PEPLOMYCIN;peplomycine;	0	-3.16320221					O=C(N)C(N)CNC(CC(=O)N)c1nc(N)c(C)c(n1)C(=O)NC(C(O[C@@H]3O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]3O[C@H]2O[C@H](CO)[C@@H](O)[C@H](OC(=O)N)[C@@H]2O)c4cncn4)C(=O)NC(C)C(O)C(C)C(=O)NC(C(=O)NCCc5nc(cs5)c6nc(cs6)C(=O)NCCCN[C@@H](C)c7ccccc7)C(C)O.O=S(=O)(O)O	ACC	PEPLOMYCIN SULFATE	3.02665958	-0.27489663	0.00234406	3.30893529	2.7825963	-1.54077415	-3.16320221									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165993-02	Picolinic acid	170466822		DPI_SARS-CoV-2_General	2019_NPC_01	98-98-6				8.8976627698	4	7		0	4.98846671					O=C(O)c1ccccn1	Bosche	P0843	2.48105923	-0.79409681	-0.22665789	0.2683924	4.49931483	2.82026526	4.98846671									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166206-04	1,2-Benzenedicarboxaldehyde	170466016		DPI_SARS-CoV-2_General	2019_NPC_01	643-79-8				2.7135055568	4	7		0	-0.08618286					O=Cc1ccccc1C=O	Vitas	STK802214	-0.52525839	2.51911941	-1.41112817	-0.29849249	0.58112978	3.06926165	-0.08618286									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017400-10	Dihydroergotamine	174006617	serontonin, dopamine, epinephrine receptor agonist	DPI_SARS-CoV-2_General	2019_NPC_01	511-12-6	 Dihydroergotamine; ;Dihydroergotamine;DIHYDROERGOTAMINE MESYLATE; Dihydergot plus; Migranal; Dihidroergotamina; Venelbin; Silentan	6.2237985085	-5.2059444758	-80.8824620667	-2.2	7		-83.9596081179	-78.20334085	0.0000466201	0.9972000166			CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@]8(C)O[C@]7(O)N([C@@H](Cc5ccccc5)C(=O)N6CCC[C@H]67)C8=O	Microsource	01500248	0.33645584	1.13616928	-1.27952036	-2.76669928	-11.67081155	-42.48691499	-78.20334085									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389390-01	Abiraterone acetate		Cytochrome P450 17A1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	154229-18-2		6.9832167823	-5.1559444758	-42.6424898274	-2.2	7		-56.5094182528	-50.00713504	0.0000651087	0.9966890148			CC(=O)OC1CCC\2(C)C3CCC\4(C)C(C\C=C4C5=CN=CC=C5)C3C\C=C2C1	APExBIO	A8202	3.03590834	0.81544965	2.27608354	-1.03126535	-2.57823824	-25.71871477	-50.00713504									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182073-03	Nedocromil	170464978	mast cell degranulation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	69049-73-6				4.6411269169	4	7		0	-1.80754412					O=C(O)C2=CC(=O)c3cc1c(OC(=CC1=O)C(=O)O)c(CCC)c3N2CC	Kemprotec	69049-73-6	1.32488612	4.03566726	-0.89777549	0.46535556	1.58971556	1.53137918	-1.80754412									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091051-04	4-Aminobenzoic acid	170466660	Carbonic anhydrase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	150-13-0				-5.1484441243	4	7		0	-2.84403437					OC(=O)c1ccc(N)cc1	Specs	AE-562/J257681	-1.93885702	-1.24367777	0.21690917	-1.55767928	-0.39841648	-0.36079069	-2.84403437									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016913-14	Astemizole	170465888	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	68844-77-9		11.0676527398	-4.9559444758	-49.0468068876	-2.2	7		-70.413487612	-53.7223391	0.0000224679	0.9980593862			Fc1ccc(cc1)Cn4c5ccccc5nc4NC3CCN(CCc2ccc(OC)cc2)CC3	Enzo	NH101	1.83235301	0.45202434	1.04067656	-2.19981438	-5.84936304	-24.87423141	-53.7223391									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093347-05	Mestranol	170465357	Estrogen Receptor (ER) Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	72-33-3	; Sequens;Mestranol; Infecundin; Aconcen;Ethynylestradiol 3-methyl ether; Norinyl 1-50; Angravid; Estirona; Orthonovin; Bisecurin I; Ovosiston; Ovaras; Ortho Novum; Sequence-Ovosiston; Bisecurin; Sesquelan; ; Ovulen; Ortho-Novum; Norinyl; Femigen; C-quens; Gestranol; Mestranol; Enovid-E	3.499899101	-5.4559444758	-4.1490984246	4	7		-11.237370404	-8.94780867	0.0534735509	0.8881416003	2099	ESR1	COc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)c4cc3	Prestwick Chemical, Inc.	Prestw-846	2.52462905	0.80142693	4.6330823	-0.92557755	0.9567071	-7.10401951	-8.94780867									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021141-05	Phenyltoloxamine citrate	170465477	Histamine H1 receptor Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	1176-08-5		12.4181106199	-4.9059444758	-0.1440252179	4	7		-13.100909992	-7.58409166	0.0311012253	0.9189691437			O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCOc2ccccc2Cc1ccccc1	SIGMA	P8404	3.51221165	2.70481589	0.76283785	0.60451	-0.22077856	-1.73789319	-7.58409166									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532510-01	PREDNISOLONE VALERATE ACETATE			DPI_SARS-CoV-2_General	2019_NPC_02			9.8640558873	-5.0059444758	-31.0954253916	-2.2	7		-55.0583646484	-47.77148837	0.0000016615	0.9994735528			CCCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CC\C4=C\C(=O)\C=C/[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O	Biosynth	Q-101384	1.92143171	1.62396914	1.34783526	2.37822417	0.54891524	-16.21570838	-47.77148837									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181749-01	Cefminox sodium	144206473	Peptidoglycan biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	75498-96-3	Cefminox; Tencef; Meicelin; Alteporina; 			8.1777641054	4	7	cefminox Sodium;Alter brand of cefminox sodium;Tedec Meiji brand of cefminox sodium;CEFMINOX;Cefminox sodium;Alteporina;Cefminox Sodium;cefminox;MT 141;CEFMINOX SODIUM;Cefminox;CIPLUS_685509;cefminox sodium;Tencef;CIPLUS_733759;cefminoxum;LS-177815;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7alpha,7(S*)))-;CIPLUS_213346;Meicelin;MT-141;	0	-0.55177663					[Na+].[O-]C(=O)[C@H](N)CSCC(=O)N[C@]3(OC)C(=O)N2C(=C(CSc1nnnn1C)CS[C@@H]23)C(=O)O	ACC	CEFMINOX SODIUM	3.59083447	1.45533507	0	1.55508266	3.78537652	1.84611048	-0.55177663									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094594-13	Bacitracin			DPI_SARS-CoV-2_General	2019_NPC_02	1405-87-4		6.0306904668	-5.2196329617	-33.068692529	-2.2	7		-54.7970793844	-40.75536317	0.0000627076	0.9967515545			CCC(C)C(N)\C1=N\C(CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC3=CN=C[NH]3)NC(=O)[C@@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC	Enzo	AC3027	4.95040348	4.58546051	2.03933335	3.56149007	1.00040396	-12.86170613	-40.75536317									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00532509-01	ISAVUCONAZONIUM SULFATE		Lanosterol 14-alpha demethylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			11.0676527398	-4.9559444758	-17.4153512776	4	7		-14.35121058	-13.20934215	0.0622696764	0.8774784296			CNCC(=O)OCC1=C(N=CC=C1)N(C)C(=O)OC(C)[N+]2=C[N](C[C@@](O)([C@@H](C)C3=NC(=CS3)C4=CC=C(C=C4)C#N)C5=CC(=CC=C5F)F)N=C2	Astatech	40206	1.35725682	-3.24562822	-3.57469351	-1.76086804	-1.3093173	-6.37448328	-13.20934215									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178145-03	Thonzylamine hydrochloride	170465519		DPI_SARS-CoV-2_General	2019_NPC_02	63-56-9				-16.1216693468	4	7		0	-4.78047852					Cl.COc1ccc(cc1)CN(CCN(C)C)c2ncccn2	Microsource	01503135	-3.21625934	-5.2322761	-1.76507817	-3.51472067	-0.59168785	-5.24239008	-4.78047852									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386382-03	Lurasidone (Hydrochloride)			DPI_SARS-CoV-2_General	2019_NPC_02	367514-88-3		8.7913490634	-5.0559444758	-64.1029927492	-2.2	7		-51.8431391256	-51.79565238	0.0002564282	0.9933938859			O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]4CCCC[C@H]4CN5CCN(CC5)C6=NSC7=C6C=CC=C7	MedChem Express	HY-B0032	-2.52260168	-6.60444917	-6.89857247	-4.91780277	-6.83648979	-24.94363021	-51.79565238									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00538144-01	NCGC00538144-01		Taenia pisiformis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			15.6334750258	-4.8059444758	-21.6167537994	4	7		-20.080863816	-16.73405318	0.0394113138	0.9064551302			CC1CCCC(C)N1C(=S)NC2=CC(=CC=C2)C(F)(F)F	Pharmaron	PH-NIH-2017-009-L1-6-0	0.81620384	-2.12294116	-1.98541994	-4.58574001	-4.3699356	-6.03156708	-16.73405318									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179435-06	Ifomide	170464854	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC_01	3778-73-2	 Isofamide (Ifosfamide?);Ifosfamide; Asta Z 4942; Ifosfamida;; Holoxan; Iso Endoxa;IFOSFAMIDE; Iphosphamide; Iso-Endoxan; Ifosfamide Sterile			9.8424705267	4	7		0	0				H2AFX	O=P1(NCCCl)OCCCN1CCCl	Microsource	01505480	4.61598044	0	4.60871049	2.07690571	0	2.92189644	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263447-01	alpha-Santonin	170465728		DPI_SARS-CoV-2_General	2019_NPC_01	481-06-1				-17.4005263248	4	7		0	-3.93399407					O=C1C=C[C@]2(C)CC[C@H]3[C@H](C)C(=O)O[C@@H]3C2=C1C	Specs	AE-562/J257885	-2.09377194	-4.16106727	-3.28775804	-1.27674518	-4.75308329	-6.4230906	-3.93399407									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015542-07	Ibudilast	170466049	Phosphodiesterase 4A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	50847-11-5				8.1518952189	4	7		0	0					CC(C)C(=O)c1c2ccccn2nc1C(C)C	Prestwick	Prestw-1286	0	3.06887874	4.75494139	0.98828605	2.84728214	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00242597-01	Saxagliptin	124950715	DPP-IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	361442-04-8	Saxagliptin			8.2231018479	4	7		0	3.56898431			1803	DPP4	O=C([C@@H](N)C13CC2CC(C1)CC(O)(C2)C3)N5[C@H](C#N)C[C@@H]4C[C@@H]45	ACC	API0007051	0.75278968	-0.19302661	0.0658039	3.27840068	1.3525859	3.84165862	3.56898431									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179291-04	Fursultiamine Hydrochloride			DPI_SARS-CoV-2_General	2019_NPC_02	2105-43-3				16.0010427245	4	7		0	2.09770252					CC1=NC(=C(CN(C=O)C(/C)=C(\CCO)SSCC2CCCO2)C=N1)N	Prestwick	Prestw-1007	0	4.1326896	4.26384754	4.86635643	4.26538032	3.78147313	2.09770252									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015439-11	Flumazenil	170464960	GABA(A) BZ Site Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	78755-81-4	 Lanexat; Anexate; Romazicon; ; Ro- 15-1788; Flumazenil;Flumazenil; Roche Brand of Flumazenil;FUMAZENIL; Ro 15178;FlUMAZENIL; Ro 15-1788; Ro 15 178			10.513873148	4	7		0	0.36500976			2554	GABRA1	O=C(OCC)c3ncn2c3CN(C)C(=O)c1cc(F)ccc12	Microsource	01505701	4.05441386	2.30898918	4.12614852	2.02924725	0	2.37308806	0.36500976									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015089-17	Amiloride hydrochloride	170465124	Epithelial Sodium Channels (ENaC) Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	2609-46-3	 Amilorida; uranidil-A;Amiloride HCl;Amiloride hydrochloride; Amiloride hydrochloride; ;;AMILORIDE; Moduretic;AMILORIDE HYDROCHLORIDE; Esmaloride; Esmalorid;Amiloride; uranidil A;Amiloride..HCl; Midamor; Moducren			-8.6984442417	4	7		0	-5.04930167			6339	SCNN1D	Clc1nc(C(=O)NC(=N)N)c(N)nc1N	Enzo	CA200	-0.079878	0.02199037	0.32414516	-3.53425139	-4.95609806	-0.41668784	-5.04930167									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095787-05	(-)-Inosine			DPI_SARS-CoV-2_General	2019_NPC_01	58-63-9				-13.5025670513	4	7		0	-7.3458214					OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C2N=CNC3=O	Bosche	I0819	-3.24595164	2.13795294	-3.09278351	-3.87036898	-3.86489367	-1.94115555	-7.3458214									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016324-09	Sulfamethoxypyridazine	170466374		DPI_SARS-CoV-2_General	2019_NPC_01	80-35-3				-28.592690821	4	7		0	-8.24820664					O=S(=O)(Nc1ccc(OC)nn1)c2ccc(N)cc2	Microsource	01501156	-5.77784233	-6.09133335	-4.85242865	-8.11448065	-5.51438867	-4.51750597	-8.24820664									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095255-08	dl-alpha-Tocopheryl acetate	170465444		DPI_SARS-CoV-2_General	2019_NPC_01	52225-20-4				3.6805921202	4	7		0	0					CC(=O)Oc2c(C)c(C)c1O[C@@](C)(CCc1c2C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C	Microsource	00310040	1.34824389	0	3.95554581	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181034-03	Liarozole	170465610	Cytochrome P450 CYP17A1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	145858-50-0		15.6334750258	-4.8059444758	2.7495871949	4	7		-19.527705256	-14.18975438	0.0325944651	0.9160529475		CYP17A1	Cl.Clc1cc(ccc1)C(c2ccc3ncnc3c2)n4ccnc4	Tocris	2705	4.98390337	3.10797273	2.81007043	4.06100283	-1.14957113	0.98074089	-14.18975438									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015385-18	Dipyridamole	170464694	Phosphodiesterase PDE3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	58-32-2	; ; Prandiol; Dipyridamole;DIPYRIDAMOLE; Asasantin; Dipiridamol;Dipyridamole; Persantine	12.4181106199	-4.9059444758	-51.3646434357	-3	7		-84.2926034811	-82.27421358	0.0001673399	0.9946728912	8654	PDE5A	OCCN(CCO)c2nc1c(nc(nc1c(n2)N3CCCCC3)N(CCO)CCO)N4CCCCC4	Enzo	EI127	-3.24595164	-0.17347961	0.61660696	-3.03760002	3.28122621	-8.96387012	-82.27421358									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00319022-01	Octotiamine	170465976		DPI_SARS-CoV-2_General	2019_NPC_01	137-86-0				1.7349900888	4	7		0	0					Nc1nc(C)ncc1CN(C=O)C(\C)=C(/CCO)SSCCC(CCCCC(=O)OC)SC(C)=O	GVK	FFS-11-286-NCI-250	2.56335778	0	0	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00177995-02	Sarafloxacin hydrochloride	170466185	Antibacterial	DPI_SARS-CoV-2_General	2019_NPC_02	91296-87-6	;Sarafloxacin hydrochloride;SARAFLOXACIN HYDROCHLORIDE;Sarafloxacin HCl; Sarafloxacin Hcl; Sarafloxacin HCl; Sarafloxacino	6.0306904668	-5.2196329617	-27.9236670291	4	7		-10.535849024	-12.33411026	0.1072213374	0.8284054617			Cl.Fc1ccc(cc1)N2C=C(C(=O)O)C(=O)c3cc(F)c(cc23)N4CCNCC4	Vitas	STK713346	-4.1735069	-3.74460024	-5.44525445	-5.19374225	-1.47090274	-7.23412251	-12.33411026									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00178357-03	BUCLADESINE			DPI_SARS-CoV-2_General	2019_NPC_02	362-74-3				-1.8841878948	4	7		0	-3.6483851					CCCC(=O)NC1=C2N=C[N](C3O[C@@H]4CO[P](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1	Microsource	01503043	2.62896252	-1.61472891	-1.605682	1.01723453	-0.43485493	0.15031943	-3.6483851									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00014482-03	Methdilazine hydrochloride	124878446	ion channel	DPI_SARS-CoV-2_General	2019_NPC_02			6.2237985085	-5.2059444758	-72.1785110295	-2.2	7	Methdilazine hydrochloride	-68.4286885444	-64.80997003	0.0000688551	0.9965941			CN1CC[C@@H](C1)CN2C3=C(SC4=C2C=CC=C4)C=CC=C3	NCGC	NSC-169091	-2.53647483	-1.62396914	-0.88839924	-2.47643991	-11.55573509	-35.39083051	-64.80997003									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164127-07	4-(1,1,3,3-Tetramethylbutyl)phenol	170465157		DPI_SARS-CoV-2_General	2019_NPC_01	140-66-9		11.0676527398	-4.9559444758	-13.31468682	-3	7		-43.863856426	-37.01807305	0.0003318338	0.9924751998			Oc1ccc(cc1)C(C)(C)CC(C)(C)C	SIGMA	290823	4.67891463	2.70970264	1.01630475	4.91885519	2.82444298	-7.12434575	-37.01807305									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164594-02	Loteprednol etabonate	170465195	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC_01	82034-46-6	Loteprednol etabonate; Lotemax; Loteprednol etabonate; Alrex; 	9.8640558873	-5.0059444758	-24.5490341333	4	7		-17.864921036	-15.72076753	0.0456472475	0.8981322021		NR3C1	O=C(OCCl)[C@@]4(OC(=O)OCC)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Sequoia	SRP01583l	-2.88771089	0.85762455	-3.11715532	-4.93892192	-5.20479115	-8.06443417	-15.72076753									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249936-01	Iocarmic acid	170465965		DPI_SARS-CoV-2_General	2019_NPC_01	10397-75-8				4.598964302	4	7		0	1.013916					O=C(Nc1c(I)c(c(I)c(c1I)C(=O)O)C(=O)NC)CCCCC(=O)Nc2c(I)c(C(=O)NC)c(I)c(C(=O)O)c2I	GVK	FFS-11-286-NCI-245	0	0	0	0	2.86504593	2.95238579	1.013916									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018098-07	Iodoquinol	170465640		DPI_SARS-CoV-2_General	2019_NPC_01	83-73-8		0.4943738883	-6.3059444758	-205.000767459	-1.1	7		-85.8328279162	-93.97987377	0.0000130631	0.9985209867			Oc1c(I)cc(I)c2cccnc12	Vitas	STK070581	-5.17270593	-7.72839446	-11.80814506	-31.2614443	-77.75211897	-88.89679354	-93.97987377									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015216-17	Chlorpropamide	170464898	"Sulfonylurea receptor 1, Kir6.2 Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC_01	94-20-2				11.8065047639	4	7		0	0.56272338					O=S(=O)(NC(=O)NCCC)c1ccc(Cl)cc1	Microsource	01500185	1.90012829	0	2.02529795	2.98743322	4.7175557	4.8986229	0.56272338									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159346-04	Terbinafine	170465174	Fungal Squalene Monooxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	91161-71-6	 ;Terbinafine; terbinafine, (Z)-isomer; Lamasil;TERBINAFINE HYDROCHLORIDE; Terbinafine; TERBINAFINE HCl;Terbinafine?HCl; Terbinafine HCl	8.7913490634	-5.0559444758	-90.008958276	-2.1	7		-88.037210714	-85.21963955	0.0034394727	0.975060346			CC(C)(C)C#C\C=C\CN(C)Cc2cccc1ccccc12	Vitas	STK802069	-11.20470554	-4.60087473	-8.04026224	-5.95730805	1.8804243	-36.92260786	-85.21963955									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390545-01	Valrubicin		DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	56124-62-0		1.9681378985	-5.7059444758	-128.3509324626	-1.1	7		-98.3612091508	-88.26999001	0.000104073	0.9958065336		TOP2A	CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C3=C(C1)C(=C4C(=O)C5=C(C(=O)C4=C3O)C(=CC=C5)OC)O	MedChem Express	HY-13772	2.41161645	4.53463928	-0.5274138	-12.61604658	-34.57690754	-76.23543781	-88.26999001									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182079-09	TRANDOLAPRIL			DPI_SARS-CoV-2_General	2019_NPC_02	87679-37-6				11.8197245591	4	7		0	2.52580507					[H][C@@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC3=CC=CC=C3)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O	Microsource	01505264	4.31686282	0	2.22920232	4.47349344	2.75883373	1.36226982	2.52580507									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167480-02	N-Hydroxymethylsuccinimide	225144289		DPI_SARS-CoV-2_General	2019_NPC_02					-8.7806073385	4	7		0	-3.91951672					OCN1C(=O)CCC1=O	Innovapharm	BBS-00004790	0.12717057	-5.88833191	-3.20901995	0.23150855	0.092674	-0.95358888	-3.91951672									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510315-02	Finafloxacin			DPI_SARS-CoV-2_General	2019_NPC_02	209342-40-5				-2.2884323374	4	7		0	-3.03477144					OC(=O)\C1=C\N(C2CC2)C3=C(C#N)C(=C(F)C=C3C1=O)N4C[C@@H]5NCCO[C@H]5C4	MedChem Express	HY-13451	2.21276793	-2.9915221	-2.07918239	-1.58314431	2.81111138	0.71871477	-3.03477144									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00244253-12	Ruxolitinib		Jak1/2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	941678-49-5				-14.0061446827	4	7		0	-9.24701517				JAK1	N#CC[C@H](C1CCCC1)[N]2C=C(C=N2)C3=NC=NC4=C3C=C[NH]4	MedChem Express	HY-50856	-1.47286642	-4.92734875	-1.80727128	-0.76935669	-0.14970416	-3.98346486	-9.24701517									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021277-04	Hydrocortisone acetate	170466796		DPI_SARS-CoV-2_General	2019_NPC_01	50-03-3				8.0588987356	4	7		0	1.14572508					CC(=O)OCC(=O)[C@@]4(O)CCC3C2CCC1=CC(=O)CC[C@]1(C)C2[C@@H](O)C[C@@]34C	Prestwick	Prestw-1486	0.23237238	4.63996872	-0.53861714	0	4.51454093	1.82936125	1.14572508									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015767-10	Oxybutynin chloride		Muscarinic Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	1508-65-2	 Oxibutinina; ;; Oxytrol; Tropax;Oxybutynin Chloride; Esoxybutynin Chloride; Ditropan; Oxybutinin;OXYBUTYNIN CHLORIDE; Oxybutynin Hcl; Oxybutynin Chloride;Oxybutynin chloride	17.5410474839	-4.7559444758	-19.1311242254	4	7		-28.5677802879	-21.72315024	0.0035783601	0.9746052111		CHRM1	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C2=CC=CC=C2	SIGMA	O2881	-1.83235301	1.61507074	-1.70358997	-1.01086111	-2.48946861	-5.62020428	-21.72315024									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016016-18	Triamterene	170464706	Heart phosphodiesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	396-01-0				-51.6368067231	4	7		0	-17.08955413					Nc2nc(N)nc1nc(N)c(nc12)c3ccccc3	Vitas	STK300348	-14.37077917	-8.90121436	-8.71779874	-8.77668247	-9.09759935	-11.57579145	-17.08955413									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182059-03	Febuxostat	170465220	Xanthine Oxidase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	144060-53-7	 ; Febuxostat;Febuxostat	11.0676527398	-4.9559444758	-8.7917702225	4	7		-17.756571448	-15.21380954	0.0086868191	0.9595289047	7498	XDH	CC(C)COc1ccc(cc1C#N)c2nc(C)c(s2)C(=O)O	Tocris	4427	-0.1379711	-0.06108437	-0.38751188	3.20816716	0.43394407	-4.16179684	-15.21380954									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390657-02	Lesinurad (sodium)		Solute carrier family 22 member 12 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1151516-14-1				0.2266081168	4	7		0	-5.08015031					[Na]OC(=O)CSC1=NN=C(Br)[N]1C2=C3C=CC=CC3=C(C=C2)C4CC4	MedChem Express	HY-15258A	0	0	0	0	4.38419314	-0.22547914	-5.08015031									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00509861-02	Auristatin PE		microtubule polymerization Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	149606-27-9		15.6334750258	-4.8059444758	-1.2126481149	4	7		-13.568972084	-8.39081007	0.0658051968	0.8736503125			CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCC2=CC=CC=C2)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C	MedChem Express	HY-14672	4.47871627	0.42274019	1.39002836	0.60566377	-0.35406221	-1.80853063	-8.39081007									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274273-01	NCGC00274273-01	225144371	Mu opioid receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_02			9.8640558873	-5.0059444758	-28.7509368739	-2.2	7		-45.5396470576	-40.56033868	0.0001209546	0.9954792894			C[C@@]12CCCCC[C@@H](CC3=C1C=C(O)C=C3)[C@@H]2N	GVK	FFS-11-286-NCI-03	0	0	0.53444598	0.79741833	2.12199701	-13.99379932	-40.56033868									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178027-08	VALSARTAN		Neprilysin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	137862-53-4				0.3809831162	4	7		0	-6.66888646					CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=N[NH]N=N3)[C@@H](C(C)C)C(O)=O	Microsource	01505209	1.1260376	0.59368431	-2.09793488	2.8225335	3.1152722	0.05636979	-6.66888646									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016354-11	Butylparaben	170465688		DPI_SARS-CoV-2_General	2019_NPC_01	94-26-8		22.0828704269	-4.6559444758	-3.9111460171	4	7		-13.543015388	-10.86917949	0.0015947547	0.9833887504			Oc1ccc(cc1)C(=O)OCCCC	Microsource	01505995	0	0.22723386	0	1.59781273	0.24108004	0.53864526	-10.86917949									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093560-05	Finasteride	170464818	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	98319-26-7	; ; Propecia; Proscar; Finasterida;Finasteride; Finasteride			-4.6456470196	4	7		0	-6.21023548			374	AR	CC(C)(C)NC(=O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]1[C@H]3CC[C@H]2NC(=O)C=C[C@]12C	Prestwick Chemical, Inc.	Prestw-717	-1.76457774	2.52400616	-2.8539397	1.87874683	1.49469624	-3.29285025	-6.21023548									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178317-03	Foscarnet trisodium	170465060	Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	63585-09-1				0.4431681752	4	7		0	-3.54870599					[Na+].[Na+].[Na+].[O-]C(=O)P([O-])([O-])=O	Microsource	01502019	4.09798369	-1.86429496	3.92629963	-0.63962676	-0.39334112	-1.69215915	-3.54870599									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016978-04	Repaglinide	225144184	Insulin Secretagogues	DPI_SARS-CoV-2_General	2019_NPC_01	135062-02-1	; ; Prandin; Repaglinide;Repaglinide; Repaglinida; Novonorm	22.0828704269	-4.6559444758	1.4024834412	4	7		-21.0827735639	-16.31897797	0.0059433383	0.9668762395		INS	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)C(O)=O	Prestwick	Prestw-1046	1.44990681	3.35475359	0	2.79679936	3.88011978	2.88632552	-16.31897797									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161621-03	Cepharanthine	170465994		DPI_SARS-CoV-2_General	2019_NPC_01	481-49-2		4.4061119169	-5.3559444758	-147.7329534357	-2.1	7		-91.4393838638	-88.38812704	0.0000392789	0.9974308629			COc8ccc1cc8Oc7ccc(C[C@H]4c5c(Oc3cc2c(CCN(C)[C@@H]2C1)cc3OC)c6OCOc6cc5CCN4C)cc7	Vitas	STK801907	-11.70817902	-6.96117477	-12.48568156	-16.40705345	-33.15484952	-64.36302658	-88.38812704									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016338-10	Dibucaine	170464829	Sodium channel protein type X alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	85-79-0				2.2405668062	4	7		0	-2.64125117					CCN(CC)CCNC(=O)c1cc(OCCCC)nc2ccccc12	Microsource	01500236	0	4.74747722	0	0	0	0.45225875	-2.64125117									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00043225-04	Disodium 2-hydroxybutanedioate	170465632		DPI_SARS-CoV-2_General	2019_NPC_01	676-46-0				1.2366294316	4	7		0	-0.50188842					[Na+].[Na+].[O-]C(=O)C(O)CC([O-])=O	Specs	AE-562/J255939	1.87592283	1.63950448	-0.37288879	-1.37206211	1.37288738	-0.93500686	-0.50188842									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253607-01	Watanidipine	170465844	calcium ion transmembrane transport Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	116308-55-5		0.1754104748	-6.7559444758	-199.8253601736	-1.1	7		-79.0102883464	-83.83057464	0.0002013204	0.9941517512			[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCc3ccc(cc3)N4CCN(CC4)C(c5ccccc5)c6ccccc6	GVK	FFS-11-286-NCI-247	-4.30130952	-3.30588609	-20.63561697	-49.36162741	-70.68212962	-74.53630774	-83.83057464									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018215-06	Acebutolol hydrochloride	170465309	Beta-1 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	34381-68-5				4.1595979839	4	7		0	-0.1267395					Cl.CC(C)NCC(O)COc1ccc(cc1C(C)=O)NC(=O)CCC	Microsource	01500665	2.97000944	0	0	0	1.05313912	2.11901011	-0.1267395									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167525-02	Tazarotene	170464671	Retinoid RAR Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	118292-40-3	 ; Tazarotene;Tazarotene; Zorac; Tazorac;Tazarotene (Avage)	8.7913490634	-5.0559444758	-66.5163304305	-2.2	7		-46.6986883992	-49.14957796	0.0004009095	0.9917178041	5915	RARB	O=C(OCC)c1ccc(nc1)C#Cc2ccc3SCCC(C)(C)c3c2	Sequoia	SRP01178t	-6.56694019	-8.63732988	-7.38709756	-6.19309203	-5.14896209	-24.36607551	-49.14957796									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00531792-01	PYRETHRIN II		Plasmodium falciparum Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	121-29-9		12.4181106199	-4.9059444758	-43.3227107052	-3	7		-74.9477714856	-73.63839604	0.0000129398	0.9985281723			COC(=O)C(/C)=C/[C@H]1[C@H](C(=O)O[C@@H]2CC(=O)/C(=C2/C)C\C=C\C=C)C1(C)C	Toronto Research	P991240	2.03704132	-0.89861166	-1.2118797	-0.48874027	0	-5.80139045	-73.63839604									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159435-03	Amiloxate	29215377		DPI_SARS-CoV-2_General	2019_NPC_02		Amiloxate; Neo Heliopan; 	8.9963577251	-5.0459332839	-77.535236209	-1.1	7	3-MPMBEPA;3-(4-methoxyphenyl)-2-propenoic acid 3-methylbutyl ester;CIPLUS_669269;3-(4-Methoxy-phenyl)-acrylic acid pentyl ester;3-(4-methoxyphenyl)-3-methylbutylester, propenoic acid;AMILOXATE;ISOAMY 4-METHOXYCINNAMATE;Amiloxate;Neo Heliopan;amiloxatum;	-96.5140845723	-93.76397279	1.873E-7	0.9998232731			COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1	Chembridge	CB_5258581	2.15265093	2.09984061	2.19638546	1.84505297	-1.56120048	-71.71645998	-93.76397279									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00024246-15	Daunorubicin	170465048	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	20830-81-3	 WP900 hydrochloride; Cerubidine;Daunorubicin hydrochloride; ;; Daunoblastine;DAUNORUBICIN; Daunorubicin; Daunomycin HCL; Dauno-Rubidomycine; Daunomycin, hydrochloride; Daunomycin hydrochloride; Daunoblastin; Dauno Rubidomycin;Daunomycin hydrochloride; (-)-Daunorubicin	6.2237985085	-5.2059444758	-69.3880573916	-2.2	7		-89.5598717383	-75.49111556	0.0000279632	0.9978337543		TOP2A	CC(=O)[C@@]4(O)C[C@H](O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1)c5c(O)c3C(=O)c2c(OC)cccc2C(=O)c3c(O)c5C4	Microsource	01500223	1.02147024	4.3321035	4.63795667	0.46404294	-10.46287367	-42.30906042	-75.49111556									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095188-05	Pantoprazole	170466337	H+/K+-ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	102625-70-7	; ; Protonix; PANTOPRAZOLE;Pantoprazole; Pantoprazol; Pantoprazole;PANTOPRAZOLE	13.9333492831	-4.8559444758	-44.9959151955	4	7		-18.68022174	-25.37324783	0.0059628777	0.9668296247		ATP4A	COc3c(OC)ccnc3CS(=O)c1nc2cc(ccc2n1)OC(F)F	Microsource	01505818	-8.25163992	-6.1157671	-6.05639638	-9.60443475	-6.93549206	-8.5319376	-25.37324783									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015444-07	Fenoldopam	170465321	Dopamine D1 Receptor (DRD1) Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	67227-56-9	 ;FENOLDOPAM MESYLATE;Fenoldopam; Fenoldopam bromide;Fenoldopam bromide; Fenoldopam mesilate; Hydrobromide, Fenoldopa; Fenoldopam Hydrobromide; Fenoldopam hydrochloride;Fenoldopam hydrochloride	12.4181106199	-4.9059444758	-19.0981132424	-2.4	7		-30.6851537399	-25.57096145	0.0038602726	0.9735541688	1812	DRD1	Oc1ccc(cc1)C3CNCCc2c3cc(O)c(O)c2Cl	Sequoia	67227-57-0	-0.38486675	-0.8918318	3.38037094	-1.67306293	-0.58112978	-7.90182428	-25.57096145									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094812-05	Acetarsol	170466503		DPI_SARS-CoV-2_General	2019_NPC_01	97-44-9				-8.2506550962	4	7		0	-4.02017693					Oc1ccc(cc1NC(C)=O)[As](O)(O)=O	Microsource	01500616	-2.75216034	1.32675251	-1.02117911	-0.98577771	-2.30675532	-3.12007724	-4.02017693									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179680-05	Clonidine	170464900	alpha1-Adrenoceptor Agonists	DPI_SARS-CoV-2_General	2019_NPC_01	4205-90-7				4.04470362	4	7		0	-0.4309143				ADRA1A	Clc2cccc(Cl)c2\N=C1/NCCN1	Enzo	AC152	0.21058747	2.45070491	3.83368672	-0.87039406	0.06344212	0.42685096	-0.4309143									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167489-03	Sarpogrelate hydrochloride	174006666	5HT(2A) and 5HT(2B) inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	135159-51-2	 ; Sarpogrelate;Sarpogrelate; Anplag; Sarpogrelate HCl	13.9333492831	-4.8559444758	-2.9070729958	4	7		-9.7434538999	-8.95287825	0.0068602041	0.9645995374			Cl.O=C(O)CCC(=O)OC(COc2ccccc2CCc1cccc(OC)c1)CN(C)C	Tocris	3739	0.2444751	0.78921006	0.77258658	1.42222891	-0.81459676	0.18801768	-8.95287825									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181044-04	Selenomethionine		dietary supplement	DPI_SARS-CoV-2_General	2019_NPC_02	3211-76-5				8.0869793785	4	7		0	-4.92317937				CAT	C[Se]CC[C@H](N)C(O)=O	Enzo	RD122	4.48334066	3.81852203	4.37636249	3.70179828	0	3.09564074	-4.92317937									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00178579-04	Levobupivacaine hydrochloride	170465452	Sodium channel protein type IV alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	27262-48-2				4.3736462068	4	7		0	0.75631451					Cl.Cc2cccc(C)c2NC(=O)[C@@H]1CCCCN1CCCC	Specs	AN-153/I154112	0.49480913	0	0.48756475	0	4.72162156	0	0.75631451									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00507845-01	Netarsudil	384569326	ROCK Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1253952-02-1		2.6938104809	-5.5696329617	-114.3012232665	-2.2	7		-85.0897112695	-79.71269562	0.0000217968	0.998088272		ROCK1	CC1=CC(=C(C=C1)C(=O)OCC2=CC=C(C=C2)[C@@H](CN)C(=O)NC3=CC4=C(C=C3)C=NC=C4)C	Selleck	S8226	0.0901755	-0.93557255	-3.21370807	-3.55681313	-14.00803175	-47.40229237	-79.71269562									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00168747-01	Methoxyflurane	144206179	synaptic transmission Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	76-38-0				5.016915475	4	7	Ethane, 2,2-dichloro-1,1-difluoro-1-methoxy-;CIPLUS_149389;METHOXYFLURANE;Penthrane;Pentrane;methoxyflurane;Methoxyflurane;methoxyfluranum;LS-1693;Methoxyfluranum;Anecotan;Metoxiflurano;	0	-1.37468487					ClC(Cl)C(F)(F)OC	Alfa Aesar	L17285	0	0.44353069	4.95768969	0	0	2.80909433	-1.37468487									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160469-01	Gamolenic acid	144205388	prostanoid metabolic process Interacts	DPI_SARS-CoV-2_General	2019_NPC_02	506-26-3	Gamolenic acid; 	8.0180122623	-5.0959332839	-48.5813374789	-2.2	7	CIS,CIS,CIS-6,9,12-OCTADECATRIENOIC ACID;GAMMA-LINOLENIC ACID (18:3 N-6);CIPLUS_710725;gamma-Linolenic Acid;cis,cis,cis-6,9,12-Octadecatrienoic acid;GAMMA-LINOLENIC ACID;GAMMA-LINOLENIC ACID (18:3 n-6);CIS-LINOLEIC ACID/GAMMA-LINOLENIC ACID;GAMOLENIC ACID;NCGC00160469-03;EVENING PRIMROSE OIL;6,9,12-Octadecatrienoic acid, (Z,Z,Z)-;acide gamolenique;Gamolenic acid;acidum gamolenicum;CIPLUS_153754;gamma-Linolenic acid;	-55.350449505	-47.50035675	0.0019514962	0.9814121738			O=C(O)CCCC\C=C/C/C=C\C/C=C\CCCCC	FLUKA	FLUKA_62172	0.24046799	0	0	1.26043542	-17.29201815	-30.09676813	-47.50035675									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00015443-17	Flecainide acetate	170464874	Sodium Channel Protein Type 5 Subunit alpha (Nav1.5) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	54143-55-4	Tambocor; Flecainide, (R)-Isomer; Flecainide acetate salt; ; Flecainide, (S)-Isomer;Flecainide; Flecainide; Flecainida;Flecainide acetate			8.0076551289	4	7		0	0.14194824			6331	SCN5A	FC(F)(F)COc2cc(C(=O)NCC1CCCCN1)c(OCC(F)(F)F)cc2	Enzo	AC130	0	4.36631075	3.36574785	0	3.58067299	0.03557091	0.14194824									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016393-07	2,2'-Dihydroxy-4-methoxybenzophenone	170465540		DPI_SARS-CoV-2_General	2019_NPC_01	131-53-3		13.9333492831	-4.8559444758	-21.5527331565	-3	7		-40.10093534	-31.75077945	0.0035435417	0.9746941019			O=C(c1ccc(cc1O)OC)c2ccccc2O	Microsource	01500255	1.9485392	2.24546143	1.27952036	-0.60952668	-4.11866213	-7.57152294	-31.75077945									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015122-11	Bupropion hydrochloride	170464747	Dopamine Transporter (DAT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	31677-93-7	; ;Bupropion hydrochloride; 3   Bupropion Hcl; Bupropion hydrochloride; Bupropine HCl; Amfebutamonum;BUPROPION; Amfebutamona; Bupropion hydrocloride;Bupropion?HCl; Wellbutrin	12.4181106199	-4.9059444758	-4.1313542552	4	7		-23.352754044	-15.71062837	0.0089192441	0.9589074307	6531	SLC6A3	Cl.O=C(c1cc(Cl)ccc1)C(C)NC(C)(C)C	Microsource	01504174	0	3.52090307	3.38037094	3.87538566	-0.09389433	-4.74617613	-15.71062837									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094619-06	Chloramphenicol sodium succinate	170465429	Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	982-57-0				-22.2423125603	4	7		0	-8.34452866					[Na+].O=[N+]([O-])c1ccc(cc1)[C@@H](O)[C@@H](COC(=O)CCC([O-])=O)NC(=O)C(Cl)Cl	SIGMA	C3787	-4.66439135	-2.17216019	-4.28212815	-6.56934307	-4.49423946	-3.49103105	-8.34452866									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159387-03	Laureth 10s	170465561		DPI_SARS-CoV-2_General	2019_NPC_01	13081-34-0		12.4181106199	-4.9059444758	-58.2502450523	-2.2	7		-80.2386737081	-78.67988137	0.0000900941	0.9961005792			OCCOCCSCCCCCCCCCCCC	Labotest	LT00000347	-0.14765328	-2.94915337	-5.19363408	-3.31351745	-0.28168299	-12.09919203	-78.67988137									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018295-05	Isoxsuprine hydrochloride	170465968		DPI_SARS-CoV-2_General	2019_NPC_01	579-56-6				-5.3263913906	4	7		0	-5.30785024					Cl.Oc1ccc(cc1)C(O)C(C)NC(C)COc2ccccc2	Prestwick Chemical, Inc.	Prestw-68	-2.68922615	0.56930633	-1.24052546	0.243309	0.66233568	-1.24498196	-5.30785024									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183040-01	NCGC00183040-01	124894246		DPI_SARS-CoV-2_General	2019_NPC_02		Betamethasone benzoate; Uticort; 	9.8640558873	-5.0059444758	-51.4503231355	-2.2	7	LS-118426;betamethasone 17-benzoate;9-FLUORO-11.BETA.,17,21-TRIHYDROXY-16.BETA.-METHYLPREGNA-1,4-DIENE-3,20-DIONE 17-BENZOATE;BETAMETHASONE 17-BENZOATE;BETAMETHASONE BENZOATE;W 5975;Betamethasone benzoate;CIPLUS_173148;PREGNA-1,4-DIENE-3,20-DIONE, 17-(BENZOYLOXY)-9-FLUORO-11,21-DIHYDROXY-16-METHYL-, (11.BETA.,16.BETA.)-;Betamethasone Benzoate;Uticort;Pregna-1,4-diene-3,20-dione, 17-(benzoyloxy)-9-fluoro-11,21-dihydroxy-16-methyl-,(11-beta,16-beta)-;	-77.7002330804	-61.89411597	0.0000839978	0.9962359515			C[C@H]1C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C5=CC=CC=C5)C(=O)CO	USP	1067307	3.29024949	3.22714777	-1.2118797	0.27360101	-4.1845876	-28.21777527	-61.89411597									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179514-05	Ceforanide		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	60925-61-3		13.9333492831	-4.8559444758	-25.8548282218	-2.2	7		-41.22901108	-32.2741759	0.0004760101	0.9909688254			NCC1=C(CC(=O)N[C@H]2[C@H]3SC\C(=C(/N3C2=O)C(O)=O)CSC4=NN=N[N]4CC(O)=O)C=CC=C1	Prestwick	Prestw-470	1.77345141	-1.75795237	-1.22594407	0.28295489	-1.30456479	-10.35794814	-32.2741759									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022678-23	Rifampicin			DPI_SARS-CoV-2_General	2019_NPC_02	[13292-46-1]		5.5469662594	-5.2559444758	-73.858380119	-2.2	7		-92.7305332198	-77.83380107	0.0000038518	0.999197829			CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C4=C(O)C(\C=N\N5CCN(C)CC5)=C(NC(=O)C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C	Tocris	4121	4.45096996	4.80260574	2.94648508	-0.9096649	-11.57474515	-46.5520481	-77.83380107									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00484057-01	Methenolone (acetate)	363681150		DPI_SARS-CoV-2_General	2019_NPC_02	434-05-9		8.7913490634	-5.0559444758	-5.1304788187	4	7		-11.769966228	-9.80830519	0.1157825911	0.8184363843			CC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)\C=C(C)/[C@]4(C)[C@H]3CC[C@]12C	MedChem Express	HY-A0094B	4.16425813	-2.06287972	-0.43833947	0.92369572	0.9386213	-3.33521233	-9.80830519									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00485994-01	Bivalirudin (Trifluoroacetate)			DPI_SARS-CoV-2_General	2019_NPC_02	128270-60-0				-28.8440947513	4	7		0	-9.7987918					CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]3CCCN3C(=O)[C@@H](N[2H])CC4=CC=CC=C4)C(=O)N5CCC[C@H]5C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(O)=O	MedChem Express	HY-15664	-3.72031723	-2.25692439	-4.14664448	-4.71669434	-4.02775468	-7.06971063	-9.7987918									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00346655-02	Linagliptin		DPP-IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	668270-12-0		8.7913490634	-5.0559444758	-42.1843722737	-2.2	7		-63.5777243975	-56.11948818	0.0000681772	0.9966112178		DPP4	CC#CC[N]1C(=NC2=C1C(=O)N(CC3=NC4=CC=CC=C4C(=N3)C)C(=O)N2C)N5CCC[C@@H](N)C5	Selleck	S3031	0	0.10164245	3.3027824	2.81785656	-1.32357484	-22.92841037	-56.11948818									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386241-01	Avanafil		Phosphodiesterase 5A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	330784-47-9		12.4181106199	-4.9059444758	-16.5474114337	4	7		-28.181896016	-26.81824668	4.48E-8	0.9999137247			COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N3CCC[C@H]3CO)C(=O)NCC4=NC=CC=N4)C=C1	Selleck	S4019	0	0	0	0.03273858	0	-3.47613679	-26.81824668									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378877-01	Methylnaltrexone Bromide			DPI_SARS-CoV-2_General	2019_NPC_02	73232-52-7				9.7101775374	4	7		0	-0.03805356			4988	OPRM1	[H][C@]12OC3=C4C(C[C@@H]5[C@](O)(CCC1=O)[C@]24CC[N+]5(C)CC6CC6)=CC=C3O	MedChem Express	HY-75766	1.72720757	4.29901361	4.9389372	3.1125038	-0.90060119	0.79387448	-0.03805356									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017246-10	PICROTIN			DPI_SARS-CoV-2_General	2019_NPC_02	21416-53-5				2.0698644252	4	7		0	-2.16905294					[H][C@@]12OC(=O)[C@@]([H])([C@]1([H])C(C)(C)O)[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@@]2([H])[C@]35C	Microsource	00100346	1.98617309	-2.01205849	-1.78383066	3.32764306	3.3006202	-0.15501691	-2.16905294									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021666-04	Nalmefene	170465281	Kappa opioid receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	55096-26-9				-35.1559608317	4	7		0	-11.56878153					C=C1CC[C@@]6(O)[C@H]3Cc5ccc(O)c4O[C@@H]1[C@]6(CCN3CC2CC2)c45	Prestwick Chemical, Inc.	Prestw-1490	-10.76900733	-7.45962323	-6.41709927	-3.81518549	-6.94056743	-6.50947711	-11.56878153									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017020-06	NCGC00017020-06			DPI_SARS-CoV-2_General	2019_NPC_01					-0.2064920988	4	7		0	-1.91123165					CCCC1=NC=C(C[N+]2=C(C)C=CC=C2)C(N)=N1	Vitas	STL018669	0.33645584	0.18325311	0.25590407	-1.61787945	-0.37811501	2.37816962	-1.91123165									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165736-04	Acadesine	170465608	AMPK Activator	DPI_SARS-CoV-2_General	2019_NPC_01	2627-69-2	AICAR/AR-100/SCH-900395; AICA ribonucleoside; Acadesine (AICAR); Acadesine;Acadesine; Acadesina; AICA riboside; Z-riboside; 			-22.8253152938	4	7		0	-10.56500469			5562	PRKAA1	NC(=O)c2ncn([C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c2N	Tocris	2840	-4.44654225	-0.95047279	-2.7223319	-3.8653523	-7.74755113	-5.0968037	-10.56500469									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510944-01	Cyclopentamine hydrochloride			DPI_SARS-CoV-2_General	2019_NPC_02	538-02-3				-1.1507121987	4	7		0	-2.61142558					CNC(C)CC1CCCC1	SantaCruz Bio	sc-500096	0.62660408	-0.55672342	-1.605682	-1.33994341	2.64952594	0.57309282	-2.61142558									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263480-01	Medroxyprogesterone acetate	170464622	Progesterone Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	71-58-9		11.0676527398	-4.9559444758	-9.1591705262	4	7		-22.837844268	-19.03153689	0.0015829822	0.9833504249		PGR	CC(=O)[C@@]3(OC(C)=O)CC[C@H]2[C@@H]4C[C@H](C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	Vitas	STK801943	3.06827904	0.94943288	0	0.61501766	1.47565525	-4.75854942	-19.03153689									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00188440-01	Zinc dibutyldithiocarbamate	144206589		DPI_SARS-CoV-2_General	2019_NPC_02	136-23-2		0.0622379851	-7.2059444758	-104.5986143383	-1.4	7	ZINC DIBUTYLDITHIOCARBAMATE	-44.2089561089	1.03220283	0.1346804299	0.8562000986			[Zn+2].[S-]C(=S)N(CCCC)CCCC.CCCCN(CCCC)C([S-])=S	APAC	878050	4.95040348	0	-13.96357329	-44.65308795	-50.78772901	-25.68113491	1.03220283									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00509863-01	Naloxegol (oxalate)		Mu-type opioid receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	1354744-91-4				8.8701231286	4	7		0	1.11306664			4988	OPRM1	COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3CC4=C5C(=C(O)C=C4)O[C@@H]1[C@@]25CCN3CC=C	MedChem Express	HY-A0118A	2.93879627	3.13936566	0	3.95435306	1.91288644	0	1.11306664									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263533-01	Penciclovir	170464955	Human herpesvirus 1 DNA polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	39809-25-1				-13.0862103033	4	7		0	-6.48906238			1487316		OCC(CO)CCn2cnc1c2NC(N)=NC1=O	Sequoia	SRP01095p	-1.65323264	-0.99934029	-2.30313665	-4.0961196	-2.46409176	-2.36292495	-6.48906238									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253591-01	Nepaprazole	170465906		DPI_SARS-CoV-2_General	2019_NPC_01	156601-79-5		13.9333492831	-4.8559444758	-47.8678254768	-2.2	7		-50.9975706688	-42.34113204	0.0002202726	0.9938838034			COc4ccnc1c4CCCCC1S(=O)c2nc3ccccc3n2	GVK	FFS-11-286-NCI-253	-3.88981676	-1.16060302	-3.38037094	-4.29177014	-6.9456428	-17.00289649	-42.34113204									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015467-20	Glybenclamide	170464964	Sulfonylurea receptor 2 Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	10238-21-8		15.6334750258	-4.8059444758	-38.2848739701	4	7		-17.976917284	-21.17056602	0.0599346335	0.8799533098			O=C(NC1CCCCC1)NS(=O)(=O)c3ccc(CCNC(=O)c2cc(Cl)ccc2OC)cc3	Enzo	KC120	-8.99232687	-5.28990642	-3.27313495	-8.64624878	-4.82921383	-8.05935261	-21.17056602									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016605-08	Nifenazone	170466050		DPI_SARS-CoV-2_General	2019_NPC_01	2139-47-1				6.867077724	4	7		0	-0.3041748					O=C3C(NC(=O)c1cccnc1)=C(C)N(C)N3c2ccccc2	Microsource	01503230	2.92643962	0.36406284	1.57685652	2.5559987	2.78384002	-0.06097871	-0.3041748									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510749-15	Loracarbef		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	121961-22-6		19.6813789847	-4.7059444758	-15.9157953294	4	7		-15.322670404	-13.18555867	0.0744771624	0.8632507869			N[C@@H](C(=O)N[C@H]1[C@H]2CCC(=C(N2C1=O)/C(O)=O)/Cl)C3=CC=CC=C3	USP	1370203	1.45899327	-2.4232484	-4.23571881	-1.67200617	-2.10298695	-3.80026306	-13.18555867									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263824-02	GENTAMICIN SULFATE	225144365	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	1405-41-0, 1403-66-3 [gentamicin]				9.6572473149	4	7		0	2.93012415					CN[C@H](C)[C@@H]1CC[C@@H](N)[C@H](O1)O[C@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O	Microsource	01500314	0	4.38217561	0	1.62991371	1.70377587	0.96298384	2.93012415									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00371104-01	Cevimeline hydrochloride			DPI_SARS-CoV-2_General	2019_NPC_02	[107220-28-0]				9.6549961072	4	7		0	1.03695952					C[C@H]1O[C@]2(CS1)CN3CCC2CC3	Tocris	3689	0	2.83443831	1.4181571	0	4.02300216	4.75854942	1.03695952									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160621-08	Dextrose			DPI_SARS-CoV-2_General	2019_NPC_02	50-99-7				2.8200254688	4	7		0	-4.0336774					[H][C@]1(O)O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]1([H])O	MedChem Express	HY-B0389	2.1618997	0.65836587	-1.44159771	-0.12393892	3.90894185	1.98703495	-4.0336774									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159393-03	N-Acetyl-L-tyrosine	170465742		DPI_SARS-CoV-2_General	2019_NPC_01	537-55-3				6.7882263718	4	7		0	1.70844846					Oc1ccc(C[C@H](NC(C)=O)C(=O)O)cc1	Labotest	LT03380081	-1.42570135	1.72746598	3.65820965	3.13291695	1.16987261	0.1117943	1.70844846									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016511-08	Chlorotrianisene	170465394	Estrogen receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	569-57-3		2.7800686746	-5.5559444758	-84.2792650213	-1.2	7		-72.3123241519	-69.84360346	0.0000389785	0.9974407583			COc1ccc(cc1)C(\Cl)=C(/c2ccc(OC)cc2)c3ccc(OC)cc3	Prestwick	Prestw-757	0.4937913	0.5326557	0	3.58943487	-14.55869665	-57.96026221	-69.84360346									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016600-08	Clofazimine	387065713	DNA Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	2030-63-9		0.2477738814	-6.6059444758	-224.4107324901	-1.1	7		-101.0702187473	-98.28394717	3.042E-7	0.9997747566			CC(C)\N=C\1/C=C\2N(C3=CC=C(Cl)C=C3)C4=C(C=CC=C4)\N=C2\C=C1NC5=CC=C(Cl)C=C5	SIGMA	C8895	1.65807373	0.8820583	-9.76578684	-50.9318484	-90.84149622	-97.93688704	-98.28394717									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022579-05	Carbenicillin disodium	170465106	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	4800-94-6				12.568902526	4	7		0	0					[Na+].[Na+].O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)C(c1ccccc1)C([O-])=O)[C@H]3SC2(C)C	Microsource	01500160	0.69227604	2.52889291	4.1163998	3.17806707	4.11866213	3.36907363	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016101-10	Xylometazoline hydrochloride	170465470	alpha2A/B/C-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	1218-35-5	; Otrivine-Antistin; ;XYLOMETAZOLINE HYDROCHLORIDE;Xylometazoline hydrochloride; Xylometazoline hydrochloride; Neo-Synephrine II; Xilometazolina; Otrivin hydrochloride	22.0828704269	-4.6559444758	7.443584309	4	7		-13.481863572	-8.73488631	0.0117074054	0.9526621551	150	ADRA2A	Cl.CC(C)(C)c2cc(C)c(CC1=NCCN1)c(C)c2	Microsource	01500614	2.72795488	3.55022357	1.15034974	2.27004791	3.9917779	3.63839626	-8.73488631									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021202-03	Famotidine	170464877	Histamine H2 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	76824-35-6				6.8358370151	4	7		0	-2.40298091				HRH2	N/C(N)=N/c1nc(CSCCC(\N)=N/S(N)(=O)=O)cs1	Enzo	AC925	2.8296178	0.93581254	0.20716044	1.89881356	1.79921839	4.01443163	-2.40298091									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274061-01	Trilostane	174007161	Estrogen Receptor (ER) beta Modulators	DPI_SARS-CoV-2_General	2019_NPC_01	13647-35-3	Trilostane	11.0676527398	-4.9559444758	-1.8068599982	4	7		-10.766634556	-9.38886213	0.0545456852	0.887149991	2099	ESR1	N#CC=2C[C@]4(C)[C@H]5CC[C@]1(C)[C@@H](O)CC[C@H]1[C@@H]5CC[C@@]34O[C@@H]3C=2O	Selleck	S1404	3.19754073	0	-0.4508786	0	2.65695579	-0.80288633	-9.38886213									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160397-04	Irsogladine maleate	170465947	M1 Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	84504-69-8	; ;Irsogladine maleate; Irsogladine maleate;irsogladine; Gaslon N			-26.5828265502	4	7		0	-8.63856429			1128	CHRM1	Nc1nc(nc(N)n1)c2cc(Cl)ccc2Cl.O=C(O)/C=C\C(=O)O	Enzo	PD141	-4.27710406	-5.41207516	-4.93041846	-8.5107984	-8.42765061	-0.09146806	-8.63856429									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179475-03	Halcinonide	170465389		DPI_SARS-CoV-2_General	2019_NPC_01	3093-35-4		8.7913490634	-5.0559444758	-26.0053436648	4	7		-17.075316608	-18.26062711	0.0331732966	0.9152366244			ClCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)CC[C@@]12C	Prestwick Chemical, Inc.	Prestw-655	-4.5820928	-1.40005375	-1.74745924	-5.15965586	-0.69786327	-9.99034504	-18.26062711									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094614-06	4-Chloro-3,5-dimethylphenol	170465503		DPI_SARS-CoV-2_General	2019_NPC_01	88-04-0				5.6743905496	4	7		0	-0.89731566					Oc1cc(C)c(Cl)c(C)c1	Microsource	01500182	0	0	3.75569691	0	4.93072121	0.10671274	-0.89731566									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249913-01	Isoniazid pyruvate	170465758	Isocitrate lyase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	1081-50-1				7.8121892907	4	7		0	0					O=C(N\N=C(\C)C(=O)O)c1ccncc1	GVK	FFS-11-286-NCI-164	3.21690509	0.69147507	2.12765957	0	3.30660306	1.93607399	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00092310-06	Amisulpride	170466480	Dopamine D2/D3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	71675-85-9	; Amisulprida;Amisulpride; Deniban			8.4239033477	4	7		0	2.14443233			1813	DRD2	CCN2CCCC2CNC(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC	Tocris	2132	3.37182001	0	2.81981916	0	3.64157742	0.7063367	2.14443233									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249892-01	Lexiscan	170465244	Adenosine A2a receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	313348-27-5				-41.3098002288	4	7		0	-11.46232035					CNC(=O)c1cn(nc1)c2nc(N)c3ncn(c3n2)[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O	GVK	FFS-11-286-NCI-48	-10.02347929	-9.26283383	-10.81377495	-7.98404696	-6.95071816	-5.73199858	-11.46232035									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00242596-02	Pralatrexate			DPI_SARS-CoV-2_General	2019_NPC_02	146464-95-1				-6.6124786793	4	7		0	-6.25505399					NC1=NC(N)=C2N=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=NC2=N1	Selleck	S1497	3.47522486	0.2656564	-2.66988584	-1.80763744	0.278022	-4.17136415	-6.25505399									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167544-02	2,2'-Methylenebis[6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol]	225144291		DPI_SARS-CoV-2_General	2019_NPC_02	103597-45-1				-19.7961802312	4	7		0	-4.77096513					CC(C)(C)CC(C)(C)C1=CC(=C(O)C(=C1)[N]2N=C3C=CC=CC3=N2)CC4=CC(=CC(=C4O)[N]5N=C6C=CC=CC6=N5)C(C)(C)CC(C)(C)C	SIGMA	407941	-1.20927651	-3.31492989	-4.7936054	-3.16862708	-3.23883754	-2.77621195	-4.77096513									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00167507-04	Lapatinib	170465125	EGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	231277-92-2	;Lapatinib; Lapatinib;GW-572016F?; Lapatinib base;LAPATINIB DITOSYLATE; Tykerb;Tykerb	1.3933349283	-5.8559444758	-139.5250238568	-1.1	7		-97.8835264019	-90.36526324	0.0000183821	0.9982447331	1956	EGFR	Fc1cccc(c1)COc2ccc(cc2Cl)Nc3ncnc4ccc(cc34)c5ccc(CNCCS(C)(=O)=O)o5	Sequoia	231277-92-2	-0.02178491	2.50934591	0.1730399	-14.12948052	-45.62503172	-74.4041872	-90.36526324									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025345-02	Atomoxetine hydrochloride	170465067	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	82248-59-7		12.4181106199	-4.9059444758	-6.6878219171	4	7		-20.063686604	-18.80307217	0.0073653706	0.9628777909	24409		Cl.Cc2ccccc2O[C@H](CCNC)c1ccccc1	Tocris	2011	0.83750877	0	4.1163998	0	0	-0.31505666	-18.80307217									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021274-04	ESTRADIOL BENZOATE			DPI_SARS-CoV-2_General	2019_NPC_01	50-50-0		5.5469662594	-5.2559444758	-45.461957107	-2.2	7		-51.4630427564	-49.96578033	0.0001037579	0.9958141215			C[C@]12CC[C@H]3[C@@H](CCC4=CC(=CC=C34)OC(=O)C5=CC=CC=C5)[C@@H]1CC[C@@H]2O	SIGMA	E8515	-1.07714279	2.36763017	1.9911774	-0.72992701	-0.42379333	-29.52385792	-49.96578033									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016896-06	Amrinone	170465367	platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	60719-84-8		11.0676527398	-4.9559444758	1.1912810826	4	7		-16.7721984239	-13.97683202	0.008316807	0.96044906			NC1=CC(=CNC1=O)c2ccncc2	Microsource	01503084	3.06199017	0	3.85805854	3.33860085	2.04791149	0.03557091	-13.97683202									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00013687-03	Pyrophosphoric acid			DPI_SARS-CoV-2_General	2019_NPC_01	2466-09-3				-41.4305023322	4	7		0	-11.81719095					O[P](O)(=O)O[P](O)(O)=O	SIGMA	433314	-7.93696899	-6.83411929	-9.2539787	-7.66799609	-7.8186063	-11.0981249	-11.81719095									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179504-05	Etoposide	225144306	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	33419-42-0	Etoposide, (5S)-Isomer; ;Etoposide (VP-16); EI24 protein, human;Etoposide; Etoposide; Etoposide Phosphate; Etoposido; Lastet	22.0828704269	-4.6559444758	-7.7115069612	4	7		-11.160908468	-10.13409039	0.0673030121	0.8719589095	7153	TOP2A	COC1=C(O)C(=CC(=C1)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=C2C=C7OCOC7=C6)OC	Prestwick	Prestw-396	-2.0598843	-1.08730178	-1.98142868	0.05267514	2.01745927	-0.39128004	-10.13409039									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159460-04	Indinavir sulfate	170465228	HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_01	157810-81-6	 ;Indinavir sulfate salt hydrate; Crixivan; Indivanir Sulfate; Indinavir, Sulfate (1:1);Indinavir;Indinavir Sulfate; Indinavir sulfate; Sulfate, Indinavi	17.5410474839	-4.7559444758	-57.4935099575	4	7		-14.0685922359	-18.98050746	0.1491617961	0.7848178982			O[C@H](CN1CCN(C[C@H]1C(=O)NC(C)(C)C)Cc2cccnc2)C[C@@H](Cc3ccccc3)C(=O)N[C@H]4c5ccccc5C[C@H]4O.O=S(=O)(O)O	Bosche	I2146	-11.65976811	-8.09001393	-11.71553216	-8.51581509	-14.08161194	-14.24360994	-18.98050746									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015007-14	R-(+)-Atenolol	170464744	Beta-2 adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	56715-13-0				4.8706559579	4	7		0	1.92137081					CC(C)NC[C@@H](O)COc1ccc(cc1)CC(N)=O	Vitas	STK528649	1.52736427	0	0.51424533	0	0	3.52660196	1.92137081									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094689-06	Guaifenesin	170464855		DPI_SARS-CoV-2_General	2019_NPC_01	93-14-1				2.8214421659	4	7		0	3.76162835					OCC(O)COc1ccccc1OC	Vitas	STK365152	2.05020212	0.48134483	-0.91394312	0.77006045	2.35243364	-3.47578637	3.76162835									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016246-09	Chlorhexidine	170464748	N-Acetyltransferase Eis (Mycobacterium tuberculosis) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	55-56-1	 Corsodyl ICI; Chlorhexidine base; Anticataracticum; Arlacide H; Lisium; 8   Chlorhexidine Base; Hibiclens; Tubilicid blue label; Hexidine; Curasept ADS 220; Clorhexidina;Chlorhexidine; Eludril; Instillagel; Hibisol; Trisdine; A, Sebidi; Sebidin A; Chlorhexidine; Gibitan; Hibident; Progaron; ; Anticataracticum tablet; Perio Chip; Chlorhexamed; Tubilicid red label;CHLORHEXIDINE; Tubilicid; Acetate, Chlorhexidin;Chlorhexidine diacetate; Novalsan; Hibiscrub; Dyna-Hex; Peridex; Dantroche hibitane	1.9681378985	-5.7059444758	-73.1776442437	-2.2	7		-43.9060295716	-1.82504879	0.0012453976	0.9948389948	4312	MMP1	Clc2ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)cc2	Vitas	STK089248	-2.8828698	-1.97180345	-5.83217567	-8.44558156	-20.54763234	-37.12078866	-1.82504879									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164572-02	Rimonabant	170465599	Cannabinoid CB1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	168273-06-1	 ; Rimonabant;Rimonabant; Rimonabant Base; Rimonabant(Nlt); Rimonabant HCL	8.7913490634	-5.0559444758	-66.7067683246	-2.2	7		-64.1677249444	-59.10116347	0.0001383607	0.9951608689	56144	CNR1	O=C(NN1CCCCC1)c4nn(c2ccc(Cl)cc2Cl)c(c3ccc(Cl)cc3)c4C	Sequoia	SRP01287r	-3.18785854	-1.12150903	-5.20338281	-5.49577345	-6.14880983	-29.80334367	-59.10116347									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00246968-04	Olmesartan		Angiotensin AT1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	144689-24-7		11.0676527398	-4.9559444758	-22.4356781109	-3	7		-37.6741663932	-34.66203682	0.000106879	0.9957536017		AGT	CCCC1=NC(=C([N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)C(O)=O)C(C)(C)O	Microsource	01505206	1.56535411	0.52900275	-1.24938468	0.94708042	0.33505216	-8.02799699	-34.66203682									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179273-03	Rimexolone	170464695	Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	49697-38-3				-30.0880729551	4	7		0	-10.48851258					O=C(OC)[C@@]4(C)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-1020	-6.13887026	-1.78567303	-5.28585828	-5.33405046	-7.23094836	-9.55467869	-10.48851258									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346829-03	Fotemustine		DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC_02	92118-27-9				-22.5368286083	4	7		0	-3.43433382				H2AFX	CCO[P](=O)(OCC)C(C)NC(=O)N(CCCl)N=O	SIGMA	F7307	-5.50070522	-3.48587401	-5.56714564	-6.50796249	-0.80079842	-7.96223224	-3.43433382									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166249-03	Erythrosin B	170465719		DPI_SARS-CoV-2_General	2019_NPC_02	15905-32-5		4.9437388825	-5.3059444758	-128.5441353914	-2.1	7		-100.1383314214	-94.45845027	0.0000090254	0.9987711799			Ic4c5Oc1c(I)c(O)c(I)cc1C3(OC(=O)c2ccccc23)c5cc(I)c4O	SIGMA	200964	-4.32611159	-3.5644159	-6.5328989	-11.09136403	-23.50830502	-63.79180759	-94.45845027									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159521-09	Zoledronic acid monohydrate		Farnesyl Pyrophosphate Synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	118072-93-8				-3.8007783805	4	7		0	-3.28687628				FDPS	OC(C[N]1C=CN=C1)([P](O)(O)=O)[P](O)(O)=O	APExBIO	A1352	-0.29827279	1.69789092	-2.14012799	-1.31188177	0.10217903	-1.01465614	-3.28687628									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181129-14	Dasatinib		Bcr-Abl Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	302962-49-8		13.9333492831	-4.8559444758	-32.9920201375	-2.2	7		-61.317461822	-47.21019835	0.0005080579	0.9906591163		ABL1	CC1=NC(=CC(=N1)NC2=NC=C(S2)C(=O)NC3=C(Cl)C=CC=C3C)N4CCN(CCO)CC4	Adooq	A10290	1.82894402	1.76257248	3.13400999	-2.66819447	-1.31882233	-14.27564825	-47.21019835									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166097-02	Cinnamyl alcohol	225144268	prostaglandin secretion Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	104-54-1				1.4917375065	4	7		0	-4.69010132					OC\C=C\C1=CC=CC=C1	SIGMA	108197	0.0901755	3.18556677	1.6666276	1.65797535	0.92436376	-1.85080797	-4.69010132									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159331-07	CHOLECALCIFEROL		Vitamin D receptor Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	67-97-0		2.7800686746	-5.5559444758	-90.3051161949	-2.2	7		-79.6985247572	-66.81706421	0.0000074352	0.9988849722			CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)CCC3=C	SIGMA	C9756	3.00873817	0.61817382	1.28439473	-7.36197858	-26.20666904	-50.07368261	-66.81706421									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091470-05	Isoeugenol	170465654	Tyrosyl-DNA phosphodiesterase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	97-54-1		12.4181106199	-4.9059444758	-38.2480514919	-2.2	7		-63.338825372	-53.4435122	6.798E-7	0.9996633508			Oc1ccc(cc1OC)C=CC	Bosche	I1325	0.89560187	0	0	0.32608423	-0.45932092	-15.14304589	-53.4435122									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091219-08	DEET	170466080		DPI_SARS-CoV-2_General	2019_NPC_01	134-62-3				3.6158777117	4	7		0	1.24711668					Cc1cccc(c1)C(=O)N(CC)CC	Microsource	01601020	-0.33645584	3.11530286	1.91318759	-3.93056914	2.13926813	1.32120535	1.24711668									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095048-06	Pipobroman	170465158	DNA Crosslinking Agent	DPI_SARS-CoV-2_General	2019_NPC_01	54-91-1				6.3112801961	4	7		0	2.56013789					O=C(CCBr)N1CCN(CC1)C(=O)CCBr	Microsource	01503393	1.72100792	3.84342854	3.18052204	-2.09948077	0.81459676	-0.3099751	2.56013789									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015155-11	Bepridil	170465240	Calcium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	64706-54-3	 ; Bepridil, (-)-Isomer; Bepridil;Bepridil; Vascor;Bepridil hydrochloride; Bepridil, (+)-Isomer	12.4181106199	-4.9059444758	-66.5804581033	-2.2	7		-80.2843370676	-64.27720463	0.0000546735	0.9969670081		KCNT1	CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3	BIOMOL	AC104	-3.70101421	-0.05131087	-2.87831152	-3.71485188	-8.83368015	-27.71482291	-64.27720463									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016257-10	4-Dimethylaminoantipyrine	170465863		DPI_SARS-CoV-2_General	2019_NPC_01	58-15-1				-29.7991919909	4	7		0	-12.24303566					CN(C)C=2C(=O)N(c1ccccc1)N(C)C=2C	Microsource	01500621	-4.2528986	-6.20372859	-7.97202115	-6.96064414	-4.06283307	-4.07541034	-12.24303566									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253585-01	Cyclomethycaine	170465528		DPI_SARS-CoV-2_General	2019_NPC_01	139-62-8		13.9333492831	-4.8559444758	-2.9665021794	4	7		-16.961623284	-11.63468607	0.0062489874	0.9660989702			CC3CCCCN3CCCOC(=O)c2ccc(OC1CCCCC1)cc2	GVK	FFS-11-286-NCI-76	1.91949265	2.0353312	0.32414516	3.02254998	0	-2.70847096	-11.63468607									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166289-02	Hydroxystilbamidine bis(methanesulfonate)	124893257		DPI_SARS-CoV-2_General	2019_NPC_02			7.8352981002	-5.1059444758	-72.227732836	-2.2	7		-32.9029614966	-37.09270799	0.0059448528	0.9668114996			NC(=N)C1=CC=C(C=C1)/C=C/C2=CC=C(C=C2O)C(N)=N	FLUKA	39286	-6.56893801	-10.43452147	-8.01903378	-13.57949629	-12.67257562	-24.29537768	-37.09270799									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522503-01	Velpatasvir		Nonstructural protein 5A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1377049-84-7		2.4777388143	-5.6059444758	-107.9527223679	-1.1	7		-94.2481758043	-84.02226133	0.0001189422	0.9955148163			COC[C@H]1C[C@H](N(C1)C(=O)[C@H](NC(=O)OC)C2=CC=CC=C2)C3=NC=C([NH]3)C4=CC=C5C(=C4)COC6=CC7=C(C=CC8=C7[NH]C(=N8)[C@@H]9CC[C@H](C)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C=C56	MedChem Express	HY-12530	0	2.57109196	3.58406976	1.24172766	-26.35981275	-72.14393085	-84.02226133									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181340-02	Azosemide	170465933		DPI_SARS-CoV-2_General	2019_NPC_02	27589-33-9		11.0676527398	-4.9559444758	0.9628332976	4	7		-11.622651376	-8.85220948	0.0462259136	0.8977195559			NS(=O)(=O)c2cc(c(NCc1cccs1)cc2Cl)c3nnnn3	APAC	814905	0	1.74640209	0.89543142	4.35656993	1.8606088	-0.80326945	-8.85220948									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094207-05	Pentolinium bitartrate			DPI_SARS-CoV-2_General	2019_NPC_02	52-62-0				-12.0666970222	4	7		0	-2.66374923					C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1	Prestwick	Prestw-188	-0.92718907	-4.12344938	-3.51374792	-3.58955172	-0.96238386	-2.16553927	-2.66374923									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167448-02	Trepibutone	170465772	Catechol O-methyltransferase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	41826-92-0				16.8727944568	4	7		0	2.90634067					CCOc1cc(OCC)c(cc1OCC)C(=O)CCC(=O)O	Bosche	T5812	0	4.91810853	4.51700616	4.78684844	4.43647078	3.2882375	2.90634067									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016570-06	Mephentermine hemisulfate	170465271		DPI_SARS-CoV-2_General	2019_NPC_01	1212-72-2				4.4479043914	4	7		0	-3.87822869					O=S(=O)(O)O.CC(C)(NC)Cc1ccccc1.CC(C)(NC)Cc1ccccc1	Microsource	01503250	1.86624065	0.69636181	4.90604665	0	0	1.87509528	-3.87822869									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090691-03	2',3'-Dideoxyinosine	174006954	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	69655-05-6	 Videx; Didanosina;Didanosine; ; didanosine (ddI);2',3'-Dideoxyinosine; didanosine??(ddI); 0   Didanosine; ddIno; 2',3' Dideoxyinosin; NunclonD multidishes; 2',3'-Dideoxyinosine (ddI); Inosine, 2',3'-dideoxy-			-13.7951074772	4	7		0	-5.02902335			7015	TERT	O=C3NC=Nc2c3ncn2[C@H]1CC[C@@H](CO)O1	Prestwick	Prestw-153	-4.09314259	-3.28633909	-2.26414175	-4.58775428	-1.93117799	0.09146806	-5.02902335									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167446-02	Methyclothiazide	170465243	Sodium-(potassium)-chloride cotransporter 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	135-07-9				8.0618917034	4	7		0	0.3802185					NS(=O)(=O)c2cc1c(NC(CCl)N(C)S1(=O)=O)cc2Cl	Bosche	M5731	0	4.04378528	2.68089981	0	0	4.52258753	0.3802185									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160622-04	D-delta-Tocopherol	144206758		DPI_SARS-CoV-2_General	2019_NPC_01	119-13-1		2.2082870427	-5.6559444758	-102.3436412479	-2.2	7		-79.9803807236	-68.40384274	0.0003483674	0.9922837026			CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2cc(O)cc(C)c2O1	NCGCChem	XJB03-045	0	2.5777604	-0.96268675	-16.11608599	-30.85063188	-49.49946644	-68.40384274									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344528-01	TRYPAN BLUE	225144379		DPI_SARS-CoV-2_General	2019_NPC_01	72-57-1		3.1192883571	-5.5059444758	-119.3096212356	-2.1	7		-102.0002053146	-92.03315505	0.00033536	0.9924301342			CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(O)C4=C(C=C(C=C4N)[S]([O-])(=O)=O)C=C3[S]([O-])(=O)=O)C)N=NC5=C(O)C6=C(C=C(C=C6N)[S]([O-])(=O)=O)C=C5[S]([O-])(=O)=O	SIGMA	302643	4.43686007	0	2.22027248	-10.99405523	-24.45059128	-72.38172671	-92.03315505									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162222-04	Cibenzoline succinate		Voltage-sensitive sodium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	100678-32-8				10.3825830084	4	7		0	-1.60776293					C1C/N=C(N1)/C2CC2(C3=CC=CC=C3)C4=CC=CC=C4	SIGMA	C1618	0	4.65938229	3.67314409	2.76173327	2.83012143	2.14205186	-1.60776293									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386216-07	Indacaterol (maleate)			DPI_SARS-CoV-2_General	2019_NPC_02	753498-25-8		6.2237985085	-5.2059444758	-100.5111422167	-2.1	7		-82.8502566028	-81.06835371	0.0001002291	0.9958855707			CCC1=CC2=C(CC(C2)NC[C@H](O)C3=CC=C(O)C4=C3\C=C/C(=O)N4)C=C1CC	MedChem Express	HY-14299A	-3.50297117	-4.94120908	-4.70921919	-6.33959264	-17.90509232	-45.37767756	-81.06835371									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263918-08	Epirubicin hydrochloride		DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	56390-09-1		5.5469662594	-5.2559444758	-77.4399973683	-2.2	7		-90.061242448	-72.96770204	0.000010298	0.9986872939		TOP2A	COC1=C2C(=O)C3=C(C(=C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)C4=C3O)C(=O)CO)O)C(=O)C2=CC=C1	MedChem Express	HY-13624A	4.00240468	0.9170921	1.9572912	-1.72345252	-16.09913742	-44.70124014	-72.96770204									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159403-03	Nandrolone decanoate	26754490		DPI_SARS-CoV-2_General	2019_NPC_02		Nandrolone decanoate; Deca-durabolin; Retabolyl; Decadurobolin; Decadurabolin; Retabolil; Deca-Durabol; 	6.2237985085	-5.2059444758	-38.0430907511	-2.2	7	CIPLUS_152890;Decadurabolin;Nandrolone Decanoate;Decadurobolin;Retabolil;Retabolyl;17 beta-hydroxyestr-4-en-3-one 17-decanoate;Deca-durabolin;LS-64854;NCGC00159403-03;Nandrolone decanoate;NANDROLONE DECANOATE;nandrolone decanoate;19-nor-4-androstene-17 beta-ol-3-one 17-decanoate;19-nortestosterone decanoate;Deca-Durabol;	-40.307544119	-34.91889835	0.001925648	0.9815482906			[H]C1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4([H])[C@@]3([H])CC[C@]12C)OC(=O)CCCCCCCCC	Labotest	LT01138619	0.36763856	0.42274019	-0.64461686	-0.14264668	-10.05394102	-18.03363397	-34.91889835									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182972-01	Hexocyclium	144206775	Muscarinic acetylcholine receptor M5 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	115-63-9	4-(2-cyclohexyl-2-hydroxy-2-phenethyl)-1,1- dimethylpiperazinium; Metilsulfato de hexociclo; 	19.6813789847	-4.7059444758	-21.6627124565	4	7	HEXOCYCLIUM METHYLSULFATE;Hexocyclium Methylsulfate;Metilsulfato de hexociclo;4-(.BETA.-CYCLOHEXYL-.BETA.-HYDROXYPHENETHYL)-1,1-DIMETHYLPIPERAZINUM METHYLSULFATE;LS-113656;LS-113657;4-(2-cyclohexyl-2-hydroxy-2-phenethyl)-1,1- dimethylpiperazinium;Hexocyclium metilsulfate;hexocyclii metilsulfas;Hexocyclii metilsulfas;Tral;hexocyclium;metilsulfate d'hexocyclium;Metilsulfate d'hexocyclium;hexociclium;CIPLUS_679015;CIPLUS_669959;CIPLUS_3863310;hexocyclium methylsulfate;CIPLUS_166714;TRAL;Hexocyclium;HEXOCYCLIUM METILSULFATE;	-14.3397918119	-12.40070399	0.1236796668	0.8109343808			OC(CN1CC[N+](C)(C)CC1)(c2ccccc2)C3CCCCC3.[O-]S(=O)(=O)OC	NCI	NSC_30256	-0.45087748	-4.74716441	-4.24978317	-2.99558029	-3.98498206	-5.22360015	-12.40070399									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181012-01	Cefuzonam hydrochloride	144206215	Peptidoglycan biosynthesis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	NOCAS_46800	Cefuzonam; Cefozopran; 			-7.5891098918	4	7	LS-177675;Cefuzonam Sodium;Cefuzonam sodium;5-((7-((2-amino-4-(thiazoyl)-2-(methoxy-imino))acetyl)amino-4-carboxyceph-3-em-3-yl)methyl)-1,2,3-thiadiazole;CIPLUS_772243;CEFUZONAM;CIPLUS_735294;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-5-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(1,2,3-thiadiazol-5-ylmethyl)-, (6R-(6alpha,7beta(Z)))-;Cefozopran;CEFUZONAM SODIUM;cefuzonamum;CL-118523;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-((1,2,3-thiadiazol-5-ylthio)methyl)-, (6R-(6alpha,7beta(Z)))-;CL 118523;cefuzonam;Cefuzonam;CIPLUS_213477;cefuzoname;	0	-7.54411835					Cl.Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]3C(=O)N2C(=C(CS[C@@H]23)CSc4cnns4)C(=O)O	Bosche	C3450	-0.4138824	-2.90373998	-2.66519772	-0.55421743	1.28555474	0.07515971	-7.54411835									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165752-04	Eslicarbazepine (acetate)		Sodium channel alpha subunit Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	236395-14-5				14.6448745966	4	7		0	4.2239452					CC(=O)O[C@H]1CC2=C(C=CC=C2)N(C(N)=O)C3=C1C=CC=C3	MedChem Express	HY-B0703	4.1133899	0	3.19495558	4.21158478	2.27407742	4.10090192	4.2239452									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164637-02	Nifekalant	170465960	K(ATP) Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	130636-43-0	NIFEKALANT HCl; ; Nifekalant;Nifekalant; Shinbit			1.2650602891	4	7		0	-3.2630928				KCNH2	Cl.CN1C(=CC(=O)N(C)C1=O)NCCN(CCCc2ccc(cc2)[N+]([O-])=O)CCO	Sequoia	SRP034084n	2.41161645	1.61472891	-0.7758843	1.39138975	0.08316898	-0.37579857	-3.2630928									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386381-04	Besifloxacin Hydrochloride		Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	405165-61-9				4.5489917755	4	7		0	1.01793274					N[C@@H]1CCCCN(C1)C2=C(Cl)C3=C(C=C2F)C(=O)\C(=C/N3C4CC4)C(O)=O	Glixx	GLXC-06708	0	0	0	1.74449875	0	3.99755731	1.01793274									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179367-03	Iopromide	170465023		DPI_SARS-CoV-2_General	2019_NPC_01	73334-07-3				6.6000485327	4	7		0	0					O=C(Nc1c(I)c(c(I)c(c1I)C(=O)N(C)CC(O)CO)C(=O)NCC(O)CO)COC	Prestwick Chemical, Inc.	Prestw-872	0	2.99802087	4.95966464	1.47992074	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00070736-03	Imiquimod	170464691	TLR 7 Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	99011-02-6	; ; 3M Brand of Imiquimod; Aldara; Imiquimod;Imiquimod			7.0826615596	4	7		0	2.96063471			51284	TLR7	CC(C)Cn3cnc2c(N)nc1ccccc1c23	Vitas	STK583860	4.15607678	4.38585775	0	0	0	0	2.96063471									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00015191-13	Chlormezanone	170465161	GABA Modulators	DPI_SARS-CoV-2_General	2019_NPC_01	80-77-3	 ; Beserol;CHLORMEZANONE; Chlormezanone; Trancopal; Lobak; Clormetazon; Clormezanona;Chlormezanone			7.1977562667	4	7		0	-4.97325797			2554	GABRA1	O=C1CCS(=O)(=O)C(N1C)c2ccc(Cl)cc2	Microsource	02300062	1.42570135	1.77144672	0	3.44395114	3.80906461	3.64855938	-4.97325797									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163127-04	Acitretin	225144249	retinoid	DPI_SARS-CoV-2_General	2019_NPC_01	55079-83-9	Acitretin; ; Acitretin; ACITRETIN; Soriatane	6.2237985085	-5.2059444758	-134.1234092785	-2.2	7		-90.1009863453	-88.20055258	0.0000106826	0.9986629374		RXRA	COC1=C(C)C(=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(=C1)C)C	Prestwick	Prestw-1165	-9.12303633	-11.3397024	-9.17598889	-14.46559811	-24.52164645	-57.04050003	-88.20055258									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164569-02	Capecitabine	170464779	Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	154361-50-9	Capecitabine;Capecitabine (Xeloda); Xeloda; Capecitabine; 			-2.8623015555	4	7		0	-2.24075435				TYMS	O=C(OCCCCC)NC1=NC(=O)N(C=C1F)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O	Sequoia	SRP01237c	-1.42086026	1.44892125	1.06017401	-0.98076103	0.37811501	-2.93714111	-2.24075435									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164557-11	Eprosartan mesylate		urate transport Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	144143-96-4				-50.2530362255	4	7		0	-17.50463778				AGTR1	CCCCC1=NC=C(\C=C(CC2=CC=CS2)\C(O)=O)[N]1CC3=CC=C(C=C3)C(O)=O	SIGMA	E2535	-7.78977549	-9.16399085	-8.74100466	-12.0033674	-9.43136183	-11.80947012	-17.50463778									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167429-04	Temozolomide	170464968	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	85622-93-1	Temozolomide; ; Temodar;; Temozolomide			5.6599259308	4	7		0	-1.62678971			7153	TOP2A	NC(=O)c1ncn2C(=O)N(C)N=Nc12	Prestwick	Prestw-1183	4.98739855	3.45815334	-0.6305525	-0.79274139	2.79685384	-0.33352123	-1.62678971									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379009-01	Octreotide acetate		Growth Hormone Release Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_02	79517-01-4		4.2694018929	-5.3696329617	-68.3872091343	-2.2	7		-64.8539932432	-56.32878276	0.0000707424	0.9965477328		SSTR1	CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)CC2=CC=CC=C2)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=C[NH]C5=C4C=CC=C5)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1	MedChem Express	HY-17365	-0.29364841	2.10908083	-0.31176016	-2.49982461	-3.59052349	-26.63942127	-56.32878276									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00016981-05	Troleandomycin		70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	311074		9.8640558873	-5.0059444758	-13.657592799	4	7		-19.719069592	-18.09922466	0.0015730743	0.9834141602			CO[C@@H]1C[C@@H](O[C@H](C)[C@H]1OC(C)=O)O[C@H]2[C@H](C)[C@H](O[C@@H]3O[C@@H](C)C[C@H]([C@H]3OC(C)=O)N(C)C)[C@H](C)C[C@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@H](C)[C@H](C)OC(=O)[C@@H]2C	Enzo	EI249	-0.09479988	-0.39501952	-1.14155786	1.12012721	1.04792909	-6.42615558	-18.09922466									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00188442-01	Estradiol enanthate	144206583		DPI_SARS-CoV-2_General	2019_NPC_02	4956-37-0		3.9269513795	-5.4059444758	-81.9360602306	-2.2	7	ESTRADIOL ENANTHATE	-75.044974552	-67.95414546	0.0000015676	0.9994885366			CCCCCCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCc1cc(O)ccc1[C@H]4CC[C@]23C	APAC	877917	1.75032949	0.82468988	-0.23206207	-3.73453687	-16.60290379	-47.93780534	-67.95414546									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262569-03	Thiostrepton		Toll-like receptor 9 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1393-48-2		6.2237985085	-5.2059444758	-101.0291201761	-2.2	7		-89.7560529006	-72.42543881	0.0001903423	0.9943154637	2305		CCC(C)[C@@H]1N[C@@H]2\C=C/C3=C(N=C(C=C3[C@H](C)O)C(=O)O[C@H](C)[C@@H]4NC(=O)C5=CSC(=N5)[C@@H](NC(=O)[C@H]\6CSC(=N6)\C(NC(=O)[C@@H](NC(=O)C7=CSC(=N7)[C@]8(CCC(=N/[C@H]8C9=CSC4=N9)\C%10=NC(=CS%10)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)=C/C)[C@@](C)(O)[C@@H](C)O)[C@H]2O	Prestwick	Prestw-522	-2.88792804	0.81082954	-7.09547362	-10.34305357	-23.83622841	-46.66478767	-72.42543881									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167471-02	Anethole trithione	170465669		DPI_SARS-CoV-2_General	2019_NPC_01	532-11-6		1.5633475026	-5.8059444758	-164.6205707339	-1.1	7		-97.9351171511	-97.2142658	0.0000313238	0.997706613			COc1ccc(cc1)C2=CC(=S)SS2	Prestwick	Prestw-1223	-3.212064	-2.96381362	-3.89705345	-16.23648632	-46.01075978	-90.01981808	-97.2142658									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159325-05	Desloratadine	170464781	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	100643-71-8		12.4181106199	-4.9059444758	-39.2338500221	-2.2	7		-43.8355706596	-38.41727713	0.0000082111	0.9988289376			Clc2cc3CCc4cccnc4\C(=C1\CCNCC1)c3cc2	Vitas	STK586537	-2.26321013	-2.88073888	-2.1374083	-1.56269596	-4.02223012	-14.3604858	-38.41727713									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015227-08	Dexchlorpheniramine hydrochloride	170466889	Histamine H1 Receptor Antagonists; SNRI	DPI_SARS-CoV-2_General	2019_NPC_01	5502-69-2	 ; Clorfenamina;Chlorpheniramine; Chlor-Trimeton; Mylaramine; Polaramine; Dexclorfeniramina; Chlortrimeton;Chlorpheniramine maleate; Ru-Tuss; Teldrin; Chlorpheniramine; Chlor-trimeton;Chlorpheniramine Maleate			5.3190617654	4	7		0	0.97335936				HRH1	Cl.Clc1ccc(cc1)[C@H](CCN(C)C)c2ccccn2	Vitas	STK736174	3.23142836	1.23879102	1.25027418	-2.23994783	4.8495153	-1.3516947	0.97335936									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262961-01	Cromoglicate lisetil	170465975	mast cell activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	110816-79-0	O	11.0676527398	-4.9559444758	-30.2859406773	-2.2	7		-43.64844998	-32.20704165	0.0020714757	0.9808433381			O=C(OCC)C=4Oc3cccc(OCC(OC(=O)[C@@H](N)CCCCN)COc1cccc2OC(=CC(=O)c12)C(=O)OCC)c3C(=O)C=4	GVK	FFS-11-286-NCI-234	3.45895965	0.13927236	0.09505008	-2.425565	-6.01685023	-14.18263123	-32.20704165									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016308-06	Isopropamide	170465291	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	7492-32-2				10.3761837764	4	7		0	2.49423335					CC(C)[N+](C)(CCC(c1ccccc1)(C(N)=O)c2ccccc2)C(C)C	Microsource	01500356	3.212064	2.86119188	2.70283444	1.85868011	0	2.42898521	2.49423335									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249909-01	Fenbutrazate	170465618	Monoamine transporters; Norepinephrine & dopamine Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	4378-36-3		22.0828704269	-4.6559444758	-27.9663781832	-3	7		-61.4254264756	-54.32054954	0.0022233033	0.9801166693			CCC(c1ccccc1)C(=O)OCCN2CCOC(C2C)c3ccccc3	GVK	FFS-11-286-NCI-142	-2.1712294	-2.50445916	3.50710438	-3.39880101	3.49439172	1.9716449	-54.32054954									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024994-06	Selegiline hydrochloride	170464993	MAO-B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	14611-52-0	; ; (R)-(-)-Deprenyl hydrochloride; Selegiline, (R,S)-Isomer;Selegiline hydrochloride; Selegiline, (S)-Isomer;Selegiline; Selegilina; Selegiline Hcl; Deprenyl; Jumex	13.9333492831	-4.8559444758	-5.1146477957	4	7		-7.8514866559	-7.37623888	0.2609622907	0.6725701646	4129	MAOB	Cl.C#CCN(C)[C@H](C)Cc1ccccc1	Prestwick Chemical, Inc.	Prestw-552	-3.27983928	3.07132211	-0.36801443	0.38879274	-0.92117952	-0.74698918	-7.37623888									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181080-01	Phenacaine hydrochloride	144206789	"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC_02	620-99-5	phenacaine hydrochloride; Fenacaina; 	15.6334750258	-4.8059444758	-26.5349861151	4	7	Phenacainum;phenacaine hydrochloride;Phenacaine (N,N'-bis-(4-ethoxy-phenyl)-acetamidine);phenacainum;CIPLUS_150668;PHENACAINE;Phenacaine hydrochloride;Acetamidine, N,N'-bis(p-ethoxyphenyl)-, hydrochloride;phenacaine;LS-10332;CIPLUS_155428;PHENACAINE HYDROCHLORIDE;Phenacaine;LS-176183;Phenacaine Hydrochloride;CIPLUS_743918;Fenacaina;	-22.659174336	-21.42891119	0.0050428823	0.9696303527	5136	PDE1A	Cl.CCOc1ccc(cc1)NC(\C)=N\c2ccc(OCC)cc2	NCI	NSC-9293	-4.89028648	-3.69839913	-1.29626591	-1.78892968	-3.77587149	-6.50601278	-21.42891119									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00013495-15	Benztropine mesylate		Dopamine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	132-17-2		12.4181106199	-4.9059444758	5.9373335904	4	7		-10.752723204	-7.71060267	0.0645824736	0.8750006796			CN1[C@@H]2CC[C@H]1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4	APExBIO	B1554	0	3.34727067	3.17620309	1.83569909	4.71686904	1.23543781	-7.71060267									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262907-01	Bilastine	170466329		DPI_SARS-CoV-2_General	2019_NPC_02	202189-78-4	Bilastine;Bilastinum			-43.1396599143	4	7		0	-14.67916092					O=C(O)C(C)(C)c4ccc(CCN1CCC(CC1)c3nc2ccccc2n3CCOCC)cc4	GVK	FFS-12-73-NCI-1870	-7.78977549	-9.31183442	-6.86106749	-9.22526483	-8.44283915	-9.2634348	-14.67916092									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183095-01	Tigecycline	124894296	glycylcycline antibiotics	DPI_SARS-CoV-2_General	2019_NPC_02	220620-09-7	Tigecycline; ; Tigecycline; Tygacil	6.2237985085	-5.2059444758	-106.3481092969	-2.2	7	Tigecycline;tigecycline;TIGECYCLINE;TetX protein, Bacillus fragilis;tigecycline 11a-hydroxylase, Bacillus fragilis;GAR-936;CL-346635;4,6-BIS(DIMETHYLAMINO)-9-((((DIMETHYLETHYL)AMINO)ACETYL)AMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-2-NAPHTHACENECARBOXAMIDE;2-NAPHTHACENECARBOXAMIDE, 4,7-BIS(DIMETHYLAMINO)-9-((((1,1-DIMETHYLETHYL)AMINO)ACETYL)AMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-, (4S,4AS,5AR,12AS)-;TBG-MINO;CIPLUS_736709;GAR 936;WAY-156936;9-(tert-butylglycylamido)minocycline;Tygacil;	-98.1802787397	-79.50815773	0.0002308526	0.9937333894			CC(C)(C)NCC(=O)Nc1cc(N(C)C)c2C[C@H]3C[C@H]4[C@@H](C(O)=C(C(=O)[C@@]4(O)C(O)=C3C(=O)c2c1O)C(N)=O)N(C)C	ACC	API-03922	2.76769405	-3.57827624	-4.48418931	-12.15770643	-23.38949219	-51.26832018	-79.50815773									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522560-01	Tasimelteon		Melatonin receptor type 1B Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	609799-22-6				8.9475972935	4	7		0	1.90267802			4544	MTNR1B	CCC(=O)NC[C@@H]1C[C@H]1C2=C3CCOC3=CC=C2	MedChem Express	HY-14803	0	2.58033219	0.33988889	4.83361785	2.36437516	1.24953025	1.90267802									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167514-02	Ethylestrenol	170465211	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	965-90-2		12.4181106199	-4.9059444758	-47.9186030594	-2.2	7		-47.4278157361	-39.9609951	0.0001127365	0.9956375375			C[C@]32CC[C@@H]1[C@H]4CCCC=C4CC[C@H]1[C@@H]3CC[C@@]2(O)CC	Sequoia	965-90-2	-3.09602534	-3.83238236	-4.28728816	-1.93391483	-6.97906518	-18.38594513	-39.9609951									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015199-20	Chlorambucil	170464770	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC_01	305-03-3	; ;CHLORAMBUCIL; Chlorambucil;Chlorambucil; Leukeran; Clorambucilo			3.0508172563	4	7		0	-6.03786976				H2AFX	O=C(O)CCCc1ccc(cc1)N(CCCl)CCCl	Microsource	01500171	1.25626316	2.33830967	0	1.20149497	2.67725727	1.48889679	-6.03786976									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181010-02	Mabuterol hydrochloride	170465921	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	54240-36-7				-41.5570459701	4	7		0	-10.88945781					Cl.Nc1c(cc(cc1Cl)C(O)CNC(C)(C)C)C(F)(F)F	Bosche	M5723	-9.4715949	-7.288587	-6.46096854	-18.46389244	-1.83982135	-8.01361858	-10.88945781									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166312-02	Closantel	170466628		DPI_SARS-CoV-2_General	2019_NPC_01	57808-65-8		2.7800686746	-5.5559444758	-132.9621798891	-1.1	7		-87.8144182185	-89.59468708	0.0000034356	0.9992424388			Clc3cc(NC(=O)c1cc(I)cc(I)c1O)c(C)cc3C(C#N)c2ccc(Cl)cc2	Vitas	STK378904	-4.38844916	-3.87274904	-4.34062051	-9.25326711	-26.64822616	-74.31271914	-89.59468708									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167442-03	Tamsulosin hydrochloride	170464826	alpha1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_01	106463-17-6				7.8861572445	4	7		0	-1.21162962				ADRA1A	Cl.O=S(N)(=O)c1cc(ccc1OC)C[C@@H](C)NCCOc2ccccc2OCC	Sequoia	106463-17-6	2.37455522	2.03044445	2.14715703	0	3.27107547	2.44931145	-1.21162962									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182070-03	Ioxilan	170465160		DPI_SARS-CoV-2_General	2019_NPC_02	107793-72-6				6.1055677287	4	7		0	0.27113162					OCC(O)CNC(=O)c1c(I)c(N(CC(O)CO)C(C)=O)c(I)c(c1I)C(=O)NCCO	Kemprotec	107793-72-6	1.17690582	1.03259489	1.11811725	2.8693029	1.71803341	0.65295002	0.27113162									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532515-01	ROBENACOXIB		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02			24.777388143	-4.6059444758	8.2572824451	4	7		-12.23669314	-6.86391095	0.0589241929	0.881912169			CCC1=CC=C(NC2=C(F)C(=CC(=C2F)F)F)C(=C1)CC(O)=O	J&W Pharm	99R0028	3.32262018	0	4.26853566	3.20136567	2.90140912	3.40097708	-6.86391095									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522039-01	Pyrethrin 1		Trypanosoma brucei rhodesiense Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	121-21-1		11.0676527398	-4.9559444758	-59.2429179076	-2.1	7		-91.8191980219	-83.1898397	0.0000947391	0.9960005178			CC(C)=C[C@H]1[C@H](C(=O)O[C@H]\2CC(=O)\C(=C2C)C\C=C/C=C)C1(C)C	Toronto Research	P991245	0.06705357	-2.6681143	-1.01966667	2.2659776	2.26457239	-22.91431793	-83.1898397									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160606-01	Sulbentine	144205485		DPI_SARS-CoV-2_General	2019_NPC_02	350-12-9	Dibenzthion; Sulbentina; Afungin; 	10.0940793891	-4.9959332839	-10.9785464169	4	7	Sulbentinum;Sulbentine;D 47;Afungin;Sulbentina;dibenzthione;DIBENZTHION;CIPLUS_209804;carbothialdine;2H-1,3,5-Thiadiazine-2-thione, tetrahydro-3,5-dibenzyl-;SULBENTINE;sulbentinum;CIPLUS_3866698;LS-150185;sulbentine;Dibenzthion;3,5-dibenzylperhydro-1,3,5-thiadiazine-2-thione;	-23.2066783959	-21.00556533	0.0002600633	0.9933541568			S=C3SCN(Cc1ccccc1)CN3Cc2ccccc2	SigmaAldrich	S545791	2.19427039	0.81082954	2.40266285	1.18092744	3.11051969	-15.79763247	-21.00556533									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00356592-02	Ergotamine tartrate			DPI_SARS-CoV-2_General	2019_NPC_02	379-79-3		0.4406111917	-6.3559444758	-206.4496045613	-1.1	7		-102.5058952942	-95.69043429	0.0001141326	0.995607135			CN1C[C@@H](\C=C2/[C@H]1CC3=C[NH]C4=C3C2=CC=C4)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](CC8=CC=CC=C8)N6C5=O	Prestwick	Prestw-NAT-0314	-2.95266943	-8.86830373	-18.73139401	-46.16373968	-63.03020222	-83.56820744	-95.69043429									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00248905-02	(1S,2R,5S)-(+)-Menthol	225144344	Transient receptor potential cation channel subfamily A member 1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	15356-60-2				6.784772682	4	7		0	0.33772535			8989	TRPA1	CC(C)[C@H]1CC[C@H](C)C[C@@H]1O	SIGMA	224464	1.20465213	-0.04389106	2.2667073	2.312747	1.05268161	2.69635475	0.33772535									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159455-09	Gefitinib	170464828	EGFR Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	184475-35-2	;Iressa/ZD-1839;Gefitinib; Iressa; Gefitinib	9.8640558873	-5.0059444758	-19.9915757242	-2.2	7		-41.7682821675	-36.56688043	0.0008279038	0.9880273381	1956	EGFR	Fc1ccc(cc1Cl)Nc2ncnc3cc(OC)c(cc23)OCCCN4CCOCC4	Tocris	3000	0.37760511	0	4.54534376	3.38876765	1.65203269	-10.97616749	-36.56688043									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016973-06	Letrozole	225144183	Aromatase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	112809-51-5	 Letrozole; F??mara;Letrozole; ;Femara; Femara;CGS-20267;FEM-345?			11.154902003	4	7		0	0.4816101			1588	CYP19A1	N#CC1=CC=C(C=C1)C([N]2C=NC=N2)C3=CC=C(C=C3)C#N	Prestwick	Prestw-1025	2.23416358	3.57954407	1.09429456	3.31853413	2.19002182	3.25219777	0.4816101									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016059-13	Thioridazine	170465080	Serotonin 2c (5-HT2c) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	50-52-2		4.9437388825	-5.3059444758	-98.1113204091	-2.1	7		-99.4383234904	-86.36536463	0.0000024575	0.999359425			CN4CCCCC4CCN1c3ccccc3Sc2ccc(SC)cc12	Enzo	NS835	0.81088277	1.08730178	0.28027589	-4.10615296	-19.24326245	-54.04746176	-86.36536463									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179521-03	Cefixime		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	125110-14-7				10.0221361139	4	7		0	2.65645991					NC1=NC(=CS1)\C(=N\OCC(O)=O)C(=O)N[C@H]2[C@H]3SC\C(=C(/N3C2=O)C(O)=O)C=C	FLUKA	18588	4.63534481	0	1.8059516	3.99076931	0	2.04786829	2.65645991									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015925-12	Sulfaphenazole	170465185	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	526-08-9	; ; Sulphaphenazole; Sulfaphenazole;Sulfaphenazole; Sulfafenazol; Sulfabid;SULFAPHENAZOLE	5.3748585361	-5.2696329617	-42.9233336983	4	7		-10.187979584	-17.47484221	0.0201099662	0.9364828988			Nc1ccc(cc1)S(=O)(=O)Nc3ccnn3c2ccccc2	Specs	AN-153/I226112	-7.3269915	-5.65152589	-7.54307719	-8.81681591	-6.2858448	-8.46587733	-17.47484221									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00538146-01	NCGC00538146-01		Adrenergic receptor beta Blocker	DPI_SARS-CoV-2_General	2019_NPC_02					7.1737475045	4	7		0	1.22247063					CN1\C=C(\OCC(O)CNC(C)(C)C)C2=C(C=CC=C2)C1=O	Pharmaron	PH-NIH-2017-009-L1-4-0	4.64519411	3.13474555	0	0	0	1.7098835	1.22247063									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095187-08	RAMELTEON			DPI_SARS-CoV-2_General	2019_NPC_02	196597-26-9		15.6334750258	-4.8059444758	3.202928387	4	7		-19.395661892	-11.99638491	0.0005821219	0.9900378073			CCC(=O)NCC[C@@H]1CCC2=C1C3=C(OCC3)C=C2	Microsource	01505817	3.21625934	2.55261152	4.07163451	2.27065454	2.58774327	-0.96768132	-11.99638491									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179652-04	Nalbuphine hydrochloride		Kappa opioid receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	23277-43-2				10.2221918912	4	7		0	0.81815155					O[C@H]1CC[C@@]2(O)[C@H]3CC4=C5C(=C(O)C=C4)O[C@@H]1[C@@]25CCN3CC6CCC6	Axon Medchem	1577	0	3.9709857	0.80166897	2.33145476	3.98022955	2.92653138	0.81815155									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182971-01	Hexafluorenium dibromide	144206765	Cholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	317-52-2	HEXAFLUORENIUM BROMIDE; Bromuro de hexafluronio; Bromure d'hexafluronium; Mylaxen; 	7.8352981002	-5.1059444758	-11.4204630339	4	7	Bromuro de hexafluronio;Hexafluorenium bromide;hexafluronium bromide;hexafluorenium dibromide salt;N,N'-DI-9H-FLUOREN-9-YL-N,N,N',N'-TETRAMETHYLHEXANE-1,6-DIAMINIUM DIBROMIDE;hexafluorenium bromide;HEXAMETHYLENEBIS(FLUOREN-9-YLDIMETHYLAMMONIUM) DIBROMIDE;CIPLUS_163766;IN-117;Mylaxen;Bromure d'hexafluronium;Hexafluronium bromide;Hexafluronii bromidum;hexafluorenium;Mallinckrodt Brand of Hexafluronium Bromide;1,6-HEXANEDIAMINIUM, N,N'-DI-9H-FLUOREN-9-YL-N,N,N',N'-TETRAMETHYL-, DIBROMIDE;CIPLUS_152643;hexamethylenebis(fluoren-9-yldimethylammonium) dibromide;HEXAFLUORENIUM BROMIDE;hexafluronii bromidum;HEXAFLURONIUM BROMIDE;LS-18141;bromure d'hexauronium;	-14.2199257919	-13.09993816	0.0030721148	0.9766250897	590	BCHE	[Br-].[Br-].C[N+](C)(CCCCCC[N+](C)(C)C3c1ccccc1c2ccccc23)C6c4ccccc4c5ccccc56	NCI	NSC_19477	0.57111147	1.35138257	-0.3633295	-1.22769684	-0.44435996	-6.32750846	-13.09993816									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091050-09	Phenylmercuric acetate	170465524		DPI_SARS-CoV-2_General	2019_NPC_01	62-38-4		0.4406111917	-6.3559444758	-18.0837709266	4	7		-12.5290057399	-1.85546627	0.1935555995	0.8043167504			CC(=O)O[Hg]c1ccccc1	Microsource	01500644	-0.22511074	2.04021795	0.40213497	0.15802543	-16.27417145	-6.83469688	-1.85546627									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167531-02	Rivastigmine tartrate	170464721	Acetylcholinesterase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_01	129101-54-8	Rivastigmine tartrate;Rivastigmine tartrate (Exelon); Rivastigmine tartrate; ;RIVASTIGMINE			7.8002217864	4	7		0	2.61590327			43	ACHE	O=C(Oc1cc(ccc1)[C@H](C)N(C)C)N(C)CC.O=C(O)[C@@H](O)[C@H](O)C(=O)O	Sequoia	SRP01333r	4.73216663	0	0	0	4.60589758	0	2.61590327									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021268-04	Hydroxyprogesterone caproate	170465210		DPI_SARS-CoV-2_General	2019_NPC_01	630-56-8		15.6334750258	-4.8059444758	-12.3007100298	-2.4	7		-36.064637148	-25.05386429	0.0093156172	0.9578638859			CC(=O)[C@@]3(OC(=O)CCCCC)CC[C@H]2[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	Bosche	H1727	0	4.02912503	0	4.84360499	-1.44901792	-6.12327862	-25.05386429									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015966-10	Levosulpiride	170465834	Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	23672-07-3	(?)-Sulpiride;SULPIRIDE; Sulpirida; Dogmatyl; Levosulpirida; Sulpiride (+/-)-; (?)-Sulpiride; (-)-Sulpiride;Sulpiride; (RS)-(+/-)-Sulpiride;(RS)-(+/-)-Sulpiride;(RS)-SULPIRIDE; ; (S)-(-)-Sulpiride			-6.0573707854	4	7		0	-1.47524778			1813	DRD2	CCN2CCC[C@H]2CNC(=O)c1cc(ccc1OC)S(N)(=O)=O	Prestwick	Prestw-56	-0.21542856	-4.11219977	-0.68972241	-3.18810043	0	0.645358	-1.47524778									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015801-12	Pentoxifylline	170465384	"3',5'-cyclic phosphodiesterase Inhibitor"	DPI_SARS-CoV-2_General	2019_NPC_01	6493-05-6				-39.8170131053	4	7		0	-12.08587868					CC(=O)CCCCN2C(=O)c1n(C)cnc1N(C)C2=O	Vitas	STK177321	-6.6686031	-7.97761869	-8.03538788	-10.4121203	-6.62081916	-8.34391991	-12.08587868									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015605-09	Lamotrigine	170465024	Sodium Channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	84057-84-1	; Labileno; Lamiktal; Faes Brand of Lamotrigine; Lamictal; Lamotrigine;Lamotrigine; Crisomet			8.3438113072	4	7		0	1.42962156					Clc1cccc(c1Cl)c2nnc(N)nc2N	Prestwick Chemical, Inc.	Prestw-1492	4.67891463	3.15439685	0	0	0	3.17597439	1.42962156									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160530-13	Toremifene citrate		Selective Estrogen Receptor Modulators (SERM)	DPI_SARS-CoV-2_General	2019_NPC_02	89778-27-8		4.4061119169	-5.3559444758	-119.593631773	-2.1	7		-103.3824515815	-96.09951006	0.0000063964	0.9989658353		ESR1	CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCl)C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-B0005	-1.73645633	-0.04851117	-3.89817398	-5.72691345	-20.28610128	-66.99549042	-96.09951006									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00188433-02	Hygromycin B		Ribosome-associated ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	31282-04-9				-44.0439093487	4	7		0	-11.99162822			947998	rbbA	CN[C@H]1C[C@@H](N)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@@H]3OC4(O[C@H]([C@@H](N)CO)[C@H](O)[C@H](O)[C@H]4O)O[C@H]23)[C@@H]1O	MedChem Express	HY-B0490	-8.42794053	-11.74663309	-8.82539087	-6.19460749	-9.23175629	-9.80834273	-11.99162822									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181083-01	Piperilate hydrochloride	144206255		DPI_SARS-CoV-2_General	2019_NPC_02	4544-15-4	PIPERILATE; Glymor; Pipetanato; 			11.091837976	4	7	Glymor;CIPLUS_163480;DPX-8;Benzilic acid, 2-piperidinoethyl ester, hydrochloride;2-(1-piperidino)ethyl benzilate;Pipethanate Hydrochloride;Benzilic acid, 2-piperidinoethyl ester;2-PIPERIDIN-1-YLETHYL HYDROXY(DIPHENYL)ACETATE;pipethanate;CIPLUS_163479;.ALPHA.-HYDROXY-.ALPHA.-PHENYL-, 2-(1-PIPERIDINYL)ETHYL ESTER;Pipethanatum;Pipethanate hydrochloride;pipethanate hydrochloride;LS-32519;LS-32518;Pipetanato;PIPETHANATE HYDROCHLORIDE;Piperilate;pipethanatum;N-piperidinoethyl benzilate;beta-Piperidylethyl benzilate;PIPETHANATE;PIPERILATE;piperilate;alpha-hydroxy-alpha-phenylbenzeneacetic acid, 2-(1-piperidinyl)ethyl ester;	0	0.24734814					Cl.OC(c1ccccc1)(c2ccccc2)C(=O)OCCN3CCCCC3	NCI	NSC-30793	4.47871627	2.25230428	2.5573709	0	3.63329611	2.90304397	0.24734814									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164617-04	Adapalene	170464674	topical retinoid	DPI_SARS-CoV-2_General	2019_NPC_01	106685-40-9	 ; Differin; Alcon brand of adapalene; Differine; Adapalene;Adapalene; Adapalene (Differin); Adaferin; Adapaleno	1.241811062	-5.9059444758	-74.8355713159	-1.2	7		-40.8316987615	-35.18795468	0.0151060565	0.9451994571		RARB	O=C(O)c1ccc2cc(ccc2c1)c3cc(c(OC)cc3)C46CC5CC(CC(C4)C5)C6	Tocris	2852	1.19332898	-0.44713759	-0.09017572	-5.87704116	-25.4707405	-49.82468621	-35.18795468									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018242-07	Sulfacetamide	170464944	Bacterial dihydropteroate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	144-80-9				9.5110678994	4	7		0	1.267395					Nc1ccc(cc1)S(=O)(=O)NC(C)=O	Labotest	LT00053160	3.03778472	3.45248858	1.23565109	4.60280432	0.75369233	-0.3353829	1.267395									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017112-10	Ciclopirox	170464708	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC_01	41621-49-2	; Dafnegin-CSC;Ciclopirox ethanolamine; Ciclopirox ethanolamine; Penlac;Ciclopirox; Batrafen; Loprox;ciclopirox; ciclopirox	1.5633475026	-5.8059444758	-85.6512326135	-2.2	7		-60.1046234559	-48.00385288	0.0004688793	0.9910318995		CAT	CC=2C=C(C1CCCCC1)N(O)C(=O)C=2.NCCO	Microsource	01500189	0.86897587	-2.38717717	-5.44222661	-17.95219104	-25.85646856	-35.55058692	-48.00385288									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015851-10	Protriptyline hydrochloride	170465077	Norepinephrine transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	1225-55-4		15.6334750258	-4.8059444758	-10.9489581005	-2.4	7		-39.95461458	-29.54551215	0.0004444053	0.9912784926			Cl.CNCCCC2c3ccccc3C=Cc1ccccc12	Microsource	01505984	1.57093409	4.28323601	2.09353903	2.74161587	0.32228595	-4.3396514	-29.54551215									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090851-10	5-Azacitidine	170465076	DNA Methyltransferase (DNMT) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	320-67-2	 ;AZACITIDINE; Azacytidine, 5-; Ladakamycin;Azacitidina; Azacytidine-5; 5-Azacitidine;5-Azacitidine; 5 Azacytidin; Azacytidine; Vidaza; ara-5-aza-Cyd;5-azacytidine;5-Azacytidine			10.5166658836	4	7		0	-0.84661986			1786	DNMT1	NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Microsource	01502111	3.88013458	2.76834364	0.9821842	2.98743322	3.62127595	1.57020174	-0.84661986									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093889-12	Physostigmine	170465757		DPI_SARS-CoV-2_General	2019_NPC_01	57-47-6				-0.153542501	4	7		0	0.46133178					CNC(=O)Oc1cc2c(cc1)N(C)[C@H]3N(C)CC[C@@]23C	Enzo	AC241	1.20301116	-0.10995187	0.78233531	1.76837986	-6.85936152	2.68306316	0.46133178									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162445-05	Misoprostol	225144248	Prostanoid EP3 receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	59122-46-2		22.0828704269	-4.6559444758	2.0366130547	4	7		-14.409178476	-10.75764873	0.0595215417	0.8806632074			CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC	Prestwick	Prestw-1443	3.18301745	0.5717497	4.52097195	0	0	2.85075461	-10.75764873									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262958-01	Bravavir	170466041		DPI_SARS-CoV-2_General	2019_NPC_01	77181-69-2	Bravavir;5-(2-Bromovinyl)uridine;2,4(1H,3h)-pyrimidinedione,			5.664295828	4	7		0	-0.50188842					Br\C=C/C1=CN(C(=O)NC1=O)[C@H]2O[C@H](CO)[C@@H](O)[C@@H]2O	GVK	FFS-11-286-NCI-260	0	0	0	4.93892192	3.54514541	0	-0.50188842									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091112-09	Methylrosaniline chloride	170464787	TNFR1 (p55/CD120a) Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	548-62-9	; Triple Dye; Basic Violet 3; ; Methyl violet 2B; Hexamethyl-p-rosaniline chloride (Gentian violet); Crystal Violet;GENTIAN VIOLET; Genapax; Methyl Violet 10B; Gentian violet; Crystal violet solution;Gentian violet	0.2780068675	-6.5559444758	-234.587657339	-1.1	7		-96.9168242365	-99.46515931	0.0000029106	0.9993027501		TNFR1	[Cl-].C/[N+](C)=C1\C=C\C(C=C1)=C(/c2ccc(cc2)N(C)C)c3ccc(cc3)N(C)C	Microsource	01500315	-1.95338029	-5.30945342	-10.85764422	-50.79639802	-93.26244734	-98.54159256	-99.46515931									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165957-07	Amlodipine	225144262		DPI_SARS-CoV-2_General	2019_NPC_02	88150-42-9		6.2237985085	-5.2059444758	-57.188206725	-2.2	7		-58.1728820788	-51.46744042	0.0000265645	0.9978893403			CCOC(=O)C/1=C(COCCN)/N\C(=C(C1C2=C(Cl)C=CC=C2)\C(=O)OC)C	Prestwick	Prestw-1219	0.27515087	-0.33495807	-2.38391036	-1.16689662	-9.34106409	-30.04509583	-51.46744042									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181323-02	Squalene	225144321	Steroid biosynthesis Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	111-02-4				-6.1684389426	4	7		0	-3.81962612					CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC=C(C)C	SIGMA	85634	-0.52024324	-2.86677909	-6.92201308	-1.60652901	3.03447948	2.93122886	-3.81962612									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263531-05	Linezolid		50S Ribosomal Protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	165800-03-3				-50.9746122942	4	7		0	-13.352043				MAOA	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC=C(N3CCOCC3)C(=C2)F	Selleck	S1408	-10.02335314	-9.46429809	-9.68800544	-13.14454084	-8.42858161	-12.42484029	-13.352043									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522030-01	Budralazine		adrenergic receptor signaling pathway Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	36798-79-5		8.7913490634	-5.0559444758	-31.075037524	-2.2	7		-39.1008894995	-34.16734053	0.0000751058	0.9964444451			CC(C)=C\C(C)=N/NC1=NN=CC2=C1C=CC=C2	Toronto Research	B689515	1.32951051	-0.85241054	-1.03373104	0.00233847	-2.48318799	-15.60973318	-34.16734053									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00188962-02	Pravastatin sodium	174007284	HMG-CoA Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	81131-70-6	Pravastatin			-30.850938615	4	7		0	-9.67782819			3156	HMGCR	CC[C@H](C)C(=O)O[C@H]1C[C@H](O)\C=C2\C=C/[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12	Prestwick	Prestw-1319	-3.55578147	-6.02291886	-9.23935561	-2.95231645	-7.7374004	-7.43940241	-9.67782819									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263893-02	Lactitol	170465917	Maltase-glucoamylase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	585-86-4				10.9867235752	4	7		0	0					OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO	Microsource	01505436	0	2.35785667	4.50147449	3.634585	3.27107547	1.95131866	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015520-11	Hydroxyurea	170465025	Ribonucleoside-Diphosphate Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	127-07-1	 Hydroxyurea;HYDROXYUREA;Hydroxyurea			6.8479780672	4	7		0	-2.04811031			6240	RRM1	NC(=O)NO	Microsource	01500344	1.13523588	1.81542747	3.77032	0.93059423	2.23570015	1.48889679	-2.04811031									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094652-06	DIGITOXIN			DPI_SARS-CoV-2_General	2019_NPC_01	71-63-6		13.9333492831	-4.8559444758	-19.0992349417	4	7		-18.720070472	-15.18339206	0.0512456665	0.8908680287			C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C	Sequoia	71-63-6	-2.34550868	-2.09885894	-0.09017572	0.37374269	-5.90011673	-5.88952691	-15.18339206									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179526-05	Demecarium bromide		Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	56-94-0		15.6334750258	-4.8059444758	-44.1904239881	-2.2	7		-66.7618560656	-52.47110308	0.0002097837	0.9940307734			CN(CCCCCCCCCCN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C)C(=O)OC2=CC(=CC=C2)[N+](C)(C)C	Prestwick	Prestw-616	-0.77458438	0.41812008	-1.07123602	-4.40333934	-3.13428225	-14.70311913	-52.47110308									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263155-09	Belinostat	404904701	HDAC Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	414864-00-9		11.0676527398	-4.9559444758	-38.0792048711	-2.2	7		-67.0024972636	-48.86552823	0.0002264251	0.9937960355		HDAC1	ONC(=O)/C=C/C1=CC(=CC=C1)[S+]([O-])(=O)NC2=CC=CC=C2	MedChem Express	HY-10225	2.73069898	4.47457784	1.58224139	0.27827795	-6.26143573	-20.34479519	-48.86552823									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166125-02	Meglumine	170465359	amino sugar	DPI_SARS-CoV-2_General	2019_NPC_02	6284-40-8	 hypaque(M)90; Isopaque coronar; N-Methyl-D-glucamine; Isteropac; Banamine; Urovist; Isopaque cerebral;Meglumine; Renovue-65; ; Uropolinum Polfa; Vascoray; Uropolin; Renovist II; Conraxin-H; Hypaque 76; Telebrix 350; Salicylate Meglumine; Uromiron; Meglumine iotalamate; Meglumine; Fortombrine; Sch 14714 meglumine; N-Methyl-D-Glucamine; Vasurix; Visotrast; Meglumina			-1.0136720236	4	7		0	-2.24040337				GLUT1	O[C@H]([C@@H](O)CNC)[C@H](O)[C@H](O)CO	Prestwick	Prestw-884	-0.71446739	0.72766754	0.38677012	0.29230877	0.12118908	-0.59658023	-2.24040337									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346502-04	Dienogest		Synthetic progesterone	DPI_SARS-CoV-2_General	2019_NPC_02	65928-58-7				-0.1004758473	4	7		0	-4.57594064				PGR	C[C@]12CCC\3=C\4CCC(=O)\C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N	MedChem Express	HY-B0084	0	0	0	0	2.89190409	0.41807591	-4.57594064									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390678-03	Sevelamer Hydrochloride (Technical Grade)			DPI_SARS-CoV-2_General	2019_NPC_02	152751-57-0				-12.3572927409	4	7		0	-5.9553822					CCC(CN)CC(C)CNCC(O)CNCC(CC)CC(CC)CN	Toronto Research	S256000	-0.31677033	-2.81595786	-1.09467664	-3.9122606	-0.97188889	-4.08680947	-5.9553822									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166153-02	Climbazole	170465557		DPI_SARS-CoV-2_General	2019_NPC_01	38083-17-9		0.8791349063	-6.0559444758	3.7478333782	4	7		-8.608146816	-7.17345568	0.0498700886	0.8928177108			CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n2ccnc2	Bosche	C1228	4.26258079	3.86297554	4.17001779	3.92053578	-3.42841192	-1.8852584	-7.17345568									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091575-03	2-Ethyl-1,3-hexanediol	170465521		DPI_SARS-CoV-2_General	2019_NPC_01	94-96-2				12.1238535245	4	7		0	4.27872551					CCCC(O)C(CC)CO	SIGMA	E29125	2.97969162	2.84653163	2.03992104	2.28008127	1.62665584	2.43914833	4.27872551									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018139-07	Ipriflavone	170466811	Treatment of Osteoporosis	DPI_SARS-CoV-2_General	2019_NPC_01	35212-22-7	; (Ipriflavone); Osten; Osteoquine; Quinogin;7-Isopropoxy-3-phenyl-4H-1-benzopyran-4-one;IPRIFLAVONE; Ipriflavona;Ipriflavone			8.1661409487	4	7		0	0					CC(C)Oc1ccc2c(c1)OC=C(C2=O)c3ccccc3	SIGMA	381551	1.51284099	4.83543871	0.69459677	0.33862593	4.35212912	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095086-04	PERICIAZINE		Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	2622-26-6		7.8352981002	-5.1059444758	-67.9136912377	-2.2	7		-88.2793131383	-75.96917662	0.0000335369	0.997626878			OC1CCN(CCCN2C3=CC=CC=C3SC4=CC=C(C=C24)C#N)CC1	Microsource	MS-01503936	3.87292192	0	-0.68212184	0.23618549	-5.39647839	-37.77715145	-75.96917662									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178840-05	Cloxacillin sodium	170465404	beta-lactam antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	642-78-4	; Viccillin S (combination);CLOXACILLIN SODIUM; Tegopen; Dicloxacillin Sodium; Sodium syntarpen; Cloxacilina; Sodium, Cloxacilli; Syntarpen;Cloxacillin sodium salt; Orbenin D.C.; 4   Cloxacillin Sodium;Cloxacillin sodium; Sodium cloxacillin; Cloxapen; Cloxacillin, Sodiu; Oxacillin; Ampiclox; Cloxacillin sodium salt	15.6334750258	-4.8059444758	-27.553104702	-3	7		-80.6256005287	-74.23298292	0.0000472056	0.9971824437			[Na+].O=C([O-])[C@@H]3N4C(=O)[C@@H](NC(=O)c2c(C)onc2c1ccccc1Cl)[C@H]4SC3(C)C	Microsource	01500201	4.27524336	4.30825383	0	4.4220471	3.07249958	0.64355505	-74.23298292									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346442-02	Phenprocoumon		Cytochrome P450 3A4 Substrate	DPI_SARS-CoV-2_General	2019_NPC_02	435-97-2		7.8352981002	-5.1059444758	-12.5131619325	4	7		-12.6639394959	-12.21994958	0.0232594337	0.9308993462			CCC(C1=CC=CC=C1)C/2=C(\O)C3=CC=CC=C3OC2=O	Adooq	A10656	0.31677033	0.40887985	-2.93710883	0.86289549	-1.11921679	-6.20537392	-12.21994958									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344565-01	Mizolastine	170465604	Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_02	108612-45-9		17.5410474839	-4.7559444758	-45.2218158552	-2.2	7		-38.6561841729	-34.98549208	0.0008403816	0.9879425452		HRH1	O=C1C=CN=C(N1)N(C)C2CCN(CC2)c4nc5ccccc5n4Cc3ccc(F)cc3	Prestwick	Prestw-1506	-3.68794654	-3.80466169	-6.23285905	-5.82980614	-7.36401872	-11.50413378	-34.98549208									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181294-01	Thiamine disulfide	144206326	HIV Infection Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	67-16-3	thiaminedisulfide monoorotate; Thiamine Disulfide(TDS); Allynate F; Thiamine Phosphate; 			-1.5905854669	4	7	CIPLUS_3852341;thiaminedisulfide monoorotate;Thiamine Disulfide(TDS);Allynate F;CIPLUS_3887567;thiamine disulfide;Thiamine Disulfide Phosphate;Thiamine disulfide;THIAMINE DISULFIDE;thiooratin;N,N'-(dithiobis(2-(2-hydroxyethyl)-1-methylvinylene))bis(N-((4-amino-2-methyl-5-pyrimidinyl)-methyl)formamide);thiamine disulphide;Thiamine Phosphate;CIPLUS_789114;Thiamine Disulfide;CIPLUS_206877;CIPLUS_781198;	0	-4.43799648					Nc2nc(C)ncc2CN(C=O)C(C)=C(CCO)SSC(CCO)=C(C)N(C=O)Cc1cnc(C)nc1N	ACC	thiamine disulfide	0.04855604	1.25436023	1.39002836	-3.53810537	1.20951453	0.7093198	-4.43799648									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00381723-02	Taltirelin		Thyrotropin-Releasing Hormone (TRH) Analogs	DPI_SARS-CoV-2_General	2019_NPC_02	103300-74-9		19.6813789847	-4.7059444758	-11.2651766641	4	7		-12.2185939159	-9.76549493	0.1172372873	0.8178311349		TRHR	CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=C[NH]C=N2)C(=O)N3CCC[C@H]3C(N)=O	MedChem Express	HY-B0596	-2.20351916	-0.89861166	1.61505825	-3.26684283	-1.54219043	-2.5272454	-9.76549493									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263875-02	SELAMECTIN			DPI_SARS-CoV-2_General	2019_NPC_02	165108-07-6		4.9437388825	-5.3059444758	-89.8063521948	-2.1	7		-82.1702896787	-81.63915711	0.0000882106	0.9961416273			CO[C@H]1C[C@H](O[C@@H](C)[C@H]1O)O[C@H]\2[C@@H](C)\C=C\C=C\3CO[C@@H]4C(=N/O)\C(=C/[C@@H](C(=O)O[C@H]5C[C@@H](C/C=C2C)O[C@@]6(CC[C@H](C)[C@H](O6)C7CCCCC7)C5)[C@]34O)C	Microsource	01503720	2.17114847	-0.92633232	-4.76078854	-2.12566939	-8.17669843	-53.02987599	-81.63915711									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179305-04	Lymecycline			DPI_SARS-CoV-2_General	2019_NPC_02	992-21-2		4.9437388825	-5.3059444758	-95.1127003758	-2.2	7		-96.2460400521	-76.78257147	0.0000091264	0.9987643583			CN(C)[C@H]\1[C@@H]2C[C@H]3\C(=C(\O)[C@]2(O)C(=O)\C(=C1O)C(=O)NCNC(CCCCN)C(O)=O)C(=O)C4=C(C=CC=C4O)[C@@]3(C)O	Prestwick	Prestw-1000	2.40699207	1.60548869	0.80870116	-8.584524	-22.32968182	-52.01521984	-76.78257147									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164057-03	2-Bromo-2-nitro-1,3-propanediol	225144251	reactive oxygen species biosynthetic process Activator	DPI_SARS-CoV-2_General	2019_NPC_01	52-51-7				12.5618691633	4	7		0	1.6222656					OCC(Br)(CO)[N+]([O-])=O	SIGMA	134708	2.94096289	4.44449874	3.88243036	3.60950159	0	1.96148178	1.6222656									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016934-06	Nizatidine	170464780	Histamine H2 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	76963-41-2				3.3276107836	4	7		0	-0.88210692					CN(C)Cc1nc(CSCCNC(=C[N+]([O-])=O)NC)cs1	Microsource	01505985	-1.08198388	1.51733574	1.06992274	1.39212883	2.19002182	0.30489354	-0.88210692									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159481-03	Sofalcone	170466017	Prostaglandin Synthesis and Regulation Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	64506-49-6		4.9437388825	-5.3059444758	-80.3875505057	-2.2	7		-82.5339535092	-75.02978378	0.0000028273	0.9993128864			C/C(C)=C\COc1ccc(cc1)/C=C/C(=O)c2ccc(cc2OCC(=O)O)OC\C=C(/C)C	Bionet	KS-1141	-0.1379711	1.14105603	0.52886842	0.18310884	-12.90920164	-47.24325423	-75.02978378									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016403-06	Mafenide hydrochloride	170465055	Carbonic anhydrase II Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	138-37-4				-21.3590662692	4	7		0	-11.47752909					Cl.O=S(N)(=O)c1ccc(CN)cc1	Vitas	STK083032	-3.83172367	-2.42138442	-3.14152714	-3.6847518	-3.21524641	-5.72691702	-11.47752909									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253586-01	Isalon	170465491		DPI_SARS-CoV-2_General	2019_NPC_01	5579-81-7				4.209504054	4	7		0	1.99741451					O=C(N)NC1N=C(O[Al](O)O)NC1=O	GVK	FFS-11-286-NCI-89	1.28530971	0.47645808	2.51760864	0.3988261	0.27153225	-0.3963616	1.99741451									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164604-10	Fluvastatin Na			DPI_SARS-CoV-2_General	2019_NPC_01			12.4181106199	-4.9059444758	-47.5784908105	-2.2	7		-78.245697192	-61.5497706	0.000046659	0.997199179			CC(C)N1C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C(C2=C1C=CC=C2)C3=CC=C(F)C=C3	Sequoia	SRP01980f	0	0	0.38263752	3.13793363	-3.0020809	-22.16576046	-61.5497706									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253572-01	Embutramide	170465662		DPI_SARS-CoV-2_General	2019_NPC_02	15687-14-6		13.9333492831	-4.8559444758	-8.290754232	4	7		-14.9277220199	-13.68976835	0.0094974465	0.9576151748			COc1cc(ccc1)C(CC)(CC)CNC(=O)CCCO	GVK	FFS-11-286-NCI-121	2.20351916	-0.77848876	-0.59304751	0.33907817	-1.04317658	-1.59244645	-13.68976835									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167540-03	3-Methylindole	170465747	Aryl hydrocarbon receptor Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	83-34-1		8.7913490634	-5.0559444758	-36.8449669998	-2.2	7		-37.5728013828	-35.36127099	0.0003843041	0.9918965017			Cc2cnc1ccccc12	Vitas	STK033388	-0.5341164	-2.44634896	-0.08673027	-3.71115216	-3.12952974	-16.15464111	-35.36127099									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346566-09	Roflumilast		Phosphodiesterase IIII (PDE4) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	162401-32-3				11.1785411315	4	7		0	-0.87523189				PDE4A	FC(F)OC1=CC=C(C=C1OCC2CC2)C(=O)NC3=C(Cl)C=NC=C3Cl	SIGMA	SML1099	1.46361766	4.26205272	1.96666745	3.10782686	4.34617304	1.55486659	-0.87523189									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182984-01	Tolindate	144206849		DPI_SARS-CoV-2_General	2019_NPC_01	27877-51-6	Tolindate; 	22.0828704269	-4.6559444758	-20.1498975496	-3	7	tolindate;LS-174201;Tolindate;tolindatum;CIPLUS_175837;TOLINDATE;	-37.027933382	-33.3578363	0.0129848568	0.9495693573			Cc1cc(ccc1)N(C)C(=S)Oc2ccc3CCCc3c2	Pharmaron	PH-NIH-154731	-5.67617941	-2.19170719	0.54836587	3.69478516	0	-0.21850704	-33.3578363									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166310-02	Marbofloxacin	170465732	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	115550-35-1	 ;Marbofloxacin; Marbofloxacin; Zeniquin;MARBOFLOXACIN; Marbofloxacino; Marbocyl; Marbocyl FD; Dexamethasone			9.5970926035	4	7		0	0.19264404					CN1CCN(CC1)c4c(F)cc2c3N(C=C(C2=O)C(=O)O)N(C)COc34	Sequoia	115550-35-1	3.31372691	0	1.49886671	3.11285023	3.35735675	3.75527212	0.19264404									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00015831-06	Pheniramine maleate	170464902	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	132-20-7				-33.4731070239	4	7		0	-6.24065296					[O-]C(=O)/C=C\C([O-])=O.C[NH+](C)CCC(c1ccccc1)c2[nH+]cccc2	Microsource	01500478	-5.58903977	-6.02291886	-8.05001097	-8.37534803	-6.79845709	-8.52177448	-6.24065296									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024622-05	Dantrolene sodium	170464793	Ryanodine receptor 1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	14663-23-1		11.0676527398	-4.9559444758	-74.3912558546	-2.2	7		-87.5291754328	-68.96149654	0.0004220365	0.9914961541	6261	RYR1	[Na+].[O-][N+](=O)c1ccc(cc1)c3ccc(/C=N/N2CC(=O)[N-]C2=O)o3	Enzo	AC100	-1.52736427	-2.43115792	0.71409422	-8.05929716	-8.44287672	-34.72737436	-68.96149654									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00180892-03	CLAVULANATE LITHIUM	225144312	Beta-lactamase TEM Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01					-27.0481453747	4	7		0	0					[Li].OC\C=C1/O[C@@H]2CC(=O)N2[C@H]1C(O)=O	Microsource	01505124	3.64292111	0	0	4.96400532	-47.10703954	1.46857056	0									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00164534-02	4-Phenolsulfonic acid	170465916		DPI_SARS-CoV-2_General	2019_NPC_01	98-67-9				-21.1139848364	4	7		0	-5.35854604					Oc1ccc(cc1)S(O)(=O)=O	Labotest	LT03353562	-2.48105923	-0.12949886	-2.03017231	-9.96563574	-3.62635132	-8.01361858	-5.35854604									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023373-03	Clobetasol propionate	170465385	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC_01	25122-46-7	Clobetasol propionate	11.0676527398	-4.9559444758	-63.7335881471	-2.2	7		-39.554955208	-41.0585283	0.0000444915	0.9972673679		NR3C1	ClCC(=O)[C@@]4(OC(=O)CC)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C	Prestwick Chemical, Inc.	Prestw-781	-8.29036865	-6.78525179	-8.7762911	-7.39709534	-9.14835304	-20.0772397	-41.0585283									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016523-05	Iodipamide	170464888	Complement factor B Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	606-17-7		0.4943738883	-6.3059444758	0.7311672994	4	7		-5.4919555399	0.62862792	0.4501994552	0.5325520209			O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)CCCCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I	Prestwick Chemical, Inc.	Prestw-939	2.05020212	1.19969702	2.05941849	2.71653247	-7.90996295	0.56405305	0.62862792									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263164-17	Cabozantinib		VEGFR-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	849217-68-1		5.5469662594	-5.2559444758	-80.4485422553	-2.2	7		-68.7107907712	-66.39394948	0.0000063335	0.9989710896		KDR	COC1=C(OC)C=C2C(=CC=NC2=C1)OC3=CC=C(NC(=O)C4(CC4)C(=O)NC5=CC=C(F)C=C5)C=C3	MedChem Express	HY-13016	-1.64859303	-2.52489085	-4.26853566	-3.63164418	-10.71454031	-42.29143179	-66.39394948									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167451-04	Halobetasol Propionate			DPI_SARS-CoV-2_General	2019_NPC_02	66852-54-8		15.6334750258	-4.8059444758	-41.6645200637	-2.2	7		-50.4557151728	-40.11796604	0.0116833484	0.9523640894			CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3C[C@H](F)\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl	APExBIO	B1767	0.32139471	-2.15990205	-1.61505825	-1.40074363	-11.1897916	-13.29857197	-40.11796604									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389453-01	Chlortetracycline HCl		translation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	64-72-2 		6.2237985085	-5.2059444758	-63.5914967503	-2.2	7		-76.0677353324	-64.97169766	0.0001769513	0.9945210401			CN(C)C1C2CC3\C(=C(O)/C4=C(O)C=CC(=C4C3(C)O)Cl)C(=O)C2(O)\C(=C(C(N)=O)/C1=O)O	APExBIO	B1699	1.23239844	0	4.23571881	0.666464	-12.1830668	-35.90285607	-64.97169766									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522020-01	Butropium Bromide		Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	29025-14-7		4.4061119169	-5.3559444758	-16.5492325192	4	7		-19.042001616	-15.86833468	0.0043511086	0.9718996779			CCCCOC1=CC=C(C[N+]2(C)C3CCC2CC(C3)OC(=O)[C@H](CO)C4=CC=CC=C4)C=C1	Toronto Research	B690080	2.37924576	-1.41144402	0.98684982	0.17538526	-3.41468051	-10.35325066	-15.86833468									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181341-02	Emedastine difumarate	170465197	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	87233-62-3				14.2880506383	4	7		0	-0.63739714			3269	HRH1	CN1CCCN(CC1)c3nc2ccccc2n3CCOCC.O=C(O)\C=C\C(=O)O.O=C(O)\C=C\C(=O)O	Prestwick	Prestw-1274	3.06827904	4.80722585	3.70596095	2.29871618	4.22736022	2.91243893	-0.63739714									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262526-04	CINCHONIDINE		Alkaloid; P-Glycoprotein (MDR-1) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	485-71-2				6.6820016736	4	7		0	-0.92279884				ABCB1	O[C@@H]([C@@H]1C[C@@H]2CC[N@]1C[C@@H]2C=C)C3=CC=NC4=C3C=CC=C4	Microsource	01500839	0	0	3.23714868	2.08825386	1.54219043	3.38688463	-0.92279884									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00188430-01	Moperone	144207164	Serotonin 2a (5-HT2a) receptor Inverse Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	1050-79-9		13.9333492831	-4.8559444758	-11.9147022188	4	7	Moperone	-23.031798508	-17.10983209	0.0086923593	0.9594838024			O=S(=O)(O)O.Fc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(C)cc3	Toronto Research	M610500	2.77694282	-0.21021507	0.19455709	0.61501766	-2.53546563	-4.8947764	-17.10983209									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164563-04	Entecavir (monohydrate)		DNA Polymerase Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_02	209216-23-9				13.5260455396	4	7		0	3.4533606				SLC22A3	NC/1=N/C2=C(N=C[N]2[C@H]3C[C@H](O)[C@@H](CO)C3=C)C(=O)N1	MedChem Express	HY-13623A	0	4.47457784	3.63095099	1.54105184	4.02775468	3.07215333	3.4533606									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00013226-32	NCGC00013226-32			DPI_SARS-CoV-2_General	2019_NPC_01			6.9832167823	-5.1559444758	-107.3652820089	-2.2	7		-82.358621341	-78.00055765	0.0002362325	0.9936602652			CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1	Labotest	LT00452002	-5.05167865	-5.37298116	-8.17187005	-9.17300023	-22.5168756	-44.65674069	-78.00055765									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016401-09	Hydroflumethiazide	170465082	Thiazide-sensitive sodium-chloride cotransporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	135-09-1				-30.7259683471	4	7		0	-7.12782946					FC(F)(F)c1cc2NCNS(=O)(=O)c2cc1S(N)(=O)=O	Microsource	01500341	-7.38024351	-4.23925526	-6.95327923	-6.83021045	-5.15911283	-8.25245185	-7.12782946									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016241-10	Furosemide	170464879	Loop Diuretics	DPI_SARS-CoV-2_General	2019_NPC_01	54-31-9	 ; Diumide-K; Frusemid;FUROSEMIDE; Errolon; Lasix; Furosemide;Furosemide; Furosemide and potassium; Furosemida; Furantral; Furosemide solution; Fusid; Diumide-K continus; Furanthril	19.6813789847	-4.7059444758	-16.5296381699	4	7		-13.735380604	-11.86281717	0.0688118422	0.870216697			NS(=O)(=O)c2cc(c(NCc1ccco1)cc2Cl)C(=O)O	Vitas	STK177334	-2.97969162	0.30542185	-4.30649996	-2.1947977	-1.95655484	-3.6587225	-11.86281717									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249927-01	Simetride	170466023		DPI_SARS-CoV-2_General	2019_NPC_01	154-82-5		2.2082870427	-5.6559444758	-35.0740397877	4	7		-25.244518516	-23.95376543	0.0006861246	0.9891271303			O=C(COc1ccc(CCC)cc1OC)N2CCN(CC2)C(=O)COc3ccc(CCC)cc3OC	GVK	FFS-11-286-NCI-224	-0.53009948	1.15571628	-1.38675635	-1.52256252	-6.80353246	-23.04995173	-23.95376543									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167526-02	Camostat	170465784	Serine Protease Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	59721-29-8	 ; Camostat mesylate;Camostat mesylate; Camostat Mesylate; Foipan; Foy-305;Camostat	0.4943738883	-6.3059444758	-27.7122347366	4	7		-10.381337872	-11.37613749	0.3910466307	0.5217512577		PRSS1	O=C(Oc1ccc(cc1)CC(=O)OCC(=O)N(C)C)c2ccc(NC(=N)N)cc2.CS(=O)(=O)O	Sequoia	SRP01202c	-1.59513954	-2.14283969	-2.52735736	0.09782527	-21.56778156	-3.38939987	-11.37613749									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164492-02	Sulfisomidine	170465986		DPI_SARS-CoV-2_General	2019_NPC_01	515-64-0		22.0828704269	-4.6559444758	0.4378036783	4	7		-25.3838052239	-19.90317102	0.0030345278	0.9766824364			Cc2cc(NS(=O)(=O)c1ccc(N)cc1)nc(C)n2	Labotest	LT00452030	0.73342531	3.15439685	4.33087178	3.07773346	0.99223469	3.37415519	-19.90317102									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00250382-07	Sonidegib		Smo Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	1218778-77-8		6.2237985085	-5.2059444758	-50.121815202	-2.2	7		-65.5597916608	-55.31560672	0.0001586637	0.9948148295		SMO	C[C@H]1CN(C[C@@H](C)O1)C2=NC=C(NC(=O)C3=C(C)C(=CC=C3)C4=CC=C(OC(F)(F)F)C=C4)C=C2	Aobious	AOB87343	4.88103771	0	3.18089121	0	-7.65867452	-30.24708756	-55.31560672									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179607-03	Chlorphensin carbamate	225144309		DPI_SARS-CoV-2_General	2019_NPC_02	886-74-8				-14.9778481467	4	7		0	-3.41530704					NC(=O)OCC(O)COC1=CC=C(Cl)C=C1	Prestwick	Prestw-234	-4.07177045	-5.36163922	-4.02006516	-2.18179267	-0.14495164	-3.19898534	-3.41530704									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166294-03	Sparfloxacin	170465370	DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	110871-86-8	; Esparfloxacino;Sparfloxacin; Zagam			-38.1736667408	4	7		0	-12.51486467			7155	TOP2B	C[C@@H]1CN(C[C@H](C)N1)c2c(F)c(N)c3c(c2F)N(C=C(C3=O)C(=O)O)C4CC4	Vitas	STK802067	-5.07063747	-4.03104715	-8.89571271	-9.72102051	-5.96677993	-8.4460729	-12.51486467									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00184993-03	Amfenac Sodium	225144335	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01			19.6813789847	-4.7059444758	-23.9346055176	4	7		-13.3194546439	-12.4863755	0.0694929781	0.8696678822			NC1=C(C=CC=C1CC([O-])=O)C(=O)C2=CC=CC=C2	APAC	872965	-3.27015709	-2.68526889	-5.03278009	-1.80349663	-5.97624727	-6.15884953	-12.4863755									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249932-01	Emorfazone	170465843		DPI_SARS-CoV-2_General	2019_NPC_01	38957-41-4				8.4628656145	4	7		0	-3.54870599					CCOC1=C(C=NN(C)C1=O)N2CCOCC2	GVK	FFS-11-286-NCI-236	4.42717789	3.20326435	-0.57761205	1.56269596	4.01207938	2.30194624	-3.54870599									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159404-04	Sulisobenzone	170465489		DPI_SARS-CoV-2_General	2019_NPC_01	4065-45-6		1.9681378985	-5.7059444758	2.1256485307	4	7		-10.7747598919	0	0.0345880389	0.9497819925			OS(=O)(=O)c1cc(c(O)cc1OC)C(=O)c2ccccc2	Labotest	LT03210147	4.99358555	2.18193369	3.39499403	3.25833396	0	-6.06229991	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015437-17	Fenofibrate	170464718	PPARalpha Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	49562-28-9	; Fenofibrato; Tricor; ;FENOFIBRATE; Fenofibrate;Fenofibrate; Lipofene; Lipantil; Procetofen; Fenofibrate micronised	12.4181106199	-4.9059444758	-42.1675714432	-2.2	7		-58.9393297959	-57.03277483	0.0004292394	0.9914239707	5465	PPARA	O=C(c1ccc(Cl)cc1)c2ccc(OC(C)(C)C(=O)OC(C)C)cc2	Microsource	01501010	-4.72248445	-2.99802087	0.37776315	0.36370933	0	-10.4781747	-57.03277483									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016529-07	Pramoxine hydrochloride	170465004	Sodium channel alpha subunit Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	637-58-1		17.5410474839	-4.7559444758	-34.3302248795	4	7		-27.81478544	-24.99809891	0.0096373198	0.9571362993			Cl.CCCCOc1ccc(cc1)OCCCN2CCOCC2	Microsource	01501139	-5.35666739	-5.92029711	-3.89217908	-0.98577771	-5.60574532	-8.66913969	-24.99809891									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00509905-01	Eliglustat (Tartrate)		Ceramide glucosyltransferase Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	491833-29-5		15.6334750258	-4.8059444758	-43.2647973968	-2.2	7		-69.005065884	-53.4129287	0.0002371475	0.9936492228	7357	UGCG	CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)C2=CC=C3OCCOC3=C2	Selleck	S7852	0.34451664	-0.39039941	0.93059234	-3.19201179	-4.39845068	-14.8957159	-53.4129287									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378736-01	Cinepazide Maleate		Voltage-gated calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_02	26328-04-1				-18.4125546989	4	7		0	-6.16943348					COC1=C(OC)C(=CC(=C1)\C=C/C(=O)N2CCN(CC2)CC(=O)N3CCCC3)OC	MedChem Express	HY-66010	-4.62207219	-2.91760031	-4.54044678	-5.24051166	-1.17149443	-3.33990981	-6.16943348									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510316-02	Ombitasvir			DPI_SARS-CoV-2_General	2019_NPC_02	1258226-87-7		3.499899101	-5.4559444758	-92.8783155003	-2.1	7		-86.461280504	-81.63440042	0.0000013777	0.9995204979			COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC2=CC=C(C=C2)[C@@H]3CC[C@H](N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(NC(=O)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)C=C5	MedChem Express	HY-13997	0.41850679	1.92427638	1.17906284	-0.08184646	-15.93755198	-58.81717399	-81.63440042									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167496-03	Methylene blue	170465461	antimalarial agents	DPI_SARS-CoV-2_General	2019_NPC_02	61-73-4	; Ehrlich's reagent III; Urolene Blue; Yamamoto Methylene Blue B; Methylene Blue Hydrate; Azure II eosinate; Blue, Swis; Taylor's Blue; Cloruro de metiltioninio; Blue, Methylen; ; Methylene blue trihydrate; N, Methylene Blu; Methylene blue; Methylene blue hydrate; Methylene Blue hydrate; Basic Blue 9; Chromosmon;Methylene blue; Methylene Blue solution; Blue N, Methylen; Azure II; Methylene Blue N;Methylene Blue	1.5633475026	-5.8059444758	-163.1922545059	-1.1	7		-92.357809186	-96.60371974	0.0001355264	0.9952098966		MAOA	[Cl-].CN(C)c1ccc2nc3ccc(cc3[s+]c2c1)N(C)C	Labotest	LT00032971	-4.59895026	-8.21224792	-6.18597783	-13.55143465	-49.84197895	-78.40567456	-96.60371974									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378937-01	Setiptiline		serotonin receptor signaling pathway Modulator	DPI_SARS-CoV-2_General	2019_NPC_02	57262-94-9		15.6334750258	-4.8059444758	-29.9614274303	-3	7		-64.8900252159	-53.24168768	0.0004728418	0.9909926813			CN1CC\C2=C(/C1)C3=C(CC4=CC=CC=C24)C=CC=C3	MedChem Express	HY-32329	0	0	2.6605096	4.38463157	-1.77031105	-7.98102217	-53.24168768									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263584-01	Tirofiban hydrochloride monohydrate	170465092	Integrin alpha-IIb/beta-3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	150915-40-5				-29.9841909529	4	7		0	-9.10496565					Cl.O.O=C(O)[C@@H](NS(=O)(=O)CCCC)Cc1ccc(cc1)OCCCCC2CCNCC2	Sequoia	142373-60-2	-6.45559509	-6.29169008	-8.62518584	-6.25830888	-6.19956352	-2.39849586	-9.10496565									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016362-05	Benzonatate	170465391	Slowly adapting pulmonary stretch receptor Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	104-31-4				-22.0971282073	4	7		0	-10.58021343					O=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)c1ccc(NCCCC)cc1	Prestwick	Prestw-12	-6.29583908	-1.35118626	-6.67056616	-3.21318384	-2.13926813	-4.15671528	-10.58021343									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00027930-07	Moclobemide	170465663	Monoamine oxidase A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	71320-77-9				9.3186505967	4	7		0	4.71977897					Clc1ccc(cc1)C(=O)NCCN2CCOCC2	Vitas	STK222240	2.97969162	1.492902	0	2.70148243	0	2.69322628	4.71977897									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253646-01	Agomelatine	174006904	5-HT2C Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	138112-76-2	Agomelatine			8.6821516216	4	7		0	-0.4309143			3358	HTR2C	CC(=O)NCCc1cccc2ccc(OC)cc12	GVK	FFS-12-73-NCI-2563	4.48042989	0	4.12127416	0	0	4.28375426	-0.4309143									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263949-02	Piperacillin sodium salt	170465380	Penicillin-binding protein 2B Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	59703-84-3				10.9834431594	4	7		0	3.34085321			933948	penA	[Na+].O=C([O-])[C@H]3N4C(=O)[C@@H](NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)c2ccccc2)[C@H]4SC3(C)C	Microsource	01500489	4.48527098	0	4.98891082	3.85531894	0	0	3.34085321									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00532505-01	N,N-DIMETHYLGLYCINE HYDROCHLORIDE		Glutamate [NMDA] receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02					11.1625919496	4	7		0	3.12514865					CN(C)CC(O)=O	SIGMA	MFCD00012610	4.01627783	4.34983483	0	0.87224937	1.39011002	3.11443067	3.12514865									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00507976-02	Derquantel			DPI_SARS-CoV-2_General	2019_NPC_02	187865-22-1		15.6334750258	-4.8059444758	-58.4113815868	-2.2	7		-79.2434281102	-66.01817057	0.0000814722	0.9962934096			CN1C(=O)[C@]23C[C@H]4C(C)(C)[C@]5(CNC6=C7O\C=C/C(C)(C)OC7=CC=C56)C[C@]14CN2CC[C@@]3(C)O	SantaCruz Bio	sc-391516	-1.61622234	-1.85959482	-4.48887743	-3.0657344	-6.42302117	-16.36602781	-66.01817057									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00174046-02	Imidocarb dipropionate	170466330	Adenosine deaminase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	55750-06-6		2.6938104809	-5.5696329617	-52.692300627	4	7		-8.8425049721	-17.61879846	0.0892201787	0.8471008872			CCC(=O)O.CCC(=O)O.O=C(Nc1cc(ccc1)C2=NCCN2)Nc3cccc(c3)C4=NCCN4	Vitas	STK379516	-6.08337765	-9.62600199	-9.56142613	-10.48803872	-7.22144334	-14.33671552	-17.61879846									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00531794-01	Cimicoxib			DPI_SARS-CoV-2_General	2019_NPC_02	265114-23-6		8.7913490634	-5.0559444758	-34.7304542179	-2.2	7		-45.1110212676	-40.99319793	0.0010856372	0.9862482175			COC1=CC=C(C=C1F)C2=C(Cl)N=C[N]2C3=CC=C(C=C3)[S+](N)([O-])=O	Toronto Research	C441690	3.47522486	-1.48998591	-1.16499848	-1.67668311	-0.15445667	-17.64844044	-40.99319793									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386206-03	Azilsartan (TAK-536)		Type-1 angiotensin II receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	147403-03-0				-24.9119358516	4	7		0	-11.08785616					CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4\C5=N\C(=O)ON5)C(O)=O	Adooq	A11775	-5.61631483	-5.22765599	-4.80766977	-5.18438837	-4.08953734	-2.5272454	-11.08785616									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094956-04	Cephaloridine	124891818	Solute carrier family 22 member 7 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02					4.8746295686	4	7		0	0.61361366			939990		[O-]C(=O)C/1=C(CSC2C(NC(=O)CC3=CC=CS3)C(=O)N12)\C[N+]4=CC=CC=C4	Waterstone	40972	0	4.19737116	0	0.55421743	0	1.76155581	0.61361366									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016309-06	Sulfathiazole	170465454	Escherichia coli Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	72-14-0				4.729353583	4	7		0	2.45367671					O=S(=O)(Nc1nccs1)c2ccc(N)cc2	Labotest	LT00114899	2.28257449	-3.93627679	0.43138115	3.87036898	1.09374207	1.24498196	2.45367671									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160514-02	Idebenone	170465611	Free Radical Scavenger	DPI_SARS-CoV-2_General	2019_NPC_01	58186-27-9	 ;Idebenone;IDEBENONE; Idebenone	6.2237985085	-5.2059444758	-81.9250740423	-2.1	7		-89.7175103288	-82.60880586	0.0001989793	0.9941862873			COC1=C(OC)C(=O)C(C)=C(CCCCCCCCCCO)C1=O	Vitas	STK801942	-0.28804493	3.74569355	0.4508786	-0.92557755	-13.95980308	-43.94532242	-82.60880586									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018125-05	Tripelennamine citrate	170465118	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	6138-56-3		27.8006867458	-4.5559444758	-28.7937602596	4	7		-13.492055256	-12.36977516	0.4545279428	0.4461696196			O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCN(Cc1ccccc1)c2ccccn2	Microsource	01500597	-7.46738315	-1.12639578	-5.66644732	-6.39877593	-5.92041821	-5.5185731	-12.36977516									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00188690-02	Prasugrel	174006898	P2Y12 (P2T) Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	389574-19-0	Prasugrel(Effient);Prasugrel hydrochloride	9.8640558873	-5.0059444758	-52.9224730575	-2.2	7		-74.4250209088	-68.12501584	1.15E-8	0.9999562836	64805	P2RY12	Cl.Fc1ccccc1C(N2CCc3sc(cc3C2)OC(C)=O)C(=O)C4CC4	Selleck	S1258	0	0	0	0	-1.31198295	-23.01946237	-68.12501584									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091146-08	Phenothiazine	170466563	Trichostrongylus colubriformis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	92-84-2		1.3933349283	-5.8559444758	-133.3130843006	-1.1	7		-99.0894502078	-94.40064891	7.438E-7	0.9996477426			c1ccc2Sc3ccccc3Nc2c1	SIGMA	P14831	4.16575896	4.40540475	2.7223319	-2.52088193	-43.80297417	-84.40977692	-94.40064891									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015429-14	Felbamate	170465178	GABA(A) Receptor Modulators	DPI_SARS-CoV-2_General	2019_NPC_01	25451-15-4	 Taloxa;; Felbamyl; ; Essex brand of felbamate;FELBAMATE; Felbatol;Felbamate; Felbamate			9.0347190878	4	7		0	2.50944209			2554	GABRA1	NC(=O)OCC(COC(N)=O)c1ccccc1	SIGMA	F0778	3.64776221	2.90028587	0.70921986	2.28008127	1.56575141	0.04573403	2.50944209									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181762-01	Nequinate	144206498	Eimeria tenella Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	13997-19-8	Nequinate; Nequinato; Statyl; 	5.5469662594	-5.2559444758	-3.3788031084	4	7	nequinatum;Nequinato;CIPLUS_169121;LS-173071;methyl 7-(benzyloxy)-6-butyl-1,4-dihydro-4-oxo-3-quinolinecarboxylate;benzoquate;methylbenzoquate;Statyl;Nequinatum;nequinate;NEQUINATE;Nequinate;	-19.676568524	-13.48047377	0.0047014484	0.9707316229			O=C(OC)C3=CNc2cc(OCc1ccccc1)c(CCCC)cc2C3=O	ACC	NEQUINATE	4.80242318	2.96842154	3.94036708	0.56357131	0.91485873	-7.70856821	-13.48047377									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167509-02	Pipethanate ethylbromide	170465967	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	23182-46-9				-6.0043637042	4	7		0	-5.1847976					[Br-].CC[N+]3(CCOC(=O)C(O)(c1ccccc1)c2ccccc2)CCCCC3	Sequoia	23182-46-9	1.29713982	-1.00025411	-1.55411266	-2.22388513	-0.20673431	-0.94889139	-5.1847976									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181917-01	Carbenicillin indanyl	144206652	Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	35531-88-5	Carbenicillin indanyl	13.9333492831	-4.8559444758	-34.1370890942	-2.2	7	Geocillin;Carbenicillin Indanyl Sodium;carindacillinum;Carindacillin;CARINDACILLIN;LS-149775;CARINDACILLIN SODIUM;CIPLUS_670161;Malonamic acid, N-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenyl-, 1-(5-indanyl) ester, monosodium salt;CARBENICILLIN INDANYL SODIUM;CIPLUS_175403;carbenicillin indanyl;4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 6-((3-((2,3-DIHYDRO-1H-INDEN-5-YL)OXY)-1,3-DIOXO-2-PHENYLPROPYL)AMINO)-3,3-DIMETHYL-7-OXO-, MONOSODIUM SALT, (2S,5R,6R)-;LS-88733;Carindacilline;1-(5-INDANYL)(2S,5R,6R)-N-(2-CARBOXY-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO(3.2.0)HEPT-6-YL)-2-PHENYLMALONAMATE MONOSODIUM SALT;Carindacilina;CIPLUS_197131;SODIUM (2S,5R,6R)-6-((3-(2,3-DIHYDRO-1H-INDEN-5-YLOXY)-3-OXO-2-PHENYLPROPANOYL)AMINO)-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLATE;Carindacillin sodium;4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((3-((2,3-dihydro-1H-inden-5-yl)oxy)-1,3-dioxo-2-phenylpropyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2-alpha,5-alpha,6-beta))-;4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 6-((3-((2,3-DIHYDRO-1H-INDEN-5-YL)OXY)-1,3-DIOXO-2-PHENYLPROPYL)AMINO)-3,3-DIMETHYL-7-OXO-, MONOSODIUM SALT, (2S-(2.ALPHA.,5.ALPHA.,6.BETA.))-.;carindacilline;Carbenicillin indanyl sodium;Carindacillinum;Carindacillin Sodium;	-34.595982208	-32.16477192	0.0009333756	0.9872794387			OC(=O)[C@@H]4N5C(=O)[C@@H](NC(=O)C(c1ccccc1)C(=O)Oc2cc3CCCc3cc2)[C@H]5SC4(C)C	GVK	GVK-NIH-11	-3.24400564	-0.41812008	-4.32479314	-3.65970582	-3.02497446	-10.00563698	-32.16477192									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183271-01	Bucillamine	144206469		DPI_SARS-CoV-2_General	2019_NPC_02	65002-17-7				1.3268270321	4	7	Bucilant;CIPLUS_186785;BUCILLAMINE;CIPLUS_3866301;bucillamine disulfide;Bucillamine;SA981 cpd;bucillaminum;2-mercapto-2-methylpropanoyl-L-cysteine;SA-96;N-(2-mercapto-2-methylpropionyl)-L-cysteine;L-Cysteine, N-(2-mercapto-2-methyl-1-oxopropyl)-;LS-59032;bucillamine;N-(2-MERCAPTO-2-METHYLPROPIONYL)-CYSTEINE;SA 96;tiobutarit;SA-981;SA 981;	0	-3.04428483					O=C(N[C@@H](CS)C(=O)O)C(C)(C)S	ACC	Bucillamine	-0.68672108	3.46739356	1.0665479	1.89649931	-0.0166338	-1.55486659	-3.04428483									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185990-04	Ketorolac	170464659	non-steroidal antiinflammatory	DPI_SARS-CoV-2_General	2019_NPC_02	74103-07-4	Ketorolac tromethamine;KETOROLAC TROMETHAMINE			11.2123056401	4	7		0	-3.98611045				PTGS1	OCC(N)(CO)CO.O=C(O)[C@@H]1CCn2c(ccc12)C(=O)c3ccccc3	Vitas	STL018674	3.99315591	2.98228187	2.57143527	2.78044104	2.19803721	4.65050733	-3.98611045									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164375-03	1-Phenoxy-2-propanol	170465645		DPI_SARS-CoV-2_General	2019_NPC_01	770-35-4				4.0742978893	4	7		0	2.27117183					CC(O)COc1ccccc1	SIGMA	484423	-0.06051364	2.40672417	0.36801443	0.15300875	0.19032635	1.05696428	2.27117183									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023643-15	Estrone	170465020	Steroid hormone	DPI_SARS-CoV-2_General	2019_NPC_01	53-16-7		4.9437388825	-5.3059444758	-12.6498376836	4	7		-18.582139864	-12.15178322	0.0639282234	0.8752056305		ESR1	Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)C(=O)CC[C@@H]12)c4cc3	Vitas	STK801833	0.57366931	4.91851345	-2.39087519	-0.76504377	-3.03760849	-8.21179938	-12.15178322									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018099-09	Dyphylline	170465316	Xanthine Derivative	DPI_SARS-CoV-2_General	2019_NPC_01	479-18-5	; Major Brand of Dyphylline;Diprophylline; Lufyllin; Dilin; Hauck Brand of Dyphylline; Dilor Brand of Dyphylline;Dyphylline; Dylix;DYPHYLLINE; Diprofilina; Diphylline	12.4181106199	-4.9059444758	-3.2650859483	4	7		-6.738206888	-6.44850574	0.3010135084	0.6308474444		XDH	OCC(O)Cn2cnc1c2C(=O)N(C)C(=O)N1C	Vitas	STK796769	-1.77910101	3.74569355	0.28027589	-2.03426393	0.74861696	-0.82321256	-6.44850574									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181097-01	Dimefline hydrochloride	144206266		DPI_SARS-CoV-2_General	2019_NPC_02	2740-04-7	Dimefline hydrochloride; Dimeflina; Remeflin; Reanimil; 	12.4181106199	-4.9059444758	-1.2433859693	4	7	Flavone, 8-(dimethylaminomethyl)-7-methoxy-3-methyl-;4H-1-BENZOPYRAN-4-ONE, 8-((DIMETHYLAMINO)METHYL)-7-METHOXY-3-METHYL-2-PHENYL-;dimeflinum;LS-68986;Dimeflina;Dimefline hydrochloride;dimefline;4h-1-benzopyran-4-one, 8-((dimethylamino)methyl)-7-methoxy-3-methyl-2-phenyl-, hydrochloride;3-methyl-7-methoxy-8-dimethylamino-methylflavone;Flavone, 8-((dimethylamino)methyl)-7-methoxy-3-methyl-, hydrochloride;Reanimil;dimefline hydrochloride;CIPLUS_157700;Remeflin;8-((DIMETHYLAMINO)METHYL)-7-METHOXY-3-METHYLFLAVONE;LS-68987;DIMEFLINE HYDROCHLORIDE;DIMEFLINE;CIPLUS_160797;Dimeflinum;	-16.4962184279	-13.74684869	0.0143196636	0.9470040911			Cl.CN(C)Cc3c(ccc1c3OC(=C(C)C1=O)c2ccccc2)OC	NCI	NSC-114650	3.66020024	1.49922613	0.95872108	-0.33440123	3.3006202	-0.37579857	-13.74684869									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185775-01	Salidroside	144207114	beta-Amyloid (Abeta) Protein Neurotoxicity Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_02	10338-51-9				4.5708910854	4	7		0	1.17966037				APP	Oc2ccc(CCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)cc2	Sinova	SL-02667	0	0	1.90103373	0	2.99170686	0.75629463	1.17966037									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00186628-02	Butylscopolamine bromide	170465685	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	149-64-4	Butylscopolammonium Br			3.0883182265	4	7		0	-0.16648433			1128	CHRM1	[Br-].OC[C@H](c1ccccc1)C(=O)O[C@@H]2C[C@@H]3[C@H]4O[C@H]4[C@H](C2)[N+]3(C)CCCC	Enzo	NP527	0.94106222	-1.30056134	-2.41672722	2.78979492	4.56478863	0	-0.16648433									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179306-04	Zuclopenthixol (-)-10-Camphorsulfonic Acid Salt		Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	53772-83-1		22.0828704269	-4.6559444758	-49.4058424785	-3	7		-90.1077153542	-81.23483803	0.0004769186	0.9909513479			OCCN1CCN(CC\C=C2\C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1	Toronto Research	Z701495	1.33875928	1.86883504	-2.29014791	-5.43226621	-4.84043438	0	-81.23483803									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166005-02	L-Cysteine methyl ester hydrochloride	225144264		DPI_SARS-CoV-2_General	2019_NPC_02	18598-63-5				1.2983396187	4	7		0	-7.25871664					COC(=O)[C@@H](N)CS	SIGMA	410209	2.43011399	2.16452216	0.0304728	1.31188177	1.00040396	0.4744457	-7.25871664									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183876-03	Tenofovir disoproxil fumarate	170465338	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	202138-50-9	Tenfovir disoproxil fumarate;TENOFOVIR DISOPROXIL FUMARATE			-3.9130745105	4	7		0	-2.17856633			7015	TERT	O=C(O)C=CC(=O)O.CC(C)OC(=O)OCOP(=O)(OCOC(=O)OC(C)C)CO[C@H](C)Cn2cnc1c(N)ncnc12	Sequoia	202138-50-9	-0.61735531	-2.43710873	-2.28077166	0.78806445	0.37307226	0.20199173	-2.17856633									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00096014-03	Salsalate	170465545	prostaglandin biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	552-94-3				-41.6084975785	4	7		0	-11.75635599					O=C(Oc1ccccc1C(=O)O)c2ccccc2O	Specs	AN-153/I262078	-11.43223683	-7.98250544	-8.82016037	-8.06431384	-6.75785413	-7.96280299	-11.75635599									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344535-01	5alpha-Cholestan-3beta-ol	225144382	Sterol regulatory element-binding protein cleavage-activating protein Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_02	80-97-7				3.7756721953	4	7		0	-0.8609618			22937	SCAP	CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	SIGMA	D6128	2.44398714	2.92222043	2.93242071	-0.00701541	1.89387639	-2.63528749	-0.8609618									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00016636-05	Flavoxate hydrochloride	170466285	Muscarinic acetylcholine receptors; M1 & M2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	3717-88-2		19.6813789847	-4.7059444758	-1.5797603176	4	7		-15.9509264639	-13.29243872	0.0159523291	0.943806895			Cl.O=C(OCCN1CCCCC1)c4cccc2c4OC(=C(C)C2=O)c3ccccc3	Prestwick	Prestw-242	2.43264832	3.06154861	0	0	0	2.35276183	-13.29243872									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164529-04	1-Stearoyl-rac-glycerol	170465522	Phospholipase A2 group IIA Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	123-94-4				-14.3343014908	4	7		0	-8.18737168					OCC(O)COC(=O)CCCCCCCCCCCCCCCCC	SIGMA	M2015	-1.44022463	-2.07931195	-0.30952207	-0.2683924	-2.77876466	-7.50546268	-8.18737168									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183846-01	Toborinone	144206841	Phosphodiesterase 3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	143343-83-3		11.0676527398	-4.9559444758	-23.37800865	4	7	toborinone;OPC 18790;6-(3-(3,4-DIMETHOXYBENZYLAMINO)-2-HYDROXYPROPOXY)-2(1H)-QUINOLINONE,DL-;torborinone;CIPLUS_208056;Toborinone;LS-141868;OPC-18790;TOBORINONE;2(1H)-Quinolinone, 6-(3-(((3,4-dimethoxyphenyl)methyl)amino)-2-hydroxypropoxy)-, (+-)-;6-(3-(3,4-dimethoxybenzylamino)-2-hydroxypropoxy)-2(1H)-quinolinone;toborinonum;taborinone;CIPLUS_197035;CIPLUS_698797;	-16.35493134	-17.79003948	0.0047846887	0.9705069874			COc1ccc(cc1OC)CNCC(O)COc2ccc3NC(=O)C=Cc3c2	Pharmaron	PH-NIH-152870	-3.5815857	-1.66093003	-2.18700921	-4.34721605	-2.01268921	-6.35099587	-17.79003948									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386298-01	Rifapentine		DNA-Directed RNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	61379-65-5		6.2237985085	-5.2059444758	-112.1461675206	-2.1	7		-89.8308859983	-90.51515007	0.0000275981	0.9978479425		PRKDC	CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C4=C(O)C(=C(NC(=O)\C(=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C)C(=C4C(=C3C)O)O)\C=N\N5CCN(CC5)C6CCCC6	Selleck	S1760	-4.83016948	-5.86985146	-8.95197018	-5.25454248	-14.8017014	-52.62589252	-90.51515007									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178499-08	Cefdinir		Cephalosporin antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	91832-40-5		6.9832167823	-5.1559444758	-1.846187337	4	7		-9.678518768	-7.64876564	0.0280442562	0.923602849			NC1=NC(=CS1)\C(=N\O)C(=O)N[C@H]2[C@H]3SC\C(=C(/N3C2=O)C(O)=O)C=C	Adooq	A10187	2.95266943	1.93813671	0.48522069	-0.20812385	1.29030725	-3.2365652	-7.64876564									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168759-05	PTC-124	170466862	CFTR-G542X nonsense allele Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	775304-57-9	Ataluren;PTC124			-7.6272944559	4	7		0	-2.33200679			1080	CFTR	O=C(O)c1cccc(c1)c2nc(on2)c3ccccc3F	Selleck	S6003	-1.38697262	-0.93581254	-0.01706027	-1.77841322	-6.58021621	1.49905991	-2.33200679									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090693-11	D-Nicotine	170464932	Neuronal acetylcholine receptor; alpha4/beta2 Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	25162-00-9				10.0442873555	4	7		0	-0.75536742					CN2CCC[C@@H]2c1cnccc1	Microsource	02300259	1.68712028	2.21125418	1.64022325	3.53926807	4.53484241	1.38218405	-0.75536742									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249905-01	Phthalofyne	170466477		DPI_SARS-CoV-2_General	2019_NPC_01	131-67-9				11.511842535	4	7		0	-4.68429191					O=C(O)c1ccccc1C(=O)OC(C)(C#C)CC	GVK	FFS-11-286-NCI-120	3.97695641	0.97490654	3.18539641	4.28675346	4.57036999	3.13532192	-4.68429191									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159453-05	Zileuton	170465222	5-Lipoxygenase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	111406-87-2	;Zileuton; Zileuton; Zyflo;A-64077/ABT-077			-47.09712391	4	7		0	-14.27593724			240	ALOX5	NC(=O)N(O)C(C)c1cc2ccccc2s1	Prestwick Chemical, Inc.	Prestw-1365	-11.36446155	-7.210399	-9.36121469	-12.06762485	-7.46333046	-9.50251537	-14.27593724									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095303-04	Cloxyquin	170465523	Mycobacterium tuberculosis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	130-16-5		6.2237985085	-5.2059444758	-97.7650623522	-2.2	7		-80.4036129296	-67.38485716	0.0000476052	0.997170708			Oc1ccc(Cl)c2cccnc12	Vitas	STK015543	-1.66775591	-3.67239231	-7.59182082	-10.12115283	-21.88245445	-44.17399258	-67.38485716									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263560-01	6-Aminopenicillanic acid	225144362		DPI_SARS-CoV-2_General	2019_NPC_01	551-16-6				13.467016858	4	7		0	4.52713493					CC1(C)S[C@@H]2[C@H](N)C(=O)N2[C@H]1C(O)=O	Bosche	A0928	1.98242684	3.53067657	3.71182764	3.45900118	-4.35720449	2.03770517	4.52713493									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00178376-05	Sulfaquinoxaline	170465653		DPI_SARS-CoV-2_General	2019_NPC_01	59-40-5		24.777388143	-4.6059444758	-0.3270980365	4	7		-9.810055512	-6.92504626	0.0906195715	0.8465259558			Nc1ccc(cc1)S(=O)(=O)Nc2cnc3ccccc3n2	Microsource	01501145	1.47169172	0	0	0.0501668	0	3.28268713	-6.92504626									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091737-05	Sorbic acid			DPI_SARS-CoV-2_General	2019_NPC_01	110-44-1				-0.3761344485	4	7		0	0.67425414					C/C=C/C=C/C(O)=O	SIGMA	S1626	-1.48379445	-1.05798128	-0.19253735	-0.22825896	2.42856418	-0.55897149	0.67425414									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015859-14	Procainamide	170464952	Sodium channel alpha subunit Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	51-06-9				-7.799020237	4	7		0	-1.19642088					O=C(NCCN(CC)CC)c1ccc(N)cc1	Enzo	AC127	-1.54188754	-2.87585213	-1.50861544	0.41387614	-1.25615389	-3.53676508	-1.19642088									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015204-09	Carmustine	170464880	DNA Alkylating Agent	DPI_SARS-CoV-2_General	2019_NPC_01	154-93-8	 Bicnu; Gliadel; ; Carmustina; Carmustine;Carmustine; 6   Carmustine; Nitrumon;CARMUSTINE; BiCNU			-0.119726042	4	7		0	-1.0646118				H2AFX	O=C(NCCCl)N(CCCl)N=O	Microsource	01503110	0.97063878	1.453808	0.1730399	-1.23661173	-0.27660762	-0.4217694	-1.0646118									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185767-01	Spiramycin II	144207139	Bacterial 70S ribosome Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_02	24916-51-6		15.6334750258	-4.8059444758	-28.0245011283	-2.4	7		-38.874994056	-29.89582838	0.0022655323	0.979943279			CN(C)[C@H]1CC[C@H](O[C@@H]1C)O[C@H]4C=CC=CC[C@@H](C)OC(=O)C[C@@H](OC(C)=O)[C@H](OC)[C@@H](O[C@@H]3O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]3O)N(C)C)[C@@H](CC=O)C[C@H]4C	Toronto Research	A187800	-1.83819279	1.17119823	-2.18232109	-0.17070832	-4.75964166	-9.82243517	-29.89582838									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167980-02	Pranoprofen	170465811	prostaglandin biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	52549-17-4		9.8640558873	-5.0059444758	-3.7125387898	4	7		-14.150216424	-11.79184702	0.0051413973	0.9694218307			O=C(O)C(C)c1cc2Cc3cccnc3Oc2cc1	Prestwick	Prestw-1318	1.75957826	1.9335166	-0.29769579	0.69452564	1.99843167	-2.4473882	-11.79184702									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167524-02	Amorolfine hydrochloride	170466078	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC_02	78613-35-1	 ;Amorolfine Hydrochloride;Amorolfine; Amorolfine; Amorolfine [USAN:BAN:INN];Amorolfine hcL; Loceryl; Pekiron	22.0828704269	-4.6559444758	-31.5639934013	-3	7		-59.0491128773	-53.11325691	0.0000782774	0.9963676945			C[C@H]2CN(CC(C)Cc1ccc(cc1)C(C)(C)CC)C[C@@H](C)O2	Sequoia	SRP0563571a	-0.75608685	-0.24717596	-3.34966363	-0.75532587	0	0	-53.11325691									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378832-01	Eldecalcitol			DPI_SARS-CoV-2_General	2019_NPC_02	104121-92-8		6.2237985085	-5.2059444758	-52.3739672378	-2.2	7		-69.085620507	-57.96984255	0.0000149585	0.9984173483			C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C/3C[C@@H](O)[C@@H](OCCCO)[C@H](O)C3=C	MedChem Express	HY-A0020	3.98390714	2.66349419	3.17620309	0.82080303	-9.14621106	-32.59113115	-57.96984255									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179419-05	Guanadrel sulfate		Norepinephrine transporter Partial Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	22195-34-2		22.0828704269	-4.6559444758	-1.195826515	4	7		-9.669409692	-8.05784141	0.0638507757	0.8762888838			NC(=N)NCC1COC2(CCCCC2)O1	Prestwick	Prestw-767	1.79194895	-0.65374576	-0.56491878	-0.02572317	2.59249578	1.28711011	-8.05784141									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510003-01	Vaborbactam			DPI_SARS-CoV-2_General	2019_NPC_02	1360457-46-0				0.3946897513	4	7		0	0.02378348					OB1O[C@@H](CC[C@@H]1NC(=O)CC2=CC=CS2)CC(O)=O	MedChem Express	HY-19930	-0.36301417	-2.37704729	-0.879023	3.07041134	1.79407362	-0.7093198	0.02378348									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183832-01	Ro 22-9194	144206801	Thromboxane A2 receptor Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	106134-33-2				-11.3759422746	4	7	(-)-(R)-2-AMINO-N-(3-(3-PYRIDYL)PROPYL)-2',6'-PROPIONOXYLIDIDE;Milacainide Tartrate;CIPLUS_3853846;milacainide;MILACAINIDE TARTRATE;CIPLUS_705772;Ro 22-9194;MILACAINIDE;Ro-22-9194;Milacainide tartrate;Milacainide;milacainidum;2-amino-N-(2,6-dimethylphenyl)-N-(3-(3-pyridyl)propyl)propionamide;	0	1.46981877					Cl.Cl.CC(N)C(=O)N(CCCc1cccnc1)c2c(C)cccc2C	Pharmaron	PH-NIH-100499-100	-1.38962751	-4.48381806	-0.87433487	-2.04148446	-1.00040396	-7.64280346	1.46981877									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094857-05	9-Aminoacridine, monohydrochloride, monohydrate	170465046		DPI_SARS-CoV-2_General	2019_NPC_01	52417-22-8				-26.5423763553	4	7		0	-11.53836405					Cl.O.Nc1c3ccccc3nc2ccccc12	Vitas	STK387428	-5.99085034	-5.4756029	-3.76544564	-5.29510623	-2.56052378	-6.37227501	-11.53836405									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021925-03	Prednisolone acetate	170464632	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC_01	52-21-1	; Pred forte;PREDNISOLONE ACETATE;Prednisolone acetate (Omnipred); Supercortyl;Prednisolone acetate			-0.2093815929	4	7		0	-5.33319814				NRC31	CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Bosche	P0845	1.85655847	2.59242065	1.05529965	-0.62457672	2.40318733	-3.50119417	-5.33319814									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015691-06	Cysteamine hydrochloride	170466795	Protein-glutamine gamma-glutamyltransferase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	156-57-0				-5.4732695349	4	7		0	-2.48916377			7052	TGM2	Cl.NCCS	Microsource	01504226	0.02178491	0.71590881	0.4118837	-2.19981438	-1.64188195	-3.26236089	-2.48916377									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016643-09	Trioxsalen	170465339	phototherapy treatment of skin disorders	DPI_SARS-CoV-2_General	2019_NPC_01	3902-71-4	 ; Trisoralen; ICN Brand of Trioxsalen; Trioxisalenum; Trioxisaleno; 4,5',8-Trimethylpsoralen;Trioxsalen; Trioxsalen;TRIOXSALEN	19.6813789847	-4.7059444758	-7.9342008694	4	7		-9.468543252	-9.14045271	0.0444760487	0.90055815			Cc1oc2c(C)c3OC(=O)C=C(C)c3cc2c1	Microsource	01500596	-0.48168857	-1.79588047	-1.40137944	-1.48242908	1.31198295	-0.6199502	-9.14045271									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181020-01	Zeaxanthin	144206223	osteoclast development Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	144-68-3	Lutein; alpha-Carotene-3,3'-diol; gamma Lutein; Lutein, gamm; Lutein G; Lutein F; 	8.7913490634	-5.0559444758	-35.1071352399	-2.2	7	XANTHOPHYLL;zeaxanthin;beta, epsilon-carotene;ZEAXANTHIN;(3R,3'R)-beta,beta- carotene-3,3'-diol;Lutein G;beta,epsilon-Carotene-3, 3'-Diol, (3R,3'R,6'S)-;meso-zeaxanthin;Lutein F;CIPLUS_173450;LUTEIN A;alpha-Carotene-3,3'-diol;LUTEIN;beta,epsilon-Carotene-3,3'-diol, (3R,3'R,6'R)-;CIPLUS_758859;CIPLUS_668195;beta,beta-Carotene-3,3'-diol;Xanthophyll;gamma Lutein;Lutein;Lutein, gamm;B,B-CAROTENE-3,3'-DIOL, (3R,3'R), TRANS;Zeaxanthin;B,E-CAROTENE-3,3'-DIOL, (3R,3'R,6'R), TRANS;beta, epsilon-carotene-3,3'-diol;CIPLUS_759357;beta,epsilon-Carotene-3,3'-diol, (3S,3'R,6'S)-;beta-carotene-3,3'-diol;	-39.1061456552	-36.06526186	0.0012407867	0.9852787136			CC2(C)C[C@H](O)CC(C)=C2/C=CC(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C	Sequoia	SRP00500Z	-1.87056348	1.08803622	-0.0304728	-4.21158478	-2.18853219	-15.87279218	-36.06526186									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522014-01	Zolazepam Hydrochloride			DPI_SARS-CoV-2_General	2019_NPC_02	33754-49-3				-34.1017030152	4	7		0	-9.71792798					C[N]1N=C(C)C2=C1N(C)C(=O)C\N=C2\C3=CC=CC=C3F	Toronto Research	Z613500	-5.89840228	-7.73175634	-6.14847284	-4.1320768	-7.80600242	-9.93047726	-9.71792798									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182054-03	Aranidipine	170465977	Voltage-gated calcium channel Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	86780-90-7		6.2237985085	-5.2059444758	-84.0515127214	-2.2	7		-81.9608523955	-72.77267754	0.0004573904	0.9911415967			CC=1NC(C)=C(C(C=1C(=O)OCC(C)=O)c2ccccc2[N+]([O-])=O)C(=O)OC	APAC	826079	3.12839603	0.44122063	-3.7997234	-7.29836541	-15.45754818	-42.28673431	-72.77267754									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00229511-10	Tofacitinib		Jak1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	477600-75-2				-43.3435824895	4	7		0	-13.44242021				JAK1	C[C@@H]1CCN(C[C@@H]1N(C)C2=C3C=C[NH]C3=NC=N2)C(=O)CC#N	XcessBio	M60033-2s	-8.76089621	-5.89295202	-10.14275333	-10.49739261	-6.34222845	-10.50826757	-13.44242021									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181767-03	Tolcapone	170465081	catechol-O-methyltransferase (COMT)	DPI_SARS-CoV-2_General	2019_NPC_02	134308-13-7	 ; Roche brand of tolcapone; Tasmar;TOLCAPONE; Tolcapone;Tolcapone	6.9832167823	-5.1559444758	-49.4022475072	-2.2	7		-45.3395804595	-43.83294487	0.0027150829	0.9779549801	1312	COMT	Oc1cc(cc([N+]([O-])=O)c1O)C(=O)c2ccc(C)cc2	Sequoia	134308-13-7	2.44861153	-3.79080136	-0.90246361	-5.48371256	-6.5798541	-23.23844419	-43.83294487									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167519-02	Ramatroban	170465980	prostaglandin D2 CRTH2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	116649-85-5	BAY u-3405; ; Ramatroban;Ramatroban; Baynas; BAY u3405;BAY-u3405; BAY u 3405; BAY u 3406	17.5410474839	-4.7559444758	-4.0783042382	-2.4	7		-34.9921990239	-23.32683252	0.003110778	0.9763664634	11251	PTGDR2	Fc1ccc(cc1)S(=O)(=O)N[C@H]3Cc4c2ccccc2n(CCC(=O)O)c4CC3	Sequoia	SRP0101165r	3.8498	4.95968953	3.67783221	0	2.30734501	-2.91243893	-23.32683252									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183831-01	Aceglatone	144206883		DPI_SARS-CoV-2_General	2019_NPC_02	642-83-1				3.2917431505	4	7	Aceglatone;aceglatone monosodium salt;CIPLUS_211093;2,5-di-o-acetyl-d-glucaro-1,4:6,3-dilactone;aceglatonum;Aceglatona;ACEGLATONE;LS-71328;glucaron;aceglatone;2,5-di-O-acetyl glucaro-(1,4)-(6-3)-dilactone;Glucaron;Aceglatonum;Glucaric acid, 1,4:6,3-dilactone, diacetate, D-;diacetyl glucaro-(1,4)-(6-3)-dilactone;	0	-0.50420968					O=C1O[C@H]2[C@@H](OC(C)=O)C(=O)O[C@H]2[C@@H]1OC(C)=O	Pharmaron	PH-NIH-183676	-0.96418414	4.34983483	0.43833947	-1.31188177	1.28080222	1.26832018	-0.50420968									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00229704-01	Raltitrexed	124939249	thymidylate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	112887-68-0	Raltitrexed			-21.6125400047	4	7	Raltitrexed	0	-9.42301289			7298	TYMS	O=C(N[C@@H](CCC(=O)O)C(=O)O)c1ccc(s1)N(C)Cc2ccc3N=C(C)NC(=O)c3c2	Waterstone	WS10046	-2.09253393	-4.30825383	-3.06368815	-5.56322054	-1.99367916	-6.85832394	-9.42301289									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390241-07	LX1606 (Hippurate)		5-HT Release Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1137608-69-5		4.4061119169	-5.3559444758	-80.8038076986	-2.2	7		-79.583836752	-68.81986396	0.0000015898	0.9994849151		TPH1	CCOC(=O)[C@@H](N)CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)O[C@H](C3=C(C=C(Cl)C=C3)[N]4C=CC(=N4)C)C(F)(F)F	MedChem Express	HY-13055	1.37112997	1.6101088	0.5274138	-4.43607792	-16.37953568	-46.36414882	-68.81986396									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015580-13	Ketotifen	170465378	Histamine H1 Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	34580-13-7	Ketotifen; Zaditor;Ketotifen fumarate; Ketotifen fumarate;; ; Fumarate, Ketotife; Ketotiphen;KETOTIFEN FUMARATE; Zaditen; Ketotifen fumarate salt; Ketotifen Maleate; Ketotiphene; Ketotifeno	15.6334750258	-4.8059444758	-36.8937531259	4	7		-23.838029984	-25.27692581	0.0087487328	0.9593077456	9704	HRH1	CN1CC/C(CC1)=C3\c4ccccc4CC(=O)c2sccc23	Vitas	STK048448	-8.32909738	-4.45427224	-5.125393	-3.32856749	-4.81906309	-7.92215052	-25.27692581									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023945-12	3'-Azido-3'-deoxythymidine	170464737	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	30516-87-1	3'-Azido-3'-deoxythymidine; ; 3'-Azido-3'-deoxythymidine (AZT); Zidovudine, AZT;; 3'-Azido-3'-deoxythymidine; Antiviral AZ; AZT Antiviral; Retrovir; AZTMP-MAN-SA conjugate; 3' Azido 3' deoxythymidin; bis(t-butyl-SATE)-AZTMP; zidovudine (ZDV or AZT);Zidovudine; AZT, Antiviral;Zidovudine, AZT;ZIDOVUDINE [AZT]			5.8676095249	4	7		0	-0.3548706			7015	TERT	CC1=CN(C(=O)NC1=O)[C@H]2C[C@H](\N=[N+]=[N-])[C@@H](CO)O2	Vitas	STK801891	0.43327766	0.13438561	1.58173089	4.7884215	2.59097599	-0.85370192	-0.3548706									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016868-12	Acemetacin	170466043	Cyclooxygenase-1/2/3 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	53164-05-9	; ; Acemetacina; Rantudil;ACEMETACIN; Acemetacin;Acemetacin	12.4181106199	-4.9059444758	-33.8263748916	-2.2	7		-36.71505158	-30.17920965	0.0024470361	0.9791274143	5742	PTGS1	Clc1ccc(cc1)C(=O)n3c2ccc(cc2c(CC(=O)OCC(=O)O)c3C)OC	Microsource	01500666	-0.36066129	0.12461211	-3.71182764	-4.32187022	-3.42333655	-13.94887952	-30.17920965									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249896-01	Cinnamedrine	170465535		DPI_SARS-CoV-2_General	2019_NPC_01	90-86-8		11.0676527398	-4.9559444758	-35.0048194643	-2.2	7		-35.081138028	-30.71151555	0.0012511462	0.985222845			OC(C(C)N(C)C/C=C/c1ccccc1)c2ccccc2	GVK	FFS-11-286-NCI-72	-4.34003824	-0.22723386	-1.05529965	-3.20816716	-4.01207938	-14.21312059	-30.71151555									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015558-14	Isoprenaline hydrochloride	170464679	beta-Adrenoceptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	7683-59-2	Isoproterenol;Isoproterenol HCl; Isoprenalina; Isopropyl noradrenaline; Isuprel;(-)-Isoproterenol hydrochloride; ;Isoproterenol hydrochloride; Isoproterenol HCl; Isopreterenol sulfate; Isoproterenol ALSO 123; Levisoprenalina; Isoproterenol hydrochloride;(?)-Isoproterenol hydrochloride;ISOPROTERENOL HYDROCHLORIDE; Luf-Iso; Proternol-L; Isoprenaline Hcl; (-)-Isoproterenol hydrochloride; Proternol-S	17.5410474839	-4.7559444758	-31.2714952725	-2.4	7		-33.5084606801	-26.93467846	0.0024848767	0.9789740358	153	ADRB1	Oc1ccc(cc1O)C(O)CNC(C)C	Microsource	01500357	-1.64355046	-3.38896083	-1.09429456	-3.64963504	-5.79353398	-8.90797297	-26.93467846									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274274-01	Benzquinamide	170465138	Dopamine D2 receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC_01	63-12-7		9.8640558873	-5.0059444758	-0.4193205219	4	7		-20.350447388	-16.54203949	0.0078212701	0.9616767187			CCN(CC)C(=O)C2CN3CCc1cc(OC)c(OC)cc1C3CC2OC(C)=O	GVK	FFS-11-286-NCI-037	2.64565633	3.12018961	0	4.32187022	4.23032026	-2.35276183	-16.54203949									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00521080-01	Digitoxin 3'''-Acetate		Sodium/potassium-transporting ATPase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1111-39-3		12.4181106199	-4.9059444758	0.299367762	4	7		-20.257575032	-12.71464586	0.0032202338	0.9760096642			CC1OC(CC(OC(C)=O)C1O)OC2C(O)CC(OC2C)OC3C(O)CC(OC3C)OC4CCC5(C)C(CCC6C5CCC7(C)C(CCC67O)\C8=C\C(=O)OC8)C4	Toronto Research	D445385	4.69606234	2.74203608	3.06837627	1.54572878	1.15723689	-3.04396843	-12.71464586									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181783-03	Iguratimod		NF-kappaB (NFKB) Activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	123663-49-0				5.7086355103	4	7		0	-1.46981877			24835	NFKB1	C[S+]([O-])(=O)NC1=CC2=C(C=C1OC3=CC=CC=C3)C(=O)\C(=C/O2)NC=O	MedChem Express	HY-17009	-0.12254619	1.77643281	1.9150981	4.43607792	0.00237626	1.2636227	-1.46981877									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00345885-04	Etravirine		P-glycoprotein 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	269055-15-4		3.9269513795	-5.4059444758	-20.2364589266	-2.4	7		-33.5081101599	-22.0900918	0.0025774799	0.9785625863			CC1=C(OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C(=CC(=C1)C#N)C	MedChem Express	HY-90005	3.0775278	3.78618125	3.83722838	-0.34843206	-9.38858922	-13.16704247	-22.0900918									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165924-04	(S)-Mephenytoin	170465368	Sodium channel protein type V alpha subunit Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	70989-04-7				8.3499902823	4	7		0	0					CC[C@]1(NC(=O)N(C)C1=O)c2ccccc2	Prestwick Chemical, Inc.	Prestw-1108	3.2255081	3.02386287	3.54656478	0	0	2.25009395	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00483033-01	Tildipirosin		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	328898-40-4				10.472124383	4	7		0	-2.21661989					CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](OC2OC(C)C(O)C(C2O)N(C)C)[C@@H](CCN3CCCCC3)C[C@@H](C)C(=O)\C=C\C(=C\[C@@H]1CN4CCCCC4)C	DC Chemicals	DC8853	3.51684432	4.74716441	3.30747052	0.81612609	3.42418554	0.95358888	-2.21661989									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262943-01	Tocanfil	170466061		DPI_SARS-CoV-2_General	2019_NPC_02	5634-42-4	Tocamphylum;Tocanfil;Tocamphyl	12.4181106199	-4.9059444758	4.8811398954	4	7		-11.4467963599	-7.8723303	0.035814399	0.9119212222			CC1(CCC(C(=O)O)C1(C)C)C(=O)OC(C)c2ccc(C)cc2.OCCNCCO	GVK	FFS-11-286-NCI-206	0	3.32417011	3.72002532	2.72899469	3.03923199	0.10804209	-7.8723303									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181156-01	Oxabolone cipioncate	144206313	Androgen Receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	1254-35-9	Oxabolone cipionate; Cipionato de oxabolona; 	17.5410474839	-4.7559444758	-27.6973555576	-3	7	LS-172626;oxaboloni cipionas;OXABOLONE CIPIONATE;cipionate d'oxabolone;Oxabolone cipionate;4,17beta-dihydroxy-estr-4-en-3-one 17-cyclopentylpropionate;CIPLUS_211114;Cipionato de oxabolona;Oxabolone Cipionate;oxabolone cypionate;Oxaboloni cipionas;Cipionate d'oxabolone;	-40.606835368	-31.75569614	0.0035754965	0.9745787158			OC=5C(=O)CC[C@H]4C=5CC[C@@H]2[C@@H]4CC[C@]3(C)[C@@H](OC(=O)CCC1CCCC1)CC[C@@H]23	NCI	NSC-522767	2.30525561	-1.91965626	-1.98073182	-1.47557468	-4.35092555	-8.17831642	-31.75569614									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016533-24	NCGC00016533-24			DPI_SARS-CoV-2_General	2019_NPC_01					-34.5829631081	4	7		0	-7.8527794					CC1=CC(N[S+]([O-])(=O)C2=CC=C(N)C=C2)=NO1	Labotest	LT00452029	-10.08641348	-4.92828695	-5.72006532	-9.3586174	-7.34659696	-6.43325372	-7.8527794									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016866-11	Pipemidic acid	170465767		DPI_SARS-CoV-2_General	2019_NPC_01	51940-44-4				7.6883580485	4	7		0	3.48280145					O=C(O)C2=CN(CC)c1nc(ncc1C2=O)N3CCNCC3	Microsource	01502024	1.59513954	4.32233	1.78157978	0.96571099	1.44901792	-1.69215915	3.48280145									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263922-02	Darifenacin hydrobromide	170465079	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	133099-07-7		9.8640558873	-5.0059444758	-8.5896459209	4	7		-18.351600716	-16.12633393	0.0037810227	0.9738976053	1131	CHRM3	Br.NC(=O)C(c1ccccc1)(c2ccccc2)[C@@H]3CCN(C3)CCc4cc5CCOc5cc4	Microsource	01505714	0.65112676	-0.17836636	0.53374278	0.30852585	2.88534741	-4.30408049	-16.12633393									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181913-02	Difeterol	144206884	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	14587-50-9	Difeterol; Difeterol Phosphate; Difeterol Hydrochloride; 	15.6334750258	-4.8059444758	-31.8111614332	-2.4	7	CIPLUS_783660;DIFETEROL;Difeterol;difeterolum;difeterol;Difeterol Phosphate;Difeterol Hydrochloride;	-36.451012232	-29.44412055	0.0037795228	0.9738401112			OC(C(C)N(C)CCOC(c1ccccc1)c2ccccc2)c3ccccc3	Pharmaron	PH-NIH-2	-5.07104301	-1.32675251	-0.7969584	-0.73494369	-5.03730396	-10.49850094	-29.44412055									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016244-15	Isoniazid	170466877	Cytochrome P450 CYP1A2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	54-85-3	 Isoniazid; Phthivazide;ISONIAZID; ;; Fintosid; Thiazina; Tubazide; Ftivazide; Pasiniazida;Isoniazid; Isoniazida; Isonex; Isonicotinic hydrazide			-19.0303656574	4	7		0	-6.81858508				CYP1A2	O=C(NN)c1ccncc1	Vitas	STK086288	-4.0350495	-4.67417597	-7.02152031	-3.60448491	-3.61112521	0.74190762	-6.81858508									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161827-01	NCGC00161827-01	26755462	Xanthine dehydrogenase Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_02					8.5491450872	4	7		0	0.44712933			6821		[O-][Mo]([O-])(=O)=O	SigmaAldrich	MFCD00049622	0	1.84573448	2.57143527	4.01515329	1.72753844	1.84611048	0.44712933									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00167487-15	BICALUTAMIDE		Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	90357-06-5				-1.8405166353	4	7		0	-2.68277601				AR	C[C@](O)(C[S+]([O-])(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC=C(C#N)C(=C2)C(F)(F)F	Microsource	01504827	-0.79308192	-1.55928758	-0.14298774	0.17538526	2.20754224	-0.52142052	-2.68277601									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159443-05	BETAMETHASONE 17,21-DIPROPIONATE		Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC_02	5593-20-4		12.4181106199	-4.9059444758	-36.6910656618	-2.2	7		-50.3129667527	-39.25224754	0.0010151701	0.9867136447		NR3C1	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CC\C4=C\C(=O)\C=C/[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C	Microsource	01503210	2.3977433	-0.08085195	-2.51048967	-3.05170358	-3.48121569	-16.08417888	-39.25224754									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181165-01	Sodium decanehydroxamate	144206782		DPI_SARS-CoV-2_General	2019_NPC_02	35440-53-0	n-decanohydroxamic acid; 	15.6334750258	-4.8059444758	-20.1594860802	4	7	n-decanohydroxamic acid;Decanohydroxamic acid;CIPLUS_720094;DECANOHYDROXAMIC ACID;	-14.0615587481	-15.28326119	0.0063979845	0.9656984248			[Na+].[O-]NC(=O)CCCCCCCCC	NCI	NSC-111679	-2.36999699	-2.09984061	-2.51048967	-4.57638613	-1.8986289	-3.93179256	-15.28326119									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181745-03	Bimatoprost		prostaglandin	DPI_SARS-CoV-2_General	2019_NPC_02	155206-00-1				3.5009661351	4	7		0	0				PTGER1	CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC2=CC=CC=C2	Enzo	RA121	0	0	0	0	0.30891334	4.70217963	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344546-01	Fenipentol	225144389		DPI_SARS-CoV-2_General	2019_NPC_02	583-03-9				7.7829606579	4	7		0	0					CCCCC(O)C1=CC=CC=C1	Prestwick	Prestw-1501	0	1.73254175	4.02006516	0	4.43171827	0.94889139	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183864-01	Adesulfone sodium	144206768	Dihydropteroate synthase 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	144-75-2				-0.9864627899	4	7	DIASONE;Aldesulfone sodique;aldesulfone sodique;aldesulfonum natricum;SULFOXONE SODIUM;Adesulfone Sodium;METHANESULFINIC ACID, (SULFONYLBIS(4,1-PHENYLENEIMINO))BIS-;SULFOXONE;(SULFONYLBIS(4,1-PHENYLENEIMINO))DIMETHANESULFINIC ACID;Methanesulfinic acid, (sulfonylbis(p-phenyleneimino))di-, disodium salt;DISODIUM (SULFONYLBIS(P-PHENYLENEIMINO))DIMETHANESULFINATE;(sulfonylbis(p-phenyleneimino))dimethanesulfinic acid disodium salt;ALDESULFONE SODIUM;aldesulfon sodium;sulfoxone, disodium salt;CIPLUS_152107;Aldesulfonum natricum;CIPLUS_152108;LS-90060;Sulfoxone;METHANESULFINIC ACID, (SULFONYLBIS(1,4-PHENYLENEIMINO))BIS-, DISODIUM SALT;Sulfoxone sodium;sulfoxone;sulfoxone sodium;Diasone;Aldesulfona sodica;	0	-6.95428816					[Na+].[Na+].O=S(=O)(c1ccc(NCS([O-])=O)cc1)c2ccc(NCS([O-])=O)cc2	NCI	NSC_27222	2.44398714	-0.53362286	1.18843909	2.54659402	2.06971936	-3.80496054	-6.95428816									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386235-04	Cobicistat		Cytochrome P450 3A Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1004316-88-4		9.8640558873	-5.0059444758	-30.0489714218	-2.2	7		-45.4728868448	-40.88855064	0.000079602	0.996337801			CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5	Glixx	GLXC-90002	0	0.00231006	0.59304751	0.31569347	1.64674572	-14.70781661	-40.88855064									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160391-09	Auranofin		Thioredoxin Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02					-1.4781615684	4	7		0	-5.29420159				TXNRD1	CC[P](CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O	SIGMA	A6733	1.87981225	-1.45302502	-0.35864138	1.30720483	0	0.56369786	-5.29420159									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095089-10	Fluconazole	170464782	Antifungal Agent	DPI_SARS-CoV-2_General	2019_NPC_01	86386-73-4	; ;Hexaflumuron; Hexaflumuron; Diflucan; Sonet; Fluconazole;FLUCONAZOLE;Fluconazole; FLUCONAZOLE			10.4817326743	4	7		0	1.42455198					OC(Cn1cncn1)(Cn2cncn2)c3ccc(F)cc3F	Vitas	STK619301	4.35456152	2.52400616	1.35751018	3.41886774	1.37796275	1.02647492	1.42455198									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091505-07	Nitrofurantoin	170464739	Probable pyruvate-flavodoxin oxidoreductase Substrate	DPI_SARS-CoV-2_General	2019_NPC_01	67-20-9				-4.7427599534	4	7		0	-3.65516717			946587	ydbK	O=[N+]([O-])c2ccc(/C=N/N1CC(=O)NC1=O)o2	Labotest	LT00134625	-2.1712294	1.06775478	0.87494821	0.48912635	-2.13926813	-2.22064129	-3.65516717									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091351-01	m-Dinitrobenzene	17388932		DPI_SARS-CoV-2_General	2019_NPC_02			11.0676527398	-4.9559444758	-8.0187606621	4	7	NCGC00091351-02;1,3-Dinitrobenzene-15N2;1,3-Dinitrobenzene-d4;3-dinitrobenzene;m-dinitrobenzene;1,3-dinitrobenzene;m-Dinitrobenzene;1,3-Dinitrobenzene;CIPLUS_150522;meta-dinitrobenzene;1,3-Dinitrobenzene-13C6;AB07990178-01;CIPLUS_763212;	-11.325952524	-10.68829377	0.0213062621	0.9343860392			[O-][N+](=O)C1=CC=CC(=C1)[N+]([O-])=O	NIEHS	AB07990178	1.10754006	-0.82006976	0.45240383	-2.0461614	0.41109237	-2.48027057	-10.68829377									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346701-07	Laquinimod		Immunomodulators	DPI_SARS-CoV-2_General	2019_NPC_02	248281-84-7		17.5410474839	-4.7559444758	-14.2717178982	4	7		-13.550872848	-11.29239404	0.0931700311	0.8428148082		BDNF	CCN(C(=O)C/1=C(O)/C2=C(C=CC=C2Cl)N(C)C1=O)C3=CC=CC=C3	MedChem Express	HY-13010	0.87169646	-1.24974012	-1.7697663	-4.47349344	-0.93386878	-4.3169861	-11.29239404									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160355-01	NCGC00160355-01	29216036		DPI_SARS-CoV-2_General	2019_NPC_02		Xylose; Xylan; D-Lyxopyranose; D-Arabinose-1-13C; D-Xylose-1-13C; L-(+)-Arabinose; DL-Xylose; D-(+)-Xylose; D-(-)-Arabinose; D-(-)-Lyxose; D Xylos; DL-Arabinose; 			9.4505019621	4	7	NCGC_FLUKA_95740;CIPLUS_718758;Xylose;NCGC00165998-01;D Xylos;D-Arabinose-1-13C;CIPLUS_756836;L-(+)-Arabinose;CIPLUS_148884;D-Xylose-1-13C;D-(-)-Arabinose;DL-Xylose;CIPLUS_694406;XYLOSE, D-;CIPLUS_3887049;XYLOSE;CIPLUS_149908;D-Lyxopyranose;D-(-)-Lyxose;L-(-)-Xylose, mixture of anomers;DL-Arabinose;D-(+)-Xylose;ARABINOSE, L-;Xylan;D-Xylose;D-XYLOSE;CIPLUS_711441;	0	2.61142558					[H][C@]1(O)CO[C@]([H])(O)[C@]([H])(O)[C@@]1([H])O	Alfa Aesar	A11921	3.65557585	3.44891312	0.7149387	-0.58695601	0.76277832	1.841413	2.61142558									6.38E-9	3.1899999999E-8	1.59E-7	7.97E-7	0.00000399	0.0000199	0.0000997								
NCGC00178554-03	AZLOCILLIN SODIUM		Bacterial penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	37091-66-0				2.7858580384	4	7		0	-2.60666889					CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)C4=CC=CC=C4)C(=O)N2C1C([O-])=O	Microsource	01503101	0.95493537	4.01718681	0.97278545	-0.33440123	0.69624314	-0.32412627	-2.60666889									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00344555-01	Proscillaridin	170465956	Steroid	DPI_SARS-CoV-2_General	2019_NPC_02	466-06-8		13.9333492831	-4.8559444758	-0.3781670914	4	7		-19.985896404	-12.90491367	0.01328152	0.9491346288		ATP1A1	O=C1C=CC(=CO1)[C@H]6CC[C@@]5(O)[C@]6(C)CC[C@H]3[C@H]5CCC2=C[C@H](CC[C@@]23C)O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O	Prestwick	Prestw-986	4.15963375	2.33546628	3.83254026	-0.05378481	1.58021054	-2.53194288	-12.90491367									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00408838-01	Piroheptine Hydrochloride		Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	16378-22-6		9.8640558873	-5.0059444758	-59.2184170392	-2.2	7		-69.0602005032	-63.24977406	0.0000566525	0.9969123282			CCN1CCC(C1C)=C2C3=CC=CC=C3CCC4=CC=CC=C24	Glixx	GLXC-06115	-0.77458438	-1.10651667	-2.38391036	-4.66992494	-3.10576717	-25	-63.24977406									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263467-03	2-Pyrrolidone-5-carboxylic acid	225144361		DPI_SARS-CoV-2_General	2019_NPC_02	149-87-1				3.8111426498	4	7		0	1.50311564					OC(=O)C1CCC(=O)N1	SIGMA	292915	2.56884552	1.66555014	-1.42753334	-0.93772654	0.7912934	1.74276588	1.50311564									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166213-02	2-Octyl-1-dodecanol	170465533		DPI_SARS-CoV-2_General	2019_NPC_02	5333-42-6				0.1730829466	4	7		0	0					CCCCCCCCC(CCCCCCCCCC)CO	SIGMA	464481	1.76420264	-0.84317032	-2.94648508	-2.40628581	4.74063161	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178860-06	Ethopropazine hydrochloride	170465065	Butyrylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1094-08-2		6.2237985085	-5.2059444758	-59.2065258856	-2.2	7		-74.2705608152	-66.91718594	0.0000255297	0.9979306092			Cl.CCN(CC)C(C)CN1c3ccccc3Sc2ccccc12	Microsource	01500293	3.08677657	0	2.369846	1.11545027	-5.48677613	-35.23111612	-66.91718594									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00188443-01	Dapiprazole hydrochloride	144206586	Adrenergic Receptor Alpha-1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	72822-13-0		9.8640558873	-5.0059444758	5.3149276069	4	7	DAPIPRAZOLE HYDROCHLORIDE	-12.1374684919	-8.44789041	0.0447704985	0.8994875606			Cl.Cc4ccccc4N3CCN(CCc1nnc2CCCCn12)CC3	APAC	878039	3.11452288	3.38885167	4.58263988	0	3.78537652	-0.79857197	-8.44789041									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015067-14	Aspirin	170465039	HMG-CoA Reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	50-78-2	 Komineks mixture; Alka Seltzer; Ascriptin; Micristin; 2-Acetoxybenzoic acid; Veganine; Vincents Powder; Solupsan; Istopirin; Norgesic forte; Alka-Seltzer; Carbasalato calcico; Aloxiprimum;Aspirin; Endosprin; Bayer Aspirin; Bayer EC Aspirin; Lysine acetylsalicylate; Equagesic; Dolomo; Kominek's mixture; Solprin; Sedalgin; Colfarit; DP-neuralgen; Bex Powder; Cu-aspirinate; Aspirin DL-lysine; Cogla; Magnyl; Aspisol; Apyron; Midol; Easprin; ; Acetard; Synalgos; Ecotrin; Triaminicin; Zorprin;Acetylsalicylic acid; 2-(Acetyloxy)benzoic Acid; Oxycodone w/Aspirin; Acylpyrin; Dispril;ASPIRIN; Acid, Acetylsalicyli; Polopiryna; Aspirin DL-Lysine; Fiorinal; Doleron; Astra 2167; Carisoprodol/Aspirin; Acetylsalicylic acid; Aspirin Tri-Buffered; O-Acetylsalicylic acid; Acetysal; Magnecyl; Polopirin			8.9254206284	4	7		0	2.34214595				HMGCR	O=C(C)Oc1ccccc1C(=O)O	Microsource	01500130	0	4.28323601	0.76771222	2.31018135	2.18494645	1.45840744	2.34214595									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095118-17	Rofecoxib		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	162011-90-7		9.8640558873	-5.0059444758	-51.582492281	4	7		-13.100961088	-20.95799838	0.0223434366	0.9324458965		PTGS2	C[S+]([O-])(=O)C1=CC=C(C=C1)C/2=C(/C(=O)OC2)C3=CC=CC=C3	SIGMA	SML0613	-7.12386414	-9.92168911	-10.79440238	-8.85578654	-8.11491576	-13.40191657	-20.95799838									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262578-03	Flucloxacillin sodium		Penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	1847-24-1		12.4181106199	-4.9059444758	-2.0729177691	4	7		-19.1584693	-16.38205775	0.0132566016	0.949117852			CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@H](N3C2=O)C([O-])=O)C(=NO1)C4=C(Cl)C=CC=C4F	Prestwick	Prestw-1011	0	0	4.29197628	2.15840797	3.32913528	-0.38989102	-16.38205775									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182029-01	Fosfluconazole	144206487	Cytochrome P450 51 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	194798-83-9	Fosfluconazole; Prodif; 			-3.4557526423	4	7	Fosfluconazole;fosfluconazole;fosfluconazolum;CIPLUS_787926;FOSFLUCONAZOLE;Prodif;	0	-5.10393379					Fc1ccc(c(F)c1)C(OP(=O)(O)O)(Cn2cncn2)Cn3cncn3	ACC	Fosfluconazole	1.73183195	-1.22663956	0.63992874	-2.01342282	0.39208231	-0.56369786	-5.10393379									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00345883-07	DESVENLAFAXINE SUCCINATE		Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	93413-62-8				2.2812821686	4	7		0	-3.67216858					CN(C)CC(C1=CC=C(O)C=C1)C2(O)CCCCC2	Microsource	01504280	0.83932576	0.51976253	0.72431495	-0.39520146	2.27407742	2.09977452	-3.67216858									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015919-14	Sotalol		beta-Adrenoceptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	959-24-0				1.2130542171	4	7		0	0.55177663				ADRB1	CC(C)NCC(O)C1=CC=C(N[S+](C)([O-])=O)C=C1	MedChem Express	HY-B0437	2.71220144	-1.80415348	-1.44159771	-3.29022753	2.99645938	2.2360015	0.55177663									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091519-09	p-Cresol	170465495		DPI_SARS-CoV-2_General	2019_NPC_01	106-44-5		0.4943738883	-6.3059444758	-12.9025146545	4	7		-14.5312642799	-2.75785151	0.4483554183	0.5300849479			Cc1ccc(O)cc1	Microsource	01500209	1.44506572	1.30720551	0.86032512	4.43223719	-23.3593869	-1.7734641	-2.75785151									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091439-07	Cimetidine	170464651	Multidrug and toxin extrusion protein 1 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	51481-61-9				7.2569960637	4	7		0	-0.67932372					N#C\N=C(/NC)NCCSCc1ncnc1C	Microsource	01500684	4.88708155	2.34319642	2.28851356	0	0	1.52954927	-0.67932372									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015234-19	Carbamazepine	170464712	Sodium channel protein type 5 subunit alpha Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	298-46-4				-25.0112356851	4	7		0	-10.68667461			6331	SCN5A	NC(=O)N2c3ccccc3C=Cc1ccccc12	Vitas	STK177357	-5.32762085	-2.72924964	-6.6510687	-3.53425139	-6.3010709	-3.34366584	-10.68667461									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160450-03	4-Acetylaminophenylacetic acid	170465954		DPI_SARS-CoV-2_General	2019_NPC_01	18699-02-0				-0.1963485384	4	7		0	-2.17484981					O=C(C)Nc1ccc(cc1)CC(=O)O	Specs	AE-562/J260765	-0.98032096	1.65905148	-0.95781239	-0.09782527	1.49977161	0.20834392	-2.17484981									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178404-03	Triamcinolone	170465188		DPI_SARS-CoV-2_General	2019_NPC_01	124-94-7				3.3624396594	4	7		0	1.88588375					OCC(=O)[C@@]3(O)[C@H](O)C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@@]4(F)[C@@H](O)C[C@@]23C	Microsource	01500586	0	0	0	0	0	3.38939987	1.88588375									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185753-04	Etoposide  Phosphate			DPI_SARS-CoV-2_General	2019_NPC_02	117091-64-2		9.8640558873	-5.0059444758	-27.6418768031	4	7		-13.1667573079	-15.82076773	0.0028055248	0.9777418242			COC1=C(O[P](O)(O)=O)C(=CC(=C1)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26)OC	Glixx	GLXC-06447	-3.90066822	-2.76513664	-4.80766977	-4.50155508	-3.65705867	-8.10315671	-15.82076773									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522015-01	Pirlimycin Hydrochloride		Bacterial 70S ribosome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	78822-40-9				14.2709224115	4	7		0	-0.02378348					CC[C@@H]1CCN[C@@H](C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O	Toronto Research	P509300	3.26250318	3.37037123	0	4.80555621	4.37944063	4.72566704	-0.02378348									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015358-18	Disopyramide	174006632	Na channel blocker	DPI_SARS-CoV-2_General	2019_NPC_01	3737-09-5	 Rythmodan P; ;Disopyramide; Searle 703; Disopyramide, (S)-Isomer; Norpace; Disopyramide; Disopyramide, (R)-Isomer; Disopiramida			4.0992832831	4	7		0	-1.56143064					CC(C)N(CCC(c1ccccn1)(c2ccccc2)C(N)=O)C(C)C	Microsource	01500261	-0.64144458	0.67192807	1.00168166	1.80349663	1.64695732	2.54077951	-1.56143064									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274063-01	Pimobendan	174007050	Phosphodiesterase III (PDE3) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	77469-98-8	Pimobendan(Vetmedin)	15.6334750258	-4.8059444758	-9.4957602963	-2.4	7		-33.59012446	-24.65843705	0.0052176914	0.9690254329	5139	PDE3A	Cl.COc1ccc(cc1)c2nc3ccc(cc3n2)C4=NNC(=O)CC4C	Selleck	S1550	3.82204149	4.56666748	0	0	0.64710958	-3.89755577	-24.65843705									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249919-01	Nandrolone furylpropionate	170465918		DPI_SARS-CoV-2_General	2019_NPC_01	7642-64-0		6.2237985085	-5.2059444758	-61.5084134734	-2.2	7		-81.3159489028	-77.27053814	0.0000015151	0.9994971564			O=C4C=C5CC[C@@H]2[C@H](CC[C@]3(C)[C@@H](OC(=O)CCc1ccco1)CC[C@@H]23)[C@H]5CC4	GVK	FFS-11-286-NCI-187	3.04262581	2.30898918	1.72308742	3.4289011	-0.01268842	-40.11890848	-77.27053814									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016853-06	Nabumetone	170464970	Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	42924-53-8				8.7102038412	4	7		0	0					CC(=O)CCc1ccc2cc(ccc2c1)OC	Microsource	01503650	3.27499818	1.69814548	3.6777071	3.91050242	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164593-02	Enalapril acid	170464938		DPI_SARS-CoV-2_General	2019_NPC_01	76420-72-9				-23.0907984439	4	7		0	-5.96182606					OC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N[C@H](CCc1ccccc1)C(=O)O	Sequoia	76420-72-9	-6.92518094	-6.39431182	-6.32448636	-1.12624476	-4.75815866	-3.22678998	-5.96182606									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022680-05	Chlormadinone acetate	170465776	Androgen receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	302-22-7		15.6334750258	-4.8059444758	-45.1284538022	-2.2	7		-72.257521992	-55.8769106	0.0011560549	0.9857948977	367	AR	CC(=O)[C@@]3(OC(C)=O)CC[C@H]2[C@@H]4C=C(Cl)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C	Prestwick	Prestw-1374	1.37729044	0.77454981	1.06504838	-5.2248727	-4.91041973	-15.45810255	-55.8769106									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386237-08	Brintellix		5-HT1D Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	508233-74-7		11.0676527398	-4.9559444758	-68.3771377197	-2.2	7		-50.2632061441	-44.0945631	0.0018328746	0.9820095984		HTR1D	CC1=CC=C(SC2=CC=CC=C2N3CCNCC3)C(=C1)C	MedChem Express	HY-15414	-4.11801429	-7.64859433	-5.19209583	-11.22231836	-11.10424637	-25.41807591	-44.0945631									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179313-05	Imidazolidinyl urea		T-lymphocyte activation antigen CD86 Activator	DPI_SARS-CoV-2_General	2019_NPC_02	39236-46-9				10.2613002966	4	7		0	0.11416068					OCN1C(NC(=O)NCNC(=O)NC2N(CO)C(=O)NC2=O)C(=O)NC1=O	MedChem Express	HY-B1158	0	4.6640024	0	3.02831887	3.16754984	3.73919579	0.11416068									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094916-06	Suprofen	170465412	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	40828-46-4				0.7200853663	4	7		0	0			5743	PTGS2	O=C(c1ccc(cc1)C(C)C(=O)O)c2cccs2	SIGMA	s9894	0	0.47890146	0.55080305	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182552-02	Atazanavir	170465290	HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2019_NPC_01	198904-31-3	 ;ATAZANAVIR SULFATE; Atazanavir;Atazanavir sulfate; Reyataz	13.9333492831	-4.8559444758	-2.7587690737	4	7		-18.84551722	-16.12126435	0.0276286165	0.9235736811			CC(C)(C)[C@H](NC(=O)OC)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)Cc2ccc(cc2)c3ccccn3	Sequoia	229975-97-7	0	3.24724509	0	0	4.97132416	0	-16.12126435									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022882-03	Diazoxide	170465328	"Sulfonylurea receptor 1, Kir6.2 Opener"	DPI_SARS-CoV-2_General	2019_NPC_01	364-98-7				7.6156338308	4	7		0	-1.70337888					Clc1ccc2N=C(C)NS(=O)(=O)c2c1	Enzo	KC115	-0.37518457	2.04021795	2.84419098	2.73659919	3.38780896	1.53463082	-1.70337888									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016799-08	Suxibuzone	170465972	Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	27470-51-5				2.7190262978	4	7		0	0.1013916			791253	PTGS2	O=C(O)CCC(=O)OCC2(CCCC)C(=O)N(c1ccccc1)N(C2=O)c3ccccc3	Prestwick Chemical, Inc.	Prestw-658	3.93822768	0	0	0	0	0	0.1013916									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016893-04	Clorsulon	170466229	antiparasitic agent	DPI_SARS-CoV-2_General	2019_NPC_01	60200-06-8				5.0403177158	4	7		0	-4.15198601					Nc1cc(c(cc1S(=O)(N)=O)S(N)(=O)=O)C(/Cl)=C(/Cl)Cl	Prestwick Chemical, Inc.	Prestw-540	1.18364679	2.20148069	0.97243548	3.32355081	4.42825966	-1.72773007	-4.15198601									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00273482-01	Nafcillin sodium monohydrate	170465253		DPI_SARS-CoV-2_General	2019_NPC_01	7177-50-6				-8.0569198847	4	7		0	-6.64114978					[Na+].O.O=C([O-])[C@@H]3N4C(=O)[C@@H](NC(=O)c1c2ccccc2ccc1OCC)[C@H]4SC3(C)C	Prestwick Chemical, Inc.	Prestw-843	-1.12071261	-0.01221687	-0.40213497	0.92056086	-2.43363955	-3.50627573	-6.64114978									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178854-03	Minocycline hydrochloride	170465049	Tetracycline Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_02	13614-98-7		6.2237985085	-5.2059444758	-91.3512405436	-2.2	7		-82.9433001947	-75.38885982	0.0002597029	0.993349299		PARP1	Cl.CN(C)c2ccc(O)c1C(=O)C3=C(O)[C@]4(O)C(=O)C(=C(O)[C@@H](N(C)C)[C@@H]4C[C@@H]3Cc12)C(N)=O	Microsource	01500414	1.16765706	-4.3359745	-4.00131267	-7.957814	-15.02982202	-43.64900413	-75.38885982									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178529-06	Levofloxacin		DNA Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	100986-85-4				-21.7480937372	4	7		0	-9.50387671				TOP2B	C[C@H]1COC2=C3N1\C=C(C(O)=O)/C(=O)C3=CC(=C2N4CCN(C)CC4)F	MedChem Express	HY-B0330	-1.33413489	-3.25024833	-4.51700616	-5.25921942	-4.36518309	-5.26118001	-9.50387671									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00484907-01	(-)-Scopolamine N-oxide		Acetylcholinesterase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	6106-81-6		0.0039269514	-8.4059444758	-11.406575599	4	7		10.041388236	-3.27260619	0.4075909911	0.5062091696			C[N+]1([O-])[C@H]2C[C@@H](C[C@H]1[C@H]3O[C@@H]23)OC(=O)C(CO)C4=CC=CC=C4	Enzo	NP278	-8.36782353	-1.50846635	-5.06551651	0.26424713	2.62101086	-2.0527997	-3.27260619									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183096-01	Cefcapene pivoxil hydrochloride	144206464	Penicillin-binding protein Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	147816-23-7	5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-(2-amino-4-thiazolyl)-1-oxo-2-pentenyl)amino)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6R-(6alpha,7beta(Z)))-; Flomox; 	6.2237985085	-5.2059444758	-68.3205260648	-2.2	7	Cefcapene pivoxil hydrochloride;S-1108;CIPLUS_3875022;CEFCAPENE PIVOXIL HYDROCHLORIDE;LS-171990;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-(2-amino-4-thiazolyl)-1-oxo-2-pentenyl)amino)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6R-(6alpha,7beta(Z)))-;Flomox;Cefcapene Pivoxil Hydrochloride;S 1108;CIPLUS_695832;	-79.6780906614	-68.57727251	0.0000285841	0.9978098614			Cl.Nc1scc(n1)\C(=C\CC)C(=O)N[C@@H]3C(=O)N2C(=C(COC(N)=O)CS[C@@H]23)C(=O)OCOC(=O)C(C)(C)C	ACC	API-04911	0	1.74409203	2.04636553	-0.31101653	-11.69355797	-37.81942879	-68.57727251									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016013-06	Trimipramine maleate	170465260	Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	521-78-8		9.8640558873	-5.0059444758	-18.955548388	4	7		-26.6593495719	-23.88279131	0.0015320092	0.9836144335			O=C(O)/C=C\C(=O)O.CN(C)CC(C)CN2c3ccccc3CCc1ccccc12	Microsource	01503117	0.62208022	1.94736971	-1.08454583	-1.59781273	-0.10912044	-8.86223893	-23.88279131									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024027-09	Methysergide	170464684	Serotonin 7 (5-HT7) receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	361-37-5		15.6334750258	-4.8059444758	2.5688155276	4	7		-12.475780076	-8.72981673	0.0456592715	0.8984522829			CC[C@@H](CO)NC(=O)[C@@H]3C=C2c4cccc1c4c(cn1C)C[C@H]2N(C)C3	Enzo	AC577	1.99937066	0.98223667	2.35431747	4.42220383	0	0.56405305	-8.72981673									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183026-01	Dicethiamine hydrochloride	144206821		DPI_SARS-CoV-2_General	2019_NPC_01	616-96-6	Cetotiamine; Cetotiamine Hydrochloride; O,S-dicarbethoxythiamine; Cetotiamina; 	0.3119288357	-6.5059444758	-3.1889689513	4	7	Cetotiamine Hydrochloride;Cetotiamine;O,S-dicarbethoxythiamine;CETOTIAMINE;CIPLUS_210876;Cetotiaminum;Cetotiamina;CIPLUS_697013;O,S-bis(ethoxycarbonyl)thiamine;cetotiamine;cetotiaminum;	-6.8860833359	-0.47654052	0.4841638836	0.4841040753			Cl.Nc1nc(C)ncc1CN(C=O)C(/C)=C(/CCOC(=O)OCC)SC(=O)OCC	Pharmaron	PH-NIH-149305	0.49137075	4.25391551	0.62635568	-0.51420975	-9.48840278	0.04573403	-0.47654052									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018100-08	Fasudil hydrochloride	170466011	ROCK Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	105628-07-7	;HA-1077; Fasudil; Fasudil (HA 1077); HA 1077 hydrochloride; Eril-S;Fasudil; HA-1077 dihydrochloride			-15.5965734091	4	7		0	-5.21152822			6093	ROCK1	Cl.O=S(=O)(c2cccc1cnccc12)N3CCCNCC3	Enzo	EI233	-4.38844916	-0.26632785	-3.6777071	-5.45564	-2.22554941	-2.5052086	-5.21152822									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015243-10	Clemizole hydrochloride	170465924	Histamine H1 Receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	1163-36-6		13.9333492831	-4.8559444758	-13.7888402262	-2.4	7		-38.284276692	-29.40356391	0.0009798189	0.9869578487		HRH1	Cl.Clc1ccc(cc1)Cn3c4ccccc4nc3CN2CCCC2	Microsource	01505990	1.43538354	0.93581254	2.48836246	4.11618632	-0.67248642	-5.80822196	-29.40356391									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178086-03	Aminolevulinic acid hydrochloride	170464700	DNA Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	5451-09-2				-12.0677420534	4	7		0	-6.58031482					Cl.NCC(=O)CCC(=O)O	Microsource	01504184	-3.74458403	0.50089183	1.25514855	-4.70313793	-2.42856418	-3.30301336	-6.58031482									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00521082-01	Mebezonium Iodide			DPI_SARS-CoV-2_General	2019_NPC_02	7681-78-9				3.3287665424	4	7		0	0.70399087					C[N+](C)(C)C1CCC(CC1)CC2CCC(CC2)[N+](C)(C)C	Toronto Research	M202535	0.28208745	0	0	0	0	3.95997745	0.70399087									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522533-01	Olodaterol		Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	868049-49-4		9.8640558873	-5.0059444758	-3.7009004427	4	7		-19.7440898039	-16.45340817	0.0015170191	0.9837189656	154	ADRB2	COC1=CC=C(CC(C)(C)NC[C@H](O)C2=C3OCC(=O)NC3=CC(=C2)O)C=C1	MedChem Express	HY-14301	2.82318666	0.68146642	3.1574506	1.4428361	2.6732885	-3.57478392	-16.45340817									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00184999-01	Sultopride hydrochloride	144207174	Dopamine D3 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	23694-17-9				12.2762991528	4	7	Sanofi Synthelabo brand of sultopride hydrochloride;CIPLUS_3883483;DAN 2163;N-(ethyl-1-pyrrolidinyl- 2-methyl)methoxy-2-ethylsulfonyl-5-benzamide;Sultopride;Sultopride Hydrochloride;sultopridum;SULTOPRIDE;sultopride;LIN 1418;CIPLUS_181627;sultopride hydrochloride;SULTOPRIDE HYDROCHLORIDE;Sultopride hydrochloride;Barnetil;Sultroprida;LS-20057;amisulpride;CIPLUS_182211;Solian;Sultopridum;	0	-2.74461304					Cl.CCN2CCCC2CNC(=O)c1cc(ccc1OC)S(=O)(=O)CC	Toronto Research	S790510	0	4.40527617	2.57612339	3.98709164	4.75013663	3.91770011	-2.74461304									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00531790-01	JTT-501		Peroxisome proliferator-activated receptor gamma Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	170861-63-9		11.0676527398	-4.9559444758	-63.8730865213	-2.2	7		-93.2893021928	-71.43128954	0.000048298	0.9971499495	5468	PPARG	CC1=C(CCOC2=CC=C(CC3C(=O)NOC3=O)C=C2)N=C(O1)C4=CC=CC=C4	Glixx	GLXC-08947	3.51684432	0.55210331	-1.54942453	-1.05465005	-6.69391441	-32.16835776	-71.43128954									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181045-01	Pyridoxamine phosphate	144206246		DPI_SARS-CoV-2_General	2019_NPC_02	529-96-4	Pyridoxamine phosphate; pyridoxamine-P; Pyridoxamine-5'-phosphate; 			-12.6368750313	4	7	4-Aminomethyl-5-hydroxy-6-methyl-3-pyridylmethyl phosphate;CIPLUS_3727741;Pyridoxamine Phosphate;CIPLUS_154034;pyridoxamine phosphate hydrochloride;PYRIDOXAMINE PHOSPHATE;pyridoxamine phosphate;Pyridoxamine Phosphate Anhydride;Pyridoxamine-5'-phosphate;Pyridoxamine phosphate;CIPLUS_3861203;pyridoxamine-P;	0	-2.92536745					Oc1c(CN)c(cnc1C)COP(=O)(O)O	SigmaAldrich	82890	-3.66482462	-3.20404722	-0.60711188	-3.60825948	-0.81980847	-4.08680947	-2.92536745									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390740-04	Avibactam sodium			DPI_SARS-CoV-2_General	2019_NPC_02	1192491-61-4				8.8027293276	4	7		0	1.56019598					NC(=O)[C@@H]1CC[C@@H]2C[N@]1C(=O)N2O[S]([O-])(=O)=O	Glixx	GLXC-04187	3.2856251	-1.76719259	2.05574178	3.16862708	0	4.77733935	1.56019598									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017337-17	(E)-Capsaicin		Nf-kappab Activation Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	[404-86-4]		12.4181106199	-4.9059444758	-24.4256731511	4	7		-19.8808669159	-21.63820577	0.0030886959	0.9764910708		NFKB1	COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1	Tocris	0462	-1.94917802	-4.87652752	-3.20433183	-1.73748334	-1.94140152	-4.9746336	-21.63820577									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167958-05	Imipenem	170464934	Penicillin-binding protein 2 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	64221-86-9				6.7169527564	4	7		0	1.79463131			945240	mrdA	O[C@H](C)[C@H]2C(=O)N1C(=C(C[C@@H]12)SCCNC=N)C(=O)O	Prestwick Chemical, Inc.	Prestw-519	0	0	0	0	4.43841039	3.82133238	1.79463131									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095099-05	Sildenafil citrate	170465285	Phosphodiesterase V (PDE5) Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	171599-83-0	 ; Sildenafil(Viagra); SILDENAFIL;SILDENAFIL; Caverta; Viagra;SILDENAFIL CITRATE	17.5410474839	-4.7559444758	-40.4151382149	-3	7		-33.089585472	-30.65575017	0.0012446805	0.9852679737	8654	PDE5A	CN1CCN(CC1)S(=O)(=O)c4cc(C3=Nc2c(CCC)nn(C)c2C(=O)N3)c(OCC)cc4.O=C(O)C(O)(CC(=O)O)CC(=O)O	Microsource	01504099	-6.90581657	-3.08109561	-5.06202627	-4.42722051	-5.79353398	-9.64479902	-30.65575017									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017354-07	Spectinomycin dihydrochloride	170465149	Antibiotic	DPI_SARS-CoV-2_General	2019_NPC_01	21736-83-4	; Trobicin sulfate; Spectinomycin Sulfate; Espectinomicina;SPECTINOMYCIN HYDROCHLORIDE; Spectam; Stanilo;Spectinomycin dihydrochloride; Spectinomycin Sulphate			12.849663305	4	7		0	1.2166992					Cl.Cl.C[C@H]1O[C@H]2O[C@@H]3[C@@H](O)[C@H](NC)[C@H](O)[C@H](NC)[C@H]3O[C@@]2(O)C(=O)C1	Microsource	01500538	4.79994191	4.361424	1.48911798	0	3.58574836	3.38431831	1.2166992									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163150-07	Clenbuterol	170465955	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	37148-27-9				3.8936941816	4	7		0	-3.05695673					Clc1cc(cc(Cl)c1N)C(O)CNC(C)(C)C	Enzo	AC174	1.39665481	0.78921006	3.42424021	1.74329646	2.00730853	-1.44316276	-3.05695673									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00184998-02	Dopexamine	170466408	D(2) dopamine receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	86197-47-9		11.0676527398	-4.9559444758	-31.9960405164	-2.2	7		-53.3169385916	-38.87646863	0.0032258902	0.9758922299	1813	DRD2	Oc2ccc(CCNCCCCCCNCCc1ccccc1)cc2O	APAC	877916	3.37811279	1.33752223	2.83865826	-0.76000281	-8.20521351	-14.94269072	-38.87646863									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179360-05	Tridihexethyl chloride		Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	4310-35-4				-17.0639132252	4	7		0	-4.92793607					CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C2=CC=CC=C2	Prestwick	Prestw-1042	-1.88906102	-5.13525376	-2.102623	-3.21539649	-2.84913148	-5.56651635	-4.92793607									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263129-08	Palbociclib		CDK4/6 Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	571189-11-2		12.4181106199	-4.9059444758	-47.1275575966	-2.2	7		-80.1847262552	-60.36721686	0.0003592181	0.9921635948		CDK4	CC(=O)C\1=C(/C)C2=CN=C(NC3=CC=C(C=N3)N4CCNCC4)N=C2N(C5CCCC5)C1=O	Axon Medchem	1505	4.09026798	2.28002495	1.56817702	-1.93391483	-5.86222465	-21.90905675	-60.36721686									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274078-01	Fludrocortisone	170464959		DPI_SARS-CoV-2_General	2019_NPC_02	127-31-1		12.4181106199	-4.9059444758	-11.6147301103	4	7		-9.9012510159	-9.91770918	0.229161108	0.7039038391			OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@]1(F)[C@@]3(C)CCC(=O)C=C3CC[C@H]12	SIGMA	F6127	1.58385165	-1.35138257	-5.1030215	-1.79828356	0.47287503	-2.88425404	-9.91770918									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00485891-01	Norgestimate metabolite Norelgestromin	363681397	Progesterone receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	53016-31-2		13.9333492831	-4.8559444758	-34.714207568	-2.2	7		-50.9362365087	-38.96684584	0.0000817772	0.9962882648			CC[C@]12CC[C@H]3[C@@H](CC\C4=C\C(CC[C@H]34)=N\O)[C@@H]1CC[C@@]2(O)C#C	MedChem Express	HY-G0018	0.46475063	-1.27746079	-1.82602377	0.353109	-3.14378728	-14.82995115	-38.96684584									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179364-03	Ioversol	170464725		DPI_SARS-CoV-2_General	2019_NPC_02	87771-40-2				-22.735051045	4	7		0	-5.32749845					OCC(O)CNC(=O)c1c(I)c(N(CCO)C(=O)CO)c(I)c(c1I)C(=O)NCC(O)CO	Prestwick	Prestw-878	-2.8416842	-7.95352168	-5.76404679	-2.58400954	-3.68082123	-5.77320556	-5.32749845									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016886-04	Ioxaglic Acid		Thrombin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	59017-64-0				-2.2029435971	4	7		0	-1.67435666					CNC(=O)C1=C(I)C(=C(I)C(=C1I)C(=O)NCC(=O)NC2=C(I)C(=C(I)C(=C2I)C(O)=O)C(=O)NCCO)N(C)C(C)=O	USP	1345159	1.33413489	0.86627088	0.56023066	-1.30720483	-0.95763135	-2.34404359	-1.67435666									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00186464-03	Aliskiren hemifumarate	170465199	Renin Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	173399-03-6	ALISKIREN HEMIFUMARATE;Aliskiren hydrochloride	15.6334750258	-4.8059444758	-8.1209728268	4	7		-18.018998248	-12.93249854	0.0018640944	0.9819536806		REN	Cl.NC(=O)C(C)(C)CNC(=O)[C@@H](C[C@H](O)[C@@H](N)C[C@H](Cc1cc(OCCCOC)c(cc1)OC)C(C)C)C(C)C	Microsource	01505710	0.47200639	1.26811152	-0.20228608	1.43727895	-0.96178247	-3.86198486	-12.93249854									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017326-05	(1S,9R)-beta-Hydrastine	170465706	GABA-A receptor; anion channel Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	29617-43-4				-1.8884841256	4	7		0	-7.56888292					CN2CCc1cc5OCOc5cc1[C@H]2[C@@H]4OC(=O)c3c(OC)c(ccc34)OC	Microsource	01500687	0.21542856	0.38360984	1.57198216	1.38209547	-0.99731005	0.45734031	-7.56888292									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159477-05	Phenylacetic acid	170465102		DPI_SARS-CoV-2_General	2019_NPC_01	103-82-2				-23.6845464095	4	7		0	-8.43071152					OC(=O)Cc1ccccc1	Vitas	STK297835	-3.88497567	-5.28013292	-4.13102289	-5.53590689	-6.33152312	-2.48488236	-8.43071152									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160518-03	Orbifloxacin	170465644	DNA gyrase Binding Agent	DPI_SARS-CoV-2_General	2019_NPC_01	113617-63-3				10.7628991963	4	7		0	-0.82127196					C[C@@H]1CN(C[C@H](C)N1)c2c(F)c(F)c3c(c2F)N(C=C(C3=O)C(=O)O)C4CC4	SIGMA	34041	1.00452642	4.22459501	3.29750676	3.42388442	2.09866518	2.78469434	-0.82127196									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00159424-04	Tetramethylthiuram monosulfide	170465567		DPI_SARS-CoV-2_General	2019_NPC_01	97-74-5		12.4181106199	-4.9059444758	1.2844796156	4	7		-10.2092595919	-8.09104966	0.1344426983	0.7994612223			CN(C)C(=S)SC(=S)N(C)C	Labotest	LT02090816	0	0	4.55021813	0	3.42333655	-0.03557091	-8.09104966									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015074-14	Acetazolamide	170464692	Carbonic anhydrase XII Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	59-66-5				-5.8359000912	4	7		0	-3.23946161					O=S(N)(=O)c1nnc(NC(C)=O)s1	Specs	AN-153/I110543	-3.57514584	-0.58396657	-0.36314006	-0.243309	0.58620515	-1.83952437	-3.23946161									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164344-04	Symclosene	170465634		DPI_SARS-CoV-2_General	2019_NPC_01	87-90-1				8.9519170037	4	7		0	0.94801146					ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O	SIGMA	176125	2.96516835	2.89539913	2.38112647	-1.98409712	2.88534741	3.04385385	0.94801146									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091865-02	Benzyl alcohol	124891475		DPI_SARS-CoV-2_General	2019_NPC_02					3.3114008386	4	7		0	0					OCC1=CC=CC=C1	SigmaAldrich	108006	0	0	0	0	0	4.73975949	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182851-02	Meprednisone	170465165	Glucocorticoid steroid	DPI_SARS-CoV-2_General	2019_NPC_02	1247-42-3	 ;Betapar;Meprednisone; Meprednisone; Meprednisona; Meprendisone; Betapar; Bitanisone			-7.8836171094	4	7		0	-5.14674404				NRC31	OCC(=O)[C@@]3(O)[C@@H](C)C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@H]4C(=O)C[C@@]23C	Bosche	B1751	-2.47635783	-1.57314791	-1.93853871	0.98449594	-1.77506356	-0.69522736	-5.14674404									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249938-01	Glymidine sodium	170465939		DPI_SARS-CoV-2_General	2019_NPC_01	3459-20-9				-0.2980566514	4	7		0	-1.5462219					[Na+].O=S(=O)([N-]c1ncccn1)c2cc(OCCOC)ccc2	GVK	FFS-11-286-NCI-256	-0.21542856	1.19481027	-0.05118081	1.51252916	-1.70786175	0	-1.5462219									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015080-08	Methylatropine nitrate	170465893	Muscarinic acetylcholine receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	52-88-0				8.8110215971	4	7		0	-2.65645991					C[N+]2(C)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(CO)c3ccccc3.[O-][N+]([O-])=O	Vitas	STK108600	0.80604168	3.24724509	3.95067144	0.54932651	3.24569862	2.83550993	-2.65645991									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018193-11	Fluvoxamine	170464809	5-HT Reuptake Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	54739-18-3	;FLUVOXAMINE MALEATE;Fluvoxamine; Fluvoxamina;Fluvoxamine maleate; Fluvoxamine, (Z)-Isomer	19.6813789847	-4.7059444758	-31.0101130838	4	7		-26.477560708	-21.70287192	0.0236017774	0.9300672769	3350	HTR1A	FC(F)(F)c1ccc(cc1)C(\CCCCOC)=N\OCCN	Tocris	1033	-4.06893714	-0.47157133	-5.93941166	-3.54428475	-5.8392123	-8.25753341	-21.70287192									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094779-05	Salicyl alcohol	170465547		DPI_SARS-CoV-2_General	2019_NPC_01	90-01-7				1.5514385302	4	7		0	-2.97584345					OCc1ccccc1O	Microsource	01500531	0	3.64795856	0	0	0	0.818131	-2.97584345									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095239-05	1,3,5-Trimethoxybenzene	170465963		DPI_SARS-CoV-2_General	2019_NPC_01	621-23-8				-7.3651870222	4	7		0	-2.86938227					COc1cc(cc(OC)c1)OC	Microsource	00231043	-1.38697262	-2.43604466	-1.06504838	-1.67306293	-1.40841496	-0.44717719	-2.86938227									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167421-02	Sevoflurane	225144283	GABA-B receptor Modulator	DPI_SARS-CoV-2_General	2019_NPC_02					15.7750843457	4	7		0	2.39261761			2890		FCOC(C(F)(F)F)C(F)(F)F	Alfa Aesar	L16891	3.60933201	4.70096329	3.05900002	3.24813507	3.83765416	2.42390079	2.39261761									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181775-02	Toluidine blue	170466390		DPI_SARS-CoV-2_General	2019_NPC_02	92-31-9		1.7541047484	-5.7559444758	-137.2666210791	-1.1	7		-94.1575075533	-94.01607763	0.0000930913	0.9960354387			[Cl-].CN(C)c1ccc2nc3cc(C)c(N)cc3[s+]c2c1	Labotest	LT00451843	-0.45550186	-1.79491326	-0.89777549	-6.68568622	-41.67240929	-74.01822623	-94.01607763									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185763-03	6?-Methylprednisolone 21-hemisuccinate			DPI_SARS-CoV-2_General	2019_NPC_02	2921-57-5				6.6992302932	4	7		0	-1.66008657					C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]\4(C)/C=C\C(=O)\C=C14	Cayman	11800	3.33649333	2.77899697	1.12280537	2.82721044	0.47287503	0.40398346	-1.66008657									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522464-01	Lusutrombopag		Thrombopoietin receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	1110766-97-6		2.4777388143	-5.6059444758	-86.4735559949	-1.2	7		-76.4469390621	-71.78328497	0.0000104373	0.9986783765			CCCCCCO[C@@H](C)C1=C(OC)C(=CC=C1)C2=CSC(=N2)NC(=O)C3=CC(=C(/C=C(C)/C(O)=O)C(=C3)Cl)Cl	MedChem Express	HY-19883	4.74693056	2.05363949	2.96523757	-0.31101653	-16.5696362	-62.33558812	-71.78328497									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00185772-01	Vindesine sulfate salt	124896659	Tubulin polymerization inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	59917-39-4	Vindesine sulfate salt			-7.9876172034	4	7		0	1.81230081			203068	TUBB	O=S(=O)(O)O.O=C(OC)[C@@]2(C[C@H]4C[C@@](O)(CC)C[N@@](CCc1c3ccccc3nc12)C4)c5cc9c(cc5OC)N(C)[C@@H]6[C@]98CCN7CC=C[C@@](CC)([C@@H](O)[C@]6(O)C(N)=O)[C@H]78	Toronto Research	V414550	-0.45087748	-2.30774562	-5.45463069	-3.42118186	-0.19722928	-0.9723788	1.81230081									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016311-19	Phentolamine mesilate	170464866	alpha-Adrenoceptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	50-60-2	 Regitine;Phentolamine mesylate;Phentolamine;PHENTOLAMINE; ; Regitin;Phentolamine hydrochloride; Regitin mesylate; Vasomax;PHENTOLAMINE HYDROCHLORIDE; Phentolamine hydrochloride; Fentolamina;	15.6334750258	-4.8059444758	-88.2773216502	-2.2	7		-81.6891118616	-69.17948848	0.0001218496	0.9954608766	148	ADRA1A	Cc1ccc(cc1)N(CC2=NCCN2)c3cc(O)ccc3	Vitas	STK802099	-8.88098177	-5.93984411	-9.2003607	-9.97065242	-13.27462823	-27.13044362	-69.17948848									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159376-04	Methylparaben	170465480	canonical glycolysis Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	99-76-3				7.0854838806	4	7		0	1.35864744					Oc1ccc(cc1)C(=O)OC	Labotest	LTBB002210	1.32403844	2.16238669	1.76208233	-0.98577771	3.27615084	1.61593577	1.35864744									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091285-03	Tricaprylin	170465841		DPI_SARS-CoV-2_General	2019_NPC_01	538-23-8				3.0969726516	4	7		0	0					O=C(CCCCCCC)OC(COC(=O)CCCCCCC)COC(=O)CCCCCCC	SIGMA	91039	1.20301116	3.26679209	0	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094557-06	2-Chloro-4-nitrobenzamide	170466191		DPI_SARS-CoV-2_General	2019_NPC_01	3011-89-0				12.7577813806	4	7		0	1.50059568					O=C(N)c1ccc(cc1Cl)[N+]([O-])=O	Vitas	STK061509	4.51915862	0	4.73056957	0	3.63650206	4.37522232	1.50059568									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167500-02	Etretinate	170465372	Retinoic acid receptor alpha Agonist	DPI_SARS-CoV-2_General	2019_NPC_01	54350-48-0		1.3933349283	-5.8559444758	-150.8502333358	-1.1	7		-87.4951305166	-89.40711262	0.0000015665	0.9994886576			Cc1c(C)c(/C=CC(\C)=C\C=C\C(\C)=C\C(=O)OCC)c(C)cc1OC	LKT Lab	E7668	-2.85866434	-2.6364014	-4.73544393	-10.14623624	-44.01613967	-84.12012806	-89.40711262									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015149-16	Bumetanide	170464735	Loop Diuretics	DPI_SARS-CoV-2_General	2019_NPC_01	28395-03-1	; ;BUMETANIDE;bumetanide; Bumex; Bumethanide; Bumetanida;Bumetanide; Bumetanide	8.7913490634	-5.0559444758	-7.3480874701	4	7		-13.6794757999	-12.2328965	0.0277843965	0.923541472		SLC12A2	O=S(N)(=O)c2cc(cc(NCCCC)c2Oc1ccccc1)C(=O)O	Microsource	01502004	0.89802241	-0.90649205	0.62635568	-0.29849249	3.24062326	-4.81731795	-12.2328965									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164524-02	D-Glucuronolactone	50111689		DPI_SARS-CoV-2_General	2019_NPC_02		Glucuronolactone; D-Glucurone; D-Glucurono-6,3-lactone; 			10.4443757619	4	7	NCGC00164524-01;mannurono-gamma-lactone;D-(+)-Glucurono-6,3-lactone;GLUCUROLACTONE;GLUCURONOLACTONE, D-;CIPLUS_672794;D-Glucurone;D-Glucurono-6,3-lactone;Glucurolactone;CIPLUS_149024;mannuronolactone;D-(+)-Glucuronic acid gamma-lactone;Glucuronolactone;D(+)-Glucuronic acid gamma-lactone;	0	0.02378348					[H][C@]1(O)C(O)O[C@]2([H])[C@]([H])(O)C(=O)O[C@]12[H]	Labotest	LT03210628	3.70644408	3.66605835	2.82459389	2.18646961	0.62970796	0.43686584	0.02378348									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00166226-02	4-Propylbenzoic acid	225144274		DPI_SARS-CoV-2_General	2019_NPC_02	2438-05-3				4.9122080058	4	7		0	0.71826095					CCCC1=CC=C(C=C1)C(O)=O	SIGMA	332976	1.22314967	2.67735452	0.83214177	-0.03975399	2.26457239	-0.43216836	0.71826095									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482976-01	Vorapaxar Sulfate		Proteinase-activated receptor 1 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_02	705260-08-8		3.9269513795	-5.4059444758	-56.7298111017	-2.2	7		-61.503329681	-56.14327165	0.0000465366	0.9972028165	2149	F2R	CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3C([C@@H](C)OC3=O)[C@H]2\C=C\C4=NC=C(C=C4)C5=CC(=CC=C5)F	DC Chemicals	DC8229	3.75731231	0.9586731	0.99153794	3.33232	-7.96283535	-39.78767381	-56.14327165									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510907-01	Etafedrine hydrochloride		Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2019_NPC_02	5591-29-7				3.4017405694	4	7		0	1.51738572			154	ADRB2	CCN(C)C(C)C(O)C1=CC=CC=C1	SantaCruz Bio	sc-497331	3.83592684	2.28002495	-5.38430885	3.1592732	0.76277832	-0.80326945	1.51738572									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016012-12	Triflupromazine hydrochloride	170465325	Muscarinic acetylcholine receptor M2 Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	1098-60-8		8.7913490634	-5.0559444758	-41.1559052088	-2.2	7		-56.2549365019	-51.32949735	0.0000053355	0.9990559241	1129	CHRM2	Cl.FC(F)(F)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1	Microsource	01503118	0	0	0	0	0.04314064	-20.20936023	-51.32949735									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160387-04	Clothiapine	170465938	GABA-A receptor; benzodiazepine site Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	2058-52-8		15.6334750258	-4.8059444758	-54.4782247429	-2.2	7		-52.7831055172	-44.29798991	0.0039572377	0.9731824828			CN1CCN(CC1)C3=Nc4ccccc4Sc2ccc(Cl)cc23	Enzo	D108	-2.07440757	-1.82520097	-7.83553898	-6.7399102	-9.19910674	-16.91650999	-44.29798991									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016613-10	Antazoline hydrochloride	170464765	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2019_NPC_01	2508-72-7		13.9333492831	-4.8559444758	-18.6139908881	-2.4	7		-33.127778764	-24.27314897	0.0003037636	0.9928129423			Cl.C(c1ccccc1)N(CC2=NCCN2)c3ccccc3	Microsource	01500126	0	0	0.66535059	1.78844658	-2.01745927	-8.76060775	-24.27314897									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179673-03	Idoxuridine	170465014	Anti-Herpes Simplex Virus Drug	DPI_SARS-CoV-2_General	2019_NPC_02	54-42-2	Idoxuridine			-25.4858377267	4	7		0	-7.73914284					IC1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2	Prestwick	Prestw-18	-3.51684432	-5.60650512	-5.97501231	-4.09933821	-5.07806002	-6.45903796	-7.73914284									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181137-01	Sulfathiourea	144206297		DPI_SARS-CoV-2_General	2019_NPC_02	515-49-1	Sulfatolamide; Marbadal; Sulfatolamida; Sulfanilthiocarbamide; Sulfatiourea; 	17.5410474839	-4.7559444758	-8.6575333643	4	7	LS-160708;Sulfatolamida;Sulfanilthiocarbamide;Sulfatolamidum;CIPLUS_210321;sulfathiouree;Urea, 1-sulfanilyl-2-thio-;sulfatolamidum;sulfathiourea;LS-172308;Sulfatolamide;SULFATHIOUREA;sulphatolamide;SULFATOLAMIDE;CIPLUS_213879;Sulfathiouree;Marbadal;1-sulfanilyl-2-thiourea compound with alpha-amino-p-toluenesulfonamide (1:1) marbalettes;sulfatolamide;1-sulfanilyl-2-thiourea;Sulfatiourea;Sulfathiourea;	-26.576368736	-17.98030728	0.0012617196	0.9851859633			Nc1ccc(cc1)S(=O)(=O)NC(N)=S	NCI	NSC-108228	2.72607459	1.16657811	1.53067204	0	-0.19247677	-3.96937242	-17.98030728									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015572-06	MIBG			DPI_SARS-CoV-2_General	2019_NPC_02	103346-16-3				-15.3284293194	4	7		0	-7.22541978					NC(=N)NCC1=CC=CC(=C1)I	Axon Medchem	1750	-2.74457213	-4.39603594	-0.86495863	-2.01342282	-2.80635886	-3.74389327	-7.22541978									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015159-13	Betaxolol HCl		Beta1-adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2019_NPC_02	63659-19-8				-10.0969901066	4	7		0	-5.79841126				ADRB1	CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1	Selleck	S1827	2.30063123	-3.51359468	-0.03984904	-1.49428244	-2.86338902	-4.39214581	-5.79841126									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00242506-06	Bortezomib		Proteasome Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_02	179324-69-7				-8.070666943	4	7		0	-2.4972649				PSMD1	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)B(O)O	Axon Medchem	1810_cm1	0.90869153	-2.52489085	-3.38248049	-2.8693029	0.04514887	-1.80853063	-2.4972649									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379082-01	Anidulafungin			DPI_SARS-CoV-2_General	2019_NPC_02	166663-25-8		2.6938104809	-5.5696329617	-113.5320709125	-2.1	7		-96.9310279189	-90.41050278	0.0000100354	0.9987040863			CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(O)C(O)NC(=O)C5C(O)C(C)CN5C(=O)C(NC(=O)C(NC(=O)C6CC(O)CN6C(=O)C(NC4=O)C(C)O)C(O)C(O)C7=CC=C(O)C=C7)C(C)O	MedChem Express	HY-13553	0	4.43299684	1.42987741	0.94240348	-7.50659411	-54.58944006	-90.41050278									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00168784-03	Gemcitabine	170465129	Ribonucleotide reductase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	122111-03-9	 Gemcitabine; ; Gemcitabina;Gemzar;Gemcitabine;Inno-D07001			3.8117970463	4	7		0	0			6241	RRM2	Cl.NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F	Prestwick	Prestw-1266	3.19269963	0	0	0	0	2.36292495	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160423-02	Bamethan	225144236		DPI_SARS-CoV-2_General	2019_NPC_01					8.0310590361	4	7		0	2.30158931					CCCCNCC(O)C1=CC=C(O)C=C1	SIGMA	R416398	0	1.77633347	3.34137603	0	1.9464041	2.68814472	2.30158931									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274065-01	Desonide	174007408	Corticosteroid	DPI_SARS-CoV-2_General	2019_NPC_01	638-94-8	Desonide	13.9333492831	-4.8559444758	9.7112857853	4	7		-8.9473524079	-5.78946034	0.0660120463	0.8737054101		NR3C1	OCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C	Selleck	S1701	2.40360177	4.51779999	0.76771222	4.3018035	3.71770796	2.63224757	-5.78946034									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164128-02	Hexadecanoic acid, 1-methylethyl ester	170465544	N-acylsphingosine-amidohydrolase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	142-91-6		22.0828704269	-4.6559444758	-14.8237709368	4	7		-22.959430688	-21.21619224	0.0010362453	0.9866001552			CC(C)OC(=O)CCCCCCCCCCCCCCC	SIGMA	291781	-0.44295984	-1.91804921	-2.22027248	-0.56939323	-0.06344212	0	-21.21619224									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095166-04	Clopidol	170465668		DPI_SARS-CoV-2_General	2019_NPC_01	2971-90-6				6.876362337	4	7		0	1.98220577					Oc1c(Cl)c(C)nc(C)c1Cl	Vitas	STK802181	1.80814756	4.14640702	1.0747971	3.13793363	-1.01761153	-0.82829412	1.98220577									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00018143-05	Enrofloxacin	170465572	Topoisomerase IV Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	93106-60-6				-54.1211738643	4	7		0	-14.39760716					CCN1CCN(CC1)c2cc3N(C=C(C(=O)O)C(=O)c3cc2F)C4CC4	Vitas	STK711109	-9.40381962	-9.76616903	-11.72528089	-11.66127374	-10.80799878	-13.50170232	-14.39760716									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262928-01	Clevidipine	170466066	Voltage-gated L-type calcium channel Blocker	DPI_SARS-CoV-2_General	2019_NPC_01	167221-71-8	Butyroxymethyl methyl 4-(2 ,3 -dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate;Clevidipinum;Clevidipine	3.499899101	-5.4559444758	-44.4481806718	-2.2	7		-46.1257002399	-42.6047502	0.0004878847	0.9908492103			CC=1NC(C)=C(C(C=1C(=O)OCOC(=O)CCC)c2cccc(Cl)c2Cl)C(=O)OC	GVK	FFS-12-73-NCI-1401	0	0	3.72157637	3.00248326	-8.47332893	-29.72203872	-42.6047502									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093926-05	Doxifluridine	170465861	thymidylate synthase Inhibitor	DPI_SARS-CoV-2_General	2019_NPC_01	3094-09-5	 ;5'dFUrd; Ro 21-9738; Furtulon; 5'dFUrd;Doxifluridine; Doxifluridine; Doxifluridina; 5-Fluro-5??-Deoxyuridine;5-fluoro-5'-deoxyuridine; 5-fluoro-5'-deoxyuridine			-29.8725359537	4	7		0	-7.4218651			7298	TYMS	FC1=CN(C(=O)NC1=O)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O	Bosche	D1649	-4.34003824	-3.37430058	-8.83478346	-8.43053152	-5.77830787	-6.51455867	-7.4218651									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522278-01	Oglufanide		VEGF Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					3.3456162631	4	7		0	4.55966882				FLT1	N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=C[NH]C2=CC=CC=C12)C(O)=O	Combi-Blocks	QM-5596	-3.37621919	-0.49885854	2.96069423	-0.72405471	1.0775925	1.79828901	4.55966882									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162225-04	L-tetramisol		Nicotinic Receptor Agonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	16595-80-5	; Vetavia; Hydrochloride, Levamisol; Tetramisol hydrochloride; Levamisol;LEVAMISOLE HYDROCHLORIDE;Tetramisole hydrochloride; ; dexamisole, (R)-isomer; Levomysol; Tetramisol; Decaris; (-)-Tetramisole hydrochloride; Levamisol hydrochloride; Helmoral B; Solaskil; Levamisole Base; Dekaris; Nilverm; Dexamisol; Ergamisol;(-)-Tetramisole hydrochloride			4.706082071	4	7		0	0.00893469			1136	CHRNA3	C1CN\2C[C@@H](\N=C2S1)C3=CC=CC=C3	Enzo	AC-1102	3.89863006	1.6600434	0	0	0	1.29197463	0.00893469									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163460-03	Leupeptin, Microbial			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	103476-89-7				-1.4796752663	4	7		0	-0.40801739					[H]C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O	APExBIO	A2570	-3.79859394	1.25419238	2.2460439	-0.5229284	1.00750518	-2.11837281	-0.40801739									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390251-01	Isochlorogenic acid A			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	2450-53-5		0.6983216782	-6.1559444758	-55.9655810519	-1.2	7		-33.23551836	-30.1962653	0.0000662304	0.9966625696			OC1[C@@H](CC(O)(C[C@H]1OC(=O)\C=C\C2=CC(O)=C(O)C=C2)C(O)=O)OC(=O)\C=C\C3=CC(O)=C(O)C=C3	Adooq	A12072	-0.01389391	1.07945097	-3.59026714	-10.14825882	-18.83304617	-25.79875458	-30.1962653									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181785-11	Aprepitant			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	170729-80-3		9.8640558873	-5.0059444758	-21.6767537438	-2.2	7		-35.107201356	-30.50600113	0.0006189118	0.9896804443			C[C@@H](O[C@H]1OCCN(CC2=NC(=O)NN2)[C@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F	MedChem Express	HY-10052	-1.40328452	0.30156985	1.91707787	2.17216412	-0.07884823	-10.9585055	-30.50600113									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095703-06	NOBILETIN			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	478-01-3		22.0828704269	-4.6559444758	-15.5050914225	-3	7		-34.685826604	-30.57152217	0.0000048184	0.9991036236			COC1=C(OC)C=C(C=C1)C/2=C/C(=O)C3=C(OC)C(=C(OC)C(=C3O2)OC)OC	Microsource	01505268	0	0	0.13045204	0	0	0.75074201	-30.57152217									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00096023-03	3,4 -DIHYDROXYFLAVONE			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	14919-49-4		0.6983216782	-6.1559444758	-130.8960066863	-1.2	7		-74.615257468	-75.09604789	0.0000520111	0.9970416618			OC1=CC=C(C=C1)C/2=C(O)/C(=O)C3=C(O2)C=CC=C3	Microsource	01505138	0.63078334	1.00617232	1.0322727	-14.57878405	-52.15372485	-66.58907059	-75.09604789									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510317-02	Elbasvir		Nonstructural protein 5A Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1370468-36-2		0.9864055887	-6.0059444758	-155.1625159533	-1.1	7		-92.4703130158	-93.46576526	0.0000058043	0.9990149205			COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C2=NC=C([NH]2)C3=CC=C4C(=C3)O[C@H]([N]5C6=C(C=C(C=C6)C7=CN=C([NH]7)[C@@H]8CCCN8C(=O)[C@@H](NC(=O)OC)C(C)C)C=C45)C9=CC=CC=C9	MedChem Express	HY-15789	0.9031039	0.91034638	-0.54449549	-7.36696931	-58.91131034	-86.50410289	-93.46576526									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346662-06	Geniposide		P2Y purinoceptor 14 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	24512-63-8				8.0202011074	4	7		0	3.08842362			171108	P2ry14	COC(=O)C/1=C/O[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]\3[C@@H]1C\C=C3CO	Glixx	GLXC-06546	-1.33659377	1.00617232	1.55408088	3.05137341	3.33206787	1.49566432	3.08842362									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00371259-05	Clevudine		Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	163252-36-6				-12.1986016498	4	7		0	-1.99839176					C\C1=C\N([C@H]2O[C@@H](CO)[C@H](O)[C@H]2F)C(=O)NC1=O	MedChem Express	HY-13859	-3.87639981	-3.98804994	-2.14962282	-3.44213309	-0.2423853	-2.36862015	-1.99839176									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00253627-01	Pleconaril	170466405	Human rhinovirus A protease Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	153168-05-9				-9.1620735495	4	7		0	0			1461213		Cc1cc(on1)CCCOc2c(C)cc(cc2C)c3nc(on3)C(F)(F)F	GVK	FFS-12-73-NCI-1186	-4.29877456	-3.18198472	-5.22942544	-0.52867486	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386343-01	PI-1840	363680225	26S proteosome Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1401223-22-0		22.0828704269	-4.6559444758	4.1300404138	4	7		-11.8892545439	-8.65771212	0.0996440718	0.835515477			CCCC1=CC=C(OCC(=O)N(CC2=NC(=NO2)C3=CC=CN=C3)C(C)C)C=C1	Selleck	S7462	-0.38069303	1.80660072	0	3.68348466	4.51771165	2.80509806	-8.65771212									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263152-05	Ponatinib		FGFR Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	943319-70-8		4.4061119169	-5.3559444758	-98.036880642	-2.1	7		-101.8590136091	-89.99910653	0.0000642643	0.996709713		FGFR1	CN1CCN(CC1)CC2=CC=C(NC(=O)C3=CC(=C(C)C=C3)C#CC4=CN=C5C=CC=N[N]45)C=C2C(F)(F)F	Axon Medchem	1857	-0.67524384	3.14252699	3.1762237	1.39639122	-20.57938849	-58.88378048	-89.99910653									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346433-06	Peramivir		Influenza Infection Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	330600-85-6				2.1316523889	4	7		0	0					CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O	APExBIO	A3709	0.58632284	0.60595812	1.49169077	-1.59751753	0.45264726	1.80410871	0									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00238451-08	Olaparib		PARP Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	763113-22-0				-5.4494188715	4	7		0	1.46826697				PARP1	FC1=C(C=C(C/C2=N/NC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5	Axon Medchem	1464	-2.84825076	-1.72768524	-1.97946798	-2.52844501	0.3591975	-0.26770645	1.46826697									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091011-20	CHLORAMPHENICOL			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	56-75-7				8.8396714258	4	7		0	4.17249903					OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O	Microsource	MS-01500174	-0.10837247	0	3.81146844	2.22388231	3.56569226	0	4.17249903									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023654-26	Captopril			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	62571-86-2 				-1.691307913	4	7		0	3.04672842					C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O	APExBIO	A4078	-1.17542446	1.31056058	-1.16839657	-0.87346282	0.12557311	-2.97386952	3.04672842									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024196-12	Megestrol acetate	384568021	Progesterone Receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	595-33-5		11.0676527398	-4.9559444758	-13.9526322548	-3	7		-39.158948088	-32.63245674	0.0007899412	0.9883124688		PGR	CC(=O)O[C@@]1(CC[C@H]2[C@@H]3\C=C(C)/C4=C/C(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O	MedChem Express	HY-13676	1.96459833	0	3.85117123	4.40753936	2.42093275	-7.93225863	-32.63245674									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346883-02	6-Bromoindirubin-3'-acetoxime	384568960	GSK-3 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[667463-85-6]		0.78352981	-6.1059444758	-170.6726968385	-1.1	7		-101.0097894342	-95.45522232	0.0000409087	0.9973776549		GSK3B	CC(=O)O\N=C1\C(NC2=CC=CC=C12)=C3/C(=O)NC4=C3C=CC(=C4)Br	Tocris	3874	0.73637703	1.07381415	0.91883614	-22.46868176	-60.10863534	-92.36454635	-95.45522232									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346498-06	Danoprevir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	850876-88-9		9.8640558873	-5.0059444758	-13.4137378966	-3	7		-35.179021348	-30.98251779	0.0002364875	0.9936621485			CC(C)(C)OC(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)OC(=O)N4CC5=C(C4)C(F)=CC=C5)C(=O)N[S+]([O-])(=O)C6CC6	MedChem Express	HY-10238	0.79195265	2.98469603	3.36906585	1.32743363	2.89402214	-7.1640575	-30.98251779									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00508866-01	MK-1439			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1338225-97-0 		12.4181106199	-4.9059444758	-2.4554052992	4	7		-14.7783155079	-12.73192959	0.0038605419	0.9736633381			CN\1C(=O)N\N=C1CN2\C=C/C(=C(OC3=CC(=CC(=C3)C#N)Cl)\C2=O)C(F)(F)F	Bio Vision	B1250	2.1313252	0.52704264	2.58068175	0.87920929	0.2423853	-0.20368969	-12.73192959									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167803-13	GSI-IX	384568339	g-Secretase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	208255-80-5				8.4936723039	4	7		0	3.05864133				NOTCH1	C[C@H](NC(=O)CC1=CC(=CC(=C1)F)F)C(=O)N[C@H](C(=O)OC(C)(C)C)C2=CC=CC=C2	MedChem Express	HY-13027	0.5918804	1.36129196	1.40094152	2.97666935	0	3.53256125	3.05864133									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00538163-01	NCGC00538163-01			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			15.6334750258	-4.8059444758	-3.1652428912	4	7		-11.153721296	-8.87810108	0.0509392382	0.8919121446			CC1=C(N(CC(=O)NC2=CC=C(C=C2)C3=NOC=N3)C(=O)C4CC[S+]([O-])(=O)CC4)C(=CC=C1)C	Pharmaron	PH-NIH-2017-009-L2-30-0	0.86420096	2.96778558	0	-1.12630732	0.25406652	-0.76238142	-8.87810108									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390724-02	E-7449	384569209	PARP Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1140964-99-3		12.4181106199	-4.9059444758	-48.7900246746	-2.2	7		-40.8650138399	-43.39577687	0.0021497655	0.9804673215		PARP1	O=C1NNC2=C3C(=NC(=N2)CN4CC5=C(C4)C=CC=C5)C=CC=C13	MedChem Express	HY-12418	-7.29985828	-8.2100279	-3.47115875	-3.09159867	-3.46056128	-11.76744457	-43.39577687									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346533-07	Daclatasvir dihydrochloride		HCV NS5A Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1009119-64-5		6.2237985085	-5.2059444758	-73.3781613264	-2.2	7		-85.4535396227	-77.73475891	0.0000105368	0.9986721018			COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C2=NC=C([NH]2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C([NH]5)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C	MedChem Express	HY-10466	1.67004752	1.29365012	2.63172821	0.7757729	-9.34789592	-43.33352732	-77.73475891									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167356-14	Raltegravir Potassium		Human immunodeficiency virus type 1 integrase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	871038-72-1				8.3023071094	4	7		0	-1.78991572					CN1C(=O)\C(=C(/N=C1/C(C)(C)NC(=O)C2=NN=C(C)O2)C(=O)NCC3=CC=C(F)C=C3)[O-]	Glixx	GLXC-90403	0.63078334	3.16507426	3.82281209	4.15469486	2.3333236	-0.86131642	-1.78991572									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015817-17	Promethazine HCl			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	58-33-3		13.9333492831	-4.8559444758	-36.4518678301	-2.2	7		-70.1431336906	-57.25645531	0.0000535646	0.9969982156			CC(CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C	Selleck	S4293	-0.20285103	2.38719315	2.22902842	1.011378	-1.67917531	-12.71605657	-57.25645531									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024683-20	NCGC00024683-20			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					13.1036096693	4	7		0	0.57479822					C\C1=C/CC[C@@]2(C)O[C@H]2[C@H]3OC(=O)C(=C)[C@@H]3CC1	BIOMOL	T-113	1.69783533	4.90121473	0	3.76393518	4.45930555	3.55002037	0.57479822									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165856-15	Orlistat			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	96829-58-2				9.357611641	4	7		0	0					[H]C(=O)N[C@@H](CC(C)C)C(=O)O[C@@H](CCCCCCCCCCC)C[C@@H]1OC(=O)[C@H]1CCCCCC	APExBIO	A8492	2.58148776	3.35108932	0.16448301	4.95920009	2.41509214	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016034-05	Tulobuterol hydrochloride	170465781	Beta-2 adrenergic receptor Agonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	56776-01-3				-17.7866998268	4	7		0	-4.55966882					Cl.OC(CNC(C)(C)C)c1ccccc1Cl	Microsource	01503954	-5.98827354	-2.63521321	-1.59378368	-5.37294564	-3.30286482	-3.30559274	-4.55966882									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162073-12	H-89	384568218	AKT Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	130964-39-5		8.7913490634	-5.0559444758	-49.1404843906	-2.2	7		-69.1900556863	-56.58337552	0.0001347963	0.9952239896		AKT1	[O-][S+](=O)(NCCNC\C=C\C1=CC=C(Br)C=C1)C2=CC=CC3=CN=CC=C23	MedChem Express	HY-15979A	1.9090227	0	0	3.38466843	-6.0421108	-26.82302276	-56.58337552									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00373041-01	Favipiravir		RNA-dependant RNA polymeriase	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	259793-96-9				-18.540585504	4	7		0	-3.80319862					NC(=O)C1=NC(=CN=C1O)F	Synthonix	F11025G1	-5.05460305	-5.10414024	0.72032216	-5.31548098	-4.61116141	-4.45789443	-3.80319862									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00092327-05	4-HQN			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[491-36-1]				4.5844544974	4	7		0	4.62518986					OC1=NC=NC2=C1C=CC=C2	Tocris	2192	-0.12504516	-0.41430625	0.83375872	0	2.77136933	0	4.62518986									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164100-01	Trisiloxane, octamethyl-	26757517		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	107-51-7	Octamethyltrisiloxane; Poly(dimethylsiloxane); Trisiloxane, octamethyl-; 			-25.3133904994	4	7	Trisiloxane, octamethyl-;Octamethyltrisiloxane;NCGC00164100-01;Poly(dimethylsiloxane);CIPLUS_208116;	0	-4.72049319					C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C	SigmaAldrich	MFCD00008264	-5.37138411	-6.32733012	-6.81753729	-3.72370992	-4.15559384	-5.31921085	-4.72049319									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00509914-02	NMS-P118		PARP Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1262417-51-5				9.5926879786	4	7		0	0				PARP1	NC(=O)C1=CC(=CC2=C1C(=O)N(C2)C3CCN(CC3)C4CCC(F)(F)CC4)F	MedChem Express	HY-18954	3.33175869	4.50100054	3.54489252	-0.00574647	0	2.45591573	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00180420-04	Picroside 2			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	39012-20-9				2.9831059332	4	7		0	0.41397385					COc1cc(ccc1O)C(=O)O[C@@H]2[C@@H]3O[C@]3(CO)[C@@H]4[C@H]2C=CO[C@H]4O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O	DC Chemicals	DCH-008	0	0	0	0	0	3.95739976	0.41397385									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00601806-01	TH34			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	2196203-96-8		9.8640558873	-5.0059444758	-33.9841040368	-2.2	7		-43.8622271132	-40.80471751	0.0006351659	0.9895385844			CC1=CC=C(C=C1NCC2=CC=CC=C2)C(=O)NO	Selleck	S8773	-1.97015589	-2.34773541	1.23645851	-1.06884266	1.02502701	-14.78205203	-40.80471751									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378968-01	Lersivirine	363678296	Reverse transcriptase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	473921-12-9		12.4181106199	-4.9059444758	-2.8261341797	4	7		-9.053310296	-8.37775858	0.0174264723	0.9415390984			CCC1=N[N](CCO)C(=C1OC2=CC(=CC(=C2)C#N)C#N)CC	MedChem Express	HY-14267	0	0	2.27440304	0	0	0	-8.37775858									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016672-07	Chloropyramine hydrochloride		Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	6170-42-9		11.0676527398	-4.9559444758	-0.1649203591	4	7		-13.36952378	-10.72460315	0.1265890567	0.806767021			CN(C)CCN(CC1=CC=C(Cl)C=C1)C2=CC=CC=N2	Prestwick	Prestw-807	3.63742463	-2.24063583	3.14786456	0	4.25488421	-0.83221789	-10.72460315									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166236-04	Oxonic acid potassium salt			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	2207-75-2				-7.2943035642	4	7		0	-0.87262114					OC1=NC(=NC(O)=N1)C([O-])=O	SIGMA	156124	-3.51515825	1.33874468	-3.48250241	-0.91943455	-2.61951348	-1.83320724	-0.87262114									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00378751-01	Balapiravir	377020534		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	690270-29-2		17.5410474839	-4.7559444758	-25.0031501169	4	7		-17.2882559001	-15.91863478	0.0353623502	0.9123103208			CC(C)C(=O)OC[C@]1(O[C@H]([C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C)N2/C=C\C(=N/C2=O)N)N=[N+]=[N-]	MedChem Express	HY-10443	-2.15355545	-5.15487162	-1.92842153	-2.60889553	-5.90777677	-6.08159227	-15.91863478									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182390-05	NCGC00182390-05			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			17.5410474839	-4.7559444758	-14.1249847074	4	7		-25.260982216	-17.71748518	0.0057920192	0.9673424746			C[N]1N=NN=C1SC2=C3C(=NC=N2)SC=C3C4=CC(=CC=C4)[S+](C)([O-])=O	NCGCChem	SPA014-029	-0.9031039	-0.40866943	2.3481368	-0.91368808	-1.92448092	-5.07478322	-17.71748518									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167959-12	(+)-Chelidonine		microtubule polymerization Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	476-32-4		22.0828704269	-4.6559444758	5.7089076886	4	7		-12.474685048	-8.31223754	0.1686139536	0.7642254213			CN1CC2=C(C=CC3=C2OCO3)[C@H]4[C@@H](O)CC5=CC6=C(OCO6)C=C5[C@@H]14	Enzo	NP050	2.18134326	3.64984076	3.49951789	3.58004827	-2.4559764	4.05051504	-8.31223754									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00247542-02	Amentoflavone			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1617-53-4		1.106765274	-5.9559444758	-159.2023087908	-1.1	7		-82.2950677077	-84.25708074	0.0000017594	0.9994580812			OC1=CC=C(C=C1)\C2=C\C(=O)C3=C(O2)C(=C(O)C=C3O)C4=C(O)C=CC(=C4)\C5=C\C(=O)C6=C(O5)C=C(O)C=C6O	DC Chemicals	DCS-044	-5.62147442	-4.71519968	-9.64210765	-22.56062522	-49.45536314	-72.43205494	-84.25708074									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378806-01	Nucleozin	363678210		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	341001-38-5		4.9437388825	-5.3059444758	-61.1180876478	-2.2	7		-73.658456682	-64.6126813	8.702E-7	0.9996190091			CC1=C(C(=O)N2CCN(CC2)C3=C(Cl)C=C(C=C3)[N+]([O-])=O)C(=NO1)C4=CC=CC=C4	MedChem Express	HY-50001	3.52627338	2.9734224	2.98905337	0.35053442	-8.66454458	-39.78350695	-64.6126813									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160539-02	Adefovir	225144241	DNA polymerase/reverse transcriptase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	106941-25-7				7.4175442562	4	7		0	-0.8071001					NC1=NC=NC2=C1N=C[N]2CCOC[P](O)(O)=O	Bosche	A2312	2.50923945	1.35565514	4.87777211	3.95931502	2.13474287	-0.05237735	-0.8071001									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00163432-05	Calpeptin		Proteasome Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	117591-20-5				10.0475777496	4	7		0	1.1347053					CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)C=O	Cayman	14593	1.31992108	3.36236295	2.23470024	1.77565797	3.36127092	1.50730373	1.1347053									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00483135-03	CPI-0610	384569263	Bromodomain-containing protein 4 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1380087-89-7		13.9333492831	-4.8559444758	-37.2427859124	-2.2	7		-41.9989312849	-34.31813444	0.0009245122	0.9873383201			CC1=NOC2=C1C3=CC=CC=C3C(=N[C@H]2CC(N)=O)C4=CC=C(Cl)C=C4	ChemieTek	CT-C0610_cm2	-0.96979465	-0.25083848	-3.65265725	-4.12596253	-4.83894519	-13.5890124	-34.31813444									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346654-11	INK-128	384568885	mTORC1/2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	?1224844-38-5		11.0676527398	-4.9559444758	-9.2677907432	4	7		-17.594528992	-15.07877416	0.0329671729	0.9155559299		MTOR	CC(C)[N]1N=C(C2=CC3=C(OC(=N3)N)C=C2)C4=C(N)N=CN=C14	ActiveBioChem	A-1023	-3.10945619	2.65212367	0.83375872	0.83323756	1.29953567	-4.49281266	-15.07877416									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00370872-07	UPF1069	363677900	Poly [ADP-ribose] polymerase 2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1048371-03-4				-6.3311641884	4	7		0	-6.9184263			10038	PARP2	O=C(COC1=C2\C=C/NC(=O)C2=CC=C1)C3=CC=CC=C3	Glixx	GLXC-06427	-1.9090227	0.53831628	0.72599399	0.24135157	-2.49686067	-1.00098935	-6.9184263									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166414-05	Pemetrexed	384568308	Thymidylate synthase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	150399-23-8				-2.9611128647	4	7		0	0.0923251					NC/1=N/C(=O)C2=C([NH]C=C2CCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1	Selleck	S1135	-1.54778114	-0.14937572	0.66927571	2.02275601	-2.19314896	-3.1601001	0.0923251									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00685392-02	Cenicriviroc Mesylate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	497223-28-6		1.7541047484	-5.7559444758	-144.3717190556	-1.1	7		-98.795753049	-94.09119338	0.0000948089	0.9959987427			CCCCOCCOC1=CC=C(C=C1)C2=CC=C3N(CC(C)C)CCCC(=CC3=C2)C(=O)NC4=CC=C(C=C4)[S@@+]([O-])CC5=CN=CN5CCC	MedChem Express	HY-14882A	0.53630478	3.42436797	-2.46157337	-12.60199977	-39.40367374	-85.09573416	-94.09119338									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379189-01	P005091			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[882257-11-6]		2.7800686746	-5.5559444758	-82.9246637738	-1.2	7		-76.6760282395	-67.93638503	0.000263019	0.9933062631			CC(=O)C1=CC(=C(S1)SC2=CC=CC(=C2Cl)Cl)[N+]([O-])=O	Tocris	4733	3.57629144	4.37135368	3.23861381	-4.34432824	-16.23981544	-57.91188966	-67.93638503									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379087-02	Tipranavir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	174484-41-4		12.4181106199	-4.9059444758	-50.5098591518	-2.2	7		-86.6675998388	-64.14212109	0.0002503078	0.993472385			CCC[C@@]1(CCC2=CC=CC=C2)CC(=C([C@H](CC)C3=CC=CC(=C3)N[S+]([O-])(=O)C4=CC=C(C=N4)C(F)(F)F)/C(=O)O1)\O	MedChem Express	HY-15148	1.91458026	4.61373693	3.8852022	-2.25836111	-5.90777677	-26.07810045	-64.14212109									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00388311-01	Z-VAD(OH)-FMK			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	161401-82-7				5.9252149116	4	7		0	2.47490842					CC(C)[C@H](NC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)CF	Cayman	14467	0.97535221	3.27217384	0.05104645	1.44236295	0.57530006	0.32590351	2.47490842									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160580-02	2-Hydroxy-N-(4-hydroxyphenyl)-benzamide		Ribonucleoside-diphosphate reductase M2 chain Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	526-18-1		13.9333492831	-4.8559444758	-52.378787844	4	7		-20.0996892399	-23.25699139	0.0357574093	0.9115565955			OC1=CC=C(NC(=O)C2=CC=CC=C2O)C=C1	DC Chemicals	DC8981	-10.06752438	-6.09058369	-10.78214509	-6.57395702	-10.06629092	-14.13024501	-23.25699139									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386253-01	Valganciclovir HCl	363680169	Human herpesvirus 5 DNA polymerase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	175865-59-5				7.8706136737	4	7		0	0					CC(C)[C@H](N)C(=O)OCC(CO)OCN1\C=N/C2C1\N=C(N)/NC2=O	Selleck	S4050	0.00833634	3.57092528	4.06102887	0	3.61825775	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017063-13	Amodiaquine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	86-42-0		17.5410474839	-4.7559444758	-29.0166530184	4	7		-27.9780280201	-22.42904369	0.0043640388	0.971838819			CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1	Cayman	15954_cm1	-0.36402034	-3.37927341	-3.55056435	-3.50534421	-5.12513506	-8.68300064	-22.42904369									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263556-10	P 22077			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1247819-59-5		3.499899101	-5.4559444758	-30.1859187742	-1.2	7		-37.5794442578	-33.84161777	0.0000371927	0.9975015327			CC(=O)C1=CC(=C(S1)SC2=CC=C(F)C=C2F)[N+]([O-])=O	MedChem Express	HY-13865	1.94792564	1.93061075	4.12909081	2.95368348	-1.88359665	-26.68916953	-33.84161777									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263103-09	Pelitinib		EGFR Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	257933-82-7		11.0676527398	-4.9559444758	-67.731110675	-2.2	7		-79.529325644	-63.5703011	0.0000869134	0.9961708672		EGFR	CCOC1=C(NC(=O)\C=C\CN(C)C)C=C2C(=C1)N=CC(=C2NC3=CC(=C(F)C=C3)Cl)C#N	MedChem Express	HY-32718	-0.31955984	-3.42436797	-1.3158641	-3.24100678	-11.21105043	-29.45934936	-63.5703011									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263173-05	Rucaparib	384568643	PARP Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	459868-92-9		13.9333492831	-4.8559444758	-43.8155016393	-2.2	7		-52.8535154171	-42.91926021	0.0004600783	0.9911196676		PARP1	CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=CC(=CC(=C34)[NH]2)F	Selleck	S1098	-4.12093256	-1.18655055	-1.88304691	-0.66659005	-6.36918494	-16.21951929	-42.91926021									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095196-07	TILORONE			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	27591-69-1, 27591-97-5 [tilorone]		8.7913490634	-5.0559444758	-30.4422723095	-2.2	7		-52.3473508692	-46.47526581	0.0001015598	0.9958594161			CCN(CC)CCOC1=CC=C2C(=C1)C(=O)C3=CC(=CC=C23)OCCN(CC)CC	Microsource	02300009	0.20840859	3.04106423	0.81674324	2.0399954	1.91864031	-16.51632427	-46.47526581									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024379-25	Emetine		antiprotozoal agent	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	316-42-7		8.7913490634	-5.0559444758	-1.3512780835	4	7		-19.923325488	-15.35277124	0.0013841644	0.9844681073			CC[C@H]1CN2CCC3=CC(=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(=C(OC)C=C45)OC)OC	USP	1235004_cm1	2.61483313	1.82914799	2.98905337	2.55143087	4.20231872	-4.45789443	-15.35277124									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00180669-03	Gentiopicroside			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	20831-76-9				3.0405213125	4	7		0	1.2061828					OC[C@H]1O[C@@H](O[C@@H]2O\C=C/3C(=O)OC/C=C3[C@H]2C=C)[C@H](O)[C@@H](O)[C@@H]1O	DC Chemicals	DCL-005	0.48628671	2.78177053	1.78662583	0.28157683	-1.71421896	-0.16877146	1.2061828									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00387092-01	PF 429242		cholesterol biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[947303-87-9]		9.8640558873	-5.0059444758	-0.778628559	4	7		-8.287816068	-6.90651339	0.1161497629	0.8192374841			CCN(CC)CC1=CC=C(C=C1)C(=O)N(CCC2=CC=CC=C2OC)[C@@H]3CCNC3	Tocris	3354	2.37585795	0.6285054	0.55016732	-1.21825078	3.15684957	-1.32107315	-6.90651339									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00650297-01	Biphenyl-4-sulfonyl chloride			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1623-93-4				7.5873603534	4	7		0	0					[O-][S+](Cl)(=O)C1=CC=C(C=C1)C2=CC=CC=C2	Selleck	S5438	-1.26990302	1.38383924	1.38392604	4.20641306	1.38714482	3.72461153	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015385-22	Dipyridamole	384567839	Phosphodiesterase PDE3 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	58-32-2		8.7913490634	-5.0559444758	-69.4882744722	-2.1	7		-89.4839285497	-82.66670638	0.0000069975	0.9989183092		PDE5A	OCCN(CCO)C1=NC(=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO)N4CCCCC4	Prestwick	Prestw-142	-0.66412871	-0.19447028	-0.11343656	-2.23537524	-1.56820372	-32.31100506	-82.66670638									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386232-01	Cathepsin Inhibitor 1	363680160		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	225120-65-0				5.5339831247	4	7		0	-2.02817405					C[N]1N=C(C=C1C(=O)N[C@@H](CC2=CC=CC(=C2)Cl)C(=O)NCC#N)C(C)(C)C	Selleck	S2847	1.31992108	3.24962656	0	4.42477876	2.82977543	-2.33370191	-2.02817405									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018257-16	Methocarbamol		Muscle relaxant	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	532-03-6				-38.5286115562	4	7		0	-7.9608065					COC1=C(OCC(O)COC(N)=O)C=CC=C1	MedChem Express	HY-B0262	-8.40025565	-8.85262535	-7.01037945	-8.2289392	-6.6436936	-10.24850143	-7.9608065									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510794-01	KIN1408			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1903800-11-2		0.0986405589	-7.0059444758	-196.1955786936	-1.2	7		-81.7256008544	-76.51368496	0.0000018662	0.9994418694			COC1=CC=C2SC(=NC2=C1)NC(C3=CC=C(OC(F)F)C=C3)C4=CC=C5C=CC=NC5=C4O	SIGMA	SML1866	1.84233195	-6.2935092	-27.28149283	-50.89644868	-66.95382998	-73.36320782	-76.51368496									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166291-04	Lycopene		response to oxidative stress Modulator	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	502-65-8		6.2237985085	-5.2059444758	-53.2118380721	-2.2	7		-39.1764108079	-39.5359919	0.0000183902	0.9982456537			CC(C)=CCC\C(C)=C\C=C\C(C)=C\C=C\C(C)=C\C=C\C=C(C)\C=C\C=C(C)\C=C\C=C(C)\CCC=C(C)C	Glixx	GLXC-06674	-4.50440437	-3.54274119	-3.35205037	-3.8961039	-8.00455568	-23.15660828	-39.5359919									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164563-06	Entecavir (monohydrate)		DNA Polymerase Inhibitors	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	209216-23-9				-0.2578562942	4	7		0	3.13011883					NC/1=N/C2=C(N=C[N]2[C@H]3C[C@H](O)[C@@H](CO)C3=C)C(=O)N1	MedChem Express	HY-13623A	-2.18134326	-1.22037147	-1.16272475	0.93667395	1.75510323	-0.92533318	3.13011883									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263625-09	AnacardicAcid			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	16611-84-0		2.4777388143	-5.6059444758	-81.4628566476	-1.2	7		-65.7928343872	-60.44911696	0.0002544784	0.993417348			CCCCCCCCCCCCCCCC1=C(C(O)=O)C(=CC=C1)O	Bio Vision	1849	1.55333871	-2.21245173	2.66008735	-0.63785772	-17.65908361	-54.63539545	-60.44911696									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163510-01	Aloe-emodin	26756894	Caspase 3 Activator	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	481-72-1	ALOE-EMODINE;Aloe-emodin	1.106765274	-5.9559444758	-107.7552928483	-1.2	7	ALOE-EMODINE;Aloe Emodin;aloe-emodin;ALOE-EMODIN;LS-2202;aloe-emodin 1-O-glucopyranoside;Aloeemodin:9,10-Anthracenedione,1,8-dihydroxy-3-(hydroxymethyl)-,;Aloe-emodin;ALOE EMODIN;Anthraquinone, 1,8-dihydroxy-3-hydroxymethyl-;NCGC00163510-02;NCGC00163510-01;aloe-emodin 1-O-Glc;1,8-Dihydroxy-3-(hydroxymethyl)anthraquinone;CIPLUS_153452;	-48.529404844	-51.67525389	0.0003607462	0.9921472727	836	CASP3	OCC1=CC(O)=C2C(=O)C3=C(C=CC=C3O)C(=O)C2=C1	BIOMOL	BIOMOL_NP-005	-4.69336149	-7.1784899	-6.34110374	-14.84312148	-30.50258447	-51.80119886	-51.67525389									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094565-03	Hinokitiol	26753708		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			6.2237985085	-5.2059444758	-40.5375535275	-2.2	7	beta-Thujaplicin;hinokitiol;4-isopropyltropolone;alpha-thujaplicin;NCGC00094565-03;NCGC00094565-01;NCGC00094565-02;4-Isopropyltropolone;2-Hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one;CIPLUS_153635;HINOKITIOL;Hinokitiol;beta-thujaplicin;beta-thujaplicin, sodium salt;LS-56183;LS-173664;2-hydroxy-4-isopropyl- 2,4,6-cycloheptatriene-1-one;	-44.048009052	-36.70667421	0.0032982588	0.9756146091			CC(C)C\1=C\C=C/C(=O)\C(=C1)O	BIOMOL	FR-110	-1.84788952	0.19447028	3.32369123	-1.71819331	-10.61530824	-19.71716231	-36.70667421									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025291-03	Arctigenin		tumor necrosis factor biosynthetic process Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1777		13.9333492831	-4.8559444758	4.9115064767	4	7		-17.543467252	-13.78622271	0.0109531041	0.9541403629			COC1=C(O)C=CC(=C1)C[C@@H]2[C@H](COC2=O)CC3=CC(=C(OC)C=C3)OC	Tocris	1777	0.84752827	3.93731856	4.95150587	1.89058729	4.01541921	1.80992842	-13.78622271									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00184994-11	Cidofovir	384568422	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	113852-37-2		0.0031920282	-8.4959332839	-7.6724009054	4	7		6.139244732	-1.96860946	0.406398119	0.5071509075			NC/1=N/C(=O)N(C[C@@H](CO)OC[P](O)(O)=O)/C=C1	MedChem Express	HY-17438	-5.94937061	-5.38034441	1.51437808	-1.13205379	4.36001519	-3.91084211	-1.96860946									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00345492-06	PCI-34051	384568736	HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	950762-95-5		1.241811062	-5.9059444758	-133.0270437639	-1.1	7		-82.8578074312	-84.72168449	0.0006340455	0.9895418931		HDAC8	COC1=CC=C(C[N]2C=CC3=C2C=C(C=C3)C(=O)NO)C=C1	Selleck	S2012	-3.19281963	0.70742087	-1.52004991	-7.61406735	-47.14832228	-67.78792993	-84.72168449									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090851-14	5-Azacitidine		DNA Methyltransferase (DNMT) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	320-67-2				0.0935322265	4	7		0	3.7198082				DNMT1	NC/1=N/C(=O)N(/C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	XcessBio	M60131-5s	-1.13652152	0.29593303	-0.86211786	-0.36777382	0.02044213	-0.65762672	3.7198082									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00487399-01	TAK-779			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	229005-80-5		3.499899101	-5.4559444758	-94.918947396	-2.2	7		-84.8691961719	-79.89099681	0.0000219153	0.9980830066			CC1=CC=C(C=C1)C2=CC\3=C(CCC\C(=C3)C(=O)NC4=CC=C(C[N+](C)(C)C5CCOCC5)C=C4)C=C2	SIGMA	SML0911	0	0	0	1.65498219	-17.68244605	-59.5355875	-79.89099681									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263182-04	Mocetinostat	384568650	HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	726169-73-9		11.0676527398	-4.9559444758	-29.1450043348	-2.2	7		-51.0217857508	-45.84983769	0.0000433514	0.9973013737		HDAC1	NC1=C(NC(=O)C2=CC=C(CNC3=NC(=CC=N3)C4=CC=CN=C4)C=C2)C=CC=C1	Selleck	S1122	-0.15839053	1.54730701	0	2.17791058	1.24697018	-11.93039632	-45.84983769									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167535-16	Tenofovir		Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	147127-20-6				-40.0291956721	4	7		0	-9.42609524					C[C@H](C[N]1C=NC2=C1N=CN=C2N)OC[P](O)(O)=O	MedChem Express	HY-13910	-8.49473421	-8.84135171	-5.42793942	-9.87817492	-8.39003592	-9.39882442	-9.42609524									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346556-07	Semagacestat			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	425386-60-3				8.0238252631	4	7		0	2.33790988					CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@H]1C2=C(CCN(C)C1=O)C=CC=C2	DC Chemicals	DC7496	0	-1.73895888	4.59985253	2.17791058	0	4.67322353	2.33790988									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00686671-01	Brincidofovir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	444805-28-1				8.3666256435	4	7		0	4.15462966					CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)CN1C=CC(N)=NC1=O	MedChem Express	HY-14532	1.57556896	0.75251543	0.54449549	-0.30456269	-0.73883713	3.64313566	4.15462966									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00522593-01	RSV604 (R enantiomer)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	932108-20-8		13.9333492831	-4.8559444758	-23.6190352514	-3	7		-42.4828305089	-33.71653215	0.0002448562	0.9935495387			FC1=CC=CC=C1NC(=O)N[C@@H]2\N=C(C3=CC=CC=C3)/C4=CC=CC=C4NC2=O	MedChem Express	HY-12993B	0.14171784	1.17527691	0.77704044	1.16078612	-2.66039775	-8.95070709	-33.71653215									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160398-05	Nafamostat mesilate	170465855	Tryptase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	82956-11-4	 Nafamostat mesylate; Ronastat; ;;Nafamostat mesylate	9.8640558873	-5.0059444758	-0.6717451206	4	7		-14.53460702	-11.69550585	0.0536794641	0.8877671147	7177	TPSAB1	CS(=O)(=O)O.N=C(N)Nc1ccc(cc1)C(=O)Oc2ccc3cc(ccc3c2)C(=N)N	Enzo	PI143	4.02089643	0	0	1.48258821	4.68708933	-2.19984869	-11.69550585									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00345839-16	Baricitinib		Jak2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1187594-09-7				14.7895703857	4	7		0	2.58212467				JAK2	CC[S+]([O-])(=O)N1CC(CC#N)(C1)[N]2C=C(C=N2)C3=NC=NC4=C3C=C[NH]4	MedChem Express	HY-15315	1.78119877	4.81666244	3.33503488	3.40765429	3.20357445	2.72362218	2.58212467									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183808-18	ML324		JMJ Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			13.9333492831	-4.8559444758	-91.518979673	-2.1	7		-127.983992022	-98.09393335	0.001540326	0.9835381379		JARID2	CN(C)CCCNC(=O)C1=CC=C(C=C1)C2=CC3=CC=CN=C3C(=C2)O	NCGCChem	GRB059-084	1.70339289	1.33874468	-0.65793205	-5.83266291	-17.99783897	-35.45364605	-98.09393335									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00384200-03	HPOB		Histone deacetylase 6 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1429651-50-2		17.5410474839	-4.7559444758	-15.0838701212	4	7		-25.9257229599	-18.2714358	0.013691104	0.9482237958			OCCN(C(=O)CC1=CC=C(C=C1)C(=O)NO)C2=CC=CC=C2	Adooq	A14197	0.86420096	2.16172036	-2.79621122	-1.33892656	-1.00750518	-5.65093406	-18.2714358									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00246971-04	Polydatin	363677157	V/ICAM1 Expression Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	65914-17-2		12.4181106199	-4.9059444758	-12.4390395057	4	7		-9.840247792	-9.86687316	0.0594820313	0.88163766		ICAM1	OC[C@H]1O[C@@H](OC2=CC(=CC(=C2)/C=C/C3=CC=C(O)C=C3)O)[C@H](O)[C@@H](O)[C@@H]1O	Selleck	S2390	-1.62002946	-1.69386432	-1.4973626	-2.70083898	0.98998335	-3.88174358	-9.86687316									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164555-10	Entacapone		NCI-H1299 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	130929-57-6		8.7913490634	-5.0559444758	-43.5311882563	4	7		-29.707179972	-30.39878488	0.0001333711	0.9952558283			CCN(CC)C(=O)/C(=C/C1=CC(=C(O)C(=C1)[N+]([O-])=O)O)C#N	MedChem Express	HY-14280	-3.14280157	-4.85048336	-4.11774715	-5.51660729	-5.79096458	-16.03328872	-30.39878488									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00371119-04	S1RA	363678035	Sigma opioid receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	878141-96-9		17.5410474839	-4.7559444758	-13.3640106935	4	7		-16.592816512	-12.99401376	0.0292382369	0.9214061693			CC1=CC(=N[N]1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4	Glixx	GLXC-90073	-3.12612888	0.5439531	0.01134366	-0.2183657	-2.63703531	-3.99231799	-12.99401376									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163409-07	Betulinic acid	384568234	Caspase 3/8 Activator	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	472-15-1		3.499899101	-5.4559444758	-12.2593637509	4	7		-16.500580752	-13.75048396	0.0026324293	0.9783839153		CASP3	CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O	Prestwick	Prestw-NAT-0019	1.13096396	0.07609707	2.89830412	1.22974371	-3.11596531	-9.35808648	-13.75048396									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165993-02	Picolinic acid	170466822		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	98-98-6				-2.69821427	4	7		0	-0.89644697					O=C(O)c1ccccn1	Bosche	P0843	-3.46514019	-2.53938728	0.66360388	0.89644868	3.37295214	-2.22312751	-0.89644697									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163572-01	ISORHAMNETINE	26756952		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			1.7541047484	-5.7559444758	-86.2801343216	-1.2	7	ISOHAMNETIN:3'-METHOXY-3,4',5,7-TETRAHYDRO-XY-FLAVONE;3'-Methoxy-3,4',5,7-tetrahydroxyflavone;3-methyl-quercetin;3-methylquercetin;isorhamnetin;CIPLUS_153428;isorhamnetine;NCGC00163572-01;iso-rhamnetin;3'-methoxyquercetin;TAMARIXETINE;NCGC00163572-02;Isorhamnetin;3,4',5,7-tetrahydroxy-3'-methoxyflavone;ISORHAMNETIN;LS-69043;ISORHAMNETINE;CIPLUS_155089;3,4',5,7-tetrahydroxy-3'-methoxy-flavone;	-64.057003306	-61.16389195	0.0002023203	0.9941376608			COC1=CC(=CC=C1O)C2=C(O)C(=O)C3=C(O2)C=C(O)C=C3O	BIOMOL	BIOMOL_NP-148	0.16394809	4.10078634	-2.64307186	-2.97666935	-25.795053	-50.17168131	-61.16389195									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163431-06	CA-074 Me	384568238	Cathepsin B Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	147859-80-1				3.3265891412	4	7		0	0				CTSB	CCCNC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](C(C)CC)C(=O)N2CCC[C@H]2C(=O)OC	APExBIO	A8239	1.64781727	0.38048533	1.93976519	-0.51718193	1.66165348	-0.30262469	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161662-08	Calpain Inhibitor I, ALLN			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	110044-82-1				5.3789205587	4	7		0	-3.95806653					CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O)C=O	APExBIO	A2602	1.31992108	0	3.25562929	2.97092288	1.59156616	1.5829599	-3.95806653									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00388362-02	Glycitin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	40246-10-4				5.150576257	4	7		0	0					COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C3O\C=C(/C(=O)C3=C1)C4=CC=C(O)C=C4	Prestwick	Prestw-NAT-0037	-1.37549671	3.32290522	1.38392604	2.0917136	2.2749175	-0.37246115	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00246187-06	Pyronaridine Tetraphosphate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	76748-86-2		1.3933349283	-5.8559444758	-162.389001968	-1.1	7		-94.4010711366	-93.96610775	0.0000043381	0.9991485851			COC1=CC=C2NC3=C(C=CC(Cl)=C3)C(N=C4C=C(CN5CCCC5)C(=O)C(CN6CCCC6)=C4)=C2N1	AvaChem	1554_cm1	-5.48253536	-3.02979059	-5.30315921	-18.06688886	-48.90050521	-80.88226736	-93.96610775									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00180911-03	Pyrvinium pamoate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	3546-41-6		0.5546966259	-6.2559444758	-178.5235140765	-1.1	7		-101.3709920475	-97.17663877	1.953E-7	0.9998195543			CN(C)c1ccc2[n+](C)c(\C=C/c3cc(C)n(c3C)-c4ccccc4)ccc2c1.Oc5c(cc6ccccc6c5Cc7c(O)c(cc8ccccc78)C([O-])=O)C([O-])=O	Prestwick	Prestw-1040	3.07611082	4.60246329	0.8507742	-20.83668544	-75.4051923	-94.36652505	-97.17663877									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015897-20	Ranolazine	384567904	Sodium channel Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	95635-56-6				10.851577403	4	7		0	4.41671382				SCN9A	COC1=C(OCC(O)CN2CCN(CC2)CC(=O)NC3=C(C)C=CC=C3C)C=CC=C1	MedChem Express	HY-17401	2.69263901	3.46382571	2.89830412	0.2700839	2.95242823	0	4.41671382									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386215-05	Alogliptin (SYR-322)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	850649-61-5				4.1754734363	4	7		0	-3.59472258					CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC3=CC=CC=C3C#N)C1=O	APExBIO	A4038	1.88679245	1.06817733	2.13827917	3.60303413	0.92573665	-0.87877553	-3.59472258									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00381558-03	AZD-2461		PARP Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1174043-16-3				-10.7387040168	4	7		0	-4.01763112			142	PARP1	COC1CCN(CC1)C(=O)C2=CC(=CC=C2F)CC/3=N/NC(=O)C4=CC=CC=C34	Axon Medchem	2241	-4.1598355	1.50784927	-1.12302195	-0.97115274	-4.92655433	-2.79345865	-4.01763112									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379250-01	ME 0328		Poly [ADP-ribose] polymerase 3 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[1445251-22-8]				11.3873031786	4	7		0	-0.53905948					C[C@H](NC(=O)CCC/1=N/C2=CC=CC=C2C(=O)N1)C3=CC=CC=C3	Tocris	5054	2.65373607	4.0049604	4.29924565	0	3.40215518	2.4209975	-0.53905948									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017331-07	CIANIDANOL		superoxide anion generation Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	154-23-4		11.0676527398	-4.9559444758	-37.8923378232	-2.2	7		-44.2763498792	-34.30026506	0.001749489	0.9824400757			O[C@H]1CC2=C(O[C@@H]1C3=CC(=C(O)C=C3)O)C=C(O)C=C2O	Microsource	MS-00210205	-2.81490538	2.25190947	-1.84901594	-2.5801632	-6.80723067	-16.63271838	-34.30026506									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00115775-02	NCGC00115775-02			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			4.9437388825	-5.3059444758	-58.2900141548	4	7		-23.2253751641	-30.20222176	0.002505369	0.9788809748			CC(C)C[S+]([O-])(=O)C1=C(N=C(O1)C2=CC=C(F)C=C2)[S+]([O-])(=O)C3=CC=CC=C3	Chemdiv	D093-0011	-7.64442715	-5.43107579	-9.84629346	-6.41880244	-9.35957714	-22.15561893	-30.20222176									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163544-09	E-64			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	66701-25-5				5.291792782	4	7		0	0					CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(O)=O)C(=O)NCCCCNC(N)=N	Selleck	S7379	3.25951038	1.1724585	3.23861381	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165961-04	FTI-277 hydrochloride			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			4.9437388825	-5.3059444758	-94.528603306	-2.1	7		-95.3314858409	-89.80254341	0.0000785969	0.9963591474			COC(=O)[C@H](CCSC)NC(=O)C1=CC=C(NC[C@@H](N)CS)C=C1C2=CC=CC=C2	Bio Vision	2874-5	-1.03092783	-2.35337223	2.3878396	3.13182393	-11.71918348	-57.97590642	-89.80254341									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00087387-05	Droxinostat	384568077	HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	99873-43-5		11.0676527398	-4.9559444758	0.9498380556	4	7		-10.360321052	-8.21693421	0.058971407	0.8818597914		HDAC6	CC1=CC(=CC=C1OCCCC(=O)NO)Cl	Selleck	S1422	2.46477895	0	0	1.8216297	3.77595421	-0.4248385	-8.21693421									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263136-04	Pracinostat	363677222	HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	929016-96-6 		15.6334750258	-4.8059444758	-24.986246968	4	7		-25.378374736	-20.36810912	0.0173191574	0.941103672		HDAC1	CCCCC1=NC2=CC(=CC=C2[N]1CCN(CC)CC)/C=C/C(=O)NO	Arking Pharma	SB-939	-0.05279684	-5.43107579	-0.99256991	-1.51132054	-3.91612884	-8.48513065	-20.36810912									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522453-02	IXAZOMIB CITRATE		Proteasome subunit beta type-5 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					4.5968814856	4	7		0	2.12943384			5693	PSMB5	CC(C)C[C@H](NC(=O)CNC(=O)C1=CC(=CC=C1Cl)Cl)B2OC(=O)C(CC(O)=O)(CC(O)=O)O2	MedChem Express	HY-10452	-0.11948759	-1.76150616	3.66967274	0.43673141	1.42218848	1.31525345	2.12943384									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00385384-01	NCGC00385384-01			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			4.4061119169	-5.3559444758	-68.6337152775	-2.2	7		-79.1596479691	-64.80924442	0.0006562778	0.9893579024			CC(=O)OC(C)(C)CCC(=O)[C@](C)(O)C1[C@H](O)C[C@@]2(C)C3C/C=C/4C(C[C@H](O)[C@@H](O)C4(C)C)[C@]3(C)C(=O)C[C@]12C	Analyticon	NP-015959	3.90974519	3.0889772	0.03403097	3.59728767	-18.76879946	-41.06384217	-64.80924442									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00189073-04	Selumetinib	384568456	Mek1/2 inibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	606143-52-6		15.6334750258	-4.8059444758	-13.9817868702	4	7		-18.194939992	-15.57911666	0.029718594	0.9204702112		MAP2K1	C[N]1C=NC2=C1C=C(C(=O)NOCCO)C(=C2F)NC3=CC=C(Br)C=C3Cl	Selleck	S1008	-3.29285575	-1.05126688	1.38959787	0.8102517	-2.32164238	-3.89338299	-15.57911666									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346475-02	Birinapant	384568790	IAP Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1260251-31-7		6.0306904668	-5.2196329617	-69.918418483	-2.2	7		-65.6970694164	-50.90687077	0.0033427806	0.9754352975		XIAP	CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1CC2=C([NH]C3=C2C=CC(=C3)F)C4=C(C[C@@H]5C[C@H](O)CN5C(=O)[C@H](CC)NC(=O)[C@H](C)NC)C6=C([NH]4)C=C(F)C=C6	Selleck	S7015	-0.44738378	-3.23835292	-2.10992003	1.56303873	-12.78217446	-22.89472153	-50.90687077									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00263117-14	Panobinostat		HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	404950-80-7		1.3933349283	-5.8559444758	-144.7566719957	-2.1	7		-85.8083532806	-85.85341156	0.0007963319	0.9882549855		HDAC1	CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C3=CC=CC=C3[NH]1	Aobious	AOB87727	-4.64890099	-2.73103915	-5.50167319	-14.67647397	-49.41447887	-65.55316301	-85.85341156									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094047-16	Ivermectin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	70288-86-7		3.1192883571	-5.5059444758	-114.0112072759	-1.2	7		-69.2319376846	-73.77967061	0.0001260234	0.9953826032			[H][C@@](C)(CC)[C@@]1([H])O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@]([H])(C\C=C(C)\[C@@H](O[C@@]4([H])C[C@H](OC)[C@@H](O[C@@]5([H])C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C6/CO[C@]7([H])[C@H](O)C(C)=C[C@@]([H])(C(=O)O3)[C@]67O)O2	MedChem Express	HY-15310_cm1	-9.18387195	-3.10870607	-7.54920311	-8.21744627	-18.87977105	-60.83338183	-73.77967061									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379085-03	Kaempferide			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	491-54-3		0.3499899101	-6.4559444758	-149.2346136821	-1.2	7		-61.7155132183	-62.80787444	0.000014648	0.9984337418			COC1=CC=C(C=C1)/C2=C(O)/C(=O)C3=C(O)C=C(O)C=C3O2	MedChem Express	HY-15449	-3.50960069	-3.15943745	-6.23333901	-27.48534651	-59.664749	-66.23406856	-62.80787444									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163469-10	Sodium Monensin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	22373-78-0				8.5042474552	4	7		0	0					[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]2(CC)CC[C@@]([H])(O2)[C@]3(C)CCC4(C[C@H](O)[C@@H](C)[C@]([H])(O4)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O3)[C@@]5([H])O[C@@](O)(CO)[C@H](C)C[C@@H]5C	Selleck	S2324	3.03720788	0	0	4.03976554	3.78179482	2.83419659	0									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00388372-01	Angelicin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	523-50-2		31.9557356388	-4.4954511803	-17.3546548784	-3	7		-51.2645114195	-46.28465914	0.0001023752	0.9958429341			O=C\1OC2=C(\C=C1)C=CC3=C2C=CO3	Cayman	11683	-0.04168172	-1.76150616	1.06063184	-1.37915182	-0.4176036	0.96025141	-46.28465914									3.19E-9	1.59E-8	7.9699999999E-8	3.99E-7	0.00000199	0.00000997	0.0000498								
NCGC00016564-06	Metformin	170464804	AMPK Activator	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1115-70-4	La-6023;SMP-862;Metformin hydrochloride;Metformin?HCl;Metformin HCl; Metformin HCl;ADX-155			14.8503413257	4	7		0	0			5562	PRKAA1	Cl.N=C(N)NC(=N)N(C)C	Vitas	STK011633	3.95976325	4.64192103	2.36515229	4.27537065	3.13348714	2.99714834	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016535-12	Alprostadil			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	745-65-3		24.777388143	-4.6059444758	-7.5369947474	4	7		-11.9692497879	-10.39104149	0.0026449362	0.9784896635			CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O	Selleck	S1508	-1.51443577	-0.6285054	-0.62390108	-0.43098494	0.03796396	0.16877146	-10.39104149									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346633-03	SNX-2112		Heat Shock Protein 90 (hsp90) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	908112-43-6		15.6334750258	-4.8059444758	-15.8079305568	4	7		-21.492107692	-20.82675641	0.0130624488	0.9494976018		HSP90AB1	CC1(C)CC(=O)C2=C(C1)[N](N=C2C(F)(F)F)C3=CC(=C(C=C3)C(N)=O)NC4CCC(O)CC4	Adooq	A11189	-3.50960069	-2.5732082	0.51046452	1.5687852	-0.70379348	-2.31042309	-20.82675641									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00347066-11	KUC105555N	384568981	p97 ATPase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	177355-84-9		8.7913490634	-5.0559444758	-58.9317041314	-2.2	7		-84.2362926955	-71.39113083	0.0000340102	0.9976101873		VCP	C(NC1=NC2=CC=CC=C2C(=N1)NCC3=CC=CC=C3)C4=CC=CC=C4	MedChem Express	HY-15945	0	0	3.62996994	1.94805195	-3.88692579	-32.16551243	-71.39113083									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346694-03	MK-2048		HIV Integrase Inhibitors	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	869901-69-9		13.9333492831	-4.8559444758	-40.2543914576	-2.2	7		-60.9495636832	-46.55269976	0.0001270092	0.9953660675			CCN1C[C@H](C)[N]2C(=C(O)C3=C2\C(=N/N(CC4=CC=C(F)C(=C4)Cl)C3=O)C(=O)NC)C1=O	APExBIO	A4072	-2.60371801	0.52704264	0.26090409	0.56890013	-3.73506994	-17.58133038	-46.55269976									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510789-01	RSV604			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	676128-63-5		11.0676527398	-4.9559444758	-22.7753071099	4	7		-40.176623876	-28.06385323	0.1019939821	0.8317938272			FC1=CC=CC=C1NC(=O)N[C@H]2\N=C(\C3=CC=CC=C3)C4=CC=CC=C4NC2=O	SIGMA	SML1695	1.35326646	2.92269102	1.11167829	3.45362602	-12.9865958	-7.23389396	-28.06385323									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018248-25	MELOXICAM SODIUM		Neuropharmacol 39: 1653 (2000)	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	71125-38-7		3.9269513795	-5.4059444758	-4.7591686257	4	7		-7.5376448199	-6.69803735	0.1015126438	0.8341116225			CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3[S+]1([O-])=O	Microsource	MS-01504150	-0.55297746	0.55522674	3.80579661	-0.83323756	0.86148994	-5.61601583	-6.69803735									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262306-24	ML323		USP1/UAF1 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1572414-83-5		13.9333492831	-4.8559444758	-18.7047675566	-2.4	7		-34.677651364	-29.31470947	0.0001596493	0.9948040084		USP1	CC(C)C1=C(C=CC=C1)C2=NC=C(C)C(=N2)NCC3=CC=C(C=C3)[N]4C=CN=N4	MedChem Express	HY-17543	0.8586434	-1.18655055	0.93585162	0.85622342	-0.45848787	-5.62765524	-29.31470947									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095055-08	Salinomycin		Anticoccidial/Antibacterial	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	53003-10-4				1.6397206563	4	7		0	0				WNT1	CCC(C1CCC(C)C(O1)C(C)C(O)C(C)C(=O)C(CC)C2OC\3(O[C@]4(CC[C@@](C)(O4)C5CC[C@@](O)(CC)C(C)O5)C(O)\C=C3)C(C)CC2C)C([O-])=O	Enzo	NP267	1.97015589	1.36411037	0	0	0	0	0									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00345885-02	Etravirine (TMC125)		P-glycoprotein 1 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	269055-15-4		6.2237985085	-5.2059444758	-34.5708982701	-2.2	7		-37.3716681079	-30.72639009	0.0060823141	0.9664014754			CC1=C(OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C(=CC(=C1)C#N)C	Selleck	S3080	-0.30844472	-0.2282912	1.50870626	-1.14929318	-10.84893263	-15.276727	-30.72639009									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016032-14	THIOCTIC ACID			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1077-24-7		22.0828704269	-4.6559444758	1.4854782553	4	7		-16.249382016	-12.29115168	0.0570109282	0.8835769727			OC(=O)CCCCC1CCSS1	Microsource	01503941	3.24283769	0	3.90788951	0	0	4.34732003	-12.29115168									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00408803-01	Bicyclol			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	118159-48-1		15.6334750258	-4.8059444758	-14.3588772787	4	7		-20.8739762279	-16.14498019	0.0701523361	0.8677416375			COC(=O)C1=CC(=C2OCOC2=C1C3=C4OCOC4=C(OC)C=C3CO)OC	Glixx	GLXC-06162	-3.22060744	-1.04563006	1.61647099	2.95942995	-3.72922933	-5.05150439	-16.14498019									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091208-11	HEXYLRESORCINOL		Tyrosinase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	136-77-6		9.8640558873	-5.0059444758	-51.126414845	-2.2	7		-78.6780981011	-60.74098341	0.0001765689	0.9945272502			CCCCCCC1=C(O)C=C(O)C=C1	Microsource	01500330	-1.10873371	4.31498549	2.04752992	2.22388231	-6.51520019	-28.33614619	-60.74098341									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164462-05	NCGC00164462-05			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			7.1460609507	-5.1459332839	-111.9325987445	-2.1	7		-93.1512880812	-94.13884504	0.0011719371	0.9856913185			C[C@@H](COc1ccc(Oc2ccccc2)cc1)Oc3ccccn3	EPA	TV000265	-8.57809765	-6.24277782	-6.30140094	4.34432824	-20.32240166	-72.62992493	-94.13884504									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00522552-01	PI4KIIIbeta-IN-10			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1881233-39-1		6.9832167823	-5.1559444758	-98.9340236863	-2.2	7		-80.1619368095	-79.60508682	0.0000389702	0.9974411028			COC1=CC=C(C=C1[S+]([O-])(=O)NC2=CC=C(O)C=C2)C3=C(C)N=C(NC(=O)C(C)(C)C)S3	MedChem Express	HY-100198	-3.59296413	-6.10185733	-5.07061426	-8.18871394	-14.19560202	-44.47418961	-79.60508682									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00601813-01	Bictegravir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1611493-60-7		13.9333492831	-4.8559444758	-18.6485658346	-2.4	7		-30.242621436	-21.45218453	0.00172825	0.9825758947			OC1=C2N(CC3OC4CCC(C4)N3C2=O)C=C(C(=O)NCC5=C(F)C=C(F)C=C5F)C1=O	Selleck	S5911	0.34734765	1.70513796	-0.02835914	-0.69532238	-3.81099787	-8.0079148	-21.45218453									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016246-21	Chlorhexidine HCl			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	3697-42-5		3.499899101	-5.4559444758	-105.5194035976	-2.2	7		-60.4973706425	-60.76480924	0.0000653085	0.996683747			ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1	APExBIO	B1695	-8.48917665	-6.7219075	-8.67222506	-10.46431445	-26.23309874	-44.83501135	-60.76480924									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179135-02	EPICATECHIN MONOGALLATE			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1257-08-5		1.106765274	-5.9559444758	-187.4584861902	-1.1	7		-99.1714928317	-91.52395985	0.0000433223	0.9973012121			OC1=CC2=C(C[C@@H](OC(=O)C3=CC(=C(O)C(=C3)O)O)[C@H](O2)C4=CC(=C(O)C=C4)O)C(=C1)O	Microsource	MS-00210238	-7.68888765	-6.2653251	-19.55079122	-32.04229399	-56.17790497	-77.70470814	-91.52395985									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091162-09	Aminothiazole			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	96-50-4		31.920281752	-4.4959332839	3.2528757819	4	7		-12.03289454	-9.61074545	0.1265633	0.8070676695			NC1=NC=CS1	APExBIO	B1659	1.77008364	-2.55066092	2.21768476	2.12619239	4.33081214	0.84967701	-9.61074545									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00344588-04	I-BET151		Brd4 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			15.6334750258	-4.8059444758	-4.110958077	-2.4	7		-36.911472144	-27.00956012	0.0005694523	0.9901095224		BRD4	COC1=CC2=C(C=C1C3=C(C)ON=C3C)N=CC4=C2N([C@H](C)C5=CC=CC=N5)C(=O)N4	Tocris	4650	1.52555089	4.57427919	3.72071919	4.43052523	2.00624945	-1.71681313	-27.00956012									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166300-02	Pyridoxal phosphate hydrate	170466028	P2X purinoceptor 2 Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	41468-25-1				14.0368113212	4	7		0	2.76677488					O.Oc1c(C=O)c(cnc1C)COP(=O)(O)O	SIGMA	P3657	3.43179481	0	2.62038455	4.86151017	3.20357445	3.98649828	2.76677488									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00421826-01	NCGC00421826-01	363681094		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			17.5410474839	-4.7559444758	-17.3683513777	4	7		-17.669501544	-17.61026893	0.0202576962	0.9358402869			CN1CCCC1CCOC(C2=CC3=C([NH]2)C(=CC=N3)C(O)=O)C4=C(Cl)C=CC=C4	NCGCChem	GRB052-095	-5.12685136	-1.02308278	-0.38568431	-1.43087001	-1.04838945	-2.71198277	-17.61026893									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182552-14	Atazanavir		Human immunodeficiency virus type 1 protease Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	198904-31-3		15.6334750258	-4.8059444758	-27.462487133	4	7		-15.435573932	-18.74199601	0.0120978389	0.9516711684			COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C	SIGMA	SML1796	-2.76488732	-4.08387588	-6.12557427	-2.5456844	-5.06672897	-4.64994471	-18.74199601									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00244248-01	NCGC00244248-01			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					-8.3817729381	4	7		0	-4.21419424					CC(C)C[C@H](N[C@@H](CC1=CN=C[N]1CC2=CC(=CC(=C2)Cl)Cl)C(O)=O)C(O)=O	NCGCChem	JKJ16-009	-2.33139745	-1.03435642	-0.20985764	-1.66072865	0.08468884	-3.73625095	-4.21419424									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00370784-05	Resiquimod	363677855	Toll-Like Receptor 7 (TLR7) Agonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	144875-48-9				-16.7192856979	4	7		0	-1.19426989				TLR7	CCOCC1=NC2=C(N)N=C3C=CC=CC3=C2[N]1CC(C)(C)O	MedChem Express	HY-13740	-4.58776781	-3.23835292	-2.35948046	-3.41914722	-5.76760214	-3.794448	-1.19426989									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482709-01	Licochalcone A			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	58749-22-7		1.5633475026	-5.8059444758	-136.2704544027	-1.1	7		-96.8004288686	-92.94159693	0.0000020576	0.9994138862			COC1=CC(=C(C=C1\C=C\C(=O)C2=CC=C(O)C=C2)C(C)(C)C=C)O	DC Chemicals	DCG-033	1.11429127	1.07663256	1.3952697	-7.63705321	-42.11955728	-78.69405808	-92.94159693									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378881-01	Tegobuvir	363678254		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1000787-75-6		4.4061119169	-5.3559444758	-20.2327710675	4	7		-23.1786341879	-21.81552849	0.008662574	0.9594803988			FC1=CC=CC=C1C2=NC3=C[N](CC4=NN=C(C=C4)C5=CC=C(C=C5C(F)(F)F)C(F)(F)F)C=CC3=N2	MedChem Express	HY-10544	1.93681051	1.0005355	2.94935058	-3.22951385	-0.32415384	-14.77041262	-21.81552849									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00686670-01	GS-441524			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1191237-69-0				-17.2786661728	4	7		0	-5.67948298					NC1=NC=NN2C1=CC=C2[C@@]3(O[C@H](CO)[C@@H](O)[C@H]3O)C#N	MedChem Express	HY-103586	-3.56517631	-2.0884417	-2.7111338	-5.34421331	-1.32873872	-5.51126113	-5.67948298									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00480790-01	Coptisine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	3486-66-6		12.4181106199	-4.9059444758	-21.954480834	4	7		-27.5394466399	-26.2828722	0.0205938225	0.9350777107			C1OC2=C(O1)C=C3C(=C2)CC[N+]4=C3C=C5C=CC6=C(OCO6)C5=C4	Adooq	A14548	-2.32028232	-5.00267749	-1.87170325	2.09746006	1.80766872	-6.36675784	-26.2828722									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346888-03	UK-383367	363677552	Procollagen C-Endopeptidase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	348622-88-8		17.5410474839	-4.7559444758	-8.6886565542	4	7		-26.3113589639	-18.17613247	0.001913666	0.9816492938			NC(=O)C1=NOC(=N1)[C@H](CCCC2CCCCC2)CC(=O)NO	Selleck	S2224	1.40884208	1.11327189	2.76785208	0	-0.62202494	-3.34633068	-18.17613247									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160628-18	RUTOSIDE  (rutin)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	153-18-4		15.6334750258	-4.8059444758	-18.2464959092	4	7		-22.082288476	-17.56857373	0.017922204	0.9400326739			[H][C@@]1(C)O[C@@]([H])(OC[C@@]2([H])O[C@@]([H])(OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C5=CC=C(O)C(O)=C5)[C@]([H])(O)[C@@]([H])(O)[C@]2([H])O)[C@]([H])(O)[C@]([H])(O)[C@@]1([H])O	Microsource	MS-00300607	-0.04723928	1.16400327	-1.85468777	-1.93655902	-4.44178372	-5.73822965	-17.56857373									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018268-05	Itraconazole		cytochrome inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	84625-61-6		1.3933349283	-5.8559444758	-108.1499831637	-1.2	7		-56.6428108016	-50.57330911	0.0118725407	0.9519199842			CCC(C)N1\N=C/N(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OCC5COC(C[N]6C=NC=N6)(O5)C7=CC=C(Cl)C=C7Cl)C=C4	Prestwick	Prestw-1139	-2.54258482	-4.69265241	-3.82281209	-5.20055166	-29.40454984	-71.03532561	-50.57330911									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093704-43	Cyclosporin A			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	59865-13-3		6.7665459959	-5.1696329617	-47.1300031644	-2.2	7		-49.398311836	-42.99073771	0.0000093367	0.9987508064			CCC1NC(=O)C(C(O)C(C)C\C=C\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C	Selleck	S2286	-1.56445383	-1.39511288	-0.15881118	-0.7585335	-2.18146775	-11.14473608	-42.99073771									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00346623-04	BMS-378806	384568863	HIV Attachment Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	357263-13-9		0.4406111917	-6.3559444758	-5.7245887211	4	7		-6.9555091559	-1.28957322	0.5214528801	0.4265234041			COC1=C2C(=NC=C2C(=O)C(=O)N3CCN(C[C@H]3C)C(=O)C4=CC=CC=C4)[NH]C=C1	MedChem Express	HY-14134	0.46961403	1.43457062	0.30627871	0.97115274	-12.04625763	0.38992027	-1.28957322									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249613-08	Carfilzomib		Proteasome Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	868540-17-4		15.6334750258	-4.8059444758	-25.245895291	-3	7		-36.636477356	-31.36373113	0.0002076219	0.994067002		PSMD1	CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4	Aobious	AOB87759	-1.62002946	-2.1166258	-0.51613635	0.16090105	-2.30412055	-6.1165105	-31.36373113									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094960-07	ANTHRAQUINONE		Beta amyloid A4 protein Binding Agent	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	84-65-1		15.6334750258	-4.8059444758	-5.014085384	4	7		-27.567992972	-17.55666081	0.001256526	0.9852138944			O=C1C2=C(C=CC=C2)C(=O)C3=CC=CC=C13	Microsource	MS-01502103	2.80379026	1.53603337	3.07413079	3.00540168	-0.34751628	-3.91666182	-17.55666081									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390255-01	Maslinic acid	384569181	Glycogen Phosphorylase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	4373-41-5		11.0676527398	-4.9559444758	-11.8382106573	-3	7		-42.2222354553	-38.79143461	0.00062324	0.9896386631		PYGL	CC1(C)CC[C@@]2(CC[C@]3(C)\C(=C/C[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2C1)C(O)=O	Adooq	A12089	2.29805207	4.861757	0	2.82726123	4.46514616	-2.04853634	-38.79143461									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522288-01	PERETINOIN			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			9.8640558873	-5.0059444758	-10.9712524439	-2.4	7		-35.870983116	-29.89248593	0.001283879	0.9850208055			CC(C)=CCC/C(C)=C/CC/C(C)=C/C=C/C(C)=C/C(O)=O	Ark Pharm	AK162192	3.59296413	0	4.11207532	3.51683715	4.13807201	-8.39783507	-29.89248593									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263531-05	Linezolid		50S Ribosomal Protein Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	165800-03-3				-16.548623453	4	7		0	-6.70399381				MAOA	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC=C(N3CCOCC3)C(=C2)F	Selleck	S1408	-1.92013783	-3.41309433	-6.16527707	-0.43098494	0.45264726	-7.19897573	-6.70399381									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00492296-03	eFT508		MNK1/2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1849590-01-7		13.9333492831	-4.8559444758	-17.0463868529	-2.4	7		-32.133737376	-28.02811448	0.0007429346	0.9886783765		MKNK1	CC/1=C2/N(C(=O)C(=C1)/NC3=CC(=NC=N3)N)C4(CCCCC4)NC2=O	MedChem Express	HY-100022	0.95312196	-0.72996815	0.47643355	2.02275601	-1.51563823	-4.4229762	-28.02811448									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386289-08	Dynasore	387065823	Dynamin-2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[304448-55-3]		1.9681378985	-5.7059444758	-139.4109952375	-2.1	7		-98.800011911	-84.91229115	0.0005284978	0.9904667337	10059		OC1=C(O)C=C(C=C1)\C=N\NC(=O)C2=C(O)C=C3C=CC=CC3=C2	Tocris	2897	1.38105427	0.89907274	-11.55918553	-24.78450753	-39.20509301	-62.11371705	-84.91229115									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00246387-06	Arbidol		antiinfluenza drug	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	131707-23-8		5.5469662594	-5.2559444758	-84.347741657	-2.1	7		-94.6164189789	-87.18765822	0.0000287426	0.9978035697			CCOC(=O)C1=C(CSC2=CC=CC=C2)[N](C)C3=CC(=C(O)C(=C13)CN(C)C)Br	MedChem Express	HY-14904A	4.64334343	0	0	1.50557407	-9.54063604	-51.38799977	-87.18765822									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00387263-05	Oltipraz		Nuclear Factor Erythroid 2-Related Factor 2 (NFE2-Related Factor 2; NFE2L2; NRF2) Activator	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	64224-21-1		11.0676527398	-4.9559444758	-59.4599881576	-2.2	7		-94.5790422044	-71.27200167	0.0000717816	0.996521831		NRF2	C\C1=C(\SSC1=S)C2=CN=CC=N2	SIGMA	O9389	3.54850363	1.72768524	-0.11910839	2.99965521	-8.01039629	-31.35075365	-71.27200167									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482578-01	D-Pinitol			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	10284-63-6				0.8546643377	4	7		0	0					COC1[C@@H](O)[C@@H](O)C(O)[C@H](O)[C@H]1O	DC Chemicals	DCS-033	1.1254064	-1.00617232	1.5370654	0.95965981	-0.39424116	-0.96607112	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00481588-01	ACY-241	384569257		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			6.9832167823	-5.1559444758	-17.313368372	-2.4	7		-31.090165884	-27.15847157	0.0009054488	0.9874738589		HDAC1	ONC(=O)CCCCCCNC(=O)C1=CN=C(N=C1)N(C2=CC=CC=C2)C3=C(Cl)C=CC=C3	APExBIO	B5936	0	1.44020743	3.78878112	3.3214573	-0.0613264	-12.78007333	-27.15847157									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378746-04	NBD 556		Envelope glycoprotein gp160 Binding Agent	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[333353-44-9]				7.923659797	4	7		0	4.82770944					CC1(C)CC(CC(C)(C)N1)NC(=O)C(=O)NC2=CC=C(Cl)C=C2	Tocris	5811	3.41512213	0	0	-0.08619699	0	4.47535355	4.82770944									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159483-04	Hydroxychloroquine sulfate	170464696	Autophagy Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	747-36-4	; Hidroxicloroquina;Plaquenil???;Hydroxychloroquine sulfate; Oxychlorochin;Plaquenil; Plaquenil;HYDROXYCHLOROQUINE SULFATE; Hydroxychloroquine sulfate; Hydroxychloroguine			-0.7579193066	4	7		0	1.15853114			84557	MAP1LC3A	O=S(=O)(O)O.CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12	Microsource	01503978	0.83085559	-1.40638652	0.02268731	-1.2642225	-0.28911018	-1.09410464	1.15853114									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00015793-12	Palmitoylethanolamide			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[544-31-0]				5.6435374291	4	7		0	0					CCCCCCCCCCCCCCCC(=O)NCCO	Tocris	0879	2.10909495	0.1437389	0.7089785	-1.22399724	1.80766872	4.59756736	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00371106-01	(±)-PPCC oxalate	363678033	Sigma-1 receptor Agonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[932736-91-9]		17.5410474839	-4.7559444758	-5.4917181873	4	7		-15.2337165279	-10.61143044	0.0613234033	0.878726424			COC(=O)[C@]1(C[C@H]1CN2CCC(O)(CC2)C3=CC=CC=C3)C4=CC=C(C)C=C4	Tocris	3870	-1.95904076	1.18091373	1.87737508	2.43075509	-1.26449201	-2.18238957	-10.61143044									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00485944-01	TAPI-1	363681435	ADAM17 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	163847-77-6				5.6383066923	4	7		0	-3.62450487					CC(C)C[C@H](CC(=O)NO)C(=O)N[C@@H](CC1=CC2=CC=CC=C2C=C1)C(=O)N[C@@H](C)C(=O)NCCN	MedChem Express	HY-16657	-0.34179009	0.72433133	3.18756735	3.87311803	2.06465555	1.28033522	-3.62450487									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00013414-04	Procodazole	170466381		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	23249-97-0				3.0410656347	4	7		0	2.56425529					O=C(O)CCc1nc2ccccc2n1	Vitas	STK387005	-1.10873371	1.22037147	0.61822926	0	0.50521274	1.14648199	2.56425529									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178714-18	Topiramate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	97240-79-4				-6.6269909846	4	7		0	0.12210739					CC1(C)O[C@@H]2CO[C@@]3(CO[S+](N)([O-])=O)OC(C)(C)O[C@H]3[C@@H]2O1	DC Chemicals	DC9074	-2.27026426	-5.87638454	-0.39702796	3.70647052	1.24112957	-6.05249374	0.12210739									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015798-15	Propranolol HCl			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	318-98-9				7.6885764594	4	7		0	3.05864133					CC(C)NCC(O)COC1=C2C=CC=CC2=CC=C1	APExBIO	B1346	0	0	0	4.12021607	0	4.57428854	3.05864133									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00319175-08	Rilpivirine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	500287-72-9		2.7800686746	-5.5559444758	-73.1116403516	-1.2	7		-65.6640706465	-61.24132591	0.0000307033	0.9977298325			CC1=C(NC2=CC=NC(=N2)NC3=CC=C(C=C3)C#N)C(=CC(=C1)\C=C\C#N)C	MedChem Express	HY-10574	1.98682858	4.41081142	0.87346152	-2.09746006	-14.90815641	-48.62945935	-61.24132591									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274056-12	Risedronate sodium			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					-11.1792879277	4	7		0	-1.70056884					OC(CC1=CC=CN=C1)(P(O)(O)=O)P(O)([O-])=O	Selleck	S1428	-8.31133465	-1.6318593	-0.7486813	-1.94230548	-2.74800689	0.40737939	-1.70056884									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510002-01	GLPG0187	384569406	Integrin Receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	298708-81-3		17.5410474839	-4.7559444758	-4.7595000539	4	7		-14.827664768	-11.93972064	0.1166782036	0.8170908962			COC(=O)\C1=C(C)\N=C(N[C@H]1C2=CC=C(F)C=C2Cl)\C3=NC=C(F)C=C3F	MedChem Express	HY-100029	-1.34770889	0.171923	4.97419318	0.81599816	-1.93032153	-0.53541291	-11.93972064									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164126-01	Octyl gallate	26757543		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1034-01-1		15.9980377079	-4.7959332839	-98.7835119464	-2.2	7	OCTYL-GALLATE;CIPLUS_197519;NCGC00164126-01;3,4,5-trihydroxybenzoic acid octyl ester;octyl gallate dihydrate;Octyl gallate;octyl gallate;	-98.4919438928	-77.64541204	0.0027511229	0.9777947482			CCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1	SigmaAldrich	MFCD00002197	1.59224164	-6.96992757	-12.6878793	-15.07298012	-22.11546885	-47.93691439	-77.64541204									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00163699-10	Fumagillin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	23110-15-8		11.0676527398	-4.9559444758	-31.2920930885	4	7		-21.865542236	-19.3852935	0.0396070827	0.9061113992			[H][C@@]1([C@H](OC)[C@@H](CC[C@]12CO2)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O)[C@@]3(C)O[C@@H]3CC=C(C)C	Cayman	11332	-0.33067497	-4.3488064	-5.6661562	-4.10872314	-5.89609555	-9.80620381	-19.3852935									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183095-07	Tigecycline	384568415	glycylcycline antibiotics	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	220620-09-7		3.9269513795	-5.4059444758	-120.9318738239	-2.1	7		-102.548893586	-86.75879322	0.0000994901	0.9959006681			CN(C)[C@H]\1[C@@H]2C[C@@H]\3CC4=C(C(=C(NC(=O)CNC(C)(C)C)C=C4N(C)C)O)C(=O)C3=C(O)/[C@@]2(O)C(=O)\C(=C1O)C(N)=O	Enzo	AC3268	1.46441771	-4.70392604	-1.78662583	-8.88403632	-32.68113191	-60.96723506	-86.75879322									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017363-18	Cycloheximide			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	66-81-9		50.5902372502	-4.2959332839	-11.0217442078	4	7		-10.03289454	-9.61074545	0.089082815	0.848029235			[H][C@]1(C[C@@H](C)C[C@H](C)C1=O)[C@H](O)CC2CC(=O)NC(=O)C2	SIGMA	1810_cm3	-3.1817045	-3.2327161	-1.14003743	-1.43087001	-1.16520165	0.45393703	-9.61074545									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00016251-17	Probenecid		Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	57-66-9				-4.2813391865	4	7		0	0.68201447					CCCN(CCC)[S+]([O-])(=O)C1=CC=C(C=C1)C(O)=O	APExBIO	B2014	-4.79895518	-2.172994	0.35165334	0.90219515	-0.38255994	-0.69254496	0.68201447									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390587-03	G-007-LK		Tachykinin NK1 Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			4.9437388825	-5.3059444758	-31.3287312433	-2.2	7		-45.2574232339	-41.44205855	0.0000309315	0.9977219453	80351	TACR1	C[S+]([O-])(=O)C1=CC=C(N=C1)C2=NN=C(\C=C\C3=NN=C(O3)C4=CC=C(C=C4)C#N)[N]2C5=C(Cl)C=CC=C5	APExBIO	B5830	1.62002946	4.50100054	3.12517724	2.95368348	1.80766872	-27.52720712	-41.44205855									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522503-02	VELPATASVIR		Nonstructural protein 5A Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			1.7541047484	-5.7559444758	-117.6518025118	-1.1	7		-87.5495607075	-84.87059594	8.04E-8	0.9998842137			COC[C@H]1C[C@H](N(C1)C(=O)[C@H](NC(=O)OC)C2=CC=CC=C2)C3=NC=C([NH]3)C4=CC=C5C(=C4)COC6=CC7=C(C=CC8=C7[NH]C(=N8)[C@@H]9CC[C@H](C)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C=C56	Astatech	40127	2.11465251	2.21808855	1.63348647	-3.03413401	-33.20094618	-74.00919513	-84.87059594									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00411883-01	NCGC00411883-01			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			1.106765274	-5.9559444758	-102.2659468788	-1.2	7		-72.57981654	-66.73318045	0.0000324509	0.9976657082			COCCNC(=O)NC1=CC2=C(C=C1)N=C(C3=CC=CS3)C(=N2)C4=CC=CS4	NCGCChem	MLS000534714-02pur	4.16539306	4.54609509	2.21201293	-7.18882887	-34.78959203	-64.82569982	-66.73318045									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378604-04	ABT-333	377020340		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1132935-63-7		6.2237985085	-5.2059444758	-100.3648876709	-2.2	7		-74.5919227809	-75.18539476	0.0001845799	0.9944030102			COC1=C(C=C(C=C1C2=CC3=CC=C(N[S+](C)([O-])=O)C=C3C=C2)N4\C=C/C(=O)NC4=O)C(C)(C)C	MedChem Express	HY-13998	-7.98343846	-8.2100279	-4.6735863	-5.143087	-17.19183483	-43.9445964	-75.18539476									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00511370-02	ACY-738		HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1375465-91-0				-1.0680357761	4	7		0	-3.26116091				HDAC1	ONC(=O)C1=CN=C(NC2(CC2)C3=CC=CC=C3)N=C1	MedChem Express	HY-19327	1.21988496	0.32411713	-2.93233509	1.39064475	2.62535409	-1.65279637	-3.26116091									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00345451-03	A-966492		PARP-1 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	934162-61-5		0.0311928836	-7.5059444758	-18.8967177034	4	7		17.676587464	-0.69392739	0.3519353028	0.5677788683			NC(=O)C1=C2N=C([NH]C2=CC=C1)C3=C(F)C=C(C=C3)[C@@H]4CCCN4	MedChem Express	HY-10614	-3.90418762	-28.89715622	1.46900346	3.01689461	2.61951348	-0.948612	-0.69392739									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015801-17	Pentoxifylline	363676463	"3',5'-cyclic phosphodiesterase Inhibitor"	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	6493-05-6				6.9235901584	4	7		0	3.10033654					C[N]1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C	MedChem Express	HY-B0715	1.62558702	3.86403991	2.12693551	0	0	0	3.10033654									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161670-08	Pepstatin	384568214	Aspartyl Protease Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	26305-03-3				-20.5430556181	4	7		0	-1.71843822					CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC(C)C)C(C)C)C(C)C)[C@@H](O)CC(O)=O	Prestwick	Prestw-405	-7.30541584	-1.12454553	-5.86467018	-3.62602	-3.32622726	-7.07676192	-1.71843822									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522475-03	Verubecestat (MK-8931)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1286770-55-5(free base)				-18.9535587198	4	7		0	-10.8318194					CN1C(N)=N[C@@](C)(C[S+]1([O-])=O)C2=CC(NC(=O)C3=NC=C(F)C=C3)=CC=C2F	Selleck	S8173	-3.88751494	-2.68594459	-3.00606886	-0.86196989	-3.20357445	-5.42396555	-10.8318194									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00481568-01	AZD3839			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			0.5546966259	-6.2559444758	-36.9762901474	4	7		-21.187206148	-26.88447449	0.278163134	0.6495186138			FC(F)C1=NC=CC(=C1)[C@@]2(NC(=N)C3=C2C=CC=C3F)C4=CC=CC(=C4)C5=CN=CN=C5	APExBIO	B5951	0.43626865	0.43121671	-1.74692303	3.45937249	-30.57267179	-4.62666589	-26.88447449									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178124-03	LOGANIN			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	18524-94-2				16.3869142593	4	7		0	2.45108259					COC(=O)\C1=C\O[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]3[C@@H](C)[C@@H](O)C[C@H]13	Microsource	MS-01504066	2.70375413	2.85504918	3.62429811	3.53407654	4.64620506	4.3182215	2.45108259									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378845-08	Trelagliptin (succinate)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1029877-94-8				-2.2755706622	4	7		0	-0.55097239					CN1C(=O)\C=C(\N2CCC[C@@H](N)C2)N(CC3=C(C=CC(=C3)F)C#N)C1=O	MedChem Express	HY-15408A	-1.16430933	-0.8877991	2.21201293	-1.7871509	0.32415384	-1.5771402	-0.55097239									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00356069-06	GSK1324726A		Bromodomain-containing protein 4 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1300031-52-0		6.9832167823	-5.1559444758	-49.3477095912	-2.2	7		-45.4599165071	-43.65786104	0.0009204145	0.9873606527	23476	BRD4	C[C@H]1C[C@@H](NC2=CC=C(Cl)C=C2)C3=C(C=CC(=C3)C4=CC=C(C=C4)C(O)=O)N1C(C)=O	MedChem Express	HY-13960	-1.53666602	-2.68594459	-0.15881118	-1.55729227	-9.61656397	-22.17307804	-43.65786104									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346463-01	Nesbuvir	174007343	RNA-Directed RNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	691852-58-1	Nesbuvir			-1.3377279998	4	7		0	-1.69461238					CNC(=O)C1=C(OC2=CC(=C(C=C12)C3CC3)N(CCO)[S+](C)([O-])=O)C4=CC=C(F)C=C4	Chemscene	CS-0689	-3.47069775	3.57092528	0	2.20664291	-3.27950238	0.22696852	-1.69461238									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024379-17	Emetine dihydrochloride hydrate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	7083-71-8		11.0676527398	-4.9559444758	-6.2519291988	4	7		-21.8589957439	-15.29916312	0.0006060617	0.9898175438			CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=CC(OC)=C(OC)C=C45	SIGMA	E2375	2.09797983	1.60367521	1.28183313	3.03413401	-0.05548579	-5.30175173	-15.29916312									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510231-01	GDC-0077	384569416	PARP inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			17.5410474839	-4.7559444758	1.113768207	4	7	Pamiparib	-11.818804536	-9.84900378	0.1013102175	0.8335767655		PARP1	C[C@]12CCCN1C/C3=N/NC(=O)C4=CC(=CC5=C4C3=C2[NH]5)F	ChemGood	C-1286	0.20285103	-1.35001832	1.15705292	4.70635559	2.9349064	1.37927021	-9.84900378									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346477-02	Emricasan	384568791	Caspase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	254750-02-2				11.5667909751	4	7		0	3.80915508				CASP3	C[C@H](NC(=O)C(=O)NC1=CC=CC=C1C(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)COC2=C(F)C(=CC(=C2F)F)F	MedChem Express	HY-10396	0.34179009	1.79532708	1.97946798	2.12044593	4.33081214	0	3.80915508									5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7	0.0000016599999999	0.00000831								
NCGC00261043-01	Desipramine hydrochloride	312344483	Serotonin transporter Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			15.6334750258	-4.8059444758	-46.8485814986	4	7		-19.9736145321	-20.79101766	0.0373870971	0.9093461685			Cl.CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2	SIGMA	D 3900	-7.96676578	-4.56300555	-8.54177301	-7.12561774	-11.15848495	-12.23884071	-20.79101766									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015508-23	Hydrochlorothiazide	384567858	Hypertension treatment	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	58-93-5				-7.4139728184	4	7		0	-2.30217113					N[S+]([O-])(=O)C1=C(Cl)C=C2NCN[S+]([O-])(=O)C2=C1	Enzo	AC3145	-2.1313252	0.79197317	-2.75083659	-2.26410757	-1.64997226	-0.93115288	-2.30217113									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015202-21	NCGC00015202-21			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					7.7362774781	4	7		0	-0.02680406					CC(C)(OC1=CC=C(C=C1)C2CC2(Cl)Cl)C(O)=O	SigmaAldrich	C0330	-0.05279684	-0.2282912	1.08899098	3.47661188	2.64871653	4.15526974	-0.02680406									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159447-01	Sodium Salicylate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	54-21-7				-37.0367686218	4	7		0	-7.15072818					OC(=O)C1=CC=CC=C1O	MedChem Express	HY-B0167A_cm1	-9.53399839	-4.8053888	-7.73637343	-9.78623147	-7.14014543	-8.89251004	-7.15072818									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00490649-01	NCGC00490649-01			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			15.6334750258	-4.8059444758	-6.959260771	4	7		-24.804896204	-19.00408017	0.0020130023	0.9811574813			CN(C)C/C=C/C(=O)NC1=CC(=CC=C1)C(OCCN2CCCCC2)C3=CC4=NC=CC(=C4S3)C(O)=O	NCGCChem	DJJ006-024	0.03612416	3.14252699	2.17231014	0.78726583	0.42928482	-2.18820928	-19.00408017									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00370733-05	Retro-2			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1429192-00-6		2.4777388143	-5.6059444758	-35.6723196321	4	7		-11.0049227801	-14.02448104	0.0708269073	0.867259289			CC1=CC=C(S1)C2NC3=C(C=CC=C3)C(=O)N2C4=CC=CC=C4	Glixx	GLXC-02449	-7.26095534	-2.2011781	-3.8454994	-5.49936789	-6.3458225	-15.53861375	-14.02448104									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168776-10	Delavirdine (mesylate)		Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	147221-93-0		13.9333492831	-4.8559444758	-25.9173519874	-3	7		-56.2932066549	-53.76597075	0.0000808191	0.9963087103			CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C([NH]3)C=CC(=C4)N[S+](C)([O-])=O	MedChem Express	HY-10571A	-0.78083752	1.57549111	0.08507742	3.24675325	1.06007067	-1.72845254	-53.76597075									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249611-05	Ixazomib	384568528	Proteasome Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1072833-77-2				6.0571811078	4	7		0	0				PSMD1	CC(C)C[C@H](NC(=O)CNC(=O)C1=C(Cl)C=CC(=C1)Cl)B(O)O	Adooq	A10600	4.12649012	3.98241312	0.1417957	0	0	0.54705232	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00485478-02	Oritavancin (diphosphate)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	192564-14-0		2.4777388143	-5.6059444758	-112.3128384597	-2.1	7		-103.0487595644	-95.00848795	0.0000183505	0.9982462196			[H][C@@]1(C[C@](C)(NCC2=CC=C(C=C2)C3=CC=C(Cl)C=C3)[C@@H](O)[C@H](C)O1)O[C@@H]4[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]4OC5=C6OC7=CC=C(C=C7Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@]8([H])C(C=C5OC9=CC=C(C=C9Cl)[C@@H](O[C@@]%10([H])C[C@](C)(N)[C@@H](O)[C@H](C)O%10)[C@]%11([H])NC(=O)[C@]([H])(NC8=O)C%12=CC(=C(O)C=C%12)C%13=C(C=C(O)C=C%13O)[C@]([H])(NC%11=O)C(O)=O)=C6	MedChem Express	HY-B1831A_cm1	4.44882874	2.8325019	3.76042198	1.72393978	-28.76792337	-72.9150905	-95.00848795									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182549-04	Vicriviroc (SCH-417690)	384568410	Chemokine CCR5 Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	541503-81-5				12.3013379962	4	7		0	0.51523364				CCR5	COC[C@H](N1CCN(C[C@@H]1C)C2(C)CCN(CC2)C(=O)C3=C(C)N=CN=C3C)C4=CC=C(C=C4)C(F)(F)F	Adooq	A10971	4.49884681	4.69265241	3.4201123	0.68957591	4.20815933	-0.15713205	0.51523364									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016853-13	Nabumetone		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	42924-53-8		1.3933349283	-5.8559444758	-20.2370808113	4	7		9.4643719119	0	0.0231248839	0.9311273373			COC1=CC2=CC=C(CCC(C)=O)C=C2C=C1	Enzo	DL454	-7.44435491	-7.18976354	-7.46979752	-8.30364326	-2.87650031	4.10289239	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482596-01	Germacrone			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	6902-91-6				-29.8674442469	4	7		0	-4.5060607					CC(C)=C1C\C=C(/C)CC\C=C(/C)CC1=O	DC Chemicals	DCJ-025	-3.44290994	-4.13460725	-19.22749702	-4.6201586	-4.39505884	-3.60239772	-4.5060607									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015442-24	Fluorouracil		Pyrimidine Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	51-21-8				-3.1573377185	4	7		0	3.32668195				TYMS	F\C1=C\NC(=O)NC1=O	MedChem Express	HY-90006	-3.57073388	0.12682844	0.94719528	1.90782669	-7.91694653	1.36181109	3.32668195									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091149-26	Valproic acid sodium salt (Sodium valproate)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1069-66-5				11.1519854913	4	7		0	0					CCCC(CCC)C(O)=O	Selleck	S1168	3.137244	3.94295538	2.97203789	2.01126307	3.48392372	0.50631438	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386028-03	BAICALIN		prolyl endopeptidase inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	21967-41-9		6.9832167823	-5.1559444758	-15.4795685772	4	7		-27.492450188	-21.24370849	0.0008670872	0.9877572915			O[C@@H]1[C@@H](O)[C@@H](O[C@@H]([C@H]1O)C(O)=O)OC2=C(O)C(=C3C(=O)\C=C(/OC3=C2)C4=CC=CC=C4)O	Microsource	01505040	1.59779921	3.10306925	2.97770972	-0.26433743	-3.01083433	-10.48128965	-21.24370849									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00387769-02	Gardiquimod	363680656	Toll-Like Receptor 7 (TLR7) Agonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1020412-43-4				-39.6504485252	4	7		0	-8.12163088			51284	TLR7	CCNCC1=NC2=C([N]1CC(C)(C)O)C3=C(C=CC=C3)N=C2N	Bio Vision	2002	-9.84522189	-7.4095995	-9.16000227	-8.64843121	-7.33288555	-8.51422918	-8.12163088									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482529-01	Epigoitrin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1072-93-1		22.0828704269	-4.6559444758	-29.1123037834	4	7		-14.90595078	-17.86639664	0.0096019298	0.9573823655			C=C[C@@H]1CNC(=S)O1	DC Chemicals	DCB-014	-6.23280629	-4.24170683	-4.65089898	-5.45914263	-4.83894519	-2.94477099	-17.86639664									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00180407-02	NCGC00180407-02			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					6.2608478539	4	7		0	2.04008696					CC(=O)C\C1=C\C(=O)C2=C(O1)C(=C(O)C=C2C)C3OC(CO)C(O)C(O)C3O	Analyticon	NP-000313	0	0	0	3.19503505	0	4.22510621	2.04008696									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165833-11	Entinostat		HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	209783-80-2		12.4181106199	-4.9059444758	-12.3736292877	4	7		-13.6220925	-13.85174375	0.0428764436	0.9018468617		HDAC1	NC1=C(NC(=O)C2=CC=C(CNC(=O)OCC3=CC=CN=C3)C=C2)C=CC=C1	Selleck	S1053	-0.98090977	-1.91370029	-3.12517724	-0.2356051	2.04713372	-3.07280452	-13.85174375									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482878-01	VR23			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1624602-30-7		1.9681378985	-5.7059444758	-110.4805952736	-1.2	7		-76.724186198	-74.74461685	0.0000348084	0.9975820725			[O-][N+](=O)C1=CC=C(C(=C1)[N+]([O-])=O)[S+]([O-])(=O)N2CCN(CC2)C3=CC=NC4=CC(=CC=C34)Cl	DC Chemicals	DC8448	-2.88159613	2.27445675	-0.79972775	-7.04516722	-30.2222352	-63.13216551	-74.74461685									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163363-01	N'-NITROSONORNICOTINE	26756720		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					2.2184881311	4	7	N'-nitrosonornicotine, (S)-isomer;nitrosonornicotine;Pyridine, 3-(1-nitroso-2-pyrrolidinyl)-, (S)-;N-nitrosonor-nicotine;N'-nitrosonornicotine;CIPLUS_675838;N'-NITROSONORNICOTINE;NCGC00163363-01;N'-nitrosonornicotine, (+-)-isomer;N-nitrosonornicotine;CIPLUS_170449;CIPLUS_199562;	0	0.53310302					O=NN1CCCC1C2=CN=CC=C2	BIOMOL	BIOMOL_AC-1066	-1.43662989	0.39175897	2.75650842	0.37926675	0.31247262	0.3200838	0.53310302									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095133-09	Famciclovir	384568149	antiviral	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	104227-87-4				12.1669031777	4	7		0	1.48017989					CC(=O)OCC(CC[N]1C=NC2=CN=C(N)N=C12)COC(C)=O	APExBIO	B1942	0.05835441	1.22600829	3.24995746	4.85001724	3.93365067	2.97386952	1.48017989									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016508-03	Methazolamide		Carbonic anhydrase XII Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	554-57-4				5.1675362304	4	7		0	0					CN/1\N=C(/SC1=N\C(C)=O)[S+](N)([O-])=O	MedChem Express	HY-B0553	1.53110846	0	-0.39135613	2.7985289	-0.28326957	3.7886283	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168784-12	Gemcitabine		Ribonucleotide reductase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	122111-03-9				9.128818436	4	7		0	3.7912857				RRM2	NC/1=N/C(=O)N(/C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F	MedChem Express	HY-B0003	-0.08058466	0.89343592	2.04185809	1.59177106	1.32289811	4.4287959	3.7912857									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379018-02	BMS-626529	363678318	Human immunodeficiency virus 1 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	701213-36-7				0.9629150738	4	7		0	-5.32805194					COC1=CN=C([N]2C=NC(=N2)C)C3=C1C(=C[NH]3)C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5	MedChem Express	HY-15440	0.66968628	0.79197317	2.04185809	-0.31605563	1.06007067	1.16976081	-5.32805194									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00370887-06	AC-55541			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	916170-19-9		5.5469662594	-5.2559444758	-85.3783137069	-2.2	7		-80.6511897996	-77.45480537	0.0004568237	0.991146896			C\C(=N/NC(=O)C(NC(=O)C1=CC=CC=C1)C/2=N/NC(=O)C3=CC=CC=C23)C4=CC=CC(=C4)Br	MedChem Express	HY-14350	-0.40848084	-7.38141541	0.19851398	0.51143547	-10.30575592	-46.37141361	-77.45480537									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346462-07	Sofosbuvir	384568785	RNA-Directed RNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1190307-88-0				9.5387308329	4	7		0	4.05336987					CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2\C=C/C(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC3=CC=CC=C3	MedChem Express	HY-15005	0	0	2.49560433	3.17779566	4.91487311	0	4.05336987									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166215-04	PHENYLETHYL ALCOHOL			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	60-12-8				15.1020937899	4	7		0	3.73172112					OCCC1=CC=CC=C1	Microsource	MS-01505398	2.87048101	4.95758293	4.93449039	2.67785312	2.22235201	1.21631845	3.73172112									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386265-04	TCID			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	30675-13-9		1.3933349283	-5.8559444758	-151.5244817087	-1.1	7		-98.3889358812	-94.85362004	0.0000021395	0.9994023212			ClC1=C(Cl)C(=C2C(=O)CC(=O)C2=C1Cl)Cl	APExBIO	B1467	-1.05315808	1.19782419	-1.6788611	-12.57901391	-48.74280875	-82.45940755	-94.85362004									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090753-20	Azithromycin	384568081	50S Ribosomal Protein Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	83905-01-5				6.7493618116	4	7		0	-0.24719302					CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O	MedChem Express	HY-17506	1.0809459	0.38048533	3.20458284	2.63762786	2.01209006	0.55869173	-0.24719302									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094916-09	.		Prostaglandin G/H synthase 2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	GRT01099				7.2882104744	4	7		0	0			5743	PTGS2	CC(C(O)=O)C1=CC=C(C=C1)C(=O)C2=CC=CS2	SIGMA	SML1495	2.80934782	3.48637299	3.01174068	0	0	0	0									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00015142-02	Benzamide	124879383		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					-9.2081172969	4	7	Benzamide-15N;Benzamide-13C1 (carbonyl-13C);NCGC00015142-01;Benzoylamide;AB07990186-01;Benzamide;benzamide;NCGC00091355-03;CIPLUS_148736;Benzoic acid amide;Benzamide-alpha-13C;NCGC00091355-02;	0	-2.391518					NC(=O)C1=CC=CC=C1	NIEHS	AB07990186	-3.14280157	-1.17527691	-1.48601894	-1.24698311	-1.24697018	-3.17173951	-2.391518									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159461-08	Amprenavir		HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	161814-49-9				6.9491113495	4	7		0	-4.75623194					CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)[S+]([O-])(=O)C3=CC=C(N)C=C3	MedChem Express	HY-17430	1.66448995	0.63414222	2.10992003	3.73520285	3.47808311	1.96124076	-4.75623194									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
MLS000543798-03	MLS000543798-03			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			3.1192883571	-5.5059444758	-148.9757957916	-2.1	7		-84.8441933578	-88.45042738	6.007E-7	0.9996834842			C1CN(CCO1)C2=NC(NC3=CC=CC=C3)=NC(N\N=C\C4=CNC5=C4C=CC=C5)=N2	Specs	AG-205/33155024	-9.68405257	-10.31819847	-9.6931541	-15.32582462	-32.69281313	-69.03916662	-88.45042738									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025029-03	U-0126	26752096	Mek 1/2 inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	218601-62-8	U0126;U0126-EtOH;U-0126	6.9832167823	-5.1559444758	-89.5115773956	-2.2	7	1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene;UO126;CIPLUS_753356;U0126 ethanolate;U 0126;UO-126;1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene;U0126;U126 cpd;1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene ethanolate;NCGC00094462-02;NCGC00094462-01;NCGC00016074-01;UO 126;U-0126;NCGC00025029-03;NCGC00025029-02;NCGC00025029-01;U0126 cpd;	-71.4142510055	-67.26330524	0.0003269855	0.992527857	5604	MAP2K1	NC(/SC1=CC=CC=C1N)=C(C#N)\C(C#N)=C(N)\SC2=CC=CC=C2N	BIOMOL	EI282	-4.66001612	-4.38826414	-4.67925812	-10.14251235	-16.71874544	-36.89693302	-67.26330524									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160146-02	Cephalotaxlen			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	24316-19-6				6.3468056448	4	7		0	-2.36769217					COC/1=C/[C@]23CCCN2CCC4=C(C=C5OCOC5=C4)[C@@H]3[C@@H]1O	MedChem Express	HY-N0838	3.92086031	0	0	3.85013217	3.22109628	0	-2.36769217									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346534-07	MC-1568		HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	852475-26-4		0.8791349063	-6.0559444758	-148.503313496	-1.1	7		-92.8421240771	-90.74962028	0.0000183122	0.998248057		HDAC2	C[N]1C=C(/C=C/C(=O)C2=CC=CC(=C2)F)C=C1\C=C\C(=O)NO	Adooq	A10560	2.20357351	1.62058567	3.23861381	-12.07907137	-57.36938936	-81.60973055	-90.74962028									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510496-01	VLX-1570	384569458	Ubiquitin C-terminal Hydrolase L5 (UCH-L5) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1431280-51-1		2.4777388143	-5.6059444758	-77.7753705632	-1.2	7		-64.9498019415	-58.67409238	0.0000436651	0.997290779		UCHL5	[O-][N+](=O)C1=CC(=CC=C1F)/C=C/2CCN(CC(=C/C3=CC=C(F)C(=C3)[N+]([O-])=O)\C2=O)C(=O)C=C	MedChem Express	HY-12471	1.0364854	2.05462078	0.61822926	-1.97678428	-17.61819934	-51.12029331	-58.67409238									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00169713-02	Oxyresveratrol			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			3.499899101	-5.4559444758	-102.6768289835	-2.1	7		-89.0267742742	-81.76728117	1.66E-7	0.9998336505			OC1=CC(=C(C=C1)\C=C\C2=CC(=CC(=C2)O)O)O	Analyticon	NP-003143	1.01981271	0.10991798	0.13045204	-4.70635559	-22.92731361	-58.84304254	-81.76728117									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016382-09	Oxethazaine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	126-27-2		11.0676527398	-4.9559444758	-10.9712761672	-2.4	7		-33.786535424	-22.73877952	0.0074447339	0.9626211598			CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1=CC=CC=C1)C(C)(C)CC2=CC=CC=C2	APExBIO	A8494	-0.25286909	4.05005496	4.19148091	4.15469486	-2.2749175	-8.4269336	-22.73877952									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00483210-07	NCGC00483210-07			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			6.2237985085	-5.2059444758	-64.5120378052	-2.2	7		-69.6530363004	-64.49355213	0.0000950071	0.99599522			CC1=NOC(C)=C1C2=CC3=C(N=C(N=C3C=C2)C4=CN(CC(C)(C)O)N=C4)N5CCOC[C@@H]5C6=CC=CC=C6	NCGCChem	YSM025-049	-0.8586434	-0.9723514	1.91707787	-0.85622342	-8.92737202	-33.99289996	-64.49355213									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161634-09	Artemisinin	384568213	antimalarial agents	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	63968-64-9				3.2169341576	4	7		0	2.89781696				PfATP6	C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	Selleck	S1282	0.35290522	0.10991798	0.27224775	0.43098494	2.0938586	-0.83221789	2.89781696									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165875-04	PB-28	384568294	sigma1/2 Receptor Agonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	172907-03-8		6.2237985085	-5.2059444758	-32.1247951637	-2.2	7		-32.8362718559	-31.11355988	0.0001316671	0.9952840262		SIGMAR1	COC1=C2CCCC(CCCN3CCN(CC3)C4CCCCC4)C2=CC=C1	Axon Medchem	1272	-0.93089171	-1.54167019	0.6465884	0.18963338	-3.74675116	-17.14485247	-31.11355988									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178913-14	Celastrol			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[34157-83-0]		3.499899101	-5.4559444758	-111.991665067	-2.1	7		-87.5199094869	-87.95604134	7.5E-8	0.9998881607			CC1=C(O)C(=O)C=C2C1=CC=C3[C@@]2(C)CC[C@@]4(C)[C@@H]5C[C@@](C)(CC[C@]5(C)CC[C@]34C)C(O)=O	Tocris	3203	-2.28137939	-2.37028269	-2.2460439	-3.36742903	-17.54811202	-66.16423209	-87.95604134									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015273-15	Chlorpromazine hydrochloride	124879758	Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	69-09-0		9.8640558873	-5.0059444758	-63.7227392403	-2.2	7	CHLORPROMAZINE HCl	-84.8676474984	-66.56639962	0.0001524155	0.9949184454			CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2	BIOMOL	AC749	-1.71450802	-0.2846594	1.95678067	1.43087001	-10.16558129	-32.2469883	-66.56639962									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00250404-15	ABT-888			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	912445-05-7				5.9926006906	4	7		0	0.03871698					C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(N)=O	ChemieTek	CT-A888	-0.42515353	1.3161974	1.70154841	2.47672681	0.47016909	2.99132864	0.03871698									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00408859-01	Cetilistat		Pancreatic lipase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	282526-98-1		24.777388143	-4.6059444758	-23.1724257862	4	7		10.296951196	2.64168925	0.2610139464	0.6709378312			CCCCCCCCCCCCCCCCOC/1=N/C2=C(C=C(C)C=C2)C(=O)O1	Glixx	GLXC-06700	-5.32136605	-7.39832586	-2.66008735	-3.48810482	-8.99745933	-7.45504277	2.64168925									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263606-06	Tubastatin A	384568693	HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1310693-92-5		13.9333492831	-4.8559444758	-75.9748231184	-2.2	7		-48.0726351736	-44.40837478	0.000659633	0.9893380761		HDAC6	CN1CCC2=C(C1)C3=C(C=CC=C3)[N]2CC4=CC=C(C=C4)C(=O)NO	Selleck	S2627	-7.12201628	-10.76914405	-10.39646078	-9.28628893	-14.29489239	-23.55816796	-44.40837478									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015034-21	INO-1001		PARP Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	3544-24-9				8.1298003153	4	7		0	2.3498228				PARP1	NC(=O)C1=CC(=CC=C1)N	MedChem Express	HY-12022	-0.07502709	0.00281841	-0.1814985	2.96517642	4.47682738	2.67124483	2.3498228									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00402349-02	GN6958	363681035	Sentrin-specific protease 1 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1392278-32-8		3.9269513795	-5.4059444758	-98.8900812761	-2.2	7		-75.91978134	-74.43488102	0.0000350062	0.9975752529	29843	SENP1	CCOC(=O)C1=CC=CC(=C1)CNC2=CC=C(C=C2)N(C)C(=O)NC3=CC=CC=C3	Glixx	GLXC-02687	-3.88751494	-2.65212367	-1.16839657	-7.16584301	-15.86601641	-54.74015015	-74.43488102									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346529-03	Safinamide		Sodium channel inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	133865-89-1				3.4391676536	4	7		0	-2.76677488					C[C@H](NCC1=CC=C(OCC2=CC(=CC=C2)F)C=C1)C(N)=O	MedChem Express	HY-70057	0.99758246	0.68487359	0.47643355	1.47109528	0.84980872	2.56067043	-2.76677488									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386200-01	Vildagliptin (LAF-237)	363680148	Dipeptidyl peptidase IV Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	274901-16-5				8.390558464	4	7		0	4.91109986					OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N4CCC[C@H]4C#N	Selleck	S3033	-2.94272932	2.5732082	1.42362884	0.48270314	4.62284262	2.04853634	4.91109986									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015608-22	Loperamide hydrochloride	384567873	mu-Opioid Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	34552-83-5		7.8352981002	-5.1059444758	-6.9907149797	4	7		-25.5064031959	-20.83866933	0.0032711097	0.9757461843		OPRM1	CN(C)C(=O)C(CCN1CCC(O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4	MedChem Express	HY-B0418A	3.04276544	4.23043319	0	4.36156764	2.28075811	-8.10103009	-20.83866933									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090730-05	Camphor			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	76-22-2				9.0095726155	4	7		0	3.51728862					CC1(C)C2CCC1(C)C(=O)C2	MedChem Express	HY-N0808	1.36993914	0	4.3899949	0.79875876	3.71754811	0	3.51728862									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095049-04	Exalamide	170465990		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	53370-90-4				-29.3076910565	4	7		0	-4.11889091					NC(=O)c1ccccc1OCCCCCC	Microsource	01503403	-5.2546753	-5.69036949	-10.27168056	-6.9302379	-5.76176153	-5.07478322	-4.11889091									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00250390-07	ISOX		HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1045792-66-2		13.9333492831	-4.8559444758	-39.7826421572	-2.2	7		-61.2844506648	-46.42761414	0.0125729097	0.9504196233		HDAC6	CC(C)(C)OC(=O)NC1=CC=C(C=C1)C2=CC(=NO2)C(=O)NCCCCCCC(=O)NO	Axon Medchem	1645	4.02089643	0	0.22120129	0	-11.49724031	-14.52016528	-46.42761414									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091469-15	Saquinavir Mesylate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	149845-06-7		6.9832167823	-5.1559444758	-67.5134296866	-2.2	7		-58.501022528	-57.5006701	0.0000126024	0.9985477507			[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=C(C=CC=C5)C=C4)[C@@H](C2)C(=O)NC(C)(C)C	Enzo	AC3247	-3.84305444	-3.35108932	-4.02132607	-2.16641765	-7.60739421	-32.35756271	-57.5006701									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263093-14	Apilimod mesylate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	870087-36-8		4.9437388825	-5.3059444758	-78.6383305071	-2.1	7		-92.5838669375	-82.52970784	0.0000030726	0.9992836304			CC1=CC=CC(\C=N\NC2=NC(OCCC3=CC=CC=N3)=NC(=C2)N4CCOCC4)=C1	AChemBlock	O33823	3.96532081	2.02643668	3.81146844	2.94219055	-9.93779751	-52.95932026	-82.52970784									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095169-07	Miltefosine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	58066-85-6				5.1455832565	4	7		0	0					CCCCCCCCCCCCCCCCO[P]([O-])(=O)OCC[N+](C)(C)C	Selleck	S3056	1.75896852	0.78633635	3.57325166	2.12044593	0	0	0									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00091367-08	DANTHRON		DNA topoisomerase II alpha Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	117-10-2		0.8791349063	-6.0559444758	-94.1201469984	-1.2	7		-62.5001191279	-56.66676594	0.0000132208	0.9985122682			OC1=CC=CC2=C1C(=O)C3=C(O)C=CC=C3C2=O	Microsource	MS-00211468	4.35990774	1.7727798	-0.88480517	-10.61372256	-33.29439593	-53.14555084	-56.66676594									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379028-01	PSI-6130		Hepatitis C virus NS5B RNA-dependent RNA polymerase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	817204-33-4				2.2663614509	4	7		0	0					C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N2/C=C\C(=N/C2=O)N	MedChem Express	HY-10165	3.34843138	0	0	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090548-05	Deferiprone		Iron Chelating Agent	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	30652-11-0				6.5810437382	4	7		0	3.82106799					CN/1\C=C/C(=O)/C(=C1C)O	APExBIO	B1723	0.23063884	-0.92725684	0	2.96517642	2.84729726	1.42582785	3.82106799									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00488726-01	NCGC00488726-01			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					9.9934352645	4	7		0	2.36769217					NC1=CC(=CC=C1)C(OCCN2CCCCC2)C3=CC4=NC=CC(=C4S3)C(O)=O	NCGCChem	DJJ005-090	-1.29213327	2.55066092	3.12517724	1.14354672	4.17895628	2.76436012	2.36769217									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00479249-03	Enasidenib	363681106	IDH1 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1446502-11-9		13.9333492831	-4.8559444758	-19.856019398	4	7		-19.018986208	-18.76582184	0.2582973546	0.6711835943		IDH1	CC(C)(O)CNC1=NC(=NC(=N1)NC2=CC(=NC=C2)C(F)(F)F)C3=CC=CC(=N3)C(F)(F)F	ChemieTek	CT-AG221	1.14207908	-11.39483104	0.22687312	-0.05746466	1.24697018	-5.38322761	-18.76582184									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378947-03	AMD-070 (hydrochloride)		Human immunodeficiency virus 1 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	880549-30-4		12.4181106199	-4.9059444758	-19.0112157445	4	7		-14.178932008	-13.48244334	0.0329680616	0.9158852668			NCCCCN(CC1=NC2=CC=CC=C2[NH]1)[C@H]3CCCC4=CC=CN=C34	MedChem Express	HY-50101A	-2.84269319	-2.65212367	-3.22159832	0.64360418	-3.01667494	-6.02921492	-13.48244334									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00188640-01	NCGC00188640-01	124899261		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			8.0180122623	-5.0959332839	-88.1258920793	-2.2	7		-64.1028243752	-61.75358132	0.0001879212	0.9943526641			C[C@@H](NC(=O)C1=CC(N)=CC=C1C)C2=CC=CC3=CC=CC=C23	Acesys	A9608	-5.97160086	-5.58890674	-5.77392093	-7.81519366	-25.00073008	-42.71081883	-61.75358132									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00483052-01	Saikosaponin B2			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	58316-41-9		15.6334750258	-4.8059444758	-27.5462087228	-2.2	7		-57.2838848044	-42.63930667	0.000566239	0.9901312313			C[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)C(CC[C@]4(C)[C@@H]3\C=C/C5=C6\CC(C)(C)CC[C@]6(CO)[C@H](O)C[C@]45C)[C@]2(C)CO)[C@H](O)[C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]7O)[C@H]1O	DC Chemicals	DCC-051	-0.02500903	4.48409008	0	1.39064475	-1.58572555	-11.51137752	-42.63930667									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023212-30	Stavudine (d4T)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	3056-17-5				2.8394588106	4	7		0	1.31339905					CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O	Selleck	S1398	-3.23728013	-0.83706773	1.15705292	0.15515458	4.01541921	1.71681313	1.31339905									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262963-03	Fiacitabine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	69123-90-6				6.0977246104	4	7		0	1.69461238					NC\1=N\C(=O)N(\C=C1I)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F	MedChem Express	HY-50735	-1.0364854	0	4.18013726	-0.2528445	1.63245043	2.88657394	1.69461238									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160338-03	Oxymatrine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	16837-52-8				2.3847613092	4	7		0	-0.32462698					[O-][N@+]12CCC[C@@H]3C[N@@]4[C@H](CCCC4=O)[C@H](CCC1)[C@H]23	Selleck	S2338	1.90346514	0.21138074	0.84510238	1.24123664	-3.08676226	2.60140837	-0.32462698									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018100-16	Fasudil hydrochloride	384567990	ROCK Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	105628-07-7				-23.5238570711	4	7		0	-5.79265569				ROCK1	[O-][S+](=O)(N1CCCNCC1)C2=C3C=CN=CC3=CC=C2	MedChem Express	HY-10341	-4.55997999	-2.99033285	-5.5640633	-1.56303873	-7.36792921	-7.38520631	-5.79265569									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015693-13	Mitoxantrone		DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	70476-82-3		0.3119288357	-6.5059444758	-214.9553404581	-1.1	7		-103.7423533925	-98.76701313	0.0000768657	0.9963995566		TOP2A	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(C(=CC=C3O)O)C2=O	Selleck	S1889	4.12093256	-0.5439531	-16.22142817	-40.57004942	-83.29585609	-96.44415993	-98.76701313									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017222-10	OLEANOIC ACID			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	508-02-1				7.8805247268	4	7		0	2.30217113					[H][C@@]12CC(C)(C)CC[C@@]1(CC[C@]3(C)C2=CC[C@]4([H])[C@@]5(C)CC[C@H](O)C(C)(C)[C@]5([H])CC[C@@]34C)C(O)=O	Microsource	00100550	0.75582849	4.61937375	3.40876865	2.73531778	0	-1.96124076	2.30217113									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00262945-10	Rivaroxaban			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	366789-02-8				3.2748228374	4	7		0	2.26047592					ClC1=CC=C(S1)C(=O)NC[C@H]2CN(C(=O)O2)C3=CC=C(C=C3)N4CCOCC4=O	Glixx	GLXC-90151	1.13096396	0	0	0	0	1.88558459	2.26047592									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163470-28	FK-506	384568242	mTOR Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	104987-11-3		11.0676527398	-4.9559444758	-31.7151464122	-2.2	7		-58.0247044096	-44.33689728	0.0003605717	0.9921503947		MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O)/C=C(C)/[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)C\C(=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC)[C@H](C[C@H]4C)OC	Bio Vision	1563	4.33767749	0	3.71504736	0	-1.79014689	-18.06436594	-44.33689728									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091231-18	NCGC00091231-18			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					-2.9157323948	4	7		0	-5.18509694					[H][C@@]1(C[C@@H]2CCN1C[C@@H]2C=C)[C@@H](O)C3=C4C=C(OC)C=CC4=NC=C3	BIOMOL	AC-129	-3.38733432	-0.46503763	2.31410584	2.67785312	0.03212335	-1.54222196	-5.18509694									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179673-05	Idoxuridine		Anti-Herpes Simplex Virus Drug	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	54-42-2				3.4640263941	4	7		0	1.80182863					OC[C@H]1O[C@H](C[C@@H]1O)N2\C=C(\I)C(=O)NC2=O	Selleck	S1883	0.00277878	-1.23728193	1.3952697	1.68371452	2.23403323	-0.48303556	1.80182863									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181337-01	2,4-Dichlorobenzyl alcohol	144206349		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1777-82-8	DICHLOROBENZYL ALCOHOL; 			5.7059583699	4	7	2,4-Dichlorobenzyl alcohol;DICHLOROBENZYL ALCOHOL;2,4-DICHLOROBENZYL ALCOHOL;CIPLUS_158985;	0	0					OCc1ccc(Cl)cc1Cl	SigmaAldrich	146668	-0.17506322	0	3.97027962	0	4.36001519	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164574-25	Erlotinib		EGFR Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	183321-74-6				10.536503039	4	7		0	-3.13011883				EGFR	COCCOC1=CC2=NC=NC(=C2C=C1OCCOC)NC3=CC=CC(=C3)C#C	DC Chemicals	DC2101	1.55889627	2.52247682	4.11207532	3.25824618	4.88567006	1.14648199	-3.13011883									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378657-01	Simeprevir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	923604-59-5		3.1192883571	-5.5059444758	-92.9678432476	-1.2	7		-77.4379336999	-76.61494475	0.0000197583	0.998180096			COC1=C(C)C2=C(C=C1)C(=CC(=N2)C3=NC(=CS3)C(C)C)O[C@@H]4C[C@@H]5C(C4)C(=O)N(C)CCCC\C=C/[C@@H]6C[C@]6(NC5=O)C(=O)N[S+]([O-])(=O)C7CC7	MedChem Express	HY-10241	-1.09206102	-0.08737071	0	2.02850247	-15.10089653	-61.02543211	-76.61494475									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017388-08	(+)-Usniacin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	7562-61-0		6.2237985085	-5.2059444758	-60.9693739693	-2.2	7		-73.3466807628	-66.52470441	0.0000744918	0.9964564706			CC(=O)C1=C(O)C(C)=C(O)C2=C1OC3=CC(=O)C(C(C)=O)=C(O)[C@@]23C	DC Chemicals	DCS-001	4.09314475	1.85733209	0	0	-7.51394446	-35.36635046	-66.52470441									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016280-11	Zoxazolamine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	61-80-3				9.7079633201	4	7		0	0					NC1=NC2=C(O1)C=CC(=C2)Cl	APExBIO	B1871	1.93125295	1.61494885	4.20282457	0	1.24112957	4.95838911	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167328-03	Aloxistatin	363676654	Calpain Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	88321-09-9				8.791878141	4	7		0	0				CAPN1	CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C	Selleck	S7393	1.96459833	1.98697895	2.94367875	0	2.73048506	3.01460746	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095802-05	Flavanone			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	487-26-32				5.9254381178	4	7		0	3.00503321					O=C1CC(OC2=CC=CC=C12)C3=CC=CC=C3	Enzo	AC1548	2.76488732	-0.38048533	0	3.91334329	0	0	3.00503321									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522116-02	Presatovir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1353625-73-6		6.7665459959	-5.1696329617	-33.3692890774	-2.4	7		-38.048649368	-28.79054114	0.0011283395	0.9859843713			CC1=C[N]2N=C(C=C2N=C1N3CC[C@H](N)C3)[C@@H]4CCCCN4C(=O)C5=CC(=CC=C5N[S+](C)([O-])=O)Cl	MedChem Express	HY-16727	0.75860727	-2.11098898	2.09857637	-0.7412941	-2.2165114	-11.05744049	-28.79054114									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00015619-13	Loratadine	170464867	Histamine H1 Receptor Antagonists	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	79794-75-5	 Sch2985; ; Claritin; Sch-434;LORATADINE; Wyeth Brand of Loratadine; Clarium; Sch 2985;Loratidine; Alavert; Loratadine Hydrochloride; Sch 434; Loratidine; Loratadine Wyeth Bran; Loratadine W/Pseudo; Loratadine;Loratadine;	13.9333492831	-4.8559444758	-39.1443858317	-2.2	7		-61.2768710744	-48.31581142	0.0000548391	0.9969630255	9704	HRH1	Clc3cc4CCc1cccnc1C(=C2/CCN(CC2)C(=O)OCC)\c4cc3	Vitas	STK574925	0.20840859	-1.32183422	-0.56151097	1.22974371	-3.36711153	-15.74230344	-48.31581142									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00189220-03	UNC-0638	363677129	EHMT2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1255580-76-7	UNC0638;UNC-0638	13.9333492831	-4.8559444758	-28.3153125864	-2.2	7		-52.4359085036	-39.34538523	0.000618167	0.9896822211	10919	EHMT2	COC1=C(OCCCN2CCCC2)C=C3N=C(N=C(NC4CCN(CC4)C(C)C)C3=C1)C5CCCCC5	SGC	UNC0638 	2.47033651	0	0	2.28709344	-3.57737348	-11.93621603	-39.34538523									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021394-04	Anisotropine methylbromide	144207024	Muscarinic acetylcholine receptor M3 Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	80-50-2	Anisotropine methylbromide; Valpin; Lytispasm; Valpin 50; 			-16.109025474	4	7	LS-157873;Octatropini methylbromidum;ANISOTROPINE;(3-ENDO)-8,8-DIMETHYL-3-((2-PROPYLPENTANOYL)OXY)-8-AZONIABICYCLO(3.2.1)OCTANE BROMIDE;METHYLOCTATROPINE BROMIDE;OCTATROPINE METHYLBROMIDE;8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide;ANISOTROPINE METHYLBROMIDE;methylbromure d'octatropine;8-AZONIABICYCLO(3.2.1)OCTANE, 8,8-DIMETHYL-3-((1-OXO-2-PROPYLPENTYL)OXY)-, BROMIDE, (3-ENDO);3.ALPHA.-HYDROXY-8-METHYL-1.ALPHA.H,5.ALPHA.H-TROPANIUM BROMIDE 2-PROPYLVALERATE;Octatropine methylbromide;Valpin;CIPLUS_750008;Lytispasm;octatropine;Anisotropine methyl bromide;Metilbromuro de octatropina;CIPLUS_149624;anisotropine methylbromide;anisotropine methylbromide, (endo)-isomer;Methyloctatropine bromide;8-Azoniabicyclo(3.2.1)octane, 8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-, bromide, endo-, mixt. with 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one;octotropine methylbromide;Valpin 50;valpinax;Methylbromure d'octatropine;CIPLUS_709435;octatropini methylbromidum;Methyloctatropine Bromide;Anisotropine methylbromide;	0	-6.57890818					[Br-].C[N+]2(C)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(CCC)CCC	SigmaAldrich	A5181	-2.42031845	-2.42665088	-2.85860133	-3.17779566	-1.63245043	-5.64511436	-6.57890818									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00250401-11	Flavopiridol	384568550	CDK1/2/4/6/7/9 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	146426-40-6		9.8640558873	-5.0059444758	-48.1503857794	-2.2	7		-83.1745689036	-68.69285523	0.0001025382	0.995838255		CDK1	CN1CC[C@H]([C@@H](O)C1)C2=C(O)C=C(O)C3=C2O\C(=C/C3=O)C4=CC=CC=C4Cl	MedChem Express	HY-10005	4.99902743	2.47738226	0	4.6201586	-2.01209006	-27.00343363	-68.69285523									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015097-03	4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride	90340895		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					8.0079157919	4	7		0	0					NCCC1=CC=C(C=C1)[S+]([O-])(F)=O	SigmaAldrich	Lopac-A-8456	3.44290994	0	0	0	4.71045177	3.41616714	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522434-01	DPC-681			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	284661-68-3		6.2237985085	-5.2059444758	-48.0197719606	-2.2	7		-52.7471781299	-48.83997975	0.0000196647	0.9981849666			CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNCC2=CC=CC(=C2)F)C(C)(C)C)[S+]([O-])(=O)C3=CC(=CC=C3)N	MedChem Express	HY-19400	-0.6363409	0.37484851	1.32720776	-1.48258821	-4.44762433	-27.02671245	-48.83997975									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482457-02	KDM5A-IN-1	363681129	Lysine-specific demethylase 5A Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1905481-36-8				7.6221468179	4	7		0	4.29758466					CC(C)C1=N[NH]C(=C1)C(=O)N2CC[C@H](C2)NC(=O)C3CC3	MedChem Express	HY-100014	2.15911301	0.93289366	2.85860133	0.51718193	1.83687177	-0.57615085	4.29758466									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095694-06	Ostol		GABAA Receptor Modulator	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			17.5410474839	-4.7559444758	-10.1489686693	-2.4	7		-33.120469372	-29.26705781	0.0006301354	0.9895862866			COC1=C(CC=C(C)C)C2=C(\C=C/C(=O)O2)C=C1	Analyticon	NP-000408	3.12057132	0	2.54097896	1.0458568	0	0.948612	-29.26705781									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00483024-01	BMS-791325 hydrochloride	377020421		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	958002-36-3		5.5469662594	-5.2559444758	-85.7813170533	-2.1	7		-101.4113827962	-88.65890342	0.0000362524	0.9975321323			COC1=CC2=C(C=C1)C3=C(C4CCCCC4)C5=C(C=C(C=C5)C(=O)N[S+]([O-])(=O)N(C)C)[N]3C[C@]6(C[C@@H]26)C(=O)N7[C@H]8CC[C@@H]7CN(C)C8	DC Chemicals	DC9232	1.87567733	1.81223754	2.35380863	4.50522928	-13.26110446	-53.09899319	-88.65890342									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178638-13	Valaciclovir	384568359	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	124832-27-5				-8.5467819962	4	7		0	-4.71453674					CC(C)[C@H](N)C(=O)OCCOC[N]1C=NC2=C1\N=C(N)/NC2=O	MedChem Express	HY-17425A	-2.67596632	-0.34666441	0.4253871	-1.21825078	-1.41050726	-3.53256125	-4.71453674									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00180839-02	Penta-O-galloyl-Î²-D-glucose hydrate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	14937-32-7 (anhydrous)		0.1968137898	-6.7059444758	-242.2576030678	-1.1	7		-108.7181729418	-93.92441254	0.0020508537	0.9809242997			OC1=C(O)C(=CC(=C1)C(=O)OC[C@H]2O[C@@H](OC(=O)C3=CC(=C(O)C(=C3)O)O)[C@H](OC(=O)C4=CC(=C(O)C(=C4)O)O)[C@@H](OC(=O)C5=CC(=C(O)C(=C5)O)O)[C@@H]2OC(=O)C6=CC(=C(O)C(=C6)O)O)O	SIGMA	G7548	-3.88751494	-22.31898763	-43.78651239	-54.39029997	-67.78903718	-83.71064424	-93.92441254									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00371131-03	NMS-873		p97 ATPase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1418013-75-8		4.9437388825	-5.3059444758	-54.1053925005	-2.2	7		-48.2101885272	-46.23700748	0.0002405216	0.9936041931		VCP	CC1=C(C=CC(=C1)OCC2=NN=C(SC3CCCC3)[N]2C4=CN=CC=C4)C5=CC=C(C=C5)[S+](C)([O-])=O	Selleck	S7285	-3.37066163	1.54167019	-1.54840905	-2.02850247	-7.55482872	-29.68631787	-46.23700748									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024936-06	N-Desmethylclozapine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	6104-71-8		7.8352981002	-5.1059444758	-35.2207201579	-2.2	7		-42.7690532256	-38.08261608	0.0002798663	0.9930968375			ClC1=CC2=C(NC3=C(C=CC=C3)C(=N2)N4CCNCC4)C=C1	Adooq	A13762	0.98646734	-0.77506271	-1.49169077	1.88484082	-3.63577958	-18.60559856	-38.08261608									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016360-07	Monobenzone	384567934	topical medical depigmentation treatment	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	103-16-2		13.9333492831	-4.8559444758	-26.0865268269	-3	7		-38.228713104	-30.60726092	0.000486134	0.9908733492			OC1=CC=C(OCC2=CC=CC=C2)C=C1	Selleck	S1652	-1.79787145	0.43685353	1.04928819	-1.90782669	-2.12306165	-9.95169644	-30.60726092									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263570-02	Sivelestat sodium salt			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	150374-95-1				11.3786536057	4	7		0	2.98716383					CC(C)(C)C(=O)OC1=CC=C(C=C1)[S+]([O-])(=O)NC2=CC=CC=C2C(=O)NCC(O)=O	Tocris	3535	0.90866146	4.99140385	3.83415575	0	4.31913092	0	2.98716383									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00371158-09	XEN 445		Endothelial lipase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[1515856-92-4]				15.5003832796	4	7		0	3.34455133			9388	LIPG	OC(=O)C1=C(C=CC(=C1)C(F)(F)F)N2CC[C@@H](C2)OCC3=CC=CC=N3	Tocris	5839	1.63114458	4.72647332	4.26521468	4.21215952	4.86814823	0	3.34455133									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165783-04	Vadimezan		Interferon Inducer	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	117570-53-3		22.0828704269	-4.6559444758	1.8550613555	4	7		-15.23440152	-11.4453346	0.0425453926	0.9022440615			CC1=C(C)C2=C(C=C1)C(=O)C3=C(O2)C(=CC=C3)CC(O)=O	APExBIO	A8233	3.63186706	0	0	0.8102517	3.64746079	3.31723215	-11.4453346									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346581-06	AZ-960		Jak2/3 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	(905586-69-8)		6.2237985085	-5.2059444758	-75.9158636883	-2.2	7		-81.0651338712	-75.06030914	0.0000032207	0.9992665916		JAK2	C[C@H](NC1=NC(=C(F)C=C1C#N)NC2=N[NH]C(=C2)C)C3=CC=C(F)C=C3	SynKinase	SYN-1015	0.91421902	-1.12454553	0.38568431	-0.92518101	-8.70542885	-42.52458826	-75.06030914									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165722-19	Plerixafor hydrochloride	384568275	Chemokine CXCR4 (SDF-1 Receptor) Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					-31.8567159635	4	7		0	-7.87145963			7852	CXCR4	C1CNCCNCCCN(CCNC1)CC2=CC=C(CN3CCCNCCNCCCNCC3)C=C2	NCGCChem	AED021-093	-7.65554228	-4.7208365	-3.85117123	-4.59142627	-9.52311421	-9.54431706	-7.87145963									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510505-01	WT-161	384569466	HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1206731-57-8		2.7800686746	-5.5559444758	-111.3726210015	-2.1	7		-97.806793336	-87.75947821	0.0000287171	0.9978045065		HDAC1	ONC(=O)CCCCCCC(=O)N\N=C\C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=CC=CC=C3	MedChem Express	HY-100871	3.00942007	0	1.93976519	-0.94242041	-26.74707239	-70.34278066	-87.75947821									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386432-07	BLZ945			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	953769-46-5		15.6334750258	-4.8059444758	-7.7103650949	-2.4	7		-33.800830928	-22.75069244	0.0001200817	0.9955011294			CNC(=O)C1=NC=CC(OC2=CC3=C(C=C2)N=C(N[C@@H]4CCCC[C@H]4O)S3)=C1	MedChem Express	HY-12768_cm2	2.49256676	2.07716806	2.37649594	3.6087806	0.68627165	-5.03404528	-22.75069244									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00241099-04	Saracatinib	384568470	cSRC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	379231-04-6		11.0676527398	-4.9559444758	-43.837247893	-2.2	7		-44.7673109528	-36.94493254	0.0075622893	0.9622783463		SRC	CN1CCN(CCOC2=CC3=NC=NC(=C3C(=C2)OC4CCOCC4)NC5=C6OCOC6=CC=C5Cl)CC1	Selleck	S1006	-2.47033651	-2.11098898	1.31019227	-7.99908057	-4.96159799	-18.70453355	-36.94493254									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378907-02	Edoxaban 		Coagulation factor X Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	480449-70-5				-13.041548722	4	7		0	-4.24397653					CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(Cl)C=C4)C(=O)N(C)C	Glixx	GLXC-90139	-5.1212938	-3.65547758	0.40837162	-4.72934146	-0.21318226	-2.31042309	-4.24397653									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346506-05	LY-2886721	384568809	beta-Secretase 1/2 (BACE1/2) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1262036-50-9				-18.0900695846	4	7		0	-4.80984007				BACE1	NC/1=N/[C@]2(COC[C@H]2CS1)C3=CC(=CC=C3F)NC(=O)C4=NC=C(F)C=C4	MedChem Express	HY-13240	-4.24319893	-4.29243821	-1.95678067	-2.35605103	-1.70253774	-7.83914334	-4.80984007									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378691-05	Asunaprevir (Prop INN; USAN) BMS-650032   Sunvepra  			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			9.8640558873	-5.0059444758	-32.7770461497	-2.2	7		-62.7037555443	-53.56345117	0.0000193228	0.9982007065			COC1=CN=C(O[C@@H]2C[C@H](N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)N[C@@]3(C[C@H]3C=C)C(=O)N[S+]([O-])(=O)C4CC4)C5=CC(Cl)=CC=C15	AK Scientific	Y1367	2.73154195	1.4289338	3.87953037	2.09746006	2.0354525	-18.58231973	-53.56345117									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386712-02	TMP195			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1314891-22-9		6.2237985085	-5.2059444758	-15.3090611752	-2.4	7		-31.2892753919	-26.07439616	0.0012902862	0.984985851			CC(C)(CNC(=O)C1=CC=CC(=C1)C2=NOC(=N2)C(F)(F)F)C3=COC(=N3)C4=CC=CC=C4	Selleck	S8502	0	4.42772188	3.13084907	3.49959775	0	-13.29802712	-26.07439616									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00480772-03	Oroxylin A	376241613		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	480-11-5		9.8640558873	-5.0059444758	-66.3575681526	-2.2	7		-79.5575244975	-64.05873068	0.0000549801	0.9969584062			COC1=C(O)C=C2O\C(=C/C(=O)C2=C1O)C3=CC=CC=C3	CANVASS	57a2faeef1704b5b7a46901d	1.46441771	-2.62393957	-1.0322727	-3.72945638	-8.30242677	-32.35756271	-64.05873068									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00247029-06	2-Deoxyglucose		sugar	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	154-17-6				6.2008262179	4	7		0	0					OC[C@H]1OC(O)C[C@@H](O)[C@@H]1O	MedChem Express	HY-13966	-1.43107233	1.47966517	2.76785208	4.91322836	0	1.09410464	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00250410-11	GSK-650394	384568558	SGK1 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	890842-28-1		13.9333492831	-4.8559444758	-32.2063722538	-2.2	7		-68.2346397796	-49.79896953	0.0003225909	0.9925798389		SGK1	OC(=O)C1=C(C=C(C=C1)C2=C[NH]C3=NC=C(C=C23)C4=CC=CC=C4)C5CCCC5	MedChem Express	HY-15192	1.9979437	4.05569178	0	4.41328583	-2.16978653	-16.74911249	-49.79896953									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183912-01	FR-180204	174006438	ERK1/2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	865362-74-9		12.4181106199	-4.9059444758	-32.1814379616	-2.2	7		-38.8206063703	-35.84894422	0.0058389965	0.9671114865	5598	MAPK7	NC1=N[NH]C2=NN=C(C=C12)C3=C4C=CC=C[N]4N=C3C5=CC=CC=C5	NCGCChem	SP01-087	0.93089171	-2.33082495	-6.18229255	0.62636479	-1.86023421	-10.14956643	-35.84894422									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015898-28	Rolipram	384567905	Phosphodiesterase IIII (PDE4) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	61413-54-5				12.3508172933	4	7		0	4.12484737				PDE4A	COC1=C(OC2CCCC2)C=C(C=C1)C3CNC(=O)C3	MedChem Express	HY-16900	3.59296413	3.12561653	0	0	4.73965482	3.21829715	4.12484737									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00181129-22	Dasatinib			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	302962-49-8		11.0676527398	-4.9559444758	-49.7274068311	-2.2	7		-55.0511919068	-52.17559639	0.0004017758	0.9917075042			CC1=NC(=CC(=N1)NC2=NC=C(S2)C(=O)NC3=C(Cl)C=CC=C3C)N4CCN(CCO)CC4	Selleck	S1021_CM1	-2.40920332	-6.0342155	-1.54840905	-0.68382944	-3.12180592	-18.07018565	-52.17559639									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090705-24	Zalcitabine		Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	7481-89-2				9.4403917511	4	7		0	2.29621467					NC/1=N/C(=O)N(/C=C1)[C@H]2CC[C@@H](CO)O2	MedChem Express	HY-17392	3.63742463	0.61723176	3.26130112	1.05734973	1.42218848	1.89140429	2.29621467									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482789-01	8-O-Acetylharpagide			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	6926-14-3				5.9437946152	4	7		0	1.85543676					CC(=O)O[C@@]1(C)C[C@@H](O)[C@]2(O)\C=C/O[C@@H](OC3OC(CO)C(O)C(O)C3O)[C@H]12	DC Chemicals	DCY-112	-0.60855309	2.34773541	3.62429811	1.39064475	-2.11138043	2.43845661	1.85543676									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165962-02	L-685458			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	292632-98-5		13.9333492831	-4.8559444758	-39.1680191115	-2.2	7		-41.5761620257	-33.48423028	0.0001950616	0.994250563			CC(C)C[C@H](NC(=O)[C@@H](C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OC(C)(C)C)CC2=CC=CC=C2)C(=O)N[C@@H](CC3=CC=CC=C3)C(N)=O	Glixx	GLXC-06622	-3.64853975	-2.79304416	-0.93585162	-3.5743018	-5.25946909	-14.68893674	-33.48423028									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094931-06	Lapachol			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	84-79-7		14.2582661155	-4.8459332839	-87.4247158441	-2.2	7		-75.779166164	-71.9808202	0.0000049047	0.9990947416			CC(C)=CCC/1=C(O)/C(=O)C2=C(C=CC=C2)C1=O	Prestwick	Prestw-NAT-0052	-6.3495151	-6.96992757	-5.64914072	-8.91276865	-15.86601641	-42.85049177	-71.9808202									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00378990-05	Ledipasvir (D-tartrate)		Nonstructural protein 5A Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1502654-87-6		1.5633475026	-5.8059444758	-137.1416036518	-1.1	7		-83.5933724032	-87.3187003	0.000089583	0.9961114159			COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1C3=NC=C([NH]3)C4=CC5=C(C=C4)C6=C(C=C(C=C6)C7=CC=C8N=C([NH]C8=C7)[C@@H]9[C@H]%10CC[C@H](C%10)N9C(=O)[C@@H](NC(=O)OC)C(C)C)C5(F)F	MedChem Express	HY-15602B	-3.94309056	-4.3488064	-2.77352391	-5.36145271	-40.32649009	-73.75312809	-87.3187003									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00370995-10	SRPIN340	363677983	Serine/threonine-protein kinase SRPK1 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	218156-96-8		13.9333492831	-4.8559444758	-6.5894525322	-2.4	7		-33.430517916	-24.10876493	0.0008057586	0.9882020742			FC(F)(F)C1=CC(=C(C=C1)N2CCCCC2)NC(=O)C3=CC=NC=C3	Glixx	GLXC-02516	3.68188513	2.52247682	2.84725767	3.75244225	0.00876091	-3.93994064	-24.10876493									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00345799-06	Oprozomib	384568748	Proteasome Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	935888-69-0				4.9492025451	4	7		0	0				PSMD1	COC[C@H](NC(=O)[C@H](COC)NC(=O)C1=CN=C(C)S1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)[C@@]3(C)CO3	MedChem Express	HY-12113	1.51443577	1.7445957	3.12517724	0.7412941	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165841-02	NH125			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	278603-08-0		5.5469662594	-5.2559444758	-58.2618270652	4	7		-22.019599012	-29.14792864	0.381447304	0.5327023336			CCCCCCCCCCCCCCCC[N+]1=C(C)[N](CC2=CC=CC=C2)C=C1	Selleck	S7436	-2.88159613	-25.84763676	-2.92666326	-3.97655442	-3.93365067	-21.90537159	-29.14792864									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179342-03	Oxprenolol hydrochloride	170464995	Adrenergic receptor beta Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	6452-73-9				5.8635036405	4	7		0	0					Cl.CC(C)NCC(O)COc1ccccc1OCC=C	Tocris	3288	-1.26434546	2.59575547	0	2.614642	0	4.40551708	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00241102-05	Midostaurin		PKC/flt3 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	120685-11-2		4.9437388825	-5.3059444758	-75.3299742398	-2.2	7		-77.8544241644	-71.80212646	0.0000681144	0.9966122804		PRKCA	CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N3C4=CC=CC=C4C5=C6CNC(=O)C6=C7C8=CC=CC=C8N2C7=C35)N(C)C(=O)C9=CC=CC=C9	MedChem Express	HY-10230	-1.14763665	2.31391449	-0.20985764	2.48247328	-11.10591946	-45.99895245	-71.80212646									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00180681-03	Isochlorogenic acid C			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	32451-88-0		0.0622379851	-7.2059444758	-67.4261477128	-1.4	7		-30.6630133759	-28.88584448	0.0051305199	0.9692909911			O[C@@H]1C[C@@](O)(C[C@@H](OC(=O)\C=C\c2ccc(O)c(O)c2)[C@H]1OC(=O)\C=C\c3ccc(O)c(O)c3)C(O)=O	DC Chemicals	DCY-070	1.58668408	-3.49200981	-11.28126595	-18.60705666	-19.78506556	-23.05185358	-28.88584448									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263120-06	Enzalutamide	384568604	Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	915087-33-1		22.0828704269	-4.6559444758	-1.4467056131	4	7		-11.203755548	-8.91979629	0.0654936929	0.8740536489		AR	CNC(=O)C1=CC=C(C=C1F)N2C(=S)N(C(=O)C2(C)C)C3=CC(=C(C=C3)C#N)C(F)(F)F	MedChem Express	HY-70002	-0.00833634	1.86296891	2.10992003	-0.59188599	-1.06591128	2.35116103	-8.91979629									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091641-16	6-Mercaptopurine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	50-44-2				9.5040709728	4	7		0	0					S=C1NC=NC2=C1NC=N2	MedChem Express	HY-13677	1.70895045	2.74794961	4.23685554	0	4.95575738	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161621-13	Cepharanthine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	481-49-2		5.5469662594	-5.2559444758	-83.6272727533	-2.2	7		-82.8797688924	-72.70155166	0.0000223387	0.9980646297			[H][C@@]12CC3=CC(OC4=CC=C(C[C@]5([H])N(C)CCC6=C5C(OC7=CC1=C(CCN2C)C=C7OC)=C8OCOC8=C6)C=C4)=C(OC)C=C3	APExBIO	N2771	-1.40884208	0.47631127	-0.68629119	-1.59177106	-16.56688958	-45.09107839	-72.70155166									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00345452-02	Ac-DEVD-CHO			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	184179-08-6				3.1215181183	4	7		0	0.14593323					CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(C)=O)C(=O)N[C@@H](CC(O)=O)C=O	Cayman	10017	3.92086031	-1.4007497	1.13436561	4.03976554	-0.61034372	-2.60722807	0.14593323									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017251-06	alpha-MANGOSTIN			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	6147-11-1		1.106765274	-5.9559444758	-171.9511771279	-1.1	7		-97.4877324699	-98.33814814	0.0000052542	0.9990628363			COC1=C(CC=C(C)C)C2=C(OC3=C(C(=C(CC=C(C)C)C(=C3)O)O)C2=O)C=C1O	Microsource	MS-01504015	-2.70375413	-0.60595812	-7.35068913	-18.32547983	-55.50039424	-87.47599371	-98.33814814									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378984-02	Pritelivir (BAY 57-1293)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	348086-71-5		9.8640558873	-5.0059444758	-4.7766700964	4	7		-19.996515476	-17.49709623	0.009745838	0.9568940126			CN(C(=O)CC1=CC=C(C=C1)C2=NC=CC=C2)C3=NC(=C(S3)[S+](N)([O-])=O)C	Selleck	S7546	2.15911301	1.13018235	1.11735012	0	4.82142336	-2.79345865	-17.49709623									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00244253-21	INCB018424			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	941678-49-5		15.6334750258	-4.8059444758	-5.2177657405	4	7		-26.3627632	-19.885636	0.0011951208	0.9855812965			N#CC[C@H](C1CCCC1)N2C=C(C=N2)C3=NC=NC4=C3C=CN4	ChemieTek	CT-INCB	2.64817851	2.17863082	1.76961035	3.08010573	-0.1781386	-1.87976488	-19.885636									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091502-16	COUMARIN		Vitamin k epoxide reductase complex subunit 1 isoform 1 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	91-64-5				-13.7355144208	4	7		0	-2.92759925					O=C\1OC2=C(C=CC=C2)\C=C1	Microsource	01400208	-4.8545308	-2.41537724	1.25914582	-2.42500862	-4.69292994	-3.11936216	-2.92759925									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00386206-04	Azilsartan	363680151	Type-1 angiotensin II receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	147403-03-0		0.4943738883	-6.3059444758	-6.9806065531	4	7		-14.6062698999	0	0.4696129451	0.500936195			CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4\C5=N\C(=O)ON5)C(O)=O	Glixx	GLXC-05169	3.48737044	0	4.58850888	4.6201586	-22.58855825	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386235-06	Cobicistat		Cytochrome P450 3A Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1004316-88-4		13.9333492831	-4.8559444758	-40.8756566031	-2.2	7		-54.29640825	-42.27000625	0.0007803393	0.988382392			CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5	Cayman	13433	-1.9979437	-2.57884502	-0.71465033	0.89070222	-6.5210408	-15.74230344	-42.27000625									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510442-01	Abametapir	384569434	MMP-9 (Gelatinase B) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					12.2168402555	4	7		0	0				MMP	CC1=CN=C(C=C1)C2=NC=C(C)C=C2	SIGMA	513040	1.33659377	2.50556636	4.71328909	4.99942535	3.96285372	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018158-11	Doxazosin Mesylate		alpha1-Adrenoceptor Antagonists	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	77883-43-3		11.0676527398	-4.9559444758	-33.0870890973	-2.2	7		-62.6740477083	-54.67730887	0.0000914569	0.9960716561			COC1=C(OC)C=C2C(=NC(=NC2=C1)N3CCN(CC3)C(=O)C4COC5=C(O4)C=CC=C5)N	Selleck	S1324	0.34179009	0	2.29141852	3.60303413	2.21067079	-14.53180469	-54.67730887									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482644-02	Scutellarein			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	529-53-3		13.9333492831	-4.8559444758	-36.446230723	4	7		-36.992152368	-29.57679364	0.0652760794	0.8731209236			OC1=CC=C(C=C1)C2=CC(=O)C3=C(O)C(O)=C(O)C=C3O2	MedChem Express	HY-N0752	1.73673827	2.26318311	-6.27871363	-9.0047121	-4.73381421	-13.75778386	-29.57679364									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00246968-07	Olmesartan	384568514	Angiotensin AT1 Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	144689-24-7		11.0676527398	-4.9559444758	6.4857644567	4	7		-12.5682907919	-9.22357566	0.0325572696	0.9163971839		AGT	CCCC1=NC(=C([N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)C(O)=O)C(C)(C)O	MedChem Express	HY-17004	0.29177203	3.62165666	2.76785208	3.95931502	4.67540811	0.93115288	-9.22357566									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346743-03	Givinostat hydrochloride	384568939	HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			11.0676527398	-4.9559444758	-73.6746519185	-2.2	7		-67.0969313136	-56.58933198	0.0000213983	0.9981063714		HDAC1	CCN(CC)CC1=CC2=C(C=C1)C=C(COC(=O)NC3=CC=C(C=C3)C(=O)NO)C=C2	Bio Vision	9431-5	-6.42176341	-5.27888165	-3.83415575	-6.12573267	-11.70166165	-29.56992376	-56.58933198									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00384596-01	NCGC00384596-01			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			6.2237985085	-5.2059444758	-105.677401513	-2.2	7		-76.847186992	-69.69354022	0.0001357461	0.9952067784			OC(=O)[C@@H](CC1=CC(O)=C(O)C=C1)OC(=O)\C=C\C2=C3[C@@H]([C@H](OC3=C(O)C=C2)C4=CC(O)=C(O)C=C4)C(O)=O	Analyticon	NP-017967	-3.98755106	-8.82444125	-6.67574159	-12.40087346	-22.34325264	-44.53238666	-69.69354022									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017159-23	Curcumin	384567975	NF-kappaB Activation Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	458-37-7		0.6223798508	-6.2059444758	-188.867705226	-1.1	7		-94.9061318588	-95.77091461	0.0000033099	0.9992564267		NFKB1	COC1=CC(=CC=C1O)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(O)C=C2)OC	MedChem Express	HY-N0005	-2.19245839	-2.93396466	-8.20146333	-31.12860591	-67.11736705	-86.5157423	-95.77091461									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00509859-02	Paritaprevir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1216941-48-8		8.7913490634	-5.0559444758	-49.0257903779	-2.2	7		-63.2442445664	-50.94260952	0.0001232955	0.9954342743			CC1=CN=C(C=N1)C(=O)N[C@H]2CCCCC\C=C/[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)OC5=NC6=C(C=CC=C6)C7=C5C=CC=C7)C(=O)N[S+]([O-])(=O)C8CC8	MedChem Express	HY-12594	-1.94792564	2.18990446	0.12478022	0.41374555	-6.69041848	-25.87441075	-50.94260952									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346435-07	Niraparib	384568775	PARP Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1038915-60-4		13.9333492831	-4.8559444758	-13.7986915154	4	7		-29.635747688	-21.77978974	0.0121600617	0.9513879466		PARP1	NC(=O)C1=CC=CC2=C[N](N=C12)C3=CC=C(C=C3)[C@@H]4CCCNC4	MedChem Express	HY-10619	-0.1917359	-1.7727798	3.31234757	3.48810482	-1.18856409	-6.97200722	-21.77978974									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163532-06	Daidzin	384568245	Alcohol Dehydrogenase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	552-66-9				-26.5850204394	4	7		0	-3.29689966				ADH1	OC[C@H]1O[C@@H](OC2=CC3=C(C=C2)C(=O)\C(=C/O3)C4=CC=C(O)C=C4)[C@H](O)[C@@H](O)[C@@H]1O	Adooq	A10283	-7.28874316	-5.98348412	-5.67749986	-7.9760947	-2.35668604	-6.49479136	-3.29689966									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167778-02	ZK 756326			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[874911-96-3]				10.1482875758	4	7		0	0					OCCOCCN1CCN(CC1)CC2=CC=CC(=C2)OC3=CC=CC=C3	Tocris	2565	4.93233668	0	3.11383359	3.16630272	3.46056128	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015989-22	Thalidomide	384567913	TNF-alpha Production Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	50-35-1				-6.4172447341	4	7		0	-4.16058612				TNF	O=C1CCC(N2C(=O)C3=C(C=CC=C3)C2=O)C(=O)N1	Microsource	01503607	-4.06535693	-0.2282912	0.35732517	-1.13780025	1.42218848	-2.51993249	-4.16058612									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159554-09	Salubrinal			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	405060-95-9		1.3933349283	-5.8559444758	-109.7277615882	-1.2	7		-58.2234570383	-62.05140423	0.0000419555	0.9973446162			ClC(Cl)(Cl)C(NC(=O)\C=C\C1=CC=CC=C1)NC(=S)NC2=C3N=CC=CC3=CC=C2	SIGMA	SML0951	-6.22724873	-3.79639807	-2.51261982	-9.99310424	-32.14963642	-55.72950009	-62.05140423									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183867-02	Aloin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1415-73-2		6.2237985085	-5.2059444758	-68.3766435691	-2.2	7		-82.301054296	-66.50087858	0.0001213935	0.9954690265			[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@@]2([H])C3=C(C(O)=CC=C3)C(=O)C4=C2C=C(CO)C=C4O	APExBIO	N2491	2.1313252	3.62165666	-0.17015484	0.12642225	-15.60902958	-37.71169179	-66.50087858									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00371045-07	AMD-3465	384569040	Chemokine CXCR4 (SDF-1 Receptor) Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	185991-07-5				-5.3070464548	4	7		0	-7.10307651				CXCR4	C1CNCCNCCCN(CCNC1)CC2=CC=C(CNCC3=NC=CC=C3)C=C2	MedChem Express	HY-15971	-1.67004752	0.71305769	1.47467529	-1.09182853	1.3170575	-3.03206658	-7.10307651									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378713-01	Nirogacestat	363678166	g-Secretase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1290543-63-3		9.8640558873	-5.0059444758	-34.1242893239	-2.2	7		-63.0153378812	-55.31464991	0.0002538475	0.9934264531		NOTCH1	CCC[C@H](N[C@H]1CCC2=CC(=CC(=C2C1)F)F)C(=O)NC3=C[N](C=N3)C(C)(C)CNCC(C)(C)C	MedChem Express	HY-15185	0	3.76257715	0	4.43052523	2.12306165	-17.41255892	-55.31464991									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015471-09	Ganciclovir	384567853	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	82410-32-0		0.3119288357	-6.5059444758	-53.49409045	4	7		-16.7434262307	-5.29826965	0.4849516731	0.4788109329			N\C1=N\C2=C(N=C[N]2COC(CO)CO)C(=O)N1	Selleck	S1878	-7.01086503	-5.46489671	-3.15353638	-10.791863	-35.29188447	-8.58406565	-5.29826965									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346655-06	Linagliptin	384568886	DPP-IV Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	668270-12-0		11.0676527398	-4.9559444758	-57.1527203717	-2.2	7		-69.2896327784	-60.06790362	0.0002709262	0.99320639		DPP4	CC#CC[N]1C(=NC2=C1C(=O)N(CC3=NC4=CC=CC=C4C(=N3)C)C(=O)N2C)N5CCC[C@@H](N)C5	MedChem Express	HY-10284	-4.75449468	1.35001832	-2.68277466	-1.58602459	-4.70461116	-24.2332538	-60.06790362									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263102-06	Degrasyn	384568591	Jak2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	856243-80-6		6.2237985085	-5.2059444758	-60.9803938049	-2.2	7		-68.454730922	-62.92104715	0.0001013225	0.9958633465		JAK2	CCC[C@H](NC(=O)\C(=C\C1=NC(=CC=C1)Br)C#N)C2=CC=CC=C2	MedChem Express	HY-13264	2.12576764	2.172994	-1.06630367	0.64360418	-9.04418421	-34.55741139	-62.92104715									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017376-12	Tetrandrine		Calcium Channel Blocker	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	518-34-3		6.2237985085	-5.2059444758	-69.183703073	-2.2	7		-76.5258063561	-66.25070733	0.0001863294	0.9943763994			COC1=CC=C2C[C@@H]3N(C)CCC4=C3C(=C(OC)C(=C4)OC)OC5=C(OC)C=C6CCN(C)[C@@H](CC7=CC=C(OC1=C2)C=C7)C6=C5	Prestwick	Prestw-NAT-0181	2.73154195	1.89115301	-1.76393852	-2.78703597	-12.82889934	-36.17528953	-66.25070733									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00686697-01	4E2RCat			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	432499-63-3		1.7541047484	-5.7559444758	-121.0724148224	-2.1	7		-96.128346789	-87.26509218	0.0000407518	0.9973827984			OC(=O)C1=CC(=CC=C1Cl)C2=CC=C(O2)\C=C3/SC(=S)N(CC4=CC=CC=C4)C3=O	MedChem Express	HY-100733	4.09870231	2.5450241	0.9301798	-9.10814849	-39.67234179	-66.09439562	-87.26509218									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00388427-02	Tizoxanide		Trichomonas vaginalis Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	173903-47-4		1.5633475026	-5.8059444758	-30.8184121928	4	7		-18.5765107079	-19.23042559	0.0018132221	0.9821360097			OC1=C(C=CC=C1)C(=O)NC2=NC=C(S2)[N+]([O-])=O	MedChem Express	HY-12687	-2.90938394	0.75815225	0	-0.9941386	-8.55357299	-17.98870977	-19.23042559									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00370899-04	Golgicide A			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1139889-93-2		15.6334750258	-4.8059444758	-19.6874005911	-2.4	7		-31.2623968759	-28.13533073	0.0490782731	0.8931711562			[H][C@@]12CC=C[C@]1([H])C3=C(NC2C4=CN=CC=C4)C(F)=CC(F)=C3	APExBIO	B1385	0.86975852	-0.19447028	0.72032216	3.30421791	-8.1388897	-3.4801839	-28.13533073									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274063-04	Pimobendan		Phosphodiesterase III (PDE3) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	74150-27-9		13.9333492831	-4.8559444758	-11.1403092316	-2.4	7		-37.269887124	-28.55823927	0.0015747219	0.9833688093		PDE3A	COC1=CC=C(C=C1)C2=NC3=CC(=CC=C3[NH]2)/C4=N/NC(=O)CC4C	Adooq	A10733	1.57556896	0.18319664	4.92881856	3.01114814	1.03086762	-5.08060292	-28.55823927									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00242597-10	Saxagliptin		DPP-IV Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	709031-78-7				-13.230213392	4	7		0	-7.3472913				DPP4	N[C@H](C(=O)N1[C@@H](C[C@@H]2C[C@H]12)C#N)C34CC5CC(CC(O)(C5)C3)C4	DC Chemicals	DCAPI1568	-0.55853503	-3.18198472	-3.52220521	-2.68359959	-3.5306486	0.07565617	-7.3472913									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160398-13	NafamostatMesylate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	82956-11-4		15.6334750258	-4.8059444758	-19.4366814549	4	7		-24.0050332119	-19.17086101	0.0395878887	0.9060450263			NC(=N)NC1=CC=C(C=C1)C(=O)OC2=CC=C3C=C(C=CC3=C2)C(N)=N	Bio Vision	1760	-1.36993914	-0.43121671	0.54449549	-0.39075968	-6.4626347	-5.28429261	-19.17086101									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163662-01	NCGC00163662-01	26757041		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			19.6813789847	-4.7059444758	-4.30955782	4	7	schisandrin A;deoxyschisandrin;Schizandrin A;CIPLUS_183967;SCHISANDRIN A, R(+)-;Deoxyschizandrin;schizandrin A;Dibenzo(a,c)cyclooctene, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, stereoisomer;CIPLUS_732662;NCGC00163662-01;	-23.376716208	-19.48059684	0.0102011551	0.9558008158			COC1=C(OC)C(OC)=C2C(C[C@H](C)[C@H](C)CC3=CC(OC)=C(OC)C(OC)=C23)=C1	BIOMOL	NP-455	4.37102287	0	0.18717032	-0.15515458	3.06339982	1.20467904	-19.48059684									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015520-13	Hydroxyurea	384567861	Ribonucleoside-Diphosphate Reductase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	127-07-1				-2.2319028065	4	7		0	3.00503321				RRM1	NC(=O)NO	Selleck	S1896	-4.33767749	0.60595812	2.71680563	-3.66624526	0.73883713	-1.65861607	3.00503321									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00385072-01	Schisandrin C	363679517	<MOA Unknown> | Class: Shikimate | Genus: N/A | Family: N/A | Species: N/A	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			9.6105006695	-5.0172539867	-51.9580278954	-2.2	7		-59.6406021995	-48.52428746	0.0003349093	0.9924385698			COC1=C2OCOC2=CC3=C1C4=C(CC(C)C(C)C3)C=C5OCOC5=C4OC	Analyticon	NP-015228	0.45294134	-4.11205998	-0.32896603	-2.7985289	-3.60657653	-15.16033289	-48.52428746									1.42E-9	7.1199999999E-9	3.56E-8	1.7799999999E-7	8.9E-7	0.00000445	0.0000223								
NCGC00163450-06	Ilomastat (GM6001, Galardin)	384568240	MMP Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	142880-36-2				-17.2616027406	4	7		0	-5.70330881				MMP1	CNC(=O)[C@H](CC1=C[NH]C2=C1C=CC=C2)NC(=O)[C@H](CC(C)C)CC(=O)NO	Selleck	S7157	-2.02573151	-4.09514952	-2.21768476	-3.75244225	-2.43261396	-5.93609963	-5.70330881									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167491-06	Lenalidomide		TNF-alpha Production Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	191732-72-6				9.1423512032	4	7		0	3.36837716				TNF	NC1=CC=CC2=C1CN([C@H]3CCC(=O)NC3=O)C2=O	Selleck	S1029	1.09761858	1.15836645	2.84158584	1.85036203	3.62409836	0	3.36837716									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00479257-01	NCGC00479257-01			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					-24.4023264079	4	7		0	-6.26917235					OC(=O)C1=CC=NC2=C1[NH]C(=C2)C(OCCN3CCCCC3)C4=C(Cl)C=CC=C4	NCGCChem	GRB054-049_1st_neg	-3.67632756	-3.28344748	-6.85724009	-3.8788645	-4.59948019	-8.00209509	-6.26917235									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015412-21	Ebselen			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	60940-34-3		6.9832167823	-5.1559444758	-20.95807353	-2.4	7		-37.577240376	-28.81436698	0.0021132562	0.980645172			[O]=[C]1[N]([Se]C2=C1C=CC=C2)C3=CC=CC=C3	Bio Vision	2169	4.15427793	0.1155548	4.75866372	1.75841857	-4.57611775	-14.33975441	-28.81436698									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00387111-01	TMCB			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[905105-89-7]				-8.0621355253	4	7		0	-4.73836257					CN(C)C1=NC2=C(Br)C(=C(Br)C(=C2[N]1CC(O)=O)Br)Br	Tocris	3675	-2.24247645	-0.53267946	-1.93409336	-0.2183657	-4.17895628	1.07664552	-4.73836257									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017325-10	KOJIC ACID		Tyrosinase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	501-30-4				3.7818418915	4	7		0	2.67147154					OC\C1=C\C(=O)\C(=C/O1)O	Microsource	01504324	0.92533415	3.3172684	0.45374624	1.02287093	-4.78053909	2.77017983	2.67147154									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00510887-02	Celgosivir (hydrochloride)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	141117-12-6				4.8845744472	4	7		0	-2.77868779					CCCC(=O)O[C@H]1C[N@]2CC[C@H](O)[C@@H]2[C@@H](O)[C@@H]1O	MedChem Express	HY-16134A	0	1.73895888	3.42578413	0	1.22360774	2.69452366	-2.77868779									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017351-07	Psoralen			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	66-97-7				6.8691013581	4	7		0	0					O=C\1OC2=CC3=C(C=CO3)C=C2\C=C1	MedChem Express	HY-N0053	0.33067497	-1.15272963	0.8507742	3.1030916	1.82519055	4.88273293	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378631-01	Boceprevir		"Hepatitis C virus serine protease, NS3/NS4A Inhibitor"	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	394730-60-0				7.2253877764	4	7		0	-1.00366322					CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC3CCC3)C(=O)C(N)=O)C2(C)C)C(C)(C)C	MedChem Express	HY-10237	0.33623253	0.98362504	1.96812433	1.86185496	4.73381421	1.22213816	-1.00366322									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00388284-12	Darunavir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	635728-49-3		17.5410474839	-4.7559444758	-6.1988450748	4	7		-14.340247792	-9.86687316	0.1292723058	0.8046077173			[H][C@]12OCC[C@@]1([H])[C@H](CO2)OC(=O)N[C@@H](CC3=CC=CC=C3)[C@H](O)CN(CC(C)C)[S+]([O-])(=O)C4=CC=C(N)C=C4	APExBIO	A8206	-0.74749215	2.28009357	-1.42362884	3.02838754	-2.35084543	-2.23476692	-9.86687316									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178864-04	Ethambutol HCl			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1070-11-7				9.1078936108	4	7		0	0					CC[C@@H](CO)NCCN[C@@H](CC)CO	Selleck	S4004	2.49256676	4.79975198	2.13827917	3.6432594	2.29827994	-2.26386545	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015243-17	Clemizole (hydrochloride)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1163-36-6		9.8640558873	-5.0059444758	-45.9503701129	4	7		-27.399937488	-30.89317092	0.0004556064	0.9911732865			ClC1=CC=C(C[N]2C(=NC3=C2C=CC=C3)CN4CCCC4)C=C1	MedChem Express	HY-30234A	-4.30988968	-6.56971337	-5.31450286	-6.75209746	-5.39380311	-14.23499971	-30.89317092									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390283-02	Vesatolimod		Toll-Like Receptor 7 (TLR7) Agonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1228585-88-3		12.4181106199	-4.9059444758	-49.9670827108	-2.2	7		-67.6405724164	-51.62164577	0.0000804287	0.9963179183		TLR7	CCCCOC1=NC2=C(NC(=O)CN2CC3=CC(=CC=C3)CN4CCCC4)C(=N1)N	MedChem Express	HY-15601	-2.50923945	-0.35230123	0.94152345	-2.36754396	-5.93697982	-22.41168597	-51.62164577									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164615-05	Prulifloxacin	384568265	Antibacterial	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	123447-62-1				3.6945318612	4	7		0	-1.00366322					CC1SC/2=C(C(O)=O)/C(=O)C3=CC(=C(C=C3N12)N4CCN(CC4)C\C5=C(C)\OC(=O)O5)F	Glixx	GLXC-06577	0.39736572	0	0	2.71807838	3.11596531	-0.17459117	-1.00366322									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386356-05	Bepotastine (Beslilate)		Histamine H1 receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	190786-44-8				10.0473651725	4	7		0	0					OC(=O)CCCN1CCC(CC1)O[C@@H](C2=CC=C(Cl)C=C2)C3=NC=CC=C3	MedChem Express	HY-A0015	3.12057132	3.73439306	4.34462027	3.26973911	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379032-06	Tasquinimod	384569088	S100A9 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	254964-60-8				-13.9241132966	4	7		0	-6.81716651			6280	S100A9	COC1=CC=CC2=C1C(=C(/C(=O)N(C)C3=CC=C(C=C3)C(F)(F)F)C(=O)N2C)/O	MedChem Express	HY-10528	-3.67077	-2.60702911	-0.45941807	-1.70670038	-2.26323628	-4.19018798	-6.81716651									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016016-28	Triamterene		Heart phosphodiesterase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	396-01-0				-4.1283815691	4	7		0	-2.93355571					NC1=NC(=C2N=C(C3=CC=CC=C3)C(=NC2=N1)N)N	MedChem Express	HY-B0575	-1.68116264	-0.6003213	-0.43673076	-2.62038846	2.05297433	-0.45975674	-2.93355571									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346531-06	Oligomycin A			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	579-13-5		4.9437388825	-5.3059444758	-81.40770872	-2.2	7		-79.006298953	-72.37394645	0.0000228665	0.998041809			[H][C@@]1(C)[C@@H]2CC[C@@H](CC)\C=C/C=C\C[C@@H](C)[C@H](O)[C@@](C)(O)C(=O)[C@@H](C)[C@]([H])(O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)\C=C\C(=O)O[C@H]1[C@H](C)[C@@]3(CC[C@H](C)[C@H](C[C@@H](C)O)O3)O2	APExBIO	A5588	-2.14799789	-0.5439531	1.10600647	-0.16090105	-12.75881202	-47.45969854	-72.37394645									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00485878-01	Nucleoside-Analog-2	363681388	NS5B Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	876708-01-9				8.5293991435	4	7		0	4.67284153					OC[C@]1(O[C@H]([C@@H](O)[C@@H]1O)N2\C=C/C(=O)NC2=O)N=[N+]=[N-]	MedChem Express	HY-77652	1.14207908	4.12333362	0	0	0	3.45108537	4.67284153									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021139-11	5,5-Diphenylhydantoin	170464785		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	57-41-0				-14.3646523859	4	7		0	-4.24397653					O=C1NC(=O)C(N1)(c2ccccc2)c3ccccc3	Vitas	STK182871	-3.18726207	-1.38947606	0.78271227	-3.53407654	-4.62284262	-5.50544142	-4.24397653									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346587-16	Bergenin monohydrate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	477-90-7				-19.2631559774	4	7		0	-2.69529738					[H][C@]12OC(=O)C3=C(C(O)=C(OC)C(O)=C3)[C@]1([H])O[C@H](CO)[C@@H](O)[C@@H]2O	Prestwick	Prestw-NAT-0201	-6.77744741	-3.99368676	-2.43321422	-3.98804735	-4.42426189	-4.12617122	-2.69529738									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016961-11	ATOVAQUONE		Synergistic with proguanil, mitochondrial sensitizer (cytochrome bc1 complex)	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	95233-18-4		0.5546966259	-6.2559444758	-127.6901229628	-1.2	7		-55.9851370332	-63.21887006	0.0004255465	0.9914603049			O\C1=C(/C2CCC(CC2)C3=CC=C(Cl)C=C3)C(=O)C4=C(C=CC=C4)C1=O	Microsource	01504210	-3.33175869	-5.05904569	-6.05184051	-18.41167682	-48.45077826	-53.83227609	-63.21887006									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00522539-01	Trovirdine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	149488-17-5		22.0828704269	-4.6559444758	-22.687651927	4	7		-13.676109448	-15.61485541	0.0065239311	0.9653552142			BrC1=CN=C(NC(=S)NCCC2=NC=CC=C2)C=C1	MedChem Express	HY-15349	-5.13796649	-3.67802486	-2.8529295	-2.55143087	-3.74091055	-2.88075423	-15.61485541									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00381559-05	Resminostat		HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1187075-34-8		13.9333492831	-4.8559444758	-15.5013832777	4	7		-29.2558894519	-20.21324121	0.0044045422	0.9716881486		HDAC1	CN(C)CC1=CC=C(C=C1)[S+]([O-])(=O)[N]2C=CC(=C2)\C=C\C(=O)NO	MedChem Express	HY-14718A	-0.46405646	-0.62286858	3.034428	1.49982761	-2.15810531	-8.24070302	-20.21324121									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00484060-01	NM107	363681153	Picornaviridae Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	20724-73-6				-32.1688619461	4	7		0	-6.11430443					C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1N2/C=C\C(=N/C2=O)N	MedChem Express	HY-10468	-4.84341568	-4.69265241	-8.14474505	-7.14860361	-6.59696872	-9.60833382	-6.11430443									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00481318-01	NCGC00481318-01			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					-11.2491045112	4	7		0	-7.21029276					CN1C(=O)N(C)C2=C([N](CC(=O)NC3=CC=C(N=N3)C4=CC=CC=C4)C=N2)C1=O	MedChem Express	HY-18988	-1.05315808	-3.30599476	-2.08723272	-4.131709	1.51563823	-1.62369784	-7.21029276									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167526-06	Camostat	384568326	Serine Protease Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	59721-29-8				-16.6178046316	4	7		0	-5.56631027					CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1	MedChem Express	HY-13512	-2.54258482	-1.79532708	-2.13827917	-1.67796805	-5.5631808	-5.94191934	-5.56631027									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00381566-06	Nexturastat A			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1403783-31-2		13.9333492831	-4.8559444758	-1.8021020171	4	7		-23.188819728	-16.82401644	0.0005443334	0.9903515401			CCCCN(CC1=CC=C(C=C1)C(=O)NO)C(=O)NC2=CC=CC=C2	MedChem Express	HY-16699	3.74301831	1.33310786	2.77352391	2.66636019	2.10553982	-2.39189897	-16.82401644									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378916-02	MK-5172			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1350514-68-9		11.0676527398	-4.9559444758	-69.7489054237	-2.2	7		-41.4636007058	-46.88626143	0.0005211269	0.9905407497			COC1=CC2=C(C=C1)N=C3CCCCC[C@@H]4C[C@H]4OC(=O)N[C@H](C(=O)N5C[C@@H](C[C@H]5C(=O)N[C@@]6(C[C@H]6C=C)C(=O)N[S+]([O-])(=O)C7CC7)OC3=N2)C(C)(C)C	MedChem Express	HY-15298	-10.41209326	-6.34424058	-10.35675798	-8.36110792	-9.47638934	-19.79863819	-46.88626143									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017375-03	Berbamine dihydrochloride			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	6078-17-7		12.4181106199	-4.9059444758	-47.6330533446	-2.2	7		-82.7835125239	-61.1996307	0.0000182136	0.9982531435			COC1=CC2=C3C=C1OC4=C(OC)C(=CC5=C4[C@@H](CC6=CC=C(O)C(=C6)OC7=CC=C(C[C@@H]3N(C)CC2)C=C7)N(C)CC5)OC	Prestwick	Prestw-NAT-0350	1.58668408	1.96443167	2.1042482	1.94230548	-5.57486202	-23.96554734	-61.1996307									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263180-08	Trametinib	384568648	Mek 1/2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	871700-17-3		13.9333492831	-4.8559444758	-29.0026594112	-2.2	7		-70.8051642492	-53.81362242	0.0001324137	0.9952668888		MAP2K1	CN1C(=O)C(=C/2N(C(=O)N(C3CC3)C(=O)C2=C1/NC4=CC=C(I)C=C4F)C5=CC=CC(=C5)NC(C)=O)\C	APExBIO	A3018	3.07611082	3.04106423	4.95150587	0	1.06591128	-12.94302508	-53.81362242									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00507869-01	LY-3314814	384569343	beta-Secretase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1383982-64-6		12.4181106199	-4.9059444758	-17.3756597113	4	7		-25.215400424	-23.09616702	0.0001951946	0.9942546913		BACE1	CO[C@H]1CC[C@]2(CC1)CC3=C(C=C(C=C3)C4=CN=CC(=C4)C#CC)[C@@]2/5\N=C(C)/C(=N5)N	Selleck	S8193	-1.04204296	-0.76378907	-0.13045204	0.89644868	-0.86733055	-5.56363848	-23.09616702									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510316-01	ombitasvir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1258226-87-7		2.7800686746	-5.5559444758	-102.1067479107	-2.1	7		-88.0496887738	-83.38148137	0.000030492	0.9977374586			COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC2=CC=C(C=C2)[C@@H]3CC[C@H](N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(NC(=O)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)C=C5	MedChem Express	HY-13997	-0.21952372	1.46275471	3.11950542	0.2183657	-24.04871069	-63.76069371	-83.38148137									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167474-06	Candesartan	363676659	Type-1 angiotensin II receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	139481-59-7				10.8073894242	4	7		0	4.9766209					CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=N[NH]5)C(O)=O	Selleck	S1578	3.68188513	0	0.73733764	2.93644409	0	4.46953384	4.9766209									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160217-03	Sophocarpine	363676600	HERG Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	6483-15-4				-2.8110364302	4	7		0	0.19358489				KCNH2	O=C1\C=C/C[C@@H]2[C@H]3CCCN4CCC[C@@H](CN12)[C@@H]34	Selleck	S2405	-1.80898658	-0.16628618	-1.18541206	-1.14354672	-1.05423006	1.13484258	0.19358489									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00599698-01	4-Butylresorcinol Rucinol			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			15.6334750258	-4.8059444758	-1.2643296455	4	7		-26.210262972	-16.84188581	0.0025833817	0.9785676431			CCCCC1=C(O)C=C(O)C=C1	BLD Pharma	BD66959	3.08722594	2.77049689	2.05320175	4.77531318	0.7154747	-2.40935809	-16.84188581									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510921-01	Lucanthone	384569494	DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	548-57-2		3.9269513795	-5.4059444758	-109.0955565154	-2.1	7		-106.6723799056	-96.45590732	0.0000013915	0.9995180892		TOP2A	CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1	SantaCruz Bio	sc-396381	2.21468864	1.99261577	3.50518972	-2.19514998	-20.766288	-68.03817727	-96.45590732									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161831-04	Mefloquine hydrochloride	170465100	antimalarial agents; Inhibtion of heme crystallization	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	51773-92-3		6.2237985085	-5.2059444758	-12.0565443459	4	7		-25.570390444	-20.47532537	0.0000186192	0.9982368065		GJD2	Cl.O[C@@H](c2cc(nc1c2cccc1C(F)(F)F)C(F)(F)F)[C@H]3CCCCN3	SIGMA	M2319	2.67596632	2.81559144	2.77352391	1.2987013	-0.41176299	-10.87702962	-20.47532537									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263617-13	M-344	384568694	HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	251456-60-7				-20.092619155	4	7		0	-8.87810108				HDAC1	CN(C)C1=CC=C(C=C1)C(=O)NCCCCCCC(=O)NO	MedChem Express	HY-13506	-2.05351933	-10.68459175	-0.11343656	-1.04011033	-3.88108519	-4.34732003	-8.87810108									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095522-06	DIMETHYLCAFFEIC ACID			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	14737-89-4				10.9602490559	4	7		0	0					COC1=CC=C(/C=C/C(O)=O)C=C1OC	Microsource	00210567	2.34807014	1.61494885	2.21201293	0	4.90319189	4.67904324	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015074-17	ACETAZOLAMIDE		Carbonic anhydrase XII Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	59-66-5				-14.4034760093	4	7		0	-5.22679215					CC(=O)NC1=NN=C(S1)[S+](N)([O-])=O	Microsource	01500102	-4.94900936	-0.41994307	-1.66184561	-2.87323296	-3.48976433	-3.42780655	-5.22679215									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482516-02	Ginsenoside Rb2			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	11021-13-9		9.5580002666	-5.0196329617	-6.7912033787	4	7		-17.987655244	-15.40637937	0.0319170322	0.9170580761			CC(C)=CCC[C@](C)(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)[C@H]3CC[C@]4(C)[C@@H]3[C@H](O)C[C@@H]5[C@@]6(C)CC[C@H](OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)[C@@H]6CC[C@@]45C	MedChem Express	HY-N0040	-1.34215133	3.48073617	0.38568431	0	4.00373799	1.39090962	-15.40637937									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00092314-15	Triciribine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	35943-35-2		11.0676527398	-4.9559444758	-15.4944718396	4	7		-11.806221524	-11.92185127	0.1824015996	0.7505138532			CN1N=C(N)C2=CN([C@@H]3O[C@H](CO)[C@@H](O)C3O)C4=C2C1=NC=N4	MedChem Express	HY-15457	-2.38141551	-2.35337223	-0.890477	-5.04539708	2.17562714	-4.75469941	-11.92185127									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091823-01	Chrysophanol	17389107	VEGFR-1/2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	481-74-3	CHRYSOPHANOL;Chrysophanic acid (1,8-Dihydroxy-3-methylanthraquinone)	1.9681378985	-5.7059444758	-96.8434076823	-2.2	7	chrysophanic acid, ion (1-);Chrysophanic acid;chrysophanic acid;1,8-Dihydroxy-3-methylanthraquinone;CHRYSOPHANOL;NCGC00160154-01;Chrysophanol:9,10-Anthracenedione,1,8-dihydroxy-3-methyl;CHRYSOPHANIC ACID;Chrysophanic acid (1,8-Dihydroxy-3-methylanthraquinone);AB08582917-01;2-methyl-4,5-dihydroxyanthraquinone;chrysophanol 8-O-(6'-galloyl)glucopyranoside;1,8-Dihydroxy-3-methyl-anthraquinone;chrysophanol;CIPLUS_153453;3-methyl-1,8-dihydroxyanthraquinone;Chrysophanic Acid;NCGC00091823-02;chrysophanol 8-O-GGlc;	-71.2085865544	-60.44911696	0.0006411562	0.9894841496	2321	FLT1	CC1=CC(=C2C(=O)C3=C(O)C=CC=C3C(=O)C2=C1)O	NIEHS	AB08582917	-0.16950565	-0.73560497	-3.99863876	-12.73991495	-32.80962532	-42.53040796	-60.44911696									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263184-03	MK-0752		g-Secretase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	471905-41-6		6.2237985085	-5.2059444758	-10.1247707817	4	7		-17.0444947399	-15.03707895	0.0063435409	0.9657396465		NOTCH1	OC(=O)CCC1CCC(CC1)(C2=CC(=CC=C2F)F)[S+]([O-])(=O)C3=CC=C(Cl)C=C3	Adooq	A11194	1.03092783	0	3.6016108	0	0.05548579	-7.80422511	-15.03707895									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161602-07	Doxycycline		Matrix Metalloproteinase (MMP) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[1293992-19-4]		9.8640558873	-5.0059444758	-4.8162540981	4	7		-19.295008484	-15.66250707	0.0118135189	0.9522113967		MMP1	C[C@@H]1[C@H]\2[C@H](O)[C@H]3[C@H](N(C)C)\C(=C(C(N)=O)/C(=O)[C@@]3(O)\C(=C2C(=O)C4=C(O)C=CC=C14)O)O	Tocris	4090	0.47517159	4.8335729	1.06063184	0.67233651	2.16978653	-4.27166385	-15.66250707									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183128-02	Glycyrrhizic acid			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1405-86-3				8.9401875879	4	7		0	-5.34592132					[H][C@@]7(O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@]1([H])O[C@H]2CC[C@@]3(C)[C@@]([H])(CC[C@]4(C)[C@]3([H])C(=O)C=C5[C@]6([H])C[C@](C)(CC[C@]6(C)CC[C@@]45C)C(O)=O)C2(C)C)C(O)=O)O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)C(O)=O	Prestwick	Prestw-NAT-0335	3.79303637	2.83813872	0	2.81002184	3.8927664	3.61403713	-5.34592132									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00274060-07	Posaconazole			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	171228-49-2		2.7800686746	-5.5559444758	-119.6731070332	-1.1	7		-92.3338356658	-85.94275844	0.0001130322	0.9956285117			CC[C@@H]([C@H](C)O)N1\N=C/N(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@@H]5CO[C@](CN6C=NC=N6)(C5)C7=CC=C(F)C=C7F)C=C4	APExBIO	A1718	-3.09834107	0.13246526	-1.24213034	-2.37903689	-25.95274947	-73.98009661	-85.94275844									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346532-04	VX-222			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1026785-59-0		13.9333492831	-4.8559444758	-70.6745318062	-2.2	7		-48.3124685811	-44.10459541	0.0000222438	0.9980701741			C[C@H]1CC[C@@H](CC1)C(=O)N([C@@H]2CC[C@H](O)CC2)C3=C(SC(=C3)C#CC(C)(C)C)C(O)=O	MedChem Express	HY-75800	-8.52807958	-7.8379978	-8.31489989	-9.98161131	-11.38626873	-22.06832334	-44.10459541									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015264-24	Clomipramine hydrochloride	384567835	Serotonin Transporter (SERT) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	17321-77-6		9.8640558873	-5.0059444758	-22.8954116229	4	7		-28.332504388	-26.52708699	0.0022370745	0.9800794333		SLC6A4	CN(C)CCCN1C2=C(CCC3=C1C=C(Cl)C=C3)C=CC=C2	MedChem Express	HY-B0457	-0.42515353	0.77506271	-3.40876865	-0.43098494	0.21902287	-9.48612	-26.52708699									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095649-07	Trigonelline hydrochloride			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	6138-41-6				8.3628957137	4	7		0	0					C[N+]1=CC(=CC=C1)C([O-])=O	Prestwick	Prestw-NAT-0039	1.28101815	0.98926186	3.66967274	2.05148833	1.3170575	2.69452366	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016759-38	Naproxen sodium			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	26159-34-2				-15.3583395693	4	7		0	-1.37296364					COC1=CC2=CC=C(C=C2C=C1)[C@H](C)C(O)=O	DC Chemicals	DC9000	-2.19801595	-3.90913447	-2.84725767	-5.6315366	-3.09260287	-3.32887156	-1.37296364									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094792-17	Tioguanine		Purine Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	154-42-7				-15.8586457796	4	7		0	-2.90377342				HPRT1	NC/1=N/C2=C([NH]C=N2)C(=S)N1	MedChem Express	HY-13765	-4.31544724	-2.44919816	-4.23685554	-3.61452707	-3.92781006	-2.08927428	-2.90377342									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482625-01	Dendrobine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	2115-91-5				2.5170653003	4	7		0	1.34318134					CC(C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@@H]3CC[C@@H]4CN(C)[C@H]2[C@]34C	DC Chemicals	DCS-082	-2.99830494	1.25419238	1.48034712	3.51683715	-0.68627165	-0.07565617	1.34318134									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00371122-02	Betrixaban	363678038	Coagulation factor X Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	330942-05-7		12.4181106199	-4.9059444758	-32.7414648058	4	7		-29.570092624	-28.80841052	0.0090812895	0.9584404556			COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC3=NC=C(Cl)C=C3	MedChem Express	HY-10268	-5.91046767	-4.81666244	-1.73557938	0.2356051	-3.34374909	-9.73054763	-28.80841052									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00242506-13	Bortezomib	384568504	Proteasome Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	179324-69-7				1.4275397749	4	7		0	-0.31867052				PSMD1	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)B(O)O	ActiveBioChem	A-1014	1.18653958	0.58904766	-1.76961035	0.13791518	1.68501592	0.49467497	-0.31867052									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386421-08	Verdinexor		Exportin-1 Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1392136-43-4		6.9832167823	-5.1559444758	-71.0827308328	-2.2	7		-66.0999252308	-62.91509069	0.0000111899	0.9986316561		XPO1	FC(F)(F)C1=CC(=CC(=C1)C(F)(F)F)C2=N[N](\C=C/C(=O)NNC3=CC=CC=N3)C=N2	MedChem Express	HY-15970	-3.8930725	-3.79076125	-2.28007487	-2.0399954	-7.91110592	-34.4584764	-62.91509069									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015500-24	Haloperidol		Dopamine D2 Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	52-86-8				4.7986132839	4	7		0	-4.1486732					OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3	Selleck	S1920	1.09206102	0	2.62038455	1.5343064	3.5890547	1.19303963	-4.1486732									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389337-01	Epoxomicin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	134381-21-8				6.8829343245	4	7		0	2.0639128					CC[C@H](C)[C@H](NC(=O)[C@H]([C@@H](C)CC)N(C)C(C)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1	APExBIO	A2606	4.04868425	0	1.20809937	3.66624526	0	-0.50631438	2.0639128									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094932-06	LANATOSIDE C			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	17575-22-3				13.5233657629	4	7		0	4.27971528					CC1O[C@@H](CC(O)[C@H]1O[C@H]2CC(O)[C@@H](O[C@H]3CC(OC(C)=O)[C@H](O[C@H]4OC(CO)C(O)C(O)C4O)[C@@H](C)O3)C(C)O2)OC5CC[C@]6(C)C(CCC7C6CC(O)[C@@]8(C)C(CC[C@@]78O)\C9=C\C(=O)OC9)C5	Microsource	MS-01501205	4.99902743	4.52354781	4.19148091	0	0	2.56067043	4.27971528									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00371133-07	Atglistatin	363678049	Patatin-like phospholipase domain-containing protein 2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1469924-27-3		12.4181106199	-4.9059444758	-82.7198347554	-2.2	7		-91.529487254	-75.45939185	0.0000131998	0.9985134384	57104	PNPLA2	CN(C)C(=O)NC1=CC=CC(=C1)C2=CC=C(C=C2)N(C)C	Glixx	GLXC-04086	-3.404007	-5.01395113	-3.39742499	-5.42466383	-11.56732763	-32.73584357	-75.45939185									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510523-01	Pimodivir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1629869-44-8				9.5887206935	4	7		0	-4.23206361					OC(=O)[C@H]1C2CCC(CC2)[C@@H]1NC3=NC(=NC=C3F)C4=C[NH]C5=NC=C(F)C=C45	MedChem Express	HY-12353A	1.98682858	1.87987937	4.70761726	4.29261004	4.38337762	-0.27934587	-4.23206361									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346712-02	Verteporfin		photosensitizer	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	129497-78-5		0.4943738883	-6.3059444758	-224.0375869647	-1.1	7		-87.1837631772	-97.76037168	0.0003609433	0.992142843			COC(=O)CCC1=C(C)C2=CC3=NC(=CC4=C(C)C(=C([NH]4)C=C\5N=C(C=C1[NH]2)\C(=C5C)CCC(O)=O)C=C)\C6=C\C=C(/[C@@H](C(=O)OC)[C@@]36C)C(=O)OC	Selleck	S1786	-5.15463918	-9.47267552	-18.91554648	-30.27812895	-87.09225243	-96.08915789	-97.76037168									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346443-01	Rupintrivir	174007383	HRV 3C Protease Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	223537-30-2	AG-7088 (Rupintrivir)			5.2613155964	4	7		0	-3.28498675					CCOC(=O)\C=C\[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@@H](NC(=O)C2=NOC(=C2)C)C(C)C)CC3=CC=C(F)C=C3	Axon Medchem	1571	0	1.00617232	-0.31762237	2.43075509	3.93949128	2.9505907	-3.28498675									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00092388-15	Conessine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	546-06-5				4.8613776123	4	7		0	0.88453406					[H][C@]12CC[C@@]3([H])[C@]4([H])CC=C5C[C@H](CC[C@]5(C)[C@@]4([H])CC[C@]13CN(C)[C@H]2C)N(C)C	Enzo	NP495	2.02017395	1.6600434	0.03403097	3.12607746	0.70379348	-1.13484258	0.88453406									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00601824-01	UPGL00004			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1890169-95-5		6.2237985085	-5.2059444758	-54.5534412231	-2.2	7		-63.5592369811	-58.38818239	0.0000230549	0.9980339435			O=C(CC1=CC=CC=C1)NC2=NN=C(NC3CCN(CC3)C4=NN=C(NC(=O)CC5=CC=CC=C5)S4)S2	Selleck	S8778	-0.6808014	2.1166258	1.79796949	-0.51718193	-3.70002628	-33.05592737	-58.38818239									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390668-02	(±)-BI-D			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1416258-16-6		11.0676527398	-4.9559444758	-0.5671650296	4	7		-16.000580752	-13.75048396	0.0022038919	0.9802927508			CC1=NC2=C(C=CC=C2)C(=C1C(OC(C)(C)C)C(O)=O)C3=CC4=C(OCCC4)C=C3	MedChem Express	HY-18601	0.35290522	1.6600434	2.22335659	2.86174003	2.71880384	-0.24442763	-13.75048396									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166142-07	Diperodon HCl		sodium ion transmembrane transport Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	537-12-2		13.9333492831	-4.8559444758	-0.244692514	4	7		-15.6278702679	-12.18989189	0.0283650554	0.9225942472			O=C(NC1=CC=CC=C1)OCC(CN2CCCCC2)OC(=O)NC3=CC=CC=C3	APExBIO	A8413	3.23172257	3.99932358	0	0	1.55068189	0.16877146	-12.18989189									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162241-09	N6-Methyladenosine		DNA oxidative demethylase ALKBH1 Substrate	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1867-73-8				2.4685922908	4	7		0	3.63046133			8846	ALKBH1	CNC1=C2N=C[N]([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1	MedChem Express	HY-N0086	-1.08650346	1.97570531	0.90182066	-0.37926675	-1.44555092	0.79147995	3.63046133									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386310-01	Selinexor		Exportin-1 Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1393477-72-9		11.0676527398	-4.9559444758	-15.8052829162	-3	7		-37.16609584	-32.6384132	0.0014190782	0.9842303555		XPO1	FC(F)(F)C1=CC(=CC(=C1)C2=N[N](\C=C/C(=O)NNC3=CN=CC=N3)C=N2)C(F)(F)F	Selleck	S7252	4.88787618	0	0.22687312	1.87334789	2.29243933	-7.11749985	-32.6384132									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346716-03	Dabrafenib		Raf kinase B Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1195765-45-7		12.4181106199	-4.9059444758	-32.6376713719	-2.2	7		-67.766372812	-51.7169491	0.0000062783	0.9989757346		BRAF	CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(F)C(=CC=C3)N[S+]([O-])(=O)C4=C(F)C=CC=C4F	ChemieTek	CT-DABRF	2.6203907	2.05462078	1.86035959	3.5915412	-0.48769091	-17.24378746	-51.7169491									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482751-01	Casticin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	479-91-4		1.5633475026	-5.8059444758	-91.3723202647	-1.2	7		-34.0237606263	-40.31033148	0.0009001308	0.9875039618			COC1=C(O)C=C(C=C1)\C2=C(/OC)C(=O)C3=C(O)C(=C(OC)C=C3O2)OC	DC Chemicals	DCM-037	-9.95081557	-7.0093853	-7.78174806	-10.54476497	-21.44379873	-43.92131758	-40.31033148									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346719-03	LY-2811376	384568932	beta-Secretase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1194044-20-6		15.6334750258	-4.8059444758	-22.1054908791	4	7		-23.9166088961	-24.68058492	0.0007549419	0.9885944767		BACE1	C[C@]\1(CCS\C(=N1)N)C2=CC(=C(F)C=C2F)C3=CN=CN=C3	Axon Medchem	2225	-1.99238614	-0.58341084	-2.12126368	-3.58004827	-1.52731945	-3.2648548	-24.68058492									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00023945-24	Zidovudine		Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	30516-87-1				6.029630532	4	7		0	1.52783155					C\C1=C\N([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O	MedChem Express	HY-17413	0.03056659	0	0	2.3445581	3.55401104	1.54804167	1.52783155									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378936-01	Letermovir	363678286	Tripartite terminase subunit UL28 homolog Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	917389-32-3		8.7913490634	-5.0559444758	-39.5522892701	-2.2	7		-50.6933019604	-46.73734997	0.0000870357	0.9961690123	3077457	TRM1	COC1=CC(=CC=C1)N2CCN(CC2)/C3=N/C4=C(F)C=CC=C4[C@H](CC(O)=O)N3C5=CC(=CC=C5OC)C(F)(F)F	MedChem Express	HY-15233	1.18098202	-1.40638652	-0.21552947	-1.70095391	-0.34167567	-18.81510796	-46.73734997									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00021305-27	Sirolimus		mTOR Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	53123-88-9		4.9437388825	-5.3059444758	-66.1004553742	-2.2	7		-76.8734550478	-69.18724127	0.0000354531	0.9975597797		MTOR	CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC	Enzo	A275	1.2587879	4.76029424	3.77176564	-0.57464659	-7.70668458	-43.86894023	-69.18724127									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016622-11	Hycanthone			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	3105-97-3		6.2237985085	-5.2059444758	-77.4684155217	-2.1	7		-88.5613217331	-82.46418679	0.0000158041	0.9983728855			CCN(CC)CCNC1=C2C(=O)C3=C(SC2=C(CO)C=C1)C=CC=C3	Prestwick	Prestw-355	0.42515353	2.30827767	1.23645851	-1.91931962	-6.5852875	-44.09590875	-82.46418679									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346536-05	PIK-93		PI3K Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	593960-11-3		12.4181106199	-4.9059444758	6.2557017113	4	7		-16.384504276	-11.57042023	0.0044510607	0.9716035398		PIK3CA	CC(=O)NC1=NC(=C(S1)C2=CC(=C(Cl)C=C2)[S+]([O-])(=O)NCCO)C	Adooq	A10731	3.581849	4.05005496	1.6391583	3.62602	4.71629238	0.18041087	-11.57042023									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178090-03	Pristimerin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1258-84-0		0.6983216782	-6.1559444758	-156.4412013813	-1.1	7		-90.2041427128	-85.98445364	0.0000016388	0.9994769738			COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)\C4=C\C=C\5\C(=C(\O)C(=O)\C=C5[C@]4(C)CC[C@@]3(C)[C@@H]2C1)C	SIGMA	P0020	2.92049907	2.37028269	-2.66008735	-19.08401333	-60.69853693	-81.7668626	-85.98445364									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159564-05	Scriptaid			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[287383-59-9]		11.0676527398	-4.9559444758	-12.2968382615	4	7		-27.170116452	-20.14176371	0.0069815455	0.9638982322			ONC(=O)CCCCCN1C(=O)C2=CC=CC3=C2C(=CC=C3)C1=O	Tocris	2421	-0.05835441	0.27338576	2.9947252	3.94782209	-1.64997226	-7.91479951	-20.14176371									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015950-14	SB-415286		GSK-3 beta Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	264218-23-7		4.9437388825	-5.3059444758	-87.7020803158	-2.1	7		-95.1469577388	-86.72901093	0.0000148244	0.9984242178		GSK3B	OC1=C(Cl)C=C(N\C2=C(\C(=O)NC2=O)C3=C(C=CC=C3)[N+]([O-])=O)C=C1	MedChem Express	HY-15438	3.12057132	0	4.24252737	0.15515458	-11.19936921	-56.29983123	-86.72901093									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095709-02	Tanshinone IIA	50107688	TNF-alpha Production Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	568-72-9	TANSHINONE IIA	2.2082870427	-5.6559444758	-134.9802753065	-2.1	7	Tanshinone Iia;tanshinone;Tanshinone IIA;CIPLUS_762550;1,6-dimethylphenanthro(1,2-b)furan-10,11-dione;NCGC00095709-01;Tanshinon I;NCGC00095709-02;tanshinone IIB;tanshinone IIA;LS-175776;TANSHINONE IIA;tanshinone II A;CIPLUS_742126;tanshinone II B;	-98.0287164421	-91.19635465	0.0000420936	0.9973398689	7124	TNF	CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C	Prestwick Chemical, Inc.	GPN1A_01G09	-1.97015589	-0.38612215	-3.50518972	-8.27491093	-39.02403411	-71.26229413	-91.19635465									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016623-07	Moroxydine HCl		antiinfluenza drug	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	3160-91-6				5.0177851522	4	7		0	3.49941925					NC(=N)NC(=N)N1CCOCC1	Selleck	S2486	-1.67004752	1.94752121	0.47643355	-0.70681531	0.94909909	3.49182331	3.49941925									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346705-02	PMSF	384568924	Serine Protease Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	329-98-6				-36.5088411265	4	7		0	-7.39494297					[O-][S+](F)(=O)CC1=CC=CC=C1	Selleck	S3025	-8.40025565	-8.45804797	-8.8423799	-6.36708424	-10.22982799	-4.62084619	-7.39494297									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025297-10	Gabexate mesilate		NF-kappaB Activation Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	56974-61-9				-53.9854823848	4	7		0	-8.65175567				NFKB1	CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1	MedChem Express	HY-B0385	-5.62703198	-4.42772188	-48.06874256	-4.77531318	-0.45264726	-7.4841413	-8.65175567									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095150-16	Telmisartan	384568151	Angiotensin AT1 Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	144701-48-4		2.4777388143	-5.6059444758	-4.5432257037	4	7		-11.07754758	-7.55576734	0.0233151084	0.9306759624		AGT	CCCC1=NC2=C(C=C(C=C2C)C3=NC4=CC=CC=C4[N]3C)[N]1CC5=CC=C(C=C5)C6=CC=CC=C6C(O)=O	Enzo	DL511	1.48664796	0.10991798	4.0667007	2.11469946	1.94200274	-10.48128965	-7.55576734									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378981-01	RO-9187			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	876708-03-1				-11.8614863902	4	7		0	-7.07925068					NC/1=N/C(=O)N(/C=C1)[C@@H]2O[C@@](CO)(N=[N+]=[N-])[C@@H](O)[C@@H]2O	MedChem Express	HY-10870	-2.53702726	0.07046025	-4.63955533	-2.12044593	-0.66874982	-1.80992842	-7.07925068									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00076924-03	Salicylanilide			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	87-17-2		15.6334750258	-4.8059444758	-22.9144651558	4	7		-12.3716695079	-13.03570897	0.0054773783	0.9685772355			OC1=CC=CC=C1C(=O)NC2=CC=CC=C2	Selleck	S4187	-2.72598438	-2.77049689	-4.24252737	-3.82139984	-4.19647811	-5.27847291	-13.03570897									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178317-04	Foscarnet Sodium		Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	63585-09-1				-5.3240999644	4	7		0	-2.42130029					[O-][C](=[O])[P]([O-])([O-])=[O]	Selleck	S3076	-2.75932976	2.78177053	-1.29884862	-0.77002643	-2.82977543	-1.00098935	-2.42130029									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093846-07	3-Deazaadenosine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	6736-58-9				5.1345514299	4	7		0	0					NC1=NC=CC2=C1N=CN2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O	Bio Vision	2771	3.38733432	0	4.06102887	0	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379006-04	PSI-6206			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	863329-66-2				13.7577126607	4	7		0	4.98257736					C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N2\C=C/C(=O)NC2=O	MedChem Express	HY-15236	-1.35882402	1.99825259	4.41835404	3.04562694	2.82393482	4.9525694	4.98257736									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160391-12	Auranofin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	34031-32-8				7.9577388515	4	7		0	-0.67010156					CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O	Cayman	15316	4.37658043	0	4.23685554	0	4.59363958	-1.18140022	-0.67010156									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017338-03	Antimycin A	124883057	Antifungal Agent	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1397-94-0	Antimycin A;ANTIMYCIN A1	5.5469662594	-5.2559444758	-89.0985542173	-2.1	7	Antimycin- A from Streptomyces sp.;Antimycin A1;NCGC00016578-01;9   Antimycin A (A3+A4 >90%);ANTIMYCIN A;ANTIMYCIN A (A1 shown);NCGC00142516-03;NCGC_Prestw-222;NCGC00095884-01;ANTIMYCIN A1;Butanoic acid, 2(or 3)-methyl-, 3-((3-(formylamino)-2-hydroxybenzoyl)amino)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester;LS-86460;CIPLUS_155874;Antimycin A;NCGC00142516-02;CIPLUS_158270;	-95.9017124864	-85.03737678	0.0000044632	0.9991363997			CCCCCC[C@@H]1[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)[C@@H](NC(=O)C2=C(O)C(=CC=C2)NC=O)[C@@H](C)OC1=O	BIOMOL	NP-009	0.34734765	3.01288013	0.26090409	-0.68382944	-13.60570044	-52.66833498	-85.03737678									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00345794-11	MLN-4924	384568745	NEDD8-Activating Enzyme (NAE) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	905579-51-3		12.4181106199	-4.9059444758	-44.1627568876	-2.2	7		-69.4081811988	-53.71831909	0.000052403	0.997031248		NAE1	N[S+]([O-])(=O)OC[C@@H]1C[C@H](C[C@@H]1O)[N]2C=CC3=C2N=CN=C3N[C@H]4CCC5=C4C=CC=C5	ChemieTek	CT-M4924	-0.49184428	0.83143091	1.74692303	0.43098494	-5.11929445	-20.08380376	-53.71831909									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263155-04	Belinostat	384568629	HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	414864-00-9		6.2237985085	-5.2059444758	-35.4146235929	-2.2	7		-52.7494117944	-46.06427018	0.0000672133	0.9966358054		HDAC1	ONC(=O)/C=C/C1=CC(=CC=C1)[S+]([O-])(=O)NC2=CC=CC=C2	Selleck	S1085	2.41476089	3.11434289	3.47115875	2.14917826	-4.17895628	-22.82488506	-46.06427018									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017236-16	Baicalein	384567977	Cyp2C9 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	491-67-8		11.0676527398	-4.9559444758	-63.6694465699	-2.2	7		-87.3376567256	-65.78610358	0.0002647211	0.9932850087		CYP2C9	OC1=CC2=C(C(=O)\C=C(/O2)C3=CC=CC=C3)C(=C1O)O	APExBIO	N1858	2.65373607	2.0320735	-1.24213034	-3.30996437	-11.5498058	-29.97730315	-65.78610358									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346560-12	telbivudine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	3424-98-4				9.6963546781	4	7		0	0					C\C1=C\N([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O	DC Chemicals	DC4211	3.53183094	3.21580564	4.57149339	2.66061372	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090774-05	Nitazoxanide	170465090	antiprotozoal agent	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	55981-09-4	Nitazoxanide; ; Alinia; Nitazoxanida; Nitazoxanide	5.5469662594	-5.2559444758	-70.1121399074	-2.2	7		-79.181508172	-69.8960598	0.0000308743	0.9977234344			O=C(Nc1ncc(s1)[N+]([O-])=O)c2ccccc2OC(C)=O	Vitas	STK395664	3.62075194	2.27445675	0.16448301	-1.8043903	-8.44260141	-43.29860909	-69.8960598									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378626-06	TMP269	363678130	Histone deacetylase 9 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1314890-29-3		15.6334750258	-4.8059444758	-50.9648456646	4	7		-20.2077341119	-23.86455014	0.0021791345	0.980410958	9734	HDAC9	FC(F)(F)C1=NC(=NO1)C2=CC(=CC=C2)C(=O)NCC3(CCOCC3)C4=NC(=CS4)C5=CC=CC=C5	Glixx	GLXC-05455	-8.36135271	-7.65198275	-7.44143838	-8.97023331	-10.32327775	-12.430891	-23.86455014									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164140-08	DOCUSATE SODIUM			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	577-11-7				4.2330062233	4	7		0	-3.5768532					CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)[S]([O-])(=O)=O	Microsource	01503881	-2.55369995	4.67574195	3.18756735	3.06286634	4.6695675	-4.37059885	-3.5768532									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346841-07	LY-411575	384568950	g-Secretase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	209984-57-6		11.0676527398	-4.9559444758	-0.5211822437	4	7		-22.65479346	-18.87899455	0.0006216665	0.98967062		NOTCH1	C[C@H](NC(=O)[C@@H](O)C1=CC(=CC(=C1)F)F)C(=O)N[C@@H]2C(=O)N(C)C3=C(C=CC=C3)C4=C2C=CC=C4	MedChem Express	HY-50752	3.23728013	1.73332206	4.50910328	2.70083898	2.6311947	-1.21631845	-18.87899455									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390568-02	Bevirimat		Gag-Pol polyprotein Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	174022-42-5		6.9832167823	-5.1559444758	-45.9364613998	-2.2	7		-63.2765434723	-56.64889657	0.0000462036	0.9972129868			CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O	MedChem Express	HY-N0842	0	4.16279135	1.93409336	1.66072865	-2.17562714	-28.58057382	-56.64889657									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390686-01	NBD-557	363680970	Envelope glycoprotein gp160 Binding Agent	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	333352-59-3				4.1983611948	4	7		0	-0.11615094					CC1(C)CC(CC(C)(C)N1)NC(=O)C(=O)NC2=CC=C(Br)C=C2	MedChem Express	HY-76649	1.02537027	-0.2564753	1.58811185	0.26433743	2.85313787	0.65180702	-0.11615094									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095143-05	Rosuvastatin Calcium			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	147098-20-2		9.8640558873	-5.0059444758	-0.3372181823	4	7		-10.8463680439	-8.62197337	0.025961705	0.9267155384			CC(C)C1=C(\C=C\C(O)CC(O)CC(O)=O)C(=NC(=N1)N(C)[S+](C)([O-])=O)C2=CC=C(F)C=C2	Selleck	S2169	1.61447189	1.78405344	1.99081164	-0.41374555	3.06924043	-1.97288017	-8.62197337									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00180626-04	Cephaeline			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	483-17-0		15.6334750258	-4.8059444758	-18.4236339365	-3	7		-44.801903092	-32.75158591	0.0008040343	0.9882074583			CC[C@H]1CN2CCC3=C(C=C(OC)C(=C3)OC)[C@@H]2C[C@@H]1C[C@H]4NCCC5=C4C=C(OC)C(=C5)O	Carbosynth	FC19891	-0.77527996	3.39054705	1.99648347	2.3100793	-0.82060567	-7.78094628	-32.75158591									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179623-07	Lisinopril		Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	83915-83-7				9.236220963	4	7		0	0					NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N2CCC[C@H]2C(O)=O	Prestwick	Prestw-301	3.74857587	0	0	2.30433284	4.09718775	4.93511028	0									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00188641-04	PLpro inhibitor			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1093070-14-4				5.3901507975	4	7		0	0.13997677					C[C@@H](NC(=O)C1=C(C)C=CC(=C1)NC(C)=O)C2=C3C=CC=CC3=CC=C2	MedChem Express	HY-17542	-0.49184428	-0.16628618	3.15920821	0	2.86481909	2.22312751	0.13997677									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00070736-17	Imiquimod	384568073	TLR 7 Receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	99011-02-6				12.7318212137	4	7		0	0				TLR7	CC(C)C[N]1C=NC2=C(N)N=C3C=CC=CC3=C12	MedChem Express	HY-B0180	1.68116264	3.58783574	3.95326414	2.18365705	3.02835616	4.55682942	0									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00163589-02	LUTEOLIN-7-GLUCOSIDE			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			3.499899101	-5.4559444758	-100.8436062903	-2.2	7		-82.7235309916	-59.63903863	0.0009051223	0.987464684			OC[C@H]1O[C@@H](OC2=CC(=C3C(=O)\C=C(/OC3=C2)C4=CC=C(O)C(=C4)O)O)[C@H](O)[C@@H](O)[C@@H]1O	Analyticon	NP-001730	0.77527996	-3.62729348	-8.39997731	-19.6126882	-28.24226849	-40.17342722	-59.63903863									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379057-02	TMC353121		Respiratory syncytial virus Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	857066-90-1		4.9437388825	-5.3059444758	-89.7217531507	-2.1	7		-100.4204723421	-86.36566697	0.0000057175	0.999022364			CC1=CC=C(CCCO)C(=C1)NCC2=CC=C3N=C(NCCCN4CCOCC4)[N](CC5=NC(=CC=C5O)C)C3=C2	MedChem Express	HY-11097	1.00314002	4.19097545	3.17055187	0.22985864	-16.0412347	-55.76441832	-86.36566697									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263639-15	Tacedinaline		HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					-4.533493544	4	7		0	-6.76355839				HDAC1	CC(=O)NC1=CC=C(C=C1)C(=O)NC2=C(N)C=CC=C2	SIGMA	C0621	-2.62594826	-1.72768524	-0.47076173	1.63199632	0.32999445	1.39672933	-6.76355839									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016925-21	Omeprazole	384567968	ABCC3 Expression Enhancer	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	73590-58-6		15.6334750258	-4.8059444758	-6.3790374829	4	7		-20.637072996	-14.69756083	0.0262770885	0.9257800585		ABCC3	COC1=CC2=C([NH]C(=N2)[S+]([O-])CC3=C(C)C(=C(C)C=N3)OC)C=C1	MedChem Express	HY-B0113	2.53702726	3.55965164	-0.53315183	1.17802551	-1.78430628	-2.91567247	-14.69756083									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164361-03	Decanedioic acid			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					-1.8324827507	4	7		0	-3.78532924					OC(=O)CCCCCCCCC(O)=O	Analyticon	NP-002989	-2.77044488	2.39282997	1.82632863	-0.33904149	0.66874982	-1.89140429	-3.78532924									3.19E-9	1.59E-8	7.9699999999E-8	3.99E-7	0.00000199	0.00000997	0.0000498								
NCGC00168085-15	Vorinostat (SAHA)		HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	149647-78-9				1.2867486685	4	7		0	-2.96929446				HDAC1	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1	Microsource	01502267	-2.85936588	-0.61723176	2.29709035	2.31582577	1.08927372	1.76337077	-2.96929446									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166328-02	Ammonium diethyldithiocarbamate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	21124-33-4				-8.6651631986	4	7		0	-0.86666468					CCN(CC)C(S)=S	SIGMA	359548	-0.83085559	-3.61601984	-1.41228518	-1.87909436	-2.29827994	-1.73427225	-0.86666468									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00182080-04	Valpromide			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	2430-27-5				-4.1825512836	4	7		0	-0.10423802					CCCC(CCC)C(N)=O	SIGMA	V3640	-2.37585795	-1.58112793	-0.76569678	-0.24135157	0.30663201	-0.32590351	-0.10423802									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00371120-06	Dapivirine?TMC-120	363678036	Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	244767-67-7		7.8352981002	-5.1059444758	-35.8645760942	-2.2	7		-57.5867111383	-48.92932662	0.0003125773	0.9926972397			CC1=CC(=C(NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C(=C1)C)C	Glixx	GLXC-04864	-1.05315808	4.20224909	3.41444047	3.05137341	-1.0775925	-22.98201711	-48.92932662									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164524-02	D-Glucuronolactone	50111689		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01		Glucuronolactone; D-Glucurone; D-Glucurono-6,3-lactone; 			6.4704619832	4	7	NCGC00164524-01;mannurono-gamma-lactone;D-(+)-Glucurono-6,3-lactone;GLUCUROLACTONE;GLUCURONOLACTONE, D-;CIPLUS_672794;D-Glucurone;D-Glucurono-6,3-lactone;Glucurolactone;CIPLUS_149024;mannuronolactone;D-(+)-Glucuronic acid gamma-lactone;Glucuronolactone;D(+)-Glucuronic acid gamma-lactone;	0	4.33332341					[H][C@]1(O)C(O)O[C@]2([H])[C@]([H])(O)C(=O)O[C@]12[H]	Labotest	LT03210628	1.00314002	-1.13581917	1.80364131	-0.63785772	4.76301726	0.89623465	4.33332341									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00018130-08	PHENAZOPYRIDINE HYDROCHLORIDE			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	136-40-3, 94-78-0 [phenazopyridine]		6.2237985085	-5.2059444758	-97.3978551894	-2.1	7		-88.6588350676	-84.70977157	0.0000576293	0.996885242			NC1=CC=C(\N=N\C2=CC=CC=C2)C(=N1)N	Microsource	MS-01500473	-2.38141551	-4.33189594	-1.93976519	-4.78105965	-15.29947727	-46.80789152	-84.70977157									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095125-15	Losartan potassium		Angiotensin II receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	124750-99-8		11.0676527398	-4.9559444758	4.0795657444	4	7		-15.334127528	-11.11177294	0.0064460227	0.9655114894			CCCCC1=NC(=C(CO)[N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[NH]4)Cl	Glixx	GLXC-05212	2.47589407	3.30035794	1.59378368	4.88449603	2.62535409	-0.58197055	-11.11177294									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159459-03	Mycophenolate mofetil	29215410	Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	128794-94-5	 Mycophenolate mofetil; ;MYCOPHENOLATE MOFETIL; Cellcept;	12.4181106199	-4.9059444758	-1.2159360317	4	7	Mycophenolate mofetil hydrochloride;mycophenolic acid morpholinoethyl ester;RS 61443;Mycophenolate Mofetil;Mycophenolate Mofetil Hydrochloride;mycophenolate mofetil hydrochloride;MYCOPHENOLATE MOFETIL HYDROCHLORIDE;RS-61443;Cellcept;CIPLUS_196921;mycophenolate mofetil;CIPLUS_739758;2-(4-MORPHOLINO)ETHYL (E)-6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL)-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-4-HEXENOATE;HS_286;LS-172327;Mycophenolate mofetil;LS-172272;MYCOPHENOLATE MOFETIL;CIPLUS_660816;	-14.807249012	-13.17270751	0.0398685748	0.905797755	727833	IMPDH1	COC1=C(C\C=C(/C)CCC(=O)OCCN2CCOCC2)C(O)=C3C(=O)OCC3=C1C	AKos	AKJ-92025	0	0	0	4.4017929	3.46640189	0.33172321	-13.17270751									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178086-06	AMINOLEVULINIC ACID HYDROCHLORIDE		DNA Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	5451-09-2				-27.0030814269	4	7		0	-5.07788069					NCC(=O)CCC(O)=O	Microsource	01504184	-6.95528941	-4.4615428	-5.94407578	-4.07424434	-5.28283153	-8.30471978	-5.07788069									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015436-09	Fluphenazine hydrochloride	124880096	Nicotinic alpha7 Receptor Ligands	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	146-56-5	 Motipress; Liogen;Fluphenazine; Flumezin;; ; Fluphenazine dihydrochloride;Fluphenazine di?HCl; Flufenazine; Prolixin; Lyogen; Motival;Fluphenazine dihydrochloride; Fluphenazine Hcl; prolixin S	6.2237985085	-5.2059444758	-98.4122804978	-2.2	7	FLUPHENAZINE 2HCl	-75.9144552934	-71.05161271	0.0001062504	0.9957631972	1813	DRD2	OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1	BIOMOL	AC753	-5.16019674	-5.07031933	-6.95933299	-6.17745087	-20.81885349	-43.19385439	-71.05161271									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159341-20	LAMIVUDINE			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	134678-17-4				-3.6485468303	4	7		0	-0.86070822					[H][C@@]1(CO)O[C@@]([H])(CS1)N2C=CC(N)=NC2=O	Microsource	01503839	0.06946953	-2.1448099	-3.85117123	0.90794162	-0.70963409	1.1639411	-0.86070822									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163654-01	HARRINGTONINE	26757033		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					-10.6266004595	4	7	Harringtonine;harringtonine hydrochloride;CIPLUS_701701;HARRINGTONINE;LS-52750;NCGC00163654-01;LS-177419;LS-176258;harringtonine, (S)-isomer;harringtonin;CIPLUS_214594;harringtonine;harringtonine, (R)-isomer;LS-176636;	0	-2.98120737					[H][C@]12[C@H](OC(=O)[C@](O)(CCC(C)(C)O)CC(=O)OC)C(OC)=C[C@@]13CCCN3CCC4=CC5=C(OCO5)C=C24	BIOMOL	BIOMOL_NP-435	-1.1698669	-2.92269102	-4.14610629	-0.2356051	-2.14058348	-2.37443985	-2.98120737									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00013226-25	Trifluoperazine hydrochloride	384567788	CaMK-II Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	440-17-5		6.2237985085	-5.2059444758	-74.1617043727	-2.2	7		-82.9426988674	-71.87956041	0.0000361032	0.9975374415		DRD2	CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1	MedChem Express	HY-B0532A	-0.1472754	2.92832784	-0.91883614	-1.27571543	-12.16306982	-40.32473957	-71.87956041									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016403-11	Mafenide (Acetate)		Carbonic anhydrase II Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	13009-99-9				0.5648882263	4	7		0	3.08842362					NCC1=CC=C(C=C1)[S+](N)([O-])=O	MedChem Express	HY-B0614A	-1.74785339	0.52140582	-0.13045204	0	-0.49937213	0.27934587	3.08842362									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00420698-02	BPTES	384569223	Glutaminase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[314045-39-1]		1.241811062	-5.9059444758	-25.1128173948	4	7		-13.41736018	-10.70077732	0.0457069016	0.8978194837		GLS	O=C(CC1=CC=CC=C1)NC2=NN=C(CCSCCC3=NN=C(NC(=O)CC4=CC=CC=C4)S3)S2	Tocris	5301	-3.17058938	0.63977904	0.47643355	-0.52867486	-8.78719738	-16.59780015	-10.70077732									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346545-08	Telaprevir (VX-950)	384568831	HCV NS3 NS4A Protease Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	402957-28-2		2.4777388143	-5.6059444758	-141.1295890013	-1.1	7		-103.6172500836	-96.21169253	0.0000115622	0.9986087443			CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C3=NC=CN=C3)C4CCCCC4)C(C)(C)C)C(=O)C(=O)NC5CC5	APExBIO	A4031	-0.4584989	-0.30720667	-2.27440304	-10.15975175	-35.7299302	-80.46324856	-96.21169253									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017352-31	Resveratrol		Cyclooxygenase-2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			1.241811062	-5.9059444758	-135.4154607352	-1.1	7		-91.282291453	-86.53244781	0.0000634814	0.9967299172		PTGS2	OC1=CC=C(C=C1)/C=C/C2=CC(=CC(=C2)O)O	Analyticon	NP-012969	-1.14207908	4.12333362	0.81107141	-15.13044478	-44.05279911	-73.15369842	-86.53244781									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159462-20	Ritonavir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	155213-67-5		12.4181106199	-4.9059444758	-31.4065138883	-2.2	7		-54.7113798132	-41.44801501	0.0000117225	0.9985998729			[H][C@](CC1=CC=CC=C1)(C[C@]([H])(O)[C@]([H])(CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)NC(=O)[C@@]([H])(NC(=O)N(C)CC4=CSC(=N4)C(C)C)C(C)C	MedChem Express	HY-90001_cm1	2.09797983	0.89907274	1.32153593	-0.20687277	-1.66165348	-16.05656754	-41.44801501									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016872-19	Ticlopidine hydrochloride	384567964	P2Y12 (P2T) Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	53885-35-1		22.0828704269	-4.6559444758	-39.4083171295	-3	7		-76.6265151689	-68.53203085	0.0011969695	0.9855375994		P2RY12	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1	MedChem Express	HY-B0153A	-4.81562787	-2.59011865	-2.47858885	-1.39064475	2.67207896	3.77698888	-68.53203085									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386330-03	Z-FA-FMK			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	197855-65-5				7.8221763453	4	7		0	2.37364863					C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2)C(=O)CF	DC Chemicals	DC7567	-2.09797983	2.84941236	0	0	4.96159799	3.62567654	2.37364863									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017254-11	Cyanein	404904668	Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	20350-15-6				8.532713611	4	7		0	3.61854841				GBF1	C[C@H]1CCC/C=C/C2C[C@H](O)C[C@H]2[C@H](O)\C=C\C(=O)O1	APExBIO	B1400	0.91421902	3.44127843	3.57325166	4.15469486	-0.05548579	-2.5257522	3.61854841									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482848-01	Orientin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	28608-75-5				-41.8881151624	4	7		0	-13.87556959					OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C2=C(O)C=C(O)C3=C2O\C(=C/C3=O)C4=CC(=C(O)C=C4)O	DC Chemicals	DCH-044	-8.22241365	-6.12440461	-7.24292439	-6.80956212	-10.90733873	-10.41727289	-13.87556959									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016777-10	Probucol	384567958	Serine Protease Hepsin Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	23288-49-5		1.241811062	-5.9059444758	-26.0112711935	4	7		-10.408747016	-11.67168002	0.1562870965	0.7761286133			CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(O)C(=C2)C(C)(C)C)C(C)(C)C	Selleck	S2119	-4.97679718	-5.41980215	1.12869378	1.39639122	-7.44969775	-13.25728918	-11.67168002									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015673-19	Minoxidil		K(ATP) Channel Activator	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	38304-91-5				-10.0956767006	4	7		0	-1.49804926					NC1=[N+]([O-])C(=NC(=C1)N2CCCCC2)N	MedChem Express	HY-B0112	-1.50887821	-3.80767171	0.16448301	-2.86174003	-3.26198055	-2.08927428	-1.49804926									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00508898-01	UCPH 101			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[1118460-77-7]		3.1192883571	-5.5059444758	-70.7282478213	-2.2	7		-69.1425827193	-62.41474819	0.000025596	0.9979279036			COC1=CC=C(C=C1)C\2C(=C(/N)O\C3=C2C(=O)CC(C3)C4=C5C=CC=CC5=CC=C4)/C#N	Tocris	3490	0.98646734	3.21016882	4.40701038	-0.17814044	-16.32158397	-46.20846185	-62.41474819									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094857-06	AMINACRINE			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			11.0676527398	-4.9559444758	-13.506960849	4	7		-15.737483996	-15.19790333	0.0107388317	0.9546908679			NC1=C2C=CC=CC2=NC3=C1C=CC=C3	Microsource	MS-01500810	-3.18726207	-0.30720667	-0.18717032	0.36777382	-0.14893555	-4.49863237	-15.19790333									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389393-01	Lopinavir		HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	192725-17-0		9.8640558873	-5.0059444758	-28.390114035	-2.2	7		-51.0951842044	-42.49635167	0.0000414814	0.9973605947			CC(C)C(N1CCCNC1=O)C(=O)NC(CC(O)C(CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4	APExBIO	A8204	3.09834107	0.23392802	2.09857637	2.20664291	-0.07300762	-16.03328872	-42.49635167									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166276-06	N-ACETYLNEURAMIC ACID			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	131-48-6				10.3272603337	4	7		0	0					CC(=O)N[C@H]([C@@H](O)CC(=O)C(O)=O)[C@@H](O)[C@H](O)[C@H](O)CO	Microsource	MS-02300147	0	3.86403991	4.31626113	2.36179749	0	4.23092592	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482591-01	Atractylon			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	6989-21-5		6.3095734448	-5.2	-71.7803726216	-2.2	7		-68.3982487968	-60.90776424	0.0011523552	0.9858161584			CC1=COC2=C1C[C@H]3C(=C)CCC[C@]3(C)C2	DC Chemicals	DCZ-188	1.34770889	1.83478481	-1.70154841	-1.09182853	-28.34739947	-45.13763604	-60.90776424									6.38E-9	3.1899999999E-8	1.59E-7	7.97E-7	0.00000399	0.0000199	0.0000997								
NCGC00095095-04	SENNOSIDE A		Helv Chim Acta 33: 313 (1950)	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	81-27-6		1.9681378985	-5.7059444758	-149.376731641	-1.1	7		-97.7441552209	-98.27858355	0.0000570625	0.9969004315			[H][C@@]1(C2=CC(=CC(O)=C2C(=O)C3=C1C=CC=C3O[C@@H]4OC(CO)C(O)C(O)C4O)C(O)=O)[C@@]5([H])C6=CC(=CC(O)=C6C(=O)C7=C5C=CC=C7O[C@@H]8OC(CO)C(O)C(O)C8O)C(O)=O	Microsource	MS-01504078	-0.54186234	0.34102759	-3.77743747	-9.21733134	-34.36322752	-92.07938078	-98.27858355									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00484798-01	Anagliptin	363681178	Dipeptidyl peptidase IV Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	739366-20-2				-18.881953603	4	7		0	-7.77019984					CC1=N[N]2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N	MedChem Express	HY-14877	-4.44882874	-5.48744398	-1.50870626	-3.8616251	-4.16727506	-1.82156783	-7.77019984									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095122-14	Irbesartan			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	138402-11-6				10.0798633296	4	7		0	0.60458052					CCCCC/1=N/C2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=N[NH]5	MedChem Express	HY-B0202	1.55333871	0	4.96852135	4.26962418	0	3.21829715	0.60458052									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510185-01	CCT365623			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	N/A		12.4181106199	-4.9059444758	-17.7992557549	-2.4	7		-30.771212432	-21.47601036	0.0003089918	0.9927540181			C[S+]([O-])(=O)C1=CC(=CC(=C1)C2=CC=CC=C2)[S+]([O-])(=O)C3=CC=C(CN)S3	Glixx	GLXC-10154	1.39216939	0.9723514	0.99256991	-0.62061832	-3.11596531	-8.84595239	-21.47601036									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00264069-01	OLEANDRIN		Sodium/potassium-transporting ATPase Blocker	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			8.7913490634	-5.0559444758	-11.367534039	4	7		-21.5765107079	-19.23042559	0.6163147396	0.9882335226			CO[C@@H]1C[C@@H](OC(C)[C@H]1O)O[C@H]2CC[C@@]3(C)[C@H](CCC4C3CC[C@]5(C)[C@H]([C@H](C[C@]45O)OC(C)=O)/C6=C/C(=O)OC6)C2	Microsource	MS-01501209	-21.79398116	0.98362504	0.07940559	1.011378	2.2749175	-7.0593028	-19.23042559									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00186037-10	Ibandronate sodium hydrate	384568439	Treatment of Osteoporosis	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	138926-19-9				8.0463183946	4	7		0	0					CCCCCN(C)CCC(O)([P](O)(O)=O)[P](O)([O-])=O	APExBIO	B1772	3.06499569	0	1.89439056	4.12021607	3.96869433	0	0									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00262641-04	S31-201	384568576	STAT-3 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	501919-59-1		7.8352981002	-5.1059444758	-5.8127388222	4	7		-9.853858292	-9.04488191	0.1238757188	0.8103095332		STAT3	CC1=CC=C(C=C1)[S+]([O-])(=O)OCC(=O)NC2=CC=C(C(O)=O)C(=C2)O	Selleck	S1155	-1.85900464	-0.14937572	-0.73733764	3.70072405	1.25281079	-3.75952977	-9.04488191									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346877-07	Batimastat	384568955	Matrix Metalloproteinase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	130370-60-4		15.6334750258	-4.8059444758	-18.0674027498	4	7		-10.562222812	-10.92116627	0.0790449803	0.8590674101		MMP1	CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(C)C)[C@H](CSC2=CC=CS2)C(=O)NO	MedChem Express	HY-13564	-3.63186706	-2.34209859	-4.37865124	-2.48821974	-0.45264726	-4.4287959	-10.92116627									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016786-25	Mycophenolic acid		Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	24280-93-1				-4.1945697448	4	7		0	-3.27307383				IMPDH1	COC1=C(C)C2=C(C(=C1C\C=C(/C)CCC(O)=O)O)C(=O)OC2	MedChem Express	HY-B0421	1.1254064	-0.89907274	0.69196302	-0.75278704	-1.89527787	-1.76919048	-3.27307383									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00247556-02	Fangchinoline			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	436-77-1		6.2237985085	-5.2059444758	-63.1140726094	-2.2	7		-81.160466991	-68.56181315	0.0001282134	0.9953424455			COC1=C2OC3=CC=C(C[C@@H]4N(C)CCC5=CC(=C(OC6=C(O)C(=CC7=C6[C@H](CC(=C2)C=C1)N(C)CC7)OC)C=C45)OC)C=C3	DC Chemicals	DCF-007	3.27618307	4.39390096	2.24037207	-0.83323756	-11.70166165	-35.86684514	-68.56181315									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00480778-01	Scutellarin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	27740-01-8		12.4181106199	-4.9059444758	-14.438339856	4	7		-29.80151592	-23.5845966	0.0009038526	0.9874934864			O[C@@H]1[C@@H](O)[C@@H](O[C@@H]([C@H]1O)C(O)=O)OC2=C(O)C(=C3C(=O)/C=C(OC3=C2)/C4=CC=C(O)C=C4)O	Adooq	A12117	-0.08614222	1.33874468	2.91531961	-0.2528445	0.21902287	-7.00692545	-23.5845966									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025208-05	Splitomicin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	5690-03-9				11.0011700658	4	7		0	0					O=C1CCC2=C3C=CC=CC3=CC=C2O1	Enzo	GR-331	2.44810626	3.15943745	1.50870626	3.01689461	2.28075811	3.40452773	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166296-02	L-(+)-Lysine monohydrochloride	225144279	Serotonin 4 (5-HT4) receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	657-27-2				0.0645461239	4	7		0	0.13997677					NCCCC[C@H](N)C(O)=O	Bosche	L1919	-2.27026426	1.66568022	-1.75826669	-0.46546374	2.12890226	-0.84967701	0.13997677									2.13E-11	1.06E-10	5.32E-10	2.66E-9	1.3299999999E-8	6.64E-8	3.32E-7								
NCGC00016343-13	Gramine	376241757		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	87-52-5				-19.6406208221	4	7		0	-7.10903297					CN(C)CC1=C[NH]C2=C1C=CC=C2	CANVASS	578ff292f1709662a82ed8de	-1.39772696	-2.93396466	-3.26130112	-5.22928399	-4.71629238	-5.24355468	-7.10903297									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00013216-05	2,3-Dimercapto-1-propanol			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	59-52-9		9.8640558873	-5.0059444758	-26.9053816404	-2.4	7		-36.9693391279	-27.89111594	0.0000695446	0.9965808952			OC[C@H](S)CS	SIGMA	D1129	-0.29732959	0.82579409	0.62390108	0.17814044	-4.85646702	-13.94401443	-27.89111594									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167465-07	Calcipotriol		Vitamin D receptor Activator	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	112965-21-6		9.8640558873	-5.0059444758	-85.1129020691	-2.2	7		-72.8400916672	-63.57625756	0.000069572	0.9965765335			C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]2CC[C@H]3\C(CCC[C@]23C)=C\C=C/4C[C@@H](O)C[C@H](O)C4=C	MedChem Express	HY-10001	-6.29949704	-7.79290324	-3.81714026	-8.25767153	-12.97491458	-34.8833149	-63.57625756									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164600-15	Artesunate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	88495-63-0				-18.5446459287	4	7		0	-3.74363404					C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(O)=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4	MedChem Express	HY-N0193	-6.6607386	-5.38598123	-1.61079916	-4.20066659	-1.93032153	-4.13199092	-3.74363404									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00247490-02	3-Hydroxy-4-methoxycinnamic acid			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			20.1627060996	-4.6954511803	-29.2646278012	-2.2	7		-58.2527176324	-44.50963457	0.0003541985	0.9922213869			COC1=C(O)C=C(\C=C\C(O)=O)C=C1	Analyticon	NP-013745	-1.95904076	-0.53831628	2.24037207	1.49982761	-3.47808311	-16.84804749	-44.50963457									3.19E-9	1.59E-8	7.9699999999E-8	3.99E-7	0.00000199	0.00000997	0.0000498								
NCGC00169121-02	Neochlorogenic acid			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			9.8640558873	-5.0059444758	-12.5250560885	4	7		-15.4944604879	-14.99538374	0.0410558229	0.904168384			O[C@@H]1C[C@@](O)(C[C@@H](OC(=O)\C=C\C2=CC(=C(O)C=C2)O)[C@H]1O)C(O)=O	Analyticon	NP-000060	-2.29805207	-2.99596967	0.83375872	1.84461556	0.98998335	-5.0573241	-14.99538374									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165733-10	Apicidin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	183506-66-3		8.7913490634	-5.0559444758	-48.3917927098	-2.2	7		-64.2086994127	-55.08234804	0.0003085664	0.9927444382			CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2=C[N](OC)C3=CC=CC=C23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]4CCCCN4C1=O	Enzo	GR-340	-0.7697224	-1.57549111	1.02092905	3.54556947	-4.76885787	-25.17022639	-55.08234804									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390564-04	GS7340			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	379270-37-8				-26.0746585508	4	7		0	-6.42999672					CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)C[N]1C=NC2=C1N=CN=C2N)OC3=CC=CC=C3	Glixx	GLXC-07981	-5.7437408	-5.08159297	-5.9497476	-6.67164694	-3.5306486	-5.65675377	-6.42999672									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482790-01	tetrahydroxyl diphenylethylene-2-o-glucoside			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	82373-94-2		15.6334750258	-4.8059444758	-47.1966983402	4	7		-28.1062674561	-29.40405635	0.0070211815	0.9637863656			OC[C@H]1O[C@@H](OC2=C(O)C=C(O)C=C2\C=C\C3=CC=C(O)C=C3)[C@H](O)[C@@H](O)[C@@H]1O	DC Chemicals	DCS-029	-6.19946092	-6.72754432	-5.92138846	-5.14883347	-10.51017726	-11.03416167	-29.40405635									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263555-02	Spautin-1	174006174	Ubiquitin Specific Peptidase (USP10/13) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1262888-28-7	Spautin-1			8.9582262691	4	7		0	-4.10102153			84669	USP10	FC1=CC=C(CNC2=C3C=C(F)C=CC3=NC=N2)C=C1	SIGMA	SML0440	2.12576764	1.96443167	4.82672565	4.43052523	-2.01209006	4.6383053	-4.10102153									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00402337-02	BGP-15	384569215	Insulin Sensitizers	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	66611-37-8				-36.1203898975	4	7		0	-3.67811299				PARP1	N\C(=N/OCC(O)CN1CCCCC1)C2=CN=CC=C2	Glixx	GLXC-05825	-9.02826021	-7.73089823	-9.33015711	-8.43006551	-9.14347458	-5.52290054	-3.67811299									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00160670-08	Mecarbinate	384568202	antiinfluenza drug	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	15574-49-9		13.9333492831	-4.8559444758	-35.5695553855	-2.2	7		-56.2042767371	-46.98752122	0.0003609283	0.9921466227			CCOC(=O)C1=C(C)[N](C)C2=CC=C(O)C=C12	MedChem Express	HY-B0376	-2.41476089	2.34209859	-1.63348647	0.01149293	-1.94784335	-11.87801897	-46.98752122									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00485876-01	Nucleoside-Analog-1			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	876707-99-2				7.7455648826	4	7		0	0					OC[C@]1(O[C@@H]2[C@@H](OC\3=N\C(=O)\C=C/N23)[C@@H]1O)N=[N+]=[N-]	MedChem Express	HY-77651	2.40920332	2.26318311	0.1417957	1.09182853	2.2749175	2.97968923	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095192-08	Tegaserod maleate		5-HT4 Partial Agonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	189188-57-6		6.2237985085	-5.2059444758	-53.3706494864	-2.2	7		-61.5375107991	-56.05325074	0.0003758594	0.9919820083		HTR4	CCCCCNC(=N)N/N=C/C1=C[NH]C2=C1C=C(OC)C=C2	Cayman	14692	0	4.01059722	0	-1.5343064	-7.67164092	-28.88901822	-56.05325074									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00356072-01	N/A	363677795	Lysine-specific histone demethylase 1 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			3.1192883571	-5.5059444758	-50.5546457746	-2.2	7		-47.6845906359	-41.0489323	0.0011773543	0.9856640073			N[C@H]1C[C@H]1C2=CC=C(C=C2)C3=CC=CC(=C3)O	Selleck	S7237	1.21988496	-1.3161974	3.95893596	-2.05148833	-14.88479397	-28.27212943	-41.0489323									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379064-01	R-7128	377020456		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	940908-79-2				8.3486513584	4	7		0	-1.03344551					CC(C)C(=O)OC[C@H]1O[C@@H](N2/C=C\C(=N/C2=O)N)[C@](C)(F)[C@@H]1OC(=O)C(C)C	MedChem Express	HY-10240	4.60444049	0	3.28398843	1.10906792	0	3.87010417	-1.03344551									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263219-03	Elacridar	384568673	P-Glycoprotein (MDR-1) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	143664-11-3		2.7800686746	-5.5559444758	-119.8337059245	-1.1	7		-98.6466628972	-93.5312863	0.0000017773	0.9994553068		ABCBA	COC1=C2NC3=C(C=CC=C3C(=O)NC4=CC=C(CCN5CCC6=C(C5)C=C(OC)C(=C6)OC)C=C4)C(=O)C2=CC=C1	Selleck	S7772	0.7697224	2.09407852	0.81107141	-4.62590507	-25.10002044	-74.85305244	-93.5312863									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00408830-04	BRD73954			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1440209-96-0		5.5469662594	-5.2559444758	-12.7101812429	4	7		-7.6104923	-8.42541025	0.2004740341	0.7334996622			ONC(=O)C1=CC(=CC=C1)C(=O)NCCC2=CC=CC=C2	Tocris	6284	-0.61966821	-4.21915955	-0.34598151	-2.33306516	1.71421896	-6.04667404	-8.42541025									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379154-03	U-104	363678388	Carbonic anhydrase XII Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	178606-66-1				10.9714725563	4	7		0	-0.14593323					N[S+]([O-])(=O)C1=CC=C(NC(=O)NC2=CC=C(F)C=C2)C=C1	APExBIO	A4358	1.22544252	2.34773541	3.4598151	0	4.69292994	4.12035151	-0.14593323									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090691-14	Didanosine		Human immunodeficiency virus type 1 reverse transcriptase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	69655-05-6				9.5630502072	4	7		0	-0.54501593					OC[C@@H]1CC[C@@H](O1)[N]2C=NC3=C2\N=C/NC3=O	MedChem Express	HY-B0249	2.05907689	0.18883346	-0.76569678	4.82703138	4.7863797	3.06698481	-0.54501593									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183682-13	VX-765		Caspase-1 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	273404-37-8				-10.9698141538	4	7		0	-5.62587485				CASP1	CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)C3=CC(=C(N)C=C3)Cl)C(C)(C)C	ChemieTek	CT-VX765	-2.43699114	-0.80888363	-0.11910839	-1.03436387	-1.39298543	-5.73822965	-5.62587485									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159491-11	Rimantadine		M2 Channel Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1501-84-4				7.0379947208	4	7		0	0					CC(N)C12CC3CC(CC(C3)C1)C2	MedChem Express	HY-B0338A	0	0	0.97555442	4.22939892	0	4.86527382	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510187-01	BMS-663068			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	864953-29-7				-10.4925418157	4	7		0	-0.96792447					COC1=CN=C([N]2C=NC(=N2)C)C3=C1C(=C[N]3CO[P](O)(O)=O)C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5	Glixx	GLXC-90326	-3.63186706	-5.33524985	-0.4253871	0.2183657	-2.28659872	-2.93895129	-0.96792447									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164319-07	EPIGALLOCATECHIN-3-MONOGALLATE			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	989-51-5		0.1968137898	-6.7059444758	-232.0064391415	-1.1	7		-95.4145440655	-95.15144295	0.0000312132	0.9977107375			OC1=CC(=C2C[C@@H](OC(=O)C3=CC(=C(O)C(=C3)O)O)[C@H](OC2=C1)C4=CC(=C(O)C(=C4)O)O)O	Microsource	MS-00210239	-3.33175869	-14.02722584	-25.70472463	-54.53970808	-75.18324913	-87.51091195	-95.15144295									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163638-01	TUBERCIDIN	26757019		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					5.4809206493	4	7	NCGC00163638-01;CIPLUS_740558;7-DEAZAADENOSINE;Sparsomycin A;CIPLUS_158314;CIPLUS_149167;7 Deazaadenosin;xylotubercidin hydrochloride;7-Deazaadenosine;LS-139541;Tubercidin;4-Amino-7 beta-D-ribofuranosyl-7H-pyrrolo(2,3-d)pyrimidine;Deazaadenosine;7H-Pyrrolo(2,3-d)pyrimidin-4-amine, 7-beta-D-ribofuranosyl-;ara-tubercidin;TUBERCIDIN;CIPLUS_701898;xylotubercidin;	0	0					NC1=C2C=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1	BIOMOL	BIOMOL_NP-327	-0.48628671	2.61830275	2.61471272	1.43661648	0	1.64115696	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090726-30	Ribavirin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	36791-04-5				8.4691986755	4	7		0	0					NC(=O)C1=NN(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O	Bio Vision	2199	2.1757857	-0.58904766	4.50343146	4.15469486	1.93616214	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263096-16	Iniparib	384568587	PARP Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[160003-66-7]				-12.5377132977	4	7		0	-4.44053966				PARP1	NC(=O)C1=CC(=C(I)C=C1)[N+]([O-])=O	Tocris	5817	-4.33767749	-1.47402835	-1.76961035	-1.46534881	-2.16394592	-3.51510214	-4.44053966									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346526-03	PHA-680632	384568820	Aurora-A/B/c Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	398493-79-3		13.9333492831	-4.8559444758	-31.0624551646	-2.2	7		-58.8360038096	-44.19394228	0.0002311929	0.9937311995		AURKA	CCC1=CC=CC(=C1NC(=O)N2CC3=C(C2)C(=N[NH]3)NC(=O)C4=CC=C(C=C4)N5CCN(C)CC5)CC	Selleck	S1454	-0.19729347	1.81787436	3.23861381	0.84473049	-2.96410945	-13.85671885	-44.19394228									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018261-09	Perhexiline	384568001	mitochondrial carnitine palmitoyltransferase-1 inhbitior	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	6724-53-4, 6621-47-2 [perhexiline]		7.8352981002	-5.1059444758	-36.9498815478	-2.2	7		-36.7164725879	-33.09706049	0.0016677565	0.982868317			C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3	Microsource	01503227	-0.16950565	-0.2282912	0.20418581	-4.21215952	-7.13430482	-16.37083164	-33.09706049									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159337-04	Efavirenz	170464810	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	154598-52-4	 Sustiva;0   Efavirenz;DMP-266;L-743726; ;Stocrin;Sustiva; efavirenz (EFV or EFZ); Efavirenz;Efavirenz; efavirenz, (R)-isomer	13.9333492831	-4.8559444758	-29.085441167	-2.2	7		-48.9452303668	-38.59487149	0.0013321824	0.9847303157	7015	TERT	FC(F)(F)[C@@]3(C#CC1CC1)OC(=O)Nc2ccc(Cl)cc23	Vitas	STK582240	0.59743796	0.84270455	3.02875617	-2.98816228	-2.29243933	-11.67432928	-38.59487149									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166076-09	Arbutin		Free Radical Scavenger	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	497-76-7				11.3182961338	4	7		0	3.38624654					OC[C@H]1O[C@@H](OC2=CC=C(O)C=C2)[C@H](O)[C@@H](O)[C@@H]1O	Prestwick	Prestw-1026	2.12021008	0.99489868	4.83239748	0	2.62535409	3.08444393	3.38624654									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00247668-03	LDN-57444	384568515	Reversible, competitive Inhibitor of UCH-L1 deubiquitinase	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	668467-91-2		3.9269513795	-5.4059444758	-99.5696532384	-2.1	7		-99.9027429465	-88.25386425	0.0000019735	0.9994260015			CC(=O)O/N=C/1C(=O)N(CC2=CC(=CC=C2Cl)Cl)C3=CC=C(Cl)C=C13	XcessBio	M60204-2s	4.0709145	1.17527691	2.36515229	-1.81013677	-19.7500219	-61.83437118	-88.25386425									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263621-06	I-BET762		Brd4 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1260907-17-2				4.1898682053	4	7		0	-3.05864133				BRD4	CCNC(=O)C[C@@H]1\N=C(C2=CC=C(Cl)C=C2)/C3=C(C=CC(=C3)OC)[N]4C(=NN=C14)C	Cayman	10676	1.1698669	-0.03100251	0	1.22974371	4.63452384	1.33853227	-3.05864133									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163523-01	CATALPOL	26756908		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					6.7390031924	4	7	NCGC00163523-01;CIPLUS_668279;CATALPOL;catalpol;	0	0					[H][C@@]12C=CO[C@@H](O[C@]3([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@]1([H])[C@@]4(CO)O[C@H]4[C@H]2O	BIOMOL	BIOMOL_NP-046	2.50368189	1.78405344	0.84510238	0.26433743	4.32497153	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00651732-01	ROC-325			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1859141-26-6		0.6766545996	-6.1696329617	-49.9039216897	4	7		-26.99758764	-27.4979897	0.0003158112	0.9926643039			CN(CCNC1=CC=NC2=C1C=CC(Cl)=C2)CCNC3=CC=C(C)C4=C3C(=O)C5=CC=CC=C5S4	Selleck	S8527	-0.77527996	1.35565514	-1.28183313	-0.86196989	-13.66994714	-23.94226852	-27.4979897									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00402247-01	BG45			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	926259-99-6				-9.7691348423	4	7		0	-2.11752092					NC1=C(NC(=O)C2=NC=CN=C2)C=CC=C1	SynKinase	SYN-5062	-2.62594826	-4.57991601	-0.38001248	-1.55729227	-1.97120579	-1.35017168	-2.11752092									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00347064-06	KUC107871N		p97 ATPase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1346527-98-7		3.499899101	-5.4559444758	-69.0777939472	-2.2	7		-73.3153497879	-66.51279149	0.0000030221	0.9992895976		VCP	COC1=C2N=C(N=C(NCC3=CC=CC=C3)C2=CC=C1)[N]4C(=NC5=C4C=CC=C5)N	SIGMA	SML1071	2.5759302	3.70057214	4.73030458	0.63785772	-12.06962007	-48.17552232	-66.51279149									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00183109-05	Maraviroc	384568416		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	376348-65-1				-14.6979024813	4	7		0	-2.99907675				CCR5	CC(C)C1=NN=C(C)N1C2CC3CCC(C2)N3CC[C@H](NC(=O)C4CCC(F)(F)CC4)C5=CC=CC=C5	Enzo	AC3169	-3.66521244	-3.42436797	-4.03834156	-4.54545455	-0.57530006	-2.6305069	-2.99907675									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378589-01	Merimepodib	363678106	Inosine-5'-monophosphate dehydrogenase 2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	198821-22-6		12.4181106199	-4.9059444758	-41.3648673917	-2.2	7		-74.9745659224	-56.04133782	0.0003412712	0.9923646967			COC1=CC(=CC=C1C2=CN=CO2)NC(=O)NC3=CC(=CC=C3)CNC(=O)O[C@H]4CCOC4	MedChem Express	HY-13986	-1.41995721	4.15151771	3.43712779	1.52855994	-3.92196945	-20.73561078	-56.04133782									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346833-03	PD-151746			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	179461-52-0		2.7800686746	-5.5559444758	-143.0822798756	-2.1	7		-95.4439175555	-91.35122256	0.0000721144	0.9965134287			OC(=O)/C(S)=C/C1=C[NH]C2=C1C=C(F)C=C2	Glixx	GLXC-06766	-5.02681524	-3.1763479	-4.52611877	-16.33145615	-33.34112081	-73.59017634	-91.35122256									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00389721-01	Q-VD-OPh hydrate	363680840	Irreversible pan-Caspase inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1135695-98-5				-24.0770275162	4	7		0	-10.88542752				CASP3	CC(C)C(NC(=O)C1=NC2=CC=CC=C2C=C1)C(=O)NC(CC(O)=O)C(=O)COC3=C(F)C=CC=C3F	APExBIO	A1901	-2.43143357	-4.47281644	-3.61295446	-2.88472589	-3.64162019	-9.2707909	-10.88542752									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163651-06	DIHYDROTANSHINONE I			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			2.7800686746	-5.5559444758	-130.5786955114	-2.1	7		-94.4375200109	-91.43461298	0.0000032694	0.9992610142			C[C@H]1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3C=CC=C4C	Microsource	01505825	-1.76452608	-4.0331445	-2.17231014	-8.79783933	-31.70575008	-69.46400512	-91.43461298									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346542-10	Hesperadin		Aurora Kinase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	422513-13-1		11.0676527398	-4.9559444758	-73.2257489834	-2.2	7		-106.3900140024	-79.46213182	0.0000501567	0.9970952324		AURKA	CC[S+]([O-])(=O)NC1=CC=C2NC(=O)C(=C(NC3=CC=C(CN4CCCCC4)C=C3)/C5=CC=CC=C5)/C2=C1	Glixx	GLXC-03283	0.91421902	0.90470956	3.93624865	-3.29272497	-9.23108373	-38.043415	-79.46213182									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346637-05	Odanacatib	384568871	Cathepsin K Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	603139-19-1				-1.1935806064	4	7		0	-1.03344551				CTSK	CC(C)(F)C[C@H](N[C@@H](C1=CC=C(C=C1)C2=CC=C(C=C2)[S+](C)([O-])=O)C(F)(F)F)C(=O)NC3(CC3)C#N	MedChem Express	HY-10042	-0.21396615	-1.18091373	0.95853894	0.86771635	0.64538738	-2.01361811	-1.03344551									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164564-09	Emtricitabine		Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	143491-57-0				3.6852505186	4	7		0	2.83825238					NC\1=N\C(=O)N(\C=C1F)[C@@H]2CS[C@H](CO)O2	MedChem Express	HY-17427	0.79195265	-1.87424255	1.05496001	1.95954488	1.00166457	0.22114881	2.83825238									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346946-03	CDK9 Inhibitor		CDK 9 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1415559-43-1		4.4061119169	-5.3559444758	-57.5327771118	-2.2	7		-62.9038627602	-57.81040593	0.0000381854	0.9974672969		CDK9	CC1=CC=C(NC2=NC=NC(=C2)C3=CC=CC(=C3)N4C(=O)C5=C(C=CC=C5)C4=O)C=C1N[S+](C)([O-])=O	MedChem Express	HY-13231	1.67560508	4.18533863	0	1.45385588	-6.7605058	-39.21899552	-57.81040593									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386359-03	Santacruzamate A (CAY10683)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1477949-42-0				-17.3586482611	4	7		0	-3.41602883					CCOC(=O)NCCCC(=O)NCCC1=CC=CC=C1	APExBIO	B4794	-4.12649012	1.30492376	-5.08762974	-5.19480519	-3.98037555	-5.30175173	-3.41602883									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159352-06	Etidronate		ATP Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	2809-21-4				12.2276434391	4	7		0	4.99449028					CC(O)([P](O)(O)=O)[P](O)(O)=O	Selleck	S1857	-0.58632284	2.0602576	0.15313936	0	3.08676226	3.73043124	4.99449028									4.25E-10	2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999								
NCGC00093656-03	Brivudine	90341813	Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	69304-47-8	(E)-5-(2-Bromovinyl)-2'-deoxyuridine;Brivudine			-20.0382357352	4	7		0	-4.11293445			7015	TERT	OC[C@H]1O[C@H](C[C@@H]1O)N2/C=C(/C=C/Br)C(=O)NC2=O	SigmaAldrich	Lopac-B-9647	-5.39917192	-3.92040811	-2.48426068	-2.5629238	-6.07131385	-5.30175173	-4.11293445									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178869-11	Vidarabine	384568366	Adenosine Receptor Agonist; Anti-Herpes Simplex Virus Drug	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	5536-17-4				2.2870357423	4	7		0	0					NC1=C2N=C[N]([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O)C2=NC=N1	MedChem Express	HY-B0277	0.19729347	2.30264085	1.20242754	1.70095391	-1.53900067	-0.58779026	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095707-04	SOLANESOL		tobacco isoprenoid alcohol	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	13190-97-1				-9.9031592877	4	7		0	-4.66092861					CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CO	Microsource	01505325	-7.8444994	-5.71855359	2.04185809	-0.9941386	0.18981982	0.05819706	-4.66092861									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00159460-01	INDINAVIR SULFATE	363676591	HIV Protease Inhibitors	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	0157810-81-6				-43.9709227513	4	7		0	-14.03639396					CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=CC=CC=C34)CC5=CC=CN=C5	Microsource	01506401	-9.90635507	-6.0060314	-8.2354943	-6.56246408	-11.02415092	-10.90030844	-14.03639396									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178483-14	Limonin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1180-71-8				-29.3352827795	4	7		0	-9.00318671					CC1(C)O[C@H]2CC(=O)OC[C@@]23[C@H]1CC(=O)[C@]4(C)[C@@H]3CC[C@@]5(C)[C@@H](OC(=O)[C@H]6O[C@@]456)c7ccoc7	Enzo	NP440	-5.04348793	-5.71855359	-6.67574159	-4.35582117	-4.31913092	-9.22423325	-9.00318671									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00651745-01	ABBV-744			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	2138861-99-9		9.8640558873	-5.0059444758	-70.8388211453	-2.2	7		-93.7555022823	-73.67841082	0.0000254602	0.9979333844			CCNC(=O)C1=CC2=C(N1)C(=O)N(C)C=C2C3=C(OC4=C(C)C=C(F)C=C4C)C=CC(=C3)C(C)(C)O	Selleck	S8723	-1.49220552	-0.32411713	2.19499745	-0.18388691	-9.26028677	-36.76889949	-73.67841082									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164561-11	Zanamivir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	139110-80-8				9.408753584	4	7		0	3.48154987					[H][C@@](O)(CO)[C@@]([H])(O)[C@]1([H])OC(=C[C@]([H])(NC(N)=N)[C@@]1([H])NC(C)=O)C(O)=O	Enzo	AC3291	3.4484675	4.85612018	0.09642108	1.74692564	0.79724323	0	3.48154987									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00599627-01	Adaptavir   D-Ala1-peptide T-NH2   DAPTA   RAP-101  			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					9.9627743937	4	7		0	2.80251363					C[C@@H](O)[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(N)=O	MedChem Express	HY-P1034	0.18617834	2.52811364	1.11735012	2.49971268	4.63452384	1.18140022	2.80251363									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016435-06	HARMINE	124882259		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					7.9452828252	4	7	LS-133548;HARMINE;HARMINE HYDROCHLORIDE;NCGC00094869-01;NCGC00094869-02;7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole;CIPLUS_711790;9H-Pyrido(3,4-b)indole, 7-methoxy-1-methyl-;Harmine hydrochloride;Harmine;CIPLUS_153150;harmine;CIPLUS_165046;7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole hydrochloride;CIPLUS_758970;NCGC00016435-01;NCGC00094869-04;CIPLUS_152786;NCGC00094869-05;NCGC_Prestw-613;Harmine Hydrochloride;	0	0.8071001					COC1=CC2=C(C=C1)C3=CC=NC(=C3[NH]2)C	BIOMOL	AC-1053	2.38141551	0	3.87953037	0	4.57027714	0	0.8071001									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263533-12	Penciclovir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	39809-25-1				4.2242743171	4	7		0	-1.9209578					N\C1=N\C2=C(N=CN2CCC(CO)CO)C(=O)N1	APExBIO	B1809	-0.71970434	1.78969026	3.05144348	1.0286174	1.29953567	1.01844847	-1.9209578									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00025146-05	NU-1025			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	90417-38-2				0.9535673486	4	7		0	2.92759925					CC/1=N/C2=C(C=CC=C2O)C(=O)N1	SIGMA	N7287	-3.3595465	2.36464587	-0.07940559	-0.19537984	2.38004848	-2.06017576	2.92759925									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00065890-14	Nevirapine		Reverse Transcriptase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	129618-40-2				-24.8807926449	4	7		0	-4.4345832				TERT	CC1=CC=NC2=C1NC(=O)C3=CC=CN=C3N2C4CC4	MedChem Express	HY-10570	-3.67077	-7.10521124	-4.19148091	-3.18928859	-7.98119324	-6.23290461	-4.4345832									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179244-11	Dorzolamide hydrochloride	384568369	Carbonic Anhydrase Type II Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	130693-82-2				-16.0368606736	4	7		0	-4.98853382				CA2	CCN[C@H]1C[C@H](C)[S+]([O-])(=O)C2=C1C=C(S2)[S+](N)([O-])=O	MedChem Express	HY-B0109A	-4.33767749	-1.55858065	-1.41795701	-4.79255258	-3.05755921	-4.15526974	-4.98853382									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095003-07	Tioxolone	384568140	Carbonic Anhydrase Type I Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	4991-65-5		17.5410474839	-4.7559444758	-4.730013542	4	7		-15.6503410119	-13.45861751	0.0016641929	0.9829671678		CA1	OC1=CC2=C(SC(=O)O2)C=C1	Selleck	S2603	1.11429127	1.32747104	0.96988259	-0.72980117	0.88485238	-0.14549264	-13.45861751									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482601-01	Patchouli alcohol			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	5986-55-0				4.2614944049	4	7		0	2.2068678					C[C@H]1CC[C@@]2(O)C(C)(C)[C@@H]3CC[C@@]2(C)[C@H]1C3	DC Chemicals	DC6504	-1.89235002	-0.17755982	0.58419829	4.12021607	1.7375814	0	2.2068678									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015810-24	Papaverine hydrochloride		Phosphodiesterase X (PDE10) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			15.6334750258	-4.8059444758	-11.4636759978	4	7		-22.0465497159	-17.53879143	0.0067859179	0.9644866666		PDE10A	COC1=C(OC)C=C(CC2=C3C=C(OC)C(=CC3=CC=N2)OC)C=C1	Analyticon	NP-014100	0.56409259	2.58448184	-0.74300947	-0.65509712	-1.45139153	-3.45108537	-17.53879143									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346519-03	Teicoplanin		glycopeptide antibiotic	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			9.8640558873	-5.0059444758	-50.4894901196	-2.2	7		-68.6941507576	-52.41981118	0.0000594491	0.9968369494			CC(C)CCCCCCCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC2=C3OC4=CC=C(C[C@H]5NC(=O)[C@H](N)C6=CC(=C(O)C=C6)OC7=CC(=CC(=C7)O)[C@H](NC5=O)C(=O)N[C@H]8C(=O)N[C@H]9C(=O)N[C@@H]([C@H](O[C@@H]%10O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%10NC(C)=O)C%11=CC(=C(OC2=CC8=C3)C=C%11)Cl)C(=O)N[C@@H](C(O)=O)C%12=CC(=CC(=C%12C%13=C(O)C=CC9=C%13)O[C@H]%14O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%14O)O)C=C4Cl	MedChem Express	HY-A0097	2.46477895	1.35001832	-1.02660087	-2.00551661	-7.63659726	-25.76965606	-52.41981118									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346512-02	BMS-707035	363677435	HIV Integrase Inhibitors	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	729607-74-3		24.777388143	-4.6059444758	9.8988819517	4	7		-13.717023552	-7.68085296	0.0231188854	0.9312443606			CN\1C(=O)/C(=C(\N=C1N2CCCC[S+]2([O-])=O)C(=O)NCC3=CC=C(F)C=C3)O	Selleck	S1366	2.19245839	4.26425411	4.13476263	4.30410298	1.41634787	3.71297212	-7.68085296									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00169833-02	Aucubin	363676896	TNF-alpha Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			6.8037134348	-5.1672539867	-23.8192137094	-3	7		-33.729398096	-31.44116508	0.0041073215	0.9726650636			OC[C@H]1O[C@@H](O[C@@H]2O\C=C/[C@H]3[C@H](O)\C=C(\CO)[C@@H]23)[C@H](O)[C@@H](O)[C@@H]1O	Analyticon	NP-009911	-2.60371801	0.27338576	0.11343656	3.06286634	3.29702421	-7.43176395	-31.44116508									1.42E-9	7.1199999999E-9	3.56E-8	1.7799999999E-7	8.9E-7	0.00000445	0.0000223								
NCGC00386434-02	GSK744 (S/GSK1265744)	363680286	Solute carrier family 22 member 8 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1051375-10-0		7.8352981002	-5.1059444758	-15.152159638	4	7		-18.04278226	-12.95231855	0.0166441708	0.9425275189			C[C@H]1CO[C@@H]2CN\3/C=C(/C(=O)NCC4=C(F)C=C(F)C=C4)C(=O)\C(=C3C(=O)N12)O	APExBIO	A8566	0.34734765	0	1.97946798	-3.29272497	-2.89986275	-8.03701333	-12.95231855									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015735-22	Niclosamide		STAT-3 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	50-65-7		2.4777388143	-5.6059444758	-89.5937694365	-1.2	7		-66.302439174	-61.59275695	0.000085754	0.9961964425		STAT3	OC1=C(C=C(Cl)C=C1)C(=O)NC2=C(Cl)C=C(C=C2)[N+]([O-])=O	MedChem Express	HY-B0497	1.41439964	-3.43564161	-1.15705292	-5.648776	-22.06874398	-50.80602921	-61.59275695									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346566-10	Roflumilast	384568843	Phosphodiesterase IIII (PDE4) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	162401-32-3				7.7718842532	4	7		0	2.49277779				PDE4A	FC(F)OC1=CC=C(C=C1OCC2CC2)C(=O)NC3=C(Cl)C=NC=C3Cl	MedChem Express	HY-15455	-1.16430933	3.10306925	2.86427316	4.42477876	-2.32164238	2.29296398	2.49277779									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390429-01	Isoxanthohumol			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	70872-29-6		9.8640558873	-5.0059444758	-38.3649264398	-2.2	7		-62.6128897767	-55.76734074	0.0001519627	0.9949265993			COC1=CC(=C(CC=C(C)C)C2=C1C(=O)CC(O2)C3=CC=C(O)C=C3)O	Bio Vision	2529	0.94200684	0	0	4.39604643	-0.34167567	-17.79083978	-55.76734074									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161626-04	Euphobiasteroid			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	28649-59-4		3.499899101	-5.4559444758	-58.582810112	-1.2	7		-43.018092736	-43.76507728	0.0002034765	0.9941224686			[H][C@]12CC[C@@]3(CO3)[C@@H](OC(C)=O)[C@@]4([H])[C@@H](OC(=O)CC5=CC=CC=C5)[C@@H](C)C[C@]4(OC(C)=O)C(=O)\C(C)=C\[C@@]1([H])C2(C)C	DC Chemicals	DCQ-059	-3.65409731	0.79197317	-2.69411831	-2.21813585	-9.16099641	-33.99289996	-43.76507728									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00249377-04	IU1	363677167	Ubiquitin carboxyl-terminal hydrolase 14 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	314245-33-5		6.2237985085	-5.2059444758	-68.2734924669	-2.2	7		-88.3945260156	-79.06900557	0.000025233	0.9979425613			CC1=CC(=C(C)[N]1C2=CC=C(F)C=C2)C(=O)CN3CCCC3	Selleck	S7134	2.53702726	4.56300555	2.12693551	3.90185036	-8.03959933	-43.06000116	-79.06900557									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386282-01	NSC 405020			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	7497-07-6				3.9971215101	4	7		0	0					CCCC(C)NC(=O)C1=CC=C(Cl)C(=C1)Cl	Selleck	S8072	0.03056659	-0.70178405	1.52572174	0.79875876	0.31831323	3.74789036	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015818-25	Praziquantel	384567893	antiparasitic agent	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	55268-74-1				2.9815279099	4	7		0	-0.26506239					O=C1CN(CC2N1CCC3=C2C=CC=C3)C(=O)C4CCCCC4	MedChem Express	HY-B0244	-2.68152388	3.04106423	-0.45374624	3.22376738	1.34041994	-0.08729558	-0.26506239									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346708-03	Aloperine		Mediator Release Inhibitors	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	56293-29-9				1.7816776744	4	7		0	0					C1CCN2C[C@H]3C[C@H](\C=C/4CCCN[C@@H]34)[C@H]2C1	APExBIO	B1654	0.444605	0.17474141	0	0	1.88067634	0.06401676	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178734-13	Sitagliptin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	486460-32-6				13.5959439583	4	7		0	3.80915508					N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc3cc(F)c(F)cc3F	DC Chemicals	DC5112	0.86975852	2.37028269	4.19148091	3.89035743	3.31454604	1.96706047	3.80915508									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163567-08	Honokiol		NF-kappaB Activation Modulator	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	35354-74-6				7.3456011746	4	7		0	1.98052238					OC1=CC=C(C=C1CC=C)C2=CC(=CC=C2O)CC=C	Adooq	A10453	-0.00277878	-0.08737071	1.36123873	3.3214573	2.40341092	2.01943782	1.98052238									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017115-04	Thiethylperazine Malate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	52239-63-1		3.1192883571	-5.5059444758	-137.0572545696	-2.1	7		-96.7064775396	-95.42544003	0.0000079756	0.9988449774			CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN4CCN(C)CC4)C=C1	USP	1657005	-5.10462111	-3.74002988	-2.55232261	-10.40684979	-28.70367666	-73.79386603	-95.42544003									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168771-04	Fosamprenavir Calcium Salt			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	226700-81-8				0.4759670364	4	7		0	-4.96470798					CC(C)CN(C[C@@H](OP([O-])([O-])=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@@H]2CCOC2)[S+]([O-])(=O)C3=CC=C(N)C=C3	APExBIO	A3421	0	4.42772188	0	0	0	0	-4.96470798									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386258-01	Deoxyarbutin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	53936-56-4				-2.4907611033	4	7		0	-3.05268487					OC1=CC=C(OC2CCCCO2)C=C1	Selleck	S4132	0.01945147	2.4886559	-1.84334411	-1.12056085	1.25281079	-2.05435605	-3.05268487									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091023-07	CETYLPYRIDINIUM CHLORIDE			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	6004-24-6, 123-03-5 [anhydrous]		2.4777388143	-5.6059444758	-1.6619544829	4	7		-10.925100392	0.25910594	0.0458521494	0.9382636802			CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1	Microsource	MS-01500169	3.42623725	2.63521321	3.72639102	0.68382944	0.3007914	-7.43758366	0.25910594									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015562-39	Indomethacin	384567865	Prostaglandin G/H Synthase 2 (PTGS2; COX-2) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	53-86-1		12.4181106199	-4.9059444758	1.8606594604	4	7		-19.372606244	-14.47717187	0.0023374775	0.9796661858		PTGS2	COC1=CC2=C(C=C1)[N](C(=C2CC(O)=O)C)C(=O)C3=CC=C(Cl)C=C3	MedChem Express	HY-14397	1.06427321	3.92040811	2.81889853	3.13757039	3.62993897	-0.95443171	-14.47717187									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00507862-01	LDC4297 (LDC044297)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1453834-21-3		6.2237985085	-5.2059444758	-11.0079768386	4	7		-21.983932452	-19.56994371	0.0018518197	0.9819393785			CC(C)C1=C2N=C(OC3CCCNC3)N=C(NCC4=CC=CC=C4[N]5C=CC=N5)[N]2N=C1	Selleck	S7992	2.21468864	-0.35793805	1.87737508	3.14331686	2.50270128	-10.30087878	-19.56994371									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164624-11	Adefovir dipivoxil	377020406	DNA Polymerase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	142340-99-6				9.9565610489	4	7		0	3.08246717					CC(C)(C)C(=O)OCO[P](=O)(COCC[N]1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C	MedChem Express	HY-B0255	1.7756412	-1.38947606	2.84725767	4.96494656	3.51312677	0.26188675	3.08246717									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00479258-01	NCGC00479258-01			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					-26.0347827614	4	7		0	-10.35530274					OC(=O)C1=CC=NC2=C1[NH]C(=C2)C(OCCN3CCCCC3)C4=C(Cl)C=CC=C4	NCGCChem	GRB054-050_2nd_pos	-4.90454886	-5.29015529	-6.39215019	-3.28123204	-2.9933125	-6.72757958	-10.35530274									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00350413-05	ESI-09			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	263707-16-0		4.4061119169	-5.3559444758	-97.7003439387	-2.2	7		-80.2614172085	-76.82342079	0.0000098194	0.9987182204			CC(C)(C)C1=CC(=NO1)C(=O)\C(=N\NC2=CC=CC(=C2)Cl)C#N	MedChem Express	HY-16704	-3.29841332	-2.34773541	-4.04401339	-2.88472589	-17.54227141	-51.83611709	-76.82342079									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378559-03	Maribavir		Serine/threonine protein kinase UL97 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	176161-24-3				-0.4116934611	4	7		0	-2.65955863				UL97	CC(C)NC1=NC2=CC(=C(Cl)C=C2[N]1[C@H]3O[C@@H](CO)[C@H](O)[C@@H]3O)Cl	MedChem Express	HY-16305	-0.66412871	1.93624757	1.37258238	-0.33329502	1.66165348	-2.57812955	-2.65955863									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164560-17	Abacavir hemisulfate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[188062-50-2]				9.4483987354	4	7		0	1.53974447					NC1=NC2=C(N=C[N]2[C@@H]\3C[C@H](CO)\C=C3)C(=N1)NC4CC4	Tocris	4148	0.88643121	3.50328345	1.87170325	3.09734513	2.23987384	0.78566025	1.53974447									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024246-18	Daunorubicin		DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	23541-50-6		5.5469662594	-5.2559444758	-91.0209214483	-2.2	7		-81.433823748	-71.61151979	0.000029683	0.9977679891		TOP2A	COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(=C3C2=O)O	APExBIO	B2285	0.08058466	-2.16172036	-4.97986501	-5.75795886	-16.90564495	-46.49362742	-71.61151979									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00486904-01	MRT-68601 hydrochloride	377020217	IKK-epsilon Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			11.0676527398	-4.9559444758	-62.049069867	-2.2	7		-86.927346094	-66.23283795	0.000008009	0.9988427217		IKBKE	O=C(NCCCNC1=C(C=NC(=N1)NC2=CC=C(C=C2)N3CCOCC3)C4CC4)C5CCC5	Tocris	5067	0.00833634	0.07046025	1.84334411	-1.71819331	-7.84685921	-31.18198219	-66.23283795									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00090782-17	Nelfinavir Mesylate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	159989-65-8		7.8352981002	-5.1059444758	-46.3679341305	-2.2	7		-73.054322902	-63.67751735	0.0000112484	0.9986280067			[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC3=CC=CC=C3)NC(=O)C4=C(C)C(O)=CC=C4)[C@@H](C2)C(=O)NC(C)(C)C	APExBIO	A3653	2.58148776	4.83920972	1.97379615	2.10895299	-1.25281079	-28.48163883	-63.67751735									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162409-10	Bafilomycin A1 from Streptomyces griseus			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	88899-55-2		0.9864055887	-6.0059444758	-50.6382218964	4	7		-27.71270512	-28.5105876	0.0035027834	0.9748569409			CO[C@H]1\C=C/C=C(C)\C[C@H](C)[C@H](O)[C@H](C)\C=C(C)/C=C(OC)\C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](O)[C@H](C)[C@H](O2)C(C)C	SantaCruz Bio	sc-201550B	-1.13096396	-1.10763507	1.9624525	-3.56855534	-1.8543936	-5.02240587	-28.5105876									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00090791-01	2'	17389408		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					7.5629830125	4	7	NCGC00090791-02;Kolibri-D 002;NCGC00090791-03;2',3'-Dideoxyadenosine;2',3'-Dideoxyadenosine (ddA);2',3' Dideoxyadenosin;2',3'-DIDEOXYADENOSINE;Adenosine, 2',3'-dideoxy-;Dideoxyadenosine;CIPLUS_162883;LS-112;NunclonD multidishes;AB02911402-01;	0	2.1770855					NC1=NC=NC2=C1N=C[N]2[C@H]3CC[C@@H](CO)O3	NIEHS	AB02911402	-1.28657571	1.86860573	3.35772219	2.35605103	2.19898957	0.64016761	2.1770855									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00250412-15	JQ1		Brd4 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1268524-70-4		9.8640558873	-5.0059444758	-31.4417030192	-2.2	7		-65.5642552907	-56.48807219	0.0001384209	0.9951596295		BRD4	CC1=C(C)C2=C(S1)[N]3C(=NN=C3[C@H](CC(=O)OC(C)(C)C)/N=C2/C4=CC=C(Cl)C=C4)C	MedChem Express	HY-13030	4.45994387	4.58555283	0	3.98230088	2.35084543	-17.61042891	-56.48807219									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00686699-01	S(-)-Verapamil hydrochloride hydrate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	36622-28-3 (anhydrous)		4.9437388825	-5.3059444758	-47.2547968171	4	7		-16.3148054921	-22.38734848	0.0029215449	0.9771745868			COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1	SIGMA	V105	-7.38877928	-4.62501057	-7.7704044	-6.50499943	-7.72420641	-16.94116278	-22.38734848									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379005-02	Silvestrol			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	697235-38-4				-10.5199176786	4	7		0	-7.84167734					CO[C@@H]1OC[C@@H](O[C@H]1OC2=CC(=C3C(=C2)O[C@]4([C@@H]([C@H]([C@@H](O)[C@@]34O)C(=O)OC)C5=CC=CC=C5)C6=CC=C(OC)C=C6)OC)[C@H](O)CO	MedChem Express	HY-13251	-2.24803401	2.00388941	-1.33287959	-2.62038846	-1.84271238	-3.1659198	-7.84167734									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015529-22	Ibuprofen lysine	384567862	Cyclooxygenase-1/2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	15687-27-1				-12.5789941816	4	7		0	-2.963338				PTGS1	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O	APExBIO	A8446	-4.19873843	-4.08387588	-4.33894844	-1.47109528	-0.03212335	-0.71582378	-2.963338									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00093674-07	CYCLOSERINE (L)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	339-72-0		0.8018012262	-6.0959332839	-9.1841955164	4	7		-11.384239116	0	0.5872311346	0.3078230864			[H][C@]1(N)CONC1=O	Microsource	01506178	1.55333871	0	4.92314673	0.90219515	-23.23686593	4.19600768	0									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00015256-29	Chloroquine		antimalarial agents	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	50-63-5		0.0003499899	-9.4559444758	-0.1470422319	4	7		15.3358990759	1.95074009	0.0991714831	0.8354175265			CCN(CC)CCCC(C)NC1=CC=NC2=C1C=CC(=C2)Cl	SIGMA	C6628_cm1	-13.61324923	0.62286858	-2.31410584	-2.40776922	2.31580177	4.10289239	1.95074009									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00347398-04	Ginsenoside Rb1			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	41753-43-9		6.0306904668	-5.2196329617	-24.4264164506	4	7		-14.901882244	-15.33490187	0.1729872934	0.7594696967			CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]3CC[C@]4(C)[C@@H]3[C@H](O)C[C@@H]5[C@@]6(C)CC[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)C(C)(C)[C@@H]6CC[C@@]45C	MedChem Express	HY-N0039	-7.49993053	-2.34773541	-1.5994555	-3.80416044	0.00876091	-4.99912704	-15.33490187									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00345802-01	ACY-1215	174006356	HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1316214-52-4	ACY-1215	9.8640558873	-5.0059444758	-5.320870686	4	7		-20.4668969799	-16.22241415	0.0088287002	0.9591289252	10013	HDAC6	ONC(=O)CCCCCCNC(=O)C1=CN=C(N=C1)N(C2=CC=CC=C2)C3=CC=CC=C3	ChemieTek	CT-ACY12	0.34734765	1.4289338	4.9571777	1.31019423	1.53900067	-4.9525694	-16.22241415									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00162068-04	Opipramol dihydrochloride	144206704	Serotonin 2 (5-HT2) receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	909-39-7	Opipramol dihydrochloride; Insidon; Hydrochloride, Opipramo; 	13.9333492831	-4.8559444758	-16.9980545091	-3	7	NCGC00093619-01;opipramol hydrochloride;Opipramol;1-Piperazineethanol, 4-(3-(5H-dibenz(b,f)azepin-5-yl)propyl)-;NCGC00093619-02;CIPLUS_152628;Opipramolum;opipramolum;Opipramol Hydrochloride;OPIPRANMOL DIHYDROCHLORIDE;LS-112246;4-(3-(5H-Dibenz(b,f)azepin-5-yl)propyl)-1-piperazineethanol;LS-112248;OPIPRAMOL;OPIPRAMOL HYDROCHLORIDE;opipramol;Opipramol hydrochloride;Insidon;Hydrochloride, Opipramo;CIPLUS_213844;NCGC00162068-02;Opipramol dihydrochloride;4-[3-(5H-Dibenz[b,f]azepin-5-yl)propyl]-1-piperazineethanol dihydrochloride;NCGC00162068-01;	-42.4077493519	-31.17312446	0.0016967825	0.9827148187			Cl.Cl.OCCN1CCN(CC1)CCCN3c4ccccc4C=Cc2ccccc23	Kemprotec	909-39-7	4.83230055	2.79304416	0	0	0.56361884	-8.84013269	-31.17312446									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346565-08	Elvitegravir		HIV Integrase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	697761-98-1		5.5469662594	-5.2559444758	-69.3223788944	-2.2	7		-72.895642852	-59.91303571	0.0001571554	0.9948395585			COC1=CC2=C(C=C1CC3=C(F)C(=CC=C3)Cl)C(=O)\C(=C/N2[C@H](CO)C(C)C)C(O)=O	APExBIO	A4070	1.1698669	0.29593303	-0.78271227	-0.35053442	-17.174313	-37.12390153	-59.91303571									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00371093-04	Marimastat	384569041	Matrix Metalloproteinase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	154039-60-8				-10.3569762163	4	7		0	0.85475176				MMP1	CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C	MedChem Express	HY-12169	-3.30397088	-1.58112793	-4.33894844	-1.02287093	-2.06465555	-3.25321539	0.85475176									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346683-02	YM-201636	384568907	PIKfyve Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	371942-69-7		3.1192883571	-5.5059444758	-140.473462782	-1.1	7		-90.3326835189	-95.10974774	1.02E-7	0.9998696024		PIKFYVE	NC1=CC=C(C=N1)C(=O)NC2=CC=CC(=C2)C3=NC(=C4OC5=NC=CC=C5C4=N3)N6CCOCC6	Selleck	S1219	-5.98271598	-6.10749415	-7.11247235	-8.90127572	-25.57310983	-75.77256591	-95.10974774									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386395-01	YYA-021	363680252	Envelope glycoprotein gp160 Binding Agent	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	144217-65-2				13.4285890117	4	7		0	1.66483009				env	CC1=CC=C(NC(=O)C(=O)NC2CC(C)(C)NC(C)(C)C2)C=C1	Selleck	S7487	-0.24175397	4.04441814	4.9174749	3.48810482	4.05630348	1.6818949	1.66483009									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00018113-18	Sodium Phenylbutyrate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1716-12-7				7.0516667767	4	7		0	0					OC(=O)CCCC1=CC=CC=C1	APExBIO	A4107	0.92533415	2.70849187	0	0	2.1522647	4.33568061	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346555-08	Apixaban	363677453	Coagulation Factor Xa Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	503612-47-3		19.6813789847	-4.7059444758	-52.2526376791	4	7		-27.20911726	-26.19948179	0.0089154863	0.9589204035		F10	COC1=CC=C(C=C1)[N]2N=C(C(N)=O)C3=C2C(=O)N(CC3)C4=CC=C(C=C4)N5CCCCC5=O	Glixx	GLXC-90058	-9.5173257	-7.4377836	-8.38296183	-5.60855074	-10.56274275	-13.78688238	-26.19948179									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015061-29	Acyclovir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[59277-89-3]				12.3855873597	4	7		0	3.60067904					NC1=NC2=C(N=CN2COCCO)C(=O)N1	Tocris	2513	3.89863006	0.4875849	3.11950542	0	4.93239494	2.68870395	3.60067904									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163489-05	Shikonin		Drugs Acting on Chemokine Receptors	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	517-89-5		0.1563347503	-6.8059444758	-240.4363805143	-1.1	7		-99.0521576894	-97.98076064	0.0000011896	0.9995544392		CCR5	CC(C)=CC[C@@H](O)C/1=C/C(=O)C2=C(O)C=CC(=C2C1=O)O	Cayman	14751	-0.03056659	-1.61494885	-22.39804889	-61.73428342	-88.84443536	-95.50718734	-97.98076064									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015036-23	Amantadine hydrochloride	384567799	Dopamine Receptor Agonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	665-66-7				-35.5090377465	4	7		0	-7.46046401				DRD1	NC12CC3CC(CC(C3)C1)C2	MedChem Express	HY-B0402A	-8.53919471	-8.44113751	-7.02739493	-7.72899667	-6.38086616	-7.32700925	-7.46046401									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00599701-01	BDD   BFD   DDB   alpha-DDB   Bifendate Biphenyldimethyldicarboxylate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					-4.7070458507	4	7		0	-3.65428716					COC(=O)C1=C(C2=C(OCO2)C(OC)=C1)C3=C(C=C(OC)C4=C3OCO4)C(=O)OC	BLD Pharma	BD40653	-3.97643594	2.07153124	0.33463785	1.77565797	-3.52480799	-0.78566025	-3.65428716									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015829-14	PROMAZINE HYDROCHLORIDE		Serotonin 2a (5-HT2a) receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	53-60-1, 58-40-2 [promazine]		6.9832167823	-5.1559444758	-70.346880655	-2.2	7		-69.4267653503	-65.67293088	0.0008357106	0.9879638516			CN(C)CCCN1C2=C(SC3=C1C=CC=C3)C=CC=C2	Microsource	01500509	-3.00386251	1.69386432	0.09074925	-3.91334329	-12.72376836	-33.35855206	-65.67293088									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00384199-05	4SC-202	384569106	HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	910462-43-0		1.9681378985	-5.7059444758	-79.7746203174	-1.2	7		-64.2657473863	-60.43124758	0.0000245027	0.9979727767		HDAC1	C[N]1C=C(C=N1)C2=CC=C(C=C2)[S+]([O-])(=O)[N]3C=CC(=C3)/C=C/C(=O)NC4=C(N)C=CC=C4	MedChem Express	HY-16012A	1.03092783	4.57991601	0.98122625	-1.71819331	-20.5852291	-52.83128674	-60.43124758									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161826-02	Phenylmercuric borate	124892360	platelet aggregation Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					12.9181866373	4	7		0	3.95806653					[Hg+]C1=CC=CC=C1	SigmaAldrich	S366137	2.84269319	3.13125335	0	0.95965981	4.94407616	3.71297212	3.95806653									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00166323-16	Trifluorothymidine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[70-00-8]				-6.2523643438	4	7		0	-3.83298091					[H][C@]1(O)C[C@@]([H])(O[C@]1([H])CO)N2C=C(C(=O)NC2=O)C(F)(F)F	Tocris	4460	-3.03165032	1.40638652	0.30627871	-1.06884266	-0.2365447	-3.52674155	-3.83298091									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164566-08	Pitavastatin calcium			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[147526-32-7]		13.9333492831	-4.8559444758	-21.8413642113	-2.4	7		-30.0009679239	-22.91747327	0.0008350691	0.9879936986			O[C@H](C[C@H](O)\C=C\C1=C(C2=CC=C(F)C=C2)C3=C(C=CC=C3)N=C1C4CC4)CC([O-])=O	Tocris	4942	-1.91458026	1.02308278	-0.43673076	-1.55729227	-2.18730835	-8.95070709	-22.91747327									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482994-01	20(S)-Ginsenoside Rh2			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	67400-17-3		7.8352981002	-5.1059444758	-60.0085511531	-2.2	7		-81.643967592	-74.3514906	0.0004772571	0.9909482275			CC(C)=CCC[C@](C)(O)[C@H]1CC[C@@]2(C)[C@H]1[C@@H](O)CC3[C@@]4(C)CC[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)(C)C4CC[C@@]23C	DC Chemicals	DCR-036	-2.28693695	-0.43685353	3.69236005	-0.93667395	2.68960079	-32.57289181	-74.3514906									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164571-04	Dutasteride	384568256	Steroid 5alpha-Reductase Inhibitors	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			1.9681378985	-5.7059444758	-45.2492267205	4	7		-8.7273798079	-14.4593025	0.0681572436	0.8705644172			C[C@]12CCC3[C@@H](CC[C@H]4NC(=O)\C=C/[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F	Selleck	S1202	-5.64370467	-6.37242468	-6.31841643	-9.95287898	-8.22649885	-17.49985451	-14.4593025									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016028-08	Tyrphostin AG 555	90341437		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			2.4777388143	-5.6059444758	-156.6180877393	-2.2	7		-92.4932940661	-75.6083033	0.0025626196	0.9785981664			OC1=C(O)C=C(C=C1)\C=C(/C#N)C(=O)NCCCC2=CC=CC=C2	SigmaAldrich	Lopac-T-4818	-7.31097341	-9.26411319	-24.41154784	-30.68038157	-41.66983033	-53.94285049	-75.6083033									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00382803-03	Desaminotyrosine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	501-97-3				15.2852052161	4	7		0	3.77937278					OC(=O)CCC1=CC=C(O)C=C1	MedChem Express	HY-W015346	3.759691	4.03878132	4.14610629	4.29261004	0.32415384	2.57230984	3.77937278									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346486-03	Abexinostat	384568795	HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	783355-60-2				7.8479502638	4	7		0	0.07445573				HDAC1	CN(C)CC1=C(OC2=CC=CC=C12)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO	Selleck	S1090	1.58112652	0.61441335	0	4.86725664	0	4.16108945	0.07445573									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016480-10	Kaempferol		flavanoid	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[520-18-3]		0.9864055887	-6.0059444758	-91.3476323582	-1.2	7		-57.907198376	-56.58933198	0.0000233253	0.9980222972			OC1=CC=C(C=C1)\C2=C(O)\C(=O)C3=C(O2)C=C(O)C=C3O	Tocris	3603	3.20393475	1.55012542	-0.87346152	-6.45328123	-34.31066203	-51.05045685	-56.58933198									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00510509-02	Vesnarinone		p97 ATPase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	81840-15-5				-17.5081311212	4	7		0	-8.85427525				VCP	COC1=CC=C(C=C1OC)C(=O)N2CCN(CC2)C3=CC4=C(NC(=O)CC4)C=C3	MedChem Express	HY-15297	-0.78639509	-3.50328345	-1.61079916	-3.08010573	-4.12055019	-5.29593203	-8.85427525									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378617-04	XL 413 hydrochloride	384569057	Serine/threonine-protein kinase PIM1  Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[1169562-71-3]				11.68495551	4	7		0	1.29552968					ClC1=CC=C2OC3=C(\N=C(NC3=O)\[C@@H]4CCCN4)C2=C1	Tocris	5493	1.43662989	3.05797469	3.49951789	2.95942995	2.61951348	2.2114881	1.29552968									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00601698-01	Glecaprevir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1365970-03-1		13.9333492831	-4.8559444758	-51.8552885159	-2.2	7		-41.8870523944	-35.77746672	0.0000932539	0.9960365596			[H]\C1=C([H])/C(F)(F)C2=NC3=CC=CC=C3N=C2O[C@@]4([H])CN(C(=O)[C@@]([H])(\N=C(O)\O[C@]5([H])CCC[C@@]5([H])OC1)C(C)(C)C)[C@@]([H])(C4)C(\O)=N\[C@@]6(C[C@@]6([H])C(F)F)C(\O)=N\[S+]([O-])(=O)C7(C)CC7	Bio Vision	B2347	-5.86600717	-5.1210507	-4.03266973	-6.49350649	-8.39003592	-17.4882151	-35.77746672									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00022304-23	ACETYLCYSTEINE			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	616-91-1				-12.7614335127	4	7		0	0.45566906					CC(=O)N[C@@H](CS)C(O)=O	Microsource	01500105	-2.49812432	-3.6047462	-1.71856389	-3.03988047	-4.07382531	-3.74789036	0.45566906									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016012-08	Triflupromazine hydrochloride	124881619	Muscarinic acetylcholine receptor M2 Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			8.7913490634	-5.0559444758	-72.8178744528	-2.2	7	Triflupromazinum;NCGC00094410-03;triflupromazinum;10H-PHENOTHIAZINE-10-PROPANAMINE, N,N-DIMETHYL-2-(TRIFLUOROMETHYL)-;Triflupromazine Hcl;NCGC00094410-02;NCGC00094410-01;CIPLUS_208142;Triflupromazine Hydrochloride;NCGC_Prestw-53;Phenothiazine, 10-(3-(dimethylamino)propyl)-2-(trifluoromethyl)-, monohydrochloride;Trifluopromazine;NCGC00016012-02;NCGC00016012-01;NCGC00024300-04;Triflupromazina;TRIFLUPROMAZINE HYDROCHLORIDE;TRIFLUPROMAZINE;TRIFLUPROMAZINE MALEATE;trifluopromazine;Triflupromazine;LS-105501;Vesprin;Triflupromazine hydrochloride;LS-105500;10-3-(DIMETHYLAMINO)PROPYL-2-(TRIFLUOROMETHYL)PHENOTHIAZINE;triflupromazine;Vesprin hydrochloride;10-(3-(DIMETHYLAMINO)PROPYL)-2-(TRIFLUOROMETHYL)PHENOTHIAZINE MONOHYDROCHLORIDE;10H-PHENOTHIAZINE-10-PROPANAMINE, N,N-DIMETHYL-2-(TRIFLUOROMETHYL)-, MONOHYDROCHLORIDE;CIPLUS_170810;10H-Phenothiazine-10-propanamine, N,N-dimethyl-2-(trifluoromethyl)-;CIPLUS_152129;	-69.2455640841	-61.6999732	0.0000601433	0.9968182087	1129	CHRM2	CN(C)CCCN1C2=C(SC3=C1C=C(C=C3)C(F)(F)F)C=CC=C2	SIGMA	T-2896	-4.19318087	-3.32290522	-1.83200045	-6.78657626	-9.41798324	-32.22952919	-61.6999732									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00186460-07	Bardoxolone methyl		NF-kappaB signaling Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	218600-53-4		4.4061119169	-5.3559444758	-49.0914934102	-2.2	7		-54.5091580489	-51.32382285	0.0000768754	0.9964002739		NFKB1	COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]3C(=O)\C=C\4[C@@](C)(CC[C@H]5C(C)(C)C(=O)\C(=C/[C@]45C)C#N)[C@]3(C)CC2	Adooq	A11323	0.58632284	0	3.924905	2.39627629	-3.59489531	-34.83093755	-51.32382285									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346504-07	Avagacestat	384568808	g-Secretase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1146699-66-2		9.8640558873	-5.0059444758	-58.7907512594	-2.2	7		-37.0978831264	-33.83566132	0.0000114862	0.9986152537		NOTCH1	NC(=O)[C@@H](CCC(F)(F)F)N(CC1=C(F)C=C(C=C1)C2=NOC=N2)[S+]([O-])(=O)C3=CC=C(Cl)C=C3	MedChem Express	HY-50845	-6.81635035	-5.88765818	-6.01213771	-7.75198253	-11.01831031	-21.32340104	-33.83566132									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00388216-01	Corilagin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	23094-69-1		6.9832167823	-5.1559444758	-42.6649780231	-2.4	7		-36.047279384	-27.12273282	0.0128785526	0.9498363403			OC1C2COC(=O)C3=CC(=C(O)C(=C3C4=C(O)C(=C(O)C=C4C(=O)OC1C(O)C(O2)OC(=O)C5=CC(=C(O)C(=C5)O)O)O)O)O	Cayman	11832	0.66968628	-1.27673966	-5.5243605	-8.56223423	-10.68539556	-15.18361171	-27.12273282									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00480786-05	Brequinar sodium			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[96201-88-6]				-11.2956278347	4	7		0	-8.48497483					CC1=C(N=C2C=CC(F)=CC2=C1C(O)=O)C3=CC=C(C=C3)C4=CC=CC=C4F	Tocris	6196	-2.3091672	-1.75023252	-0.35732517	-2.72957131	-0.42344421	-2.26386545	-8.48497483									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00164557-06	Eprosartan (mesylate)	363676634	urate transport Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	144143-96-4				-0.2235062596	4	7		0	-2.76677488					CCCCC1=NC=C(\C=C(CC2=CC=CS2)\C(O)=O)[N]1CC3=CC=C(C=C3)C(O)=O	MedChem Express	HY-15834A	-0.26398422	-1.49093881	1.34422324	0.71256177	1.11263616	0.34336263	-2.76677488									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482702-01	Dehydroandrographolide			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	134418-28-3		4.9437388825	-5.3059444758	5.0610208531	4	7		-10.673794556	-7.22816213	0.0416246711	0.9036903871			CC1(CO)C(O)CCC2(C)C(C\C=C3/C=C\OC3=O)C(=C)CCC12	DC Chemicals	DCT-012	0.46961403	3.13689017	4.88911576	4.33858177	3.39047397	-3.52092184	-7.22816213									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00538156-01	NCGC00538156-01			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			9.8640558873	-5.0059444758	-59.4079444623	-2.2	7		-80.3396819219	-68.81794085	0.0000134371	0.9985001174			CN(C)C1=C2C=CC=C(C2=CC=C1)[S+]([O-])(=O)NC3=CC=C(NC(=O)C(C)(C)CO)C=C3	Pharmaron	PH-NIH-2017-009-L2-56-0	-0.17506322	1.92497393	-0.34030968	-1.70670038	-3.75259177	-29.04615026	-68.81794085									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178332-02	Genkwanin			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	437-64-9		11.0676527398	-4.9559444758	-104.2915337322	-2.2	7		-77.4514098256	-64.95815588	0.0156752318	0.9440776109			COC1=CC2=C(C(=C1)O)C(=O)\C=C(/O2)C3=CC=C(O)C=C3	DC Chemicals	DCY-091	-7.74446328	-7.96200784	-9.28478249	-14.10757384	-29.91852349	-31.44968865	-64.95815588									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00247606-02	Methyl gallate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	99-24-1				-5.8723718157	4	7		0	-2.91568633					COC(=O)C1=CC(=C(O)C(=C1)O)O	DC Chemicals	DCM-014	-0.2806569	1.29365012	-1.5994555	-1.95379841	-3.4138364	-0.25606704	-2.91568633									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016612-14	Sulfadoxine		Dihydropteroate Synthase (DHPS) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	2447-57-6				7.1013211389	4	7		0	2.25451946					COC1=NC=NC(=C1OC)N[S+]([O-])(=O)C2=CC=C(N)C=C2	SIGMA	S7821	-0.33067497	-0.23956484	2.25738756	0.93092748	3.77595421	2.05435605	2.25451946									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016000-18	Disulfiram	170464767	Aldehyde Dehydrogenase (ALDH2) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	97-77-8	 ;Tetraethylthiuram disulfide; Disulfiram; Tetraethylthiuram disulfide; Disulfiramo; Teturam; Antabuse;Disulfiram;DISULFIRAM	15.6334750258	-4.8059444758	-66.495904208	-2.2	7		-90.4745430692	-70.72400751	0.000649037	0.9894181812	217	ALDH2	CCN(CC)C(=S)SSC(=S)N(CC)CC	Microsource	01500262	-1.57556896	-1.24291875	-0.31762237	-7.28077233	-8.88648775	-22.53971949	-70.72400751									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00094614-07	CHLOROXYLENOL			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	88-04-0				10.3090791743	4	7		0	-3.10033654					CC1=CC(=CC(=C1Cl)C)O	Microsource	01500182	4.73226443	4.94630929	2.13260734	2.76405011	1.6733347	0.98934994	-3.10033654									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346692-04	CUDC-907		PI3K Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1339928-25-4		1.9681378985	-5.7059444758	-108.1326033149	-2.2	7		-72.2965090468	-69.72332251	0.0004430474	0.9912836616		PIK3CA	COC1=CC=C(C=N1)C2=NC3=C(SC(=C3)CN(C)C4=NC=C(C=N4)C(=O)NO)C(=N2)N5CCOCC5	Selleck	S2759	-2.23691889	-2.53375046	-2.08723272	-8.7863464	-34.7720702	-51.79537915	-69.72332251									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00351072-01	ML414			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			7.8352981002	-5.1059444758	-0.4237461654	4	7		-8.66630432	-6.8052536	0.1372372398	0.7971930734			CN(C)[S+]([O-])(=O)C1=CC(=C(C=C1)N2CCCC2)C(=O)NC3=NC=C(C)S3	NCGCChem	YSM004-073	3.759691	0	0	0	3.25613994	-2.36862015	-6.8052536									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00370866-10	PJ34 Hydrochloride	363677895	Poly [ADP-ribose] polymerase-1 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	344458-15-7		19.6813789847	-4.7059444758	-35.2226996148	4	7		-26.02035058	-22.7983441	0.0184163791	0.9390826832			CN(C)CC(=O)NC1=CC2=C(NC(=O)C3=CC=CC=C23)C=C1	Glixx	GLXC-05505	-5.83821936	-4.21915955	-4.78702286	-1.94805195	-7.97535263	-8.61316417	-22.7983441									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00384206-05	b-AP15			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1009817-63-3		11.0676527398	-4.9559444758	-65.9005109356	-2.2	7		-88.0971200572	-65.98266671	0.0160503863	0.9433412755			[O-][N+](=O)C1=CC=C(C=C1)/C=C/2CN(CC(=C/C3=CC=C(C=C3)[N+]([O-])=O)\C2=O)C(=O)C=C	Cayman	11324	-1.78675633	3.49200981	3.19891101	-3.59728767	-21.14008702	-24.75120759	-65.98266671									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378896-04	MP-513   Tenelia   Tenglyn   Teneligliptin hydrobromide hydrate (Prop INNM)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			12.4181106199	-4.9059444758	7.5618948194	4	7		-13.2030705559	-8.08589213	0.0102182702	0.9560410394			CC1=NN(C(=C1)N2CCN(CC2)[C@@H]3CN[C@@H](C3)C(=O)N4CCSC4)C5=CC=CC=C5	BLD Pharma	BD627730	2.3536277	4.94630929	3.68668822	2.41926215	2.79473177	0.79147995	-8.08589213									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159322-05	Cyclocytidine		antiviral	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	10212-25-6				-31.8698964719	4	7		0	-5.57226673					OC[C@H]1O[C@@H]2[C@@H](OC/3=N/C(=N)/C=C\N23)[C@@H]1O	Enzo	DL369	-9.71184039	-7.33068403	-6.39782202	-4.52821515	-4.89151067	-8.84013269	-5.57226673									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346932-04	SB-3CT	384568968	MMP2/9 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	292605-14-2		22.0828704269	-4.6559444758	-29.2873404349	4	7		-13.5542842001	-17.0444054	0.0675318241	0.8711478802		MMP2	[O-][S+](=O)(CC1CS1)C2=CC=C(OC3=CC=CC=C3)C=C2	MedChem Express	HY-12354	-5.46586267	-2.8325019	-3.71504736	-5.65452247	-8.08632421	-3.46272479	-17.0444054									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00686694-01	Remdesivir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1809249-37-3		11.0676527398	-4.9559444758	-21.9894093667	4	7		-29.513253116	-29.17771093	0.0016323256	0.9830623206			CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C2=CC=C3N2N=CN=C3N)OC4=CC=CC=C4	MedChem Express	HY-104077	-1.36993914	-1.15272963	-2.63172821	-0.17239398	1.83103116	-5.99429669	-29.17771093									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390751-02	SPK-601			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1096687-52-3				0.0438102378	4	7		0	-0.46758198					[K]SC(=S)O[C@H]1C[C@H]2C[C@@H]1[C@@H]3CCC[C@H]23	MedChem Express	HY-70083	-1.28657571	-0.05354979	-1.00391356	0.44247788	0.02044213	2.25804574	-0.46758198									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00381565-04	RG2833		Histone deacetylase 3 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1215493-56-3		11.0676527398	-4.9559444758	-16.3837260442	4	7		-9.6976352839	-10.16469607	0.2448669098	0.6881463168	8841	HDAC3	CC1=CC=C(C=C1)C(=O)NCCCCCC(=O)NC2=CC=CC=C2N	MedChem Express	HY-16425	-2.94272932	-5.81437953	-1.93409336	0.31030916	-0.15477616	-5.33085026	-10.16469607									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263598-10	Chidamide		Histone deacetylase 8 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	743420-02-2		11.0676527398	-4.9559444758	-33.5909017871	4	7		-14.1600923399	-18.13443726	0.0199597123	0.9365032473			NC1=C(NC(=O)C2=CC=C(CNC(=O)/C=C/C3=CN=CC=C3)C=C2)C=C(F)C=C1	MedChem Express	HY-13592	-7.77225109	-4.64192103	-5.03658329	-4.54545455	-3.83436031	-8.79357505	-18.13443726									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00161679-13	MG-132			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	133407-82-6				-6.5134078065	4	7		0	-5.48291986					CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)C=O	APExBIO	A2585	-2.20913108	-1.59240157	-1.0322727	-0.36202735	-1.69669714	1.64115696	-5.48291986									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168108-06	AG-14361		PARP Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	328543-09-5				-9.0755330083	4	7		0	0.42588677				PARP1	CN(C)CC1=CC=C(C=C1)C2=NC3=CC=CC4=C3[N]2CCNC4=O	APExBIO	A4158	-2.50923945	-3.35108932	-0.4253871	-1.20101138	-0.87317116	-5.02822557	0.42588677									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159456-06	Imatinib	124892208	Bcr-Abl Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	152459-95-5	GGP-57148B; ; Imatinib base; Imatinib base(IMA-3);STI-571; Imatinib;Imatinib;Gleevec; Glivec	8.7913490634	-5.0559444758	-40.3573363048	-2.2	7	STI571;Imatinib mesilate;IMATINIB;CIPLUS_700313;Imatinib Mesilate;4-(4-(4-METHYL-1-PIPERAZINYL)METHYL)-N-(4-METHYL-3-((4-(3-PYRIDINYL)-2-PYRIMIDINYL)AMINO)-PHENYL)BENZAMIDE MESYLATE;CIPLUS_670910;Imatinib mesylate;HS_649;imatinib;CPG-57148B;Glivec;Imatinib base;Genpharm brand of imatinib mesylate;IMATINIB MESILATE;Gleevec;CGP-57148;CGP 57148;imatinib mesylate;Imatinib;IMATINIB MESYLATE;CGP57148B;STI 571;imatinibum;Imatinib base(IMA-3);Novartis brand of imatinib mesylate;STI-571;	-38.3178412061	-36.77219525	0.0009690113	0.9870282189	25	ABL1	CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=C(C)C(=C3)NC4=NC=CC(=N4)C5=CC=CN=C5	Sequoia	IMATINIB	-5.37694167	-2.30827767	-0.60121377	-1.5515458	-3.63577958	-16.70255485	-36.77219525									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00179542-09	Brinzolamide		Carbonic anhydrase II Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	138890-62-7				1.0523511142	4	7		0	0					CCN[C@H]1CN(CCCOC)[S+]([O-])(=O)C2=C1C=C(S2)[S+](N)([O-])=O	MedChem Express	HY-B0588	0	0	0	1.50557407	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00017013-06	Thiamine chloride			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	59-43-8				6.7151361944	4	7		0	-0.30080114					CC1=C(CCO)SC=[N+]1CC2=CN=C(C)N=C2N	DC Chemicals	DCZ-120	-1.38105427	4.25298047	2.22335659	-0.98839214	2.14642409	3.53838096	-0.30080114									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378998-01	HIV-1 integrase inhibitor 2	363678307	Human immunodeficiency virus type 1 integrase Negative Allosteric Modulator	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	957890-42-5		15.6334750258	-4.8059444758	-4.5816860669	4	7		-29.6074991759	-22.17291598	0.0056274581	0.967775306			CCCC(C(O)=O)C1=C(C2=CC=CC=C2)C3=CC(=CC=C3N=C1C)Cl	MedChem Express	HY-10522	3.53183094	0.43967194	3.33503488	4.83852431	0.02628274	-1.89140429	-22.17291598									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346487-05	Quisinostat	385842041	HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	807640-87-5		11.0676527398	-4.9559444758	-41.5730827468	-2.2	7		-48.884800766	-37.81457545	0.000302272	0.9928231926		HDAC1	C[N]1C=C(CNCC2CCN(CC2)C3=NC=C(C=N3)C(=O)NO)C4=CC=CC=C14	ActiveBioChem	A-1162	-2.69819657	-0.02536569	-2.13827917	-0.31605563	-6.78386824	-19.08281441	-37.81457545									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00093560-19	Finasteride		Androgen Receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[98319-26-7]				12.3001165164	4	7		0	3.92232778				AR	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)\C=C/[C@]4(C)[C@H]3CC[C@]12C	Tocris	3293	-0.27509934	3.13689017	0	3.61452707	3.75259177	4.40551708	3.92232778									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095987-05	NCGC00095987-05			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			5.4605959255	-5.2627599593	-49.0405653168	-2.2	7		-54.5384340496	-49.57262412	0.0000158372	0.9983716082			CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC(=O)[C@@H](NC(=O)[C@H](C)OC(=O)[C@@H](NC(=O)[C@H](OC(=O)[C@@H](NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC1=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C	Analyticon	NP-007859	1.68116264	1.07381415	1.89439056	-0.14940811	-6.08883567	-27.81237269	-49.57262412									1.91E-9	9.57E-9	4.78E-8	2.3899999999E-7	0.0000012	0.00000598	0.0000299								
NCGC00015415-05	N-Ethylmaleimide			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	128-53-0				10.474565953	4	7		0	0.26506239					CCN1C(=O)\C=C/C1=O	Enzo	PI149	1.11984883	4.8899411	3.35772219	3.20078152	0	1.83902695	0.26506239									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00537955-01	GSK2838232			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1443460-91-0		1.106765274	-5.9559444758	-7.8679998377	4	7		-13.333785032	-10.69482086	0.0086265133	0.9596513698			CC(C)\C1=C2/[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@]2(CC1=O)[C@@H](O)CN(CCN(C)C)CC6=CC=C(Cl)C=C6	DC Chemicals	LL-510	0.89754634	2.34773541	4.18580909	4.88449603	-5.84937067	-9.63743235	-10.69482086									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00168902-03	Hyperoside			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			5.5469662594	-5.2559444758	-69.0626699573	-2.2	7		-63.2237929914	-50.41844119	0.0000424041	0.997330936			OC[C@H]1O[C@@H](O\C2=C(\OC3=C(C(=CC(=C3)O)O)C2=O)C4=CC(=C(O)C=C4)O)[C@H](O)[C@@H](O)[C@H]1O	Analyticon	NP-001009	-0.25286909	-0.66232632	-3.26130112	-6.57970348	-18.02704202	-32.01420008	-50.41844119									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015156-28	Baclofen			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1134-47-0				3.3113981728	4	7		0	1.83756738					NCC(CC(O)=O)C1=CC=C(Cl)C=C1	MedChem Express	HY-B0007_cm1	-1.42551477	0.2001071	3.07980262	-1.52281347	-0.18397921	1.75173136	1.83756738									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00023595-03	Loxistatin Acid (E-64C)	363676526		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	76684-89-4				2.4535813767	4	7		0	3.07055425					CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(O)=O	Selleck	S7392	-0.84197071	-0.45376399	0.69763485	3.08010573	-1.14183921	-0.17459117	3.07055425									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00178027-11	Valsartan		Neprilysin Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	137862-53-4				8.5503558844	4	7		0	0					CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=N[NH]N=N3)[C@@H](C(C)C)C(O)=O	MedChem Express	HY-18204	0.92533415	1.14709281	0.62390108	2.01126307	3.46056128	4.09707269	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00229511-27	Tofacitinib			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	477600-75-2				-1.9258607567	4	7		0	-2.95738154					C[C@@H]1CCN(C[C@@H]1N(C)C2=C3C=CNC3=NC=N2)C(=O)CC#N	MedChem Express	HY-40354_cm1	1.35882402	1.47402835	-5.73421814	1.2642225	2.36252665	-1.19885934	-2.95738154									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263153-10	AR-42(HDAC-42)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	935881-37-1		5.5469662594	-5.2559444758	-72.9764034105	-2.2	7		-51.9889819596	-52.82485034	0.0000649655	0.9966927965			CC(C)[C@H](C(=O)NC1=CC=C(C=C1)C(=O)NO)C2=CC=CC=C2	Bio Vision	2716	-3.10945619	-6.2935092	-4.26521468	-6.41880244	-9.97868177	-34.60396904	-52.82485034									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00485882-01	BCX 4430	363681391		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	222631-44-9				-34.8793943876	4	7		0	-5.17318402					NC1=NC=NC2=C1[NH]C=C2[C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O	MedChem Express	HY-18649	-9.28946564	-7.80417688	-7.39039192	-7.7060108	-6.1063575	-7.99627539	-5.17318402									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00651741-01	2,2 -Cyclouridine			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	3736-77-4				6.65454791	4	7		0	0					OC[C@H]1O[C@@H]2[C@@H](OC3=NC(=O)C=C[N@@]23)[C@@H]1O	Selleck	S4984	4.45438631	-0.81452045	2.94935058	3.0686128	0	0	0									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263546-03	Moexipril HCl		Angiotensin-converting enzyme Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	82586-52-5				-24.3552772939	4	7		0	-6.91246985					CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC(=C(OC)C=C3C[C@H]2C(O)=O)OC	Selleck	S2079	-4.38769556	-3.76257715	-5.25778458	-4.20066659	-4.92071372	-7.23971367	-6.91246985									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00481317-01	CB-5083	363681118	p97 ATPase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1542705-92-9		13.9333492831	-4.8559444758	-40.2262064102	-2.2	7		-52.2128391492	-40.69154481	0.0005172228	0.9905763666		VCP	CC1=CC2=C(C=CC=C2C(N)=O)[N]1C3=NC(=C4COCCC4=N3)NCC5=CC=CC=C5	ActiveBioChem	A-1513	-3.33175869	1.15836645	-1.74125121	-1.8388691	-5.37044067	-15.84123843	-40.69154481									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091914-04	Cichoric Acid			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			8.7913490634	-5.0559444758	-90.9117342471	-2.2	7		-51.1021674721	-50.76987223	0.0055791309	0.9678825288			OC(=O)[C@H](OC(=O)\C=C\C1=CC(=C(O)C=C1)O)[C@@H](OC(=O)\C=C\C2=CC=C(O)C(=C2)O)C(O)=O	Analyticon	NP-015790	-11.00119488	-5.68473267	-10.58930293	-15.41776807	-19.91939959	-29.51172671	-50.76987223									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386335-01	SC75741	363680219	Nuclear factor NF-kappa-B complex Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	913822-46-5		5.5469662594	-5.2559444758	-99.5254009196	-2.1	7		-91.4679095775	-86.54436072	0.0000104948	0.9986747274			O=C(NC1=NC2=CC=C(C=C2[NH]1)C(=O)C3=CC=CC=C3)C4=CSC(=N4)C5CCN(CC5)C6=C7SC=CC7=NC=N6	Selleck	S7273	-3.08722594	-2.09971534	0.04537462	-4.84427077	-14.09631165	-53.14555084	-86.54436072									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015992-01	Tyrphostin A9	11111849		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			1.3933349283	-5.8559444758	-139.3053802681	-1.2	7	NCGC00015992-01;[[3,5-bis(1,1-Dimethylethyl)-4-hydroxyphenyl]methylene]propanedinitrile;SF6847;Malonoben;CIPLUS_168096;[[3,5-bis(1,1-Dimethylethyl)-4-hydroxyphenyl]methylene]-propanedinitrile;NCGC00094494-01;TYRPHOSTIN 9;NCGC00094494-02;NCGC00094494-03;NCGC00094494-04;SF 6847;3,5-di-tert-butyl-4-hydroxybenzylidenemalononitrile;SF-6847;tyrphostin A9;Tyrphostin A9;	-65.9259561009	-69.90201626	0.0005710006	0.9900848333			CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C(C#N)C#N	SigmaAldrich	Lopac-T-182	-5.57701392	-5.76928497	-8.13907322	-15.05574072	-38.45749496	-73.78804632	-69.90201626									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00356145-10	CB-839	384569029	Glutaminase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1439399-58-2		4.4061119169	-5.3559444758	-18.9540499365	4	7		-26.7722399319	-22.72686661	0.0028792764	0.9772958361		GLS	FC(F)(F)OC1=CC=CC(=C1)CC(=O)NC2=NN=C(CCCCC3=NN=C(NC(=O)CC4=CC=CC=N4)S3)C=C2	MedChem Express	HY-12248	0	0.76660748	3.924905	3.27548558	-3.36127092	-14.59000175	-22.72686661									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015067-24	Aspirin		HMG-CoA Reductase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	50-78-2				-3.2622720055	4	7		0	1.88521905				HMGCR	CC(=O)OC1=C(C=CC=C1)C(O)=O	Enzo	DL313	-2.88715369	-2.34773541	-1.25347399	1.32743363	-1.15352043	0.13385323	1.88521905									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379210-02	LMK235		Histone deacetylase 6 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1418033-25-6				-9.8753794925	4	7		0	-6.11430443			10013	HDAC6	CC1=CC(=CC(=C1)C)C(=O)NOCCCCCC(=O)NO	XcessBio	M60145-2s	-3.65409731	-5.23942392	0.3232942	2.28134697	0.90821482	-4.25420474	-6.11430443									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346469-08	Delanzomib		Proteasome Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	847499-27-8				3.149245139	4	7		0	0.5211901				PSMD1	CC(C)C[C@H](NC(=O)[C@@H](NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)[C@@H](C)O)B(O)O	Bio Vision	2433	4.19873843	0	0	0	0	0.04655764	0.5211901									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390740-02	Avibactam (sodium)			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1192491-61-4				-9.5657261095	4	7		0	1.80778509					NC(=O)[C@@H]1CC[C@@H]2C[N@]1C(=O)N2O[S]([O-])(=O)=O	MedChem Express	HY-14879A 	-6.09942479	-3.22707928	-1.30452045	-1.66072865	0.58114067	-3.53256125	1.80778509									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00381560-10	RGFP966			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1357389-11-7		3.1192883571	-5.5059444758	-31.5715350738	4	7		-29.9189623799	-27.43246865	0.0023117377	0.979726919			NC1=CC(=CC=C1NC(=O)\C=C\C2=C[N](C\C=C\C3=CC=CC=C3)N=C2)F	MedChem Express	HY-13909	-0.8141829	-0.52704264	4.36163576	-0.19537984	-5.94866104	-21.3932375	-27.43246865									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00482458-01	NCGC00482458-01	363681130	Lysine-specific demethylase 5A Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					7.0311199172	4	7		0	4.01167466					CC(C)C1=N[NH]C(=C1)C(=O)N2CC[C@@H](C2)NC(=O)C3CC3	NCGCChem	GRB056-019	2.59816045	0	2.86427316	1.64923572	0	0	4.01167466									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00386403-01	Z-DEVD-FMK	363680258	Caspase-3 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	210344-95-9				1.9292735538	4	7		0	-0.05658635			836	CASP3	COC(=O)CC[C@@H](CC(=O)[C@H](CC(=O)OC)NC(=O)OCC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)OC)C(=O)CF	Selleck	S7312	-1.35326646	0.25083848	2.25738756	3.02264108	0.58698128	-2.00779841	-0.05658635									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00263192-04	Silmitasertib	384568656	Casein Kinase 2 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1009820-21-6 (parent)		15.6334750258	-4.8059444758	-11.5563518474	-2.4	7		-34.0973136359	-27.16442803	0.0013918363	0.9843936487		CSNK2A1	OC(=O)C1=CC2=C(C=C1)C3=CN=CC=C3C(=N2)NC4=CC=CC(=C4)Cl	Axon Medchem	1965	1.54222358	0	4.16312177	1.03436387	0.31247262	-3.04952569	-27.16442803									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00686698-01	Migalastat			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	75172-81-5				-16.7286625337	4	7		0	-4.09506507					OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O	SIGMA	D9641	-0.9920249	-2.38155633	-5.1386762	-2.26410757	-4.38921823	-5.70913112	-4.09506507									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016055-11	Trimethoprim	124881736	Bacterial dihydrofolate reductase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					-5.3317969407	4	7	trimet;tridoxine;LS-31253;sulfaton;CIPLUS_751110;CN-3123;2,4-PYRIMIDINEDIAMINE, 5-((3,4,5-TRIMETHOXYPHENYL)METHYL)-, MONOHYDROCHLORIDE;kelfiprim;Proloprim;trimethoprim sulfamethizole;2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine;TRIMETHOPRIM LACTATE;syraprim;WHO NO. 1047;co-trimazine;berlocombin;NCGC_Prestw-208;cotrifamol;2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL)PYRIMIDINE SULFATE;Quam;Borgal;potrox;HS_1413;SULFAMETHOXAZOLE;LS-175750;CIPLUS_3886364;Trimethoprim-Sulfamethoxazole Combination;co-trifamole;Trimethoprim Sulfate;Benzenesulfonamide, 4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine;trimithoprime;Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine;BACTRIM;sulfamoxole and trimethoprim;Trimethoprimum;TRIMETHOPRIM HYDROCHLORIDE;Co-soltrim;Tribrissen;CIPLUS_167341;Potesept;CIPLUS_732710;lidaprim;Trimethoprim sulfate;Trimethoprim lactate;CIPLUS_3883816;Supristol;trimerazine;CIPLUS_206865;CIPLUS_206866;CIPLUS_206868;CIPLUS_206867;CIPLUS_206869;benzenesulfonamide, 4-amino-N-2-pyrimidinyl-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine;trimethoprim-sulfadiazine mixture;TRIMETHOPRIM SULFATE;NCGC00024707-08;sulfatroxazole-trimethoprim combination;LS-178642;BW-72U;NCGC00024707-06;NCGC00024707-04;Trimpex;NCGC00024707-05;NCGC00024707-01;cotrifamole;CIPLUS_206870;CIPLUS_156267;CIPLUS_206871;CIPLUS_206872;Trimetoprima;Trimethoprime;Trimethoprim;Co-trimadine;4-amino-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide, mixt. with 5-((3,4,5-trimethoxyphenyl)meth yl)-2,4-pyrimidinediamine;LS-178650;2,4-Pyrimidinediamine, 5-((3,4,5-trimethoxyphenyl)methyl)-;Ditrim;Diaziprim Forte;PHENAZOPYRIDINE HYDROCHLORIDE;LS-1627;trimethoprimum;trimethoprim-sulfadoxine;SEPTRA;CIPLUS_740266;NCGC00016055-02;CN 3123;NCGC00016055-01;sulfadiazine-trimethoprim mixture;TRIMETHOPRIM;Linaris;BISPORIN;LS-2191;CIPLUS_748857;Poteseptyl;Bactrim;Triglobe;AB07944729-01;Ro 6-2153;	0	-3.04672842					COC1=CC(=CC(=C1OC)OC)CC2=C(N)N=C(N)N=C2	SIGMA	T7883	-4.47105899	0.23392802	-1.75826669	-1.2814619	3.72922933	-1.92050282	-3.04672842									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016441-03	(Z)-Capsaicin	124882263		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	25775-90-0		12.4181106199	-4.9059444758	-9.4686654695	4	7	TRPV Cation Channels;CAPSAICIN (E);Zucapsaicin;LS-96940;Cation Channels, TRP;Zostrix;6-nonenamide, 8-methyl-n-vanillyl-, (z)- (8ci);CAPSAICIN (Z)-;TRANS-8-METHYL-N-VANILLYL-6-NONENAMIDE;6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (E)-;Z-Capsaicin;Receptors, Vanilloi;zucapsaicin;CIS-CAPSAICIN;LS-2138;CIPLUS_213626;Capsaicin;CIPLUS_153053;8-Methyl-N-vanillyl-trans-6-nonenamide;Vanilloid Receptors;NCGC_Prestw-879;TRPV1 protein, mouse;capsaicin;AB07930300-01;civamide;Channels, TRPV Catio;NCGC00016441-01;transient receptor potential cation channel V1, mouse;capsaicin receptor, mouse;NCGC00090853-02;CAPSAICIN;Receptors, Capsaici;CAPSAICIN OLEORESIN;CIS-8-METHYL-N-VANILLYL-6-NONENAMIDE;6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (Z)-;N-1107;transient receptor potential cation channel, subfamily V, member 1 protein, mouse;zucapsaicinum;ZUCAPSAICIN;NCGC00024601-01;NCGC00024601-02;vanilloid receptor 1 receptor, mouse;Capsaicin Receptors;NCGC00090853-03;CIVAMIDE;E-CAPSAICIN;NCGC00090853-07;NCGC00090853-08;trans-n-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide;	-21.18779224	-15.5731602	0.0151684331	0.9452791552			COC1=C(O)C=CC(CNC(=O)CCCC\C=C/C(C)C)=C1	Tocris	Tocris-0463	0.27509934	0	1.30452045	3.61452707	-2.06465555	-4.92347087	-15.5731602									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00356067-12	OTX-015			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	202590-98-5		11.0676527398	-4.9559444758	-48.6542695151	-2.2	7		-83.883089616	-64.6841588	0.0000513894	0.9970598257			CC1=NN=C2[C@H](CC(=O)NC3=CC=C(O)C=C3)N=C(C4=C(SC(C)=C4C)N12)C5=CC=C(Cl)C=C5	APExBIO	A3692	0	2.33082495	3.82848392	2.77554304	-4.09134714	-25.67072106	-64.6841588									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00345539-05	Dacinostat		HDAC Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	404951-53-7		6.2237985085	-5.2059444758	-58.2853480085	-2.2	7		-72.0324031298	-61.43193257	0.0001617151	0.9947644636		HDAC1	OCCN(CCC1=C[NH]C2=C1C=CC=C2)CC3=CC=C(\C=C\C(=O)NO)C=C3	Selleck	S1095	0.02500903	4.38262732	1.20242754	2.01700954	-10.51017726	-34.17913054	-61.43193257									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00095191-16	Oseltamivir phosphate			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	204255-11-8				7.0505517743	4	7		0	3.55004914					CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1	APExBIO	B1803	3.10389863	4.12615202	0.27791957	0	0	0	3.55004914									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00159521-16	Zoledronic acid monohydrate	384568184	Farnesyl Pyrophosphate Synthase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	165800-06-6				-8.8065568389	4	7		0	0.84879531				FDPS	OC(C[N]1C=CN=C1)([P](O)(O)=O)[P](O)(O)=O	MedChem Express	HY-13777A	-2.18690083	-0.6003213	-0.44240259	-3.72945638	-3.94533189	-4.64994471	0.84879531									2.13E-10	1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999								
NCGC00522444-01	TAK-220			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	333994-00-6				8.7289302143	4	7		0	-1.17044405					CC(=O)N1CCC(CC1)C(=O)N(CCCN2CCC(CC2)CC3=CC=C(C=C3)C(N)=O)C4=CC=C(C)C(=C4)Cl	MedChem Express	HY-19974	4.12649012	4.91812519	0	1.18377198	0	3.27649421	-1.17044405									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00016509-08	TRIMETHOBENZAMIDE HYDROCHLORIDE		Dopamine D2 receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	554-92-7, 138-56-7 [trimethobenzamide]				8.7252314684	4	7		0	0.15784614					COC1=CC(=CC(=C1OC)OC)C(=O)NCC2=CC=C(OCCN(C)C)C=C2	Microsource	01500594	-1.55333871	1.42329698	0.79405592	4.1144696	3.20357445	4.33568061	0.15784614									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00370683-05	GI254023X			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	260264-93-5				-21.6034666738	4	7		0	-7.38898651					CNC(=O)[C@@H](NC(=O)[C@H](CCCC1=CC=CC=C1)[C@H](C)N(O)C=O)C(C)(C)C	SIGMA	SML0789	-4.62667074	-3.73439306	-4.5317906	-1.96529135	-4.42426189	-6.19798638	-7.38898651									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00356073-10	RVX-208		Brd4 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01					4.8543663682	4	7		0	0.65223218				BRD4	COC1=CC(=C2C(=O)N\C(=N/C2=C1)C3=CC(=C(OCCO)C(=C3)C)C)OC	Bio Vision	9408-5	1.40328452	0.15219413	0	4.94196069	0	0	0.65223218									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390606-01	TNKS-656	363680925	Tachykinin NK2 Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1419949-20-4				-37.7676928151	4	7		0	-13.30970605				TACR2	COC1=CC=C(C=C1)C(=O)C2CCN(CC2)CC(=O)N(CC3CC3)C\C4=N\C5=C(\COCC5)C(=O)N4	MedChem Express	HY-13990	-6.27170923	-8.35094839	-9.46628098	-6.08550741	-9.05586543	-4.95838911	-13.30970605									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00167972-05	Ciclesonide		Glucocorticoid receptor Agonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	126544-47-6		5.5469662594	-5.2559444758	-68.9816232288	-2.2	7		-63.7642429539	-62.74830985	0.0000072616	0.9988981591			CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]3[C@@H]4CC\C5=C\C(=O)\C=C/[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)C6CCCCC6	MedChem Express	HY-B0625	-1.38105427	-0.41994307	-2.88128864	-1.45385588	-5.69167421	-39.58563697	-62.74830985									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00390769-01	HIV-1 integrase inhibitor			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	544467-07-4		12.4181106199	-4.9059444758	-61.2410535589	-2.2	7		-58.3077473196	-48.28602913	0.0004954718	0.990778238			OC(=O)\C(O)=C\C(=O)C1=CC=CC(=C1)CN=[N+]=[N-]	MedChem Express	HY-13025	-4.83230055	-6.45697697	-2.02484261	-4.22365245	-10.68539556	-23.13332945	-48.28602913									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00379165-02	IT1t dihydrochloride			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1092776-63-0				5.3373196594	4	7		0	-6.18578193					CC1(C)CN2C(CS\C(NC3CCCCC3)=N\C4CCCCC4)=CSC2=N1	Glixx	GLXC-01713	1.08650346	3.36236295	2.05887357	3.1030916	3.12180592	-0.39573998	-6.18578193									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00480888-01	STING agonist G10			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	702662-50-8		6.2237985085	-5.2059444758	-53.1303189177	-2.2	7		-65.62244989	-59.83560175	0.0000909423	0.9960824439			FC1=C(CN2C(=O)CSC3=CC=C(C=C23)C(=O)NCC4=CC=CO4)C(=CC=C1)Cl	Glixx	GLXC-07341	-0.64189846	0.88216228	2.8926323	3.5915412	-4.22568116	-33.41092941	-59.83560175									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00091110-02	Glutaraldehyde	124890454		DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	111-30-8				13.1287521689	4	7	Glutaraldehyde	0	0					O=CCCCC=O	SIGMA	NTP-SID_831	1.67560508	4.0895127	2.25171573	3.21802092	4.21984055	2.65960542	0									4.25E-9	2.13E-8	1.06E-7	5.32E-7	0.00000266	0.0000133	0.0000664								
NCGC00263237-09	JZL-184	384568681	Monoacylglycerol lipase (MAGL) Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01			2.7800686746	-5.5559444758	-66.9989294392	-1.2	7		-64.7259284611	-60.49676862	0.0000048272	0.9991019042		MGLL	OC(C1CCN(CC1)C(=O)OC2=CC=C(C=C2)[N+]([O-])=O)(C3=CC4=C(OCO4)C=C3)C5=CC=C6OCOC6=C5	SIGMA	J3455	3.53183094	2.52811364	2.21201293	2.03424894	-14.01454312	-46.42379096	-60.49676862									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00165862-04	Pamidronate Disodium		Farnesyl diphosphate synthase Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	57248-88-1				-14.9379996094	4	7		0	-2.78464425					NCCC(O)([P](O)([O-])=O)[P](O)([O-])=O	APExBIO	A2456	-5.88823742	-3.49764663	-2.84725767	-0.37926675	-2.87650031	-3.96903917	-2.78464425									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378668-01	PD 144418 oxalate	363678143	Sigma opioid receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[154130-99-1]		15.6334750258	-4.8059444758	-14.147840193	-2.4	7		-34.8542901399	-26.96190845	0.0005031325	0.9907145201			CCCN1CC\C=C(/C1)C2=CC(=NO2)C3=CC=C(C)C=C3	Tocris	2606	0.56965015	2.74231279	0	2.06298127	-0.2365447	-5.02240587	-26.96190845									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378687-03	Verbascoside			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	61276-17-3		6.2237985085	-5.2059444758	-60.6837865335	-2.2	7		-78.9264377417	-66.60213837	0.000022854	0.9980424084			C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCC3=CC(=C(O)C=C3)O)O[C@H](CO)[C@H]2OC(=O)\C=C\C4=CC(=C(O)C=C4)O)[C@H](O)[C@H](O)[C@H]1O	MedChem Express	HY-N0021	1.13096396	4.45026916	3.06278714	1.08608206	-9.27196799	-37.01914683	-66.60213837									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00015099-12	Alprenolol hydrochloride		Beta-adrenergic receptor Antagonist	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	[13707-88-5]				-9.1453887164	4	7		0	-2.8918605					CC(C)NCC(O)COC1=C(CC=C)C=CC=C1	Tocris	2806	-5.33248117	-1.73332206	1.55975271	-3.01689461	0.03796396	-2.58976896	-2.8918605									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00024415-61	Doxorubicin		DNA Topoisomerase II Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	23214-92-8		11.0676527398	-4.9559444758	-48.1572103483	-2.2	7		-73.27305894	-54.3735295	0.0000160322	0.9983615191		TOP2A	COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(=C3C2=O)O	Microsource	01505483	1.93681051	1.42329698	1.1740684	-1.43087001	-6.41590982	-24.51841937	-54.3735295									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00346629-09	GSK1349572		HIV Integrase Inhibitors	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	1051375-16-6		11.0676527398	-4.9559444758	-27.6080066427	4	7		-24.584343452	-20.07028621	0.016541025	0.9425777469			C[C@@H]1CCO[C@H]2CN\3/C=C(/C(=O)NCC4=C(F)C=C(F)C=C4)C(=O)\C(=C3C(=O)N12)O	DC Chemicals	DC7273	-1.59779921	0.69051041	-2.22335659	-5.57981841	-5.63326811	-10.06809055	-20.07028621									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00378593-08	Alvelestat (AZD9668£©			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	848141-11-7		0.0240086112	-7.6196329617	1.6986993945	4	7		9.3959161239	1.2776603	0.2119477775	0.7198698942			CN1N=CC=C1C2=C(C)N(C(=O)C(=C2)C(=O)NCC3=NC=C(C=C3)[S+](C)([O-])=O)C4=CC=CC(=C4)C(F)(F)F	Selleck	S7218	-1.67560508	-10.74659677	0	4.6201586	3.51312677	4.44625502	1.2776603									1.0599999999E-9	5.32E-9	2.6599999999E-8	1.33E-7	6.64E-7	0.0000033199999999	0.0000166								
NCGC00378650-01	Narlaprevir			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	865466-24-6		17.5410474839	-4.7559444758	-16.15610478	4	7		-21.7963784679	-17.33031539	0.0096200304	0.9572483792			CCCC[C@H](NC(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)NC3(CCCCC3)C[S+]([O-])(=O)C(C)(C)C)C(C)(C)C)C2(C)C)C(=O)C(=O)NC4CC4	MedChem Express	HY-10300	-2.15355545	-0.52140582	1.4576598	-2.36179749	-1.95952457	-4.57428854	-17.33031539									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00371134-02	PR-619		Ubiquitin carboxyl-terminal hydrolase isozyme L3 Inhibitor	DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	2645-32-1		8.7913490634	-5.0559444758	-17.4810061758	-2.2	7		-38.0592220919	-32.96601841	0.0006179769	0.9896856185	7347	UCHL3	NC1=NC(=C(SC#N)C=C1SC#N)N	Selleck	S7130	3.68188513	3.86403991	0	1.40788415	2.45013579	-11.42990165	-32.96601841									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								
NCGC00163413-03	Lycorine HCl			DPI_SARS-CoV-2_General	2020_Anti-Infectives_01	2188-68-3		24.777388143	-4.6059444758	8.5499885899	4	7		-11.365756324	-6.13813027	0.2065923949	0.7266201521			O[C@H]1\C=C/2CCN3CC4=CC5=C(OCO5)C=C4[C@H]([C@@H]1O)[C@@H]23	Prestwick	Prestw-NAT-0046	0	3.04106423	4.99688049	4.61441214	0	4.20764709	-6.13813027									2.13E-9	1.0599999999E-8	5.3199999999E-8	2.66E-7	0.00000133	0.0000066399999999	0.0000332								